,pubmed_id,title,abstract,keywords,journal,publication_date,authors,methods,conclusions,results,copyrights,doi,xml
0,"38250049
34614409
29424317
9737646
3075276
7575771
32737252
31144547
20704527
31389309
31727409
33808030
28614708
28153798
30404008
31495690
19144836
22201683
30140371
36915539
34407830
36223777
34841227
32188837
17587760
28683288
15382020
18279013
25497089
24107256
18832722
28949382
25874616
17965192
33472023
9729044
23356264
24657242
16596808
10776745
31549442
31577260
27616557
34430820
24560969
27932556
30563192
33024813
32449761
29705240
9687370
33208407
32504036
31927141
32795415
30500539
31056798
31959954
31086327
36328744",Palmitoylation of PKCδ by ZDHHC5 in hypothalamic microglia presents as a therapeutic target for fatty liver disease.,"The hypothalamus plays a fundamental role in controlling lipid metabolism through neuroendocrine signals. However, there are currently no available drug targets in the hypothalamus that can effectively improve human lipid metabolism. In this study, we found that the antimalarial drug artemether (ART) significantly improved lipid metabolism by specifically inhibiting microglial activation in the hypothalamus of high-fat diet-induced mice. Mechanically, ART protects the thyrotropin-releasing hormone (TRH) neurons surrounding microglial cells from inflammatory damage and promotes the release of TRH into the peripheral circulation. As a result, TRH stimulates the synthesis of thyroid hormone (TH), leading to a significant improvement in hepatic lipid disorders. Subsequently, we employed a biotin-labeled ART chemical probe to identify the direct cellular target in microglial cells as protein kinase Cδ (PKCδ). Importantly, ART directly targeted PKCδ to inhibit its palmitoylation modification by blocking the binding of zinc finger DHHC-type palmitoyltransferase 5 (ZDHHC5), which resulted in the inhibition of downstream neuroinflammation signaling. In vivo, hypothalamic microglia-specific PKCδ knockdown markedly impaired ART-dependent neuroendocrine regulation and lipid metabolism improvement in mice. Furthermore, single-cell transcriptomics analysis in human brain tissues revealed that the level of PKCδ in microglia positively correlated with individuals who had hyperlipemia, thereby highlighting a clinical translational value. Collectively, these data suggest that the palmitoylation of microglial PKCδ in the hypothalamus plays a role in modulating peripheral lipid metabolism through hypothalamus-liver communication, and provides a promising therapeutic target for fatty liver diseases.","['artemether', 'hepatic lipid metabolism', 'hypothalamic microglia', 'palmitoylation modification', 'protein kinase Cδ (PKCδ)']",Theranostics,2024-01-22,"[{'lastname': 'Wang', 'firstname': 'Yan-Hang', 'initials': 'YH', 'affiliation': 'State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.'}, {'lastname': 'Chen', 'firstname': 'Xin', 'initials': 'X', 'affiliation': 'Department of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.'}, {'lastname': 'Bai', 'firstname': 'Yi-Zhen', 'initials': 'YZ', 'affiliation': 'State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.'}, {'lastname': 'Gao', 'firstname': 'Peng', 'initials': 'P', 'affiliation': 'State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.'}, {'lastname': 'Yang', 'firstname': 'Zhuo', 'initials': 'Z', 'affiliation': 'State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.'}, {'lastname': 'Guo', 'firstname': 'Qiang', 'initials': 'Q', 'affiliation': 'State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.'}, {'lastname': 'Lu', 'firstname': 'Ying-Yuan', 'initials': 'YY', 'affiliation': 'State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.'}, {'lastname': 'Zheng', 'firstname': 'Jiao', 'initials': 'J', 'affiliation': 'School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China.'}, {'lastname': 'Liu', 'firstname': 'Dan', 'initials': 'D', 'affiliation': 'Proteomics Laboratory, Medical and Healthy Analytical Center, Peking University Health Science Center, Beijing 100191, China.'}, {'lastname': 'Yang', 'firstname': 'Jun', 'initials': 'J', 'affiliation': 'Department of Neurosurgery, Peking University Third Hospital, Beijing 100191, China.'}, {'lastname': 'Tu', 'firstname': 'Peng-Fei', 'initials': 'PF', 'affiliation': 'State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.'}, {'lastname': 'Zeng', 'firstname': 'Ke-Wu', 'initials': 'KW', 'affiliation': 'State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.'}]",,,,© The author(s).,10.7150/thno.89602,<Element 'PubmedArticle' at 0x7f05dcd0cc70>
1,38181530,"Neuroprotective potentials of Lead phytochemicals against Alzheimer's disease with focus on oxidative stress-mediated signaling pathways: Pharmacokinetic challenges, target specificity, clinical trials and future perspectives.","Alzheimer's diseases (AD) and dementia are among the highly prevalent neurological disorders characterized by deposition of beta amyloid (Aβ) plaques, dense deposits of highly phosphorylated tau proteins, insufficiency of acetylcholine (ACh) and imbalance in glutamatergic system. Patients typically experience cognitive, behavioral alterations and are unable to perform their routine activities. Evidence also suggests that inflammatory processes including excessive microglia activation, high expression of inflammatory cytokines and release of free radicals. Thus, targeting inflammatory pathways beside other targets might be the key factors to control- disease symptoms and progression.
This review is aimed to highlight the mechanisms and pathways involved in the neuroprotective potentials of lead phytochemicals. Further to provide updates regarding challenges associated with their use and their progress into clinical trials as potential lead compounds.
Most recent scientific literature on pre-clinical and clinical data published in quality journals especially on the lead phytochemicals including curcumin, catechins, quercetin, resveratrol, genistein and apigenin was collected using SciFinder, PubMed, Google Scholar, Web of Science, JSTOR, EBSCO, Scopus and other related web sources.
Literature review indicated that the drug discovery against AD is insufficient and only few drugs are clinically approved which have limited efficacy. Among the therapeutic options, natural products have got tremendous attraction owing to their molecular diversity, their safety and efficacy. Research suggest that natural products can delay the disease onset, reduce its progression and regenerate the damage via their anti-amyloid, anti-inflammatory and antioxidant potentials. These agents regulate the pathways involved in the release of neurotrophins which are implicated in neuronal survival and function. Highly potential lead phytochemicals including curcumin, catechins, quercetin, resveratrol, genistein and apigenin regulate neuroprotective signaling pathways implicated in neurotrophins-mediated activation of tropomyosin receptor kinase (Trk) and p75 neurotrophins receptor (p75NTR) family receptors.
Phytochemicals especially phenolic compounds were identified as highly potential molecules which ameliorate oxidative stress induced neurodegeneration, reduce Aβ load and inhibit vital enzymes. Yet their clinical efficacy and bioavailability are the major challenges which need further interventions for more effective therapeutic outcomes.","['Clinical trials', 'Neuro-degenerative disorders', 'Neurotrophins', 'Phytochemicals', 'Pro-inflammatory cytokines', 'Signaling pathways']",Phytomedicine : international journal of phytotherapy and phytopharmacology,2024-01-06,"[{'lastname': 'Ayaz', 'firstname': 'Muhammad', 'initials': 'M', 'affiliation': 'Department of Pharmacy, Faculty of Biological Sciences, University of Malakand, Chakdara, 18000 Dir (L), KP, Pakistan. Electronic address: ayazuop@gmail.com.'}, {'lastname': 'Mosa', 'firstname': 'Osama F', 'initials': 'OF', 'affiliation': 'Public health Department, Health Sciences College at Lieth, Umm Al Qura University, Makkah, KSA.'}, {'lastname': 'Nawaz', 'firstname': 'Asif', 'initials': 'A', 'affiliation': 'Department of Pharmacy, Faculty of Biological Sciences, University of Malakand, Chakdara, 18000 Dir (L), KP, Pakistan.'}, {'lastname': 'Hamdoon', 'firstname': 'Alashary Adam Eisa', 'initials': 'AAE', 'affiliation': 'Public health Department, Health Sciences College at Lieth, Umm Al Qura University, Makkah, KSA; University of Khartoum, Faculty of Public and Environmental Health, Sudan.'}, {'lastname': 'Elkhalifa', 'firstname': 'Modawy Elnour Modawy', 'initials': 'MEM', 'affiliation': 'Public health Department, Health Sciences College at Lieth, Umm Al Qura University, Makkah, KSA; University of Khartoum, Faculty of Public and Environmental Health, Sudan.'}, {'lastname': 'Sadiq', 'firstname': 'Abdul', 'initials': 'A', 'affiliation': 'Department of Pharmacy, Faculty of Biological Sciences, University of Malakand, Chakdara, 18000 Dir (L), KP, Pakistan.'}, {'lastname': 'Ullah', 'firstname': 'Farhat', 'initials': 'F', 'affiliation': 'Department of Pharmacy, Faculty of Biological Sciences, University of Malakand, Chakdara, 18000 Dir (L), KP, Pakistan.'}, {'lastname': 'Ahmed', 'firstname': 'Alshebli', 'initials': 'A', 'affiliation': 'Public health Department, Health Sciences College at Lieth, Umm Al Qura University, Makkah, KSA; University of Khartoum, Faculty of Public and Environmental Health, Sudan.'}, {'lastname': 'Kabra', 'firstname': 'Atul', 'initials': 'A', 'affiliation': 'University Institute of Pharma Sciences, Chandigarh University, Gharuan, Mohali, Punjab, India.'}, {'lastname': 'Khan', 'firstname': 'Haroon', 'initials': 'H', 'affiliation': 'Department of Pharmacy, Abdul Wali Khan University Mardan, Pakistan.'}, {'lastname': 'Murthy', 'firstname': 'H C Ananda', 'initials': 'HCA', 'affiliation': 'Department of Applied Chemistry, School of Applied Natural Science, Adama Science and Technology University, P O Box 1888, Adama, Ethiopia; Department of Prosthodontics, Saveetha Dental College & Hospital, Saveetha Institute of Medical and technical science (SIMATS), Saveetha University, Chennai-600077, Tamil Nadu, India.'}]",,,"Literature review indicated that the drug discovery against AD is insufficient and only few drugs are clinically approved which have limited efficacy. Among the therapeutic options, natural products have got tremendous attraction owing to their molecular diversity, their safety and efficacy. Research suggest that natural products can delay the disease onset, reduce its progression and regenerate the damage via their anti-amyloid, anti-inflammatory and antioxidant potentials. These agents regulate the pathways involved in the release of neurotrophins which are implicated in neuronal survival and function. Highly potential lead phytochemicals including curcumin, catechins, quercetin, resveratrol, genistein and apigenin regulate neuroprotective signaling pathways implicated in neurotrophins-mediated activation of tropomyosin receptor kinase (Trk) and p75 neurotrophins receptor (p75NTR) family receptors.",Copyright © 2023 Elsevier GmbH. All rights reserved.,10.1016/j.phymed.2023.155272,<Element 'PubmedArticle' at 0x7f05dcf64cc0>
2,38147832,Dapagliflozin ameliorates ovulation disorders via attenuating activated microglia-mediated hypothalamic inflammation in HFD-fed mice.,"Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have shown neuroprotective effects in obese mice. However, whether SGLT2i can ameliorate high-fat diet (HFD)-related ovulation disorders remains unknown. The aim of this research was to investigate whether dapagliflozin improves HFD-induced ovulatory dysfunction by attenuating microglia-mediated hypothalamic inflammation.
C57BL/6J female mice fed HFD were treated with dapagliflozin (1mg/kg) for 22 weeks. Plasma insulin, leptin, luteinizing hormone (LH), estradiol (E2), and IL-1β levels were also tested. Microglial morphology, cell numbers and SGLT2 expression were evaluated using immunofluorescence. The expression of IL-1, NLRP3, Kisspeptin, GnRH, SGLT2, insulin, and leptin receptors in the hypothalamus was determined using immunohistochemical staining. We also examined the effects of dapagliflozin on glucose metabolism and the release of inflammatory factor in palmitic acid (PA)-treated HMC3 cells.
As expected, dapagliflozin improved HFD-induced metabolic disturbances, peripheral versus central insulin and leptin resistance, and also restored the regular estrous cycle. Furthermore, dapagliflozin blunted microglia activation, NLRP3 inflammasome priming, hypothalamic inflammation, and increased the expression of gonadotropin-releasing hormone (GnRH) and Kisspeptin at proestrus in the hypothalamus. Additionally, dapagliflozin markedly reduced IL-6 and NO release and fat accumulation, decreased lactic acid production and glucose consumption, and inhibited mammalian target of rapamycin (mTOR) and hexokinase 2 (HK2) expression in PA-treated HMC3 cells. These effects suggest that dapagliflozin reduced the mTOR/HK2-mediated aerobic glycolysis.
Dapagliflozin improved HFD-related ovulation disorders by regulating glucose metabolism through mTOR/HK2 signaling and attenuating microglia-mediated hypothalamic inflammation. These results validate the novel role for the neuroprotection of SGLT2i in HFD-induced obesity and ovulation disorders.",[],Neuroendocrinology,2023-12-27,"[{'lastname': 'Chen', 'firstname': 'Xiaolin', 'initials': 'X', 'affiliation': None}, {'lastname': 'Xiao', 'firstname': 'Zhuoni', 'initials': 'Z', 'affiliation': None}, {'lastname': 'Liu', 'firstname': 'Qing', 'initials': 'Q', 'affiliation': None}, {'lastname': 'Luo', 'firstname': 'Deng', 'initials': 'D', 'affiliation': None}, {'lastname': 'Cai', 'firstname': 'Yuli', 'initials': 'Y', 'affiliation': None}, {'lastname': 'Fan', 'firstname': 'Mingxia', 'initials': 'M', 'affiliation': None}]",,,"As expected, dapagliflozin improved HFD-induced metabolic disturbances, peripheral versus central insulin and leptin resistance, and also restored the regular estrous cycle. Furthermore, dapagliflozin blunted microglia activation, NLRP3 inflammasome priming, hypothalamic inflammation, and increased the expression of gonadotropin-releasing hormone (GnRH) and Kisspeptin at proestrus in the hypothalamus. Additionally, dapagliflozin markedly reduced IL-6 and NO release and fat accumulation, decreased lactic acid production and glucose consumption, and inhibited mammalian target of rapamycin (mTOR) and hexokinase 2 (HK2) expression in PA-treated HMC3 cells. These effects suggest that dapagliflozin reduced the mTOR/HK2-mediated aerobic glycolysis.","S. Karger AG, Basel.",10.1159/000535420,<Element 'PubmedArticle' at 0x7f05dd1775e0>
3,38145743,[Oxytocin as a neuroprotective strategy in neonates: concept and preclinical evidence].,"Prematurity and intra-uterine growth retardation are responsible for brain damage associated with various neurocognitive and behavioral disorders in more than 9 million children each year. Most pharmacological strategies aimed at preventing perinatal brain injury have not demonstrated substantial clinical benefits so far. In contrast, enrichment of the newborn's environment appears to have positive effects on brain structure and function, influences newborn hormonal responses, and has lasting neurobehavioral consequences during infancy and adulthood. Oxytocin (OT), a neuropeptide released by the hypothalamus, may represent the hormonal basis for these long-term effects.
This review of the literature summarizes the knowledge concerning the effect of OT in the newborn and the preclinical data supporting its neuroprotective effect.
OT plays a role during the perinatal period, in parent-child attachment and in social behavior. Furthermore, preclinical studies strongly suggest that endogenous and synthetic OT is capable of regulating the inflammatory response of the central nervous system in response to situations of prematurity or more generally insults to the developing brain. The long-term effect of synthetic OT administration during labor is also discussed.
All the conceptual and experimental data converge to indicate that OT would be a promising candidate for neonatal neuroprotection, in particular through the regulation of neuroinflammation.","['Lésions cérébrales', 'Microglia', 'Microglie', 'Neuroprotection', 'Nouveau-né prématuré', 'Oxytocin', 'Oxytocine', 'Preterm infants']","Gynecologie, obstetrique, fertilite & senologie",2023-12-26,"[{'lastname': 'Baud', 'firstname': 'Olivier', 'initials': 'O', 'affiliation': 'Laboratoire du développement, Université de Genève, Genève, Suisse; Inserm U1141, Université Paris Cité, Paris, France; Service de Soins Intensifs Pédiatriques et Néonatologie, Hôpitaux Universitaires de Genève, Genève, Suisse. Electronic address: Olivier.baud@hcuge.ch.'}, {'lastname': 'Knoop', 'firstname': 'Marit', 'initials': 'M', 'affiliation': 'Laboratoire du développement, Université de Genève, Genève, Suisse.'}]",This review of the literature summarizes the knowledge concerning the effect of OT in the newborn and the preclinical data supporting its neuroprotective effect.,"All the conceptual and experimental data converge to indicate that OT would be a promising candidate for neonatal neuroprotection, in particular through the regulation of neuroinflammation.","OT plays a role during the perinatal period, in parent-child attachment and in social behavior. Furthermore, preclinical studies strongly suggest that endogenous and synthetic OT is capable of regulating the inflammatory response of the central nervous system in response to situations of prematurity or more generally insults to the developing brain. The long-term effect of synthetic OT administration during labor is also discussed.",Copyright © 2023 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.,10.1016/j.gofs.2023.12.005,<Element 'PubmedArticle' at 0x7f05dd1d9130>
4,38056710,Hippocampal estrogens rescued the decline of synaptic plasticity after surgery and anesthesia by inhibiting microglia overactivation.,"Elderly patients experience postoperative cognitive impairment frequently; therefore, effective interventions are urgently needed. Central nervous inflammation characterized by microglia may promote the progression of POCD by reducing synaptic plasticity. Notably, clinical studies revealed that the incidence of female patients was significantly lower than that of male patients. Besides, the brain estrogens have an anti-inflammatory effect and regulate the microglia at the same times. This study aimed to determine whether suppressing microglia overactivation by hippocampal estrogens can rescue the decrease of synaptic plasticity after surgery and anesthesia.
Exploratory laparotomy was used to establish the POCD model in 15-month-old male or female C57BL/6 J mice and animal behavioral tests were performed to test hippocampal-dependent memory capacity. Western blot and immunofluorescence were used to detect the microglial activation and plasticity related protein expressions. Elisa was used to detect the content of estrogens in the hippocampus. Estrogens and estrogen receptor inhibitor were used to replenish the estrogens in the brain and inhibit the effect of estrogens.
Surgery and anesthesia did not cause POCD in female mice (P > 0.05), while the cognitive function decreased significantly after estrogen receptor inhibitor was given(P < 0.05). Male mice experienced cognitive dysfunction after surgery and anesthesia, and their cognitive function improved after estrogens supplementation (P < 0.05). Given estrogens and estrogen receptor inhibitors at the same time, the cognitive function of male mice could not be saved (P < 0.05). By correlation analysis, there was a negative correlation between the content of hippocampal estrogens and microglia (P < 0.05). The number or degree of activation of microglia affected the synaptic plasticity, which ultimately regulated the cognitive function of mice.
Hippocampal estrogens rescued the decline of synaptic plasticity after surgery and anesthesia by inhibiting microglia overactivation.","['Estrogens', 'Microglia', 'Postoperative cognitive dysfunction', 'Synaptic plasticity']",Behavioural brain research,2023-12-07,"[{'lastname': 'Tan', 'firstname': 'Xiao-Xiang', 'initials': 'XX', 'affiliation': 'Department of Anesthesiology, Surgery and Pain Management, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu Province, China.'}, {'lastname': 'Dai', 'firstname': 'Hong-Yu', 'initials': 'HY', 'affiliation': 'Department of Anesthesiology, Surgery and Pain Management, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu Province, China.'}, {'lastname': 'Yao', 'firstname': 'Juan', 'initials': 'J', 'affiliation': 'Department of Anesthesiology, Surgery and Pain Management, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu Province, China.'}, {'lastname': 'Wang', 'firstname': 'Jia-Jia', 'initials': 'JJ', 'affiliation': 'Department of Anesthesiology, Surgery and Pain Management, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu Province, China.'}, {'lastname': 'Dai', 'firstname': 'Yu-Chen', 'initials': 'YC', 'affiliation': 'Department of Anesthesiology, Surgery and Pain Management, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu Province, China.'}, {'lastname': 'Zhang', 'firstname': 'Tian-Hao', 'initials': 'TH', 'affiliation': 'Department of Anesthesiology, Surgery and Pain Management, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu Province, China.'}, {'lastname': 'Qiu', 'firstname': 'Li-Li', 'initials': 'LL', 'affiliation': 'Department of Anesthesiology, Surgery and Pain Management, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu Province, China. Electronic address: qiulili915@163.com.'}, {'lastname': 'Sun', 'firstname': 'Jie', 'initials': 'J', 'affiliation': 'Department of Anesthesiology, Surgery and Pain Management, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu Province, China. Electronic address: dgsunjie@hotmail.com.'}]",,Hippocampal estrogens rescued the decline of synaptic plasticity after surgery and anesthesia by inhibiting microglia overactivation.,"Surgery and anesthesia did not cause POCD in female mice (P > 0.05), while the cognitive function decreased significantly after estrogen receptor inhibitor was given(P < 0.05). Male mice experienced cognitive dysfunction after surgery and anesthesia, and their cognitive function improved after estrogens supplementation (P < 0.05). Given estrogens and estrogen receptor inhibitors at the same time, the cognitive function of male mice could not be saved (P < 0.05). By correlation analysis, there was a negative correlation between the content of hippocampal estrogens and microglia (P < 0.05). The number or degree of activation of microglia affected the synaptic plasticity, which ultimately regulated the cognitive function of mice.",Copyright © 2023 Elsevier B.V. All rights reserved.,10.1016/j.bbr.2023.114794,<Element 'PubmedArticle' at 0x7f05dd1bbc70>
5,"38023622
23622250
24899047
23334579
28549481
24162737
36524682
20484116
28480512
8805703
30572908
34275100
8643691
22876243
28792888
22728242
9244303
20810657
33631273
23508172
24302498
28820267
23340136
7153458
20201823
27942529
12882960
36971657
20052709
17264160
20200281
22033675
32049315
33672717
31780579
19694723
20558154
19531013
23434638
30103190
30418016
32208767
35755818
29930256
28955790
34267198
26862211
11781306
34750195
28431241",SHIP1 therapeutic target enablement: Identification and evaluation of inhibitors for the treatment of late-onset Alzheimer's disease.,"The risk of developing Alzheimer's disease is associated with genes involved in microglial function. Inositol polyphosphate-5-phosphatase (
We identified inhibitors and screened the enzymatic domain of SHIP1. A protein construct containing two domains was used to evaluate enzyme inhibitor potency and selectivity versus SHIP2. Inhibitors were tested against a construct containing all ordered domains of the human and mouse proteins. A cellular thermal shift assay (CETSA) provided evidence of target engagement in cells. Phospho-AKT levels provided further evidence of on-target pharmacology. A high-content imaging assay was used to study the pharmacology of SHIP1 inhibition while monitoring cell health. Physicochemical and absorption, distribution, metabolism, and excretion (ADME) properties were evaluated to select a compound suitable for in vivo studies.
SHIP1 inhibitors displayed a remarkable array of activities and cellular pharmacology. Inhibitory potency was dependent on the protein construct used to assess enzymatic activity. Some inhibitors failed to engage the target in cells. Inhibitors that were active in the CETSA consistently destabilized the protein and reduced pAKT levels. Many SHIP1 inhibitors were cytotoxic either at high concentration due to cell stress or they potently induced cell death depending on the compound and cell type. One compound activated microglia, inducing phagocytosis at concentrations that did not result in significant cell death. A pharmacokinetic study demonstrated brain exposures in mice upon oral administration.
3-((2,4-Dichlorobenzyl)oxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl) pyridine activated primary mouse microglia and demonstrated exposures in mouse brain upon oral dosing. Although this compound is our recommended chemical probe for investigating the pharmacology of SHIP1 inhibition at this time, further optimization is required for clinical studies.
Cellular thermal shift assay (CETSA) and signaling (pAKT) assays were developed to provide evidence of src homology 2 (SH2) domain-contaning inositol phosphatase 1 (SHIP1) target engagement and on-target activity in cellular assays.A phenotypic high-content imaging assay with simultaneous measures of phagocytosis, cell number, and nuclear intensity was developed to explore cellular pharmacology and monitor cell health.SHIP1 inhibitors demonstrate a wide range of activity and cellular pharmacology, and many reported inhibitors are cytotoxic.The chemical probe 3-((2,4-dichlorobenzyl)oxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl) pyridine is recommended to explore SHIP1 pharmacology.","['INPP5D', 'SHIP1', 'SHIP1 inhibitors', 'cellular thermal shift assay (CETSA)', 'pharmacokinetics', 'phenotypic high‐content imaging assay']","Alzheimer's & dementia (New York, N. Y.)",2023-11-29,"[{'lastname': 'Jesudason', 'firstname': 'Cynthia D', 'initials': 'CD', 'affiliation': 'Lgenia Fortville Indiana USA.'}, {'lastname': 'Mason', 'firstname': 'Emily R', 'initials': 'ER', 'affiliation': 'Indiana University School of Medicine Indianapolis Indiana USA.'}, {'lastname': 'Chu', 'firstname': 'Shaoyou', 'initials': 'S', 'affiliation': 'Indiana University School of Medicine Indianapolis Indiana USA.'}, {'lastname': 'Oblak', 'firstname': 'Adrian L', 'initials': 'AL', 'affiliation': 'Indiana University School of Medicine Indianapolis Indiana USA.\nStark Neurosciences Research Institute Indiana University School of Medicine Indianapolis Indiana USA.'}, {'lastname': 'Javens-Wolfe', 'firstname': 'June', 'initials': 'J', 'affiliation': 'Indiana Biosciences Research Institute Indianapolis Indiana USA.'}, {'lastname': 'Moussaif', 'firstname': 'Mustapha', 'initials': 'M', 'affiliation': 'Indiana Biosciences Research Institute Indianapolis Indiana USA.'}, {'lastname': 'Durst', 'firstname': 'Greg', 'initials': 'G', 'affiliation': 'Lgenia Fortville Indiana USA.'}, {'lastname': 'Hipskind', 'firstname': 'Philip', 'initials': 'P', 'affiliation': 'Lgenia Fortville Indiana USA.'}, {'lastname': 'Beck', 'firstname': 'Daniel E', 'initials': 'DE', 'affiliation': 'Institute for Drug Discovery Purdue University West Lafayette Indiana USA.'}, {'lastname': 'Dong', 'firstname': 'Jiajun', 'initials': 'J', 'affiliation': 'Department of Medicinal Chemistry and Molecular Pharmacology Purdue University West Lafayette Indiana USA.'}, {'lastname': 'Amarasinghe', 'firstname': 'Ovini', 'initials': 'O', 'affiliation': 'Department of Medicinal Chemistry and Molecular Pharmacology Purdue University West Lafayette Indiana USA.'}, {'lastname': 'Zhang', 'firstname': 'Zhong-Yin', 'initials': 'ZY', 'affiliation': 'Institute for Drug Discovery Purdue University West Lafayette Indiana USA.\nDepartment of Medicinal Chemistry and Molecular Pharmacology Purdue University West Lafayette Indiana USA.'}, {'lastname': 'Hamdani', 'firstname': 'Adam K', 'initials': 'AK', 'affiliation': 'Department of Biochemistry Purdue University West Lafayette Indiana USA.'}, {'lastname': 'Singhal', 'firstname': 'Kratika', 'initials': 'K', 'affiliation': 'Department of Biochemistry Purdue University West Lafayette Indiana USA.'}, {'lastname': 'Mesecar', 'firstname': 'Andrew D', 'initials': 'AD', 'affiliation': 'Department of Biochemistry Purdue University West Lafayette Indiana USA.'}, {'lastname': 'Souza', 'firstname': 'Sarah', 'initials': 'S', 'affiliation': 'Evotec Princeton New Jersey USA.'}, {'lastname': 'Jacobson', 'firstname': 'Marlene', 'initials': 'M', 'affiliation': 'Evotec Princeton New Jersey USA.'}, {'lastname': 'Salvo', 'firstname': 'Jerry Di', 'initials': 'JD', 'affiliation': 'Evotec Princeton New Jersey USA.'}, {'lastname': 'Soni', 'firstname': 'Disha M', 'initials': 'DM', 'affiliation': 'Indiana University School of Medicine Indianapolis Indiana USA.'}, {'lastname': 'Kandasamy', 'firstname': 'Murugesh', 'initials': 'M', 'affiliation': 'Indiana University School of Medicine Indianapolis Indiana USA.'}, {'lastname': 'Masters', 'firstname': 'Andrea R', 'initials': 'AR', 'affiliation': 'Indiana University School of Medicine Indianapolis Indiana USA.'}, {'lastname': 'Quinney', 'firstname': 'Sara K', 'initials': 'SK', 'affiliation': 'Indiana University School of Medicine Indianapolis Indiana USA.'}, {'lastname': 'Doolen', 'firstname': 'Suzanne', 'initials': 'S', 'affiliation': 'University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA.'}, {'lastname': 'Huhe', 'firstname': 'Hasi', 'initials': 'H', 'affiliation': 'University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA.'}, {'lastname': 'Rizzo', 'firstname': 'Stacey J Sukoff', 'initials': 'SJS', 'affiliation': 'University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA.'}, {'lastname': 'Lamb', 'firstname': 'Bruce T', 'initials': 'BT', 'affiliation': 'Indiana University School of Medicine Indianapolis Indiana USA.\nStark Neurosciences Research Institute Indiana University School of Medicine Indianapolis Indiana USA.'}, {'lastname': 'Palkowitz', 'firstname': 'Alan D', 'initials': 'AD', 'affiliation': 'Indiana University School of Medicine Indianapolis Indiana USA.\nIndiana Biosciences Research Institute Indianapolis Indiana USA.'}, {'lastname': 'Richardson', 'firstname': 'Timothy I', 'initials': 'TI', 'affiliation': 'Indiana University School of Medicine Indianapolis Indiana USA.\nStark Neurosciences Research Institute Indiana University School of Medicine Indianapolis Indiana USA.\nIndiana Biosciences Research Institute Indianapolis Indiana USA.'}]",,,"SHIP1 inhibitors displayed a remarkable array of activities and cellular pharmacology. Inhibitory potency was dependent on the protein construct used to assess enzymatic activity. Some inhibitors failed to engage the target in cells. Inhibitors that were active in the CETSA consistently destabilized the protein and reduced pAKT levels. Many SHIP1 inhibitors were cytotoxic either at high concentration due to cell stress or they potently induced cell death depending on the compound and cell type. One compound activated microglia, inducing phagocytosis at concentrations that did not result in significant cell death. A pharmacokinetic study demonstrated brain exposures in mice upon oral administration.",© 2023 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer's Association.,"10.1002/trc2.12429
10.1016/j.cell.2013.03.030
10.1093/hmg/ddu277
10.1038/nn.3318
10.1186/s13024-017-0184-x
10.5281/zenodo.7231788
10.1038/ng.2802
10.1002/alz.12849
10.1126/scisignal.2000500
10.1002/eji.201646795
10.1038/383263a0
10.1186/s13024-018-0298-9
10.1007/s12035-021-02477-9
10.1073/pnas.93.4.1689
10.3389/fimmu.2012.00226
10.7554/eLife.26640
10.1016/j.febslet.2012.06.006
10.1016/s0092-8674(00)80337-2
10.1074/jbc.M110.128827
10.1016/j.nbd.2021.105303
10.1038/nchembio.1197
10.5281/zenodo.6208450
10.5281/zenodo.4429248
10.1002/med.21305
10.1021/acs.jmedchem.7b00762
10.1016/j.exphem.2013.01.005
10.1016/0165-022x(82)90031-8
10.2174/138620710790218203
10.21037/atm.2016.08.53
10.1074/jbc.M305021200
10.1002/cpz1.724
10.2210/pdb5RWL/pdb
10.1002/cbic.200900545
10.1096/fj.06-7691com
10.4049/jimmunol.0902844
10.2119/molmed.2011.00178
10.1042/BST20190775
10.3390/cancers13040890
10.1242/jcs.238030
10.1111/j.1476-5381.2009.00358.x
10.2174/138620709789104870
10.1016/j.ejmech.2013.01.014
10.1016/j.ejmech.2018.07.071
10.1021/acs.biochem.8b01057
10.1146/annurev-biochem-011420-092302
10.3389/fmolb.2022.866764
10.1038/s41598-018-27834-y
10.1016/j.bbrep.2017.08.002
10.1038/s41467-021-24639-y
10.1042/BST20150214
10.1074/jbc.M106755200
10.1124/dmd.121.000552
10.1016/j.cell.2017.04.001",<Element 'PubmedArticle' at 0x7f05dd2237c0>
6,37996009,Microglial activation and toll-like receptor 4-Dependent regulation of angiotensin II type I receptor-mu-opioid receptor 1 heterodimerization and hypertension in fructose-fed rats.,"Our previous study reported that the heterodimer of Angiotensin II Type I Receptor (AT1R) and Mu-Opioid Receptor 1 (MOR1) involves Nitric Oxide (NO) reduction which leads to elevation of blood pressure. Secondly, we showed that Toll-like Receptor 4 (TLR4) may be involved in the heterodimerization of AT1R and MOR1 in the brainstem Nucleus Tractus Solitarii (NTS), which regulates systemic blood pressure and gastric nitric oxide through the insulin pathway. Here, we investigated the role of microglial activation and TLR4 in the heterodimerization of AT1R and MOR1. Hypertensive rats were established after four weeks of fructose consumption. SBP of rats was measured using non-invasive blood pressure method. PLA technique was utilized to determine protein-protein interaction in the nucleus tractus solitarii. Results showed that the level of MOR-1 and AT1R was induced significantly in the fructose group compared with control. PLA signal potentially showed that AT1R and MOR1 were formed in the nucleus tractus solitarii after fructose consumption. Meanwhile, the innate immune cell in the CNS microglia was observed in the nucleus tractus solitarii using biomarkers and was activated. TLR4 inhibitor CLI-095, was administered to animals to suppress the neuroinflammation and microglial activation. CLI-095 treatment reduced the heterodimer formation of AT1R and MOR1 and restored nitric oxide production in the nucleus tractus solitarii. These findings imply that TLR4-primed neuroinflammation involves formation of heterodimers AT1R and MOR1 in the nucleus tractus solitarii which leads to increase in systemic blood pressure.","['HMGB1', 'Hypertension', 'Neuroinflammation', 'Nucleus tractus solitarii', 'TLR4']",European journal of pharmacology,2023-11-24,"[{'lastname': 'Ho', 'firstname': 'Chiu-Yi', 'initials': 'CY', 'affiliation': 'Department of Anesthesiology, Kaohsiung Veterans General Hospital, Kaohsiung 81362, Taiwan.'}, {'lastname': 'Sun', 'firstname': 'Gwo-Ching', 'initials': 'GC', 'affiliation': 'Department of Anesthesiology, Kaohsiung Veterans General Hospital, Kaohsiung 81362, Taiwan; School of Medicine, National Defense Medicine Center, Taipei, Taiwan.'}, {'lastname': 'Lin', 'firstname': 'Yu-Te', 'initials': 'YT', 'affiliation': 'Section of Neurology, Kaohsiung Veterans General Hospital, Kaohsiung 81300, Taiwan; Center for Geriatrics and Gerontology, Kaohsiung Veterans General Hospital, Kaohsiung 81300, Taiwan; Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, 80424, Taiwan.'}, {'lastname': 'Wong', 'firstname': 'Tzyy-Yue', 'initials': 'TY', 'affiliation': 'Cross College Elite Program, National Cheng Kung University, Tainan 70101, Taiwan.'}, {'lastname': 'Hsiao', 'firstname': 'Michael', 'initials': 'M', 'affiliation': 'Genomics Research Center, Academia Sinica, Taipei 11529, Taiwan; Department and Graduate Institute of Veterinary Medicine, School of Veterinary Medicine, National Taiwan University, Taipei 10617, Taiwan.'}, {'lastname': 'Tseng', 'firstname': 'Ching-Jiunn', 'initials': 'CJ', 'affiliation': 'Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung 81362, Taiwan; Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, 80424, Taiwan; Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, 40402, Taiwan.'}, {'lastname': 'Cheng', 'firstname': 'Pei-Wen', 'initials': 'PW', 'affiliation': 'Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung 81362, Taiwan; Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, 80424, Taiwan. Electronic address: pwcheng@vghks.gov.tw.'}]",,,,Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.,10.1016/j.ejphar.2023.176171,<Element 'PubmedArticle' at 0x7f05dd6a8040>
7,37972878,Gonadal hormones impart male-biased behavioral vulnerabilities to immune activation via microglial mitochondrial function.,"There is a strong male bias in the prevalence of many neurodevelopmental disorders such as autism spectrum disorder. However, the mechanisms underlying this sex bias remain elusive. Infection during the perinatal period is associated with an increased risk of neurodevelopmental disorder development. Here, we used a mouse model of early-life immune activation that reliably induces deficits in social behaviors only in males. We demonstrate that male-biased alterations in social behavior are dependent upon microglial immune signaling and are coupled to alterations in mitochondrial morphology, gene expression, and function specifically within microglia, the innate immune cells of the brain. Additionally, we show that this behavioral and microglial mitochondrial vulnerability to early-life immune activation is programmed by the male-typical perinatal gonadal hormone surge. These findings demonstrate that social behavior in males over the lifespan are regulated by microglia-specific mechanisms that are shaped by events that occur in early development.",[],"Brain, behavior, and immunity",2023-11-17,"[{'lastname': 'Bordt', 'firstname': 'Evan A', 'initials': 'EA', 'affiliation': 'Department of Pediatrics, Lurie Center for Autism, Massachusetts General Hospital for Children, Harvard Medical School, Boston, MA 02129, USA.'}, {'lastname': 'Moya', 'firstname': 'Haley A', 'initials': 'HA', 'affiliation': 'Department of Pediatrics, Lurie Center for Autism, Massachusetts General Hospital for Children, Harvard Medical School, Boston, MA 02129, USA.'}, {'lastname': 'Jo', 'firstname': 'Young Chan', 'initials': 'YC', 'affiliation': 'Department of Pediatrics, Lurie Center for Autism, Massachusetts General Hospital for Children, Harvard Medical School, Boston, MA 02129, USA; Department of Psychology and Neuroscience, Duke University, Durham, NC 27708, USA.'}, {'lastname': 'Ravichandran', 'firstname': 'Caitlin T', 'initials': 'CT', 'affiliation': 'Department of Pediatrics, Lurie Center for Autism, Massachusetts General Hospital for Children, Harvard Medical School, Boston, MA 02129, USA; McLean Hospital, Belmont, MA 02478, USA.'}, {'lastname': 'Bankowski', 'firstname': 'Izabella M', 'initials': 'IM', 'affiliation': 'Department of Pediatrics, Lurie Center for Autism, Massachusetts General Hospital for Children, Harvard Medical School, Boston, MA 02129, USA.'}, {'lastname': 'Ceasrine', 'firstname': 'Alexis M', 'initials': 'AM', 'affiliation': 'Department of Psychology and Neuroscience, Duke University, Durham, NC 27708, USA.'}, {'lastname': 'McDougle', 'firstname': 'Christopher J', 'initials': 'CJ', 'affiliation': 'Department of Pediatrics, Lurie Center for Autism, Massachusetts General Hospital for Children, Harvard Medical School, Boston, MA 02129, USA; Department of Psychiatry, Harvard Medical School, Boston, MA 02115, USA.'}, {'lastname': 'Carlezon', 'firstname': 'William A', 'initials': 'WA', 'affiliation': 'McLean Hospital, Belmont, MA 02478, USA.'}, {'lastname': 'Bilbo', 'firstname': 'Staci D', 'initials': 'SD', 'affiliation': 'Department of Pediatrics, Lurie Center for Autism, Massachusetts General Hospital for Children, Harvard Medical School, Boston, MA 02129, USA; Department of Psychology and Neuroscience, Duke University, Durham, NC 27708, USA. Electronic address: staci.bilbo@duke.edu.'}]",,,,Copyright © 2023 Elsevier Inc. All rights reserved.,10.1016/j.bbi.2023.11.010,<Element 'PubmedArticle' at 0x7f05dda11cc0>
8,37923146,Multi-parametric MRI assessment of melatonin regulating the polarization of microglia in rats after cerebral ischemia/reperfusion injury.,"Multi-parametric magnetic resonance imaging (MRI) can provide comprehensive and valuable information for precise diagnosis and treatment evaluation of a number of diseases. In this study, the neuroprotective effects of melatonin (Mel) on a rat model of cerebral ischemia/reperfusion injury (CIRI) were assessed by multi-parametric MRI combined with histopathological techniques for longitudinal monitoring of the lesion microenvironment.
Sixty Sprague Dawley (SD) rats were randomly divided into three groups: the Sham, CIRI and CIRI + Mel groups. At multiple time points after ischemia, MRI scanning was performed on a 7.0 Tesla MRI scanner. Multi-parametric MRI includes T2-weighted imaging (T2WI), diffusion weighted imaging (DWI), and chemical exchange saturation transfer (CEST)-MRI. CEST effects were calculated by the Lorentzian difference method, 3.5 ppm indicates amide protons of mobile proteins/peptide (Amide-CEST) and 2.0 ppm indicates amine protons (Guan-CEST). Multiple histopathological techniques were used to examine the histopathological changes and explore the therapeutic effects of Mel.
T2WI and DWI-MRI could localize the infarct foci and areas in CIRI rats, which was further validated by staining, 2, 3, 5-triphenyl tetrazolium chloride (TTC) staining, hematoxylin and eosin (H&E) staining, and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labelling (TUNEL) staining. After Mel treatment, T2WI and DWI-MRI showed smaller infarct volume, and neurons displayed improved morphology with less apoptosis rates. Notably, Amide-CEST and Guan-CEST signal decreased as early as 2 h after CIRI (all P <0.001), reflecting the change of pH after ischemia. After Mel treatment, both Amide-CEST and Guan-CEST signal increased in ischemic cortex and striatum compared with control group (all P < 0.001). The immunofluorescence staining and western blotting analysis suggested the expression of M2 microglia increased after Mel treatment; While，after Mel treatment the inflammatory factor interleukin-1β (IL-1β) decreased compared with control CIRI rats.
Multi-parametric MRI was shown to be an effective method to monitor the brain damage in a rat model of CIRI and assess the therapeutic effects of Mel treatment. Amide-CEST and Guan-CEST were especially sensitive to the changes in brain microenvironment during the early stage after CIRI. Furthermore, the neuroprotective effect of Mel treatment is associated with its promotion of the microglia polarized to M2 type in CIRI rats.","['Acute ischemic stroke', 'Cerebral ischemia/reperfusion injury', 'Chemical exchange saturation transfer', 'Magnetic resonance imaging', 'Microglial polarization', 'Neuroprotection']",Brain research bulletin,2023-11-06,"[{'lastname': 'Li', 'firstname': 'Zhen', 'initials': 'Z', 'affiliation': 'School of Medical Imaging, Weifang Medical University, Weifang 261053, Shandong Province, China; Medical Imaging Center, Affiliated Hospital of Weifang Medical University, Weifang 261031, Shandong Province, China.'}, {'lastname': 'Gong', 'firstname': 'Ping', 'initials': 'P', 'affiliation': 'Medical Imaging Center, Affiliated Hospital of Weifang Medical University, Weifang 261031, Shandong Province, China.'}, {'lastname': 'Zhang', 'firstname': 'Mengbei', 'initials': 'M', 'affiliation': 'School of Medical Imaging, Weifang Medical University, Weifang 261053, Shandong Province, China; Department of Radiology, Zibo Central Hospital, Zibo 255020, Shandong Province, China.'}, {'lastname': 'Li', 'firstname': 'Chen', 'initials': 'C', 'affiliation': 'School of Medical Imaging, Weifang Medical University, Weifang 261053, Shandong Province, China.'}, {'lastname': 'Xiao', 'firstname': 'Peilun', 'initials': 'P', 'affiliation': 'Department of Anatomy, School of Basic Medicine, Weifang Medical University, Weifang 261053, Shandong Province, China.'}, {'lastname': 'Yu', 'firstname': 'Miao', 'initials': 'M', 'affiliation': 'School of Medical Imaging, Weifang Medical University, Weifang 261053, Shandong Province, China.'}, {'lastname': 'Wang', 'firstname': 'Xizhen', 'initials': 'X', 'affiliation': 'Medical Imaging Center, Affiliated Hospital of Weifang Medical University, Weifang 261031, Shandong Province, China.'}, {'lastname': 'An', 'firstname': 'Lin', 'initials': 'L', 'affiliation': 'School of Medical Imaging, Weifang Medical University, Weifang 261053, Shandong Province, China.'}, {'lastname': 'Bi', 'firstname': 'Fangfang', 'initials': 'F', 'affiliation': 'Department of Neurology, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhuhai 519000, Guangdong Province, China. Electronic address: biff3@mail.sysu.edu.cn.'}, {'lastname': 'Song', 'firstname': 'Xiaolei', 'initials': 'X', 'affiliation': 'Center for Biomedical Imaging Research, School of Medicine, Tsinghua University, Beijing 100084, China. Electronic address: songxl@tsinghua.edu.cn.'}, {'lastname': 'Wang', 'firstname': 'Xiaoli', 'initials': 'X', 'affiliation': 'School of Medical Imaging, Weifang Medical University, Weifang 261053, Shandong Province, China; Medical Imaging Center, Affiliated Hospital of Weifang Medical University, Weifang 261031, Shandong Province, China. Electronic address: wxlpine@163.com.'}]",,,"T2WI and DWI-MRI could localize the infarct foci and areas in CIRI rats, which was further validated by staining, 2, 3, 5-triphenyl tetrazolium chloride (TTC) staining, hematoxylin and eosin (H&E) staining, and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labelling (TUNEL) staining. After Mel treatment, T2WI and DWI-MRI showed smaller infarct volume, and neurons displayed improved morphology with less apoptosis rates. Notably, Amide-CEST and Guan-CEST signal decreased as early as 2 h after CIRI (all P <0.001), reflecting the change of pH after ischemia. After Mel treatment, both Amide-CEST and Guan-CEST signal increased in ischemic cortex and striatum compared with control group (all P < 0.001). The immunofluorescence staining and western blotting analysis suggested the expression of M2 microglia increased after Mel treatment; While，after Mel treatment the inflammatory factor interleukin-1β (IL-1β) decreased compared with control CIRI rats.",Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.,10.1016/j.brainresbull.2023.110807,<Element 'PubmedArticle' at 0x7f05dda3fb30>
9,37923002,TREM2 regulates BV2 microglia activation and influences corticosterone-induced neuroinflammation in depressive disorders.,"Depressive disorders is a serious mental illness, and its underlying pathological mechanisms remain unclear. The overactivation of microglia and neuroinflammation are thought to play an essential role in the occurrence and development of depressive disorders. TREM2, an immune protein mainly expressed in microglia, is an important part of nerve cells involved in inflammatory response. Corticosterone (CORT) is often referred to as a stress hormone and plays a role in the immune system and stress response. Therefore, this study investigated the role of TREM2 in CORT-induced BV2 cell damage and preliminarily analyzed the effects of TREM2 on JAK2/STAT3 signaling pathway and microglia polarization. The cell model of CORT-induced depression in vitro was established, and the effect of CORT on the activity of BV2 microglia was detected by CCK8. Plasmid transfection was used to overexpress and interfere with TREM2 in BV2 cells cultured by CORT. Western blotting, PCR, and ELISA analyzed the expression of related proteins and inflammatory factors. The results showed that CORT could affect BV2 cell proliferation and TREM2 levels. In the presence of CORT, overexpression of TREM2 decreased the levels of TNF-α, IL-1β, and IL-6 and increased the levels of IL-10. Interference with TREM2 increased the levels of TNF-α, IL-1β, and IL-6 and decreased the levels of IL-10. TREM2 can affect the release of inflammatory factors through the JAK2/STAT3 signaling pathway and regulate the M1/M2 phenotypic transformation of microglia. TREM2 plays a role in regulating CORT-induced inflammatory responses, revealing the influence of TREM2 on the neuroinflammatory pathogenesis of depressive disorders and suggesting that TREM2 may be a new target for the prevention and treatment of depressive disorders.","['Corticosterone', 'Depressive disorders', 'Microglia polarization', 'Neuroinflammation', 'TREM2']",Brain research,2023-11-06,"[{'lastname': 'Shi', 'firstname': 'Jingjing', 'initials': 'J', 'affiliation': 'Department of Psychiatry, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang Province 150001, China.'}, {'lastname': 'Wang', 'firstname': 'Xiaohong', 'initials': 'X', 'affiliation': 'Department of Psychiatry, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang Province 150001, China.'}, {'lastname': 'Kang', 'firstname': 'Chuanyi', 'initials': 'C', 'affiliation': 'Department of Psychiatry, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang Province 150001, China.'}, {'lastname': 'Liu', 'firstname': 'Jiacheng', 'initials': 'J', 'affiliation': 'Department of Psychiatry, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang Province 150001, China.'}, {'lastname': 'Ma', 'firstname': 'Caina', 'initials': 'C', 'affiliation': 'Harbin First Specialized Hospital, Heilongjiang Province, China.'}, {'lastname': 'Yang', 'firstname': 'Liying', 'initials': 'L', 'affiliation': 'Department of Psychiatry, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang Province 150001, China.'}, {'lastname': 'Hu', 'firstname': 'Jian', 'initials': 'J', 'affiliation': 'Department of Psychiatry, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang Province 150001, China. Electronic address: drhujian@outlook.com.'}, {'lastname': 'Zhao', 'firstname': 'Na', 'initials': 'N', 'affiliation': 'Department of Psychiatry, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang Province 150001, China. Electronic address: zhaona@hrbmu.edu.cn.'}]",,,,Copyright © 2023 Elsevier B.V. All rights reserved.,10.1016/j.brainres.2023.148664,<Element 'PubmedArticle' at 0x7f05dda924a0>
10,"37838007
27021778
27770818
28379303
30448285
29378861
31870439
16862116
31980280
28453791
26509463
7582095
32783030
17923627
31099551
17076895
23699531
16862115
34298019
23706646
19963041
30696728
24100384
19158106
35982091
22781549
24077561
12900424
10383119
33381010
28828399
26048578
36618392
21092856
31855245
30444070
4094481
8105154
18568075
28100408
26811050
28438992
37322482
29740434
21212639
24163244
28743268
27114033
27215202
23041626
23398167
27703466
27778404
33384578
34344440
26682689
31701892
19946692
27903606
24771538
27356620
23609919
20737593
28647554
29149899
24046442
1618805
18723524
35810449
28330615
18479928
19860916
30096299
17984093
24680777
2236009
22608501
34507520
22509390
21530615
23201826
21393509
36398980
12820146
8980237
18378771
21613335
20028451
26408020
26971930
24534188
20026663
23273845
26757107
25186741
32866962
35120524
37120788
26370502
28835281
28541286
12526812",Regulation of extracellular progranulin in medial prefrontal cortex.,"Progranulin is a secreted pro-protein that has anti-inflammatory and neurotrophic effects and is necessary for maintaining lysosomal function. Mutations in progranulin (GRN) are a major cause of frontotemporal dementia. Most pathogenic GRN mutations cause progranulin haploinsufficiency, so boosting progranulin levels is a promising therapeutic strategy. Progranulin is constitutively secreted, then taken up and trafficked to lysosomes. Before being taken up from the extracellular space, progranulin interacts with receptors that may mediate anti-inflammatory and growth factor-like effects. Modifying progranulin trafficking is a viable approach to boosting progranulin, but progranulin secretion and uptake by cells in the brain is poorly understood and may involve distinct mechanisms from other parts of the body. Understanding the cell types and processes that regulate extracellular progranulin in the brain could provide insight into progranulin's mechanism of action and inform design of progranulin-boosting therapies. To address this question we used microdialysis to measure progranulin in interstitial fluid (ISF) of mouse medial prefrontal cortex (mPFC). Grn","['Microdialysis', 'Microglia', 'Progranulin', 'Secretion']",Neurobiology of disease,2023-10-15,"[{'lastname': 'Kaplelach', 'firstname': 'Azariah K', 'initials': 'AK', 'affiliation': ""Center for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, Evelyn F. McKnight Brain Institute, Departments of Neurology and Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA.""}, {'lastname': 'Fox', 'firstname': 'Stephanie N', 'initials': 'SN', 'affiliation': ""Center for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, Evelyn F. McKnight Brain Institute, Departments of Neurology and Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA.""}, {'lastname': 'Cook', 'firstname': 'Anna K', 'initials': 'AK', 'affiliation': ""Center for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, Evelyn F. McKnight Brain Institute, Departments of Neurology and Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA.""}, {'lastname': 'Hall', 'firstname': 'Justin A', 'initials': 'JA', 'affiliation': ""Center for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, Evelyn F. McKnight Brain Institute, Departments of Neurology and Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA.""}, {'lastname': 'Dannemiller', 'firstname': 'Ryan S', 'initials': 'RS', 'affiliation': ""Center for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, Evelyn F. McKnight Brain Institute, Departments of Neurology and Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA.""}, {'lastname': 'Jaunarajs', 'firstname': 'Karen L', 'initials': 'KL', 'affiliation': ""Center for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, Evelyn F. McKnight Brain Institute, Departments of Neurology and Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA.""}, {'lastname': 'Arrant', 'firstname': 'Andrew E', 'initials': 'AE', 'affiliation': ""Center for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, Evelyn F. McKnight Brain Institute, Departments of Neurology and Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: andrewarrant@uabmc.edu.""}]",,,,Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.,10.1016/j.nbd.2023.106326,<Element 'PubmedArticle' at 0x7f05ddb82a90>
11,"37720534
28930295
14679176
30355499
30692905
27796748
27939451
31244863
32305098
37012544
35618862
30953761
34703027
31543877
31379820
31903735
33268480
30144345
25242226
32140136
21587064
18829989
35557041
36889280
30229891
19633658
23493569
27050305
31597606
35480482
26916240
28808264
27795298
28179656
24906151
26413469
30872317
26779183
10427991
32403975
26993069
26779432
15530839
33597245
22981538
29760084
20357360
23449529
25392242
17848624
31257031
28954231
35806422
26972048
36402403
24484282
36433684
22396530
22645141
25436972
32694683
25395302
22385416
23483102
30285581
28228283
25729921
24012153
36911659
22851575
21436399
37295715
24692138
27041634
35798021
32210070
28045404
30842418
32411096
1636711
35833135
24587847
35008925
31076404
31398325
26868085
32599603
11418690
8892629
33762736
31701087
31829469
35934868
28045398
24030890
26041698
22314623
16352667
32123188
33398164
35484323
28884198
25128759
29166590
26347472
29133420
35183119
37274331
24009176
34054838
21333554
28571979
20508158
26154056
25863246
28246016
31269440
31318874
29717059
35361917
34418352
30819964
34480117
30667374
32850961
28942920
29133512
33450179
33447986
31278836
31204283
37175451
35057862
37210227
36423694
34675439
7900918
8408625
33113371
22539169
28953873
22101429
28414329
33193086
29035364
35622894
30559435
10839541
24313447
34997096
23929694
32182560
28044208
29129819
28724799
33776997
32516787
25036630
26777404
30659469
34694010
25497089
30531847
25824676
28576837
30254630
31614951
35079937
28214555
27199291
26089260
28448947
35742824
28489068
22483785
20966214
28683286
32848611
36869375
23884544
24848869
31159189
28094236
33358943
28319103
17617622
30448612
20152116
11438173
23935253
29642210
27133169
25147279
15546155
27898074
28542876
32222288
28467927
29660453
23831150
27566530
22201683
28683278
32928871
19915164
24917578
34038733
35716660
33741533",Peripheral and central macrophages in obesity.,"Obesity is associated with chronic, low-grade inflammation. Excessive nutrient intake causes adipose tissue expansion, which may in turn cause cellular stress that triggers infiltration of pro-inflammatory immune cells from the circulation as well as activation of cells that are residing in the adipose tissue. In particular, the adipose tissue macrophages (ATMs) are important in the pathogenesis of obesity. A pro-inflammatory activation is also found in other organs which are important for energy metabolism, such as the liver, muscle and the pancreas, which may stimulate the development of obesity-related co-morbidities, including insulin resistance, type 2 diabetes (T2D), cardiovascular disease (CVD) and non-alcoholic fatty liver disease (NAFLD). Interestingly, it is now clear that obesity-induced pro-inflammatory signaling also occurs in the central nervous system (CNS), and that pro-inflammatory activation of immune cells in the brain may be involved in appetite dysregulation and metabolic disturbances in obesity. More recently, it has become evident that microglia, the resident macrophages of the CNS that drive neuroinflammation, may also be activated in obesity and can be relevant for regulation of hypothalamic feeding circuits. In this review, we focus on the action of peripheral and central macrophages and their potential roles in metabolic disease, and how macrophages interact with other immune cells to promote inflammation during obesity.","['adipose tissue', 'hypothalamus', 'macrophages', 'microglia', 'obesity; inflammation', 'small extracellular vesicles']",Frontiers in endocrinology,2023-09-18,"[{'lastname': 'Mukherjee', 'firstname': 'Sayani', 'initials': 'S', 'affiliation': 'Hormone Laboratory, Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.\nMohn Center for Diabetes Precision Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway.\nDepartment of Physiology, CIMUS, University of Santiago de Compostela, Santiago de Compostela, Spain.\nCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain.'}, {'lastname': 'Skrede', 'firstname': 'Silje', 'initials': 'S', 'affiliation': 'Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.\nDepartment of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.'}, {'lastname': 'Haugstøyl', 'firstname': 'Martha', 'initials': 'M', 'affiliation': 'Hormone Laboratory, Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.\nMohn Center for Diabetes Precision Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway.'}, {'lastname': 'López', 'firstname': 'Miguel', 'initials': 'M', 'affiliation': 'Department of Physiology, CIMUS, University of Santiago de Compostela, Santiago de Compostela, Spain.\nCIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Santiago de Compostela, Spain.'}, {'lastname': 'Fernø', 'firstname': 'Johan', 'initials': 'J', 'affiliation': 'Hormone Laboratory, Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Bergen, Norway.\nMohn Center for Diabetes Precision Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway.'}]",,,,"Copyright © 2023 Mukherjee, Skrede, Haugstøyl, López and Fernø.","10.3389/fendo.2023.1232171
10.1038/nrgastro.2017.109
10.1172/JCI19246
10.1016/j.celrep.2018.09.070
10.3389/fnins.2018.01027
10.1007/s12035-016-0193-8
10.1016/j.it.2016.11.004
10.3389/fimmu.2019.01330
10.1016/j.tem.2020.01.008
10.1038/s41590-023-01479-0
10.1038/s41467-022-30646-4
10.1016/j.bbalip.2019.04.001
10.1038/s41574-021-00575-1
10.3389/fimmu.2019.02035
10.3389/fimmu.2019.01587
10.1002/oby.22674
10.4049/jimmunol.2000490
10.1111/jdi.12918
10.1016/j.cmet.2014.08.010
10.3389/fendo.2020.00062
10.1097/MCO.0b013e328347970b
10.2337/db08-0872
10.1631/jzus.B2100930
10.1016/j.cmet.2023.02.002
10.1111/imm.13002
10.1038/nm.1964
10.2337/db12-1404
10.1016/j.cmet.2016.03.002
10.1016/j.tem.2019.08.011
10.3389/fendo.2022.856530
10.1002/oby.21377
10.1038/s41598-017-08131-6
10.1128/mcb.00282-16
10.1038/nature21363
10.1016/j.cell.2014.05.012
10.1016/j.molmet.2015.07.001
10.15252/embr.201847388
10.3389/fimmu.2015.00637
10.1002/(sici)1521-4141(199907)29:07<2280::Aid-immu2280>3.0.Co;2-c
10.1080/21623945.2020.1760674
10.2337/db15-1156
10.1016/j.molmet.2015.07.005
10.1016/j.it.2004.09.015
10.1126/sciadv.abe2480
10.1016/j.immuni.2012.06.016
10.1073/pnas.1802611115
10.2337/db09-0287
10.1038/nutd.2012.3
10.2337/db14-0744
10.2337/db07-0767
10.1016/j.cell.2019.05.054
10.1016/j.celrep.2017.08.096
10.3390/ijms23137417
10.1016/j.bbadis.2016.03.004
10.1016/j.molmet.2022.101642
10.1111/imm.12262
10.1002/eji.202249990
10.1074/jbc.M112.350066
10.1074/jbc.M112.371807
10.1038/ni.3047
10.1038/s42255-019-0160-6
10.1189/jlb.3A0414-211RR
10.1111/j.1365-2567.2012.03582.x
10.4161/onci.22892
10.1096/fj.201800696RR
10.1016/j.immuni.2017.01.008
10.1038/ni.3120
10.1016/j.metabol.2013.07.011
10.3389/fimmu.2023.1130370
10.2337/db11-1523
10.1126/science.1201475
10.1016/j.metabol.2023.155613
10.1002/cphy.c130024
10.1038/cmi.2016.09
10.1016/S2468-1253(22)00165-0
10.3390/nu12030855
10.1172/jci88881
10.1038/s41467-019-09046-8
10.3389/fendo.2020.00259
10.1152/ajpgi.1992.263.1.G17
10.3389/fimmu.2022.940867
10.1007/s12072-013-9468-6
10.3390/ijms23010498
10.1136/gutjnl-2019-318382
10.1016/j.molcel.2019.07.028
10.1016/j.cyto.2016.01.020
10.12659/MSM.923726
10.4049/jimmunol.167.1.514
10.1038/s41586-021-03233-8
10.1038/s42255-019-0076-1
10.1002/jlb.3ma1119-173r
10.12659/MSM.937528
10.1016/s0168-8278(18)30953-x
10.1172/JCI88880
10.1002/oby.20615
10.1038/ijo.2015.104
10.1038/oby.2012.24
10.1152/ajpendo.00506.2005
10.1038/s41598-020-60185-1
10.1038/s41580-020-00317-7
10.1038/s41577-022-00728-x
10.1007/s00125-017-4416-y
10.1053/j.gastro.2014.08.008
10.1016/j.immuni.2017.10.015
10.1084/jem.20150496
10.1073/pnas.1713543114
10.1186/s12876-022-02146-8
10.3389/fendo.2023.1185456
10.1189/jlb.0213075
10.3389/fimmu.2021.668654
10.1016/j.immuni.2011.01.016
10.1016/j.biochi.2017.05.019
10.1152/ajpgi.00098.2010
10.1016/j.cmet.2015.06.001
10.1016/j.cmet.2015.03.001
10.1053/j.gastro.2017.02.016
10.1016/j.celrep.2019.06.016
10.1371/journal.pbio.3000363
10.1042/ebc20170087
10.1038/s41574-022-00666-7
10.1016/j.cmet.2021.08.002
10.1126/science.aaw2586
10.1038/s41574-021-00563-5
10.1172/jci123069
10.3389/fmolb.2020.00171
10.1016/j.cell.2017.08.035
10.2337/db17-0356
10.1016/j.cmet.2020.12.019
10.1007/s11154-020-09625-x
10.1111/apha.13339
10.1016/j.cmet.2019.05.015
10.3390/ijms24097745
10.1186/s13287-021-02668-0
10.1016/j.molmed.2023.04.006
10.1016/j.metabol.2022.155350
10.1038/s42255-021-00467-8
10.1152/ajpregu.1995.268.3.R744
10.1172/jci116760
10.1016/j.celrep.2020.108270
10.1152/japplphysiol.01604.2011
10.1038/nature24022
10.1038/nature10653
10.1038/nm.4316
10.3389/fendo.2020.568682
10.1038/nm.4422
10.1073/pnas.2023285119
10.1038/s41467-018-07764-z
10.1038/35013070
10.1111/sji.12141
10.1038/s41598-021-04154-2
10.1136/gutjnl-2013-30467
10.1016/j.mehy.2020.109671
10.1007/s00535-016-1304-z
10.1016/j.metabol.2017.11.002
10.1172/jci.insight.93340
10.3389/fimmu.2021.613979
10.1159/000506483
10.1016/j.cell.2014.04.050
10.1016/j.cell.2015.12.023
10.1007/s10620-019-5458-4
10.1111/cen.14615
10.1016/j.celrep.2014.11.018
10.1038/s41593-018-0286-y
10.1038/nrendo.2015.48
10.2337/db17-0067
10.3389/fimmu.2018.01992
10.3390/ijms20205081
10.1007/s12035-022-02756-z
10.1016/j.mcn.2017.02.004
10.1038/nrendo.2016.67
10.1007/s12020-015-0658-y
10.1016/j.redox.2017.04.019
10.3390/ijms23126380
10.1038/ncomms15143
10.1016/j.physbeh.2012.03.021
10.1126/science.1194637
10.1016/j.cmet.2017.05.015
10.3389/fncel.2020.00198
10.1186/s12974-023-02740-x
10.1007/s12031-013-0068-7
10.1210/en.2014-1074
10.3390/nu11061241
10.1016/j.ebiom.2017.01.007
10.1016/j.metabol.2020.154694
10.1038/nutd.2017.10
10.4049/jimmunol.179.2.1292
10.1016/j.neurobiolaging.2018.10.018
10.1016/j.neuron.2009.11.032
10.1016/s0165-5728(01)00282-x
10.1155/2013/982458
10.1097/MD.0000000000010415
10.1016/j.cell.2016.03.033
10.1126/science.1252945
10.1002/ana.20315
10.1038/tp.2016.229
10.1002/1873-3468.12691
10.1016/j.neuint.2020.104733
10.1016/j.cmet.2017.04.002
10.1016/j.metabol.2018.04.005
10.1016/j.bbi.2013.06.007
10.1186/s12974-016-0666-8
10.1172/jci59660
10.1016/j.cmet.2017.06.013
10.2337/db20-0262
10.1210/en.2009-1002
10.2337/db14-0302
10.1016/j.celrep.2021.109163
10.1016/j.cmet.2022.06.002
10.1016/j.molmet.2021.101214",<Element 'PubmedArticle' at 0x7f05dddec630>
12,"37702891
11994745
36750096
12045102
20637261
20920479
17000013
7531418
10797543
11701931
12411487
9218507
18466341
19656258
22101005
20637285
9681954
21421841
20854368
15140180
19651157
27829994
9773776
24269535
17720802
22910909
9443474
29108865
15094069
27988872
20817067
25301694
16448778
24310731
27448243
11255015
23536230
16842873
7642623
9541123
23909735
23385081
24599963
22930583
22863914
3702709
26240147
17729440
11560943
21148344
23238794
15136588
28275161
25855193
3536982
16278749
12467491",Low Density Lipoprotein Receptor-related Protein 2 Expression and Function in Cultured Astrocytes and Microglia.,"Activation of glial cells, astrocytes and microglia, has been observed in neurodegenerative diseases including Alzheimer's disease (AD). Amyloid β (Aβ), which is aggregated and the aggregation is detected as characteristic pathology in AD brain, is known to be produced by neurons and to activate glial cells. Clearance of Aβ from the brain via active transport system is important to prevent the accumulation and aggregation. Low density lipoprotein receptor-related protein 2 (LRP2/megalin) is an Aβ transporter. However, expression and contribution of LRP2 in astrocytes and microglia remain to be clarified. In the present study, we examined the expression of LRP2 and its roles in cultured astrocytes prepared from rat embryonic brain cortex and mouse microglial cell line BV-2. Both cultured rat astrocytes and BV-2 cells expressed LRP2 mRNA detected by RT-PCR. When lipopolysaccharide (LPS) or all-trans retinoic acid (ATRA) were added to BV-2 cells, LRP2 mRNA expression and uptake of microbeads, Aβ and insulin were increased. On the other hand, LPS decreased LRP2 expression and uptake of Aβ and insulin in cultured astrocytes. Knockdown of LRP2 using siRNA attenuated the LPS- or ATRA-increased uptake of microbeads, Aβ and insulin in BV-2 cells. These results suggest that LRP2 was expressed in both astrocytes and microglia and might be involved in endocytosis activities. Adequate control of LRP2 expression and function in astrocytes and microglia might regulate Aβ and insulin levels in brain and would be a potential target in AD pathology.","['Amyloid β', 'Astrocyte', 'Insulin', 'LRP2', 'Microglia']",Neurochemical research,2023-09-13,"[{'lastname': 'Takano-Kawabe', 'firstname': 'Katsura', 'initials': 'K', 'affiliation': 'Laboratory of Integrative Physiology in Veterinary Sciences, Osaka Metropolitan University, 1-58, Rinku-Ourai Kita, Izumisano, Osaka, 598-8531, Japan. takano@omu.ac.jp.'}, {'lastname': 'Matoba', 'firstname': 'Kazuyuki', 'initials': 'K', 'affiliation': 'Laboratory of Integrative Physiology in Veterinary Sciences, Osaka Metropolitan University, 1-58, Rinku-Ourai Kita, Izumisano, Osaka, 598-8531, Japan.'}, {'lastname': 'Nakamura', 'firstname': 'Yoichi', 'initials': 'Y', 'affiliation': 'Laboratory of Integrative Physiology in Veterinary Sciences, Osaka Metropolitan University, 1-58, Rinku-Ourai Kita, Izumisano, Osaka, 598-8531, Japan.'}, {'lastname': 'Moriyama', 'firstname': 'Mitsuaki', 'initials': 'M', 'affiliation': 'Laboratory of Integrative Physiology in Veterinary Sciences, Osaka Metropolitan University, 1-58, Rinku-Ourai Kita, Izumisano, Osaka, 598-8531, Japan.'}]",,,,"© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.","10.1007/s11064-023-04022-7
10.1038/nrm778
10.1016/j.cell.2023.01.016
10.3389/fphys.2012.00269
10.1146/annurev.biochem.71.110601.135342
10.1016/j.neulet.2010.07.012
10.1016/j.bcp.2010.09.018
10.1016/j.tins.2006.09.002
10.1002/ana.410370212
10.1002/(SICI)1097-4547(20000501)60:3<401::AID-JNR15>3.0.CO;2-L
10.1126/science.294.5545.1354
10.1093/emboj/cdf568
10.1172/JCI119536
10.1111/j.1471-4159.2008.05462.x
10.1111/j.1471-4159.2009.06304.x
10.1016/j.expneurol.2011.11.001
10.1016/j.mcn.2010.07.005
10.1016/s0306-4522(97)00661-1
10.1016/j.bbadis.2016.08.018
10.1073/pnas.1017033108
10.1111/j.1471-4159.2010.07002.x
10.1111/j.1471-4159.2004.02385.x
10.1016/j.brainresrev.2009.05.007
10.2478/v10136-011-0013-4
10.3233/JAD-2009-1074
10.3233/JAD-131604
10.1681/ASN.V9101759
10.1016/j.cellsig.2013.11.017
10.1096/fj.06-7703com
10.1074/jbc.M112.348300
10.1212/wnl.50.1.164
10.1016/j.neuint.2017.10.017
10.1016/j.ejphar.2004.02.040
10.1007/s40265-016-0674-0
10.1016/j.neuint.2010.08.019
10.1159/000365484
10.1016/j.neuroscience.2005.12.025
10.1039/c3fo60309a
10.1002/jnr.23843
10.1016/s0378-1119(01)00351-1
10.1152/ajprenal.00108.2017
10.1002/glia.22479
10.1016/j.neures.2006.06.005
10.1074/jbc.270.33.19417
10.1046/j.1365-2362.1998.00253.x
10.1080/01635581.2013.805422
10.1016/j.jneuroim.2012.11.005
10.1074/jbc.M113.526095
10.1002/glia.22412
10.1248/bpb.b12-00314
10.1016/s0076-6879(86)23015-3
10.1074/jbc.M115.662908
10.1007/112_0604
10.1172/JCI13992
10.1126/science.1197623
10.1007/s11481-012-9427-3
10.1189/jlb.1203620
10.1523/JNEUROSCI.3442-16.2017
10.1523/JNEUROSCI.5180-14.2015
10.1210/jcem-64-1-190
10.2165/00023210-200317010-00003",<Element 'PubmedArticle' at 0x7f05de48dd60>
13,"37679787
32235325
35790958
35084376
28857628
36115588
35668399
34500853
30767756
20080186
21964469
28066250
27912889
29205359
16298249
35422219
35461094
35964426
11459850
29739819
19747114
16759685
24333364
35443102
36100045
36100127
19549986
31953827
34641624
34406655
24738055
18478112
28381303
32043530
34960109
23455590
31178825
31976839
25013464
25907742
27856392
29079442
16817027
30487265
36772863
35589416
31207575
30470289
35504401
35822633
19484594
32664019
31404802
31368878
34503515
35236988
32203083
32171529
32130258
26928197
34343616
33719165
34473429
31127971
34685649
33571507
23616747
31063987
32376998
35777903
25002497",Supraphysiologic doses of 17β-estradiol aggravate depression-like behaviors in ovariectomized mice possibly via regulating microglial responses and brain glycerophospholipid metabolism.,"17β-Estradiol (E2) is generally considered neuroprotective in humans. However, the current clinical use of estrogen replacement therapy (ERT) is based on the physiological dose of E2 to treat menopausal syndrome and has limited therapeutic efficacy. The efficacy and potential toxicity of superphysiological doses of ERT for menopausal neurodegeneration are unknown.
In this study, we investigated the effect of E2 with a supraphysiologic dose (0.5 mg/kg, sE2) on the treatment of menopausal mouse models established by ovariectomy. We performed the open field, Y-maze spontaneous alternation, forced swim tests, and sucrose preference test to investigate behavioral alterations. Subsequently, the status of microglia and neurons was detected by immunohistochemistry, HE staining, and Nissl staining, respectively. Real-time PCR was used to detect neuroinflammatory cytokines in the hippocampus and cerebral cortex. Using mass spectrometry proteomics platform and LC-MS/ MS-based metabolomics platform, proteins and metabolites in brain tissues were extracted and analyzed. BV2 and HT22 cell lines and primary neurons and microglia were used to explore the underlying molecular mechanisms in vitro.
sE2 aggravated depression-like behavior in ovariectomized mice, caused microglia response, and increased proinflammatory cytokines in the cerebral cortex and hippocampus, as well as neuronal damage and glycerophospholipid metabolism imbalance. Subsequently, we demonstrated that sE2 induced the pro-inflammatory phenotype of microglia through ERα/NF-κB signaling pathway and downregulated the expression of cannabinoid receptor 1 in neuronal cells, which were important in the pathogenesis of depression.
These data suggest that sE2 may be nonhelpful or even detrimental to menopause-related depression, at least partly, by regulating microglial responses and glycerophospholipid metabolism.","['17β-Estradiol', 'Depression', 'Estrogen replacement therapy', 'Glycerophospholipid metabolism', 'Menopausal syndrome', 'Microglial']",Journal of neuroinflammation,2023-09-08,"[{'lastname': 'Li', 'firstname': 'Ming', 'initials': 'M', 'affiliation': 'Center for Reproductive Medicine, Shandong University, Jinan, 250012, Shandong, China.\nKey Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, 250012, Shandong, China.\nNational Research Center for Assisted Reproductive Technology and Reproductive Genetics, Shandong University, Jinan, 250012, Shandong, China.'}, {'lastname': 'Zhang', 'firstname': 'Jing', 'initials': 'J', 'affiliation': 'Center for Reproductive Medicine, Shandong University, Jinan, 250012, Shandong, China.\nKey Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, 250012, Shandong, China.\nNational Research Center for Assisted Reproductive Technology and Reproductive Genetics, Shandong University, Jinan, 250012, Shandong, China.'}, {'lastname': 'Chen', 'firstname': 'Wendi', 'initials': 'W', 'affiliation': 'Center for Reproductive Medicine, Shandong University, Jinan, 250012, Shandong, China.\nKey Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, 250012, Shandong, China.\nNational Research Center for Assisted Reproductive Technology and Reproductive Genetics, Shandong University, Jinan, 250012, Shandong, China.'}, {'lastname': 'Liu', 'firstname': 'Shuang', 'initials': 'S', 'affiliation': 'Center for Reproductive Medicine, Shandong University, Jinan, 250012, Shandong, China.\nKey Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, 250012, Shandong, China.\nNational Research Center for Assisted Reproductive Technology and Reproductive Genetics, Shandong University, Jinan, 250012, Shandong, China.'}, {'lastname': 'Liu', 'firstname': 'Xin', 'initials': 'X', 'affiliation': 'Center for Reproductive Medicine, Shandong University, Jinan, 250012, Shandong, China.\nKey Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, 250012, Shandong, China.\nNational Research Center for Assisted Reproductive Technology and Reproductive Genetics, Shandong University, Jinan, 250012, Shandong, China.'}, {'lastname': 'Ning', 'firstname': 'Yunna', 'initials': 'Y', 'affiliation': 'Center for Reproductive Medicine, Shandong University, Jinan, 250012, Shandong, China.\nKey Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, 250012, Shandong, China.\nNational Research Center for Assisted Reproductive Technology and Reproductive Genetics, Shandong University, Jinan, 250012, Shandong, China.'}, {'lastname': 'Cao', 'firstname': 'Yongzhi', 'initials': 'Y', 'affiliation': 'Center for Reproductive Medicine, Shandong University, Jinan, 250012, Shandong, China.\nKey Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, 250012, Shandong, China.\nNational Research Center for Assisted Reproductive Technology and Reproductive Genetics, Shandong University, Jinan, 250012, Shandong, China.'}, {'lastname': 'Zhao', 'firstname': 'Yueran', 'initials': 'Y', 'affiliation': 'Center for Reproductive Medicine, Shandong University, Jinan, 250012, Shandong, China. yrzhao@sdu.edu.cn.\nKey Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, 250012, Shandong, China. yrzhao@sdu.edu.cn.\nNational Research Center for Assisted Reproductive Technology and Reproductive Genetics, Shandong University, Jinan, 250012, Shandong, China. yrzhao@sdu.edu.cn.'}]",,"These data suggest that sE2 may be nonhelpful or even detrimental to menopause-related depression, at least partly, by regulating microglial responses and glycerophospholipid metabolism.","sE2 aggravated depression-like behavior in ovariectomized mice, caused microglia response, and increased proinflammatory cytokines in the cerebral cortex and hippocampus, as well as neuronal damage and glycerophospholipid metabolism imbalance. Subsequently, we demonstrated that sE2 induced the pro-inflammatory phenotype of microglia through ERα/NF-κB signaling pathway and downregulated the expression of cannabinoid receptor 1 in neuronal cells, which were important in the pathogenesis of depression.","© 2023. BioMed Central Ltd., part of Springer Nature.","10.1186/s12974-023-02889-5
10.3390/nu12040945
10.1186/s12905-022-01710-4
10.1097/GME.0000000000001894
10.1080/09513590.2017.1371129
10.1016/j.neuropharm.2022.109249
10.1186/s12974-022-02492-0
10.3390/molecules26175413
10.2174/1874467212666190215112036
10.1016/j.phrs.2010.01.002
10.1016/j.neuroscience.2011.09.031
10.3389/fphar.2016.00503
10.1016/j.fertnstert.2016.09.046
10.1002/cne.24366
10.1016/j.neurobiolaging.2004.12.012
10.2174/1568009622666220413084456
10.1016/j.envint.2022.107250
10.1016/j.ejmech.2022.114658
10.1074/jbc.R100029200
10.1124/mol.117.111385
10.2174/156652409789839116
10.1016/j.pbb.2006
10.1016/j.jep.2013.12.008
10.1111/acel.13619
10.1016/j.expneurol.2022.114225
10.1016/j.ejphar.2022.175264
10.1182/blood-2009-01-200725
10.1007/978-1-0716-0239-319
10.3390/molecules26196077
10.1002/bit.27918
10.1155/2014/361590
10.1371/journal.pone.0002170
10.1186/s12974-017-0845-2
10.1042/BSR20193629
10.1042/BSR20193629
10.1007/s00406-013-0399-y
10.3389/fendo.2019.00245.\
10.2174/1570159X18666200123165652
10.3892/ol.2014.2170
10.1016/j.bbr.2015.04.017
10.1016/S2215-0366(16)30263-2
10.1016/j.yhbeh.2017.10.009
10.1007/s00395-006-0608-1
10.2337/db18-0638
10.1111/jog.15565
10.1016/j.jaci.2022.03.028
10.1016/j.biopha.2019.109114
10.1016/bs.pmbts.2018.07.008
10.1016/j.jad.2022.04.153
10.1002/gps.5779
10.1080/13607860802534583
10.1016/j.jad.2020.05.143
10.1016/j.comppsych.2019.07.006
10.2174/1871520619666190801094059
10.1186/s12958-021-00823-z
10.1038/s41586-022-04463-0
10.1038/s41401-020-0384-8
10.1016/j.bbrc.2020.03.039
10.1371/journal.pone.0229626
10.1016/j.bbi.2016.02.022
10.1016/j.bbi.2021.07.022
10.1111/jne.12962
10.1002/brb3.2316
10.1111/jne.12751
10.3390/cells10102669
10.1016/j.yhbeh.2021.104948
10.3389/fncel.2013.00045
10.1172/JCI123689
10.1038/s41380-020-0744-2
10.1016/j.jare.2021.10.002
10.1073/pnas.1402663111",<Element 'PubmedArticle' at 0x7f05de9eaf40>
14,37640149,The exploration of neuroinflammatory mechanism by which CRHR2 deficiency induced anxiety disorder.,"Inflammation stimulates the hypothalamic-pituitary adrenal (HPA) axis and triggers glial neuroinflammatory phenotypes, which reduces monoamine neurotransmitters by activating indoleamine 2,3-dioxygenase enzyme. These changes can induce psychiatric diseases, including anxiety. Corticotropin releasing hormone receptor 2 (CRHR2) in the HPA axis is involved in the etiology of anxiety. Omega(n)-3 polyunsaturated fatty acids (PUFAs) can attenuate anxiety through anti-inflammation and HPA axis modulation. However, the underlying molecular mechanism by CRHR2 modulates anxiety and its correlation with neuroinflammation remain unclear. Here, we first constructed a crhr2 zebrafish mutant line, and evaluated anxiety-like behaviors, gene expression associated with the HPA axis, neuroinflammatory response, neurotransmitters, and PUFAs profile in crhr2","['Anxiety disorder', 'HPA axis', 'Neuroinflammation', 'Zebrafish', 'crhr2']",Progress in neuro-psychopharmacology & biological psychiatry,2023-08-29,"[{'lastname': 'Deng', 'firstname': 'Shuyi', 'initials': 'S', 'affiliation': 'Research Institute for Marine Drugs and Nutrition, College of Food Science and Technology, Guangdong Ocean University, Zhanjiang 524088, China.'}, {'lastname': 'Guo', 'firstname': 'Anqi', 'initials': 'A', 'affiliation': 'The Affiliated Kangning Hospital of Wenzhou Medical University, Zhejiang Provincial Clinical Research Center for Mental Disorders, Wenzhou, Zhejiang 325000, China.'}, {'lastname': 'Huang', 'firstname': 'Zhengwei', 'initials': 'Z', 'affiliation': 'The Affiliated Kangning Hospital of Wenzhou Medical University, Zhejiang Provincial Clinical Research Center for Mental Disorders, Wenzhou, Zhejiang 325000, China.'}, {'lastname': 'Guan', 'firstname': 'Kaiyu', 'initials': 'K', 'affiliation': ""Wenzhou Seventh People's Hospital, Wenzhou, Zhejiang 325000, China.""}, {'lastname': 'Zhu', 'firstname': 'Ya', 'initials': 'Y', 'affiliation': 'The Affiliated Kangning Hospital of Wenzhou Medical University, Zhejiang Provincial Clinical Research Center for Mental Disorders, Wenzhou, Zhejiang 325000, China; State Key Laboratory of Freshwater Ecology and Biotechnology, Hubei Hongshan Laboratory, The Innovation Academy of Seed Design, University of Chinese Academy of Sciences, Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, China.'}, {'lastname': 'Chan', 'firstname': 'Cheekai', 'initials': 'C', 'affiliation': 'College of Science and Technology, Wenzhou-Kean University, Zhejiang 325000, China.'}, {'lastname': 'Gui', 'firstname': 'Jianfang', 'initials': 'J', 'affiliation': 'State Key Laboratory of Freshwater Ecology and Biotechnology, Hubei Hongshan Laboratory, The Innovation Academy of Seed Design, University of Chinese Academy of Sciences, Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, China.'}, {'lastname': 'Song', 'firstname': 'Cai', 'initials': 'C', 'affiliation': 'Research Institute for Marine Drugs and Nutrition, College of Food Science and Technology, Guangdong Ocean University, Zhanjiang 524088, China. Electronic address: cai.song@dal.ca.'}, {'lastname': 'Li', 'firstname': 'Xi', 'initials': 'X', 'affiliation': 'The Affiliated Kangning Hospital of Wenzhou Medical University, Zhejiang Provincial Clinical Research Center for Mental Disorders, Wenzhou, Zhejiang 325000, China. Electronic address: xili@wmu.edu.cn.'}]",,,,Copyright © 2023. Published by Elsevier Inc.,10.1016/j.pnpbp.2023.110844,<Element 'PubmedArticle' at 0x7f05dd602cc0>
15,37598678,The Regulatory Effect of the Paraventricular Nucleus on Hypertension.,"Hypertension is among the most harmful factors of cardiovascular and cerebrovascular diseases and poses an urgent problem for the development of human society. In addition to previous studies on its pathogenesis focusing on the peripheral sympathetic nervous system, investigating the central causes of high blood pressure involving the neuroendocrine and neuroinflammatory mechanisms of the hypothalamic paraventricular nucleus (PVN) is paramount. This nucleus is considered to regulate the output of neurohormones and sympathetic nerve activity. In this article, we focussed on the neuroendocrine mechanism, primarily exploring the specific contributions and interactions of various neurons and neuroendocrine hormones, including GABAergic and glutamatergic neurons, nitric oxide, arginine vasopressin, oxytocin, and the renin-angiotensin system. Additionally, the neuroinflammatory mechanism in the PVN was discussed, encompassing microglia, reactive oxygen species, inflammatory factors, and pathways, as well as immune connections between the brain and extracerebral organs. Notably, the two central mechanisms involved in the PVN not only exist independently but also communicate with each other, jointly maintaining the hypertensive state of the body. Furthermore, we introduce well-known molecules and signal transduction pathways within the PVN that can play a regulatory role in the two mechanisms to provide a basis and inspire ideas for further research.","['Hypertension', 'Neuroendocrine regulation', 'Neuroinflammation', 'Paraventricular nucleus']",Neuroendocrinology,2023-08-21,"[{'lastname': 'Xi', 'firstname': 'Hanyu', 'initials': 'H', 'affiliation': 'The Fifth Clinical Medical College of Shanxi Medical University, Taiyuan, China.'}, {'lastname': 'Li', 'firstname': 'Xingru', 'initials': 'X', 'affiliation': 'The Fifth Clinical Medical College of Shanxi Medical University, Taiyuan, China.'}, {'lastname': 'Zhou', 'firstname': 'Yun', 'initials': 'Y', 'affiliation': 'The Fifth Clinical Medical College of Shanxi Medical University, Taiyuan, China.\nDepartment of Nephrology, Shanxi Provincial Integrated Traditional Chinese Medicine and Western Medicine Hospital, Taiyuan, China.'}, {'lastname': 'Sun', 'firstname': 'Yaojun', 'initials': 'Y', 'affiliation': 'Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, China.\nSchool of Basic Medicine, Shanxi Medical University, Taiyuan, China.'}]",,,,"© 2023 S. Karger AG, Basel.",10.1159/000533691,<Element 'PubmedArticle' at 0x7f05dd1aa090>
16,"37587511
27546235
24833586
30471926
26786204
28732515
34107254
33214681
35228310
23273845
28122230
31493147
35260865
30783653
19910308
27508061
16199517
35589920
24994846
21369534
35974106
28602351
30082275
37393197
17969104
28863860
16626397
12670482
25896511
21490621
21642987
17851529
32848093
28970783
36617879
23545502
25666439
34530748
26235985
35177477
30944478
34140954
31959936
25309543
24963278
22198949
18981147
31324751
35487953
28245991
30782788
15833363
34294785
33301878
19689368
34281564
23965734
32379705
27374120
24162652
31018141
28930663
36747024
35181976
11322887
26354916
24019961
35922662
33732142
32589933
28340339
18256700
28928743
28665028
22171895
22036569
24411104
15728241
19503107
20484116
27091843
36257314
33008530
36449413
36624497",Microglial senescence contributes to female-biased neuroinflammation in the aging mouse hippocampus: implications for Alzheimer's disease.,"Microglia, the brain's principal immune cells, have been implicated in the pathogenesis of Alzheimer's disease (AD), a condition shown to affect more females than males. Although sex differences in microglial function and transcriptomic programming have been described across development and in disease models of AD, no studies have comprehensively identified the sex divergences that emerge in the aging mouse hippocampus. Further, existing models of AD generally develop pathology (amyloid plaques and tau tangles) early in life and fail to recapitulate the aged brain environment associated with late-onset AD. Here, we examined and compared transcriptomic and translatomic sex effects in young and old murine hippocampal microglia.
Hippocampal tissue from C57BL6/N and microglial NuTRAP mice of both sexes were collected at young (5-6 month-old [mo]) and old (22-25 mo) ages. Cell sorting and affinity purification techniques were used to isolate the microglial transcriptome and translatome for RNA-sequencing and differential expression analyses. Flow cytometry, qPCR, and imaging approaches were used to confirm the transcriptomic and translatomic findings.
There were marginal sex differences identified in the young hippocampal microglia, with most differentially expressed genes (DEGs) restricted to the sex chromosomes. Both sex chromosomally and autosomally encoded sex differences emerged with aging. These sex DEGs identified at old age were primarily female-biased and enriched in senescent and disease-associated microglial signatures. Normalized gene expression values can be accessed through a searchable web interface ( https://neuroepigenomics.omrf.org/ ). Pathway analyses identified upstream regulators induced to a greater extent in females than in males, including inflammatory mediators IFNG, TNF, and IL1B, as well as AD-risk genes TREM2 and APP.
These data suggest that female microglia adopt disease-associated and senescent phenotypes in the aging mouse hippocampus, even in the absence of disease pathology, to a greater extent than males. This sexually divergent microglial phenotype may explain the difference in susceptibility and disease progression in the case of AD pathology. Future studies will need to explore sex differences in microglial heterogeneity in response to AD pathology and determine how sex-specific regulators (i.e., sex chromosomal or hormonal) elicit these sex effects.","['Alzheimer’s disease', 'Brain aging', 'Disease-associated microglia', 'Hippocampus', 'Microglia', 'Neuroinflammation', 'Senescence', 'Sex divergence', 'Sex effects', 'Transcriptomics']",Journal of neuroinflammation,2023-08-17,"[{'lastname': 'Ocañas', 'firstname': 'Sarah R', 'initials': 'SR', 'affiliation': 'Genes and Human Disease Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, 73104, USA.\nDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.'}, {'lastname': 'Pham', 'firstname': 'Kevin D', 'initials': 'KD', 'affiliation': 'Genes and Human Disease Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, 73104, USA.'}, {'lastname': 'Cox', 'firstname': 'Jillian E J', 'initials': 'JEJ', 'affiliation': 'Genes and Human Disease Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, 73104, USA.\nGraduate Program in Biomedical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.'}, {'lastname': 'Keck', 'firstname': 'Alex W', 'initials': 'AW', 'affiliation': 'Genes and Human Disease Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, 73104, USA.'}, {'lastname': 'Ko', 'firstname': 'Sunghwan', 'initials': 'S', 'affiliation': 'Genes and Human Disease Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, 73104, USA.\nGraduate Program in Biomedical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.'}, {'lastname': 'Ampadu', 'firstname': 'Felix A', 'initials': 'FA', 'affiliation': 'Graduate Program in Biomedical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.'}, {'lastname': 'Porter', 'firstname': 'Hunter L', 'initials': 'HL', 'affiliation': 'Genes and Human Disease Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, 73104, USA.'}, {'lastname': 'Ansere', 'firstname': 'Victor A', 'initials': 'VA', 'affiliation': 'Genes and Human Disease Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, 73104, USA.\nDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.'}, {'lastname': 'Kulpa', 'firstname': 'Adam', 'initials': 'A', 'affiliation': 'Genes and Human Disease Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, 73104, USA.'}, {'lastname': 'Kellogg', 'firstname': 'Collyn M', 'initials': 'CM', 'affiliation': 'Genes and Human Disease Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, 73104, USA.\nDepartment of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.'}, {'lastname': 'Machalinski', 'firstname': 'Adeline H', 'initials': 'AH', 'affiliation': 'Genes and Human Disease Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, 73104, USA.'}, {'lastname': 'Thomas', 'firstname': 'Manu A', 'initials': 'MA', 'affiliation': 'Genes and Human Disease Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, 73104, USA.'}, {'lastname': 'Wright', 'firstname': 'Zsabre', 'initials': 'Z', 'affiliation': 'Genes and Human Disease Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, 73104, USA.'}, {'lastname': 'Chucair-Elliott', 'firstname': 'Ana J', 'initials': 'AJ', 'affiliation': 'Genes and Human Disease Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, 73104, USA.'}, {'lastname': 'Freeman', 'firstname': 'Willard M', 'initials': 'WM', 'affiliation': 'Genes and Human Disease Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK, 73104, USA. bill-freeman@omrf.org.\nDepartment of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. bill-freeman@omrf.org.\nOklahoma City Veterans Affairs Medical Center, Oklahoma City, OK, USA. bill-freeman@omrf.org.'}]",,,"There were marginal sex differences identified in the young hippocampal microglia, with most differentially expressed genes (DEGs) restricted to the sex chromosomes. Both sex chromosomally and autosomally encoded sex differences emerged with aging. These sex DEGs identified at old age were primarily female-biased and enriched in senescent and disease-associated microglial signatures. Normalized gene expression values can be accessed through a searchable web interface ( https://neuroepigenomics.omrf.org/ ). Pathway analyses identified upstream regulators induced to a greater extent in females than in males, including inflammatory mediators IFNG, TNF, and IL1B, as well as AD-risk genes TREM2 and APP.","© 2023. BioMed Central Ltd., part of Springer Nature.",10.1186/s12974-023-02870-2,<Element 'PubmedArticle' at 0x7f05dd1a4d10>
17,37586522,Bisphenol analogues induced social defects and neural impairment in zebrafish.,"There is evidence in humans that endocrine disrupting chemicals exposure, such as bisphenol A (BPA), is tied to social behavior impacts when evaluated in early life stage. However, the potential social impact of BPA alternatives and its association with central nervous system (CNS) is poorly understood. Here, we performed behavioral test for zebrafish that are continuously exposed to environmental relevant concentrations (5 and 500 ng/L) of BPA, BPF, and BPAF since embryonic stage. Surprisingly, significant social behavior defects, including increased social distance and decreased contact time, were identified in zebrafish treated by 500 ng/L BPAF and BPA. These behavioral changes were accompanied by apparent histological injury, microglia activation, enhanced apoptosis and neuron loss in brain. The gut-brain transcriptional profile showed that genes involved in neuronal development pathways were up-regulated in all bisphenol analogs treatments, indicating a protective phenotype of CNS; however, these pathways were inhibited in gut. Besides, a variety of key regulators in the gut-brain regulation were identified based on protein interaction prediction, such as rac1-limk1, insrb1 and fosab. These findings implicated that the existence of bisphenol analogues in water would influence the social life of fish, and revealed a potential role of gut-brain transcriptional alteration in mediating this effect.","['Bisphenol analogues', 'Gut-brain transcriptional changes', 'Neural damage', 'Social behavior defect', 'Zebrafish']",The Science of the total environment,2023-08-17,"[{'lastname': 'Mu', 'firstname': 'Xiyan', 'initials': 'X', 'affiliation': ""Institute of Quality Standard and Testing Technology for Agro-Products, Chinese Academy of Agricultural Sciences, Beijing, People's Republic of China.""}, {'lastname': 'Liu', 'firstname': 'Zaiteng', 'initials': 'Z', 'affiliation': ""Institute of Quality Standard and Testing Technology for Agro-Products, Chinese Academy of Agricultural Sciences, Beijing, People's Republic of China.""}, {'lastname': 'Zhao', 'firstname': 'Xiaoyu', 'initials': 'X', 'affiliation': ""Institute of Quality Standard and Testing Technology for Agro-Products, Chinese Academy of Agricultural Sciences, Beijing, People's Republic of China.""}, {'lastname': 'Chen', 'firstname': 'Lu', 'initials': 'L', 'affiliation': ""Institute of Quality Standard and Testing Technology for Agro-Products, Chinese Academy of Agricultural Sciences, Beijing, People's Republic of China.""}, {'lastname': 'Jia', 'firstname': 'Qi', 'initials': 'Q', 'affiliation': ""Institute of Quality Standard and Testing Technology for Agro-Products, Chinese Academy of Agricultural Sciences, Beijing, People's Republic of China.""}, {'lastname': 'Wang', 'firstname': 'Chengju', 'initials': 'C', 'affiliation': ""College of Sciences, China Agricultural University, Beijing, People's Republic of China.""}, {'lastname': 'Li', 'firstname': 'Tiejun', 'initials': 'T', 'affiliation': 'Zhejiang Marine Fisheries Research Institute, China.'}, {'lastname': 'Guo', 'firstname': 'Yuanming', 'initials': 'Y', 'affiliation': 'Zhejiang Marine Fisheries Research Institute, China.'}, {'lastname': 'Qiu', 'firstname': 'Jing', 'initials': 'J', 'affiliation': ""Institute of Quality Standard and Testing Technology for Agro-Products, Chinese Academy of Agricultural Sciences, Beijing, People's Republic of China. Electronic address: qiujing@caas.cn.""}, {'lastname': 'Qian', 'firstname': 'Yongzhong', 'initials': 'Y', 'affiliation': ""Institute of Quality Standard and Testing Technology for Agro-Products, Chinese Academy of Agricultural Sciences, Beijing, People's Republic of China.""}]",,,,Copyright © 2023 Elsevier B.V. All rights reserved.,10.1016/j.scitotenv.2023.166307,<Element 'PubmedArticle' at 0x7f05dcf68cc0>
18,"37578424
24691477
25104651
24211245
33876574
27330279
12882811
16903779
33022379
35569553
26210152
17975672
34948115
31676122
33559854
31734129
21166540
35548357
31588227
26260587
14068225
432640
6656879
17198543
18155917
10831154
8989725
29630951
23889107
28658514
30597604
9645491
11694323
28655998
32323368
27156982
24136346
25704819
35310341
29225722
29411894
35436360
36031799
36113764
23933169
25963977
22296808
28729727
27716746
16217133
34139338
32691289
18410310
19090913
16879320
23562078
34361062
31006904
34302814
33790896
30173051
33411973
34153300
23756865
23796350
16835236
10861063
10657644
12754507",Therapeutic Benefit of Melatonin in Choroidal Neovascularization During Aging Through the Regulation of Senescent Macrophage/Microglia Polarization.,"This study aimed to investigate the age-dependent anti-angiogenic capability of melatonin in choroidal neovascularization (CNV) and to explore the underlying molecular mechanisms.
In the present study, a laser-induced CNV model was established in both young (three months of age) and old (18 months of age) mice, and the size of CNV lesions and vascular leakage was detected by morphological and imaging examination. Next, Western blot and immunostaining were used to observe the levels of M2 markers, senescence-related markers, and molecules involved in IL-10/STAT3 pathway. Additionally, colivelin was used to study the effect of IL-10/STAT3 pathway activation on the expression of M2 markers and senescence-related markers by Western blot and immunostaining. Finally, the effects of colivelin on melatonin-induced reduction of CNV size and vascular leakage in mice at different ages were assessed using morphological and imaging examination.
Our results revealed that aging promoted M2 macrophage/microglia polarization, and aggravated CNV and vascular leakage. Melatonin significantly inhibited the M2 polarization of senescent macrophage/microglia and reduced the CNV area and vascular leakage. Moreover, melatonin markedly suppressed IL-10/STAT3 pathway activation in the macrophage/microglia of old mice, and STAT3 activator colivelin reversed the suppressive effect of melatonin on M2 polarization of senescent macrophage/microglia and laser-induced CNV in old mice.
Our data demonstrated that melatonin significantly prevented the M2 polarization of senescent macrophage/microglia by inhibiting the IL-10/STAT3 pathway, and eventually attenuated senescence-associated CNV. These findings suggested that melatonin could serve as a promising therapeutic agent to treat CNV and other age-related ocular diseases.",[],Investigative ophthalmology & visual science,2023-08-14,"[{'lastname': 'Cui', 'firstname': 'Kaixuan', 'initials': 'K', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China.'}, {'lastname': 'Tang', 'firstname': 'Xiaoyu', 'initials': 'X', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China.'}, {'lastname': 'Hu', 'firstname': 'Andina', 'initials': 'A', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China.'}, {'lastname': 'Fan', 'firstname': 'Matthew', 'initials': 'M', 'affiliation': 'Yale College, Yale University, New Haven, Connecticut, United States.'}, {'lastname': 'Wu', 'firstname': 'Peiqi', 'initials': 'P', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China.'}, {'lastname': 'Lu', 'firstname': 'Xi', 'initials': 'X', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China.'}, {'lastname': 'Lin', 'firstname': 'Jicheng', 'initials': 'J', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China.'}, {'lastname': 'Yang', 'firstname': 'Fengmei', 'initials': 'F', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China.'}, {'lastname': 'Zhao', 'firstname': 'Xinyu', 'initials': 'X', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China.'}, {'lastname': 'Huang', 'firstname': 'Jingjing', 'initials': 'J', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China.'}, {'lastname': 'Yu', 'firstname': 'Shanshan', 'initials': 'S', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China.'}, {'lastname': 'Xu', 'firstname': 'Yue', 'initials': 'Y', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China.'}, {'lastname': 'Liang', 'firstname': 'Xiaoling', 'initials': 'X', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China.'}]",,,"Our results revealed that aging promoted M2 macrophage/microglia polarization, and aggravated CNV and vascular leakage. Melatonin significantly inhibited the M2 polarization of senescent macrophage/microglia and reduced the CNV area and vascular leakage. Moreover, melatonin markedly suppressed IL-10/STAT3 pathway activation in the macrophage/microglia of old mice, and STAT3 activator colivelin reversed the suppressive effect of melatonin on M2 polarization of senescent macrophage/microglia and laser-induced CNV in old mice.",,10.1167/iovs.64.11.19,<Element 'PubmedArticle' at 0x7f05de35bd60>
19,37573252,The role of microglial activation on ischemic stroke: Modulation by fibroblast growth factors.,"Stroke is one of the devastating clinical conditions that causes death and permanent disability. Its occurrence causes the reduction of oxygen and glucose supply, resulting in events such as inflammatory response, oxidative stress, and apoptosis in the brain. Microglia are brain-resident immune cells in the central nervous system (CNS) that exert diverse roles and respond to pathological process after an ischemic insult. The discovery of fibroblast growth factors (FGFs) in mammals, resulted to the findings that they can treat experimental models of stroke in animals effectively. FGFs function as homeostatic factors that control cells and hormones involved in metabolism, and they also regulate the secretion of proinflammatory (M1) and anti-inflammatory (M2) cytokines after stroke. In this review, we outline current evidence of microglia activation in experimental models of stroke focusing on its ability to exacerbate damage or repair tissue. Also, our review sheds light on the pharmacological actions of FGFs on multiple targets to regulate microglial modulation and highlighted their theoretical molecular mechanisms to provide possible therapeutic targets, as well as their limitations for the treatment of stroke. DATA AVAILABILITY: Not applicable.","['FGFs', 'Ischemic stroke', 'Microglia', 'Theoretical mechanism', 'Therapeutic effect']",Cytokine & growth factor reviews,2023-08-13,"[{'lastname': 'Dordoe', 'firstname': 'Confidence', 'initials': 'C', 'affiliation': 'Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.'}, {'lastname': 'Huang', 'firstname': 'Wenting', 'initials': 'W', 'affiliation': 'The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.'}, {'lastname': 'Bwalya', 'firstname': 'Canol', 'initials': 'C', 'affiliation': 'Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.'}, {'lastname': 'Wang', 'firstname': 'Xue', 'initials': 'X', 'affiliation': 'Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.'}, {'lastname': 'Shen', 'firstname': 'Bixin', 'initials': 'B', 'affiliation': 'Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.'}, {'lastname': 'Wang', 'firstname': 'Hao', 'initials': 'H', 'affiliation': 'Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.'}, {'lastname': 'Wang', 'firstname': 'Jing', 'initials': 'J', 'affiliation': 'Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.'}, {'lastname': 'Ye', 'firstname': 'Shasha', 'initials': 'S', 'affiliation': 'Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.'}, {'lastname': 'Wang', 'firstname': 'Peng', 'initials': 'P', 'affiliation': 'Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.'}, {'lastname': 'Xiaoyan', 'firstname': 'Bao', 'initials': 'B', 'affiliation': 'Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.'}, {'lastname': 'Li', 'firstname': 'Xiaokun', 'initials': 'X', 'affiliation': 'Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; Research Units of Clinical Translation of Cell Growth Factors and Diseases Research, Chinese Academy of Medical Science, Wenzhou, Zhejiang 325035, China. Electronic address: lixk1964@163.com.'}, {'lastname': 'Lin', 'firstname': 'Li', 'initials': 'L', 'affiliation': 'Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; Research Units of Clinical Translation of Cell Growth Factors and Diseases Research, Chinese Academy of Medical Science, Wenzhou, Zhejiang 325035, China. Electronic address: linliwz@163.com.'}]",,,,Copyright © 2023. Published by Elsevier Ltd.,10.1016/j.cytogfr.2023.07.005,<Element 'PubmedArticle' at 0x7f05de341d60>
20,37572876,Intranasal Insulin Alleviates Traumatic Brain Injury by Inhibiting Autophagy and Endoplasmic Reticulum Stress-mediated Apoptosis Through the PI3K/Akt/mTOR Signaling Pathway.,"Intranasal insulin reduces lesion size and enhances memory capacity in traumatic brain injury (TBI) models, but the molecular mechanisms behind this neuroprotective action not yet understood. Here we used Feeney's free-falling method to construct TBI mouse models and administrated intranasal insulin, rapamycin, insulin and rapamycin, or normal saline to assess their effects on neurological functions, cerebral edema, and the expression of Iba1 in microglia through immunofluorescence assay. We also measured concentrations of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in the brain using enzyme immunosorbent assay, investigated apoptosis with TUNEL staining and Western blotting, and evaluated autophagy, endoplasmic reticulum (ER) stress, and PI3K/Akt/mTOR signaling pathway with Western blotting. The autophagosome was assessed through transmission electron microscopy. Our findings demonstrated that intranasal insulin promoted neurological recovery, decreased brain swelling, and reduced injury lesions on days 1, 3, and 7 post TBI. Moreover, intranasal insulin reduced microglia activation and the concentration of IL-1β or TNF-α on the same days. Through Western blotting and transmission electron microscopy, we observed that intranasal insulin suppressed autophagy while activating the PI3K/AKT/mTOR signaling pathway on days 1 and 3 post TBI. TUNEL assay and Western blotting also indicated that intranasal insulin inhibited ER stress-mediated apoptosis. Interestingly, the mTOR inhibitor rapamycin partially blocked the pro-autophagy and anti-apoptosis effects of intranasal insulin both on days 1 and 3 post TBI. Our results suggest that intranasal insulin can ameliorate TBI by regulating autophagy and ER stress-mediated apoptosis through the PI3K/AKT/mTOR signaling pathway, providing a promising therapeutic strategy for TBI.","['PI3K/AKT/mTOR signaling pathway', 'apoptosis', 'autophagy', 'endoplasmic reticulum stress', 'intranasal insulin', 'traumatic brain injury']",Neuroscience,2023-08-13,"[{'lastname': 'Ding', 'firstname': 'Xin', 'initials': 'X', 'affiliation': ""Department of Neurology, Chengdu Second People's Hospital, No. 2, Huatai Road, Chenghua District, Chengdu, Sichuan 610017, People's Republic of China.""}, {'lastname': 'Zhang', 'firstname': 'Lili', 'initials': 'L', 'affiliation': ""Department of Neurology, The First Affiliated Hospital of Chengdu Medical College, No, 278, Middle Baoguang Avenue, Xindu District, Chengdu, Sichuan 610050, People's Republic of China.""}, {'lastname': 'Zhang', 'firstname': 'Xinping', 'initials': 'X', 'affiliation': ""Department of General Medicine, Chengdu Second People's Hospital, No. 2, Huatai Road, Chenghua District, Chengdu, Sichuan 610017, People's Republic of China.""}, {'lastname': 'Qin', 'firstname': 'Yang', 'initials': 'Y', 'affiliation': ""Department of General Medicine, The General Hospital of Western Theatre Command, No. 270, Tianhui Road, Rongdu Avenue, Jinniu District, Chengdu, Sichuan 610083, People's Republic of China. Electronic address: yangqin0280838@163.com.""}, {'lastname': 'Yu', 'firstname': 'Ke', 'initials': 'K', 'affiliation': ""Department of General Medicine, The General Hospital of Western Theatre Command, No. 270, Tianhui Road, Rongdu Avenue, Jinniu District, Chengdu, Sichuan 610083, People's Republic of China.""}, {'lastname': 'Yang', 'firstname': 'Xiaokun', 'initials': 'X', 'affiliation': ""Department of Emergency, The General Hospital of Western Theatre Command, No. 270, Tianhui Road, Rongdu Avenue, Jinniu District, Chengdu, Sichuan 610083, People's Republic of China.""}]",,,,Copyright © 2023 IBRO. Published by Elsevier Ltd. All rights reserved.,10.1016/j.neuroscience.2023.08.009,<Element 'PubmedArticle' at 0x7f05de33d9a0>
21,"37561258
21338871
23470902
30698724
21564086
30787373
30890355
15317861
27956668
30206330
12191486
24133343
33549727
26931361
25060102
29318587
30242884
31803045
31327964
32117301
34015428
20083193
30536556
26479925
28987324
33607128
29178967
15356140
34389559
17919885
27012766
33871050
29559889
32393298
33298171
31209039
35131445
32905811
34398403
23321159
18584038
30208926
27352782
32413745
34891000
32971182
33383130
27365531
21783017
32600435
25745356
30173051",Toll-like Receptor 2-Melatonin Feedback Loop Regulates the Activation of Spinal NLRP3 Inflammasome in Morphine-Tolerant Rats.,"Morphine is amongst the most effective analgesics available for the management of severe pain. However, prolonged morphine treatment leads to analgesic tolerance which limits its clinical usage. Previous studies have demonstrated that melatonin ameliorates morphine tolerance by reducing neuroinflammation. However, little is known about the relationship between Toll like receptor 2 (TLR2) and neuroinflammation in morphine tolerance. The aim of this study was to explore the role of TLR2 in morphine tolerance and its connections with melatonin and Nod-like receptor protein 3 (NLRP3) inflammasome.
Sprague-Dawley rats were treated with morphine for 7 days and tail-flick latency test was performed to identify the induction of analgesic tolerance. The roles of TLR2 in microglia activation and morphine tolerance were assessed pharmacologically, and the possible interactions between melatonin, TLR2 and NLRP3 inflammasome were investigated.
Morphine tolerance was accompanied by increased TLR2 expression and NLRP3 inflammasome activation in spinal cord. whereas melatonin level was down-regulated. Chronic melatonin administration resulted in a reduced TLR2 expression and NLRP3 inflammasome activation. Moreover, the analgesic effect of morphine was partially restored. Inhibition of TLR2 suppressed the microglia and NLRP3 inflammasome activation, as well as restored the spinal melatonin level while attenuated the development of morphine tolerance. Furthermore, the inhibition of microglia activation ameliorated morphine tolerance via inhibiting TLR2-NLRP3 inflammasome signaling in spinal cord.
In this study, we directly demonstrate a TLR2-melatonin negative feedback loop regulating microglia and NLRP3 inflammasome activation during the development of morphine tolerance.","['Melatonin', 'Morphine tolerance', 'Nod-like receptor protein 3 inflammasome', 'Toll-like receptor 2']",Neurochemical research,2023-08-10,"[{'lastname': 'Peng', 'firstname': 'Xiaoling', 'initials': 'X', 'affiliation': 'Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Ave, Wuhan, 430030, China.'}, {'lastname': 'Wang', 'firstname': 'Jihong', 'initials': 'J', 'affiliation': 'Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Ave, Wuhan, 430030, China.'}, {'lastname': 'Li', 'firstname': 'Zheng', 'initials': 'Z', 'affiliation': 'Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Ave, Wuhan, 430030, China.'}, {'lastname': 'Jia', 'firstname': 'Xiaoqian', 'initials': 'X', 'affiliation': 'Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Ave, Wuhan, 430030, China.'}, {'lastname': 'Zhang', 'firstname': 'Anqi', 'initials': 'A', 'affiliation': 'Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Ave, Wuhan, 430030, China.'}, {'lastname': 'Ju', 'firstname': 'Jie', 'initials': 'J', 'affiliation': 'Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Ave, Wuhan, 430030, China.'}, {'lastname': 'Eulenburg', 'firstname': 'Volker', 'initials': 'V', 'affiliation': 'Department for Translational Anaesthesiology and Intensive Care Medicine, Medical Faculty University of Augsburg, 86156, Augsburg, Germany. Volker.Eulenburg@med.uni-augsburg.de.'}, {'lastname': 'Gao', 'firstname': 'Feng', 'initials': 'F', 'affiliation': 'Department of Anesthesiology, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Ave, Wuhan, 430030, China. fgao@tjh.tjmu.edu.cn.'}]",,"In this study, we directly demonstrate a TLR2-melatonin negative feedback loop regulating microglia and NLRP3 inflammasome activation during the development of morphine tolerance.",,"© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.","10.1007/s11064-023-03998-6
10.1016/j.neuron.2011.02.001
10.1016/j.bbr.2013.02.034
10.1093/jmcb/mjz002
10.1111/j.1476-5381.2011.01482.x
10.1038/s41598-019-39555-x
10.1016/j.peptides.2019.01.003
10.1523/JNEUROSCI.1850-04.2004
10.1093/bja/aew376
10.1038/s41583-018-0055-7
10.1016/s1097-2765(02)00599-3
10.3346/jkms.2013.28.10.1415
10.1016/j.phrs.2021.105482
10.1186/s12974-016-0520-z
10.1111/jpi.12162
10.1111/bph.14116
10.1111/jpi.12525
10.3389/fnagi.2019.00314
10.3389/fimmu.2019.01511
10.3389/fimmu.2020.00172
10.1016/j.bbi.2021.05.013
10.1016/j.freeradbiomed.2010.01.006
10.1002/jcp.27929
10.1038/nm.3978
10.1016/j.pharmthera.2017.10.006
10.1016/j.taap.2021.115458
10.1186/s12974-017-0997-0
10.4049/jimmunol.173.6.3916
10.1158/2326-6066.CIR-20-1019
10.1016/j.bbi.2007.07.014
10.1016/j.lfs.2016.03.032
10.1111/jnc.15368
10.3389/fnmol.2018.00072
10.1186/s12974-020-1731-x
10.1186/s13578-020-00501-4
10.1073/pnas.1901182116
10.1016/j.bbi.2022.02.001
10.1016/j.bbr.2020.112896
10.1007/s12035-021-02463-1
10.1124/pr.112.005942
10.1155/2008/453120
10.1186/s12974-018-1301-7
10.1093/schbul/sbw088
10.1016/j.redox.2020.101560
10.1016/j.intimp.2021.108397
10.1016/j.bbi.2020.09.017
10.1016/j.tox.2020.152668
10.1189/jlb.2A1215-555RR
10.1016/S0929-6646(11)60074-0
10.1186/s13287-020-01756-x
10.1186/1471-2253-15-12
10.1016/j.intimp.2018.08.034",<Element 'PubmedArticle' at 0x7f05dbba0b30>
22,37524128,"The many ""Neurofaces"" of Prohibitins 1 and 2: Crucial for the healthy brain, dysregulated in numerous brain disorders.","Prohibitin 1 (PHB1) and prohibitin 2 (PHB2) are proteins that are nearly ubiquitously expressed. They are localized in mitochondria, cytosol and cell nuclei. In the healthy CNS, they occur in neurons and non-neuronal cells (oligodendrocytes, astrocytes, microglia, and endothelial cells) and fulfill pivotal functions in brain development and aging, the regulation of brain metabolism, maintenance of structural integrity, synapse formation, aminoacidergic neurotransmission and, probably, regulation of brain action of certain hypothalamic-pituitary hormones.With regard to the diseased brain there is increasing evidence that prohibitins are prominently involved in numerous major diseases of the CNS, which are summarized and discussed in the present review (brain tumors, neurotropic viruses, Alzheimer disease, Down syndrome, Fronto-temporal and vascular dementia, dementia with Lewy bodies, Parkinson disease, Huntington disease, Multiple sclerosis, Amyotrophic lateral sclerosis, stroke, alcohol use disorder, schizophrenia and autism). Unfortunately, there is no PHB-targeted therapy available for any of these diseases.","['Brain development', 'Energy metabolism', 'Glia', 'Mitochondria', 'Neurologic disorders', 'Neuron', 'Neurotransmission', 'Prohibitin 1', 'Prohibitin 2', 'Psychiatric disorders']",Journal of chemical neuroanatomy,2023-08-01,"[{'lastname': 'Bernstein', 'firstname': 'Hans-Gert', 'initials': 'HG', 'affiliation': 'Department of Psychiatry, Otto-von-Guericke University, Leipziger Str. 44, D-39120 Magdeburg, Germany. Electronic address: Hans-Gert.Bernstein@med.ovgu.de.'}, {'lastname': 'Smalla', 'firstname': 'Karl-Heinz', 'initials': 'KH', 'affiliation': 'Leibniz Institute for Neurobiology, RG Neuroplasticity, D-39118 Magdeburg, Germany; Institute for Pharmacology and Toxicology, Otto-von-Guericke University, Magdeburg, Germany, Center for Behavioral Brain Sciences, Magdeburg, Germany.'}, {'lastname': 'Keilhoff', 'firstname': 'Gerburg', 'initials': 'G', 'affiliation': 'Institute of Biochemistry and Cell Biology, Otto-von-Guericke University, Magdeburg, Germany.'}, {'lastname': 'Dobrowolny', 'firstname': 'Henrik', 'initials': 'H', 'affiliation': 'Department of Psychiatry, Otto-von-Guericke University, Leipziger Str. 44, D-39120 Magdeburg, Germany.'}, {'lastname': 'Kreutz', 'firstname': 'Michael R', 'initials': 'MR', 'affiliation': 'Leibniz Institute for Neurobiology, RG Neuroplastcity, D-39118 Magdeburg, Germany; University Medical Center Hamburg Eppendorf, Leibniz Group ""Dendritic Organelles and Synaptic Function"" ZMNH, Hamburg, Germany.'}, {'lastname': 'Steiner', 'firstname': 'Johann', 'initials': 'J', 'affiliation': 'Department of Psychiatry, Otto-von-Guericke University, Leipziger Str. 44, D-39120 Magdeburg, Germany.'}]",,,,Copyright © 2023 Elsevier B.V. All rights reserved.,10.1016/j.jchemneu.2023.102321,<Element 'PubmedArticle' at 0x7f05dbb7f860>
23,37483155,Luteolin/ZnO nanoparticles attenuate neuroinflammation associated with diabetes via regulating MicroRNA-124 by targeting C/EBPA.,"The most prevalent brain-specific microRNA, MicroRNA-124, exhibits anti-inflammatory properties. Luteolin nano-formulation with Zn oxide in the form of L/ZnO NPs may boost anti-diabetic properties; however, its beneficial effect on miRNAs is yet unknown in diabetes. The effectiveness of L/ZnONPs supplements in preventing diabetic neurodegeneration by modulating inflammatory responses in a diabetic model was investigated.
A diabetic rat model was induced by a high-fat diet and streptozotocin (30 mg/kg I.P.). Plasma glucose, insulin, and HOMR-IR levels, as well as cytokines, lipid peroxidation, GSH/GSSG, and glucose transporter 1, were determined along with the tight junction proteins occludin (OCLN) and zona occludens 1 (ZO-1). Moreover, the expressions of brain CCAAT/enhancer-binding protein (C/EBPA mRNA), miR-124, glial fibrillary acidic protein (GFAP), and NF-kBp65 were measured alongside the histological investigation.
The results revealed that L/ZnO NPs were able to diminish lipid peroxidation, increase the activity of antioxidant enzymes, and reduce inflammation under oxidative stress. Consequently, it was able to reduce hyperglycemia, elevate insulin levels, and improve insulin resistance. Besides, L/ZnO NPs upregulate miR-124, reduce C/EBPA mRNA, increase BCl-2, and inhibit apoptosis. The results indicate that diabetes raises BBB permeability via tight junction protein decline, which is restored following L/ZnO NPs treatment. Luteolin/ZnO NPs regulate miR-124 and microglia polarization by targeting C/EBPA and are expected to alleviate inflammatory injury via modulation of the redox-sensitive signal transduction pathways. Luteolin/ZnO NPs have a novel target for the protection of the BBB and the prevention of neurological complications in diabetes.","['Luteolin/ZnO NPs', 'blood brain-barrier', 'diabetes', 'miR-124']",Environmental toxicology,2023-07-24,"[{'lastname': 'Moustafa', 'firstname': 'Enas M', 'initials': 'EM', 'affiliation': 'Radiation Biology, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt.'}, {'lastname': 'Moawed', 'firstname': 'Fatma S M', 'initials': 'FSM', 'affiliation': 'Health radiation research, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt.'}, {'lastname': 'Elmaghraby', 'firstname': 'Dina F', 'initials': 'DF', 'affiliation': 'Health radiation research, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt.'}]",,,"The results revealed that L/ZnO NPs were able to diminish lipid peroxidation, increase the activity of antioxidant enzymes, and reduce inflammation under oxidative stress. Consequently, it was able to reduce hyperglycemia, elevate insulin levels, and improve insulin resistance. Besides, L/ZnO NPs upregulate miR-124, reduce C/EBPA mRNA, increase BCl-2, and inhibit apoptosis. The results indicate that diabetes raises BBB permeability via tight junction protein decline, which is restored following L/ZnO NPs treatment. Luteolin/ZnO NPs regulate miR-124 and microglia polarization by targeting C/EBPA and are expected to alleviate inflammatory injury via modulation of the redox-sensitive signal transduction pathways. Luteolin/ZnO NPs have a novel target for the protection of the BBB and the prevention of neurological complications in diabetes.",© 2023 Wiley Periodicals LLC.,10.1002/tox.23903,<Element 'PubmedArticle' at 0x7f05dbb972c0>
24,37479016,Insulin alleviates lipopolysaccharide-induced cognitive impairment via inhibiting neuroinflammation and ferroptosis.,"Neuroinflammation is regarded to be a key mediator in cerebral diseases with attendant cognitive decline. Ferroptosis, characterized by iron-dependent lipid peroxidation, participates in neuroinflammation and cognitive impairment. Recent studies have revealed insulin's neuroprotective effects and involvement in the regulation of numerous central functions. But the effect of insulin on cognitive impairment induced by neuroinflammation has been rarely explored. In this study, we constructed a cognitive impairment model by intracerebroventricular injection of lipopolysaccharide (LPS) and a single dosage of insulin was mixed in the LPS solution to explore the potential mechanisms through which insulin treatment could improve LPS-induced cognitive dysfunction. At 24 h after treatment, we found that insulin treatment significantly improved LPS-induced cognitive decline, neuronal injuries, and blood-brain barrier (BBB) disruption. Insulin treatment could also inhibit the LPS-induced activation of microglia and astrocytes, and the release of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in the hippocampus. Furthermore, insulin treatment inhibited LPS-induced ferroptosis in the hippocampus by decreasing iron accumulation levels, regulating ferroptosis-related proteins including transferrin, glutathione peroxidase 4 (GPX4), ferritin heavy chin 1 (FTH1) and cystine/glutamate antiporter (xCT), inhibiting oxidative stress injuries and lipid peroxidation in the hippocampus. In conclusion, our finding that insulin treatment could alleviate LPS-induced cognitive impairment by inhibiting neuroinflammation and ferroptosis provides a new potential therapeutic method to ameliorate cognitive decline.","['Cognitive impairment', 'Ferroptosis', 'Insulin', 'Lipopolysaccharide', 'Neuroinflammation']",European journal of pharmacology,2023-07-22,"[{'lastname': 'Sun', 'firstname': 'Miao', 'initials': 'M', 'affiliation': 'Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China; Department of Anesthesiology, The First Affiliated Hospital, Jinzhou Medical University, Jinzhou, Liaoning Province, 121000, China.'}, {'lastname': 'Li', 'firstname': 'Yang', 'initials': 'Y', 'affiliation': 'Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.'}, {'lastname': 'Liu', 'firstname': 'Min', 'initials': 'M', 'affiliation': 'Department of Anesthesiology, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.'}, {'lastname': 'Li', 'firstname': 'Qingxiao', 'initials': 'Q', 'affiliation': 'Department of Nuclear Medicine, The First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.'}, {'lastname': 'Shi', 'firstname': 'Likai', 'initials': 'L', 'affiliation': 'Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.'}, {'lastname': 'Ruan', 'firstname': 'Xianghan', 'initials': 'X', 'affiliation': 'Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.'}, {'lastname': 'Huo', 'firstname': 'Yuting', 'initials': 'Y', 'affiliation': 'Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.'}, {'lastname': 'Zhou', 'firstname': 'Zhikang', 'initials': 'Z', 'affiliation': 'Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.'}, {'lastname': 'Zhang', 'firstname': 'Xiaoying', 'initials': 'X', 'affiliation': 'Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China. Electronic address: zxystudy@163.com.'}, {'lastname': 'Ma', 'firstname': 'Yulong', 'initials': 'Y', 'affiliation': 'Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China. Electronic address: yulongma123@163.com.'}, {'lastname': 'Mi', 'firstname': 'Weidong', 'initials': 'W', 'affiliation': 'Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China. Electronic address: wwdd1962@163.com.'}]",,,,Copyright © 2023 Elsevier B.V. All rights reserved.,10.1016/j.ejphar.2023.175929,<Element 'PubmedArticle' at 0x7f05dde12d10>
25,37460327,Senso-immunology: The Emerging Connection between Pain and Immunity.,"The sensory and immune systems have been studied independently for a long time, whereas the interaction between the two has received little attention. We have carried out research to understand the interaction between the sensory and immune systems and have found that inflammation and bone destruction caused by fungal infection are suppressed by nociceptors. Furthermore, we have elucidated the molecular mechanism whereby fungal receptors are expressed on nociceptors and skin epithelium, how they cooperate to generate fungal pain, and how colitis and bone metabolism are regulated by mechanosensors expressed on the gut epithelium. Recently, we found that nociceptors prevent septic death by inhibiting microglia via nociceptor-derived hormones. This review summarizes our current state of knowledge on pain biology and outlines the mechanisms whereby pain and immunity interact. Our findings indicate that the sensory and immune systems share a variety of molecules and interact with each other to regulate our pathological and homeostatic conditions. This prompted us to advocate the interdisciplinary science named ""senso-immunology,"" and this emerging field is expected to generate new ideas in both physiology and immunology, leading to the development of novel drugs to treat pain and inflammation.","['immunology', 'infection', 'pain', 'physiology']",The Keio journal of medicine,2023-07-18,"[{'lastname': 'Maruyama', 'firstname': 'Kenta', 'initials': 'K', 'affiliation': 'National Institute for Physiological Sciences, Okazaki, Japan.'}]",,,,,10.2302/kjm.2022-0037-IR,<Element 'PubmedArticle' at 0x7f05dde07310>
26,"37400893
28971799
27578619
22455417
16133546
7726314
22801496
29203879
28800490
27393312
21674499
15044184
19247273
15968634
13694291
11386983
16002529
36914703
30253045
35858325
23064363
24166765
28954222
556308
31327049
1425443
22896675
2557773
25947369
25824676
32814716
24425068
18628631
9620771
10882782
30472090
36941447
25448678
11448938
29274352
35108515
37248328
25233153
25646713
31953399
35347267
34848489
29184212
37217978
34823066
31068220
31843930
25392498
22201683
3540468
24136970
24024123
20060897
28489068
27893874
28625488
31916277",Reduction of oxytocin-containing neurons and enhanced glymphatic activity in the hypothalamic paraventricular nucleus of patients with type 2 diabetes mellitus.,"Evidence from animal experiments has shown that the hypothalamic paraventricular nucleus (PVN) plays a key role in regulating body weight and blood glucose levels. However, it is unclear whether neuron populations in the human PVN are involved in the development of type 2 diabetes mellitus (T2DM). To address this, we investigated the neuronal and glial populations in the PVN of 26 T2DM patients and 20 matched controls. Our findings revealed a significant reduction in oxytocin (Oxt) neuron density in the PVN of T2DM patients compared to controls, while other neuronal populations remained unchanged. This suggests that Oxt neurons may play a specific role in the pathophysiology of T2DM. Interestingly, the reduction in Oxt neurons was accompanied by a decreased melanocortinergic input in to the PVN as reflected by a reduction in alpha-MSH immunoreactivity. We also analysed two glial cell populations, as they are important for maintaining a healthy neural microenvironment. We found that microglial density, phagocytic capacity, and their proximity to neurons were not altered in T2DM patients, indicating that the loss of Oxt neurons is independent of changes in microglial immunity. However, we did observe a reduction in the number of astrocytes, which are crucial for providing trophic support to local neurons. Moreover, a specific subpopulation of astrocytes characterized by aquaporin 4 expression was overrepresented in T2DM patients. Since this subset of astrocytes is linked to the glymphatic system, their overrepresentation might point to alterations in the hypothalamic waste clearance system in T2DM. Our study shows selective loss of Oxt neurons in the PVN of T2DM individuals in association with astrocytic reduction and gliovascular remodelling. Therefore, hypothalamic Oxt neurons may represent a potential target for T2DM treatment modalities.","['Astrocytes', 'Glymphatic', 'Hypothalamus', 'Insulin resistance', 'Microglia', 'Oxytocin', 'Type 2 diabetes mellitus']",Acta neuropathologica communications,2023-07-04,"[{'lastname': 'Correa-da-Silva', 'firstname': 'Felipe', 'initials': 'F', 'affiliation': 'Department of Endocrinology and Metabolism, Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.\nLaboratory of Endocrinology, Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.\nNetherlands Institute for Neuroscience, Amsterdam, The Netherlands.'}, {'lastname': 'Kalsbeek', 'firstname': 'Martin J', 'initials': 'MJ', 'affiliation': 'Department of Endocrinology and Metabolism, Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.\nLaboratory of Endocrinology, Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.\nNetherlands Institute for Neuroscience, Amsterdam, The Netherlands.'}, {'lastname': 'Gadella', 'firstname': 'Femke S', 'initials': 'FS', 'affiliation': 'Department of Endocrinology and Metabolism, Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.\nLaboratory of Endocrinology, Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.'}, {'lastname': 'Oppersma', 'firstname': 'Jorn', 'initials': 'J', 'affiliation': 'Department of Endocrinology and Metabolism, Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.\nLaboratory of Endocrinology, Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.'}, {'lastname': 'Jiang', 'firstname': 'Wei', 'initials': 'W', 'affiliation': 'Department of Endocrinology and Metabolism, Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.\nLaboratory of Endocrinology, Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.\nNetherlands Institute for Neuroscience, Amsterdam, The Netherlands.'}, {'lastname': 'Wolff', 'firstname': 'Samantha E C', 'initials': 'SEC', 'affiliation': 'Department of Endocrinology and Metabolism, Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.\nLaboratory of Endocrinology, Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.\nNetherlands Institute for Neuroscience, Amsterdam, The Netherlands.'}, {'lastname': 'Korpel', 'firstname': 'Nikita L', 'initials': 'NL', 'affiliation': 'Laboratory of Endocrinology, Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.'}, {'lastname': 'Swaab', 'firstname': 'Dick F', 'initials': 'DF', 'affiliation': 'Netherlands Institute for Neuroscience, Amsterdam, The Netherlands.'}, {'lastname': 'Fliers', 'firstname': 'Eric', 'initials': 'E', 'affiliation': 'Department of Endocrinology and Metabolism, Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.'}, {'lastname': 'Kalsbeek', 'firstname': 'Andries', 'initials': 'A', 'affiliation': 'Department of Endocrinology and Metabolism, Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.\nLaboratory of Endocrinology, Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.\nNetherlands Institute for Neuroscience, Amsterdam, The Netherlands.'}, {'lastname': 'Yi', 'firstname': 'Chun-Xia', 'initials': 'CX', 'affiliation': 'Department of Endocrinology and Metabolism, Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. c.yi@amsterdamumc.nl.\nLaboratory of Endocrinology, Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, The Netherlands. c.yi@amsterdamumc.nl.\nNetherlands Institute for Neuroscience, Amsterdam, The Netherlands. c.yi@amsterdamumc.nl.'}]",,,,© 2023. The Author(s).,"10.1186/s40478-023-01606-w
10.7554/eLife.29738
10.1016/j.dsx.2016.08.008
10.1056/NEJMra1005073
10.1007/s00401-005-1052-2
10.1176/ajp.152.5.738
10.1038/nature11270
10.1038/s41598-017-17204-5
10.1016/j.psyneuen.2017.07.486
10.1007/s00401-016-1595-4
10.1002/cne.22698
10.1152/ajpregu.00604.2003
10.1038/oby.2009.12
10.1002/glia.20239
10.1001/archopht.1961.00960010368014
10.1001/archpsyc.58.6.545
10.1210/en.2004-1520
10.1038/s41598-023-30630-y
10.1111/obr.12757
10.1073/pnas.2204527119
10.1172/JCI64102
10.1002/glia.22580
10.1016/j.celrep.2017.09.008
10.1126/science.556308
10.1007/s00125-019-4953-7
10.1210/endo.131.5.1425443
10.1126/scitranslmed.3003748
10.1152/ajpregu.1989.257.6.R1370
10.1007/s11064-015-1581-6
10.1038/nrendo.2015.48
10.1172/jci.insight.133868
10.1001/jamaneurol.2013.5857
10.1159/000144083
10.1038/509
10.1016/s0006-8993(00)02423-9
10.1016/j.cmet.2018.10.016
10.1038/s41574-023-00818-3
10.1016/j.febslet.2014.10.010
10.1093/hmg/10.14.1465
10.1016/j.peptides.2017.12.019
10.1016/j.cmet.2021.12.020
10.1038/s43587-023-00424-y
10.1210/jc.2014-2206
10.1210/en.2014-1849
10.1038/s41467-019-14195-x
10.1038/s41386-022-01305-5
10.2337/dc21-1535
10.1038/s41593-017-0014-z
10.1186/s40478-023-01568-z
10.1016/j.molmet.2021.101401
10.1186/s40478-019-0728-0
10.1073/pnas.1913611116
10.1523/JNEUROSCI.0226-14.2014
10.1172/JCI59660
10.1016/0165-0270(86)90111-1
10.1126/science.1241224
10.1016/j.molmet.2012.08.004
10.1016/j.bbadis.2010.01.006
10.1038/ncomms15143
10.1001/jamaneurol.2016.4370
10.1016/j.neuron.2017.05.031
10.1002/ana.25670",<Element 'PubmedArticle' at 0x7f05dddfb400>
27,37390476,Exosome-like nanoparticles derived from Allium tuberosum prevent neuroinflammation in microglia-like cells.,"Exosome-like nanoparticles (ELNs), which are plant-derived extracellular membrane vesicles, can regulate mammalian gene expression. ELNs can cross the blood-brain barrier, making them potential therapeutic agents or drug-delivery carriers for neuroinflammation-related diseases. Here, we investigated the anti-neuroinflammatory potential of ELNs extracted from Allium tuberosum (A-ELNs).
A-ELNs were extracted, and their miRNA profile was characterized. A-ELNs were also applied to BV-2 microglial and MG-6 cells derived from C57/BL6 mice stimulated with lipopolysaccharide (LPS), followed by an examination of levels of inflammatory-related factors. To test their drug-carrying potential, A-ELNs were mixed with dexamethasone, an anti-inflammatory drug, to prepare dexamethasone-incorporated A-ELNs (Dex-A-ELNs).
A-ELNs showed a particle size of 145 ± 2 nm and characteristic miRNAs. A-ELNs significantly decreased the LPS-induced nitric oxide (NO) and inflammatory cytokines levels in BV-2 and MG-6 cells. The mRNA expression of heme oxygenase-1 was significantly increased, and that of inducible NO synthase and inflammatory cytokines was significantly decreased by A-ELNs in BV-2 cells. Dex-A-ELNs inhibited NO production in BV-2 cells more potently than either A-ELNs or dexamethasone alone.
A-ELNs can alleviate microglial inflammation. Their effects can be potentiated by incorporating anti-inflammatory drugs, such as dexamethasone, making them potential therapeutic agents or drug-delivery carriers for neuroinflammation.","['\n          Allium tuberosum\n        ', 'BV-2', 'MG-6', 'exosome-like nanoparticles', 'extracellular vesicles', 'miRNA', 'neuroinflammation']",The Journal of pharmacy and pharmacology,2023-06-30,"[{'lastname': 'Ishida', 'firstname': 'Tomoaki', 'initials': 'T', 'affiliation': 'Department of Pharmacy, Kochi Medical School Hospital, Nankoku, Kochi, Japan.'}, {'lastname': 'Kawada', 'firstname': 'Kei', 'initials': 'K', 'affiliation': 'Department of Pharmacy, Kochi Medical School Hospital, Nankoku, Kochi, Japan.\nGraduate School of Integrated Arts and Sciences, Kochi University, Nankoku, Kochi, Japan.'}, {'lastname': 'Jobu', 'firstname': 'Kohei', 'initials': 'K', 'affiliation': 'Department of Pharmacy, Kochi Medical School Hospital, Nankoku, Kochi, Japan.'}, {'lastname': 'Morisawa', 'firstname': 'Shumpei', 'initials': 'S', 'affiliation': 'Department of Pharmacy, Kochi Medical School Hospital, Nankoku, Kochi, Japan.'}, {'lastname': 'Kawazoe', 'firstname': 'Tetsushi', 'initials': 'T', 'affiliation': 'Graduate School of Integrated Arts and Sciences, Kochi University, Nankoku, Kochi, Japan.\nKagawa School of Pharmaceutical Sciences, Tokushima Bunri University, Sanuki, Kagawa, Japan.'}, {'lastname': 'Nishimura', 'firstname': 'Satomi', 'initials': 'S', 'affiliation': 'Department of Pharmacy, Kochi Medical School Hospital, Nankoku, Kochi, Japan.\nGraduate School of Integrated Arts and Sciences, Kochi University, Nankoku, Kochi, Japan.'}, {'lastname': 'Akagaki', 'firstname': 'Keita', 'initials': 'K', 'affiliation': 'Department of Pharmacy, Kochi Medical School Hospital, Nankoku, Kochi, Japan.'}, {'lastname': 'Yoshioka', 'firstname': 'Saburo', 'initials': 'S', 'affiliation': 'Department of Pharmacy, Kochi Medical School Hospital, Nankoku, Kochi, Japan.'}, {'lastname': 'Miyamura', 'firstname': 'Mitsuhiko', 'initials': 'M', 'affiliation': 'Department of Pharmacy, Kochi Medical School Hospital, Nankoku, Kochi, Japan.\nGraduate School of Integrated Arts and Sciences, Kochi University, Nankoku, Kochi, Japan.'}]",,"A-ELNs can alleviate microglial inflammation. Their effects can be potentiated by incorporating anti-inflammatory drugs, such as dexamethasone, making them potential therapeutic agents or drug-delivery carriers for neuroinflammation.",,"© The Author(s) 2023. Published by Oxford University Press on behalf of the Royal Pharmaceutical Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.",10.1093/jpp/rgad062,<Element 'PubmedArticle' at 0x7f05dcf14a90>
28,"37382264
14415935
24730690
30686584
29311566
34710360
18155917
23190034
31718830
18571301
35788069
35617916
18078444
34665406
28750305
16302852
35166175
34744713
32868461
33314324
34815787
30462183
34997092
32579923
20071539
20803696
19460404
30112701
31332839
17950543
34952157
31802434
32323368
31960824
31931758
30779947
35217644
33931651
32483349
26558769
34949832
34617321
33957167
21044144
11113238
31674060
26971528
17803521
34596053
34689364
33730443
8158517
15571523
33641195
27920283
24497269
27554793
28987707
35035475
16313502
36081602
12562500
34897839
34585328
35803929
23298675
24398620
21302311",Melatonin regulates microglial polarization to M2 cell via RhoA/ROCK signaling pathway in epilepsy.,"Melatonin (MEL), an endogenous hormone, has been widely investigated in neurological diseases. Microglia (MG), a resident immunocyte localizing in central nervous system is reported to play important functions in the animal model of temporal lobe epilepsy (TLE). Some evidence showed that MEL influenced activation of MG, but the detailed model of action that MEL plays in remains uncertain.
In this study, we established a model of TLE in mice by stereotactic injection of kainic acid (KA). We treated the mice with MEL. Lipopolysaccharide, ROCK2-knockdown (ROCK-KD) and -overexpression (ROCK-OE) of lentivirus-treated cells were used in cell experiments to simulate an in vitro inflammatory model.
The results of electrophysiological tests showed that MEL reduced frequency and severity of seizure. The results of behavioral tests indicated MEL improved cognition, learning, and memory ability. Histological evidences demonstrated a significant reduction of neuronal death in the hippocampus. In vivo study showed that MEL changed the polarization status of MG from a proinflammatory M1 phenotype to an anti-inflammatory M2 phenotype by inversely regulating the RhoA/ROCK signaling pathway. In cytological study, we found that MEL had a significant protective effect in LPS-treated BV-2 cells and ROCK-KD cells, while the protective effect of MEL was significantly attenuated in ROCK-OE cells.
MEL played an antiepileptic role in the KA-induced TLE modeling mice both in behavioral and histological levels, and changed MG polarization status by regulating the RhoA/ROCK signaling pathway.","['RhoA/ROCK', 'epilepsy', 'melatonin', 'microglia', 'polarization']","Immunity, inflammation and disease",2023-06-29,"[{'lastname': 'Li', 'firstname': 'Pingping', 'initials': 'P', 'affiliation': 'Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.'}, {'lastname': 'Ji', 'firstname': 'Xuefei', 'initials': 'X', 'affiliation': 'Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.'}, {'lastname': 'Shan', 'firstname': 'Ming', 'initials': 'M', 'affiliation': 'Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.'}, {'lastname': 'Wang', 'firstname': 'Yi', 'initials': 'Y', 'affiliation': 'Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.'}, {'lastname': 'Dai', 'firstname': 'Xingliang', 'initials': 'X', 'affiliation': 'Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.'}, {'lastname': 'Yin', 'firstname': 'Mengyuan', 'initials': 'M', 'affiliation': 'Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.'}, {'lastname': 'Liu', 'firstname': 'Yunlong', 'initials': 'Y', 'affiliation': 'First Clinical Medical College, Anhui Medical University, Hefei, China.'}, {'lastname': 'Guan', 'firstname': 'Liao', 'initials': 'L', 'affiliation': 'Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.'}, {'lastname': 'Ye', 'firstname': 'Lei', 'initials': 'L', 'affiliation': 'Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.'}, {'lastname': 'Cheng', 'firstname': 'Hongwei', 'initials': 'H', 'affiliation': 'Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.'}]",,"MEL played an antiepileptic role in the KA-induced TLE modeling mice both in behavioral and histological levels, and changed MG polarization status by regulating the RhoA/ROCK signaling pathway.","The results of electrophysiological tests showed that MEL reduced frequency and severity of seizure. The results of behavioral tests indicated MEL improved cognition, learning, and memory ability. Histological evidences demonstrated a significant reduction of neuronal death in the hippocampus. In vivo study showed that MEL changed the polarization status of MG from a proinflammatory M1 phenotype to an anti-inflammatory M2 phenotype by inversely regulating the RhoA/ROCK signaling pathway. In cytological study, we found that MEL had a significant protective effect in LPS-treated BV-2 cells and ROCK-KD cells, while the protective effect of MEL was significantly attenuated in ROCK-OE cells.","© 2023 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.",10.1002/iid3.900,<Element 'PubmedArticle' at 0x7f05dcee4950>
29,37345882,Microglia: sculptors of the polycystic ovary syndrome (PCOS)-like brain?,"Neuroendocrine dysfunction and transgenerational susceptibility associated with polycystic ovary syndrome (PCOS) suggest that programmed changes within the brain contribute to adult development of the syndrome. This review discusses a potentially important role for microglia in mediating prenatal androgen-programmed changes in the female brain that contribute to PCOS-like features.
Several lines of evidence support a role for the brain in both the development and maintenance of polycystic ovary syndrome (PCOS), the most common cause of anovulatory infertility worldwide. Persistently elevated luteinizing hormone secretion and impaired gonadal steroid hormone feedback in PCOS patients suggest impairments within the neuronal networks that regulate the reproductive axis. Evidence from preclinical models has linked androgen excess during prenatal life with altered structure and function of the developing female brain that might underpin syndrome development in adulthood. Studies investigating the mechanisms by which excess androgens program changes in the female brain have highlighted an important role for microglia. This review discusses how these non-neuronal cells shape the developing female brain in response to excess androgens and focuses on how microglia may be involved in the development of the neuroendocrine dysfunctions associated with PCOS.",[],"Reproduction (Cambridge, England)",2023-06-22,"[{'lastname': 'Sati', 'firstname': 'Aisha', 'initials': 'A', 'affiliation': 'Centre for Neuroendocrinology and Department of Physiology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.'}, {'lastname': 'Desroziers', 'firstname': 'Elodie', 'initials': 'E', 'affiliation': 'Centre for Neuroendocrinology and Department of Physiology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.\nSorbonne Université, CNRS INSERM Neuroscience Paris Seine - Institut de Biologie Paris Seine Neuroplasticity of Reproductive Behaviours Team, Paris, France.'}, {'lastname': 'Campbell', 'firstname': 'Rebecca E', 'initials': 'RE', 'affiliation': 'Centre for Neuroendocrinology and Department of Physiology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.'}]",,,,,10.1530/REP-22-0343,<Element 'PubmedArticle' at 0x7f05dcdced10>
30,"37333896
29239374
29323634
21383758
27607312
28658409
31358617
31527724
31325156
29367475
32682847
28737515
25033177
29871522
25578260
29717413
24480947
25230819
31760579
29775163
19364523
34644613
34758829
33620047
31790262
25590687
23861057
23132929
33221975
30736436
30242121
29194780
24912546
26327797
17953994
31747966
26750430
28553710
26124111
32130884
11844532
31728042
17721514
12944518
34876174
32898475
34259342
24078881
28628111
29054466
34784649
23554135
29513146
23034914
24602609
9088941
15634734
11274346
36147469
31444938
26156997
36549669
34847433
33001420
21373950
32300650
11942415
28189739
32515141",Modified black phosphorus quantum dots promotes spinal cord injury repair by targeting the AKT signaling pathway.,"Spinal cord injury (SCI) is a serious refractory disease of the central nervous system (CNS), which mostly caused by high-energy trauma. Existing interventions such as hormone shock and surgery are insufficient options, which relate to the secondary inflammation and neuronal dysfunction. Hydrogel with neuron-protective behaviors attracts tremendous attention, and black phosphorus quantum dots (BPQDs) encapsulating with Epigallocatechin-3-gallate (EGCG) hydrogels (E@BP) is designed for inflammatory modulation and SCI treatment in this study. E@BP displays good stability, biocompatibility and safety profiles. E@BP incubation alleviates lipopolysaccharide (LPS)-induced inflammation of primary neurons and enhances neuronal regeneration in vitro. Furthermore, E@BP reconstructs structural versus functional integrity of spinal cord tracts, which promotes recovery of motor neuron function in SCI rats after transplantation. Importantly, E@BP restarts the cell cycle and induces nerve regeneration. Moreover, E@BP diminishes local inflammation of SCI tissues, characterized by reducing accumulation of astrocyte, microglia, macrophages, and oligodendrocytes. Indeed, a common underlying mechanism of E@BP regulating neural regenerative and inflammatory responses is to promote the phosphorylation of key proteins related to AKT signaling pathway. Together, E@BP probably repairs SCI by reducing inflammation and promoting neuronal regeneration via the AKT signaling pathway.","['AKT signaling pathway', 'Spinal cord injury', 'anti-inflammation', 'black phosphorus quantum dots', 'neuro-regeneration']",Journal of tissue engineering,2023-06-19,"[{'lastname': 'Xie', 'firstname': 'Dong-Mei', 'initials': 'DM', 'affiliation': 'Department of Cardiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.'}, {'lastname': 'Sun', 'firstname': 'Chuanwei', 'initials': 'C', 'affiliation': ""Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.""}, {'lastname': 'Tu', 'firstname': 'Qingqiang', 'initials': 'Q', 'affiliation': 'Zhongshan Medical College, Sun Yat-sen University, Guangzhou, China.'}, {'lastname': 'Li', 'firstname': 'Suyi', 'initials': 'S', 'affiliation': ""Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.\nDepartment of Orthopedics, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.""}, {'lastname': 'Zhang', 'firstname': 'Yu', 'initials': 'Y', 'affiliation': ""Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.\nDepartment of Orthopedics, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.""}, {'lastname': 'Mei', 'firstname': 'Xifan', 'initials': 'X', 'affiliation': 'Department of Orthopedics, The Third Affiliated Hospital of Jinzhou Medical University, Jinzhou Medical University, Jinzhou, China.'}, {'lastname': 'Li', 'firstname': 'Yuanlong', 'initials': 'Y', 'affiliation': ""Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.\nDepartment of Orthopedics, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.""}]",,,,© The Author(s) 2023.,10.1177/20417314231180033,<Element 'PubmedArticle' at 0x7f05dcdd4db0>
31,37331704,Glucocorticoids Orchestrate Adult Hippocampal Plasticity: Growth Points and Translational Aspects.,"The review analyzes modern concepts about the control of various mechanisms of the hippocampal neuroplasticity in adult mammals and humans by glucocorticoids. Glucocorticoid hormones ensure the coordinated functioning of key components and mechanisms of hippocampal plasticity: neurogenesis, glutamatergic neurotransmission, microglia and astrocytes, systems of neurotrophic factors, neuroinflammation, proteases, metabolic hormones, neurosteroids. Regulatory mechanisms are diverse; along with the direct action of glucocorticoids through their receptors, there are conciliated glucocorticoid-dependent effects, as well as numerous interactions between various systems and components. Despite the fact that many connections in this complex regulatory scheme have not yet been established, the study of the factors and mechanisms considered in the work forms growth points in the field of glucocorticoid-regulated processes in the brain and primarily in the hippocampus. These studies are fundamentally important for the translation into the clinic and the potential treatment/prevention of common diseases of the emotional and cognitive spheres and respective comorbid conditions.","['Alzheimer’s disease', 'BDNF', 'aging', 'depression', 'glucocorticoids', 'glutamatergic transmission', 'hippocampus', 'hypothalamic-pituitary-adrenal axis', 'insulin resistance', 'neurogenesis', 'neuroinflammation', 'neuroplasticity', 'proteases', 'stress', 'synaptic plasticity']",Biochemistry. Biokhimiia,2023-06-19,"[{'lastname': 'Gulyaeva', 'firstname': 'Natalia V', 'initials': 'NV', 'affiliation': 'Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow, 117485, Russia. nata_gul@ihna.ru.\nResearch and Clinical Center for Neuropsychiatry of Moscow Healthcare Department, Moscow, 115419, Russia.'}]",,,,,10.1134/S0006297923050012,<Element 'PubmedArticle' at 0x7f05dcda7bd0>
32,37301531,Melatonin regulates microglial polarization and protects against ischemic stroke-induced brain injury in mice.,"Ischemic stroke is a leading cause of mortality and morbidity worldwide, with neuroinflammation playing a key role in its pathophysiology. Microglia, the primary immune cells in the brain, undergo rapid activation and phenotypic polarization, which are crucial for regulating neuroinflammatory responses following ischemic stroke. Melatonin is a promising neuroprotective agent that can regulate microglial polarization in central nervous system (CNS) diseases. However, the specific mechanism underlying the neuroprotective effects of melatonin against ischemic stroke-induced brain injury by modulating microglial polarization after ischemic stroke remains poorly understood. To investigate this mechanism, we used the transient middle cerebral artery occlusion/reperfusion (tMCAO/R) model in C57BL/6 mice to induce ischemic stroke and administered intraperitoneal melatonin (20 mg/kg) or an equivalent volume of vehicle daily after reperfusion. Our results demonstrated that melatonin treatment reduced the infarct volume, prevented neuronal loss and apoptosis, and improved neurological deficits after ischemic stroke. Furthermore, melatonin attenuated microglial activation and reactive astrogliosis, while promoting the polarization of microglia toward M2 phenotype via signal transducer and activator of transcription 1/6 (STAT1/6) pathways. Collectively, these findings suggest that melatonin exerts neuroprotective effects against ischemic stroke-induced brain injury by modulating microglial polarization toward M2 phenotype and has the potential as a promising candidate for the treatment of ischemic stroke.","['Ischemic stroke', 'Melatonin', 'Microglial polarization', 'Neuroinflammation', 'Neuroprotection']",Experimental neurology,2023-06-11,"[{'lastname': 'Li', 'firstname': 'Donghai', 'initials': 'D', 'affiliation': 'Gansu Key Laboratory of Biomonitoring and Bioremediation for Environmental Pollution, School of Life Sciences, Lanzhou University, Lanzhou 730000, PR China.'}, {'lastname': 'He', 'firstname': 'Tianpeng', 'initials': 'T', 'affiliation': 'First Department of Critical Care Medicine, Gansu Provincial Hospital, Lanzhou 730000, PR China.'}, {'lastname': 'Zhang', 'firstname': 'Yue', 'initials': 'Y', 'affiliation': 'Gansu Key Laboratory of Biomonitoring and Bioremediation for Environmental Pollution, School of Life Sciences, Lanzhou University, Lanzhou 730000, PR China.'}, {'lastname': 'Liu', 'firstname': 'Junru', 'initials': 'J', 'affiliation': 'Gansu Key Laboratory of Biomonitoring and Bioremediation for Environmental Pollution, School of Life Sciences, Lanzhou University, Lanzhou 730000, PR China.'}, {'lastname': 'Zhao', 'firstname': 'Haiyu', 'initials': 'H', 'affiliation': 'Gansu Key Laboratory of Biomonitoring and Bioremediation for Environmental Pollution, School of Life Sciences, Lanzhou University, Lanzhou 730000, PR China.'}, {'lastname': 'Wang', 'firstname': 'Dongliang', 'initials': 'D', 'affiliation': 'First Department of Critical Care Medicine, Gansu Provincial Hospital, Lanzhou 730000, PR China.'}, {'lastname': 'Wang', 'firstname': 'Quanchao', 'initials': 'Q', 'affiliation': 'First Department of Critical Care Medicine, Gansu Provincial Hospital, Lanzhou 730000, PR China.'}, {'lastname': 'Yuan', 'firstname': 'Yuan', 'initials': 'Y', 'affiliation': 'First Department of Critical Care Medicine, Gansu Provincial Hospital, Lanzhou 730000, PR China. Electronic address: lanzhouyy@163.com.'}, {'lastname': 'Zhang', 'firstname': 'Shengxiang', 'initials': 'S', 'affiliation': 'Gansu Key Laboratory of Biomonitoring and Bioremediation for Environmental Pollution, School of Life Sciences, Lanzhou University, Lanzhou 730000, PR China. Electronic address: sxzhang@lzu.edu.cn.'}]",,,,Copyright © 2023 Elsevier Inc. All rights reserved.,10.1016/j.expneurol.2023.114464,<Element 'PubmedArticle' at 0x7f05dcf60400>
33,37269608,"Protective effect of Prolactin releasing peptide against 1,2-diacetylbenzene -induced neuroinflammation.","Prolactin-releasing peptide (PrRP) has been investigated as a potential therapeutic for diabetes by the effect of food intake reduction, increasing leptin signaling, and insulin tolerance. Recent studies focused on its synaptogenesis and protective effects against neurodegeneration. Whereas 1,2-diacetylbenzene (DAB), a common metabolite of a neurotoxicant 1,2-diethyl benzene, causes memory impairment and neurotoxicity partly through the inflammatory process. Our present study assessed the effect of PrRP in microglia and its action in balancing the inflammation to protect against DAB. We observed that PrRP modulated NADPH oxidase - regulated NLRP3 inflammasome and PRL signaling pathways differently between physical and toxic conditions in microglia.","['1,2-diacetylbenzene', 'NADPH oxidase', 'Neuroinflammation', 'Prolactin-releasing peptide']",Neuropeptides,2023-06-04,"[{'lastname': 'Hoang', 'firstname': 'Ngoc Minh Hong', 'initials': 'NMH', 'affiliation': 'Department of Pharmacy, College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, Suncheon, Jeonnam 57922, Republic of Korea.'}, {'lastname': 'Jo', 'firstname': 'Wonhee', 'initials': 'W', 'affiliation': 'Department of Pharmacy, College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, Suncheon, Jeonnam 57922, Republic of Korea.'}, {'lastname': 'Kim', 'firstname': 'Min-Sun', 'initials': 'MS', 'affiliation': 'Department of Pharmacy, College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, Suncheon, Jeonnam 57922, Republic of Korea. Electronic address: minsun@scnu.ac.kr.'}]",,,,Copyright © 2023. Published by Elsevier Ltd.,10.1016/j.npep.2023.102349,<Element 'PubmedArticle' at 0x7f05dcf54bd0>
34,"37269471
36367091
35650595
36293857
35507278
31314968
33876965
35151003
34355740
36069195
18479218
32594802
32760236
30337707
26573717
33328624
34915155
35250473
28842207
33165770
20156424
28226226
27738491
35128704
7965799
1681742
32142651
34400158
30928868
33040727
33683626
33872730
24262633
26571201
33009401
36422196",SARS-CoV-2 Spike Protein S1 Exposure Increases Susceptibility to Angiotensin II-Induced Hypertension in Rats by Promoting Central Neuroinflammation and Oxidative Stress.,"The SARS-CoV-2 spike S1 subunit (S1) can cross the blood-brain barrier and elicit neuroinflammatory response independent of viral infection. Here we examined whether S1 influences blood pressure (BP) and sensitizes the hypertensive response to angiotensin (ANG) II by enhancing neuroinflammation and oxidative stress in hypothalamic paraventricular nucleus (PVN), a key brain cardiovascular regulatory center. Rats received central S1 or vehicle (VEH) injection for 5 days. One week after injection, ANG II or saline (control) was subcutaneously delivered for 2 weeks. S1 injection induced greater increases in BP, PVN neuronal excitation and sympathetic drive in ANG II rats but had no effects in control rats. One week after S1 injection, mRNA for proinflammatory cytokines and oxidative stress marker were higher but mRNA of Nrf2, the master regulator of inducible antioxidant and anti-inflammatory responses, was lower in the PVN in S1-injected rats than in VEH-injected rats. Three weeks after S1 injection, mRNA for proinflammatory cytokines and oxidative stress marker, microglia activation and reactive oxygen species in the PVN were comparable between S1 and VEH treated control rats but were elevated in two groups of ANG II rats. Notably, ANG II-induced elevations in these parameters were exaggerated by S1. Interestingly, ANG II increased PVN Nrf2 mRNA in VEH-treated rats but not in S1-treated rats. These data suggest that S1 exposure has no effect on BP, but post-S1 exposure increases susceptibility to ANG II-induced hypertension by downregulating PVN Nrf2 to promote neuroinflammation and oxidative stress and augment sympathetic excitation.","['Brain', 'COVID-19', 'Hypertension', 'SARS-CoV-2 spike protein', 'Sensitization']",Neurochemical research,2023-06-03,"[{'lastname': 'Sun', 'firstname': 'Qingmei', 'initials': 'Q', 'affiliation': 'Department of Anesthesiology, Qilu Hospital of Shandong University, No.107 Wenhua Xi Road, Jinan, 250012, China.'}, {'lastname': 'Li', 'firstname': 'Liang', 'initials': 'L', 'affiliation': 'Department of Anesthesiology, Qilu Hospital of Shandong University, No.107 Wenhua Xi Road, Jinan, 250012, China.'}, {'lastname': 'Jin', 'firstname': 'Feihong', 'initials': 'F', 'affiliation': 'Department of Anesthesiology, Qilu Hospital of Shandong University, No.107 Wenhua Xi Road, Jinan, 250012, China.'}, {'lastname': 'Liu', 'firstname': 'Yu', 'initials': 'Y', 'affiliation': 'Department of Anesthesiology, Qilu Hospital of Shandong University, No.107 Wenhua Xi Road, Jinan, 250012, China.'}, {'lastname': 'Yang', 'firstname': 'Bo', 'initials': 'B', 'affiliation': 'Department of Anesthesiology, Qilu Hospital of Shandong University, No.107 Wenhua Xi Road, Jinan, 250012, China.'}, {'lastname': 'Meng', 'firstname': 'Wanping', 'initials': 'W', 'affiliation': 'Department of Anesthesiology, Qilu Hospital of Shandong University, No.107 Wenhua Xi Road, Jinan, 250012, China.'}, {'lastname': 'Zhang', 'firstname': 'Zibin', 'initials': 'Z', 'affiliation': 'Department of Anesthesiology, Qilu Hospital of Shandong University, No.107 Wenhua Xi Road, Jinan, 250012, China.'}, {'lastname': 'Qi', 'firstname': 'Feng', 'initials': 'F', 'affiliation': 'Department of Anesthesiology, Qilu Hospital of Shandong University, No.107 Wenhua Xi Road, Jinan, 250012, China. 198962001111@sdu.edu.cn.'}]",,,,"© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.","10.1007/s11064-023-03949-1
10.1042/CS20220235
10.1186/s40246-022-00392-1
10.3390/ijerph192013280
10.1007/s11883-022-01032-8
10.1056/NEJMoa1803180
10.2217/fca-2020-0235
10.1016/j.autneu.2022.102954
10.1093/ajh/hpab124
10.1161/HYPERTENSIONAHA.122.18550
10.1517/14728222.12.6.717
10.1161/HYPERTENSIONAHA.120.14521
10.3389/fnins.2020.00650
10.1038/s41581-018-0068-5
10.1161/HYPERTENSIONAHA.115.06263
10.1038/s41593-020-00771-8
10.1016/j.bbi.2021.12.007
10.3389/fnins.2022.848079
10.1016/j.taap.2017.08.012
10.1007/s12012-020-09619-w
10.1016/j.brainres.2010.02.028
10.1146/annurev-immunol-051116-052358
10.1155/2016/7432797
10.1002/jmv.27640
10.1016/j.cell.2020.02.052
10.1016/j.expneurol.2021.113837
10.1016/j.jneuroim.2019.03.012
10.1134/S0006297920070111
10.1007/s12035-021-02344-7
10.1016/j.tox.2021.152785
10.1016/j.neuropharm.2013.11.004
10.1016/j.exger.2015.11.004
10.1038/s41467-020-18764-3
10.3390/medicina58111658",<Element 'PubmedArticle' at 0x7f05dcf4c5e0>
35,"37207231
18492988
21248330
21177444
2443625
10579417
10696570
16458032
8352945
10966456
15353317
15722356
6947303
16997129
23458502
24141321
33461120
12495726
15936435
23212517
29343453
27713030
16424167
10824964
22080012
35804628
29901761
35007929
30367342
20478430
23707377
16988703
28821663
29269733
30390283
33441043
12829246
15058305
28090781
29775631
12023064
20068134
23265946
11739335
3139815
1924095
27072430
27718095
31569788
29636886
23488692
11264472
17447842
18587394
23300802
23128233
16554545
16946079
25038274
36318114
1678697
32296574
34177398
28928639
20097762",Lipopolysaccharide-induced immune stress negatively regulates broiler chicken growth ,"Immune stress in broiler chickens is characterized by the development of persistent pro-inflammatory responses that contribute to degradation of production performance. However, the underlying mechanisms that cause growth inhibition of broilers with immune stress are not well defined.
A total of 252 1-day-old Arbor Acres(AA) broilers were randomly allocated to three groups with six replicates per group and 14 broilers per replicate. The three groups comprised a saline control group, an Lipopolysaccharide (LPS) (immune stress) group, and an LPS and celecoxib group corresponding to an immune stress group treated with a selective COX-2 inhibitor. Birds in LPS group and saline group were intraperitoneally injected with the same amount of LPS or saline from 14d of age for 3 consecutive days. And birds in the LPS and celecoxib group were given a single intraperitoneal injection of celecoxib 15 min prior to LPS injection at 14 d of age.
The feed intake and body weight gain of broilers were suppressed in response to immune stress induced by LPS which is an intrinsic component of the outer membrane of Gram-negative bacteria. Cyclooxygenase-2 (COX-2), a key enzyme that mediates prostaglandin synthesis, was up-regulated through MAPK-NF-κB pathways in activated microglia cells in broilers exposed to LPS. Subsequently, the binding of prostaglandin E2 (PGE2) to the EP4 receptor maintained the activation of microglia and promoted the secretion of cytokines interleukin-1β and interleukin-8, and chemokines CX3CL1 and CCL4. In addition, the expression of appetite suppressor proopiomelanocortin protein was increased and the levels of growth hormone-releasing hormone were reduced in the hypothalamus. These effects resulted in decreased expression of insulin-like growth factor in the serum of stressed broilers. In contrast, inhibition of COX-2 normalized pro-inflammatory cytokine levels and promoted the expression of Neuropeptide Y and growth hormone-releasing hormone in the hypothalamus which improved the growth performance of stressed broilers. Transcriptomic analysis of the hypothalamus of stressed broilers showed that inhibition of COX-2 activity significantly down-regulated the expression of the TLR1B, IRF7, LY96, MAP3K8, CX3CL1, and CCL4 genes in the MAPK-NF-κB signaling pathway.
This study provides new evidence that immune stress mediates growth suppression in broilers by activating the COX-2-PGE2-EP4 signaling axis. Moreover, growth inhibition is reversed by inhibiting the activity of COX-2 under stressed conditions. These observations suggest new approaches for promoting the health of broiler chickens reared in intensive conditions.","['COX-2', 'broilers', 'growth', 'hypothalamus', 'immune stress']",Frontiers in immunology,2023-05-19,"[{'lastname': 'Liu', 'firstname': 'Kexin', 'initials': 'K', 'affiliation': 'Department of Animal Physiology, College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, China.'}, {'lastname': 'Zhen', 'firstname': 'Wenrui', 'initials': 'W', 'affiliation': 'Department of Animal Physiology, College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, China.\nHenan International Joint Laboratory of Animal Welfare and Health Breeding, College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, China.'}, {'lastname': 'Bai', 'firstname': 'Dongying', 'initials': 'D', 'affiliation': 'Department of Animal Physiology, College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, China.\nHenan International Joint Laboratory of Animal Welfare and Health Breeding, College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, China.'}, {'lastname': 'Tan', 'firstname': 'Haiqiu', 'initials': 'H', 'affiliation': 'Department of Animal Physiology, College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, China.'}, {'lastname': 'He', 'firstname': 'Xianglong', 'initials': 'X', 'affiliation': 'Department of Animal Physiology, College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, China.'}, {'lastname': 'Li', 'firstname': 'Yuqian', 'initials': 'Y', 'affiliation': 'Department of Animal Physiology, College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, China.'}, {'lastname': 'Liu', 'firstname': 'Yanhao', 'initials': 'Y', 'affiliation': 'Department of Animal Physiology, College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, China.'}, {'lastname': 'Zhang', 'firstname': 'Yi', 'initials': 'Y', 'affiliation': 'Department of Animal Physiology, College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, China.\nHenan International Joint Laboratory of Animal Welfare and Health Breeding, College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, China.'}, {'lastname': 'Ito', 'firstname': 'Koichi', 'initials': 'K', 'affiliation': 'Department of Food and Physiological Models, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Ibaraki, Japan.'}, {'lastname': 'Zhang', 'firstname': 'Bingkun', 'initials': 'B', 'affiliation': 'State Key Laboratory of Animal Nutrition, Department of Animal Nutrition and Feed Science, College of Animal Science and Technology, China Agricultural University, Beijing, China.'}, {'lastname': 'Ma', 'firstname': 'Yanbo', 'initials': 'Y', 'affiliation': 'Department of Animal Physiology, College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, China.\nLongmen Laboratory, Science & Technology Innovation Center for Completed Set Equipment, Luoyang, China.\nHenan International Joint Laboratory of Animal Welfare and Health Breeding, College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, China.'}]",,"This study provides new evidence that immune stress mediates growth suppression in broilers by activating the COX-2-PGE2-EP4 signaling axis. Moreover, growth inhibition is reversed by inhibiting the activity of COX-2 under stressed conditions. These observations suggest new approaches for promoting the health of broiler chickens reared in intensive conditions.","The feed intake and body weight gain of broilers were suppressed in response to immune stress induced by LPS which is an intrinsic component of the outer membrane of Gram-negative bacteria. Cyclooxygenase-2 (COX-2), a key enzyme that mediates prostaglandin synthesis, was up-regulated through MAPK-NF-κB pathways in activated microglia cells in broilers exposed to LPS. Subsequently, the binding of prostaglandin E2 (PGE2) to the EP4 receptor maintained the activation of microglia and promoted the secretion of cytokines interleukin-1β and interleukin-8, and chemokines CX3CL1 and CCL4. In addition, the expression of appetite suppressor proopiomelanocortin protein was increased and the levels of growth hormone-releasing hormone were reduced in the hypothalamus. These effects resulted in decreased expression of insulin-like growth factor in the serum of stressed broilers. In contrast, inhibition of COX-2 normalized pro-inflammatory cytokine levels and promoted the expression of Neuropeptide Y and growth hormone-releasing hormone in the hypothalamus which improved the growth performance of stressed broilers. Transcriptomic analysis of the hypothalamus of stressed broilers showed that inhibition of COX-2 activity significantly down-regulated the expression of the TLR1B, IRF7, LY96, MAP3K8, CX3CL1, and CCL4 genes in the MAPK-NF-κB signaling pathway.","Copyright © 2023 Liu, Zhen, Bai, Tan, He, Li, Liu, Zhang, Ito, Zhang and Ma.","10.3389/fimmu.2023.1193798
10.3382/ps.2007-00142
10.3382/ps.2010-00997
10.3382/ps.2010-01017
10.1093/jn/117.9.1629
10.1080/00071669987359
10.1210/edrv.21.1.0389
10.1016/j.cbpa.2005.12.030
10.1016/0896-6273(93)90192-T
10.1146/annurev.biochem.69.1.145
10.17221/8403-CJAS
10.2741/1439
10.1074/jbc.M412075200
10.1016/0091-3057(81)90014-9
10.1016/j.prostaglandins.2006.06.008
10.1016/j.brainres.2013.02.042
10.1292/jvms.13-0234
10.1016/j.rvsc.2020.12.025
10.1016/S0952-7915(02)00013-4
10.1016/j.dci.2005.02.002
10.1182/blood-2012-05-432674
10.1016/j.ijbiomac.2018.01.070
10.1016/j.clim.2016.09.014
10.4049/jimmunol.176.3.1402
10.1093/ps/79.5.743
10.3382/ps.2011-01591
10.3390/ani12131729
10.3382/ps/pey204
10.1016/j.psj.2021.101641
10.1007/s11427-018-9371-4
10.1016/S0079-6123(08)81002-3
10.1016/j.ygcen.2013.05.006
10.1038/nature05026
10.1523/JNEUROSCI.0798-17.2017
10.1038/s41598-017-17922-w
10.1007/978-981-13-1286-1_2
10.1152/jn.00359.2020
10.1016/S0014-5793(03)00560-X
10.1038/nature02440
10.1080/00071668.2017.1280774
10.1016/j.physbeh.2018.05.015
10.1016/S0304-3940(02)00241-0
10.2337/db09-1024
10.1016/j.tem.2012.11.003
10.1210/edrv.22.6.0452
10.1677/joe.0.1180233
10.3382/ps.0701764
10.1038/srep24394
10.1007/s10753-016-0447-7
10.3390/cells8101163
10.1111/sji.12041
10.1146/annurev.pharmtox.41.1.661
10.1371/journal.pgen.0030058
10.1038/ng.175
10.1371/journal.pone.0052873
10.1038/nature11582
10.1152/physiolgenomics.00306.2005
10.1152/ajpregu.00511.2006
10.1016/j.bbalip.2014.07.008
10.2337/db21-1072
10.1210/endo-129-3-1275
10.20892/j.issn.2095-3941.2019.0339
10.1177/15593258211024393
10.3389/fnana.2017.00077
10.1074/jbc.M109.070706",<Element 'PubmedArticle' at 0x7f05dd3e1180>
36,"37202450
16763038
24412518
15695184
32619816
32343929
28746305
21732491
32075759
34686336
33004674
16949068
26431938
27540165
24916856
25085975
28416692
33326790
32034934
30881223
23986016
27208862
22048009
29028353
26193917
25701805
34527806
36827603
34058271
30769046
19825406
24995512
29777869
29674564
34551316
22238673
34184634
35132245
1400587
25342811
32072708
29031617
28226245
31922724
27831568
32034934
22886421
29974860
30886241
36120571
35538305
34006636
29804544
33428898
33494791
33568815
29020624
32023447
30471926
33208372
34033756
32010790
25263555
33916186
29999568
23022380
25339752
35672150
34782554
26445458
26159717
23542552
30069915
24499315
19910308",Nanoparticle-based targeting of microglia improves the neural regeneration enhancing effects of immunosuppression in the zebrafish retina.,"Retinal Müller glia function as injury-induced stem-like cells in zebrafish but not mammals. However, insights gleaned from zebrafish have been applied to stimulate nascent regenerative responses in the mammalian retina. For instance, microglia/macrophages regulate Müller glia stem cell activity in the chick, zebrafish, and mouse. We previously showed that post-injury immunosuppression by the glucocorticoid dexamethasone accelerated retinal regeneration kinetics in zebrafish. Similarly, microglia ablation enhances regenerative outcomes in the mouse retina. Targeted immunomodulation of microglia reactivity may therefore enhance the regenerative potential of Müller glia for therapeutic purposes. Here, we investigated potential mechanisms by which post-injury dexamethasone accelerates retinal regeneration kinetics, and the effects of dendrimer-based targeting of dexamethasone to reactive microglia. Intravital time-lapse imaging revealed that post-injury dexamethasone inhibited microglia reactivity. The dendrimer-conjugated formulation: (1) decreased dexamethasone-associated systemic toxicity, (2) targeted dexamethasone to reactive microglia, and (3) improved the regeneration enhancing effects of immunosuppression by increasing stem/progenitor proliferation rates. Lastly, we show that the gene rnf2 is required for the enhanced regeneration effect of D-Dex. These data support the use of dendrimer-based targeting of reactive immune cells to reduce toxicity and enhance the regeneration promoting effects of immunosuppressants in the retina.",[],Communications biology,2023-05-19,"[{'lastname': 'Emmerich', 'firstname': 'Kevin', 'initials': 'K', 'affiliation': 'McKusick-Nathans Institute of the Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.\nDepartment of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA.'}, {'lastname': 'White', 'firstname': 'David T', 'initials': 'DT', 'affiliation': 'Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA.'}, {'lastname': 'Kambhampati', 'firstname': 'Siva P', 'initials': 'SP', 'affiliation': 'Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA.\nThe Center for Nanomedicine, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA.'}, {'lastname': 'Casado', 'firstname': 'Grace L', 'initials': 'GL', 'affiliation': 'Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA.'}, {'lastname': 'Fu', 'firstname': 'Tian-Ming', 'initials': 'TM', 'affiliation': 'Janelia Farms Research Campus, Howard Hughes Medical Institute, Ashburn, VA, USA.\nDepartment of Electrical and Computer Engineering and Princeton Bioengineering Initiative, Princeton University, Princeton, NJ, USA.'}, {'lastname': 'Chunawala', 'firstname': 'Zeeshaan', 'initials': 'Z', 'affiliation': 'Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA.'}, {'lastname': 'Sahoo', 'firstname': 'Arpan', 'initials': 'A', 'affiliation': 'Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA.'}, {'lastname': 'Nimmagadda', 'firstname': 'Saumya', 'initials': 'S', 'affiliation': 'Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA.'}, {'lastname': 'Krishnan', 'firstname': 'Nimisha', 'initials': 'N', 'affiliation': 'Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA.'}, {'lastname': 'Saxena', 'firstname': 'Meera T', 'initials': 'MT', 'affiliation': 'Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA.'}, {'lastname': 'Walker', 'firstname': 'Steven L', 'initials': 'SL', 'affiliation': 'School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China.'}, {'lastname': 'Betzig', 'firstname': 'Eric', 'initials': 'E', 'affiliation': 'Janelia Farms Research Campus, Howard Hughes Medical Institute, Ashburn, VA, USA. betzige@janelia.hhmi.org.'}, {'lastname': 'Kannan', 'firstname': 'Rangaramanujam M', 'initials': 'RM', 'affiliation': 'Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA. krangar1@jhmi.edu.\nThe Center for Nanomedicine, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA. krangar1@jhmi.edu.'}, {'lastname': 'Mumm', 'firstname': 'Jeff S', 'initials': 'JS', 'affiliation': 'McKusick-Nathans Institute of the Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. jmumm3@jhmi.edu.\nDepartment of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA. jmumm3@jhmi.edu.\nThe Center for Nanomedicine, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA. jmumm3@jhmi.edu.\nSolomon H Snyder Department of Neuroscience, Johns Hopkins University, Baltimore, MD, USA. jmumm3@jhmi.edu.'}]",,,,© 2023. The Author(s).,"10.1038/s42003-023-04898-9
10.1016/j.preteyeres.2013.12.007
10.1016/j.gde.2020.05.025
10.1016/j.celrep.2020.01.075
10.1016/j.celrep.2021.109857
10.1126/science.abb8598
10.1016/j.it.2015.08.008
10.1016/j.celrep.2020.108507
10.1002/glia.23792
10.4317/medoral.19087
10.1016/j.jconrel.2016.05.044
10.1167/iovs.14-16250
10.1016/j.ejpb.2015.02.013
10.1002/adtp.202000181
10.1021/acs.biomac.2c01381
10.1016/j.jconrel.2021.05.035
10.1111/joim.12280
10.1016/j.cell.2021.08.030
10.1371/journal.pone.0029916
10.7554/eLife.57245
10.1038/s41592-021-01364-4
10.1083/jcb.119.3.493
10.1002/dvdy.163
10.1021/acsnano.9b07233
10.1002/cne.23213
10.1016/j.devcel.2018.06.003
10.1038/s41598-019-41298-8
10.3389/fcell.2022.892271
10.1007/s12035-022-02857-9
10.1073/pnas.2017198118
10.1186/s12974-018-1185-6
10.1016/j.ejphar.2021.173854
10.1186/s13287-021-02136-9
10.1038/s41586-021-03199-7
10.1016/j.celrep.2017.09.039
10.1016/j.celrep.2020.01.010
10.1016/j.immuni.2018.11.004
10.1126/sciadv.abd1160
10.1016/j.devcel.2021.04.031
10.1126/sciadv.aay8514
10.1016/j.celrep.2014.08.048
10.3390/cells10040783
10.1002/stem.2889
10.1016/j.molcel.2012.08.022
10.1523/JNEUROSCI.0498-14.2014
10.1523/JNEUROSCI.0244-22.2022
10.4103/1673-5374.327326
10.1016/j.ymeth.2013.03.017
10.1093/bioinformatics/btp616",<Element 'PubmedArticle' at 0x7f05dd3e29f0>
37,"37185803
12714258
15572589
25879284
28405620
25447485
34238316
31210333
26200058
30966861
35021057
30026524
35965153
32457419
25180262
30215696
30242884
28766251
31558839
25879283
26888116
28722711
18267068
32096904
35484406
24622758
32252777
23254930
29665808
24236147
25594175
26440431
35042977",Melatonin-Driven NLRP3 Inflammation Inhibition Via Regulation of NF-κB Nucleocytoplasmic Transport: Implications for Postoperative Cognitive Dysfunction.,"The aseptic inflammatory response of the central nervous system is one of the important causes of neurodegenerative diseases in individuals and is also recognized in postoperative cognitive dysfunction (POCD). Inflammasome is thought to be closely related to brain homeostasis. However, there are few drugs targeting the inflammasome to suppress inflammation in clinical practice. Here, we showed that the neuroinflammatory response mediated by the NLRP3 (NLR family, pyrin domain containing 3) inflammasome was involved in the pathological process of POCD. Melatonin protected mice from nerve damage by inhibiting activation of the NLRP3-caspase-1-interleukin 1 beta (IL-β) pathway and thus reduced the secretion of IL-1β inflammatory factors in microglia. Further research found that melatonin has a potential binding effect with NLRP3 protein, and at the same time could reduce the phosphorylation of nuclear factor kappa-B (NF-κB) and inhibit its nuclear translocation. The underlying mechanism was that melatonin inhibited the expression of acetylation of histone H3 and melatonin attenuated the binding of NF-κb to the NLRP3 promoter region 1-200 bp, where there are two potential binding target sites of NF-κb and NLRP3, namely the sequences 5'-GGGAACCCCC-3' and 5'-GGAAATCCA -3'. Therefore, we confirmed a novel mechanism of action of melatonin in the prevention and treatment of POCD.","['NF-κB', 'NLRP3 inflammasome', 'microglia', 'neuroinflammation', 'postoperative cognitive dysfunction']",Inflammation,2023-05-15,"[{'lastname': 'Zhu', 'firstname': 'Hong', 'initials': 'H', 'affiliation': 'Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, 1# Minde Road, Nanchang, China.\nJiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang, China.\nJiangxi Health Commission Key Laboratory of Neurological Medicine, Nanchang, China.\nInstitute of Neuroscience, Nanchang University, Nanchang, China.'}, {'lastname': 'Zhang', 'firstname': 'Lieliang', 'initials': 'L', 'affiliation': 'Department of Anesthesiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.\nKey Laboratory of Anesthesiology of Jiangxi Province, Nanchang, China.'}, {'lastname': 'Xiao', 'firstname': 'Feng', 'initials': 'F', 'affiliation': 'Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, 1# Minde Road, Nanchang, China.\nJiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang, China.\nJiangxi Health Commission Key Laboratory of Neurological Medicine, Nanchang, China.\nInstitute of Neuroscience, Nanchang University, Nanchang, China.'}, {'lastname': 'Wu', 'firstname': 'Lei', 'initials': 'L', 'affiliation': 'Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, 1# Minde Road, Nanchang, China.\nJiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang, China.\nJiangxi Health Commission Key Laboratory of Neurological Medicine, Nanchang, China.\nInstitute of Neuroscience, Nanchang University, Nanchang, China.'}, {'lastname': 'Guo', 'firstname': 'Yun', 'initials': 'Y', 'affiliation': 'Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, 1# Minde Road, Nanchang, China.\nJiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang, China.\nJiangxi Health Commission Key Laboratory of Neurological Medicine, Nanchang, China.\nInstitute of Neuroscience, Nanchang University, Nanchang, China.'}, {'lastname': 'Zhang', 'firstname': 'Zhe', 'initials': 'Z', 'affiliation': 'Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, 1# Minde Road, Nanchang, China.\nJiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang, China.\nJiangxi Health Commission Key Laboratory of Neurological Medicine, Nanchang, China.\nInstitute of Neuroscience, Nanchang University, Nanchang, China.'}, {'lastname': 'Xiao', 'firstname': 'Yao', 'initials': 'Y', 'affiliation': 'Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, 1# Minde Road, Nanchang, China.\nJiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang, China.\nJiangxi Health Commission Key Laboratory of Neurological Medicine, Nanchang, China.\nInstitute of Neuroscience, Nanchang University, Nanchang, China.'}, {'lastname': 'Sun', 'firstname': 'Gufeng', 'initials': 'G', 'affiliation': 'Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, 1# Minde Road, Nanchang, China.\nJiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang, China.\nJiangxi Health Commission Key Laboratory of Neurological Medicine, Nanchang, China.\nInstitute of Neuroscience, Nanchang University, Nanchang, China.'}, {'lastname': 'Yang', 'firstname': 'Qing', 'initials': 'Q', 'affiliation': 'Department of Respiratory Medicine, The Second Affiliated Hospital of Nanchang University, 1# Minde Road, Nanchang, China. ndefy02020@ncu.edu.cn.'}, {'lastname': 'Guo', 'firstname': 'Hua', 'initials': 'H', 'affiliation': 'Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, 1# Minde Road, Nanchang, China. ndefy02014@ncu.edu.cn.\nJiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang, China. ndefy02014@ncu.edu.cn.\nJiangxi Health Commission Key Laboratory of Neurological Medicine, Nanchang, China. ndefy02014@ncu.edu.cn.\nInstitute of Neuroscience, Nanchang University, Nanchang, China. ndefy02014@ncu.edu.cn.'}]",,,,"© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.","10.1007/s10753-023-01822-5
10.1016/S0047-6374(03)00027-7
10.1182/blood-2004-07-2599
10.1111/imr.12295
10.1172/jci.insight.91229
10.1038/nrneurol.2014.226
10.1186/s12974-021-02206-y
10.1590/0004-282X20150057
10.1080/15548627.2019.1596481
10.1016/j.immuni.2021.12.013
10.1038/nrd.2018.97
10.1016/j.it.2022.07.004
10.1038/cddis.2017.470
10.1038/s41401-020-0411-9
10.1210/er.2018-00084
10.1111/jpi.12525
10.1007/s12975-017-0559-x
10.1038/s41577-019-0215-7
10.1111/imr.12285
10.1111/jpi.12322
10.1038/ni.3772
10.1016/j.cell.2008.01.020
10.1126/science.aat0473
10.1002/dneu.22737
10.1038/s41593-022-01049-x
10.1186/s12974-020-01778-5
10.1038/nature11729
10.1186/s12974-018-1137-1
10.1371/journal.pone.0079624
10.1016/j.cell.2014.11.047
10.1016/j.tplants.2015.07.005
10.1038/s41580-021-00441-y",<Element 'PubmedArticle' at 0x7f05dda749a0>
38,"37120788
30878483
27021778
30831070
27190236
16862116
19795409
28453791
32579115
25631124
25317628
32807643
28226226
16862115
35880011
29478591
25293493
23104886
34103390
32572497
20463744
21204008
16950801
22781549
30180904
24659953
30995509
33731174
32957621
29196460
9537838
30258234
18701698
28828399
36618392
24184798
21047645
21092856
33028409
22265587
32848611
22890097
28435163
27546235
28438992
21212639
25516281
35431903
27306735
21644037
31959936
23041626
11145196
23872599
31039256
22277331
24360280
29744576
23609919
25893602
21068834
28330615
23280835
27780071
34890221
34461088
24680777
30045765
23707197
18349131
22608501
32796538
12946022
16199517
25022663
28073925
35468000
18378771
20154673
30586924
27280887
28424375
26447062
21613335
30112957
34433069
26820675
35838759
20026663
29155950
35120524
31285425
32504082
28835281
28541286
35526004",Progranulin deficiency results in sex-dependent alterations in microglia in response to demyelination.,"Heterozygous mutations in the granulin (GRN) gene, resulting in the haploinsufficiency of the progranulin (PGRN) protein, is a leading cause of frontotemporal lobar degeneration (FTLD). Complete loss of the PGRN protein causes neuronal ceroid lipofuscinosis (NCL), a lysosomal storage disorder. Polymorphisms in the GRN gene have also been associated with several other neurodegenerative diseases, including Alzheimer's disease (AD), and Parkinson's disease (PD). PGRN deficiency has been shown to cause myelination defects previously, but how PGRN regulates myelination is unknown. Here, we report that PGRN deficiency leads to a sex-dependent myelination defect with male mice showing more severe demyelination in response to cuprizone treatment. This is accompanied by exacerbated microglial proliferation and activation in the male PGRN-deficient mice. Interestingly, both male and female PGRN-deficient mice show sustained microglial activation after cuprizone removal and a defect in remyelination. Specific ablation of PGRN in microglia results in similar sex-dependent phenotypes, confirming a microglial function of PGRN. Lipid droplets accumulate in microglia specifically in male PGRN-deficient mice. RNA-seq analysis and mitochondrial function assays reveal key differences in oxidative phosphorylation in male versus female microglia under PGRN deficiency. A significant decrease in myelination and accumulation of myelin debris and lipid droplets in microglia were found in the corpus callosum regions of FTLD patients with GRN mutations. Taken together, our data support that PGRN deficiency leads to sex-dependent alterations in microglia with subsequent myelination defects.","['Frontotemporal lobar degeneration (FTLD)', 'Microglia', 'Myelination', 'Progranulin (PGRN)', 'Sex']",Acta neuropathologica,2023-04-30,"[{'lastname': 'Zhang', 'firstname': 'Tingting', 'initials': 'T', 'affiliation': 'Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, USA.'}, {'lastname': 'Feng', 'firstname': 'Tuancheng', 'initials': 'T', 'affiliation': 'Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, USA.'}, {'lastname': 'Wu', 'firstname': 'Kenton', 'initials': 'K', 'affiliation': 'Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, USA.'}, {'lastname': 'Guo', 'firstname': 'Jennifer', 'initials': 'J', 'affiliation': 'Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, USA.'}, {'lastname': 'Nana', 'firstname': 'Alissa L', 'initials': 'AL', 'affiliation': 'Department of Neurology, University of California, San Francisco, CA, 94158, USA.'}, {'lastname': 'Yang', 'firstname': 'Guang', 'initials': 'G', 'affiliation': 'Department of Anesthesiology, Columbia University Irving Medical Center, New York, NY, 10032, USA.'}, {'lastname': 'Seeley', 'firstname': 'William W', 'initials': 'WW', 'affiliation': 'Department of Neurology, University of California, San Francisco, CA, 94158, USA.\nDepartment of Pathology, University of California, San Francisco, CA, 94158, USA.'}, {'lastname': 'Hu', 'firstname': 'Fenghua', 'initials': 'F', 'affiliation': 'Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, USA. fh87@cornell.edu.'}]",,,,"© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.","10.1007/s00401-023-02578-w
10.1016/j.jmb.2019.03.006
10.1016/j.neurobiolaging.2016.02.019S0197-4580(16)00178-0
10.1016/j.expneurol.2019.02.016
10.1093/nar/gkw419
10.1038/nature05016
10.1002/bies.200900086
10.1093/hmg/ddx1623768439
10.7554/eLife.57495
10.1007/s00401-015-1388-1
10.1001/jamaneurol.2014.1316
10.1016/j.semcdb.2020.08.001
10.1146/annurev-immunol-051116-052358
10.1038/nature05017
10.3389/fncel.2022.874258
10.1016/B978-0-444-64076-5.00027-2
10.1007/s10863-014-9583-7
10.1093/bioinformatics/bts635
10.26508/lsa.202000874
10.1093/brain/awaa154
10.1038/gene.2010.18
10.1007/s13238-010-0067-1
10.1093/hmg/ddl241
10.1186/1750-1326-7-33
10.1186/s13024-018-0281-5
10.3389/fncel.2014.00073
10.1016/j.immuni.2019.03.016
10.1186/s12974-021-02124-z
10.3390/ijms21186824
10.1083/jcb.201709069
10.1038/s41593-018-0242-x
10.1523/JNEUROSCI.0616-08.2008
10.1523/eneuro.0100-17.2017
10.3389/fimmu.2022.1056417
10.1016/j.nbd.2013.10.023
10.1016/j.jns.2010.10.009
10.1016/j.neuron.2010.09.034
10.1186/s40478-020-01037-x
10.1016/j.jalz.2011.10.007S1552-5260(11)02980-3
10.3389/fncel.2020.00198
10.3233/JAD-2012-120946
10.1038/nrn.2017.36
10.1038/nri.2016.90
10.1073/pnas.1700477114
10.1159/000322538
10.1186/s13059-014-0550-8
10.3389/fnagi.2022.868448
10.1111/jnc.13588
10.1007/s00401-011-0845-8
10.1038/s41593-019-0566-1
10.1172/JCI63113
10.1111/j.1750-3639.2001.tb00385.x
10.1038/nn.3469
10.1093/brain/awz099
10.1186/alzrt102
10.1016/j.cell.2013.11.030
10.1007/s00401-018-1861-8
10.1001/2013.jamaneurol.3931680455
10.1172/JCI77983
10.1038/nature09615
10.1016/j.cels.2017.02.009
10.1002/ana.23722
10.1016/j.cub.2016.07.074
10.1126/sciadv.abk1131
10.1016/j.jbc.2021.101140
10.1016/j.gene.2014.03.041S0378-1119(14)00352-7
10.1186/s13293-018-0193-7
10.1016/j.ceb.2013.04.007
10.2353/ajpath.2008.070850
10.1016/j.ajhg.2012.04.021S0002-9297(12)00254-6
10.3390/jcm9082596
10.1111/j.1750-3639.2003.tb00032.x
10.1073/pnas.0506580102
10.1186/s40478-014-0078-x
10.1093/hmg/ddx011
10.1161/STROKEAHA.122.039138
10.1083/jcb.200712039
10.1038/ng.536
10.3390/ijms20010066
10.1371/journal.pone.0157022
10.1042/CS20160485
10.1177/1352458515610646
10.1177/1352458511406164
10.1080/13554794.2018.1506039
10.1016/j.celrep.2021.109581
10.1007/s12035-016-9698-4
10.1007/s00109-022-02233-z
10.1084/jem.20091568
10.1093/nar/gkx1098
10.1186/s13024-021-00513-9
10.1038/s41419-019-1754-3
10.1093/brain/awaa141
10.1186/s13024-017-0205-9
10.1038/ncomms15277
10.1186/s13024-022-00538-8",<Element 'PubmedArticle' at 0x7f05ddf19ea0>
39,37098655,Melatonin protects against NMDA-induced retinal ganglion cell injury by regulating the microglia-TNFα-RGC p38 MAPK pathway.,"Glaucoma, one of the most common ocular neurodegenerative diseases worldwide, is characterized by retinal ganglion cell (RGC) loss. There is a large body of literature that describes the neuroprotective role of melatonin against neurodegenerative diseases by regulating neuroinflammation, although the exact mechanism through which melatonin acts on RGC is still uncertain. This study assessed the protective effects of melatonin using a NMDA-induced RGC injury model, and studied the possible mechanisms involved in this process. Melatonin promoted RGC survival, improved retinal function, and inhibited the apoptosis and necrosis of retinal cells. To understand the mechanism of the neuroprotective effects of melatonin on RGC, microglia and inflammation-related pathways were assessed after melatonin administration and microglia ablation. Melatonin promoted RGC survival by suppressing microglia-derived proinflammatory cytokines, in particular TNFα, which in turn inhibited the activation of p38 MAPK pathway. Inhibiting TNFα or manipulating p38 MAPK pathway protected damaged RGC. Our results suggest that melatonin protects against NMDA-induced RGC injury by inhibiting the microglial TNFα-RGC p38 MAPK pathway. It should be considered a candidate neuroprotective therapy against retinal neurodegenerative diseases.","['Inflammation', 'Melatonin', 'Microglia', 'Retinal ganglion cell', 'Retinal neurodegenerative diseases', 'TNFα']",International immunopharmacology,2023-04-26,"[{'lastname': 'Zou', 'firstname': 'Jingling', 'initials': 'J', 'affiliation': 'Department of Ophthalmology, The Second Xiangya Hospital of Central South University, Changsha, China; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, China.'}, {'lastname': 'Yang', 'firstname': 'Jia', 'initials': 'J', 'affiliation': 'Department of Ophthalmology, The Second Xiangya Hospital of Central South University, Changsha, China; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, China.'}, {'lastname': 'Chen', 'firstname': 'Biyue', 'initials': 'B', 'affiliation': ""Chinese People's Liberation Army Medical School, Beijing, China.""}, {'lastname': 'Jiang', 'firstname': 'Jikuan', 'initials': 'J', 'affiliation': 'Department of Ophthalmology, The Second Xiangya Hospital of Central South University, Changsha, China; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, China.'}, {'lastname': 'Liu', 'firstname': 'Jingyuan', 'initials': 'J', 'affiliation': 'Department of Ophthalmology, The Second Xiangya Hospital of Central South University, Changsha, China; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, China.'}, {'lastname': 'Wang', 'firstname': 'Cong', 'initials': 'C', 'affiliation': 'Department of Ophthalmology, The Second Xiangya Hospital of Central South University, Changsha, China; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, China.'}, {'lastname': 'Yu', 'firstname': 'Juan', 'initials': 'J', 'affiliation': 'Hunan University of Chinese Medicine, Changsha, Hunan, China; The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.'}, {'lastname': 'Peng', 'firstname': 'Qinghua', 'initials': 'Q', 'affiliation': 'Hunan University of Chinese Medicine, Changsha, Hunan, China; The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.'}, {'lastname': 'Zeng', 'firstname': 'Jun', 'initials': 'J', 'affiliation': 'Department of Ophthalmology, The Second Xiangya Hospital of Central South University, Changsha, China; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, China.'}, {'lastname': 'Zhang', 'firstname': 'Lusi', 'initials': 'L', 'affiliation': 'Department of Ophthalmology, The Second Xiangya Hospital of Central South University, Changsha, China; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, China. Electronic address: zhanglusi@csu.edu.cn.'}, {'lastname': 'Jiang', 'firstname': 'Bing', 'initials': 'B', 'affiliation': 'Department of Ophthalmology, The Second Xiangya Hospital of Central South University, Changsha, China; Hunan Clinical Research Center of Ophthalmic Disease, Changsha, China. Electronic address: drjiangb@csu.edu.cn.'}]",,,,Copyright © 2023 Elsevier B.V. All rights reserved.,10.1016/j.intimp.2023.109976,<Element 'PubmedArticle' at 0x7f05dcd4fa40>
40,37094770,Systemic treatment with GnRH agonist produces antidepressant-like effects in LPS induced depression male mouse model.,"Gonadotropin-releasing hormone (GnRH) is at the head of the neuroendocrine reproductive axis. However, the non-reproductive functions of GnRH expressed in various tissues, including hippocampus, are still not known. Here, we unveil a previously unknown effect of GnRH, which mediates depression-like behaviors through the modulation of microglia function during immune challenge. Specifically, we found that either systemic treatment with GnRH agonist or over-expression of endogenous hippocampal GnRH via viral tool abolished the depression-like behavior after LPS challenges in mice. And the anti-depressant of GnRH was dependent on the hippocampal GnRHR signaling, since antagonizing GnRHR by drug treatment or by hippocampal GnRHR knockdown could block the antidepressant-effect of GnRH agonist. Interestingly, we found that the peripheral GnRH treatment prevented the microglia activation mediated inflammation in the hippocampus of mice. In light of the research findings presented here, we propose that, at least in the hippocampus, GnRH appears to act on GnRHR to regulate higher order non-reproductive functions associated with the microglia mediated neuroinflammation. These findings also provide insights into the function and cross-talk of GnRH, a known neuropeptide hormone, in neuro-immune response.","['Depression', 'GnRH', 'Hppocampus', 'Microglia', 'Neuroinflammation']",Neuropharmacology,2023-04-25,"[{'lastname': 'Xu', 'firstname': 'Yang', 'initials': 'Y', 'affiliation': 'Institute of Neuroscience, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.'}, {'lastname': 'Li', 'firstname': 'Wei', 'initials': 'W', 'affiliation': 'Department of Human Anatomy, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.'}, {'lastname': 'Shi', 'firstname': 'Mengmeng', 'initials': 'M', 'affiliation': 'Department of Human Anatomy, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.'}, {'lastname': 'Xu', 'firstname': 'Xiaofan', 'initials': 'X', 'affiliation': 'Department of Human Anatomy, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.'}, {'lastname': 'Guo', 'firstname': 'Dongmin', 'initials': 'D', 'affiliation': 'Department of Human Anatomy, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.'}, {'lastname': 'Liu', 'firstname': 'Zhenghai', 'initials': 'Z', 'affiliation': 'Department of Human Anatomy, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.'}, {'lastname': 'Chen', 'firstname': 'Ling', 'initials': 'L', 'affiliation': 'Department of Metabolism and Endocrinology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.'}, {'lastname': 'Zhong', 'firstname': 'Xiaolin', 'initials': 'X', 'affiliation': 'Department of Metabolism and Endocrinology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. Electronic address: zhxl20130623@163.com.'}, {'lastname': 'Cao', 'firstname': 'Wenyu', 'initials': 'W', 'affiliation': 'Department of Human Anatomy, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China. Electronic address: marksman0@163.com.'}]",,,,Copyright © 2023 Elsevier Ltd. All rights reserved.,10.1016/j.neuropharm.2023.109560,<Element 'PubmedArticle' at 0x7f05dcd27d10>
41,"37030549
29487568
27065166
23629538
31939479
28389277
27208894
23485579
36327147
26940385
23590874
22851280
23785317
29460051
24517230
33792539
15833590
9344566
21756906
27072946
33152340
31470413
31366244
30737388
31479305
32229232
32317389
33069692
33972988
33769619
35395079
35803590
35779583
28462074
36633824
1673916
10521563
19115393
15090034
23792323
12586785
26268661
1791834
23349524
36099517
24751572
24316468
34562435
29459441
25237935
21490921
23939786
24699247
21098272
30377664
26470014
28524175
22201683
31182869
36543864
26275221
20625432
35568227
27508869",Central growth hormone action regulates neuroglial and proinflammatory markers in the hypothalamus of male mice.,"Growth hormone (GH) action in specific neuronal populations regulates neuroendocrine responses, metabolism, and behavior. However, the potential role of central GH action on glial function is less understood. The present study aims to determine how the hypothalamic expression of several neuroglial markers is affected by central GH action in male mice. The dwarf GH- and insulin-like growth factor-1 (IGF-1)-deficient Ghrhr","['Astrocyte', 'Cytokine', 'GH', 'IGF-1', 'Microglia', 'Neuroinflammation']",Neuroscience letters,2023-04-09,"[{'lastname': 'Wasinski', 'firstname': 'Frederick', 'initials': 'F', 'affiliation': 'Department of Neurology and Neurosurgery, Universidade Federal de Sao Paulo, Sao Paulo, SP 04039-032, Brazil.'}, {'lastname': 'Tavares', 'firstname': 'Mariana R', 'initials': 'MR', 'affiliation': 'Department of Physiology and Biophysics, Instituto de Ciencias Biomedicas, Universidade de Sao Paulo, Sao Paulo, SP 05508-000, Brazil.'}, {'lastname': 'Gusmao', 'firstname': 'Daniela O', 'initials': 'DO', 'affiliation': 'Department of Physiology and Biophysics, Instituto de Ciencias Biomedicas, Universidade de Sao Paulo, Sao Paulo, SP 05508-000, Brazil.'}, {'lastname': 'List', 'firstname': 'Edward O', 'initials': 'EO', 'affiliation': 'Edison Biotechnology Institute and Heritage College of Osteopathic Medicine, Ohio University, Athens, OH 45701, USA.'}, {'lastname': 'Kopchick', 'firstname': 'John J', 'initials': 'JJ', 'affiliation': 'Edison Biotechnology Institute and Heritage College of Osteopathic Medicine, Ohio University, Athens, OH 45701, USA.'}, {'lastname': 'Alves', 'firstname': 'Guilherme A', 'initials': 'GA', 'affiliation': 'Department of Anatomy, Instituto de Ciencias Biomedicas, Universidade de Sao Paulo, Sao Paulo, SP 05508-900, Brazil.'}, {'lastname': 'Frazao', 'firstname': 'Renata', 'initials': 'R', 'affiliation': 'Department of Anatomy, Instituto de Ciencias Biomedicas, Universidade de Sao Paulo, Sao Paulo, SP 05508-900, Brazil.'}, {'lastname': 'Donato', 'firstname': 'Jose', 'initials': 'J', 'affiliation': 'Department of Physiology and Biophysics, Instituto de Ciencias Biomedicas, Universidade de Sao Paulo, Sao Paulo, SP 05508-000, Brazil. Electronic address: jdonato@icb.usp.br.'}]",,,,Copyright © 2023 Elsevier B.V. All rights reserved.,"10.1016/j.neulet.2023.137236
10.3389/fendo.2018.00035
10.1002/cphy.c150002
10.1038/nrendo.2013.78
10.20945/2359-399700000018
10.1016/j.yhbeh.2017.04.001
10.1093/gerona/glw088
10.1172/JCI64595
10.1530/JOE-22-0159
10.1016/bs.pmbts.2015.10.014
10.1016/i.pnpbp.2013.04.005
10.1007/s11357-012-9460-4
10.3389/fnbeh.2013.00066
10.1007/s00429-018-1627-z
10.1210/en.2013-2086
10.7554/eLife.67267
10.1016/j.brainresbull.2005.01.012
10.1006/exnr.1997.6629
10.1016/i.expneurol.2011.06.014
10.1007/s00429-016-1221-1
10.1016/i.brainres.2020.147189
10.1530/JOE-19-0242
10.1096/fi.201901315R
10.1038/s41467-019-08607-1
10.1152/aipendo.00229.2019
10.1016/i.neuroscience.2020.03.037
10.1523/JNEUROSCI.2531-19.2020
10.1016/i.peptides.2020.170426
10.1210/endocr/bqab097
10.1111/ine.12957
10.1210/endocr/bqac045
10.1210/endocr/bqac103
10.1016/i.brainres.2022.147995
10.1016/j.molmet.2017.03.001
10.1007/s11357-023-00726-4
10.1016/0742-8413(91)90200-D
10.1016/s0165-3806(99)00081-4
10.1002/glia.20829
10.1111/j.0953-816X.2004.03308.x
10.1530/JOE-13-0053
10.1210/en.2002-220667
10.1111/acel.12382
10.1210/mend-5-12-1845
10.1210/me.2012-1330
10.1210/endocr/bqac151
10.1016/j.brainres.2014.04.018
10.1016/i.neuroscience.2013.11.050
10.1016/j.lfs.2021.119970
10.1530/EJE-18-0018
10.1210/en.2014-1367
10.1371/journal.pone.0018535
10.1002/cne.23451
10.1371/journal.pone.0090381
10.1073/pnas.1016485107
10.1002/btm2.10109
10.1002/glia.22930
10.1038/nrneurol.2017.69
10.1172/JCI59660
10.1038/s41593-019-0418-z
10.1038/s41598-022-26671-4
10.1371/iournal.pone.0135502
10.1371/iournal.pone.0011443
10.1016/i.lfs.2022.120636
10.1016/i.cmet.2016.07.017",<Element 'PubmedArticle' at 0x7f05dcd38630>
42,"37028118
23614055
24319628
24325836
31403827
27261371
24392031
28740734
32653024
6417042
21228311
16182882
23160641
29301251
9298058
16505053
16936187
22455417
33469209
30849371
24101699
28131016
19768732
11006253
19661235
25159209
11551669
24968134
34006945
26074354
9374245
27344677
7775123
22253747
11110671
22982179
27605617
34368894
24272709
29084332
23616782
19660572
16839797
11742414
35334909
35628887
33581416
19668417
16422002
29626212
27966642
28066685
24917142
31758977
26514658
18709137
29167646
24677107
27033597
30682331
19729487
2326002
16815997
12461701
31664225
25023148
34203793
28367520
33239667
32690710
22589436
21116609
15331552
26432657
8125711
2642484
29126927
25172424
24367610
19217421
22275532
26222724
28631889
16284605
28492550
4608446
8682937
25637717
24809310
24826069
12407162
19544395
19298848
15371279
24067647
31346658
25789112
12569129
33396512
31936869
33965378
30968170
24672740
35001686
35852358
22608371
21283568
17485670
26068541
31486227
32094231
19748503
4266466
14992289
34360931
26720448
9344364
14967208
15205231
17267004
26044490
15493012
15623795
19409449
18552386
24894585
11319911
25258680
30401898
15555527
27355244
22248073
18344966
25816073
9539795
9568700
18028233
25878490
30826549
9344359
28737509
7738205
35061025
14533779
17566653
21317295
21042558
8631205
12112376
19465144
29752166
22406746
22605924
25476242
35502410
17988728
32859800
17259381
32785136
12586176
28303331
33240260
29095861
11914198
30541565
23272269
15505070
15377563
15377563
15855346
27467659
30204781
24286086
32953243
31607865
34068807
8764174
34546323
34389792
26733784
31888774
12202536
9588455
32134944
29264825
21266043
22615852
26781437
10321533
33024932
33946446
18224243
22110070
34594230
25873768
26822858
35536323
17728481
27314883
35672457
27783952
24630762
31175392
18326754
20519377
31129252
20830810
18220584
18190523
9519752
34299111
32816099
29527913
31719846
22915034
2181319
19156441
23963372
26009774
29713567
22330964
34042263
33790859
3117025
27549131
2191174
28836097
32230876
28266268
29916142
9731116
10934244
16505225
28772209
17908174
31427727
15355738
19369238
18653375
20034478
18241054
21364670
35325286
31408629
29368003
35163410
30222965
12147608
25015056
19050292
27474370
16020260
27730450
8530182
22235381
32908451
22491408
19596320
34425110
25153686
28729832
30712280
31884019
25329075
33828528
32231336
35688146
10756073
33671690
31765625
22730475
7790896
27374120
29565290
10845624
33869173
34903661
19057892
11978657
17197563
34257518
15627831
20424229
24550151
26137497
30126320
17591902
12821538
28860123
25068294
27512731
24353900
24548736
24224119
9222639
24382888
18083105
31921199
31953631
34364890
14636845
21353595
30476243
2300805
30607767
19029143
31637263
23874797
30300266
33940045
22201683
24940027
33188897
27548900
28755268
26783535
30813473
35094425
9421181
33640465
9732337
29203723
32734440
10647992
26113209
18501660
28510630
8814748
17920532
17359975
25660574
24974304
20530741
25596942
26937019
21733316
27779095
21172954
24076411
20544853
25287897
31485452
15544519
22537944
12601017
31425690
35371110
25443742
30154465
17715340
21436845
31871502
35085503
34963484
34434927
31958216
30025404
32626782
35087408
19897019
20398651
30146696
22986110
32824669
26245868
26890140
31550487
16597346
18268214
10910112
21554091
24658178
26139610
25621293
22409294
28639050
25191897
33915127
21590515
11313884
10652441",Elucidating glial responses to products of diabetes-associated systemic dyshomeostasis.,"Diabetic retinopathy (DR) is a leading cause of blindness in working age adults. DR has non-proliferative stages, characterized in part by retinal neuroinflammation and ischemia, and proliferative stages, characterized by retinal angiogenesis. Several systemic factors, including poor glycemic control, hypertension, and hyperlipidemia, increase the risk of DR progression to vision-threatening stages. Identification of cellular or molecular targets in early DR events could allow more prompt interventions pre-empting DR progression to vision-threatening stages. Glia mediate homeostasis and repair. They contribute to immune surveillance and defense, cytokine and growth factor production and secretion, ion and neurotransmitter balance, neuroprotection, and, potentially, regeneration. Therefore, it is likely that glia orchestrate events throughout the development and progression of retinopathy. Understanding glial responses to products of diabetes-associated systemic dyshomeostasis may reveal novel insights into the pathophysiology of DR and guide the development of novel therapies for this potentially blinding condition. In this article, first, we review normal glial functions and their putative roles in the development of DR. We then describe glial transcriptome alterations in response to systemic circulating factors that are upregulated in patients with diabetes and diabetes-related comorbidities; namely glucose in hyperglycemia, angiotensin II in hypertension, and the free fatty acid palmitic acid in hyperlipidemia. Finally, we discuss potential benefits and challenges associated with studying glia as targets of DR therapeutic interventions. In vitro stimulation of glia with glucose, angiotensin II and palmitic acid suggests that: 1) astrocytes may be more responsive than other glia to these products of systemic dyshomeostasis; 2) the effects of hyperglycemia on glia are likely to be largely osmotic; 3) fatty acid accumulation may compound DR pathophysiology by promoting predominantly proinflammatory and proangiogenic transcriptional alterations of macro and microglia; and 4) cell-targeted therapies may offer safer and more effective avenues for DR treatment as they may circumvent the complication of pleiotropism in retinal cell responses. Although several molecules previously implicated in DR pathophysiology are validated in this review, some less explored molecules emerge as potential therapeutic targets. Whereas much is known regarding glial cell activation, future studies characterizing the role of glia in DR and how their activation is regulated and sustained (independently or as part of retinal cell networks) may help elucidate mechanisms of DR pathogenesis and identify novel drug targets for this blinding disease.","['Angiogenesis', 'Diabetic retinopathy', 'Dysregulation', 'Homeostasis', 'Hyperglycemia', 'Hyperlipidemia', 'Hypertension', 'Inflammation', 'Retinal glia', 'Visual impairment']",Progress in retinal and eye research,2023-04-08,"[{'lastname': 'Padovani-Claudio', 'firstname': 'Dolly Ann', 'initials': 'DA', 'affiliation': 'Department of Ophthalmology and Visual Sciences, Vanderbilt University School of Medicine, B3321A Medical Center North, 1161 21st Avenue South, Nashville, TN, 37232-0011, USA. Electronic address: dolly.a.padovani-claudio@vumc.org.'}, {'lastname': 'Ramos', 'firstname': 'Carla J', 'initials': 'CJ', 'affiliation': 'Department of Ophthalmology and Visual Sciences, Vanderbilt University School of Medicine, AA1324 Medical Center North, 1161 21st Avenue South, Nashville, TN, 37232-0011, USA. Electronic address: carla.ramos@vumc.org.'}, {'lastname': 'Capozzi', 'firstname': 'Megan E', 'initials': 'ME', 'affiliation': 'Duke Molecular Physiology Institute, Duke University School of Medicine, 300 North Duke Street, Durham, NC, 27701, USA. Electronic address: megan.capozzi@duke.edu.'}, {'lastname': 'Penn', 'firstname': 'John S', 'initials': 'JS', 'affiliation': 'Department of Ophthalmology and Visual Sciences, Vanderbilt University School of Medicine, B3307 Medical Center North, 1161 21st Avenue South, Nashville, TN, 37232-0011, USA. Electronic address: john.s.penn@vumc.org.'}]",,,,Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.,10.1016/j.preteyeres.2022.101151,<Element 'PubmedArticle' at 0x7f05dd2878b0>
43,"36986248
34607184
22654183
30452725
28928187
22071480
19444258
28539349
27738642
31997771
32502393
32245147
18929315
15531540
33717063
18626975
23037511
29316965
30385457
33063712
25808285
33671691
28534820
29492848
27739530
35115853
23825629
30971965
28948675
28546539
23321809
17825425
942051
21727141
19777393
26340637
31997771
10693912
33924958
27478531
25945148
23262504
15472007
12167758
9389587
14998234
26336034
25325492
32424276
33849404
25451613
25640603
18561896
26425116
30826520
17012759
11150007
26140821
9435302
21296109
28914794
31061539
32155131
30854594
30794924
30959049
28793992
26340330
31691101
35153150
32277831
31060892
18073775
30109920
31472194
35573324
35745273
32062613
35874738
35236257
36362220
32824322
27110066
21565248
28053336
32433598
30566363
33584665
28448082",Probiotics Supplementation Attenuates Inflammation and Oxidative Stress Induced by Chronic Sleep Restriction.,,"['inflammation', 'microglia', 'oxidative stress', 'probiotics', 'sleep deprivation']",Nutrients,2023-03-30,"[{'lastname': 'Zheng', 'firstname': 'Yadong', 'initials': 'Y', 'affiliation': 'School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, MC, Italy.\nCenter for Neuroscience, University of Camerino, 62032 Camerino, MC, Italy.'}, {'lastname': 'Zhang', 'firstname': 'Luyan', 'initials': 'L', 'affiliation': 'School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, MC, Italy.\nCenter for Neuroscience, University of Camerino, 62032 Camerino, MC, Italy.\nSchool of Food and Biological Engineering, Zhengzhou University of Light Industry, Zhengzhou 450001, China.'}, {'lastname': 'Bonfili', 'firstname': 'Laura', 'initials': 'L', 'affiliation': 'School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, MC, Italy.\nCenter for Neuroscience, University of Camerino, 62032 Camerino, MC, Italy.'}, {'lastname': 'de Vivo', 'firstname': 'Luisa', 'initials': 'L', 'affiliation': 'Center for Neuroscience, University of Camerino, 62032 Camerino, MC, Italy.\nSchool of Pharmacy, University of Camerino, 62032 Camerino, MC, Italy.'}, {'lastname': 'Eleuteri', 'firstname': 'Anna Maria', 'initials': 'AM', 'affiliation': 'School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, MC, Italy.\nCenter for Neuroscience, University of Camerino, 62032 Camerino, MC, Italy.'}, {'lastname': 'Bellesi', 'firstname': 'Michele', 'initials': 'M', 'affiliation': 'School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, MC, Italy.\nCenter for Neuroscience, University of Camerino, 62032 Camerino, MC, Italy.\nSchool of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol BS8 1TD, UK.'}]",,,,,"10.3390/nu15061518
10.1016/j.smrv.2021.101556
10.5665/sleep.1846
10.1093/sleep/zsy221
10.1136/bmjopen-2017-016873
10.1007/s00424-011-1044-0
10.1038/nrendo.2009.23
10.1523/JNEUROSCI.3981-16.2017
10.1155/2016/4576012
10.1016/j.cell.2020.04.049
10.3390/cells9030767
10.1016/S1389-9457(08)70013-3
10.1210/jc.2004-1003
10.3389/fimmu.2021.578386
10.1002/ibd.20602
10.1159/000342079
10.1186/s12974-018-1055-2
10.1084/jem.20180794
10.4103/1673-5374.295270
10.1021/jf506326t
10.3390/antiox10020323
10.3390/nu9050521
10.1007/s12035-018-0973-4
10.1038/srep35405
10.2147/NSS.S334985
10.1371/journal.pone.0067102
10.3389/fpsyt.2019.00164
10.1111/jam.13594
10.1038/s41598-017-02587-2
10.1038/tp.2012.136
10.1016/j.jneumeth.2007.07.007
10.1016/0003-2697(76)90527-3
10.1093/bioinformatics/btr390
10.3390/nu7095341
10.1016/bs.apcsb.2019.03.001
10.1016/S0026-0495(00)80077-3
10.3390/ijms22094642
10.1155/2016/1245049
10.1155/2015/234952
10.1097/WNR.0b013e32835d4b74
10.1152/ajpregu.00565.2004
10.1097/00001756-200208070-00007
10.1016/S0304-3940(97)00706-4
10.1093/sleep/27.1.27
10.1016/j.bbi.2015.08.024
10.5665/sleep.4244
10.1038/s41467-020-16361-y
10.1080/13510002.2021.1913374
10.1016/j.bbi.2014.09.017
10.1016/j.bbi.2015.01.004
10.1016/j.biopsych.2008.05.004
10.1186/s12950-015-0102-3
10.1016/j.neuroscience.2019.02.021
10.1002/biof.5520270101
10.1067/mai.2001.112270
10.1016/j.biopsych.2015.05.014
10.1172/JCI1368
10.1016/j.bbamcr.2011.01.034
10.4103/2347-8659.139719
10.3390/nu9091021
10.1038/s41591-019-0439-x
10.18632/aging.102927
10.1007/s00394-019-01931-8
10.1016/j.phrs.2019.02.016
10.1016/j.ejphar.2019.04.003
10.3945/ajcn.117.156265
10.3109/07853890.2015.1071872
10.1007/s40199-019-00302-2
10.1016/j.hlc.2021.09.006
10.1093/advances/nmaa030
10.1016/j.clnu.2019.04.004
10.1038/nrn2297
10.1021/acschemneuro.8b00386
10.1016/j.bbr.2019.112183
10.3389/fpsyt.2022.879491
10.3390/nu14122543
10.18632/aging.102810
10.1080/1028415X.2022.2042915
10.3390/ijms232113432
10.3390/ijms21165887
10.1155/2016/3094642
10.1016/j.mce.2011.04.019
10.1038/nrrheum.2016.209
10.1038/s41430-020-0656-x
10.1139/apnm-2018-0645
10.3389/fimmu.2020.599547
10.1007/s12603-016-0818-7",<Element 'PubmedArticle' at 0x7f05dba70630>
44,36975047,Formononetin Inhibits Microglial Inflammatory Response and Contributes to Spinal Cord Injury Repair by Targeting the EGFR/MAPK Pathway.,"Zhenbao Pill contains many Chinese herbal medicinal ingredients and has been proven to have therapeutic effects on the repair of spinal cord injury (SCI). This study attempts to investigate the role of formononetin (FMN), an ingredient of Zhenbao Pill, in regulating neuroinflammation after SCI and the underlying mechanism. Primary microglia isolated from the spinal cord of newborn rats and human microglial clone 3 (HMC3) cells were stimulated with IL-1β followed by FMN incubation. The cell viability and inflammatory cytokine levels were detected. The target of FMN was predicted and screened using databases. By silencing or overexpression of epidermal growth factor receptor (EGFR), the anti-neuroinflammatory effect of FMN was assessed in vitro. In vivo, FMN was intraperitoneally injected into rats after SCI followed by the neurological function and histopathology examination. The isolated microglia were in high purity, and the different concentrations of FMN incubation had no toxic effects on primary microglia and HMC3 cells. FMN reduced the inflammatory cytokine levels (TNF-α and IL-6) in a concentration-dependent manner. EGFR silencing or FMN incubation decreased p-EGFR and p-p38 levels and down-regulated inflammatory cytokine levels in IL-1β-stimulated cells or supernatants. Nevertheless, the effects of FMN on microglial inflammation were reversed by EGFR overexpression. In vivo, FMN treatment improved the neuromotor function, repaired tissue injury, and inhibited EGFR/p38MAPK phosphorylation. Formononetin inhibits microglial inflammatory response and contributes to SCI repair via the EGFR/p38MAPK signaling pathway.","['Epidermal growth factor receptor (EGFR)', 'formononetin (FMN)', 'microglia', 'p38MAPK', 'spinal cord injury (SCI)']",Immunological investigations,2023-03-29,"[{'lastname': 'Fu', 'firstname': 'Haiping', 'initials': 'H', 'affiliation': ""Department of Spine Surgery, Inner Mongolia People's Hospital, Hohhot, Inner Mongolia, China.""}, {'lastname': 'Li', 'firstname': 'Mingdong', 'initials': 'M', 'affiliation': 'Department of Orthopedics and Traumatology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan China.'}, {'lastname': 'Huan', 'firstname': 'Yanqiang', 'initials': 'Y', 'affiliation': ""Department of Spine Surgery, Inner Mongolia People's Hospital, Hohhot, Inner Mongolia, China.""}, {'lastname': 'Wang', 'firstname': 'Xiaolei', 'initials': 'X', 'affiliation': ""Department of Spine Surgery, Inner Mongolia People's Hospital, Hohhot, Inner Mongolia, China.""}, {'lastname': 'Tao', 'firstname': 'Mingkai', 'initials': 'M', 'affiliation': ""Department of Spine Surgery, Inner Mongolia People's Hospital, Hohhot, Inner Mongolia, China.""}, {'lastname': 'Jiang', 'firstname': 'Tianqi', 'initials': 'T', 'affiliation': ""Department of Spine Surgery, Inner Mongolia People's Hospital, Hohhot, Inner Mongolia, China.""}, {'lastname': 'Xie', 'firstname': 'Hongbin', 'initials': 'H', 'affiliation': ""Department of Spine Surgery, Inner Mongolia People's Hospital, Hohhot, Inner Mongolia, China.""}, {'lastname': 'Wujisiguleng', 'firstname': None, 'initials': None, 'affiliation': ""Department of Spine Surgery, Inner Mongolia People's Hospital, Hohhot, Inner Mongolia, China.""}, {'lastname': 'Gegentana', 'firstname': None, 'initials': None, 'affiliation': 'Department of International Medical Center, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.'}, {'lastname': 'He', 'firstname': 'Yongxiong', 'initials': 'Y', 'affiliation': 'Department of Spine Surgery, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.'}]",,,,,10.1080/08820139.2023.2183135,<Element 'PubmedArticle' at 0x7f05dd4979f0>
45,"36974372
2411494
21880787
11160401
19208690
9579413
18314276
8150210
26635271
24768715
11274346
26320951
24671993
4834082
12112375
30847860
13688845
17006895
11867745
9361277
21316588
10840047
15920731
16766541
24948802
14572468
2450448
9005851
15139018
26134004
19515974
21706018
15519240
34403440
19619658
18614687
32017258
9038334
28193689
35543322
12186854
21401967
20592216
27775720
26279377
10756062
25810530
20853437
8441812
25849987
24204311
9485064
27307235
30761608
32973451
17900814
27581459
17049173
16388308
3367155
17099706
8507907
23407966
23589937
18160645
16682644
23143512
11955448
24391468
20672298
22984073
30332636
2171589
25774051
25849985
17906634
15895088
31440144
29358753
29986163
3297961
14966869
22020875
19474313
25288117
26166299
10938440
11958820
3287176
24423059
24392271
12167410
19170162
32015540
28862639
3287177
1693848
18787118
19126863
19160500
16136172
24501362
33898427
26101081
24439382
25024457
12417647
15102707
12842915
11799060
30503207
20229602
16129398
21389228
31696982
31614602
7869079
32317939
12176324
26798014
12139924
24671992
9697852
15048854
25564492
2680425
15703389
12122065
24262204
35301318
22431229
22627280
26166300",The Initial Myelination in the Central Nervous System.,"Myelination contributes not only to the rapid nerve conduction but also to axonal insulation and protection. In the central nervous system (CNS), the initial myelination features a multistep process where oligodendrocyte precursor cells undergo proliferation and migration before differentiating into mature oligodendrocytes. Mature oligodendrocytes then extend processes and wrap around axons to form the multilayered myelin sheath. These steps are tightly regulated by various cellular and molecular mechanisms, such as transcription factors (Olig family, Sox family), growth factors (PDGF, BDNF, FGF-2, IGF), chemokines/cytokines (TGF-β, IL-1β, TNFα, IL-6, IFN-γ), hormones (T3), axonal signals (PSA-NCAM, L1-CAM, LINGO-1, neural activity), and intracellular signaling pathways (Wnt/β-catenin, PI3 K/AKT/mTOR, ERK/MAPK). However, the fundamental mechanisms for initial myelination are yet to be fully elucidated. Identifying pivotal mechanisms for myelination onset, development, and repair will become the focus of future studies. This review focuses on the current understanding of how CNS myelination is initiated and also the regulatory mechanisms underlying the process.","['central nervous system', 'development', 'microglia', 'myelin sheath', 'oligodendrocyte']",ASN neuro,2023-03-29,"[{'lastname': 'Yu', 'firstname': 'Qiang', 'initials': 'Q', 'affiliation': 'Department of Human Anatomy and Cell Science, 8664University of Manitoba, Winnipeg, Manitoba, Canada.'}, {'lastname': 'Guan', 'firstname': 'Teng', 'initials': 'T', 'affiliation': 'Department of Human Anatomy and Cell Science, 8664University of Manitoba, Winnipeg, Manitoba, Canada.'}, {'lastname': 'Guo', 'firstname': 'Ying', 'initials': 'Y', 'affiliation': 'Department of Human Anatomy and Cell Science, 8664University of Manitoba, Winnipeg, Manitoba, Canada.\nDepartment of Forensic Medicine, 261761Hebei North University, Zhangjiakou, Hebei, China.'}, {'lastname': 'Kong', 'firstname': 'Jiming', 'initials': 'J', 'affiliation': 'Department of Human Anatomy and Cell Science, 8664University of Manitoba, Winnipeg, Manitoba, Canada.'}]",,,,,"10.1177/17590914231163039
10.1159/000112275
10.1242/dev.071001
10.1523/jneurosci.21-04-01302.2001
10.1093/brain/awn334
10.1002/(sici)1097-4547(19980415)52:2<230::Aid-jnr11>3.0.Co;2-b
10.1016/j.neuroscience.2008.01.015
10.1006/dbio.1994.1105
10.2174/1381612822666151204000636
10.1016/j.bbamcr.2014.04.018
10.1152/physrev.2001.81.2.871
10.1016/j.cub.2015.07.056
10.1523/jneurosci.4314-13.2014
10.1038/249577a0
10.1002/glia.10088
10.1007/s11064-019-02753-0
10.1083/jcb.10.1.67
10.1002/glia.20424
10.1073/pnas.052704499
10.1006/mcne.1997.0641
10.1016/j.devcel.2010.12.008
10.1073/pnas.100076197
10.1002/glia.20232
10.1093/brain/awl144
10.1523/jneurosci.0311-14.2014
10.1016/s1044-7431(03)00210-0
10.2214/ajr.150.4.889
10.1126/science.275.5300.661
10.1002/jnr.20063
10.1101/cshperspect.a020461
10.1101/gad.1806309
10.1038/nn.2855
10.1016/j.mcn.2004.06.015
10.1371/journal.pone.0256207
10.1016/j.mcn.2009.07.010
10.1523/jneurosci.0150-08.2008
10.1002/glia.23789
10.1016/s0092-8674(00)81883-8
10.1523/jneurosci.3316-16.2017
10.7554/eLife.77019
10.1083/jcb.200202002
10.1186/1742-2094-8-24
10.1523/jneurosci.0219-10.2010
10.1038/nn.4425
10.1016/bs.vh.2015.05.005
10.1002/(SICI)1097-4695(200004)43:1<1::AID-NEU1gt;3.0.CO;2-0
10.1523/jneurosci.4787-14.2015
10.1002/ana.22090
10.1016/0301-0082(93)90015-k
10.1038/nn.3992
10.1371/journal.pgen.1003907
10.1002/ana.410430213
10.1523/jneurosci.0299-16.2016
10.1002/glia.23602
10.3389/fncel.2020.00239
10.1016/j.neuroscience.2007.07.044
10.1523/jneurosci.1444-16.2016
10.1016/j.neuroscience.2006.08.070
10.1038/nn1620
10.1097/00005072-198805000-00003
10.1038/nn1803
10.1523/jneurosci.3467-12.2013
10.1038/nprot.2013.039
10.1523/jneurosci.4456-07.2007
10.1073/pnas.0511001103
10.1038/nn.3263
10.1016/s0092-8674(02)00678-5
10.1371/journal.pbio.1001743
10.1002/stem.480
10.1126/science.1220845
10.1016/j.celrep.2018.09.052
10.1016/0896-6273(90)90215-2
10.1242/jcs.114454
10.1038/nn.3991
10.1038/nm1664
10.1038/nn1460
10.3389/fncel.2019.00363
10.1038/s41467-017-02719-2
10.1146/annurev-neuro-080317-061853
10.1159/000180681
10.1002/glia.10338
10.1002/glia.21260
10.1523/jneurosci.0232-09.2009
10.1146/annurev-cellbio-100913-013101
10.1016/j.devcel.2015.05.013
10.1016/s0306-4522(00)00194-9
10.1016/s0165-5728(02)00011-5
10.1038/333560a0
10.1186/1471-2202-15-12
10.1002/brb3.152
10.1006/dbio.2002.0738
10.1002/jnr.22004
10.1038/s41593-019-0578-x
10.1172/JCI90610
10.1038/333562a0
10.1007/BF01067791
10.1073/pnas.0805640105
10.1093/molbev/msn298
10.1038/nn.2172
10.1038/nrn1743
10.1523/jneurosci.1619-13.2014
10.3389/fcell.2021.640169
10.1101/cshperspect.a020479
10.1016/j.cell.2013.11.044
10.1242/jcs.151043
10.1523/jneurosci.22-21-09221.2002
10.1242/dev.01114
10.1101/gad.259003
10.1101/gad.215802
10.1016/j.cell.2018.10.044
10.1002/glia.20981
10.1016/j.neuron.2005.08.017
10.1523/jneurosci.4270-10.2011
10.1002/glia.23735
10.3390/cells8101236
10.1523/jneurosci.15-02-01012.1995
10.3389/fncel.2020.00079
10.1016/s0092-8674(02)00838-3
10.1126/science.aad3839
10.1006/mcne.2002.1127
10.1523/jneurosci.4311-13.2014
10.1016/s0896-6273(00)80515-2
10.1002/glia.20006
10.1093/brain/awu375
10.1242/dev.105.2.387
10.1523/jneurosci.3034-04.2005
10.1523/jneurosci.22-14-06041.2002
10.1016/j.expneurol.2013.11.012
10.1038/s41467-022-29068-z
10.1002/ar.22446
10.1242/dev.078873
10.1016/j.devcel.2015.06.011",<Element 'PubmedArticle' at 0x7f05dd4843b0>
46,"36973385
18801110
33715467
24413388
7492257
30714555
25981208
15285801
36357946
30922465
35493953
34050937
28963000
24342992
28758144
24130763
26847047
31158497
34295224
25487770
26897419
30366016
32398677
33402212
35025183
19077109
31261683
34589784
33556139
17194565
16717171
13688369
27510423
25889665
26783231
25807946
34773851
33098761
31532458
26918313
21525267
22386198
24439304
21878486
33342261
35803999
32408032
23934130
33748354
35098788
29496589
29971587
35806185
34651587
36228925
19083209
1932883
10887767
22472607
7712061
18355686
32017280
16797168
21522163",Investigating TSPO levels in occupation-related posttraumatic stress disorder.,"Microglia are immune brain cells implicated in stress-related mental illnesses including posttraumatic stress disorder (PTSD). Their role in the pathophysiology of PTSD, and on neurobiological systems that regulate stress, is not completely understood. We tested the hypothesis that microglia activation, in fronto-limbic brain regions involved in PTSD, would be elevated in participants with occupation-related PTSD. We also explored the relationship between cortisol and microglia activation. Twenty participants with PTSD and 23 healthy controls (HC) completed positron emission tomography (PET) scanning of the 18-kDa translocator protein (TSPO), a putative biomarker of microglia activation using the probe [",[],Scientific reports,2023-03-28,"[{'lastname': 'Watling', 'firstname': 'Sarah E', 'initials': 'SE', 'affiliation': 'Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.\nBrain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada.'}, {'lastname': 'Gill', 'firstname': 'Talwinder', 'initials': 'T', 'affiliation': 'Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.\nBrain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada.'}, {'lastname': 'Gaudette', 'firstname': 'Erin V', 'initials': 'EV', 'affiliation': 'Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.\nBrain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada.'}, {'lastname': 'Richardson', 'firstname': 'J Don', 'initials': 'JD', 'affiliation': ""The MacDonald Franklin OSI Research Centre, Lawson Health Research Institute, London, ON, Canada.\nDepartment of Psychiatry, University of Western Ontario, London, ON, Canada.\nDepartment of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada.\nSt Joseph's, London OSI, Parkwood Institute, St. Joseph's Health Care, London, ON, Canada.""}, {'lastname': 'McCluskey', 'firstname': 'Tina', 'initials': 'T', 'affiliation': 'Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada.\nCampbell Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.'}, {'lastname': 'Tong', 'firstname': 'Junchao', 'initials': 'J', 'affiliation': 'Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada.\nCampbell Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.\nDepartment of Psychiatry, University of Toronto, Toronto, ON, Canada.'}, {'lastname': 'Meyer', 'firstname': 'Jeffrey H', 'initials': 'JH', 'affiliation': 'Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.\nBrain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada.\nCampbell Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.\nDepartment of Psychiatry, University of Toronto, Toronto, ON, Canada.\nDepartment of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.'}, {'lastname': 'Warsh', 'firstname': 'Jerry', 'initials': 'J', 'affiliation': 'Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.\nBrain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada.\nCampbell Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.\nDepartment of Psychiatry, University of Toronto, Toronto, ON, Canada.\nDepartment of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.'}, {'lastname': 'Jetly', 'firstname': 'Rakesh', 'initials': 'R', 'affiliation': 'Directorate of Mental Health, Canadian Forces Health Services, Ottawa, ON, Canada.\nDepartment of Psychiatry, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.\nDepartment of Psychiatry, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada.'}, {'lastname': 'Hutchison', 'firstname': 'Michael G', 'initials': 'MG', 'affiliation': ""Faculty of Kinesiology and Physical Education, University of Toronto, Toronto, ON, Canada.\nDavid L. MacIntosh Sport Medicine Clinic, Faculty of Kinesiology and Physical Education, University of Toronto, Toronto, ON, Canada.\nKeenan Research Centre for Biomedical Science of St. Michael's Hospital, Toronto, ON, Canada.""}, {'lastname': 'Rhind', 'firstname': 'Shawn G', 'initials': 'SG', 'affiliation': 'Faculty of Kinesiology and Physical Education, University of Toronto, Toronto, ON, Canada.\nDefence Research and Development Canada, Toronto Research Centre, Toronto, ON, Canada.'}, {'lastname': 'Houle', 'firstname': 'Sylvain', 'initials': 'S', 'affiliation': 'Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada.\nCampbell Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.\nDepartment of Psychiatry, University of Toronto, Toronto, ON, Canada.'}, {'lastname': 'Kish', 'firstname': 'Stephen J', 'initials': 'SJ', 'affiliation': 'Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.\nBrain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada.\nCampbell Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.\nDepartment of Psychiatry, University of Toronto, Toronto, ON, Canada.\nDepartment of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.'}, {'lastname': 'Boileau', 'firstname': 'Isabelle', 'initials': 'I', 'affiliation': 'Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada. isabelle.boileau@camh.ca.\nBrain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada. isabelle.boileau@camh.ca.\nCampbell Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada. isabelle.boileau@camh.ca.\nDepartment of Psychiatry, University of Toronto, Toronto, ON, Canada. isabelle.boileau@camh.ca.'}]",,,,© 2023. The Author(s).,"10.1038/s41598-023-31327-y
10.1111/j.1755-5949.2008.00049.x
10.1177/07067437211000636
10.1057/s41599-020-00584-x
10.1001/archpsyc.1995.03950240066012
10.1016/j.neuroscience.2015.05.018
10.1186/1742-2094-1-14
10.1016/j.biopsych.2019.02.002
10.3389/fnbeh.2022.848232
10.1111/jnc.15439
10.1016/j.bbi.2017.09.016
10.1038/mp.2013.155
10.1016/j.cobeha.2017.01.005
10.1371/journal.pone.0076146
10.1007/s00213-016-4218-9
10.1016/j.bbi.2019.05.042
10.3389/fncir.2021.660199
10.1016/j.euroneuro.2014.11.012
10.1016/j.jpsychires.2016.02.003
10.1016/j.neulet.2018.10.027
10.1038/s41467-020-15930-5
10.1186/s12974-020-02069-9
10.1111/j.1365-2990.2008.01006.x
10.3390/ijms20133161
10.1016/j.bbih.2021.100287
10.1371/journal.pone.0246152
10.1016/j.bbi.2006.11.006
10.1001/archinte.166.10.1092
10.3928/0048-5713-20020901-06
10.1001/archpsyc.1961.01710120031004
10.1038/npp.2016.146
10.1177/0269881115625115
10.2174/1389557515666150324122642
10.1016/j.euroneuro.2021.10.006
10.1016/S2215-0366(20)30255-8
10.1001/jamapsychiatry.2019.2516
10.1002/da.22478
10.1523/JNEUROSCI.0450-11.2011
10.1016/j.psyneuen.2012.02.003
10.1016/j.biopsych.2013.11.029
10.1093/cercor/bhr229
10.1177/1759091420979567
10.1038/s41598-022-15617-5
10.1016/j.jcmgh.2020.04.020
10.1172/JCI67569
10.1016/j.ynstr.2021.100312
10.1177/02698811211069110
10.1016/S2215-0366(18)30048-8
10.1186/s13550-018-0401-9
10.3390/ijms23137185
10.1016/j.neubiorev.2022.104901
10.1007/s00213-008-1422-2
10.1111/j.1360-0443.1991.tb01879.x
10.1037/1040-3590.12.2.210
10.1038/jcbfm.2012.46
10.1002/jts.2490080106
10.1016/j.nucmedbio.2007.12.009
10.1111/adb.12876
10.1016/j.pscychresns.2006.01.011
10.1038/jcbfm.2011.55",<Element 'PubmedArticle' at 0x7f05df60ba90>
47,36951074,[Electroacupuncture alleviates cerebral ischemia injury in rats by regulating melatonin-NLRP3 and inhibiting pyroptosis].,"To investigate the mechanism of electroacupuncture in alleviating cerebral ischemia injury in cerebral ischemia-reperfusion rats by regulating melatonin - NOD-like receptor protein 3 (NLRP3) mediated pyroptosis.
A total of 48 SD rats were randomly divided into sham operation group, model group, electroacupuncture (EA) group and EA +Luz group, with 12 rats in each group. The focal cerebral ischemia-reperfusion injury model was established by middle cerebral artery embolization. Rats of the EA group was treated with EA stimulation (4 Hz/20 Hz, 0.5 mA,20 min) at ""Baihui"" (GV20) and ""Shenting"" (GV24) once a day for 7 consecutive days; rats of EA+Luz group were given the same EA treatment and intraperitoneally administered melatonin receptor antagonist (luzindole, 30 mg/kg), once a day for 7 consecutive days. The neurological impairment was evaluated by Zea Longa score. The level of serum melatonin content at 12:00 and 24:00 was detected by ELISA. The percentage of cerebral infarction volume was evaluated by MRI of small animals. The apoptosis rate of nerve cells in cerebral cortex of infarct side was detected by TUNEL staining. The activation of microglia cells was detected by immunofluorescence staining. The expression levels of pyroptosis-related proteins NLRP3, Caspase-1 and interleukin (IL) -1β were detected by Western blot.
Compared with the sham operation group, the neural function score was significantly increased (
EA at GV20 and GV24 can reduce the neurolo-gical injury in cerebral ischemia reperfusion model rats, which may be related to regulating the expression of endogenous melatonin, inhibiting cell scorchification and reducing cerebral ischemia injury.","['Cerebral ischemia', 'Electroacupuncture', 'Melatonin', 'NOD-like receptor protein 3', 'Pyroptosis']",Zhen ci yan jiu = Acupuncture research,2023-03-24,"[{'lastname': 'Yan', 'firstname': 'Nian-Wen', 'initials': 'NW', 'affiliation': ""Neurology Department, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou 350004, China.""}, {'lastname': 'Ruan', 'firstname': 'Su', 'initials': 'S', 'affiliation': ""Neurology Department, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou 350004, China.""}, {'lastname': 'Wang', 'firstname': 'Fang', 'initials': 'F', 'affiliation': ""Neurology Department, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou 350004, China.""}, {'lastname': 'Wang', 'firstname': 'Yan-Xu', 'initials': 'YX', 'affiliation': ""Neurology Department, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou 350004, China.""}, {'lastname': 'Chen', 'firstname': 'Bin', 'initials': 'B', 'affiliation': ""Rehabilitation Department, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou 350004, China.""}, {'lastname': 'Luo', 'firstname': 'Jing', 'initials': 'J', 'affiliation': ""Research Department, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou 350004, China.""}, {'lastname': 'Liu', 'firstname': 'Jia-Jing', 'initials': 'JJ', 'affiliation': ""Neurology Department, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou 350004, China.""}, {'lastname': 'Liang', 'firstname': 'Hui', 'initials': 'H', 'affiliation': ""Neurology Department, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou 350004, China.""}, {'lastname': 'Zhong', 'firstname': 'Xiao-Yong', 'initials': 'XY', 'affiliation': ""Neurology Department, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou 350004, China.""}]",,"EA at GV20 and GV24 can reduce the neurolo-gical injury in cerebral ischemia reperfusion model rats, which may be related to regulating the expression of endogenous melatonin, inhibiting cell scorchification and reducing cerebral ischemia injury.","Compared with the sham operation group, the neural function score was significantly increased (",,10.13702/j.1000-0607.20220657,<Element 'PubmedArticle' at 0x7f05deafeef0>
48,"36949062
29576504
17052660
17531851
24561324
15130950
22450508
24191028
23804112
9200430
15699175
14698857
25765436
27072778
23365095
27930320
12325070
24634831
17502467
33484204
11489988
20483780
32655371
17096403
11389183
19023878
31182869
23872599
33606969
29346778
30471926
28602351
28930663
31018141
18304834
30420755
31061481
28636962
28099414
23127814
32498089
21697255
30441762
15654051
31404977
3283939
23157556
28031322
27152449
28397586
27895121
12467589
33921461
33589835
32317939
34475201
32139584
29301957
26463675
9628453
27794524
16373508
23507975
23273845
12573808
19089688
19515974
25005074
23595275
29203879
28646208
25150836",Androgens show sex-dependent differences in myelination in immune and non-immune murine models of CNS demyelination.,"Neuroprotective, anti-inflammatory, and remyelinating properties of androgens are well-characterized in demyelinated male mice and men suffering from multiple sclerosis. However, androgen effects mediated by the androgen receptor (AR), have been only poorly studied in females who make low androgen levels. Here, we show a predominant microglial AR expression in demyelinated lesions from female mice and women with multiple sclerosis, but virtually undetectable AR expression in lesions from male animals and men with multiple sclerosis. In female mice, androgens and estrogens act in a synergistic way while androgens drive microglia response towards regeneration. Transcriptomic comparisons of demyelinated mouse spinal cords indicate that, regardless of the sex, androgens up-regulate genes related to neuronal function integrity and myelin production. Depending on the sex, androgens down-regulate genes related to the immune system in females and lipid catabolism in males. Thus, androgens are required for proper myelin regeneration in females and therapeutic approaches of demyelinating diseases need to consider male-female differences.",[],Nature communications,2023-03-24,"[{'lastname': 'Zahaf', 'firstname': 'Amina', 'initials': 'A', 'affiliation': 'U1195 Inserm, Paris-Saclay University, Kremlin-Bicêtre, France.'}, {'lastname': 'Kassoussi', 'firstname': 'Abdelmoumen', 'initials': 'A', 'affiliation': 'U1195 Inserm, Paris-Saclay University, Kremlin-Bicêtre, France.'}, {'lastname': 'Hutteau-Hamel', 'firstname': 'Tom', 'initials': 'T', 'affiliation': 'UMR996 Inserm, Paris-Saclay University, Clamart, France.'}, {'lastname': 'Mellouk', 'firstname': 'Amine', 'initials': 'A', 'affiliation': 'UMR996 Inserm, Paris-Saclay University, Clamart, France.'}, {'lastname': 'Marie', 'firstname': 'Corentine', 'initials': 'C', 'affiliation': 'Paris Brain Institute, Sorbonne University, Paris, France.'}, {'lastname': 'Zoupi', 'firstname': 'Lida', 'initials': 'L', 'affiliation': 'Centre for Regenerative Medicine, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh BioQuarter, Edinburgh, UK.'}, {'lastname': 'Tsouki', 'firstname': 'Foteini', 'initials': 'F', 'affiliation': 'Centre for Regenerative Medicine, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh BioQuarter, Edinburgh, UK.'}, {'lastname': 'Mattern', 'firstname': 'Claudia', 'initials': 'C', 'affiliation': 'M et P Pharma AG, Emmetten, Switzerland.'}, {'lastname': 'Bobé', 'firstname': 'Pierre', 'initials': 'P', 'affiliation': 'UMR996 Inserm, Paris-Saclay University, Clamart, France.'}, {'lastname': 'Schumacher', 'firstname': 'Michael', 'initials': 'M', 'affiliation': 'U1195 Inserm, Paris-Saclay University, Kremlin-Bicêtre, France.'}, {'lastname': 'Williams', 'firstname': 'Anna', 'initials': 'A', 'affiliation': 'Centre for Regenerative Medicine, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh BioQuarter, Edinburgh, UK.'}, {'lastname': 'Parras', 'firstname': 'Carlos', 'initials': 'C', 'affiliation': 'Paris Brain Institute, Sorbonne University, Paris, France.'}, {'lastname': 'Traiffort', 'firstname': 'Elisabeth', 'initials': 'E', 'affiliation': 'U1195 Inserm, Paris-Saclay University, Kremlin-Bicêtre, France. elisabeth.traiffort@inserm.fr.'}]",,,,© 2023. The Author(s).,"10.1038/s41467-023-36846-w
10.1016/S0140-6736(18)30481-1
10.1016/S1474-4422(06)70581-6
10.1016/S0074-7742(07)79017-7
10.1177/1352458513519181
10.1093/brain/awh152
10.1038/nrneurol.2012.43
10.1073/pnas.1311763110
10.1523/JNEUROSCI.0886-13.2013
10.4049/jimmunol.159.1.3
10.4049/jimmunol.174.4.2387
10.1016/j.jneuroim.2003.11.004
10.1159/000381064
10.1038/ncomms11350
10.1093/brain/aws284
10.1073/pnas.1614826113
10.1002/ana.10301
10.1016/j.nicl.2014.03.001
10.1001/archneur.64.5.683
10.1002/glia.23967
10.4049/jimmunol.167.4.2060
10.4049/jimmunol.0804356
10.3389/fncel.2020.00165
10.1002/glia.20449
10.1046/j.1471-4159.2001.00345.x
10.1002/path.2476
10.1038/s41593-019-0418-z
10.1038/nn.3469
10.1016/j.neuron.2021.01.027
10.1016/j.celrep.2017.12.066
10.1016/j.immuni.2018.11.004
10.1016/j.cell.2017.05.018
10.1016/j.immuni.2017.08.008
10.1016/j.celrep.2019.03.099
10.1016/j.cyto.2008.01.006
10.1038/s41591-018-0236-y
10.1038/s41587-019-0114-2
10.1016/j.immuni.2017.06.006
10.1038/nature21029
10.1016/j.steroids.2012.10.010
10.1210/clinem/dgaa343
10.1210/jc.2010-3012
10.3390/ijms19113589
10.1136/jnnp.2003.033324
10.3390/cells8080861
10.1146/annurev-physiol-030212-183656
10.1096/fj.201601047R
10.1016/j.conb.2016.04.013
10.1177/1073858417703030
10.1074/jbc.M116.744482
10.1016/S0896-6273(02)01067-X
10.3390/ijms22083975
10.1038/s41593-020-00783-4
10.3389/fncel.2020.00079
10.1523/JNEUROSCI.0783-21.2021
10.1523/JNEUROSCI.1434-18.2020
10.1093/brain/awv289
10.1016/S0165-5728(97)00214-2
10.1073/pnas.0506736102
10.3389/fncel.2013.00026
10.1016/j.immuni.2012.12.001
10.1016/S0303-7207(02)00362-3
10.1080/10611860802382777
10.1101/gad.1806309
10.1007/7651_2014_88
10.1007/s00401-013-1112-y
10.1038/s41598-017-17204-5
10.1038/s41598-017-04520-z
10.1038/nbt.2931",<Element 'PubmedArticle' at 0x7f05de6c0db0>
49,"36945656
27546235
24833586
30471926
26786204
28732515
34107254
33214681
35228310
23273845
28122230
31493147
35260865
30783653
19910308
27508061
16199517
35589920
24994846
21369534
35974106
28602351
30082275
17969104
28863860
16626397
12670482
25896511
21490621
21642987
17851529
32848093
28970783
36617879
23545502
25666439
34530748
26235985
35177477
30944478
34140954
31959936
25309543
24963278
22198949
18981147
31324751
35487953
28245991
30782788
15833363
34294785
33301878
19689368
34281564
23965734
32379705
24162652
31018141
28930663
36747024
35181976
11322887
26354916
24019961
18256700
28928743
28665028
15728241
19503107
20484116
27091843
36257314
33008530
36449413
36624497",Microglial senescence contributes to female-biased neuroinflammation in the aging mouse hippocampus: implications for Alzheimer's disease.,"Microglia, the brain's principal immune cells, have been implicated in the pathogenesis of Alzheimer's disease (AD), a condition shown to affect more females than males. Although sex differences in microglial function and transcriptomic programming have been described across development and in disease models of AD, no studies have comprehensively identified the sex divergences that emerge in the aging mouse hippocampus. Further, existing models of AD generally develop pathology (amyloid plaques and tau tangles) early in life and fail to recapitulate the aged brain environment associated with late-onset AD. Here, we examined and compared transcriptomic and translatomic sex effects in young and old murine hippocampal microglia.
Hippocampal tissue from C57BL6/N and microglial NuTRAP mice of both sexes were collected at young (5-6 month-old [mo]) and old (22-25 mo) ages. Cell sorting and affinity purification techniques were used to isolate the microglial transcriptome and translatome for RNA-sequencing and differential expression analyses. Flow cytometry, qPCR, and imaging approaches were used to confirm the transcriptomic and translatomic findings.
There were marginal sex differences identified in the young hippocampal microglia, with most differentially expressed genes (DEGs) restricted to the sex chromosomes. Both sex chromosomally-and autosomally-encoded sex differences emerged with aging. These sex DEGs identified at old age were primarily female-biased and enriched in senescent and disease-associated microglial signatures. Normalized gene expression values can be accessed through a searchable web interface ( https://neuroepigenomics.omrf.org/ ). Pathway analyses identified upstream regulators induced to a greater extent in females than in males, including inflammatory mediators IFNG, TNF, and IL1B, as well as AD-risk genes TREM2 and APP.
These data suggest that female microglia adopt disease-associated and senescent phenotypes in the aging mouse hippocampus, even in the absence of disease pathology, to a greater extent than males. This sexually divergent microglial phenotype may explain the difference in susceptibility and disease progression in the case of AD pathology. Future studies will need to explore sex differences in microglial heterogeneity in response to AD pathology and determine how sex-specific regulators (i.e., sex chromosomal or hormonal) elicit these sex effects.",[],bioRxiv : the preprint server for biology,2023-03-23,"[{'lastname': 'Ocañas', 'firstname': 'Sarah R', 'initials': 'SR', 'affiliation': 'Genes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK USA.\nDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK USA.'}, {'lastname': 'Pham', 'firstname': 'Kevin D', 'initials': 'KD', 'affiliation': 'Genes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK USA.'}, {'lastname': 'Cox', 'firstname': 'Jillian E J', 'initials': 'JEJ', 'affiliation': 'Genes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK USA.\nGraduate Program in Biomedical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK.'}, {'lastname': 'Keck', 'firstname': 'Alex W', 'initials': 'AW', 'affiliation': 'Genes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK USA.'}, {'lastname': 'Ko', 'firstname': 'Sunghwan', 'initials': 'S', 'affiliation': 'Genes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK USA.\nGraduate Program in Biomedical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK.'}, {'lastname': 'Ampadu', 'firstname': 'Felix A', 'initials': 'FA', 'affiliation': 'Graduate Program in Biomedical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK.'}, {'lastname': 'Porter', 'firstname': 'Hunter L', 'initials': 'HL', 'affiliation': 'Genes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK USA.'}, {'lastname': 'Ansere', 'firstname': 'Victor A', 'initials': 'VA', 'affiliation': 'Genes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK USA.\nDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK USA.'}, {'lastname': 'Kulpa', 'firstname': 'Adam', 'initials': 'A', 'affiliation': 'Genes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK USA.'}, {'lastname': 'Kellogg', 'firstname': 'Collyn M', 'initials': 'CM', 'affiliation': 'Genes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK USA.\nDepartment of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK USA.'}, {'lastname': 'Machalinski', 'firstname': 'Adeline H', 'initials': 'AH', 'affiliation': 'Genes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK USA.'}, {'lastname': 'Chucair-Elliott', 'firstname': 'Ana J', 'initials': 'AJ', 'affiliation': 'Genes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK USA.'}, {'lastname': 'Freeman', 'firstname': 'Willard M', 'initials': 'WM', 'affiliation': 'Genes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK USA.\nDepartment of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK USA.\nOklahoma City Veterans Affairs Medical Center, Oklahoma City, OK USA.'}]",,,"There were marginal sex differences identified in the young hippocampal microglia, with most differentially expressed genes (DEGs) restricted to the sex chromosomes. Both sex chromosomally-and autosomally-encoded sex differences emerged with aging. These sex DEGs identified at old age were primarily female-biased and enriched in senescent and disease-associated microglial signatures. Normalized gene expression values can be accessed through a searchable web interface ( https://neuroepigenomics.omrf.org/ ). Pathway analyses identified upstream regulators induced to a greater extent in females than in males, including inflammatory mediators IFNG, TNF, and IL1B, as well as AD-risk genes TREM2 and APP.",,10.1101/2023.03.07.531562,<Element 'PubmedArticle' at 0x7f05de6b6d60>
50,"36848562
656937
959852
25124430
7440781
10792577
22521312
21414342
14525915
11534967
1887219
15452574
15294140
28734725
19804754
2394991
7217370
4027683
2331785
8896803
9445086
17013925
18164816
19226350
8344188
22336348
16310316
26833829
25917865
22829357
22632727
10668987
34177884
22682109
24646669
20805564
14980203
18685038
14999074
30827729
23467340
12914815
26699615
31197255
15961088
18215238
18195084
6824962
2861581
4040790
20538023
11279593
24925240
31742329
35552544
28689984
19160494
19207822",Microglia phagocytosis mediates the volume and function of the rat sexually dimorphic nucleus of the preoptic area.,"The sexually dimorphic nucleus of the preoptic area (SDN-POA) is the oldest and most robust sex difference reported in mammalian brain and is singular for its presence across a wide range of species from rodents to ungulates to man. This small collection of Nissl-dense neurons is reliably larger in volume in males. Despite its notoriety and intense interrogation, both the mechanism establishing the sex difference and the functional role of the SDN have remained elusive. Convergent evidence from rodent studies led to the conclusion that testicular androgens aromatized to estrogens are neuroprotective in males and that higher apoptosis (naturally occurring cell death) in females determines their smaller SDN. In several species, including humans, a smaller SDN correlates with a preference for mating with males. We report here that this volume difference is dependent upon a participatory role of phagocytic microglia which engulf more neurons in the female SDN and assure their destruction. Selectively blocking microglia phagocytosis temporarily spared neurons from apoptotic death and increased SDN volume in females without hormone treatment. Increasing the number of neurons in the SDN in neonatal females resulted in loss of preference for male odors in adulthood, an effect paralleled by dampened excitation of SDN neurons as evidenced by reduced immediate early gene (IEG) expression when exposed to male urine. Thus, the mechanism establishing a sex difference in SDN volume includes an essential role for microglia, and SDN function as a regulator of sexual partner preference is confirmed.","['microglia', 'neurodevelopment', 'phagocytosis', 'preoptic area', 'sex dimorphism']",Proceedings of the National Academy of Sciences of the United States of America,2023-02-28,"[{'lastname': 'Pickett', 'firstname': 'Lindsay A', 'initials': 'LA', 'affiliation': 'Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD 21201.\nProgram in Neuroscience, University of Maryland School of Medicine, Baltimore, MD 21201.'}, {'lastname': 'VanRyzin', 'firstname': 'Jonathan W', 'initials': 'JW', 'affiliation': 'Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD 21201.\nProgram in Neuroscience, University of Maryland School of Medicine, Baltimore, MD 21201.'}, {'lastname': 'Marquardt', 'firstname': 'Ashley E', 'initials': 'AE', 'affiliation': 'Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD 21201.\nProgram in Neuroscience, University of Maryland School of Medicine, Baltimore, MD 21201.'}, {'lastname': 'McCarthy', 'firstname': 'Margaret M', 'initials': 'MM', 'affiliation': 'Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD 21201.\nProgram in Neuroscience, University of Maryland School of Medicine, Baltimore, MD 21201.'}]",,,,,"10.1073/pnas.2212646120
10.1016/j.yhbeh.2015.04.013
10.1016/j.neuron.2019.02.006
10.5061/dryad.qbzkh18nj",<Element 'PubmedArticle' at 0x7f05dea4e040>
51,"36843585
27940123
27441006
20687966
14660837
22302630
25683973
30032199
26893597
29422210
15058904
12965088
28854913
31087311
24135069
30174608
35682969
34103657
20444932
16434511
10776988
34332202
34695613
31109059
36313771
32108381
27838934
29808008
21810990
31538701
31983467
30501879
25819810
26268616
27014074
27194361
32494846
23583307
36153734
31241463
35293971
27621448
22552791
34963058
21889207
35760917
11846609
18823877
32380473
34982814
30320110
27542691
26811378
30984109
11805154
18275518
33774619
30471926
32968276
18662396
33463813
33704799
20484459
11356123
9266760
1030789
3324681
20233782
35118402
14665706
21307141
16123151
21930913
1644821
8136522
8973644
15647114
11327547
15772125
15647114
6787188
6605089
6186269
34755504
6601703
33141023
27578176
28025777
23637172
23644076
23364171
26159724
21112119
23937191
28588450
34544755
11005258
4005353
10199793
7799320
19451204
36484327
21839735",Characterization of placental endocrine function and fetal brain development in a mouse model of small for gestational age.,"Conditions such as small for gestational age (SGA), which is defined as birthweight less than 10","['animal models', 'endocrinology', 'fetal growth', 'mouse', 'placenta', 'pregnancy', 'pregnancy specific glycoprotein', 'prolactin']",Frontiers in endocrinology,2023-02-28,"[{'lastname': 'Lopez-Tello', 'firstname': 'Jorge', 'initials': 'J', 'affiliation': 'Centre for Trophoblast Research - Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom.'}, {'lastname': 'Sferruzzi-Perri', 'firstname': 'Amanda N', 'initials': 'AN', 'affiliation': 'Centre for Trophoblast Research - Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom.'}]",,,,Copyright © 2023 Lopez-Tello and Sferruzzi-Perri.,"10.3389/fendo.2023.1116770
10.1016/j.bpobgyn.2016.10.006
10.4137/CMPed.S40070
10.1186/1471-2458-10-460
10.1002/uog.11112
10.1002/uog.14818
10.1210/jc.2018-00917
10.3345/kjp.2016.59.1.1
10.1016/j.ajog.2017.11.577
10.1053/j.semperi.2003.10.014
10.1016/S0301-2115(03)00170-2
10.1186/s12916-017-0928-z
10.1055/s-0039-1688472
10.1161/CIRCULATIONAHA.113.003881
10.3389/fphys.2018.01091
10.3390/ijms23116287
10.1038/s42003-021-02214-x
10.1210/jc.2010-0517
10.1210/er.2005-0011
10.1515/jpem.2000.13.4.343
10.1016/j.placenta.2021.07.293
10.1016/j.ecoenv.2021.112916
10.3390/nu11051107
10.3389/fendo.2022.972033
10.1002/jnr.24603
10.1176/appi.ajp.2016.16020138
10.1038/s41591-018-0021-y
10.1073/pnas.1106022108
10.1002/mrd.23271
10.1016/j.theriogenology.2020.01.029
10.1016/j.placenta.2018.10.003
10.1016/j.placenta.2015.03.003
10.1017/S2040174415001385
10.3389/fphys.2016.00033
10.2174/1389201017666160519111529
10.1007/s00018-020-03566-z
10.1016/j.pneurobio.2013.04.001
10.1016/j.xpro.2022.101721
10.7554/eLife.45282
10.1101/2021.07.22.453249
10.1073/pnas.1602012113
10.1152/ajpregu.00600.2011
10.1101/520536
10.1016/j.placenta.2011.08.007
10.1007/s00018-022-04379-y
10.1006/meth.2001.1262
10.1016/j.biopsych.2008.08.005
10.1530/JOE-20-0128
10.1242/dev.199811
10.3389/fcell.2018.00123
10.1016/j.ydbio.2016.08.014
10.1242/dev.128553
10.3389/fendo.2019.00186
10.1084/jem.20011741
10.1111/j.1600-0897.2007.00573.x
10.1159/000514709
10.1016/j.immuni.2018.11.004
10.1038/s41586-020-2745-3
10.1186/1471-2164-9-352
10.1111/jne.12888
10.1113/JP281082
10.1210/en.2009-1385
10.1042/0300-5127:0290038
10.1002/(SICI)1098-2795(199709)48:1<45::AID-MRD6>3.0.CO;2-P
10.1007/978-1-4684-5395-9_19
10.1210/jc.2010-0023
10.1530/RAF-21-0020
10.1093/molehr/gah005
10.1210/jc.2010-2504
10.1210/me.2005-0275
10.1073/pnas.1107341108
10.1016/S0021-9258(18)42012-1
10.1002/aja.1001980303
10.1111/j.1432-1033.1996.0280r.x
10.1186/1471-2164-6-4
10.1111/j.8755-8920.2001.450403.x
10.1189/jlb.0804453
10.1186/1471-2164-6-4
10.1515/jpme.1981.9.2.67
10.1016/s0002-9378(16)32239-6
10.1111/j.1471-0528.1983.tb08899.x
10.5935/1518-0557.20210068
10.1515/jpme.1983.11.1.19
10.7554/eLife.60266
10.1242/dev.137075
10.1007/s12031-016-0872-y
10.1523/JNEUROSCI.3294-12.2013
10.1016/j.pharmthera.2013.04.013
10.1038/pr.2012.188
10.1186/s12864-015-1728-5
10.1016/j.ejcb.2010.10.002
10.1186/1471-2202-14-87
10.3389/fnmol.2017.00148
10.1523/ENEURO.0062-21.2021
10.1093/jnen/59.9.774
10.1095/biolreprod32.4.969
10.1210/jcem.84.4.5607
10.1530/jrf.0.1020245
10.1113/jphysiol.2009.173013
10.1113/EP090442
10.1016/j.ydbio.2011.07.036",<Element 'PubmedArticle' at 0x7f05dce5b4f0>
52,36813224,Activation of glucagon-like peptide-1 receptor in microglia exerts protective effects against sepsis-induced encephalopathy via attenuating endoplasmic reticulum stress-associated inflammation and apoptosis in a mouse model of sepsis.,"Sepsis-induced encephalopathy (SAE) is a detrimental complication in patients with severe sepsis, while there is still no effective treatment. Previous studies have elucidated the neuroprotective effects of glucagon-like peptide-1 receptor (GLP-1R) agonists. However, the role of GLP-1R agonists in the pathological process of SAE is unclear. Here, we found that GLP-1R was up-regulated in the microglia of septic mice. The activation of GLP-1R with Liraglutide could inhibit endoplasmic reticulum stress (ER stress) and associated inflammatory response as well as apoptosis triggered by LPS or tunicamycin (TM) in BV2 cells. In vivo experiments confirmed the benefits of Liraglutide in the regulation of microglial activation, ER stress, inflammation, and apoptosis in the hippocampus of septic mice. Additionally, the survival rate and cognitive dysfunction of septic mice were also improved after Liraglutide administration. Mechanically, cAMP/PKA/CREB signaling is involved in the protection of ER stress-induced inflammation and apoptosis in cultured microglial cells under LPS or TM stimulations. In conclusion, we speculated that GLP-1/GLP-1R activation in microglia might be a potential therapeutic target for the treatment of SAE.","['Endoplasmic reticulum stress', 'Glucagon-like peptide-1 receptor', 'Liraglutide', 'Neuroinflammation', 'Sepsis-induced encephalopathy']",Experimental neurology,2023-02-23,"[{'lastname': 'Yi', 'firstname': 'Hongyu', 'initials': 'H', 'affiliation': 'Department of Critical Care Medicine, The First Medical Centre, Chinese PLA General Hospital, Beijing, China; Medical School of Chinese PLA, Beijing, China.'}, {'lastname': 'Duan', 'firstname': 'Yali', 'initials': 'Y', 'affiliation': 'Department of Critical Care Medicine, The First Medical Centre, Chinese PLA General Hospital, Beijing, China; Medical School of Chinese PLA, Beijing, China.'}, {'lastname': 'Song', 'firstname': 'Renjie', 'initials': 'R', 'affiliation': 'Department of Critical Care Medicine, The First Medical Centre, Chinese PLA General Hospital, Beijing, China; Medical School of Chinese PLA, Beijing, China.'}, {'lastname': 'Zhou', 'firstname': 'Yibo', 'initials': 'Y', 'affiliation': 'Department of Critical Care Medicine, The First Medical Centre, Chinese PLA General Hospital, Beijing, China; Medical School of Chinese PLA, Beijing, China.'}, {'lastname': 'Cui', 'firstname': 'Yating', 'initials': 'Y', 'affiliation': 'Department of Critical Care Medicine, The First Medical Centre, Chinese PLA General Hospital, Beijing, China; Medical School of Chinese PLA, Beijing, China.'}, {'lastname': 'Liu', 'firstname': 'Chao', 'initials': 'C', 'affiliation': 'Department of Critical Care Medicine, The First Medical Centre, Chinese PLA General Hospital, Beijing, China.'}, {'lastname': 'Mao', 'firstname': 'Zhi', 'initials': 'Z', 'affiliation': 'Department of Critical Care Medicine, The First Medical Centre, Chinese PLA General Hospital, Beijing, China.'}, {'lastname': 'Hu', 'firstname': 'Jie', 'initials': 'J', 'affiliation': 'Department of Critical Care Medicine, The First Medical Centre, Chinese PLA General Hospital, Beijing, China.'}, {'lastname': 'Zhou', 'firstname': 'Feihu', 'initials': 'F', 'affiliation': 'Department of Critical Care Medicine, The First Medical Centre, Chinese PLA General Hospital, Beijing, China. Electronic address: feihuzhou301@126.com.'}]",,,,Copyright © 2023. Published by Elsevier Inc.,10.1016/j.expneurol.2023.114348,<Element 'PubmedArticle' at 0x7f05dd1952c0>
53,"36804773
33900197
27546235
30014014
26786204
28732515
32725944
29924994
34309657
10567732
23307732
25693054
24360280
33924200
29752066
31691400
27604565
24445162
31862977
33239064
21088683
25017883
14730714
26257642
31572186
25792098
32610143
28549481
33402227
32357266
20711177
23462811
16388896
22913619
31018141
29985474
29319430
31497858
33902726
31282427
33450279
24142147
32859258
35431903
22396398
11459768
8840551
21062860
18865105
368670
17129764
21068834
33636592
11595490
21546088
12914815
21745188
19190671
18083105
22632727
21358642
35732977
34429552
25254187
19664713
22144466
17715340
24161715
31007172
33758788
30231628
24309662
26590417
30601672
26277326
23497361
24669210
32635451
24833586
23746838
29731617
15919760
15890435
16981890
19840553
32745586
15895084
23994069
23953759
30276315
25598354
31325960
27131225
26827649
23514886
34644556
23252647
30108586
30471926
28602351
31959936
34497421
30606613
33606969
31675495
33470505
33731174
31171460
30481522
22182318
22179516
7349961
29275859
22182318
23407936
14432658
29139169
28732515
30184509
35388616
18832152
17327579
16603089
28747539
34171353
1249196
946570
1908479
22290220
21397624
29967999
32615687
33271219
25901041
23007862
32104920
4857496
34331974
1657578
28685836
31253786
23661874
18413150
33661585
22450372
4744471
843929
6141639
24971815
12697714
8818400
10368772
15251260
32210745
18522863
10697060
31803046
7394127
15135772
31513774
29981391
14568325
15334383
17284595
19589949
25225714
30401546
9661077
27421538
22692332
28392079
28202700
15213206
12771112
9496988
8050041
31453973
18276750
36624497
656937
12052919
15452574
6370082
23407936
25821913
20153946
11158037
12914733
24910824
16487665
16310318
18286612
21565615
25080336
23653459
14611865
29054014
32513838
29772377
29782911
27843532
24999330
16469811
28830026
35305084
17561817
24509348
23643377
33648717
21818630
19568271
27109640
32419557
29382506
24278745
33297945
30552425
24602248
28853720
36041859
35589920
34307355
26235985
35762573
32848093
22568433
31371505
9381176
22954211
33522783
27064253
24777449
32193254
27231129
22196921
30154659
30158665
31632970
14467629
23819035
16424298
11481444
31632970
28947656
15772666
21614513
28837144
33498655
32047510
12848952
28618077
21953569
31704908
32828189
34489625
28078219
33352594
31098671
28650095
32852713
35724494
29403434
33038381
27252160
22239082
32850784
6889895
6541508
28423534
30314533
14568026
35349034
19776215
21385306
26717576
12878732
9608509
32541832
32573436
10805752
23273845
35045285
31371457
20616010
25848008
18171720
20029965
23489470
21886162
34880498
2401216
19207816
32980399
18499648
18363850
1743079
20363980
16261194
24411735
27870435
23935125
23406909
19265696
28553119
25283790
27297671
23126652
26538404
29422891
18286612
25186741
19847162
18026097
28846081
28746864
28118842
33296655
28930663",Chromosomal and gonadal factors regulate microglial sex effects in the aging brain.,"Biological sex contributes to phenotypic sex effects through genetic (sex chromosomal) and hormonal (gonadal) mechanisms. There are profound sex differences in the prevalence and progression of age-related brain diseases, including neurodegenerative diseases. Inflammation of neural tissue is one of the most consistent age-related phenotypes seen with healthy aging and disease. The pro-inflammatory environment of the aging brain has primarily been attributed to microglial reactivity and adoption of heterogeneous reactive states dependent upon intrinsic (i.e., sex) and extrinsic (i.e., age, disease state) factors. Here, we review sex effects in microglia across the lifespan, explore potential genetic and hormonal molecular mechanisms of microglial sex effects, and discuss currently available models and methods to study sex effects in the aging brain. Despite recent attention to this area, significant further research is needed to mechanistically understand the regulation of microglial sex effects across the lifespan, which may open new avenues for sex informed prevention and treatment strategies.","['Aging', 'Estrogen', 'Microglia', 'Neuroimmune', 'Sex chromosome', 'Sex difference', 'Sex hormones', 'X-chromosome inactivation']",Brain research bulletin,2023-02-23,"[{'lastname': 'Ocañas', 'firstname': 'Sarah R', 'initials': 'SR', 'affiliation': 'Genes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Electronic address: sarah-ocanas@omrf.org.'}, {'lastname': 'Ansere', 'firstname': 'Victor A', 'initials': 'VA', 'affiliation': 'Genes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.'}, {'lastname': 'Kellogg', 'firstname': 'Collyn M', 'initials': 'CM', 'affiliation': 'Genes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.'}, {'lastname': 'Isola', 'firstname': 'Jose V V', 'initials': 'JVV', 'affiliation': 'Aging & Metabolism Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.'}, {'lastname': 'Chucair-Elliott', 'firstname': 'Ana J', 'initials': 'AJ', 'affiliation': 'Genes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.'}, {'lastname': 'Freeman', 'firstname': 'Willard M', 'initials': 'WM', 'affiliation': 'Genes & Human Disease Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; Oklahoma City Veterans Affairs Medical Center, Oklahoma City, OK, USA; Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.'}]",,,,Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.,10.1016/j.brainresbull.2023.02.008,<Element 'PubmedArticle' at 0x7f05dd188310>
54,36744980,[Oxytocin: a new target for neuroprotection?].,"Every year, 30 million infants worldwide are delivered after intra-uterine growth restriction (IUGR) and 15 million are born preterm. These two conditions are the leading causes of ante-/perinatal stress and brain injury responsible for neurocognitive and behavioral disorders affecting more than 9 million children each year. Most pharmacological candidates to prevent perinatal brain damage have failed to demonstrate substantial benefits. In contrast, environment enrichment based on developmental care, skin-to-skin contact and vocal/music exposure appear to exert positive effects on brain structure and function. However, mechanisms underlying these effects remain unknown. There is strong evidence that an adverse environment during pregnancy and the neonatal period can influence hormonal responses of the newborn with long-lasting neurobehavioral consequences in infancy and adulthood. In particular, excessive cortisol release in response to perinatal stress associated with prematurity or IUGR is recognized to induce brain-programming effects and neuroinflammation, a key predictor of subsequent neurological impairments. These deleterious effects are known to be balanced by oxytocin (OT), a neuropeptide released by the hypothalamus, which plays a role during the perinatal period and in social behavior. In addition, preclinical studies suggest that OT is able to regulate the central inflammatory response to injury in the adult brain. Using a rodent model of IUGR associated with developing white matter damage, we recently reported that carbetocin, a brain permeable OT receptor (OTR) agonist, induced a significant reduction of activated microglia, the primary immune cells of the brain. Moreover, this reduced microglia reactivity was associated with long-term neuroprotection. These findings make OT a promising candidate for neonatal neuroprotection through neuroinflammation regulation. However, the mechanisms linking endogenous OT and central inflammation response to injury have not yet been established. Further studies are needed to assess the protective role of OT in the developing brain through modulation of microglial activation, a key feature of brain injury observed in infants born preterm or growth-restricted. They are expected to have several impacts in the near future not only for improving knowledge of microglial cell physiology and reactivity during brain development, but also to design clinical trials testing interventions associated with endogenous OT release as a relevant strategy to alleviate neuroinflammation in neonates.
Ocytocine  : une nouvelle cible de neuroprotection ?
Chaque année, dans le monde, 30 millions de nouveau-nés naissent après un retard de croissance intra-utérin (RCIU) et 15 millions naissent prématurément. Ces deux conditions sont les principales causes de stress anté-/périnatal et de lésions cérébrales responsables de troubles neurocognitifs et comportementaux chez plus de 9 millions d’enfants chaque année. La plupart des stratégies pharmacologiques visant à prévenir les lésions cérébrales périnatales n’ont pas réussi à démontrer des bénéfices cliniques substantiels. En revanche, l’enrichissement de l’environnement basé sur les soins de développement, le contact peau à peau et l’exposition vocale/musicale semblent avoir des effets positifs sur la structure et la fonctionnalité du cerveau. Toutefois, les mécanismes qui sous-tendent ces effets restent inconnus. De nombreuses évidences montrent qu’un environnement défavorable pendant la grossesse et la période néonatale peut influencer les réponses hormonales du nouveau-né et avoir des conséquences neurocomportementales durables pendant la petite enfance et à l’âge adulte. L’ocytocine (OT), un neuropeptide libéré par l’hypothalamus, joue un rôle pendant la période périnatale dans l’attachement parents-enfant et dans le comportement social. En outre, des études précliniques suggèrent que l’OT est capable de réguler la réponse inflammatoire centrale aux lésions dans le cerveau adulte. Ces données font de l’OT un candidat prometteur pour la neuroprotection néonatale par la régulation de la neuro-inflammation.","['brain lesions', 'lésions cérébrales', 'microglia', 'microglie', 'neuroprotection', 'nouveau-né prématuré', 'ocytocine', 'oxytocin', 'preterm infants']",Biologie aujourd'hui,2023-02-07,"[{'lastname': 'Baud', 'firstname': 'Olivier', 'initials': 'O', 'affiliation': 'Laboratoire du développement, Université de Genève, Genève, Suisse - Inserm U1141, Université Paris Cité, 75019 Paris, France - Service de Soins Intensifs Pédiatriques et Néonatologie, Hôpitaux Universitaires de Genève, 30 boulevard de Cluse, 1205 Genève, Suisse.'}, {'lastname': 'Knoop', 'firstname': 'Marit', 'initials': 'M', 'affiliation': 'Laboratoire du développement, Université de Genève, Genève, Suisse.'}, {'lastname': 'Jacquens', 'firstname': 'Alice', 'initials': 'A', 'affiliation': 'Laboratoire du développement, Université de Genève, Genève, Suisse - Inserm U1141, Université Paris Cité, 75019 Paris, France.'}, {'lastname': 'Possovre', 'firstname': 'Marie-Laure', 'initials': 'ML', 'affiliation': 'Laboratoire du développement, Université de Genève, Genève, Suisse.'}]",,,,"© Société de Biologie, 2023.
© Société de Biologie, 2023.",10.1051/jbio/2022012,<Element 'PubmedArticle' at 0x7f05dd42c360>
55,"36739968
14572468
23473318
21092857
18849983
21266410
24205170
33082115
25324381
27455109
31753579
32042175
29020619
29556025
29556031
32595455
20093161
23562080
25721933
34260928
20738281
32413277
21062956
15836427
9736024
32030468
16399703
28683286
27166944
34368163
23624515
15450085
21228163
24514565
30654924
26780511
22201683
25428410",Median eminence myelin continuously turns over in adult mice.,"Oligodendrocyte progenitor cell differentiation is regulated by nutritional signals in the adult median eminence (ME), but the consequences on local myelination are unknown. The aim of this study was to characterize myelin plasticity in the ME of adult mice in health or in response to chronic nutritional challenge and determine its relevance to the regulation of energy balance.
We assessed new oligodendrocyte (OL) and myelin generation and stability in the ME of healthy adult male mice using bromodeoxyuridine labelling and genetic fate mapping tools. We evaluated the contribution of microglia to ME myelin plasticity in PLX5622-treated C57BL/6J mice and in Pdgfra-Cre/ER
We show that myelinating OLs are continuously and rapidly generated in the adult ME. Paradoxically, OL number and myelin amounts remain remarkably stable in the adult ME. In fact, the high rate of new OL and myelin generation in the ME is offset by continuous turnover of both. We show that microglia are required for continuous OL and myelin production, and that ME myelin plasticity regulates the recruitment of local immune cells. Finally, we provide evidence that ME myelination is regulated by the body's energetic status and demonstrate that ME OL and myelin plasticity are required for the regulation of energy balance and hypothalamic leptin sensitivity.
This study identifies a new mechanism modulating leptin sensitivity and the central control of energy balance and uncovers a previously unappreciated form of structural plasticity in the ME.","['Hypothalamus', 'Median eminence', 'Microglia', 'Myelin', 'Nutrient sensing', 'Oligodendrocyte']",Molecular metabolism,2023-02-06,"[{'lastname': 'Buller', 'firstname': 'Sophie', 'initials': 'S', 'affiliation': 'Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Disease Unit, University of Cambridge, Cambridge, UK. Electronic address: sab236@medschl.cam.ac.uk.'}, {'lastname': 'Kohnke', 'firstname': 'Sara', 'initials': 'S', 'affiliation': 'Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Disease Unit, University of Cambridge, Cambridge, UK. Electronic address: sara.kohnke@gmail.com.'}, {'lastname': 'Hansford', 'firstname': 'Robert', 'initials': 'R', 'affiliation': 'Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Disease Unit, University of Cambridge, Cambridge, UK. Electronic address: rh747@medscl.cam.ac.uk.'}, {'lastname': 'Shimizu', 'firstname': 'Takahiro', 'initials': 'T', 'affiliation': 'Wolfson Institute for Biomedical Research, University College London, London, UK. Electronic address: t.shimizu@ucl.ac.uk.'}, {'lastname': 'Richardson', 'firstname': 'William D', 'initials': 'WD', 'affiliation': 'Wolfson Institute for Biomedical Research, University College London, London, UK. Electronic address: w.richardson@ucl.ac.uk.'}, {'lastname': 'Blouet', 'firstname': 'Clemence', 'initials': 'C', 'affiliation': 'Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Disease Unit, University of Cambridge, Cambridge, UK. Electronic address: csb69@medschl.cam.ac.uk.'}]",,,"We show that myelinating OLs are continuously and rapidly generated in the adult ME. Paradoxically, OL number and myelin amounts remain remarkably stable in the adult ME. In fact, the high rate of new OL and myelin generation in the ME is offset by continuous turnover of both. We show that microglia are required for continuous OL and myelin production, and that ME myelin plasticity regulates the recruitment of local immune cells. Finally, we provide evidence that ME myelination is regulated by the body's energetic status and demonstrate that ME OL and myelin plasticity are required for the regulation of energy balance and hypothalamic leptin sensitivity.",Copyright © 2023 The Author(s). Published by Elsevier GmbH.. All rights reserved.,"10.1016/j.molmet.2023.101690
10.1371/journal.pone.0078236
10.1016/j.celrep.2021.109362",<Element 'PubmedArticle' at 0x7f05de3aedb0>
56,"36717883
22524785
24571856
12498988
18064422
9285589
16116451
20147530
19666749
22411015
26109933
21256197
21501147
18534982
16364651
11586361
16732431
26541090
24845457
18096503
19635411
22813736
26212325
22021672
23122958
33939165
25378159
25492114
25927213
30059673
23142242
28638858
25298214
28373073
20479749
33239064
36254984
15390110
26565024
35136958
26779719
34940397
29608179
31819264
17698379
26147761
34896479
32783256
28183803
33414433
11605159
23076048
30453285
29901792
28900165
31903891
21454566
25635046
32575773
33168968
28733897
2825898
19365736
34831202
16140167
17531086
31730792
22519513
28585542
26910882
21729288
25906979
31559913
21105875
31727174
32703941
28099414
29769726
33662621
33114694",Inhibition of 2-arachidonoylglycerol degradation enhances glial immunity by single-cell transcriptomic analysis.,"2-Arachidonoylglycerol (2-AG) is the most abundant endogenous cannabinoid. Inhibition of 2-AG metabolism by inactivation of monoacylglycerol lipase (MAGL), the primary enzyme that degrades 2-AG in the brain, produces anti-inflammatory and neuroprotective effects in neurodegenerative diseases. However, the molecular mechanisms underlying these beneficial effects are largely unclear.
Hippocampal and cortical cells were isolated from cell type-specific MAGL knockout (KO) mice. Single-cell RNA sequencing was performed by 10 × Genomics platform. Cell Ranger, Seurat (v3.2) and CellChat (1.1.3) packages were used to carry out data analysis.
Using single-cell RNA sequencing analysis, we show here that cell type-specific MAGL KO mice display distinct gene expression profiles in the brain. Inactivation of MAGL results in robust changes in expression of immune- and inflammation-related genes in microglia and astrocytes. Remarkably, upregulated expression of chemokines in microglia is more pronounced in mice lacking MAGL in astrocytes. In addition, expression of genes that regulate other cellular functions and Wnt signaling in astrocytes is altered in MAGL KO mice.
Our results provide transcriptomic evidence that cell type-specific inactivation of MAGL induces differential expression of immune-related genes and other fundamental cellular pathways in microglia and astrocytes. Upregulation of the immune/inflammatory genes suggests that tonic levels of immune/inflammatory vigilance are enhanced in microglia and astrocytes, particularly in microglia, by inhibition of 2-AG metabolism, which likely contribute to anti-inflammatory and neuroprotective effects produced by inactivation of MAGL in neurodegenerative diseases.","['Endocannabinoid', 'Immunity', 'Monoacylglycerol lipase', 'Neurodegenerative disease', 'Neuroinflammation', 'Single-cell RNA sequencing', 'Transcriptome', 'Vigilance']",Journal of neuroinflammation,2023-02-01,"[{'lastname': 'Zhu', 'firstname': 'Dexiao', 'initials': 'D', 'affiliation': 'Department of Cellular and Integrative Physiology, Joe R. and Teresa Lozano Long School of Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX, 78229, USA.'}, {'lastname': 'Zhang', 'firstname': 'Jian', 'initials': 'J', 'affiliation': 'Department of Cellular and Integrative Physiology, Joe R. and Teresa Lozano Long School of Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX, 78229, USA.'}, {'lastname': 'Hashem', 'firstname': 'Jack', 'initials': 'J', 'affiliation': 'Department of Cellular and Integrative Physiology, Joe R. and Teresa Lozano Long School of Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX, 78229, USA.'}, {'lastname': 'Gao', 'firstname': 'Fei', 'initials': 'F', 'affiliation': 'Department of Cellular and Integrative Physiology, Joe R. and Teresa Lozano Long School of Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX, 78229, USA.'}, {'lastname': 'Chen', 'firstname': 'Chu', 'initials': 'C', 'affiliation': 'Department of Cellular and Integrative Physiology, Joe R. and Teresa Lozano Long School of Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX, 78229, USA. chenc7@uthscsa.edu.\nCenter for Biomedical Neuroscience, Joe R. and Teresa Lozano Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, 78229, USA. chenc7@uthscsa.edu.'}]",,,"Using single-cell RNA sequencing analysis, we show here that cell type-specific MAGL KO mice display distinct gene expression profiles in the brain. Inactivation of MAGL results in robust changes in expression of immune- and inflammation-related genes in microglia and astrocytes. Remarkably, upregulated expression of chemokines in microglia is more pronounced in mice lacking MAGL in astrocytes. In addition, expression of genes that regulate other cellular functions and Wnt signaling in astrocytes is altered in MAGL KO mice.",© 2023. The Author(s).,10.1186/s12974-023-02701-4,<Element 'PubmedArticle' at 0x7f05de389450>
57,"36618392
29053785
35169707
28828399
28743268
28435163
34366786
32416272
35246670
28404863
18543312
18565828
18752597
19016491
24064467
25578179
34693284
27114033
16873554
35672480
34633319
33590953
33028409
30149180
32436108
17475886
29519253
19114008
33207193
21283776
20026663
28237313
31572186
24275605
12165466
34522039
23041626
21804537
27601660
29063348
27546235
25741341
12421945
24850301
29196459
17827392
29078813
29422891
21457936
21331226
27765768
28832681
19721334
28916533
29985474
32284961
34103390
30184509
33867943
29924994
20709912
28433199
34054862
17284525
30104766
32872326
24808180",Progranulin loss results in sex-dependent dysregulation of the peripheral and central immune system.,"Progranulin (PGRN) is a secreted glycoprotein, the expression of which is linked to several neurodegenerative diseases. Although its specific function is still unclear, several studies have linked it with lysosomal functions and immune system regulation. Here, we have explored the role of PGRN in peripheral and central immune system homeostasis by investigating the consequences of PGRN deficiency on adaptive and innate immune cell populations.
First, we used gene co-expression network analysis of published data to test the hypothesis that 
Male PGRN KO mice exhibited a lower abundance of microglial cells with higher MHC-II expression, increased CD44 expression on monocytes in the brain, and more CNS-associated CD8
Our data suggest that PGRN and GPNMB jointly regulate the peripheral and the central immune system in a sex-specific manner; thus, understanding their associated mechanisms could pave the way for developing new neuroprotective strategies to modulate central and peripheral inflammation to lower risk for neurodegenerative diseases and possibly delay or halt progression.","['GPNMB', 'T cells', 'microglia', 'monocytes', 'neurodegenaration', 'peripheral-brain crosstalk', 'progranulin']",Frontiers in immunology,2023-01-10,"[{'lastname': 'Houser', 'firstname': 'Madelyn C', 'initials': 'MC', 'affiliation': 'Department of Physiology, Emory University School of Medicine, Atlanta, GA, United States.'}, {'lastname': 'Uriarte Huarte', 'firstname': 'Oihane', 'initials': 'O', 'affiliation': 'Department of Neuroscience, University of Florida College of Medicine, Gainesville, FL, United States.\nCenter for Translational Research in Neurodegenerative Disease, University of Florida College of Medicine, Gainesville, FL, United States.'}, {'lastname': 'Wallings', 'firstname': 'Rebecca L', 'initials': 'RL', 'affiliation': 'Department of Neuroscience, University of Florida College of Medicine, Gainesville, FL, United States.\nCenter for Translational Research in Neurodegenerative Disease, University of Florida College of Medicine, Gainesville, FL, United States.'}, {'lastname': 'Keating', 'firstname': 'Cody E', 'initials': 'CE', 'affiliation': 'Department of Neuroscience, University of Florida College of Medicine, Gainesville, FL, United States.\nCenter for Translational Research in Neurodegenerative Disease, University of Florida College of Medicine, Gainesville, FL, United States.'}, {'lastname': 'MacPherson', 'firstname': 'Kathryn P', 'initials': 'KP', 'affiliation': 'Department of Physiology, Emory University School of Medicine, Atlanta, GA, United States.'}, {'lastname': 'Herrick', 'firstname': 'Mary K', 'initials': 'MK', 'affiliation': 'Department of Neuroscience, University of Florida College of Medicine, Gainesville, FL, United States.\nCenter for Translational Research in Neurodegenerative Disease, University of Florida College of Medicine, Gainesville, FL, United States.'}, {'lastname': 'Kannarkat', 'firstname': 'George T', 'initials': 'GT', 'affiliation': 'Department of Physiology, Emory University School of Medicine, Atlanta, GA, United States.'}, {'lastname': 'Kelly', 'firstname': 'Sean D', 'initials': 'SD', 'affiliation': 'Department of Physiology, Emory University School of Medicine, Atlanta, GA, United States.'}, {'lastname': 'Chang', 'firstname': 'Jianjun', 'initials': 'J', 'affiliation': 'Department of Physiology, Emory University School of Medicine, Atlanta, GA, United States.'}, {'lastname': 'Varvel', 'firstname': 'Nicholas H', 'initials': 'NH', 'affiliation': 'Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, United States.'}, {'lastname': 'Rexach', 'firstname': 'Jessica E', 'initials': 'JE', 'affiliation': 'Department of Neurology, University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, CA, United States.'}, {'lastname': 'Tansey', 'firstname': 'Malú Gámez', 'initials': 'MG', 'affiliation': 'Department of Neuroscience, University of Florida College of Medicine, Gainesville, FL, United States.\nCenter for Translational Research in Neurodegenerative Disease, University of Florida College of Medicine, Gainesville, FL, United States.\nNorman Fixel Institute for Neurodegenerative Disease, University of Florida Health, Gainesville, FL, United States.\nEvelyn F. and William L. McKnight Brain Institute, University of Florida, Gainesville, FL, United States.'}]",,,"Male PGRN KO mice exhibited a lower abundance of microglial cells with higher MHC-II expression, increased CD44 expression on monocytes in the brain, and more CNS-associated CD8","Copyright © 2022 Houser, Uriarte Huarte, Wallings, Keating, MacPherson, Herrick, Kannarkat, Kelly, Chang, Varvel, Rexach and Tansey.","10.3389/fimmu.2022.1056417
10.1093/brain/awx198
10.1093/braincomms/fcab310
10.1523/ENEURO.0100-17.2017
10.1186/s13024-017-0196-6
10.1038/nrn.2017.36
10.3389/fnmol.2021.713031
10.1016/j.bbapap.2020.140443
10.1038/s41577-022-00684-6
10.1126/scitranslmed.aah5642
10.1002/humu.20785
10.1212/01.wnl.0000319688.89790.7a
10.1111/j.1468-1331.2008.02266.x
10.1002/ajmg.b.30889
10.3233/JAD-131151
10.1007/s00415-014-7630-2
10.1093/braincomms/fcab095
10.1016/j.cell.2016.04.001
10.1152/ajpregu.00616.2005
10.1007/s10072-022-06185-7
10.3233/JAD-210688
10.1002/alz.12299
10.1186/s40478-020-01037-x
10.1016/j.nbd.2018.08.013
10.1007/s12035-020-01921-6
10.4049/jimmunol.178.10.6557
10.1186/s12974-018-1100-1
10.1186/1471-2105-9-559
10.1016/j.celrep.2020.108398
10.1371/journal.pcbi.1001057
10.1084/jem.20091568
10.1016/j.nbd.2017.02.010
10.3389/fphar.2019.01008
10.3233/JPD-130250
10.1016/S0896-6273(02)00794-8
10.1038/s41582-021-00549-x
10.1172/JCI63113
10.1038/nn.2887
10.1073/pnas.1604263113
10.1007/s00702-017-1795-7
10.1038/nri.2016.90
10.3389/fimmu.2015.00068
10.4049/jimmunol.169.10.5660
10.1093/abbs/gmu042
10.4049/jimmunol.1700713
10.1182/blood-2007-02-076539
10.1186/s13024-017-0222-8
10.3389/fimmu.2017.01905
10.1016/j.ajpath.2011.01.039
10.4161/cib.3.6.13495
10.1161/ATVBAHA.116.308198
10.1371/journal.pone.0183594
10.1262/jrd.20249
10.1212/WNL.0000000000004494
10.1038/s41582-018-0032-9
10.1038/s41531-020-0109-1
10.26508/lsa.202000874
10.1016/j.celrep.2018.08.001
10.3389/fncel.2021.660523
10.1016/j.celrep.2018.05.048
10.1096/fj.10-154757
10.1016/j.cellimm.2017.03.006
10.3389/fimmu.2021.674739
10.1182/blood-2006-11-053769
10.1038/s41591-018-0135-2
10.3390/ijms21176242
10.1074/jbc.M113.535500",<Element 'PubmedArticle' at 0x7f05de0c5450>
58,"36614031
33466824
29074503
22560215
18974038
12543708
16550215
32256356
9062341
11994399
12440980
23415954
28411173
18952570
16723730
19945371
21680734
31178403
30092598
21532591
24179149
10564271
10500120
21288373
24847353
15304479
27146479
18522833
19081072
19708857
21644928
23888053
20066008
29180630
23281479
18852460
22116877
34381963
11779464
31666338
18556558
21407177
29381485
23040070
22195283
33727534
12110171
11163209
17765679
23583182
34831188
19420237
21521793
17765680
33398919
14765107
27207533
28564599
31959936
15895084
15831717
20966214
30618635
22613055
24162652
21778362
22715882
24360280
23525041
28685323
28963396
33498265
29599706
31256193
29301957
30103935
22289388
20424161
35388616
26374899
31902528
32135085
33627648
28642277
21266330
34695418
24986598
31257031
35862581
20597103
33004525
32015091
34742349
34919143
31602788
32798273
34686867
21849292
16977381
16493068
19002241
18591669
11560944
29045901
28027924
17202362
17101731
34548649
33790857
18559343
11399774
14707038
26767504
18536741
29343628
32132994
31308834
35221690
28822689
35237348
32463301
31685212
29644527
25889044
18078024
12595916
15684478
11122726
16278712
8620338
25760954
29508377
3278832
32557581
25415541
21663949
9935036
19694602
18199003
23752925
27143992
10339591
23856291
29386753
29654284
29483608
35822617
30442494
27444197
21921268
17606258
25263561
28760743
16741148
22536247
11818483
23349482
30952864
32826849
31496957
18509489
25043817
16085647
16505490
23374710
27185873
25713102
29709897
30235785
25016145
23604321
21617040
33679452
23532117
24983318
29348847
31080057
26231484
15728586
26930600
31477883
33855029
28838620
25815993
27664420
25699256
17308299
33792344
11254742
24315368
25086775",Current Understanding on the Role of Lipids in Macrophages and Associated Diseases.,"Lipid metabolism is the major intracellular mechanism driving a variety of cellular functions such as energy storage, hormone regulation and cell division. Lipids, being a primary component of the cell membrane, play a pivotal role in the survival of macrophages. Lipids are crucial for a variety of macrophage functions including phagocytosis, energy balance and ageing. However, functions of lipids in macrophages vary based on the site the macrophages are residing at. Lipid-loaded macrophages have recently been emerging as a hallmark for several diseases. This review discusses the significance of lipids in adipose tissue macrophages, tumor-associated macrophages, microglia and peritoneal macrophages. Accumulation of macrophages with impaired lipid metabolism is often characteristically observed in several metabolic disorders. Stress signals differentially regulate lipid metabolism. While conditions such as hypoxia result in accumulation of lipids in macrophages, stress signals such as nutrient deprivation initiate lipolysis and clearance of lipids. Understanding the biology of lipid accumulation in macrophages requires the development of potentially active modulators of lipid metabolism.","['AMPK', 'HIF-1α', 'autophagy', 'hypoxia', 'lipid droplets', 'macrophages', 'microglia', 'phosphocholines']",International journal of molecular sciences,2023-01-09,"[{'lastname': 'Florance', 'firstname': 'Ida', 'initials': 'I', 'affiliation': 'Centre for Nanobiotechnology, Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India.'}, {'lastname': 'Ramasubbu', 'firstname': 'Seenivasan', 'initials': 'S', 'affiliation': 'Centre for Nanobiotechnology, Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India.'}]",,,,,"10.3390/ijms24010589
10.3390/metabo11010052
10.15252/embr.201643426
10.1016/j.cmet.2012.03.007
10.1194/jlr.R800054-JLR200
10.1146/annurev.biochem.72.121801.161712
10.1038/nrm1912
10.3389/fphar.2020.00265
10.1172/JCI119248
10.1172/JCI0215593
10.1042/bst0301091
10.1016/j.devcel.2013.01.013
10.1016/j.bbamem.2017.04.007
10.1194/jlr.R800049-JLR200
10.1242/jcs.03019
10.1016/j.cell.2009.11.005
10.1074/jbc.M111.256008
10.1016/j.devcel.2019.05.016
10.1159/000492522
10.1038/nature09968
10.1194/jlr.M043299
10.1091/mbc.10.11.3787
10.1073/pnas.96.20.11041
10.1017/S1462399410001742
10.3389/fgene.2014.00112
10.1074/jbc.M408235200
10.1194/jlr.R067595
10.1016/j.cmet.2008.04.011
10.1016/j.devcel.2008.10.015
10.1042/BJ20090785
10.1042/BJ20110263
10.1074/jbc.M113.470526
10.1038/cr.2010.4
10.1038/s41598-017-16587-9
10.1074/jbc.M112.432344
10.1073/pnas.0808517105
10.1126/science.1209038
10.1016/j.isci.2021.102819
10.1016/S0092-8674(01)00611-0
10.1074/jbc.REV119.007036
10.1126/science.1158042
10.1038/emboj.2011.52
10.1172/JCI95864
10.1016/j.cmet.2012.09.004
10.1155/2012/841362
10.1038/s41467-021-21931-9
10.1016/S1534-5807(02)00203-4
10.1016/S1097-2765(00)00133-7
10.1016/j.devcel.2007.07.005
10.1016/j.celrep.2013.03.024
10.3390/cells10112965
10.1242/jcs.045625
10.1073/pnas.1101379108
10.1016/j.devcel.2007.07.018
10.1111/jcmm.16255
10.1038/sj.emboj.7600106
10.2337/db15-1637
10.1016/j.celrep.2017.05.020
10.1038/s41593-019-0566-1
10.1038/nn1472
10.1126/science.1110647
10.1126/science.1194637
10.3389/fncel.2018.00488
10.1017/S1740925X12000063
10.1038/nn.3554
10.1126/science.1202529
10.1146/annurev-neuro-061010-113810
10.1016/j.cell.2013.11.030
10.1038/nn.3358
10.1007/s00401-017-1747-1
10.15252/embj.201696056
10.3390/cells10020198
10.3389/fnmol.2018.00057
10.1038/s41582-019-0184-2
10.1126/science.aan4183
10.1016/j.plefa.2018.07.006
10.1016/j.bbalip.2012.01.007
10.1074/jbc.M110.107854
10.1111/acel.13606
10.1074/jbc.M115.679043
10.1016/j.neuron.2019.12.007
10.1016/j.neuron.2020.02.008
10.1038/s41467-021-21428-5
10.1189/jlb.1A0317-082RR
10.2337/db10-0705
10.1016/j.jbc.2021.101341
10.1152/ajpendo.00187.2014
10.1016/j.cell.2019.05.054
10.1158/0008-5472.CAN-22-1427
10.1002/emmm.201000079
10.1183/16000617.0134-2020
10.1158/0008-5472.CAN-19-2994
10.1186/s13045-021-01200-4
10.1084/jem.20210564
10.15252/emmm.201910698
10.1111/cas.14616
10.1038/s41590-021-01047-4
10.1093/infdis/jir432
10.1007/s00011-006-5205-0
10.4049/jimmunol.176.5.3087
10.1371/journal.ppat.1000204
10.1073/pnas.0712241105
10.1172/JCI14006
10.1016/j.immuni.2017.09.010
10.1016/j.freeradbiomed.2016.12.034
10.4049/jimmunol.178.2.993
10.1083/JCB1755OIA10
10.1038/s41577-021-00618-8
10.3389/fendo.2021.626842
10.1074/jbc.M800352200
10.1074/jbc.M011488200
10.1161/01.ATV.0000115638.27381.97
10.1186/s12929-016-0218-7
10.1038/bjp.2008.248
10.1098/rsif.2017.0774
10.3389/fimmu.2020.00131
10.2147/CE.S174169
10.2147/VHRM.S191965
10.1016/j.ymthe.2017.07.017
10.1155/2022/8129513
10.2217/fca-2020-0016
10.1016/j.amjcard.2019.09.010
10.1007/s11010-018-3353-5
10.1186/s12944-015-0006-5
10.1016/j.jacl.2017.04.071
10.1111/j.1527-3466.2003.tb00104.x
10.1248/bpb.28.247
10.1007/s11883-000-0096-y
10.1080/08998280.2003.11927928
10.1016/S0214-9168(11)70004-3
10.1161/01.ATV.16.2.236
10.1002/14651858.CD008226.pub3
10.1002/14651858.CD012282.pub2
10.1093/ajhp/45.2.410
10.1002/14651858.CD012735
10.1016/S0140-6736(11)60739-3
10.1016/S0735-1097(98)00514-2
10.1080/08923970902785253
10.1089/ars.2007.1825
10.1038/cr.2013.75
10.1155/2016/2795090
10.1073/pnas.96.11.6353
10.1016/j.bcp.2013.07.002
10.1155/2017/9029327
10.1038/s41368-018-0015-0
10.1038/s41598-018-22039-9
10.7554/eLife.77457
10.1016/j.molmed.2018.10.006
10.1161/ATVBAHA.116.307830
10.1161/CIRCRESAHA.111.246363
10.1016/j.atherosclerosis.2007.05.026
10.1016/j.celrep.2014.08.056
10.1096/fj.201700235R
10.1161/01.ATV.0000229665.78997.0b
10.1155/2012/282041
10.1146/annurev.med.53.082901.104018
10.2337/db12-1397
10.1038/s41467-019-08829-3
10.1038/s41419-020-02811-4
10.3389/fphys.2019.01077
10.1155/2008/930705
10.1016/j.cmet.2014.06.010
10.1074/jbc.M504611200
10.1074/jbc.M510660200
10.1128/MCB.00244-16
10.1194/jlr.M047654
10.1248/bpb.b17-00724
10.3390/ijms19092826
10.1016/j.bbadis.2014.07.002
10.1038/ncb2718
10.1126/science.1204592
10.3389/fphys.2021.639920
10.1038/srep01561
10.1172/JCI74068
10.18632/oncotarget.22575
10.1016/j.devcel.2019.04.009
10.1074/jbc.M414220200
10.1371/journal.pone.0149677
10.1038/s41573-019-0036-1
10.3389/fcell.2021.658995
10.1016/j.tcb.2017.07.006
10.1016/j.cell.2015.01.036
10.7554/eLife.21635
10.3389/fcell.2015.00003
10.1194/jlr.M600390-JLR200
10.1161/ATVBAHA.120.316063
10.1016/S0022-2275(20)31654-0
10.1016/j.cmet.2013.11.001
10.1038/ni.2956",<Element 'PubmedArticle' at 0x7f05dc3ea7c0>
59,"36614029
34404558
36113750
36062310
17435755
36309345
35312356
36106501
36084484
32827689
34997540
35360111
36226890
32003689
31694154
33994932
32286313
28798369
29507931
30282815
36359827
34402459
33359475
36229415
36143200
28476168
34063031
34194442
33428242
29740382
30273830
23479184
28469467
32847483
33173626
36265904
20967129
33987813
34439576
30479062
28475686
35225121
32726472
36339574
27236050
24126629
33906932
33562464
31155341
30122477
15634730
25007701
36207110
36030868
35963408
35627250
35821195
31434333
35275534
33502259
35629374
36171975
35330775
34438504
19921535
36394122
35111752
34345834
20843610
36316501
32387710
30799335
35897073
34562505
15837590
28864422
29105727
23284853
18047560
35042241
34812899
27876107
32206061
35743274
32300942
22258407
22761934
31310736
29453779
20133677
35996201
33713393
31991143
20398699
23009576
35464311
11870718
25370336
32067069
35396327
36219378
29393419
29178967
35796871
31024256
35227277
35120624
36231090
35234205
35857844
36529538
33381076
31646358
21712640
34384732
36101441
36144449
35418836
33977269
33815879
30143570
11274993
35338770
34067082
25079897
35302338
33661767
17803519
36293534
36233180
36163369
23498975
36111770
35805131
36051435
36077343
35933467
35740329
35628504
34593556
33918437
35302001
34163016
32415434
23099315
33375613
34564387
32600237
32470498
33761613
35181755
28785808
30500346
31185338
16359757
33219201
33098511
26490872
35987825
34975458
20228251
31164420
25288107
17910605
34800614
32398374
31233613
35401022
30929354
35328673
35124154
35395731
30578840
36325902
35316243
28522826
36332718
34911782
31195846
35342020
35813465
33471078
35948658
36276655
31837465
31252126
33812014
18708058
35203709
35203128
36068739
33503294
31874349
33569008
30605748
35563796
31342895
35950208
35348812
26431492
33626479
35216298
28099762
29687900
18575574
25931122
32777465","Amyotrophic Lateral Sclerosis Pathoetiology and Pathophysiology: Roles of Astrocytes, Gut Microbiome, and Muscle Interactions via the Mitochondrial Melatonergic Pathway, with Disruption by Glyphosate-Based Herbicides.","The pathoetiology and pathophysiology of motor neuron loss in amyotrophic lateral sclerosis (ALS) are still to be determined, with only a small percentage of ALS patients having a known genetic risk factor. The article looks to integrate wider bodies of data on the biological underpinnings of ALS, highlighting the integrative role of alterations in the mitochondrial melatonergic pathways and systemic factors regulating this pathway across a number of crucial hubs in ALS pathophysiology, namely glia, gut, and the muscle/neuromuscular junction. It is proposed that suppression of the mitochondrial melatonergic pathway underpins changes in muscle brain-derived neurotrophic factor, and its melatonergic pathway mimic, N-acetylserotonin, leading to a lack of metabolic trophic support at the neuromuscular junction. The attenuation of the melatonergic pathway in astrocytes prevents activation of toll-like receptor agonists-induced pro-inflammatory transcription factors, NF-kB, and yin yang 1, from having a built-in limitation on inflammatory induction that arises from their synchronized induction of melatonin release. Such maintained astrocyte activation, coupled with heightened microglia reactivity, is an important driver of motor neuron susceptibility in ALS. Two important systemic factors, gut dysbiosis/permeability and pineal melatonin mediate many of their beneficial effects via their capacity to upregulate the mitochondrial melatonergic pathway in central and systemic cells. The mitochondrial melatonergic pathway may be seen as a core aspect of cellular function, with its suppression increasing reactive oxygen species (ROS), leading to ROS-induced microRNAs, thereby altering the patterning of genes induced. It is proposed that the increased occupational risk of ALS in farmers, gardeners, and sportsmen and women is intimately linked to exposure, whilst being physically active, to the widely used glyphosate-based herbicides. This has numerous research and treatment implications.","['amyotrophic lateral sclerosis', 'aryl hydrocarbon receptor', 'astrocytes', 'butyrate', 'glyphosate', 'gut microbiome', 'melatonin', 'mitochondria', 'motor neurons', 'treatment']",International journal of molecular sciences,2023-01-09,"[{'lastname': 'Anderson', 'firstname': 'George', 'initials': 'G', 'affiliation': 'CRC Scotland & London, Eccleston Square, London SW1V 1PG, UK.'}]",,,,,"10.3390/ijms24010587
10.1016/j.neurobiolaging.2021.07.008
10.1016/j.nbd.2022.105859
10.1177/10738584221120182
10.1038/nn1876
10.1002/dneu.22905
10.1073/pnas.2107391119
10.7555/JBR.36.20220009
10.1016/j.biomaterials.2022.121752
10.1016/j.nbd.2020.105052
10.1007/s12035-021-02658-6
10.3389/fcimb.2022.839526
10.1002/cjp2.297
10.2174/1568026620666200131094445
10.3390/ijms20215500
10.3389/fnins.2021.657465
10.1038/s41467-020-15644-8
10.1038/s41598-017-08233-1
10.1001/jamaneurol.2018.0035
10.1172/jci.insight.123249
10.3390/cells11213431
10.1097/WCO.0000000000000983
10.1016/j.expneurol.2020.113576
10.3390/jpm12091418
10.1186/s13024-017-0177-9
10.3390/biom11050691
10.3389/fimmu.2021.701550
10.1002/mus.27168
10.3389/fneur.2018.00218
10.1016/j.neurobiolaging.2018.08.025
10.1001/jamaneurol.2013.2334
10.1177/1178646917691738
10.1016/j.aimed.2014.12.007
10.2217/nmt-2020-0033
10.7759/cureus.10818
10.1523/ENEURO.0001-22.2022
10.1371/journal.pone.0013346
10.1007/s13311-021-01064-z
10.3390/antiox10081328
10.1002/term.2776
10.1093/protein/gzx025
10.1080/21678421.2022.2045323
10.1111/bph.15217
10.3389/fphar.2022.1017364
10.1016/j.pneurobio.2016.05.004
10.1038/nrneurol.2013.203
10.1136/jnnp-2020-325994
10.3390/brainsci11020193
10.1016/j.jocn.2019.05.036
10.1016/j.mehy.2018.07.009
10.1093/brain/awh373
10.3109/21678421.2014.932383
10.1136/oemed-2022-108371
10.1016/j.scitotenv.2022.158259
10.1016/j.scitotenv.2022.157973
10.3390/genes13050865
10.7555/JBR.36.20220088
10.3390/ijms20164068
10.3233/JAD-215411
10.1289/EHP6990
10.3390/life12050707
10.3389/fphys.2022.974688
10.3389/fmicb.2022.853762
10.1016/j.envpol.2021.117685
10.1007/s12640-009-9129-7
10.1002/cbic.202200334
10.3389/fcell.2021.775102
10.1016/j.crtox.2020.04.001
10.1016/j.mehy.2010.08.029
10.1038/s41583-022-00641-1
10.1016/j.neulet.2020.135032
10.2169/internalmedicine.2028-18
10.1186/s12974-022-02544-5
10.1016/j.neuro.2021.09.004
10.1016/j.nbd.2005.01.012
10.1016/j.bbrc.2017.08.127
10.1111/bph.14083
10.1371/journal.pone.0052010
10.1111/j.1471-4159.2007.05150.x
10.1093/brain/awab328
10.1007/s00213-021-06025-0
10.1017/S0007114516004025
10.1155/2020/2410264
10.3390/ijms23126831
10.1007/s11064-020-03013-2
10.1038/cddis.2011.143
10.1371/journal.pone.0039946
10.1016/j.bcp.2019.07.014
10.1111/jpi.12478
10.1073/pnas.0912531107
10.1186/s40478-022-01418-4
10.1002/jdn.10102
10.1016/j.neuro.2020.01.007
10.1016/j.pharmthera.2010.02.009
10.1111/jpi.12013
10.3389/fnins.2022.813472
10.1002/mus.10049
10.1007/s11033-014-3805-2
10.1007/s00204-020-02677-7
10.1523/JNEUROSCI.1922-21.2022
10.1007/s10571-022-01294-5
10.3892/mmr.2018.8485
10.1186/s12974-017-0997-0
10.1007/s43440-022-00384-x
10.3389/fncel.2019.00109
10.1186/s12974-022-02421-1
10.1016/j.stemcr.2022.01.004
10.3390/cells11193128
10.1097/SHK.0000000000001914
10.1126/sciadv.abo3610
10.1002/bdr2.2138
10.3389/fneur.2020.592851
10.1007/s00018-019-03337-5
10.1292/jvms.11-0123
10.1016/j.jsxm.2021.07.009
10.3390/biology11071063
10.3390/microorganisms10091848
10.3389/fncel.2022.812887
10.1093/braincomms/fcab081
10.14336/AD.2020.0708
10.1523/JNEUROSCI.0956-18.2018
10.1016/S0014-2999(01)00823-8
10.1002/ar.24922
10.3390/ijms22094977
10.3109/01913123.2014.937842
10.4081/ejtm.2022.10064
10.1172/jci.insight.143469
10.1111/j.1600-079X.2007.00466.x
10.3390/ijms232012676
10.3390/ijms231911881
10.1038/s41598-022-20405-2
10.1016/j.neuron.2013.02.028
10.2174/1570159X20666220915092703
10.3390/cells11132049
10.3389/fcell.2022.950767
10.3390/ijms23179946
10.1007/s12035-022-02980-7
10.3390/biomedicines10061307
10.3390/ijms23105694
10.26508/lsa.202101224
10.3390/biomedicines9040376
10.1016/j.chemosphere.2022.134308
10.1038/s41430-021-00960-z
10.1007/s12031-020-01569-w
10.1016/j.tiv.2012.09.021
10.3390/ijms22010141
10.3390/metabo11090572
10.2174/1871527319666200628015039
10.1016/j.pnpbp.2020.109976
10.1016/j.biopha.2021.111397
10.1038/s41380-022-01473-2
10.1007/s00018-017-2610-1
10.1016/j.ejphar.2018.11.035
10.1016/j.chemosphere.2019.05.064
10.1016/j.neurobiolaging.2005.11.004
10.1038/s41467-020-19576-1
10.1007/s10517-020-04986-4
10.1523/JNEUROSCI.1910-15.2015
10.1007/s00018-022-04520-x
10.3389/fnagi.2021.785727
10.1096/fj.09-149997
10.1073/pnas.1819541116
10.1007/s12640-014-9489-5
10.1111/j.1600-079X.2007.00487.x
10.1016/j.toxlet.2021.11.007
10.1073/pnas.1922287117
10.1002/mus.26617
10.1016/j.sjbs.2022.03.028
10.3760/cma.j.issn.1001-9391.2019.02.009
10.3390/ijms23063253
10.1016/j.jevs.2022.103892
10.1186/s12877-022-02954-3
10.1016/j.neuint.2018.12.009
10.1161/ATVBAHA.121.317735
10.2106/JBJS.RVW.21.00183
10.1038/s41598-017-02152-x
10.1016/j.tox.2022.153369
10.1136/jnnp-2021-327877
10.1080/14789450.2019.1628643
10.1016/j.anai.2022.03.016
10.7150/ijbs.67587
10.1093/cvr/cvab014
10.1038/s41380-022-01716-2
10.7150/thno.75069
10.1016/j.cellsig.2019.109498
10.1016/j.envpol.2019.06.040
10.1016/j.etap.2021.103651
10.1016/j.febslet.2008.08.010
10.3390/biomedicines10020500
10.3390/ani12040420
10.1016/j.ecoenv.2022.113803
10.1111/jpi.12718
10.1016/j.envint.2019.105414
10.3389/fphar.2020.619265
10.1016/j.toxlet.2018.12.013
10.3390/cells11091490
10.1016/j.mrrev.2019.02.001
10.1007/s44228-022-00011-9
10.1007/s00262-022-03165-w
10.18632/oncotarget.5440
10.1016/j.neurobiolaging.2021.01.015
10.3390/ijms23042184
10.1111/j.1365-2621.2005.tb09966.x
10.1111/jpi.12390
10.1002/cphy.c170032
10.1371/journal.pone.0002476
10.1074/jbc.M115.659318
10.1016/j.cbpc.2020.108845",<Element 'PubmedArticle' at 0x7f05dcda0bd0>
60,36610138,Formononetin improves cardiac function and depressive behaviours in myocardial infarction with depression by targeting GSK-3β to regulate macrophage/microglial polarization.,"Depression is a common complication after myocardial infarction (MI) that can seriously affect the prognosis of MI.
To investigate whether formononetin could ameliorate MI injury and depressive behaviours in a mouse model of MI with depression and elucidate its underlying molecular mechanisms.
Haemodynamic measurements (systolic blood pressure (SYS), the maximum rate of rise of LV pressure (± dp/dtmax)) and behavior tests (tail suspension test, sucrose preference test, forced swimming test) were used to evaluate the effects of formononetin on male C57BL/6N mice after left anterior descending (LAD) coronary artery ligation and chronic unpredictable stress. RT-qPCR, immunohistochemistry, immunofluorescence analysis, western blotting, molecular docking technology, surface plasmon resonance and gene-directed mutagenesis were used to clarify the underlying mechanism.
Formononetin significantly suppressed the depressive behaviours and improved cardiac dysfunction in MI with depression mice model. Formononetin inhibited M1 polarization in macrophages/microglia, while promoting M2 polarization. Importantly, elevated serum IL-6 and IL-17A levels were found in patient with MI, and the patient serum induced M1 microglial polarization; however, formononetin reversed the polarization. Further mechanistic studies showed that formononetin inhibited GSK-3β activity and downstream Notch1 and C/EBPα signaling pathways. Covalent molecular docking showed that formononetin bound to Cys199 of GSK-3β and it has a high affinity for GSK-3β. When Cys199 was mutation, the inhibitory effect of formononetin on GSK-3β activity and M1 polarization in macrophages/microglia were also partly blocked.
Our results firstly uncovered that formononetin improved cardiac function and suppressed depressive behaviours in mice after MI with depression by targeting GSK-3β to regulate macrophage/microglial polarization. More importantly, IL-6 and IL-17A produced after MI may cause neuroinflammation, which might be the key factors for depression. Formononetin may be a potential drug for treating MI with depression.","['Formononetin', 'GSK-3β', 'IL-17A', 'IL-6', 'Macrophage/microglial polarization', 'Myocardial infarction with depression']",Phytomedicine : international journal of phytotherapy and phytopharmacology,2023-01-08,"[{'lastname': 'Yang', 'firstname': 'Ying', 'initials': 'Y', 'affiliation': ""Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, Guangdong Key Laboratory for translational Cancer research of Chinese Medicine, International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, China.""}, {'lastname': 'Huang', 'firstname': 'Ting', 'initials': 'T', 'affiliation': ""Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, Guangdong Key Laboratory for translational Cancer research of Chinese Medicine, International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, China.""}, {'lastname': 'Zhang', 'firstname': 'Hongli', 'initials': 'H', 'affiliation': ""Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, Guangdong Key Laboratory for translational Cancer research of Chinese Medicine, International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, China.""}, {'lastname': 'Li', 'firstname': 'Xuping', 'initials': 'X', 'affiliation': ""Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, Guangdong Key Laboratory for translational Cancer research of Chinese Medicine, International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, China.""}, {'lastname': 'Shi', 'firstname': 'Shuotao', 'initials': 'S', 'affiliation': ""Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, Guangdong Key Laboratory for translational Cancer research of Chinese Medicine, International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, China.""}, {'lastname': 'Tian', 'firstname': 'Xiaoyu', 'initials': 'X', 'affiliation': ""Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, Guangdong Key Laboratory for translational Cancer research of Chinese Medicine, International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, China.""}, {'lastname': 'Huang', 'firstname': 'Ziwei', 'initials': 'Z', 'affiliation': ""Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, Guangdong Key Laboratory for translational Cancer research of Chinese Medicine, International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, China.""}, {'lastname': 'Zhang', 'firstname': 'Rong', 'initials': 'R', 'affiliation': ""Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, Guangdong Key Laboratory for translational Cancer research of Chinese Medicine, International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, China; Shunde Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Foshan, Guangdong 528333, China; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou Univ Chinese Med, Guangzhou, Guangdong 510006, China.""}, {'lastname': 'Liu', 'firstname': 'Zhongqiu', 'initials': 'Z', 'affiliation': ""Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, Guangdong Key Laboratory for translational Cancer research of Chinese Medicine, International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, China; Shunde Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Foshan, Guangdong 528333, China; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou Univ Chinese Med, Guangzhou, Guangdong 510006, China.""}, {'lastname': 'Cheng', 'firstname': 'Yuanyuan', 'initials': 'Y', 'affiliation': ""Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, Guangdong Key Laboratory for translational Cancer research of Chinese Medicine, International Institute for Translational Chinese Medicine, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, China; Shunde Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Foshan, Guangdong 528333, China; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou Univ Chinese Med, Guangzhou, Guangdong 510006, China. Electronic address: chengyuanyuan@gzucm.edu.cn.""}]",,,"Formononetin significantly suppressed the depressive behaviours and improved cardiac dysfunction in MI with depression mice model. Formononetin inhibited M1 polarization in macrophages/microglia, while promoting M2 polarization. Importantly, elevated serum IL-6 and IL-17A levels were found in patient with MI, and the patient serum induced M1 microglial polarization; however, formononetin reversed the polarization. Further mechanistic studies showed that formononetin inhibited GSK-3β activity and downstream Notch1 and C/EBPα signaling pathways. Covalent molecular docking showed that formononetin bound to Cys199 of GSK-3β and it has a high affinity for GSK-3β. When Cys199 was mutation, the inhibitory effect of formononetin on GSK-3β activity and M1 polarization in macrophages/microglia were also partly blocked.",Copyright © 2022. Published by Elsevier GmbH.,10.1016/j.phymed.2022.154602,<Element 'PubmedArticle' at 0x7f05dd308630>
61,36587502,"The GLP-1 receptor agonist exenatide ameliorates neuroinflammation, locomotor activity, and anxiety-like behavior in mice with diet-induced obesity through the modulation of microglial M2 polarization and downregulation of SR-A4.","Obesity is associated with multiple comorbidities, such as metabolic abnormalities and cognitive dysfunction. Moreover, accumulating evidence indicates that neurodegenerative disorders are associated with chronic neuroinflammation. GLP-1 receptor agonists (RAs) have been extensively studied as a treatment for type 2 diabetes. Emerging evidence has demonstrated a protective effect of GLP-1 RAs on neurodegenerative disease, which is independent of its glucose-lowering effects. In this study, we aimed to examine the effects of a long-acting GLP-1 RA, exenatide, on high-fat diet (HFD)-induced neuroinflammation and related brain function impairment. First, mice treated with exenatide exhibited significantly reduced HFD-increased body weight and blood glucose. In an open field test, exenatide treatment ameliorated the reduction in local motor activity and anxiety in HFD-fed mice. Moreover, HFD induced astrogliosis, microgliosis, and upregulation of IL-1β, IL-6 and TNF-α in hippocampus and cortex. Exenatide treatment reduced HFD-induced astrogliosis and IL-1β and TNF-α expressions. Moreover, exenatide increased phosphor-ERK and M2-type microglia marker arginase-1 expression in the hippocampus and cortex. In addition, we found that scavenger receptor-A4 protein expression was induced by HFD and was subsequently inhibited by exenatide. SR-A4 knockout reversed the locomotor activity impairment but not the anxiety behavior caused by HFD consumption. SR-A4 knockout also reduced HFD-induced neuroinflammation, as shown by the reduced expression of GFAP and IBA-1 compared with that in wild-type control mice. These results demonstrate that exenatide decreases HFD-increased neuroinflammation and promotes anti-inflammatory M2 differentiation. The inhibition of SR-A4 by exenatide exerts anti-inflammatory activity.","['Exenatide', 'Neuroinflammation', 'Obesity', 'SR-A4', 'T2DM']",International immunopharmacology,2023-01-02,"[{'lastname': 'Lin', 'firstname': 'Ming-Hong', 'initials': 'MH', 'affiliation': 'Department of Microbiology and Immunology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan; M.Sc. Program in Tropical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan; Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan. Electronic address: mhlin@kmu.edu.tw.'}, {'lastname': 'Cheng', 'firstname': 'Po-Ching', 'initials': 'PC', 'affiliation': 'Department of Molecular Parasitology and Tropical Diseases, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan; Center for International Tropical Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan. Electronic address: bonjovi@tmu.edu.tw.'}, {'lastname': 'Hsiao', 'firstname': 'Pi-Jung', 'initials': 'PJ', 'affiliation': 'Division of Endocrinology and Metabolism, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan; School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan. Electronic address: pjhsiao101@isu.edu.tw.'}, {'lastname': 'Chen', 'firstname': 'Szu-Chia', 'initials': 'SC', 'affiliation': 'Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Division of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. Electronic address: chensc@kmu.edu.tw.'}, {'lastname': 'Hung', 'firstname': 'Chih-Hsing', 'initials': 'CH', 'affiliation': 'Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Pediatrics, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Pediatrics, Kaohsiung Municipal Siaogang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan. Electronic address: 1086066@kmuh.org.tw.'}, {'lastname': 'Kuo', 'firstname': 'Chao-Hung', 'initials': 'CH', 'affiliation': 'Department of Internal Medicine, Kaohsiung Municipal Siaogang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan. Electronic address: jhkao@kmu.edu.tw.'}, {'lastname': 'Huang', 'firstname': 'Shau-Ku', 'initials': 'SK', 'affiliation': 'National Institute of Environmental Health Sciences, National Health Research Institutes, Miaoli County 350, Taiwan; Department of Medicine, Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. Electronic address: skhuang@nhri.org.tw.'}, {'lastname': 'Clair Chiou', 'firstname': 'Hsin-Ying', 'initials': 'HY', 'affiliation': 'Center of Teaching and Research, Kaohsiung Municipal Siaogang Hospital, Kaohsiung Medical University, Kaohsiung 812, Taiwan; Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan; Department of Applied Chemistry, National Chi Nan University, Nantou, Taiwan. Electronic address: 1086093@mail.kmuh.org.tw.'}]",,,,Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.,10.1016/j.intimp.2022.109653,<Element 'PubmedArticle' at 0x7f05dd310c20>
62,"36481985
17258671
33078345
16482081
30628008
33964000
33017422
33242144
27402251
32079653
20194433
17488637
33809291
23268465
15914121
23135910
25241037
17956739
25863252
32529327
15713377
33967760
24291745
17870179
30076703
29273596
12086646
11157197
21808223
23050259
31203572
29021779
32894401
23175281
29246870
17051205
25463632
30555809
11359878
21356518
29735694
23050013
20418374
11025225
18430751
30809287
10412986
15087503
21984601
31037127
25196599
29311941
26120888
28500761
28340340
25727910",Role of Estrogen-Related Receptor γ and PGC-1α/SIRT3 Pathway in Early Brain Injury After Subarachnoid Hemorrhage.,"Estrogen-related receptors (ERRs) were shown to play an important role in the regulation of free radical-mediated pathology. This study aimed to investigate the neuroprotective effect of ERRγ activation against early brain injury (EBI) after subarachnoid hemorrhage (SAH) and the potential underlying mechanisms. In a rat model of SAH, the time course of ERRs and SIRT3 and the effects of ERRγ activation were investigated. ERRγ agonist DY131, selective inhibitor GSK5182, or SIRT3 selective inhibitor 3-TYP were administered intracerebroventricularly (icv) in the rat model of SAH. The use of 3-TYP was for validating SIRT3 as the downstream signaling of ERRγ activation. Post-SAH assessments included SAH grade, neurological score, Western blot, Nissl staining, and immunofluorescence staining in rats. In an vitro study, the ERRγ agonist DY131 and ERRγ siRNA were administered to primary cortical neurons stimulated by Hb, after which cell viability and neuronal deaths were accessed. Lastly, the brain ERRγ levels and neuronal death were accessed in SAH patients. We found that brain ERRγ expressions were significantly increased, but the expression of SIRT3 dramatically decreased after SAH in rats. In the brains of SAH rats, ERRγ was expressed primarily in neurons, astrocytes, and microglia. The activation of ERRγ with DY131 significantly improved the short-term and long-term neurological deficits, accompanied by reductions in oxidative stress and neuronal apoptosis at 24 h after SAH in rats. DY131 treatment significantly increased the expressions of PGC-1α, SIRT3, and Bcl-2 while downregulating the expressions of 4-HNE and Bax. ERRγ antagonist GSK5182 and SIRT3 inhibitor 3-TYP abolished the neuroprotective effects of ERRγ activation in the SAH rats. An in vitro study showed that Hb stimulation significantly increased intracellular oxidative stress in primary cortical neurons, and DY131 reduced such elevations. Primary cortical neurons transfected with the ERRγ siRNA exhibited notable apoptosis and abolished the protective effect of DY131. The examination of SAH patients' brain samples revealed increases in ERRγ expressions and neuronal apoptosis marker CC3. We concluded that ERRγ activation with DY131 ameliorated oxidative stress and neuronal apoptosis after the experimental SAH. The effects were, at least in part, through the ERRγ/PGC-1α/SIRT3 signaling pathway. ERRγ may serve as a novel therapeutic target to ameliorate EBI after SAH.","['Apoptosis', 'Estrogen-related receptors', 'Neuroprotection', 'Oxidative stress', 'Subarachnoid hemorrhage']",Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics,2022-12-10,"[{'lastname': 'Guo', 'firstname': 'Yong', 'initials': 'Y', 'affiliation': ""Department of Neurosurgery, Henan Provincial People's Hospital, (People's Hospital of Zhengzhou University), Zhengzhou, 450003, China.\nDepartment of Physiology and Pharmacology, Loma Linda University, Loma Linda, CA, 92350, USA.""}, {'lastname': 'Hu', 'firstname': 'Yongmei', 'initials': 'Y', 'affiliation': ""Department of Physiology and Pharmacology, Loma Linda University, Loma Linda, CA, 92350, USA.\nDepartment of Nursing, Henan Provincial People's Hospital, (People's Hospital of Zhengzhou University), Zhengzhou, Henan, 450003, China.""}, {'lastname': 'Huang', 'firstname': 'Yi', 'initials': 'Y', 'affiliation': 'Department of Physiology and Pharmacology, Loma Linda University, Loma Linda, CA, 92350, USA.\nDepartment of Neurosurgery, Ningbo Hospital, Zhejiang University School of Medicine, Ningbo, Zhejiang, 315010, China.'}, {'lastname': 'Huang', 'firstname': 'Lei', 'initials': 'L', 'affiliation': 'Department of Physiology and Pharmacology, Loma Linda University, Loma Linda, CA, 92350, USA.\nDepartment of Neurosurgery, Loma Linda University, Loma Linda, CA, 92350, USA.'}, {'lastname': 'Kanamaru', 'firstname': 'Hideki', 'initials': 'H', 'affiliation': 'Department of Physiology and Pharmacology, Loma Linda University, Loma Linda, CA, 92350, USA.'}, {'lastname': 'Takemoto', 'firstname': 'Yushin', 'initials': 'Y', 'affiliation': 'Department of Physiology and Pharmacology, Loma Linda University, Loma Linda, CA, 92350, USA.'}, {'lastname': 'Li', 'firstname': 'Hao', 'initials': 'H', 'affiliation': ""Department of Neurosurgery, Henan Provincial People's Hospital, (People's Hospital of Zhengzhou University), Zhengzhou, 450003, China.""}, {'lastname': 'Li', 'firstname': 'Dujuan', 'initials': 'D', 'affiliation': 'Department of Physiology and Pharmacology, Loma Linda University, Loma Linda, CA, 92350, USA.'}, {'lastname': 'Gu', 'firstname': 'Jianjun', 'initials': 'J', 'affiliation': ""Department of Neurosurgery, Henan Provincial People's Hospital, (People's Hospital of Zhengzhou University), Zhengzhou, 450003, China. gujianjundt@163.com.""}, {'lastname': 'Zhang', 'firstname': 'John H', 'initials': 'JH', 'affiliation': 'Department of Physiology and Pharmacology, Loma Linda University, Loma Linda, CA, 92350, USA. johnzhang3910@yahoo.com.\nDepartment of Neurosurgery, Loma Linda University, Loma Linda, CA, 92350, USA. johnzhang3910@yahoo.com.'}]",,,,"© 2022. The American Society for Experimental Neurotherapeutics, Inc.","10.1007/s13311-022-01330-8
10.1007/s12975-020-00867-0
10.1038/sj.jcbfm.9600283
10.1007/s12975-018-0685-0
10.1007/s12975-021-00912-6
10.1371/journal.pone.0240122
10.1007/s12975-020-00874-1
10.1038/ncomms12156
10.1101/gad.330746.119
10.1101/gad.1871610
10.1016/j.cmet.2007.03.007
10.3390/antiox10030437
10.1016/j.cardiores.2005.01.026
10.1158/0008-5472.CAN-12-3709
10.1038/ncb3039
10.1016/j.cell.2007.09.012
10.1016/j.cmet.2015.03.004
10.1007/s10120-020-01097-x
10.1016/j.bmcl.2005.01.025
10.3389/fphar.2021.626166
10.1016/j.brainres.2013.11.023
10.1016/j.jneumeth.2007.08.004
10.1002/jcp.27035
10.1161/STROKEAHA.117.018593
10.3791/2920
10.4103/1947-2714.100998
10.1007/s12035-019-01668-9
10.3389/fneur.2017.00511
10.1007/s12975-020-00847-4
10.1038/nrm3479
10.1016/j.mito.2017.12.005
10.1038/nature05292
10.1016/j.bbadis.2014.10.009
10.3389/fped.2018.00369
10.1016/j.cmet.2011.01.019
10.1073/pnas.1804965115
10.1371/journal.pone.0046324
10.1074/jbc.M110.125401
10.1093/cvr/cvn098
10.7150/thno.29130
10.1016/S0092-8674(00)80611-X
10.1073/pnas.0308686101
10.1007/s00018-011-0850-z
10.7150/thno.30398
10.3390/ijms150814591
10.3389/fphar.2017.00943
10.1080/15548627.2015.1052208
10.1111/jpi.12419
10.1016/j.cell.2017.03.001
10.1111/jnc.13085",<Element 'PubmedArticle' at 0x7f05dd2fb0e0>
63,"36447154
26761770
17470522
25374509
30181779
30922248
26067058
26303850
30305119
30086290
7709410
28810246
31890179
35450066
28237799
14500942
28290606
30616172
30710045
33867831
28597596
27311857
29264750
29885598
26851161
21511199
27870427
30355197
29876879
26354916
29129157
30017543
32889778
31823113
34258805
35563304
29849895
28189727
29867570
28742995
32194375
34634743
29575461
24012531
30001721
31590042
31726033",Icaritin inhibits neuroinflammation in a rat cerebral ischemia model by regulating microglial polarization through the GPER-ERK-NF-κB signaling pathway.,"Activated microglia play a key role in initiating the inflammatory cascade following ischemic stroke and exert proinflammatory or anti-inflammatory effects, depending on whether they are polarized toward the M1 or M2 phenotype. The present study investigated the regulatory effect of icaritin (ICT) on microglial polarization in rats after cerebral ischemia/reperfusion injury (CI/RI) and explored the possible anti-inflammatory mechanisms of ICT.
A rat model of transient middle cerebral artery occlusion (tMCAO) was established. Following treatment with ICT, a G protein-coupled estrogen receptor (GPER) inhibitor or an extracellular signal-regulated kinase (ERK) inhibitor, the Garcia scale and rotarod test were used to assess neurological and locomotor function. 2,3,5-Triphenyltetrazolium chloride (TTC) and Fluoro-Jade C (FJC) staining were used to evaluate the infarct volume and neuronal death. The levels of inflammatory factors in the ischemic penumbra were evaluated using enzyme-linked immunosorbent assays (ELISAs). In addition, western blotting, immunofluorescence staining and quantitative PCR (qPCR) were performed to measure the expression levels of markers of different microglial phenotypes and proteins related to the GPER-ERK-nuclear factor kappa B (NF-κB) signaling pathway.
ICT treatment significantly decreased the cerebral infarct volume, brain water content and fluorescence intensity of FJC; improved the Garcia score; increased the latency to fall and rotation speed in the rotarod test; decreased the levels of interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), Iba1, CD40, CD68 and p-P65-NF-κB; and increased the levels of CD206 and p-ERK. U0126 (an inhibitor of ERK) and G15 (a selective antagonist of GPER) antagonized these effects.
These findings indicate that ICT plays roles in inhibiting the inflammatory response and achieving neuroprotection by regulating GPER-ERK-NF-κB signaling and then inhibiting microglial activation and M1 polarization while promoting M2 polarization, which provides a new therapeutic for against cerebral ischemic stroke.","['Cerebral ischemia/reperfusion injury', 'ERK', 'GPER', 'Icaritin', 'Microglia', 'NF-κB']","Molecular medicine (Cambridge, Mass.)",2022-11-30,"[{'lastname': 'Yu', 'firstname': 'Zining', 'initials': 'Z', 'affiliation': 'Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, Gannan Medical University, Ganzhou, 341000, China.\nGanzhou Key Laboratory of Neuroinflammation Research, Gannan Medical University, Ganzhou, 341000, China.\nGraduate School, Gannan Medical University, Ganzhou, 341000, China.'}, {'lastname': 'Su', 'firstname': 'Guangjun', 'initials': 'G', 'affiliation': 'Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, Gannan Medical University, Ganzhou, 341000, China.\nGanzhou Key Laboratory of Neuroinflammation Research, Gannan Medical University, Ganzhou, 341000, China.\nGraduate School, Gannan Medical University, Ganzhou, 341000, China.'}, {'lastname': 'Zhang', 'firstname': 'Limei', 'initials': 'L', 'affiliation': 'Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, Gannan Medical University, Ganzhou, 341000, China.\nGanzhou Key Laboratory of Neuroinflammation Research, Gannan Medical University, Ganzhou, 341000, China.\nSchool of Basic Medicine Sciences, Gannan Medical University, Ganzhou, 341000, China.'}, {'lastname': 'Liu', 'firstname': 'Gaigai', 'initials': 'G', 'affiliation': 'Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, Gannan Medical University, Ganzhou, 341000, China.\nGanzhou Key Laboratory of Neuroinflammation Research, Gannan Medical University, Ganzhou, 341000, China.\nGraduate School, Gannan Medical University, Ganzhou, 341000, China.'}, {'lastname': 'Zhou', 'firstname': 'Yonggang', 'initials': 'Y', 'affiliation': 'Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, Gannan Medical University, Ganzhou, 341000, China.\nGanzhou Key Laboratory of Neuroinflammation Research, Gannan Medical University, Ganzhou, 341000, China.\nSchool of Basic Medicine Sciences, Gannan Medical University, Ganzhou, 341000, China.'}, {'lastname': 'Fang', 'firstname': 'Shicai', 'initials': 'S', 'affiliation': 'Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, Gannan Medical University, Ganzhou, 341000, China.\nGanzhou Key Laboratory of Neuroinflammation Research, Gannan Medical University, Ganzhou, 341000, China.\nGraduate School, Gannan Medical University, Ganzhou, 341000, China.'}, {'lastname': 'Zhang', 'firstname': 'Qian', 'initials': 'Q', 'affiliation': 'Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, Gannan Medical University, Ganzhou, 341000, China.\nGanzhou Key Laboratory of Neuroinflammation Research, Gannan Medical University, Ganzhou, 341000, China.\nGraduate School, Gannan Medical University, Ganzhou, 341000, China.'}, {'lastname': 'Wang', 'firstname': 'Tianyun', 'initials': 'T', 'affiliation': 'Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, Gannan Medical University, Ganzhou, 341000, China.\nGanzhou Key Laboratory of Neuroinflammation Research, Gannan Medical University, Ganzhou, 341000, China.\nSchool of Basic Medicine Sciences, Gannan Medical University, Ganzhou, 341000, China.'}, {'lastname': 'Huang', 'firstname': 'Cheng', 'initials': 'C', 'affiliation': 'Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, Gannan Medical University, Ganzhou, 341000, China.\nGanzhou Key Laboratory of Neuroinflammation Research, Gannan Medical University, Ganzhou, 341000, China.\nInstitute for Medical Sciences of Pain, Department of Physiology, School of Basic Medical Sciences, Gannan Medical University, Ganzhou, 341000, China.'}, {'lastname': 'Huang', 'firstname': 'Zhihua', 'initials': 'Z', 'affiliation': 'Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, Gannan Medical University, Ganzhou, 341000, China. zh.huang@gmu.edu.cn.\nGanzhou Key Laboratory of Neuroinflammation Research, Gannan Medical University, Ganzhou, 341000, China. zh.huang@gmu.edu.cn.\nInstitute for Medical Sciences of Pain, Department of Physiology, School of Basic Medical Sciences, Gannan Medical University, Ganzhou, 341000, China. zh.huang@gmu.edu.cn.\nSchool of Basic Medicine Sciences, Gannan Medical University, Ganzhou, 341000, China. zh.huang@gmu.edu.cn.'}, {'lastname': 'Li', 'firstname': 'Liangdong', 'initials': 'L', 'affiliation': 'First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China. ld.li@gmu.edu.cn.\nKey Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, Gannan Medical University, Ganzhou, 341000, China. ld.li@gmu.edu.cn.\nGanzhou Key Laboratory of Neuroinflammation Research, Gannan Medical University, Ganzhou, 341000, China. ld.li@gmu.edu.cn.'}]",,,"ICT treatment significantly decreased the cerebral infarct volume, brain water content and fluorescence intensity of FJC; improved the Garcia score; increased the latency to fall and rotation speed in the rotarod test; decreased the levels of interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), Iba1, CD40, CD68 and p-P65-NF-κB; and increased the levels of CD206 and p-ERK. U0126 (an inhibitor of ERK) and G15 (a selective antagonist of GPER) antagonized these effects.",© 2022. The Author(s).,"10.1186/s10020-022-00573-7
10.1016/j.atherosclerosis.2015.12.040
10.1677/JOE-07-0017
10.3389/fncel.2014.00338
10.1177/1756286418794184
10.1186/s12885-019-5471-1
10.1016/j.pneurobio.2015.05.003
10.1038/nrneurol.2015.144
10.1186/s12974-018-1323-1
10.1016/j.neuropharm.2018.08.003
10.1161/01.STR.26.4.627
10.1159/000478908
10.1002/fsn3.1263
10.3389/fimmu.2022.860977
10.1016/j.neulet.2017.02.046
10.1161/01.STR.0000089015.51603.CC
10.3892/ijmm.2017.2915
10.1016/j.intimp.2018.12.055
10.4049/jimmunol.1801166
10.7150/ijbs.56800
10.1111/nmo.13121
10.1016/j.bbrc.2016.06.044
10.1007/s00774-017-0889-5
10.1016/j.jnutbio.2018.04.018
10.1016/j.pneurobio.2016.01.005
10.1016/S1474-4422(11)70066-7
10.1002/jnr.23809
10.1161/STROKEAHA.118.022207
10.1007/s12035-018-1135-4
10.1523/JNEUROSCI.1599-15.2015
10.1056/NEJMoa1706442
10.1016/j.cjtee.2018.04.003
10.1111/cas.14641
10.1007/s11064-019-02922-1
10.1111/ejn.15385
10.3390/ijms23094910
10.1016/j.chmed.2017.12.005
10.1155/2018/4248526
10.1016/j.bcp.2017.02.004
10.3389/fphys.2018.00529
10.1016/j.biopha.2017.07.071
10.3389/fnmol.2020.00028
10.1016/j.phymed.2021.153745
10.1002/anie.201802309
10.1016/j.neuint.2013.08.008
10.1186/s12974-018-1246-x
10.1016/j.molimm.2019.09.020
10.1016/j.neuroscience.2019.10.048",<Element 'PubmedArticle' at 0x7f05dd11af40>
64,"36362220
12597862
30201764
11549663
20012068
33381011
25239737
15788704
10604470
31784044
21524673
29576534
12130749
28552455
30874792
11162448
20497419
15232612
23071554
29845448
24381790
17983863
21903149
26042199
21219177
20720512
24727365
34939700
27303049
12663466
19384567
25785032
22159999
31306657
18523304
29599941
31447640
30177523
11057670
20584998
15339247
12970297
20587751
25607843
20826561
15855322
23900445
29197160
26569220
32710901
30129476
33714946
29057768
26033219
28232667
33333485
26542050
27337340
32959884
29151590
25800044
25035950
23454862
31062335
25385337
35016495
24327949
32508567
22201683
35681242
30524228
35742824
16600402
16460274
26016745
30578932
28697569
28504110
28592656
31758009
28507516
31178685
21371747
1941102
22355802
32320406
30309945
30833177
20948643
33582568
31835423
34305953
30628018
21565248
28782532
31780940
32859774
21389984
19463757
33838250
11274343
30116300
21605050
21949705
22908267
33154069
30065032
28469442
26090621
12447443
22476196
25111866
20351014
26079709
25792098
21718498
19740737
25309797
19382238
15507538
23565247
23506735
30339715
16491079
19349094
30949921
28380673
20930280
30443455
25173805
1933245
31077796
9278044
31787891
29626177
32736085
31862977
20028343
26872221
29277488
24009547
12068076
16233968",The Interplay between Ghrelin and Microglia in Neuroinflammation: Implications for Obesity and Neurodegenerative Diseases.,"Numerous studies have shown that microglia are capable of producing a wide range of chemokines to promote inflammatory processes within the central nervous system (CNS). These cells share many phenotypical and functional characteristics with macrophages, suggesting that microglia participate in innate immune responses in the brain. Neuroinflammation induces neurometabolic alterations and increases in energy consumption. Microglia may constitute an important therapeutic target in neuroinflammation. Recent research has attempted to clarify the role of Ghre signaling in microglia on the regulation of energy balance, obesity, neuroinflammation and the occurrence of neurodegenerative diseases. These studies strongly suggest that Ghre modulates microglia activity and thus affects the pathophysiology of neurodegenerative diseases. This review aims to summarize what is known from the current literature on the way in which Ghre modulates microglial activity during neuroinflammation and their impact on neurometabolic alterations in neurodegenerative diseases. Understanding the role of Ghre in microglial activation/inhibition regulation could provide promising strategies for downregulating neuroinflammation and consequently for diminishing negative neurological outcomes.","['Alzheimer’s disease', 'Ghrelin', 'Ghrelin receptor', 'Parkinson’s disease', 'inflammation', 'microglia', 'neurodegenerative diseases', 'neuroinflammation']",International journal of molecular sciences,2022-11-12,"[{'lastname': 'Russo', 'firstname': 'Cristina', 'initials': 'C', 'affiliation': 'Section of Pathology, Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, 95123 Catania, Italy.'}, {'lastname': 'Valle', 'firstname': 'Maria Stella', 'initials': 'MS', 'affiliation': 'Laboratory of Neuro-Biomechanics, Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, 95123 Catania, Italy.\nSection of Physiology, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.'}, {'lastname': 'Russo', 'firstname': 'Antonella', 'initials': 'A', 'affiliation': 'Section of Physiology, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.'}, {'lastname': 'Malaguarnera', 'firstname': 'Lucia', 'initials': 'L', 'affiliation': 'Section of Pathology, Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, 95123 Catania, Italy.'}]",,,,,"10.3390/ijms232113432
10.1016/S0896-6273(03)00063-1
10.1523/JNEUROSCI.0789-18.2018
10.1210/jcem.86.9.7866
10.1007/s00401-009-0619-8
10.3389/fnins.2020.614828
10.1016/j.jalz.2014.06.016
10.1152/physrev.00012.2004
10.1038/45230
10.1016/j.npep.2019.101997
10.1016/j.peptides.2011.04.010
10.1016/j.cmet.2018.02.008
10.1124/jpet.102.034827
10.1016/j.neulet.2017.05.049
10.1210/en.2019-00074
10.1006/bbrc.2000.4039
10.1111/j.1440-1681.2010.05409.x
10.1172/JCI21134
10.1371/journal.pone.0046321
10.1007/s00221-018-5298-z
10.1155/2013/518909
10.1016/j.mce.2011.08.034
10.1016/j.molmet.2015.03.005
10.1146/annurev-immunol-031210-101322
10.1097/SHK.0b013e3181f48a37
10.1016/j.bbi.2014.04.001
10.1096/fj.202101297R
10.1042/CS20160077
10.2337/diabetes.52.4.948
10.1007/s12640-009-9037-x
10.1152/ajpheart.00390.2010
10.1016/j.lfs.2019.116654
10.4049/jimmunol.180.12.8369
10.1155/2018/1564748
10.3389/fnins.2019.00828
10.1042/BSR20181061
10.1038/35038090
10.2337/db10-0504
10.1530/eje.0.151s067
10.1210/jc.2002-021940
10.1152/ajpendo.00414.2009
10.1172/JCI73688
10.1210/en.2010-0556
10.2337/diabetes.54.5.1371
10.1038/ijo.2013.140
10.1002/dneu.22562
10.3390/ijms161125990
10.1016/j.brainres.2020.147023
10.1016/S1474-4422(18)30238-2
10.18632/aging.202805
10.1507/endocrj.EJ17-0281
10.1007/s12035-015-9227-x
10.1038/nrendo.2016.222
10.1016/j.npep.2020.102112
10.1016/j.tem.2015.09.010
10.1038/nature18283
10.1093/hmg/ddaa209
10.1038/nri.2017.125
10.1111/bph.13139
10.1016/j.immuni.2014.06.008
10.1016/j.bbi.2013.02.005
10.1007/s12264-019-00388-3
10.1038/nrneurol.2014.207
10.4081/ejh.2022.3350
10.1016/j.molmet.2013.08.003
10.3389/fnins.2020.00444
10.1172/JCI59660
10.1186/s12974-022-02519-6
10.3389/fnins.2018.00846
10.3390/ijms23126380
10.1016/j.regpep.2006.02.005
10.1146/annurev.physiol.68.040504.094635
10.1530/JOE-15-0139
10.1016/j.bbi.2018.12.008
10.3233/JAD-170248
10.1016/S1474-4422(17)30084-4
10.1242/dmm.026609
10.1038/s41598-019-53578-4
10.3389/fnagi.2017.00115
10.3389/fnins.2019.00513
10.1016/S0140-6736(10)61349-9
10.1523/JNEUROSCI.11-11-03679.1991
10.1101/cshperspect.a009399
10.1371/journal.pone.0231720
10.1126/science.aat0473
10.1016/j.it.2019.02.001
10.3410/B1-42
10.1016/j.neurobiolaging.2021.01.011
10.3390/biom9120850
10.3389/fimmu.2021.714340
10.1007/s11064-018-02714-z
10.1016/j.mce.2011.04.019
10.1016/j.lfs.2017.08.004
10.3389/fphar.2019.01320
10.4103/1673-5374.290881
10.1038/nature09788
10.1016/j.peptides.2009.03.001
10.1016/j.bbi.2021.04.001
10.1152/physrev.2001.81.2.741
10.1177/1756286418791107
10.2174/156720511796391818
10.1371/journal.pone.0024325
10.1073/pnas.1205847109
10.2337/db20-0231
10.2337/db18-0451
10.1177/1178626417703995
10.1038/srep11452
10.1038/nature01137
10.1172/JCI57256
10.1097/MCO.0000000000000101
10.1677/JOE-10-0040
10.1016/j.nbd.2015.06.002
10.1016/S1474-4422(15)70016-5
10.1186/1750-1326-6-45
10.1074/jbc.M109.045104
10.3803/EnM.2014.29.3.371
10.1002/jnr.22088
10.1152/ajpendo.00196.2004
10.1371/journal.pone.0060437
10.1016/j.neuroscience.2013.02.062
10.1111/jnc.14615
10.1038/nn1656
10.1016/j.neurobiolaging.2009.02.025
10.1007/s13668-019-0271-4
10.1111/jne.12476
10.3233/JAD-2010-101263
10.7759/cureus.3285
10.1016/j.nbd.2014.08.026
10.1093/brain/114.5.2283
10.1016/j.semcdb.2019.05.004
10.1038/42166
10.3389/fnagi.2019.00302
10.1212/WNL.0000000000005475
10.1016/j.nbd.2020.105028
10.1038/s41467-019-13812-z
10.1111/j.1600-0404.2009.01185.x
10.1111/jnc.13576
10.1016/j.neuropharm.2017.12.027
10.3389/fnins.2013.00148
10.1046/j.1471-4159.2002.00928.x
10.1016/j.exger.2005.09.003",<Element 'PubmedArticle' at 0x7f05dd0e4180>
65,"36362056
23435359
20224007
26311042
27541692
9505873
28301775
29522742
27647980
24679531
28215162
26179554
31551115
25078296
29326727
22674330
30614568
34642268
30915065
28035535
30591521
31007175
30935126
30972292
19026645
33248167
27195116
11374689
25664852
32587537
32054443
15133062
32698378
21966581
20600016
21683077
19837031
11557989
24811377
27811267
21041960
12403987
20650402
21060341
24733808
30269986
30705252
20117131
30448975
27912057
32889847
30839179
24762069
28968189
28714953
29963257
34073257
22674334
27449871
31789672
28722709
27107961
29552006
7900526
27717732
30778155
16940291
32192080
31087436
32299442
32046455
35038957
15763911
21272848
19883331
30496104
22607834
26930255
35860242
32607819
32878054
35980963
26662472
25416067
25808229
31597349
34702353
28251905
23433203
15667495
20014457
19903265
24583088
22713265
21073731
30940523
24815298
21418261
23829297
28045459
29089436
31290688
32134496
28483500
35326422
23797870
15521849
17195902
33814115
33071256
30934533
32577079
25467060
19954800
35317140
29902437
29089597
27116971
30209745
22754309
31601124
11691868
28755521
29174530
30022437
21876150
29101366
29789115
33793965
29523342
18268332
11703169
28537581
19567715
11755892
27868217
28280004
28211545
31209039
29888757
20208051
23287068
18626975
20299599
30560330
29329362
30402954
20518856
27156182
27306945
30592480
27403301
25298006
30109908
25584177
29202473
25473176
27747984
27382323
28765473
34393197
27329806
30423561
31009405
32991818
22183182
23323867
26929784",The Role of the Human Microbiome in the Pathogenesis of Pain.,"Understanding of the gut microbiome's role in human physiology developed rapidly in recent years. Moreover, any alteration of this microenvironment could lead to a pathophysiological reaction of numerous organs. It results from the bidirectional communication of the gastrointestinal tract with the central nervous system, called the gut-brain axis. The signals in the gut-brain axis are mediated by immunological, hormonal, and neural pathways. However, it is also influenced by microorganisms in the gut. The disturbances in the gut-brain axis are associated with gastrointestinal syndromes, but recently their role in the development of different types of pain was reported. The gut microbiome could be the factor in the central sensitization of chronic pain by regulating microglia, astrocytes, and immune cells. Dysbiosis could lead to incorrect immune responses, resulting in the development of inflammatory pain such as endometriosis. Furthermore, chronic visceral pain, associated with functional gastrointestinal disorders, could result from a disruption in the gut microenvironment. Any alteration in the gut-brain axis could also trigger migraine attacks by affecting cytokine expression. Understanding the gut microbiome's role in pain pathophysiology leads to the development of analgetic therapies targeting microorganisms. Probiotics, FODMAP diet, and fecal microbiota transplantation are reported to be beneficial in treating visceral pain.","['IBS', 'microbiome', 'neuropathy', 'pain']",International journal of molecular sciences,2022-11-12,"[{'lastname': 'Ustianowska', 'firstname': 'Klaudia', 'initials': 'K', 'affiliation': 'Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland.'}, {'lastname': 'Ustianowski', 'firstname': 'Łukasz', 'initials': 'Ł', 'affiliation': 'Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland.'}, {'lastname': 'Machaj', 'firstname': 'Filip', 'initials': 'F', 'affiliation': 'Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland.\nDepartment of Medical Biology, Medical University of Warsaw, 00-575 Warsaw, Poland.'}, {'lastname': 'Gorący', 'firstname': 'Anna', 'initials': 'A', 'affiliation': 'Independent Laboratory of Invasive Cardiology, Pomeranian Medical University, 70-111 Szczecin, Poland.'}, {'lastname': 'Rosik', 'firstname': 'Jakub', 'initials': 'J', 'affiliation': 'Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland.\nDepartment of Chemistry, The University of Chicago, Chicago, IL 60637, USA.'}, {'lastname': 'Szostak', 'firstname': 'Bartosz', 'initials': 'B', 'affiliation': 'Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland.'}, {'lastname': 'Szostak', 'firstname': 'Joanna', 'initials': 'J', 'affiliation': 'Department of Experimental and Clinical Pharmacology, Pomeranian Medical University, 70-111 Szczecin, Poland.'}, {'lastname': 'Pawlik', 'firstname': 'Andrzej', 'initials': 'A', 'affiliation': 'Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland.'}]",,,,,"10.3390/ijms232113267
10.1038/nrmicro2974
10.1152/ajpgi.00327.2009
10.1016/S1473-3099(15)00293-5
10.1371/journal.pbio.1002533
10.1136/gut.42.1.2
10.1146/annurev-neuro-072116-031347
10.1016/j.cell.2018.02.044
10.1155/2016/5080438
10.1016/j.cell.2014.03.011
10.2174/0929867324666170216113756
10.1002/mds.26307
10.1016/j.bja.2019.07.026
10.1016/j.bbr.2014.07.027
10.3389/fimmu.2017.01882
10.1126/science.1223813
10.1111/jne.12684
10.3389/fimmu.2019.00277
10.15252/emmm.201809302
10.1016/j.bbadis.2018.07.004
10.3390/cancers11040459
10.3389/fonc.2019.00178
10.1053/j.gastro.2008.10.080
10.1016/j.imlet.2020.11.010
10.1038/cti.2016.17
10.1111/j.1572-0241.2001.03804.x
10.1172/JCI76309
10.1186/s10194-020-1078-9
10.1113/jphysiol.2004.063388
10.3390/brainsci10070465
10.4161/cib.15702
10.1053/j.gastro.2010.06.063
10.1053/j.gastro.2011.04.052
10.1016/j.cell.2009.09.028
10.1038/35093019
10.1016/j.neuron.2014.01.018
10.1126/science.aaf8924
10.1172/JCI43766
10.1038/nn942
10.1016/S1474-4422(10)70143-5
10.1038/nrneurol.2010.160
10.1200/JCO.2013.54.0914
10.1016/j.neuron.2018.08.030
10.1038/s41398-019-0379-8
10.1016/j.pharmthera.2010.01.002
10.1007/s00540-018-2579-4
10.1016/j.cell.2016.11.018
10.1213/ANE.0000000000005155
10.1002/brb3.1260
10.2217/imt.13.170
10.1146/annurev-pharmtox-042017-031849
10.1038/nn.4606
10.18632/oncotarget.25524
10.3390/ijms22115644
10.1126/science.1223490
10.1093/infdis/jiw184
10.1097/QCO.0000000000000620
10.1038/ni.3780
10.1186/s12879-016-1513-3
10.3389/fimmu.2018.00208
10.3109/00016349509008942
10.1016/j.ajog.2016.09.075
10.1038/s41598-019-39700-6
10.1530/rep.1.01110
10.3390/diagnostics10030163
10.1111/aji.13147
10.1186/s12941-020-00356-0
10.1007/s43032-019-00113-5
10.1080/21655979.2022.2027059
10.1080/10647440400020711
10.1016/j.ajog.2010.11.012
10.1586/eri.09.87
10.1016/S0140-6736(18)32279-7
10.1016/j.jpain.2012.03.009
10.1016/j.juro.2016.02.2959
10.3389/fimmu.2022.915218
10.1007/s11684-019-0731-7
10.3390/nu12092648
10.1371/journal.pone.0269140
10.1111/cns.12490
10.1136/gutjnl-2014-308514
10.1007/s00535-015-1064-1
10.3390/nu11102403
10.1186/s40168-021-01165-z
10.1126/scitranslmed.aaf6397
10.1111/nmo.12103
10.1111/j.1572-0241.2005.40312.x
10.3748/wjg.15.5936
10.1111/j.1365-2982.2009.01427.x
10.1053/j.gastro.2014.02.037
10.4161/gmic.21009
10.1186/1471-230X-10-134
10.1053/j.gastro.2019.03.049
10.1111/apt.12787
10.1111/j.1365-2036.2011.04633.x
10.1111/jgh.12322
10.1038/ismej.2016.176
10.1523/JNEUROSCI.1672-17.2017
10.1152/ajpgi.00052.2019
10.1113/JP279075
10.1053/j.gastro.2017.05.003
10.3390/cells11060971
10.1038/nrgastro.2013.105
10.1111/j.1365-2036.2004.02180.x
10.1007/s10350-006-0763-3
10.2220/biomedres.41.199
10.3390/ijms20061482
10.1177/1178646920928984
10.1016/j.jpsychires.2014.11.003
10.1016/j.jpsychires.2009.11.002
10.12998/wjcc.v10.i6.1754
10.1016/j.chom.2018.05.003
10.1038/ja.2017.142
10.1007/s11274-016-2060-1
10.1007/s12551-018-0452-1
10.3390/ijms13055482
10.1096/fj.201901192R
10.1111/j.1469-7793.2001.00727.x
10.1111/bph.13965
10.1016/j.euroneuro.2017.11.001
10.1007/s12031-018-1124-0
10.1073/pnas.1102999108
10.1038/s41467-017-01403-9
10.3238/arztebl.2018.0299
10.1111/head.14099
10.1016/S0140-6736(18)30478-1
10.1073/pnas.0711891105
10.1038/ejcn.2017.57
10.1016/S0025-6196(11)60750-7
10.1016/S0002-9610(01)00782-6
10.1111/apt.13858
10.1096/fj.201601068R
10.1038/srep42658
10.1073/pnas.1901182116
10.1016/j.isci.2018.03.003
10.2146/ajhp090168
10.1016/j.nut.2012.07.017
10.1002/ibd.20602
10.1016/j.idairyj.2004.06.001
10.1152/ajpgi.00243.2009
10.1007/s10620-018-5416-6
10.1093/abbs/gmx138
10.1111/jgh.14536
10.1111/j.1365-2982.2010.01520.x
10.1016/j.jpeds.2016.04.003
10.1097/MCG.0000000000000528
10.1001/jamapediatrics.2018.4575
10.1177/2050640615602571
10.1111/nmo.12450
10.1111/nmo.13440
10.1172/JCI92390
10.3748/wjg.v20.i43.16215
10.1111/nmo.12969
10.2147/CEG.S86798
10.1136/gutjnl-2017-314792
10.1097/j.pain.0000000000002438
10.1038/nrgastro.2016.98
10.1159/000494252
10.14309/ctg.0000000000000034
10.1080/19490976.2020.1794263
10.1038/nrgastro.2011.244
10.1056/NEJMoa1205037
10.1177/1756283X15607414",<Element 'PubmedArticle' at 0x7f05dd2d2630>
66,"36326686
8700956
28746310
23636330
23746838
25800044
24158306
23550011
17334929
24904852
17519946
30306845
17213691
19770291
20501670
30042117
6820341
20407007
30922440
24952104
24112790
23584855
21241779
26141841
30890930
21371294
18004231
23497056
17916769
24561490
26635525
26067058
18441260
570913
573635
27842268
16787965
17412800
19846537
27340201
19629762
24889886
16988717
17342777",IGF1 gene therapy in middle-aged female rats delays reproductive senescence through its effects on hypothalamic GnRH and kisspeptin neurons.,"The process of aging is the result of progressive loss of homeostasis and functional body impairment, including the central nervous system, where the hypothalamus plays a key role in regulating aging mechanisms. The consequences of aging include a chronic proinflammatory environment in the hypothalamus that leads to decreased secretion of gonadotropin-releasing hormone (GnRH) and impairs kisspeptin neuron functionality. In this work, we investigated the effect of insulin-like growth factor 1 (IGF1) gene therapy on hypothalamic kisspeptin/GnRH neurons and on microglial cells, that mediate the inflammatory process related with the aging process. The results show that IGF1 rats have higher kisspeptin expression in the anteroventral periventricular (AVPV) nucleus and higher immunoreactivity of GnRH in the arcuate nucleus and median eminence. In addition, IGF1-treated animals exhibit increased numbers of Iba1","['GnRH', 'IGF1', 'gene therapy', 'kisspeptin', 'microglia', 'reproductive senescence']",Aging,2022-11-04,"[{'lastname': 'Dolcetti', 'firstname': 'Franco Juan Cruz', 'initials': 'FJC', 'affiliation': 'Laboratorio de Bioquímica del Envejecimiento, Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), Facultad de Ciencias Médicas, UNLP-CONICET, La Plata, Argentina.'}, {'lastname': 'Falomir-Lockhart', 'firstname': 'Eugenia', 'initials': 'E', 'affiliation': 'Laboratorio de Bioquímica del Envejecimiento, Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), Facultad de Ciencias Médicas, UNLP-CONICET, La Plata, Argentina.'}, {'lastname': 'Acuña', 'firstname': 'Francisco', 'initials': 'F', 'affiliation': 'Laboratorio de Histología y Embriología Descriptiva, Experimental y Comparada, Facultad de Ciencias Veterinarias, Universidad Nacional de La Plata, La Plata, Argentina.'}, {'lastname': 'Herrera', 'firstname': 'Macarena Lorena', 'initials': 'ML', 'affiliation': 'Laboratorio de Bioquímica del Envejecimiento, Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), Facultad de Ciencias Médicas, UNLP-CONICET, La Plata, Argentina.\nInstituto de Farmacología Experimental de Córdoba-CONICET, Departamento de Farmacología, Facultad de Ciencias Químicas, UNC-CONICET, Córdoba, Argentina.'}, {'lastname': 'Cervellini', 'firstname': 'Sofia', 'initials': 'S', 'affiliation': 'Laboratorio de Bioquímica del Envejecimiento, Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), Facultad de Ciencias Médicas, UNLP-CONICET, La Plata, Argentina.'}, {'lastname': 'Barbeito', 'firstname': 'Claudio Gustavo', 'initials': 'CG', 'affiliation': 'Laboratorio de Histología y Embriología Descriptiva, Experimental y Comparada, Facultad de Ciencias Veterinarias, Universidad Nacional de La Plata, La Plata, Argentina.'}, {'lastname': 'Grassi', 'firstname': 'Daniela', 'initials': 'D', 'affiliation': 'Department of Anatomy, Histology and Neuroscience, Autonomous University of Madrid, Madrid, España.'}, {'lastname': 'Arevalo', 'firstname': 'Maria-Angeles', 'initials': 'MA', 'affiliation': 'Instituto Cajal, CSIC, Madrid, España.\nCentro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, España.'}, {'lastname': 'Bellini', 'firstname': 'María José', 'initials': 'MJ', 'affiliation': 'Laboratorio de Bioquímica del Envejecimiento, Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), Facultad de Ciencias Médicas, UNLP-CONICET, La Plata, Argentina.'}]",,,,,"10.18632/aging.204360
10.1016/0031-9384(95)02101-9
10.1038/nature23282
10.1038/nature12143
10.1016/j.cell.2013.05.039
10.1111/bph.13139
10.1007/s11154-013-9279-z
10.1007/978-1-4614-6199-9_13
10.1007/s11154-007-9026-4
10.6065/apem.2013.18.2.55
10.1038/sj.bjp.0707295
10.1530/JOE-18-0269
10.1262/jrd.18146
10.1210/er.2009-0005
10.1210/en.2010-0022
10.1530/JOE-18-0108
10.1080/03610738208260367
10.1152/ajpendo.00081.2010
10.1071/rd18277
10.1016/j.yhbeh.2014.06.007
10.1016/j.neurobiolaging.2013.08.038
10.1210/en.2013-1069
10.1016/j.neuroscience.2011.01.013
10.1016/j.neuroscience.2015.06.050
10.3389/fnagi.2019.00048
10.1186/1742-2094-8-21
10.1097/shk.0b013e31815d0780
10.1186/1742-2094-10-37
10.1161/ATVBAHA.107.156257
10.1016/j.bbi.2014.02.008
10.3389/fncel.2015.00440
10.1016/j.pneurobio.2015.05.003
10.1177/0192623308315665
10.1210/endo-103-5-1855
10.1095/biolreprod21.1.193
10.1016/j.neurobiolaging.2016.10.018
10.1152/ajpendo.00040.2006
10.1210/en.2007-0207
10.1210/me.2009-0013
10.1530/JOE-15-0538
10.1007/s12035-009-8077-9
10.1186/1742-2094-11-98
10.1038/sj.gt.3302870
10.1002/bdrb.20106",<Element 'PubmedArticle' at 0x7f05de474450>
67,"36318114
33684608
20679202
22201683
28602351
26470014
28683286
19095631
15369681
34324439
21896757
27940259
33879780
20483760
24760848
20566843
26271253
24360280
30448612
31233242
28223698
27033548
32241286
33192308
28489068
31495690
30333759
32446877
12215436
19041765
25186741
26687838
28954222
22884327
24462248
26166568
18083105
27049947
29581545
32615087
33691116
28886007
27405276
28073831",Prostaglandin PGE2 Receptor EP4 Regulates Microglial Phagocytosis and Increases Susceptibility to Diet-Induced Obesity.,"In rodents, susceptibility to diet-induced obesity requires microglial activation, but the molecular components of this pathway remain incompletely defined. Prostaglandin PGE2 levels increase in the mediobasal hypothalamus during high-fat-diet (HFD) feeding, and the PGE2 receptor EP4 regulates microglial activation state and phagocytic activity, suggesting a potential role for microglial EP4 signaling in obesity pathogenesis. To test the role of microglial EP4 in energy balance regulation, we analyzed the metabolic phenotype in a microglia-specific EP4 knockout (MG-EP4 KO) mouse model. Microglial EP4 deletion markedly reduced weight gain and food intake in response to HFD feeding. Corresponding with this lean phenotype, insulin sensitivity was also improved in HFD-fed MG-EP4 KO mice, though glucose tolerance remained surprisingly unaffected. Mechanistically, EP4-deficient microglia showed an attenuated phagocytic state marked by reduced CD68 expression and fewer contacts with pro-opiomelanocortin (POMC) neuron processes. These cellular changes observed in the MG-EP4 KO mice corresponded with an increased density of POMC neurites extending into the paraventricular nucleus (PVN). These findings reveal that microglial EP4 signaling promotes body weight gain and insulin resistance during HFD feeding. Furthermore, the data suggest that curbing microglial phagocytic function may preserve POMC cytoarchitecture and PVN input to limit overconsumption during diet-induced obesity.",[],Diabetes,2022-11-02,"[{'lastname': 'Niraula', 'firstname': 'Anzela', 'initials': 'A', 'affiliation': 'UW Medicine Diabetes Institute, University of Washington, Seattle, WA.\nDepartment of Medicine, University of Washington, Seattle, WA.'}, {'lastname': 'Fasnacht', 'firstname': 'Rachael D', 'initials': 'RD', 'affiliation': 'UW Medicine Diabetes Institute, University of Washington, Seattle, WA.\nDepartment of Medicine, University of Washington, Seattle, WA.'}, {'lastname': 'Ness', 'firstname': 'Kelly M', 'initials': 'KM', 'affiliation': 'UW Medicine Diabetes Institute, University of Washington, Seattle, WA.\nDepartment of Medicine, University of Washington, Seattle, WA.'}, {'lastname': 'Frey', 'firstname': 'Jeremy M', 'initials': 'JM', 'affiliation': 'UW Medicine Diabetes Institute, University of Washington, Seattle, WA.\nDepartment of Medicine, University of Washington, Seattle, WA.'}, {'lastname': 'Cuschieri', 'firstname': 'Sophia A', 'initials': 'SA', 'affiliation': 'UW Medicine Diabetes Institute, University of Washington, Seattle, WA.\nDepartment of Medicine, University of Washington, Seattle, WA.'}, {'lastname': 'Dorfman', 'firstname': 'Mauricio D', 'initials': 'MD', 'affiliation': 'UW Medicine Diabetes Institute, University of Washington, Seattle, WA.\nDepartment of Medicine, University of Washington, Seattle, WA.'}, {'lastname': 'Thaler', 'firstname': 'Joshua P', 'initials': 'JP', 'affiliation': 'UW Medicine Diabetes Institute, University of Washington, Seattle, WA.\nDepartment of Medicine, University of Washington, Seattle, WA.'}]",,,,© 2023 by the American Diabetes Association.,10.2337/db21-1072,<Element 'PubmedArticle' at 0x7f05de492ea0>
68,"36309938
27751558
26096665
25492702
1549228
11733217
33093662
25689247
33400081
33169684
32132364
11750861
34341712
26984188
27179961
29643512
34445042
31506009
24138599
34864312
31488882
27443609
28546539
31471351
35180124
32596386
31063846
27776263
31064831
29051531
32687964
28643167
29095058
21395585
32781194
31180143
33892083
29903615
24581881
32832679
18192426
24150108
27634977
25589730
14670989
27166282
26113365
27196727
28515690
23884544
33239064
27033548
25800044
31715222
24554058
27500468
20605968
26514204
21994366
15617532
33254429
30929267
30230594
15778722
20164562
1674117
29233786
21807098
24618355
20638440
27186358
20951130
21525299
34199496
22190648
28710078
33818491
21395482
27717506
21170538
11904135
20810904
29475564
24434111
21357268
24981012
21945538
23555795
24607811
28681915
19428144
9546791
18374402
27306650
19410597
22732134
25092805
23958466
23639063
24917787
12414884
25576906
22227454
29311911
31544208
29163128
27389922
27445795
26844375
34873153
34594000
23840908
30559440
36450980
14671188
34737456
22476197
7653697
33554915
34206322
23122920
28625867
27889451
27346602
27299848
25550456
24892638
24244158
18197168
19776140
29311617
27279214
24212060
19193944
17395901
18662857
27405092
24415571
29412823
10727618
30739077
32946754
22975058
16491079
23411585
20858966
31434007
9013743
10482243
28992793
18931303
25161883
25092133
15576490
30948838
27392632
15802305
21873225
24466315
24636517
34194038
33839232
28918360
32795610
27821775
16877118
21040743
29291614
31972462
31123355
24781306
25170769
8822146
26957230
24425100
22001683
26578870
28242013
34854884
32593306
31097468
31302669
29555333
31816337
31753762
22254078
32053787
30420754
31383855
30298433
26803556
31968211
34500036",Intestinal Flora Affect Alzheimer's Disease by Regulating Endogenous Hormones.,"Alzheimer's disease (AD) is a central nervous system disease that can lead to cognitive impairment and progressive memory loss. An increasing number of studies have shown that intestinal flora play a crucial role in regulating the brain-gut axis. Short-chain fatty acids are metabolites of intestinal flora that regulate hormone synthesis and play an essential role in microbial-intestinal-brain communication. An imbalance of intestinal flora can promote microglia to secrete proinflammatory factors, cause nerve inflammation, and then affect cognitive and learning ability. However, the mechanism is not clear. From this, we infer that endogenous hormones may be the medium for intestinal flora to affect the process of AD. This review of the relationships among AD, endogenous hormones, and intestinal flora expounds on the critical role of various hormones in the brain-gut axis. It discusses intervention measures aimed at intestinal flora to prevent or delay AD occurrence. Finally, the potential development prospects of fecal microbiota transplantation in treating AD are put forward, which provide potential ideas for future AD research.","[""Alzheimer's disease"", 'Fecal microbiota transplantation', 'Hormones', 'Intestinal flora', 'Short-chain fatty acids']",Neurochemical research,2022-10-31,"[{'lastname': 'Wu', 'firstname': 'Yawen', 'initials': 'Y', 'affiliation': 'Daxing Research Institute, University of Science and Technology Beijing, 112 Lab, Lihua BLDG, No.30 Xueyuan Road, Haidian District, Beijing, 100083, China.\nSchool of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing, 100083, China.'}, {'lastname': 'Hang', 'firstname': 'Zhongci', 'initials': 'Z', 'affiliation': 'Daxing Research Institute, University of Science and Technology Beijing, 112 Lab, Lihua BLDG, No.30 Xueyuan Road, Haidian District, Beijing, 100083, China.\nSchool of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing, 100083, China.'}, {'lastname': 'Lei', 'firstname': 'Tong', 'initials': 'T', 'affiliation': 'Daxing Research Institute, University of Science and Technology Beijing, 112 Lab, Lihua BLDG, No.30 Xueyuan Road, Haidian District, Beijing, 100083, China.\nSchool of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing, 100083, China.'}, {'lastname': 'Du', 'firstname': 'Hongwu', 'initials': 'H', 'affiliation': 'Daxing Research Institute, University of Science and Technology Beijing, 112 Lab, Lihua BLDG, No.30 Xueyuan Road, Haidian District, Beijing, 100083, China. hongwudu@ustb.edu.cn.\nSchool of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing, 100083, China. hongwudu@ustb.edu.cn.'}]",,,,"© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.","10.1007/s11064-022-03784-w
10.1016/S1474-4422(16)30235-6
10.1001/jamapsychiatry.2014.2476
10.1016/j.jalz.2015.05.017
10.1007/s00401-014-1371-2
10.1212/WNL.42.3.631
10.1016/S1471-4914(01)02173-6
10.1126/scitranslmed.3009759
10.1038/s41579-020-00460-0
10.1172/JCI76304
10.1007/s10571-020-01024-9
10.1016/j.lfs.2020.118627
10.1097/CM9.0000000000000706
10.1016/S1043-2760(01)00503-3
10.14336/AD.2021.0122
10.1093/brain/aww017
10.1016/j.jalz.2016.02.010
10.1038/s41586-018-0023-4
10.3390/nu13020690
10.1146/annurev-pharmtox-010919-023628
10.1586/1744666X.2013.848793
10.1016/j.biopha.2021.112343
10.1038/s41422-019-0216-x
10.1038/srep30028
10.1038/s41598-017-02587-2
10.1136/gutjnl-2018-317431
10.3233/JAD-215495
10.1155/2020/8456596
10.1016/j.bbi.2019.05.008
10.1016/j.neurobiolaging.2016.08.019
10.1128/mBio.00632-19
10.1038/s41598-017-13601-y
10.1016/j.pnpbp.2020.110039
10.1007/s00018-017-2550-9
10.1080/14737175.2018.1400909
10.1111/j.1471-4159.2011.07245.x
10.1016/j.yfrne.2020.100857
10.3233/JAD-190872
10.1111/nyas.14129
10.1016/j.brainresbull.2021.04.010
10.1016/j.brainres.2018.03.015
10.1016/j.ijmm.2014.01.002
10.1126/sciadv.aba0466
10.1128/AEM.02274-07
10.3233/JAD-131394
10.1093/nutrit/nuw023
10.3233/JAD-142841
10.1210/en.2003-1383
10.1152/ajpendo.00121.2016
10.15252/embr.201439837
10.1210/er.2016-1007
10.3389/fnagi.2017.00129
10.1007/s12031-013-0068-7
10.1186/s40035-020-00221-2
10.1126/science.aad8373
10.1111/bph.13139
10.1016/j.pneurobio.2019.101720
10.1007/s00018-014-1579-2
10.1111/jpi.12360
10.1124/pr.110.002832
10.1146/annurev-pharmtox-010814-124742
10.1523/JNEUROSCI.3059-11.2011
10.1111/j.1600-079X.2004.00169.x
10.1016/j.biopha.2020.110887
10.1111/jpi.12574
10.1111/jpi.12448
10.1038/nm1206
10.3233/JAD-2010-1385
10.1212/WNL.41.5.716
10.1016/j.arr.2017.12.002
10.1016/j.mcn.2011.07.008
10.1111/acel.12213
10.1016/j.pneurobio.2010.07.003
10.1111/jdi.12464
10.1016/j.ejphar.2010.10.008
10.1523/JNEUROSCI.0529-11.2011
10.3390/ijms22020860
10.2337/db11-1019
10.1530/EC-17-0111
10.4103/1673-5374.310608
10.1517/13543784.2011.565330
10.1016/j.tips.2016.09.004
10.1007/s00401-010-0789-4
10.1016/S0006-3223(01)01235-5
10.1523/JNEUROSCI.2985-10.2010
10.1016/j.tins.2018.01.010
10.1016/j.yfrne.2014.01.002
10.4049/jimmunol.1002205
10.1016/j.nbd.2014.06.014
10.1016/j.nbd.2011.08.035
10.1371/journal.pone.0059825
10.1016/j.jsbmb.2014.02.018
10.1002/jcp.26083
10.1016/j.neurobiolaging.2009.04.008
10.1038/nm0498-447
10.1016/j.yfrne.2008.02.001
10.1111/jne.12402
10.1016/j.yfrne.2009.04.014
10.1016/j.yhbeh.2012.06.003
10.1002/glia.22736
10.1016/j.pneurobio.2013.07.006
10.1111/jne.12043
10.3389/fncel.2014.00134
10.1210/jc.2002-020878
10.1016/j.jsbmb.2015.01.002
10.1016/j.brainres.2010.11.090
10.3389/fnagi.2017.00430
10.1210/endrev/bnz005
10.3389/fnagi.2017.00345
10.3389/fendo.2015.00013
10.1016/j.steroids.2016.06.004
10.3389/fnagi.2016.00152
10.1210/en.2015-1959
10.1038/s41467-021-27187-7
10.1038/s41423-021-00757-x
10.1371/annotation/90c76048-2edd-4315-8404-4d9d8cbd411e
10.1038/s41422-018-0123-6
10.1038/s41586-022-04463-0
10.1210/jc.2003-030833
10.1038/s41380-021-01368-8
10.1172/JCI59903
10.1176/ajp.152.9.1372
10.3233/JAD-201411
10.3390/ijms22136656
10.1016/j.neurobiolaging.2012.10.007
10.1016/j.cmet.2017.05.008
10.1016/j.molcel.2016.10.025
10.1016/j.neuint.2016.06.011
10.1021/acs.chemrev.6b00056
10.1096/fj.14-259598
10.1210/me.2014-1108
10.1371/journal.ppat.1003726
10.1038/nrmicro1836
10.3945/ajcn.2009.28095
10.1038/s41598-017-18259-0
10.1038/nature18309
10.1016/j.neuropharm.2013.10.031
10.1152/ajpregu.90825.2008
10.1152/ajpgi.00249.2006
10.1016/j.nut.2008.06.011
10.1111/cmi.12648
10.1212/WNL.0000000000000106
10.1016/j.peptides.2017.09.007
10.1016/S0006-8993(99)02477-4
10.1016/j.neurobiolaging.2019.01.002
10.1016/j.cub.2020.08.069
10.1016/B978-0-12-381272-8.00016-7
10.3389/fendo.2015.00044
10.1038/nn1656
10.1507/endocrj.EJ13-0008
10.3233/JAD-2010-100873
10.1016/j.arr.2019.100945
10.1055/s-2007-979879
10.1016/S0896-6273(01)80035-0
10.1111/j.1365-2362.2010.02278.x
10.1089/scd.2017.0035
10.1073/pnas.0808567105
10.1016/j.molmet.2014.06.003
10.1016/j.metabol.2014.07.004
10.1096/fj.04-2572com
10.1038/s41583-019-0151-3
10.1016/j.neuropharm.2016.07.002
10.1093/intimm/dxh242
10.1073/pnas.1107411108
10.1371/journal.pone.0087014
10.1016/j.psyneuen.2014.01.014
10.1038/s41586-021-03669-y
10.1016/j.bbi.2021.04.005
10.1016/j.neubiorev.2017.09.016
10.1016/j.jcmgh.2020.08.002
10.1016/j.jff.2019.05.043
10.1073/pnas.1607235113
10.1016/j.ncl.2006.03.006
10.1016/j.neubiorev.2010.10.013
10.5056/jnm16167
10.1016/j.conb.2019.12.003
10.1038/s41575-019-0157-3
10.1038/ncomms4611
10.1371/journal.pone.0103740
10.1016/j.neulet.2016.03.003
10.1007/s10151-013-1106-8
10.1016/j.neuroscience.2011.10.005
10.3389/fnins.2015.00413
10.1016/j.biopsych.2016.12.031
10.1084/jem.20200895
10.1186/s12974-020-01873-7
10.1084/jem.20182386
10.1001/jama.2019.9879
10.1016/j.phrs.2018.03.012
10.1016/j.bbr.2019.112419
10.1016/S1474-4422(19)30356-4
10.3390/nu3010118
10.1016/j.chom.2020.01.018
10.1038/s41591-018-0238-9
10.1038/s41398-019-0525-3
10.1007/s00281-018-0716-7
10.1016/j.jhin.2015.10.024
10.1016/j.cca.2019.12.010
10.1016/j.bbi.2021.09.002",<Element 'PubmedArticle' at 0x7f05dda31e00>
69,"36285248
30185958
31043575
19071157
17200939
28192062
24949965
17538612
20156206
24011076
23636330
32205429
25968226
27304509
27061590
30858345
25619689
28355573
28166221
27991900
33119507
30858605
32868762
32066983
30586455
32341560
32561888
26653891
33531494
11172053
8581497
9487391
10192391
33470505
31551601
29298427
30452418
29914932
32103204
12845521
28570864
20334662
24658644
29775591
28602351
33974008
21118898
25785854
29022598
31768052
34239132
23473313
28462073
15134868
35027729
10632593
26072239
11442356
3493444
16046283
33432193
15254318
29281814
30560587
31178118
26771021
30787437
27141961",Single-cell analysis of the aging female mouse hypothalamus.,"Alterations in metabolism, sleep patterns, body composition, and hormone status are all key features of aging. While the hypothalamus is a well-conserved brain region that controls these homeostatic and survival-related behaviors, little is known about the intrinsic features of hypothalamic aging. Here, we perform single nuclei RNA-sequencing of 40,064 hypothalamic nuclei from young and aged female mice. We identify cell type-specific signatures of aging in neuronal subtypes as well as astrocytes and microglia. We uncover changes in cell types critical for metabolic regulation and body composition, and in an area of the hypothalamus linked to cognition. Our analysis also reveals an unexpected female-specific feature of hypothalamic aging: the master regulator of X-inactivation, ","['Aging', 'Brain', 'Hypothalamus', 'Single cell RNA-seq']",Nature aging,2022-10-27,"[{'lastname': 'Hajdarovic', 'firstname': 'Kaitlyn H', 'initials': 'KH', 'affiliation': 'Neuroscience Graduate Program, Brown University, Providence, RI, 02912, USA.\nThese authors contributed equally: Kaitlyn H. Hajdarovic, Doudou Yu.'}, {'lastname': 'Yu', 'firstname': 'Doudou', 'initials': 'D', 'affiliation': 'Molecular Biology, Cell Biology, and Biochemistry Graduate Program, Brown University, Providence, RI 02912, USA.\nThese authors contributed equally: Kaitlyn H. Hajdarovic, Doudou Yu.'}, {'lastname': 'Hassell', 'firstname': 'Lexi-Amber', 'initials': 'LA', 'affiliation': 'Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, RI 02912, USA.'}, {'lastname': 'Evans', 'firstname': 'Shane', 'initials': 'S', 'affiliation': 'Graduate program in Computational Biology, Brown University, Providence, RI, 02912, USA.'}, {'lastname': 'Packer', 'firstname': 'Sarah', 'initials': 'S', 'affiliation': 'Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, RI 02912, USA.'}, {'lastname': 'Neretti', 'firstname': 'Nicola', 'initials': 'N', 'affiliation': 'Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, RI 02912, USA.\nCenter on the Biology of Aging, Brown University, Providence, RI 02912, USA.'}, {'lastname': 'Webb', 'firstname': 'Ashley E', 'initials': 'AE', 'affiliation': 'Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, RI 02912, USA.\nCenter on the Biology of Aging, Brown University, Providence, RI 02912, USA.\nCarney Institute for Brain Science, Brown University, Providence, RI 02912, USA.\nCenter for Translational Neuroscience, Brown University, Providence, RI 02912, USA.'}]",,,,,"10.1038/s43587-022-00246-4
10.1101/060012
10.1038/s41587-021-01139-4",<Element 'PubmedArticle' at 0x7f05ddc29310>
70,"36233235
28390960
28093992
24744751
26089777
17016550
20719855
22945636
26770096
26747302
31372822
17315033
25122491
24216002
30505285
25643925
21745103
22870949
29436670
24205791
14519490
22070634
24978200
18680156
29796989
20970492
28790893
25948102
21921910
31873127
28318543
30073507
24783015
29267168
8344193
19359381
9013778
32284835
16926069
18585460
34030373
25555216
24910631
26260547
25673868
27241943
32800705
25527793
33096140
17303248
25595973
25726916
23386810
26847047
9630473
23313316
11803437
16902999
15058481
7781067
19428625
29669582
19419557
11487666
20665622
33106949
31150388
27501182
24386638
11844744
9927339
12184808
11846609
25820735",A Fine Regulation of the Hippocampal Thyroid Signalling Protects Hypothyroid Mice against Glial Cell Activation.,"Adult-onset hypothyroidism is associated with learning and cognitive dysfunctions, which may be related to alterations in synaptic plasticity. Local reduced levels of thyroid hormones (THs) may impair glia morphology and activity, and promote the increase of pro-inflammatory cytokine levels mainly in the hippocampus. Given that neuroinflammation induces memory impairments, hypothyroidism-related glia dysfunction may participate in brain disorders. Thus, we investigated the mechanisms linking hypothyroidism and neuroinflammation, from a protective perspective. We induced hypothyroidism in adult C57BL/6J and wild-derived WSB/EiJ male mice by a seven-week propylthiouracil (PTU) treatment. We previously showed that WSB/EiJ mice were resistant to high-fat diet (HFD)-induced obesity, showing no neuroinflammatory response through adaptive abilities, unlike C57BL/6J. As PTU and HFD treatments are known to induce comparable inflammatory responses, we hypothesized that WSB/EiJ mice might also be protected against hypothyroidism-induced neuroinflammation. We showed that hypothyroid WSB/EiJ mice depicted no hippocampal neuroinflammatory response and were able to maintain their hippocampal thyroid signalling despite low circulatisng TH levels. In contrast, C57BL/6J mice exhibited disturbed hippocampal TH signalling, accompanied by neuroinflammation and memory impairment. Our results reinforce the preponderance of the hippocampal TH regulatory system over TH circulating levels in the hippocampal glial reactivity.","['astrocytes', 'hippocampus', 'hypothyroidism', 'microglia']",International journal of molecular sciences,2022-10-15,"[{'lastname': 'Chamas', 'firstname': 'Lamis', 'initials': 'L', 'affiliation': 'CNRS/MNHN UMR 7221-Phyma ""Physiologie Moléculaire et Adaptation"" Department of ""Life Adaptations"" Muséum National d\'Histoire Naturelle 57, rue Cuvier CP 32, CEDEX 05, 75231 Paris, France.'}, {'lastname': 'Seugnet', 'firstname': 'Isabelle', 'initials': 'I', 'affiliation': 'CNRS/MNHN UMR 7221-Phyma ""Physiologie Moléculaire et Adaptation"" Department of ""Life Adaptations"" Muséum National d\'Histoire Naturelle 57, rue Cuvier CP 32, CEDEX 05, 75231 Paris, France.'}, {'lastname': 'Poirier', 'firstname': 'Roseline', 'initials': 'R', 'affiliation': 'Institut des Neurosciences Paris-Saclay, Université Paris-Saclay, CNRS, 91400 Saclay, France.'}, {'lastname': 'Clerget-Froidevaux', 'firstname': 'Marie-Stéphanie', 'initials': 'MS', 'affiliation': 'CNRS/MNHN UMR 7221-Phyma ""Physiologie Moléculaire et Adaptation"" Department of ""Life Adaptations"" Muséum National d\'Histoire Naturelle 57, rue Cuvier CP 32, CEDEX 05, 75231 Paris, France.'}, {'lastname': 'Enderlin', 'firstname': 'Valérie', 'initials': 'V', 'affiliation': 'Institut des Neurosciences Paris-Saclay, Université Paris-Saclay, CNRS, 91400 Saclay, France.'}]",,,,,"10.3390/ijms231911938
10.1016/j.ygcen.2017.04.001
10.2174/1389200218666170116112407
10.3389/fendo.2014.00040
10.3389/fncel.2015.00194
10.1172/JCI29812
10.1210/en.2010-0450
10.1172/JCI60047
10.7326/M15-1799
10.1007/s12020-019-02023-7
10.1038/ncpendmet0424
10.1097/MED.0000000000000089
10.1016/j.brainresbull.2013.10.011
10.3389/fpsyt.2018.00589
10.1002/glia.22792
10.1089/thy.2010.0429
10.1089/thy.2010.0400
10.3892/mmr.2018.8605
10.1089/thy.2013.0058
10.1016/S0165-3806(03)00191-3
10.1111/j.1365-2826.2011.02253.x
10.1002/hipo.22319
10.1002/hipo.20476
10.1007/s12035-018-1111-z
10.1016/j.bbi.2010.10.015
10.3389/fncel.2017.00216
10.1038/npp.2015.127
10.1038/nature10413
10.1038/s41598-019-56051-4
10.1016/j.tins.2017.02.005
10.1007/s12035-018-1270-y
10.1159/000342994
10.1515/jbcpp-2017-0116
10.1210/endo.133.2.8344193
10.1210/en.2009-0050
10.1016/S0169-328X(96)00126-X
10.32598/bcn.9.10.330
10.1016/j.burns.2006.01.002
10.1016/j.nbd.2008.05.015
10.1016/j.scitotenv.2021.145196
10.1172/JCI77588
10.3389/fendo.2014.00082
10.1016/j.neuint.2015.08.004
10.1523/JNEUROSCI.3516-14.2015
10.1016/j.neuroscience.2016.05.043
10.1016/j.it.2020.07.007
10.4049/jimmunol.1401867
10.1016/j.imlet.2020.10.004
10.1016/j.jneumeth.2007.01.001
10.1016/j.neuroscience.2015.01.007
10.1016/j.ceb.2015.02.004
10.3389/fncel.2013.00003
10.1007/s00213-016-4218-9
10.1016/S0169-328X(98)00040-0
10.1016/j.nbd.2012.12.016
10.1038/sj/mp/4000988
10.1002/jnr.21014
10.1002/hipo.10165
10.1016/0092-8674(95)90010-1
10.1016/j.bbr.2009.01.039
10.1186/s12974-018-1141-5
10.1186/1750-1326-4-20
10.1523/JNEUROSCI.21-16-06423.2001
10.1002/iub.357
10.1007/s12035-020-02178-9
10.1371/journal.pgen.1008155
10.1210/en.2016-1272
10.1155/2013/565218
10.1210/edrv.23.1.0455
10.1210/endo.140.2.6678
10.1186/gb-2002-3-7-research0034
10.1006/meth.2001.1262
10.1007/978-1-4939-2550-6_27",<Element 'PubmedArticle' at 0x7f05dddc1770>
71,"36147561
30109816
35314797
22981652
23182816
27934864
31249398
26859870
30247555
30335147
31620083
25901041
24423980
26603190
31915267
15450358
16099461
15726019
16139950
25146699
23581176
25277397
18925949
19131956
19033363
15972284
31249432
31701148
31649620
16265670
25018103
28741521
26491052
22304911
32111982
28678506
25158968
27828722
18669596
29769550
31444346
33908609
32684623
24328848
31825461
31882740
34061962
26674550
18081553
28181484
29373545
28855316
29717932
29978719
32047276
28885623
30734143
25137025
31444106
31432271
23990349
28572045
23529784
32730232
27595394
34128478
20709796
26968975
28611780
20309720
22355073",CRHR1 mediates the transcriptional expression of pituitary hormones and their receptors under hypoxia.,"Hypothalamus-pituitary-adrenal (HPA) axis plays critical roles in stress responses under challenging conditions such as hypoxia, ","['hypothalamus', 'hypoxia', 'pituitary', 'receptor', 'stress', 'transcription']",Frontiers in endocrinology,2022-09-24,"[{'lastname': 'Wang', 'firstname': 'Tong Ying', 'initials': 'TY', 'affiliation': 'Department of Neurobiology, Department of Neurology of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.\nNational Health Commission and Chinese Academy of Medical Sciences Key Laboratory of Medical Neurobiology, Ministry of Education Frontier Science Center for Brain Research and Brain Machine Integration, School of Brain Science and Brain Medicine, Zhejiang University, Hangzhou, China.\nDepartment of Research and Development, Jiuyuan Gene Engineering, Hangzhou, China.'}, {'lastname': 'Xia', 'firstname': 'Fang Yuan', 'initials': 'FY', 'affiliation': 'Department of Neurobiology, Department of Neurology of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.\nNational Health Commission and Chinese Academy of Medical Sciences Key Laboratory of Medical Neurobiology, Ministry of Education Frontier Science Center for Brain Research and Brain Machine Integration, School of Brain Science and Brain Medicine, Zhejiang University, Hangzhou, China.'}, {'lastname': 'Gong', 'firstname': 'Jing Wen', 'initials': 'JW', 'affiliation': 'Department of Pathology, and Department of Medical Oncology of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.'}, {'lastname': 'Xu', 'firstname': 'Xiao Kang', 'initials': 'XK', 'affiliation': 'Department of Neurobiology, Department of Neurology of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.\nNational Health Commission and Chinese Academy of Medical Sciences Key Laboratory of Medical Neurobiology, Ministry of Education Frontier Science Center for Brain Research and Brain Machine Integration, School of Brain Science and Brain Medicine, Zhejiang University, Hangzhou, China.'}, {'lastname': 'Lv', 'firstname': 'Min Chao', 'initials': 'MC', 'affiliation': ""Department of Orthopedics, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, China.""}, {'lastname': 'Chatoo', 'firstname': 'Mahanand', 'initials': 'M', 'affiliation': 'Department of Neurobiology, Department of Neurology of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.\nNational Health Commission and Chinese Academy of Medical Sciences Key Laboratory of Medical Neurobiology, Ministry of Education Frontier Science Center for Brain Research and Brain Machine Integration, School of Brain Science and Brain Medicine, Zhejiang University, Hangzhou, China.'}, {'lastname': 'Shamsi', 'firstname': 'Bilal Haider', 'initials': 'BH', 'affiliation': 'Department of Neurobiology, Department of Neurology of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.\nNational Health Commission and Chinese Academy of Medical Sciences Key Laboratory of Medical Neurobiology, Ministry of Education Frontier Science Center for Brain Research and Brain Machine Integration, School of Brain Science and Brain Medicine, Zhejiang University, Hangzhou, China.'}, {'lastname': 'Zhang', 'firstname': 'Meng Chen', 'initials': 'MC', 'affiliation': 'Department of Neurobiology, Department of Neurology of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.\nNational Health Commission and Chinese Academy of Medical Sciences Key Laboratory of Medical Neurobiology, Ministry of Education Frontier Science Center for Brain Research and Brain Machine Integration, School of Brain Science and Brain Medicine, Zhejiang University, Hangzhou, China.'}, {'lastname': 'Liu', 'firstname': 'Qian Ru', 'initials': 'QR', 'affiliation': 'Department of Neurobiology, Department of Neurology of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.\nNational Health Commission and Chinese Academy of Medical Sciences Key Laboratory of Medical Neurobiology, Ministry of Education Frontier Science Center for Brain Research and Brain Machine Integration, School of Brain Science and Brain Medicine, Zhejiang University, Hangzhou, China.'}, {'lastname': 'Liu', 'firstname': 'Tian Xing', 'initials': 'TX', 'affiliation': 'Department of Cell and System Biology, University of Toronto, St. George, NB, Canada.'}, {'lastname': 'Zhang', 'firstname': 'Dan Dan', 'initials': 'DD', 'affiliation': 'Department of Pathology, and Department of Medical Oncology of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.'}, {'lastname': 'Lu', 'firstname': 'Xin Jiang', 'initials': 'XJ', 'affiliation': 'Department of Physiology, Zhejiang University School of Medicine, Hangzhou, China.'}, {'lastname': 'Zhao', 'firstname': 'Yang', 'initials': 'Y', 'affiliation': 'Department of Physiology, Zhejiang University School of Medicine, Hangzhou, China.'}, {'lastname': 'Du', 'firstname': 'Ji Zeng', 'initials': 'JZ', 'affiliation': 'National Health Commission and Chinese Academy of Medical Sciences Key Laboratory of Medical Neurobiology, Ministry of Education Frontier Science Center for Brain Research and Brain Machine Integration, School of Brain Science and Brain Medicine, Zhejiang University, Hangzhou, China.'}, {'lastname': 'Chen', 'firstname': 'Xue Qun', 'initials': 'XQ', 'affiliation': 'Department of Neurobiology, Department of Neurology of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.\nNational Health Commission and Chinese Academy of Medical Sciences Key Laboratory of Medical Neurobiology, Ministry of Education Frontier Science Center for Brain Research and Brain Machine Integration, School of Brain Science and Brain Medicine, Zhejiang University, Hangzhou, China.'}]",,,,"Copyright © 2022 Wang, Xia, Gong, Xu, Lv, Chatoo, Shamsi, Zhang, Liu, Liu, Zhang, Lu, Zhao, Du and Chen.","10.3389/fendo.2022.893238
10.1152/physrev.00042.2017
10.1038/s41574-022-00663-w
10.1016/j.yfrne.2012.08.002
10.1159/000341733
10.1038/nrendo.2016.193
10.1038/s41574-019-0228-0
10.1371/journal.pone.0148465
10.1210/en.2018-00587
10.1210/en.2018-00750
10.3389/fendo.2019.00623
10.1530/JOE-15-0113
10.1210/er.2013-1087
10.1016/j.cmet.2015.09.026
10.1523/ENEURO.0345-19.2019
10.1016/j.neuroscience.2004.06.023
10.1016/j.yhbeh.2005.06.004
10.1016/j.mce.2005.07.005
10.1073/pnas.1404493111
10.2337/db14-0500
10.1186/1471-2164-9-488
10.1038/nprot.2008.211
10.1093/nar/gkn923
10.1093/bioinformatics/bti551
10.6026/97320630015307
10.1093/nar/gkz1001
10.3389/fendo.2019.00683
10.1002/glia.20282
10.1016/j.cell.2014.04.052
10.1016/j.trecan.2016.10.016
10.1152/ajpcell.00279.2015
10.1016/j.cell.2012.01.021
10.1038/s41388-020-1223-6
10.1021/acs.jproteome.6b00914
10.4155/bio.14.132
10.1210/er.2016-1101
10.1210/en.2008-0834
10.1038/s41598-018-25785-y
10.1038/s41467-019-11791-9
10.1093/neuonc/noab102
10.1038/s41417-020-0196-5
10.1111/bph.12551
10.1083/jcb.201904054
10.1038/s41598-019-56480-1
10.1210/clinem/dgab387
10.1152/physiol.00027.2015
10.1111/j.1365-2826.2007.01616.x
10.1038/srep42002
10.3390/ijms19020375
10.1530/JOE-17-0258
10.1152/physrev.00043.2017
10.1177/0963689718781330
10.1038/s41574-020-0324-1
10.1038/nrendo.2017.103
10.1007/s11102-019-00941-3
10.1210/en.2014-1034
10.1016/j.molcel.2019.07.025
10.1007/s00429-019-01942-5
10.1007/s11102-013-0512-2
10.1016/j.mce.2017.05.031
10.1007/s12035-013-8444-4
10.1172/JCI137560
10.1038/nature19796
10.1172/JCI139202
10.2353/ajpath.2010.100138
10.1186/s12974-016-0528-4
10.3389/fimmu.2017.00628
10.1007/s11060-010-0152-6
10.1210/en.2011-1937",<Element 'PubmedArticle' at 0x7f05de320040>
72,36137504,Extracellular Vesicles and the Stress System.,"Extracellular vesicles (EVs) are membrane-enclosed nanoparticles that contain various biomolecules, including nucleic acids, proteins and lipids, and are manufactured and released by virtually all cell types. There is evidence that EVs are involved in intercellular communication, acting in an autocrine, paracrine or/and endocrine manner. EVs are released by the cells of the central nervous system (CNS), including neurons, astrocytes, oligodendrocytes and microglia, and have the ability to cross the blood-brain barrier (BBB) and enter the systemic circulation. Neuroendocrine cells are specialized neurons that secrete hormones directly into blood vessels, such as the hypophyseal portal system or the systemic circulation, a process that allows neuroendocrine integration to take place. In mammals, neuroendocrine cells are widely distributed throughout various anatomic compartments, with the hypothalamus being a central neuroendocrine integrator. The hypothalamus is a key part of the stress system (SS), a highly conserved neuronal/neuroendocrine system aiming at maintaining systemic homeostasis when the latter is threatened by various stressors. The central parts of the SS are the interconnected hypothalamic corticotropin-releasing hormone (CRH) and the brainstem locus caeruleus-norepinephrine (LC-NE) systems, while their peripheral parts are, respectively, the pituitary-adrenal axis and the sympathetic nervous/sympatho-adrenomedullary systems (SNS-SAM) as well as components of the parasympathetic nervous system (PSNS). During stress, multiple CNS loci show plasticity and undergo remodeling, partly mediated by increased glutamatergic and noradrenergic activity, and the actions of cytokines and glucocorticoids, all regulated by the interaction of the hypothalamic-pituitary-adrenal (HPA) axis and the LC-NE/SNS-SAM systems. In addition, there are peripheral changes due to the increased secretion of stress hormones and pro-inflammatory cytokines in the context of stress-related systemic (para)inflammation. We speculate that during stress, central and peripheral, cellular and molecular alterations take place, with some of them generated, communicated, and spread via the release of stress-induced neural/neuroendocrine cell-derived EVs.","['Exosomes', 'Extracellular vesicles', 'Hypothalamus', 'Locus caeruleus', 'Neuroendocrine cells', 'Neuroglia', 'Neurons', 'Stress system']",Neuroendocrinology,2022-09-23,"[{'lastname': 'Makrygianni', 'firstname': 'Evanthia A', 'initials': 'EA', 'affiliation': 'University Research Institute of Maternal and Child Health and Precision Medicine, National and Kapodistrian University of Athens, Athens, Greece.'}, {'lastname': 'Chrousos', 'firstname': 'George P', 'initials': 'GP', 'affiliation': ""University Research Institute of Maternal and Child Health and Precision Medicine, National and Kapodistrian University of Athens, Athens, Greece.\nCenter for Adolescent Medicine and UNESCO Chair on Adolescent Health Care, First Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, Aghia Sophia Children's Hospital, Athens, Greece.""}]",,,,"© 2022 S. Karger AG, Basel.",10.1159/000527182,<Element 'PubmedArticle' at 0x7f05de526040>
73,"36078135
10766253
24506870
14679172
20148674
11574398
16531754
20846876
12531878
22961082
26740596
15897298
19254698
11479628
11533050
21459325
20357764
17268472
31159801
19906806
28635626
26993043
12351435
30897345
17618856
24564394
32739435
24592982
25550990
34192547
26192107
7592907
8631877
8619847
18971219
11522676
33584324
31128596",Evidence for the Neuronal Expression and Secretion of Adiponectin.,"Peripheral adiponectin acts on the hypothalamus to inhibit energy expenditure and increase food intake through its receptors AdipoR1 and adipoR2. The hypothalamic expression of adiponectin is poorly documented. We hypothesize that whether hypothalamic adiponectin is confirmed, its expression and secretion could be regulated as peripheral adiponectin. Thus, in the present work, we aim to determine whether adiponectin is expressed in the hypothalamus and in two neuronal cell lines and investigate the potential mechanisms regulating its neuronal expression. Using immunohistochemistry, we show that adiponectin is expressed in the mediobasal hypothalamic neurons of mice. Adiponectin expression is also evidenced in two neuronal cell lines mHypo POMC (an adult mouse hypothalamic cell line) and SH-SY5Y (human neuroblastoma). The neuronal expression of adiponectin is increased in response to rosiglitazone treatment (a PPARγ agonist) and FGF21 and is decreased in insulin-resistant neurons. Furthermore, we show that adiponectin expressed by mHypo POMC neurons is secreted in a culture medium. Adiponectin also diminished the resistin-induced IL6 expression in SIMA9 cells, a microglia cell line. In conclusion, we evidenced the hypothalamic expression of adiponectin and its regulation at the neuronal level.","['adiponectin', 'hypothalamus', 'neurons', 'signaling']",Cells,2022-09-10,"[{'lastname': 'Abgrall', 'firstname': 'Azénor', 'initials': 'A', 'affiliation': 'Paris-Saclay Institute of Neurosciences (NeuroPSI), University of Paris-Saclay, CNRS, F-91400 Saclay, France.'}, {'lastname': 'Poizat', 'firstname': 'Ghislaine', 'initials': 'G', 'affiliation': 'Paris-Saclay Institute of Neurosciences (NeuroPSI), University of Paris-Saclay, CNRS, F-91400 Saclay, France.'}, {'lastname': 'Prevost', 'firstname': 'Marianne', 'initials': 'M', 'affiliation': 'Paris-Saclay Institute of Neurosciences (NeuroPSI), University of Paris-Saclay, CNRS, F-91400 Saclay, France.'}, {'lastname': 'Riffault', 'firstname': 'Laure', 'initials': 'L', 'affiliation': 'Paris-Saclay Institute of Neurosciences (NeuroPSI), University of Paris-Saclay, CNRS, F-91400 Saclay, France.'}, {'lastname': 'De La Barrera', 'firstname': 'Laura', 'initials': 'L', 'affiliation': 'Paris-Saclay Institute of Neurosciences (NeuroPSI), University of Paris-Saclay, CNRS, F-91400 Saclay, France.'}, {'lastname': 'Hanine', 'firstname': 'Rita', 'initials': 'R', 'affiliation': 'Paris-Saclay Institute of Neurosciences (NeuroPSI), University of Paris-Saclay, CNRS, F-91400 Saclay, France.'}, {'lastname': 'Djordjevic', 'firstname': 'Katarina', 'initials': 'K', 'affiliation': 'Paris-Saclay Institute of Neurosciences (NeuroPSI), University of Paris-Saclay, CNRS, F-91400 Saclay, France.'}, {'lastname': 'Benomar', 'firstname': 'Yacir', 'initials': 'Y', 'affiliation': 'Paris-Saclay Institute of Neurosciences (NeuroPSI), University of Paris-Saclay, CNRS, F-91400 Saclay, France.'}, {'lastname': 'Taouis', 'firstname': 'Mohammed', 'initials': 'M', 'affiliation': 'Paris-Saclay Institute of Neurosciences (NeuroPSI), University of Paris-Saclay, CNRS, F-91400 Saclay, France.'}]",,,,,"10.3390/cells11172725
10.1038/35007534
10.1016/j.cmet.2013.12.015
10.1172/JCI20514
10.1146/annurev-physiol-021909-135846
10.2337/diabetes.50.10.2199
10.1097/01.mol.0000217899.59820.9a
10.1016/j.tem.2010.08.002
10.1172/JCI16521
10.2337/db12-0237
10.2337/db15-1029
10.1210/er.2005-0005
10.1016/j.bbrc.2009.02.131
10.1038/90992
10.1074/jbc.M103241200
10.1016/j.cmet.2011.02.010
10.1038/nature08991
10.1038/nm1557
10.1186/s12902-019-0386-z
10.3945/ajcn.2009.28449C
10.3390/ijms18061321
10.1093/jmcb/mjw013
10.2337/diabetes.51.10.2968
10.1096/fj.201802643R
10.1016/j.cmet.2007.06.003
10.1210/en.2013-1734
10.1016/j.ygcen.2020.113575
10.1111/rda.12282
10.1016/j.celrep.2021.109331
10.1210/me.2015-1084
10.1074/jbc.270.45.26746
10.1074/jbc.271.18.10697
10.1006/bbrc.1996.0587
10.1677/JOE-08-0348
10.2337/diabetes.50.9.2094
10.3389/fphys.2020.567678
10.1186/s12974-019-1492-6",<Element 'PubmedArticle' at 0x7f05de5044a0>
74,"36078099
30479916
27147970
28979667
29998371
18980476
27957787
18790013
25278785
31997824
23477737
34948371
18059979
17662717
17071951
8989657
29311826
25266700
15115592
15037862
28672950
29130941
25939377
31843491
34685763
12794745
22824323
30705270
27220367
20085927
16374800
33578421
33745920
11406187
30206190
30471926
33085226
34132743
35149686
35232960
29196042
26582736
21674586
24722853
19158301
9219976
15763246
15992367
10931531
4378090
26377802
25902336
15684769
24583148
27153777
25972240
26796989
17912625
21806470
26122134
17111361
22154967
24972324
19878566
16038625
23317037
24975034
18572364
21559863
22968128
19036970
16129904
25473931
29051850
22842524
18029549
16918386
12675973
18971481
20849956
14753477
27764754
25243650
15217394
20457564
24166720
19441883
26790672
18438913
27736748
29957379
19444307
32710081
11923434
25017893
15084655
17439492
11378514
12429857
27309476
27306339
27965141
25309797
18634597
19620309
25788907
28041951
22745823
25190142
18191837
22902590
18408713
24561219
23403365
19670441
8534265
21138398
32164967
32676138
20440299
26722386
18974065
29055745
26791582
21151161
27573340
1731369
19831872
15009633
20817464
23236036
27847197
28482882
20400636
29159201
27509306
21251802
17703359
19469692
27563878
28085005
24220051
12600901
24344836
24866054
16633368
20954833
27909916
24685114
20382225
33358981
29860396
22920456
28330471",Inflammation: A Target for Treatment in Spinal Cord Injury.,"Spinal cord injury (SCI) is a significant cause of disability, and treatment alternatives that generate beneficial outcomes and have no side effects are urgently needed. SCI may be treatable if intervention is initiated promptly. Therefore, several treatment proposals are currently being evaluated. Inflammation is part of a complex physiological response to injury or harmful stimuli induced by mechanical, chemical, or immunological agents. Neuroinflammation is one of the principal secondary changes following SCI and plays a crucial role in modulating the pathological progression of acute and chronic SCI. This review describes the main inflammatory events occurring after SCI and discusses recently proposed potential treatments and therapeutic agents that regulate inflammation after insult in animal models.","['cytokines', 'hormonal therapy', 'macrophages', 'microglia', 'natural compounds', 'neutrophils', 'pharmaceuticals', 'spinal cord']",Cells,2022-09-10,"[{'lastname': 'Freyermuth-Trujillo', 'firstname': 'Ximena', 'initials': 'X', 'affiliation': 'Unidad de Investigación Médica en Enfermedades Neurológicas, Hospital de Especialidades Dr. Bernardo Sepúlveda, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City CP 06720, Mexico.\nPosgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México, Mexico City CP 04510, Mexico.'}, {'lastname': 'Segura-Uribe', 'firstname': 'Julia J', 'initials': 'JJ', 'affiliation': 'Subdirección de Gestión de la Investigación, Hospital Infantil de México Federico Gómez, Secretaría de Salud, Mexico City CP 06720, Mexico.'}, {'lastname': 'Salgado-Ceballos', 'firstname': 'Hermelinda', 'initials': 'H', 'affiliation': 'Unidad de Investigación Médica en Enfermedades Neurológicas, Hospital de Especialidades Dr. Bernardo Sepúlveda, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City CP 06720, Mexico.'}, {'lastname': 'Orozco-Barrios', 'firstname': 'Carlos E', 'initials': 'CE', 'affiliation': 'CONACyT-Unidad de Investigación Médica en Enfermedades Neurológicas, Hospital de Especialidades Dr. Bernardo Sepúlveda, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City CP 06720, Mexico.'}, {'lastname': 'Coyoy-Salgado', 'firstname': 'Angélica', 'initials': 'A', 'affiliation': 'CONACyT-Unidad de Investigación Médica en Enfermedades Neurológicas, Hospital de Especialidades Dr. Bernardo Sepúlveda, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City CP 06720, Mexico.'}]",,,,,"10.3390/cells11172692
10.1002/advs.201800529
10.3389/fncel.2016.00098
10.1007/s10143-018-1008-3
10.3171/FOC.2008.25.11.E2
10.1111/jcmm.13034
10.1016/j.neuroscience.2008.08.021
10.2147/CLEP.S68889
10.4103/1673-5374.274348
10.1016/j.immuni.2013.02.012
10.3390/ijms222413577
10.1016/j.cnr.2006.09.007
10.1016/j.expneurol.2007.06.009
10.1093/brain/awl296
10.1002/(sici)1096-9861(19970120)377:33.0.co;2-s
10.3389/fncel.2017.00391
10.1038/sc.2014.158
10.1089/089771504323004575
10.1038/sj.sc.3101603
10.3892/etm.2017.4505
10.1159/000484460
10.1111/bph.13179
10.1016/B978-0-12-804214-4.00008-7
10.1016/j.expneurol.2019.113143
10.3390/cells10102783
10.1002/cne.10736
10.1186/1742-2094-9-178
10.1038/s41467-019-08446-0
10.1186/s12974-016-0581-z
10.1093/brain/awp322
10.1002/cne.20827
10.1093/brain/awaa360
10.1016/j.expneurol.2021.113704
10.1016/s0028-3908(01)00019-3
10.15252/embr.201846171
10.1016/j.immuni.2018.11.004
10.1002/iid3.362
10.1084/jem.20210040
10.1038/s41467-022-28473-8
10.1038/s41392-022-00885-4
10.1016/j.jconrel.2017.11.044
10.1016/j.nano.2015.10.011
10.1002/ana.22421
10.1007/s10875-014-0021-8
10.1523/JNEUROSCI.4918-08.2009
10.1016/s0306-4522(97)00011-0
10.1016/j.ejphar.2005.01.033
10.1111/j.1471-4159.2005.03280.x
10.1002/1097-4547(20000815)61:43.0.CO;2-W
10.1016/0005-2744(71)90281-6
10.1186/s12974-015-0391-8
10.1016/j.taap.2015.04.004
10.1089/neu.2004.21.1778
10.1016/j.intimp.2014.02.017
10.1016/j.lfs.2016.05.004
10.1007/s12035-015-9203-5
10.1080/1028415X.2015.1103460
10.1007/s10571-007-9219-0
10.1089/neu.2011.1922
10.1016/j.intimp.2015.06.015
10.1002/cne.21149
10.1016/j.jep.2011.11.040
10.1016/j.molimm.2014.05.019
10.1186/1477-3155-7-8
10.1111/j.1745-7254.2005.00152.x
10.1186/1742-2094-10-6
10.1002/jnr.23429
10.1016/j.jvs.2008.04.011
10.1007/s10753-011-9341-5
10.1016/j.jpain.2012.06.007
10.1523/JNEUROSCI.3512-08.2008
10.1385/CRIAI:28:3:197
10.1039/C4FO00761A
10.1002/advs.201700034
10.1016/j.brainres.2012.07.037
10.1124/jpet.107.127746
10.2174/156720206778018776
10.1089/08977150360547116
10.1523/JNEUROSCI.3708-08.2008
10.1016/j.mcn.2010.09.001
10.1007/978-3-7091-0651-8_85
10.1016/j.biopha.2016.10.007
10.1055/s-0034-1389950
10.1111/j.0953-816X.2004.03441.x
10.1101/cshperspect.a001651
10.1007/s10072-013-1566-7
10.1089/jir.2008.0027
10.1007/s12035-016-9709-5
10.1002/jnr.21658
10.1242/dmm.025833
10.1016/j.jneuroim.2018.05.007
10.1038/nri2550
10.1038/s41467-020-17564-z
10.1523/JNEUROSCI.22-07-02690.2002
10.1016/j.expneurol.2014.04.023
10.1523/JNEUROSCI.0406-04.2004
10.1111/j.1460-9568.2007.05458.x
10.1016/s1471-4914(01)01993-1
10.1073/pnas.232565399
10.1016/j.neuropharm.2016.12.007
10.3803/EnM.2014.29.3.371
10.1017/S1740925X05000037
10.4049/jimmunol.0803362
10.4103/1673-5374.150640
10.1016/j.steroids.2016.12.011
10.1371/journal.pone.0039751
10.1038/cdd.2014.134
10.1016/j.expneurol.2007.11.025
10.1016/j.jconrel.2012.07.044
10.1038/nchembio.83
10.1016/j.neuroscience.2014.02.007
10.1016/j.neures.2013.01.004
10.1002/ana.21673
10.1016/0006-2952(95)02110-8
10.3109/00207454.2010.537415
10.1016/bs.podrm.2019.10.006
10.1155/2019/3642491
10.1016/j.nutres.2004.07.005
10.1038/sc.2010.45
10.1093/carcin/bgn244
10.1016/j.phrs.2017.10.008
10.3109/10799893.2015.1049358
10.1038/aps.2010.181
10.3892/mmr.2016.5651
10.1152/physrev.1992.72.1.101
10.1089/neu.2009.1044
10.1046/j.1471-4159.2003.02240.x
10.1016/j.jocn.2010.04.027
10.1136/bmj.e8346
10.1016/j.brainres.2016.11.015
10.1186/s12951-017-0272-7
10.1242/jeb.035162
10.1016/j.omtm.2017.10.001
10.1590/1414-431x20165319
10.1016/j.colsurfb.2010.12.034
10.1007/s11064-007-9426-6
10.1089/neu.2008.0725
10.3390/ijms17091380
10.1088/1741-2552/aa596b
10.1097/MOT.0000000000000026
10.1161/01.CIR.0000057525.13182.24
10.1186/1742-2094-10-155
10.3109/10715762.2014.927578
10.1097/01.fjc.0000167010.98177.78
10.3109/10715762.2010.526604
10.1007/s10103-016-2120-7
10.1111/cns.12258
10.1016/j.nbd.2010.04.003
10.1016/j.bbi.2020.12.013
10.1093/brain/awy128
10.1016/j.apmr.2012.04.032
10.1186/s12984-017-0232-3",<Element 'PubmedArticle' at 0x7f05de4f5e00>
75,"36070120
18607383
28415916
31865786
21263005
27502908
28097354
27052349
29361405
30026701
25767283
14597461
31421410
28835252
30742657
31924219
32242284
32663572
21949114
23929945
24766893
32424334
27648547
27696330
24077100
29446653
24528868
26048136
30842662
34090935
32820126
20144757
35083148
33628380
33300167
31493481
34601668
23311642
31100304
15169837
26432171
6166045
30978539
28217927
29543776
30354851
10615411
34610452
28515690
31142798
30306667
25654547
22343943
30617086
30515090
22124756
29446712
23445494",Inhibition of cGAS in Paraventricular Nucleus Attenuates Hypertensive Heart Injury Via Regulating Microglial Autophagy.,"Neuroinflammation in the cardiovascular center plays a critical role in the progression of hypertensive heart disease. And microglial autophagy is involved in the regulation of neuroinflammation. Cyclic GMP-AMP synthase (cGAS), a cytosolic DNA sensor, senses mitochondrial DNA (mtDNA) and regulates autophagy. The detailed mechanisms of central cGAS affects neuroinflammatory response in hypertensive heart disease via regulating autophagy remain unknown. Angiotensin II (Ang II, 1.5 mg·kg","['Autophagy', 'Hypertension', 'Microglia', 'Neuroinflammation', 'cGAS-STING']",Molecular neurobiology,2022-09-08,"[{'lastname': 'Han', 'firstname': 'Chengzhi', 'initials': 'C', 'affiliation': ""Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, No. 130, Dongan Road, Shanghai, 200032, People's Republic of China.\nDepartment of Clinical Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, People's Republic of China.""}, {'lastname': 'Qian', 'firstname': 'Xinyi', 'initials': 'X', 'affiliation': ""Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, No. 130, Dongan Road, Shanghai, 200032, People's Republic of China.\nDepartment of Clinical Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, People's Republic of China.""}, {'lastname': 'Ren', 'firstname': 'Xiaorong', 'initials': 'X', 'affiliation': ""Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, No. 130, Dongan Road, Shanghai, 200032, People's Republic of China.\nDepartment of Clinical Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, People's Republic of China.""}, {'lastname': 'Zhang', 'firstname': 'Shutian', 'initials': 'S', 'affiliation': ""Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, No. 130, Dongan Road, Shanghai, 200032, People's Republic of China.\nDepartment of Clinical Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, People's Republic of China.""}, {'lastname': 'Hu', 'firstname': 'Li', 'initials': 'L', 'affiliation': ""Department of Cardiovascular Diseases, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.""}, {'lastname': 'Li', 'firstname': 'Jingyao', 'initials': 'J', 'affiliation': ""Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, No. 130, Dongan Road, Shanghai, 200032, People's Republic of China.""}, {'lastname': 'Huang', 'firstname': 'Yijun', 'initials': 'Y', 'affiliation': ""Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, No. 130, Dongan Road, Shanghai, 200032, People's Republic of China.\nDepartment of Clinical Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, People's Republic of China.""}, {'lastname': 'Huang', 'firstname': 'Renhui', 'initials': 'R', 'affiliation': ""Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, No. 130, Dongan Road, Shanghai, 200032, People's Republic of China.\nDepartment of Clinical Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, People's Republic of China.""}, {'lastname': 'Ooi', 'firstname': 'Kokwin', 'initials': 'K', 'affiliation': ""Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, No. 130, Dongan Road, Shanghai, 200032, People's Republic of China.""}, {'lastname': 'Lin', 'firstname': 'Hong', 'initials': 'H', 'affiliation': ""Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, No. 130, Dongan Road, Shanghai, 200032, People's Republic of China.\nDepartment of Clinical Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, People's Republic of China.""}, {'lastname': 'Xia', 'firstname': 'Chunmei', 'initials': 'C', 'affiliation': ""Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, No. 130, Dongan Road, Shanghai, 200032, People's Republic of China. cmxia@fudan.edu.cn.""}]",,,,"© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.","10.1007/s12035-022-02994-1
10.1038/ijo.2008.102
10.1080/01616412.2017.1317904
10.1161/hypertensionaha.119.14240
10.1161/CIRCULATIONAHA.108.845792
10.1161/CIRCULATIONAHA.115.018912
10.1001/jama.2016.19043
10.1016/j.jash.2016.02.015
10.1016/j.autneu.2018.01.002
10.3389/fphys.2018.00840
10.1161/CIRCRESAHA.116.303587
10.7326/0003-4819-139-9-200311040-00011
10.1016/j.redox.2019.101295
10.1371/journal.pone.0212138
10.1007/s12264-020-00484-9
10.1016/j.lfs.2020.118084
10.1152/ajpheart.00554.2011
10.1126/science.1240933
10.1016/j.molcel.2014.03.040
10.1038/s41580-020-0244-x
10.1038/ni.3558
10.1007/s13238-016-0320-3
10.1038/nature12640
10.1152/ajpgi.00326.2017
10.1016/j.chom.2014.01.009
10.1016/j.chom.2015.05.004
10.1038/s41586-019-1006-9
10.1016/j.brainresbull.2021.06.002
10.1126/science.abb4255
10.1016/j.cell.2010.01.028
10.3389/fonc.2021.790821
10.1155/2021/6679100
10.1111/bph.15340
10.1016/j.lfs.2019.116837
10.1007/s12035-021-02488-6
10.1186/1742-2094-10-4
10.1016/j.neuint.2019.104469
10.1242/jcs.01131
10.1111/febs.13540
10.1126/science.6166045
10.1016/j.redox.2019.101186
10.1113/JP273043
10.3390/ijms19030876
10.1080/14779072.2018.1540301
10.1016/s0008-6363(99)00145-5
10.1016/j.phrs.2021.105877
10.3389/fnagi.2017.00129
10.1038/s41423-019-0240-2
10.1111/tra.12617
10.1172/jci73939
10.1038/emboj.2012.32
10.3389/fnagi.2018.00378
10.1007/s00395-011-0231-7
10.1152/japplphysiol.00842.2017
10.1111/psyp.12027",<Element 'PubmedArticle' at 0x7f05de287d10>
76,36049163,Glucose and fructose directly stimulate brain-derived neurotrophic factor gene expression in microglia.,"Brain-derived neurotrophic factor (BDNF) is expressed in both hypothalamic neurons and microglia, and plays a critical role in the regulation of metabolism. Although hypothalamic expression of BDNF is regulated by metabolic signals such as nutrients and hormones, it remains unknown whether these signals differentially regulate BDNF expression in different cell types. The present study aimed to determine whether glucose and fructose regulate BDNF expression in microglia via the specific glucose transporter. To determine the effect of glucose and fructose on Bdnf mRNA and protein expression, murine microglial cell line SIM-A9 cells were exposed to the maintenance concentration of glucose (17.5 mmol/l), high glucose (25 mmol/l), or fructose (7.5 mmol/l) for 40 min to 24 h. To determine whether the blockade of glucose transporter 5 (GLUT5) negates the effect of glucose on Bdnf mRNA expression, cells were exposed to 25 mmol/l glucose in the presence or absence of the GLUT5 inhibitor for 4 h. Levels of Bdnf mRNA and protein were measured by real-time PCR and ELISA, respectively. High glucose caused a significant increase in both pan-Bdnf and long-form Bdnf (L-Bdnf) mRNA as well as protein levels when compared with the maintenance of concentration of glucose in a time-dependent manner. Fructose treatment also increased L-Bdnf mRNA expression. Pharmacological blockade of GLUT5 did not affect glucose-induced Bdnf mRNA expression. These findings suggest that glucose and fructose directly stimulate Bdnf mRNA expression in microglia and these responses may mediate the metabolic actions of glucose and fructose.",[],Neuroreport,2022-09-02,"[{'lastname': 'Aldhshan', 'firstname': 'Muhammad S', 'initials': 'MS', 'affiliation': 'Division of Endocrinology and Metabolic Diseases, Department of Physiology and Pathophysiology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.'}, {'lastname': 'Jhanji', 'firstname': 'Gursagar', 'initials': 'G', 'affiliation': None}, {'lastname': 'Mizuno', 'firstname': 'Tooru M', 'initials': 'TM', 'affiliation': None}]",,,,"Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.",10.1097/WNR.0000000000001820,<Element 'PubmedArticle' at 0x7f05dd2596d0>
77,36041608,Exposure to dibutyl phthalate adsorbed to multi-walled carbon nanotubes causes neurotoxicity in mice by inducing the release of BDNF.,"Multi-walled carbon nanotubes (MWCNTs) and dibutyl phthalate (DBP) exist extensively in the environment, and they are easy to form compound pollution through π-π interactions in the environment. We investigate whether DBP, an environmental hormone disruptor, mediated by CNTs can more easily cross the blood-brain barrier, and whether DBP entering the brain has neurotoxic effects on the cells in the brain. Experimental subjects were 40 male Kunming (KM) mice randomly divided into 4 groups: the control group; the MWCNTs group; the DBP group; and the MWCNTs+DBP group. The mice were exposed via tail intravenous injection once every 3 days for 21 days, following which toxicology studies were carried out. The results of behavioral experiments showed that the mice in the combined exposure group (MWCNTs+DBP) exhibited spatial learning and memory impairment, and anxiety-like behavior. Staining of hippocampal sections of mouse brain tissue showed that, in the CA1, CA2, and DG areas, the number of neurons decreased, the nucleus was pyknotic, the cell body was atrophied, and levels of the microglia marker Iba-1 increased. By proteomic KEGG analysis, we found that the DEPs were mainly those related to neurodegenerative diseases. Immunohistochemistry in the hippocampus indicated that the level of brain-derived neurotrophic factor (BDNF) in the DG region was significantly increased. RT-PCR results revealed that the expression levels of P53, caspase3, and Bax genes related to apoptosis were up-regulated. The experimental results demonstrated that the mechanism of the combined-exposure injury to neurons in the hippocampus of mice may be that MWCNTs with adsorbed DBP can induce the release of BDNF, accelerate the apoptosis of neurons, and reduce the number of nerve cells, which activates microglia, causing neuroinflammation and nervous system toxicity.","['Brain-derived neurotrophic factor', 'Dibutyl phthalate', 'Multi-walled carbon nanotubes', 'Neurotoxicity', 'The combined exposure']",The Science of the total environment,2022-08-31,"[{'lastname': 'Zhou', 'firstname': 'Tingting', 'initials': 'T', 'affiliation': 'Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Hubei, China. Electronic address: ztt89757@mails.ccnu.edu.cn.'}, {'lastname': 'He', 'firstname': 'Suli', 'initials': 'S', 'affiliation': 'Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Hubei, China.'}, {'lastname': 'Ye', 'firstname': 'Xin', 'initials': 'X', 'affiliation': 'Liquor Marking Biological Technology and Application of Key Laboratory of Sichuan Province, College of Bioengineering, Sichuan University of Science & Engineering, Yibin, China. Electronic address: yexinxy@suse.edu.cn.'}, {'lastname': 'Wei', 'firstname': 'Zhaolan', 'initials': 'Z', 'affiliation': 'Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Hubei, China.'}, {'lastname': 'Wan', 'firstname': 'Jian', 'initials': 'J', 'affiliation': 'Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Hubei, China. Electronic address: Jianw@ccnu.edu.cn.'}, {'lastname': 'Zhang', 'firstname': 'Hongmao', 'initials': 'H', 'affiliation': 'Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Hubei, China. Electronic address: zhanghm@ccnu.edu.cn.'}, {'lastname': 'Ding', 'firstname': 'Shumao', 'initials': 'S', 'affiliation': 'Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Hubei, China. Electronic address: dingsm@ccnu.edu.cn.'}]",,,,Copyright © 2022 Elsevier B.V. All rights reserved.,10.1016/j.scitotenv.2022.158319,<Element 'PubmedArticle' at 0x7f05dd250d10>
78,"36012212
15850667
11351342
19450619
32632943
27196727
31544208
19250198
33435208
21320576
29931997
32898475
20045216
8476763
15582747
16426763
24718039
15364411
14694190
16843834
20842717
17643294
18601693
14611865
30084008
21622487
19282383
18258683
18948396
22978812
32634520
32592754
15101089
29305886
21564348
23206327
28902684
20012068
20404154
29771302
8476762
26633263
28528204
9688370
14512376
27250720
28856805
32192154
17078026
32696216",Immunofluorescent Evidence for Nuclear Localization of Aromatase in Astrocytes in the Rat Central Nervous System.,"Estrogens regulate a variety of neuroendocrine, reproductive and also non-reproductive brain functions. Estradiol biosynthesis in the central nervous system (CNS) is catalyzed by the enzyme aromatase, which is expressed in several brain regions by neurons, astrocytes and microglia. In this study, we performed a complex fluorescent immunocytochemical analysis which revealed that aromatase is colocalized with the nuclear stain in glial fibrillary acidic protein (GFAP) positive astrocytes in cell cultures. Confocal immunofluorescent Z-stack scanning analysis confirmed the colocalization of aromatase with the nuclear DAPI signal. Nuclear aromatase was also detectable in the S100β positive astrocyte subpopulation. When the nuclear aromatase signal was present, estrogen receptor alpha was also abundant in the nucleus. Immunostaining of frozen brain tissue sections showed that the nuclear colocalization of the enzyme in GFAP-positive astrocytes is also detectable in the adult rat brain. CD11b/c labelled microglial cells express aromatase, but the immunopositive signal was distributed only in the cytoplasm both in the ramified and amoeboid microglial forms. Immunostaining of rat ovarian tissue sections and human granulosa cells revealed that aromatase was present only in the cytoplasm. This novel observation suggests a new unique mechanism in astrocytes that may regulate certain CNS functions via estradiol production.","['aromatase', 'astrocyte', 'central nervous system', 'estrogen', 'estrogen receptor alpha', 'microglia']",International journal of molecular sciences,2022-08-27,"[{'lastname': 'Kata', 'firstname': 'Diána', 'initials': 'D', 'affiliation': 'Department of Laboratory Medicine, Albert Szent-Györgyi Medical School, University of Szeged, 6725 Szeged, Hungary.\nDepartment of Cell Biology and Molecular Medicine, Albert Szent-Györgyi Medical School, University of Szeged, 6720 Szeged, Hungary.'}, {'lastname': 'Gróf', 'firstname': 'Ilona', 'initials': 'I', 'affiliation': 'Institute of Biophysics, Biological Research Centre, 6726 Szeged, Hungary.'}, {'lastname': 'Hoyk', 'firstname': 'Zsófia', 'initials': 'Z', 'affiliation': 'Institute of Biophysics, Biological Research Centre, 6726 Szeged, Hungary.'}, {'lastname': 'Ducza', 'firstname': 'Eszter', 'initials': 'E', 'affiliation': 'Department of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, 6720 Szeged, Hungary.'}, {'lastname': 'Deli', 'firstname': 'Mária A', 'initials': 'MA', 'affiliation': 'Institute of Biophysics, Biological Research Centre, 6726 Szeged, Hungary.'}, {'lastname': 'Zupkó', 'firstname': 'István', 'initials': 'I', 'affiliation': 'Department of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, 6720 Szeged, Hungary.'}, {'lastname': 'Földesi', 'firstname': 'Imre', 'initials': 'I', 'affiliation': 'Department of Laboratory Medicine, Albert Szent-Györgyi Medical School, University of Szeged, 6725 Szeged, Hungary.'}]",,,,,"10.3390/ijms23168946
10.1016/j.brainresrev.2004.12.018
10.1002/neu.1038
10.1016/j.yfrne.2009.04.016
10.1002/cne.24978
10.1210/er.2016-1007
10.1210/endrev/bnz005
10.1111/j.1749-6632.2009.03703.x
10.3390/ijms22020631
10.1016/j.neuroscience.2011.02.012
10.1177/1073858418783959
10.1016/j.neuron.2020.08.012
10.1016/j.neurobiolaging.2009.12.014
10.1016/0960-0760(93)90253-S
10.1016/j.neurobiolaging.2004.03.010
10.1016/j.neuroscience.2005.11.054
10.1016/j.neulet.2004.07.010
10.1073/pnas.2630225100
10.1016/j.nucmedbio.2006.03.009
10.1002/syn.20791
10.1016/j.jsbmb.2007.05.014
10.1111/j.1365-2826.2008.01713.x
10.1016/j.pneurobio.2003.09.005
10.1007/s10571-018-0607-4
10.1210/er.2011-0004
10.1210/en.2008-1812
10.1210/me.2007-0484
10.1210/en.2008-1201
10.1111/jmp.12000
10.1016/j.taap.2020.115116
10.1016/j.reprotox.2020.06.011
10.1002/cne.20068
10.1016/j.yhbeh.2018.01.002
10.1111/j.1365-2826.2011.02156.x
10.1186/1742-2094-9-264
10.1097/j.pain.0000000000000991
10.1007/s00401-009-0619-8
10.1073/pnas.0910627107
10.1210/en.2018-00319
10.1016/0960-0760(93)90252-R
10.1016/j.neuroscience.2015.11.053
10.1016/j.brainresbull.2017.05.009
10.1093/humrep/13.6.1455
10.1165/rcmb.2003-0309OC
10.1016/j.mce.2016.05.024
10.1002/glia.23212
10.3390/cells9030739
10.1002/glia.20445
10.1007/s00441-020-03244-3",<Element 'PubmedArticle' at 0x7f05dd243e50>
79,35993820,"Soy isoflavones alleviate lipopolysaccharide-induced depressive-like behavior by suppressing neuroinflammation, mediating tryptophan metabolism and promoting synaptic plasticity.","Depression is highly prevalent in patients suffering from chronic inflammatory diseases. Dysregulated neuroinflammation and concomitant-activated microglia play a pivotal role in the pathogenesis of depression. As one of the biologically functional phytochemicals in soybeans, soy isoflavones (SI) have been reported to exhibit anti-inflammatory, antioxidant, estrogen-like and neuroprotective activities. However, there is no research on how SI administration affects the depressive-like behavior induced by neuroinflammation. Therefore, this study was conducted to evaluate the antidepressant-like action of SI in acute lipopolysaccharide (LPS)-treated mice and to explore its underlying mechanisms. An open field test, a sucrose preference experiment, a tail suspension test and a forced swimming task were conducted to assess the influence of SI on the depressive-like behavior induced by LPS injection. Then, the levels of the pro-inflammation cytokines, tryptophan (Trp) metabolism in the cortex and hippocampus, and the synaptic plasticity-related signal pathway in the hippocampus, which are involved in the pathophysiology of depression, were examined. The results showed that SI administration remarkably alleviated LPS-induced depressive-like behavior as indicated by the increased sucrose preference index and the decreased immobility time both in the tail suspension test and the forced swimming task. SI significantly suppressed neuroinflammation in the hippocampus of LPS mice, as indicated by a decrease in the levels of interleukin (IL)-1β, IL-10, tumor necrosis factor (TNF-α) and suppression of the signal pathway of TLR4/NF-κB. Additionally, SI administration regulated tryptophan (Trp) metabolism by increasing 5-hydroxytryptamine (5-HT) levels, inhibiting the release of kynurenine (KYN) in the cortex and hippocampus, and elevating the expressions of synaptic plasticity-related protein markers such as postsynaptic density-95 (PSD-95) and synaptophysin (SYN). The current study demonstrated that soy isoflavones could reverse LPS-induced depressive-like behavior by suppressing neuroinflammation, normalizing the Trp metabolism, up-regulating the expressions of synaptic plasticity-related proteins, and inhibiting the TLR4/NF-κB pathway activation in the hippocampus of mice, exerting their antidepressant-like action.",[],Food & function,2022-08-23,"[{'lastname': 'Lu', 'firstname': 'Cong', 'initials': 'C', 'affiliation': 'Institute of Food Science and Technology, Chinese Academy of Agricultural Sciences (CAAS), Beijing 100193, China. fanbei5172021@126.com.'}, {'lastname': 'Wei', 'firstname': 'Zhen', 'initials': 'Z', 'affiliation': 'Institute of Food Science and Technology, Chinese Academy of Agricultural Sciences (CAAS), Beijing 100193, China. fanbei5172021@126.com.\nCollege of Food Science, Fujian Agriculture and Forestry University, Fuzhou 350001, China.'}, {'lastname': 'Wang', 'firstname': 'Yongquan', 'initials': 'Y', 'affiliation': 'Institute of Food Science and Technology, Chinese Academy of Agricultural Sciences (CAAS), Beijing 100193, China. fanbei5172021@126.com.'}, {'lastname': 'Li', 'firstname': 'Shuying', 'initials': 'S', 'affiliation': 'Institute of Food Science and Technology, Chinese Academy of Agricultural Sciences (CAAS), Beijing 100193, China. fanbei5172021@126.com.'}, {'lastname': 'Tong', 'firstname': 'Litao', 'initials': 'L', 'affiliation': 'Institute of Food Science and Technology, Chinese Academy of Agricultural Sciences (CAAS), Beijing 100193, China. fanbei5172021@126.com.'}, {'lastname': 'Liu', 'firstname': 'Xinmin', 'initials': 'X', 'affiliation': 'Institute of Medicinal Plant Development (IMPLAD), Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing 100193, China.'}, {'lastname': 'Fan', 'firstname': 'Bei', 'initials': 'B', 'affiliation': 'Institute of Food Science and Technology, Chinese Academy of Agricultural Sciences (CAAS), Beijing 100193, China. fanbei5172021@126.com.'}, {'lastname': 'Wang', 'firstname': 'Fengzhong', 'initials': 'F', 'affiliation': 'Institute of Food Science and Technology, Chinese Academy of Agricultural Sciences (CAAS), Beijing 100193, China. fanbei5172021@126.com.'}]",,,,,10.1039/d2fo01437h,<Element 'PubmedArticle' at 0x7f05dd01b4a0>
80,"35977514
30792151
33583110
25425146
16964252
27620976
32661396
26232154
30679375
34233165
25264773
29752066
29301984
35263225
33069991
23616747
19726647
31209379
17627044
23100431
33000004
33184269
9276173
21951685
23757570
25474030
30308165
18234887
32452062
24278397
30359598
29915195
23289420
18272682
24695713
25337876
26844833
27338705
14603031
17209010
33318667
32685931
28408413
23720611
27558646
17634372
18644426
29069595
24695228
27516412
21778362
15170216
7414326
24157548
27098042
10195160
22072675
22492031
26187728
22632727
28951447
22930834
33097639
27621059
17329212
32551601
23041929
25159150
18083105
30476243
27899622
31365857
27477017
25085881
26844832
27497284
29040472
24487234
29318762",Microglia contribute to the postnatal development of cortical somatostatin-positive inhibitory cells and to whisker-evoked cortical activity.,"Microglia play a key role in shaping the formation and refinement of the excitatory network of the brain. However, less is known about whether and how they organize the development of distinct inhibitory networks. We find that microglia are essential for the proper development of somatostatin-positive (SST","['CP: Neuroscience', 'cerebral cortex', 'development', 'inhibitory synapses', 'interneurons', 'microglia', 'somatostatin']",Cell reports,2022-08-18,"[{'lastname': 'Gesuita', 'firstname': 'Lorenzo', 'initials': 'L', 'affiliation': 'Laboratory of Neural Circuit Assembly, Brain Research Institute, University of Zurich, Zurich 8057, Switzerland; Neuroscience Center Zurich (ZNZ), Zurich 8057, Switzerland.'}, {'lastname': 'Cavaccini', 'firstname': 'Anna', 'initials': 'A', 'affiliation': 'Laboratory of Neural Circuit Assembly, Brain Research Institute, University of Zurich, Zurich 8057, Switzerland; Neuroscience Center Zurich (ZNZ), Zurich 8057, Switzerland.'}, {'lastname': 'Argunsah', 'firstname': 'Ali Özgür', 'initials': 'AÖ', 'affiliation': 'Laboratory of Neural Circuit Assembly, Brain Research Institute, University of Zurich, Zurich 8057, Switzerland; Neuroscience Center Zurich (ZNZ), Zurich 8057, Switzerland.'}, {'lastname': 'Favuzzi', 'firstname': 'Emilia', 'initials': 'E', 'affiliation': 'Department of Neurobiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.'}, {'lastname': 'Ibrahim', 'firstname': 'Leena Ali', 'initials': 'LA', 'affiliation': 'Department of Neurobiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.'}, {'lastname': 'Stachniak', 'firstname': 'Tevye Jason', 'initials': 'TJ', 'affiliation': 'Laboratory of Neural Circuit Assembly, Brain Research Institute, University of Zurich, Zurich 8057, Switzerland; Neuroscience Center Zurich (ZNZ), Zurich 8057, Switzerland.'}, {'lastname': 'De Gennaro', 'firstname': 'Martina', 'initials': 'M', 'affiliation': 'Laboratory of Neural Circuit Assembly, Brain Research Institute, University of Zurich, Zurich 8057, Switzerland; Neuroscience Center Zurich (ZNZ), Zurich 8057, Switzerland.'}, {'lastname': 'Utz', 'firstname': 'Sebastian', 'initials': 'S', 'affiliation': 'Institute of Experimental Immunology, University of Zurich, Zurich 8057, Switzerland.'}, {'lastname': 'Greter', 'firstname': 'Melanie', 'initials': 'M', 'affiliation': 'Institute of Experimental Immunology, University of Zurich, Zurich 8057, Switzerland.'}, {'lastname': 'Karayannis', 'firstname': 'Theofanis', 'initials': 'T', 'affiliation': 'Laboratory of Neural Circuit Assembly, Brain Research Institute, University of Zurich, Zurich 8057, Switzerland; Neuroscience Center Zurich (ZNZ), Zurich 8057, Switzerland. Electronic address: karayannis@hifo.uzh.ch.'}]",,,,Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.,"10.1016/j.celrep.2022.111209
10.1016/j.neuron.2019.01.036
10.1002/dneu.22814
10.1038/ncomms6611
10.1038/nn1764
10.1093/cercor/bhw280
10.1038/s41593-020-0672-0
10.1186/s12974-015-0366-9
10.1126/science.aau8977
10.1016/j.cell.2021.06.018
10.1038/nmeth.3125
10.1016/j.immuni.2018.04.016
10.1042/BCJ20170867
10.1073/pnas.2114476119
10.1016/j.conb.2020.09.002
10.3389/fncel.2013.00045
10.1523/JNEUROSCI.2012-09.2009
10.1038/s41593-019-0419-y
10.2307/2346830
10.1109/TPAMI.2007.1154
10.1523/JNEUROSCI.1167-12.2012
10.1016/j.xpro.2020.100081
10.1117/12.2081147
10.1038/s41467-020-19427-z
10.1093/cercor/7.6.476
10.1182/blood-2011-04-348946
10.1109/TSMCB.2012.2228639
10.1038/nprot.2015.001
10.1016/j.neuron.2018.09.017
10.1523/JNEUROSCI.4602-07.2008
10.15252/embj.2019104136
10.1371/journal.pone.0081218
10.1016/j.neuron.2018.10.009
10.1038/s41593-018-0162-9
10.1111/nan.12015
10.1523/JNEUROSCI.4651-07.2008
10.1523/JNEUROSCI.4351-12.2014
10.1038/nature13902
10.1016/j.neuron.2016.01.015
10.1126/science.aad8670
10.1073/pnas.2235688100
10.1073/pnas.0610155104
10.1038/s41593-020-00756-7
10.1016/j.xpro.2020.100027
10.1523/JNEUROSCI.3325-16.2017
10.3389/fncel.2013.00070
10.1038/ncomms12540
10.1523/JNEUROSCI.1807-07.2007
10.1016/j.neuroscience.2008.06.046
10.1016/j.celrep.2017.10.012
10.1038/nature13186
10.1126/science.aaf5206
10.1109/TSMC.1979.4310076
10.1126/science.1202529
10.1038/nature02615
10.1126/science.7414326
10.1038/nprot.2013.143
10.1093/NAR/GKW199
10.1038/1092
10.1523/JNEUROSCI.3667-11.2011
10.1523/JNEUROSCI.6412-11.2012
10.1101/cshperspect.a020545
10.1016/j.neuron.2012.03.026
10.1523/JNEUROSCI.2679-16.2017
10.1038/nmeth.2089
10.1523/JNEUROSCI.0686-20.2020
10.1242/dev.137901
10.1016/j.neuron.2007.02.012
10.1021/acs.biomac.0c00401
10.1038/nature11523
10.1016/j.celrep.2014.07.042
10.1016/j.cell.2007.10.036
10.1093/nar/gky1131
10.1093/nar/gkw1099
10.1016/j.celrep.2019.06.086
10.1016/j.neuron.2016.06.033
10.1093/cercor/bhu164
10.1016/j.neuron.2015.11.020
10.1093/cercor/bhw230
10.1093/cercor/bhx261
10.1038/nn.3641
10.1002/dneu.22576",<Element 'PubmedArticle' at 0x7f05dcffe3b0>
81,"35966104
25465326
20127760
27166944
16344112
33863883
22446882
31129757
32173924
34341568
11999726
30941008
34260928
31050045
21486931
27903745
29796992
27530416
20093161
23554498
35429588
24982613
23562080
34360816
11169733
10836632
24506870
34324439
32388344
25721933
20492366
31077470
34970803
32143135
25942072
28883467
28766273
24023592
24260717
28956320
21266410
18045844
19096367
32814050
34496137
26606998
32848611
35413354
29706957
32694719
35090101
32375817
26960267
23874274
12485415
16893426
31585077
21072242
2636710
28683286
34063496
20012068
26912893
29021743
14515326
18803307
35233849
30531847
30167784
20546773
33848272
33994951
32407670
24618750
34154608
30355499
35681242
34129812",The Properties and Functions of Glial Cell Types of the Hypothalamic Median Eminence.,"The median eminence (ME) is part of the neuroendocrine system (NES) that functions as a crucial interface between the hypothalamus and pituitary gland. The ME contains many non-neuronal cell types, including oligodendrocytes, oligodendrocyte precursor cells (OPCs), tanycytes, astrocytes, pericytes, microglia and other immune cells, which may be involved in the regulation of NES function. For example, in mice, ablation of tanycytes (a special class of ependymal glia with stem cell-like functions) results in weight gain, feeding, insulin insensitivity and increased visceral adipose, consistent with the demonstrated ability of these cells to sense and transport both glucose and leptin, and to differentiate into neurons that control feeding and metabolism in the hypothalamus. To give a further example, OPCs in the ME of mice have been shown to rapidly respond to dietary signals, in turn controlling composition of the extracellular matrix in the ME, derived from oligodendrocyte-lineage cells, which may contribute to the previously described role of these cells in actively maintaining leptin-receptor-expressing dendrites in the ME. In this review, we explore and discuss recent advances such as these, that have developed our understanding of how the various cell types of the ME contribute to its function in the NES as the interface between the hypothalamus and pituitary gland. We also highlight avenues of future research which promise to uncover additional functions of the ME and the glia, stem and progenitor cells it contains.","['NG2 glia', 'astrocytes', 'hypothalamus', 'median eminence (ME)', 'microglia', 'oligodendrocyte precursor cells (OPCs)', 'pituitary gland', 'tanycytes']",Frontiers in endocrinology,2022-08-16,"[{'lastname': 'Clayton', 'firstname': 'Richard W', 'initials': 'RW', 'affiliation': 'Laboratory of Stem Cell Biology and Developmental Genetics, The Francis Crick Institute, London, United Kingdom.'}, {'lastname': 'Lovell-Badge', 'firstname': 'Robin', 'initials': 'R', 'affiliation': 'Laboratory of Stem Cell Biology and Developmental Genetics, The Francis Crick Institute, London, United Kingdom.'}, {'lastname': 'Galichet', 'firstname': 'Christophe', 'initials': 'C', 'affiliation': 'Laboratory of Stem Cell Biology and Developmental Genetics, The Francis Crick Institute, London, United Kingdom.'}]",,,,"Copyright © 2022 Clayton, Lovell-Badge and Galichet.","10.3389/fendo.2022.953995
10.1016/j.cub.2014.10.023
10.1002/cne.22273
10.1016/j.cmet.2016.04.013
10.1016/S0074-7696(05)47003-5
10.1038/s41467-021-22640-z
10.1038/nn.3079
10.1007/s00109-019-01799-5
10.1002/glia.23817
10.1038/s42255-021-00432-5
10.1046/j.0007-1331.2001.00772.x
10.3389/fnins.2019.00240
10.1016/j.celrep.2021.109362
10.1111/jne.12726
10.1210/en.2010-1434
10.2337/db16-0586
10.1007/s12035-018-1099-4
10.1016/j.mce.2016.08.020
10.1016/j.peptides.2010.01.003
10.1523/JNEUROSCI.2437-12.2013
10.1016/j.neulet.2022.136633
10.3389/fnins.2014.00157
10.1016/j.cmet.2013.03.004
10.3390/ijms22158049
10.1002/1097-4644(20010315)80:4<491::AID-JCB1003>3.0.CO;2-7
10.1007/s002219900289
10.1016/j.cmet.2013.12.015
10.1172/JCI140521
10.1016/j.domaniend.2020.106438
10.1038/ncomms7385
10.1111/j.1365-2826.2010.02033.x
10.1111/jne.12733
10.1111/jne.13079
10.1016/j.isci.2020.100921
10.1210/en.2014-1885
10.1038/s41467-017-00604-6
10.1007/s13311-017-0562-7
10.1155/2013/836486
10.1007/7854_2017_28
10.1242/dev.047951
10.1242/dev.004895
10.1038/nrn2495
10.1016/j.celrep.2020.108047
10.1111/febs.16190
10.1111/cen3.12358
10.1016/j.neuron.2015.10.046
10.3389/fncel.2020.00198
10.1016/j.imlet.2022.04.001
10.3389/fimmu.2018.00698
10.1038/s42255-019-0040-0
10.1002/npr2.12225
10.1186/s12974-020-01811-7
10.1038/srep22864
10.3389/fnint.2013.00053
10.1046/j.1471-4159.2003.01544.x
10.1111/j.1471-4159.2006.03933.x
10.1016/j.cell.2019.08.053
10.1371/journal.pbio.1000527
10.1016/0306-4522(89)90409-0
10.1016/j.cmet.2017.05.015
10.3390/ijms22105243
10.1007/s00401-009-0619-8
10.1126/science.aab3103
10.3389/fncel.2017.00300
10.1002/glia.10272
10.1002/glia.20762
10.1111/jne.13104
10.1038/s41593-018-0286-y
10.1007/s00540-018-2548-y
10.1016/j.yfrne.2010.05.003
10.1172/JCI144239
10.3389/fncel.2021.673132
10.1016/j.neuron.2020.04.020
10.1371/journal.pbio.1001808
10.1186/s12974-021-02183-2
10.1016/j.celrep.2018.09.070
10.1186/s12974-022-02519-6
10.1016/j.cmet.2021.05.017",<Element 'PubmedArticle' at 0x7f05dd1451d0>
82,35939944,Activin A is a novel chemoattractant for migration of microglial BV2 cells.,"Microglia are involved in many neurodegenerative diseases and repairment of traumatic injury to the CNS. Activin A is a neurotrophic and neuroprotective factor that can regulate the activities of macrophages/microglia. However, the effects of activin A on the migration of microglia are still unclear. In this study, the role of activin A in regulation of the microglia migration was investigated with the murine microglial BV2 cell.
The levels of cytokines were detected by enzyme-linked immunosorbent assay (ELISA). The protein expression was examined by Western blotting. The adhesion of BV2 cells was assayed by real-time cell analysis (RTCA). The migration of BV2 cells was determined by transwell chamber and microfluidics device. Smad3 was overexpressed or knocked down in BV2 cells by transfection of Smad3 or Smad3 shRNA-expressing plasmids.
Activin A inhibited the release of nitric oxide (NO) and inflammatory cytokines of TNF-α and IL-6 and the expression of TNF-α and IL-6 mRNA by BV2 cells. In contrast, activin A promoted the production of TGF-β1. Activin A inhibited adhesion, promoted wound healing and migration which is related to the expression of N-cadherin and E-cadherin expression. Additionally, Smad3 overexpression in BV2 cells decreased the levels of TNF-α and IL-6, and promoted the wound healing, whereas Smad3 knockdown showed the opposite effects.
These findings revealed that activin A regulated the biological behavior of BV2 cells via Smad3 signaling, suggesting that activin A may serve as a potential treatment target for neuroinflammation and glia scar formation in nervous system.","['Activin A', 'BV2 cells', 'Microglia', 'Migration', 'Smad3']",Journal of neuroimmunology,2022-08-09,"[{'lastname': 'Wang', 'firstname': 'Yunfeng', 'initials': 'Y', 'affiliation': 'Department of Immunology, College of Basic Medical Sciences, Jilin University, Changchun 130021, PR China.'}, {'lastname': 'Qi', 'firstname': 'Yan', 'initials': 'Y', 'affiliation': 'Department of Immunology, College of Basic Medical Sciences, Jilin University, Changchun 130021, PR China.'}, {'lastname': 'Qi', 'firstname': 'Jianfei', 'initials': 'J', 'affiliation': 'Department of Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, MD 21201, USA.'}, {'lastname': 'Wu', 'firstname': 'Jiandong', 'initials': 'J', 'affiliation': 'Department of Physics and Astronomy, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.'}, {'lastname': 'Lin', 'firstname': 'Francis', 'initials': 'F', 'affiliation': 'Institute of Biomedical and Health Engineering, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, PR China.'}, {'lastname': 'Cui', 'firstname': 'Xueling', 'initials': 'X', 'affiliation': 'Department of Genetics, College of Basic Medical Sciences, Jilin University, Changchun 130021, PR China.'}, {'lastname': 'Ge', 'firstname': 'Jingyan', 'initials': 'J', 'affiliation': 'Department of Physiology, College of Basic Medical Sciences, Jilin University, Changchun 130021, PR China. Electronic address: gejy@jlu.edu.cn.'}, {'lastname': 'Liu', 'firstname': 'Zhonghui', 'initials': 'Z', 'affiliation': 'Department of Immunology, College of Basic Medical Sciences, Jilin University, Changchun 130021, PR China. Electronic address: liuzh@jlu.edu.cn.'}]",,,"Activin A inhibited the release of nitric oxide (NO) and inflammatory cytokines of TNF-α and IL-6 and the expression of TNF-α and IL-6 mRNA by BV2 cells. In contrast, activin A promoted the production of TGF-β1. Activin A inhibited adhesion, promoted wound healing and migration which is related to the expression of N-cadherin and E-cadherin expression. Additionally, Smad3 overexpression in BV2 cells decreased the levels of TNF-α and IL-6, and promoted the wound healing, whereas Smad3 knockdown showed the opposite effects.",Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.,10.1016/j.jneuroim.2022.577929,<Element 'PubmedArticle' at 0x7f05dcfd6b30>
83,"35933009
9855500
20369906
16862116
16862115
16950801
19795409
22859297
28435163
22277331
29744576
27021778
22608501
21092856
26370502
28828399
28743268
28835281
34344440
28453791
30690031
29036611
28493053
31291241
31870439
31600775
34450028
34433069
35120524
27869795
11044971
28944282
28541286
28640985
18359860
8962141
9465098
21572087
20026663
15485583
21356739
34103390
23136129",Progranulin-derived granulin E and lysosome membrane protein CD68 interact to reciprocally regulate their protein homeostasis.,"Progranulin (PGRN) is a glycoprotein implicated in several neurodegenerative diseases. It is highly expressed in microglia and macrophages and can be secreted or delivered to the lysosome compartment. PGRN comprises 7.5 granulin repeats and is processed into individual granulin peptides within the lysosome, but the functions of these peptides are largely unknown. Here, we identify CD68, a lysosome membrane protein mainly expressed in hematopoietic cells, as a binding partner of PGRN and PGRN-derived granulin E. Deletion analysis of CD68 showed that this interaction is mediated by the mucin-proline-rich domain of CD68. While CD68 deficiency does not affect the lysosomal localization of PGRN, it results in a specific decrease in the levels of granulin E but no other granulin peptides. On the other hand, the deficiency of PGRN, and its derivative granulin peptides, leads to a significant shift in the molecular weight of CD68, without altering CD68 localization within the cell. Our results support that granulin E and CD68 reciprocally regulate each other's protein homeostasis.","['CD68', 'frontotemporal dementia', 'granulin', 'lysosome', 'microglia', 'progranulin']",The Journal of biological chemistry,2022-08-07,"[{'lastname': 'Santos', 'firstname': 'Mariela Nunez', 'initials': 'MN', 'affiliation': 'Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, USA.'}, {'lastname': 'Paushter', 'firstname': 'Daniel H', 'initials': 'DH', 'affiliation': 'Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, USA.'}, {'lastname': 'Zhang', 'firstname': 'Tingting', 'initials': 'T', 'affiliation': 'Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, USA.'}, {'lastname': 'Wu', 'firstname': 'Xiaochun', 'initials': 'X', 'affiliation': 'Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, USA.'}, {'lastname': 'Feng', 'firstname': 'Tuancheng', 'initials': 'T', 'affiliation': 'Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, USA.'}, {'lastname': 'Lou', 'firstname': 'Jiaoying', 'initials': 'J', 'affiliation': 'Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, USA; Department of Gynecology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, P. R. China.'}, {'lastname': 'Du', 'firstname': 'Huan', 'initials': 'H', 'affiliation': 'Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, USA.'}, {'lastname': 'Becker', 'firstname': 'Stephanie M', 'initials': 'SM', 'affiliation': 'Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, USA.'}, {'lastname': 'Fragoza', 'firstname': 'Robert', 'initials': 'R', 'affiliation': 'Department of Computational Biology, Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, USA.'}, {'lastname': 'Yu', 'firstname': 'Haiyuan', 'initials': 'H', 'affiliation': 'Department of Computational Biology, Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, USA.'}, {'lastname': 'Hu', 'firstname': 'Fenghua', 'initials': 'F', 'affiliation': 'Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, USA. Electronic address: fh87@cornell.edu.'}]",,,,Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.,"10.1016/j.jbc.2022.102348
10.1523/ENEURO.0100-17.2017
10.1101/pdb.prot5080",<Element 'PubmedArticle' at 0x7f05dcfc6c70>
84,35878808,Sleep deprivation leads to further impairment of hippocampal synaptic plasticity by suppressing melatonin secretion in the pineal gland of chronically unpredictable stress rats.,"There has been ample research showing that insomnia is a potential trigger of depression as well as a symptom of depression. These two factors contribute to behavioural problems and are closely related to the plasticity of hippocampal synapses. Although depression and insomnia impair hippocampal synaptic plasticity, the mechanism by which this happens remains a mystery. This study aimed to investigate the pathogenesis of insomnia comorbidity in depression and the regulatory effect of venlafaxine combined with melatonin on hippocampal synaptic plasticity in chronic unpredictable mild stress (CUMS) with sleep deprivation (SD) rats. Thus, rats were subjected to 14 days of chronic mild unpredictable stress, gradually acclimated to sleep deprivation on days 12-14. Followed by 21 consecutive days of sleep deprivation, 18 h per day, with daily gavage of venlafaxine (13.5 mg/kg) + melatonin (72 mg/kg) on days 15-36. Venlafaxine + melatonin treatment improves depression-like behaviour, pentobarbital sodium experimental sleep latency, and sleep duration in CUMS +SD rats. In addition to improving depressive-like behaviors, sleep deprivation also upregulates the expression of caspase-specific cysteine protein 3 (Caspase 3) in the pineal glial cells of chronic mild rats, as well as in hippocampal microglia. Expression of ionic calcium-binding adaptor 1 (iba-1), downregulates the secretion of several synaptic plasticity-related proteins, notably cAMP response element binding protein (CREB), glial cell line-derived neurotrophic factor (GDNF), and the synaptic scaffolding protein Spinophiline (Spinophiline). Hematoxylin-eosin staining showed that the structure of the pineal gland and hippocampus was damaged, and Golgi staining showed that the dendrites and spines in the DG area of the hippocampus were destroyed, vaguely aggregated or even disappeared, and the connection network could not be established. Western blot analysis further revealed a positive correlation between low melatonin levels and reduced Spinophiline protein. Interestingly, venlafaxine + melatonin reversed these events by promoting hippocampal synaptic plasticity by regulating melatonin secretion from the pineal gland. Therefore, it exerted an antidepressant effect in sleep deprivation combined with CUMS model rats. Overall, the results of this study suggest that the pathophysiology of depressive insomnia comorbidity is mediated by impaired pineal melatonin secretion and impaired hippocampal synaptic plasticity. In addition, these responses are associated with melatonin secretion from the pineal gland.","['Chronic mild unpredictable stress', 'Depressive insomnia comorbidity', 'Melatonin', 'Sleep deprivation', 'Synaptic plasticity']",European journal of pharmacology,2022-07-26,"[{'lastname': 'Li', 'firstname': 'Zi-Rong', 'initials': 'ZR', 'affiliation': 'Department of Neurology, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Guangxi, Nanning, 530022, China; State Key Laboratory of Chinese Medicine Powder and Medicine Innovation in Hunan (incubation), Hunan University of Chinese Medicine, Hunan, Changsha, 410208, China.'}, {'lastname': 'Liu', 'firstname': 'De-Guo', 'initials': 'DG', 'affiliation': 'Department of Breast Surgery, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Guangxi, Nanning, 530022, China.'}, {'lastname': 'Xie', 'firstname': 'Sheng', 'initials': 'S', 'affiliation': 'Prevention of Diseases with Traditional Chinese Medicine Center, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Guangxi, Nanning, 530022, China. Electronic address: xsh916566@126.com.'}, {'lastname': 'Wang', 'firstname': 'Yu-Hong', 'initials': 'YH', 'affiliation': 'State Key Laboratory of Chinese Medicine Powder and Medicine Innovation in Hunan (incubation), Hunan University of Chinese Medicine, Hunan, Changsha, 410208, China. Electronic address: wyhyjy620@126.com.'}, {'lastname': 'Han', 'firstname': 'Yuan-Shan', 'initials': 'YS', 'affiliation': 'Department of Experimental Center for Medical Innovation, The First Affiliated Hospital of Hunan University of Chinese Medicine, Hunan, Changsha, 410021, China.'}, {'lastname': 'Li', 'firstname': 'Chun-Yan', 'initials': 'CY', 'affiliation': 'State Key Laboratory of Chinese Medicine Powder and Medicine Innovation in Hunan (incubation), Hunan University of Chinese Medicine, Hunan, Changsha, 410208, China.'}, {'lastname': 'Zou', 'firstname': 'Man-Shu', 'initials': 'MS', 'affiliation': 'State Key Laboratory of Chinese Medicine Powder and Medicine Innovation in Hunan (incubation), Hunan University of Chinese Medicine, Hunan, Changsha, 410208, China.'}, {'lastname': 'Jiang', 'firstname': 'Hai-Xing', 'initials': 'HX', 'affiliation': 'Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Guangxi, Nanning, 530021, China.'}]",,,,Copyright © 2022 Elsevier B.V. All rights reserved.,10.1016/j.ejphar.2022.175149,<Element 'PubmedArticle' at 0x7f05dcfa55e0>
85,"35858111
19478287
30858963
31069792
22781489
28472621
30178724
18988842
33823654
24863032
33479477
31029798
33367612
31659946
31560883
32438751
30259418
29706926
28367116
28714861
23307732
18490917
20880500
27004698
26187728
28076784
28414331
1603325
24713688
21952260
28099414
31256193
31373067
27459405
25800044
21745188
19844812
12379907
27459063
29151590
27049947
15831717
21072242
19339593
23312512
22072675
18538419
16547515
18549780
20646045
15788779
23201120
21527731
20234358
12379901
19302036
22387107
20966214
23467340
23525041
18685038
14980203
9459440
22632727
18083105
21778362
25159150
23100431
24607651
24593277
20404134
9760700
7814688
8742054
23836548
2050568
3434186
8986873
9728764
23334579
22492350
9414002
9436786
21305616
10402264
10366704
24316888
26884166
22895712
25468773
2089275
17920538
21143141
11880486
19780198
10716891
19696964
22715882
33353966
20375278
34417332
24487234
16261181
26948129
34764226
29087650
20176265
16497588
30629914
9692887
34000374
8384717
20457564
30242265
27016501
15546155
16401547
31207234
28864976
27603327
2636710
11755899
1720582
19759333
8374734
9500146
33415683
7895660
27273834
7798245
11250916
16569740
15494465
11027214
28100270
29158945
28049625
2108152
9325313
21204712
8589505
7588251
9032770
7588281
9579693
23401502
21565615
32819381
33434610
30245334
12270111
31519790
18940936
26520666
18752652
17076768
28618077
21960564
27075756
28521131
9851930
31159306
27939247
18239171
26851161
30506969
26926566
33167418
34040156
21872599
33628199
28710956
17252002
32683141
11264328
28812274
17383819
19845972
19335381
33748121
30827729
30254300
27613230
34252501
32860938
33611133
34589789
20650569
28625767
15044702
12904319
12432938
30926983
30123107
25190079
31319868
10640779
14654230
15064226
21981277
27326668
16697939
23877071
30840048
33120051
34390899
23880236
27687291
33887203
32900927
23613074
30098544
26152864
24503856
33127853
12405473
30521240
2852460
20016090
17675020
20096699
21993208
27184741
20096332
35111003
34088332
27315483
30522820
34879222
34644471",Oxytocin and microglia in the development of social behaviour.,"Oxytocin is a well-established regulator of social behaviour. Microglia, the resident immune cells of the central nervous system, regulate brain development and maintenance in health and disease. Oxytocin and microglia interact: microglia appear to regulate the oxytocin system and are, in turn, regulated by oxytocin, which appears to have anti-inflammatory effects. Both microglia and oxytocin are regulated in sex-specific ways. Oxytocin and microglia may work together to promote experience-dependent circuit refinement through multiple developmental-sensitive periods contributing to individual differences in social behaviour. This article is part of the theme issue 'Interplays between oxytocin and other neuromodulators in shaping complex social behaviours'.","['development', 'microglia', 'oxytocin', 'sex differences', 'social behaviour']","Philosophical transactions of the Royal Society of London. Series B, Biological sciences",2022-07-21,"[{'lastname': 'Gonzalez', 'firstname': 'Alicia', 'initials': 'A', 'affiliation': 'Department of Psychology and Program in Neuroscience, Florida State University, 1107 West Call Street, Tallahassee, FL 32306, USA.'}, {'lastname': 'Hammock', 'firstname': 'Elizabeth A D', 'initials': 'EAD', 'affiliation': 'Department of Psychology and Program in Neuroscience, Florida State University, 1107 West Call Street, Tallahassee, FL 32306, USA.'}]",,,,,"10.1098/rstb.2021.0059
10.1192/bjp.bp.108.059345
10.1186/s13229-018-0246-0
10.1111/jcpp.13066
10.1017/S003329171200147X
10.1016/j.expneurol.2017.04.017
10.1017/S0033291718002283
10.1126/science.1158668
10.1146/annurev-neuro-102320-102847
10.1038/npp.2014.120
10.1038/s41577-020-00487-7
10.1016/j.bbi.2019.04.037
10.1210/endocr/bqaa223
10.1017/S1092852919001603
10.1016/j.yfrne.2019.100794
10.3390/jcm9051534
10.1007/s12640-018-9962-7
10.3389/fneur.2018.00229
10.3389/fncel.2017.00069
10.1172/JCI90602
10.1126/science.1227901
10.1038/nrn2398
10.1016/j.nurt.2010.05.014
10.1016/j.tcb.2016.02.006
10.1101/cshperspect.a020545
10.1016/j.celrep.2016.12.041
10.1038/nn.4547
10.1016/0306-4522(92)90500-2
10.1038/nrn3722
10.1038/nn.2923
10.1038/nature21029
10.1038/s41582-019-0184-2
10.15252/embj.2019101997
10.1038/nn.4338
10.1111/bph.13139
10.1042/CS20110164
10.1007/s12017-009-8099-5
10.1002/glia.10148
10.1016/j.devcel.2016.07.006
10.1038/nri.2017.125
10.1038/nature17630
10.1126/science.1110647
10.1371/journal.pbio.1000527
10.1523/JNEUROSCI.4363-08.2009
10.1016/j.neuron.2012.12.023
10.1523/JNEUROSCI.3667-11.2011
10.1016/j.jneuroim.2008.04.012
10.1038/nature04671
10.1016/j.neuron.2008.04.023
10.1111/j.1460-9568.2010.07343.x
10.1523/JNEUROSCI.4486-04.2005
10.1016/j.devcel.2012.10.027
10.1152/physrev.00011.2010
10.1038/nrneurol.2010.17
10.1002/glia.10154
10.1146/annurev.immunol.021908.132528
10.1016/j.yhbeh.2012.02.018
10.1126/science.1194637
10.1523/JNEUROSCI.3441-12.2013
10.1038/nn.3358
10.1523/JNEUROSCI.1006-08.2008
10.1016/s0896-6273(04)00069-8
10.1016/s0896-6273(00)80432-8
10.1016/j.neuron.2012.03.026
10.1016/j.cell.2007.10.036
10.1126/science.1202529
10.1016/j.celrep.2014.07.042
10.1523/JNEUROSCI.1167-12.2012
10.1016/j.conb.2014.02.004
10.1111/ejn.12508
10.1182/blood-2009-12-257832
10.1016/s0301-0082(98)00035-5
10.1002/cne.903480204
10.1007/BF00214704
10.1002/glia.22540
10.1159/000146465
10.1002/(SICI)1096-9861(19970106)377:1<70::AID-CNE7>3.0.CO;2-G
10.1002/(sici)1098-1136(199810)24:2<180::aid-glia3>3.0.co;2-8
10.1038/nn.3318
10.1242/dev.069963
10.1002/(SICI)1096-9861(19971222)389:3<390::AID-CNE3>3.0.CO;2-W
10.1002/(sici)1098-1136(199801)22:1<31::aid-glia4>3.0.co;2-b
10.1002/glia.21140
10.1002/(SICI)1097-0029(19990615)45:6<359::AID-JEMT4>3.0.CO;2-D
10.1016/s0165-3806(99)00043-7
10.1038/nn.3599
10.1073/pnas.1525528113
10.1523/JNEUROSCI.6182-11.2012
10.1016/j.jneuroim.2014.11.018
10.1016/0306-4522(90)90229-w
10.1016/j.nurt.2007.07.002
10.2174/187152711794488575
10.1523/JNEUROSCI.22-05-01562.2002
10.1002/glia.20929
10.1006/exnr.2000.7334
10.1007/s10072-009-0123-x
10.1146/annurev-neuro-061010-113810
10.1038/s41593-020-00763-8
10.1073/pnas.0913449107
10.1523/JNEUROSCI.0555-21.2021
10.1038/nn.3641
10.1038/nrn1787
10.1038/ncomms10905
10.1073/pnas.2115539118
10.1016/j.jaci.2009.12.980
10.1016/j.cell.2006.02.015
10.1016/j.chom.2018.12.006
10.1002/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO;2-D
10.1016/j.bbadis.2021.166170
10.1073/pnas.90.6.2207
10.1101/cshperspect.a001651
10.1038/s41577-018-0068-5
10.1016/j.bbamcr.2016.03.018
10.1002/ana.20315
10.1080/02646830500381930
10.1016/j.ajog.2019.06.013
10.1007/7854_2017_19
10.1002/dneu.22449
10.1016/0306-4522(89)90409-0
10.1016/s0006-8993(01)03258-9
10.1016/0166-2236(91)90032-p
10.1152/ajpregu.00340.2009
10.1016/0006-8993(93)90622-t
10.1159/000097330
10.1007/s12035-020-02241-5
10.1210/endo.136.4.7895660
10.1002/dneu.22403
10.1016/S0021-9258(18)31656-9
10.1210/endo.142.4.8107
10.1210/jc.2005-2649
10.1210/jc.2004-0277
10.1186/s13046-017-0490-8
10.1038/sigtrans.2017.23
10.1152/ajpendo.00346.2016
10.1016/S0021-9258(19)39297-X
10.1074/jbc.272.41.25832
10.5858/2010-0448-RAR.1
10.1540/jsmr.31.175
10.1210/endo.136.11.7588251
10.1159/000127160
10.1210/endo.136.12.7588281
10.1097/00001756-199803300-00031
10.1073/pnas.1300313110
10.1016/j.cell.2011.03.050
10.1186/s12944-020-01364-x
10.1016/j.yexmp.2021.104604
10.1016/j.theriogenology.2018.09.004
10.1016/s0006-291x(02)02009-0
10.1042/CS20190756
10.1152/ajpendo.90718.2008
10.1016/j.bbagen.2015.10.025
10.1111/j.1365-2826.2008.01783.x
10.1111/j.1365-2826.2006.01490.x
10.1002/glia.23176
10.1161/STROKEAHA.111.628008
10.1186/s12974-016-0541-7
10.1016/j.neuron.2017.04.043
10.1126/science.282.5396.2085
10.3390/cells8060527
10.1016/j.bbi.2016.12.005
10.1161/STROKEAHA.107.496695
10.1016/j.pneurobio.2016.01.005
10.1002/glia.23546
10.1016/j.bbrc.2016.02.109
10.3390/ijms21218290
10.1038/s41386-021-01040-3
10.1016/j.yhbeh.2011.08.003
10.3389/fendo.2020.612651
10.1016/j.psyneuen.2017.06.020
10.1038/sj.mp.4001911
10.1016/j.psyneuen.2020.104793
10.1523/JNEUROSCI.21-07-02546.2001
10.1007/7854_2017_25
10.1016/j.neulet.2007.02.001
10.1186/1741-7015-7-62
10.1111/j.1440-1819.2009.01944.x
10.3389/fcell.2021.634837
10.1016/j.neuron.2019.02.006
10.1038/s41467-018-06118-z
10.1016/j.bbr.2016.09.006
10.1016/j.bbr.2021.113449
10.1016/j.bbi.2020.08.013
10.1016/j.psyneuen.2021.105164
10.1016/j.bbih.2021.100296
10.1016/j.psyneuen.2010.06.005
10.1016/j.bbi.2017.06.008
10.1073/pnas.0401124101
10.1095/biolreprod.103.019620
10.1016/s0090-6980(02)00050-3
10.1093/intimm/dxz021
10.3389/fnmol.2018.00272
10.1101/cshperspect.a016295
10.1186/s12974-019-1538-9
10.4049/jimmunol.164.3.1588
10.1016/j.bbamcr.2003.09.003
10.1152/ajplung.00348.2003
10.1111/j.1365-2826.2011.02235.x
10.1016/j.nbd.2016.06.010
10.1016/j.jsgi.2006.02.011
10.1038/pr.2013.126
10.1001/jamapsychiatry.2019.0029
10.1016/j.placenta.2020.10.017
10.1016/j.jri.2021.103360
10.1016/j.bbi.2013.07.002
10.1002/glia.23079
10.1016/j.devcel.2021.03.018
10.1073/pnas.1922788117
10.1001/jama.2013.2270
10.1016/j.biopha.2018.07.148
10.1038/nrn3956
10.1126/science.1247190
10.1523/JNEUROSCI.1171-20.2020
10.1111/1469-7610.00102
10.1007/978-1-4899-2064-5_24
10.1523/JNEUROSCI.4106-09.2009
10.1016/j.yhbeh.2007.06.004
10.1016/j.yhbeh.2010.01.007
10.1038/npp.2011.239
10.1186/s12974-016-0575-x
10.1016/j.neuroscience.2010.01.029
10.3389/fnbeh.2021.802569
10.1186/s13229-021-00448-4
10.1016/j.cell.2016.06.001
10.1016/j.neuron.2018.11.018
10.1016/j.immuni.2021.11.005
10.1056/NEJMoa2103583",<Element 'PubmedArticle' at 0x7f05dd4de720>
86,35842075,Identification of oxytocin expression in human and murine microglia.,"Oxytocin is a neuropeptide synthesized in the hypothalamus. In addition to its role in parturition and lactation, oxytocin mediates social behavior and pair bonding. The possibility of using oxytocin to modify behavior in neurodevelopmental disorders, such as autism spectrum disorder, is of clinical interest. Microglia are tissue-resident macrophages with roles in neurogenesis, synapse pruning, and immunological mediation of brain homeostasis. Recently, oxytocin was found to attenuate microglial secretion of proinflammatory cytokines, but the source of this oxytocin was not established. This prompted us to investigate whether microglia themselves were the source.
We examined oxytocin expression in human and murine brain tissue in both sexes using immunohistochemistry. Oxytocin mRNA expression and secretion were examined in isolated murine microglia from wild type and oxytocin-knockout mice. Also, secretion of oxytocin and cytokines was measured in cultured microglia (MG6) stimulated with lipopolysaccharide (LPS).
We identified oxytocin expression in microglia of human brain tissue, cultured microglia (MG6), and primary murine microglia. Furthermore, LPS stimulation increased oxytocin mRNA expression in primary murine microglia and MG6 cells, and oxytocin secretion as well. A positive correlation between oxytocin and IL-1β, IL-10 secretion emerged, respectively.
This may be the first demonstration of oxytocin expression in microglia. Functionally, oxytocin might regulate inflammatory cytokine release from microglia in a paracrine/autocrine manner.","['IL-10', 'IL-1β', 'Iba-1', 'MG6', 'Microglia', 'Oxytocin']",Progress in neuro-psychopharmacology & biological psychiatry,2022-07-17,"[{'lastname': 'Maejima', 'firstname': 'Yuko', 'initials': 'Y', 'affiliation': 'Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan; Department of Obesity and Inflammation Research, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan. Electronic address: maejimay@fmu.ac.jp.'}, {'lastname': 'Yokota', 'firstname': 'Shoko', 'initials': 'S', 'affiliation': 'Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan.'}, {'lastname': 'Ono', 'firstname': 'Tomoyuki', 'initials': 'T', 'affiliation': 'Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan; Department of Obesity and Inflammation Research, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan.'}, {'lastname': 'Yu', 'firstname': 'Zhiqian', 'initials': 'Z', 'affiliation': 'Department of Psychiatry, Graduate School of Medicine, Tohoku University, Sendai 980-8573, Japan.'}, {'lastname': 'Yamachi', 'firstname': 'Megumi', 'initials': 'M', 'affiliation': 'Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan.'}, {'lastname': 'Hidema', 'firstname': 'Shizu', 'initials': 'S', 'affiliation': 'Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan.'}, {'lastname': 'Nollet', 'firstname': 'Kenneth E', 'initials': 'KE', 'affiliation': 'Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan.'}, {'lastname': 'Nishimori', 'firstname': 'Katsuhiko', 'initials': 'K', 'affiliation': 'Department of Obesity and Inflammation Research, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan.'}, {'lastname': 'Tomita', 'firstname': 'Hiroaki', 'initials': 'H', 'affiliation': 'Department of Psychiatry, Graduate School of Medicine, Tohoku University, Sendai 980-8573, Japan.'}, {'lastname': 'Yaginuma', 'firstname': 'Hiroyuki', 'initials': 'H', 'affiliation': 'Department of Neuroanatomy and Embryology, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan.'}, {'lastname': 'Shimomura', 'firstname': 'Kenju', 'initials': 'K', 'affiliation': 'Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan; Department of Obesity and Inflammation Research, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan. Electronic address: shimomur@fmu.ac.jp.'}]",,"This may be the first demonstration of oxytocin expression in microglia. Functionally, oxytocin might regulate inflammatory cytokine release from microglia in a paracrine/autocrine manner.","We identified oxytocin expression in microglia of human brain tissue, cultured microglia (MG6), and primary murine microglia. Furthermore, LPS stimulation increased oxytocin mRNA expression in primary murine microglia and MG6 cells, and oxytocin secretion as well. A positive correlation between oxytocin and IL-1β, IL-10 secretion emerged, respectively.",Copyright © 2022 Elsevier Inc. All rights reserved.,10.1016/j.pnpbp.2022.110600,<Element 'PubmedArticle' at 0x7f05de9e3270>
87,"35829942
20060739
20055707
22016365
10693807
11809412
26545340
28694024
23615502
26437604
17557118
30415773
20967426
22949875
22393169
21698703
23266600
21782937
22224344
11087781
16785600
19527179
22535765
11746612
9566410
16013043
26170904
23523718
23041085
10747949
22869379
21586296
17785421
15155257
15256495
26051538
22749492
28810246
30132882
19011085
10882071
1494904
17200797
11741608
27729173
19699718
12160928
28941592
28980042
17320868
23804112
23271418
23401502
15101093
12697714
31392675
18460549
16527848
14500559
16556737
24530924
19420011
26170064
25565980
19430488
16520733
31949017
24148819
15537344",Estrogen Up-Regulates Iron Transporters and Iron Storage Protein Through Hypoxia Inducible Factor 1 Alpha Activation Mediated by Estrogen Receptor β and G Protein Estrogen Receptor in BV2 Microglia Cells.,"Estrogen is a steroid hormone produced mainly by the ovaries. It has been found that estrogen could regulate iron metabolism in neurons and astrocytes in different ways. The role of estrogen on iron metabolism in microglia is currently unknown. In this study, we investigated the effect and mechanism of 17β-estrogen (E2) on iron transport proteins. We found that following E2 treatment for 24h in BV2 microglial cell lines, the iron importer divalent metal transporter 1 (DMT1) and iron exporter ferroportin 1 (FPN1) were up-regulated , iron storage protein ferritin (FT) was increased. The protein levels of iron regulatory proteins (IRPs) and hepcidin remained unchanged, but hypoxia inducible factor 1 alpha (HIF-1α) was up-regulated. Two kinds of estrogen receptor β (ERβ) antagonist G15 and G protein estrogen receptor (GPER) antagonist PHTPPcould block the effects of E2 in BV2 microglial cell lines. These results suggest that estrogen could increase the protein expressions of DMT1, FPN1, FT-L and FT-H in BV2 microglia cells, which were not related to the regulation of IRP1 and hepcidin, but to the upregulation of HIF-1α. In addition, estrogen might regulate the expressions of iron-related proteins through both ER β and GPER in BV2 microglia cells.","['Estrogen', 'Iron metabolism', 'Microglia']",Neurochemical research,2022-07-14,"[{'lastname': 'Qu', 'firstname': 'Yan', 'initials': 'Y', 'affiliation': 'School of Basic Medicine, Qingdao University, Qingdao, 266071, China.'}, {'lastname': 'Li', 'firstname': 'Na', 'initials': 'N', 'affiliation': 'School of Basic Medicine, Qingdao University, Qingdao, 266071, China.'}, {'lastname': 'Xu', 'firstname': 'Manman', 'initials': 'M', 'affiliation': 'Institute of Brain Science and Disease, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Qingdao University, Qingdao, 266071, China.'}, {'lastname': 'Zhang', 'firstname': 'Danyang', 'initials': 'D', 'affiliation': 'School of Basic Medicine, Qingdao University, Qingdao, 266071, China.'}, {'lastname': 'Xie', 'firstname': 'Junxia', 'initials': 'J', 'affiliation': 'Institute of Brain Science and Disease, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Qingdao University, Qingdao, 266071, China. jxiaxie@163.com.'}, {'lastname': 'Wang', 'firstname': 'Jun', 'initials': 'J', 'affiliation': 'School of Basic Medicine, Qingdao University, Qingdao, 266071, China. junwang@qdu.edu.cn.\nInstitute of Brain Science and Disease, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Qingdao University, Qingdao, 266071, China. junwang@qdu.edu.cn.'}]",,,,"© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.","10.1007/s11064-022-03658-1
10.1016/j.tem.2009.12.006
10.1146/annurev.pharmtox.010909.105600
10.1136/gut.2010.214312
10.1038/35001596
10.1016/S1357-2725(01)00104-2
10.1111/jnc.13425
10.1016/j.tracli.2017.06.015
10.1053/j.gastro.2010.12.037
10.1038/ki.2013.142
10.1016/j.cmet.2015.09.006
10.1172/JCI31370
10.1016/j.bbrc.2018.10.185
10.1007/s00204-010-0577-x
10.3390/ijms130810478
10.1001/archneurol.2011.2945
10.1002/jmri.22590
10.1016/j.neuint.2012.12.006
10.1016/j.bbadis.2011.06.016
10.1212/WNL.55.9.1358
10.1385/ENDO:29:2:243
10.1089/ars.2009.2576
10.1210/en.2011-2045
10.1002/mds.1170
10.1212/WNL.50.4.1141
10.1002/jnr.20583
10.3892/etm.2015.2484
10.1016/j.bone.2013.03.008
10.1016/j.gene.2012.09.060
10.1074/jbc.M000713200
10.1074/jbc.M112.368142
10.1016/j.neuropharm.2011.04.031
10.1073/pnas.0703783104
10.1152/ajpheart.00227.2004
10.1210/en.2004-0619
10.1016/j.nbd.2015.05.017
10.1016/j.neurobiolaging.2012.05.022
10.1159/000478908
10.1002/jcp.27188
10.1073/pnas.0804373105
10.1016/S1097-2765(00)80425-6
10.1111/j.1471-4159.1992.tb08362.x
10.1007/s11010-006-9393-2
10.1016/S0014-5793(01)03189-1
10.1016/j.clnu.2016.09.021
10.1016/j.brainres.2009.08.043
10.1016/S0891-5849(02)00842-0
10.1016/j.clinbiochem.2017.09.014
10.1007/978-3-319-56895-9_6
10.1016/j.expneurol.2007.01.020
10.1523/JNEUROSCI.0886-13.2013
10.1073/pnas.1300313110
10.1002/cne.20128
10.1210/en.2002-221069
10.1007/978-1-4939-9658-2_3
10.1677/JOE-07-0294
10.1210/en.2005-1177
10.1210/en.2003-0550
10.1210/me.2005-0459
10.1016/j.mce.2014.02.002
10.1677/JOE-09-0066
10.1111/nmo.13121
10.1016/j.bbadis.2015.07.004
10.3389/fnana.2014.00155
10.1038/nchembio.168
10.1038/nchembio775
10.3324/haematol.2019.232124
10.1093/carcin/bgt348
10.1021/jm049631k",<Element 'PubmedArticle' at 0x7f05de9c77c0>
88,35819552,Metabolism regulator adiponectin prevents cardiac remodeling and ventricular arrhythmias via sympathetic modulation in a myocardial infarction model.,"The stellate ganglia play an important role in cardiac remodeling after myocardial infarction (MI). This study aimed to investigate whether adiponectin (APN), an adipokine mainly secreted by adipose tissue, could modulate the left stellate ganglion (LSG) and exert cardioprotective effects through the sympathetic nervous system (SNS) in a canine model of MI. APN microinjection and APN overexpression with recombinant adeno-associated virus vector in the LSG were performed in acute and chronic MI models, respectively. The results showed that acute APN microinjection decreased LSG function and neural activity, and suppressed ischemia-induced ventricular arrhythmia. Chronic MI led to a decrease in the effective refractory period and action potential duration at 90% and deterioration in echocardiography performance, all of which was blunted by APN overexpression. Moreover, APN gene transfer resulted in favorable heart rate variability alteration, and decreased cardiac SNS activity, serum noradrenaline and neuropeptide Y, which were augmented after MI. APN overexpression also decreased the expression of nerve growth factor and growth associated protein 43 in the LSG and peri-infarct myocardium, respectively. Furthermore, RNA sequencing of LSG indicated that 4-week MI up-regulated the mRNA levels of macrophage/microglia activation marker Iba1, chemokine ligands (CXCL10, CCL20), chemokine receptor CCR5 and pro-inflammatory cytokine IL6, and downregulated IL1RN and IL10 mRNA, which were reversed by APN overexpression. Our results reveal that APN inhibits cardiac sympathetic remodeling and mitigates cardiac remodeling after MI. APN-mediated gene therapy may provide a potential therapeutic strategy for the treatment of MI.","['Adiponectin', 'Cardiac remodeling', 'Left stellate ganglion', 'Myocardial infarction', 'Sympathetic nervous system', 'Ventricular arrhythmia']",Basic research in cardiology,2022-07-13,"[{'lastname': 'Zhou', 'firstname': 'Zhen', 'initials': 'Z', 'affiliation': ""Department of Cardiology, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuchang District, Wuhan, 430060, Hubei Province, People's Republic of China.\nCardiac Autonomic Nervous System Research Center of Wuhan University, Wuhan, 430060, People's Republic of China.\nInstitute of Molecular Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.\nCardiovascular Research Institute, Wuhan University, Wuhan, 430060, People's Republic of China.\nHubei Key Laboratory of Cardiology, Wuhan, 430060, People's Republic of China.""}, {'lastname': 'Liu', 'firstname': 'Chengzhe', 'initials': 'C', 'affiliation': ""Cardiac Autonomic Nervous System Research Center of Wuhan University, Wuhan, 430060, People's Republic of China.\nInstitute of Molecular Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.\nCardiovascular Research Institute, Wuhan University, Wuhan, 430060, People's Republic of China.\nHubei Key Laboratory of Cardiology, Wuhan, 430060, People's Republic of China.""}, {'lastname': 'Xu', 'firstname': 'Saiting', 'initials': 'S', 'affiliation': ""Department of Cardiology, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuchang District, Wuhan, 430060, Hubei Province, People's Republic of China.\nCardiac Autonomic Nervous System Research Center of Wuhan University, Wuhan, 430060, People's Republic of China.\nInstitute of Molecular Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.\nCardiovascular Research Institute, Wuhan University, Wuhan, 430060, People's Republic of China.\nHubei Key Laboratory of Cardiology, Wuhan, 430060, People's Republic of China.""}, {'lastname': 'Wang', 'firstname': 'Jun', 'initials': 'J', 'affiliation': ""Department of Cardiology, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuchang District, Wuhan, 430060, Hubei Province, People's Republic of China.\nCardiac Autonomic Nervous System Research Center of Wuhan University, Wuhan, 430060, People's Republic of China.\nInstitute of Molecular Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.\nCardiovascular Research Institute, Wuhan University, Wuhan, 430060, People's Republic of China.\nHubei Key Laboratory of Cardiology, Wuhan, 430060, People's Republic of China.""}, {'lastname': 'Guo', 'firstname': 'Fuding', 'initials': 'F', 'affiliation': ""Department of Cardiology, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuchang District, Wuhan, 430060, Hubei Province, People's Republic of China.\nCardiac Autonomic Nervous System Research Center of Wuhan University, Wuhan, 430060, People's Republic of China.\nInstitute of Molecular Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.\nCardiovascular Research Institute, Wuhan University, Wuhan, 430060, People's Republic of China.\nHubei Key Laboratory of Cardiology, Wuhan, 430060, People's Republic of China.""}, {'lastname': 'Duan', 'firstname': 'Shoupeng', 'initials': 'S', 'affiliation': ""Department of Cardiology, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuchang District, Wuhan, 430060, Hubei Province, People's Republic of China.\nCardiac Autonomic Nervous System Research Center of Wuhan University, Wuhan, 430060, People's Republic of China.\nInstitute of Molecular Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.\nCardiovascular Research Institute, Wuhan University, Wuhan, 430060, People's Republic of China.\nHubei Key Laboratory of Cardiology, Wuhan, 430060, People's Republic of China.""}, {'lastname': 'Deng', 'firstname': 'Qiang', 'initials': 'Q', 'affiliation': ""Department of Cardiology, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuchang District, Wuhan, 430060, Hubei Province, People's Republic of China.\nCardiac Autonomic Nervous System Research Center of Wuhan University, Wuhan, 430060, People's Republic of China.\nInstitute of Molecular Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.\nCardiovascular Research Institute, Wuhan University, Wuhan, 430060, People's Republic of China.\nHubei Key Laboratory of Cardiology, Wuhan, 430060, People's Republic of China.""}, {'lastname': 'Sun', 'firstname': 'Ji', 'initials': 'J', 'affiliation': ""Department of Cardiology, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuchang District, Wuhan, 430060, Hubei Province, People's Republic of China.\nCardiac Autonomic Nervous System Research Center of Wuhan University, Wuhan, 430060, People's Republic of China.\nInstitute of Molecular Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.\nCardiovascular Research Institute, Wuhan University, Wuhan, 430060, People's Republic of China.\nHubei Key Laboratory of Cardiology, Wuhan, 430060, People's Republic of China.""}, {'lastname': 'Yu', 'firstname': 'Fu', 'initials': 'F', 'affiliation': ""Department of Cardiology, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuchang District, Wuhan, 430060, Hubei Province, People's Republic of China.\nCardiac Autonomic Nervous System Research Center of Wuhan University, Wuhan, 430060, People's Republic of China.\nInstitute of Molecular Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.\nCardiovascular Research Institute, Wuhan University, Wuhan, 430060, People's Republic of China.\nHubei Key Laboratory of Cardiology, Wuhan, 430060, People's Republic of China.""}, {'lastname': 'Zhou', 'firstname': 'Yuyang', 'initials': 'Y', 'affiliation': ""Department of Cardiology, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuchang District, Wuhan, 430060, Hubei Province, People's Republic of China.\nCardiac Autonomic Nervous System Research Center of Wuhan University, Wuhan, 430060, People's Republic of China.\nInstitute of Molecular Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.\nCardiovascular Research Institute, Wuhan University, Wuhan, 430060, People's Republic of China.\nHubei Key Laboratory of Cardiology, Wuhan, 430060, People's Republic of China.""}, {'lastname': 'Wang', 'firstname': 'Meng', 'initials': 'M', 'affiliation': ""Department of Cardiology, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuchang District, Wuhan, 430060, Hubei Province, People's Republic of China.\nCardiac Autonomic Nervous System Research Center of Wuhan University, Wuhan, 430060, People's Republic of China.\nInstitute of Molecular Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.\nCardiovascular Research Institute, Wuhan University, Wuhan, 430060, People's Republic of China.\nHubei Key Laboratory of Cardiology, Wuhan, 430060, People's Republic of China.""}, {'lastname': 'Wang', 'firstname': 'Yueyi', 'initials': 'Y', 'affiliation': ""Department of Cardiology, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuchang District, Wuhan, 430060, Hubei Province, People's Republic of China.\nCardiac Autonomic Nervous System Research Center of Wuhan University, Wuhan, 430060, People's Republic of China.\nInstitute of Molecular Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.\nCardiovascular Research Institute, Wuhan University, Wuhan, 430060, People's Republic of China.\nHubei Key Laboratory of Cardiology, Wuhan, 430060, People's Republic of China.""}, {'lastname': 'Zhou', 'firstname': 'Liping', 'initials': 'L', 'affiliation': ""Department of Cardiology, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuchang District, Wuhan, 430060, Hubei Province, People's Republic of China.\nCardiac Autonomic Nervous System Research Center of Wuhan University, Wuhan, 430060, People's Republic of China.\nInstitute of Molecular Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.\nCardiovascular Research Institute, Wuhan University, Wuhan, 430060, People's Republic of China.\nHubei Key Laboratory of Cardiology, Wuhan, 430060, People's Republic of China.""}, {'lastname': 'Jiang', 'firstname': 'Hong', 'initials': 'H', 'affiliation': ""Department of Cardiology, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuchang District, Wuhan, 430060, Hubei Province, People's Republic of China. hong-jiang@whu.edu.cn.\nCardiac Autonomic Nervous System Research Center of Wuhan University, Wuhan, 430060, People's Republic of China. hong-jiang@whu.edu.cn.\nInstitute of Molecular Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China. hong-jiang@whu.edu.cn.\nCardiovascular Research Institute, Wuhan University, Wuhan, 430060, People's Republic of China. hong-jiang@whu.edu.cn.\nHubei Key Laboratory of Cardiology, Wuhan, 430060, People's Republic of China. hong-jiang@whu.edu.cn.""}, {'lastname': 'Yu', 'firstname': 'Lilei', 'initials': 'L', 'affiliation': ""Department of Cardiology, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuchang District, Wuhan, 430060, Hubei Province, People's Republic of China. lileiyu@whu.edu.cn.\nCardiac Autonomic Nervous System Research Center of Wuhan University, Wuhan, 430060, People's Republic of China. lileiyu@whu.edu.cn.\nInstitute of Molecular Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China. lileiyu@whu.edu.cn.\nCardiovascular Research Institute, Wuhan University, Wuhan, 430060, People's Republic of China. lileiyu@whu.edu.cn.\nHubei Key Laboratory of Cardiology, Wuhan, 430060, People's Republic of China. lileiyu@whu.edu.cn.""}]",,,,"© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.","10.1007/s00395-022-00939-2
10.1172/jci.insight.94715
10.1161/CIRCULATIONAHA.109.929703
10.1038/nn.4593
10.1038/s41467-02125766-2
10.1007/BF00788735
10.3390/cells10081871
10.1161/HYPERTENSIONAHA.120.15922
10.1113/JP278864
10.1093/eurheartj/ehz950
10.1161/01.cir.62.5.980
10.1016/j.jacc.2018.12.064
10.1016/j.jacc.2011.11.030
10.1186/s12933-017-0634-3
10.1016/j.brainres.2006.09.054
10.1038/s41569-019-0221-2
10.1093/eurheartj/ehz115
10.1016/01651838(85)90020-7
10.1093/eurheartj/ehab371
10.1172/jci.insight.135519
10.1210/en.2009-1390
10.1016/j.cell.2019.01.044
10.1016/j.cmet.2013.04.009
10.1093/eurheartj/ehz852
10.1093/cvr/cvp160
10.1136/heart.89.6.667
10.1093/cvr/cvab209
10.1093/ehjci/jev014
10.1161/HYPERTENSIONAHA.115.05290
10.1007/s00395020-0813-3
10.1016/j.pneurobio.2021.102125
10.1038/s41586-02103534-y
10.1038/s41380-020-0701-0
10.1152/ajpheart.00409.2015
10.1038/s41574-0190230-6
10.1093/eurheartj/ehac134
10.1016/j.hrthm.2019.06.018
10.1016/j.jacc.2018.08.2186
10.1136/hrt.80.2.156
10.1007/s12035-020-02012-2
10.1016/j.jacc.2003.07.053
10.1055/s-2004-826022
10.1007/s12024-022-00466-5
10.1016/j.jacc.2017.04.035
10.1016/j.ijcard.2017.08.011
10.1016/j.hrthm.2015.03.023
10.1161/CIRCHEARTFAILURE.114.001564
10.1002/adfm.201902128
10.1016/j.jcin.2017.04.036
10.1016/j.hrthm.2017.02.010
10.1016/j.hrthm.2011.12.023
10.1016/j.jacep.2015.11.006
10.1016/j.jacc.2017.09.1107
10.1161/HYPERTENSIONAHA.120.16545
10.1007/s00395-021-00871-x
10.1161/CIRCRESAHA.108.192302
10.1161/CIRCRESAHA.120.314458
10.1161/01.RES.0000133678.22968.e3
10.1016/j.ijcard.2019.12.031
10.1093/cvr/cvx227",<Element 'PubmedArticle' at 0x7f05dd68f2c0>
89,35761673,Ergosterol isolated from cloud ear mushroom (Auricularia polytricha) attenuates bisphenol A-induced BV2 microglial cell inflammation.,"Bisphenol A (BPA) has been reported to have neurotoxic properties that may increase the risk of neurodegenerative diseases by inducing neuroinflammation. Auricularia polytricha (AP) is an edible mushroom with several medicinal properties. Herein, the anti-neuroinflammatory effects of AP extracts against BPA-induced inflammation of BV2 microglial cells were investigated. Hexane (APH) and ethanol (APE) extracts of AP inhibited BPA-induced neuroinflammation in BV2 microglia by reducing microglial activation and the expression of pro-inflammatory cytokines. These anti-inflammatory effects were regulated by the NF-κB signaling pathway. In addition, APH and APE exhibited antioxidative effects by increasing the activity of the SOD-1 enzyme and restoring the accumulation of reactive oxygen species (ROS) in BPA-induced BV2 cells. Moreover, the conditioned medium prepared using BPA-induced BV2 cells demonstrated that the presence of APH or APE could attenuate ROS production in HT-22 cells. Further, ergosterol was isolated from APE and also showed anti-inflammatory and antioxidative activities. In conclusion, AP extracts and ergosterol attenuated neuroinflammation against BPA induction in BV2 microglial cells through the NF-κB signaling pathway.","['Auricularia polytricha', 'Bisphenol A', 'Ergosterol', 'Neuroinflammation']","Food research international (Ottawa, Ont.)",2022-06-29,"[{'lastname': 'Sillapachaiyaporn', 'firstname': 'Chanin', 'initials': 'C', 'affiliation': 'Program in Clinical Biochemistry and Molecular Medicine, Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand; Laboratory of Signal Transduction, Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul 08826, Korea.'}, {'lastname': 'Chuchawankul', 'firstname': 'Siriporn', 'initials': 'S', 'affiliation': 'Department of Transfusion Medicine and Clinical Microbiology, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand; Immunomodulation of Natural Products Research Group, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand.'}, {'lastname': 'Nilkhet', 'firstname': 'Sunita', 'initials': 'S', 'affiliation': 'Program in Clinical Biochemistry and Molecular Medicine, Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand.'}, {'lastname': 'Moungkote', 'firstname': 'Nuntanat', 'initials': 'N', 'affiliation': 'Department of Transfusion Medicine and Clinical Microbiology, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand.'}, {'lastname': 'Sarachana', 'firstname': 'Tewarit', 'initials': 'T', 'affiliation': 'Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand; SYstems Neuroscience of Autism and PSychiatric Disorders (SYNAPS) Research Unit, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand.'}, {'lastname': 'Ung', 'firstname': 'Alison T', 'initials': 'AT', 'affiliation': 'Department of Transfusion Medicine and Clinical Microbiology, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand; Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand; School of Mathematical and Physical Sciences, Faculty of Science, The University of Technology Sydney, Sydney, NSW 2007, Australia.'}, {'lastname': 'Baek', 'firstname': 'Seung Joon', 'initials': 'SJ', 'affiliation': 'Laboratory of Signal Transduction, Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul 08826, Korea. Electronic address: baeksj@snu.ac.kr.'}, {'lastname': 'Tencomnao', 'firstname': 'Tewin', 'initials': 'T', 'affiliation': 'Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand; Natural Products for Neuroprotection and Anti-ageing (Neur-Age Natura) Research Unit, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand. Electronic address: tewin.t@chula.ac.th.'}]",,,,Copyright © 2022 Elsevier Ltd. All rights reserved.,10.1016/j.foodres.2022.111433,<Element 'PubmedArticle' at 0x7f05dd676810>
90,35750198,Microglial polarization differentially affects neuronal vulnerability to the β-amyloid protein: Modulation by melatonin.,"Microglial cells play a central but yet debated role in neuroinflammatory events occurring in Alzheimer's disease (AD). We here explored how microglial features are modulated by melatonin following β-amyloid (Aβ42)-induced activation and examined the cross-talk with Aβ-challenged neuronal cells. Human microglial HMC3 cells were exposed to Aβ42 (200 nM) in the presence of melatonin (MEL; 1 μM) added since the beginning (MELco) or after a 72 h-exposure to Aβ42 (MELpost). In both conditions, MEL favored an anti-inflammatory activation and rescued SIRT1 and BDNF expression/release. Caspase-1 up-regulation and phospho-ERK induction following a prolonged exposure to Aβ42 were prevented by MEL. In addition, MEL partially restored proteasome functionality that was altered by long-term Aβ42 treatment, re-establishing both 20S and 26S chymotrypsin-like activity. Differentiated neuronal-like SH-SY5Y cells were exposed to Aβ42 (200 nM for 24 h) in basal medium or in the presence of conditioned medium (CM) collected from microglia exposed for different times to Aβ42 alone or in combination with MELco or MELpost. Aβ42 significantly reduced pre-synaptic proteins synaptophysin and VAMP2 and mean neuritic length. These effects were prevented by CM from anti-inflammatory microglia (Aβ42 for 6 h), or from MELco and MELpost microglia, but the reduction of neuritic length was not rescued when the SIRT1 inhibitor EX527 was added. In conclusion, our data add to the concept that melatonin shows a promising anti-inflammatory action on microglia that is retained even after pro-inflammatory activation, involving modulation of proteasome function and translating into neuroprotective microglial effects.","['HMC3 microglial cell line', 'Immunoproteasome', 'Neuritic length', 'Neuroinflammation', 'SIRT1', 'Synaptic proteins']",Biochemical pharmacology,2022-06-25,"[{'lastname': 'Merlo', 'firstname': 'Sara', 'initials': 'S', 'affiliation': 'Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, Via Santa Sofia 97, 95123 Catania, Italy. Electronic address: sara_merlo@hotmail.com.'}, {'lastname': 'Caruso', 'firstname': 'Grazia Ilaria', 'initials': 'GI', 'affiliation': 'Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, Via Santa Sofia 97, 95123 Catania, Italy. Electronic address: grazia.caruso@outlook.it.'}, {'lastname': 'Bonfili', 'firstname': 'Laura', 'initials': 'L', 'affiliation': 'School of Biosciences and Veterinary Medicine, University of Camerino, via Gentile III da Varano, 62032 Camerino, MC, Italy. Electronic address: laura.bonfili@unicam.it.'}, {'lastname': 'Spampinato', 'firstname': 'Simona Federica', 'initials': 'SF', 'affiliation': 'Department of Scienza e Tecnologia del Farmaco, University of Turin, Via P. Giuria 13, Turin 10125, Italy. Electronic address: simonafederica.spampinato@unito.it.'}, {'lastname': 'Costantino', 'firstname': 'Giuseppe', 'initials': 'G', 'affiliation': 'Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, Via Santa Sofia 97, 95123 Catania, Italy. Electronic address: giuseppe.costantino@unifg.it.'}, {'lastname': 'Eleuteri', 'firstname': 'Anna Maria', 'initials': 'AM', 'affiliation': 'School of Biosciences and Veterinary Medicine, University of Camerino, via Gentile III da Varano, 62032 Camerino, MC, Italy. Electronic address: annamaria.eleuteri@unicam.it.'}, {'lastname': 'Sortino', 'firstname': 'Maria Angela', 'initials': 'MA', 'affiliation': 'Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, Via Santa Sofia 97, 95123 Catania, Italy. Electronic address: msortino@unict.it.'}]",,,,Copyright © 2022 Elsevier Inc. All rights reserved.,10.1016/j.bcp.2022.115151,<Element 'PubmedArticle' at 0x7f05dd6649f0>
91,35750050,The cephalic phase of insulin release is modulated by IL-1β.,"The initial cephalic phase of insulin secretion is mediated through the vagus nerve and is not due to glycemic stimulation of pancreatic β cells. Recently, IL-1β was shown to stimulate postprandial insulin secretion. Here, we describe that this incretin-like effect of IL-1β involves neuronal transmission. Furthermore, we found that cephalic phase insulin release was mediated by IL-1β originating from microglia. Moreover, IL-1β activated the vagus nerve to induce insulin secretion and regulated the activity of the hypothalamus in response to cephalic stimulation. Notably, cephalic phase insulin release was impaired in obesity, in both mice and humans, and in mice, this was due to dysregulated IL-1β signaling. Our findings attribute a regulatory role to IL-1β in the integration of nutrient-derived sensory information, subsequent neuronally mediated insulin secretion, and the dysregulation of autonomic cephalic phase responses in obesity.","['CX3CR1+ cells', 'IL-1β', 'cephalic phase', 'inflammation', 'insulin', 'microglia', 'nutrition', 'obesity']",Cell metabolism,2022-06-25,"[{'lastname': 'Wiedemann', 'firstname': 'Sophia J', 'initials': 'SJ', 'affiliation': 'Clinic of Endocrinology, Diabetes and Metabolism University Hospital Basel, Basel, Switzerland; Department of Biomedicine, University of Basel, Basel, Switzerland. Electronic address: sophia.j.wiedemann@gmail.com.'}, {'lastname': 'Trimigliozzi', 'firstname': 'Kelly', 'initials': 'K', 'affiliation': 'Clinic of Endocrinology, Diabetes and Metabolism University Hospital Basel, Basel, Switzerland; Department of Biomedicine, University of Basel, Basel, Switzerland.'}, {'lastname': 'Dror', 'firstname': 'Erez', 'initials': 'E', 'affiliation': 'Clinic of Endocrinology, Diabetes and Metabolism University Hospital Basel, Basel, Switzerland; Department of Biomedicine, University of Basel, Basel, Switzerland.'}, {'lastname': 'Meier', 'firstname': 'Daniel T', 'initials': 'DT', 'affiliation': 'Clinic of Endocrinology, Diabetes and Metabolism University Hospital Basel, Basel, Switzerland; Department of Biomedicine, University of Basel, Basel, Switzerland.'}, {'lastname': 'Molina-Tijeras', 'firstname': 'Jose Alberto', 'initials': 'JA', 'affiliation': 'Clinic of Endocrinology, Diabetes and Metabolism University Hospital Basel, Basel, Switzerland; Department of Biomedicine, University of Basel, Basel, Switzerland.'}, {'lastname': 'Rachid', 'firstname': 'Leila', 'initials': 'L', 'affiliation': 'Clinic of Endocrinology, Diabetes and Metabolism University Hospital Basel, Basel, Switzerland; Department of Biomedicine, University of Basel, Basel, Switzerland.'}, {'lastname': 'Le Foll', 'firstname': 'Christelle', 'initials': 'C', 'affiliation': 'Institute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.'}, {'lastname': 'Magnan', 'firstname': 'Christophe', 'initials': 'C', 'affiliation': 'Université de Paris, BFA, UMR 8251, CNRS, 75013 Paris, France.'}, {'lastname': 'Schulze', 'firstname': 'Friederike', 'initials': 'F', 'affiliation': 'Clinic of Endocrinology, Diabetes and Metabolism University Hospital Basel, Basel, Switzerland; Department of Biomedicine, University of Basel, Basel, Switzerland.'}, {'lastname': 'Stawiski', 'firstname': 'Marc', 'initials': 'M', 'affiliation': 'Clinic of Endocrinology, Diabetes and Metabolism University Hospital Basel, Basel, Switzerland; Department of Biomedicine, University of Basel, Basel, Switzerland.'}, {'lastname': 'Häuselmann', 'firstname': 'Stéphanie P', 'initials': 'SP', 'affiliation': 'Clinic of Endocrinology, Diabetes and Metabolism University Hospital Basel, Basel, Switzerland; Department of Biomedicine, University of Basel, Basel, Switzerland.'}, {'lastname': 'Méreau', 'firstname': 'Hélène', 'initials': 'H', 'affiliation': 'Clinic of Endocrinology, Diabetes and Metabolism University Hospital Basel, Basel, Switzerland; Department of Biomedicine, University of Basel, Basel, Switzerland.'}, {'lastname': 'Böni-Schnetzler', 'firstname': 'Marianne', 'initials': 'M', 'affiliation': 'Clinic of Endocrinology, Diabetes and Metabolism University Hospital Basel, Basel, Switzerland; Department of Biomedicine, University of Basel, Basel, Switzerland.'}, {'lastname': 'Donath', 'firstname': 'Marc Y', 'initials': 'MY', 'affiliation': 'Clinic of Endocrinology, Diabetes and Metabolism University Hospital Basel, Basel, Switzerland; Department of Biomedicine, University of Basel, Basel, Switzerland.'}]",,,,Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.,10.1016/j.cmet.2022.06.001,<Element 'PubmedArticle' at 0x7f05de198040>
92,35724494,Gonadal hormone trigger the dynamic microglial alterations through Traf6/TAK1 axis that correlate with depressive behaviors.,"Gonadal hormone deficiency is associated with the development of depression, but what mediates this association is unclear. To test the possibility that it reflects neuroimmune and neuroinflammatory processes, we analyzed how gonadal hormone deficiency and replacement affect microglial activation and inflammatory response during the development of depressive symptomatology in gonadectomized male mice. Testosterone level and the ratio of testosterone to estradiol in the serum and brain tissue of mice exposed to 3-35 days of chronic unpredictable stress were much lower than in control animals. Gonadal hormone sustained deficiency in gonadectomized mice and subsequent led to acute inflammation at day 7 following castration. Activating microglia in mice exposed to 7 days of castration subsequently suppressed the proliferation of microglia, such that their numbers in hippocampus and cortex were lower than the numbers in sham-operated mice after 30 days of castration. Here, we showed that gonadal hormone deficiency induces Traf6-mediated microglia activation, a type of inflammatory mediator. Microglia treated in this way for long time showed down-regulation of activation markers, abnormal morphology and depressive-like behaviors. Restoration and maintenance of a fixed ratio of testosterone to estradiol significantly suppressed microglial activation, neuronal necroptosis, dramatically inducing hippocampal neurogenesis and reducing depressive behaviors via the suppression of Traf6/TAK1 pathway. These findings suggest that activated or immunoreactive microglia contribute to gonadal hormone deficiency-induced depression, as well as testosterone and estradiol exert synergistic anti-depressant effects via suppressing microglial activaton in gonadectomized male mice, possibly through Traf6 signaling.","['Deficiency', 'Depression', 'Gonadal hormone', 'Inflammation', 'Microglia', 'Neuroimmune', 'Replacement']",Journal of psychiatric research,2022-06-21,"[{'lastname': 'Peng', 'firstname': 'Rui', 'initials': 'R', 'affiliation': 'Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan, China. Electronic address: pengruiwec@163.com.'}, {'lastname': 'Dai', 'firstname': 'Wen', 'initials': 'W', 'affiliation': 'Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.'}, {'lastname': 'Li', 'firstname': 'Di', 'initials': 'D', 'affiliation': 'Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.'}, {'lastname': 'Li', 'firstname': 'Yan', 'initials': 'Y', 'affiliation': 'Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan, China. Electronic address: yanlitf1120@163.com.'}]",,,,Copyright © 2022. Published by Elsevier Ltd.,10.1016/j.jpsychires.2022.06.026,<Element 'PubmedArticle' at 0x7f05de194c20>
93,"35720361
26561051
30793349
30055734
8502506
30667078
28155585
31260658
32415164
33970466
34281379
27166859
34822458
34899720
31648632
29486166
31128596
29184485
30190288
29499303
34275493
26739391
32859236
32918259
31902083
28524175
27261088
34921829
29162556
26269636
29649924
20026491
19816235
30711510
30126439
26861995
34086200
28007523
25963415
28326017
34333040
34462350
33378955
31798583
34022892
31176703
12638733
7235629
22524990
33343300
9149257",Adiponectin Ameliorates GMH-Induced Brain Injury by Regulating Microglia M1/M2 Polarization ,"Adiponectin (APN), a fat-derived plasma hormone, is a classic anti-inflammatory agent. Multiple studies have demonstrated the beneficial role of APN in acute brain injury, but the effect of APN in germinal matrix hemorrhage (GMH) is unclear, and the underlying molecular mechanisms remain largely undefined. In the current study, we used a GMH rat model with rh-APN treatment, and we observed that APN demonstrated a protective effect on neurological function and an inhibitory effect on neuroinflammation after GMH. To further explore the underlying mechanisms of these effects, we found that the expression of Adiponectin receptor 1 (AdipoR1) primarily colocalized with microglia and neurons in the brain. Moreover, AdiopR1, but not AdipoR2, was largely increased in GMH rats. Meanwhile, further investigation showed that APN treatment promoted AdipoR1/APPL1-mediated AMPK phosphorylation, further increased peroxisome proliferator-activated receptor gamma (PPARγ) expression, and induced microglial M2 polarization to reduce the neuroinflammation and enhance hematoma resolution in GMH rats. Importantly, either knockdown of AdipoR1, APPL1, or LKB1, or specific inhibition of AMPK/PPARγ signaling in microglia abrogated the protective effect of APN after GMH in rats. In all, we propose that APN works as a potential therapeutic agent to ameliorate the inflammatory response following GMH by enhancing the M2 polarization of microglia ","['GMH', 'adiponectin', 'hematoma resolution', 'microglial polarization', 'neuroinflammation']",Frontiers in immunology,2022-06-21,"[{'lastname': 'Xu', 'firstname': 'Ningbo', 'initials': 'N', 'affiliation': 'Neurosurgery Center, Department of Cerebrovascular Surgery, Engineering Technology Research Center of Education Ministry of China on Diagnosis and Treatment of Cerebrovascular Disease, Zhujiang Hospital, Southern Medical University, Guangzhou, China.\nDepartment of Physiology and Pharmacology, Basic Sciences, School of Medicine, Loma Linda University, Loma Linda, CA, United States.'}, {'lastname': 'Li', 'firstname': 'Xifeng', 'initials': 'X', 'affiliation': 'Neurosurgery Center, Department of Cerebrovascular Surgery, Engineering Technology Research Center of Education Ministry of China on Diagnosis and Treatment of Cerebrovascular Disease, Zhujiang Hospital, Southern Medical University, Guangzhou, China.'}, {'lastname': 'Weng', 'firstname': 'Jun', 'initials': 'J', 'affiliation': 'Department of Hepatobiliary Surgery II, Zhujiang Hospital, Southern Medical University, Guangzhou, China.'}, {'lastname': 'Wei', 'firstname': 'Chunhua', 'initials': 'C', 'affiliation': 'Department of Medical Oncology, The Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, China.'}, {'lastname': 'He', 'firstname': 'Zhenyan', 'initials': 'Z', 'affiliation': 'Department of Neurosurgery, The Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, China.'}, {'lastname': 'Doycheva', 'firstname': 'Desislava Met', 'initials': 'DM', 'affiliation': 'Department of Physiology and Pharmacology, Basic Sciences, School of Medicine, Loma Linda University, Loma Linda, CA, United States.'}, {'lastname': 'Lenahan', 'firstname': 'Cameron', 'initials': 'C', 'affiliation': 'Department of Biomedical Sciences, Burrell College of Osteopathic Medicine, Las Cruces, NM, United States.'}, {'lastname': 'Tang', 'firstname': 'Wenhui', 'initials': 'W', 'affiliation': 'Neurosurgery Center, Department of Cerebrovascular Surgery, Engineering Technology Research Center of Education Ministry of China on Diagnosis and Treatment of Cerebrovascular Disease, Zhujiang Hospital, Southern Medical University, Guangzhou, China.'}, {'lastname': 'Zhou', 'firstname': 'Jian', 'initials': 'J', 'affiliation': 'Neurosurgery Center, Department of Cerebrovascular Surgery, Engineering Technology Research Center of Education Ministry of China on Diagnosis and Treatment of Cerebrovascular Disease, Zhujiang Hospital, Southern Medical University, Guangzhou, China.'}, {'lastname': 'Liu', 'firstname': 'Yanchao', 'initials': 'Y', 'affiliation': 'Neurosurgery Center, Department of Cerebrovascular Surgery, Engineering Technology Research Center of Education Ministry of China on Diagnosis and Treatment of Cerebrovascular Disease, Zhujiang Hospital, Southern Medical University, Guangzhou, China.'}, {'lastname': 'Xu', 'firstname': 'Qiang', 'initials': 'Q', 'affiliation': 'Department of Medical Science, Shunde Polytechnic College, Foshan, China.'}, {'lastname': 'Liu', 'firstname': 'Yahong', 'initials': 'Y', 'affiliation': 'Neurosurgery Center, Department of Cerebrovascular Surgery, Engineering Technology Research Center of Education Ministry of China on Diagnosis and Treatment of Cerebrovascular Disease, Zhujiang Hospital, Southern Medical University, Guangzhou, China.'}, {'lastname': 'He', 'firstname': 'Xuying', 'initials': 'X', 'affiliation': 'Neurosurgery Center, Department of Cerebrovascular Surgery, Engineering Technology Research Center of Education Ministry of China on Diagnosis and Treatment of Cerebrovascular Disease, Zhujiang Hospital, Southern Medical University, Guangzhou, China.'}, {'lastname': 'Tang', 'firstname': 'Jiping', 'initials': 'J', 'affiliation': 'Department of Physiology and Pharmacology, Basic Sciences, School of Medicine, Loma Linda University, Loma Linda, CA, United States.'}, {'lastname': 'Zhang', 'firstname': 'John H', 'initials': 'JH', 'affiliation': 'Department of Physiology and Pharmacology, Basic Sciences, School of Medicine, Loma Linda University, Loma Linda, CA, United States.\nDepartments of Anesthesiology, Neurosurgery and Neurology, Loma Linda University School of Medicine, Loma Linda, CA, United States.'}, {'lastname': 'Duan', 'firstname': 'Chuanzhi', 'initials': 'C', 'affiliation': 'Neurosurgery Center, Department of Cerebrovascular Surgery, Engineering Technology Research Center of Education Ministry of China on Diagnosis and Treatment of Cerebrovascular Disease, Zhujiang Hospital, Southern Medical University, Guangzhou, China.'}]",,,,"Copyright © 2022 Xu, Li, Weng, Wei, He, Doycheva, Lenahan, Tang, Zhou, Liu, Xu, Liu, He, Tang, Zhang and Duan.","10.3389/fimmu.2022.873382
10.1007/s12975-015-0432-8
10.1002/jnr.24394
10.1016/j.ijporl.2018.06.026
10.1542/peds.91.6.1083
10.1002/jnr.24388
10.1177/0271678x16684355
10.1016/j.expneurol.2019.113003
10.1038/s41598-020-65144-4
10.1007/s13311-021-01052-3
10.1161/STROKEAHA.121.034673
10.1016/j.pneurobio.2016.05.001
10.3390/md19110587
10.3389/fimmu.2021.770744
10.1161/STROKEAHA.119.026280
10.1016/j.neuropharm.2018.02.024
10.1186/s12974-019-1492-6
10.3389/fncel.2017.00352
10.1084/jem.20171905
10.1016/j.bbi.2018.02.015
10.1186/s12974-021-02209-9
10.1016/j.nbd.2015.12.015
10.1186/s12974-020-01926-x
10.1007/s12975-020-00842-9
10.1007/s12975-019-00768-x
10.1038/nrneurol.2017.69
10.1016/j.bbi.2016.05.020
10.1016/j.neuropharm.2021.108927
10.1016/j.bbi.2017.11.012
10.1523/JNEUROSCI.1685-15.2015
10.1089/neu.2017.5540
10.1542/peds.2009-2416
10.1203/PDR.0b013e3181c1b176
10.1016/j.bbi.2019.01.028
10.1186/s12974-018-1279-1
10.1093/jb/mvw009
10.1007/s13311-021-01066-x
10.1016/j.bbi.2016.12.012
10.1016/j.neuropharm.2015.04.028
10.3389/fncel.2017.00064
10.1016/j.pneurobio.2021.102125
10.1073/pnas.2103084118
10.1016/j.biopha.2020.111048
10.3389/fimmu.2019.02650
10.1186/s12974-021-02174-3
10.1016/j.neuroscience.2019.05.060
10.1093/jnen/62.3.292
10.1002/ana.410090206
10.1016/j.expneurol.2012.04.003
10.3389/fncel.2020.535320
10.1097/00006123-199705000-00021",<Element 'PubmedArticle' at 0x7f05de187680>
94,"35691467
24018757
11382396
20392965
25378524
19473767
7990513
30830471
12811596
30705532
27184839
12784053
32820378
34748768
17676058
20880510
33137409
24913307
20633279
20518076
19714588
30147637
3340425
15152023
25889371
6893963
29462012
31308730
19052875
17443351
15158178
10985866
30264645
21173082
21795548
32723345
11173090
29079540
33262643
31427925
31427925
30955244
18295886
31785264
19036970
31579849
32119278
27539739
27420480
27974216
30586068
27130316
26692002
25846618
10911921
33181066
26763728
22021636
10604842
20948535
31863285
30281531
24995975
17965656
22226600
15836969
12126581
19647141
21833699
16304628
28068976
30586067
26205660
22486535
31921220
23614573
30959278
15647484
29935309
32497757
8787838
8659718
25995479
25242211
30556174
26746151
19050032
28389721
33407059",Spinal CCK1 Receptors Contribute to Somatic Pain Hypersensitivity Induced by Malocclusion via a Reciprocal Neuron-Glial Signaling Cascade.,"Recent studies have shown that the incidence of chronic primary pain including temporomandibular disorders (TMD) and fibromyalgia syndrome (FMS) often exhibit comorbidities. We recently reported that central sensitization and descending facilitation system contributed to the development of somatic pain hypersensitivity induced by orofacial inflammation combined with stress. The purpose of this study was to explore whether TMD caused by unilateral anterior crossbite (UAC) can induce somatic pain hypersensitivity, and whether the cholecystokinin (CCK) receptor-mediated descending facilitation system promotes hypersensitivity through neuron-glia cell signaling cascade. UAC evoked thermal and mechanical pain hypersensitivity of the hind paws from day 5 to 70 that peaked at week 4 post UAC. The expression levels of CCK1 receptors, interleukin-18 (IL-18) and IL-18 receptors (IL-18R) were significantly up-regulated in the L4 to L5 spinal dorsal horn at 4 weeks post UAC. Intrathecal injection of CCK1 and IL-18 receptor antagonists blocked somatic pain hypersensitivity. IL-18 mainly co-localized with microglia, while IL-18R mainly co-localized with astrocytes and to a lesser extent with neurons. These findings indicate that the signaling transduction between neurons and glia at the spinal cord level contributes to the descending pain facilitation through CCK1 receptors during the development of the comorbidity of TMD and FMS. PERSPECTIVE: CCK1 receptor-dependent descending facilitation may mediate central mechanisms underlying the development of widespread somatic pain via a reciprocal neuron-glial signaling cascade, providing novel therapeutic targets for the clinical treatment of TMD and FMS comorbidities.","['Cholecystokinin', 'IL-18', 'comorbidity', 'fibromyalgia syndrome', 'temporomandibular disorders']",The journal of pain,2022-06-13,"[{'lastname': 'Xiang', 'firstname': 'Ting', 'initials': 'T', 'affiliation': ""Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, Research Center of Stomatology, Xi'an Jiaotong University College of Stomatology, Xi'an, Shaanxi, China; Department of Orthodontics, Xi'an Jiaotong University College of Stomatology, Xi'an, Shaanxi, China.""}, {'lastname': 'Li', 'firstname': 'Jia-Heng', 'initials': 'JH', 'affiliation': ""Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, Research Center of Stomatology, Xi'an Jiaotong University College of Stomatology, Xi'an, Shaanxi, China.""}, {'lastname': 'Su', 'firstname': 'Han-Yu', 'initials': 'HY', 'affiliation': ""Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, Research Center of Stomatology, Xi'an Jiaotong University College of Stomatology, Xi'an, Shaanxi, China.""}, {'lastname': 'Bai', 'firstname': 'Kun-Hong', 'initials': 'KH', 'affiliation': ""Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, Research Center of Stomatology, Xi'an Jiaotong University College of Stomatology, Xi'an, Shaanxi, China.""}, {'lastname': 'Wang', 'firstname': 'Shuang', 'initials': 'S', 'affiliation': ""Department of Orthodontics, Xi'an Jiaotong University College of Stomatology, Xi'an, Shaanxi, China.""}, {'lastname': 'Traub', 'firstname': 'Richard J', 'initials': 'RJ', 'affiliation': 'Department of Neural and Pain Sciences, School of Dentistry; Center to Advance Chronic Pain Research, University of Maryland Baltimore, Baltimore, Maryland. Electronic address: rtraub@umaryland.edu.'}, {'lastname': 'Cao', 'firstname': 'Dong-Yuan', 'initials': 'DY', 'affiliation': ""Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, Research Center of Stomatology, Xi'an Jiaotong University College of Stomatology, Xi'an, Shaanxi, China. Electronic address: dongyuan_cao@hotmail.com.""}]",,,,"Copyright © 2022 United States Association for the Study of Pain, Inc. Published by Elsevier Inc. All rights reserved.",10.1016/j.jpain.2022.05.009,<Element 'PubmedArticle' at 0x7f05dd652090>
95,35688319,Central and peripheral regulations mediated by short-chain fatty acids on energy homeostasis.,"The human gut microbiota influences obesity, insulin resistance, and the subsequent development of type 2 diabetes (T2D). The gut microbiota digests and ferments nutrients resulting in the production of short-chain fatty acids (SCFAs), which generate various beneficial metabolic effects on energy and glucose homeostasis. However, their roles in the central nervous system (CNS)-mediated outputs on the metabolism have only been minimally studied. Here, we explore what is known and future directions that may be worth exploring in this emerging area. Specifically, we searched studies or data in English by using PubMed, Google Scholar, and the Human Metabolome Database. Studies were filtered by time from 1978 to March 2022. As a result, 195 studies, 53 reviews, 1 website, and 1 book were included. One hundred and sixty-five of 195 studies describe the production and metabolism of SCFAs or the effects of SCFAs on energy homeostasis, glucose balance, and mental diseases through the gut-brain axis or directly by a central pathway. Thirty of 195 studies show that inappropriate metabolism and excessive of SCFAs are metabolically detrimental. Most studies suggest that SCFAs exert beneficial metabolic effects by acting as the energy substrate in the TCA cycle, regulating the hormones related to satiety regulation and insulin secretion, and modulating immune cells and microglia. These functions have been linked with AMPK signaling, GPCRs-dependent pathways, and inhibition of histone deacetylases (HDACs). However, the studies focusing on the central effects of SCFAs are still limited. The mechanisms by which central SCFAs regulate appetite, energy expenditure, and blood glucose during different physiological conditions warrant further investigation.",[],Translational research : the journal of laboratory and clinical medicine,2022-06-11,"[{'lastname': 'Luo', 'firstname': 'Pei', 'initials': 'P', 'affiliation': 'Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, The University of Illinois at Chicago, Chicago, Illinois, 60612; Guangdong Laboratory of Lingnan Modern Agriculture and Guangdong Province Key Laboratory of Animal Nutritional Regulation, National Engineering Research Center for Breeding Swine Industry, College of Animal Science, South China Agricultural University, Guangzhou, Guangdong 510642, China.'}, {'lastname': 'Lednovich', 'firstname': 'Kristen', 'initials': 'K', 'affiliation': 'Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, The University of Illinois at Chicago, Chicago, Illinois, 60612.'}, {'lastname': 'Xu', 'firstname': 'Kai', 'initials': 'K', 'affiliation': 'Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, The University of Illinois at Chicago, Chicago, Illinois, 60612.'}, {'lastname': 'Nnyamah', 'firstname': 'Chioma', 'initials': 'C', 'affiliation': 'Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, The University of Illinois at Chicago, Chicago, Illinois, 60612.'}, {'lastname': 'Layden', 'firstname': 'Brian T', 'initials': 'BT', 'affiliation': 'Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, The University of Illinois at Chicago, Chicago, Illinois, 60612; Department of Physiology and Biophysics, The University of Illinois at Chicago, Chicago, Illinois, 60612; Jesse Brown VA Medical Chicago, Chicago, Illinois, 60612.'}, {'lastname': 'Xu', 'firstname': 'Pingwen', 'initials': 'P', 'affiliation': 'Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, The University of Illinois at Chicago, Chicago, Illinois, 60612; Department of Physiology and Biophysics, The University of Illinois at Chicago, Chicago, Illinois, 60612. Electronic address: pingwenx@uic.edu.'}]",,,,Copyright © 2022 Elsevier Inc. All rights reserved.,10.1016/j.trsl.2022.06.003,<Element 'PubmedArticle' at 0x7f05dda0b9a0>
96,35643064,The etiology of poststroke-depression: a hypothesis involving HPA axis.,"Approximately, one in three ischemic stroke survivors suffered from depression, namely, post-stroke depression (PSD). PSD affects functional rehabilitation and may lead to poor quality of life of patients. There are numerous explanations about the etiologies of PSD. Here, we speculated that PSD are likely to be the result of specific changes in brain pathology. We hypothesized that the stroke-induced hyperactivity of hypothalamic-pituitary-adrenal (HPA) axis plays an important role in PSD. Stroke initiates a complex sequence of events in neuroendocrine system including HPA axis. The HPA axis is involved in the pathophysiology of depression, especially, the overactivity of the HPA axis occurs in major depressive disorder. This review summarizes the possible etiologies of PSD, focusing on the stroke-induced activation of HPA axis, mainly including the stress followed by severe brain damage and the proinflammatory cytokines release. The role of hyperactive of HPA axis in PSD was discussed in detail, which includes the role of high level corticotropin-releasing hormone in PSD, the effects of glucocorticoids on the alterations in specific brain structures, the expression of enzymes, excitotoxicity, the change in intestinal permeability, and the activation of microglia. The relationship between neuroendocrine regulation and inflammation was also described. Finally, the therapy of PSD by regulating HPA axis, neuroendocrine, and immunity was discussed briefly. Nevertheless, the change of HPA axis and the occurring of PSD maybe interact and promote on each other, and future investigations should explore this hypothesis in more depth.","['Corticosteroids', 'Cytokines', 'HPA axis', 'Post-stroke depression', 'Stress']",Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,2022-06-02,"[{'lastname': 'Zhou', 'firstname': 'Lin', 'initials': 'L', 'affiliation': 'School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong 264005, PR China.'}, {'lastname': 'Wang', 'firstname': 'Tian', 'initials': 'T', 'affiliation': 'School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong 264005, PR China.'}, {'lastname': 'Yu', 'firstname': 'Yawen', 'initials': 'Y', 'affiliation': 'School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong 264005, PR China.'}, {'lastname': 'Li', 'firstname': 'Mingan', 'initials': 'M', 'affiliation': 'School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong 264005, PR China.'}, {'lastname': 'Sun', 'firstname': 'Xiaohui', 'initials': 'X', 'affiliation': 'School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong 264005, PR China.'}, {'lastname': 'Song', 'firstname': 'Wenhao', 'initials': 'W', 'affiliation': 'School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong 264005, PR China.'}, {'lastname': 'Wang', 'firstname': 'Yunjie', 'initials': 'Y', 'affiliation': 'School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong 264005, PR China.'}, {'lastname': 'Zhang', 'firstname': 'Ce', 'initials': 'C', 'affiliation': 'School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong 264005, PR China.'}, {'lastname': 'Fu', 'firstname': 'Fenghua', 'initials': 'F', 'affiliation': 'School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong 264005, PR China. Electronic address: fufenghua@luye.com.'}]",,,,Copyright © 2022 The Authors. Published by Elsevier Masson SAS.. All rights reserved.,10.1016/j.biopha.2022.113146,<Element 'PubmedArticle' at 0x7f05dda1e090>
97,"35642214
26644079
20638485
10683423
27959620
20048196
30318562
26324508
28826800
33842566
27568995
24381729
18026097
30108586
15831717
27714685
24889886
14980203
15601948
21778362
15890528
19193879
25002752
21804537
27459405
24669294
32023447
31585077
32259484
30539780
20547972
22958438
26056339
25963715
26874752
24324037
27155147
16940209
27113409
9809195
17519130
29351470
22526255
25302502
22387113
32532282
6132853
29038201
1655143
1317760
20074796
32087235
26374897
25047746
25732305
34489683
25568124
31924219
28698257
23608137
31421410
25811788
23441900
26637556
34610452
28143587
25870193
35113664
30612527
28222814
26715471
31923755
26254332
24561814
20156424
15148057
24794248
22591793
16242142
32566102
24879505
25524407
21487505
30353660
30978539
27184295
26344664
25446007
28320099
28164443
32963707",Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Cardiovascular Diseases.,"Microglia are tissue-resident macrophages of the central nervous system (CNS). In the CNS, microglia play an important role in the monitoring and intervention of synaptic and neuron-level activities. Interventions targeting microglia have been shown to improve the prognosis of various neurological diseases. Recently, studies have observed the activation of microglia in different cardiovascular diseases. In addition, different approaches that regulate the activity of microglia have been shown to modulate the incidence and progression of cardiovascular diseases. The change in autonomic nervous system activity after neuroinflammation may be a potential intermediate link between microglia and cardiovascular diseases. Here, in this review, we will discuss recent updates on the regulatory role of microglia in hypertension, myocardial infarction and ischemia/reperfusion injury. We propose that microglia serve as neuroimmune modulators and potential targets for cardiovascular diseases.","['autonomic nervous system', 'central-peripheral crosstalk', 'neuroimmune', 'sympathetic nervous system']",Journal of inflammation research,2022-06-02,"[{'lastname': 'Wang', 'firstname': 'Menglong', 'initials': 'M', 'affiliation': ""Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.\nCardiovascular Research Institute, Wuhan University, Wuhan, 430060, People's Republic of China.\nHubei Key Laboratory of Cardiology, Wuhan, 430060, People's Republic of China.""}, {'lastname': 'Pan', 'firstname': 'Wei', 'initials': 'W', 'affiliation': ""Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.\nCardiovascular Research Institute, Wuhan University, Wuhan, 430060, People's Republic of China.\nHubei Key Laboratory of Cardiology, Wuhan, 430060, People's Republic of China.""}, {'lastname': 'Xu', 'firstname': 'Yao', 'initials': 'Y', 'affiliation': ""Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.\nCardiovascular Research Institute, Wuhan University, Wuhan, 430060, People's Republic of China.\nHubei Key Laboratory of Cardiology, Wuhan, 430060, People's Republic of China.""}, {'lastname': 'Zhang', 'firstname': 'Jishou', 'initials': 'J', 'affiliation': ""Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.\nCardiovascular Research Institute, Wuhan University, Wuhan, 430060, People's Republic of China.\nHubei Key Laboratory of Cardiology, Wuhan, 430060, People's Republic of China.""}, {'lastname': 'Wan', 'firstname': 'Jun', 'initials': 'J', 'affiliation': ""Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.\nCardiovascular Research Institute, Wuhan University, Wuhan, 430060, People's Republic of China.\nHubei Key Laboratory of Cardiology, Wuhan, 430060, People's Republic of China.""}, {'lastname': 'Jiang', 'firstname': 'Hong', 'initials': 'H', 'affiliation': ""Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.\nCardiovascular Research Institute, Wuhan University, Wuhan, 430060, People's Republic of China.\nHubei Key Laboratory of Cardiology, Wuhan, 430060, People's Republic of China.""}]",,,,© 2022 Wang et al.,"10.2147/JIR.S350109
10.1016/j.resp.2015.11.015
10.1016/j.biocel.2010.07.005
10.1016/S0306-4522(99)00538-2
10.1146/annurev-physiol-022516-034406
10.1161/HYPERTENSIONAHA.109.142042
10.1007/s12264-018-0298-3
10.1161/HYPERTENSIONAHA.115.03624
10.1016/j.ijcard.2017.08.011
10.3389/fcvm.2021.668387
10.1016/j.autneu.2016.08.014
10.12703/P5-53
10.1038/nn2014
10.3389/fimmu.2018.01753
10.1126/science.1110647
10.1186/1742-2094-11-98
10.1016/S0896-6273(04)00069-8
10.1523/JNEUROSCI.2251-04.2004
10.1126/science.1202529
10.1016/j.mcn.2005.03.005
10.1523/JNEUROSCI.5505-08.2009
10.1084/jem.20132477
10.1038/nn.2887
10.1038/nn.4338
10.12703/P6-13
10.1016/j.celrep.2020.01.010
10.1016/j.cell.2019.08.053
10.1016/j.cell.2020.03.021
10.1016/j.cyto.2018.07.003
10.1161/HYPERTENSIONAHA.110.150409
10.1186/1742-2094-9-212
10.1161/HYPERTENSIONAHA.115.05333
10.1161/CIRCRESAHA.117.305853
10.1016/j.jjcc.2016.01.004
10.1161/HYPERTENSIONAHA.113.02429
10.1016/j.neuroscience.2016.04.044
10.1016/j.pharmthera.2016.04.006
10.1111/j.1440-1681.1998.tb02303.x
10.1007/s11906-007-0041-3
10.1152/ajpheart.00616.2017
10.1161/HYPERTENSIONAHA.111.190108
10.1371/journal.pone.0092937
10.1016/j.neuroscience.2012.02.018
10.1016/0306-3623(83)90001-0
10.1161/HYPERTENSIONAHA.117.09744
10.1111/j.1476-5381.1991.tb12341.x
10.1042/cs0820513
10.1016/j.npep.2009.12.011
10.1016/j.phrs.2020.104715
10.1074/jbc.M115.677286
10.1038/npp.2014.164
10.1084/jem.20142322
10.3389/fnagi.2021.716917
10.1523/JNEUROSCI.3561-14.2015
10.1186/s12974-019-1673-3
10.1161/STROKEAHA.117.017370
10.1016/j.psyneuen.2013.03.017
10.1016/j.redox.2019.101295
10.1371/journal.pone.0122850
10.2174/1389203711314010006
10.1152/ajpheart.00247.2015
10.1016/j.phrs.2021.105877
10.1186/s40168-016-0222-x
10.1161/HYPERTENSIONAHA.115.05315
10.1161/CIRCRESAHA.121.319816
10.1161/CIRCRESAHA.118.313882
10.1017/S0954422416000275
10.1186/s12967-015-0759-7
10.1016/j.jnutbio.2019.108318
10.1152/ajpheart.00349.2015
10.1249/MSS.0000000000000307
10.1016/j.brainres.2010.02.028
10.1152/ajpheart.01072.2003
10.1016/j.autneu.2014.03.007
10.1016/j.autneu.2012.04.004
10.1016/j.yjmcc.2005.09.002
10.1155/2020/7956274
10.1007/s00380-014-0527-2
10.1016/j.neulet.2014.12.026
10.4161/self.1.4.13736
10.1111/jcmm.13890
10.1016/j.redox.2019.101186
10.1016/j.neures.2016.05.002
10.1179/1743132815Y.0000000090
10.1016/j.brainres.2014.10.005
10.1016/j.biopha.2017.03.024
10.1002/jbio.201600244
10.1155/2020/9343160",<Element 'PubmedArticle' at 0x7f05dda0e810>
98,"35563181
33174475
28686222
28367411
24507514
18970977
32682869
30967783
33173466
30578090
32265902
34356682
27459405
31652490
27934854
28987266
25254187
11286782
32825077
33603230
31768073
7690856
18567623
9590212
20637861
28721047
16632554
27766432
22837037
31066630
31467299
19847447
23595275
25986556
9126051
11212131
23524331
28127589
19339255
26515289
32669900
32702337
33935649
26696956
18439226
15895084
26990767
24889886
17634104
21549181
11835378
10852536
27988845
28541408
1698025
20138983
20682002
12495638
12044976
16280350
20411441
29426702
21976503
32635596
32317939
10532806
21910624
26990661
31040847
15735651
25002752
21507994
33758401
23917093
18341408
16399703
23981039
26962228
14500997
12609490
9517470
32718316
21800138
19171755
25893602
21401967
23334594
22776089
18615637
16374778
15006698
9314552
26990204
21347448
33691116
29379818
25695599
25265470
20805564
32772264
17425404
31902528
34424266
12776204
28987033
28214109
12080485
30042649
18790823
31101881
25631124
17407101
17304573
15728241
22072381
11600888
29397421
31071011
23872599
27009332
32078678
11264668
20186338
1349613
25853624
10845916
23319875
20478301
30087595
32623621
31089059
32856125
25267631
34006329
30306644
23517078
24856828
32196442
32765225
21895607
30345481
21524252
22544516
29619773
18835258
34867774
35164469
19190179
20978211
27357191
25305591
17476341
34610465
28863829
20477831
25658447
24246222
31920495
32767188
23500093
23720065
24801739
12923064
31619964
12112366
12525573
34681607
35008762
22318286
8278627
8557521
22328918
28104390
10515428
33031415
25800044
23589621
12754213
12054537
22643083
22583372
15476707
15194876
18442091
27208432
34948457
21084670
23906635
16006741
19181454
20559421
35199308
34400297
29863024
21244427
33405317
16371949
24498101
9603224
21524251
26991551
11854096
9753136
11687615
26718601
33429934
35163768
34070429
21730107
28093710
28288671
11356873
21726625
15282712
23734144
22203900
31616249
25779633
21187959
9973433",Exploring the Pro-Phagocytic and Anti-Inflammatory Functions of PACAP and VIP in Microglia: Implications for Multiple Sclerosis.,"Multiple sclerosis (MS) is a chronic neuroinflammatory and demyelinating disease of the central nervous system (CNS), characterised by the infiltration of peripheral immune cells, multifocal white-matter lesions, and neurodegeneration. In recent years, microglia have emerged as key contributors to MS pathology, acting as scavengers of toxic myelin/cell debris and modulating the inflammatory microenvironment to promote myelin repair. In this review, we explore the role of two neuropeptides, pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP), as important regulators of microglial functioning during demyelination, myelin phagocytosis, and remyelination, emphasising the potential of these neuropeptides as therapeutic targets for the treatment of MS.","['anti-inflammatory', 'inflammation', 'microglia', 'multiple sclerosis', 'phagocytosis', 'pituitary adenylate cyclase-activating polypeptide (PACAP)', 'vasoactive intestinal peptide (VIP)']",International journal of molecular sciences,2022-05-15,"[{'lastname': 'Jansen', 'firstname': 'Margo I', 'initials': 'MI', 'affiliation': 'Laboratory of Cellular and Molecular Neuroscience (LCMN), School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW 2007, Australia.'}, {'lastname': 'Thomas Broome', 'firstname': 'Sarah', 'initials': 'S', 'affiliation': 'Laboratory of Cellular and Molecular Neuroscience (LCMN), School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW 2007, Australia.'}, {'lastname': 'Castorina', 'firstname': 'Alessandro', 'initials': 'A', 'affiliation': 'Laboratory of Cellular and Molecular Neuroscience (LCMN), School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW 2007, Australia.'}]",,,,,"10.3390/ijms23094788
10.1177/1352458520970841
10.3390/brainsci7070078
10.22074/cellj.2016.4867
10.1016/B978-0-444-52001-2.00004-2
10.1016/S0140-6736(08)61620-7
10.1016/j.amjmed.2020.05.049
10.3389/fphar.2019.00286
10.3389/fncel.2020.00284
10.1016/j.molmed.2018.11.005
10.3389/fimmu.2020.00374
10.3390/biom11071058
10.1038/nn.4338
10.3390/cells8101293
10.1038/nrneurol.2016.187
10.1016/j.tig.2017.09.004
10.5493/wjem.v4.i3.27
10.1016/S1471-4914(00)01909-2
10.3390/sci3010012
10.3390/jfmk3010013
10.3390/ijms21175960
10.1038/s41593-021-00801-z
10.1038/s41590-019-0539-2
10.1002/jnr.490350504
10.1093/brain/awn109
10.1016/j.bbadis.2010.07.008
10.2147/NDT.S140634
10.1093/brain/awl075
10.1007/s00401-016-1631-4
10.1038/nn.3168
10.1152/physrev.00031.2018
10.1038/s41467-019-11638-3
10.1007/s00401-009-0601-5
10.1007/s00401-013-1112-y
10.1101/cshperspect.a020594
10.1093/brain/120.3.393
10.1177/135245850000600602
10.1136/jnnp-2012-304094
10.1093/brain/awp070
10.1177/1352458515587598
10.2147/DNND.S54391
10.1016/S1474-4422(20)30140-X
10.3389/fncel.2021.604865
10.3389/fneur.2015.00257
10.1111/j.1600-0404.2008.01036.x
10.1038/nn1472
10.1111/jnc.13607
10.1186/1742-2094-11-98
10.1186/1471-2172-8-10
10.1016/j.neuroscience.2011.04.053
10.1002/ana.10092
10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q
10.1007/s00401-016-1653-y
10.1093/brain/awx113
10.1016/j.bbi.2010.01.014
10.1111/j.1365-2249.2010.04143.x
10.1016/S1044-5323(02)00125-2
10.1016/S0165-5728(02)00097-8
10.1093/brain/awh680
10.1007/s12017-010-8112-z
10.1016/j.immuni.2018.01.011
10.1523/JNEUROSCI.6595-10.2011
10.3390/ijms21134768
10.3389/fncel.2020.00079
10.1006/mcne.1999.0771
10.1146/annurev-pathol-011811-132445
10.1038/cdd.2015.172
10.3389/fimmu.2019.00790
10.1038/nm1202
10.1084/jem.20132477
10.1093/brain/awr014
10.1038/s41593-021-00829-1
10.1212/01.CON.0000433291.23091.65
10.3171/FOC/2008/24/3-4/E4
10.1523/JNEUROSCI.2615-05.2006
10.1111/imm.12163
10.4049/jimmunol.1502562
10.1385/JMN:21:1:65
10.1016/S0969-9961(02)00008-6
10.1111/j.1460-9568.1997.tb01694.x
10.1186/s12974-020-01899-x
10.1007/s00251-011-0562-4
10.1083/jcb.200808080
10.1172/JCI77983
10.1186/1742-2094-8-24
10.1097/NEN.0b013e31827fd9e8
10.1186/1742-2094-9-166
10.1002/glia.20713
10.1002/glia.20304
10.1016/j.nbd.2003.11.007
10.1084/jem.186.7.1027
10.1371/journal.pgen.1005853
10.1371/journal.pone.0016964
10.1016/j.celrep.2021.108835
10.1212/NXI.0000000000000402
10.1038/cddis.2015.18
10.7554/eLife.03385
10.1084/jem.20101157
10.1007/s00401-020-02193-z
10.1371/journal.pmed.0040124
10.1016/j.neuron.2019.12.007
10.1084/jem.20210227
10.1038/nri1106
10.1111/bpa.12564
10.1016/j.neurobiolaging.2017.01.015
10.1086/342259
10.5152/npa.2017.19484
10.1093/brain/awn217
10.1038/s41598-019-43535-6
10.1007/s00401-015-1388-1
10.1002/eji.200636837
10.1002/jnr.21206
10.1084/jem.20041611
10.1002/glia.21266
10.1038/nn738
10.1007/s00401-018-1813-3
10.7554/eLife.41869
10.1038/nn.3469
10.1186/s12974-016-0531-9
10.1084/jem.20191390
10.1046/j.0953-816x.2001.01470.x
10.1371/journal.pone.0009380
10.1016/0165-5728(92)90085-Y
10.1186/s40478-015-0192-4
10.1182/blood.V95.12.3823
10.5607/en.2012.21.4.151
10.1016/j.expneurol.2010.04.020
10.3389/fncel.2018.00215
10.1007/s10616-020-00409-4
10.4103/1673-5374.255975
10.1007/s00109-020-01968-x
10.1073/pnas.1407447111
10.1186/s40478-021-01186-7
10.1002/glia.23517
10.1111/bph.12181
10.5483/BMBRep.2014.47.7.086
10.2174/0929867327666200320162436
10.3389/fncel.2020.00221
10.1042/AN20110024
10.1007/s11357-018-0045-8
10.2174/138161211795589364
10.1007/s12031-012-9781-x
10.1186/s10194-018-0855-1
10.1016/j.brainres.2008.09.035
10.3389/fendo.2021.711906
10.31083/j.jin2101033
10.1073/pnas.0812257106
10.1073/pnas.1007622107
10.1186/s12974-016-0626-3
10.1016/j.bbi.2014.09.020
10.1172/JCI31720
10.1016/j.nbd.2021.105524
10.1016/j.nrl.2017.07.002
10.1111/j.1750-3639.2010.00401.x
10.1371/journal.pone.0117799
10.1016/j.yexcr.2013.11.003
10.3390/app11167673
10.3389/fnins.2019.01326
10.1007/s12031-020-01672-y
10.1016/j.neuroscience.2013.03.002
10.1007/s12031-013-0017-5
10.1002/glia.22682
10.1096/fj.02-1029fje
10.3389/fncel.2019.00421
10.1002/glia.10098
10.1189/jlb.0702372
10.3390/ijms222010947
10.3390/ijms23010337
10.1160/TH11-08-0567
10.1016/0167-0115(93)90163-3
10.1016/0162-3109(95)00025-O
10.1371/journal.pone.0029790
10.1016/j.mce.2017.01.022
10.1183/09031936.99.14244399
10.1371/journal.ppat.1008971
10.1111/bph.13139
10.4049/jimmunol.1203121
10.1074/jbc.M303199200
10.1016/S0006-291X(02)00283-8
10.1179/1743132812Y.0000000028
10.1089/neu.2011.2244
10.1016/j.brainres.2004.08.017
10.1097/01.wnr.0000130541.29635.6f
10.1002/glia.20681
10.1016/j.intimp.2016.05.007
10.3390/ijms222413660
10.4049/jimmunol.1001829
10.1016/j.neuroscience.2013.07.053
10.1254/jphs.FMJ05001X4
10.1016/j.psyneuen.2008.12.013
10.1371/journal.pone.0011091
10.1007/s12031-022-01968-1
10.1016/j.freeradbiomed.2021.08.011
10.4103/1673-5374.232489
10.1111/j.1471-4159.2011.07185.x
10.1111/1751-2980.12932
10.1038/nrn1824
10.1371/journal.pone.0087420
10.1046/j.1471-4159.1998.70062574.x
10.2174/138161211795589409
10.1111/jnc.13614
10.1677/jme.0.0280019
10.1046/j.1460-9568.1998.00052.x
10.1073/pnas.231094498
10.1016/j.neuroscience.2015.12.034
10.3390/life11010035
10.3390/ijms23031845
10.3390/cells10061312
10.1096/fj.11-182337
10.1007/978-3-319-47861-6_7
10.1186/s12974-017-0805-x
10.1523/JNEUROSCI.21-11-03849.2001
10.1016/j.ijdevneu.2011.06.008
10.1002/cne.20231
10.3389/fendo.2013.00055
10.1155/2011/383087
10.3389/fnmol.2019.00225
10.1084/jem.20141656
10.1371/journal.pone.0015299",<Element 'PubmedArticle' at 0x7f05ddf92680>
99,35514286,Vitamin D Enhances Hematoma Clearance and Neurologic Recovery in Intracerebral Hemorrhage.,"Erythrophagocytosis by reparative monocyte-derived macrophage contributes to hematoma clearance and neurological recovery after intracerebral hemorrhage (ICH). Vitamin D (VitD) is a neuroprotective hormone and regulates the differentiation of monocyte-derived macrophage from monocytes. In this study, we examined the effects of VitD supplementation on monocyte-derived macrophage and hematoma clearance in rodent with ICH.
Neurobehavioral functions and hematoma volume were assessed using a collagenase injection model in both young- and middle-aged mice with or without VitD treatment given 2 hours post-ICH induction. We used flow cytometry to analyze CD36 expression and macrophage and undifferentiated monocyte cell numbers during in vivo erythrophagocytosis in collagenase and autologous blood injection models. Western blot analysis and immunofluorescence were used to assess the expression levels of the PPAR-γ (peroxisome proliferator-activated receptor γ)-CD36 axis and CD206. A macrophage differentiation study was conducted on murine bone marrow-derived monocytes.
VitD promoted neurological recovery and facilitated hematoma clearance in both young- and middle-aged mice after ICH. Within the perihematomal region, mature macrophages, rather than undifferentiated monocytes, expressed higher levels of CD36 in driving erythrocyte clearance. VitD increased the macrophage number but decreased the monocyte number and elevated the levels of CD36 and PPAR-γ in the brain. In vitro, VitD accelerated the differentiation of reparative macrophages from bone marrow-derived monocytes.
VitD promotes reparative macrophage differentiation, facilitates hematoma clearance, and improves neurobehavioral performance in mice with ICH, suggesting that VitD should be further examined as a potentially promising treatment for ICH.","['cerebral hemorrhage', 'hormones', 'macrophages', 'monocytes', 'vitamin D']",Stroke,2022-05-07,"[{'lastname': 'Liu', 'firstname': 'Jiaxin', 'initials': 'J', 'affiliation': 'Department of Surgery, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, China (J.L., N.L., Z.Z., K.K., A.N.).'}, {'lastname': 'Li', 'firstname': 'Ning', 'initials': 'N', 'affiliation': 'Department of Surgery, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, China (J.L., N.L., Z.Z., K.K., A.N.).\nDepartment of Neurosurgery, Zhongda Hospital, Southeast University, Nanjing, China (N.L.).'}, {'lastname': 'Zhu', 'firstname': 'Zhiyuan', 'initials': 'Z', 'affiliation': 'Department of Surgery, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, China (J.L., N.L., Z.Z., K.K., A.N.).\nDepartment of Functional neurosurgery, Zhujiang Hospital, Southern Medical University, The National Key Clinical Specialty, The Engineering Technology Research Center of Education Ministry of China, Guangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, The Neurosurgery Institute of Guangdong Province, Guangzhou, China (Z.Z.).'}, {'lastname': 'Kiang', 'firstname': 'Karrie Mei-Yee', 'initials': 'KM', 'affiliation': 'Department of Surgery, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, China (J.L., N.L., Z.Z., K.K., A.N.).'}, {'lastname': 'Ng', 'firstname': 'Anson Cho Kiu', 'initials': 'ACK', 'affiliation': None}, {'lastname': 'Dong', 'firstname': 'Celia M', 'initials': 'CM', 'affiliation': 'Department of Electrical and Electronic Engineering, Faculty of Engineering, The University of Hong Kong, China (C.M.D.).'}, {'lastname': 'Leung', 'firstname': 'Gilberto Ka-Kit', 'initials': 'GK', 'affiliation': 'Department of Surgery, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, China (J.L., N.L., Z.Z., K.K., A.N.).'}]",,,"VitD promoted neurological recovery and facilitated hematoma clearance in both young- and middle-aged mice after ICH. Within the perihematomal region, mature macrophages, rather than undifferentiated monocytes, expressed higher levels of CD36 in driving erythrocyte clearance. VitD increased the macrophage number but decreased the monocyte number and elevated the levels of CD36 and PPAR-γ in the brain. In vitro, VitD accelerated the differentiation of reparative macrophages from bone marrow-derived monocytes.",,10.1161/STROKEAHA.121.037769,<Element 'PubmedArticle' at 0x7f05de4d3180>
100,"35496905
30038282
26884166
25768734
22982535
34489419
29033027
33326786
35354026
33214681
23467340
31896673
30359409
25100586
29339791
34233165
24166765
17976923
26043079
30471926
16844302
28602351
2089275
23407936
31888774
24124122
31158432
32375817
30760929
31555101
34159699
27558646
32661024
21778362
22072675
33887203
22632727
22182318
30835074
25530985
29285893
34589871
25658639
31772305
31325456
28683286
25497089
31883839
28736330
31597593
32286273
25186741",Microglia Don't Treat All Neurons the Same: The Importance of Neuronal Subtype in Microglia-Neuron Interactions in the Developing Hypothalamus.,"Microglia are now well-known as integral regulators of brain development, phagocytosing whole neurons, and pruning weak or excess synapses in order to sculpt and refine immature circuits. However, the importance of neuronal subtype in guiding microglial activity has not received much attention until recently. This perspective will delineate what is known about this topic so far, starting with the developing brain as a whole and then focusing on the developing hypothalamus in particular. There is emerging evidence that subpopulations of microglia treat excitatory and inhibitory neurons differently, and our recent work has shown that even the type of neuropeptide produced by the nearby neurons is important. For example, microglia abutting corticotropin-releasing hormone (CRH)-expressing neurons in the paraventricular nucleus of the hypothalamus (PVN) engulf fewer excitatory synapses than do microglia on the borders of the PVN that are not contacting CRH+ neurons. Potential future directions and technical considerations will be discussed in an effort to catalyze this emerging and exciting area of research. Applications of this research may hold promise in creating more specific therapies that target unique subtypes of microglia-neuron interactions in the atypically developing brain.","['PVN', 'development', 'heterogeneity', 'hypothalamus', 'microglia', 'microglia-neuron interactions', 'neuron-specific', 'subpopulation']",Frontiers in cellular neuroscience,2022-05-03,"[{'lastname': 'Ngozi', 'firstname': 'Zuri', 'initials': 'Z', 'affiliation': 'Neuroscience Institute, Georgia State University, Atlanta, GA, United States.'}, {'lastname': 'Bolton', 'firstname': 'Jessica L', 'initials': 'JL', 'affiliation': 'Neuroscience Institute, Georgia State University, Atlanta, GA, United States.'}]",,,,Copyright © 2022 Ngozi and Bolton.,"10.3389/fncel.2022.867217
10.1038/s41593-018-0192-3
10.1073/pnas.1525528113
10.1371/journal.pone.0118842
10.1016/j.yfrne.2012.08.006
10.1038/s41467-021-25590-8
10.1016/j.biopsych.2017.08.023
10.1016/j.celrep.2020.108511
10.1016/j.celrep.2022.110600
10.1038/s42003-020-01418-x
10.1523/JNEUROSCI.3441-12.2013
10.1523/JNEUROSCI.0993-19.2019
10.1371/journal.pone.0206093
10.1523/JNEUROSCI.0405-14.2014
10.1038/s41598-018-19205-4
10.1016/j.cell.2021.06.018
10.1002/glia.22580
10.1016/j.psyneuen.2007.09.004
10.1038/cddis.2015.151
10.1016/j.immuni.2018.11.004
10.1016/j.neuroscience.2006.06.003
10.1016/j.cell.2017.05.018
10.1016/0306-4522(90)90229-w
10.1523/JNEUROSCI.1268-12.2013
10.1186/s13064-019-0137-x
10.1002/aur.1338
10.1016/j.neulet.2019.134310
10.1186/s12974-020-01811-7
10.1038/s41586-019-0924-x
10.3389/fncir.2019.00055
10.1111/brv.12750
10.1038/ncomms12540
10.1523/JNEUROSCI.3006-19.2020
10.1126/science.1202529
10.1523/JNEUROSCI.3667-11.2011
10.1016/j.devcel.2021.03.018
10.1016/j.neuron.2012.03.026
10.1111/j.1471-4159.2011.07630.x
10.1007/s12272-019-01138-9
10.1016/j.bpsgos.2021.12.006
10.1016/j.ynstr.2014.10.007
10.1002/dneu.22572
10.1016/j.bbih.2020.100111
10.1371/journal.pone.0116644
10.1038/s41380-019-0609-8
10.1016/j.yfrne.2019.100771
10.1016/j.cmet.2017.05.015
10.1016/j.celrep.2014.11.018
10.1016/j.immuni.2019.12.004
10.1016/j.bbr.2017.07.023
10.1016/j.molmed.2019.08.013
10.1038/s41467-020-15530-3
10.1523/JNEUROSCI.1860-14.2014",<Element 'PubmedArticle' at 0x7f05de4c36d0>
101,"35474339
20093161
20951768
25824676
30109819
30379595
21778362
22632727
17344397
16355225
25497089
28683286
29380303
31257031
27988382
22915019
30319362
31610887
29795463
22201683
29793524
25423565
30460775
27393312
28636961
28323268
21952260
20966214
26287683
28546318
31509751
32923636
32513737
29706957
30355499
31727092
30804800
31474875
29321684
31447640
24166765
19922787
29174000
7592907
11344187
17618856
18971219
29184485
16517403
21693680
16720054
28336086
27908915
25202980
31881271
26916241
11931352
30279161
10604470
11880196
31780940
26208455
28223698
33731174
28544365
31923417
29924994
24411942
22483785
21219177
24625061
32659044
28298267
17991637
17456850
19735725
29030613
29396567
32450884
25186741
25646713
23741455
30353127
28500692
19052722
25375037
19883619
22751700
24815961
28785099
19144836
29681442
15047622
24681566
32715746
11786910
28402851
20808781
32142677
32078586
26025052
16931789
32670063
14747283
22747686
30017356
19901143
32235875
16002529
25373903
19116375
24075847
29793524
28752053
27903745
31159189
11812732
22560217
15155754
32694719
32209097
22674334
15505215
27616451
23478685
16033867
26030851
29275859
31123355
25695945
25500202
29769726
25417104
28489068
30618635
31061494
27135602
30173915
31849963
31792059
27776109
31762013
26884166
31371457
32573436
17115040
32541832
20016782
33333014
32720646
29581545
31801075
31831638
28602351
31959936",Metabolic factors in the regulation of hypothalamic innate immune responses in obesity.,"The hypothalamus is a central regulator of body weight and energy homeostasis. There is increasing evidence that innate immune activation in the mediobasal hypothalamus (MBH) is a key element in the pathogenesis of diet-induced obesity. Microglia, the resident immune cells in the brain parenchyma, have been shown to play roles in diverse aspects of brain function, including circuit refinement and synaptic pruning. As such, microglia have also been implicated in the development and progression of neurological diseases. Microglia express receptors for and are responsive to a wide variety of nutritional, hormonal, and immunological signals that modulate their distinct functions across different brain regions. We showed that microglia within the MBH sense and respond to a high-fat diet and regulate the function of hypothalamic neurons to promote food intake and obesity. Neurons, glia, and immune cells within the MBH are positioned to sense and respond to circulating signals that regulate their capacity to coordinate aspects of systemic energy metabolism. Here, we review the current knowledge of how these peripheral signals modulate the innate immune response in the MBH and enable microglia to regulate metabolic control.",[],Experimental & molecular medicine,2022-04-28,"[{'lastname': 'Folick', 'firstname': 'Andrew', 'initials': 'A', 'affiliation': 'Diabetes Center and Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, CA, USA.'}, {'lastname': 'Cheang', 'firstname': 'Rachel T', 'initials': 'RT', 'affiliation': 'Diabetes Center and Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, CA, USA.'}, {'lastname': 'Valdearcos', 'firstname': 'Martin', 'initials': 'M', 'affiliation': 'Diabetes Center and Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, CA, USA. Martin.ValdearcosContreras@ucsf.edu.'}, {'lastname': 'Koliwad', 'firstname': 'Suneil K', 'initials': 'SK', 'affiliation': 'Diabetes Center and Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, CA, USA. Suneil.Koliwad@ucsf.edu.'}]",,,,© 2022. The Author(s).,"10.1038/s12276-021-00666-z
10.1016/j.peptides.2010.01.003
10.1016/j.neulet.2010.10.019
10.1038/nrendo.2015.48
10.1152/physrev.00035.2017
10.1146/annurev-immunol-042718-041812
10.1126/science.1202529
10.1016/j.neuron.2012.03.026
10.1523/JNEUROSCI.5360-06.2007
10.1038/nature04223
10.1016/j.celrep.2014.11.018
10.1016/j.cmet.2017.05.015
10.1007/s13311-017-0600-5
10.1016/j.cell.2019.05.054
10.1053/j.gastro.2016.10.046
10.1242/dmm.009902
10.3389/fncel.2018.00323
10.1016/j.npep.2019.101972
10.1038/s41366-018-0086-1
10.1172/JCI59660
10.1002/oby.21248
10.1210/jc.2014-2682
10.1002/oby.22324
10.1172/jci.insight.131329
10.1038/s41366-019-0399-8
10.1172/jci.insight.133868
10.1007/s00401-016-1595-4
10.1016/j.immuni.2017.06.007
10.1038/ni.3703
10.1038/nn.2923
10.1126/science.1194637
10.1016/j.immuni.2015.07.016
10.1126/science.aal3222
10.1016/j.celrep.2019.08.019
10.1126/sciadv.abb2119
10.1073/pnas.1919887117
10.3389/fimmu.2018.00698
10.1016/j.celrep.2018.09.070
10.1186/s12974-019-1607-0
10.3389/fphys.2019.00051
10.3389/fphys.2019.01036
10.1038/nrn.2017.168
10.3389/fnins.2019.00828
10.1002/glia.22580
10.1016/j.bbi.2009.11.003
10.1016/j.molmet.2017.11.003
10.1074/jbc.270.45.26746
10.1210/jcem.86.5.7463
10.1016/j.cmet.2007.06.003
10.1677/JOE-08-0348
10.3390/ijms20225738
10.3389/fncel.2017.00352
10.1016/j.cmet.2006.01.004
10.1210/en.2011-0174
10.1016/j.neures.2006.04.008
10.1016/j.ejcb.2017.03.004
10.2337/db16-1102
10.1172/JCI75276
10.1016/j.phrs.2019.104615
10.1002/oby.21387
10.1385/JMN:18:1-2:07
10.2337/db18-0729
10.1038/45230
10.1016/S0304-3940(01)02544-7
10.3389/fphar.2019.01320
10.1016/j.bbrc.2015.07.097
10.1038/ijo.2015.114
10.1038/ncomms14556
10.1186/s12974-021-02124-z
10.1111/acel.12590
10.1016/j.yhbeh.2020.104675
10.1016/j.celrep.2018.05.048
10.3390/cells8121609
10.1016/j.cmet.2013.12.003
10.1016/j.physbeh.2012.03.021
10.1146/annurev-immunol-031210-101322
10.1186/1742-2094-11-48
10.1002/glia.23882
10.3945/an.116.014431
10.1093/ajcn/86.5.1286
10.2337/db06-1491
10.1016/j.bbi.2009.09.001
10.1038/s41598-017-13302-6
10.1038/s41598-018-20643-3
10.1186/s12974-020-01837-x
10.1523/JNEUROSCI.1860-14.2014
10.1210/en.2014-1849
10.1371/journal.pone.0065061
10.1038/s41598-018-33928-4
10.1002/oby.21871
10.1007/s00125-008-1221-7
10.1210/en.2014-1552
10.1016/j.cmet.2009.09.006
10.2337/db11-1595
10.1038/ncomms4878
10.1038/s41598-017-07858-6
10.1523/JNEUROSCI.2760-08.2009
10.1016/j.cmet.2018.03.014
10.2337/diabetes.53.4.1060
10.1038/ni.2865
10.1152/ajpendo.00306.2020
10.1038/nm0102-75
10.1016/j.celrep.2017.03.043
10.1371/journal.pbio.1000465
10.1016/j.cell.2020.02.013
10.1172/JCI133572
10.1016/j.jneuroim.2015.05.001
10.1161/01.ATV.0000242905.41404.68
10.3389/fphar.2020.00943
10.2337/diabetes.53.2.336
10.1186/1742-2094-9-149
10.1016/j.cmet.2018.06.010
10.1001/archinternmed.2009.343
10.1038/s41574-020-0346-8
10.1210/en.2004-1520
10.1016/j.celrep.2014.09.025
10.1152/ajpendo.90377.2008
10.1016/j.bbi.2013.09.011
10.1186/s13041-018-0372-9
10.1016/j.molmet.2017.06.008
10.2337/db16-0586
10.3390/nu11061241
10.2337/diabetes.51.2.271
10.1016/j.cmet.2012.01.013
10.1074/jbc.M400458200
10.1038/s42255-019-0040-0
10.1186/s12974-020-01742-3
10.1126/science.1223490
10.1073/pnas.0407076101
10.1038/nrendo.2016.150
10.1073/pnas.0504978102
10.1038/nn.4030
10.1016/j.cell.2017.11.042
10.1038/s41575-019-0157-3
10.2337/db14-1213
10.1136/gutjnl-2014-307913
10.1038/s41586-018-0119-x
10.1016/j.cell.2014.09.048
10.1038/ncomms15143
10.3389/fncel.2018.00488
10.1038/s41593-019-0393-4
10.1038/ni.3423
10.1016/j.cell.2018.07.048
10.3389/fimmu.2019.02780
10.26508/lsa.201900453
10.1038/ni.3585
10.1002/eji.201948342
10.1073/pnas.1525528113
10.7554/eLife.54590
10.1038/nn1805
10.1038/s41590-020-0707-4
10.1371/journal.pone.0008354
10.1016/j.immuni.2020.11.007
10.7554/eLife.55909
10.1038/s41467-018-03566-5
10.1016/j.celrep.2019.11.013
10.1126/science.aax6752
10.1016/j.cell.2017.05.018
10.1038/s41593-019-0566-1",<Element 'PubmedArticle' at 0x7f05de5ac9a0>
102,"35445462
27199290
32240664
19226510
27187682
30309945
28243193
23735672
23271957
27233760
11095431
9467578
31265059
32310267
27283249
29351512
32224231
18948166
29076504
29351662
28143732
31691400
34216402
23090753
34795451
8547943
9468012
12488355
1855453
8552246
7782106
8300192
16943543
10579572
17680884
19969095
20133455
21846489
16079265
17845906
21486934
21486931
17927663
25721933
21143658
11181550
23404564
11564686
2263621
21143655
21896757
9364061
26562259
34292152
32042146
27939582
30052961
16580394
28938422
25550522
20713501
15096602
29760445
31415088
31178425
28453773
29618656
29374136
21778362
11897698
34715023
31947687
21168133
22178787
15985479
21839436
25256873
26849353
22192135
31815927
17495003
32386521
30566500
12514220
35107859
25730107
28384629
31156550
31216630
21609943
33848272
33166810
29931997
16998725",Unusual suspects: Glial cells in fertility regulation and their suspected role in polycystic ovary syndrome.,"Gonadotropin-releasing-hormone (GnRH) neurons sitting within the hypothalamus control the production of gametes and sex steroids by the gonads, therefore ensuring survival of species. As orchestrators of reproductive function, GnRH neurons integrate information from external and internal cues. This occurs through an extensively studied neuronal network known as the ""GnRH neuronal network."" However, the brain is not simply composed of neurons. Evidence suggests a role for glial cells in controlling GnRH neuron activity, secretion and fertility outcomes, although numerous questions remain. Glial cells have historically been seen as support cells for neurons. This idea has been challenged by the discovery that some neurological diseases originate from glial dysfunction. The prevalence of infertility disorders is increasing worldwide, with one in four couples being affected; therefore, it remains essential to understand the mechanisms by which the brain controls fertility. The ""GnRH glial network"" could be a major player in infertility disorders and represent a potential therapeutic target. In polycystic ovary syndrome (PCOS), the most common infertility disorder of reproductive aged women worldwide, the brain is considered a prime suspect. Recent studies have demonstrated pathological neuronal wiring of the ""GnRH neuronal network"" in PCOS-like animal models. However, the role of the ""GnRH glial network"" remains to be elucidated. In this review, I aim to propose glial cells as unusual suspects in infertility disorders such as PCOS. In the first part, I state our current knowledge about the role of glia in the regulation of GnRH neurons and fertility. In the second part, based on our recent findings, I discuss how glial cells could be implicated in PCOS pathology.","['GnRH', 'PCOS', 'astrocyte', 'fertility', 'glia', 'microglia', 'tanycyte']",Journal of neuroendocrinology,2022-04-22,"[{'lastname': 'Desroziers', 'firstname': 'Elodie', 'initials': 'E', 'affiliation': 'Department of Physiology, Centre for Neuroendocrinology, University of Otago, Dunedin, New Zealand.\nSorbonne Université, CNRS, INSERM, Neuroscience Paris Seine - Institut de Biologie Paris Seine, Neuroplasticity of Reproductive Behaviours Team, Paris, France.'}]",,,,© 2022 British Society for Neuroendocrinology.,10.1111/jne.13136,<Element 'PubmedArticle' at 0x7f05de99a8b0>
103,35437979,Corticosterone potentiates ochratoxin A-induced microglial activation.,"Microglial activation in the central nervous system (CNS) has been associated with brain damage and neurodegenerative disorders. Ochratoxin A (OTA) is a mycotoxin that occurs naturally in food and feed and has been associated with neurotoxicity, while corticosteroids are CNS' physiological function modulators. This study examined how OTA affected microglia activation and how corticosteroids influenced microglial neuroinflammation. Murine microglial cells (BV-2) were stimulated by OTA, and the potentiation effects on OTA-induced inflammation were determined by corticosterone pre-treatment. Expressions of pro-inflammatory mediators including tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), and inducible nitric oxide synthase (iNOS) were determined. Phosphorylation of mitogen-activated protein kinases (MAPKs) was analyzed by western blotting. OTA significantly increased the mRNA expression of IL-6, TNF-α, IL-1β, and iNOS and also elevated IL-6 and NO levels. Corticosterone pre-treatment enhanced the neuroinflammatory response to OTA in a mineralocorticoid receptor (MR)-dependent mechanism, which is associated with increases in extracellular signal-regulated kinase (ERK) and p38 MAPK activation. In response to OTA, microglial cells produced pro-inflammatory cytokines and NO, while corticosterone increased OTA-induced ERK and p38 MAPK phosphorylation via MR. Findings indicated the direct role of OTA in microglia activation and neuroinflammatory response and suggested that low corticosterone concentrations in the brain exacerbated neurodegeneration.","['corticosterone', 'microglia', 'mitogen-activated protein kinases', 'neuroinflammation', 'ochratoxin A']",Biomolecular concepts,2022-04-20,"[{'lastname': 'Chansawhang', 'firstname': 'Anchana', 'initials': 'A', 'affiliation': 'The Center for Veterinary Diagnosis, Faculty of Veterinary Science, Mahidol University, Salaya, Phutthamonthon, Nakhon Pathom 73170, Thailand.'}, {'lastname': 'Phochantachinda', 'firstname': 'Sataporn', 'initials': 'S', 'affiliation': 'Prasu-Arthorn Animal Hospital, Faculty of Veterinary Science, Mahidol University, Salaya, Phutthamonthon, Nakhon Pathom 73170, Thailand.'}, {'lastname': 'Temviriyanukul', 'firstname': 'Piya', 'initials': 'P', 'affiliation': 'Institute of Nutrition, Mahidol University, Salaya, Phutthamonthon, Nakhon Pathom 73170, Thailand.'}, {'lastname': 'Chantong', 'firstname': 'Boonrat', 'initials': 'B', 'affiliation': 'Department of Pre-clinical and Applied Animal Science, Faculty of Veterinary Science, Mahidol University, Salaya, Phutthamonthon, Nakhon Pathom 73170, Thailand.'}]",,,,"© 2022 Anchana Chansawhang et al., published by De Gruyter.",10.1515/bmc-2022-0017,<Element 'PubmedArticle' at 0x7f05dcab8310>
104,"35435643
31558576
21293843
19234401
24464188
28091799
26236074
31994950
29235982
29363986
10895561
11411788
23406909
23989936
23023300
33610079
31278524
21122776
21947663
24105364
22912506
22095612
32314393
33220170
17216333
19275906
31297179
8331044
31572228
27899710
26798446
25717130
22976615
11772687
20385342
11911007
25283790
30768399
9401332
18367759
18713489
11349697
20921120
29214007
20877284
29451303
30156362
9256583
26046624
8135506
25821913
18195084
8871783
15862182
7094885
7925130
14432658
30857571
30065244
16624315
19175758
20678186
24888361
31358906
31901731
30104728
22412026
27460188
26085846
23110806
21359227
26056561
20966214
20557401
26884166
27004698
24146637
25445483
24501362
28341582
19840550
23525041
33129890
14980203
18685038
22035837
20887954
23467340
4705508
9336221
21778362
22632727
27558646
29581545
24360280
25159150
27338705
31365857
28618077
30184509
33731174
33798637
23407936
30827729
22182318
29239126
15156148
24338663
30254300
30056204
27957532
27613230
24487234
32076115
23404112
15546155
20674603
22466688
21614001
25494366
27919067
24410870
29439242
31097668
32286273
30104731
26892004
32066658
24581740
31283899
32765501
12421344
21745355
6366155
29420261
34080730
22561833
17764664
2261679
23845731
24903914
9284284
15662442
25529562
23445315
17297524
28577971
27895892
32917815
30093566
31054843
19004805
22632453
23535246
24436118
21561602
33516739
20074449
24003389
33658968
24997632
25722050
25681541
2030244
20716320
20574059
21599704
25280829
23400216
29980754
29524252
26846570
17140851
27677781
22928105
23239965
22917523
20705131
27688738
29137272
24934179
31125917
18762342
17030376
22474485
26493496
27344332
31671361
9627004
29804052
34589832
33221139
31003786
33353966
18580852
25346392
18821565
20509936
28006890
20534153
24232168
30568281
31379804
17804536
21134442
22323074
23712861
23510584
27095560
25468771
28822049
26439953
26327239
26456415
23395715
29955164
34290368
24366406
33479207
26809250
23816781
15289276
11673791
29648618
9690329
17822540
11790516
19442688
26830140
18480098
21047156
32499649
26814963
23938317
25849982
20362647
22714803
22310922
26822608
17913903
20203530
24927995
24509090
28526515
20226214
32636457
22802640
29870753
24973728
29096641
21752601
28485733
27622677
29472840
30886382
28739513
33803154
24129217
16672647
30797960
22697211
34331970
23823752
28698032
29134693
28620294
28405874
29884819
33862170
16135757
24107964
15727533
22031897
27566530
17938639
20685869
25418810
29423909
28209774
23658839
28536974
25934038
32860938",Sex Differences in Neurodevelopmental Disorders: A Key Role for the Immune System.,"Sex differences are prominent defining features of neurodevelopmental disorders. Understanding the sex biases in these disorders can shed light on mechanisms leading to relative risk and resilience for the disorders, as well as more broadly advance our understanding of how sex differences may relate to brain development. The prevalence of neurodevelopmental disorders is increasing, and the two most common neurodevelopmental disorders, Autism Spectrum Disorder (ASD) and Attention-Deficit/Hyperactivity Disorder (ADHD) exhibit male-biases in prevalence rates and sex differences in symptomology. While the causes of neurodevelopmental disorders and their sex differences remain to be fully understood, increasing evidence suggests that the immune system plays a critical role in shaping development. In this chapter we discuss sex differences in prevalence and symptomology of ASD and ADHD, review sexual differentiation and immune regulation of neurodevelopment, and discuss findings from human and rodent studies of immune dysregulation and perinatal immune perturbation as they relate to potential mechanisms underlying neurodevelopmental disorders. This chapter will give an overview of how understanding sex differences in neuroimmune function in the context of neurodevelopmental disorders could lend insight into their etiologies and better treatment strategies.","['Cytokines', 'Development', 'Hormones', 'Inflammation', 'Microglia']",Current topics in behavioral neurosciences,2022-04-19,"[{'lastname': 'Breach', 'firstname': 'Michaela R', 'initials': 'MR', 'affiliation': 'Neuroscience Graduate Program, The Ohio State University, Columbus, OH, USA.'}, {'lastname': 'Lenz', 'firstname': 'Kathryn M', 'initials': 'KM', 'affiliation': 'Department of Psychology, The Ohio State University, Columbus, OH, USA. lenz.56@osu.edu.\nDepartment of Neuroscience, The Ohio State University, Columbus, OH, USA. lenz.56@osu.edu.\nInstitute for Behavioral Medicine Research, The Ohio State University, Columbus, OH, USA. lenz.56@osu.edu.'}]",,,,"© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.",10.1007/7854_2022_308,<Element 'PubmedArticle' at 0x7f05dcaafef0>
105,"35430298
31447324
24681814
22128031
33508122
20944627
27136446
28667118
34002087
34380697
34129812
28166221
28355573
26500843
30473097
34844019
34519040
27166944
33962048
29617641
27038883
30293770
32213703
17506645
32554468
25822252
24670647
34062119
27725773
29095968
34260928
28462073
17151600
25673413
34095876
33767443
27284195
30858605
33119507
30385464
33942194
35100822
27013681
25116706
24296712
25202980
24762441
33653955
29443965
29069441
33567185
27238020
23007189
30096314
33278342",A comparative transcriptomic analysis of glucagon-like peptide-1 receptor- and glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus.,"The hypothalamus is a key region of the brain implicated in homeostatic regulation, and is an integral centre for the control of feeding behaviour. Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are incretin hormones with potent glucoregulatory function through engagement of their respective cognate receptors, GLP-1R and GIPR. Recent evidence indicates that there is a synergistic effect of combining GIP- and GLP-1-based pharmacology on appetite and body weight. The mechanisms underlying the enhanced weight loss exhibited by GIPR/GLP-1R co-agonism are unknown. Gipr and Glp1r are expressed in the hypothalamus in both rodents and humans. To better understand incretin receptor-expressing cell populations, we compared the cell types and expression profiles of Gipr- and Glp1r-expressing hypothalamic cells using single-cell RNA sequencing.
Using Glp1r-Cre or Gipr-Cre transgenic mouse lines, fluorescent reporters were introduced into either Glp1r- or Gipr-expressing cells, respectively, upon crossing with a ROSA26-EYFP reporter strain. From the hypothalami of these mice, fluorescent Glp1r
A total of 14,091 Glp1r
We have provided a detailed comparison of Glp1r and Gipr cells of the hypothalamus with single-cell resolution. This resource will provide mechanistic insight into how engaging Gipr- and Glp1r-expressing cells of the hypothalamus may result in changes in feeding behaviour and energy balance.","['Appetite', 'Feeding', 'Glucagon-like peptide-1', 'Glucose-dependent insulinotropic polypeptide', 'Gut-brain axis', 'Hypothalamus', 'Transcriptomics']",Appetite,2022-04-18,"[{'lastname': 'Smith', 'firstname': 'Christopher', 'initials': 'C', 'affiliation': ""Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.""}, {'lastname': 'Patterson-Cross', 'firstname': 'Ryan', 'initials': 'R', 'affiliation': ""Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.""}, {'lastname': 'Woodward', 'firstname': 'Orla', 'initials': 'O', 'affiliation': ""Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.""}, {'lastname': 'Lewis', 'firstname': 'Jo', 'initials': 'J', 'affiliation': ""Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.""}, {'lastname': 'Chiarugi', 'firstname': 'Davide', 'initials': 'D', 'affiliation': ""Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK; Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.""}, {'lastname': 'Merkle', 'firstname': 'Florian', 'initials': 'F', 'affiliation': ""Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.""}, {'lastname': 'Gribble', 'firstname': 'Fiona', 'initials': 'F', 'affiliation': ""Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.""}, {'lastname': 'Reimann', 'firstname': 'Frank', 'initials': 'F', 'affiliation': ""Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK. Electronic address: fr222@cam.ac.uk.""}, {'lastname': 'Adriaenssens', 'firstname': 'Alice', 'initials': 'A', 'affiliation': ""Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK. Electronic address: aea35@medschl.cam.ac.uk.""}]",,,"A total of 14,091 Glp1r",Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.,"10.1016/j.appet.2022.106022
10.1016/j.cmet.2019.07.013
10.1038/npp.2014.74
10.1210/en.2011-1443
10.1210/endocr/bqaa246
10.1038/nature09522
10.1038/nutd.2016.15
10.2337/db17-0480
10.1038/s41593-021-00854-0
10.2337/db21-0459
10.1016/j.cmet.2021.05.017
10.1038/nn.4495
10.1016/j.celrep.2017.03.004
10.1016/j.molmet.2015.07.008
10.1016/j.molmet.2018.09.009
10.1016/j.molmet.2021.101407
10.1111/bph.15683
10.1016/j.cmet.2016.04.013
10.1016/j.molmet.2021.101240
10.1016/j.cmet.2018.03.001
10.1016/j.molmed.2016.03.005
10.1016/s0140-6736(18)32260-8
10.1172/jci.insight.133429
10.1146/annurev.neuro.30.051606.094324
10.1074/jbc.RA120.014368
10.1371/journal.pone.0120074
10.1038/nature13165
10.1016/j.cell.2021.04.048
10.1038/srep35108
10.1210/en.2017-00812
10.1016/j.celrep.2021.109362
10.1016/j.molmet.2017.02.007
10.1038/nature05453
10.1038/nature14177
10.1016/j.xcrm.2021.100263
10.1038/s42255-021-00363-1
10.1126/science.aaf6463
10.1038/s41593-019-0349-8
10.7554/eLife.58901
10.1126/science.aau5324
10.1007/s00395-021-00873-9
10.1161/CIRCRESAHA.121.319874
10.1523/JNEUROSCI.3579-15.2016
10.1210/en.2014-1248
10.2337/db13-1440
10.1172/JCI75276
10.1172/JCI72434
10.1073/pnas.2016587118
10.1038/nature25739
10.1093/nar/gkx1000
10.1056/NEJMoa2032183
10.1016/j.cell.2016.05.011
10.1038/nn.3211
10.1016/j.cell.2018.06.021
10.1016/j.neuron.2020.11.010",<Element 'PubmedArticle' at 0x7f05dbc90b30>
106,"35371022
33104828
25873768
29864456
29301251
27634048
28194256
28349217
33386422
29129724
29915052
33934736
24460899
24553808
26272235
26762621
27143993
29203148
33432588
12606543
27267343
21317295
33240260
25023148
26139610
19444297
22346115
21635964
26054568
26942449
30223824
32744650
29495082
33016801
15364122
32116667
24864157
32992875
28864909
25786174",Melatonin Maintains Inner Blood-Retinal Barrier by Regulating Microglia ,"Microglial activation and melatonin protection have been reported in diabetic retinopathy (DR). Whether melatonin could regulate microglia to protect the inner blood-retinal barrier (iBRB) remains unknown. In this study, the role of microglia in iBRB breakdown and the mechanisms of melatonin's regulation on microglia were explored. In diabetic rat retinas, activated microglia proliferated and migrated from the inner retina to the outer retina, accompanied by the obvious morphological changes. Meanwhile, significant leakage of albumin was evidenced at the site of close interaction between activated microglia and the damaged pericytes and endothelial cells. ","['diabetic retinopathy', 'inner blood–retinal barrier', 'melatonin', 'microglia', 'pericyte', 'vascular endothelial cells']",Frontiers in immunology,2022-04-05,"[{'lastname': 'Tang', 'firstname': 'Lei', 'initials': 'L', 'affiliation': 'Department of Ophthalmology of Tongji Hospital and Laboratory of Clinical and Visual Sciences of Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China.'}, {'lastname': 'Zhang', 'firstname': 'Chaoyang', 'initials': 'C', 'affiliation': ""Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, China.\nNational Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China.""}, {'lastname': 'Lu', 'firstname': 'Lixia', 'initials': 'L', 'affiliation': 'Department of Ophthalmology of Tongji Hospital and Laboratory of Clinical and Visual Sciences of Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China.'}, {'lastname': 'Tian', 'firstname': 'Haibin', 'initials': 'H', 'affiliation': 'Department of Ophthalmology of Tongji Hospital and Laboratory of Clinical and Visual Sciences of Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China.'}, {'lastname': 'Liu', 'firstname': 'Kun', 'initials': 'K', 'affiliation': ""Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, China.\nNational Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China.""}, {'lastname': 'Luo', 'firstname': 'Dawei', 'initials': 'D', 'affiliation': ""Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, China.\nNational Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China.""}, {'lastname': 'Qiu', 'firstname': 'Qinghua', 'initials': 'Q', 'affiliation': ""Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, China.\nNational Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China.""}, {'lastname': 'Xu', 'firstname': 'Guo-Tong', 'initials': 'GT', 'affiliation': 'Department of Ophthalmology of Tongji Hospital and Laboratory of Clinical and Visual Sciences of Tongji Eye Institute, Tongji University School of Medicine, Shanghai, China.'}, {'lastname': 'Zhang', 'firstname': 'Jingfa', 'initials': 'J', 'affiliation': ""Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, Shanghai, China.\nNational Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China.""}]",,,,"Copyright © 2022 Tang, Zhang, Lu, Tian, Liu, Luo, Qiu, Xu and Zhang.","10.3389/fimmu.2022.831660
10.1007/s00125-020-05299-x
10.1155/2015/673090
10.1016/j.pneurobio.2018.05.006
10.3390/ijms19010110
10.1002/glia.23046
10.1155/2017/9208489
10.1007/s00592-017-0984-z
10.1007/s00011-020-01427-w
10.1016/j.preteyeres.2017.11.001
10.1073/pnas.1719601115
10.1017/S0952523821000031
10.1111/jne.12134
10.1007/s00429-014-0719-7
10.1111/jpi.12267
10.1139/cjpp-2015-0277
10.1155/2016/3528274
10.1016/j.lfs.2017.12.001
10.1002/jcp.30269
10.1074/jbc.M300463200
10.1016/j.bbadis.2016.05.024
10.2337/db10-1160
10.3389/fimmu.2020.564077
10.1007/s00417-014-2727-y
10.15252/emmm.201505298
10.1038/eye.2009.108
10.4103/0974-9233.92116
10.1016/j.preteyeres.2011.05.002
10.1016/j.phrs.2015.05.013
10.1089/hgtb.2015.169
10.1186/s12886-018-0886-z
10.26355/eurrev_201908_18620
10.1111/fcp.12361
10.1080/10717544.2020.1818882
10.1016/j.pathophys.2004.06.006
10.3389/fphar.2019.01633
10.1155/2014/696218
10.3390/molecules25194410
10.32794/mr11250045
10.1007/s00018-017-2609-7
10.1016/j.immuni.2015.02.005",<Element 'PubmedArticle' at 0x7f05deb4ae50>
107,"35354026
27228556
17073652
11578530
30038282
32999463
20674602
26334107
32081365
29033027
30833892
33326786
16221841
26105143
26402844
27807170
24270812
10374819
24298036
21108733
21888923
15895084
32066984
33473245
31896673
34390649
33878393
22841309
25100587
24174309
29867123
34233165
27049947
34734741
8888044
29530713
24336719
30471926
10685902
22101006
9822384
33659365
23100431
31767678
19188534
7917833
20881118
18501521
26087162
23577177
33361813
23407936
31822817
17360046
29084329
18620092
32863044
24589888
30093568
32455344
27558646
24910169
26731439
32661024
15850668
15831717
20215108
32732436
21778362
29288586
34013588
34343616
26005403
18566122
24157239
33921365
22632727
22743772
22182318
32657463
31530940
28070121
26948129
14526225
29358666
33911229
21072242
16772325
32044129
32716294
29420261
32015543
28617197
34544455
25024921
11902119
29581545
15860230
24487234
25068800
25186741
31341912",Early stress-induced impaired microglial pruning of excitatory synapses on immature CRH-expressing neurons provokes aberrant adult stress responses.,"Several mental illnesses, characterized by aberrant stress reactivity, often arise after early-life adversity (ELA). However, it is unclear how ELA affects stress-related brain circuit maturation, provoking these enduring vulnerabilities. We find that ELA increases functional excitatory synapses onto stress-sensitive hypothalamic corticotropin-releasing hormone (CRH)-expressing neurons, resulting from disrupted developmental synapse pruning by adjacent microglia. Microglial process dynamics and synaptic element engulfment were attenuated in ELA mice, associated with deficient signaling of the microglial phagocytic receptor MerTK. Accordingly, selective chronic chemogenetic activation of ELA microglia increased microglial process dynamics and reduced excitatory synapse density to control levels. Notably, selective early-life activation of ELA microglia normalized adult acute and chronic stress responses, including stress-induced hormone secretion and behavioral threat responses, as well as chronic adrenal hypertrophy of ELA mice. Thus, microglial actions during development are powerful contributors to mechanisms by which ELA sculpts the connectivity of stress-regulating neurons, promoting vulnerability to stress and stress-related mental illnesses.","['2-photon imaging', 'CP: Neuroscience', 'MerTK', 'chemogenetics', 'corticotropin-releasing factor', 'microglia', 'process dynamics', 'stress', 'synaptic pruning']",Cell reports,2022-03-31,"[{'lastname': 'Bolton', 'firstname': 'Jessica L', 'initials': 'JL', 'affiliation': 'Department of Pediatrics, University of California, Irvine, Irvine, CA, USA; Department of Anatomy/Neurobiology, University of California, Irvine, Irvine, CA, USA. Electronic address: jbolton@gsu.edu.'}, {'lastname': 'Short', 'firstname': 'Annabel K', 'initials': 'AK', 'affiliation': 'Department of Pediatrics, University of California, Irvine, Irvine, CA, USA; Department of Anatomy/Neurobiology, University of California, Irvine, Irvine, CA, USA.'}, {'lastname': 'Othy', 'firstname': 'Shivashankar', 'initials': 'S', 'affiliation': 'Department of Physiology and Biophysics, University of California, Irvine, Irvine, CA, USA.'}, {'lastname': 'Kooiker', 'firstname': 'Cassandra L', 'initials': 'CL', 'affiliation': 'Department of Pediatrics, University of California, Irvine, Irvine, CA, USA; Department of Anatomy/Neurobiology, University of California, Irvine, Irvine, CA, USA.'}, {'lastname': 'Shao', 'firstname': 'Manlin', 'initials': 'M', 'affiliation': 'Department of Pediatrics, University of California, Irvine, Irvine, CA, USA; Department of Anatomy/Neurobiology, University of California, Irvine, Irvine, CA, USA.'}, {'lastname': 'Gunn', 'firstname': 'Benjamin G', 'initials': 'BG', 'affiliation': 'Department of Pediatrics, University of California, Irvine, Irvine, CA, USA; Department of Anatomy/Neurobiology, University of California, Irvine, Irvine, CA, USA; Division of Neuroscience, Medical Research Institute, Dundee University, Ninewells Hospital and Medical School, Dundee, UK.'}, {'lastname': 'Beck', 'firstname': 'Jaclyn', 'initials': 'J', 'affiliation': 'Department of Anatomy/Neurobiology, University of California, Irvine, Irvine, CA, USA.'}, {'lastname': 'Bai', 'firstname': 'Xinglong', 'initials': 'X', 'affiliation': 'Department of Pediatrics, University of California, Irvine, Irvine, CA, USA; Department of Anatomy/Neurobiology, University of California, Irvine, Irvine, CA, USA.'}, {'lastname': 'Law', 'firstname': 'Stephanie M', 'initials': 'SM', 'affiliation': 'Department of Pediatrics, University of California, Irvine, Irvine, CA, USA; Department of Anatomy/Neurobiology, University of California, Irvine, Irvine, CA, USA.'}, {'lastname': 'Savage', 'firstname': 'Julie C', 'initials': 'JC', 'affiliation': 'Département de Médecine Moléculaire, Université Laval, Québec City, QC, Canada; Axe Neurosciences, Centre de recherche du CHU de Québec, Québec City, QC, Canada.'}, {'lastname': 'Lambert', 'firstname': 'Jeremy J', 'initials': 'JJ', 'affiliation': 'Division of Neuroscience, Medical Research Institute, Dundee University, Ninewells Hospital and Medical School, Dundee, UK.'}, {'lastname': 'Belelli', 'firstname': 'Delia', 'initials': 'D', 'affiliation': 'Division of Neuroscience, Medical Research Institute, Dundee University, Ninewells Hospital and Medical School, Dundee, UK.'}, {'lastname': 'Tremblay', 'firstname': 'Marie-Ève', 'initials': 'MÈ', 'affiliation': 'Département de Médecine Moléculaire, Université Laval, Québec City, QC, Canada; Axe Neurosciences, Centre de recherche du CHU de Québec, Québec City, QC, Canada.'}, {'lastname': 'Cahalan', 'firstname': 'Michael D', 'initials': 'MD', 'affiliation': 'Department of Physiology and Biophysics, University of California, Irvine, Irvine, CA, USA.'}, {'lastname': 'Baram', 'firstname': 'Tallie Z', 'initials': 'TZ', 'affiliation': 'Department of Pediatrics, University of California, Irvine, Irvine, CA, USA; Department of Anatomy/Neurobiology, University of California, Irvine, Irvine, CA, USA; Department of Physiology and Biophysics, University of California, Irvine, Irvine, CA, USA. Electronic address: tallie@uci.edu.'}]",,,,Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.,10.1016/j.celrep.2022.110600,<Element 'PubmedArticle' at 0x7f05df2d5b80>
108,"35348977
32668062
29928190
32717399
32848594
26923778
33513867
32178222
29712997
19630576
27869327
32166165
31785168
27911858
28948971
20937274
28430869
32194944
30774631
33691249
23805233
32441783
30588079
33385878
32538857
32291463
32228035
25550769
29075178
33285234
33536545
31986264
32076399
32365642
30678080
29773951
30649612
32546655
23514317
33174962
32399719
33662680
27844095
32192578
32469400
22797452
31174279
33328588
32437679
32125452
29467654
34563872
29512466
32767095
28382917
31371719
34537482
15283741
33124941
31477683
32223077
32732883
22353665
32235786
32150310
32298803
31616477
15123501
30664971
33369818
30397195
27269743
32534467
32166013
32075877
32725449
28646910
33420763",Therapeutic Potential of the Purinergic System in Major Depressive Disorder Associated with COVID-19.,"Neuroinflammation is closely related to the development of depression, since the latter is caused, among other factors, by inflammatory processes, mainly related to the activation of microglia and expression of specific genes, which occurs during the neuroinflammatory process. Thus, COVID-19 is an important risk factor for the development of depression, since in addition to generating the feeling of stress, which also increases the activity of the immune system, it is also the cause of pathological processes and physiological ones that lead to the development of neuroinflammation, microglial activation, gene expression dysfunction and decreased concentration of available serotonin. That said, drugs are being used to combat COVID-19 to reduce the oxidative stress presented in the disease. Thus, tramadol and fluoxetine are highlighted as drugs used, however, although they present some positive results, such as the reduction of pro-inflammatory cytokines, they are also associated with negative effects such as dependence, pulmonary, cardiac and brain impairment. From this, the purinergic system is highlighted in the literature as a possible therapeutic target. This is because its mechanisms are related to the regulation of microglia, astrocytes and the physiology of important neurotransmitters and hormones. Added to this, there is a modulation of inflammatory activity, especially with regard to the P2X7 receptors of this system. The latter is an important target for the treatment of depression and COVID-19, since positive results were obtained through the genetic exclusion of this receptor and the use of selective antagonists.","['Major depression disorder', 'Neuroinflammation', 'Purinergic signaling']",Cellular and molecular neurobiology,2022-03-30,"[{'lastname': 'Simões', 'firstname': 'Júlia Leão Batista', 'initials': 'JLB', 'affiliation': 'Medical School, Federal University of Fronteira Sul, Chapecó, SC, Brazil.'}, {'lastname': 'Galvan', 'firstname': 'Agatha Carina Leite', 'initials': 'ACL', 'affiliation': 'Nursing School, Federal University of Fronteira Sul, Chapecó, SC, Brazil.'}, {'lastname': 'da Silva', 'firstname': 'Eduarda Luiza Maciel', 'initials': 'ELM', 'affiliation': 'Nursing School, Federal University of Fronteira Sul, Chapecó, SC, Brazil.'}, {'lastname': 'Ignácio', 'firstname': 'Zuleide Maria', 'initials': 'ZM', 'affiliation': 'Graduate Program in Medical Sciences, Federal University of Fronteira Sul, Chapecó, SC, Brazil.'}, {'lastname': 'Bagatini', 'firstname': 'Margarete Dulce', 'initials': 'MD', 'affiliation': 'Graduate Program in Medical Sciences, Federal University of Fronteira Sul, Chapecó, SC, Brazil. margaretebagatini@yahoo.com.br.'}]",,,,"© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.","10.1007/s10571-022-01215-6
10.1111/ene.14442
10.3389/fnins.2018.00386
10.1016/J.BBI.2020.07.026
10.3389/FNMOL.2020.00124
10.21451/1984-3143-AR823
10.2174/1570159X14666160229114755
10.3390/PH14020097
10.3390/brainsci10030160
10.1038/s41380-018-0057-x
10.1146/ANNUREV.MED.60.042307.110802
10.1002/JBMR.3045
10.1177/2398212818817494
10.1111/ejn.14631
10.18632/ONCOTARGET.13689
10.1038/mp.2017.188
10.1016/J.FEBSLET.2010.10.001
10.1093/BRAIN/AWX085
10.12688/f1000research.22457.2
10.3389/FIMMU.2019.00119
10.1016/J.BIOPHA.2021.111437
10.1371/JOURNAL.PONE.0066547
10.1111/BPH.15138
10.2147/JPR.S184782
10.1016/J.MEHY.2020.110468
10.3233/JAD-200581
10.1007/S00134-020-06033-2
10.1164/RCCM.202003-0817LE
10.3389/FNMOL.2017.00325
10.1016/J.PHRS.2020.105363
10.1038/S41380-021-01021-4
10.1016/S0140-6736(20)30183-5
10.3389/FNMOL.2019.00331
10.3390/cells9051108
10.3390/ijms20030485
10.2147/JIR.S141033
10.1007/S00441-018-02987-4
10.1212/WNL.0000000000010111
10.1146/ANNUREV-PUBLHEALTH-031912-114409
10.1590/0037-8682-0504-2020
10.1007/s12640-020-00219-8
10.1016/J.BIOPHA.2021.111430
10.1007/S00213-016-4483-7
10.1016/S0140-6736(20)30628-0
10.4103/1687-4315.205828
10.1001/JAMANEUROL.2020.2125
10.1001/JAMA.2012.5669
10.3390/IJMS20112778
10.1038/S41380-020-00965-3
10.1016/S2215-0366(20)30203-0
10.1007/S00134-020-05991-X
10.3389/FPHAR.2018.00052
10.1016/J.REDOX.2021.102137
10.2174/1570159X16666180302120322
10.1007/S00011-020-01389-Z
10.2807/1560-7917.ES.2017.22.13.30494
10.1038/S41419-019-1813-9
10.1016/J.INTIMP.2021.108150
10.1111/J.1600-0447.2004.00335.X
10.1152/PHYSREV.00035.2020
10.1038/s41398-019-0548-9
10.1111/APHA.13473
10.1038/s41398-020-00949-5
10.1159/000334586
10.3390/ijms21062194
10.1111/EJN.14720
10.1016/j.bbi.2020.04.027
10.3389/FGENE.2019.00898
10.1192/BJP.184.5.386
10.1016/j.pnpbp.2019.01.006
10.1111/ENE.14703
10.1038/s41398-018-0276-6
10.1080/15622975.2016.1197423
10.1002/JLB.3COVR0520-272R
10.1186/S13578-020-00388-1
10.1126/science.aax0902
10.1007/s10072-020-04575-3
10.1186/S13041-017-0306-Y
10.24272/J.ISSN.2095-8137.2020.294",<Element 'PubmedArticle' at 0x7f05df7b3cc0>
109,"35334042
25071444
23592952",Phoenixin-20 ameliorates brain infarction by promoting microglia M2 polarization in an ischemic stroke model.,"Ischemic stroke is one of the most common causes of death worldwide. The transformation of microglia from the classic M1 to the alternative M2 state has been shown to have both deleterious and immunosuppressive roles in neuroinflammation. Microglial polarization toward the M2 phase is currently proposed to be a beneficial phenotype in brain ischemic injury. Phoenixin-20 is a newly identified pleiotropic neuropeptide expressed abundantly in different brain regions. In this study, we found that administration of Phoenixin-20 in ischemic stroke middle cerebral artery occlusion (MCAO) mice significantly reduced the brain infarction area but improved the neurological deficit score. Gene expression analysis showed Phoenixin-20 treatment inhibited pro-inflammatory M1 phase microglial markers: a cluster of differentiation molecule 11b (CD11b), cluster of differentiation molecule 86 (CD86), inducible nitric oxide synthase (iNOS), tumor necrosis factor-alpha (TNF-α), interleukin 6 (IL-6), and increased anti-inflammatory M2 phase markers (found in Inflammatory Zone 1 (FIZZ1), Arginase 1 (Arg-1), Chitinase 3-like 3 (YM1), and interleukin-10 (IL-10)) in the infarcted brain. We further investigated the molecular mechanism of Phoenixin-20 in cultured microglia. We found that treatment with it induced signature genes expression in microglial M2 state, including Fizz1, Arg-1, YM1, and IL-10, indicating the promotion of microglial polarization toward the M2 state. Furthermore, we found that treatment with the M2 phase cytokine interleukin 4 (IL-4) induced the expression of microglial G Protein-Coupled Receptor (GPR173), which is the receptor of Phoenixin-20. Silencing of the microglial signal transducer and activator of transcription 6 (STAT6) partially blocked the effect of IL-4 on GPR173, suggesting that STAT6 is the upstream regulator of GPR173. Finally, we showed that the silencing of GPR173 completely abolished the effect of Phoenixin-20 in microglia, indicating the dependency of its regulatory role on GPR173. Collectively, our study demonstrates that Phoenixin-20 has a protective role in the acute stroke model. Our cell-based study demonstrates Phoenixin-20 promotes microglia toward M2 transformation, which could be the mechanism of its neuroprotection.","['GPR173', 'Microglia M2 polarization', 'Middle cerebral artery occlusion (MCAO)', 'Neuroinflammation', 'Phoenixin-20', 'STAT6']",Metabolic brain disease,2022-03-26,"[{'lastname': 'Wang', 'firstname': 'Su', 'initials': 'S', 'affiliation': 'Department of Neurology, Cangzhou Central Hospital, No. 16, Xinhua West Road, Yunhe District, Hebei, Cangzhou, 061014, China.'}, {'lastname': 'Liang', 'firstname': 'Ruobing', 'initials': 'R', 'affiliation': 'Department of Neurology, Cangzhou Central Hospital, No. 16, Xinhua West Road, Yunhe District, Hebei, Cangzhou, 061014, China.'}, {'lastname': 'Liu', 'firstname': 'Hongmei', 'initials': 'H', 'affiliation': 'Department of Neurology, Cangzhou Central Hospital, No. 16, Xinhua West Road, Yunhe District, Hebei, Cangzhou, 061014, China. liuhm023@126.com.'}]",,,,"© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.","10.1007/s11011-022-00950-5
10.3390/ijms21218378
10.1161/CIRCRESAHA.116.308398
10.1161/STROKEAHA.114.006864
10.1155/2017/5048616
10.1152/ajpregu.00426.2017
10.1152/physrev.00011.2010
10.1161/STROKEAHA.112.659656
10.1038/sj.sc.3101718
10.1177/039463201402700203
10.1007/s00401-018-1930-z
10.1038/nrneurol.2017.69
10.1038/aps.2017.195
10.1161/01.STR.20.1.84
10.1016/j.pneurobio.2016.01.005
10.3389/fphar.2019.00630
10.1210/jendso/bvab192
10.1146/annurev-immunol-032713-120240
10.1111/head.13084
10.1210/en.2019-00111
10.1210/me.2016-1039
10.1007/s00011-020-01355-9
10.1016/j.biopha.2018.05.143
10.1016/j.intimp.2015.02.019
10.1371/journal.pone.0165341
10.1016/j.clim.2016.09.014
10.2174/0929866524666170207154417
10.1111/gtc.12378
10.1007/s12640-020-00225-w
10.1038/aps.2016.162",<Element 'PubmedArticle' at 0x7f05dbdad3b0>
110,"35327616
27540165
24699227
28226226
26354893
26745839
26509334
30016687
25779633
26499989
10662535
31513776
26600009
26205628
20153425
19665809
19063914
11739531
21565615
26708712
12777709
12422368
16253392
27549171
11150483
15148390
16407456
17192562
21541365
23074265
18771935
11743142
10593612
9626133
15390121
20060904
31980574
11070493
28894299
19845386
27618740
28082899
29473218
30817930
24585880
23190582
27299736
32526552
20147251
22871921
22743772
21376707
1550679
15289442
21482827
22762015
27477018
29518356
31019284
25904803
34201844
27555812
19461673
30496700
30277599
24316888
33986301
31564456
32044947
23977697
16411894
12528312
11735609
29651949
8053664
9701676
24285878
23303920
30918278
30006508
29208634
28567989
27716798
28602351
28930663
29775591
30266932
23150934
30206190","ENT-A010, a Novel Steroid Derivative, Displays Neuroprotective Functions and Modulates Microglial Responses.","Tackling neurodegeneration and neuroinflammation is particularly challenging due to the complexity of central nervous system (CNS) disorders, as well as the limited drug accessibility to the brain. The activation of tropomyosin-related kinase A (TRKA) receptor signaling by the nerve growth factor (NGF) or the neurosteroid dehydroepiandrosterone (DHEA) may combat neurodegeneration and regulate microglial function. In the present study, we synthesized a C-17-spiro-cyclopropyl DHEA derivative (ENT-A010), which was capable of activating TRKA. ENT-A010 protected PC12 cells against serum starvation-induced cell death, dorsal root ganglia (DRG) neurons against NGF deprivation-induced apoptosis and hippocampal neurons against Aβ-induced apoptosis. In addition, ENT-A010 pretreatment partially restored homeostatic features of microglia in the hippocampus of lipopolysaccharide (LPS)-treated mice, enhanced Aβ phagocytosis, and increased ","['Aβ', 'DHEA', 'ENT-A010', 'hippocampus', 'microglia', 'neuroprotection', 'phagocytosis', 'ΤRKA']",Biomolecules,2022-03-26,"[{'lastname': 'Yilmaz', 'firstname': 'Canelif', 'initials': 'C', 'affiliation': 'Institute of Clinical Chemistry and Laboratory Medicine, University Clinic Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.'}, {'lastname': 'Rogdakis', 'firstname': 'Thanasis', 'initials': 'T', 'affiliation': 'Pharmacology Department, Faculty of Medicine, University of Crete, 71003 Heraklion, Greece.\nInstitute of Molecular Biology and Biotechnology, Foundation for Research and Technology Hellas, 71003 Heraklion, Greece.'}, {'lastname': 'Latorrata', 'firstname': 'Alessia', 'initials': 'A', 'affiliation': 'Institute of Chemical Biology, National Hellenic Research Foundation, 11635 Athens, Greece.'}, {'lastname': 'Thanou', 'firstname': 'Evangelia', 'initials': 'E', 'affiliation': 'Center for Neurogenomics and Cognitive Research, Department of Molecular and Cellular Neurobiology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.'}, {'lastname': 'Karadima', 'firstname': 'Eleftheria', 'initials': 'E', 'affiliation': 'Institute of Clinical Chemistry and Laboratory Medicine, University Clinic Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.'}, {'lastname': 'Papadimitriou', 'firstname': 'Eleni', 'initials': 'E', 'affiliation': 'Pharmacology Department, Faculty of Medicine, University of Crete, 71003 Heraklion, Greece.\nInstitute of Molecular Biology and Biotechnology, Foundation for Research and Technology Hellas, 71003 Heraklion, Greece.'}, {'lastname': 'Siapi', 'firstname': 'Eleni', 'initials': 'E', 'affiliation': 'Institute of Chemical Biology, National Hellenic Research Foundation, 11635 Athens, Greece.'}, {'lastname': 'Li', 'firstname': 'Ka Wan', 'initials': 'KW', 'affiliation': 'Center for Neurogenomics and Cognitive Research, Department of Molecular and Cellular Neurobiology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.'}, {'lastname': 'Katsila', 'firstname': 'Theodora', 'initials': 'T', 'affiliation': 'Institute of Chemical Biology, National Hellenic Research Foundation, 11635 Athens, Greece.'}, {'lastname': 'Calogeropoulou', 'firstname': 'Theodora', 'initials': 'T', 'affiliation': 'Institute of Chemical Biology, National Hellenic Research Foundation, 11635 Athens, Greece.'}, {'lastname': 'Charalampopoulos', 'firstname': 'Ioannis', 'initials': 'I', 'affiliation': 'Pharmacology Department, Faculty of Medicine, University of Crete, 71003 Heraklion, Greece.\nInstitute of Molecular Biology and Biotechnology, Foundation for Research and Technology Hellas, 71003 Heraklion, Greece.'}, {'lastname': 'Alexaki', 'firstname': 'Vasileia Ismini', 'initials': 'VI', 'affiliation': 'Institute of Clinical Chemistry and Laboratory Medicine, University Clinic Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.'}]",,,,,"10.3390/biom12030424
10.1126/science.aag2590
10.1016/j.neuroscience.2014.03.045
10.1146/annurev-immunol-051116-052358
10.1101/cshperspect.a020560
10.1016/j.conb.2015.12.004
10.1111/jnc.13411
10.1016/j.neuint.2018.07.003
10.1084/jem.20141656
10.1186/s12883-015-0478-y
10.1006/frne.1999.0188
10.1016/j.yfrne.2019.100788
10.1016/j.psyneuen.2015.11.005
10.1016/j.psychres.2015.05.093
10.1016/j.jsbmb.2010.02.007
10.1016/j.archger.2009.07.001
10.1016/j.yfrne.2008.11.002
10.4049/jimmunol.167.12.7094
10.1016/j.cell.2011.03.050
10.1016/j.neubiorev.2015.09.024
10.1385/ENDO:21:1:97
10.1002/syn.10145
10.1016/j.neurobiolaging.2005.09.028
10.4049/jimmunol.1601038
10.1016/S0006-8993(00)03077-8
10.1073/pnas.0306631101
10.1096/fj.05-5078fje
10.1196/annals.1366.003
10.1371/journal.pbio.1001051
10.1126/scisignal.2003387
10.1016/j.tem.2008.07.004
10.1177/153537020122601113
10.1016/S0736-5748(99)00067-2
10.1210/jcem.83.6.4876
10.1002/glia.20070
10.1016/j.jsbmb.2009.12.016
10.4049/jimmunol.1900746
10.1002/1097-4547(20001115)62:4<503::AID-JNR4>3.0.CO;2-A
10.1038/mp.2017.167
10.1021/jm900468p
10.1016/j.neuropharm.2016.09.007
10.3389/fphar.2016.00512
10.1002/glia.23312
10.1016/j.yexcr.2019.02.023
10.4049/jimmunol.1300825
10.1186/1479-5876-10-239
10.1021/acs.jmedchem.6b00472
10.1016/j.ejmech.2020.112327
10.1101/pdb.prot5275
10.3791/3634
10.1038/nmeth.2019
10.1016/j.brainres.2011.02.078
10.1016/j.tet.2008.04.079
10.1016/0896-6273(92)90284-K
10.1096/fj.04-1495fje
10.1074/jbc.M111.234674
10.1101/cshperspect.a006338
10.1016/j.neuron.2016.06.015
10.1016/j.neuron.2018.01.031
10.1038/s41577-019-0167-y
10.1523/JNEUROSCI.4586-14.2015
10.3390/cells10071584
10.3389/fnhum.2016.00398
10.1038/nri2565
10.1096/fj.201801539R
10.1002/glia.23507
10.1038/nn.3599
10.1038/s41572-021-00269-y
10.1016/j.cell.2019.09.001
10.1001/jama.2019.22360
10.1038/nrd4024
10.1042/CS20050161
10.2165/00003088-200140120-00003
10.2174/1570159X16666180412092859
10.1002/ana.410360221
10.1159/000017069
10.1523/JNEUROSCI.1310-13.2013
10.1523/JNEUROSCI.0399-12.2013
10.1038/s41598-019-41654-8
10.1038/s41598-018-28633-1
10.2337/db17-0391
10.1002/glia.23170
10.1371/journal.pone.0164103
10.1016/j.cell.2017.05.018
10.1016/j.immuni.2017.08.008
10.1016/j.cell.2018.05.003
10.1038/s41582-018-0072-1
10.1056/NEJMoa1211851
10.15252/embr.201846171",<Element 'PubmedArticle' at 0x7f05dbda7590>
111,35279597,Adipocytokines: Emerging therapeutic targets for pain management.,"Although pain has lower mortality rates than cancer, diabetes and stroke, pain is a predominate source of distress and disability. However, the management of pain remains an enormous problem. Many drugs used to pain treatment have more or less side effects. Therefore, the development of novel therapeutic target is critical for the treatment of pain. Notably, studies have shown that adipocytokines have a dual role in pain. Growing shreds of evidence shows that the levels of adipocytokines are upregulated or downregulated in the development of pain. In addition, substantial evidence indicates that regulation of adipocytokines levels in models of pain attenuates or promotes pain behaviors. In this review, we summarized and discussed the effect of adipocytokines in pain. These evidence indicates that adipocytokines attenuate or promote pain behaviors through interacting with their receptors, activating serotonin pathway, interacting with μ-opioid receptor, activating microglia, infiltrating macrophage and so on. Overall, adipocytokines have some potential in treating pain, but the underlying mechanisms remain unclear and need to be further studied.","['Adipocytokines', 'Pain', 'Therapeutic targets']",Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,2022-03-14,"[{'lastname': 'Gao', 'firstname': 'Shao-Jie', 'initials': 'SJ', 'affiliation': 'Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China.'}, {'lastname': 'Liu', 'firstname': 'Dai-Qiang', 'initials': 'DQ', 'affiliation': 'Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China.'}, {'lastname': 'Li', 'firstname': 'Dan-Yang', 'initials': 'DY', 'affiliation': 'Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China.'}, {'lastname': 'Sun', 'firstname': 'Jia', 'initials': 'J', 'affiliation': 'Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China.'}, {'lastname': 'Zhang', 'firstname': 'Long-Qing', 'initials': 'LQ', 'affiliation': 'Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China.'}, {'lastname': 'Wu', 'firstname': 'Jia-Yi', 'initials': 'JY', 'affiliation': 'Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China.'}, {'lastname': 'Song', 'firstname': 'Fan-He', 'initials': 'FH', 'affiliation': 'Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China.'}, {'lastname': 'Zhou', 'firstname': 'Ya-Qun', 'initials': 'YQ', 'affiliation': 'Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China. Electronic address: yqzhou2019@hust.edu.cn.'}, {'lastname': 'Mei', 'firstname': 'Wei', 'initials': 'W', 'affiliation': 'Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China. Electronic address: wmei@hust.edu.cn.'}]",,,,Copyright © 2022 The Authors. Published by Elsevier Masson SAS.. All rights reserved.,10.1016/j.biopha.2022.112813,<Element 'PubmedArticle' at 0x7f05dbabf8b0>
112,35263589,Nociceptor-derived Reg3γ prevents endotoxic death by targeting kynurenine pathway in microglia.,"Nociceptors can fine-tune local or systemic immunity, but the mechanisms of nociceptive modulation in endotoxic death remain largely unknown. Here, we identified C-type lectin Reg3γ as a nociceptor-enriched hormone that protects the host from endotoxic death. During endotoxemia, nociceptor-derived Reg3γ penetrates the brain and suppresses the expression of microglial indoleamine dioxygenase 1, a critical enzyme of the kynurenine pathway, via the Extl3-Bcl10 axis. Endotoxin-administered nociceptor-null mice and nociceptor-specific Reg3γ-deficient mice exhibit a high mortality rate accompanied by decreased brain HK1 phosphorylation and ATP production despite normal peripheral inflammation. Such metabolic arrest is only observed in the brain, and aberrant production of brain quinolinic acid, a neurotoxic metabolite of the kynurenine pathway, causes HK1 suppression. Strikingly, the central administration of Reg3γ protects mice from endotoxic death by enhancing brain ATP production. By identifying nociceptor-derived Reg3γ as a microglia-targeted hormone, this study provides insights into the understanding of tolerance to endotoxic death.","['Reg3g', 'kynurenine pathway', 'microglia', 'nociceptor']",Cell reports,2022-03-10,"[{'lastname': 'Sugisawa', 'firstname': 'Erika', 'initials': 'E', 'affiliation': 'WPI Immunology Frontier Research Center (IFReC), Osaka University, Osaka 565-0871, Japan.'}, {'lastname': 'Kondo', 'firstname': 'Takeshi', 'initials': 'T', 'affiliation': 'Department of Biochemistry, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido 060-8636, Japan.'}, {'lastname': 'Kumagai', 'firstname': 'Yutaro', 'initials': 'Y', 'affiliation': 'Biotechnology Research Institute for Drug Discovery, Department of Life Science and Biotechnology, National Institute of Advanced Industrial Science and Technology, Ibaraki 305-8565, Japan.'}, {'lastname': 'Kato', 'firstname': 'Hiroki', 'initials': 'H', 'affiliation': 'Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.'}, {'lastname': 'Takayama', 'firstname': 'Yasunori', 'initials': 'Y', 'affiliation': 'Department of Physiology, Showa University School of Medicine, Showa University, Tokyo 142-8555, Japan.'}, {'lastname': 'Isohashi', 'firstname': 'Kayako', 'initials': 'K', 'affiliation': 'Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.'}, {'lastname': 'Shimosegawa', 'firstname': 'Eku', 'initials': 'E', 'affiliation': 'Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.'}, {'lastname': 'Takemura', 'firstname': 'Naoki', 'initials': 'N', 'affiliation': 'Laboratory of Bioresponse Regulation, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.'}, {'lastname': 'Hayashi', 'firstname': 'Yoshinori', 'initials': 'Y', 'affiliation': 'Department of Physiology, School of Dentistry, Nihon University, Tokyo 101-8310, Japan.'}, {'lastname': 'Sasaki', 'firstname': 'Takuya', 'initials': 'T', 'affiliation': 'Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033, Japan.'}, {'lastname': 'Martino', 'firstname': 'Mikaël M', 'initials': 'MM', 'affiliation': 'European Molecular Biology Laboratory Australia, Australian Regenerative Medicine Institute, Monash University, Melbourne, VIC 3800, Australia.'}, {'lastname': 'Tominaga', 'firstname': 'Makoto', 'initials': 'M', 'affiliation': 'National Institute for Physiological Sciences, National Institutes of Natural Sciences, Aichi 444-8787, Japan.'}, {'lastname': 'Maruyama', 'firstname': 'Kenta', 'initials': 'K', 'affiliation': 'WPI Immunology Frontier Research Center (IFReC), Osaka University, Osaka 565-0871, Japan; National Institute for Physiological Sciences, National Institutes of Natural Sciences, Aichi 444-8787, Japan. Electronic address: maruken@nips.ac.jp.'}]",,,,Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.,10.1016/j.celrep.2022.110462,<Element 'PubmedArticle' at 0x7f05dbac8ea0>
113,"35199308
21524252
12385818
19565166
33925154
11100151
15338272
24740430
28273839
19385059
28154473
9580157
20800633
24889886
23730254
30250265
15985713
12626429
12112366
19919880
20303880
20687881
30138572
29619773
17254027
29755317
34361780
33859489
34681607
22544516
26006268
25482686
34391968
28067625
34948457
11792830
26718601
17655978
32375371
34727977
26674871
32337944
28592904
18546601
31654381
12686372
27401947
34070429
34610465
16004991
23517078
16891616
32335135
9928007
33402167
32977419",PACAP and VIP Mitigate Rotenone-Induced Inflammation in BV-2 Microglial Cells.,"Rotenone is a commercial pesticide commonly used to model Parkinson's disease (PD) due to its ability to induce dopaminergic degeneration. Studies have confirmed that rotenone causes microglial activation, which seems to contribute to the toxic effects seen in rodent models. Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) are two structurally related neuropeptides that have robust neuroprotective and anti-inflammatory properties. However, their ability to regulate microglial activity in response to rotenone is not fully understood. Using rotenone as an inflammatory stimulus, we tested whether PACAP or VIP could mitigate microglial activation in BV2 microglial cells. Rotenone dose-dependently reduced cell viability and the percentage of apoptotic cells. It also increased the release of nitric oxide (NO) in culture media and the expression of microglial activation markers and pro-inflammatory markers, including CD11b, MMP-9 and IL-6, and heightened the endogenous levels of PACAP and its preferring receptor PAC1. Co-treatment with PACAP or VIP prevented rotenone-induced increase of NO, CD11b, MMP-9 and IL-6. These results indicate that both PACAP and VIP are able to prevent the pro-inflammatory effects of rotenone in BV2 cells, supporting the idea that these molecules can have therapeutic value in slowing down PD progression.","['Microglia', 'Neuroinflammation', 'Pituitary adenylate cyclase-activating peptide (PACAP)', 'Rotenone', 'Vasoactive intestinal peptide (VIP)']",Journal of molecular neuroscience : MN,2022-02-25,"[{'lastname': 'Broome', 'firstname': 'Sarah Thomas', 'initials': 'ST', 'affiliation': 'Laboratory of Cellular and Molecular Neuroscience (LCMN), School of Life Sciences, Faculty of Science, University of Technology Sydney, PO Box 123, Broadway, NSW, 2007, Australia.'}, {'lastname': 'Musumeci', 'firstname': 'Giuseppe', 'initials': 'G', 'affiliation': 'Section of Human Anatomy, Histology and Movement Science, Department of Biomedical and Biotechnological Sciences, University of Catania, via S. Sofia, 87, 95123, Catania, Italy.'}, {'lastname': 'Castorina', 'firstname': 'Alessandro', 'initials': 'A', 'affiliation': 'Laboratory of Cellular and Molecular Neuroscience (LCMN), School of Life Sciences, Faculty of Science, University of Technology Sydney, PO Box 123, Broadway, NSW, 2007, Australia. Alessandro.Castorina@UTS.edu.au.'}]",,,,© 2022. The Author(s).,"10.1007/s12031-022-01968-1
10.2174/138161211795589364
10.1016/s0166-4328(02)00180-8
10.14573/altex.2009.2.83
10.3390/ijms22094676
10.1038/81834
10.1007/s00441-004-0956-9
10.1007/s12640-014-9468-x
10.3390/ijms18030551
10.1016/j.nbd.2009.01.016
10.1155/2017/5048616
10.1046/j.1471-4159.1998.70041584.x
10.1016/j.peptides.2010.08.013
10.1186/1742-2094-11-98
10.2174/157015912804143522
10.1038/s41593-018-0236-8
10.1096/fj.02-0799fje
10.1002/glia.10098
10.2144/000114463
10.1016/j.npep.2009.10.003
10.1016/j.cell.2010.02.016
10.2174/138161210793292465
10.1080/14728222.2018.1515917
10.1186/s10194-018-0855-1
10.1111/j.1471-4159.2006.04327.x
10.3389/fnmol.2018.00144
10.3390/molecules26154627
10.2147/JIR.S299927
10.3390/ijms222010947
10.1007/s12031-012-9781-x
10.1016/j.neuropharm.2015.05.014
10.1016/j.euroneuro.2014.11.004
10.1016/j.prp.2021.153576
10.1242/dmm.027185
10.3390/ijms222413660
10.1073/pnas.012367999
10.1016/j.neuroscience.2015.12.034
10.1016/j.peptides.2007.05.015
10.3390/ijms21093254
10.1186/s40035-021-00262-1
10.1523/JNEUROSCI.2131-15.2015
10.5114/fn.2019.89857
10.1038/nrn.2017.62
10.1038/nprot.2008.73
10.1007/s12640-019-00120-z
10.1016/s0304-3940(03)00172-1
10.1111/jnc.13691
10.3390/cells10061312
10.3390/app11167673
10.1016/j.nbd.2021.105524
10.1016/j.febslet.2005.06.013
10.1111/bph.12181
10.1124/jpet.106.102236
10.1016/j.bbagen.2020.129626
10.1111/j.1749-6632.1998.tb11173.x
10.1186/s12974-020-02065-z
10.3390/molecules25194359",<Element 'PubmedArticle' at 0x7f05dbad7ae0>
114,35143896,"Spinal cord-wide structural disruption in type 2 diabetes rescued by exenatide ""a glucagon-like peptide-1 analogue"" via down-regulating inflammatory, oxidative stress and apoptotic signaling pathways.","The mechanisms of spinal cord-wide structural and functional disruption in diabetic patients remain elusive. This study evaluated histopathological alterations of the spinal cord cytoarchitecture in T2DM model of rats and assessed the potential ameliorating effect of exenatide ""a potent GLP-1 analogue"". Thirty male rats were allocated into three groups; I (control), II (Diabetic): T2DM was induced by high fat diet for 8 weeks followed by a single I.P injection of STZ (25 mg/kg BW) and III (Diabetic/Exenatide): T2DM rats injected with exenatide (10 μg/Kg, S.C. twice daily for 2 weeks). Neurobehavioral sensory and motor tests were carried out and glycemic control biomarkers and indices of insulin resistance and sensitivity were measured. In addition, the spinal cord was processed for histological and immunohistochemical studies besides assessing its tissue homogenate levels of pro-inflammatory/anti-inflamatory cytokines and oxidant/antioxidant biomarkers. Moreover, RT-qPCR was performed to measure the expression of proapoptotic/antiapoptotic and neurotrophic genes. The diabetic rats exhibited thermal hyperalgesia, mechanical allodynia and decreased locomotor activity along with increased serum glucose, insulin, HbA1c, HOMA-IR while, quantitative insulin sensitivity check index (QUICKI) was decreased. Also, IL-1β NF-kB, MDA increased while IL-10, SOD activity and β-endorphin decreased in the spinal tissue. Up regulation of caspase-3 and down regulation of Bcl-2, nerve growth factor (NGF) and glial cell-derived neurotrophic (GDNF) in diabetic rats. Also, they exhibited histopathological changes and increased CD68 positive microglia and Bax immunoreactivity in the spinal cord. Subsequent to exenatide treatment, most biomolecular, structural and functional impairments of the spinal cord were restored in the diabetic rats. In conclusion, the neuro-modulating effect of exenatide against diabetic-induced spinal cord affection warrants the concern about its therapeutic relevance in confronting the devastating diabetic neuropathic complications.","['Exenatide', 'GLP-1 analogue', 'Histopathology', 'Rats', 'Spinal cord', 'T2DM']",Journal of chemical neuroanatomy,2022-02-11,"[{'lastname': 'Mandour', 'firstname': 'Dalia A', 'initials': 'DA', 'affiliation': 'Department of Human Anatomy and Embryology, Faculty of Medicine, Zagazig University, Egypt. Electronic address: daliamandour71@gmail.com.'}, {'lastname': 'Shalaby', 'firstname': 'Sally M', 'initials': 'SM', 'affiliation': 'Department of Medical Biochemistry, Faculty of Medicine, Zagazig University, Egypt.'}, {'lastname': 'Bendary', 'firstname': 'M A', 'initials': 'MA', 'affiliation': 'Department of Physiology, Faculty of Medicine, Menoufia University, Egypt.'}]",,,,Copyright © 2022 Elsevier B.V. All rights reserved.,10.1016/j.jchemneu.2022.102079,<Element 'PubmedArticle' at 0x7f05de7d5900>
115,"35120524
19795409
22859297
16862116
16862115
16950801
27021778
22608501
28435163
29744576
20522652
25022663
21092856
21785136
19556463
26370502
28541286
28828399
28743268
28835281
2001789
28493053
29036611
28453791
30690031
31870439
31600775
31291241
20188224
3029560
20737593
20962456
24619111
16913838
12048238
30559339
8370464
34103390
20026663
7641679
10995788
11023992
9811821
20133781
8776585
34028443
12946022",Differential regulation of progranulin derived granulin peptides.,"Haploinsufficiency of progranulin (PGRN) is a leading cause of frontotemporal lobar degeneration (FTLD). PGRN is comprised of 7.5 granulin repeats and is processed into individual granulin peptides in the lysosome. However, very little is known about the levels and regulations of individual granulin peptides due to the lack of specific antibodies.
Here we report the generation and characterization of antibodies specific to each granulin peptide. We found that the levels of granulins C, E and F are regulated differently  compared to granulins A and B in various tissues. The levels of PGRN and granulin peptides vary in different brain regions and the ratio between granulins and PGRN is highest in the cortical region in the adult male mouse brain. Granulin-A is localized in the lysosome in both neurons and microglia and its levels in microglia increase under pathological conditions. Interestingly,  the levels of granulin A in microglia change correspondingly with PGRN in response to stroke but not demyelination. Furthermore, deficiency of lysosomal proteases and the PGRN binding partner prosaposin leads to alterations in the ratios between individual granulin peptides. Granulins B, C and E are heavily glycosylated and the glycosylation patterns can be regulated.
Our results support that the levels of individual granulin peptides are differentially regulated under physiological and pathological conditions and provide novel insights into how granulin peptides function in the lysosome.","['Cathepsin', 'Frontotemporal lobar degeneration (FTLD)', 'Glycosylation', 'Granulin', 'Lysosome', 'Progranulin (PGRN)']",Molecular neurodegeneration,2022-02-06,"[{'lastname': 'Zhang', 'firstname': 'Tingting', 'initials': 'T', 'affiliation': 'Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, USA.'}, {'lastname': 'Du', 'firstname': 'Huan', 'initials': 'H', 'affiliation': 'Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, USA.'}, {'lastname': 'Santos', 'firstname': 'Mariela Nunez', 'initials': 'MN', 'affiliation': 'Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, USA.'}, {'lastname': 'Wu', 'firstname': 'Xiaochun', 'initials': 'X', 'affiliation': 'Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, USA.'}, {'lastname': 'Pagan', 'firstname': 'Mitchell D', 'initials': 'MD', 'affiliation': 'Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, USA.'}, {'lastname': 'Trigiani', 'firstname': 'Lianne Jillian', 'initials': 'LJ', 'affiliation': 'Nancy E. and Peter C. Meining School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA.'}, {'lastname': 'Nishimura', 'firstname': 'Nozomi', 'initials': 'N', 'affiliation': 'Nancy E. and Peter C. Meining School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA.'}, {'lastname': 'Reinheckel', 'firstname': 'Thomas', 'initials': 'T', 'affiliation': 'Institute of Molecular Medicine and Cell Research, Medical Faculty and BIOSS Centre for Biological Signaling Studies, Albert-Ludwigs-University Freiburg, 79104, Freiburg, Germany.'}, {'lastname': 'Hu', 'firstname': 'Fenghua', 'initials': 'F', 'affiliation': 'Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, USA. fh87@cornell.edu.'}]",,Our results support that the levels of individual granulin peptides are differentially regulated under physiological and pathological conditions and provide novel insights into how granulin peptides function in the lysosome.,"Here we report the generation and characterization of antibodies specific to each granulin peptide. We found that the levels of granulins C, E and F are regulated differently  compared to granulins A and B in various tissues. The levels of PGRN and granulin peptides vary in different brain regions and the ratio between granulins and PGRN is highest in the cortical region in the adult male mouse brain. Granulin-A is localized in the lysosome in both neurons and microglia and its levels in microglia increase under pathological conditions. Interestingly,  the levels of granulin A in microglia change correspondingly with PGRN in response to stroke but not demyelination. Furthermore, deficiency of lysosomal proteases and the PGRN binding partner prosaposin leads to alterations in the ratios between individual granulin peptides. Granulins B, C and E are heavily glycosylated and the glycosylation patterns can be regulated.",© 2022. The Author(s).,"10.1186/s13024-021-00513-9
10.1002/bies.200900086
10.1074/jbc.R112.399170
10.1038/nature05016
10.1038/nature05017
10.1093/hmg/ddl241
10.1016/j.neurobiolaging.2016.02.019
10.1016/j.ajhg.2012.04.021
10.1038/nrn.2017.36
10.1007/s00401-018-1861-8
10.2353/ajpath.2010.090915
10.1186/s40478-014-0078-x
10.1016/j.neuron.2010.09.034
10.1093/nar/gkr593
10.1126/science.1174447
10.1083/jcb.201502029
10.1038/ncomms15277
10.1186/s13024-017-0196-6
10.1186/s13024-017-0205-9
10.1096/fasebj.5.3.2001789
10.1007/s00401-017-1719-5
10.1093/hmg/ddx364
10.1093/hmg/ddx162
10.1016/j.jmb.2019.01.027
10.1186/s40478-019-0872-6
10.1093/hmg/ddz229
10.1371/journal.pone.0212382
10.1016/j.jprot.2010.02.013
10.1007/BF00230632
10.1002/cne.22430
10.1262/jrd.10-116S
10.1007/s00401-014-1262-6
10.1515/BC.2006.112
10.1073/pnas.112632299
10.1038/s41467-018-07741-6
10.1016/0014-5793(93)80908-D
10.26508/lsa.202000874
10.1084/jem.20091568
10.1002/j.1460-2075.1995.tb00029.x
10.1172/JCI9411
10.1096/fj.99-0970com
10.1073/pnas.95.23.13453
10.1073/pnas.0907240107
10.1093/hmg/5.6.711
10.1111/j.1750-3639.2003.tb00032.x",<Element 'PubmedArticle' at 0x7f05de7e1450>
116,"35091686
31536753
25693568
33711510
25984581
22913619
17077142
28150190
24326520
25206841
27923632
28934977
29524300
27470554
28948468
30079374
26435474
28577965
28544903
26303083
33065257
33296142
28421121
27522255
23348408
21958968
23602914
21354297
23707573
33369003
26111763
29961232
32739363
19142572
21471435
29518356
32868905
33758353
20967580
9630473
30676698
30266107
21812660
28811267
26251237
10987824
30775984
27019755
26488171
28088900
29288734
24608267
26788077
18317592
23093066
28863942
33534126
33788812
30196278
31814548
22451324
33191916
29520217
33034847
31091792
23839597
27561549
27566237
31293402
31585527
29237809
24444786
26432481
31127200
29288971
32595486
30745834
31885818
25322820
30668936
30655609
16365303
31349032
25354497
30190379
30196289
8709781
19931595
24418360
9040575
16216908
25420519
29096893
17559807
30685474
31006181
25747037
29453339
31168644
30675901
32297302
25964165
25332198
31655280
33011199",Patchouli alcohol as a selective estrogen receptor β agonist ameliorates AD-like pathology of APP/PS1 model mice.,"Clinical evidence shows that postmenpausal women are almost twice as likely to develop Alzheimer's disease (AD) as men of the same age, and estrogen is closely related to the occurrence of AD. Estrogen receptor (ER) α is mainly expressed in the mammary gland and other reproductive organs like uterus while ERβ is largely distributed in the hippocampus and cardiovascular system, suggesting that ERβ selective agonist is a valuable drug against neurodegenerative diseases with low tendency in inducing cancers of breast and other reproductive organs. In this study we identified a natural product patchouli alcohol (PTA) as a selective ERβ agonist which improved the cognitive defects in female APP/PS1 mice, and explore the underlying mechanisms. Six-month-old female APP/PS1 mice were administered PTA (20, 40 mg · kg","['Alzheimer’s disease', 'ER selective agonist', 'Toll-like receptor 4', 'amyloid-β', 'patchouli alcohol', 'synaptic plasticity']",Acta pharmacologica Sinica,2022-01-30,"[{'lastname': 'Yan', 'firstname': 'Qiu-Ying', 'initials': 'QY', 'affiliation': 'Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica and State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.'}, {'lastname': 'Lv', 'firstname': 'Jian-Lu', 'initials': 'JL', 'affiliation': 'Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica and State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.'}, {'lastname': 'Shen', 'firstname': 'Xing-Yi', 'initials': 'XY', 'affiliation': 'Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica and State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.'}, {'lastname': 'Ou-Yang', 'firstname': 'Xing-Nan', 'initials': 'XN', 'affiliation': 'Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica and State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.'}, {'lastname': 'Yang', 'firstname': 'Juan-Zhen', 'initials': 'JZ', 'affiliation': 'Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica and State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.'}, {'lastname': 'Nie', 'firstname': 'Rui-Fang', 'initials': 'RF', 'affiliation': 'Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica and State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.'}, {'lastname': 'Lu', 'firstname': 'Jian', 'initials': 'J', 'affiliation': 'Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica and State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.'}, {'lastname': 'Huang', 'firstname': 'Yu-Jie', 'initials': 'YJ', 'affiliation': 'Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica and State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.'}, {'lastname': 'Wang', 'firstname': 'Jia-Ying', 'initials': 'JY', 'affiliation': 'Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica and State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China. wangjy@njucm.edu.cn.'}, {'lastname': 'Shen', 'firstname': 'Xu', 'initials': 'X', 'affiliation': 'Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica and State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China. xshen@njucm.edu.cn.'}]",,,,"© 2022. The Author(s), under exclusive licence to Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Chinese Pharmacological Society.","10.1038/s41401-021-00857-4
10.1016/j.fct.2019.110822
10.1038/nature14252
10.1016/j.arr.2021.101318
10.1016/j.jalz.2015.02.003
10.1080/13803395.2012.712676
10.1073/pnas.0608128103
10.1007/s12031-017-0884-2
10.3233/JAD-130551
10.4103/1673-5374.130063
10.1016/j.brainres.2016.11.023
10.1186/s13195-017-0305-3
10.1111/cns.12842
10.1016/j.biopha.2016.06.021
10.1007/s12035-017-0777-y
10.1523/ENEURO.0057-18.2018
10.1016/j.yhbeh.2015.09.004
10.1016/j.ejphar.2017.05.059
10.1016/j.psyneuen.2017.05.016
10.1016/j.beem.2015.04.008
10.1016/j.jnutbio.2020.108525
10.1002/mnfr.202000797
10.1016/j.biopha.2016.08.005
10.1016/j.fct.2012.12.062
10.1016/j.fitote.2011.09.003
10.1016/j.intimp.2013.04.006
10.1016/j.jep.2011.02.018
10.1016/j.steroids.2013.04.018
10.1016/j.cbi.2015.06.030
10.1007/s11064-018-2589-5
10.1016/j.bbi.2020.07.041
10.1007/s00702-008-0177-6
10.1016/j.neuron.2018.01.031
10.1038/s41401-020-00506-2
10.1038/s41401-021-00634-3
10.1007/978-1-60761-744-0_2
10.1016/S0169-328X(98)00040-0
10.1111/cns.13086
10.24920/03476
10.1089/adt.2011.0380
10.1016/j.neuint.2017.08.007
10.1007/s00281-015-0518-0
10.1046/j.1471-4159.2000.0751447.x
10.3233/JAD-180904
10.1371/journal.pone.0140868
10.2174/1871527316666170113120853
10.1016/j.brainresbull.2017.12.011
10.1038/npp.2014.56
10.5114/aoms.2015.56342
10.1172/JCI32796
10.1038/jcbfm.2012.159
10.1016/j.freeradbiomed.2017.08.021
10.1007/s12640-021-00336-y
10.1097/WNR.0000000000001599
10.2174/1381612825666191209115431
10.3233/JAD-2012-120283
10.3389/fnmol.2018.00051
10.1007/s13311-020-00943-1
10.3390/jcm8050680
10.1038/nrn3486
10.1111/gbb.12324
10.1016/j.yhbeh.2016.08.006
10.3389/fnbeh.2019.00138
10.1186/s12868-019-0534-4
10.1016/j.mce.2014.01.009
10.1016/j.bbadis.2015.09.018
10.1038/s41418-019-0348-z
10.1016/j.biopha.2017.12.099
10.3389/fnagi.2020.00134
10.7150/ijbs.26703
10.1007/s11064-014-1454-4
10.1016/j.bcp.2019.01.015
10.1038/s41580-018-0089-8
10.1073/pnas.0505203102
10.1016/j.nbd.2019.104540
10.1007/s12035-014-8958-4
10.1159/000493229
10.1016/S0140-6736(96)03356-9
10.1016/j.bbagen.2009.11.013
10.1016/j.mce.2013.12.018
10.1016/S0140-6736(96)07365-5
10.1677/jme.1.01783
10.3892/ijo.2014.2778
10.1016/bs.pmbts.2017.08.002
10.1016/j.bbrc.2007.05.158
10.1016/j.fct.2019.01.017
10.4062/biomolther.2019.046
10.1016/j.expneurol.2015.02.034
10.1038/s41598-018-21596-3
10.1007/s00401-019-02032-w
10.1111/bph.14585
10.1007/s12035-020-01911-8
10.1016/j.brainres.2015.04.059
10.1002/hipo.22378
10.1016/j.pharep.2019.06.014
10.1016/j.neuropharm.2020.108334",<Element 'PubmedArticle' at 0x7f05dd89abd0>
117,35039149,Progranulin as a therapeutic target in neurodegenerative diseases.,"Progranulin (PGRN, encoded by the GRN gene) plays a key role in the development, survival, function, and maintenance of neurons and microglia in the mammalian brain. It regulates lysosomal biogenesis, inflammation, repair, stress response, and aging. GRN loss-of-function mutations cause neuronal ceroid lipofuscinosis or frontotemporal dementia-GRN (FTD-GRN) in a gene dosage-dependent manner. Mutations that reduce PGRN levels increase the risk for developing Alzheimer's disease, Parkinson's disease, and limbic-predominant age-related transactivation response DNA-binding protein 43 encephalopathy, as well as exacerbate the progression of amyotrophic lateral sclerosis (ALS) and FTD caused by the hexanucleotide repeat expansion in the C9orf72 gene. Elevating and/or restoring PGRN levels is an attractive therapeutic strategy and is being investigated for neurodegenerative diseases through multiple mechanisms of action.","['AL001', 'GRN', 'frontotemporal dementia', 'loss of function', 'neurodegenerative disorders', 'progranulin']",Trends in pharmacological sciences,2022-01-19,"[{'lastname': 'Rhinn', 'firstname': 'Herve', 'initials': 'H', 'affiliation': 'Alector, Inc., South San Francisco, CA 94080, USA.'}, {'lastname': 'Tatton', 'firstname': 'Nadine', 'initials': 'N', 'affiliation': 'Alector, Inc., South San Francisco, CA 94080, USA.'}, {'lastname': 'McCaughey', 'firstname': 'Stella', 'initials': 'S', 'affiliation': 'Alector, Inc., South San Francisco, CA 94080, USA.'}, {'lastname': 'Kurnellas', 'firstname': 'Michael', 'initials': 'M', 'affiliation': 'Alector, Inc., South San Francisco, CA 94080, USA.'}, {'lastname': 'Rosenthal', 'firstname': 'Arnon', 'initials': 'A', 'affiliation': 'Alector, Inc., South San Francisco, CA 94080, USA. Electronic address: ar@alector.com.'}]",,,,Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.,10.1016/j.tips.2021.11.015,<Element 'PubmedArticle' at 0x7f05df876c70>
118,"35031523
32985801
11054608
31155393
20346963
24222472
32575507
28273060
33824339
33231171
28166221
31420539
20097762
34260928
28730707
26243191
27853238
28355573
29875463
24413982
12406855
31611708
18689494
30606613
30108586
25792222
32039522
32103204
32968110
34296197
32544087
22965758
28841766
30318853
27608012
30471926
18338791
19573520
30865888
30420755
29967574
27548245
16624958
28376157
28249896
31178118
31253775
33431871",Critical changes in hypothalamic gene networks in response to pancreatic cancer as found by single-cell RNA sequencing.,"Cancer cachexia is a devastating chronic condition characterized by involuntary weight loss, muscle wasting, abnormal fat metabolism, anorexia, and fatigue. However, the molecular mechanisms underlying this syndrome remain poorly understood. In particular, the hypothalamus may play a central role in cachexia, given that it has direct access to peripheral signals because of its anatomical location and attenuated blood-brain barrier. Furthermore, this region has a critical role in regulating appetite and metabolism.
To provide a detailed analysis of the hypothalamic response to cachexia, we performed single-cell RNA-seq combined with RNA-seq of the medial basal hypothalamus (MBH) in a mouse model for pancreatic cancer.
We found many cell type-specific changes, such as inflamed endothelial cells, stressed oligodendrocyes and both inflammatory and moderating microglia. Lcn2, a newly discovered hunger suppressing hormone, was the highest induced gene. Interestingly, cerebral treatment with LCN2 not only induced many of the observed molecular changes in cachexia but also affected gene expression in food-intake decreasing POMC neurons. In addition, we found that many of the cachexia-induced molecular changes found in the hypothalamus mimic those at the primary tumor site.
Our data reveal that multiple cell types in the MBH are affected by tumor-derived factors or host factors that are induced by tumor growth, leading to a marked change in the microenvironment of neurons critical for behavioral, metabolic, and neuroendocrine outputs dysregulated during cachexia. The mechanistic insights provided in this study explain many of the clinical features of cachexia and will be useful for future therapeutic development.","['Cachexia models', 'Endothelial inflammation', 'Food intake regulation', 'Neuroinflammation', 'Pancreatic cancer', 'scRNA-seq of the central nervous system']",Molecular metabolism,2022-01-16,"[{'lastname': 'Huisman', 'firstname': 'Christian', 'initials': 'C', 'affiliation': 'Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, United States; Knight Cancer Institute, Oregon Health & Science University, Portland, United States. Electronic address: huisman@ohsu.edu.'}, {'lastname': 'Norgard', 'firstname': 'Mason A', 'initials': 'MA', 'affiliation': 'Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, United States.'}, {'lastname': 'Levasseur', 'firstname': 'Peter R', 'initials': 'PR', 'affiliation': 'Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, United States.'}, {'lastname': 'Krasnow', 'firstname': 'Stephanie M', 'initials': 'SM', 'affiliation': 'Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, United States.'}, {'lastname': 'van der Wijst', 'firstname': 'Monique G P', 'initials': 'MGP', 'affiliation': 'Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.'}, {'lastname': 'Olson', 'firstname': 'Brennan', 'initials': 'B', 'affiliation': 'Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, United States; Medical Scientist Training Program, Oregon Health & Science University, Portland, United States.'}, {'lastname': 'Marks', 'firstname': 'Daniel L', 'initials': 'DL', 'affiliation': 'Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, United States; Knight Cancer Institute, Oregon Health & Science University, Portland, United States; Brenden-Colson Center for Pancreatic Care, Oregon Health & Science University, Portland, United States. Electronic address: marksd@ohsu.edu.'}]",,"Our data reveal that multiple cell types in the MBH are affected by tumor-derived factors or host factors that are induced by tumor growth, leading to a marked change in the microenvironment of neurons critical for behavioral, metabolic, and neuroendocrine outputs dysregulated during cachexia. The mechanistic insights provided in this study explain many of the clinical features of cachexia and will be useful for future therapeutic development.","We found many cell type-specific changes, such as inflamed endothelial cells, stressed oligodendrocyes and both inflammatory and moderating microglia. Lcn2, a newly discovered hunger suppressing hormone, was the highest induced gene. Interestingly, cerebral treatment with LCN2 not only induced many of the observed molecular changes in cachexia but also affected gene expression in food-intake decreasing POMC neurons. In addition, we found that many of the cachexia-induced molecular changes found in the hypothalamus mimic those at the primary tumor site.",Copyright © 2022 The Authors. Published by Elsevier GmbH.. All rights reserved.,"10.1016/j.molmet.2022.101441
10.1002/jcsm.12630
10.1016/j.jphs.2019.04.005
10.1016/j.physbeh.2010.03.011
10.1007/s13539-013-0121-y
10.3390/ijms21124365
10.1038/nature21697
10.1038/s41467-021-22361-3
10.7554/eLife.58949
10.1038/nn.4495
10.1038/s41467-019-11667-y
10.1074/jbc.M109.070706
10.1016/j.celrep.2021.109362
10.1002/jcsm.12225
10.1126/scisignal.aaa5823
10.1038/srep37116
10.1016/j.celrep.2017.03.004
10.1038/s41591-018-0054-2
10.1007/s00702-013-1157-z
10.1164/rccm.200204-285OC
10.1038/s41593-019-0497-x
10.1152/ajpheart.00779.2008
10.1016/j.neuron.2018.12.006
10.3389/fimmu.2018.01753
10.1016/j.biopsych.2015.02.004
10.1002/glia.23796
10.1038/s41596-020-0292-x
10.1038/s41598-020-72172-7
10.1038/s43018-020-00121-4
10.1172/JCI138392
10.1002/eji.201142351
10.1113/JP274795
10.14814/phy2.13869
10.3390/ijms17091483
10.1016/j.immuni.2018.11.004
10.1002/glia.20653
10.1016/j.brainres.2009.06.073
10.1016/j.celrep.2019.02.060
10.1038/s41591-018-0236-y
10.3389/fnins.2018.00397
10.1038/nn.4372
10.1523/JNEUROSCI.4531-05.2006
10.1093/jnci/djw266
10.1158/0008-5472.CAN-16-1986
10.1016/j.cell.2019.05.031
10.1038/s41467-019-10649-4
10.1038/s41467-020-20511-7",<Element 'PubmedArticle' at 0x7f05df8549a0>
119,"35018802
15206773
16217129
17127351
24554058
21244359
28785808
32927647
26893170
15033929
30769106
9462850
9095378
15649736
9406036
31327964
15628673
28791422
7492947
8359270
8321083
11834835
18546475
28433459
12395907
12622846
31379746
27165273
21951153
28819865
8531047
14715696
14618273
15562014
16207296
23697902
23791176
29671706
12726883
24033352
31234024
32729676
32368857
28655998
27159033
15649735
10831154
11596111
31256787
16609073
29575122
16217123
12957828
27199894
26568121
16366599
16945173
17371545
17049787
16313501
28335007
28178380
30208798
32514788
28110436
32154907
9378964
21029156
11726736
15589378
25937837
16150105
11899099
32453975
15521903
14582858
28658527
33432584
16217125
18344019
19557144
19449447
20408738
22724080
24112071
25310649
25341518
27763686
28785805
30242884
30862067
7629689
25697044
21193011
14680136
22034907
30673309
27314334
30012383
31931006
21773809
3831305
24446866
25375034
8359272
19490755
30550751
21362033
20025641
21062352
26882442
15695169
28130830
8550809
22569208
9510432
21138476
25900041
15066046
23348014
19099187
16021634
21615491
15183071
16945113
11040043
29521332
16393710
12069043
33362546
26682214
28415828
30172748
11012083
30219671
31697951
29149454
31793209
16223598
17045454
28469767
30254716
28795196
19963060
10831160
11854034
26335311
26332964
25083875
25205852
12753069
23006670
12475181
15975667
32120833
9885995
15305379
14569400
12106998
17334663
25207999
32597503
30037127
21480979
28295567
12074097
12531250
11339508
24117944
8750343
8688911
9460704
17410109
20433638
31126958
24051248
29990691
16449799
18928424
26120888
33452667
15230868
28785807
14155806
30260503
18339127
19460395
31330909
1936532
18411159
8395408
12671308
18987585
27500468
28420185
28864909
24553808
14740000
11060493
30126181
29495303
30411173
7568007
7946354
30148726
14675124
17164175
17761903
18485648
9556098
32731545
23604474
28721826
19233254
30073921
29478834
30578379
8787196
29428440
24668754
27739090
31025320
16674804
16179266
31991655
7706239
28874589
29495398
10622237
32992875
26804589
11899100
19437546
30982132
11751596
12508312
14635944
17486113
29512136
24802882
19299628
29674717
17014688
33161138
17799239
30597604
31450679
15970569
21635892
29872034
28803211
33135223
32343612
31428688
31244920
28120943
32937627
28500761
27881406
10567232
28480597
31526949
30500551
32526704
32767062
30353656
31746366
29183837
28398674
31110599
29318587",Redox Biology of Melatonin: Discriminating Between Circadian and Noncircadian Functions.,"Melatonin has not only to be seen as a regulator of circadian clocks. In addition to its chronobiotic functions, it displays other actions, especially in cell protection. This includes antioxidant, anti-inflammatory, and mitochondria-protecting effects. Although protection is also modulated by the circadian system, the respective actions of melatonin can be distinguished and differ with regard to dose requirements in therapeutic settings. It is the aim of this article to outline these differences in terms of function, signaling, and dosage. Focus has been placed on both the nexus and the dissecting properties between circadian and noncircadian mechanisms. This has to consider details beyond the classic view of melatonin's role, such as widespread synthesis in extrapineal tissues, formation in mitochondria, effects on the mitochondrial permeability transition pore, and secondary signaling, for example, ","['circadian', 'extrapineal', 'melatonin', 'miRNAs', 'mitochondria', 'sirtuins']",Antioxidants & redox signaling,2022-01-13,"[{'lastname': 'Hardeland', 'firstname': 'Rüdiger', 'initials': 'R', 'affiliation': 'Johann Friedrich Blumenbach Institute of Zoology and Anthropology, University of Goettingen, Goettingen, Germany.'}]",,,,,10.1089/ars.2021.0275,<Element 'PubmedArticle' at 0x7f05deaadc70>
120,"35017199
25792098
29643512
11513911
23623698
21282636
23000955
17943118
27776263
31063846
29051531
29758946
31064831
28035935
29575030
32832679
28176819
17257165
20553961
20157512
4005573
18703605
18931664
18537667
21920632
18255193
17998412
23683389
23034916
25326800
26549211
29725016
24466171
32795415
34260075
30530690
17316818
22476197
15750215
26187728
17418803
24746363
23893854
12571239
15625306
18367585
16540375
12835322
30792307
22074460
33311478
18388310
20128796
9724811
24462904
26108977
25113171
19164449
12665574
25543525
21270887
10614631
15299028
18631945
25411471
24608097
20398713
23917584
31354471
33063458
28659803
26030851
27338705
31097468
27446020
30804569",Gut microbiota regulate Alzheimer's disease pathologies and cognitive disorders via PUFA-associated neuroinflammation.,"This study is to investigate the role of gut dysbiosis in triggering inflammation in the brain and its contribution to Alzheimer's disease (AD) pathogenesis.
We analysed the gut microbiota composition of 3×Tg mice in an age-dependent manner. We generated germ-free 3×Tg mice and recolonisation of germ-free 3×Tg mice with fecal samples from both patients with AD and age-matched healthy donors.
Microbial 16S rRNA sequencing revealed Bacteroides enrichment. We found a prominent reduction of cerebral amyloid-β plaques and neurofibrillary tangles pathology in germ-free 3×Tg mice as compared with specific-pathogen-free mice. And hippocampal RNAseq showed that inflammatory pathway and insulin/IGF-1 signalling in 3×Tg mice brain are aberrantly altered in the absence of gut microbiota. Poly-unsaturated fatty acid metabolites identified by metabolomic analysis, and their oxidative enzymes were selectively elevated, corresponding with microglia activation and inflammation. AD patients' gut microbiome exacerbated AD pathologies in 3×Tg mice, associated with C/EBPβ/asparagine endopeptidase pathway activation and cognitive dysfunctions compared with healthy donors' microbiota transplants.
These findings support that a complex gut microbiome is required for behavioural defects, microglia activation and AD pathologies, the gut microbiome contributes to pathologies in an AD mouse model and that dysbiosis of the human microbiome might be a risk factor for AD.",['brain/gut interaction'],Gut,2022-01-13,"[{'lastname': 'Chen', 'firstname': 'Chun', 'initials': 'C', 'affiliation': 'Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA.'}, {'lastname': 'Liao', 'firstname': 'Jianming', 'initials': 'J', 'affiliation': 'Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA.\nDepartment of Neurosurgery, Renmin Hospital, Wuhan University, Wuhan, Hubei, China.'}, {'lastname': 'Xia', 'firstname': 'Yiyuan', 'initials': 'Y', 'affiliation': 'Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA.'}, {'lastname': 'Liu', 'firstname': 'Xia', 'initials': 'X', 'affiliation': 'Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA.'}, {'lastname': 'Jones', 'firstname': 'Rheinallt', 'initials': 'R', 'affiliation': 'Department of Pediatrics, Emory University, Atlanta, Georgia, USA.'}, {'lastname': 'Haran', 'firstname': 'John', 'initials': 'J', 'affiliation': 'Department of Emergency Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.\nCenter for Microbiome Research, University of Massachusetts Medical School, Worcester, Massachusetts, USA.\nDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, USA.'}, {'lastname': 'McCormick', 'firstname': 'Beth', 'initials': 'B', 'affiliation': 'Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, USA.'}, {'lastname': 'Sampson', 'firstname': 'Timothy Robert', 'initials': 'TR', 'affiliation': 'Department of Physiology, Emory University, Atlanta, Georgia, USA.'}, {'lastname': 'Alam', 'firstname': 'Ashfaqul', 'initials': 'A', 'affiliation': 'Microbiology, Immunology & Molecular Genetics, University of Kentucky, Lexington, Kentucky, USA.\nMarkey Cancer Center, University of Kentucky, Lexington, KY, USA.'}, {'lastname': 'Ye', 'firstname': 'Keqiang', 'initials': 'K', 'affiliation': 'Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA kq.ye@siat.ac.cn.\nFaculty of Life and Health Sciences, The Brain Cognition and Brain Disorders Institute (BCBDI), Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences, Shenzhen, Guangdong, China.'}]",,,"Microbial 16S rRNA sequencing revealed Bacteroides enrichment. We found a prominent reduction of cerebral amyloid-β plaques and neurofibrillary tangles pathology in germ-free 3×Tg mice as compared with specific-pathogen-free mice. And hippocampal RNAseq showed that inflammatory pathway and insulin/IGF-1 signalling in 3×Tg mice brain are aberrantly altered in the absence of gut microbiota. Poly-unsaturated fatty acid metabolites identified by metabolomic analysis, and their oxidative enzymes were selectively elevated, corresponding with microglia activation and inflammation. AD patients' gut microbiome exacerbated AD pathologies in 3×Tg mice, associated with C/EBPβ/asparagine endopeptidase pathway activation and cognitive dysfunctions compared with healthy donors' microbiota transplants.",© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.,10.1136/gutjnl-2021-326269,<Element 'PubmedArticle' at 0x7f05dd6c8a40>
121,"35010897
25477778
28420148
33946461
8229312
33915261
32804018
33492296
30475761
22023986
21389247
28680065
28066237
30779205
21702898
20383131
20709691
32603429
24815961
33177790
19073790
32729948
22279140
16364299
31440144
31602309
28467922
22717075
8197147
26686654
26828918
33920923
29018410
23831042
27118489
22855869
32699414
21822921",Bioactive Foods Decrease Liver and Brain Alterations Induced by a High-Fat-Sucrose Diet through Restoration of Gut Microbiota and Antioxidant Enzymes.,"Obesity is associated with cognitive deficit and liver alterations; however, it remains unclear whether a combination of functional foods could reverse cognitive damage and to what extent it would be associated with changes in gut microbiota and liver. With this aim, male Wistar rats were fed a high-fat-5%sucrose diet (HFS) for 4 mo. And were then fed for 1 mo. with bioactive foods. At the end of this period, liver, serum, feces, intestine, and brain samples were taken. Body composition, energy expenditure, LPS, hormones, intraperitoneal glucose tolerance test, behavioral tests, and gut microbiota were evaluated. We showed that male rats fed high-fat-sucrose diet developed gut microbiota dysbiosis, increased in body fat, decreased antioxidant activity, decreased brain neuropeptide Y, increased the number of astrocytes and activated microglia, along with reduced spine density associated with deficits in working memory. Ingestion of a combination of nopal, soy protein, curcumin, and chia seed oil (bioactive foods) for three months was associated with an increase in a cluster of bacteria with anti-inflammatory capacity, a decrease in serum LPS levels and an increase in serum eicosapentaenoic acid (EPA) with neuroprotective properties. In the liver, ingestion of bioactive food significantly increased antioxidant enzymes, decreased lipogenesis, reduced inflammation mediated by the TLR4-TNFα pathway along with a decrease in body fat, glucose intolerance, and metabolic inflexibility. Finally, neuroinflammation in the brain was reduced and working memory improved. Our study demonstrates that consumption of bioactive foods was associated with reduced liver, brain, and gut microbiota alterations in obese rats.","['bioactive foods', 'cognitive function', 'gut microbiota', 'hepatic antioxidant enzymes']",Nutrients,2022-01-12,"[{'lastname': 'Syeda', 'firstname': 'Tauqeerunnisa', 'initials': 'T', 'affiliation': 'Laboratorio de Neuroplasticidad y Neurodegeneración, Departamento de Farmacología, CINVESTAV, Mexico City 07360, Mexico.'}, {'lastname': 'Sánchez-Tapia', 'firstname': 'Mónica', 'initials': 'M', 'affiliation': 'Departamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico.'}, {'lastname': 'Orta', 'firstname': 'Itzel', 'initials': 'I', 'affiliation': 'Departamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico.'}, {'lastname': 'Granados-Portillo', 'firstname': 'Omar', 'initials': 'O', 'affiliation': 'Departamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico.'}, {'lastname': 'Pérez-Jimenez', 'firstname': 'Lizbeth', 'initials': 'L', 'affiliation': 'Laboratorio de Neuroplasticidad y Neurodegeneración, Departamento de Farmacología, CINVESTAV, Mexico City 07360, Mexico.'}, {'lastname': 'Rodríguez-Callejas', 'firstname': 'Juan-de-Dios', 'initials': 'JD', 'affiliation': 'Laboratorio de Neuroplasticidad y Neurodegeneración, Departamento de Farmacología, CINVESTAV, Mexico City 07360, Mexico.'}, {'lastname': 'Toribio', 'firstname': 'Samuel', 'initials': 'S', 'affiliation': 'Laboratorio de Neuroplasticidad y Neurodegeneración, Departamento de Farmacología, CINVESTAV, Mexico City 07360, Mexico.'}, {'lastname': 'Silva-Lucero', 'firstname': 'Maria-Del-Carmen', 'initials': 'MD', 'affiliation': 'Laboratorio de Neuroplasticidad y Neurodegeneración, Departamento de Farmacología, CINVESTAV, Mexico City 07360, Mexico.'}, {'lastname': 'Rivera', 'firstname': 'Ana-Leonor', 'initials': 'AL', 'affiliation': 'Instituto de Ciencias Nucleares y Centro de Ciencias de la Complejidad, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.'}, {'lastname': 'Tovar', 'firstname': 'Armando R', 'initials': 'AR', 'affiliation': 'Departamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico.'}, {'lastname': 'Torres', 'firstname': 'Nimbe', 'initials': 'N', 'affiliation': 'Departamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico.'}, {'lastname': 'Perez-Cruz', 'firstname': 'Claudia', 'initials': 'C', 'affiliation': 'Laboratorio de Neuroplasticidad y Neurodegeneración, Departamento de Farmacología, CINVESTAV, Mexico City 07360, Mexico.'}]",,,,,"10.3390/nu14010022
10.3389/fnins.2014.00375
10.3390/nu9040393
10.3390/antiox10050714
10.1093/jn/123.11.1939
10.1016/j.jnutbio.2021.108751
10.1080/19490976.2020.1801301
10.3233/JAD-201367
10.3233/JAD-180556
10.1016/j.arcmed.2011.10.004
10.1523/JNEUROSCI.6142-10.2011
10.1038/s41598-017-05096-4
10.3389/fnagi.2016.00315
10.1002/ajp.22956
10.1186/gb-2011-12-6-r60
10.1038/nmeth.f.303
10.1093/bioinformatics/btq461
10.1210/endocr/bqaa102
10.1038/ncomms4878
10.3748/wjg.v26.i40.6141
10.3945/ajcn.2008.26482
10.1002/mnfr.202000532
10.3945/jn.111.155259
10.1016/j.expneurol.2005.09.004
10.3389/fncel.2019.00363
10.1038/s41522-019-0101-x
10.1016/j.cmet.2017.04.015
10.1017/S0007114512001213
10.1073/pnas.91.11.4854
10.1016/j.cell.2015.11.023
10.1038/nrgastro.2016.4
10.3390/antiox10040608
10.3389/fmicb.2017.01765
10.1016/j.mib.2013.06.003
10.1038/mi.2016.42
10.1016/j.tifs.2017.09.003
10.1212/WNL.0b013e318264e394
10.1038/s41586-020-2527-y
10.1007/s11064-011-0563-6",<Element 'PubmedArticle' at 0x7f05dd6b1cc0>
122,34990615,Phytoestrogen genistein modulates neuron-microglia signaling in a mouse model of chronic social defeat stress.,"Microglia, resident immune cells in the brain, are shown to mediate the crosstalk between psychological stress and depression. Interestingly, increasing evidence indicates that sex hormones, particularly estrogen, are involved in the regulation of immune system. In this study, we aimed to understand the potential effects of chronic social defeat stress (CSDS) and genistein (GEN), an estrogenic compound of the plant origin, on neuron-microglia interactions in the mouse hippocampus. The time spent in the avoidance zone in the social interaction test was increased by CSDS 1 day after the exposure, while the avoidance behavior returned to control levels 14 days after the CSDS exposure. Similar results were obtained from the elevated plus-maze test. However, the immobility time in the forced swim test was increased by CSDS 14 days after the exposure, and the depression-related behavior was in part alleviated by GEN. The numerical densities of microglia in the hippocampus were increased by CSDS, and they were decreased by GEN. The voxel densities of synaptic structures and synaptic puncta colocalized with microglia were decreased by CSDS, and they were increased by GEN. Neither CSDS nor GEN affected the gene expressions of major pro-inflammatory cytokines. Conversely, the expression levels of genes related to neurotrophic factors were decreased by CSDS, and they were partially reversed by GEN. These findings show that GEN may in part alleviate stress-related symptoms, and the effects of GEN may be associated with the modulation of neuron-microglia signaling via chemokines and neurotrophic factors in the hippocampus.","['Genistein', 'Hippocampus', 'Microglia', 'Social defeat stress', 'Synapse']",Neuropharmacology,2022-01-07,"[{'lastname': 'Fujikawa', 'firstname': 'Risako', 'initials': 'R', 'affiliation': 'Department of Anatomy and Neuroscience, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan.'}, {'lastname': 'Yamada', 'firstname': 'Jun', 'initials': 'J', 'affiliation': 'Department of Anatomy and Neuroscience, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan.'}, {'lastname': 'Iinuma', 'firstname': 'Kyoko M', 'initials': 'KM', 'affiliation': 'Department of Anatomy and Neuroscience, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan.'}, {'lastname': 'Jinno', 'firstname': 'Shozo', 'initials': 'S', 'affiliation': 'Department of Anatomy and Neuroscience, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan. Electronic address: sjnno@med.kyushu-u.ac.jp.'}]",,,,Copyright © 2022 Elsevier Ltd. All rights reserved.,10.1016/j.neuropharm.2021.108941,<Element 'PubmedArticle' at 0x7f05dd34dd60>
123,"34985189
30300457
33174475
29311122
26290108
29617641
27030669
25380238
26500843
26831302
27186358
26977279
31031702
28781108
29462693
30944040
29435980
29623090
27295427
31998717
30020885
29705602
29549796
34119519
33567615
32380197
30934882
28456941
29864483
31881271
27917122
24529520
30823403
31593687
29305122
29571736
31236111
31886288
23325217
27500459
27725120
33328897
28086065
33290962
27997058
29895691
20225396
31759969
21744074
24719110
31706303
10657494
34260042
34118986
33467075
30428311
34355526
28844606
30501132
26010513
29077002
16340011
23116613
31629984
33901504
21106820
28336086
26861286",Liraglutide attenuate central nervous inflammation and demyelination through AMPK and pyroptosis-related NLRP3 pathway.,"Multiple sclerosis (MS) still maintains increasing prevalence and poor prognosis, while glucagon-like peptide-1 receptor (GLP-1R) agonists show excellent neuroprotective capacities recently. Thus, we aim to evaluate whether the GLP-1R agonist liraglutide (Lira) could ameliorate central nervous system demyelination and inflammation.
The therapeutic effect of Lira was tested on experimental autoimmune encephalitis (EAE) in vivo and a microglia cell line BV2 in vitro.
Lira administration could ameliorate the disease score of EAE mice, delay the disease onset, ameliorate pathological demyelination and inflammation score in lumbar spinal cord, reduce pathogenic T helper cell transcription in spleen, restore phosphorylated adenosine monophosphate-activated protein kinase (pAMPK) level, autophagy level, and inhibit pyroptosis-related NLR family, pyrin domain-containing protein 3 (NLRP3) pathway in lumbar spinal cord. Additionally, cell viability test, lactate dehydrogenase release test, and dead/live cell staining test for BV2 cells showed Lira could not salvage BV2 from nigericin-induced pyroptosis significantly.
Lira has anti-inflammation and anti-demyelination effect on EAE mice, and the protective effect of Lira in the EAE model may be related to regulation of pAMPK pathway, autophagy, and NLRP3 pathway. However, Lira treatment cannot significantly inhibit pyroptosis of BV2 cells in vitro. Our study provides Lira as a potential candidate for Multiple Sclerosis treatment.","['AMPK', 'GLP-1R agonist', 'NLPR3', 'autophagy', 'experimental autoimmune encephalitis', 'multiple sclerosis', 'pyroptosis']",CNS neuroscience & therapeutics,2022-01-06,"[{'lastname': 'Song', 'firstname': 'Shuang', 'initials': 'S', 'affiliation': 'Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.\nKey Laboratory of Neurology of Hebei Province, Shijiazhuang, China.'}, {'lastname': 'Guo', 'firstname': 'Ruoyi', 'initials': 'R', 'affiliation': 'Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.\nKey Laboratory of Neurology of Hebei Province, Shijiazhuang, China.'}, {'lastname': 'Mehmood', 'firstname': 'Arshad', 'initials': 'A', 'affiliation': 'Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.\nKey Laboratory of Neurology of Hebei Province, Shijiazhuang, China.'}, {'lastname': 'Zhang', 'firstname': 'Lu', 'initials': 'L', 'affiliation': 'Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.\nKey Laboratory of Neurology of Hebei Province, Shijiazhuang, China.'}, {'lastname': 'Yin', 'firstname': 'Bowen', 'initials': 'B', 'affiliation': 'Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.\nKey Laboratory of Neurology of Hebei Province, Shijiazhuang, China.\nDepartment of Neurology, The First Hospital of Qinhuangdao, Qinhuangdao, China.'}, {'lastname': 'Yuan', 'firstname': 'Congcong', 'initials': 'C', 'affiliation': 'Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.\nKey Laboratory of Neurology of Hebei Province, Shijiazhuang, China.\nDepartment of Neurology, Baoding First Central Hospital, Baoding, China.'}, {'lastname': 'Zhang', 'firstname': 'Huining', 'initials': 'H', 'affiliation': 'Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.\nKey Laboratory of Neurology of Hebei Province, Shijiazhuang, China.'}, {'lastname': 'Guo', 'firstname': 'Li', 'initials': 'L', 'affiliation': 'Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.\nKey Laboratory of Neurology of Hebei Province, Shijiazhuang, China.'}, {'lastname': 'Li', 'firstname': 'Bin', 'initials': 'B', 'affiliation': 'Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.\nKey Laboratory of Neurology of Hebei Province, Shijiazhuang, China.'}]",,"Lira has anti-inflammation and anti-demyelination effect on EAE mice, and the protective effect of Lira in the EAE model may be related to regulation of pAMPK pathway, autophagy, and NLRP3 pathway. However, Lira treatment cannot significantly inhibit pyroptosis of BV2 cells in vitro. Our study provides Lira as a potential candidate for Multiple Sclerosis treatment.","Lira administration could ameliorate the disease score of EAE mice, delay the disease onset, ameliorate pathological demyelination and inflammation score in lumbar spinal cord, reduce pathogenic T helper cell transcription in spleen, restore phosphorylated adenosine monophosphate-activated protein kinase (pAMPK) level, autophagy level, and inhibit pyroptosis-related NLR family, pyrin domain-containing protein 3 (NLRP3) pathway in lumbar spinal cord. Additionally, cell viability test, lactate dehydrogenase release test, and dead/live cell staining test for BV2 cells showed Lira could not salvage BV2 from nigericin-induced pyroptosis significantly.",© 2022 The Authors. CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd.,"10.1111/cns.13791
10.1111/ene.13819
10.1177/1352458520970841
10.1101/cshperspect.a028977
10.1152/ajpregu.00333.2015
10.1016/j.cmet.2018.03.001
10.1152/ajpregu.00520.2015
10.1210/en.2014-1675
10.1016/j.molmet.2015.07.008
10.1007/s00125-016-3874-y
10.1111/jdi.12464
10.1177/2040622315620180
10.3389/fendo.2019.00155
10.1016/S0140-6736(17)31585-4
10.1016/j.neuropharm.2018.02.012
10.1186/s13063-019-3259-x
10.1002/path.5056
10.1155/2018/3094504
10.1056/NEJMoa1603827
10.3389/fcell.2019.00356
10.1515/hmbci-2018-0031
10.1016/j.brainres.2018.04.031
10.1016/j.eplepsyres.2018.03.009
10.1016/j.neuropharm.2021.108662
10.3390/molecules26040889
10.1016/j.pharmthera.2020.107559
10.3390/ijms20071584
10.1007/s12035-017-0550-2
10.1016/j.taap.2018.05.035
10.1016/j.phrs.2019.104615
10.3389/fphar.2016.00433
10.1016/j.jalz.2013.12.007
10.3390/ijms20051050
10.1016/j.ejphar.2019.172715
10.1016/j.bbrc.2018.03.142
10.1155/2019/1567095
10.1155/2019/8905917
10.1038/nature11862
10.1016/j.intimp.2016.07.036
10.1016/j.jneuroim.2016.08.014
10.3389/fncel.2020.603710
10.17305/bjbms.2017.1696
10.1016/j.intimp.2020.107092
10.1111/bpa.12477
10.1073/pnas.1722041115
10.1016/j.ajpath.2019.10.008
10.1007/s00125-011-2232-3
10.1523/JNEUROSCI.4703-13.2014
10.1186/s12933-019-0954-6
10.1007/s13311-021-01088-5
10.1186/s13195-021-00853-0
10.3390/ijms22020860
10.1016/j.neuropharm.2018.11.002
10.1111/febs.16151
10.1016/j.expneurol.2017.08.013
10.3390/ijms19123812
10.1111/cns.12404
10.3390/nu9111176
10.1016/j.peptides.2012.10.006
10.1016/j.jneuroim.2019.577067
10.1016/j.pharmthera.2021.107880
10.1523/JNEUROSCI.4088-10.2010
10.1016/j.ejcb.2017.03.004
10.3390/ijms17020190",<Element 'PubmedArticle' at 0x7f05dd33b450>
124,"34944065
16757564
20981830
21724806
25336758
15044805
24531968
25607655
29367382
32452062
32242018
25713288
27657451
19572147
10100861
10049584
21349848
27184850
26834243
15674329
24309898
27564538
33752749
7358770
24157548
18941248
11328886
30423086
19451168
26677855
27560171
29855662
31363148
18509043
17576745
21768377
27068534
28380450
12189386
34054860
30271982
25186741
30867424",Adhesion GPCR GPR56 Expression Profiling in Human Tissues.,Despite the immense functional relevance of GPR56 (gene ,"['ADGRG1', 'GPR56', 'microglia', 'thyroid']",Cells,2021-12-25,"[{'lastname': 'Kaiser', 'firstname': 'Fyn', 'initials': 'F', 'affiliation': 'Research Laboratories and Clinic of Visceral, Transplantation, Thoracic, and Vascular Surgery, Leipzig University and University Hospital Leipzig, 04103 Leipzig, Germany.'}, {'lastname': 'Morawski', 'firstname': 'Markus', 'initials': 'M', 'affiliation': 'Paul Flechsig Institute of Brain Research, Leipzig University, 04103 Leipzig, Germany.'}, {'lastname': 'Krohn', 'firstname': 'Knut', 'initials': 'K', 'affiliation': 'Core Unit DNA-Technologies, Leipzig University, 04103 Leipzig, Germany.'}, {'lastname': 'Rayes', 'firstname': 'Nada', 'initials': 'N', 'affiliation': 'Research Laboratories and Clinic of Visceral, Transplantation, Thoracic, and Vascular Surgery, Leipzig University and University Hospital Leipzig, 04103 Leipzig, Germany.'}, {'lastname': 'Hsiao', 'firstname': 'Cheng-Chih', 'initials': 'CC', 'affiliation': 'Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, 1105 Amsterdam, The Netherlands.'}, {'lastname': 'Quaas', 'firstname': 'Marianne', 'initials': 'M', 'affiliation': 'Research Laboratories and Clinic of Visceral, Transplantation, Thoracic, and Vascular Surgery, Leipzig University and University Hospital Leipzig, 04103 Leipzig, Germany.'}, {'lastname': 'Aust', 'firstname': 'Gabriela', 'initials': 'G', 'affiliation': 'Research Laboratories and Clinic of Visceral, Transplantation, Thoracic, and Vascular Surgery, Leipzig University and University Hospital Leipzig, 04103 Leipzig, Germany.'}]",,,,,"10.3390/cells10123557
10.1073/pnas.0602681103
10.1002/dvdy.22468
10.1189/jlb.0211092
10.1073/pnas.1417898111
10.1126/science.1092780
10.1126/science.1244392
10.1038/ncomms7121
10.1084/jem.20161714
10.15252/embj.2019104136
10.1038/s41467-020-15423-5
10.1124/pr.114.009647
10.1016/j.neuron.2016.08.022
10.1007/s00432-009-0635-z
10.1016/S0014-5793(99)00230-6
10.1006/geno.1998.5644
10.1074/jbc.M110.183830
10.1016/j.celrep.2016.04.053
10.1182/blood-2015-11-683649
10.1038/sj.onc.1208395
10.1074/mcp.M113.035600
10.1111/bpa.12442
10.1186/s40478-021-01145-2
10.1007/BF00412894
10.1038/nprot.2013.143
10.4049/jimmunol.181.9.6574
10.1093/nar/29.9.e45
10.1093/bioinformatics/bty560
10.1093/bioinformatics/btp324
10.1371/journal.pgen.1005728
10.1038/nprot.2016.095
10.1007/s00018-018-2846-4
10.1038/s41598-019-46265-x
10.1523/JNEUROSCI.0853-08.2008
10.1093/hmg/ddm144
10.1073/pnas.1104821108
10.1242/jcs.174458
10.18632/oncotarget.16506
10.1038/nrc822
10.3389/fimmu.2021.674189
10.1038/s42003-018-0106-7
10.1523/JNEUROSCI.1860-14.2014
10.1038/s41467-019-08976-7",<Element 'PubmedArticle' at 0x7f05ddfd2180>
125,34850494,Daidzein exerts neuroprotective activity against MPTP-induced Parkinson's disease in experimental mice and lipopolysaccharide-induced  BV2 microglial cells.,"Parkinson's disease (PD) ranks as the second most neurodegenerative disease characterized by loss of neurons, bradykinesia, anosmia, sleep disorder, and motor deficiency with increased global prevalence. Here, we have analyzed daidzein's neuroprotective functions in in vitro and in vivo models of PD. BV2 microglial cells induced with lipopolysaccharide (LPS) and C57BL6 mice induced with MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) were used in this study to investigate neuroprotective functions of daidzein. BV2 cells induced with LPS do not exert and significant (p < 0.05) reduction in cell viability up to concentration range (5-100 µM/ml). Furthermore, LPS exposed BV2 microglia exhibited significantly (p < 0.05) increased NO production, pro-inflammatory mediators PGE2, interleukin-6 (IL6), and interleukin-1β (IL-1β) levels. Treatment with daidzein (10, 25, and 50 µM/ml) to LPS-induced BV2 microglia exhibited significantly (p < 0.05) decreased NO, pro-inflammatory mediators PGE2, IL6, and IlL-1β. Similar to the in vitro results, C57BL6 mice induced with MPTP showed defects in motor functions as observed from altered forelimb and hindlimb footprint analyses, grip strength, and perturbed motor coordination observed via rotarod tests. Additionally, levels of dopamine were significantly reduced, and pro-inflammatory mediators tumor necrosis factor alpha (TNF-α), IL-1β, IL6 were found to be increased in MPTP-induced C57BL6 PD mice. Administering daidzein significantly restored the functional levels of dopamine and pro-inflammatory mediators TNF-α, IL-1β, IL6 to near normal physiology as seen in healthy C57BL6 mice controls. Similarly, daidzein treatment to PD mice also restored the histological architecture to near normal levels as in control mice. Together, our results collectively endorse the neuroprotective functions of daidzein as observed from our initial studies, and further studies aimed at investigating daidzein's ability in regulating the catecholamine synthesis pathway to protect substantia nigra pars compacta (SNpc) neurons are in focus.","['BV2 microglial cell', 'MPTP', 'daidzein', 'neurodegeneration', 'neuroinflammation']",Journal of biochemical and molecular toxicology,2021-12-02,"[{'lastname': 'Wu', 'firstname': 'Qiong', 'initials': 'Q', 'affiliation': ""Department of Rehabilitation Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.""}, {'lastname': 'Wang', 'firstname': 'Maode', 'initials': 'M', 'affiliation': ""Neurosurgery Department, The First Affiliated Hospital of Xi' an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.""}, {'lastname': 'Chen', 'firstname': 'Wei', 'initials': 'W', 'affiliation': ""Neurosurgery Department, The First Affiliated Hospital of Xi' an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.""}, {'lastname': 'Wang', 'firstname': 'Kaili', 'initials': 'K', 'affiliation': ""Department of Rehabilitation Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.""}, {'lastname': 'Wang', 'firstname': 'Yujing', 'initials': 'Y', 'affiliation': ""Department of Rehabilitation Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.""}]",,,,© 2021 Wiley Periodicals LLC.,10.1002/jbt.22949,<Element 'PubmedArticle' at 0x7f05dd51f0e0>
126,34826653,New insights and therapeutic opportunities for progranulin-deficient frontotemporal dementia.,"Frontotemporal dementia (FTD) is the second most common form of dementia. It affects the frontal and temporal lobes of the brain and has a highly heterogeneous clinical representation with patients presenting with a wide range of behavioral, language, and executive dysfunctions. Etiology of FTD is complex and consists of both familial and sporadic cases. Heterozygous mutations in the GRN gene, resulting in GRN haploinsufficiency, cause progranulin (PGRN)-deficient FTD characterized with cytoplasmic mislocalization of TAR DNA-binding protein 43 kDa (TDP-43) aggregates. GRN codes for PGRN, a secreted protein that is also localized in the endolysosomes and plays a critical role in regulating lysosomal homeostasis. How PGRN deficiency modulates immunity and causes TDP-43 pathology and FTD-related neurodegeneration remains an active area of intense investigation. In the current review, we discuss some of the significant progress made in the past two years that links PGRN deficiency with microglial-associated neuroinflammation, TDP-43 pathology, and lysosomal dysfunction. We also review the opportunities and challenges toward developing therapies and biomarkers to treat PGRN-deficient FTD.",[],Current opinion in neurobiology,2021-11-27,"[{'lastname': 'Amin', 'firstname': 'Sadaf', 'initials': 'S', 'affiliation': ""Helen and Robert Appel Alzheimer's Disease Research Institute, Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, 10021, USA.""}, {'lastname': 'Carling', 'firstname': 'Gillian', 'initials': 'G', 'affiliation': ""Helen and Robert Appel Alzheimer's Disease Research Institute, Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, 10021, USA; Neuroscience Graduate Program, Weill Cornell Medicine, New York, NY, 10021, USA.""}, {'lastname': 'Gan', 'firstname': 'Li', 'initials': 'L', 'affiliation': ""Helen and Robert Appel Alzheimer's Disease Research Institute, Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, 10021, USA. Electronic address: lig2033@med.cornell.edu.""}]",,,,Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.,10.1016/j.conb.2021.10.001,<Element 'PubmedArticle' at 0x7f05dd5112c0>
127,"34768987
28435163
29744576
28073925
28887373
33315139
28404863
31855245
31578378
11988019
28487519
27654426
33800998
25234724
25155018
27030285
28490764
27021778
12231647
24233842
32025182
29915052
26292978
11286898
12634111
30372735
18421223
25626968
32895435
32352930
16567401
23239020
23830905
30696728
34304733
27114033
26321509
28509387
33547385
17764761",Retinal Degeneration and Microglial Dynamics in Mature Progranulin-Deficient Mice.,Progranulin (PGRN) is a secreted glycoprotein that regulates numerous cellular processes. The role of PGRN as a regulator of lysosomes has recently received attention. The purpose of this study was to characterize the retinal phenotype in mature PGRN knockout (,"['lysosome', 'microglia', 'neuronal ceroid lipofuscinosis', 'progranulin', 'retina', 'retinal pigment epithelium']",International journal of molecular sciences,2021-11-14,"[{'lastname': 'Takahashi', 'firstname': 'Kei', 'initials': 'K', 'affiliation': 'Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu 501-1196, Japan.'}, {'lastname': 'Nakamura', 'firstname': 'Shinsuke', 'initials': 'S', 'affiliation': 'Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu 501-1196, Japan.'}, {'lastname': 'Shimazawa', 'firstname': 'Masamitsu', 'initials': 'M', 'affiliation': 'Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu 501-1196, Japan.'}, {'lastname': 'Hara', 'firstname': 'Hideaki', 'initials': 'H', 'affiliation': 'Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu 501-1196, Japan.'}]",,,,,"10.3390/ijms222111557
10.1038/nrn.2017.36
10.1007/s00401-018-1861-8
10.1093/hmg/ddx011
10.1212/WNL.0000000000004500
10.1007/s00347-020-01282-4
10.1126/scitranslmed.aah5642
10.1093/brain/awz377
10.1038/s41598-019-50726-8
10.1006/mcne.2001.1099
10.1038/s41598-017-01716-1
10.1167/iovs.16-20158
10.3390/cells10030696
10.1016/j.brainres.2014.09.023
10.1084/jem.20140214
10.1038/srep23811
10.1038/s41598-017-01933-8
10.1016/j.neurobiolaging.2016.02.019
10.1113/jphysiol.2002.019703
10.5966/sctm.2013-0020
10.1073/pnas.1719601115
10.1189/jlb.3RI0615-239R
10.1016/S1350-9462(00)00025-2
10.1016/S0014-4835(02)00332-9
10.1167/iovs.18-24757
10.1159/000119860
10.1167/iovs.14-15334
10.1038/s41598-020-71626-2
10.1172/JCI136160
10.1093/jb/mvj037
10.1007/s12035-012-8380-8
10.1016/j.neuroscience.2013.06.049
10.1523/JNEUROSCI.3498-17.2019
10.1186/s12974-021-02203-1
10.1016/j.cell.2016.04.001
10.1016/j.exer.2015.08.018
10.1002/jnr.24081
10.1038/s42003-021-01682-5
10.1016/j.bbr.2007.07.020",<Element 'PubmedArticle' at 0x7f05dd506c20>
128,34752743,Genistein protects epilepsy-induced brain injury through regulating the JAK2/STAT3 and Keap1/Nrf2 signaling pathways in the developing rats.,"Epilepsy is a common chronic neurological disease. Recurrent seizures can cause irreversible brain damage. This study aimed to explore the regulation of Genistein on JAK2/STAT3 and Keap1/Nrf2 signaling pathway and the protective effects on brain injury after epilepsy.
Pentylenetetrazole (PTZ) was used to induce epilepsy in developing rats and Genistein was used for pretreatment of epilepsy. The seizure latency, grade scores and duration of the first generalized tonic-clonic seizure (GTCs) were recorded. Hippocampus tissue was sampled at 24 h post-epilepsy. Immunofluorescence staining was used to observe mature neurons, activated microglia and astrocytes in the hippocampal CA1 region. Western blot and qRT-PCR were used to determine the protein and mRNA levels of JAK2, STAT3, TNF-α, IL-1β, Keap1, Nrf2, HO-1, NQO1, caspase3, Bax and Bcl2 in the hippocampus.
Immunofluorescence showed that the number of neurons significantly decreased, and activated microglia and astrocytes significantly increased after epilepsy; Western blot and q-PCR showed that the expressions of JAK2, STAT3, TNF-α, IL-1β, Keap1, caspase3 and Bax significantly increased, while Nrf2, HO-1, NQO1 and Bcl-2 were significantly reduced after epilepsy. These effects were reversed by Genistein treatment. Moreover, Genistein was found to prolong seizure latency and reduce seizure intensity score and duration of generalized tonic-clonic seizures(GTCs) CONCLUSIONS: Genistein can activate the Keap1/Nrf2 antioxidant stress pathway and attenuate the activation of microglia and astrocytes. Genistein also inhibits the JAK2-STAT3 inflammation pathway and expression of apoptotic proteins, and increases the number of surviving neurons, thus having a protective effect on epilepsy-induced brain damage.","['Astrocyte', 'Epilepsy', 'Genistein', 'JAK2-STAT3', 'Keap1/Nrf2', 'Microglia']",European journal of pharmacology,2021-11-10,"[{'lastname': 'Hu', 'firstname': 'Qing-Peng', 'initials': 'QP', 'affiliation': 'Department of Pediatrics, the Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China. Electronic address: yanguowuhen0011@sina.com.'}, {'lastname': 'Yan', 'firstname': 'Hong-Xia', 'initials': 'HX', 'affiliation': 'Department of Pediatrics, the Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China. Electronic address: hqpeng26986@126.com.'}, {'lastname': 'Peng', 'firstname': 'Fang', 'initials': 'F', 'affiliation': 'Department of Pediatrics, the Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China. Electronic address: fly1101962782021@163.com.'}, {'lastname': 'Feng', 'firstname': 'Wei', 'initials': 'W', 'affiliation': 'Department of Pediatrics, the Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.'}, {'lastname': 'Chen', 'firstname': 'Fen-Fang', 'initials': 'FF', 'affiliation': 'Department of Pediatrics, the Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.'}, {'lastname': 'Huang', 'firstname': 'Xiang-Yi', 'initials': 'XY', 'affiliation': 'Department of Pediatrics, the Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.'}, {'lastname': 'Zhang', 'firstname': 'Xin', 'initials': 'X', 'affiliation': 'Department of Pediatrics, the Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.'}, {'lastname': 'Zhou', 'firstname': 'Yang-Yu', 'initials': 'YY', 'affiliation': 'Department of Pediatrics, the Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.'}, {'lastname': 'Chen', 'firstname': 'Yi-Shui', 'initials': 'YS', 'affiliation': 'Department of Pediatrics, the Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.'}]",,,"Immunofluorescence showed that the number of neurons significantly decreased, and activated microglia and astrocytes significantly increased after epilepsy; Western blot and q-PCR showed that the expressions of JAK2, STAT3, TNF-α, IL-1β, Keap1, caspase3 and Bax significantly increased, while Nrf2, HO-1, NQO1 and Bcl-2 were significantly reduced after epilepsy. These effects were reversed by Genistein treatment. Moreover, Genistein was found to prolong seizure latency and reduce seizure intensity score and duration of generalized tonic-clonic seizures(GTCs) CONCLUSIONS: Genistein can activate the Keap1/Nrf2 antioxidant stress pathway and attenuate the activation of microglia and astrocytes. Genistein also inhibits the JAK2-STAT3 inflammation pathway and expression of apoptotic proteins, and increases the number of surviving neurons, thus having a protective effect on epilepsy-induced brain damage.",Copyright © 2021. Published by Elsevier B.V.,10.1016/j.ejphar.2021.174620,<Element 'PubmedArticle' at 0x7f05dd7928b0>
129,34699875,Progesterone alters the activation and typing of the microglia in the optic nerve crush model.,"Microglia have a protective effect on the central nervous system (CNS), but their over-proliferation can cause secondary injury to the retina following optic nerve crush (ONC). Progesterone as a steroid gonadal hormone has been used in some experimental animal models for its neuroprotective effect. However, there is limited attention on the interactions between progesterone and microglia in retinal diseases. This study investigated the proliferation, morphology changes, and cell types of microglia at 3 days and 7 days after ONC. We found that progesterone treatment in unilateral optic nerve injury mice significantly reduced densities and morphological change of microglia at 7 days in the ganglion cell layer (GCL), especially in the retinal central. Inhibition of the microglia proliferation and transformation of ramified microglia into ameboid macrophages also appeared in the inner plexiform layer (IPL). Moreover, progesterone also regulated the TNF signal pathway, which was similar to the specific elimination of the M1 phenotype. M1 marks such as tumor necrosis factor alpha (TNF-α), inducible NOS(iNOS), interleukin-6 (IL-6), and Fc receptor (CD16 and CD32) significantly downregulated by progesterone treatment whether at 3 days or 7 days after ONC. On the other hand, progesterone continuously increased the expression of the M2 marks, including interleukin-4 (IL-4), arginase 1 (Arg1), and mannose receptor (CD206) since the third day, while the expression levels of transforming growth factor (TGF-β) only increased at 7 days. In general, this study elucidated the mechanism that progesterone prevented further damage on the retina by inhibiting proliferation, activation, and changing the type of microglia.","['Cell types', 'Microglia', 'Optic nerve crush', 'Progesterone', 'Retina']",Experimental eye research,2021-10-27,"[{'lastname': 'Yang', 'firstname': 'Pengfei', 'initials': 'P', 'affiliation': 'School of Life Sciences, Lanzhou University, Lanzhou, 730000, China.'}, {'lastname': 'Chen', 'firstname': 'Linchi', 'initials': 'L', 'affiliation': 'School of Life Sciences, Lanzhou University, Lanzhou, 730000, China.'}, {'lastname': 'Shi', 'firstname': 'Yongpeng', 'initials': 'Y', 'affiliation': 'School of Life Sciences, Lanzhou University, Lanzhou, 730000, China.'}, {'lastname': 'Zhou', 'firstname': 'Fangfang', 'initials': 'F', 'affiliation': 'College of Pastoral Agriculture Science and Technology, Lanzhou University, Lanzhou, 730020, China.'}, {'lastname': 'Tian', 'firstname': 'Huanbing', 'initials': 'H', 'affiliation': 'School of Life Sciences, Lanzhou University, Lanzhou, 730000, China.'}, {'lastname': 'Li', 'firstname': 'Jiande', 'initials': 'J', 'affiliation': 'School of Life Sciences, Lanzhou University, Lanzhou, 730000, China.'}, {'lastname': 'Gao', 'firstname': 'Lan', 'initials': 'L', 'affiliation': 'School of Life Sciences, Lanzhou University, Lanzhou, 730000, China. Electronic address: gaolan@lzu.edu.cn.'}]",,,,Copyright © 2021. Published by Elsevier Ltd.,10.1016/j.exer.2021.108805,<Element 'PubmedArticle' at 0x7f05dd78b770>
130,"34681607
25429645
17504139
16489357
15356140
21636077
18624755
27506744
27889895
16081203
18599350
28154473
17005052
27230456
25445485
17913905
18504291
19908287
18465657
31167136
16259628
25598354
23196997
19655259
19645497
24588829
21781347
16866919
9445407
25777539
24246222
18835258
15985713
12112366
2698176
23466699
23517078
12570810
11133067
12525573
10457173
11356873
23340020
8790778
8790783
8790782
9581803
12626429
12923064
15577749
19565166
33066101
32655777
29863024
24643018
23220033
9166714
12845153
15145615
21185277
31350349
17118695
12535703
15379674
15518898
19712974
21281617
12409220
11792830
9928007
15632701
25305591
11862320
15197240
2110186
4079980
10428049
9932447
10800968
10385257
7692452
7684434
18717813
11193883
10202009
9630473
30148218
31867739
8843599
23467340
25524416
17904651
11596125
27528056
32044129
19459212
25658447
23906635",PACAP and VIP Modulate LPS-Induced Microglial Activation and Trigger Distinct Phenotypic Changes in Murine BV2 Microglial Cells.,"Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) are two structurally related immunosuppressive peptides. However, the underlying mechanisms through which these peptides regulate microglial activity are not fully understood. Using lipopolysaccharide (LPS) to induce an inflammatory challenge, we tested whether PACAP or VIP differentially affected microglial activation, morphology and cell migration. We found that both peptides attenuated LPS-induced expression of the microglial activation markers ","['BV2', 'GFAP', 'Iba1', 'PACAP', 'VIP', 'inflammatory markers', 'microglial activation', 'morphological analyses']",International journal of molecular sciences,2021-10-24,"[{'lastname': 'Karunia', 'firstname': 'Jocelyn', 'initials': 'J', 'affiliation': 'Laboratory of Cellular and Molecular Neuroscience (LCMN), School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW 2007, Australia.'}, {'lastname': 'Niaz', 'firstname': 'Aram', 'initials': 'A', 'affiliation': 'Laboratory of Cellular and Molecular Neuroscience (LCMN), School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW 2007, Australia.'}, {'lastname': 'Mandwie', 'firstname': 'Mawj', 'initials': 'M', 'affiliation': 'Laboratory of Cellular and Molecular Neuroscience (LCMN), School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW 2007, Australia.'}, {'lastname': 'Thomas Broome', 'firstname': 'Sarah', 'initials': 'S', 'affiliation': 'Laboratory of Cellular and Molecular Neuroscience (LCMN), School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW 2007, Australia.'}, {'lastname': 'Keay', 'firstname': 'Kevin A', 'initials': 'KA', 'affiliation': 'School of Medical Science, [Neuroscience] and Brain and Mind Centre, The University of Sydney, Sydney, NSW 2006, Australia.'}, {'lastname': 'Waschek', 'firstname': 'James A', 'initials': 'JA', 'affiliation': 'Intellectual Development and Disabilities Research Centre, Semel Institute for Neuroscience and Human Behaviour/Neuropsychiatric Institute, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA 90095, USA.'}, {'lastname': 'Al-Badri', 'firstname': 'Ghaith', 'initials': 'G', 'affiliation': 'Laboratory of Cellular and Molecular Neuroscience (LCMN), School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW 2007, Australia.'}, {'lastname': 'Castorina', 'firstname': 'Alessandro', 'initials': 'A', 'affiliation': 'Laboratory of Cellular and Molecular Neuroscience (LCMN), School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW 2007, Australia.\nSchool of Medical Science, [Neuroscience] and Brain and Mind Centre, The University of Sydney, Sydney, NSW 2006, Australia.'}]",,,,,"10.3390/ijms222010947
10.3390/ph7121028
10.2174/092986707780597961
10.1038/nature04596
10.4049/jimmunol.173.6.3916
10.1016/j.brainres.2011.04.046
10.1111/j.1582-4934.2008.00402.x
10.1016/j.metabol.2016.05.018
10.1007/s12035-016-0297-1
10.1016/j.pneurobio.2005.06.004
10.1016/j.it.2008.05.002
10.1155/2017/5048616
10.1186/1742-2094-3-27
10.5213/inj.1632604.302
10.1016/j.neuropharm.2014.10.028
10.1523/JNEUROSCI.1922-07.2007
10.1093/brain/awn101
10.1002/glia.20947
10.1016/j.celrep.2019.05.010
10.1186/1742-2094-2-24
10.1007/s12035-014-9070-5
10.1097/YCO.0b013e32835aa4b4
10.1007/s11481-009-9164-4
10.1021/tx900086v
10.2174/1381612820666140130202911
10.1186/1742-2094-8-85
10.1111/j.1600-0404.2006.00694.x
10.1056/NEJM199801293380502
10.3892/mmr.2015.3494
10.1016/j.yexcr.2013.11.003
10.1016/j.brainres.2008.09.035
10.1002/glia.10098
10.1007/BF02740606
10.1016/j.nbd.2013.02.010
10.1111/bph.12181
10.2174/1381612033391586
10.1189/jlb.0702372
10.1046/j.1460-9568.1999.00693.x
10.1523/JNEUROSCI.21-11-03849.2001
10.1016/j.peptides.2013.01.007
10.1016/S0960-5428(96)00008-3
10.1016/S0960-5428(96)00002-2
10.1016/S0960-5428(96)00007-1
10.1002/jlb.63.5.591
10.1096/fj.02-0799fje
10.1096/fj.02-1029fje
10.14573/altex.2009.2.83
10.3390/metabo10100408
10.1371/journal.pone.0091541
10.1016/j.peptides.2012.11.015
10.1046/j.1471-4159.1997.68062227.x
10.1385/MN:27:3:325
10.1016/j.jneuroim.2004.02.005
10.1016/j.clinbiochem.2010.12.011
10.1073/pnas.1903336116
10.1016/j.biocel.2006.10.008
10.1016/S0196-9781(02)00262-0
10.2174/1381612043383548
10.1016/j.regpep.2004.05.017
10.1016/j.npep.2009.08.002
10.1016/j.brainres.2011.01.082
10.1016/S0167-0115(02)00191-X
10.1073/pnas.012367999
10.1111/j.1749-6632.1998.tb11173.x
10.1016/j.bbi.2014.09.020
10.1007/s00109-001-0291-5
10.1242/jcs.01166
10.1016/0165-5728(90)90073-V
10.1038/318667a0
10.1046/j.1471-4159.1999.0730538.x
10.1046/j.1471-4159.2000.0742213.x
10.1038/sj.bjp.0702549
10.1073/pnas.90.20.9730
10.1084/jem.177.6.1779
10.1111/j.1471-4159.2008.05633.x
10.1111/j.1749-6632.2000.tb06954.x
10.1016/S0169-328X(98)00040-0
10.1016/j.heliyon.2018.e00730
10.1111/jphp.13219
10.1016/0166-2236(96)10049-7
10.1523/JNEUROSCI.3441-12.2013
10.1038/srep07514
10.1016/j.tins.2007.07.007
10.1002/glia.1106
10.2174/0929867323666160814001040
10.1016/j.tins.2020.01.003
10.1002/glia.20892
10.1371/journal.pone.0117799
10.1016/j.neuroscience.2013.07.053",<Element 'PubmedArticle' at 0x7f05dd77eef0>
131,34627986,Anti-depressive effects of Jiao-Tai-Wan on CORT-induced depression in mice by inhibiting inflammation and microglia activation.,"Jiao-Tai-Wan (JTW) is a very famous traditional Chinese medicine formula for the treatment of psychiatric disorders, especially in anxiety, insomnia and depression. However, its molecular mechanism of treatment remains indistinct.
We aimed to reveal the action mechanism of JTW on anti-depression via inhibiting microglia activation and pro-inflammatory response both in vivo and in vitro.
The corticosterone (CORT)-induced depression mouse model was used to evaluate the therapeutic efficacy of JTW. Behavioral tests (open field, elevated plus maze, tail suspension and forced swim test) were conducted to evaluate the effect of JTW on depressive-like behaviors. The levels of inflammatory factors and the concentration of neurotransmitters were detected by RT-qPCR or ELISA assays. Then three hippocampal tissue samples per group (Control, CORT, and JTW group) were sent for RNA sequencing (RNA-seq). Transcriptomics data analysis was used to screen the key potential therapeutic targets and signaling pathways of JTW. Based on 8 bioactive species of JTW by our previous study using High-performance liquid chromatography (HPLC) analysis, molecular docking analyses were used to predict the interaction of JTW-derived compounds and depression targets. Finally, the results of transcriptome and molecular docking analyses were combined to verify the targets, key pathways, and efficacy of JTW treatment in vivo and vitro.
JTW ameliorated CORT-induced depressive-like behaviors, neuronal damage and enhanced the levels of monoamine neurotransmitters in the serum of mice. JTW also inhibited CORT-induced inflammatory activation of microglia and decreased the serum levels of interleukin- 6(IL-6) and interleukin- 1β (IL-1β) in vivo. Transcriptomic data analysis showed there were 10 key driver analysis (KDA) genes with the strongest correlation which JTW regulated in depression mice. Molecular docking analysis displayed bioactive compound Magnoflorine had the strongest binding force to the key gene colony-stimulating factor 1 receptor (CSF1R), which is the signaling microglia dependent upon for their survival. Meanwhile, CSF1R staining showed it was consistent with inflammatory activation of microglia. Our vitro experiment also showed JTW and CSF1R inhibitor significantly reduced lipopolysaccharide (LPS)/interferon-gamma (IFNɣ)-induced inflammatory activation response in macrophage cells.
Our study suggests that JTW might ameliorate CORT-induced neuronal damage in depression mice by inhibiting CSF1R mediated microglia activation and pro-inflammatory response.","['Anti-depression', 'Chinese medicine formula', 'Immunomodulatory', 'Molecular docking', 'Transcriptomics']",Journal of ethnopharmacology,2021-10-11,"[{'lastname': 'Bai', 'firstname': 'Guiqin', 'initials': 'G', 'affiliation': 'Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. Electronic address: 20193118198@stu.gzucm.edu.cn.'}, {'lastname': 'Qiao', 'firstname': 'Yiqi', 'initials': 'Y', 'affiliation': 'Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. Electronic address: 20202110186@stu.gzucm.edu.cn.'}, {'lastname': 'Lo', 'firstname': 'Po-Chieh', 'initials': 'PC', 'affiliation': 'Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. Electronic address: 1725210646@qq.com.'}, {'lastname': 'Song', 'firstname': 'Lei', 'initials': 'L', 'affiliation': 'Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. Electronic address: 1092550319@qq.com.'}, {'lastname': 'Yang', 'firstname': 'Yuna', 'initials': 'Y', 'affiliation': 'Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China; Laboratory Animal Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. Electronic address: 463877815@qq.com.'}, {'lastname': 'Duan', 'firstname': 'Lining', 'initials': 'L', 'affiliation': 'Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China; Clinical Medical College of Acupuncture Moxibustion and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. Electronic address: 20194103053@stu.gzucm.edu.cn.'}, {'lastname': 'Wei', 'firstname': 'Sufen', 'initials': 'S', 'affiliation': 'Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. Electronic address: 13825081143@163.com.'}, {'lastname': 'Li', 'firstname': 'Min', 'initials': 'M', 'affiliation': 'Clinical Medical College of Acupuncture Moxibustion and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. Electronic address: doctorlimin@gzucm.edu.cn.'}, {'lastname': 'Huang', 'firstname': 'Shuiqing', 'initials': 'S', 'affiliation': 'Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. Electronic address: hsq@gzucm.edu.cn.'}, {'lastname': 'Zhang', 'firstname': 'Beiping', 'initials': 'B', 'affiliation': 'Guangdong Province Hospital of Traditional Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. Electronic address: doctorzbp@163.com.'}, {'lastname': 'Wang', 'firstname': 'Qi', 'initials': 'Q', 'affiliation': 'Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. Electronic address: wangqi@gzucm.edu.cn.'}, {'lastname': 'Yang', 'firstname': 'Cong', 'initials': 'C', 'affiliation': 'Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. Electronic address: yangcong303@163.com.'}]",,,"JTW ameliorated CORT-induced depressive-like behaviors, neuronal damage and enhanced the levels of monoamine neurotransmitters in the serum of mice. JTW also inhibited CORT-induced inflammatory activation of microglia and decreased the serum levels of interleukin- 6(IL-6) and interleukin- 1β (IL-1β) in vivo. Transcriptomic data analysis showed there were 10 key driver analysis (KDA) genes with the strongest correlation which JTW regulated in depression mice. Molecular docking analysis displayed bioactive compound Magnoflorine had the strongest binding force to the key gene colony-stimulating factor 1 receptor (CSF1R), which is the signaling microglia dependent upon for their survival. Meanwhile, CSF1R staining showed it was consistent with inflammatory activation of microglia. Our vitro experiment also showed JTW and CSF1R inhibitor significantly reduced lipopolysaccharide (LPS)/interferon-gamma (IFNɣ)-induced inflammatory activation response in macrophage cells.",Copyright © 2021 Elsevier B.V. All rights reserved.,10.1016/j.jep.2021.114717,<Element 'PubmedArticle' at 0x7f05dd8f9e00>
132,"34618685
21691802
22859297
16862116
19649643
16862115
18543312
22608501
23609919
28070672
23383383
20522652
23516300
28379303
25234724
28728022
20667979
25261995
24804730
28647554
29149899
30448285
17291356
22781549
18568075
18378771
27114033
28073925
30696728
27770818
25556567
21943601
23041626
34298019
25186741
21092856
26370502
10391247
10391246
22373574
10380924
17038519
24926618
19840224
19345186
28993646
28835281
23719801
24664870
11944939
17146780
26359774
23273845
23287718
27213486
25155018
28404863
21933710
24800652
20026663
16679763
17764761
22062772
27515686
17846163
27144467
28435163
28828399
28743268
28493053
30180904
31398187
27693922
29044416
21289198
23791832
26308581",Microglia regulate brain progranulin levels through the endocytosis/lysosomal pathway.,"Genetic variants in Granulin (GRN), which encodes the secreted glycoprotein progranulin (PGRN), are associated with several neurodegenerative diseases, including frontotemporal lobar degeneration, neuronal ceroid lipofuscinosis, and Alzheimer's disease. These genetic alterations manifest in pathological changes due to a reduction of PGRN expression; therefore, identifying factors that can modulate PGRN levels in vivo would enhance our understanding of PGRN in neurodegeneration and could reveal novel potential therapeutic targets. Here, we report that modulation of the endocytosis/lysosomal pathway via reduction of Nemo-like kinase (Nlk) in microglia, but not in neurons, can alter total brain Pgrn levels in mice. We demonstrate that Nlk reduction promotes Pgrn degradation by enhancing its trafficking through the endocytosis/lysosomal pathway, specifically in microglia. Furthermore, genetic interaction studies in mice showed that Nlk heterozygosity in Grn haploinsufficient mice further reduces Pgrn levels and induces neuropathological phenotypes associated with PGRN deficiency. Our results reveal a mechanism for Pgrn level regulation in the brain through the active catabolism by microglia and provide insights into the pathophysiology of PGRN-associated diseases.","['Dementia', 'Mouse models', 'Neurodegeneration', 'Neuroscience']",JCI insight,2021-10-08,"[{'lastname': 'Dong', 'firstname': 'Tingting', 'initials': 'T', 'affiliation': 'Department of Genetics, Yale School of Medicine, New Haven, Connecticut, USA.'}, {'lastname': 'Tejwani', 'firstname': 'Leon', 'initials': 'L', 'affiliation': 'Interdepartmental Neuroscience Program, Yale University, New Haven, Connecticut, USA.\nDepartment of Neuroscience.'}, {'lastname': 'Jung', 'firstname': 'Youngseob', 'initials': 'Y', 'affiliation': 'Department of Genetics, Yale School of Medicine, New Haven, Connecticut, USA.'}, {'lastname': 'Kokubu', 'firstname': 'Hiroshi', 'initials': 'H', 'affiliation': 'Department of Genetics, Yale School of Medicine, New Haven, Connecticut, USA.'}, {'lastname': 'Luttik', 'firstname': 'Kimberly', 'initials': 'K', 'affiliation': 'Interdepartmental Neuroscience Program, Yale University, New Haven, Connecticut, USA.\nDepartment of Neuroscience.'}, {'lastname': 'Driessen', 'firstname': 'Terri M', 'initials': 'TM', 'affiliation': 'Department of Genetics, Yale School of Medicine, New Haven, Connecticut, USA.'}, {'lastname': 'Lim', 'firstname': 'Janghoo', 'initials': 'J', 'affiliation': 'Department of Genetics, Yale School of Medicine, New Haven, Connecticut, USA.\nInterdepartmental Neuroscience Program, Yale University, New Haven, Connecticut, USA.\nDepartment of Neuroscience.\nProgram in Cellular Neuroscience, Neurodegeneration and Repair, and.\nYale Stem Cell Center, Yale School of Medicine, New Haven, Connecticut, USA.'}]",,,,,"10.1172/jci.insight.136147
10.1007/s12031-011-9569-4
10.1074/jbc.R112.399170
10.1038/nature05016
10.1007/s00401-009-0576-2
10.1038/nature05017
10.1002/humu.20785
10.1016/j.ajhg.2012.04.021
10.1001/2013.jamaneurol.393
10.1007/s00401-017-1668-z
10.2353/ajpath.2010.090915
10.1523/JNEUROSCI.6103-11.2013
10.1093/brain/awx060
10.1016/j.brainres.2014.09.023
10.1016/j.neuron.2017.06.026
10.1038/nm.3672
10.1371/journal.pone.0097032
10.1016/j.nbd.2017.06.012
10.1186/s12974-017-1000-9
10.1016/j.nbd.2018.11.011
10.1186/1742-2094-4-7
10.1186/1750-1326-7-33
10.1083/jcb.200712039
10.1016/j.cell.2016.04.001
10.1523/JNEUROSCI.3498-17.2019
10.1186/s13024-016-0132-1
10.1016/j.stemcr.2014.12.001
10.1016/j.neuron.2011.07.021
10.1172/JCI63113
10.1016/j.jbc.2021.100993
10.1523/JNEUROSCI.1860-14.2014
10.1016/j.neuron.2010.09.034
10.1083/jcb.201502029
10.1038/21674
10.1038/21666
10.1038/emboj.2012.46
10.1016/S0092-8674(00)80784-9
10.1242/dev.02603
10.1038/cdd.2014.78
10.1111/j.1471-4159.2009.06400.x
10.1016/j.cell.2009.01.038
10.1038/s41467-017-00922-9
10.1101/2020.04.19.049395
10.1186/s13024-017-0205-9
10.1523/JNEUROSCI.3465-12.2013
10.1002/jcp.24625
10.1006/dbio.2002.0597
10.1002/dvg.20256
10.1146/annurev-cellbio-100814-125353
10.1016/j.immuni.2012.12.001
10.1126/science.1231143
10.1111/gbb.12300
10.1084/jem.20140214
10.1126/scitranslmed.aah5642
10.1016/j.nbd.2011.08.029
10.1016/j.tins.2014.04.003
10.1084/jem.20091568
10.1159/000093102
10.1016/j.bbr.2007.07.020
10.1016/j.nbd.2011.10.016
10.1016/j.ebiom.2016.08.004
10.1196/annals.1401.025
10.1038/nrn.2017.36
10.1186/s13024-017-0196-6
10.1007/s00401-017-1719-5
10.1186/s13024-018-0281-5
10.1371/journal.pgen.1008295
10.1016/j.pep.2016.09.019
10.1093/jnen/nlx085
10.1101/2021.01.08.425959
10.1523/JNEUROSCI.5757-10.2011
10.1016/j.bbrc.2013.06.036
10.7554/eLife.08493",<Element 'PubmedArticle' at 0x7f05dd8e9c20>
133,34594305,Editorial: Systemic Regulation of Organ Homeostasis and Implications of Hormones and Immunity.,,"['Leydig cells', 'Sertoli cells', 'circadian rhythm', 'microglia', 'neuroimmune interaction', 'neurotrophic factor']",Frontiers in endocrinology,2021-10-02,"[{'lastname': 'Anbazhagan', 'firstname': 'Rajakumar', 'initials': 'R', 'affiliation': 'Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (NIH), Bethesda, MD, United States.'}, {'lastname': 'Kavarthapu', 'firstname': 'Raghuveer', 'initials': 'R', 'affiliation': 'Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (NIH), Bethesda, MD, United States.'}, {'lastname': 'Mathur', 'firstname': 'Premendu P', 'initials': 'PP', 'affiliation': 'Department of Biochemistry and Molecular Biology, School of Life Sciences, Pondicherry University, Pondicherry, India.'}, {'lastname': 'Kostic', 'firstname': 'Tatjana S', 'initials': 'TS', 'affiliation': 'Department of Biology and Ecology, Faculty of Sciences, University of Novi Sad, Novi Sad, Serbia.'}, {'lastname': 'Prakash', 'firstname': 'Hridayesh', 'initials': 'H', 'affiliation': 'Amity Institute of Virology and Immunology, Noida, India.'}]",,,,,10.3389/fendo.2021.740835,<Element 'PubmedArticle' at 0x7f05ddcf6590>
134,"34589812
29804835
30406198
10975906
19318467
15295027
10322493
23943137
11271408
20018408
32999463
28216088
17950926
23339575
17470522
16646155
23219473
23554175
32745992
10762353
18073775
25151944
33232758
15339653
25979764
17024679
28755863
18805467
31235930
17976923
19171181
30184509
20300101
11256079
11144361
26404713
22159118
11870871
30635056
30108482
6289442
11553304
25017883
23599891
27546235
27870401
23183882
29324460
32291137
29857518
22497984
11182095
30728170
29669258
22025910
24051097
10845078
11121525
20506473
17006898
14704216
18364018
32615087
33837868
26937008
20934505
7911978
25834045
34488804
16316783
22466658
17678962
24933434
25810524
22072675
14597099
21382557
21745355
9636227
28363835
7972026
15788779
9180080
23356992
7190730
30083579
27870428
31473031
27337340
20847426
14507968
32297671
30209204
27375619
1353794
16918306
24013012
30214058
19918929
14638938
32725944
20970492
32912598
22153080
10652441
11282163","Three's Company: Neuroimmune activation, sex, and memory at the tripartite synapse.","The neuroimmune system is required for normal cognitive functions such as learning and memory in addition to its critical role in detecting and responding to invading pathogens and injury. Understanding the functional convergence of neurons, astrocytes, and microglia at the synapse, particularly in the hippocampus, is key to understanding the nuances of such diverse roles. In the healthy brain, communication between all three cells is important for regulating neuronal activation and synaptic plasticity mechanisms, and during neuroinflammation, the activity and functions of all three cells can produce and be modulated by inflammatory cytokines. An important remaining component to this system is the conclusive evidence of sex differences in hippocampal plasticity mechanisms, hormone modulation of synaptic plasticity, functional properties of hippocampal neurons, and in neuroimmune activation. Sex as a biological variable here is necessary to consider given sex differences in the prevalence of memory-related disorders such as Alzheimer's disease and Post-Traumatic Stress disorder, both of which present with neuroimmune dysregulation. To make meaningful progress towards a deeper understanding of sex biases in memory-related disease prevalence, I propose that the next chapter of psychoneuroimmune research must focus on the signal integration and transduction at the synapse between experience-dependent plasticity mechanisms, neuroimmune activation, and the influence of biological sex.","['Astrocytes', 'Memory', 'Microglia', 'Neuroimmune', 'Sex differences', 'Tripartite synapse']","Brain, behavior, & immunity - health",2021-10-01,"[{'lastname': 'Posillico', 'firstname': 'Caitlin K', 'initials': 'CK', 'affiliation': 'Psychology Department, University of Michigan, Ann Arbor, 48109, USA.'}]",,,,© 2021 The Author.,"10.1016/j.bbih.2021.100326
10.1016/j.cell.2018.05.002
10.1523/ENEURO.0088-18.2018
10.1002/1098-1136(200010)32:1%3c1::AID-GLIA10%3e3.0.CO;2-W
10.1101/lm.918309
10.1523/JNEUROSCI.0473-04.2004
10.1016/S0166-2236(98)01349-6
10.1007/s12640-013-9417-0
10.1007/s002130000590
10.1016/j.neurobiolaging.2009.11.022
10.1038/s41586-020-2777-8
10.1016/j.bbi.2017.02.006
10.1016/j.tins.2007.08.007
10.1186/1756-6606-6-5
10.1677/JOE-07-0017
10.1016/j.jphysparis.2005.12.008
10.1016/j.psyneuen.2012.11.007
10.1002/hipo.22129
10.1016/j.ebiom.2020.102919
10.1046/j.1460-9568.2000.00011.x
10.1038/nrn2297
10.1016/J.NLM.2014.08.008
10.1016/j.neuint.2020.104921
10.1016/j.neuron.2004.08.011
10.1016/j.euroneuro.2015.04.020
10.1002/hipo.20230
10.1016/j.physbeh.2017.07.028
10.1016/j.neuroscience.2008.08.043
10.1038/s41593-019-0427-y
10.1016/J.PSYNEUEN.2007.09.004
10.1016/J.NEUROSCIENCE.2009.01.009
10.1016/j.celrep.2018.08.001
10.1038/nrn2803
10.1038/35058528
10.1016/S0896-6273(00)00130-6
10.1038/nn.4113
10.1523/JNEUROSCI.4067-11.2011
10.1002/glia.10037
10.1186/s13293-019-0219-9
10.3389/fnmol.2018.00266
10.1126/science.6289442
10.1046/j.0953-816X.2001.01664.x
10.1016/j.expneurol.2014.01.001
10.7554/eLife.00362
10.1038/nri.2016.90
10.1002/jnr.23864
10.1038/nrneurol.2012.236
10.1097/YCO.0000000000000401
10.1016/j.jaut.2020.102452
10.3390/jcm7060132
10.1016/j.psyneuen.2012.02.018
10.1016/S0896-6273(01)00194-5
10.1523/JNEUROSCI.1970-18.2019
10.1016/j.yhbeh.2018.04.007
10.3389/fncel.2011.00022
10.1101/lm.028357.112
10.1146/annurev.neuro.23.1.649
10.1016/S0006-8993(00)02877-8
10.1002/cne.22361
10.1002/glia.20367
10.1093/cercor/bhg118
10.1111/j.1460-9568.2008.06109.x
10.1016/j.cell.2020.05.050
10.1007/s11064-021-03317-x
10.1523/JNEUROSCI.4437-15.2016
10.1016/J.BBI.2010.10.003
10.1038/369744a0
10.1523/JNEUROSCI.4255-14.2015
10.1101/2020.11.23.394742
10.1007/978-1-4614-4729-0_3
10.1016/J.IT.2005.11.006
10.1172/JCI58644
10.1016/S0074-7742(07)82010-1
10.1016/j.bbi.2014.04.009
10.1523/JNEUROSCI.4485-14.2015
10.1523/JNEUROSCI.3667-11.2011
10.1016/J.JNEUROIM.2003.08.030
10.1016/j.neuron.2011.02.003
10.1186/2042-6410-2-7
10.1073/PNAS.95.13.7778
10.1101/378257
10.1016/j.neuroimage.2017.03.051
10.1073/pnas.91.23.11158
10.1523/JNEUROSCI.4486-04.2005
10.1126/science.276.5319.1699
10.1186/1756-6606-6-6
10.1126/science.7190730
10.1016/j.cobeha.2018.04.005
10.1002/jnr.23921
10.1016/j.tins.2019.07.009
10.1038/nature18283
10.3233/JAD-2010-101089
10.1523/jneurosci.23-25-08692.2003
10.1111/bjh.16659
10.1523/JNEUROSCI.0801-18.2018
10.3389/fimmu.2016.00219
10.1523/jneurosci.12-08-03217.1992
10.1146/annurev.pharmtox.47.120505.105219
10.1016/j.bbr.2013.08.048
10.1038/s41386-018-0208-4
10.1002/da.20629
10.1073/pnas.2431073100
10.1111/acel.13182
10.1016/J.BBI.2010.10.015
10.1016/j.jpsychires.2020.06.022
10.1016/j.cell.2011.11.029
10.1002/(SICI)1098-1136(20000215)29:4
10.1016/S0165-5728(01)00259-4",<Element 'PubmedArticle' at 0x7f05ddcee950>
135,34562326,Extracellular vesicles derived from melatonin-preconditioned mesenchymal stem cells containing USP29 repair traumatic spinal cord injury by stabilizing NRF2.,"Spinal cord injury (SCI) is a devastating trauma that leads to irreversible motor and sensory dysfunction and is, so far, without effective treatment. Recently, however, nano-sized extracellular vesicles derived from preconditioned mesenchymal stem cells (MSCs) have shown great promise in treating various diseases, including SCI. In this study, we investigated whether extracellular vesicles (MEVs) derived from MSCs pretreated with melatonin (MT), which is well recognized to be useful in treating diseases, including Alzheimer's disease, non-small cell lung cancer, acute ischemia-reperfusion liver injury, chronic kidney disease, and SCI, are better able to promote functional recovery in mice after SCI than extracellular vesicles derived from MSCs without preconditioning (EVs). MEVs were found to facilitate motor behavioral recovery more than EVs and to increase microglia/macrophages polarization from M1-like to M2-like in mice. Experiments in BV2 microglia and RAW264.7 macrophages confirmed that MEVs facilitate M2-like polarization and also showed that they reduce the production of reactive oxygen species (ROS) and regulate mitochondrial function. Proteomics analysis revealed that ubiquitin-specific protease 29 (USP29) was markedly increased in MEVs, and knockdown of USP29 in MEVs (shUSP29-MEVs) abolished MEVs-mediated benefits in vitro and in vivo. We then showed that USP29 interacts with, deubiquitinates and therefore stabilizes nuclear factor-like 2 (NRF2), thereby regulating microglia/macrophages polarization. In NRF2 knockout mice, MEVs failed to promote functional recovery and M2-like microglia/macrophages polarization. We also showed that MT reduced global N6-methyladenosine (m","['USP29/NRF2', 'extracellular vesicles', 'm6A', 'melatonin', 'microglia/macrophages polarization', 'spinal cord injury']",Journal of pineal research,2021-09-26,"[{'lastname': 'Liu', 'firstname': 'Wei', 'initials': 'W', 'affiliation': 'Department of Orthopedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.'}, {'lastname': 'Tang', 'firstname': 'Pengyu', 'initials': 'P', 'affiliation': 'Department of Orthopedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.'}, {'lastname': 'Wang', 'firstname': 'Jiaxing', 'initials': 'J', 'affiliation': 'Department of Orthopedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.'}, {'lastname': 'Ye', 'firstname': 'Wu', 'initials': 'W', 'affiliation': 'Department of Orthopedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.'}, {'lastname': 'Ge', 'firstname': 'Xuhui', 'initials': 'X', 'affiliation': 'Department of Orthopedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.'}, {'lastname': 'Rong', 'firstname': 'Yuluo', 'initials': 'Y', 'affiliation': 'Department of Orthopedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.'}, {'lastname': 'Ji', 'firstname': 'Chengyue', 'initials': 'C', 'affiliation': 'Department of Orthopedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.'}, {'lastname': 'Wang', 'firstname': 'Zhuanghui', 'initials': 'Z', 'affiliation': 'Department of Orthopedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.'}, {'lastname': 'Bai', 'firstname': 'Jianling', 'initials': 'J', 'affiliation': 'Department of Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.'}, {'lastname': 'Fan', 'firstname': 'Jin', 'initials': 'J', 'affiliation': 'Department of Orthopedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.'}, {'lastname': 'Yin', 'firstname': 'Guoyong', 'initials': 'G', 'affiliation': 'Department of Orthopedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.'}, {'lastname': 'Cai', 'firstname': 'Weihua', 'initials': 'W', 'affiliation': 'Department of Orthopedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.'}]",,,,© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.,10.1111/jpi.12769,<Element 'PubmedArticle' at 0x7f05dd92be00>
136,"34536123
3496802
31211281
15705605
17403030
23930978
18936077
19596122
30177510
33271068
26937618
22339950
17046693
17482371
17237775
33450292
32541852
25402857
31215725
30560944
24346134
11337098
27528460
20071535
24068818
30844397
22973194
11846609
30377363
29627713
17113057
34001626
23835040
21788995
30975859
6334362
24486962
9657418
18195714
23262300
21673960
18675469
30556815
7824192
17804020
25552429
33383688
7824085
7653697
17481824
30229855
10330448
10576557
15488227
21814201
8775763
2035992
15266352
25446914
21543610
16720574
25887240
24264146
31352506
23511700
11282253
27209403
20097270
30060908
29753198
29390057
26988743",PSD-93 up-regulates the synaptic activity of corticotropin-releasing hormone neurons in the paraventricular nucleus in depression.,"Since the discovery of ketamine anti-depressant effects in last decade, it has effectively revitalized interest in investigating excitatory synapses hypothesis in the pathogenesis of depression. In the present study, we aimed to reveal the excitatory synaptic regulation of corticotropin-releasing hormone (CRH) neuron in the hypothalamus, which is the driving force in hypothalamic-pituitary-adrenal (HPA) axis regulation. This study constitutes the first observation of an increased density of PSD-93-CRH co-localized neurons in the hypothalamic paraventricular nucleus (PVN) of patients with major depression. PSD-93 overexpression in CRH neurons in the PVN induced depression-like behaviors in mice, accompanied by increased serum corticosterone level. PSD-93 knockdown relieved the depression-like phenotypes in a lipopolysaccharide (LPS)-induced depression model. Electrophysiological data showed that PSD-93 overexpression increased CRH neurons synaptic activity, while PSD-93 knockdown decreased CRH neurons synaptic activity. Furthermore, we found that LPS induced increased the release of glutamate from microglia to CRH neurons resulted in depression-like behaviors using fiber photometry recordings. Together, these results show that PSD-93 is involved in the pathogenesis of depression via increasing the synaptic activity of CRH neurons in the PVN, leading to the hyperactivity of the HPA axis that underlies depression-like behaviors.","['Corticotropin-releasing hormone', 'Depression', 'PSD-93', 'Paraventricular nucleus', 'Synaptic regulation']",Acta neuropathologica,2021-09-19,"[{'lastname': 'Qin', 'firstname': 'Xin-Ya', 'initials': 'XY', 'affiliation': 'Chinese Academy of Sciences Key Laboratory of Brain Function and Diseases, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.\nInstitute of Brain Science, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.'}, {'lastname': 'Shan', 'firstname': 'Qing-Hong', 'initials': 'QH', 'affiliation': 'Chinese Academy of Sciences Key Laboratory of Brain Function and Diseases, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.\nInstitute of Brain Science, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.'}, {'lastname': 'Fang', 'firstname': 'Hui', 'initials': 'H', 'affiliation': ""Chinese Academy of Sciences Key Laboratory of Brain Function and Diseases, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.\nAnhui Institute of Pediatric Research, Anhui Provincial Children's Hospital, Hefei, Anhui, China.""}, {'lastname': 'Wang', 'firstname': 'Yu', 'initials': 'Y', 'affiliation': 'Chinese Academy of Sciences Key Laboratory of Brain Function and Diseases, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.\nInstitute of Brain Science, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.'}, {'lastname': 'Chen', 'firstname': 'Peng', 'initials': 'P', 'affiliation': 'Chinese Academy of Sciences Key Laboratory of Brain Function and Diseases, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.\nInstitute of Brain Science, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.'}, {'lastname': 'Xiong', 'firstname': 'Zhi-Qi', 'initials': 'ZQ', 'affiliation': 'Institute of Neuroscience and State Key Laboratory of Neuroscience, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.\nCenter for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China.'}, {'lastname': 'Swaab', 'firstname': 'Dick F', 'initials': 'DF', 'affiliation': 'Neuropsychiatric Disorders Group, Netherlands Institute for Neuroscience, An Institute of the Royal Netherlands Academy of Arts and Sciences, Amsterdam, the Netherlands.'}, {'lastname': 'Zhou', 'firstname': 'Jiang-Ning', 'initials': 'JN', 'affiliation': 'Chinese Academy of Sciences Key Laboratory of Brain Function and Diseases, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. jnzhou@ustc.edu.cn.\nInstitute of Brain Science, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. jnzhou@ustc.edu.cn.\nCenter for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China. jnzhou@ustc.edu.cn.'}]",,,,"© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.","10.1007/s00401-021-02371-7
10.1176/ajp.144.7.873
10.1016/j.ibror.2018.11.008
10.1093/brain/awh448
10.1046/j.1471-4159.2001.00075.x
10.1111/j.1471-4159.2007.04487.x
10.1073/pnas.1714530115
10.1523/JNEUROSCI.04-02-00394.1984
10.3109/00207454.2013.833510
10.1113/jphysiol.2008.163469
10.1016/j.euroneuro.2010.06.019
10.1016/j.biopsych.2009.05.031
10.1016/j.neuron.2020.01.033
10.1242/dev.165753
10.1016/j.neuron.2020.11.007
10.1038/nm.4050
10.1017/S1461145712000016
10.1016/j.neuron.2006.09.012
10.1016/j.psyneuen.2007.03.005
10.1097/00008877-200409000-00003
10.1038/nn1837
10.1016/j.pbb.2021.173108
10.1038/s41592-020-0858-0
10.1038/nn.3872
10.1016/S0149-7634(88)80004-6
10.1111/pcn.12902
10.1038/s41467-018-05310-5
10.1038/tp.2013.98
10.1016/S0196-9781(01)00398-9
10.1038/mp.2016.120
10.1016/S0896-6273(00)80284-6
10.1126/science.7569905
10.1523/JNEUROSCI.4214-09.2010
10.1523/JNEUROSCI.0019-12.2013
10.1016/j.neuron.2019.02.005
10.3389/fncel.2012.00024
10.1161/01.HYP.33.5.1218
10.1006/meth.2001.1262
10.1038/s41592-018-0171-3
10.1016/j.psyneuen.2018.03.020
10.1016/j.brainres.2006.09.011
10.1523/JNEUROSCI.1419-20.2021
10.1016/j.jpsychires.2013.06.008
10.1007/s12264-011-1014-8
10.1126/science.aat8078
10.2174/18715273113126660174
10.1126/science.6334362
10.1016/j.neuroscience.2014.01.034
10.1523/JNEUROSCI.16-07-02157.1996
10.1016/s0165-1781(98)00012-2
10.1038/sj.mp.4002148
10.1016/j.pbb.2012.12.003
10.1371/journal.pone.0020719
10.1016/j.tins.2008.06.006
10.1038/nbt.4281
10.1016/0304-3940(94)90755-2
10.1016/j.lfs.2007.08.003
10.1002/eji.1830220936
10.1016/0014-2999(78)90414-4
10.1093/ijnp/pyu006
10.3390/ijms21082677
10.1159/000126778
10.1176/ajp.152.9.1372
10.1016/j.neuroscience.2007.03.027
10.1111/acps.12958
10.1177/002215549904700601
10.1016/s0024-3205(99)00430-0
10.1016/j.jneumeth.2004.04.020
10.1038/nature10287
10.1007/BF00428203
10.1016/0924-977x(95)00039-r
10.1146/annurev.me.42.020191.002511
10.1038/sj.npp.1300532
10.1016/j.ejphar.2014.09.049
10.1523/JNEUROSCI.5616-10.2011
10.1074/jbc.M600504200
10.1016/j.tins.2015.03.003
10.1038/ncomms3771
10.1007/s00429-019-01926-5
10.1038/npp.2013.71
10.1038/mp.2008.38
10.1038/nature25509
10.1016/S0893-133X(00)00226-8
10.1007/s11011-016-9839-5
10.1016/j.neuroscience.2010.01.030
10.1016/j.biopsych.2018.06.019
10.1016/j.jpsychires.2018.04.020
10.1210/en.2017-03176
10.1038/nrn.2016.18",<Element 'PubmedArticle' at 0x7f05ddd60540>
137,34520827,"Anti-neuroinflammatory activity of 6,7-dihydroxy-2,4-dimethoxy phenanthrene isolated from Dioscorea batatas Decne partly through suppressing the p38 MAPK/NF-κB pathway in BV2 microglial cells.","The rhizome of Dioscorea batatas Decne (called Chinses yam) widely distributed in East Asian countries including China, Japan, Korea and Taiwan has long been used in oriental folk medicine owing to its tonic, antitussive, expectorant and anti-ulcerative effects. It has been reported to have anti-inflammatory, antioxidative, cholesterol-lowering, anticholinesterase, growth hormone-releasing, antifungal and immune cell-stimulating activities.
Neuroinflammation caused by activated microglia contributes to neuronal dysfunction and neurodegeneration. In the present study, the anti-neuroinflammatory activity of 6,7-dihydroxy-2,4-dimethoxy phenanthrene (DHDMP), a phenanthrene compound isolated from Dioscorea batatas Decne, was examined in microglial and neuronal cells.
A natural phenanthrene compound, DHDMP, was isolated from the peel of Dioscorea batatas Decne. The anti-neuroinflammatory capability of the compound was examined using the co-culture system of BV2 murine microglial and HT22 murine neuronal cell lines. The expression levels of inflammatory mediators and cytoprotective proteins in the cells were quantified by enzyme-linked immunosorbent assay and Western blot analysis.
DHDMP at the concentrations of ≤1 μg/mL did not exhibit a cytotoxic effect for BV2 and HT22 cells. Rather DHDMP effectively restored the growth rate of HT22 cells, which was reduced by co-culture with lipopolysaccharide (LPS)-treated BV2 cells. DHDMP significantly decreased the production of proinflammatory mediators, such as nitric oxide, tumor necrosis factor-α, interleukin-6, inducible nitric oxide synthase, and cyclooxygenase-2 in BV2 cells. Moreover, DHDMP strongly inhibited the nuclear translocation of nuclear factor κB (NF-κB) and phosphorylation of p38 mitogen-activated protein kinase (MAPK) in BV2 cells. The compound did not affect the levels and phosphorylation of ERK and JNK. Concurrently, DHDMP increased the expression of heme oxygenase-1 (HO-1), an inducible cytoprotective enzyme, in HT22 cells.
Our findings indicate that DHDMP effectively dampened LPS-mediated inflammatory responses in BV2 microglial cells by suppressing transcriptional activity of NF-κB and its downstream mediators and contributed to HT22 neuronal cell survival. This study provides insight into the therapeutic potential of DHDMP for inflammation-related neurological diseases.","['6,7-Dihydroxy-2,4-dimethoxy phenanthrene', 'BV2 microglial cell line', 'Dioscorea batatas Decne', 'HT22 neuronal cell line', 'Neuroinflammation']",Journal of ethnopharmacology,2021-09-15,"[{'lastname': 'Lim', 'firstname': 'Ji Sun', 'initials': 'JS', 'affiliation': 'Institute of Agricultural Science and Technology, Kyungpook National University, Daegu, 41566, South Korea. Electronic address: lzsunny@daum.net.'}, {'lastname': 'Oh', 'firstname': 'Jisun', 'initials': 'J', 'affiliation': 'Institute of Agricultural Science and Technology, Kyungpook National University, Daegu, 41566, South Korea. Electronic address: j.oh@knu.ac.kr.'}, {'lastname': 'Yun', 'firstname': 'Hyun Seok', 'initials': 'HS', 'affiliation': 'School of Food Science and Biotechnology, Kyungpook National University, Daegu, 41566, South Korea. Electronic address: solideo0116@naver.com.'}, {'lastname': 'Lee', 'firstname': 'Jeong Soon', 'initials': 'JS', 'affiliation': 'Forest Resources Development Institute of Gyeongsangbuk-do, Andong, 36605, South Korea. Electronic address: ljs7942@korea.kr.'}, {'lastname': 'Hahn', 'firstname': 'Dongyup', 'initials': 'D', 'affiliation': 'School of Food Science and Biotechnology, Kyungpook National University, Daegu, 41566, South Korea. Electronic address: dohahn@knu.ac.kr.'}, {'lastname': 'Kim', 'firstname': 'Jong-Sang', 'initials': 'JS', 'affiliation': 'Institute of Agricultural Science and Technology, Kyungpook National University, Daegu, 41566, South Korea; School of Food Science and Biotechnology, Kyungpook National University, Daegu, 41566, South Korea. Electronic address: vision@knu.ac.kr.'}]",,,"DHDMP at the concentrations of ≤1 μg/mL did not exhibit a cytotoxic effect for BV2 and HT22 cells. Rather DHDMP effectively restored the growth rate of HT22 cells, which was reduced by co-culture with lipopolysaccharide (LPS)-treated BV2 cells. DHDMP significantly decreased the production of proinflammatory mediators, such as nitric oxide, tumor necrosis factor-α, interleukin-6, inducible nitric oxide synthase, and cyclooxygenase-2 in BV2 cells. Moreover, DHDMP strongly inhibited the nuclear translocation of nuclear factor κB (NF-κB) and phosphorylation of p38 mitogen-activated protein kinase (MAPK) in BV2 cells. The compound did not affect the levels and phosphorylation of ERK and JNK. Concurrently, DHDMP increased the expression of heme oxygenase-1 (HO-1), an inducible cytoprotective enzyme, in HT22 cells.",Copyright © 2021 Elsevier B.V. All rights reserved.,10.1016/j.jep.2021.114633,<Element 'PubmedArticle' at 0x7f05dde5e540>
138,"34519040
29776968
24042499
21804537
18026097
31710719
10567732
11181976
10322493
10566947
26851597
28781108
29861285
17803225
23123165
30414379
26163371
11756501
30934882
10657494
12414798
29578519
26500843
11369436
24742461
24439267
22465309
24910901
25489228
30944040
23040071
32132220
23064363
32213703
21343257
27252647
20359773
20966214
21880259
24719110
28546318
23089631
19363500
28611581
32579912
20148679
21312223
22592020
18492290
22366059
20226203
21356521
24819325
20074530
17911224
19348788
29497166
25902481
25035078
28461695
17974623
17317774
20951130
16720054
27030669
11006237
24880214
19570816
23318256
15459118
12556393
23649873
28456941
27110066
22722451
20308787
19164583
32999409
28099414
15694265
26141845
31880353
29274121
16322792
20035739
21525299
24391532
23313342
22867941
9886047
18026096
1356598
17021376
10781100
12704399
7911978
10936189
20197503
12183643
12749025
20920042
23667132
27013681
32180468
24296712
6264602
16887153
23900416
25202980
26287683
22842565
24048027
23613987
28533296
24133407
29336844
26072178
22374757
28336086
32152264
33147455
33147455
34413054
12730992
12824248
18063676
23071306
9870336
20727946
12796784
30081456
32042146
29892066
31341912","The role of glia in the physiology and pharmacology of glucagon-like peptide-1: implications for obesity, diabetes, neurodegeneration and glaucoma.","The medical applications of glucagon-like peptide-1 receptor (GLP-1R) agonists is evergrowing in scope, highlighting the urgent need for a comprehensive understanding of the mechanisms through which GLP-1R activation impacts physiology and behaviour. A new area of research aims to elucidate the role GLP-1R signalling in glia, which play a role in regulating energy balance, glycemic control, neuroinflammation and oxidative stress. Once controversial, existing evidence now suggests that subsets of glia (e.g. microglia, tanycytes and astrocytes) and infiltrating macrophages express GLP-1Rs. In this review, we discuss the implications of these findings, with particular focus on the effectiveness of both clinically available and novel GLP-1R agonists for treating metabolic and neurodegenerative diseases, enhancing cognition and combating substance abuse. LINKED ARTICLES: This article is part of a themed issue on GLP1 receptor ligands (BJP 75th Anniversary). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.4/issuetoc.","['astrocyte', 'beta cell', 'blood glucose', 'exendin', 'food intake', 'gliosis', 'inflammation', 'liraglutide', 'macrophage', 'microglia', 'neuroprotection', 'semaglutide']",British journal of pharmacology,2021-09-15,"[{'lastname': 'Cui', 'firstname': 'Qi N', 'initials': 'QN', 'affiliation': 'Scheie Eye Institute, Philadelphia, Pennsylvania, USA.'}, {'lastname': 'Stein', 'firstname': 'Lauren M', 'initials': 'LM', 'affiliation': 'Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.'}, {'lastname': 'Fortin', 'firstname': 'Samantha M', 'initials': 'SM', 'affiliation': 'Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.'}, {'lastname': 'Hayes', 'firstname': 'Matthew R', 'initials': 'MR', 'affiliation': 'Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.'}]",,,,© 2021 The British Pharmacological Society.,"10.1111/bph.15683
10.2337/db17-1385
10.1113/jphysiol.2013.261289
10.1038/nn.2887
10.1038/nn2014
10.1111/bph.14747
10.1016/s0165-3806(99)00113-3
10.1146/annurev.physiol.63.1.795
10.1016/j.drudis.2016.01.013
10.1016/S0140-6736(17)31585-4
10.1016/j.neuron.2018.05.014
10.1002/jnr.21483
10.1016/j.cmet.2012.10.003
10.1002/cpim.70
10.1016/j.immuni.2015.06.012
10.3390/ijms20071584
10.1054/npep.1999.0757
10.1074/jbc.M209454200
10.3791/57122
10.1016/j.molmet.2015.07.008
10.1016/j.neuron.2014.02.040
10.1016/j.immuni.2013.11.019
10.1016/j.physbeh.2012.03.014
10.1016/j.exer.2014.05.004
10.1186/s13063-019-3259-x
10.1016/j.cmet.2012.09.005
10.1126/scitranslmed.aay8071
10.1172/JCI64102
10.1172/jci.insight.133429
10.1210/en.2010-1252
10.3389/fnagi.2016.00108
10.1016/j.neurobiolaging.2010.02.014
10.1126/science.1194637
10.1051/medsci/2011278013
10.1523/JNEUROSCI.4703-13.2014
10.1126/science.aal3222
10.1038/mp.2012.141
10.1038/ijo.2009.10
10.3389/fnins.2017.00308
10.1016/j.celrep.2020.107776
10.1146/annurev-physiol-021909-135843
10.1002/jnr.22565
10.1016/j.neurobiolaging.2012.04.009
10.1186/1742-2094-5-19
10.1016/j.physbeh.2012.02.017
10.1016/j.physbeh.2010.02.029
10.1016/j.cmet.2011.02.001
10.1146/annurev-nutr-071812-161201
10.1016/j.cmet.2009.10.009
10.1177/1073858407305725
10.1016/j.brainres.2009.03.059
10.1038/s41386-018-0010-3
10.1016/j.immuni.2015.03.011
10.1038/npp.2014.175
10.1038/mp.2017.91
10.1210/en.2007-0633
10.1210/en.2006-1572
10.1016/j.ejphar.2010.10.008
10.1016/j.neures.2006.04.008
10.1152/ajpregu.00520.2015
10.1038/nn.3725
10.1677/JOE-09-0132
10.1016/j.brainres.2013.01.012
10.1210/en.2004-0419
10.1167/iovs.02-0255
10.1002/cne.23355
10.1007/s12035-017-0550-2
10.1155/2016/3094642
10.1007/s00125-012-2592-3
10.3233/JAD-2010-1314
10.1073/pnas.0806720106
10.1038/s41366-020-00658-5
10.1038/nature21029
10.1016/j.neulet.2004.11.016
10.1016/j.neuroscience.2015.06.054
10.1002/glia.23774
10.1002/glia.23283
10.1172/JCI26309
10.1016/j.ejphar.2009.12.023
10.1523/JNEUROSCI.0529-11.2011
10.3389/fnins.2013.00249
10.1016/j.autneu.2012.12.006
10.1016/j.brainres.2012.07.029
10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5
10.1038/nn2015
10.1038/sj.ijo.0802265
10.1038/369744a0
10.1152/ajpendo.00464.2009
10.1124/jpet.102.037481
10.1002/jnr.10611
10.1111/j.1463-1326.2010.01259.x
10.18632/aging.100557
10.1523/JNEUROSCI.3579-15.2016
10.1080/02713683.2020.1737137
10.2337/db13-1440
10.1126/science.6264602
10.1016/j.physbeh.2006.05.036
10.1152/ajpendo.00367.2013
10.1172/JCI75276
10.1016/j.immuni.2015.07.016
10.1016/j.bbrc.2012.07.086
10.1073/pnas.1306799110
10.1371/journal.pone.0061965
10.2337/db16-1364
10.3389/fnins.2013.00181
10.1016/j.tig.2017.12.008
10.1016/j.physbeh.2015.06.013
10.1152/ajpendo.00025.2012
10.1016/j.ejcb.2017.03.004
10.1038/s41398-020-0767-0
10.1101/2020.06.18.146720
10.1016/j.celrep.2020.108271
10.1101/2021.01.16.21249949
10.1002/ana.10519
10.1167/iovs.02-1136
10.1210/en.2007-1166
10.1073/pnas.1210150109
10.1016/s0304-3940(98)00813-1
10.1016/j.neuroscience.2010.08.028
10.1038/nn1073
10.3390/brainsci8080143
10.1038/s41583-020-0264-8
10.1038/s41591-018-0051-5
10.1155/2019/9605265",<Element 'PubmedArticle' at 0x7f05dde51810>
139,34516974,Harpagide alleviate neuronal apoptosis and blood-brain barrier leakage by inhibiting TLR4/MyD88/NF-κB signaling pathway in Angiotensin II-induced microglial activation in vitro.,"Angiotensin II, the effector peptide of the renin-angiotensin system, is not only a pivotal peptide implicated in the regulation of blood pressure but also a key mediator of the inflammatory processes that play an important role in the pathology of hypertension-related cSVD. Harpagide is the major bioactive constituent of Scrophulariae Radix widely used in traditional Chinese medicine for numerous diseases including hypertension. The present study aimed to investigate the effect of harpagide on Ang II-induced neuroinflammation and the potential mechanism. Pretreated with harpagide or resatorvid (the TLR4 pathway inhibitor), BV2 cells were treated with Ang II or LPS (the TLR4 activator). NO, pro-inflammatory cytokines, the proteins on TLR4/MyD88/NF-κB signaling pathway and the expression of CD86, CD206, TREM2 in BV2 cells were detected respectively. Subsequently, the effects of harpagide on neurotoxicity and BBB destruction triggered by Ang II-induced neuroinflammation were investigated in the co-cultures of BV2 microglia/HT22 hippocampal neurons, BV2 microglia/bEnd.3 endotheliocyte and BV2 microglia/BBB monolayer model. We found that Ang II converted microglia into M1 state and resulted in neuroinflammation through activating TLR4/MyD88/NF-κB signaling pathway. It also triggered the imbalance of TLR4/TREM2 in microglia. Ang II-mediated inflammation microglia further led to neuronal apoptosis and BBB damage. Harpagide showed the effect of alleviating Ang II-mediated neuroinflammation as well as the resulting neurotoxicity and BBB destruction through inhibiting the TLR4/MyD88/NF-κB pathway. The anti-inflammatory and neuroprotective effect of harpagide suggested that it might be a potential therapeutic strategy in hypertensive cSVD.","['Angiotensin II', 'Co-culture', 'Harpagide', 'Microglia', 'Neuroinflammation', 'TLR4']",Chemico-biological interactions,2021-09-14,"[{'lastname': 'Lu', 'firstname': 'Yunwei', 'initials': 'Y', 'affiliation': 'Department of Neurology, Jiangsu Province Hospital of Chinese Medicine, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, 210001, China.'}, {'lastname': 'Hao', 'firstname': 'Renjuan', 'initials': 'R', 'affiliation': 'Department of Neurology, Jiangsu Province Hospital of Chinese Medicine, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, 210001, China.'}, {'lastname': 'Hu', 'firstname': 'Yingchao', 'initials': 'Y', 'affiliation': 'Department of Neurology, Jiangsu Province Hospital of Chinese Medicine, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, 210001, China.'}, {'lastname': 'Wei', 'firstname': 'Yuyan', 'initials': 'Y', 'affiliation': 'Department of Neurology, Jiangsu Province Hospital of Chinese Medicine, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, 210001, China.'}, {'lastname': 'Xie', 'firstname': 'Yuyan', 'initials': 'Y', 'affiliation': 'Department of Neurology, Jiangsu Province Hospital of Chinese Medicine, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, 210001, China.'}, {'lastname': 'Shen', 'firstname': 'Yu', 'initials': 'Y', 'affiliation': 'Department of Neurology, Jiangsu Province Hospital of Chinese Medicine, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, 210001, China.'}, {'lastname': 'Rui', 'firstname': 'Qinglin', 'initials': 'Q', 'affiliation': 'Department of Emergency, Jiangsu Province Hospital of Chinese Medicine, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, 210001, China. Electronic address: rql1964jsszyy@163.com.'}, {'lastname': 'Yu', 'firstname': 'Guran', 'initials': 'G', 'affiliation': 'Department of Neurology, Jiangsu Province Hospital of Chinese Medicine, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, 210001, China. Electronic address: yushengzh@126.com.'}]",,,,Copyright © 2021 Elsevier B.V. All rights reserved.,10.1016/j.cbi.2021.109653,<Element 'PubmedArticle' at 0x7f05de1282c0>
140,"34512747
23794642
22710756
15995723
17643733
30571942
31803024
33125041
26546042
29265673
29084866
24719110
32184015
34111331
28202578
25247855
17406327
7965003
31511520
29928964
2542867
7507519
26179626
32427844
32175522
32695961
32914057
31922090
31179435
1333581
14607246
18615568
31858405
18480275
14507968
27241733
30778044
30042425
30578561
16098668
17347278",Microglial Activation of GLP-1R Signaling in Neuropathic Pain Promotes Gene Expression Adaption Involved in Inflammatory Responses.,"Neuropathic pain is a common chronic pain, which is related to hypersensitivity to stimulus and greatly affects the quality of life of patients. Maladaptive gene changes and molecular signaling underlie the sensitization of nociceptive pathways. We previously found that the activation of microglial glucagon-like peptide 1 receptor (GLP-1R) could potently relieve formalin-, bone cancer-, peripheral nerve injury-, and diabetes-induced pain hypersensitivity. So far, little is known about how the gene profile changes upon the activation of GLP-1R signaling in the pathophysiology of neuropathic pain.
Spinal nerve ligation (SNL) was performed to induce neuropathic pain in rats. Mechanical allodynia was assessed using von Frey filaments. The expression of IL-10, 
The GLP-1R agonist, exenatide, has an antiallodynic effect on neuropathic pain, which could be reversed by intrathecal injections of the microglial inhibitor minocycline. Furthermore, differential gene expression analysis (WGCNA) indicated that intrathecal injections of exenatide could reverse the abnormal expression of 591 genes in the spinal dorsal horn induced by nerve injury. WGCNA revealed 58 modules with a close relationship between the microglial GLP-1R pathway and features of nerve injuries, including pain, ligation, paw withdrawal latency (PWL), and anxiety. The brown module was identified as the highest correlated module, and the Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis indicated that inflammatory responses were most correlated with PWL. To further unravel the changes of hyperalgesia-related neuronal electrophysiological activity mediated by microglia GLP-1 receptors, whole-cell recording identified that MOR agonism stimulated a robust outward current in the sham groups compared with the spinal nerve ligation (SNL) groups. This inhibitory effect on the SNL group was more sensitive than that of the sham group after bath application of 
Our results further confirmed that the GLP-1R pathway is involved in alleviating pain hypersensitivity mediated by spinal microglia activation, and inflammatory responses were the most correlated pathway associated with PWL changes in response to exenatide treatment. We found that the identification of gene regulation in response to GLP-1R activation is an effective strategy for identifying new therapeutic targets for neuropathic pain. Investigation for the activation of spinal microglial GLP-1R which might ameliorate inflammatory responses through gene expression and structural changes is providing a potential biomarker in pain management.",[],Neural plasticity,2021-09-14,"[{'lastname': 'Ma', 'firstname': 'Le', 'initials': 'L', 'affiliation': ""Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University, School of Medicine, School of Pharmacy, Shanghai 200240, China.\nKing's Lab, Shanghai Jiao Tong University School of Pharmacy, Shanghai 200240, China.""}, {'lastname': 'Ju', 'firstname': 'Peijun', 'initials': 'P', 'affiliation': 'Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University, School of Medicine, School of Pharmacy, Shanghai 200240, China.'}, {'lastname': 'Wang', 'firstname': 'Wei', 'initials': 'W', 'affiliation': 'Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University, School of Medicine, School of Pharmacy, Shanghai 200240, China.'}, {'lastname': 'Wei', 'firstname': 'Jinbao', 'initials': 'J', 'affiliation': ""Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University, School of Medicine, School of Pharmacy, Shanghai 200240, China.\nKing's Lab, Shanghai Jiao Tong University School of Pharmacy, Shanghai 200240, China.""}, {'lastname': 'Wang', 'firstname': 'Weidi', 'initials': 'W', 'affiliation': 'Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University, School of Medicine, School of Pharmacy, Shanghai 200240, China.'}, {'lastname': 'Zhao', 'firstname': 'Mengjing', 'initials': 'M', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, Shanghai 200240, China.""}, {'lastname': 'Ahmad', 'firstname': 'Khalil Ali', 'initials': 'KA', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, Shanghai 200240, China.""}, {'lastname': 'Wang', 'firstname': 'Yongxiang', 'initials': 'Y', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, Shanghai 200240, China.""}, {'lastname': 'Chen', 'firstname': 'Jinghong', 'initials': 'J', 'affiliation': 'Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University, School of Medicine, School of Pharmacy, Shanghai 200240, China.'}]",,,"The GLP-1R agonist, exenatide, has an antiallodynic effect on neuropathic pain, which could be reversed by intrathecal injections of the microglial inhibitor minocycline. Furthermore, differential gene expression analysis (WGCNA) indicated that intrathecal injections of exenatide could reverse the abnormal expression of 591 genes in the spinal dorsal horn induced by nerve injury. WGCNA revealed 58 modules with a close relationship between the microglial GLP-1R pathway and features of nerve injuries, including pain, ligation, paw withdrawal latency (PWL), and anxiety. The brown module was identified as the highest correlated module, and the Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis indicated that inflammatory responses were most correlated with PWL. To further unravel the changes of hyperalgesia-related neuronal electrophysiological activity mediated by microglia GLP-1 receptors, whole-cell recording identified that MOR agonism stimulated a robust outward current in the sham groups compared with the spinal nerve ligation (SNL) groups. This inhibitory effect on the SNL group was more sensitive than that of the sham group after bath application of ",Copyright © 2021 Le Ma et al.,"10.1155/2021/9923537
10.1093/bja/aet128
10.1016/S1474-4422(12)70134-5
10.1038/nrn1700
10.1016/j.pneurobio.2007.06.005
10.1016/j.neuron.2018.11.009
10.3389/fncel.2019.00514
10.1210/endocr/bqaa201
10.1016/j.phrs.2015.10.008
10.1002/biof.1406
10.1523/JNEUROSCI.1799-17.2017
10.1523/JNEUROSCI.4703-13.2014
10.1016/j.bbrc.2020.03.023
10.1111/cns.13694
10.1124/mol.116.107102
10.1097/ALN.0000000000000320
10.1038/nprot.2006.120
10.1152/jn.1994.72.1.169
10.1038/s41467-019-12049-0
10.1016/j.bbi.2018.06.015
10.1016/0304-3959(89)90160-7
10.1152/jn.1993.70.5.1841
10.1038/ncomms8660
10.1038/s41467-020-16198-5
10.1136/gpsych-2019-100057
10.1136/gpsych-2020-100214
10.1136/gpsych-2020-100276
10.1136/gpsych-2019-100144
10.1136/gpsych-2019-100056
10.1016/0304-3959(92)90041-9
10.1016/j.lfs.2003.09.006
10.1002/glia.20699
10.1007/s12017-019-08581-3
10.1523/JNEUROSCI.3338-07.2008
10.1523/JNEUROSCI.23-25-08692.2003
10.1038/ncomms11697
10.1038/s41419-019-1425-4
10.1038/s41419-018-0859-4
10.1002/glia.23557
10.1016/j.pain.2005.05.035
10.1113/jphysiol.2006.123919",<Element 'PubmedArticle' at 0x7f05de2ec950>
141,"34440676
31513774
24440641
27693730
26891883
29654072
29649433
26122294
33766745
18369406
23795744
15024130
26190834
29378226
25423896
22493583
27825818
27542528
29992530
33675812
33166649
20367258
25616953
30237546
17942367
23036890
29357734
23904011
28904863
22864183
11742077
18198211
22787149
23639789
12621155
21093435
24098534
22583764
31320982
22703519
24642455
24675030
18025470
17560688
26346601
19010568
29101592
22659017
18711728
22079573
23429294
27957684
20091232
29802248
29416029
28951213
20544857
23190172
24281943
26037411
31827177
27787886
27250720
28466269
28332151
30536184
31849688
28774717
31882813
15808606
17566657
25023896
31947806
21335947
23357651
24395659
27313512
27891320
19818384
24444786
30084008
32243028
32636794
24491879
16627790
28948468
16603429
33704934
33740236
26996171
15155257
23633287
27517478
15351102
15337246
15337241
15383625
19464167
28191467
32507541
29582398
31992325
34282519",Role of Neuroglobin in the Neuroprotective Actions of Estradiol and Estrogenic Compounds.,"Estradiol exerts neuroprotective actions that are mediated by the regulation of a variety of signaling pathways and homeostatic molecules. Among these is neuroglobin, which is upregulated by estradiol and translocated to the mitochondria to sustain neuronal and glial cell adaptation to injury. In this paper, we will discuss the role of neuroglobin in the neuroprotective mechanisms elicited by estradiol acting on neurons, astrocytes and microglia. We will also consider the role of neuroglobin in the neuroprotective actions of clinically relevant synthetic steroids, such as tibolone. Finally, the possible contribution of the estrogenic regulation of neuroglobin to the generation of sex differences in brain pathology and the potential application of neuroglobin as therapy against neurological diseases will be examined.","['astrocytes', 'estrogen receptors', 'microglia', 'mitochondria', 'neuron', 'sex differences', 'tibolone']",Cells,2021-08-28,"[{'lastname': 'Barreto', 'firstname': 'George E', 'initials': 'GE', 'affiliation': 'Department of Biological Sciences, University of Limerick, V94 T9PX Limerick, Ireland.'}, {'lastname': 'McGovern', 'firstname': 'Andrew J', 'initials': 'AJ', 'affiliation': 'Department of Biological Sciences, University of Limerick, V94 T9PX Limerick, Ireland.'}, {'lastname': 'Garcia-Segura', 'firstname': 'Luis M', 'initials': 'LM', 'affiliation': 'Instituto Cajal, Consejo Superior de Investigaciones Científicas (C.S.I.C.), 28002 Madrid, Spain.'}]",,,,,"10.3390/cells10081907
10.1016/j.yfrne.2019.100787
10.1016/j.expneurol.2014.01.008
10.1016/j.yfrne.2016.09.003
10.1016/j.pneurobio.2015.12.008
10.1530/JOE-18-0129
10.1016/j.neuropharm.2018.04.005
10.1016/j.yhbeh.2015.06.010
10.1016/j.mad.2021.111473
10.2174/138920206779315737
10.1111/jne.12068
10.1073/pnas.0306948101
10.1016/j.mce.2015.07.016
10.1016/j.steroids.2018.01.010
10.1038/nrn3856
10.3389/fphys.2012.00073
10.1016/j.mam.2016.10.004
10.1016/j.neuroscience.2016.07.042
10.1007/s12035-018-1212-8
10.1016/j.abb.2021.108823
10.1016/j.freeradbiomed.2020.11.002
10.1089/ars.2009.2977
10.1007/s12035-014-9077-y
10.1038/s41419-018-1007-x
10.1016/j.coph.2007.09.003
10.1016/j.bbamcr.2012.09.009
10.1089/scd.2017.0097
10.1007/s12035-013-8506-7
10.1002/2211-5463.12271
10.1016/j.neuroscience.2012.07.052
10.1073/pnas.251466698
10.1096/fj.07-100784
10.1074/jbc.M112.373381
10.1016/j.nbd.2013.04.015
10.1073/pnas.0637726100
10.1016/j.expneurol.2010.11.009
10.1371/journal.pone.0076565
10.1016/j.neulet.2012.05.018
10.1155/2019/5728129
10.1186/1471-2202-13-67
10.1016/j.neulet.2014.03.012
10.1016/j.brainres.2014.03.020
10.1073/pnas.0706167104
10.1016/j.neurobiolaging.2007.05.001
10.1007/s12031-015-0645-z
10.1016/j.neurobiolaging.2008.10.003
10.1007/s10072-017-3168-2
10.1016/j.neuroscience.2012.05.054
10.1002/jnr.21826
10.1016/j.neuroscience.2011.10.046
10.1038/cddis.2013.30
10.1007/s12035-016-0337-x
10.1007/s10495-009-0436-5
10.1038/s41419-018-0656-0
10.1038/s41419-017-0260-8
10.1016/j.bbrc.2017.09.127
10.1002/glia.21002
10.1111/jne.12007
10.1007/s10571-013-0008-7
10.1002/glia.22867
10.1038/s41598-019-55315-3
10.1111/jnc.13876
10.1016/j.mce.2016.05.024
10.1007/s12035-017-0567-6
10.1007/s12035-017-0481-y
10.1007/s12035-018-1442-9
10.3389/fphar.2019.01452
10.1016/j.neuint.2017.07.012
10.1038/s41598-019-56595-5
10.1016/j.transproceed.2004.12.270
10.1016/j.neulet.2007.05.046
10.1179/1743132814Y.0000000420
10.3390/pharmaceutics12010040
10.1159/000323906
10.1016/j.bbapap.2013.01.015
10.1002/iub.1235
10.3389/fncel.2016.00147
10.3389/fonc.2016.00238
10.1016/j.bbagen.2009.10.002
10.1016/j.mce.2014.01.009
10.1007/s10571-018-0607-4
10.1111/ejn.14731
10.3389/fneur.2020.00504
10.1016/j.freeradbiomed.2014.01.032
10.1161/01.STR.0000221308.94473.14
10.1007/s12035-017-0777-y
10.1080/09513590500519161
10.1002/brb3.2100
10.1007/s12640-021-00353-x
10.2174/1871527315666160321105612
10.1152/ajpheart.00227.2004
10.1002/jnr.23219
10.1111/jne.12415
10.1016/j.maturitas.2004.06.022
10.1016/j.maturitas.2004.02.012
10.1016/j.maturitas.2004.02.013
10.1124/mol.104.004515
10.1016/j.jsbmb.2009.03.008
10.1155/2017/8630764
10.1016/j.tem.2020.04.007
10.1007/s12035-018-1008-x
10.1186/s12974-020-1719-6
10.1007/s11030-021-10274-8",<Element 'PubmedArticle' at 0x7f05de2c6d10>
142,"34413330
23028126
28872215
28927263
18218341
17047313
29259137
22556362
26333800
28127589
20303880
17296833
29744576
28835281
27333743
29053785
16862116
17345602
18157829
25261995
28379303
23398167
25611616
30928644
23404368
31022188
10632585
16386336
12684452
27567878
15518235
18378771
28640985
25309543
21497117
8822355
29955652
15952887
15509549
25104558
28261874
32130580
25787746
10858277
21092856
26370502
2001789
19302036
20234358
23252647
16541438
28912710
12359772
23741441
12524533
10537317
11134521
11274345
21820214
21540081
16862115
16950801
22608501
18565828
17923627
33844830
15307186
26112872
17057756
9460750
23123349
13413144
8102969
10401555
7557541
32663219
26334574
2268320
27312666","AZP2006, a new promising treatment for Alzheimer's and related diseases.","Progranulin (PGRN) is a protein with multiple functions including the regulation of neuroinflammation, neuronal survival, neurite and synapsis growth. Although the mechanisms of action of PGRN are currently unknown, its potential therapeutic application in treating neurodegenerative diseases is huge. Thus, strategies to increase PGRN levels in patients could provide an effective treatment. In the present study, we investigated the effects of AZP2006, a lysotropic molecule now in phase 2a clinical trial in Progressive Supranuclear Palsy patients, for its ability to increase PGRN level and promote neuroprotection. We showed for the first time the in vitro and in vivo neuroprotective effects of AZP2006 in neurons injured with Aβ",[],Scientific reports,2021-08-21,"[{'lastname': 'Callizot', 'firstname': 'N', 'initials': 'N', 'affiliation': 'Alzprotect, Parc Eurasanté, 85C rue Nelson Mandela, 59120, Loos, France. n.callizot@alzprotect.com.\nNeuro-Sys, 410 Chemin Départemental 60, 13120, Gardanne, France. n.callizot@alzprotect.com.'}, {'lastname': 'Estrella', 'firstname': 'C', 'initials': 'C', 'affiliation': 'Alzprotect, Parc Eurasanté, 85C rue Nelson Mandela, 59120, Loos, France.'}, {'lastname': 'Burlet', 'firstname': 'S', 'initials': 'S', 'affiliation': 'Alzprotect, Parc Eurasanté, 85C rue Nelson Mandela, 59120, Loos, France.'}, {'lastname': 'Henriques', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Neuro-Sys, 410 Chemin Départemental 60, 13120, Gardanne, France.'}, {'lastname': 'Brantis', 'firstname': 'C', 'initials': 'C', 'affiliation': 'Alzprotect, Parc Eurasanté, 85C rue Nelson Mandela, 59120, Loos, France.'}, {'lastname': 'Barrier', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Alzprotect, Parc Eurasanté, 85C rue Nelson Mandela, 59120, Loos, France.'}, {'lastname': 'Campanari', 'firstname': 'M L', 'initials': 'ML', 'affiliation': 'Neuro-Sys, 410 Chemin Départemental 60, 13120, Gardanne, France.'}, {'lastname': 'Verwaerde', 'firstname': 'P', 'initials': 'P', 'affiliation': 'Alzprotect, Parc Eurasanté, 85C rue Nelson Mandela, 59120, Loos, France.'}]",,,,© 2021. The Author(s).,"10.1038/s41598-021-94708-1
10.1101/cshperspect.a006296
10.1111/ene.13439
10.14348/molcells.2017.2319
10.1016/j.molmed.2007.12.002
10.1155/JBB/2006/74539
10.1074/jbc.M117.815357
10.1093/hmg/dds161
10.1212/WNL.0000000000001946
10.1016/j.cell.2010.02.016
10.1001/archneur.64.2.185
10.1007/s00401-018-1861-8
10.1186/s13024-017-0205-9
10.1093/brain/awx198
10.1038/nature05016
10.1002/humu.20651
10.1038/nm.3672
10.1093/brain/awx060
10.1111/ene.12090
10.1021/cn5003013
10.1016/j.nbd.2019.03.028
10.1002/jnr.23193
10.1371/journal.pone.0215277
10.1523/JNEUROSCI.20-02-00558.2000
10.1016/j.neurobiolaging.2005.11.003
10.1523/JNEUROSCI.23-07-02665.2003
10.3233/JAD-160612
10.1080/08977190410001723308
10.1083/jcb.200712039
10.1111/jnc.14110
10.3389/fimmu.2014.00461
10.1016/j.immuni.2011.01.018
10.1016/0006-8993(95)01032-7
10.1016/j.trci.2017.12.003
10.1146/annurev.biochem.74.082803.133339
10.1016/S0002-9440(10)63436-0
10.1016/j.neurobiolaging.2014.06.015
10.1111/neup.12373
10.1007/s10522-020-09867-x
10.1007/s00213-015-3906-1
10.1177/002215540004800713
10.1016/j.neuron.2010.09.034
10.1083/jcb.201502029
10.1096/fasebj.5.3.2001789
10.1146/annurev.immunol.021908.132528
10.1038/nrneurol.2010.17
10.1111/nan.12011
10.1002/jnr.20767
10.3389/fnagi.2017.00277
10.1126/scisignal.aah5146
10.1371/journal.pone.0064989
10.1038/nm816
10.1073/pnas.98.1.142
10.1152/physrev.2001.81.2.807
10.1016/j.neuroscience.2011.04.037
10.1038/nature05017
10.1093/hmg/ddl241
10.1016/j.ajhg.2012.04.021
10.1212/01.wnl.0000319688.89790.7a
10.1001/archneur.64.10.1436
10.1093/brain/awaa428
10.1002/eji.200425218
10.1186/s12974-015-0349-x
10.1038/sj.bjp.0706927
10.1016/S0306-4522(97)00405-3
10.1016/j.ejphar.2012.10.033
10.1111/j.1476-5381.1957.tb01354.x
10.1016/0014-2999(93)90469-X
10.1038/sj.bjp.0702595
10.1016/0891-5849(95)00020-X
10.1371/journal.pbio.3000410
10.1016/j.ymeth.2015.08.023
10.1016/S0006-291X(05)80908-8
10.1038/srep28188",<Element 'PubmedArticle' at 0x7f05de0f1590>
143,"34409198
460932
10491980
17177754
8783314
17590272
24105754
21796057
20068448
24500412
10846153
19712899
26525230
16698416
24237004
9884866
31343465
18456219
12764087
30761997
16093381
24752199
20103545
22699129
23881791
29178038
23216170
10561444
9350845
27069626
20961685
31079836
18615140
32221089
29794783
20364022
25822923
23578860
29052225
30124544
17543812
26869374
23390475
26650425
31491863
26966331
29392204
28767509
29026331
31626143
25790453
30726237
19542791
12421200
18952472
25985024
28681962
28366128
28233180
28035535
31234188
27974040
28220542
29899036
31534227
24798884
25415497
26432952
24956966
30650376
31573550
31469291
28356427
29397391
27814521
26822992
29409054
30489316
25146375
22972295
31460832
24997031
29380303
31123355
31552496
31653850
31551115
10401557
26324094
18268332
19400724
22365541
32807072
28486769
28714953
31889131
29872383
30705252
14581119
30267869
26930255
28629511
16105890
28265110
27729657
26793178
25888704
23618829
31063849
31974315
30925514
30925707
27793219
30883471
23225871
31809997
32115044
24948120
27793571
17943118
19686699
29292393
18304834
20404851
32305572
23872358
20576919
18027846
21393555
28155242
25846205
33392418
27195116
30915065
19807780
25637492
22684624
21981302
29903615
15475622
20332520
20003079
18194152
27406353
29619131
26045134
25910186
27102666
31785713
23157347
22978429
25073649
27749354
21799397
21773855
25209095
22546966",Postoperative pain and the gut microbiome.,"In excess of 300 million surgical procedures are undertaken worldwide each year. Despite recognition of the prevalence of postoperative pain, and improvements in pain management techniques, poorly controlled postoperative pain remains a major unresolved challenge globally. An estimated 71% and 51% of patients experience moderate to severe pain after surgery in in-patient and outpatient settings, respectively. Inadequately controlled pain after surgery is associated with significant perioperative morbidity including myocardial infarction and pulmonary complications. As many as 20-56% of patients develop chronic pain after commonly performed procedures such as hernia repair, hysterectomy, and thoracotomy. Traditional analgesics and interventions are often ineffective or partially effective in the treatment of postoperative pain, resulting in a chronic pain condition with related socio-economic impacts and reduced quality of life for the patient. Such chronic pain which occurs after surgery is referred to as Persistent Post-Surgical Pain (PPSP). The complex ecosystem that is the gastrointestinal microbiota (including bacteria, fungi, viruses, phage) plays essential roles in the maintenance of the healthy state of the host. A disruption to the balance of this microbiome has been implicated not only in gastrointestinal disease but also neurological disorders including chronic pain. The influence of the gut microbiome is well documented in the context of visceral pain from the gastrointestinal tract while a greater understanding is emerging of the impact on inflammatory pain and neuropathic pain (both of which can occur during the perioperative period). The gut microbiome is an essential source for driving immune maturation and maintaining appropriate immune response. Given that inflammatory processes have been implicated in postoperative pain, aberrant microbiome profiles may play a role in the development of this type of pain. Furthermore, the microorganisms in our gut produce metabolites, neurotransmitters, and neuromodulators which interact with their receptors to regulate peripheral and central sensitisation associated with chronic pain. Microbiota-derived mediators can also regulate neuroinflammation, which is associated with activation of microglia as well as infiltration by immune cells, known to modulate the development and maintenance of central sensitisation. Moreover, risk factors for developing postoperative pain include anxiety, depression, and increased stress response. These central nervous system-related disorders have been associated with an altered gut microbiome and microbiome targeted intervention studies indicate improvements. Females are more likely to suffer from postoperative pain. As gonadal hormones are associated with a differential microbiome and pre-clinical studies show that male microbiome confers protection from inflammatory pain, it is possible that the composition of the microbiome and its by-products contribute to the increased risk for the development of postoperative pain. Very little evidence exists relating the microbiome to somatic pain. Here we discuss the potential role of the gut microbiome in the aetiology and pathophysiology of postoperative pain in the context of other somatic pain syndromes and what is known about microbe-neuron interactions. Investigations are needed to determine the specific role of the gut microbiome in this type of pain which may help inform the development of preventative interventions as well as management strategies to improve patient outcome.","['Microbiome', 'Microbiome-gut-brain axis', 'Post surgical pain', 'Postoperative pain', 'Stress']","Neurobiology of pain (Cambridge, Mass.)",2021-08-20,"[{'lastname': 'Brenner', 'firstname': 'David', 'initials': 'D', 'affiliation': 'Department of Anesthesia and Intensive Care Medicine, Cork University Hospital and University College Cork, Ireland.'}, {'lastname': 'Shorten', 'firstname': 'George D', 'initials': 'GD', 'affiliation': 'Department of Anesthesia and Intensive Care Medicine, Cork University Hospital and University College Cork, Ireland.'}, {'lastname': ""O'Mahony"", 'firstname': 'Siobhain M', 'initials': 'SM', 'affiliation': 'APC Microbiome Ireland, University College Cork, Cork, Ireland.\nDepartment of Anatomy and Neuroscience, University College Cork, Cork, Ireland.'}]",,,,© 2021 Published by Elsevier Inc.,10.1016/j.ynpai.2021.100070,<Element 'PubmedArticle' at 0x7f05de449900>
144,"34402181
20007989
17325517
19225398
32898475
21788491
29175959
26317476
28636962
23709617
28099414
32665021
32264970
32801156
32701842
26380235
2062448
23994230
31456515
33794246
33640870
15501525
10548280
30739077
33000126
32877641
32663096
33658918
32975883
32488976
11457528
17406317
30685530
21317632
30296006
17695343
28724382
24894913
3576201
18836704
30850520
8872869
6268760
14678773
22496389
18995821
32159240
25663667
22553043
32711525
15707899
22722203
11223341
17151913
33147455
32916201
31147505
27199659
30883423
34271016",Cholecystokinin octapeptide improves hippocampal glutamatergic synaptogenesis and postoperative cognition by inhibiting induction of A1 reactive astrocytes in aged mice.,"Delayed neurocognitive recovery (dNCR) is a common postoperative complication in geriatric surgical patients for which there is no efficacious therapy. Cholecystokinin octapeptide (CCK-8), an immunomodulatory peptide, regulates memory and learning. Here, we explored the effects and mechanism of action of CCK-8 on dNCR.
We applied laparotomy to establish a model of dNCR in aged mice. Morris water maze and fear conditioning tests were used to evaluate cognition. Immunofluorescence was used to detect the density of CCK-8, A1 reactive astrocytes, glutamatergic synapses, and activation of microglia in the hippocampus. Quantitative PCR was performed to determine mRNA levels of synapse-associated factors. A1 reactive astrocytes, activated microglia, and glutamatergic synapse-associated protein levels in the hippocampus were assessed by western blotting.
Administration of CCK-8 suppressed the activation of microglia, the induction of A1 reactive astrocytes, and the expression of tumor necrosis factor alpha, complement 1q, and interleukin 1 alpha in the hippocampus. Furthermore, it promoted glutamatergic synaptogenesis and neurocognitive recovery in aged dNCR model mice.
Our findings indicated that CCK-8 alleviated cognitive impairment and promoted glutamatergic synaptogenesis by inhibiting the induction of A1 reactive astrocytes and the activation of microglia. CCK-8 is, therefore, a potential therapeutic target for dNCR.","['A1 reactive astrocyte', 'activated microglia', 'cholecystokinin octapeptide', 'delayed neurocognitive recovery', 'glutamatergic synaptogenesis']",CNS neuroscience & therapeutics,2021-08-18,"[{'lastname': 'Chen', 'firstname': 'Lei', 'initials': 'L', 'affiliation': 'Department of Anesthesiology, Peking University Third Hospital, Beijing, China.'}, {'lastname': 'Yang', 'firstname': 'Ning', 'initials': 'N', 'affiliation': 'Department of Anesthesiology, Peking University Third Hospital, Beijing, China.'}, {'lastname': 'Li', 'firstname': 'Yue', 'initials': 'Y', 'affiliation': 'Department of Anesthesiology, Peking University Third Hospital, Beijing, China.'}, {'lastname': 'Li', 'firstname': 'Yitong', 'initials': 'Y', 'affiliation': 'Department of Anesthesiology, Peking University Third Hospital, Beijing, China.'}, {'lastname': 'Hong', 'firstname': 'Jingshu', 'initials': 'J', 'affiliation': 'Department of Anesthesiology, Peking University Third Hospital, Beijing, China.'}, {'lastname': 'Wang', 'firstname': 'Qian', 'initials': 'Q', 'affiliation': 'Department of Anesthesiology, Peking University Third Hospital, Beijing, China.'}, {'lastname': 'Liu', 'firstname': 'Kaixi', 'initials': 'K', 'affiliation': 'Department of Anesthesiology, Peking University Third Hospital, Beijing, China.'}, {'lastname': 'Han', 'firstname': 'Dengyang', 'initials': 'D', 'affiliation': 'Department of Anesthesiology, Peking University Third Hospital, Beijing, China.'}, {'lastname': 'Han', 'firstname': 'Yongzheng', 'initials': 'Y', 'affiliation': 'Department of Anesthesiology, Peking University Third Hospital, Beijing, China.'}, {'lastname': 'Mi', 'firstname': 'Xinning', 'initials': 'X', 'affiliation': 'Department of Anesthesiology, Peking University Third Hospital, Beijing, China.'}, {'lastname': 'Shi', 'firstname': 'Chengmei', 'initials': 'C', 'affiliation': 'Department of Anesthesiology, Peking University Third Hospital, Beijing, China.'}, {'lastname': 'Zhou', 'firstname': 'Ying', 'initials': 'Y', 'affiliation': 'Department of Anesthesiology, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.'}, {'lastname': 'Li', 'firstname': 'Zhengqian', 'initials': 'Z', 'affiliation': 'Department of Anesthesiology, Peking University Third Hospital, Beijing, China.'}, {'lastname': 'Liu', 'firstname': 'Taotao', 'initials': 'T', 'affiliation': 'Department of Anesthesiology, Peking University Third Hospital, Beijing, China.'}, {'lastname': 'Guo', 'firstname': 'Xiangyang', 'initials': 'X', 'affiliation': 'Department of Anesthesiology, Peking University Third Hospital, Beijing, China.'}]",,"Our findings indicated that CCK-8 alleviated cognitive impairment and promoted glutamatergic synaptogenesis by inhibiting the induction of A1 reactive astrocytes and the activation of microglia. CCK-8 is, therefore, a potential therapeutic target for dNCR.","Administration of CCK-8 suppressed the activation of microglia, the induction of A1 reactive astrocytes, and the expression of tumor necrosis factor alpha, complement 1q, and interleukin 1 alpha in the hippocampus. Furthermore, it promoted glutamatergic synaptogenesis and neurocognitive recovery in aged dNCR model mice.",© 2021 The Authors. CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd.,10.1111/cns.13718,<Element 'PubmedArticle' at 0x7f05de031900>
145,"34400876
10496275
23320783
32080393
16087714
17706564
26092914
32961928
32670177
33310876
30663608
33323985
29465257
26819962
30513364
33411674
33406479
33456515
33186537
20128675
23637915
22948743
30718956
28886007
31062335
31033014
32568215
24345222
33679755
33309338
32568214
25072195
15743872
23122444
19655191
16148087
25103368
25898198
23136552
26522462
28519900
24588027
24348680
33241604
30051922
22807325
24492996
10340761
32044129
28340598
30240044
31077796
25800044
25889216
32733433
31059788
27459405
32070155
24252536
28435163
20026663
28100408
26879559
22068162
22225875
31775776
23516300
27778404
22265214
28550707
26521232
26941100
27393339
32547558
33107309
29246612
33517686
28808113
33002329
32728203
32722601
33287883
32674730
30890930",The role and mechanisms of Microglia in Neuromyelitis Optica Spectrum Disorders.,"Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune neurological disease that can cause blindness and disability. As the major mediators in the central nervous system, microglia plays key roles in immunological regulation in neuroinflammatory diseases, including NMOSD. Microglia can be activated by interleukin (IL)-6 and type I interferons (IFN-Is) during NMOSD, leading to signal transducer and activator of transcription (STAT) activation. Moreover, complement C3a secreted from activated astrocytes may induce the secretion of complement C1q, inflammatory cytokines and progranulin (PGRN) by microglia, facilitating injury to microglia, neurons, astrocytes and oligodendrocytes in an autocrine or paracrine manner. These processes involving activated microglia ultimately promote the pathological course of NMOSD. In this review, recent research progress on the roles of microglia in NMOSD pathogenesis is summarized, and the mechanisms of microglial activation and microglial-mediated inflammation, and the potential research prospects associated with microglial activation are also discussed.","['demyelination', 'microglia', 'microglial activation', 'neuromyelitis optica spectrum disorder']",International journal of medical sciences,2021-08-18,"[{'lastname': 'Li', 'firstname': 'Wenqun', 'initials': 'W', 'affiliation': 'Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.\nInstitute of Clinical Pharmacy, Central South University, Changsha, 410011, Hunan, China.'}, {'lastname': 'Liu', 'firstname': 'Jiaqin', 'initials': 'J', 'affiliation': 'Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.\nInstitute of Clinical Pharmacy, Central South University, Changsha, 410011, Hunan, China.'}, {'lastname': 'Tan', 'firstname': 'Wei', 'initials': 'W', 'affiliation': 'Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.\nHunan Clinical Research Center of Ophthalmic Disease, Changsha, Hunan 410011, China.'}, {'lastname': 'Zhou', 'firstname': 'Yedi', 'initials': 'Y', 'affiliation': 'Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.\nHunan Clinical Research Center of Ophthalmic Disease, Changsha, Hunan 410011, China.'}]",,,,© The author(s).,10.7150/ijms.61153,<Element 'PubmedArticle' at 0x7f05dc68c040>
146,34400215,The funny current: Even funnier than 40 years ago. Uncanonical expression and roles of HCN/f channels all over the body.,"Discovered some 40 years ago, the I","['HCN channels', 'Hyperpolarization-activated current', 'I(h) current', 'Leukocytes', 'Max 6) I(f) current', 'Smooth muscle']",Progress in biophysics and molecular biology,2021-08-18,"[{'lastname': 'Benzoni', 'firstname': 'Patrizia', 'initials': 'P', 'affiliation': 'The Cell Physiology MiLab, Department of Biosciences, Università degli Studi di Milano, Via G. Celoria 26, 20133, Milan, Italy.'}, {'lastname': 'Bertoli', 'firstname': 'Giorgia', 'initials': 'G', 'affiliation': 'The Cell Physiology MiLab, Department of Biosciences, Università degli Studi di Milano, Via G. Celoria 26, 20133, Milan, Italy.'}, {'lastname': 'Giannetti', 'firstname': 'Federica', 'initials': 'F', 'affiliation': 'The Cell Physiology MiLab, Department of Biosciences, Università degli Studi di Milano, Via G. Celoria 26, 20133, Milan, Italy.'}, {'lastname': 'Piantoni', 'firstname': 'Chiara', 'initials': 'C', 'affiliation': 'The Cell Physiology MiLab, Department of Biosciences, Università degli Studi di Milano, Via G. Celoria 26, 20133, Milan, Italy; Present Address: Institute of Neurophysiology, Hannover Medical School, Carl-Neuberg-Str.1, 30625, Hannover, Germany.'}, {'lastname': 'Milanesi', 'firstname': 'Raffaella', 'initials': 'R', 'affiliation': ""The Cell Physiology MiLab, Department of Biosciences, Università degli Studi di Milano, Via G. Celoria 26, 20133, Milan, Italy; Present Address: Dipartimento di Medicina Veterinaria, Università degli Studi di Milano, Via Dell'Università 6, 26900, Lodi, Italy.""}, {'lastname': 'Pecchiari', 'firstname': 'Matteo', 'initials': 'M', 'affiliation': 'Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Via L. Mangiagalli 32, 20133, Milan, Italy.'}, {'lastname': 'Barbuti', 'firstname': 'Andrea', 'initials': 'A', 'affiliation': 'The Cell Physiology MiLab, Department of Biosciences, Università degli Studi di Milano, Via G. Celoria 26, 20133, Milan, Italy.'}, {'lastname': 'Baruscotti', 'firstname': 'Mirko', 'initials': 'M', 'affiliation': 'The Cell Physiology MiLab, Department of Biosciences, Università degli Studi di Milano, Via G. Celoria 26, 20133, Milan, Italy.'}, {'lastname': 'Bucchi', 'firstname': 'Annalisa', 'initials': 'A', 'affiliation': 'The Cell Physiology MiLab, Department of Biosciences, Università degli Studi di Milano, Via G. Celoria 26, 20133, Milan, Italy. Electronic address: annalisa.bucchi@unimi.it.'}]",,,,Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.,10.1016/j.pbiomolbio.2021.08.007,<Element 'PubmedArticle' at 0x7f05de923a40>
147,"34375614
26902870
27852725
33422763
23721075
28818092
32772264
25030696
20021390
21745103
32531244
24586048
30186412
19185596
31462511
29846550
32787092
28272516
31379859
23150934
22948220
8710493
30996143
18640783
27927222
31257031
25047746
23159010
23150908
28343318
8366086
24990881
28432014
3475698
30127720
28930663
29518357
29104891
8566748
31256193
32192578
28756656
30655956
32376901
29942252
31214123
26463675
12109914
24215914
29374630
11328886
18790823
17407101
27707627
28316349
27148736
9075699
15483087
25904803
19002578
22930834
30922332
17425404
30683932
26854967
29648626
28109981
17532082
25897174
11084025
26478868
31398325
27102437
11427693
29104108
29285146",TREM2 is thyroid hormone regulated making the TREM2 pathway druggable with ligands for thyroid hormone receptor.,"Triggering receptor expressed on myeloid cells-2 (TREM2) is a cell surface receptor on macrophages and microglia that senses and responds to disease-associated signals to regulate the phenotype of these innate immune cells. The TREM2 signaling pathway has been implicated in a variety of diseases ranging from neurodegeneration in the central nervous system to metabolic disease in the periphery. Here, we report that TREM2 is a thyroid hormone-regulated gene and its expression in macrophages and microglia is stimulated by thyroid hormone and synthetic thyroid hormone agonists (thyromimetics). Our findings report the endocrine regulation of TREM2 by thyroid hormone, and provide a unique opportunity to drug the TREM2 signaling pathway with orally active small-molecule therapeutic agents.","['SARS-CoV-2', 'TREM2', 'innate immunity', 'neurodegeneration', 'therapeutics', 'thyroid hormone']",Cell chemical biology,2021-08-11,"[{'lastname': 'Ferrara', 'firstname': 'Skylar J', 'initials': 'SJ', 'affiliation': 'Department of Chemical Physiology and Biochemistry and Program in Chemical Biology, Oregon Health & Science University, L334, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.'}, {'lastname': 'Chaudhary', 'firstname': 'Priya', 'initials': 'P', 'affiliation': 'VA Portland Health Care System, Portland, OR 97239, USA; Department of Neurology, Oregon Health & Science University, Portland, OR 97239, USA.'}, {'lastname': 'DeBell', 'firstname': 'Margaret J', 'initials': 'MJ', 'affiliation': 'Department of Chemical Physiology and Biochemistry and Program in Chemical Biology, Oregon Health & Science University, L334, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.'}, {'lastname': 'Marracci', 'firstname': 'Gail', 'initials': 'G', 'affiliation': 'VA Portland Health Care System, Portland, OR 97239, USA; Department of Neurology, Oregon Health & Science University, Portland, OR 97239, USA.'}, {'lastname': 'Miller', 'firstname': 'Hannah', 'initials': 'H', 'affiliation': 'Department of Chemical Physiology and Biochemistry and Program in Chemical Biology, Oregon Health & Science University, L334, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.'}, {'lastname': 'Calkins', 'firstname': 'Evan', 'initials': 'E', 'affiliation': 'VA Portland Health Care System, Portland, OR 97239, USA; Department of Neurology, Oregon Health & Science University, Portland, OR 97239, USA.'}, {'lastname': 'Pocius', 'firstname': 'Edvinas', 'initials': 'E', 'affiliation': 'VA Portland Health Care System, Portland, OR 97239, USA; Department of Neurology, Oregon Health & Science University, Portland, OR 97239, USA.'}, {'lastname': 'Napier', 'firstname': 'Brooke A', 'initials': 'BA', 'affiliation': 'Department of Biology, Portland State University, OR 97201, USA.'}, {'lastname': 'Emery', 'firstname': 'Ben', 'initials': 'B', 'affiliation': 'Department of Neurology, Oregon Health & Science University, Portland, OR 97239, USA; Jungers Center for Neurosciences Research, Oregon Health & Science University, Portland, OR 97239, USA.'}, {'lastname': 'Bourdette', 'firstname': 'Dennis', 'initials': 'D', 'affiliation': 'VA Portland Health Care System, Portland, OR 97239, USA; Department of Neurology, Oregon Health & Science University, Portland, OR 97239, USA.'}, {'lastname': 'Scanlan', 'firstname': 'Thomas S', 'initials': 'TS', 'affiliation': 'Department of Chemical Physiology and Biochemistry and Program in Chemical Biology, Oregon Health & Science University, L334, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA. Electronic address: scanlant@ohsu.edu.'}]",,,,Copyright © 2021 Elsevier Ltd. All rights reserved.,10.1016/j.chembiol.2021.07.014,<Element 'PubmedArticle' at 0x7f05de901270>
148,34371064,Ovarian insufficiency impairs glucose-stimulated insulin secretion through activation of hypothalamic de novo ceramide synthesis.,"Oestrogens regulate body weight through their action on hypothalamus to modulate food intake and energy expenditure. Hypothalamic de novo ceramide synthesis plays a central role on obesity induced by oestrogen deficiency. Depletion in oestrogens is also known to be associated with glucose intolerance, which favours type 2 diabetes (T2D). However, the implication of hypothalamic ceramide in the regulation of glucose homeostasis by oestrogen is unknown. Here, we studied glucose homeostasis and insulin secretion in ovariectomized (OVX) female rats. OVX induces body weight gain associated with a hypothalamic inflammation and impaired glucose homeostasis. Genetic blockade of ceramide synthesis in the ventromedial nucleus of the hypothalamus (VMH) reverses hypothalamic inflammation and partly restored glucose tolerance induced by OVX. Furthermore, glucose-stimulated insulin secretion (GSIS) is increased in OVX rats due to a raise of insulin secretion second phase, a characteristic of early stage of T2D. In contrast, GSIS from isolated islets of OVX rats is totally blunted. Inhibition of ceramide synthesis in the VMH restores GSIS from isolated OVX islets and represses the second phase of insulin secretion. Stimulation of oestrogen receptor α (ERα) by oestradiol (E2) down-regulates ceramide synthesis in hypothalamic neuronal GT1-7 cells but no in microglial SIM-A9 cells. In contrast, genetic inactivation of ERα in VMH upregulates ceramide synthesis. These results indicate that hypothalamic neuronal de novo ceramide synthesis triggers the OVX-dependent impairment of glucose homeostasis which is partly mediated by a dysregulation of GSIS.","['Hypothalamus: ceramide', 'Insulin secretion', 'Obesity', 'Ovariectomy: oestrogens']",Metabolism: clinical and experimental,2021-08-10,"[{'lastname': 'Meneyrol', 'firstname': 'Kelly', 'initials': 'K', 'affiliation': 'Unité de Biologie Fonctionnelle et Adaptative, CNRS UMR 8251, Université de Paris, Paris, France.'}, {'lastname': 'Estévez-Salguero', 'firstname': 'Ánxela', 'initials': 'Á', 'affiliation': 'NeurObesity Group, Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela 15782, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), 15706, Spain.'}, {'lastname': 'González-García', 'firstname': 'Ismael', 'initials': 'I', 'affiliation': 'NeurObesity Group, Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela 15782, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), 15706, Spain.'}, {'lastname': 'Guitton', 'firstname': 'Jeanne', 'initials': 'J', 'affiliation': 'Institut des Neurosciences Paris-Saclay, CNRS UMR 9197, Université Paris Saclay, Orsay, France.'}, {'lastname': 'Taouis', 'firstname': 'Mohammed', 'initials': 'M', 'affiliation': 'Institut des Neurosciences Paris-Saclay, CNRS UMR 9197, Université Paris Saclay, Orsay, France.'}, {'lastname': 'Benomar', 'firstname': 'Yacir', 'initials': 'Y', 'affiliation': 'Institut des Neurosciences Paris-Saclay, CNRS UMR 9197, Université Paris Saclay, Orsay, France.'}, {'lastname': 'Magnan', 'firstname': 'Christophe', 'initials': 'C', 'affiliation': 'Unité de Biologie Fonctionnelle et Adaptative, CNRS UMR 8251, Université de Paris, Paris, France.'}, {'lastname': 'López', 'firstname': 'Miguel', 'initials': 'M', 'affiliation': 'NeurObesity Group, Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela 15782, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), 15706, Spain. Electronic address: m.lopez@usc.es.'}, {'lastname': 'Le Stunff', 'firstname': 'Hervé', 'initials': 'H', 'affiliation': 'Unité de Biologie Fonctionnelle et Adaptative, CNRS UMR 8251, Université de Paris, Paris, France; Institut des Neurosciences Paris-Saclay, CNRS UMR 9197, Université Paris Saclay, Orsay, France. Electronic address: herve.le-stunff@universite-paris-saclay.fr.'}]",,,,Copyright © 2021 Elsevier Inc. All rights reserved.,10.1016/j.metabol.2021.154846,<Element 'PubmedArticle' at 0x7f05ded6e220>
149,34343616,Microglial-glucocorticoid receptor depletion alters the response of hippocampal microglia and neurons in a chronic unpredictable mild stress paradigm in female mice.,"Chronic psychological stress is one of the most important triggers and environmental risk factors for neuropsychiatric disorders. Chronic stress can influence all organs via the secretion of stress hormones, including glucocorticoids by the adrenal glands, which coordinate the stress response across the body. In the brain, glucocorticoid receptors (GR) are expressed by various cell types including microglia, which are its resident immune cells regulating stress-induced inflammatory processes. To study the roles of microglial GR under normal homeostatic conditions and following chronic stress, we generated a mouse model in which the GR gene is depleted in microglia specifically at adulthood to prevent developmental confounds. We first confirmed that microglia were depleted in GR in our model in males and females among the cingulate cortex and the hippocampus, both stress-sensitive brain regions. Then, cohorts of microglial-GR depleted and wild-type (WT) adult female mice were housed for 3 weeks in a standard or stressful condition, using a chronic unpredictable mild stress (CUMS) paradigm. CUMS induced stress-related behavior in both microglial-GR depleted and WT animals as demonstrated by a decrease of both saccharine preference and progressive ratio breakpoint. Nevertheless, the hippocampal microglial and neural mechanisms underlying the adaptation to stress occurred differently between the two genotypes. Upon CUMS exposure, microglial morphology was altered in the WT controls, without any apparent effect in microglial-GR depleted mice. Furthermore, in the standard environment condition, GR depleted-microglia showed increased expression of pro-inflammatory genes, and genes involved in microglial homeostatic functions (such as Trem2, Cx3cr1 and Mertk). On the contrary, in CUMS condition, GR depleted-microglia showed reduced expression levels of pro-inflammatory genes and increased neuroprotective as well as anti-inflammatory genes compared to WT-microglia. Moreover, in microglial-GR depleted mice, but not in WT mice, CUMS led to a significant reduction of CA1 long-term potentiation and paired-pulse ratio. Lastly, differences in adult hippocampal neurogenesis were observed between the genotypes during normal homeostatic conditions, with microglial-GR deficiency increasing the formation of newborn neurons in the dentate gyrus subgranular zone independently from stress exposure. Together, these findings indicate that, although the deletion of microglial GR did not prevent the animal's ability to respond to stress, it contributed to modulating hippocampal functions in both standard and stressful conditions, notably by shaping the microglial response to chronic stress.","['Behavior', 'Chronic unpredictable mild stress', 'Depletion', 'Depression', 'Glucocorticoid receptor', 'Microglia', 'Mouse model', 'Neurogenesis', 'Synaptic plasticity']","Brain, behavior, and immunity",2021-08-04,"[{'lastname': 'Picard', 'firstname': 'Katherine', 'initials': 'K', 'affiliation': 'Axe neurosciences, Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada; Molecular Medicine Department, Université Laval, Québec City, QC, Canada; Division of Medical Sciences, University of Victoria, Victoria, BC, Canada.'}, {'lastname': 'Bisht', 'firstname': 'Kanchan', 'initials': 'K', 'affiliation': 'Axe neurosciences, Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada.'}, {'lastname': 'Poggini', 'firstname': 'Silvia', 'initials': 'S', 'affiliation': 'Center for Behavioral Sciences and Mental Health, Istituto Superiore di Sanità, Rome, Italy.'}, {'lastname': 'Garofalo', 'firstname': 'Stefano', 'initials': 'S', 'affiliation': 'Department of Physiology and Pharmacology, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Italy.'}, {'lastname': 'Golia', 'firstname': 'Maria Teresa', 'initials': 'MT', 'affiliation': 'Department of Physiology and Pharmacology, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Italy.'}, {'lastname': 'Basilico', 'firstname': 'Bernadette', 'initials': 'B', 'affiliation': 'Department of Physiology and Pharmacology, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Italy; Institute of Science and Technology (IST) Austria, Klosterneuburg, Austria.'}, {'lastname': 'Abdallah', 'firstname': 'Fatima', 'initials': 'F', 'affiliation': 'Center for Behavioral Sciences and Mental Health, Istituto Superiore di Sanità, Rome, Italy.'}, {'lastname': 'Ciano Albanese', 'firstname': 'Naomi', 'initials': 'N', 'affiliation': 'Center for Behavioral Sciences and Mental Health, Istituto Superiore di Sanità, Rome, Italy; Institute of Science and Technology (IST) Austria, Klosterneuburg, Austria.'}, {'lastname': 'Amrein', 'firstname': 'Irmgard', 'initials': 'I', 'affiliation': 'Functional Neuroanatomy, Institute of Anatomy, University of Zürich, Zurich, Switzerland.'}, {'lastname': 'Vernoux', 'firstname': 'Nathalie', 'initials': 'N', 'affiliation': 'Axe neurosciences, Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada.'}, {'lastname': 'Sharma', 'firstname': 'Kaushik', 'initials': 'K', 'affiliation': 'Axe neurosciences, Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada.'}, {'lastname': 'Hui', 'firstname': 'Chin Wai', 'initials': 'CW', 'affiliation': 'Axe neurosciences, Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada.'}, {'lastname': 'C Savage', 'firstname': 'Julie', 'initials': 'J', 'affiliation': 'Axe neurosciences, Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada.'}, {'lastname': 'Limatola', 'firstname': 'Cristina', 'initials': 'C', 'affiliation': 'Department of Physiology and Pharmacology, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Italy; IRCCS Neuromed, Pozzilli, Italy.'}, {'lastname': 'Ragozzino', 'firstname': 'Davide', 'initials': 'D', 'affiliation': 'Department of Physiology and Pharmacology, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Italy.'}, {'lastname': 'Maggi', 'firstname': 'Laura', 'initials': 'L', 'affiliation': 'Department of Physiology and Pharmacology, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Italy.'}, {'lastname': 'Branchi', 'firstname': 'Igor', 'initials': 'I', 'affiliation': 'Center for Behavioral Sciences and Mental Health, Istituto Superiore di Sanità, Rome, Italy.'}, {'lastname': 'Tremblay', 'firstname': 'Marie-Ève', 'initials': 'MÈ', 'affiliation': 'Axe neurosciences, Centre de recherche du CHU de Québec-Université Laval, Québec, QC, Canada; Molecular Medicine Department, Université Laval, Québec City, QC, Canada; Division of Medical Sciences, University of Victoria, Victoria, BC, Canada; The Department of Biochemistry and Molecular Biology, The University of British Columbia, Vancouver, BC, Canada. Electronic address: evetremblay@uvic.ca.'}]",,,,Copyright © 2021 Elsevier Inc. All rights reserved.,10.1016/j.bbi.2021.07.022,<Element 'PubmedArticle' at 0x7f05ded5c680>
150,"34341712
12476342
28259169
30548343
20729991
14670989
26470014
19345186
11750861
14611864
24704258
10662535
31513776
30618719
30400090
26540080
20811568
15295589
12214075
33239064
31855379
32823921
29748506
32241688
28623000
31580307
31982474
32810649
27877121
29931997
28886007
30319362
3614616
12788335
31715222
10737694
32848613
23884544
11596125
25800044
28862638
31093687
26067058
30459555
27825853
31429127
24638131
20303880
30249283
24760020
32391019
18564425
17684513
26931456
23492769
12601160
27528245
28716963
16038625
7739519
25224917
29710717
26790758
21753171
25833819
23486975
20864679
28372330
33240722
32829453
28643167
25411471
30066368
25589730
27776263
26869995
31544208
15344917
15814846
31050045
32646017
16319920
21514366
20488256
12414884
15374110
20153425
19665809
10664834
2570275
19428144
16365303
25206601
29179999
32276438
30900203
33069760
33114450
27697052
17569208
32953558
19966973
31560864
30669068
31137655
33160067
26059355
31376068
8741021
22086747
25506211
25114079
26268332
20104449
26819725
32153388
31016201
28086917
26362286
28940752
12873849
25446949
22932777
11395173
17982894
30958356
33287198
32771949
18097616
23717092
18580589
32806490
33050575
27840992
29064461
26401779
27048893
16353824
30223002
30642737
30569089
32928279
31488882
28642806
23493529
30995776
26035622
17569224
18417733
30477087
15545088
21291975
22470237
12434011
12631693
21575276
19260079
30096397
9795834
21258872
16624639
9883965
23911887
29324687
29864481
25218903
26551702
12447370
28594115
22185664
30717203
27560534
19132916
21048386
7622446
21331635
12469318
28991199
23815956
32795898
32838181
33268824
29614679
32813239
30796934
32059690
31831363
33187212
32949638",Promising Intervention Approaches to Potentially Resolve Neuroinflammation And Steroid Hormones Alterations in Alzheimer's Disease and Its Neuropsychiatric Symptoms.,"Neuroinflammation is a biological process by which the central nervous system responds to stimuli/injuries affecting its homeostasis. So far as this reactive response becomes exacerbated and uncontrolled, it can lead to neurodegeneration, compromising the cognitive and neuropsychiatric domains. Parallelly, modifications in the hypothalamic signaling of neuroprotective hormones linked also to the inflammatory responses of microglia and astrocytes can exacerbate these processes. To complicate the picture, modulations in the gut microbiota (GM) can induce changes in neuroinflammation, altering cognitive and neuropsychiatric functioning. We conducted a web-based search on PubMed. We described studies regarding the cross-talk among microglia and astrocytes in the neuroinflammation processes, along with the role played by the steroid hormones, and how this can reflect on cognitive decline/neurodegeneration, in particular on Alzheimer's Disease (AD) and its neuropsychiatric manifestations. We propose and support the huge literature showing the potentiality of complementary/alternative therapeutic approaches (nutraceuticals) targeting the sustained inflammatory response, the dysregulation of hypothalamic system and the GM composition. NF-κB and Keap1/Nrf2 are the main molecular targets on which a list of nutraceuticals can modulate the altered processes. Since there are some limitations, we propose a new intervention natural treatment in terms of Oxygen-ozone (O","['Alzheimer’s Disease', 'Keap1/Nrf2', 'NF-κB', 'Neuroinflammation', 'Nutraceuticals', 'Oxygen-Ozone Therapy', 'Steroid hormones']",Aging and disease,2021-08-04,"[{'lastname': 'Scassellati', 'firstname': 'Catia', 'initials': 'C', 'affiliation': '1Biological Psychiatry Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.'}, {'lastname': 'Galoforo', 'firstname': 'Antonio Carlo', 'initials': 'AC', 'affiliation': '2Oxygen-Ozone Therapy Scientific Society (SIOOT), Gorle, Italy.\n3University of Pavia, Pavia, Italy.'}, {'lastname': 'Esposito', 'firstname': 'Ciro', 'initials': 'C', 'affiliation': '4Department of Internal Medicine and Therapeutics, University of Pavia, Italy.\n5Nephrology and dialysis unit, ICS S. Maugeri SPA SB Hospital, Pavia, Italy.\n6P.D. High School in Geriatrics, University of Pavia, Italy.'}, {'lastname': 'Ciani', 'firstname': 'Miriam', 'initials': 'M', 'affiliation': '7Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.'}, {'lastname': 'Ricevuti', 'firstname': 'Giovanni', 'initials': 'G', 'affiliation': '6P.D. High School in Geriatrics, University of Pavia, Italy.\n8Department of Drug Sciences, University of Pavia, Italy.\n9St. Camillus Medical University, Rome, Italy.'}, {'lastname': 'Bonvicini', 'firstname': 'Cristian', 'initials': 'C', 'affiliation': '7Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.'}]",,,,copyright: © 2021 Scassellati et al.,"10.14336/AD.2021.0122
10.3390/nu12113458",<Element 'PubmedArticle' at 0x7f05ded493b0>
151,"34304733
25104651
23702979
26852158
24574826
31232702
32459994
17909628
19578022
8784346
19795409
16862116
24779634
25234724
28404863
28490764
30090016
17764761
24136346
31675076
27869795
25927172
21092856
26339140
24591016
19056610
19321167
30862089
33555074
12524533
27345409
21224065
29249750
26757107
16009831
12882811
28979997
26603154
30132279
29042140
21514452
26900328
27747237
28231837
17364026
24135266
27114033
23830905
28073925
26354916
28435163",Progranulin deficiency in Iba-1,"Age-related macular degeneration (AMD) is the principal cause of permanent blindness among elderly individuals worldwide. Chronic inflammation in the subretinal space is associated with a progression of exudative AMD. Progranulin (PGRN) is a growth factor secreted from myeloid cells and plays an important role in controlling the lysosomal function. A deficiency in PGRN leads to inflammation of the neurons in the central nervous system. The purpose of this study was to investigate the role played by PGRN in the size of the choroidal neovascularization (CNV) in laser-induced CNV mice.
CNVs were induced in C57BL/6J mice by laser photocoagulation of the retina. The expression of PGRN and the accumulation of Iba-1
Iba-1
These findings indicate that PGRN deficiency in Iba-1","['Inflammation', 'Lysosome', 'Macrophage', 'Microglia', 'Neovascularization', 'Progranulin']",Journal of neuroinflammation,2021-07-27,"[{'lastname': 'Takahashi', 'firstname': 'Kei', 'initials': 'K', 'affiliation': 'Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu, 501-1196, Japan.'}, {'lastname': 'Nakamura', 'firstname': 'Shinsuke', 'initials': 'S', 'affiliation': 'Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu, 501-1196, Japan.'}, {'lastname': 'Otsu', 'firstname': 'Wataru', 'initials': 'W', 'affiliation': 'Department of Biomedical Research Laboratory, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu, 501-1196, Japan.'}, {'lastname': 'Shimazawa', 'firstname': 'Masamitsu', 'initials': 'M', 'affiliation': 'Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu, 501-1196, Japan.\nDepartment of Biomedical Research Laboratory, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu, 501-1196, Japan.'}, {'lastname': 'Hara', 'firstname': 'Hideaki', 'initials': 'H', 'affiliation': 'Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu, 501-1196, Japan. hidehara@gifu-pu.ac.jp.\nDepartment of Biomedical Research Laboratory, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu, 501-1196, Japan. hidehara@gifu-pu.ac.jp.'}]",,,Iba-1,© 2021. The Author(s).,"10.1186/s12974-021-02203-1
10.1016/S2214-109X(13)70145-1
10.1038/nri3459
10.1007/s00018-016-2147-8
10.3904/kjim.2014.29.1.1
10.1172/JCI129862
10.1016/j.tins.2020.03.012
10.1172/JCI31692
10.1167/iovs.09-3462
10.1038/nsb0996-747
10.1002/bies.200900086
10.1038/nature05016
10.1016/j.brainres.2014.09.023
10.1038/s41598-017-01933-8
10.1016/j.bbr.2007.07.020
10.1038/nprot.2013.135
10.1167/iovs.19-27493
10.1038/labinvest.2016.116
10.1038/srep09898
10.1016/j.neuron.2010.09.034
10.1007/s10620-014-3089-3
10.2337/db08-1147
10.1016/j.atherosclerosis.2009.02.017
10.15252/embj.2020105123
10.1038/nm816
10.1038/onc.2016.226
10.1016/j.ajpath.2010.11.002
10.1292/jvms.17-0638
10.1111/jcmm.12756
10.1001/archopht.123.7.914
10.1167/iovs.03-0038
10.1167/iovs.16-21283
10.1161/ATVBAHA.115.306681
10.1007/s00417-018-4107-5
10.1016/j.exer.2017.10.011
10.1016/j.ajpath.2011.01.013
10.1186/s12974-017-0820-y
10.1172/JCI29919
10.1016/j.humimm.2013.09.016
10.1016/j.cell.2016.04.001
10.1016/j.neuroscience.2013.06.049
10.1523/JNEUROSCI.1599-15.2015
10.1038/nrn.2017.36",<Element 'PubmedArticle' at 0x7f05dcbe3130>
152,"34299330
10572156
17286590
8705846
7886816
7986484
33192310
10850730
15895084
15681802
12379913
12488575
30910443
31831863
15543349
25347455
15894331
14657172
15728830
29454025
23515018
22248049
14757702
21546126
29579222
22813736
26362942
31121907
23644076
11021405
18686032
19840553
32234529
27470986
16322748
16949823
25339865
25800044
32941933
33027950
12478284
12511873
26408161
29962346
31979368
20468046
22388959
21187088
21461357
34063708
28963903
16834756
16343349
28336953
19476641
22321194
22970888
17217969
21778362
29563239
33847763
33154976
26336035
31915009
25989853
31922322
16859761
14744429
23707391
10066831
29888765
29246246
18000012
28334226
29158718
17200137
16513651
11789671
26086345
29560022
32117037
28877953
23949608
25619654
26402623
24937045
30098312
17543306
28825114
6832887
11846609",Fatty Acid Amide Hydrolase (FAAH) Inhibition Modulates Amyloid-Beta-Induced Microglia Polarization.,"The ability of endocannabinoid (eCB) to change functional microglial phenotype can be explored as a possible target for therapeutic intervention. Since the inhibition of fatty acid amide hydrolase (FAAH), the main catabolic enzyme of anandamide (AEA), may provide beneficial effects in mice model of Alzheimer's disease (AD)-like pathology, we aimed at determining whether the FAAH inhibitor URB597 might target microglia polarization and alter the cytoskeleton reorganization induced by the amyloid-β peptide (Aβ). The morphological evaluation showed that Aβ treatment increased the surface area of BV-2 cells, which acquired a flat and polygonal morphology. URB597 treatment partially rescued the control phenotype of BV-2 cells when co-incubated with Aβ. Moreover, URB597 reduced both the increase of Rho protein activation in Aβ-treated BV-2 cells and the Aβ-induced migration of BV-2 cells, while an increase of Cdc42 protein activation was observed in all samples. URB597 also increased the number of BV-2 cells involved in phagocytosis. URB597 treatment induced the polarization of microglial cells towards an anti-inflammatory phenotype, as demonstrated by the decreased expression of iNOS and pro-inflammatory cytokines along with the parallel increase of Arg-1 and anti-inflammatory cytokines. Taken together, these data suggest that FAAH inhibition promotes cytoskeleton reorganization, regulates phagocytosis and cell migration processes, thus driving microglial polarization towards an anti-inflammatory phenotype.","['M1/M2 phenotypes', 'N-arachidonoylethanolamine (AEA)', 'URB597', 'actin cytoskeleton', 'cell migration', 'fatty acid amide hydrolase (FAAH)', 'microglia', 'neuroinflammation']",International journal of molecular sciences,2021-07-25,"[{'lastname': 'Grieco', 'firstname': 'Maddalena', 'initials': 'M', 'affiliation': 'Department of Biochemical Sciences, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.'}, {'lastname': 'De Caris', 'firstname': 'Maria Giovanna', 'initials': 'MG', 'affiliation': 'Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy.'}, {'lastname': 'Maggi', 'firstname': 'Elisa', 'initials': 'E', 'affiliation': 'Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica 79, 04100 Latina, Italy.'}, {'lastname': 'Armeli', 'firstname': 'Federica', 'initials': 'F', 'affiliation': 'Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica 79, 04100 Latina, Italy.'}, {'lastname': 'Coccurello', 'firstname': 'Roberto', 'initials': 'R', 'affiliation': 'Fondazione Santa Lucia IRCCS, Preclinical Neuroscience, Via del Fosso di Fiorano 64, 00143 Rome, Italy.\nInstitute for Complex Systems (ISC), C.N.R., Via dei Taurini 19, 00185 Rome, Italy.'}, {'lastname': 'Bisogno', 'firstname': 'Tiziana', 'initials': 'T', 'affiliation': 'Endocannabinoid Research Group, Institute of Translational Pharmacology, CNR, Via Fosso del Cavaliere 100, 00133 Rome, Italy.'}, {'lastname': ""D'Erme"", 'firstname': 'Maria', 'initials': 'M', 'affiliation': 'Department of Biochemical Sciences, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.'}, {'lastname': 'Maccarrone', 'firstname': 'Mauro', 'initials': 'M', 'affiliation': ""Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via Vetoio snc, 67100 L'Aquila, Italy.\nEuropean Center for Brain Research/Santa Lucia Foundation IRCCS, Via del Fosso di Fiorano 64, 00143 Rome, Italy.""}, {'lastname': 'Mancini', 'firstname': 'Patrizia', 'initials': 'P', 'affiliation': 'Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy.'}, {'lastname': 'Businaro', 'firstname': 'Rita', 'initials': 'R', 'affiliation': 'Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica 79, 04100 Latina, Italy.'}]",,,,,"10.3390/ijms22147711
10.1056/NEJM199911253412207
10.1111/j.1471-4159.2006.04426.x
10.1038/nm0896-850
10.1016/0165-6147(94)90057-4
10.1097/00002093-199408030-00001
10.3389/fncel.2020.563446
10.1097/00002093-200000001-00008
10.1038/nn1472
10.1196/annals.1332.006
10.1002/glia.10153
10.1155/S1110724302203010
10.1016/S1474-4422(19)30032-8
10.1038/s41582-019-0284-z
10.1055/s-0037-1614296
10.3390/molecules191117078
10.1016/j.jns.2005.03.002
10.1523/JNEUROSCI.23-35-11136.2003
10.1523/JNEUROSCI.4540-04.2005
10.1016/j.phrs.2018.02.009
10.3233/JAD-130137
10.1186/1742-2094-9-8
10.1038/sj.bjp.0705667
10.1016/j.neurobiolaging.2011.03.012
10.1093/ijnp/pyy033
10.1016/j.celrep.2012.05.001
10.1016/j.neurobiolaging.2015.08.003
10.3390/cells8050491
10.1016/j.pharmthera.2013.04.013
10.1111/j.1348-0421.2000.tb02556.x
10.1007/s11064-008-9776-8
10.1016/j.neuron.2009.08.039
10.1016/j.ejphar.2020.173090
10.1002/glia.23041
10.1038/nri1733
10.1016/j.tcb.2006.08.006
10.3389/fncel.2014.00314
10.1111/bph.13139
10.1016/j.neuroscience.2020.09.024
10.3390/ijms21197354
10.1038/nature01148
10.1038/nri978
10.1007/978-3-319-20825-1_6
10.2174/1570159X16666180702144644
10.3390/ijms21030747
10.1002/glia.20983
10.1038/nn.3053
10.1016/j.febslet.2010.12.032
10.4061/2011/925050
10.3390/ijms22094850
10.1016/j.eplepsyres.2017.09.017
10.1111/j.1527-3458.2006.00021.x
10.1186/1742-2094-2-29
10.1038/s41598-017-00342-1
10.1186/1744-8069-5-25
10.1111/j.1476-5381.2012.01889.x
10.1111/j.1476-5381.2012.02208.x
10.1016/j.neuropharm.2006.11.009
10.1126/science.1202529
10.1523/JNEUROSCI.1136-17.2017
10.1007/s00018-021-03810-0
10.20517/2347-8659.2020.02
10.1016/j.bbi.2015.08.023
10.1186/s12974-019-1694-y
10.1007/s00429-015-1067-y
10.1002/glia.23782
10.1016/j.tins.2006.07.001
10.1016/S0092-8674(04)00003-0
10.1016/j.cellsig.2013.05.023
10.1128/MMBR.63.1.54-105.1999
10.1016/j.isci.2018.01.004
10.1186/s13195-017-0320-4
10.1093/brain/awm260
10.1093/cercor/bhw309
10.1016/j.jsps.2017.05.002
10.1242/jcs.03323
10.1074/jbc.M510871200
10.1016/S1567-5769(01)00147-3
10.1016/j.bbi.2015.06.002
10.1186/s13020-018-0173-1
10.3389/fneur.2020.00087
10.1189/jlb.2AB0116-009RR
10.1007/s12031-013-0063-z
10.1016/j.neuron.2014.12.068
10.3233/JAD-142832
10.1016/j.neuropharm.2014.06.006
10.1016/j.bcp.2018.08.005
10.1016/j.febslet.2007.05.037
10.1007/s00210-017-1417-9
10.1111/j.1399-3011.1983.tb03085.x
10.1006/meth.2001.1262",<Element 'PubmedArticle' at 0x7f05de214f90>
153,"34244423
16488940
24974815
21453963
30305707
10667796
12068310
10067981
28017835
26780312
23431148
15470139
22056987
29476565
10844031
12657687
16699509
19875691
12424433
27911838
25489106
27129619
27494841
17724215
11053298
6812220
18642101
22544514
21470377
22333212
24755186
11358116
10429879
18084344
22649251
15574731
31070727
28123062
28993995
25693054
27930339
18708126",Agonist of growth hormone-releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury.,"Optic neuropathies are leading causes of irreversible visual impairment and blindness, currently affecting more than 100 million people worldwide. Glaucoma is a group of optic neuropathies attributed to progressive degeneration of retinal ganglion cells (RGCs). We have previously demonstrated an increase in survival of RGCs by the activation of macrophages, whereas the inhibition of macrophages was involved in the alleviation on endotoxin-induced inflammation by antagonist of growth hormone-releasing hormone (GHRH). Herein, we hypothesized that GHRH receptor (GHRH-R) signaling could be involved in the survival of RGCs mediated by inflammation. We found the expression of GHRH-R in RGCs of adult rat retina. After optic nerve crush, subcutaneous application of GHRH agonist MR-409 or antagonist MIA-602 promoted the survival of RGCs. Both the GHRH agonist and antagonist increased the phosphorylation of Akt in the retina, but only agonist MR-409 promoted microglia activation in the retina. The antagonist MIA-602 reduced significantly the expression of inflammation-related genes ","['GHRH', 'macrophage activation', 'neuroprotection', 'optic nerve injury', 'retinal ganglion cells']",Proceedings of the National Academy of Sciences of the United States of America,2021-07-11,"[{'lastname': 'Cen', 'firstname': 'Ling-Ping', 'initials': 'LP', 'affiliation': 'Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou University Medical College, 515041 Shantou, China.'}, {'lastname': 'Ng', 'firstname': 'Tsz Kin', 'initials': 'TK', 'affiliation': 'Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou University Medical College, 515041 Shantou, China.\nShantou University Medical College, 515041 Shantou, China.\nDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong.'}, {'lastname': 'Liang', 'firstname': 'Jia-Jian', 'initials': 'JJ', 'affiliation': 'Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou University Medical College, 515041 Shantou, China.'}, {'lastname': 'Xu', 'firstname': 'Ciyan', 'initials': 'C', 'affiliation': 'Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou University Medical College, 515041 Shantou, China.'}, {'lastname': 'Zhuang', 'firstname': 'Xi', 'initials': 'X', 'affiliation': 'Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou University Medical College, 515041 Shantou, China.'}, {'lastname': 'Liu', 'firstname': 'Yu-Fen', 'initials': 'YF', 'affiliation': 'Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou University Medical College, 515041 Shantou, China.\nShantou University Medical College, 515041 Shantou, China.'}, {'lastname': 'Chen', 'firstname': 'Shao-Lang', 'initials': 'SL', 'affiliation': 'Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou University Medical College, 515041 Shantou, China.'}, {'lastname': 'Xu', 'firstname': 'Yanxuan', 'initials': 'Y', 'affiliation': 'Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou University Medical College, 515041 Shantou, China.'}, {'lastname': 'Yang', 'firstname': 'Qichen', 'initials': 'Q', 'affiliation': 'Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong.'}, {'lastname': 'Yuan', 'firstname': 'Xiang-Ling', 'initials': 'XL', 'affiliation': 'Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou University Medical College, 515041 Shantou, China.\nShantou University Medical College, 515041 Shantou, China.'}, {'lastname': 'Qin', 'firstname': 'Yong Jie', 'initials': 'YJ', 'affiliation': 'Department of Ophthalmology, Guangdong Eye Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, 510080 Guangzhou, China.'}, {'lastname': 'Chan', 'firstname': 'Sun On', 'initials': 'SO', 'affiliation': 'School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong.'}, {'lastname': 'Chen', 'firstname': 'Haoyu', 'initials': 'H', 'affiliation': 'Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou University Medical College, 515041 Shantou, China.'}, {'lastname': 'Zhang', 'firstname': 'Mingzhi', 'initials': 'M', 'affiliation': 'Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou University Medical College, 515041 Shantou, China.'}, {'lastname': 'Schally', 'firstname': 'Andrew V', 'initials': 'AV', 'affiliation': 'Department of Pathology, Miller School of Medicine, University of Miami, Miami, FL 33136; andrew.schally@va.gov cppang@cuhk.edu.hk.\nDivision of Medical Oncology, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33136.\nDivision of Endocrinology, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33136.\nSylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL 33136.\nCancer Institute, Veterans Affairs Medical Center, Miami, FL 33125.'}, {'lastname': 'Pang', 'firstname': 'Chi Pui', 'initials': 'CP', 'affiliation': 'Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou University Medical College, 515041 Shantou, China; andrew.schally@va.gov cppang@cuhk.edu.hk.\nDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong.'}]",,,,,10.1073/pnas.1920834118,<Element 'PubmedArticle' at 0x7f05de2497c0>
154,34216402,Morphological evidence indicates a role for microglia in shaping the PCOS-like brain.,"Although polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility worldwide, the aetiology of the disorder remains poorly defined. Animal-based evidence highlights the brain as a prime suspect in both the development and maintenance of PCOS. Prenatally androgenised (PNA) models of PCOS exhibit excessive GABAergic wiring associated with PCOS-like reproductive deficits in adulthood, with aberrant brain wiring detected as early as postnatal day (P) 25, prior to disease onset, in the PNA mouse. The mechanisms underlying this aberrant brain wiring remain unknown. Microglia, the immune cells of the brain, are regulators of neuronal wiring across development, mediating both the formation and removal of neuronal inputs. Here, we tested the hypothesis that microglia play a role in the excessive GABAergic wiring that leads to PCOS-like features in the PNA brain. Using specific immunolabelling, microglia number and morphology associated with activation states were analysed in PNA and vehicle-treated controls across developmental timepoints, including embryonic day 17.5, P0, P25 and P60 (n = 7-14 per group), and in two regions of the hypothalamus implicated in fertility regulation. At P0, fewer amoeboid microglia were observed in the rostral preoptic area (rPOA) of PNA mice. However, the greatest changes were observed at P25, with PNA mice exhibiting fewer total microglia, and specifically fewer ""sculpting"" microglia, in the rPOA. Based on these findings, we assessed microglia-mediated refinement of GABAergic synaptic terminals at two developmental stages of peak synaptic refinement: P7 and P15 (n = 7 per group). PNA mice showed a reduction in the uptake of GABAergic synaptic material at P15. These findings reveal time-specific changes in the microglia population and refinement of GABAergic inputs in a mouse model of PCOS driven by prenatal androgen excess and suggest a role for microglia in shaping the atypical brain wiring associated with the development of PCOS features.","['GABA', 'development', 'fertility', 'hypothalamus', 'mouse', 'polycystic ovary syndrome']",Journal of neuroendocrinology,2021-07-04,"[{'lastname': 'Sati', 'firstname': 'Aisha', 'initials': 'A', 'affiliation': 'Centre for Neuroendocrinology and Department of Physiology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.'}, {'lastname': 'Prescott', 'firstname': 'Melanie', 'initials': 'M', 'affiliation': 'Centre for Neuroendocrinology and Department of Physiology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.'}, {'lastname': 'Holland', 'firstname': 'Sarah', 'initials': 'S', 'affiliation': 'Centre for Neuroendocrinology and Department of Physiology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.'}, {'lastname': 'Jasoni', 'firstname': 'Christine L', 'initials': 'CL', 'affiliation': 'Centre for Neuroendocrinology and Department of Physiology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.'}, {'lastname': 'Desroziers', 'firstname': 'Elodie', 'initials': 'E', 'affiliation': 'Centre for Neuroendocrinology and Department of Physiology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.'}, {'lastname': 'Campbell', 'firstname': 'Rebecca E', 'initials': 'RE', 'affiliation': 'Centre for Neuroendocrinology and Department of Physiology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.'}]",,,,© 2021 British Society for Neuroendocrinology.,10.1111/jne.12999,<Element 'PubmedArticle' at 0x7f05db792a40>
155,"34196879
24374228
26242477
25012615
17898229
16499561
16879324
19893002
14536081
25404894
26937017
27659108
26711460
21960575
10825199
16721263
23929628
22007835
25157794
25040630
11953750
20955426
29766570
10814833
10390303
25808024
24281743
23195595
24875486
23008413
30452951
22207510
23613493
29570854
20472172
30139371
29411111
19187098
27177548
33245509
12728267
11717354
12606693
20398699
26542996
24755281
22656125
33321691
23311871
24350834
18639629
31062335
18000511
21220102
29908200
23050640
26493086
18568034
28855859
10082840
11742533
15502843
22277256
27000223
28156052
22632907
25815722
21871134
29408042
21474801
31270712
30098076
28469775
10066866
27914011",Modulation of α7nAchR by Melatonin Alleviates Ischemia and Reperfusion-Compromised Integrity of Blood-Brain Barrier Through Inhibiting HMGB1-Mediated Microglia Activation and CRTC1-Mediated Neuronal Loss.,"The only food and drug administration (FDA)-approved drug currently available for the treatment of acute ischemic stroke is tissue plasminogen activator (tPA), yet the therapeutic benefits of this drug are partially outweighed by the increased risk of hemorrhagic transformation (HT). Analysis of the NIH trial has shown that cigarette smoking protected tPA-treated patients from HT; however, the underlying mechanism is not clear. Nicotinic acetylcholine receptors (nAChR) has shown anti-inflammatory effect and modulation nAChR could be a strategy to reduce ischemia/reperfusion-induced blood-brain barrier (BBB) damage. Since melatonin could regulate the expression of α7nAchR and melatonin's neuroprotective effect against ischemic injury is mediated via α7nAChR modulation, here, we aim to test the hypothesis that melatonin reduces ischemia and reperfusion (I/R)-induced BBB damage through modulation of α7nACh receptor (α7nAChR). Mice were subjected to 1.5 h ischemia and 24 h reperfusion and at the onset of reperfusion, mice received intraperitoneal administration (i.p.) of either drug or saline. Mice were randomly assigned into five groups: Saline; α7nAChR agonist PNU282987; Melatonin; Melatonin+Methyllycaconitine (MLA, α7nAChR antagonist), and MLA group. BBB permeability was assessed by detecting the extravasation of Evan's blue and IgG. Our results showed that I/R significantly increased BBB permeability accompanied by occludin degradation, microglia activation, and high mobility group box 1 (HMGB1) release from the neuron. In addition, I/R significantly induced neuronal loss accompanied by the decrease of CREB-regulated transcriptional coactivator 1 (CRTC1) and p-CREB expression. Melatonin treatment significantly inhibited the above changes through modulating α7nAChR. Taken together, these results demonstrate that melatonin provides a protective effect on ischemia/reperfusion-induced BBB damage, at least in part, depending on the modulation of α7nAChR.","['Blood–brain barrier', 'HMGB1', 'Melatonin', 'Stroke', 'α7nAChR']",Cellular and molecular neurobiology,2021-07-02,"[{'lastname': 'Chen', 'firstname': 'Shuang', 'initials': 'S', 'affiliation': ""Department of Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, China.""}, {'lastname': 'Sun', 'firstname': 'Yanyun', 'initials': 'Y', 'affiliation': 'Institute of Neuroscience, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.'}, {'lastname': 'Li', 'firstname': 'Fei', 'initials': 'F', 'affiliation': 'Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, 442000, China.'}, {'lastname': 'Zhang', 'firstname': 'Xinyu', 'initials': 'X', 'affiliation': 'Institute of Neuroscience, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.'}, {'lastname': 'Hu', 'firstname': 'Xiaoyan', 'initials': 'X', 'affiliation': 'Department of Anatomy, Histology and Embrology, School of Basic Medical Sciences, Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, 100069, China.'}, {'lastname': 'Zhao', 'firstname': 'Xiaoyun', 'initials': 'X', 'affiliation': 'Department of Anatomy, Histology and Embrology, School of Basic Medical Sciences, Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, 100069, China.'}, {'lastname': 'Li', 'firstname': 'Yixuan', 'initials': 'Y', 'affiliation': 'Department of Anatomy, Histology and Embrology, School of Basic Medical Sciences, Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, 100069, China.'}, {'lastname': 'Li', 'firstname': 'Hui', 'initials': 'H', 'affiliation': 'Department of Anatomy, Histology and Embrology, School of Basic Medical Sciences, Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, 100069, China.'}, {'lastname': 'Zhang', 'firstname': 'Jianliang', 'initials': 'J', 'affiliation': 'Department of Neurobiology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100054, China.'}, {'lastname': 'Liu', 'firstname': 'Wenlan', 'initials': 'W', 'affiliation': ""The Central Laboratory, Shenzhen Second People's Hospital, Shenzhen University 1st Affiliated Hospital, Shenzhen University School of Medicine, Shenzhen, 518035, China.""}, {'lastname': 'Zheng', 'firstname': 'Guo-Qing', 'initials': 'GQ', 'affiliation': ""Department of Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, China. gq_zheng@sohu.com.""}, {'lastname': 'Jin', 'firstname': 'Xinchun', 'initials': 'X', 'affiliation': 'Institute of Neuroscience, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China. xinchunjin@gmail.com.\nDepartment of Anatomy, Histology and Embrology, School of Basic Medical Sciences, Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, 100069, China. xinchunjin@gmail.com.'}]",,,,"© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.","10.1007/s10571-021-01122-2
10.1016/j.nbd.2016.09.015
10.1007/s10571-020-00985-1
10.3390/cells9122650",<Element 'PubmedArticle' at 0x7f05db781ea0>
156,"34183019
29614878
30704681
27179961
28157094
31487775
26286145
26509334
30131755
28476157
21891870
32510331
6940133
6954532
31054361
18461449
25470401
20536472
27450729
30405628
27044335
17409235
27449092
22847556
25586141
26064215
33136892
28892027
30535688
31273711
21808223
30535682
30010645
30535683
25867960
29246456
25598354
29939190
29038483
22520439
26431692
18295562
23407936
31392674
28099414
31585084
30359599
28521126
30381423
17270176
29926672
30266970
19559767
19491240
11273004
30341179
31617375
20405578
23555730
23252647
31093687
28923083
17184520
31698022
24937047
17495247
31472195
23075524
26363149
26654366
26241337
11516773
28384498
29286104
31781286
19943905
30031930
27255539
23596391
32143008
17254567
21343177
29954581
30063850",Thymosin β4 reverses phenotypic polarization of glial cells and cognitive impairment via negative regulation of NF-κB signaling axis in APP/PS1 mice.,"Thymosin β4 (Tβ4) is the most abundant member of the β-thymosins and plays an important role in the control of actin polymerization in eukaryotic cells. While its effects in multiple organs and diseases are being widely investigated, the safety profile has been established in animals and humans, currently, little is known about its influence on Alzheimer's disease (AD) and the possible mechanisms. Thus, we aimed to evaluate the effects and mechanisms of Tβ4 on glial polarization and cognitive performance in APP/PS1 transgenic mice.
Behavior tests were conducted to assess the learning and memory, anxiety and depression in APP/PS1 mice. Thioflavin S staining, Nissl staining, immunohistochemistry/immunofluorescence, ELISA, qRT-PCR, and immunoblotting were performed to explore Aβ accumulation, phenotypic polarization of glial cells, neuronal loss and function, and TLR4/NF-κB axis in APP/PS1 mice.
We demonstrated that Tβ4 protein level elevated in all APP/PS1 mice. Over-expression of Tβ4 alone alleviated AD-like phenotypes of APP/PS1 mice, showed less brain Aβ accumulation and more Insulin-degrading enzyme (IDE), reversed phenotypic polarization of microglia and astrocyte to a healthy state, improved neuronal function and cognitive behavior performance, and accidentally displayed antidepressant-like effect. Besides, Tβ4 could downregulate both TLR4/MyD88/NF-κB p65 and p52-dependent inflammatory pathways in the APP/PS1 mice. While combination drug of TLR4 antagonist TAK242 or NF-κB p65 inhibitor PDTC exerted no further effects.
These results suggest that Tβ4 may exert its function by regulating both classical and non-canonical NF-κB signaling and is restoring its function as a potential therapeutic target against AD.","['Alzheimer’s disease', 'Cognition and emotion', 'NF-κB signaling pathway', 'Phenotypic polarization of glial cells and neuroinflammation', 'Thymosin β4']",Journal of neuroinflammation,2021-06-30,"[{'lastname': 'Wang', 'firstname': 'Meng', 'initials': 'M', 'affiliation': ""Department of Human Anatomy and Histology-Embryology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, 76 Yanta West Road, Xi'an, 710061, Shaanxi, China.\nInstitute of Neuroscience, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.""}, {'lastname': 'Feng', 'firstname': 'Li-Rong', 'initials': 'LR', 'affiliation': ""Department of Human Anatomy and Histology-Embryology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, 76 Yanta West Road, Xi'an, 710061, Shaanxi, China.\nInstitute of Neuroscience, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.""}, {'lastname': 'Li', 'firstname': 'Zi-Long', 'initials': 'ZL', 'affiliation': ""Department of Human Anatomy and Histology-Embryology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, 76 Yanta West Road, Xi'an, 710061, Shaanxi, China.\nInstitute of Neuroscience, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.""}, {'lastname': 'Ma', 'firstname': 'Kai-Ge', 'initials': 'KG', 'affiliation': ""Institute of Neuroscience, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.\nKey Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education of China, Xi'an Jiaotong University Health Science Center, 76 Yanta West Road, Xi'an, 710061, Shaanxi, China.\nInstitute of Neurobiology, Xi'an Jiaotong University Health Science Center, Xi'an, China.""}, {'lastname': 'Chang', 'firstname': 'Ke-Wei', 'initials': 'KW', 'affiliation': ""Department of Human Anatomy and Histology-Embryology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, 76 Yanta West Road, Xi'an, 710061, Shaanxi, China.\nInstitute of Neuroscience, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.\nKey Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education of China, Xi'an Jiaotong University Health Science Center, 76 Yanta West Road, Xi'an, 710061, Shaanxi, China.""}, {'lastname': 'Chen', 'firstname': 'Xin-Lin', 'initials': 'XL', 'affiliation': ""Institute of Neuroscience, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.\nKey Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education of China, Xi'an Jiaotong University Health Science Center, 76 Yanta West Road, Xi'an, 710061, Shaanxi, China.\nInstitute of Neurobiology, Xi'an Jiaotong University Health Science Center, Xi'an, China.""}, {'lastname': 'Yang', 'firstname': 'Peng-Bo', 'initials': 'PB', 'affiliation': ""Department of Human Anatomy and Histology-Embryology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, 76 Yanta West Road, Xi'an, 710061, Shaanxi, China.\nInstitute of Neuroscience, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.\nKey Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education of China, Xi'an Jiaotong University Health Science Center, 76 Yanta West Road, Xi'an, 710061, Shaanxi, China.""}, {'lastname': 'Ji', 'firstname': 'Sheng-Feng', 'initials': 'SF', 'affiliation': ""Department of Human Anatomy and Histology-Embryology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, 76 Yanta West Road, Xi'an, 710061, Shaanxi, China.\nInstitute of Neuroscience, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.\nKey Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education of China, Xi'an Jiaotong University Health Science Center, 76 Yanta West Road, Xi'an, 710061, Shaanxi, China.""}, {'lastname': 'Ma', 'firstname': 'Yan-Bing', 'initials': 'YB', 'affiliation': ""Department of Human Anatomy and Histology-Embryology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, 76 Yanta West Road, Xi'an, 710061, Shaanxi, China.\nInstitute of Neuroscience, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.\nKey Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education of China, Xi'an Jiaotong University Health Science Center, 76 Yanta West Road, Xi'an, 710061, Shaanxi, China.""}, {'lastname': 'Han', 'firstname': 'Hua', 'initials': 'H', 'affiliation': ""Department of Human Anatomy and Histology-Embryology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, 76 Yanta West Road, Xi'an, 710061, Shaanxi, China.\nInstitute of Neuroscience, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.\nKey Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education of China, Xi'an Jiaotong University Health Science Center, 76 Yanta West Road, Xi'an, 710061, Shaanxi, China.""}, {'lastname': 'Ruganzua', 'firstname': 'John Bosco', 'initials': 'JB', 'affiliation': ""Department of Human Anatomy and Histology-Embryology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, 76 Yanta West Road, Xi'an, 710061, Shaanxi, China.\nInstitute of Neuroscience, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.""}, {'lastname': 'Yang', 'firstname': 'Wei-Na', 'initials': 'WN', 'affiliation': ""Department of Human Anatomy and Histology-Embryology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, 76 Yanta West Road, Xi'an, 710061, Shaanxi, China.\nInstitute of Neuroscience, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.\nKey Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education of China, Xi'an Jiaotong University Health Science Center, 76 Yanta West Road, Xi'an, 710061, Shaanxi, China.""}, {'lastname': 'Qian', 'firstname': 'Yi-Hua', 'initials': 'YH', 'affiliation': ""Department of Human Anatomy and Histology-Embryology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, 76 Yanta West Road, Xi'an, 710061, Shaanxi, China. qianyh38@mail.xjtu.edu.cn.\nInstitute of Neuroscience, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China. qianyh38@mail.xjtu.edu.cn.\nKey Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education of China, Xi'an Jiaotong University Health Science Center, 76 Yanta West Road, Xi'an, 710061, Shaanxi, China. qianyh38@mail.xjtu.edu.cn.""}]",,,"We demonstrated that Tβ4 protein level elevated in all APP/PS1 mice. Over-expression of Tβ4 alone alleviated AD-like phenotypes of APP/PS1 mice, showed less brain Aβ accumulation and more Insulin-degrading enzyme (IDE), reversed phenotypic polarization of microglia and astrocyte to a healthy state, improved neuronal function and cognitive behavior performance, and accidentally displayed antidepressant-like effect. Besides, Tβ4 could downregulate both TLR4/MyD88/NF-κB p65 and p52-dependent inflammatory pathways in the APP/PS1 mice. While combination drug of TLR4 antagonist TAK242 or NF-κB p65 inhibitor PDTC exerted no further effects.",,"10.1186/s12974-021-02166-3
10.1177/1039856218762308
10.1016/j.mcna.2018.10.009
10.1016/j.jalz.2016.02.010
10.3233/JAD-160869
10.1186/s13195-015-0139-9
10.1111/jnc.13411
10.3389/fneur.2018.00625
10.1186/s12974-017-0871-0
10.3233/JAD-2011-110725
10.1073/pnas.78.2.1162
10.1073/pnas.79.7.2172
10.1016/j.gene.2019.04.083
10.1007/s11064-008-9712-y
10.2174/1871527313666141130224206
10.1111/j.1749-6632.2010.05474.x
10.1016/bs.vh.2016.04.006
10.3389/fimmu.2018.02434
10.1016/j.bbi.2016.03.026
10.1523/JNEUROSCI.0059-07.2007
10.18632/oncotarget.10699
10.1038/jcbfm.2014.240
10.1097/SCS.0000000000006777
10.1007/978-1-4939-8994-2_10
10.1007/978-1-4939-9554-7_22
10.1007/978-1-4939-8994-2_4
10.1007/978-1-4939-8994-2_5
10.1016/j.bbi.2017.12.007
10.1007/s12035-014-9070-5
10.1038/s41598-017-13581-z
10.1186/1742-2094-9-71
10.1016/j.bbi.2015.09.017
10.1016/j.bone.2007.12.216
10.1523/JNEUROSCI.1268-12.2013
10.1007/978-1-4939-9658-2_2
10.1038/nature21029
10.1016/j.cell.2019.09.011
10.1016/j.neuron.2018.10.018
10.1016/j.neuron.2017.04.009
10.1523/JNEUROSCI.2119-18.2018
10.1016/j.expneurol.2006.12.002
10.12047/j.cjap.5541.2018.027
10.1038/s41583-018-0067-3
10.1016/j.brainresbull.2009.06.009
10.1113/jphysiol.2009.172866
10.1093/jnen/60.2.161
10.1523/JNEUROSCI.1409-18.2018
10.1089/ars.2019.7754
10.1111/j.1471-4159.2010.06615.x
10.1371/journal.pone.0059626
10.1111/nan.12011
10.1007/s00018-019-03132-2
10.1186/s13024-017-0210-z
10.1186/1471-2202-7-81
10.1016/j.neuroscience.2019.09.032
10.1016/j.neuropharm.2014.06.004
10.1196/annals.1415.020
10.1016/j.bbr.2019.112182
10.1098/rsbl.2012.0784
10.1016/j.neuroscience.2015.09.017
10.1016/j.cub.2015.10.049
10.1016/j.neuroscience.2015.07.084
10.1016/S0165-0173(01)00067-4
10.1016/j.nlm.2017.03.019
10.3892/mmr.2017.8339
10.1155/2019/9475384
10.1111/j.1365-2958.2009.06980.x
10.1016/j.neurobiolaging.2018.06.020
10.1016/j.bbi.2016.05.016
10.3389/fncel.2013.00034
10.1016/j.intimp.2020.106354
10.1016/j.exer.2006.12.004
10.1096/fj.10-167940
10.1016/j.cellimm.2018.06.009
10.1080/14712598.2018.1486817",<Element 'PubmedArticle' at 0x7f05da21eae0>
157,34159699,"Chronic stress and Alzheimer's disease: the interplay between the hypothalamic-pituitary-adrenal axis, genetics and microglia.","Chronic psychosocial stress is increasingly being recognised as a risk factor for sporadic Alzheimer's disease (AD). The hypothalamic-pituitary-adrenal axis (HPA axis) is the major stress response pathway in the body and tightly regulates the production of cortisol, a glucocorticoid hormone. Dysregulation of the HPA axis and increased levels of cortisol are commonly found in AD patients and make a major contribution to the disease process. The underlying mechanisms remain poorly understood. In addition, within the general population there are interindividual differences in sensitivities to glucocorticoid and stress responses, which are thought to be due to a combination of genetic and environmental factors. These differences could ultimately impact an individuals' risk of AD. The purpose of this review is first to summarise the literature describing environmental and genetic factors that can impact an individual's HPA axis reactivity and function and ultimately AD risk. Secondly, we propose a mechanism by which genetic factors that influence HPA axis reactivity may also impact inflammation, a key driver of neurodegeneration. We hypothesize that these factors can mediate glucocorticoid priming of the immune cells of the brain, microglia, to become pro-inflammatory and promote a neurotoxic environment resulting in neurodegeneration. Understanding the underlying molecular mechanisms and identifying these genetic factors has implications for evaluating stress-related risk/progression to neurodegeneration, informing the success of interventions based on stress management and potential risks associated with the common use of glucocorticoids.","[""Alzheimer's disease"", 'HPA axis reactivity', 'chronic stress', 'cortisol', 'glucocorticoids', 'microglia', 'neuroinflammation']",Biological reviews of the Cambridge Philosophical Society,2021-06-24,"[{'lastname': 'Milligan Armstrong', 'firstname': 'Ayeisha', 'initials': 'A', 'affiliation': 'Curtin Health Innovation Research Institute, Curtin University, Kent St, Bentley, WA, 6102, Australia.\nCurtin Medical School, Curtin University, Kent St, Bentley, WA, 6102, Australia.'}, {'lastname': 'Porter', 'firstname': 'Tenielle', 'initials': 'T', 'affiliation': 'Curtin Medical School, Curtin University, Kent St, Bentley, WA, 6102, Australia.\nCollaborative Genomics and Translation Group, School of Medical and Health Sciences, Edith Cowan University, 270 Joondalup Drive, Joondalup, WA, 6027, Australia.'}, {'lastname': 'Quek', 'firstname': 'Hazel', 'initials': 'H', 'affiliation': 'QIMR Berghofer Medical Institute, 300 Herston Rd, Herston, QLD, Australia.'}, {'lastname': 'White', 'firstname': 'Anthony', 'initials': 'A', 'affiliation': 'QIMR Berghofer Medical Institute, 300 Herston Rd, Herston, QLD, Australia.'}, {'lastname': 'Haynes', 'firstname': 'John', 'initials': 'J', 'affiliation': 'Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC, 3052, Australia.'}, {'lastname': 'Jackaman', 'firstname': 'Connie', 'initials': 'C', 'affiliation': 'Curtin Health Innovation Research Institute, Curtin University, Kent St, Bentley, WA, 6102, Australia.\nCurtin Medical School, Curtin University, Kent St, Bentley, WA, 6102, Australia.'}, {'lastname': 'Villemagne', 'firstname': 'Victor', 'initials': 'V', 'affiliation': 'School of Medical and Health Sciences, Edith Cowan University, 270 Joondalup Drive, Joondalup, WA, 6027, Australia.\nThe Florey Institute of Neuroscience and Mental Health, The University of Melbourne, 30 Royal Parade, Parkville, VIC, 3052, Australia.'}, {'lastname': 'Munyard', 'firstname': 'Kylie', 'initials': 'K', 'affiliation': 'Curtin Health Innovation Research Institute, Curtin University, Kent St, Bentley, WA, 6102, Australia.\nCurtin Medical School, Curtin University, Kent St, Bentley, WA, 6102, Australia.'}, {'lastname': 'Laws', 'firstname': 'Simon M', 'initials': 'SM', 'affiliation': 'Curtin Medical School, Curtin University, Kent St, Bentley, WA, 6102, Australia.\nCollaborative Genomics and Translation Group, School of Medical and Health Sciences, Edith Cowan University, 270 Joondalup Drive, Joondalup, WA, 6027, Australia.'}, {'lastname': 'Verdile', 'firstname': 'Giuseppe', 'initials': 'G', 'affiliation': 'Curtin Health Innovation Research Institute, Curtin University, Kent St, Bentley, WA, 6102, Australia.\nCurtin Medical School, Curtin University, Kent St, Bentley, WA, 6102, Australia.\nSchool of Medical and Health Sciences, Edith Cowan University, 270 Joondalup Drive, Joondalup, WA, 6027, Australia.'}, {'lastname': 'Groth', 'firstname': 'David', 'initials': 'D', 'affiliation': 'Curtin Health Innovation Research Institute, Curtin University, Kent St, Bentley, WA, 6102, Australia.\nCurtin Medical School, Curtin University, Kent St, Bentley, WA, 6102, Australia.'}]",,,,© 2021 Cambridge Philosophical Society.,10.1111/brv.12750,<Element 'PubmedArticle' at 0x7f05de73bc70>
158,"34111331
15102403
19837031
19685121
10420016
23524965
18615568
14607246
19036970
30578561
15233755
24024042
18480275
22564552
19323820
27934764
20116424
21115385
22236434
21166540
21511185
25619654
22361233
29928964
15813997
17174526
18033311
21788320
26802537
24719110
29084866
28202578
32184015
32595037
32113469
30981281
14507968
7507519
32440016
28327597
1333581
20835246
20952482
28844644
19903874
27793571
29847798
25645145
25581910
7965003
2542867
21068766
22275517
20951771
19919721
24076545
23300227
26546042
30677547
25589741
32004977
31324059
29265673
29149605
22020140
16098668
29962856
25691360
31747126
26576724
31793210
20524966
29302779
22167804
19295150
31179430
29845881
28544775
30955244
27241733
30778044
32565774",Spinal microglial β-endorphin signaling mediates IL-10 and exenatide-induced inhibition of synaptic plasticity in neuropathic pain.,"This study aimed to investigate the regulation of pain hypersensitivity induced by the spinal synaptic transmission mechanisms underlying interleukin (IL)-10 and glucagon-like peptide 1 receptor (GLP-1R) agonist exenatide-induced pain anti-hypersensitivity in neuropathic rats through spinal nerve ligations.
Neuropathic pain model was established by spinal nerve ligation of L5/L6 and verified by electrophysiological recording and immunofluorescence staining. Microglial expression of β-endorphin through autocrine IL-10- and exenatide-induced inhibition of glutamatergic transmission were performed by behavioral tests coupled with whole-cell recording of miniature excitatory postsynaptic currents (mEPSCs) and miniature inhibitory postsynaptic currents (mIPSCs) through application of endogenous and exogenous IL-10 and β-endorphin.
Intrathecal injections of IL-10, exenatide, and the μ-opioid receptor (MOR) agonists β-endorphin and DAMGO inhibited thermal hyperalgesia and mechanical allodynia in neuropathic rats. Whole-cell recordings of bath application of exenatide, IL-10, and β-endorphin showed similarly suppressed enhanced frequency and amplitude of the mEPSCs in the spinal dorsal horn neurons of laminae II, but did not reduce the frequency and amplitude of mIPSCs in neuropathic rats. The inhibitory effects of IL-10 and exenatide on pain hypersensitive behaviors and spinal synaptic plasticity were totally blocked by pretreatment of IL-10 antibody, β-endorphin antiserum, and MOR antagonist CTAP. In addition, the microglial metabolic inhibitor minocycline blocked the inhibitory effects of IL-10 and exenatide but not β-endorphin on spinal synaptic plasticity.
This suggests that spinal microglial expression of β-endorphin mediates IL-10- and exenatide-induced inhibition of glutamatergic transmission and pain hypersensitivity via presynaptic and postsynaptic MORs in spinal dorsal horn.","['IL-10', 'Neuropathic pain', 'exenatide', 'mEPSCs', 'mIPSCs', 'microglia', 'β-endorphin']",CNS neuroscience & therapeutics,2021-06-11,"[{'lastname': 'Ma', 'firstname': 'Le', 'initials': 'L', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, Shanghai, China.\nShanghai Key Laboratory of Psychotic Disorders, Shanghai Jiao Tong University School of Medicine, Shanghai Mental Health Center, Shanghai, China.""}, {'lastname': 'Peng', 'firstname': 'Shiyu', 'initials': 'S', 'affiliation': 'Shanghai Key Laboratory of Psychotic Disorders, Shanghai Jiao Tong University School of Medicine, Shanghai Mental Health Center, Shanghai, China.\nSchool of Life Sciences, Westlake Institute for Advanced Study, Westlake University, Hangzhou, China.'}, {'lastname': 'Wei', 'firstname': 'Jinbao', 'initials': 'J', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, Shanghai, China.""}, {'lastname': 'Zhao', 'firstname': 'Mengjing', 'initials': 'M', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, Shanghai, China.""}, {'lastname': 'Ahmad', 'firstname': 'Khalil Ali', 'initials': 'KA', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, Shanghai, China.""}, {'lastname': 'Chen', 'firstname': 'Jinghong', 'initials': 'J', 'affiliation': 'Shanghai Key Laboratory of Psychotic Disorders, Shanghai Jiao Tong University School of Medicine, Shanghai Mental Health Center, Shanghai, China.'}, {'lastname': 'Wang', 'firstname': 'Yong-Xiang', 'initials': 'YX', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, Shanghai, China.""}]",,This suggests that spinal microglial expression of β-endorphin mediates IL-10- and exenatide-induced inhibition of glutamatergic transmission and pain hypersensitivity via presynaptic and postsynaptic MORs in spinal dorsal horn.,"Intrathecal injections of IL-10, exenatide, and the μ-opioid receptor (MOR) agonists β-endorphin and DAMGO inhibited thermal hyperalgesia and mechanical allodynia in neuropathic rats. Whole-cell recordings of bath application of exenatide, IL-10, and β-endorphin showed similarly suppressed enhanced frequency and amplitude of the mEPSCs in the spinal dorsal horn neurons of laminae II, but did not reduce the frequency and amplitude of mIPSCs in neuropathic rats. The inhibitory effects of IL-10 and exenatide on pain hypersensitive behaviors and spinal synaptic plasticity were totally blocked by pretreatment of IL-10 antibody, β-endorphin antiserum, and MOR antagonist CTAP. In addition, the microglial metabolic inhibitor minocycline blocked the inhibitory effects of IL-10 and exenatide but not β-endorphin on spinal synaptic plasticity.",© 2021 The Authors. CNS Neuroscience & Therapeutics Published by John Wiley & Sons Ltd.,"10.1111/cns.13694
10.1016/s1090-3801(97)90107-5
10.1016/j.cell.2009.09.028
10.1007/s00540-009-0767-y
10.1111/j.1469-7793.1999.0803p.x
10.1172/JCI64551
10.1002/glia.20699
10.1016/j.lfs.2003.09.006
10.1523/JNEUROSCI.3512-08.2008
10.1002/glia.23557
10.1111/j.1460-9568.2004.03514.x
10.1155/2013/753656
10.1523/JNEUROSCI.3338-07.2008
10.1016/j.neuroscience.2012.04.065
10.1186/1744-8069-5-15
10.1126/science.aah5715
10.1016/j.bbi.2010.01.007
10.1146/annurev-immunol-031210-101312
10.1016/j.immuni.2011.03.018
10.1016/j.neuron.2014.12.068
10.1016/j.neuropharm.2012.02.002
10.1016/j.bbi.2018.06.015
10.1186/1744-8069-1-9
10.1523/JNEUROSCI.4703-13.2014
10.1523/JNEUROSCI.1799-17.2017
10.1124/mol.116.107102
10.1016/j.bbrc.2020.03.023
10.1016/j.bbrc.2020.05.080
10.1186/s12974-019-1616-z
10.1186/s12974-019-1457-9
10.1152/jn.1993.70.5.1841
10.1038/s41583-020-0310-6
10.1038/srep45056
10.1016/0304-3959(92)90041-9
10.1038/nmeth.1500
10.1124/jpet.110.172353
10.1016/j.cub.2017.07.035
10.1073/pnas.0908840106
10.1016/j.it.2016.10.001
10.1016/j.celrep.2018.04.107
10.1186/1744-8069-11-3
10.1097/ALN.0000000000000593
10.1152/jn.1994.72.1.169
10.1016/0304-3959(89)90160-7
10.1038/nrn2947
10.1124/mol.111.076083
10.1016/j.neuroscience.2010.10.028
10.1186/1744-8069-5-65
10.1124/pr.112.007138
10.1124/jpet.112.201616
10.1016/j.phrs.2015.10.008
10.1016/j.eurpsy.2018.10.001
10.1016/j.biopha.2020.109898
10.3390/ijms20133375
10.1002/biof.1406
10.1016/j.cell.2017.10.035
10.1097/ALN.0b013e318238bba6
10.1016/j.pain.2005.05.035
10.4196/kjpp.2018.22.4.419
10.1002/ejp.656
10.1111/cns.13267
10.1016/j.bbi.2015.11.007
10.1111/cns.13257
10.1111/j.1471-4159.2010.06837.x
10.1007/s00401-017-1803-x
10.1073/pnas.1111098109
10.1523/JNEUROSCI.5804-08.2009
10.1136/gpsych-2018-100009
10.1177/0271678X18772998
10.1111/cns.12705
10.1111/cns.13128
10.1038/ncomms11697
10.1038/s41419-019-1425-4
10.1155/2020/1484087",<Element 'PubmedArticle' at 0x7f05de862630>
159,"34103390
20522652
26114578
30878483
27021778
25260700
31870439
30092616
16862116
19795409
28453791
28738171
23136129
28856541
30291623
30690031
27693506
17179653
28226226
16862115
28916533
29775591
32531244
31399126
23104886
20463744
29346778
16950801
30180904
24619111
26124111
32973454
30995509
17965659
29196460
24962261
30258234
28828399
28845019
21047645
21092856
33028409
30340518
31813797
22890097
27425031
28435163
27170638
17764761
28930663
24485249
28743268
29859318
27114033
21841757
23874106
23041626
30559339
30760929
31042697
30862089
25261995
19046946
30149180
29426702
28656016
19946692
27252382
28159556
31039256
22277331
17021169
29744576
19557827
23609919
22062772
21107132
21224065
23396349
33127097
28330615
19910308
11746512
33012625
24680777
18184915
22608501
27421577
29378960
32610143
27097852
19721334
11825061
9530922
28070672
25022663
18359860
29036611
31600775
30586924
28837568
19016491
29028540
28404863
24532802
26820675
11466313
20026663
29155950
28493053
28835281
31291241
26370502
28541286
31932797",A multifaceted role of progranulin in regulating amyloid-beta dynamics and responses.,"Haploinsufficiency of progranulin (PGRN) is a leading cause of frontotemporal lobar degeneration (FTLD). PGRN polymorphisms are associated with Alzheimer's disease. PGRN is highly expressed in the microglia near Aβ plaques and influences plaque dynamics and microglial activation. However, the detailed mechanisms remain elusive. Here we report that PGRN deficiency reduces human APP and Aβ levels in the young male but not female mice. PGRN-deficient microglia exhibit increased expression of markers associated with microglial activation, including CD68, galectin-3, TREM2, and GPNMB, specifically near Aβ plaques. In addition, PGRN loss leads to up-regulation of lysosome proteins and an increase in the nuclear localization of TFE3, a transcription factor involved in lysosome biogenesis. Cultured PGRN-deficient microglia show enhanced nuclear translocation of TFE3 and inflammation in response to Aβ fibril treatment. Taken together, our data revealed a sex- and age-dependent effect of PGRN on APP metabolism and a role of PGRN in regulating lysosomal activities and inflammation in plaque-associated microglia.",[],Life science alliance,2021-06-10,"[{'lastname': 'Du', 'firstname': 'Huan', 'initials': 'H', 'affiliation': 'Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA.'}, {'lastname': 'Wong', 'firstname': 'Man Ying', 'initials': 'MY', 'affiliation': 'Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.'}, {'lastname': 'Zhang', 'firstname': 'Tingting', 'initials': 'T', 'affiliation': 'Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA.'}, {'lastname': 'Santos', 'firstname': 'Mariela Nunez', 'initials': 'MN', 'affiliation': 'Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA.'}, {'lastname': 'Hsu', 'firstname': 'Charlene', 'initials': 'C', 'affiliation': 'Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA.'}, {'lastname': 'Zhang', 'firstname': 'Junke', 'initials': 'J', 'affiliation': 'Department of Computational Biology, Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, NY, USA.'}, {'lastname': 'Yu', 'firstname': 'Haiyuan', 'initials': 'H', 'affiliation': 'Department of Computational Biology, Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, NY, USA.'}, {'lastname': 'Luo', 'firstname': 'Wenjie', 'initials': 'W', 'affiliation': 'Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.'}, {'lastname': 'Hu', 'firstname': 'Fenghua', 'initials': 'F', 'affiliation': 'Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA fh87@cornell.edu.'}]",,,,© 2021 Du et al.,"10.26508/lsa.202000874
10.2353/ajpath.2010.090915
10.1080/15548627.2015.1063871
10.1016/j.jmb.2019.03.006
10.1016/j.neurobiolaging.2016.02.019
10.1093/bioinformatics/btu638
10.1186/s40478-019-0872-6
10.1111/jnc.14564
10.1038/nature05016
10.1002/bies.200900086
10.1093/hmg/ddx162
10.1080/15548627.2017.1313943
10.1093/hmg/dds475
10.1007/s12035-017-0707-z
10.1002/cne.24551
10.1016/j.jmb.2019.01.027
10.1016/j.devcel.2016.08.003
10.1262/jrd.18108
10.1146/annurev-immunol-051116-052358
10.1038/nature05017
10.1212/WNL.0000000000004494
10.1016/j.cell.2018.05.003
10.1016/j.cell.2020.05.003
10.1186/s13195-019-0524-x
10.1093/bioinformatics/bts635
10.1038/gene.2010.18
10.1016/j.celrep.2017.12.066
10.1093/hmg/ddl241
10.1186/s13024-018-0281-5
10.1007/s00401-014-1262-6
10.1073/pnas.1510329112
10.3389/fncel.2020.00260
10.1016/j.immuni.2019.03.016
10.1038/nn1997
10.1083/jcb.201709069
10.1038/nri3705
10.1038/s41593-018-0242-x
10.1523/ENEURO.0100-17.2017
10.1538/expanim.17-0060
10.1016/j.jns.2010.10.009
10.1016/j.neuron.2010.09.034
10.1186/s40478-020-01037-x
10.1186/s40478-018-0612-3
10.1016/j.devcel.2019.10.025
10.3233/JAD-2012-120946
10.1016/j.bbadis.2016.07.007
10.1038/nrn.2017.36
10.1152/ajpcell.00298.2015
10.1016/j.bbr.2007.07.020
10.1016/j.immuni.2017.08.008
10.1186/gb-2014-15-2-r29
10.1186/s13024-017-0196-6
10.1016/j.nbd.2018.05.015
10.1016/j.cell.2016.04.001
10.3791/2831
10.2147/OTT.S44906
10.1172/JCI63113
10.1038/s41467-018-07741-6
10.1038/s41586-019-0924-x
10.1038/s41586-019-1195-2
10.3390/cells8030230
10.1038/nm.3672
10.1016/j.brainres.2008.10.021
10.1016/j.nbd.2018.08.013
10.1016/j.immuni.2018.01.011
10.1007/s00401-009-0616-y
10.1242/jcs.146365
10.1016/j.bbrc.2017.01.176
10.1093/brain/awz099
10.1186/alzrt102
10.1523/JNEUROSCI.1202-06.2006
10.1007/s00401-018-1861-8
10.1002/path.2580
10.1001/2013.jamaneurol.393
10.1016/j.nbd.2011.10.016
10.1097/NEN.0b013e3181fc9aea
10.1016/j.ajpath.2010.11.002
10.3233/JAD-121606
10.1016/j.tins.2020.10.002
10.1016/j.cels.2017.02.009
10.1093/bioinformatics/btp616
10.1002/jcb.1259
10.1016/j.tibs.2020.09.004
10.1016/j.gene.2014.03.041
10.1212/01.wnl.0000289191.54852.75
10.1016/j.ajhg.2012.04.021
10.1016/j.arr.2016.07.002
10.1073/pnas.1719808115
10.1016/j.celrep.2020.107843
10.1038/ncomms11295
10.1262/jrd.20249
10.1006/mgme.2001.3274
10.1016/s0304-3940(98)00008-1
10.1007/s00401-017-1668-z
10.1186/s40478-014-0078-x
10.1110/ps.073295308
10.1093/hmg/ddx364
10.1093/hmg/ddz229
10.3390/ijms20010066
10.1371/journal.pone.0182896
10.1002/ajmg.b.30889
10.1016/j.conb.2017.09.005
10.1126/scitranslmed.aah5642
10.1074/jbc.M113.531202
10.1007/s12035-016-9698-4
10.1074/jbc.M104350200
10.1084/jem.20091568
10.1093/nar/gkx1098
10.1007/s00401-017-1719-5
10.1186/s13024-017-0205-9
10.1371/journal.pone.0212382
10.1083/jcb.201502029
10.1038/ncomms15277
10.1038/s41591-019-0695-9",<Element 'PubmedArticle' at 0x7f05dcdef9f0>
160,34038733,The gut microbiota regulates hypothalamic inflammation and leptin sensitivity in Western diet-fed mice via a GLP-1R-dependent mechanism.,"Mice lacking a microbiota are protected from diet-induced obesity. Previous studies have shown that feeding a Western diet causes hypothalamic inflammation, which in turn can lead to leptin resistance and weight gain. Here, we show that wild-type (WT) mice with depleted gut microbiota, i.e., germ-free (GF) and antibiotic-treated mice, have elevated levels of glucagon-like peptide-1 (GLP-1), are protected against diet-induced hypothalamic inflammation, and have enhanced leptin sensitivity when fed a Western diet. Using GLP-1 receptor (GLP-1R)-deficient mice and pharmacological inhibition of the GLP-1R in WT mice, we demonstrate that intact GLP-1R signaling is required for preventing hypothalamic inflammation and enhancing leptin sensitivity. Furthermore, we show that astrocytes express the GLP-1R, and deletion of the receptor in glial fibrillary acidic protein (GFAP)-expressing cells diminished the antibiotic-induced protection against diet-induced hypothalamic inflammation. Collectively, our results suggest that depletion of the gut microbiota attenuates diet-induced hypothalamic inflammation and enhances leptin sensitivity via GLP-1R-dependent mechanisms.","['GLP-1', 'astrocytes', 'diet-induced obesity', 'glucagon-like peptide-1', 'gut microbiota', 'hypothalamic inflammation', 'leptin sensitivity', 'microglia']",Cell reports,2021-05-27,"[{'lastname': 'Heiss', 'firstname': 'Christina N', 'initials': 'CN', 'affiliation': 'Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, 41345 Gothenburg, Sweden.'}, {'lastname': 'Mannerås-Holm', 'firstname': 'Louise', 'initials': 'L', 'affiliation': 'Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, 41345 Gothenburg, Sweden.'}, {'lastname': 'Lee', 'firstname': 'Ying Shiuan', 'initials': 'YS', 'affiliation': 'Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, 41345 Gothenburg, Sweden.'}, {'lastname': 'Serrano-Lobo', 'firstname': 'Julia', 'initials': 'J', 'affiliation': 'Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, 41345 Gothenburg, Sweden.'}, {'lastname': 'Håkansson Gladh', 'firstname': 'Anna', 'initials': 'A', 'affiliation': 'Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, 41345 Gothenburg, Sweden.'}, {'lastname': 'Seeley', 'firstname': 'Randy J', 'initials': 'RJ', 'affiliation': 'Department of Surgery, University of Michigan Medical School, Ann Arbor, MI 48109, USA.'}, {'lastname': 'Drucker', 'firstname': 'Daniel J', 'initials': 'DJ', 'affiliation': 'Department of Medicine, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, ON M5G 1X5, Canada.'}, {'lastname': 'Bäckhed', 'firstname': 'Fredrik', 'initials': 'F', 'affiliation': 'Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, 41345 Gothenburg, Sweden; Novo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Receptology and Enteroendocrinology, Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark; Department of Clinical Physiology, Region Västra Götaland, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden.'}, {'lastname': 'Olofsson', 'firstname': 'Louise E', 'initials': 'LE', 'affiliation': 'Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, 41345 Gothenburg, Sweden. Electronic address: louise.olofsson@wlab.gu.se.'}]",,,,Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.,10.1016/j.celrep.2021.109163,<Element 'PubmedArticle' at 0x7f05de80e0e0>
161,"34031123
16493415
28974775
30067154
28601906
28923931
24931034
3070584
16951936
3294880
116135
1905822
29910467
24084737
11000114
15855332
25733901
12021765
24703699
27518562
30893295
29664737
28580287
17550779
28385803
11248117
10903566
19504253
20196867
24485249
25605792
20610611
19131956
30893613
20729808
28093478
16340955
21195353
21109190
28096339
28166221
30327383
11701931
20093161
11528423
10098857
32789766
12453890
33446523
14764421
23585733
15234100
27539596
15757488
8036251
30765523
15448273
1597158
12388611
19160495
28745725
23007190
25703096
27643429","Peripheral Insulin Regulates a Broad Network of Gene Expression in Hypothalamus, Hippocampus, and Nucleus Accumbens.","The brain is now recognized as an insulin-sensitive tissue; however, the role of changing insulin concentrations in the peripheral circulation in gene expression in the brain is largely unknown. Here, we performed a hyperinsulinemic-euglycemic clamp on 3-month-old male C57BL/6 mice for 3 h. We show that, in comparison with results in saline-infused controls, increases in peripheral insulin within the physiological range regulate expression of a broad network of genes in the brain. Insulin regulates distinct pathways in the hypothalamus (HTM), hippocampus, and nucleus accumbens. Insulin shows its most robust effect in the HTM and regulates multiple genes involved in neurotransmission, including upregulating expression of multiple subunits of GABA-A receptors, Na",[],Diabetes,2021-05-26,"[{'lastname': 'Cai', 'firstname': 'Weikang', 'initials': 'W', 'affiliation': 'Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA.\nDepartment of Biomedical Sciences, New York Institute of Technology, College of Osteopathic Medicine, Old Westbury, NY.'}, {'lastname': 'Zhang', 'firstname': 'Xuemei', 'initials': 'X', 'affiliation': 'Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA.'}, {'lastname': 'Batista', 'firstname': 'Thiago M', 'initials': 'TM', 'affiliation': 'Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA.'}, {'lastname': 'García-Martín', 'firstname': 'Rubén', 'initials': 'R', 'affiliation': 'Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA.'}, {'lastname': 'Softic', 'firstname': 'Samir', 'initials': 'S', 'affiliation': 'Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA.\nDepartment of Pediatrics, University of Kentucky, College of Medicine, Lexington, KY.'}, {'lastname': 'Wang', 'firstname': 'Guoxiao', 'initials': 'G', 'affiliation': 'Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA.'}, {'lastname': 'Ramirez', 'firstname': 'Alfred K', 'initials': 'AK', 'affiliation': 'Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA.'}, {'lastname': 'Konishi', 'firstname': 'Masahiro', 'initials': 'M', 'affiliation': 'Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA.'}, {'lastname': ""O'Neill"", 'firstname': 'Brian T', 'initials': 'BT', 'affiliation': 'Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA.\nDivision of Endocrinology and Metabolism, Fraternal Order of Eagles Diabetes Research Center, University of Iowa Carver College of Medicine, Iowa City, IA.'}, {'lastname': 'Kim', 'firstname': 'Jong Hun', 'initials': 'JH', 'affiliation': 'Program in Molecular Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, MA.\nDepartment of Food Science and Biotechnology, Sungshin University, Seoul, South Korea.'}, {'lastname': 'Kim', 'firstname': 'Jason K', 'initials': 'JK', 'affiliation': 'Program in Molecular Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, MA.\nDivision of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Massachusetts Medical School, Worcester, MA.'}, {'lastname': 'Kahn', 'firstname': 'C Ronald', 'initials': 'CR', 'affiliation': 'Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA c.ronald.kahn@joslin.harvard.edu.'}]",,,,© 2021 by the American Diabetes Association.,10.2337/db20-1119,<Element 'PubmedArticle' at 0x7f05de81aea0>
162,33962227,Ciprofloxacin and dexamethasone in combination attenuate S. aureus induced brain abscess via neuroendocrine-immune interaction of TLR-2 and glucocorticoid receptor leading to behavioral improvement.,"Staphylococcus aureus induced brain abscess is a critical health concern throughout the developing world. The conventional surgical intervention could not regulate the abscess-induced brain inflammation. Thus further study over the alternative therapeutic strategy for treating a brain abscess is of high priority. The resident glial cells recognize the invading S. aureus by their cell surface Toll-like receptor-2 (TLR-2). Glucocorticoid receptor (GR) was known for its immunosuppressive effects. In this study, an attempt had been taken to utilize the functional relationship or cross-talking between TLR-2 and GR during the pathogenesis of brain abscesses. Here, the combination of an antibiotic (i.e. ciprofloxacin) and dexamethasone was used to regulate the brain inflammation either in TLR-2 or GR blocking condition. We were also interested to figure out the possible impact of alternative therapy on behavioral impairments. The results indicated that combination treatment during TLR-2 blockade significantly reduced the bacterial burden and abscess area score in the infected brain. However, marked improvements were observed in anxiety, depression-like behavior, and motor co-ordination. The combination treatment after TLR-2 blocking effectively scavenged free radicals (H","['Brain abscess', 'Ciprofloxacin', 'Dexamethasone', 'Inflammation', 'Microglia', 'S. aureus']",International immunopharmacology,2021-05-08,"[{'lastname': 'Dey', 'firstname': 'Rajen', 'initials': 'R', 'affiliation': 'Department of Physiology, Immunology Laboratory, University of Calcutta, University Colleges of Science and Technology, Calcutta, West Bengal, India.'}, {'lastname': 'Bishayi', 'firstname': 'Biswadev', 'initials': 'B', 'affiliation': 'Department of Physiology, Immunology Laboratory, University of Calcutta, University Colleges of Science and Technology, Calcutta, West Bengal, India. Electronic address: bbphys@caluniv.ac.in.'}]",,,,Copyright © 2021 Elsevier B.V. All rights reserved.,10.1016/j.intimp.2021.107695,<Element 'PubmedArticle' at 0x7f05daf8fcc0>
163,33949202,Amygdala microglia modify neuronal plasticity via complement C1q/C3-CR3 signaling and contribute to visceral pain in a rat model.,"Stress can trigger symptoms in patients with irritable bowel syndrome (IBS). Previously we demonstrated that chronic psychological stress induced microglial remodeling in the central nucleus of amygdala (CeA) and contributed to the development of visceral hypersensitivity via synaptic engulfment. However, the specific signaling mechanisms that microglia depend upon to recognize target neurons to facilitate visceral pain remain unknown. Here, we test the hypothesis that the microglia in the CeA contribute to chronic stress-induced visceral hypersensitivity via complement C1q/C3-CR3 signaling-mediated synaptic remodeling. In male and female Fischer-344 rats, micropellets of corticosterone (CORT) or cholesterol (control) were stereotaxically implanted bilaterally onto the CeA. After 7 days, microglial C1q, complement receptor 3 (CR3) expression, and microglia-mediated synaptic engulfment were assessed via RNAscope, quantitative PCR, and immunofluorescence. The microglial inhibitor minocycline, CR3 antagonist neutrophil inhibitory factor (NIF), or vehicle were daily infused into the CeA following CORT implantations. Visceral sensitivity was assessed via a visceromotor response (VMR) to graded pressures of isobaric colorectal distension (CRD). Our results suggest that chronic exposure to elevated CORT in the CeA induced visceral hypersensitivity and amygdala microglial morphological remodeling. CORT increased microglial C1q and CR3 expression and increased microglia-mediated synaptic engulfment. Both groups of animals with minocycline or NIF infusions reversed microglia-mediated synaptic remodeling and attenuated CORT-induced visceral hypersensitivity. Our findings demonstrate that C1q/C3-CR3 signaling is critical for microglia-mediated synaptic remodeling in the CeA and contributes to CORT-induced visceral hypersensitivity.","['IBS', 'brain-gut axis', 'chronic stress', 'synaptic remodeling', 'visceral hypersensitivity']",American journal of physiology. Gastrointestinal and liver physiology,2021-05-06,"[{'lastname': 'Yuan', 'firstname': 'Tian', 'initials': 'T', 'affiliation': 'Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.'}, {'lastname': 'Orock', 'firstname': 'Albert', 'initials': 'A', 'affiliation': 'Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.'}, {'lastname': 'Greenwood-Van Meerveld', 'firstname': 'Beverley', 'initials': 'B', 'affiliation': 'Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.\nOklahoma City Veterans Affairs Health Care System, Oklahoma City, Oklahoma.'}]",,,,,10.1152/ajpgi.00123.2021,<Element 'PubmedArticle' at 0x7f05daf9dc20>
164,"33922372
11514078
17965656
20870295
23242694
30448975
27870397
28968842
10097000
19411059
22236999
29973654
31614148
16423353
21094890
23165262
24231652
26742647
29381512
30962278
27452349
28270169
27956226
26120961
30337927
30532260
25608762
8826503
22192712
12792555
15608071
26983893
24577438
28741433
30874629
31730538
27793571
2614485
16478686
18196515
19923276
10779657
24140886
21050491
23178578
16355225
16564626
26813032
19782411
20012873
20880500
26472019
22031891
20837189
8316385
11323144
29127229
29520604
28666971
32322187
31787875
18490715
23788036
7545093
10380904
29071294
19620723
9302400
33179018
27028709
21376468
17419800
28822786
29416128
21343257
20198122
16691291
26894024
6877845
2837713
19948419
15992812
31610068",Sexually Dimorphic Immune and Neuroimmune Changes Following Peripheral Nerve Injury in Mice: Novel Insights for Gender Medicine.,"Neuropathic pain (NeP) in humans is often a life-long condition with no effective therapy available. The higher incidence of female gender in NeP onset is worldwide reported, and although the cause is generally attributed to sex hormones, the actual mechanisms and the players involved are still unclear. Glial and immune cells take part in NeP development, and orchestrate the neuroimmune and inflammatory response, releasing pro-inflammatory factors with chemoattractant properties that activate resident immune cells and recruit immune cells from circulation. The neuro-immune crosstalk is a key contributor to pain hypersensitivity following peripheral nervous system injury. Our previous works showed that in spite of the fact that female mice had an earlier analgesic response than males following nerve lesion, the recovery from NeP was never complete, suggesting that this difference could occur in the very early stages after injury. To further investigate gender differences in immune and neuroimmune responses to NeP, we studied the main immune cells and mediators elicited both in plasma and sciatic nerves by peripheral nerve lesion. After injury, we found a different pattern of distribution of immune cell populations showing either a higher infiltration of T cells in nerves from females or a higher infiltration of macrophages in nerves from males. Moreover, in comparison to male mice, the levels of cytokines and chemokines were differently up- and down-regulated in blood and nerve lysates from female mice. Our study provides some novel insights for the understanding of gender-associated differences in the generation and perseveration of NeP as well as for the isolation of specific neurodegenerative mechanisms underlying NeP. The identification of gender-associated inflammatory profiles in neuropathy is of key importance for the development of differential biomarkers and gender-specific personalized medicine.","['T-cells', 'astrocytes', 'chemokines', 'cytokines', 'estrogen', 'leptin', 'microglia', 'neuropathic pain', 'neuropathy']",International journal of molecular sciences,2021-05-01,"[{'lastname': 'Vacca', 'firstname': 'Valentina', 'initials': 'V', 'affiliation': 'CNR-National Research Council, CNR, Institute of Biochemistry and Cell Biology, Monterotondo Scalo, 00015 Rome, Italy.\nIRCCS Fondazione Santa Lucia, 00143 Rome, Italy.'}, {'lastname': 'Marinelli', 'firstname': 'Sara', 'initials': 'S', 'affiliation': 'CNR-National Research Council, CNR, Institute of Biochemistry and Cell Biology, Monterotondo Scalo, 00015 Rome, Italy.\nIRCCS Fondazione Santa Lucia, 00143 Rome, Italy.'}, {'lastname': 'De Angelis', 'firstname': 'Federica', 'initials': 'F', 'affiliation': 'CNR-National Research Council, CNR, Institute of Biochemistry and Cell Biology, Monterotondo Scalo, 00015 Rome, Italy.\nIRCCS Fondazione Santa Lucia, 00143 Rome, Italy.'}, {'lastname': 'Angelini', 'firstname': 'Daniela F', 'initials': 'DF', 'affiliation': 'IRCCS Fondazione Santa Lucia, 00143 Rome, Italy.'}, {'lastname': 'Piras', 'firstname': 'Eleonora', 'initials': 'E', 'affiliation': 'IRCCS Fondazione Santa Lucia, 00143 Rome, Italy.'}, {'lastname': 'Battistini', 'firstname': 'Luca', 'initials': 'L', 'affiliation': 'IRCCS Fondazione Santa Lucia, 00143 Rome, Italy.'}, {'lastname': 'Pavone', 'firstname': 'Flaminia', 'initials': 'F', 'affiliation': 'CNR-National Research Council, CNR, Institute of Biochemistry and Cell Biology, Monterotondo Scalo, 00015 Rome, Italy.\nIRCCS Fondazione Santa Lucia, 00143 Rome, Italy.'}, {'lastname': 'Coccurello', 'firstname': 'Roberto', 'initials': 'R', 'affiliation': 'IRCCS Fondazione Santa Lucia, 00143 Rome, Italy.\nCNR-National Research Council, CNR, Institute for Complex System (ISC), via dei Taurini 19, 00185 Rome, Italy.'}]",,,,,"10.3390/ijms22094397
10.1016/S0304-3959(01)00359-1
10.1038/nn1992
10.1016/j.jneuroim.2010.08.013
10.1007/s11481-012-9428-2
10.1007/s00540-018-2579-4
10.1002/jnr.23831
10.1093/rheumatology/kex308
10.1017/S0140525X97221485
10.1016/j.jpain.2008.12.001
10.1016/j.pain.2011.11.026
10.1038/s41386-018-0127-4
10.1016/j.lfs.2019.116926
10.1016/j.yhbeh.2005.12.002
10.1038/nrn3360
10.1016/j.pain.2013.10.027
10.1038/srep18980
10.1213/ANE.0000000000002795
10.1523/JNEUROSCI.0364-19.2019
10.1002/jnr.23841
10.1186/s13041-017-0289-8
10.1016/j.yhbeh.2016.11.017
10.1038/nn.4053
10.3389/fimmu.2018.02279
10.1371/journal.pone.0208596
10.1186/s12974-014-0225-0
10.1016/0304-3959(95)00214-6
10.1016/j.pain.2011.11.025
10.1097/00002508-200305000-00004
10.1124/jpet.104.077792
10.2217/pmt-2015-0002
10.1038/nri3621
10.1177/1744806917724559
10.1038/s41577-019-0147-2
10.1515/sjpain-2019-0138
10.1016/j.it.2016.10.001
10.1007/BF01187086
10.1016/S1359-6446(05)03637-8
10.1002/eji.200737485
10.1523/JNEUROSCI.4569-09.2009
10.1016/S0304-3959(99)00306-1
10.1016/j.lfs.2013.10.005
10.1186/1744-8069-6-76
10.1016/j.expneurol.2012.11.013
10.1038/nature04223
10.1016/j.pain.2006.02.034
10.1111/jdi.12379
10.1016/j.tins.2009.08.002
10.1007/s00401-009-0622-0
10.1016/j.nurt.2010.05.014
10.1016/j.bbi.2015.10.006
10.1523/JNEUROSCI.3859-11.2011
10.1016/j.metabol.2010.07.011
10.1016/0304-3959(93)90050-Y
10.1016/S0304-3959(01)00256-1
10.1136/bmjopen-2017-018063
10.1007/s00198-018-4414-z
10.1016/j.bone.2017.06.020
10.3389/fnins.2020.00287
10.3389/fnins.2019.01205
10.4049/jimmunol.180.11.7167
10.1038/cddis.2013.198
10.1111/j.1365-2249.1995.tb03126.x
10.1002/jlb.65.6.815
10.1016/j.dib.2017.10.005
10.1073/pnas.0903524106
10.1046/j.1365-2265.1997.2681067.x
10.1089/andro.2020.0007
10.1089/jwh.2015.5509
10.1016/j.pain.2011.01.054
10.1111/j.1471-4159.2007.04559.x
10.1016/j.lfs.2017.08.016
10.1038/nrn.2018.2
10.1210/en.2010-1252
10.2174/157339508784325046
10.1172/JCI26498
10.1016/j.krcp.2012.06.004
10.1016/0304-3959(83)90201-4
10.1016/0304-3959(88)90209-6
10.1016/j.ejpain.2009.10.016
10.1016/j.jim.2005.05.005
10.1002/ejp.1493",<Element 'PubmedArticle' at 0x7f05daf77310>
165,"33867831
31291966
32146867
31514749
21604061
31699365
25009531
22712739
30483945
26851161
24682762
22933588
17965659
28260801
28392244
31892541
27477920
28785217
31434993
12508119
22408449
15056277
26232730
22777144
15502843
25157794
25040630
21093411
10326989
10817919
26891883
27340792
28237799
28830026
29849895
2643202
7709410
20726846
28386326
24744866
24223607
20332799
23311642
31708746
24447857
28928639
28601280
27869795
28701948
26286145
20066092",Genistein-3'-sodium sulfonate Attenuates Neuroinflammation in Stroke Rats by Down-Regulating Microglial M1 Polarization through α7nAChR-NF-κB Signaling Pathway.,Microglial M1 depolarization mediated prolonged inflammation contributing to brain injury in ischemic stroke. Our previous study revealed that Genistein-3'-sodium sulfonate (GSS) exerted neuroprotective effects in ischemic stroke. This study aimed to explore whether GSS protected against brain injury in ischemic stroke by regulating microglial M1 depolarization and its underlying mechanisms. We established transient middle cerebral artery occlusion and reperfusion (tMCAO) model in rats and used lipopolysaccharide (LPS)-stimulated BV2 microglial cells as ,"['Genistein-3′-sodium sulfonate.', 'Ischemic stroke', 'Microglia polarization', 'Neuroinflammation', 'α7nAChR-NF-κB signaling']",International journal of biological sciences,2021-04-20,"[{'lastname': 'Liu', 'firstname': 'Chaoming', 'initials': 'C', 'affiliation': 'Key Laboratory of Prevention and treatment of cardiovascular and cerebrovascular diseases of Ministry of Education, Gannan Medical University, Ganzhou 341000, China.\nDepartment of Pathobiology, JiangXi College of Traditional Chinese Medicine, Fuzhou, 344000, China.'}, {'lastname': 'Liu', 'firstname': 'Song', 'initials': 'S', 'affiliation': 'Key Laboratory of Prevention and treatment of cardiovascular and cerebrovascular diseases of Ministry of Education, Gannan Medical University, Ganzhou 341000, China.'}, {'lastname': 'Xiong', 'firstname': 'Lijiao', 'initials': 'L', 'affiliation': 'Key Laboratory of Prevention and treatment of cardiovascular and cerebrovascular diseases of Ministry of Education, Gannan Medical University, Ganzhou 341000, China.\nFirst Affiliated Hospital of Gannan Medical University, Ganzhou 341000, China.'}, {'lastname': 'Zhang', 'firstname': 'Limei', 'initials': 'L', 'affiliation': 'Key Laboratory of Prevention and treatment of cardiovascular and cerebrovascular diseases of Ministry of Education, Gannan Medical University, Ganzhou 341000, China.\nDepartment of Physiology, School of Basic Medical Sciences, Gannan Medical University, Ganzhou 341000, China.'}, {'lastname': 'Li', 'firstname': 'Xiao', 'initials': 'X', 'affiliation': 'Key Laboratory of Prevention and treatment of cardiovascular and cerebrovascular diseases of Ministry of Education, Gannan Medical University, Ganzhou 341000, China.\nDepartment of Physiology, School of Basic Medical Sciences, Gannan Medical University, Ganzhou 341000, China.'}, {'lastname': 'Cao', 'firstname': 'Xingling', 'initials': 'X', 'affiliation': 'Key Laboratory of Prevention and treatment of cardiovascular and cerebrovascular diseases of Ministry of Education, Gannan Medical University, Ganzhou 341000, China.\nDepartment of Physiology, School of Basic Medical Sciences, Gannan Medical University, Ganzhou 341000, China.'}, {'lastname': 'Xue', 'firstname': 'Jinhua', 'initials': 'J', 'affiliation': 'Key Laboratory of Prevention and treatment of cardiovascular and cerebrovascular diseases of Ministry of Education, Gannan Medical University, Ganzhou 341000, China.\nDepartment of Physiology, School of Basic Medical Sciences, Gannan Medical University, Ganzhou 341000, China.'}, {'lastname': 'Li', 'firstname': 'Liangdong', 'initials': 'L', 'affiliation': 'Key Laboratory of Prevention and treatment of cardiovascular and cerebrovascular diseases of Ministry of Education, Gannan Medical University, Ganzhou 341000, China.\nFirst Affiliated Hospital of Gannan Medical University, Ganzhou 341000, China.'}, {'lastname': 'Huang', 'firstname': 'Cheng', 'initials': 'C', 'affiliation': 'Key Laboratory of Prevention and treatment of cardiovascular and cerebrovascular diseases of Ministry of Education, Gannan Medical University, Ganzhou 341000, China.\nDepartment of Physiology, School of Basic Medical Sciences, Gannan Medical University, Ganzhou 341000, China.'}, {'lastname': 'Huang', 'firstname': 'Zhihua', 'initials': 'Z', 'affiliation': 'Key Laboratory of Prevention and treatment of cardiovascular and cerebrovascular diseases of Ministry of Education, Gannan Medical University, Ganzhou 341000, China.\nDepartment of Physiology, School of Basic Medical Sciences, Gannan Medical University, Ganzhou 341000, China.'}]",,,,© The author(s).,10.7150/ijbs.56800,<Element 'PubmedArticle' at 0x7f05ddb3ee00>
166,"33853082
27065163
23953592
10696570
19488073
24361584
26215997
26189452
29180230
31989757
27589660
25010111
27440422
30111811
32734132
31249595
32795657
10466025
7458240
18489715
16110340
25516281
29458351
30944313
18295201
16214171
10674279
16150912
19575614
30364965
30169894
23899562
18063498
31699238
31399550
24687185
31167788
31847911
30638704
30481522
32023447
30108586
29948944
28454915
27981190
29020624
29599706
32411016
30565508
31122931
29073081
28533892
32934971
30444278
26435451
25272344",Brain Transcriptome Responses to Dexamethasone Depending on Dose and Sex Reveal Factors Contributing to Sex-Specific Vulnerability to Stress-Induced Disorders.,"Glucocorticoid (GC) receptor (GR) signaling in the hypothalamus (Hyp) and in the superordinate limbic structures, such as the hippocampus (Hip), conveys feedback regulation of the neuroendocrine stress response and acts upon other neurobiological functions that ultimately influence mental health. These responses are strongly influenced by sex, but the molecular causes are still largely unexplored.
To investigate GR targets and their GC sensitivity in the Hyp and Hip, we treated juvenile male and female piglets with 10 (D10) or 60 (D60) µg/kg dexamethasone (DEX), a selective GR agonist, and analyzed transcriptome responses compared to a saline control group using RNA sequencing.
Both doses influenced similar biological functions, including cellular response to lipid and immune cell-related functions, but the transcriptional response to D10 was considerably weaker, particularly in the Hip. Weighted Gene Co-expression Network Analysis revealed a network of genes coordinately regulated by DEX in both structures, among which the alpha-arrestin ARRDC2 takes a central position. Distinct functional groups of genes were differentially regulated by DEX between sexes depending on the dose; at D10, these included particularly mitochondrial genes, whereas at D60 interferon signaling and lipid homeostasis genes were enriched. The general and sex-specific transcriptional responses to DEX highlight microglia as the prominent target. Several key marker genes of disease-associated microglia were regulated by DEX depending on sex, such as TREM2 and LPL.
The discovered expression signatures suggest that DEX induced a dysfunctional state of microglia in males, while in females microglia were primed, which could entail predisposition for different mental disorders.","['Glucocorticoid receptor', 'Hypothalamus-pituitary-adrenal axis', 'Mental disorder', 'Sex differences', 'Stress', 'Transcriptome']",Neuroendocrinology,2021-04-15,"[{'lastname': 'Murani', 'firstname': 'Eduard', 'initials': 'E', 'affiliation': 'Institute of Genome Biology, Leibniz Institute for Farm Animal Biology (FBN), Dummerstorf, Germany.'}, {'lastname': 'Trakooljul', 'firstname': 'Nares', 'initials': 'N', 'affiliation': 'Institute of Genome Biology, Leibniz Institute for Farm Animal Biology (FBN), Dummerstorf, Germany.'}, {'lastname': 'Hadlich', 'firstname': 'Frieder', 'initials': 'F', 'affiliation': 'Institute of Genome Biology, Leibniz Institute for Farm Animal Biology (FBN), Dummerstorf, Germany.'}, {'lastname': 'Ponsuksili', 'firstname': 'Siriluck', 'initials': 'S', 'affiliation': 'Institute of Genome Biology, Leibniz Institute for Farm Animal Biology (FBN), Dummerstorf, Germany.'}, {'lastname': 'Wimmers', 'firstname': 'Klaus', 'initials': 'K', 'affiliation': 'Institute of Genome Biology, Leibniz Institute for Farm Animal Biology (FBN), Dummerstorf, Germany.'}]",,"The discovered expression signatures suggest that DEX induced a dysfunctional state of microglia in males, while in females microglia were primed, which could entail predisposition for different mental disorders.","Both doses influenced similar biological functions, including cellular response to lipid and immune cell-related functions, but the transcriptional response to D10 was considerably weaker, particularly in the Hip. Weighted Gene Co-expression Network Analysis revealed a network of genes coordinately regulated by DEX in both structures, among which the alpha-arrestin ARRDC2 takes a central position. Distinct functional groups of genes were differentially regulated by DEX between sexes depending on the dose; at D10, these included particularly mitochondrial genes, whereas at D60 interferon signaling and lipid homeostasis genes were enriched. The general and sex-specific transcriptional responses to DEX highlight microglia as the prominent target. Several key marker genes of disease-associated microglia were regulated by DEX depending on sex, such as TREM2 and LPL.","The Author(s). Published by S. Karger AG, Basel.",10.1159/000516500,<Element 'PubmedArticle' at 0x7f05dc1e3400>
167,33845074,The cannabinoid system and microglia in health and disease.,"Recent years have yielded significant advances in our understanding of microglia, the immune cells of the central nervous system (CNS). Microglia are key players in CNS development, immune surveillance, and the maintenance of proper neuronal function throughout life. In the healthy brain, homeostatic microglia have a unique molecular signature. In neurological diseases, microglia become activated and adopt distinct transcriptomic signatures, including disease-associated microglia (DAM) implicated in neurodegenerative disorders. Homeostatic microglia synthesise the endogenous cannabinoids 2-arachidonoylglycerol and anandamide and express the cannabinoid receptors CB1 and CB2 at constitutively low levels. Upon activation, microglia significantly increase their synthesis of endocannabinoids and upregulate their expression of CB2 receptors, which promote a protective microglial phenotype by enhancing their production of neuroprotective factors and reducing their production of pro-inflammatory factors. Here, we summarise the effects of the microglial cannabinoid system in the CNS demyelinating disease multiple sclerosis, the neurodegenerative diseases Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis, chronic inflammatory and neuropathic pain, and psychiatric disorders including depression, anxiety and schizophrenia. We discuss the therapeutic potential of cannabinoids in regulating microglial activity and highlight the need to further investigate their specific microglia-dependent immunomodulatory effects.","['Cannabinoids', 'Chronic pain', 'Demyelinating diseases', 'Microglia', 'Neurodegenerative diseases', 'Psychiatric disorders']",Neuropharmacology,2021-04-13,"[{'lastname': 'Duffy', 'firstname': 'Samuel S', 'initials': 'SS', 'affiliation': 'Translational Neuroscience Facility, School of Medical Sciences, University of New South Wales, UNSW Sydney, NSW, 2052, Australia.'}, {'lastname': 'Hayes', 'firstname': 'Jessica P', 'initials': 'JP', 'affiliation': 'Translational Neuroscience Facility, School of Medical Sciences, University of New South Wales, UNSW Sydney, NSW, 2052, Australia.'}, {'lastname': 'Fiore', 'firstname': 'Nathan T', 'initials': 'NT', 'affiliation': 'Translational Neuroscience Facility, School of Medical Sciences, University of New South Wales, UNSW Sydney, NSW, 2052, Australia.'}, {'lastname': 'Moalem-Taylor', 'firstname': 'Gila', 'initials': 'G', 'affiliation': 'Translational Neuroscience Facility, School of Medical Sciences, University of New South Wales, UNSW Sydney, NSW, 2052, Australia. Electronic address: gila@unsw.edu.au.'}]",,,,Copyright © 2021 Elsevier Ltd. All rights reserved.,10.1016/j.neuropharm.2021.108555,<Element 'PubmedArticle' at 0x7f05dc1f9ae0>
168,"33839686
23150934
23150908
29321225
15049507
26478868
25732305
25728668
24316888
18551625
28602351
27196974
31350575
30617257
31235932
29037207
28100745
30232263
28802038
28559417
19171755
24990881
25716838
30157425
28483841
29599291
29518356
16951310
31301936
25631124
31902528
27995897
26374899
26374897
27477018
25047746
29407460
29518357
28490631
32154671
26414614
26399658
29551131
31926038
28591653
31740814
27097852
28671693
28546318
19625651
31507408
12832465
12101269
17425404
30397336
24638131
29020624
31917687
31932797
26076170
26058841
26311074",MEK1/2 activity modulates TREM2 cell surface recruitment.,"Rare sequence variants in the microglial cell surface receptor TREM2 have been shown to increase the risk for Alzheimer's disease (AD). Disease-linked TREM2 mutations seem to confer a partial loss of function, and increasing TREM2 cell surface expression and thereby its function(s) might have therapeutic benefit in AD. However, druggable targets that could modulate microglial TREM2 surface expression are not known. To identify such targets, we conducted a screen of small molecule compounds with known pharmacology using human myeloid cells, searching for those that enhance TREM2 protein at the cell surface. Inhibitors of the kinases MEK1/2 displayed the strongest and most consistent increases in cell surface TREM2 protein, identifying a previously unreported pathway for TREM2 regulation. Unexpectedly, inhibitors of the downstream effector ERK kinases did not have the same effect, suggesting that noncanonical MEK signaling regulates TREM2 trafficking. In addition, siRNA knockdown experiments confirmed that decreased MEK1 and MEK2 were required for this recruitment. In iPSC-derived microglia, MEK inhibition increased cell surface TREM2 only modestly, so various cytokines were used to alter iPSC microglia phenotype, making cells more sensitive to MEK inhibitor-induced TREM2 recruitment. Of those tested, only IFN-gamma priming prior to MEK inhibitor treatment resulted in greater TREM2 recruitment. These data identify the first known mechanisms for increasing surface TREM2 protein and TREM2-regulated function in human myeloid cells and are the first to show a role for MEK1/MEK2 signaling in TREM2 activity.","['Alzheimer’s disease', 'MEK', 'TREM2', 'microglia', 'neurodegeneration', 'neuroinflammation', 'phagocytosis']",The Journal of biological chemistry,2021-04-12,"[{'lastname': 'Schapansky', 'firstname': 'Jason', 'initials': 'J', 'affiliation': 'AbbVie Inc, Cambridge Research Center, Cambridge, Massachusetts, USA. Electronic address: jason.schapansky@abbvie.com.'}, {'lastname': 'Grinberg', 'firstname': 'Yelena Y', 'initials': 'YY', 'affiliation': 'AbbVie Inc, Cambridge Research Center, Cambridge, Massachusetts, USA.'}, {'lastname': 'Osiecki', 'firstname': 'David M', 'initials': 'DM', 'affiliation': 'AbbVie Inc, Drug Discovery Science and Technology, North Chicago, Illinois, USA.'}, {'lastname': 'Freeman', 'firstname': 'Emily A', 'initials': 'EA', 'affiliation': 'AbbVie Inc, Cambridge Research Center, Cambridge, Massachusetts, USA.'}, {'lastname': 'Walker', 'firstname': 'Stephen G', 'initials': 'SG', 'affiliation': 'AbbVie Inc, Drug Discovery Science and Technology, North Chicago, Illinois, USA.'}, {'lastname': 'Karran', 'firstname': 'Eric', 'initials': 'E', 'affiliation': 'AbbVie Inc, Cambridge Research Center, Cambridge, Massachusetts, USA.'}, {'lastname': 'Gopalakrishnan', 'firstname': 'Sujatha M', 'initials': 'SM', 'affiliation': 'AbbVie Inc, Drug Discovery Science and Technology, North Chicago, Illinois, USA.'}, {'lastname': 'Talanian', 'firstname': 'Robert V', 'initials': 'RV', 'affiliation': 'AbbVie Inc, Cambridge Research Center, Cambridge, Massachusetts, USA.'}]",,,,Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.,10.1074/jbc.RA120.014352,<Element 'PubmedArticle' at 0x7f05dc21c3b0>
169,"33835366
24381729
24392228
24068392
25598354
11790539
25239168
11701768
17956303
28769820
17275323
20940366
16879708
16144539
22697788
23684303
11886435
22998440
12663437
16450011
19292870
12547223
19907144
28096133
26182354
23506423
28300826
27129231
19254567
24639653
20634490
31949017
22728873
30469435
18421430
30401708
30127723
30577543
21757877
18029230
21520181
21622652
19652026
21685415
26999213
30526044
22306005
22611157
26735394
17905609
23390933
18652890
23360889
24860505
23028567
16330325
21480335
18026094
20889504
10851062
17237610
24573038
26616859
27892764
18976966
24376517
18451267
31172340
24847265
16604073
19252486
19252488
14701870
25309543
23386688
28604512
15932798
18025230
18325389
30477086
29610275","IL-6 Regulates Hepcidin Expression Via the BMP/SMAD Pathway by Altering BMP6, TMPRSS6 and TfR2 Expressions at Normal and Inflammatory Conditions in BV2 Microglia.","The hormone hepcidin plays a central role in controlling iron homeostasis. Iron-mediated hepcidin synthesis is triggered via the BMP/SMAD pathway. At inflammation, mainly IL-6 pro-inflammatory cytokine mediates the regulation of hepcidin via the JAK/STAT signalling pathway. Microglial cells of the central nervous system are able to recognize a broad spectrum of pathogens via toll-like receptors and initiate inflammatory response. Although the regulation of hepcidin synthesis is well described in many tissues, little is known about the inflammation mediated hepcidin regulation in microglia. In this study, we investigated the pathways, which are involved in HAMP regulation in BV2 microglia due to inflammatory mediators and the possible relationships between the iron regulatory pathways. Our results showed that IL-6 produced by resting BV2 cells was crucial in maintaining the basal HAMP expression and hepcidin secretion. It was revealed that IL-6 neutralization decreased both STAT3 and SMAD1/5/9 phosphorylation suggesting that IL-6 proinflammatory cytokine is necessary to maintain SMAD1/5/9 activation. We revealed that IL-6 influences BMP6 and TMPRSS6 protein levels, moreover it modified TfR2 expression, as well. In this study, we revealed that BV2 microglia increased their hepcidin secretion upon IL-6 neutralization although the major regulatory pathways were inhibited. Based on our results it seems that both at inflammation and at normal condition the absence of IL-6 triggered HAMP transcription and hepcidin secretion via the NFκB pathway and possibly by the autocrine effect of TNFα cytokine on BV2 microglia.","['BMP/SMAD', 'Hepcidin', 'Inflammation', 'Iron metabolism', 'Microglia', 'STAT3']",Neurochemical research,2021-04-10,"[{'lastname': 'Varga', 'firstname': 'Edit', 'initials': 'E', 'affiliation': 'Department of Pharmaceutical Biology, Faculty of Pharmacy, University of Pécs, Rókus Str. 2, Pécs, 7624, Hungary.'}, {'lastname': 'Pap', 'firstname': 'Ramóna', 'initials': 'R', 'affiliation': 'Department of Pharmaceutical Biology, Faculty of Pharmacy, University of Pécs, Rókus Str. 2, Pécs, 7624, Hungary.'}, {'lastname': 'Jánosa', 'firstname': 'Gergely', 'initials': 'G', 'affiliation': 'Department of Pharmaceutical Biology, Faculty of Pharmacy, University of Pécs, Rókus Str. 2, Pécs, 7624, Hungary.'}, {'lastname': 'Sipos', 'firstname': 'Katalin', 'initials': 'K', 'affiliation': 'Department of Pharmaceutical Biology, Faculty of Pharmacy, University of Pécs, Rókus Str. 2, Pécs, 7624, Hungary.'}, {'lastname': 'Pandur', 'firstname': 'Edina', 'initials': 'E', 'affiliation': 'Department of Pharmaceutical Biology, Faculty of Pharmacy, University of Pécs, Rókus Str. 2, Pécs, 7624, Hungary. edina.pandur@aok.pte.hu.'}]",,,,,"10.1007/s11064-021-03322-0
10.12703/P5-53
10.1155/2013/425845
10.1007/s12035-014-9070-5
10.1016/S0952-7915(01)00304-1
10.1186/s12974-014-0166-7
10.1046/j.1471-4159.2001.00603.x
10.1042/BST0351166
10.3389/fphys.2017.00508
10.1016/j.smim.2006.12.004
10.1177/0022034510381264
10.1111/j.1471-4159.2006.04085.x
10.1111/j.1471-4159.2005.03422.x
10.1186/1742-2094-9-126
10.1016/j.chom.2013.04.010
10.1046/j.1365-2362.2002.0320s1070.x
10.1186/1423-0127-19-83
10.1182/blood-2003-03-0672
10.1111/j.1742-4658.2009.06937.x
10.1006/bcmd.2002.0573
10.1159/000243791
10.3945/an.116.013961
10.1042/BSR20150014
10.1111/jnc.12244
10.1038/cddis.2017.93
10.1074/jbc.M115.691543
10.1016/j.cmet.2009.01.010
10.3389/fphar.2014.00034
10.3324/haematol.2010.027003
10.3324/haematol.2019.232124
10.1016/j.jhep.2012.06.015
10.3390/PH11040127
10.1007/s00109-008-0313-7
10.1182/blood-2018-06-815894
10.3389/fncel.2018.00242
10.3390/ijms20010017
10.1159/000328989
10.1016/j.molmed.2007.09.002
10.1002/hep.24267
10.1182/blood-2011-04-348698
10.1189/jlb.1208719
10.1177/1753425911405087
10.3390/cells5010012
10.1096/fj.201801638R
10.1016/j.bbamcr.2012.01.014
10.1182/blood-2012-02-411470
10.1210/en.2015-1747
10.1016/j.bcmd.2007.07.009
10.1042/BJ20121466
10.1016/j.cellsig.2008.06.017
10.1016/j.taap.2013.01.017
10.3389/fphar.2014.00104
10.1371/journal.pone.0044622
10.1016/j.cmet.2005.10.010
10.1002/hep.24178
10.1038/nchembio.2007.54
10.1074/jbc.M110.103705
10.1038/sj.onc.1203481
10.1111/j.1348-0421.2007.tb03885.x
10.3892/ijo.2014.2310
10.1038/onc.2015.446
10.1080/15384101.2016.1259037
10.1016/j.cmet.2008.09.012
10.1371/journal.pone.0082127
10.1126/science.1157121
10.1007/s10571-019-00694-4
10.3389/fphar.2014.00093
10.1038/ng1777
10.1038/ng.335
10.1038/ng.320
10.1101/gad.1167003
10.3389/fimmu.2014.00461
10.1158/1541-7786.MCR-12-0528
10.1097/MPG.0000000000001650
10.1016/j.bcmd.2005.04.006
10.4049/jimmunol.179.11.7840
10.1053/j.gastro.2007.12.008
10.3390/PH11040129
10.1074/jbc.RA118.001949",<Element 'PubmedArticle' at 0x7f05dbcd43b0>
170,"33821330
32903682
19347295
23959857
29630631
24478366
8858144
25781857
9464988
17180163
30423423
22577091
17956292
20195798
19539698
23356710
28634745
31551509
19823118
15286700
31675424
19917131
18601698
7181105
31068207
23499795
17965659
25531577
11518703
16785991
23856194
23874274
15647746
30040149
8843599
11327828
17317019
21507086
24252319
24975292
31263869
30500398
29497773
27281131
31823113
27126559
32653559
28475602
24345324
19481975
22397361
16371322
20185806
26733801
22024597
28642697
15695371
20570717
17963758
26874070
21524691
31365278
31866556",Prolactin Attenuates Neuroinflammation in LPS-Activated SIM-A9 Microglial Cells by Inhibiting NF-κB Pathways Via ERK1/2.,"Prolactin (PRL) is a pleiotropic hormone with multiple functions in several tissues and organs, including the brain. PRL decreases lesion-induced microgliosis and modifies gene expression related to microglial functions in the hippocampus, thereby providing a possible mechanism through which it might participate in neuroimmune modulatory responses and prevent neuronal cell damage. However, the direct contribution of microglial cells to PRL-mediated neuroprotection is still unclear and no studies have yet documented whether PRL can directly activate cellular pathways in microglial cells. The aim of this study is to elucidate in vitro actions of PRL on the immortalized SIM-A9 microglia cell line in basal and LPS-stimulated conditions. PRL alone induced a time-dependent extracellular signal-regulated kinase 1/2 (ERK1/2) activation. Pretreatment with PRL attenuated LPS (200 ng/ml) stimulated pro-inflammatory markers: nitric oxide (NO) levels, inducible nitric oxide synthase (iNOS), interleukins (IL)-6, -1β and tumor necrosis factor (TNF-α) expression at 20 nM dosage. PRL suppressed LPS-induced nuclear factor (NF)-κappaB (NF-κB) p65 subunit phosphorylation and its upstream p-ERK1/2 activity. In conclusion, PRL exhibits anti-inflammatory effects in LPS-stimulated SIM-A9 microglia by downregulating pro-inflammatory mediators corresponding to suppression of LPS-activated ERK1/2 and NF-κB phosphorylation.","['Cell signaling', 'Cytokines', 'Microglia', 'PRL', 'SIM-A9']",Cellular and molecular neurobiology,2021-04-07,"[{'lastname': 'Jayakumar', 'firstname': 'Preethi', 'initials': 'P', 'affiliation': 'Departamento de Neurobiología Celular y Molecular, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Querétaro, Mexico.'}, {'lastname': 'Martínez-Moreno', 'firstname': 'Carlos G', 'initials': 'CG', 'affiliation': 'Departamento de Neurobiología Celular y Molecular, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Querétaro, Mexico.'}, {'lastname': 'Lorenson', 'firstname': 'Mary Y', 'initials': 'MY', 'affiliation': 'Department of Biomedical Sciences, University of California, Riverside, CA, USA.'}, {'lastname': 'Walker', 'firstname': 'Ameae M', 'initials': 'AM', 'affiliation': 'Department of Biomedical Sciences, University of California, Riverside, CA, USA.'}, {'lastname': 'Morales', 'firstname': 'Teresa', 'initials': 'T', 'affiliation': 'Departamento de Neurobiología Celular y Molecular, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Querétaro, Mexico. marter@unam.mx.'}]",,,,"© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.","10.1007/s10571-021-01087-2
10.1016/j.brainres.2020.147014",<Element 'PubmedArticle' at 0x7f05df5843b0>
171,"33803741
27004698
30206328
31652490
22025055
26286145
26067058
25693054
31803024
31264132
28695372
30189290
31479168
25345894
31510070
31261683
26200949
32252470
33081988
28667781
29511094
26681259
31513776
32387458
16973755
19286473
28675779
26831265
10433246
15523635
18329265
31544208
28530125
32933155
21565615
7479947
23380505
12488809
18596173
24360280
30200996
27873219
27367681
17927664
17241129
31323920
32974017
19846611
18190798
28387723
8257576
17597217
27385308
26750656
28362078
26177193
25654303
23681668
32102369
31121852
17928160
19175406
31879837
26851069
23895397
32466385
28830026
26955967
18772232
26039990
32099945
29300865
29305886
28894435
29981391
31998078
28951257
22649384
30481569
15027878
16570918
25820735",De novo Neurosteroidogenesis in Human Microglia: Involvement of the 18 kDa Translocator Protein.,"Neuroactive steroids are potent modulators of microglial functions and are capable of counteracting their excessive reactivity. This action has mainly been ascribed to neuroactive steroids released from other sources, as microglia have been defined unable to produce neurosteroids de novo. Unexpectedly, immortalized murine microglia recently exhibited this de novo biosynthesis; herein, de novo neurosteroidogenesis was characterized in immortalized human microglia. The results demonstrated that C20 and HMC3 microglial cells constitutively express members of the neurosteroidogenesis multiprotein machinery-in particular, the transduceosome members StAR and TSPO, and the enzyme CYP11A1. Moreover, both cell lines produce pregnenolone and transcriptionally express the enzymes involved in neurosteroidogenesis. The high TSPO expression levels observed in microglia prompted us to assess its role in de novo neurosteroidogenesis. TSPO siRNA and TSPO synthetic ligand treatments were used to reduce and prompt TSPO function, respectively. The TSPO expression downregulation compromised the de novo neurosteroidogenesis and led to an increase in StAR expression, probably as a compensatory mechanism. The pharmacological TSPO stimulation the de novo neurosteroidogenesis improved in turn the neurosteroid-mediated release of Brain-Derived Neurotrophic Factor. In conclusion, these results demonstrated that de novo neurosteroidogenesis occurs in human microglia, unravelling a new mechanism potentially useful for future therapeutic purposes.","['18 kDa TSPO', 'BDNF', 'CYP11A1', 'StAR protein', 'TSPO ligands', 'human microglial cells', 'neurosteroidogenesis', 'neurosteroids']",International journal of molecular sciences,2021-04-04,"[{'lastname': 'Germelli', 'firstname': 'Lorenzo', 'initials': 'L', 'affiliation': 'Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.'}, {'lastname': 'Da Pozzo', 'firstname': 'Eleonora', 'initials': 'E', 'affiliation': 'Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.'}, {'lastname': 'Giacomelli', 'firstname': 'Chiara', 'initials': 'C', 'affiliation': 'Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.'}, {'lastname': 'Tremolanti', 'firstname': 'Chiara', 'initials': 'C', 'affiliation': 'Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.'}, {'lastname': 'Marchetti', 'firstname': 'Laura', 'initials': 'L', 'affiliation': 'Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.'}, {'lastname': 'Wetzel', 'firstname': 'Christian H', 'initials': 'CH', 'affiliation': 'Department of Psychiatry and Psychotherapy, Molecular Neurosciences, University of Regensburg, 93053 Regensburg, Germany.'}, {'lastname': 'Barresi', 'firstname': 'Elisabetta', 'initials': 'E', 'affiliation': 'Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.'}, {'lastname': 'Taliani', 'firstname': 'Sabrina', 'initials': 'S', 'affiliation': 'Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.'}, {'lastname': 'Da Settimo', 'firstname': 'Federico', 'initials': 'F', 'affiliation': 'Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.'}, {'lastname': 'Martini', 'firstname': 'Claudia', 'initials': 'C', 'affiliation': 'Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.'}, {'lastname': 'Costa', 'firstname': 'Barbara', 'initials': 'B', 'affiliation': 'Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.'}]",,,,,"10.3390/ijms22063115
10.1016/j.tcb.2016.02.006
10.1038/s41583-018-0057-5
10.3390/cells8101293
10.1038/nri3086
10.1186/s13195-015-0139-9
10.1016/j.pneurobio.2015.05.003
10.1111/jnc.13062
10.3389/fncel.2019.00514
10.1007/s10787-019-00613-5
10.1007/s11307-017-1099-1
10.1016/j.pharmthera.2018.09.003
10.1002/glia.23716
10.1111/bpa.12196
10.3390/ijms20184467
10.3390/ijms20133161
10.1016/j.jsbmb.2015.07.007
10.3390/cells9040870
10.1016/j.ejmech.2020.112924
10.1111/jne.12500
10.1042/BCJ20170766
10.1111/jne.12351
10.1016/j.yfrne.2019.100788
10.1016/j.bcp.2020.114015
10.1210/me.2006-0303
10.1016/j.bbalip.2009.03.001
10.1111/jne.12502
10.2174/1871527315666160202122032
10.1210/endo.140.8.6907
10.1016/s1569-2558(03)31024-0
10.1002/jnr.20348
10.1016/j.jsbmb.2007.12.013
10.1210/endrev/bnz005
10.1177/0271678X17710182
10.3390/cells9092091
10.1016/j.cell.2011.03.050
10.1073/pnas.92.24.11110
10.1016/j.neuroscience.2013.01.025
10.1097/00001756-200212030-00020
10.1523/JNEUROSCI.5268-07.2008
10.1016/j.cell.2013.11.030
10.1186/s12974-018-1288-0
10.1007/s13365-016-0499-3
10.20517/2347-8659.2018.60
10.3390/ijms17071028
10.1111/j.1365-2826.2007.01600.x
10.1111/j.1471-4159.2006.04307.x
10.3390/ijms20133359
10.3892/br.2020.1358
10.1210/en.2009-0752
10.1016/j.bbadis.2007.12.001
10.3390/ijms18040786
10.1002/mrd.1080360219
10.1016/j.pharmthera.2007.05.006
10.1021/acschemneuro.6b00149
10.1038/srep18164
10.1021/acschemneuro.7b00027
10.1021/acs.jmedchem.5b00689
10.1055/s-0035-1558003
10.1002/emmm.201202124
10.3390/cells9020512
10.3390/cells8050486
10.1016/j.psyneuen.2007.09.002
10.1111/j.1460-9568.2008.06591.x
10.1007/s12031-019-01454-1
10.1016/j.brainresbull.2016.02.001
10.1111/jnc.12382
10.3390/ijms21113740
10.1016/j.intimp.2017.08.007
10.2174/1570159X14666160309123554
10.1210/en.2008-0988
10.1073/pnas.1502670112
10.1210/jendso/bvaa001
10.1210/en.2017-03065
10.1016/j.yhbeh.2018.01.002
10.3389/fneur.2017.00442
10.1016/j.pneurobio.2018.06.007
10.3389/fncel.2019.00569
10.1016/j.jsbmb.2017.09.015
10.3389/fendo.2011.00073
10.1016/j.neuroscience.2018.11.029
10.1021/jm030973k
10.1021/jm060055x
10.1007/978-1-4939-2550-6_27",<Element 'PubmedArticle' at 0x7f05dbcf0270>
172,"33802689
21527731
19302036
19864556
24844438
7724569
24927796
28336953
16146656
26714634
10725699
19382211
8808786
23626522
20876360
23357419
25404893
28932183
25237008
11983155
10837071
31982922
33260658
12037135
16086683
25637536
26965148
31396087
22229320
15465922
11485574
31077796
17180163
2089275
27459405
25598354
28280458
18435916
17569869
10751435
11772946
11342663
24813072
18804455
21382557
16547515
21835925
8819477
32496649
28848398
29038483
19447135
20461235",Palmitoylethanolamide Modulation of Microglia Activation: Characterization of Mechanisms of Action and Implication for Its Neuroprotective Effects.,"Palmitoylethanolamide (PEA) is an endogenous lipid produced on demand by neurons and glial cells that displays neuroprotective properties. It is well known that inflammation and neuronal damage are strictly related processes and that microglia play a pivotal role in their regulation. The aim of the present work was to assess whether PEA could exert its neuroprotective and anti-inflammatory effects through the modulation of microglia reactive phenotypes. In N9 microglial cells, the pre-incubation with PEA blunted the increase of M1 pro-inflammatory markers induced by lipopolysaccharide (LPS), concomitantly increasing those M2 anti-inflammatory markers. Images of microglial cells were processed to obtain a set of morphological parameters that highlighted the ability of PEA to inhibit the LPS-induced M1 polarization and suggested that PEA might induce the anti-inflammatory M2a phenotype. Functionally, PEA prevented Ca","['LPS', 'cannabinoid receptor', 'cytokines', 'electrophysiology', 'microglia', 'morphotypes', 'neuroinflammation', 'palmitoylethanolamide']",International journal of molecular sciences,2021-04-04,"[{'lastname': ""D'Aloia"", 'firstname': 'Alessia', 'initials': 'A', 'affiliation': 'Department of Biotechnology and Biosciences, University of Milano-Bicocca, 20126 Milano, Italy.'}, {'lastname': 'Molteni', 'firstname': 'Laura', 'initials': 'L', 'affiliation': 'School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.'}, {'lastname': 'Gullo', 'firstname': 'Francesca', 'initials': 'F', 'affiliation': 'Department of Biotechnology and Biosciences, University of Milano-Bicocca, 20126 Milano, Italy.'}, {'lastname': 'Bresciani', 'firstname': 'Elena', 'initials': 'E', 'affiliation': 'School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.'}, {'lastname': 'Artusa', 'firstname': 'Valentina', 'initials': 'V', 'affiliation': 'Department of Biotechnology and Biosciences, University of Milano-Bicocca, 20126 Milano, Italy.'}, {'lastname': 'Rizzi', 'firstname': 'Laura', 'initials': 'L', 'affiliation': 'School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.'}, {'lastname': 'Ceriani', 'firstname': 'Michela', 'initials': 'M', 'affiliation': 'Department of Biotechnology and Biosciences, University of Milano-Bicocca, 20126 Milano, Italy.'}, {'lastname': 'Meanti', 'firstname': 'Ramona', 'initials': 'R', 'affiliation': 'School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.'}, {'lastname': 'Lecchi', 'firstname': 'Marzia', 'initials': 'M', 'affiliation': 'Department of Biotechnology and Biosciences, University of Milano-Bicocca, 20126 Milano, Italy.'}, {'lastname': 'Coco', 'firstname': 'Silvia', 'initials': 'S', 'affiliation': 'School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.'}, {'lastname': 'Costa', 'firstname': 'Barbara', 'initials': 'B', 'affiliation': 'Department of Biotechnology and Biosciences, University of Milano-Bicocca, 20126 Milano, Italy.'}, {'lastname': 'Torsello', 'firstname': 'Antonio', 'initials': 'A', 'affiliation': 'School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.'}]",,,,,"10.3390/ijms22063054
10.1152/physrev.00011.2010
10.1146/annurev.immunol.021908.132528
10.1523/JNEUROSCI.3257-09.2009
10.1016/j.phrs.2014.05.006
10.1073/pnas.92.8.3376
10.1186/1742-2094-11-108
10.1038/s41598-017-00342-1
10.1016/j.jneuroim.2005.08.006
10.1186/s12974-015-0458-6
10.4049/jimmunol.164.7.3476
10.1002/glia.20874
10.1016/0197-0186(95)00141-7
10.13140/2.1.3576.6082
10.1007/BF02289263
10.3389/fncel.2013.00049
10.1085/jgp.201010476
10.1016/j.bbrc.2013.01.064
10.3389/fncel.2014.00361
10.3389/fnins.2017.00500
10.1016/j.intimp.2014.09.007
10.1016/S0092-8674(02)00703-1
10.1146/annurev.immunol.18.1.621
10.1007/s00228-019-02799-7
10.3390/ijms21239074
10.1124/pr.54.2.161
10.1111/j.1471-4159.2005.03380.x
10.1016/j.bbrc.2015.01.073
10.1016/j.plipres.2016.02.002
10.3389/fphar.2019.00821
10.2174/187152711799219307
10.1124/mol.104.006353
10.1042/bj3580249
10.1016/j.semcdb.2019.05.004
10.1038/nrn2038
10.1016/0306-4522(90)90229-W
10.1038/nn.4338
10.1007/s12035-014-9070-5
10.3389/fncel.2017.00041
10.1016/j.bbrc.2008.04.055
10.1126/science.1139111
10.1523/JNEUROSCI.20-08-02835.2000
10.1096/fj.01-0514fje
10.4049/jimmunol.166.10.6383
10.1016/j.jtbi.2014.04.024
10.1016/j.brainres.2008.08.085
10.1016/j.neuron.2011.02.003
10.1038/nature04671
10.1074/jbc.M111.280826
10.1002/sctm.19-0327
10.3389/fncel.2017.00235
10.1038/s41598-017-13581-z
10.1016/j.jneumeth.2009.05.003
10.3389/fncir.2010.00011",<Element 'PubmedArticle' at 0x7f05d9edef90>
173,33794337,17β-Estradiol Reduces Demyelination in Cuprizone-fed Mice by Promoting M2 Microglia Polarity and Regulating NLRP3 Inflammasome.,"Estrogen produces a beneficial role in animal models of multiple sclerosis (MS). The effect of 17β-estradiol therapy on microglia polarization and neuroinflammation in the corpus callosum of the cuprizone-induced demyelination model has not been elucidated. In this study, mice were given 0.2% cuprizone (CPZ) for 5 weeks to induce demyelination during which they received 50 ng of 17β-estradiol (EST), injected subcutaneously in the neck region, twice weekly. Data revealed that treatment with 17β-estradiol therapy (CPZ+EST) improved neurological behavioral deficits, displayed by a significant reduction in escape latencies, in comparison to untreated CPZ mice. Also, administration of 17β-estradiol caused a decrease in demyelination levels and axonal injury, as demonstrated by staining with Luxol fast blue, immunofluorescence to myelin basic protein, and transmission electron microscopy analysis. In addition, at the transcriptional level in the brain, mice treated with 17β-estradiol (CPZ+EST) showed a decrease in the levels of M1-assosicted microglia markers (CD86, iNOS and MHC-II) whereas M2-associated genes (Arg-1, CD206 and Trem-2) were increased, compared to CPZ mice. Moreover, administration of 17β-estradiol resulted in a significant reduction (∼3-fold) in transcript levels of NLRP3 inflammasome and its downstream product IL-18, compared to controls. In summary, this study demonstrated for the first time that exogenous 17β-estradiol therapy robustly leads to the reduction of M1 phenotype, stimulation of polarized M2 microglia, and repression of NLRP3 inflammasome in the corpus callosum of CPZ demyelination model of MS. The positive effects of 17β-estradiol on microglia and inflammasome seems to facilitate and accelerate the remyelination process.","['17β-estradiol', 'inflammasome', 'microglia', 'multiple sclerosis', 'neuroinflammation']",Neuroscience,2021-04-02,"[{'lastname': 'Aryanpour', 'firstname': 'Roya', 'initials': 'R', 'affiliation': 'Department of Anatomy, Faculty of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran.'}, {'lastname': 'Zibara', 'firstname': 'Kazem', 'initials': 'K', 'affiliation': 'PRASE and Biology Department, Faculty of Sciences-I, Lebanese University, Beirut, Lebanon. Electronic address: kzibara@ul.edu.lb.'}, {'lastname': 'Pasbakhsh', 'firstname': 'Parichehr', 'initials': 'P', 'affiliation': 'Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.'}, {'lastname': ""Jame'ei"", 'firstname': 'Seyyed Behnamodin', 'initials': 'SB', 'affiliation': 'Neuroscience Research Center (NRC), Iran University of Medical Sciences, Tehran, Iran.'}, {'lastname': 'Namjoo', 'firstname': 'Zeinab', 'initials': 'Z', 'affiliation': 'Department of Anatomical Science, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.'}, {'lastname': 'Ghanbari', 'firstname': 'Amir', 'initials': 'A', 'affiliation': 'Cell and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.'}, {'lastname': 'Mahmoudi', 'firstname': 'Reza', 'initials': 'R', 'affiliation': 'Cell and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.'}, {'lastname': 'Amani', 'firstname': 'Showan', 'initials': 'S', 'affiliation': 'Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.'}, {'lastname': 'Kashani', 'firstname': 'Iraj Ragerdi', 'initials': 'IR', 'affiliation': 'Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: ragerdi@tums.ac.ir.'}]",,,,Copyright © 2021 IBRO. Published by Elsevier Ltd. All rights reserved.,10.1016/j.neuroscience.2021.03.025,<Element 'PubmedArticle' at 0x7f05dca3a5e0>
174,"33724565
26362308
29530410
10322493
6732927
24465979
25814942
30764477
14620878
25653382
32805389
15345694
12072366
18995817
15342202
30417584
10024357
12498785
11910117
28695372
22277195
28687925
16368758
18583543
11426226
22537595
17950926
8421494
29194444
19419681
15265638
20155811
27142940
16221841
11513911
7935815
24013726
32046333
31139053
8637616
8078107
23160045
25047355
27100937
27666383
31849606
8986335
16672292
7917040
21835925
30464763
8742036
9825958
15891777
29428549
23747799
27301858
31703966
31896673
23207108
22520439
16107281
25151944
25814934
32660586
28122877
15866053
31277944
31555091
29752066
26799851
10036289
29104062
24485491
22041296
25816800
27004698
26724575
9572271
23441623
33609158
31082652
14654461
1122202
32868
29574097
32662924
17976923
20012873
31818979
26074918
18622402
31209379
26091541
7714238
23548902
26984188
31078757
9724801
12125082
16498631
26352471
23254930
20231476
24766931
22653796
9037082
28027926
11099416
27033548
17923095
8785058
21113196
14670360
31131941
9630473
26831917
11112799
28742159
29931997
26217190
19339973
21571575
16513410
23023031
29575542
16165282
22944319
16361444
16033944
19840854
19217372
23312512
27400854
28894284
21918553
19151626
30127720
9287082
16819994
22013419
2089275
31138227
27581371
30050134
30641077
31715030
9067442
3955350
28099414
24278397
10903573
25472821
20051515
31636449
28123022
17466428
25773161
26373828
30367946
19305644
27338705
32765501
9062657
26937001
19932757
10869418
28808323
26231972
27558646
6098436
12423672
23850597
24896183
8328303
16278020
25269685
32615087
26551431
1313244
11606764
8348300
14711996
20463226
24860431
21778362
22857738
24360280
26793072
31394203
19615761
2987017
24638131
10382268
21952260
19196909
9189265
30217162
27877121
2998738
29873040
15834420
20368707
24126929
19272439
29861718
30891446
22072675
19469026
9075247
16611726
9247987
26431692
14597099
15601948
7981871
10696570
19190638
30980044
26232650
22632727
22829357
28943292
23871473
19931555
22678511
30718903
27956744
25729759
20887954
18286612
31635851
24392228
15788779
22715882
18083105
31636451
17433555
31847911
31036962
9145302
10899938
1337194
12815711
29275859
26348580
21072242
22072657
17709755
20153418
32103452
29420261
29882317
27957532
26819772
25355243
27876790
23520517
11179843
29141671
23260014
18685038
26286145
32029629
28092020
29665808
8719612
25568124
30527629
23835908
29581545
23619393
8484004
22031897
21525267
1613547
8245220
26431938
26478868
25907153
26766634
30673509
21349253
19666502
20458323
22405206
24769004
25830666
20849967
21965192",An emerging role for microglia in stress-effects on memory.,"Stressful experiences evoke, among others, a rapid increase in brain (nor)epinephrine (NE) levels and a slower increase in glucocorticoid hormones (GCs) in the brain. Microglia are key regulators of neuronal function and contain receptors for NE and GCs. These brain cells may therefore potentially be involved in modulating stress effects on neuronal function and learning and memory. In this review, we discuss that stress induces (1) an increase in microglial numbers as well as (2) a shift toward a pro-inflammatory profile. These microglia have (3) impaired crosstalk with neurons and (4) disrupted glutamate signaling. Moreover, microglial immune responses after stress (5) alter the kynurenine pathway through metabolites that impair glutamatergic transmission. All these effects could be involved in the impairments in memory and in synaptic plasticity caused by (prolonged) stress, implicating microglia as a potential novel target in stress-related memory impairments.","['corticosterone', 'glucocorticoids', 'learning', 'norepinephrine', 'synapses']",The European journal of neuroscience,2021-03-17,"[{'lastname': 'Sanguino-Gómez', 'firstname': 'Jeniffer', 'initials': 'J', 'affiliation': 'Brain Plasticity Group, SILS-CNS, University of Amsterdam, Amsterdam, The Netherlands.'}, {'lastname': 'Buurstede', 'firstname': 'Jacobus C', 'initials': 'JC', 'affiliation': 'Department of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands.'}, {'lastname': 'Abiega', 'firstname': 'Oihane', 'initials': 'O', 'affiliation': 'Brain Plasticity Group, SILS-CNS, University of Amsterdam, Amsterdam, The Netherlands.'}, {'lastname': 'Fitzsimons', 'firstname': 'Carlos P', 'initials': 'CP', 'affiliation': 'Brain Plasticity Group, SILS-CNS, University of Amsterdam, Amsterdam, The Netherlands.'}, {'lastname': 'Lucassen', 'firstname': 'Paul J', 'initials': 'PJ', 'affiliation': 'Brain Plasticity Group, SILS-CNS, University of Amsterdam, Amsterdam, The Netherlands.'}, {'lastname': 'Eggen', 'firstname': 'Bart J L', 'initials': 'BJL', 'affiliation': 'Department of Biomedical Sciences of Cells & Systems, Section Molecular Neurobiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.'}, {'lastname': 'Lesuis', 'firstname': 'Sylvie L', 'initials': 'SL', 'affiliation': 'Brain Plasticity Group, SILS-CNS, University of Amsterdam, Amsterdam, The Netherlands.\nProgram in Neurosciences and Mental Health, Hospital for Sick Children, Toronto, ON, Canada.'}, {'lastname': 'Meijer', 'firstname': 'Onno C', 'initials': 'OC', 'affiliation': 'Department of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands.'}, {'lastname': 'Krugers', 'firstname': 'Harm J', 'initials': 'HJ', 'affiliation': 'Brain Plasticity Group, SILS-CNS, University of Amsterdam, Amsterdam, The Netherlands.'}]",,,,© 2021 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.,"10.1111/ejn.15188
10.1007/s12035-015-9408-7
10.1016/j.smim.2018.02.011
10.1016/S0166-2236(98)01349-6
10.1037/0735-7044.98.3.496
10.1371/journal.pone.0086236
10.3389/fnbeh.2015.00060
10.3390/cells8020125
10.1002/hipo.10135
10.1523/JNEUROSCI.3751-14.2015
10.1096/fj.04-1625fje
10.1016/S1471-4906(02)02223-8
10.1016/j.neuron.2008.10.013
10.1016/j.jneuroim.2004.06.009
10.1002/glia.23508
10.1523/JNEUROSCI.19-05-01708.1999
10.1006/mcne.2002.1185
10.1007/s11307-017-1099-1
10.1186/1742-2094-9-23
10.1007/s00441-017-2649-1
10.1073/pnas.0503878102
10.1634/stemcells.2007-0914
10.1038/89490
10.1016/j.brainresbull.2012.04.008
10.1016/j.tins.2007.08.007
10.1371/journal.pone.0187631
10.1016/j.physbeh.2009.01.012
10.1016/j.bbr.2003.12.018
10.1002/jnr.22362
10.1186/s12974-016-0563-1
10.1523/JNEUROSCI.2281-05.2005
10.1038/cdd.2013.108
10.3390/jcm9020468
10.3389/fncel.2019.00214
10.1016/0306-4522(95)00236-C
10.1002/jnr.490380213
10.1038/ncomms5486
10.1002/glia.22991
10.1016/j.ijdevneu.2016.09.010
10.3389/fnmol.2019.00292
10.1037/0735-7044.110.6.1321
10.1093/brain/awl082
10.1037/0735-7044.108.3.469
10.1074/jbc.M111.280826
10.3389/fimmu.2018.02576
10.1016/0304-3940(95)12252-4
10.1002/(SICI)1098-1063(1998)8:5<458:AID-HIPO6>3.0.CO;2-N
10.1038/nrn1683
10.1016/j.yfrne.2018.02.003
10.1016/j.bbi.2013.05.011
10.1016/j.bbi.2016.06.006
10.1016/j.neubiorev.2019.10.013
10.1523/JNEUROSCI.0993-19.2019
10.1016/j.bbi.2012.11.013
10.1186/1742-2094-9-71
10.1016/j.bbr.2005.06.020
10.1016/j.nlm.2014.08.008
10.3389/fncel.2015.00084
10.1186/s12974-020-01883-5
10.1093/brain/aww349
10.1016/j.mcn.2005.01.003
10.1016/j.bbrc.2019.06.134
10.3389/fnmol.2019.00210
10.1016/j.immuni.2018.04.016
10.1016/j.psyneuen.2016.01.006
10.1152/jn.1999.81.2.925
10.1016/j.bbi.2017.11.001
10.1016/j.psyneuen.2013.11.006
10.1016/j.bbi.2011.10.005
10.1016/j.bbi.2015.03.010
10.1016/j.tcb.2016.02.006
10.1046/j.1471-4159.1998.70051876.x
10.1111/bph.12139
10.1007/s00401-021-02263-w
10.1016/j.jpsychires.2019.05.001
10.1093/cercor/bhg108
10.1016/S0091-6773(75)91784-8
10.1016/S0091-6773(78)93045-6
10.1016/j.neuropharm.2018.03.023
10.1016/j.psyneuen.2007.09.004
10.1007/s00401-009-0622-0
10.1523/JNEUROSCI.1523-19.2019
10.3389/fimmu.2015.00249
10.1038/s41593-019-0419-y
10.1371/journal.pone.0130624
10.1002/cne.903520111
10.1074/jbc.M113.458901
10.1016/j.psyneuen.2019.04.021
10.1073/pnas.95.18.10896
10.1002/jnr.10304
10.1002/glia.20322
10.1073/pnas.0909586107
10.1016/j.tins.2014.03.006
10.1002/glia.22366
10.1073/pnas.94.4.1500
10.1016/j.bbi.2016.12.023
10.1016/j.cell.2007.09.017
10.1016/S0896-6273(00)80080-X
10.1007/s12264-010-6023-5
10.1016/j.nlm.2003.09.002
10.1111/neup.12560
10.1016/S0169-328X(98)00040-0
10.1016/j.biopsych.2015.11.026
10.1101/lm.32600
10.1371/journal.pcbi.1005657
10.1177/1073858418783959
10.3389/fncel.2015.00268
10.1038/nrn2632
10.1016/j.tics.2011.04.004
10.1016/j.tics.2006.02.002
10.1124/pr.112.005892
10.1016/j.neuroscience.2005.06.090
10.1016/j.jneuroim.2012.08.007
10.1073/pnas.0507572102
10.1152/jn.00143.2005
10.1016/j.mcn.2009.10.003
10.1016/j.neuron.2009.01.015
10.1016/j.neuron.2012.12.023
10.1038/mp.2016.103
10.1038/s41598-017-11634-x
10.1038/gt.2011.126
10.1097/NEN.0b013e3181964113
10.3389/fncel.2018.00206
10.1111/j.1460-9568.2006.04842.x
10.3389/fnbeh.2011.00062
10.1016/0306-4522(90)90229-W
10.1186/s12974-019-1506-4
10.1186/s12974-016-0672-x
10.1038/s41598-018-28737-8
10.1016/j.neuropharm.2019.01.010
10.1111/jne.12811
10.1016/S0006-8993(96)01283-8
10.1016/0006-8993(86)91049-8
10.1371/journal.pone.0081218
10.1038/77702
10.3109/10253890.2014.995085
10.1074/jbc.M109.050229
10.1523/JNEUROSCI.2235-16.2016
10.1016/j.bandc.2007.02.007
10.1016/j.semcdb.2015.03.002
10.1101/lm.039222.115
10.1016/j.neuroscience.2018.10.030
10.1371/journal.pone.0004714
10.1126/science.aad8670
10.3389/fimmu.2020.01416
10.1016/S0166-4328(97)86042-1
10.1523/JNEUROSCI.2394-15.2016
10.1016/j.nlm.2009.11.005
10.1073/pnas.090017497
10.1016/j.bbi.2015.07.024
10.1038/ncomms12540
10.1016/S0028-3908(02)00211-3
10.1016/j.nlm.2013.07.002
10.1016/0736-5748(93)90081-N
10.1016/j.jneuroim.2005.09.012
10.1002/hipo.22374
10.1016/j.cell.2020.05.050
10.1016/j.bbi.2015.08.022
10.1037/0735-7044.106.1.62
10.1073/pnas.231313998
10.1016/0006-8993(93)90468-3
10.1073/pnas.0307803100
10.1523/JNEUROSCI.0247-10.2010
10.3389/fncel.2014.00129
10.1017/S1740925X12000105
10.1016/j.cell.2013.11.030
10.1016/j.nbd.2019.104568
10.1016/j.tins.2009.05.001
10.1016/0014-4886(85)90072-X
10.1038/nrneurol.2014.38
10.1007/s004410051285
10.1038/nn.2923
10.1101/lm.1272409
10.1037/0735-7044.111.3.503
10.1186/s12974-018-1306-2
10.3389/fnhum.2016.00566
10.1210/endo-117-6-2505
10.1007/s12035-018-1161-2
10.1038/nn1441
10.1038/mp.2010.40
10.1038/mp.2013.134
10.1016/j.bbi.2009.02.020
10.3389/fcell.2019.00024
10.1523/JNEUROSCI.3667-11.2011
10.1038/nrn2651
10.1006/nlme.1996.3765
10.1073/pnas.0601874103
10.1016/S0306-4530(96)00028-5
10.1016/j.bbi.2015.09.017
10.1016/j.jneuroim.2003.08.030
10.1523/JNEUROSCI.2251-04.2004
10.1111/j.1460-9568.1994.tb00319.x
10.1038/nrn2573
10.1038/s41380-019-0414-4
10.1016/j.psyneuen.2015.07.609
10.1016/j.neuron.2012.03.026
10.1002/glia.22389
10.1016/j.bbi.2017.09.013
10.1016/j.biopsych.2013.06.001
10.1016/j.neubiorev.2009.11.015
10.1038/nrn3257
10.1038/s41593-018-0334-7
10.1038/mp.2016.220
10.1016/j.ynstr.2014.09.005
10.1016/j.stem.2010.08.014
10.1002/glia.20644
10.1016/j.tins.2019.09.004
10.1155/2013/425845
10.1523/JNEUROSCI.4486-04.2005
10.1146/annurev-neuro-061010-113810
10.1016/j.cell.2007.10.036
10.1038/s41593-019-0514-0
10.1016/j.neuroscience.2007.02.043
10.1038/s41577-019-0165-0
10.1002/(SICI)1098-1136(199705)20:1<23:AID-GLIA3>3.0.CO;2-6
10.1046/j.1471-4159.2000.0750634.x
10.1016/0304-3940(92)90071-E
10.1002/jnr.10645
10.1016/j.cell.2017.11.042
10.1016/j.bbi.2015.09.001
10.1371/journal.pbio.1000527
10.1523/JNEUROSCI.4158-11.2011
10.1073/pnas.0704621104
10.1016/j.bbi.2010.02.001
10.1007/s12264-020-00477-8
10.1126/science.aal3589
10.1111/acel.12790
10.1523/ENEURO.0297-16.2016
10.1155/2016/7215684
10.1038/npp.2014.271
10.1038/npp.2016.262
10.1371/journal.pone.0058488
10.1016/S0361-9230(00)00377-4
10.1016/j.tins.2012.11.007
10.1523/JNEUROSCI.1006-08.2008
10.1186/s13195-015-0139-9
10.1007/s12640-016-9696-3
10.1186/s12974-018-1137-1
10.1016/0006-8993(95)01059-9
10.1523/JNEUROSCI.3561-14.2015
10.1038/mp.2013.83
10.1038/s41467-018-03566-5
10.1016/j.neuint.2013.04.007
10.1016/0301-0082(93)90035-Q
10.1523/JNEUROSCI.3688-11.2011
10.1523/JNEUROSCI.0450-11.2011
10.1002/cne.903360210
10.1016/j.it.2015.08.008
10.1016/j.brainres.2015.04.010
10.1096/fj.201802297R
10.1016/j.brainres.2011.02.045
10.1073/pnas.0906791106
10.1038/mp.2010.50
10.1016/j.neuron.2011.12.033
10.1016/j.nbd.2014.04.008
10.1038/srep09513
10.1016/j.nlm.2010.09.005
10.1177/0269881111424930",<Element 'PubmedArticle' at 0x7f05dca2ca40>
175,33709562,Melatonin prevents diabetes-associated cognitive dysfunction from microglia-mediated neuroinflammation by activating autophagy via TLR4/Akt/mTOR pathway.,"Cognitive dysfunction often occurs in diabetes mellitus patients. This study aimed to investigate the efficacy of melatonin (MLT) in improving diabetes-associated cognitive decline and the underlying mechanism involved. Type 2 diabetic mice and palmitic acid (PA)-stimulated BV-2 cells were treated by MLT, and the potential mechanisms among MLT, cognition, and autophagy were explored. The results showed that type 2 diabetic mice showed obvious learning and memory impairments in the Morris water maze test compared with normal controls, which could be ameliorated by MLT treatment. Meanwhile, MLT administration significantly improved neuroinflammation and regulated microglial apoptosis. Furthermore, autophagy inhibitor 3-methyladenine (3-MA) increased the microglial inflammation and apoptosis, indicating that the treatment effect of MLT was mediated by autophagy. Lastly, MLT treatment significantly decreased the levels of toll-like receptors 4 (TLR4), phosphorylated-protein kinase B (Akt), and phosphorylated-mechanistic target of rapamycin (mTOR), indicating that blocking TLR4/Akt/mTOR pathway might be an underlying basis for the anti-inflammatory and anti-apoptosis effects of MLT. Collectively, our study suggested that MLT could improve learning and memory in type 2 diabetic mice by activating autophagy via the TLR4/Akt/mTOR pathway, thereby inhibiting neuroinflammation and microglial apoptosis.","['apoptosis', 'autophagy', 'cognition', 'melatonin', 'neuroinflammation']",FASEB journal : official publication of the Federation of American Societies for Experimental Biology,2021-03-13,"[{'lastname': 'Cui', 'firstname': 'Yixin', 'initials': 'Y', 'affiliation': 'Department of Endocrinology, Qilu Hospital of Shandong University, Jinan, China.\nInstitute of Endocrine and Metabolic Diseases, Shandong University, Jinan, China.'}, {'lastname': 'Yang', 'firstname': 'Mengmeng', 'initials': 'M', 'affiliation': 'Department of Endocrinology, Qilu Hospital of Shandong University, Jinan, China.\nInstitute of Endocrine and Metabolic Diseases, Shandong University, Jinan, China.'}, {'lastname': 'Wang', 'firstname': 'Yilin', 'initials': 'Y', 'affiliation': ""Department of Traumatic Orthopedics, Peking University People's Hospital, Beijing, China.""}, {'lastname': 'Ren', 'firstname': 'Jianmin', 'initials': 'J', 'affiliation': 'Department of Endocrinology, Qilu Hospital of Shandong University, Jinan, China.\nInstitute of Endocrine and Metabolic Diseases, Shandong University, Jinan, China.\nKey Laboratory of Endocrine and Metabolic Diseases, Shandong Province Medicine & Health, Jinan, China.\nJinan Clinical Research Center for Endocrine and Metabolic Diseases, Jinan, China.'}, {'lastname': 'Lin', 'firstname': 'Peng', 'initials': 'P', 'affiliation': 'Department of Endocrinology, Qilu Hospital of Shandong University, Jinan, China.\nInstitute of Endocrine and Metabolic Diseases, Shandong University, Jinan, China.\nKey Laboratory of Endocrine and Metabolic Diseases, Shandong Province Medicine & Health, Jinan, China.\nJinan Clinical Research Center for Endocrine and Metabolic Diseases, Jinan, China.'}, {'lastname': 'Cui', 'firstname': 'Chen', 'initials': 'C', 'affiliation': 'Department of Endocrinology, Qilu Hospital of Shandong University, Jinan, China.\nInstitute of Endocrine and Metabolic Diseases, Shandong University, Jinan, China.'}, {'lastname': 'Song', 'firstname': 'Jia', 'initials': 'J', 'affiliation': 'Department of Endocrinology, Qilu Hospital of Shandong University, Jinan, China.\nInstitute of Endocrine and Metabolic Diseases, Shandong University, Jinan, China.'}, {'lastname': 'He', 'firstname': 'Qin', 'initials': 'Q', 'affiliation': 'Department of Endocrinology, Qilu Hospital of Shandong University, Jinan, China.\nInstitute of Endocrine and Metabolic Diseases, Shandong University, Jinan, China.\nKey Laboratory of Endocrine and Metabolic Diseases, Shandong Province Medicine & Health, Jinan, China.\nJinan Clinical Research Center for Endocrine and Metabolic Diseases, Jinan, China.'}, {'lastname': 'Hu', 'firstname': 'Huiqing', 'initials': 'H', 'affiliation': 'Department of Endocrinology, Qilu Hospital of Shandong University, Jinan, China.\nInstitute of Endocrine and Metabolic Diseases, Shandong University, Jinan, China.'}, {'lastname': 'Wang', 'firstname': 'Kexin', 'initials': 'K', 'affiliation': 'Department of General Surgery, Qilu Hospital of Shandong University, Jinan, China.'}, {'lastname': 'Sun', 'firstname': 'Yu', 'initials': 'Y', 'affiliation': 'Department of Endocrinology, Qilu Hospital of Shandong University, Jinan, China.\nInstitute of Endocrine and Metabolic Diseases, Shandong University, Jinan, China.\nKey Laboratory of Endocrine and Metabolic Diseases, Shandong Province Medicine & Health, Jinan, China.\nJinan Clinical Research Center for Endocrine and Metabolic Diseases, Jinan, China.'}]",,,,© 2021 The Authors. The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology.,10.1096/fj.202002247RR,<Element 'PubmedArticle' at 0x7f05dd5377c0>
176,"33670244
21376230
18617599
15585981
26713745
16775224
18505050
30054667
27814616
30406030
33214545
31635909
22644327
26518624
26685886
30539670
31546700
19390836
32152949
29169316
32958700
29118226
27020328
26520780
29733389
30443853
31741237
21479583
30778375
28138871
20962642
29328002
15685605
15588281
18443955
26125449
21737504
16029802
22951720
20978269
18097448
32172947
29486795
25100205
25002752
24316888
25598354
23145206
21670502
23130157
6408859
26500844
30926789
31160587
29867979
31541850
30374421
31290002
23321511
32527943
33239433
33149188
24045940
22467657
28258691
24569453
30130255
22585926
20219118
19387537
20203208
30953118
31819511
32845322
33240817
31805552
24799499
29209331
28137763
25252903
28860481
12765789
33251699
29912148
25855199
19371771
9468328
367104
31882261
27892504
23650109
32101575
30864696
24651229
8884374
25650983
23991225",The Paired Siglecs in Brain Tumours Therapy: The Immunomodulatory Effect of Dexamethasone and Temozolomide in Human Glioma In Vitro Model.,"The paired sialic acid-binding immunoglobulin like lectins (Siglecs) are characterized by similar cellular distribution and ligand recognition but opposing signalling functions attributed to different intracellular sequences. Since sialic acid-Siglec axis are known to control immune homeostasis, the imbalance between activatory and inhibitory mechanisms of glycan-dependent immune control is considered to promote pathology. The role of sialylation in cancer is described, however, its importance in immune regulation in gliomas is not fully understood. The experimental and clinical observation suggest that dexamethasone (Dex) and temozolomide (TMZ), used in the glioma management, alter the immunity within the tumour microenvironment. Using glioma-microglia/monocytes transwell co-cultures, we investigated modulatory action of Dex/TMZ on paired Siglecs. Based on real-time PCR and flow cytometry, we found changes in SIGLEC genes and their products. These effects were accompanied by altered cytokine profile and immune cells phenotype switching measured by arginases expression. Additionally, the exposure to Dex or TMZ increased the binding of inhibitory Siglec-5 and Siglec-11 fusion proteins to glioma cells. Our study suggests that the therapy-induced modulation of the interplay between sialoglycans and paired Siglecs, dependently on patient's phenotype, is of particular signification in the immune surveillance in the glioma management and may be useful in glioma patient's therapy plan verification.","['Siglec', 'dexamethasone', 'glioma', 'microglia', 'temozolomide']",International journal of molecular sciences,2021-03-07,"[{'lastname': 'Wielgat', 'firstname': 'Przemyslaw', 'initials': 'P', 'affiliation': 'Department of Clinical Pharmacology, Medical University of Bialystok, Waszyngtona 15A, 15-274 Bialystok, Poland.'}, {'lastname': 'Wawrusiewicz-Kurylonek', 'firstname': 'Natalia', 'initials': 'N', 'affiliation': 'Department of Clinical Genetics, Medical University of Bialystok, Waszyngtona 13, 15-089 Bialystok, Poland.'}, {'lastname': 'Czarnomysy', 'firstname': 'Robert', 'initials': 'R', 'affiliation': 'Department of Synthesis and Technology of Drugs, Medical University of Bialystok, Kilińskiego 1, 15-089 Bialystok, Poland.'}, {'lastname': 'Rogowski', 'firstname': 'Karol', 'initials': 'K', 'affiliation': 'Department of Experimental Pharmacology, Medical University of Bialystok, Szpitalna 37, 15-295 Bialystok, Poland.'}, {'lastname': 'Bielawski', 'firstname': 'Krzysztof', 'initials': 'K', 'affiliation': 'Department of Synthesis and Technology of Drugs, Medical University of Bialystok, Kilińskiego 1, 15-089 Bialystok, Poland.'}, {'lastname': 'Car', 'firstname': 'Halina', 'initials': 'H', 'affiliation': 'Department of Clinical Pharmacology, Medical University of Bialystok, Waszyngtona 15A, 15-274 Bialystok, Poland.\nDepartment of Experimental Pharmacology, Medical University of Bialystok, Szpitalna 37, 15-295 Bialystok, Poland.'}]",,,,,"10.3390/ijms22041791
10.1016/j.cell.2011.02.013
10.1215/15228517-2008-049
10.1159/000080371
10.1038/nn.4185
10.1215/15228517-2006-008
10.1007/s00262-018-2214-0
10.2741/4486
10.3389/fonc.2018.00464
10.1038/s41392-020-00347-9
10.1016/j.nmd.2019.09.014
10.1007/s10719-012-9394-1
10.1093/glycob/cwv097
10.1007/s12253-015-0033-6
10.4155/fmc-2018-0298
10.3390/cells8101125
10.1007/s00109-009-0472-1
10.1186/s12862-017-1075-z
10.1158/1078-0432.CCR-19-2925
10.6004/jnccn.2017.0166
10.1093/brain/aww046
10.1186/s13014-015-0527-0
10.1093/neuonc/noy072
10.1007/s11010-018-3478-6
10.1007/s12026-019-09106-7
10.1007/s00701-011-1001-x
10.3389/fonc.2019.00041
10.1007/s11910-017-0713-6
10.1097/WCO.0b013e32833e5a5d
10.3171/2017.7.JNS17668
10.1002/glia.20168
10.1186/1476-4598-3-36
10.1080/07357900701788080
10.1038/bjc.2015.238
10.1158/1078-0432.CCR-11-0774
10.1016/j.ijrobp.2004.12.085
10.1038/jid.2012.273
10.1182/blood-2010-04-278432
10.1038/nri2216
10.1016/S1875-5364(20)30012-1
10.1186/s13045-018-0576-6
10.1158/2159-8290.CD-14-0157
10.1084/jem.20132477
10.1038/nn.3599
10.1007/s12035-014-9070-5
10.1172/JCI45444
10.1161/JAHA.112.000992
10.1007/978-981-10-2155-8_6
10.1016/j.molmet.2015.07.006
10.1038/s41419-019-1387-6
10.1038/s41467-019-10458-9
10.3389/fimmu.2018.01004
10.1016/j.ctrv.2019.101896
10.3389/fonc.2018.00419
10.1007/s11523-019-00655-3
10.1038/bjc.2012.504
10.1158/1078-0432.CCR-20-1135
10.1158/1078-0432.CCR-20-2291
10.1038/s42003-020-01359-5
10.1074/jbc.M113.471318
10.4049/jimmunol.1100605
10.1111/imr.12526
10.1172/JCI65899
10.1172/JCI120612
10.3945/an.112.001875
10.1186/1471-2407-10-91
10.1007/s00701-009-0324-3
10.1523/JNEUROSCI.3940-09.2010
10.1007/s00262-019-02332-w
10.2147/OTT.S223406
10.1093/glycob/cwaa082
10.3389/fonc.2020.586820
10.1159/000504323
10.1084/jem.20131853
10.3389/fimmu.2017.01601
10.1093/rheumatology/kew498
10.1038/s41598-017-09120-5
10.1016/S0300-9084(03)00051-8
10.1111/febs.15647
10.3390/cancers10060207
10.1002/iub.1351
10.1016/j.bbagen.2009.04.006
10.1016/S0304-4165(97)00077-9
10.1016/j.jfma.2019.10.019
10.1038/srep37953
10.1002/glia.22510
10.1371/journal.pone.0229534
10.3892/ijo.2019.4743
10.1213/ANE.0000000000000108
10.1016/0736-5748(96)00026-3
10.1002/biof.1199
10.1371/journal.pone.0074676",<Element 'PubmedArticle' at 0x7f05dd54bbd0>
177,"33623128
1566067
28314660
25792098
12399581
23028126
15450156
32457076
25404051
25991443
27091974
28099414
31771656
22305485
27889227
29075003
21248787
31456515
27047374
30186116
27829153
27466343
10407394
11373681
18550183
24588018
8392067
12904474
2417205
23504281
23303927
24094579
25034807
14645205
24958880
27560171
22315714
23577177
24584052
27829994
23152597
25533482
25728668
25619654
15177383
8421494
30874945
28730967
31551688
26546579
26644572
18685038
14756805
21040744
19825975
24616125
18566433
23468969
10486285
21763610
26002056
27359332
23881919",Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer's disease transgenic mouse model.,"Alzheimer's disease (AD) is a devastating neurodegenerative disorder with no disease-modifying treatment. AD progression is characterized by cognitive decline, neuroinflammation, and accumulation of amyloid-beta (Aβ) and neurofibrillary tangles in the brain, leading to neuronal and glial dysfunctions. Neuropeptides govern diverse pathophysiological processes and represent key players in AD pathogenesis, regulating synaptic plasticity, glial cell functions and amyloid pathology. Activation of the pro-opiomelanocortin (POMC)-derived neuropeptide and its receptor from the melanocortin receptor (MCR) family have previously been shown to rescue the impairment in hippocampus-dependent synaptic plasticity in the APP/PS1 mouse model of AD. However, the functional roles of MCR signaling in AD conditions, particularly in glial functions, are largely unknown. In this study, we investigated the potential benefits of MCR activation in AD. In APP/PS1 transgenic mice, we demonstrate that MCR activation mediated by the central administration of its agonist D-Tyr MTII substantially reduces Aβ accumulation, while alleviating global inflammation and astrocytic activation, particularly in the hippocampus. MCR activation prominently reduces the A1 subtype of reactive astrocytes, which is considered a key source of astrocytic neurotoxicity in AD. Concordantly, MCR activation suppresses microglial activation, while enhancing their association with amyloid plaques. The blunted activation of microglia may contribute to the reduction in the neurotoxic phenotypes of astrocytes. Importantly, transcriptome analysis reveals that MCR activation restores the impaired homeostatic processes and microglial reactivity in the hippocampus in APP/PS1 mice. Collectively, our findings demonstrate the potential of MCR signaling as therapeutic target for AD.",[],Scientific reports,2021-02-25,"[{'lastname': 'Lau', 'firstname': 'Jackie K Y', 'initials': 'JKY', 'affiliation': 'Division of Life Science, State Key Laboratory of Molecular Neuroscience and Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.\nHong Kong Center for Neurodegenerative Diseases, Hong Kong, China.'}, {'lastname': 'Tian', 'firstname': 'Min', 'initials': 'M', 'affiliation': 'Division of Life Science, State Key Laboratory of Molecular Neuroscience and Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.'}, {'lastname': 'Shen', 'firstname': 'Yang', 'initials': 'Y', 'affiliation': 'Division of Life Science, State Key Laboratory of Molecular Neuroscience and Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.'}, {'lastname': 'Lau', 'firstname': 'Shun-Fat', 'initials': 'SF', 'affiliation': 'Division of Life Science, State Key Laboratory of Molecular Neuroscience and Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.\nHong Kong Center for Neurodegenerative Diseases, Hong Kong, China.'}, {'lastname': 'Fu', 'firstname': 'Wing-Yu', 'initials': 'WY', 'affiliation': 'Division of Life Science, State Key Laboratory of Molecular Neuroscience and Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.\nHong Kong Center for Neurodegenerative Diseases, Hong Kong, China.'}, {'lastname': 'Fu', 'firstname': 'Amy K Y', 'initials': 'AKY', 'affiliation': 'Division of Life Science, State Key Laboratory of Molecular Neuroscience and Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.\nHong Kong Center for Neurodegenerative Diseases, Hong Kong, China.\nGuangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, HKUST Shenzhen Research Institute, Shenzhen-Hong Kong Institute of Brain Science, Shenzhen, 518057, Guangdong, China.'}, {'lastname': 'Ip', 'firstname': 'Nancy Y', 'initials': 'NY', 'affiliation': 'Division of Life Science, State Key Laboratory of Molecular Neuroscience and Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China. boip@ust.hk.\nHong Kong Center for Neurodegenerative Diseases, Hong Kong, China. boip@ust.hk.\nGuangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, HKUST Shenzhen Research Institute, Shenzhen-Hong Kong Institute of Brain Science, Shenzhen, 518057, Guangdong, China. boip@ust.hk.'}]",,,,,"10.1038/s41598-021-83932-4
10.1126/science.1566067
10.1016/j.jalz.2017.02.006
10.1016/s1474-4422(15)70016-5
10.1126/science.1074069
10.1101/cshperspect.a006296
10.1016/j.neuron.2004.09.012
10.1007/s13311-014-0316-8
10.1038/nrn3880
10.1073/pnas.1604032113
10.1038/nature21029
10.1101/344218
10.1186/s12974-019-1633-y
10.1016/j.conb.2012.01.003
10.1016/j.tem.2016.10.007
10.1038/nrd.2017.178
10.1038/nrn2977
10.2174/1567205016666190503152555
10.3389/fnagi.2016.00058
10.3389/fncel.2018.00258
10.1016/j.celrep.2016.10.043
10.1523/jneurosci.0206-16.2016
10.1016/s1043-2760(99)00153-8
10.1038/35078085
10.1016/j.tins.2008.04.002
10.1038/nrn3657
10.1016/S0021-9258(18)82452-8
10.1523/JNEUROSCI.23-18-07143.2003
10.1016/0196-9781(85)90128-7
10.1007/s12031-013-9998-3
10.1523/jneurosci.3282-12.2013
10.1016/j.neurobiolaging.2013.08.030
10.1016/j.ejphar.2014.06.063
10.1093/hmg/ddh019
10.1073/pnas.1405803111
10.1038/nprot.2016.095
10.1101/cshperspect.a006346
10.1371/journal.pone.0060921
10.1038/nn.3662
10.1523/jneurosci.2323-12.2012
10.1016/j.neuron.2014.11.018
10.1016/j.cell.2015.01.049
10.1016/j.neuron.2014.12.068
10.1016/j.jocn.2003.12.007
10.1038/361031a0
10.1007/s10787-019-00580-x
10.2174/1570159x15666170720095240
10.3389/fnins.2019.00925
10.1111/jnc.13424
10.1073/pnas.1516779112
10.1523/jneurosci.1006-08.2008
10.1046/j.1471-4159.2003.02213.x
10.1016/j.imlet.2010.10.015
10.1096/fj.09-141754
10.1002/glia.22647
10.4049/jimmunol.181.1.660
10.1371/journal.pone.0057313
10.1006/bbrc.1999.1276
10.1016/j.devcel.2011.05.015
10.1242/jcs.170233
10.1371/journal.pone.0158564
10.1530/jme-13-0064",<Element 'PubmedArticle' at 0x7f05dd8be310>
178,33532772,,Triggering receptor expressed on myeloid cells-2 (TREM2) is a cell surface receptor on macrophages and microglia that senses and responds to disease associated signals to regulate the phenotype of these innate immune cells. The TREM2 signaling pathway has been implicated in a variety of diseases ranging from neurodegeneration in the central nervous system to metabolic disease in the periphery. We report here that ,[],bioRxiv : the preprint server for biology,2021-02-04,"[{'lastname': 'Ferrara', 'firstname': 'Skylar J', 'initials': 'SJ', 'affiliation': None}, {'lastname': 'Chaudhary', 'firstname': 'Priya', 'initials': 'P', 'affiliation': None}, {'lastname': 'DeBell', 'firstname': 'Margaret J', 'initials': 'MJ', 'affiliation': None}, {'lastname': 'Marracci', 'firstname': 'Gail', 'initials': 'G', 'affiliation': None}, {'lastname': 'Miller', 'firstname': 'Hannah', 'initials': 'H', 'affiliation': None}, {'lastname': 'Calkins', 'firstname': 'Evan', 'initials': 'E', 'affiliation': None}, {'lastname': 'Pocius', 'firstname': 'Edvinas', 'initials': 'E', 'affiliation': None}, {'lastname': 'Napier', 'firstname': 'Brooke A', 'initials': 'BA', 'affiliation': None}, {'lastname': 'Emery', 'firstname': 'Ben', 'initials': 'B', 'affiliation': None}, {'lastname': 'Bourdette', 'firstname': 'Dennis', 'initials': 'D', 'affiliation': None}, {'lastname': 'Scanlan', 'firstname': 'Thomas S', 'initials': 'TS', 'affiliation': None}]",,,,,10.1101/2021.01.25.428149,<Element 'PubmedArticle' at 0x7f05ddc1a220>
179,"33485589
31646432
30947759
15039492
26076834
26404709
22034143
26937618
21037215
27629598
19716990
22370490
994775
9428819
15891777
27277867
28758144
17851537
30946828
31584111
15885777
30741728
18923511
31327473
27634148
19150053
23870425
29606885
26544749
30653780
29856741
10559698
19268915
17174336
20479761
25629589
29971587
32398677
29203847
25050993
24248357
18440494
21300872
21796103
16316783
32616200
32000983
28653857
22945416
29548746
28825715
26272539
25598426
26711676
23261775
26831917
32635937
25430780
18178625
17700577
20133768
26083579
28556833
27965671
15895084
15831717
25100586
23201120
17115040
16732273
24316888
24742461
28521131
31636451
20970492
9636227
16547515
24360280
11841576
22442074
16469931
32999463
18083105
21778362
22632727
19339593
30406198
27558646
27390772
29581545
18026097
21527731
26990767
32023447
26442697
17604598
9450372
18798697
21878486
24020974
22041296
16165282
21525267
28373688
24439304
23966702
25653581
24342992
26231972
20303873
24859041
25603858
25568124
17726477
24772353
22408626
14615545
16988041
11784794
19606083
11124987
12907793
19477151
18982002
21814201
25833129
29049348
26220286
15884015
19840551
19840854
19557094
21937913
22270046
19020040
17950926
21110971
20018408
21167054
26576722
26068726
24812394
27669409
31370877
26917323
28534873
23407936
28697890
31255679
32454511
32615087
31273114
26793060
32917850",How Stress Shapes Neuroimmune Function: Implications for the Neurobiology of Psychiatric Disorders.,"Chronic stress causes physiological and hormonal adaptations that lead to neurobiological consequences and behavioral and cognitive impairments. In particular, chronic stress has been shown to drive reduced neurogenesis and altered synaptic plasticity in brain regions that regulate mood and motivation. The neurobiological and behavioral effects of stress resemble the pathophysiology and symptoms observed in psychiatric disorders, suggesting that there are similar underlying mechanisms. Accumulating evidence indicates that neuroimmune systems, particularly microglia, have a critical role in regulating the neurobiology of stress. Preclinical models indicate that chronic stress provokes changes in microglia phenotype and increases inflammatory cytokine signaling, which affects neuronal function and leads to synaptic plasticity deficits and impaired neurogenesis. More recent work has shown that microglia can also phagocytose neuronal elements and contribute to structural remodeling of neurons in response to chronic stress. In this review we highlight work by the Duman research group (as well as others) that has revealed how chronic stress shapes neuroimmune function and, in turn, how inflammatory mediators and microglia contribute to the neurobiological effects of chronic stress. We also provide considerations to engage the therapeutic potential of neuroimmune systems, with the goal of improving treatment for psychiatric disorders.","['Cytokines', 'Microglia', 'Neurogenesis', 'Neuroimmune', 'Psychiatric Disorders', 'Stress', 'Synapse']",Biological psychiatry,2021-01-25,"[{'lastname': 'Koo', 'firstname': 'Ja Wook', 'initials': 'JW', 'affiliation': 'Emotion, Cognition and Behavior Research Group, Korea Brain Research Institute, Daegu, South Korea; Department of Brain and Cognitive Sciences, Daegu Gyeongbuk Institute of Science and Technology, Daegu, South Korea.'}, {'lastname': 'Wohleb', 'firstname': 'Eric S', 'initials': 'ES', 'affiliation': 'Department of Pharmacology and Systems Physiology, College of Medicine, University of Cincinnati, Cincinnati, Ohio. Electronic address: eric.wohleb@uc.edu.'}]",,,,Copyright © 2020 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.,10.1016/j.biopsych.2020.11.007,<Element 'PubmedArticle' at 0x7f05ddc0cb30>
180,"33474655
24389733
24430551
12829792
25328009
30918468
22121476
31996437
32225175
15549175
14647384
20940627
26177578
28836869
24529758
31669235
23601050
29802208
28161727
32489724
32489743
32492193
32444427
32457227
31863823
28232171
23925977
29086247
30458182
19219011
27065866
24864225
20647592
16481441
17058035
23657626
29486745
27048449
29568380
21740964
28461604
29717388
32807174
25451117
23296610
29870711
28843453
25344317
24412491
25160895
12127155
8959217
11306640
10869049
11860512
14657172
19347234
22406356
22529776
23868258
29146920
10082752
27763643
18587404
26067058
18691604
32691218
22565012
17408563
17982579
17024327
25986885
20888078
23076408
7763330
8121814
17017502
32442210
18930783
22218590
30864350
17982576
28515690
29987762
18499466
28711402
19942928
31240418
25225202
19413572",Novel Interactions Involving the Mas Receptor Show Potential of the Renin-Angiotensin system in the Regulation of Microglia Activation: Altered Expression in Parkinsonism and Dyskinesia.,The renin-angiotensin system (RAS) not only plays an important role in controlling blood pressure but also participates in almost every process to maintain homeostasis in mammals. Interest has recently increased because SARS viruses use one RAS component (ACE2) as a target-cell receptor. The occurrence of RAS in the basal ganglia suggests that the system may be targeted to improve the therapy of neurodegenerative diseases. RAS-related data led to the hypothesis that RAS receptors may interact with each other. The aim of this paper was to find heteromers formed by Mas and angiotensin receptors and to address their functionality in neurons and microglia. Novel interactions were discovered by using resonance energy transfer techniques. The functionality of individual and interacting receptors was assayed by measuring levels of the second messengers cAMP and Ca,"['GPCR', 'Mas receptor', 'Parkinson', 'angiotensin', 'angiotensin AT1 receptor', 'angiotensin AT2 receptor', 'microglia']",Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics,2021-01-22,"[{'lastname': 'Rivas-Santisteban', 'firstname': 'Rafael', 'initials': 'R', 'affiliation': 'Department Biochemistry and Molecular Biomedicine, School of Biology, University of Barcelona, Diagonal 643, Barcelona, Catalonia, 08028, Spain.\nCentro de Investigación en Red, Enfermedades Neurodegenerativas (CIberNed), Instituto de Salud Carlos III, Valderrebollo 5, Madrid, Madrid, 28031, Spain.'}, {'lastname': 'Lillo', 'firstname': 'Jaume', 'initials': 'J', 'affiliation': 'Department Biochemistry and Molecular Biomedicine, School of Biology, University of Barcelona, Diagonal 643, Barcelona, Catalonia, 08028, Spain.\nCentro de Investigación en Red, Enfermedades Neurodegenerativas (CIberNed), Instituto de Salud Carlos III, Valderrebollo 5, Madrid, Madrid, 28031, Spain.'}, {'lastname': 'Muñoz', 'firstname': 'Ana', 'initials': 'A', 'affiliation': ""Centro de Investigación en Red, Enfermedades Neurodegenerativas (CIberNed), Instituto de Salud Carlos III, Valderrebollo 5, Madrid, Madrid, 28031, Spain.\nLaboratory of Cellular and Molecular Neurobiology of Parkinson's disease, Research Center for Molecular Medicine and Chronic Diseases (CIMUS), Department of Morphological Sciences, IDIS, University of Santiago de Compostela, Santiago de Compostela, 15782, Spain.""}, {'lastname': 'Rodríguez-Pérez', 'firstname': 'Ana I', 'initials': 'AI', 'affiliation': ""Centro de Investigación en Red, Enfermedades Neurodegenerativas (CIberNed), Instituto de Salud Carlos III, Valderrebollo 5, Madrid, Madrid, 28031, Spain.\nLaboratory of Cellular and Molecular Neurobiology of Parkinson's disease, Research Center for Molecular Medicine and Chronic Diseases (CIMUS), Department of Morphological Sciences, IDIS, University of Santiago de Compostela, Santiago de Compostela, 15782, Spain.""}, {'lastname': 'Labandeira-García', 'firstname': 'José Luís', 'initials': 'JL', 'affiliation': ""Centro de Investigación en Red, Enfermedades Neurodegenerativas (CIberNed), Instituto de Salud Carlos III, Valderrebollo 5, Madrid, Madrid, 28031, Spain.\nLaboratory of Cellular and Molecular Neurobiology of Parkinson's disease, Research Center for Molecular Medicine and Chronic Diseases (CIMUS), Department of Morphological Sciences, IDIS, University of Santiago de Compostela, Santiago de Compostela, 15782, Spain.""}, {'lastname': 'Navarro', 'firstname': 'Gemma', 'initials': 'G', 'affiliation': 'Centro de Investigación en Red, Enfermedades Neurodegenerativas (CIberNed), Instituto de Salud Carlos III, Valderrebollo 5, Madrid, Madrid, 28031, Spain.\nDepartment of Biochemistry and Physiology, School of Pharmacy and Food Science, University of Barcelona, Barcelona, Catalonia, 08028, Spain.'}, {'lastname': 'Franco', 'firstname': 'Rafael', 'initials': 'R', 'affiliation': 'Department Biochemistry and Molecular Biomedicine, School of Biology, University of Barcelona, Diagonal 643, Barcelona, Catalonia, 08028, Spain. rfranco123@gmail.com.'}]",,,,"© 2021. The American Society for Experimental NeuroTherapeutics, Inc.","10.1007/s13311-020-00986-4
10.1097/SHK.0000000000000115
10.1042/CS20130515
10.1155/2012/307315
10.1038/s41586-020-2179-y
10.1038/nature02145
10.1080/13543784.2017.1371133
10.1002/mds.25614
10.1523/JNEUROSCI.3574-05.2006
10.1007/s00018-006-6216-2
10.1186/s12915-018-0491-x
10.1186/s12915-016-0247-4
10.1161/HYPERTENSIONAHA.116.08814
10.1016/j.brainres.2014.10.059
10.1007/978-1-62703-230-8_10
10.1006/nbdi.2002.0499
10.1161/HYPERTENSIONAHA.114.03743",<Element 'PubmedArticle' at 0x7f05dea179f0>
181,33465356,GR/NF-κB signaling pathway regulates hippocampal inflammatory responses in diabetic rats with chronic unpredictable mild stress.,"Clinical studies have shown that diabetes can present with underlying depression, and a combination of the two can lead to emotional, memory and cognitive disorders, closely associated with hippocampal neuroinflammation. However, the mechanism underlying the development of hippocampal neuroinflammation under the above condition remains elusive. The aims of this study were to explore the pathogenesis of diabetes combined with depression, and the effect of dexamethasone (Dex), a glucocorticoid receptor (GR) agonist, on hippocampal neuroinflammation in diabetic rats with chronic unpredictable mild stress (CUMS). Therefore, rats were intragastrically fed on a high-fat diet (10% cholesterol 10 ml/kg) for 14 days and thereafter injected with 38 mg/kg of streptozotocin on the 15th day to induce diabetes. Dex treatment of the diabetic and CUMS rats ameliorated the depression-associated behavior in the respective rats. Apart from enhanced depressive behavior, diabetes-depressed condition also up-regulated the expression of hippocampus microglia chemokine Ⅰ receptor (CX3CR1) and secretion of several pro-inflammatory factors, in particular, interleukin 1β (IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8) and tumor necrosis factor - α (TNF-α). Hematoxylin-eosin staining revealed inflammatory damages in the hippocampus. Western blot analysis further revealed repression of GR proteins converse to the nuclear factor kappa-B (NF-κB) proteins, which were up-regulated. Intriguingly, Dex reversed the above events by inhibiting inflammatory reactions in the hippocampus. Consequently, played an antidepressant effect in diabetic and CUMS model rats. Overall, findings of this research suggest that the physiopathology of diabetes with stress cormobity are mediated by inflammatory reactions in the hippocampus. In particular, the responses are associated with regulation of GR/NF-κB signaling pathway.","['Chronic unpredictable mild stress', 'Diabetic model rats', 'GR', 'Hippocampal', 'Inflammatory', 'NF-κB signaling pathway']",European journal of pharmacology,2021-01-20,"[{'lastname': 'Li', 'firstname': 'Zi-Rong', 'initials': 'ZR', 'affiliation': 'State Key Laboratory of Chinese Medicine Powder and Medicine Innovation in Hunan (incubation), Hunan University of Chinese Medicine, Changsha, Hunan, China.'}, {'lastname': 'Han', 'firstname': 'Yuan-Shan', 'initials': 'YS', 'affiliation': 'Department of Experimental Center for Medical Innovation, The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.'}, {'lastname': 'Liu', 'firstname': 'Zhuo', 'initials': 'Z', 'affiliation': 'Department of Education and Science, Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine, Changsha, China. Electronic address: 330811844@qq.com.'}, {'lastname': 'Zhao', 'firstname': 'Hong-Qing', 'initials': 'HQ', 'affiliation': 'State Key Laboratory of Chinese Medicine Powder and Medicine Innovation in Hunan (incubation), Hunan University of Chinese Medicine, Changsha, Hunan, China.'}, {'lastname': 'Liu', 'firstname': 'Jian', 'initials': 'J', 'affiliation': 'Department of Experimental Center for Medical Innovation, The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.'}, {'lastname': 'Yang', 'firstname': 'Hui', 'initials': 'H', 'affiliation': 'Department of Experimental Center for Medical Innovation, The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.'}, {'lastname': 'Wang', 'firstname': 'Yu-Hong', 'initials': 'YH', 'affiliation': 'State Key Laboratory of Chinese Medicine Powder and Medicine Innovation in Hunan (incubation), Hunan University of Chinese Medicine, Changsha, Hunan, China. Electronic address: wyhyjy620@126.com.'}]",,,,Copyright © 2021 Elsevier B.V. All rights reserved.,10.1016/j.ejphar.2021.173861,<Element 'PubmedArticle' at 0x7f05dd8099a0>
182,33434616,Inhibition of TGFβ-activated kinase 1 promotes inflammation-resolving microglial/macrophage responses and recovery after stroke in ovariectomized female mice.,"TGFβ-activated kinase 1 (TAK1) is a master regulator that drives multiple cell death and proinflammatory signaling pathways, making it a promising therapeutic target to treat ischemic stroke. However, whether targeting TAK1 could improve stroke outcomes has never been tested in female subjects, hindering its potential translation into clinical use. Here we examined the therapeutic effect of 5Z-7-Oxozeaenol (OZ), a selective TAK1 inhibitor, in ovariectomized female mice after middle cerebral artery occlusion (MCAO). OZ significantly reduced neuronal cell death and axonal injury at the acute stage and mitigated neuroinflammation at the subacute stage after MCAO in ovariectomized female mice. Consistent with RNA sequencing analysis that TAK1 activation contributed to microglia/macrophage-mediated inflammatory responses in the post-stroke brain, inhibition of TAK1 with OZ caused phenotypic shift of microglia/macrophages toward an inflammation-resolving state. Furthermore, microglia/macrophage-specific TAK1 knockout (TAK1 mKO) reproduced OZ's effects, causally confirming the role of TAK1 in determining proinflammatory microglial/macrophage responses in post-stroke females. Post-stroke treatment with OZ for 5 days effectively promoted long-term neurological recovery and the integrity of both gray matter and white matter in female mice. Together, the TAK1 inhibitor OZ elicits long-lasting improvement of stroke outcomes in female mice, at least partially through enhancing beneficial microglial/macrophage responses and inflammation resolution. Given its therapeutic efficacy on both male and female rodents, TAK1 inhibitor is worth further investigation as a valid treatment to ischemic stroke.","['5Z-7-Oxozeaenol', 'Inflammation', 'MAP3K7', 'Ovariectomized mice', 'TAK1', 'Transient focal cerebral ischemia']",Neurobiology of disease,2021-01-13,"[{'lastname': 'Liu', 'firstname': 'Yaan', 'initials': 'Y', 'affiliation': 'Pittsburgh Institute of Brain Disorders & Recovery and Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213, United States of America.'}, {'lastname': 'Li', 'firstname': 'Sicheng', 'initials': 'S', 'affiliation': 'Pittsburgh Institute of Brain Disorders & Recovery and Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213, United States of America.'}, {'lastname': 'Wang', 'firstname': 'Rongrong', 'initials': 'R', 'affiliation': 'Pittsburgh Institute of Brain Disorders & Recovery and Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213, United States of America.'}, {'lastname': 'Pu', 'firstname': 'Hongjian', 'initials': 'H', 'affiliation': 'Pittsburgh Institute of Brain Disorders & Recovery and Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213, United States of America.'}, {'lastname': 'Zhao', 'firstname': 'Yongfang', 'initials': 'Y', 'affiliation': 'Pittsburgh Institute of Brain Disorders & Recovery and Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213, United States of America.'}, {'lastname': 'Ye', 'firstname': 'Qing', 'initials': 'Q', 'affiliation': 'Pittsburgh Institute of Brain Disorders & Recovery and Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213, United States of America.'}, {'lastname': 'Shi', 'firstname': 'Yejie', 'initials': 'Y', 'affiliation': 'Pittsburgh Institute of Brain Disorders & Recovery and Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213, United States of America. Electronic address: y.shi@pitt.edu.'}]",,,,Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.,10.1016/j.nbd.2021.105257,<Element 'PubmedArticle' at 0x7f05dd7f5c70>
183,33422531,Impact of ovariectomy and CO,"The neural network that regulates breathing shows a significant sexual dimorphism. Ovarian hormones contribute to this distinction as, in rats, ovariectomy reduces the ventilatory response to CO","['Chemosensitivity', 'Hypothalamus', 'Medulla', 'Neuroinflammation', 'Pons', 'Sex hormones']",Brain research,2021-01-11,"[{'lastname': 'Marques', 'firstname': 'Danuzia A', 'initials': 'DA', 'affiliation': ""Département de Pédiatrie, Centre de Recherche de l'Institut Universitaire de Cardiologie et Pneumologie de Québec, Université Laval, Québec, QC, Canada. Electronic address: danuzia.ambrozio-marques.1@ulaval.ca.""}, {'lastname': 'Gargaglioni', 'firstname': 'Luciane H', 'initials': 'LH', 'affiliation': 'Department of Animal Morphology and Physiology, Sao Paulo State University, UNESP/FCAV at Jaboticabal, SP, Brazil.'}, {'lastname': 'Joseph', 'firstname': 'Vincent', 'initials': 'V', 'affiliation': ""Département de Pédiatrie, Centre de Recherche de l'Institut Universitaire de Cardiologie et Pneumologie de Québec, Université Laval, Québec, QC, Canada.""}, {'lastname': 'Bretzner', 'firstname': 'Frédéric', 'initials': 'F', 'affiliation': 'Département de Psychiatrie et Neurosciences, Centre de Recherche du CHU de Québec, Université Laval, Québec, QC, Canada.'}, {'lastname': 'Bícego', 'firstname': 'Kênia C', 'initials': 'KC', 'affiliation': 'Department of Animal Morphology and Physiology, Sao Paulo State University, UNESP/FCAV at Jaboticabal, SP, Brazil.'}, {'lastname': 'Fournier', 'firstname': 'Stéphanie', 'initials': 'S', 'affiliation': ""Département de Pédiatrie, Centre de Recherche de l'Institut Universitaire de Cardiologie et Pneumologie de Québec, Université Laval, Québec, QC, Canada.""}, {'lastname': 'Kinkead', 'firstname': 'Richard', 'initials': 'R', 'affiliation': ""Département de Pédiatrie, Centre de Recherche de l'Institut Universitaire de Cardiologie et Pneumologie de Québec, Université Laval, Québec, QC, Canada.""}]",,,,Copyright © 2021 Elsevier B.V. All rights reserved.,10.1016/j.brainres.2021.147276,<Element 'PubmedArticle' at 0x7f05dd7e7d10>
184,"33405022
25947331
24996040
27108670
10084932
23454115
22996126
28989916
26264823
28889957
22348542
26921136
29705849
14988088
28412496
28650979
29632361
28669797
27686844
17403397
24089203
27919641
22406114
25080336
25092805
26662122
26349009
29348500
30391857
28758994",Progesterone Attenuates Brain Inflammatory Response and Inflammation-Induced Increase in Immature Myeloid Cells in a Mouse Model.,"Progesterone has been shown to regulate immunity during pregnancy, and progesterone administration may reduce inflammation-induced preterm labor. We sought to determine the maternal brain immune response to LPS-induced inflammation in pregnant and non-pregnant mice and whether additional progesterone supplementation attenuates this response. Pregnant (P: n = 9) and non-pregnant mice (NP: n = 9) were randomized to pretreatment with vaginal progesterone/carrier (Replens), daily from days 13 to 16. On days 15 and 16, LPS/saline was administered by intraperitoneal injection (Replens + saline n = 3; Replens + LPS n = 3; progesterone + LPS n = 3). Mice were sacrificed on day 16 and maternal serum analyzed for IL-6 levels and brains analyzed for nNOS, NF-kB, IL-6 protein levels and for immature myeloid cells (IMCs) and microglial activity. LPS significantly increased brain nNOS, NF-kB, and IL-6 in both NP and P mice, with significantly greater responses in P mice. In both NP and P groups, progesterone significantly attenuated LPS-induced increase of nNOS and NF-kB, however with no effect on serum IL-6. In the NP brains, LPS significantly increased IMC population and progesterone reduced the IMC phenotype to levels similar to controls. In P mice, neither LPS nor LPS + progesterone altered the brain IMC population. LPS significantly increased the microglial activity in both NP and P groups, which was attenuated by progesterone. Progesterone attenuates brain inflammatory response to LPS in both NP and P mice although it has no effect on systemic inflammation. In NP mice, progesterone attenuated the increase in brain IMC following LPS administration. Our results suggest that endogenous progesterone during pregnancy may protect the brain from LPS-induced inflammation.","['brain immune system', 'immature myeloid cells', 'inflammation', 'microglia', 'progesterone']",Inflammation,2021-01-07,"[{'lastname': 'Gutzeit', 'firstname': 'Ola', 'initials': 'O', 'affiliation': ""Department of Obstetrics and Gynecology, Rambam Health Care Campus, Rambam Medical Center, 8 Ha'alya St., 3109601, Haifa, Israel.""}, {'lastname': 'Segal', 'firstname': 'Linoy', 'initials': 'L', 'affiliation': ""Department of Obstetrics and Gynecology, Rambam Health Care Campus, Rambam Medical Center, 8 Ha'alya St., 3109601, Haifa, Israel.""}, {'lastname': 'Korin', 'firstname': 'Ben', 'initials': 'B', 'affiliation': 'Department of Neuroscience, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.\nDepartment of Immunology, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.'}, {'lastname': 'Iluz', 'firstname': 'Roee', 'initials': 'R', 'affiliation': ""Department of Obstetrics and Gynecology, Rambam Health Care Campus, Rambam Medical Center, 8 Ha'alya St., 3109601, Haifa, Israel.""}, {'lastname': 'Khatib', 'firstname': 'Nizar', 'initials': 'N', 'affiliation': ""Department of Obstetrics and Gynecology, Rambam Health Care Campus, Rambam Medical Center, 8 Ha'alya St., 3109601, Haifa, Israel.""}, {'lastname': 'Dabbah-Assadi', 'firstname': 'Fadwa', 'initials': 'F', 'affiliation': ""Department of Obstetrics and Gynecology, Rambam Health Care Campus, Rambam Medical Center, 8 Ha'alya St., 3109601, Haifa, Israel.""}, {'lastname': 'Ginsberg', 'firstname': 'Yuval', 'initials': 'Y', 'affiliation': ""Department of Obstetrics and Gynecology, Rambam Health Care Campus, Rambam Medical Center, 8 Ha'alya St., 3109601, Haifa, Israel.""}, {'lastname': 'Fainaru', 'firstname': 'Ofer', 'initials': 'O', 'affiliation': ""Department of Obstetrics and Gynecology, Rambam Health Care Campus, Rambam Medical Center, 8 Ha'alya St., 3109601, Haifa, Israel.""}, {'lastname': 'Ross', 'firstname': 'Michael G', 'initials': 'MG', 'affiliation': 'Department of Obstetrics and Gynecology, Harbor-UCLA Medical Center, Torrance, CA, USA.'}, {'lastname': 'Weiner', 'firstname': 'Zeev', 'initials': 'Z', 'affiliation': ""Department of Obstetrics and Gynecology, Rambam Health Care Campus, Rambam Medical Center, 8 Ha'alya St., 3109601, Haifa, Israel.""}, {'lastname': 'Beloosesky', 'firstname': 'Ron', 'initials': 'R', 'affiliation': ""Department of Obstetrics and Gynecology, Rambam Health Care Campus, Rambam Medical Center, 8 Ha'alya St., 3109601, Haifa, Israel. r_beloosesky@rambam.health.gov.il.""}]",,,,,"10.1007/s10753-020-01390-y
10.1007/s10620-015-3683-z
10.1016/j.imlet.2014.06.013
10.1111/aji.12509
10.1126/science.283.5406.1277
10.1016/j.jsbmb.2013.02.008
10.1097/AOG.0b013e3182723b1b
10.5468/ogs.2017.60.5.405
10.1016/j.ajog.2015.08.010
10.1053/j.semperi.2017.07.013
10.1016/S0140-6736(16)00350-0
10.1152/ajpregu.00664.2003
10.1016/j.neuroscience.2017.03.046
10.1038/s41593-018-0128-y
10.1016/j.bbi.2017.06.016
10.1016/j.bbi.2016.09.026
10.1016/j.ajog.2006.09.005
10.1095/biolreprod.113.107995
10.1016/j.mce.2016.11.029
10.1016/j.yhbeh.2012.02.023
10.1002/glia.22736
10.1016/j.neuroscience.2015.09.007
10.1016/j.jri.2018.10.003
10.1038/nn.4610",<Element 'PubmedArticle' at 0x7f05dd85b3b0>
185,"33402704
19396704
11596847
3606332
26834586
27898072
15985324
18776186
17072346
23374344
21640161
32591631
16444750
25774123
32113910
27665001
762061
22522610
24227727
26259873
23224430
3839598
20574149
7932285
26513352
28176274
30696869
23085507
16933966
29962930
21282642
19872214
11551811
32607414
16434551
14820494
5128351
13719842
2188967
22628558
22628554
25538557
7938003
21211738
18788029
0
17245471
7583341
9694037
21208484
25893406
16550212
29209160
15890434
18793440
23328157
4291916
9326668
9525904
17738519
13341959
16007500
942389
12138085
11600416
25154512
14114860",The two-cell model of glucose metabolism: a hypothesis of schizophrenia.,"Schizophrenia is a chronic and severe mental disorder that affects over 20 million people worldwide. Common symptoms include distortions in thinking, perception, emotions, language, and self awareness. Different hypotheses have been proposed to explain the development of schizophrenia, however, there are no unifying features between the proposed hypotheses. Schizophrenic patients have perturbed levels of glucose in their cerebrospinal fluid, indicating a disturbance in glucose metabolism. We have explored the possibility that disturbances in glucose metabolism can be a general mechanism for predisposition and manifestation of the disease. We discuss glucose metabolism as a network of signaling pathways. Glucose and glucose metabolites can have diverse actions as signaling molecules, such as regulation of transcription factors, hormone and cytokine secretion and activation of neuronal cells, such as microglia. The presented model challenges well-established concepts in enzyme kinetics and glucose metabolism. We have developed a 'two-cell' model of glucose metabolism, which can explain the effects of electroconvulsive therapy and the beneficial and side effects of olanzapine treatment. Arrangement of glycolytic enzymes into metabolic signaling complexes within the 'two hit' hypothesis, allows schizophrenia to be formulated in two steps. The 'first hit' is the dysregulation of the glucose signaling pathway. This dysregulation of glucose metabolism primes the central nervous system for a pathological response to a 'second hit' via the astrocytic glycogenolysis signaling pathway.",[],Molecular psychiatry,2021-01-07,"[{'lastname': 'Roosterman', 'firstname': 'Dirk', 'initials': 'D', 'affiliation': 'Ruhr Universität Bochum, LWL-Hospital of Psychiatry, Bochum, Germany. roosterman@gmx.net.'}, {'lastname': 'Cottrell', 'firstname': 'Graeme Stuart', 'initials': 'GS', 'affiliation': 'School of Pharmacy, University of Reading, Reading, RG6 6AP, UK.'}]",,,,© 2021. The Author(s).,"10.1038/s41380-020-00980-4
10.1080/15622970902898980
10.1093/oxfordjournals.schbul.a006887
10.1001/archpsyc.1987.01800190080012
10.1038/tp.2016.239
10.1016/j.biosystems.2005.05.009
10.1002/asi.23329
10.1038/199943a0
10.1074/jbc.M801401200
10.1038/sj.onc.1210074
10.1016/j.cell.2012.12.029
10.1016/j.bbagen.2011.05.010
10.1101/2020.01.22.916023v1
10.1002/prot.20862
10.1093/schbul/sbw129
10.1016/S0021-9258(17)37918-8
10.2337/db11-1531
10.1523/JNEUROSCI.1592-13.2013
10.1007/s00018-012-1219-7
10.1126/science.3839598
10.4161/cam.4.4.12460
10.1016/0022-3956(94)90009-4
10.1371/journal.pone.0141568
10.1007/s12035-017-0422-9
10.1016/j.pnpbp.2012.09.016
10.1073/pnas.1014293108
10.1085/jgp.8.6.531
10.1016/S1043-2760(01)00454-4
10.3934/Neuroscience.2020007
10.1152/ajpendo.00594.2005
10.1083/jcb.51.3.621
10.1073/pnas.47.6.753
10.1016/S0021-9258(19)38795-2
10.1126/science.1218099
10.1126/science.1218530
10.1073/pnas.91.22.10625
10.1016/S1262-3636(10)70469-9
10.1080/00207450701870303
10.1017/S0025727300024728
10.1016/0361-9230(95)00082-P
10.1016/S0197-0186(05)80003-8
10.1017/S1461145710001471
10.1371/journal.pone.0123966
10.1038/sj.mp.4001821
10.1016/j.neuint.2005.04.001
10.1186/1471-244X-8-78
10.1093/schbul/sbs196
10.1085/jgp.50.4.893
10.1073/pnas.94.21.11669
10.1074/jbc.273.14.8040
10.1111/j.1749-6632.1999.tb10438.x
10.1126/science.201.4358.777
10.1016/0006-3002(56)90361-4
10.1007/s00232-005-0743-x
10.1042/bj1540597
10.1074/jbc.M111952200
10.1152/ajpcell.2001.281.5.C1533
10.1111/febs.13018
10.1016/S0021-9258(18)51741-5",<Element 'PubmedArticle' at 0x7f05dd83c9a0>
186,33401964,Cannabinoid receptors modulate LPS-induced increase of class-II transactivator expression levels in a microglial cell line.,"Microglial antigen generation (MAG) is an essential process in regulating disease states and homeostasis of the central nervous system. MAG is considered as responsible autoimmune mechanism in neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's diseases. Neuroprotective and regulator effects of cannabinoid receptors on these disease states and modulation with pharmacological agents are urgent subjects in recent decades. Although different aspects of microglial immune response have been investigated, specific effects of these receptor subtypes in the MAG are still unclear. Therefore, in the current study, we have investigated the effects of CB","['BV-2', 'CIITA', 'Cannabinoid receptor-1', 'MHC-II', 'microglial antigen generation']",Journal of receptor and signal transduction research,2021-01-07,"[{'lastname': 'Cankara', 'firstname': 'Fatma Nihan', 'initials': 'FN', 'affiliation': 'Department of Pharmacology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey.'}, {'lastname': 'Çelik', 'firstname': 'Zülfinaz Betül', 'initials': 'ZB', 'affiliation': 'Department of Medical Biology, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Turkey.'}, {'lastname': 'Günaydın', 'firstname': 'Caner', 'initials': 'C', 'affiliation': 'Department of Pharmacology, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Turkey.'}]",,,,,10.1080/10799893.2020.1868510,<Element 'PubmedArticle' at 0x7f05de07ba90>
187,"33367612
18765804
26210057
23974948
28041836
21208991
16255001
17118931
28135000
22885871
20688099
18988842
18655868
7619320
29523998
24032393
29480411
16468232
1348224
33125871
25912257
8319000
17055176
21368111
10571489
8413608
10603285
25950633
15051143
20141291
27793769
1398553
30658044
1321430
8910808
19193878
21851821
25874849
26893121
15488548
27371827
12716957
10718272
10443786
19707518
16327783
20557568
857268
83167
6258111
19789384
21734650
23699524
22593047
26974500
16289323
16165168
18955088
7953686
20111713
31591155
31194999
16108061
31935400
22654056
23500897
22151700
3113327
21903131
16595179
15749158
17982576
32102186
23999358
14568015
24948805
22155611
18092152
21632917
28963257
28669546
11534973
21463018
10718931
29111331
15153753
28936190
19903933
1483291
10394089
3035309
7311722
2464402
16354936
6120570
2994144
3016896
7636023
21747759
24487234
27613230
30254300
29706957
30827729
27480575
30144321
30259418
18940936
23874274
28259722
30098544
30506969
17904651
15866053
16176831
12183682
7583289
15647486
9152411
11106302
30662412
17047310
12015209
27957532
7250521
30890276
18842899
31862611
27102938
25051448
10627074
1542935
29043065
21125642
32743737
29030613
17203472
27075756
8876248
15861459
9875707
8736574
3828904
3370533
32860938
28049625
26335886
28276805
9152411
9744563
10665828
7601211
30447281
29968347
30617061
26659038
25124430
29106542
32272129
27291902
18837637
30983573
22736892
22206823
27603752
26932552","Oxytocin, Dopamine, and Opioid Interactions Underlying Pair Bonding: Highlighting a Potential Role for Microglia.","Pair bonds represent some of the strongest attachments we form as humans. These relationships positively modulate health and well-being. Conversely, the loss of a spouse is an emotionally painful event that leads to numerous deleterious physiological effects, including increased risk for cardiac dysfunction and mental illness. Much of our understanding of the neuroendocrine basis of pair bonding has come from studies of monogamous prairie voles (Microtus ochrogaster), laboratory-amenable rodents that, unlike laboratory mice and rats, form lifelong pair bonds. Specifically, research using prairie voles has delineated a role for multiple neuromodulatory and neuroendocrine systems in the formation and maintenance of pair bonds, including the oxytocinergic, dopaminergic, and opioidergic systems. However, while these studies have contributed to our understanding of selective attachment, few studies have examined how interactions among these 3 systems may be essential for expression of complex social behaviors, such as pair bonding. Therefore, in this review, we focus on how the social neuropeptide, oxytocin, interacts with classical reward system modulators, including dopamine and endogenous opioids, during bond formation and maintenance. We argue that an understanding of these interactions has important clinical implications and is required to understand the evolution and encoding of complex social behaviors more generally. Finally, we provide a brief consideration of future directions, including a discussion of the possible roles that glia, specifically microglia, may have in modulating social behavior by acting as a functional regulator of these 3 neuromodulatory systems.","['dopamine', 'microglia', 'opioid', 'oxytocin', 'pair bond', 'vole']",Endocrinology,2020-12-29,"[{'lastname': 'Loth', 'firstname': 'Meredith K', 'initials': 'MK', 'affiliation': 'Department of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, CO, USA.'}, {'lastname': 'Donaldson', 'firstname': 'Zoe R', 'initials': 'ZR', 'affiliation': 'Department of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, CO, USA.\nDepartment of Psychology & Neuroscience, University of Colorado Boulder, Boulder, CO, USA.'}]",,,,© The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society.,"10.1210/endocr/bqaa223
10.7551/mitpress/1476.003.0008
10.1016/j.cub.2020.09.089
10.1016/C2011-1-07288-0
10.3390/cells9020506
10.1523/ENEURO.0297-16.2016",<Element 'PubmedArticle' at 0x7f05de08e900>
188,"33333772
23252647
23334247
20948535
26082681
23404369
25529562
24948120
12805697
15995723
25745386
25470401
24817841
24917789
28499503
22674585
22516295
29283023
28790893
30830722
32839585
32552792
27811267
31263402
29618972
23108549
23813098
14284696
26965148
27539936
24032675
24473264
26055231
7498458
12944505
11513837
11916961
17631917
11156943
17011598
17664017
10577359
15823551
17011761
508325
9637740
19840245
12505702
11682441
15910891
10677355
19909294
22125609
23707281
9498819
17196922
19395322
25598150
20835819
29662433
25686754
13211905
17712835
16054175
24377270
27083308
23108539
19570201
28237711
33117168
24178954
32150935
31351254
9461251
25164769
29615912
32033363
28265364
23291248
29552727
17897048
26361743
23862567
22912680
26295827
27616549
28325153
22414817
25210802
29382825
29576849
32471239
26820462
18657182
31221190
26857391
22998138
26929355
30706796
27701827
30193877
26491593
18602217
23394519
23533304
23394524
26260027
26039098
21890273
25874232
30266286
28594885
32429243
33080989
22845893
24967102
29364513
29258432
28875041
31863365
29676237
25974242
20176435
24051945
21601979
23415738
26233289
31496832
27486344
30177906
32377286
26334329
30827269
14634025
8900284
11463796
19413995
24677570
7505999
7724569
8931279
11485574
31878942
10440374
11602256
18695637
24312564
15465922
17876302
28779174
9721036
23083124
25014183
28336953
21255263
22405189
30459700
26464797
19913097
32985478
24530639
29246232
30224549
24934179
23231720
33065737
30448975
31269891
28288663
31427928
31635218
26241184
32808580
30505308
31244590",Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries-A Systematic Review.,"Neuroinflammation is a physiological response aimed at maintaining the homodynamic balance and providing the body with the fundamental resource of adaptation to endogenous and exogenous stimuli. Although the response is initiated with protective purposes, the effect may be detrimental when not regulated. The physiological control of neuroinflammation is mainly achieved via regulatory mechanisms performed by particular cells of the immune system intimately associated with or within the nervous system and named ""non-neuronal cells."" In particular, mast cells (within the central nervous system and in the periphery) and microglia (at spinal and supraspinal level) are involved in this control, through a close functional relationship between them and neurons (either centrally, spinal, or peripherally located). Accordingly, neuroinflammation becomes a worsening factor in many disorders whenever the non-neuronal cell supervision is inadequate. It has been shown that the regulation of non-neuronal cells-and therefore the control of neuroinflammation-depends on the local ""","['dietary food', 'endocannabinoid system', 'mast cells', 'neuroinflammation', 'nutrient', 'palmitoylethanolamide']",International journal of molecular sciences,2020-12-19,"[{'lastname': 'Petrosino', 'firstname': 'Stefania', 'initials': 'S', 'affiliation': 'Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Via Campi Flegrei 34, 80078 Napoli, Italy.\nEpitech Group SpA, Via Einaudi 13, 35030 Padova, Italy.'}, {'lastname': 'Schiano Moriello', 'firstname': 'Aniello', 'initials': 'A', 'affiliation': 'Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Via Campi Flegrei 34, 80078 Napoli, Italy.\nEpitech Group SpA, Via Einaudi 13, 35030 Padova, Italy.'}]",,,,,"10.3390/ijms21249526
10.1111/nan.12011
10.1038/nri3392
10.1038/nm.2234
10.3389/fnins.2015.00201
10.1007/s00401-013-1092-y
10.12659/MSMBR.893093
10.1038/nrd4334
10.1100/tsw.2001.20
10.1038/nrn1700
10.3389/fncel.2015.00051
10.2174/1871527313666141130224206
10.3389/fncel.2014.00120
10.3389/fncel.2014.00152
10.1016/j.neubiorev.2017.05.001
10.1002/glia.22350
10.1096/fj.11-197194
10.1177/1073858416687249
10.3389/fncel.2017.00216
10.1111/apha.13270
10.1038/s41582-020-0398-3
10.1186/s12883-020-01812-2
10.1126/science.aaf8924
10.3389/fncel.2019.00263
10.3389/fncel.2018.00072
10.1098/rstb.2011.0391
10.1007/s12035-013-8487-6
10.1016/j.plipres.2016.02.002
10.1111/bph.13580
10.1111/imm.12170
10.1038/nn.3612
10.1007/s12035-015-9253-8
10.1016/0014-5793(95)01194-J
10.1523/JNEUROSCI.23-21-07767.2003
10.1016/S0014-2999(01)01182-7
10.1074/jbc.M110813200
10.1016/j.neuropharm.2007.05.015
10.1096/fj.00-0399fje
10.1016/j.neuropharm.2006.08.011
10.1016/j.neuint.2007.06.031
10.1006/abbi.1999.1410
10.1016/j.bbrc.2005.03.095
10.1016/j.plefa.2006.08.002
10.1016/0006-291X(79)91281-6
10.1006/abbi.1998.0688
10.1111/j.1478-3231.2009.02137.x
10.1016/S0009-3084(02)00158-5
10.1038/sj.bjp.0704339
10.1016/j.neuropharm.2005.01.001
10.1042/bj3460369
10.1111/j.1398-9995.2009.02254.x
10.1371/journal.pone.0027257
10.1016/j.pain.2013.05.002
10.1016/S0014-5793(98)00046-5
10.1016/j.ab.2006.11.027
10.1016/j.jchromb.2009.04.010
10.1111/bph.13084
10.1007/s00216-010-4103-z
10.3389/fnins.2018.00145
10.1038/nrneurol.2015.13
10.1084/jem.100.5.425
10.1021/ja01577a066
10.1002/cbdv.200790161
10.1016/j.phytochem.2005.06.014
10.1021/ac403352e
10.1016/j.phrs.2016.04.007
10.1098/rstb.2012.0313
10.1186/1744-8069-5-35
10.1016/j.bbi.2017.02.016
10.3389/fphar.2020.577319
10.1007/s10787-013-0191-7
10.3390/antiox9030216
10.1016/j.foodchem.2019.125218
10.1016/S0005-2760(97)00132-X
10.1186/s12974-014-0136-0
10.3389/fphar.2018.00249
10.3390/jcm9020428
10.1002/fsn3.392
10.1016/j.neuint.2012.12.016
10.1007/s12035-018-0959-2
10.2174/187153007781662521
10.1016/j.brainresbull.2015.09.002
10.3109/13880209.2013.792849
10.1371/journal.pone.0041880
10.2174/1871527314666150821102823
10.1016/j.phrs.2016.09.004
10.2174/1871527316666170321124949
10.1038/npp.2012.25
10.1038/cddis.2014.376
10.1038/s41398-017-0076-4
10.1155/2018/4720532
10.3390/ijms21113802
10.1007/s40520-016-0533-6
10.1111/j.1460-9568.2008.06377.x
10.1186/s12974-019-1514-4
10.1007/s13311-016-0420-z
10.2174/1871527311201070933
10.1073/pnas.1600251113
10.2174/1871527318666190131121827
10.1111/cns.12648
10.1016/j.bbi.2018.09.003
10.1155/2015/325061
10.1016/j.pain.2008.06.003
10.2174/1871527311312010008
10.1155/2013/328797
10.2174/1871527311312010009
10.1186/s13041-015-0139-5
10.1371/journal.pone.0128080
10.1016/j.pain.2011.08.010
10.1155/2015/894732
10.1016/j.nbd.2018.09.023
10.1371/journal.pone.0178553
10.3390/ijms21103509
10.3390/ijms21207700
10.1111/j.1526-4637.2012.01432.x
10.1155/2014/854560
10.1002/jcph.1070
10.1186/s12871-017-0461-9
10.1155/2017/1486010
10.1007/s40122-019-00140-9
10.2174/1871527317666180420143830
10.1097/j.pain.0000000000000220
10.1016/j.ejogrb.2010.01.008
10.1016/j.ejogrb.2011.04.011
10.1016/j.ejogrb.2013.01.009
10.1016/j.jpag.2014.12.011
10.2147/IJWH.S204275
10.2147/IMCRJ.S106323
10.3389/fneur.2018.00674
10.1155/2020/3938640
10.1007/s40122-015-0038-6
10.2174/1871527318666190227205359
10.1074/jbc.M306642200
10.1038/384083a0
10.1074/jbc.M106261200
10.1016/j.bcp.2009.04.024
10.1002/biof.1158
10.1007/BF01972748
10.1073/pnas.92.8.3376
10.1016/S0166-2236(96)10058-8
10.1042/bj3580249
10.1186/s12974-019-1671-5
10.1038/22761
10.1016/S0014-5793(01)02934-9
10.1038/bjp.2008.324
10.1371/journal.pone.0081618
10.1124/mol.104.006353
10.1038/sj.bjp.0707460
10.1038/s41598-017-07519-8
10.1016/S0014-2999(98)00392-6
10.1111/bph.12029
10.1016/j.phrs.2014.06.015
10.1038/s41598-017-00342-1
10.1111/j.1582-4934.2011.01267.x
10.1186/1742-2094-9-49
10.3389/fneur.2018.00860
10.1186/s40035-015-0042-0
10.1016/j.nbd.2009.11.004
10.4103/1673-5374.293147
10.1016/j.expneurol.2014.02.006
10.1186/s12974-017-1028-x
10.1136/jnnp-2018-318868
10.1038/mp.2014.59
10.1186/1742-2094-9-265
10.1097/j.pain.0000000000002108
10.1007/s00540-018-2579-4
10.2174/1871527318666190703110036
10.1186/s12974-017-0828-3
10.3389/fncel.2019.00353
10.3390/ijms20205164
10.1038/nrrheum.2015.100
10.1080/14787210.2020.1812384
10.3389/fimmu.2018.02671
10.3389/fnins.2019.00527",<Element 'PubmedArticle' at 0x7f05dd9a9310>
189,"33299399
33029126
32617097
32908485
31847649
21224065
24670762
19248166
31029599
27241942
21536750
25633229
24219385
21921234
30029608
25630253
23312512
24360280
29073528
23386613
25623949
25575683
25148577
28077724
28800362
7697725
30227871
27153061
26607602
22176685
21707777",Repressor Element 1 Silencing Transcription Factor (REST) Governs Microglia-Like BV2 Cell Migration via Progranulin (PGRN).,"Microglia activation contributes to Alzheimer's disease (AD) etiology, and microglia migration is a fundamental function during microglia activation. The repressor element-1 silencing transcription factor (REST), a powerful transcriptional factor, was found to play a neuroprotective role in AD. Despite its possible role in disease progression, little is known about whether REST participates in microglia migration. In this study, we aimed to explore the function of REST and its molecular basis during microglia migration under A",[],Neural plasticity,2020-12-11,"[{'lastname': 'Yu', 'firstname': 'Tongya', 'initials': 'T', 'affiliation': ""Shanghai Tenth People's Hospital of Tongji University, Tongji University, Middle Yanchang Rd. 301#, Jingan District, Shanghai, China 200072.""}, {'lastname': 'Lin', 'firstname': 'Yingying', 'initials': 'Y', 'affiliation': ""Shanghai Tenth People's Hospital of Tongji University, Tongji University, Middle Yanchang Rd. 301#, Jingan District, Shanghai, China 200072.""}, {'lastname': 'Xu', 'firstname': 'Yuzhen', 'initials': 'Y', 'affiliation': ""Shanghai Tenth People's Hospital of Tongji University, Tongji University, Middle Yanchang Rd. 301#, Jingan District, Shanghai, China 200072.""}, {'lastname': 'Dou', 'firstname': 'Yunxiao', 'initials': 'Y', 'affiliation': ""Shanghai Tenth People's Hospital of Tongji University, Tongji University, Middle Yanchang Rd. 301#, Jingan District, Shanghai, China 200072.""}, {'lastname': 'Wang', 'firstname': 'Feihong', 'initials': 'F', 'affiliation': ""Shanghai Tenth People's Hospital of Tongji University, Tongji University, Middle Yanchang Rd. 301#, Jingan District, Shanghai, China 200072.""}, {'lastname': 'Quan', 'firstname': 'Hui', 'initials': 'H', 'affiliation': ""Shanghai Tenth People's Hospital of Tongji University, Tongji University, Middle Yanchang Rd. 301#, Jingan District, Shanghai, China 200072.""}, {'lastname': 'Zhao', 'firstname': 'Yanxin', 'initials': 'Y', 'affiliation': ""Shanghai Tenth People's Hospital of Tongji University, Tongji University, Middle Yanchang Rd. 301#, Jingan District, Shanghai, China 200072.""}, {'lastname': 'Liu', 'firstname': 'Xueyuan', 'initials': 'X', 'affiliation': ""Shanghai Tenth People's Hospital of Tongji University, Tongji University, Middle Yanchang Rd. 301#, Jingan District, Shanghai, China 200072.""}]",,,,Copyright © 2020 Tongya Yu et al.,"10.1155/2020/8855822
10.1155/2020/8888871
10.1155/2020/8834275
10.1155/2020/8825954
10.1080/00207454.2019.1702548
10.1016/j.ajpath.2010.11.002
10.1038/nature13163
10.1002/ar.20849
10.1016/j.brainresbull.2019.04.019
10.1016/j.neuroscience.2016.05.047
10.1083/jcb.201010126
10.1016/j.neuint.2015.01.007
10.3109/00207454.2013.865027
10.1073/pnas.1113486108
10.1186/s12974-018-1250-1
10.1038/ncomms7176
10.1016/j.neuron.2012.12.023
10.1016/j.cell.2013.11.030
10.1016/j.conb.2017.10.001
10.1074/jbc.M112.427880
10.1016/j.ceca.2015.01.004
10.1007/s12035-014-9064-3
10.1371/journal.pone.0106087
10.1523/JNEUROSCI.2459-16.2017
10.1371/journal.pone.0183114
10.1016/0092-8674(95)90298-8
10.1186/s12964-018-0275-5
10.3390/ijms17050664
10.1016/j.yexmp.2015.11.021
10.3109/15419061.2011.641042
10.1111/j.1574-695X.2011.00833.x",<Element 'PubmedArticle' at 0x7f05dde81a40>
190,"33251159
25416141
18615177
10882622
24148086
26824948
23085269
25744564
29095719
27899748
26362566
30500552
27534533
23865742
8193937
28484229
25896094
7882902
20417414
16343349
7724569
31139184
24819918
25058046
26463937
29746358
25867462
24722525
18562209
29754263
16601488
17148956
17371820
12379902
29151103
10658595
31532239
30799631
23386810
12744466
28788104
8454848
8958228
11522576
12788989
26376816
24491581
26119836
11110643
23248040
27105658
27597805
12717622
3508700
30971685
21734248
30131074
31351490
31061158
19884325
11801337
10197818
27445150
10469884
25015040
30959794
19476641
32471272
19890068
18236016
22024597
28045021
16864706
20468046
18584858
28992427
16720574
32117037
30967852
19525393
27402121
27062097
19386456
12857775
20526697
10366638
11109000
29939190
22020035",Adjuvant Cannabinoid Receptor Type 2 Agonist Modulates the Polarization of Microglia Towards a Non-Inflammatory Phenotype in Experimental Pneumococcal Meningitis.,"Microglia initiates and sustains the inflammatory reaction that drives the pathogenesis of pneumococcal meningitis. The expression of the G-protein cannabinoid receptor type 2 (CB2) in the brain is low, but is upregulated in glial cells during infection. Its activation down-regulates pro-inflammatory processes, driving microglia towards an anti-inflammatory phenotype. CB2 agonists are therefore therapeutic candidates in inflammatory conditions like pneumococcal meningitis. We evaluated the effects of JWH-133, a specific CB2 agonist on microglial cells, inflammation, and damage driven by 
Primary mixed glial cultures were stimulated with live or heat-inactivated 
JWH-133 attenuates microglial activation and downregulates the concentrations of pro-inflammatory mediators in pneumococcal infection ","['bacterial meningitis', 'brain damage', 'endocannabinoid system', 'microglia', 'neuro-inflammation']",Frontiers in cellular and infection microbiology,2020-12-01,"[{'lastname': 'Pan', 'firstname': 'Steven D', 'initials': 'SD', 'affiliation': 'Neuroinfection Laboratory, Institute for Infectious Diseases, University of Bern, Bern, Switzerland.'}, {'lastname': 'Grandgirard', 'firstname': 'Denis', 'initials': 'D', 'affiliation': 'Neuroinfection Laboratory, Institute for Infectious Diseases, University of Bern, Bern, Switzerland.'}, {'lastname': 'Leib', 'firstname': 'Stephen L', 'initials': 'SL', 'affiliation': 'Neuroinfection Laboratory, Institute for Infectious Diseases, University of Bern, Bern, Switzerland.'}]",,,,"Copyright © 2020 Pan, Grandgirard and Leib.","10.3389/fcimb.2020.588195
10.1186/s12974-014-0191-6
10.2174/157015907780866884
10.1086/315658
10.1111/bph.12478
10.1128/AAC.02429-15
10.1016/j.ejphar.2012.09.053
10.1007/s12035-015-9107-4
10.1097/QCO.0000000000000416
10.1161/STROKEAHA.116.014793
10.1002/14651858.CD004405.pub5
10.1016/j.lfs.2018.11.058
10.1038/emm.2015.100
10.1186/1471-2334-13-326
10.1016/0361-9230(94)90189-9
10.1038/s41598-017-01747-8
10.1016/j.jinf.2015.04.006
10.3109/01902149409031733
10.1016/S1473-3099(10)70048-7
10.1186/1742-2094-2-29
10.1073/pnas.92.8.3376
10.3389/fimmu.2019.01027
10.1016/j.jns.2014.04.034
10.1016/j.expneurol.2014.07.005
10.1007/978-3-319-18497-5_24
10.1097/CCM.0000000000003220
10.1016/j.jneuroim.2015.02.008
10.1177/1073858414530512
10.1016/j.mcn.2008.05.001
10.1007/s00011-018-1158-3
10.1097/01.mop.0000193292.09894.b7
10.1159/000096218
10.1128/AAC.01014-06
10.1002/glia.10161
10.1159/000481824
10.1016/S0968-0896(99)00219-9
10.1089/dna.2019.5024
10.1096/fj.201802524R
10.3389/fncel.2013.00003
10.1111/j.1750-3639.2003.tb00012.x
10.3390/ijms18081669
10.1172/JCI119084
10.1093/brain/124.9.1734
10.1203/01.PDR.0000079185.67878.72
10.1007/s12975-015-0425-7
10.1128/IAI.00073-14
10.2217/fmb.15.43
10.1086/317921
10.1007/s00134-012-2792-9
10.1016/j.jinf.2016.04.009
10.1155/2016/5831315
10.1086/374644
10.1016/0887-8994(86)90019-6
10.1038/s41467-019-09040-0
10.1128/CMR.00008-11
10.1186/s12974-018-1272-8
10.1186/s12974-019-1549-6
10.1128/AAC.00220-19
10.1096/fj.09-141275
10.1016/S0166-2236(00)02024-5
10.1097/00005072-199903000-00006
10.1523/JNEUROSCI.0554-16.2016
10.1007/s11481-014-9554-0
10.3390/molecules24071350
10.1186/1744-8069-5-25
10.3390/ijms21113809
10.1212/WNL.0b013e3181c55d2e
10.1007/s10787-007-0013-x
10.1016/j.brainresbull.2011.10.004
10.1038/ncomms13958
10.1203/01.pdr.0000227553.47378.9f
10.1002/glia.20983
10.1016/j.pbb.2008.05.010
10.1080/21505594.2017.1389369
10.1074/jbc.M600504200
10.3389/fneur.2020.00087
10.3389/fmicb.2019.00576
10.4049/jimmunol.0900203
10.1007/s00018-016-2300-4
10.1016/j.cmi.2016.01.007
10.1016/j.medmal.2009.02.033
10.1128/CMR.16.3.415-429.2003
10.1007/s12028-010-9387-5
10.1523/JNEUROSCI.19-12-05054.1999
10.1016/s0304-3940(00)01645-1
10.3791/57648
10.1161/STROKEAHA.111.631044",<Element 'PubmedArticle' at 0x7f05ddbd4db0>
191,33230896,Hyperleptinemia as a contributing factor for the impairment of glucose intolerance in obesity.,"Obesity has emerged as a major risk factor for insulin resistance leading to the development of type 2 diabetes (T2D). The condition is characterized by high circulating levels of the adipose-derived hormone leptin and a state of chronic low-grade inflammation. Pro-inflammatory signaling in the hypothalamus is associated with a decrease of central leptin- and insulin action leading to impaired systemic glucose tolerance. Intriguingly, leptin not only regulates body weight and glucose homeostasis but also acts as a pro-inflammatory cytokine. Here we demonstrate that increasing leptin levels (62,5 µg/kg/d, PEGylated leptin) in mice fed a high-fat diet (HFD) exacerbated body weight gain and aggravated hypothalamic micro- as well as astrogliosis. In contrast, administration of a predetermined dose of a long-acting leptin antagonist (100 µg/kg/d, PESLAN) chosen to block excessive leptin signaling during diet-induced obesity (DIO) showed the opposite effect and significantly improved glucose tolerance as well as decreased the total number of microglia and astrocytes in the hypothalamus of mice fed HFD. These results suggest that high levels of leptin, such as in obesity, worsen HFD-induced micro-and astrogliosis, whereas the partial reduction of hyperleptinemia in DIO mice may have beneficial metabolic effects and improves hypothalamic gliosis.","['diabetes', 'diet-induced obesity', 'energy metabolism', 'hypothalamus', 'inflammation']",FASEB journal : official publication of the Federation of American Societies for Experimental Biology,2020-11-25,"[{'lastname': 'Pretz', 'firstname': 'Dominik', 'initials': 'D', 'affiliation': 'Centre for Neuroendocrinology, Department of Physiology, School of Medical Sciences, University of Otago, Dunedin, New Zealand.\nDepartment of Animal Physiology, Faculty of Biology, Philipps-University Marburg, Marburg, Germany.'}, {'lastname': 'Le Foll', 'firstname': 'Christelle', 'initials': 'C', 'affiliation': 'Institute of Veterinary Physiology, University of Zurich, Zurich, Switzerland.'}, {'lastname': 'Rizwan', 'firstname': 'Mohammed Z', 'initials': 'MZ', 'affiliation': 'Centre for Neuroendocrinology, Department of Physiology, School of Medical Sciences, University of Otago, Dunedin, New Zealand.'}, {'lastname': 'Lutz', 'firstname': 'Thomas A', 'initials': 'TA', 'affiliation': 'Institute of Veterinary Physiology, University of Zurich, Zurich, Switzerland.'}, {'lastname': 'Tups', 'firstname': 'Alexander', 'initials': 'A', 'affiliation': 'Centre for Neuroendocrinology, Department of Physiology, School of Medical Sciences, University of Otago, Dunedin, New Zealand.\nDepartment of Animal Physiology, Faculty of Biology, Philipps-University Marburg, Marburg, Germany.'}]",,,,© 2020 Federation of American Societies for Experimental Biology.,10.1096/fj.202001147R,<Element 'PubmedArticle' at 0x7f05deacc180>
192,33165192,Repeated and single maternal separation specifically alter microglial morphology in the prefrontal cortex and neurogenesis in the hippocampus of 15-day-old male mice.,"Early-life adversity impairs neuronal plasticity of the developing brain. In rodents, brain maturation processes, including neuro- and synaptogenesis, myelination, microglial maturation, and hypothalamic-pituitary-adrenal (HPA) axis development continue in the postnatal period. In our study, two models of early-life stress were used: repeated maternal separation (MS) from postnatal day (PND) 2 to PND14 for 3 h daily and single maternal deprivation (MD) on PND9 for 24 h. Effects of each type of early-life stress on neuron density, neurogenesis, microglial morphology, and HPA axis programming were studied in 15-day-old male mice. Neither early-life stress paradigm affected the expression of stress-related genes (Crh, Avp, Crhr1, Crhr2, Nr3c1, and Nr3c2) and the serum level of corticosterone on PND15. Immunohistochemical analysis was performed on slices of the hippocampus and prefrontal cortex (PFC) with antibodies against a marker of mature neurons (NeuN), of microglia (Iba1), proliferating cells (Ki67), and immature neurons (DCX). We found higher density of ameboid microglia and intermediate microglia in the PFC in groups MS and MD, respectively, than in a control group. In both stressed groups, a higher number of Ki67-positive cells was noted in the dentate gyrus. Thus, in mice, the process of transformation of ameboid microglia into ramified ones as well as a neurogenesis reduction take place during the second postnatal week, whereas early-life stress can disturb these processes in a stress- and region-dependent manner.",[],Neuroreport,2020-11-10,"[{'lastname': 'Reshetnikov', 'firstname': 'Vasiliy', 'initials': 'V', 'affiliation': 'Laboratory of Gene Expression Regulation, Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (SB RAS).'}, {'lastname': 'Ryabushkina', 'firstname': 'Yulia', 'initials': 'Y', 'affiliation': 'Laboratory of Gene Expression Regulation, Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (SB RAS).'}, {'lastname': 'Kovner', 'firstname': 'Anna', 'initials': 'A', 'affiliation': 'Laboratory of Gene Expression Regulation, Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (SB RAS).'}, {'lastname': 'Lepeshko', 'firstname': 'Arina', 'initials': 'A', 'affiliation': 'Faculty of Natural Science, Novosibirsk State University, Novosibirsk, Russia.'}, {'lastname': 'Bondar', 'firstname': 'Natalia', 'initials': 'N', 'affiliation': 'Laboratory of Gene Expression Regulation, Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (SB RAS).\nFaculty of Natural Science, Novosibirsk State University, Novosibirsk, Russia.'}]",,,,,10.1097/WNR.0000000000001544,<Element 'PubmedArticle' at 0x7f05deaec9f0>
193,"33158962
28420961
17379265
27241943
25982835
29775591
23756782
10575016
22414444
3228475
21826442
10077336
14611865
29854002
19997116
18614693
14694190
28740157
28930663
29524300
28636962
28099414
30728170
30995501
23170794
16783372
23750306
11264718
27529445
19401952
26627258
7996194
15723163
20012068
27870410
19064795
31907392
29849895
12878732
24198336
28942245
22553043
18716201
24508637
31338213
9101730",Astrocyte-Derived Estrogen Regulates Reactive Astrogliosis and is Neuroprotective following Ischemic Brain Injury.,"Expression of the 17β-estradiol (E2) synthesis enzyme aromatase is highly upregulated in astrocytes following brain injury. However, the precise role of astrocyte-derived E2 in the injured brain remains unclear. In the current study, we generated a glial fibrillary acidic protein (GFAP) promoter-driven aromatase knock-out (GFAP-ARO-KO) mouse model to deplete astrocyte-derived E2 in the brain and determine its roles after global cerebral ischemia (GCI) in male and female mice. GFAP-ARO-KO mice were viable and fertile, with normal gross brain structure, normal morphology, intensity and distribution of astrocytes, normal aromatase expression in neurons, and normal cognitive function basally. In contrast, after GCI, GFAP-ARO-KO mice: (1) lacked the normal elevation of astrocyte aromatase and hippocampal E2 levels; (2) had significantly attenuated reactive astrogliosis; and (3) displayed enhanced neuronal damage, microglia activation, and cognitive deficits. RNA-sequencing (RNA-seq) analysis revealed that the ischemic GFAP-ARO-KO mouse hippocampus failed to upregulate the ""A2"" panel of reactive astrocyte genes. In addition, the JAK-STAT3 pathway, which is critical for the induction of reactive astrogliosis, was significantly downregulated in the GFAP-ARO-KO hippocampus following GCI. Finally, exogenous E2 administration fully rescued the compromised JAK-STAT3 pathway and reactive astrogliosis, and reversed the enhanced neuronal damage and microglial activation in the GFAP-ARO-KO mice after GCI, suggesting that the defects in the KO mice are because of a loss of E2 rather than an increase in precursor androgens. In conclusion, the current study provides novel genetic evidence for a beneficial role of astrocyte-derived E2 in reactive astrogliosis, microglial activation, and neuroprotection following an ischemic injury to the brain.","['17β-estradiol', 'aromatase', 'astrocyte activation', 'estrogen', 'global cerebral ischemia', 'hippocampus']",The Journal of neuroscience : the official journal of the Society for Neuroscience,2020-11-08,"[{'lastname': 'Wang', 'firstname': 'Jing', 'initials': 'J', 'affiliation': 'Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta University, Augusta, Georgia 30912.'}, {'lastname': 'Sareddy', 'firstname': 'Gangadhara R', 'initials': 'GR', 'affiliation': 'Department of Obstetrics and Gynecology, University of Texas Health, San Antonio, Texas 78229.'}, {'lastname': 'Lu', 'firstname': 'Yujiao', 'initials': 'Y', 'affiliation': 'Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta University, Augusta, Georgia 30912.'}, {'lastname': 'Pratap', 'firstname': 'Uday P', 'initials': 'UP', 'affiliation': 'Department of Obstetrics and Gynecology, University of Texas Health, San Antonio, Texas 78229.'}, {'lastname': 'Tang', 'firstname': 'Fulei', 'initials': 'F', 'affiliation': 'Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta University, Augusta, Georgia 30912.'}, {'lastname': 'Greene', 'firstname': 'Karah M', 'initials': 'KM', 'affiliation': 'Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta University, Augusta, Georgia 30912.'}, {'lastname': 'Meyre', 'firstname': 'Pornjittra L', 'initials': 'PL', 'affiliation': 'Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta University, Augusta, Georgia 30912.'}, {'lastname': 'Tekmal', 'firstname': 'Rajeshwar R', 'initials': 'RR', 'affiliation': 'Department of Obstetrics and Gynecology, University of Texas Health, San Antonio, Texas 78229.'}, {'lastname': 'Vadlamudi', 'firstname': 'Ratna K', 'initials': 'RK', 'affiliation': 'Department of Obstetrics and Gynecology, University of Texas Health, San Antonio, Texas 78229 dbrann@augusta.edu vadlamudi@uthscsa.edu.'}, {'lastname': 'Brann', 'firstname': 'Darrell W', 'initials': 'DW', 'affiliation': 'Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta University, Augusta, Georgia 30912 dbrann@augusta.edu vadlamudi@uthscsa.edu.'}]",,,,Copyright © 2020 the authors.,"10.1523/JNEUROSCI.0888-20.2020
10.3389/fnmol.2017.00088
10.1016/j.steroids.2007.02.003
10.1016/j.neuroscience.2016.05.043
10.1016/j.nbd.2015.05.003
10.1016/j.cell.2018.05.003
10.1007/s00418-013-1110-0
10.1523/JNEUROSCI.19-23-10193.1999
10.1016/j.yhbeh.2012.02.026
10.1016/0166-4328(88)90157-x
10.1007/s00441-011-1221-7
10.1016/s0306-4522(98)00340-6
10.1016/j.pneurobio.2003.09.005
10.1177/1756286418774254
10.1038/jcbfm.2009.257
10.1523/JNEUROSCI.1709-08.2008
10.1073/pnas.2630225100
10.1038/s41598-017-06630-0
10.1016/j.immuni.2017.08.008
10.1111/cns.12842
10.1016/j.immuni.2017.06.006
10.1038/nature21029
10.1523/JNEUROSCI.1970-18.2019
10.1016/j.immuni.2019.03.027
10.2174/138945013804806514
10.1038/nm1425
10.1046/j.1365-2826.2001.00647.x
10.1111/jnc.13774
10.1055/s-0029-1216274
10.1073/pnas.1516729112
10.1523/JNEUROSCI.14-12-07541.1994
10.1007/s00018-004-4382-2
10.1007/s00401-009-0619-8
10.1002/jnr.23962
10.1161/STROKEAHA.108.533166
10.1038/s41418-019-0487-2
10.1155/2018/4248526
10.1073/pnas.1531957100
10.1073/pnas.1307224110
10.1016/j.freeradbiomed.2017.09.017
10.1523/JNEUROSCI.6221-11.2012
10.1523/JNEUROSCI.2752-08.2008
10.1016/j.mce.2013.12.019
10.1136/svn-2018-000196
10.1016/s0304-4165(96)00115-8",<Element 'PubmedArticle' at 0x7f05deae1d60>
194,33148438,Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway.,"A connection between gut microbiota and Parkinson's disease (PD) indicates that dysbiosis of the gut microbiota might represent a risk factor for PD. Microbiota-targeted interventions, including probiotic Clostridium butyricum (Cb), have been recently shown to have favorable effects in PD by regulating microbiota-gut-brain axis. However, the potential beneficial roles and its mechanisms of Cb on PD were still unknown. Male C57BL/6 mice were subjected to a PD model-induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) and were treated intragastrically with Cb for 4 weeks. The motor functions were assessed by a series of behavioral tests including pole test, beam walking teat, forced swimming test and open field test. The dopaminergic neuron loss, synaptic plasticity and microglia activation, as well as the levels of colonic glucagon-like peptide-1 (GLP-1), colonic G protein-coupled receptors GPR41/43 and cerebral GLP-1 receptors were assessed. Gut microbial composition was assessed by 16S rRNA sequencing analysis. Our results showed that oral administration of Cb could improve motor deficits, dopaminergic neuron loss, synaptic dysfunction and microglia activation in the MPTP-induced mice. Meanwhile, Cb treatment could reverse the dysbiosis of gut microbiota and the decreased levels of colonic GLP-1, colonic GPR41/43 and cerebral GLP-1 receptor in the MPTP-induced mice. These findings indicated that the neuroprotective mechanism of Cb on PD might be related to the improvement of abnormal gut microbiota-gut-brain axis.","['Clostridium butyricum', 'Glucagon-like peptide-1', 'Gut microbiota', 'Gut-brain axis', 'Neuroprotection', 'Parkinson’s disease']","Brain, behavior, and immunity",2020-11-06,"[{'lastname': 'Sun', 'firstname': 'Jing', 'initials': 'J', 'affiliation': ""Department of Neurology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China.""}, {'lastname': 'Li', 'firstname': 'Haijun', 'initials': 'H', 'affiliation': ""Department of Neurology, Taizhou Second People's Hospital, Taizhou, Zhejiang 317000, China.""}, {'lastname': 'Jin', 'firstname': 'Yangjie', 'initials': 'Y', 'affiliation': 'Department of Preventive Medicine, School of Public Health and Management, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.'}, {'lastname': 'Yu', 'firstname': 'Jiaheng', 'initials': 'J', 'affiliation': 'Department of Preventive Medicine, School of Public Health and Management, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.'}, {'lastname': 'Mao', 'firstname': 'Shiyin', 'initials': 'S', 'affiliation': 'Department of Preventive Medicine, School of Public Health and Management, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.'}, {'lastname': 'Su', 'firstname': 'Kuan-Pin', 'initials': 'KP', 'affiliation': 'Department of Psychiatry and Mind-Body Interface Laboratory, China Medical University Hospital, Taichung, Taiwan.'}, {'lastname': 'Ling', 'firstname': 'Zongxin', 'initials': 'Z', 'affiliation': 'Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China. Electronic address: lingzongxin@zju.edu.cn.'}, {'lastname': 'Liu', 'firstname': 'Jiaming', 'initials': 'J', 'affiliation': ""Department of Neurology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China; Department of Preventive Medicine, School of Public Health and Management, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China. Electronic address: wzjiaming_liu@163.com.""}]",,,,Copyright © 2020 Elsevier Inc. All rights reserved.,10.1016/j.bbi.2020.10.014,<Element 'PubmedArticle' at 0x7f05dd98adb0>
195,"33106949
30073507
12487768
21893493
26497402
26146876
15205881
28088629
19491714
26316431
19305790
30224761
20581817
26930371
31648182
26390974
28688896
26971628
26895770
22334391
30280789
29796989
29436670
24978200
16794016
19460632
26778970
25288670
27787894
22048644
28283887
30311190
25309334
9333125
28903487
25575682
19200883
28523372
26100815
11170718
23085314
15796810
16059974
20021662
28093992
28390960
30333975
28626114
31736784
29857029
26562261
22684107
30661803
24402351
26031379
28058581
29970188
17053024
29057768
18653772
19158478
25986948
26086870
30538224
24674959
27653365
31091354
23757764
25637286
31000769
28801921
28333139
25872478
25623802
25858486
29988130
29222622
31446520
20403092
26459113
26873855",Hypothyroidism Induces Interleukin-1-Dependent Autophagy Mechanism as a Key Mediator of Hippocampal Neuronal Apoptosis and Cognitive Decline in Postnatal Rats.,"Thyroid hormone (TH) is essential for brain development, and hypothyroidism induces cognitive deficits in children and young adults. However, the participating mechanisms remain less explored. Here, we examined the molecular mechanism, hypothesizing the involvement of a deregulated autophagy and apoptosis pathway in hippocampal neurons that regulate cognitive functions. Therefore, we used a rat model of developmental hypothyroidism, generated through methimazole treatment from gestation until young adulthood. We detected that methimazole stimulated the autophagy mechanism, characterized by increased LC3B-II, Beclin-1, ATG7, and ATG5-12 conjugate and decreased p-mTOR/mTOR and p-ULK1/ULK1 autophagy regulators in the hippocampus of developing and young adult rats. This methimazole-induced hippocampal autophagy could be inhibited by thyroxine treatment. Subsequently, probing the upstream mediators of autophagy revealed an increased hippocampal neuroinflammation, marked by upregulated interleukin (IL)-1alpha and beta and activated microglial marker, Iba1, promoting neuronal IL-1 receptor-1 expression. Hence, IL-1R-antagonist (IL-1Ra), which reduced hippocampal neuronal IL-1R1, also inhibited the enhanced autophagy in hypothyroid rats. We then linked these events with hypothyroidism-induced apoptosis and loss of hippocampal neurons, where we observed that like thyroxine, IL-1Ra and autophagy inhibitor, 3-methyladenine, reduced the cleaved caspase-3 and TUNEL-stained apoptotic neurons and enhanced Nissl-stained neuronal count in methimazole-treated rats. We further related these molecular results with cognition through Y-maze and passive avoidance tests, demonstrating an IL-1Ra and 3-methyladenine-mediated improvement in learning-memory performances of the hypothyroid rats. Taken together, our study enlightens the critical role of neuroinflammation-dependent autophagy mechanism in TH-regulated hippocampal functions, disrupted in developmental hypothyroidism.","['Autophagy', 'Hippocampus', 'Inflammation', 'Memory loss', 'Thyroid hormone deficiency']",Molecular neurobiology,2020-10-28,"[{'lastname': 'Mishra', 'firstname': 'Juhi', 'initials': 'J', 'affiliation': 'Developmental Toxicology Laboratory, Systems Toxicology & Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, Lucknow, Uttar Pradesh, 226001, India.\nDepartment of Biochemistry, Babu Banarasi Das University, Faizabad Road, Lucknow, Uttar Pradesh, India.'}, {'lastname': 'Vishwakarma', 'firstname': 'Jitendra', 'initials': 'J', 'affiliation': 'Developmental Toxicology Laboratory, Systems Toxicology & Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, Lucknow, Uttar Pradesh, 226001, India.\nAcademy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, India.'}, {'lastname': 'Malik', 'firstname': 'Rafat', 'initials': 'R', 'affiliation': 'Developmental Toxicology Laboratory, Systems Toxicology & Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, Lucknow, Uttar Pradesh, 226001, India.'}, {'lastname': 'Gupta', 'firstname': 'Keerti', 'initials': 'K', 'affiliation': 'Developmental Toxicology Laboratory, Systems Toxicology & Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, Lucknow, Uttar Pradesh, 226001, India.\nAcademy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, India.'}, {'lastname': 'Pandey', 'firstname': 'Rukmani', 'initials': 'R', 'affiliation': 'Developmental Toxicology Laboratory, Systems Toxicology & Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, Lucknow, Uttar Pradesh, 226001, India.\nAcademy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, India.\nDepartment of Psychiatry, Center for Molecular Biology and Genetics of Neurodegeneration, Icahn School of Medicine at Mount Sinai, New York, NY, USA.'}, {'lastname': 'Maurya', 'firstname': 'Shailendra Kumar', 'initials': 'SK', 'affiliation': 'Division of Endocrinology, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow, Uttar Pradesh, India.\nDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.'}, {'lastname': 'Garg', 'firstname': 'Asmita', 'initials': 'A', 'affiliation': 'Developmental Toxicology Laboratory, Systems Toxicology & Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, Lucknow, Uttar Pradesh, 226001, India.\nAcademy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, India.'}, {'lastname': 'Shukla', 'firstname': 'Manoj', 'initials': 'M', 'affiliation': 'Department of Endocrinology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.'}, {'lastname': 'Chattopadhyay', 'firstname': 'Naibedya', 'initials': 'N', 'affiliation': 'Division of Endocrinology, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow, Uttar Pradesh, India.'}, {'lastname': 'Bandyopadhyay', 'firstname': 'Sanghamitra', 'initials': 'S', 'affiliation': 'Developmental Toxicology Laboratory, Systems Toxicology & Health Risk Assessment Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, Lucknow, Uttar Pradesh, 226001, India. sanghmitra@iitr.res.in.\nAcademy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh, India. sanghmitra@iitr.res.in.'}]",,,,,"10.1007/s12035-020-02178-9
10.1007/s12035-018-1270-y
10.1089/105072502761016485
10.1093/bmb/ldr030
10.1016/S2213-8587(15)00327-7
10.1001/jamapediatrics.2015.0498
10.1007/s00213-004-1795-9
10.1016/j.bbadis.2017.01.002
10.1007/BF03345560
10.1097/MNM.0b013e32832c79e0
10.4274/jcrpe.1684
10.2174/157015908784533897
10.1038/s41556-018-0201-5
10.1038/nn.2575
10.1016/j.lfs.2016.02.014
10.1530/JOE-19-0197
10.1007/s00018-015-2034-8
10.1016/j.bbr.2017.07.003
10.1016/j.bbr.2016.03.023
10.1136/acupmed-2015-010894
10.1002/ana.22620
10.26355/eurrev_201809_15941
10.1007/s12035-018-1111-z
10.3892/mmr.2018.8605
10.1002/hipo.22319
10.1210/en.2006-0027
10.1016/j.ijdevneu.2009.02.003
10.3389/fnana.2015.00161
10.1093/toxsci/kfu208
10.1111/jnc.13879
10.1093/toxsci/kfr303
10.1007/s12035-017-0469-7
10.1111/jnc.14610
10.3389/fncir.2014.00107
10.1359/jbmr.1997.12.10.1647
10.1093/toxsci/kfx124
10.1007/s12035-014-9061-6
10.1016/S0076-6879(08)03612-4
10.1007/s00394-017-1462-7
10.1186/s12929-015-0157-8
10.1006/exnr.2000.7595
10.1016/j.brainres.2012.10.025
10.1186/1471-2202-10-149
10.2174/1389200218666170116112407
10.1016/j.ygcen.2017.04.001
10.3389/fcell.2018.00128
10.1507/endocrj.EJ16-0534
10.3389/fphys.2019.01363
10.1016/j.neuroscience.2018.05.027
10.1210/en.2015-1632
10.1172/JCI60580
10.1016/j.cub.2018.12.021
10.1007/s11325-013-0930-4
10.1016/j.bbr.2015.05.049
10.1007/s12035-016-0351-z
10.1186/s13041-018-0381-8
10.1210/en.2006-0991
10.1507/endocrj.EJ17-0281
10.1634/stemcells.2008-0153
10.4161/auto.5.2.7641
10.1186/s13041-015-0119-9
10.1002/stem.2082
10.1038/s41419-018-1229-y
10.4161/auto.28264
10.1080/15548627.2016.1230583
10.1002/iub.2067
10.1093/brain/awt131
10.1186/s40478-014-0182-y
10.1038/s41401-019-0220-1
10.1002/jnr.24130
10.1038/cddis.2017.120
10.3892/mmr.2015.3611
10.1016/j.jns.2014.12.027
10.1016/j.brainres.2015.03.051
10.1038/s41591-018-0092-9
10.1007/s10571-017-0570-5
10.1007/s10753-019-01082-2
10.1111/j.1365-2826.2010.02002.x
10.1016/j.nbd.2015.10.001
10.1007/s12035-016-9735-3
10.3390/ijms18030598",<Element 'PubmedArticle' at 0x7f05dd99ad10>
196,"33101162
29998204
26343610
26351526
17618967
25702209
26981087
28042008
31963314
18458777
24090534
25218898
21845170
28420961
29036852
28576511
20504161
16503807
19698070
26667033
29488253
29701827
19998681
19359451
19938945
25767964
25635844
26963638
25035267
26415822
29385019
26239463
29388851
5496484
21525267
22041296
22386198
27317610
9444479
16361444
19484722
24117520
25801728
27956050
17765729
23290588
21939393
32038140
3690695
19657303
27604721
23735519
24151829
27712117
22569979
30199551
11846609
29939190
27306143
18275957
23723565
31569331
19339593
24830807
28736137
29038483
21710619
10510203
31068886
27029852
28337122
27560623
29128343
31030257
17184190
18373481
20560754
21277947
23384619
24444675
30248435
29179648
1169787
504410
12355329
18241053
22386641
30170157
9749718
15956051
20533863
25846436
28859530
24819916
16772325
6883453
4426083
4426082
3743644
24944032
25572386
21527731
24303068
20547972
30026701
28608978
31677290
26774527
30201764
31139072
23196064
12816543
12209854
23211561
27196727
31228875
31171460
26955967
25422582
32849211
8083742
11780867
28730967
22233388",Sex-Dependent Pathology in the HPA Axis at a Sub-acute Period After Experimental Traumatic Brain Injury.,"Over 2.8 million traumatic brain injuries (TBIs) are reported in the United States annually, of which, over 75% are mild TBIs with diffuse axonal injury (DAI) as the primary pathology. TBI instigates a stress response that stimulates the hypothalamic-pituitary-adrenal (HPA) axis concurrently with DAI in brain regions responsible for feedback regulation. While the incidence of affective symptoms is high in both men and women, presentation is more prevalent and severe in women. Few studies have longitudinally evaluated the etiology underlying late-onset affective symptoms after mild TBI and even fewer have included females in the experimental design. In the experimental TBI model employed in this study, evidence of chronic HPA dysregulation has been reported at 2 months post-injury in male rats, with peak neuropathology in other regions of the brain at 7 days post-injury (DPI). We predicted that mechanisms leading to dysregulation of the HPA axis in male and female rats would be most evident at 7 DPI, the sub-acute time point. Young adult age-matched male and naturally cycling female Sprague Dawley rats were subjected to midline fluid percussion injury (mFPI) or sham surgery. Corticotropin releasing hormone, gliosis, and glucocorticoid receptor (GR) levels were evaluated in the hypothalamus and hippocampus, along with baseline plasma adrenocorticotropic hormone (ACTH) and adrenal gland weights. Microglial response in the paraventricular nucleus of the hypothalamus indicated mild neuroinflammation in males compared to sex-matched shams, but not females. Evidence of microglia activation in the dentate gyrus of the hippocampus was robust in both sexes compared with uninjured shams and there was evidence of a significant interaction between sex and injury regarding microglial cell count. GFAP intensity and astrocyte numbers increased as a function of injury, indicative of astrocytosis. GR protein levels were elevated 30% in the hippocampus of females in comparison to sex-matched shams. These data indicate sex-differences in sub-acute pathophysiology following DAI that precede late-onset HPA axis dysregulation. Further understanding of the etiology leading up to late-onset HPA axis dysregulation following DAI could identify targets to stabilize feedback, attenuate symptoms, and improve efficacy of rehabilitation and overall recovery.","['astrocytosis', 'diffuse axonal injury', 'diffuse traumatic brain injury', 'glucocorticoid receptors', 'hypothalamic-pituitary-adrenal axis', 'microglia', 'neuroinflammation', 'sex-differences']",Frontiers in neurology,2020-10-27,"[{'lastname': 'Bromberg', 'firstname': 'Caitlin E', 'initials': 'CE', 'affiliation': ""Barrow Neurological Institute at Phoenix Children's Hospital, Phoenix, AZ, United States.\nDepartment of Child Health, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, United States.""}, {'lastname': 'Condon', 'firstname': 'Andrew M', 'initials': 'AM', 'affiliation': 'Department of Child Health, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, United States.\nDepartment of Biology and Biochemistry, University of Bath, Bath, United Kingdom.'}, {'lastname': 'Ridgway', 'firstname': 'Samantha W', 'initials': 'SW', 'affiliation': 'Department of Child Health, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, United States.\nDepartment of Biology, School of Life Sciences, Arizona State University, Tempe, AZ, United States.'}, {'lastname': 'Krishna', 'firstname': 'Gokul', 'initials': 'G', 'affiliation': ""Barrow Neurological Institute at Phoenix Children's Hospital, Phoenix, AZ, United States.\nDepartment of Child Health, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, United States.""}, {'lastname': 'Garcia-Filion', 'firstname': 'Pamela C', 'initials': 'PC', 'affiliation': 'Department of Biomedical Informatics, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, United States.'}, {'lastname': 'Adelson', 'firstname': 'P David', 'initials': 'PD', 'affiliation': ""Barrow Neurological Institute at Phoenix Children's Hospital, Phoenix, AZ, United States.\nDepartment of Child Health, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, United States.\nDepartment of Neurosurgery, Mayo Clinic School of Medicine, Phoenix, AZ, United States.\nSchool of Biological and Health Systems Engineering, Arizona State University, Tempe, AZ, United States.""}, {'lastname': 'Rowe', 'firstname': 'Rachel K', 'initials': 'RK', 'affiliation': ""Barrow Neurological Institute at Phoenix Children's Hospital, Phoenix, AZ, United States.\nDepartment of Child Health, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, United States.\nPhoenix VA Health Care System, Phoenix, AZ, United States.""}, {'lastname': 'Thomas', 'firstname': 'Theresa Currier', 'initials': 'TC', 'affiliation': ""Barrow Neurological Institute at Phoenix Children's Hospital, Phoenix, AZ, United States.\nDepartment of Child Health, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, United States.\nPhoenix VA Health Care System, Phoenix, AZ, United States.""}]",,,,"Copyright © 2020 Bromberg, Condon, Ridgway, Krishna, Garcia-Filion, Adelson, Rowe and Thomas.","10.3389/fneur.2020.00946
10.1016/j.conctc.2018.06.007
10.1016/j.jpsychires.2015.08.004
10.1016/S0079-6123(06)61002-9
10.1016/B978-0-444-52892-6.00004-0
10.4103/1673-5374.175046
10.1016/j.bbr.2016.12.038
10.3390/ijms21020588
10.1002/j.2051-5545.2008.tb00139.x
10.1111/head.12173
10.1016/j.bbi.2014.09.003
10.3390/ijerph8072980
10.3389/fnmol.2017.00088
10.1201/b18126-43
10.3233/RNN-170753
10.1016/j.neubiorev.2017.05.022
10.1089/neu.2010.1358
10.1089/neu.2006.23.241
10.1089/neu.2009.1091
10.1007/s11682-015-9489-y
10.1111/cxo.12670
10.1210/en.2018-00203
10.1097/JNN.0b013e3181b6be81
10.1176/jnp.2009.21.1.43
10.1089/neu.2009.1068
10.1097/MLR.0000000000000263
10.1080/07399332.2015.1005307
10.3109/02699052.2016.1144081
10.2522/ptj.20130597
10.1080/09602011.2015.1090459
10.1097/HTR.0000000000000383
10.3390/jcm4051025
10.1080/02699052.2018.1431844
10.1097/00000658-197012000-00008
10.1523/JNEUROSCI.0450-11.2011
10.1016/j.bbi.2011.10.005
10.1016/j.psyneuen.2012.02.003
10.1530/EC-16-0031
10.1615/CritRevNeurobiol.v12.i1-2.10
10.1073/pnas.0507572102
10.1002/syn.20654
10.1111/jnc.12478
10.1038/srep09442
10.1016/j.yfrne.2016.12.001
10.1089/neu.2010.9950
10.1016/S0079-6123(07)63021-0
10.1016/j.neurobiolaging.2012.11.019
10.1089/neu.2011.2091
10.3389/fnins.2019.01434
10.1089/cns.1987.4.119
10.1249/MSS.0b013e31819fcd1b
10.1007/978-1-4939-3816-2_13
10.1016/j.apmr.2012.12.027
10.1089/neu.2013.3151
10.1080/02699052.2016.1193628
10.1590/S0102-67202012000100011
10.1371/journal.pone.0203793
10.1006/meth.2001.1262
10.3791/57648
10.1089/neu.2015.4339
10.1016/j.ejphar.2007.11.066
10.1293/tox.26.29
10.3390/molecules24193517
10.1523/JNEUROSCI.4363-08.2009
10.1371/journal.pone.0097096
10.1016/j.neuroscience.2017.07.027
10.1038/s41598-017-13581-z
10.1002/ana.22455
10.1046/j.1460-9568.1999.00808.x
10.3389/fneur.2019.00345
10.1089/neu.2015.4377
10.3389/fnmol.2017.00044
10.1089/neu.2015.4381
10.1016/j.pharmthera.2017.11.005
10.1007/s00415-019-09335-8
10.1089/neu.2006.23.1802
10.1089/neu.2007.0486
10.1089/neu.2009.1252
10.1016/j.neuroscience.2011.01.028
10.1089/neu.2012.2847
10.1016/j.yhbeh.2014.01.003
10.1016/j.neuroscience.2018.09.014
10.1089/neu.2017.5238
10.1016/0031-9384(75)90044-X
10.1016/0031-9384(79)90361-5
10.1038/sj.ijo.0802065
10.1002/jnr.21628
10.1016/j.tins.2012.01.005
10.1016/j.neuroscience.2018.08.019
10.1046/j.1460-9568.1998.00064.x
10.1152/ajpendo.00122.2005
10.1016/j.physbeh.2015.04.003
10.1080/10253890.2017.1369523
10.1016/j.jns.2014.04.032
10.1152/ajpendo.00070.2006
10.1007/BF00213800
10.1007/BF00222998
10.1007/BF00222997
10.1055/s-0029-1210518
10.1002/cphy.c130054
10.3892/ijmm.2015.2064
10.1152/physrev.00011.2010
10.1371/journal.pone.0081744
10.1016/B978-008045046-9.00018-8
10.1161/HYPERTENSIONAHA.110.150409
10.3389/fphys.2018.00840
10.1002/glia.23171
10.1111/ejn.14611
10.1016/j.bbi.2016.01.009
10.1523/JNEUROSCI.0789-18.2018
10.3389/fnagi.2019.00094
10.1016/j.jsbmb.2012.11.006
10.1186/1477-7827-1-46
10.1002/cne.10325
10.1016/j.neuroscience.2012.11.039
10.1210/er.2016-1007
10.1111/jne.12762
10.1016/j.molmed.2019.05.001
10.2174/1570159X14666160309123554
10.2147/DDDT.S67655
10.3389/fneur.2020.00749
10.1523/JNEUROSCI.14-09-05373.1994
10.1089/08977150152725669
10.2174/1570159X15666170720095240
10.1089/neu.2011.2229",<Element 'PubmedArticle' at 0x7f05de0111d0>
197,"33100956
7420153
20738443
15148141
23474483
20420491
3758265
28917981
15288712
16936707
18230654
4272516
8777391
18373223
12453890
11992114
22265943
10991663
30148836
28058996
27554593
15735218
19004525
17659525
20883498
12392766
24409143
27306508
12065645
23135822
12821379
24652456
18549783
25869922
8955931
24028925
12812866
10818510
21911655
28372335
8786794
22329651
25088942
28034760
17003354
7429029
12406499
26528968
30542257
31629033
1692045
20644939
31160730
23817163
9720972
31275108
26297026
23335160
12937489
25232881
30619085
7861450
30869558
19679110
8854305
28382978
26497034
6377920
19091002
19164591
21738722
29351760
29614702
7649228
17251276
15030406
19242618
22424230
30718296
19318384
18344392
11859437
30125642
26833850
30202553
10438116
11598383
21194385
25273098
1621508
22777489
31611766
26855369
21610428
23416152
18551387
20880501
30796294
25492117
28304291
27733618
10774732
27457264
15094070
25702209
20176121
23968694
16444902
20966354
24409422
16825202
17959972
10616913
20236603
31022213
18936695
20148674
25800044
26777890
19844619
28943428
12148083
18077675
11071494
31856878
18784480
23025820
28853308
7279171
15964100
18430999
23146033
30524368
22865656
19116810
17376000
18627252
26401706
11849969
2186089
11118610
13406589
23829400
26650903
29444458
22035678
25833084
26159205
1613462
9548472
26503322
17988211
16286529
22476197
8584221
9555970
26958051
8548316
11735609
29056393
16337941
16207622
9895282
11794168
16916571
22610193
30296507
27084688
30309271
9609109
18455704
8443563
17892411
29515352
19232615
19761692
28099356
25107476
1797338
2679455
10574963
17980966
22424621
30488142
31828222",Role of Insulin in Neurotrauma and Neurodegeneration: A Review.,"Insulin is a hormone typically associated with pancreatic release and blood sugar regulation. The brain was long thought to be ""insulin-independent,"" but research has shown that insulin receptors (IR) are expressed on neurons, microglia and astrocytes, among other cells. The effects of insulin on cells within the central nervous system are varied, and can include both metabolic and non-metabolic functions. Emerging data suggests that insulin can improve neuronal survival or recovery after trauma or during neurodegenerative diseases. Further, data suggests a strong anti-inflammatory component of insulin, which may also play a role in both neurotrauma and neurodegeneration. As a result, administration of exogenous insulin, either via systemic or intranasal routes, is an increasing area of focus in research in neurotrauma and neurodegenerative disorders. This review will explore the literature to date on the role of insulin in neurotrauma and neurodegeneration, with a focus on traumatic brain injury (TBI), spinal cord injury (SCI), Alzheimer's disease (AD) and Parkinson's disease (PD).","['Alzheimer’s disease', 'Parkinson’s disease', 'inflammation', 'insulin', 'microglia', 'neurons', 'spinal cord injury', 'traumatic brain injury']",Frontiers in neuroscience,2020-10-27,"[{'lastname': 'Shaughness', 'firstname': 'Michael', 'initials': 'M', 'affiliation': 'Neuroscience Program, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.'}, {'lastname': 'Acs', 'firstname': 'Deanna', 'initials': 'D', 'affiliation': 'Department of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.'}, {'lastname': 'Brabazon', 'firstname': 'Fiona', 'initials': 'F', 'affiliation': 'Neuroscience Program, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.'}, {'lastname': 'Hockenbury', 'firstname': 'Nicole', 'initials': 'N', 'affiliation': 'Department of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.'}, {'lastname': 'Byrnes', 'firstname': 'Kimberly R', 'initials': 'KR', 'affiliation': 'Department of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.'}]",,,,"Copyright © 2020 Shaughness, Acs, Brabazon, Hockenbury and Byrnes.","10.3389/fnins.2020.547175
10.3171/jns.1980.53.3.0375
10.1111/j.1582-4934.2010.01164.x
10.1001/archneur.61.5.661
10.2337/db12-1146
10.1586/ern.10.40
10.1007/bf00237470
10.1016/j.neulet.2017.09.026
10.1016/j.psyneuen.2004.04.003
10.1038/sj.npp.1301193
10.1210/jc.2007-2606
10.1016/0022-510x(73)90175-5
10.1080/026990596124511
10.1007/s12028-008-9084-9
10.2337/diabetes.51.12.3384
10.1038/nn0602-849
10.1371/journal.pone.0201878
10.1177/0271678x16685106
10.1089/neu.2016.4540
10.2337/diacare.28.3.726
10.1016/j.neurobiolaging.2008.09.012
10.1002/glia.20557
10.1111/j.1742-4658.2010.07865.x
10.1016/s0197-4580(01)00340-2
10.3389/fnene.2013.00013
10.1046/j.1471-4159.2002.00892.x
10.1007/s11095-012-0915-1
10.1016/s0014-4886(03)00002-5
10.1007/s12264-013-1408-x
10.1016/j.neuron.2008.04.014
10.3233/jad-159002
10.1016/s0006-8993(96)00819-0
10.1159/000354670
10.1016/s0306-4530(02)00087-2
10.1111/j.1749-6632.2000.tb06371.x
10.1001/archneurol.2011.233
10.3233/jad-161256
10.1016/0197-4580(95)02002-0
10.2174/156720512799015037
10.1016/j.euroneuro.2014.06.008
10.2337/db06-0030
10.2337/diabetes.29.11.906
10.1016/s0891-0618(02)00058-3
10.3390/ijms161125939
10.3389/fnins.2018.00830
10.1016/j.neulet.2019.134567
10.1002/cne.902940212
10.1007/s00330-010-1877-5
10.1097/nmd.0b013e318298302e
10.1007/s007020050068
10.3389/fnins.2019.00629
10.1007/s12035-013-8404-z
10.3389/fendo.2018.00752
10.1089/neu.1994.11.587
10.1089/neu.2018.6144
10.1016/j.brainres.2009.08.005
10.1176/jnp.8.3.324
10.1007/s12035-015-9494-6
10.1186/1471-2202-9-S3-S5
10.1073/pnas.0805453106
10.1371/journal.pone.0021594
10.3233/jpd-181305
10.1006/exnr.1995.1026
10.1111/j.1471-4159.2003.02307.x
10.2340/16501977-0264
10.1016/j.cell.2012.02.040
10.4049/jimmunol.1800065
10.1038/sj.sc.3101260
10.1016/j.neulet.2018.08.022
10.1111/ejn.13194
10.1038/sj.sc.3100844
10.1159/000054694
10.1089/ars.2010.3816
10.1126/scitranslmed.3009430
10.1007/bf00310031
10.1038/sc.2012.85
10.3389/fnins.2019.01027
10.1016/j.pneurobio.2015.12.006
10.1097/ta.0b013e3182146d66
10.1016/j.brainres.2013.01.055
10.1201/b18126-2
10.1007/s12028-008-9115-6
10.1016/j.nurt.2010.07.002
10.1038/jcbfm.2014.215
10.3233/jad-161016
10.1523/jneurosci.1287-16.2016
10.1016/s0896-6273(00)81067-3
10.1111/acel.12498
10.1016/j.ejphar.2004.02.041
10.1016/b978-0-444-52892-6.00004-0
10.1016/j.nlm.2010.02.002
10.1016/j.tins.2013.07.001
10.1155/np.2005.311
10.1158/1078-0432.ccr-10-0434
10.1093/brain/awl165
10.1213/01.ane.0000281146.33391.69
10.1016/s0168-0102(99)00071-1
10.1371/journal.pone.0214364
10.1097/ccm.0b013e31818f4026
10.1146/annurev-physiol-021909-135846
10.1111/bph.13139
10.1016/j.neuroscience.2016.01.020
10.3340/jkns.2009.46.3.205
10.1016/j.bbr.2017.09.033
10.1055/s-2002-33068
10.1523/jneurosci.3949-07.2007
10.1212/wnl.55.8.1158
10.1097/aco.0b013e32830f44e4
10.1089/neu.2012.2399
10.1080/10799893.2017.1369119
10.1227/00006123-198107000-00007
10.1016/j.neurobiolaging.2005.03.016
10.3233/jad-2008-13309
10.1111/j.2042-7158.2012.01555.x
10.3389/fendo.2018.00663
10.1002/stem.1189
10.1080/09638280802532720
10.1089/neu.2006.0117
10.1089/neu.2008.0586
10.3233/jad-150307
10.1016/s0962-8924(01)02207-3
10.1177/38.6.2186089
10.1016/s0149-7634(00)00040-3
10.1136/jnnp.20.1.11
10.1089/neu.2013.2928
10.1089/neu.2015.4129
10.1016/j.abb.2018.02.004
10.1007/s12975-015-0396-8
10.2174/1567205012666150710104428
10.1084/jem.176.1.287
10.1146/annurev.physiol.70.113006.100533
10.1038/oby.2005.220
10.1172/jci59903
10.1016/0304-3940(95)12009-s
10.1089/neu.1998.15.239
10.4103/1735-1995.172984
10.1016/0006-8993(95)00637-6
10.2165/00003088-200140120-00003
10.1016/j.ajem.2017.10.029
10.1016/j.expneurol.2005.10.035
10.1080/13803390490919245
10.1042/0264-6021:3370397
10.1016/j.pneurobio.2006.06.003
10.1097/ccm.0b013e31824e0fcc
10.1016/j.neulet.2018.10.004
10.1016/j.neulet.2016.04.027
10.1007/978-1-4615-5647-3_1
10.1016/j.brainres.2008.01.107
10.1016/0197-0186(93)90062-a
10.1089/neu.2006.0228
10.3389/fnins.2018.00073
10.1016/j.ijnurstu.2009.01.004
10.1177/147323000903700414
10.1097/md.0000000000005921
10.1007/s00401-014-1328-5
10.1016/0006-8993(91)90755-k
10.1074/jbc.274.49.34893
10.1016/j.neulet.2007.09.076
10.1007/s10753-018-0933-1",<Element 'PubmedArticle' at 0x7f05df177e00>
198,"33087363
28126008
25261995
24804730
23041626
28778989
28837568
30482868
21087763
29186428
27703466
24771538
24905774
23476101
24162737
22438815
18723524
28070672
29761124
24671420
23639788
25722852
16862161
21289198
21123754
19749406
19296504
15563479
20157014
16227535
26524180
26941262
30630532
21167468
20634204
21552263
11125122
29757393
22064851
22955989
26657631
23193258
17982457
28923553
18261164
22685416
25954001
24013639
28065468
28122634
28407145
19539887
23193289
21071422
22080510
29996888
24880342
21702733
26154020
24943344
29315334
28387812",The ,Progranulin (PGRN) is a secreted pleiotropic glycoprotein associated with the development of common neurodegenerative diseases. Understanding the pathophysiological role of PGRN may help uncover biological underpinnings. We performed a genome-wide association study to determine the genetic regulators of cerebrospinal fluid (CSF) PGRN levels. Common variants in region of ,[],Science advances,2020-10-23,"[{'lastname': 'Xu', 'firstname': 'Wei', 'initials': 'W', 'affiliation': 'Department of Neurology and Institute of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Shanghai Medical College, Fudan University, Shanghai, China.\nDepartment of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.'}, {'lastname': 'Han', 'firstname': 'Si-Da', 'initials': 'SD', 'affiliation': 'Department of Neurology and Institute of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Shanghai Medical College, Fudan University, Shanghai, China.'}, {'lastname': 'Zhang', 'firstname': 'Can', 'initials': 'C', 'affiliation': 'Genetics and Aging Research Unit, McCance Center for Brain Health, Mass General Institute for Neurodegenerative Diseases (MIND), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA.'}, {'lastname': 'Li', 'firstname': 'Jie-Qiong', 'initials': 'JQ', 'affiliation': 'Department of Neurology, The Affiliated Hospital of Qingdao University, Qingdao, China.'}, {'lastname': 'Wang', 'firstname': 'Yan-Jiang', 'initials': 'YJ', 'affiliation': 'Department of Neurology and Center for Clinical Neuroscience, Daping Hospital, Third Military Medical University, Chongqing, China.'}, {'lastname': 'Tan', 'firstname': 'Chen-Chen', 'initials': 'CC', 'affiliation': 'Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.'}, {'lastname': 'Li', 'firstname': 'Hong-Qi', 'initials': 'HQ', 'affiliation': 'Department of Neurology and Institute of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Shanghai Medical College, Fudan University, Shanghai, China.'}, {'lastname': 'Dong', 'firstname': 'Qiang', 'initials': 'Q', 'affiliation': 'Department of Neurology and Institute of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Shanghai Medical College, Fudan University, Shanghai, China.'}, {'lastname': 'Mei', 'firstname': 'Cui', 'initials': 'C', 'affiliation': 'Department of Neurology and Institute of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Shanghai Medical College, Fudan University, Shanghai, China.'}, {'lastname': 'Tan', 'firstname': 'Lan', 'initials': 'L', 'affiliation': 'Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.'}, {'lastname': 'Yu', 'firstname': 'Jin-Tai', 'initials': 'JT', 'affiliation': 'Department of Neurology and Institute of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Shanghai Medical College, Fudan University, Shanghai, China. jintai_yu@fudan.edu.cn.'}]",,,,"Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).",10.1126/sciadv.abb3063,<Element 'PubmedArticle' at 0x7f05de568cc0>
199,"33050589
24798679
25874594
28611664
26055231
25164769
29615912
27227691
22845893
27083308
29618972
26251227
32150935
31396087
20152858
15655246
29567427
20736084
26857391
16845890
24952959
27539936
29382825
29576849
17712833
8900284
23425575
26310614
28499701
31103036
30962497
26639457
29046777
22515328
23520554
15317910
19386271
31263402
4748425
25106636
26134003
28990726
30229438",Synergic Therapeutic Potential of PEA-Um Treatment and NAAA Enzyme Silencing In the Management of Neuroinflammation.,"Inflammation is a key element in the pathobiology of neurodegenerative diseases and sees the involvement of different neuronal and non-neuronal cells as players able to respond to inflammatory signals of immune origin. Palmitoylethanolamide (PEA) is an endogenous potent anti-inflammatory agent, in which activity is regulated by N-acylethanolamine acid amidase (NAAA), that hydrolyzes saturated or monounsaturated fatty acid ethanolamides, such as PEA. In this research, an in vitro study was performed on different neuronal (SH-SY5Y) and non-neuronal cell lines (C6, BV-2, and Mo3.13) subjected to NAAA enzyme silencing and treated with PEA ultra-micronized (PEA-um) (1, 3, and 10 μM) to increase the amount of endogenous PEA available for counteract neuroinflammation provoked by stimulation with lipopolysaccharide (LPS) (1 μg/mL) and interferon gamma (INF-γ )(100 U/mL). Cell viability was performed by MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) staining, suggesting a protective effect of PEA-um (3 and 10 μM) on all cell lines studied. Western Blot analysis for inflammatory markers (Inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX-2)) was carried out in control and NAAA-silenced cells, highlighting how the concomitant treatment of the neuronal and non-neuronal cells with PEA-um after NAAA genic downregulation is satisfactory to counteract neuroinflammation. These in vitro findings support the protective role of endogenous PEA availability in the neuronal field, bringing interesting information for a translational point of view.","['glioma', 'microglia', 'neuroblastoma', 'neuroinflammation', 'oligodendrocytes', 'palmitoylethanolamide']",International journal of molecular sciences,2020-10-15,"[{'lastname': 'Casili', 'firstname': 'Giovanna', 'initials': 'G', 'affiliation': 'Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98165 Messina, Italy.'}, {'lastname': 'Lanza', 'firstname': 'Marika', 'initials': 'M', 'affiliation': 'Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98165 Messina, Italy.'}, {'lastname': 'Campolo', 'firstname': 'Michela', 'initials': 'M', 'affiliation': 'Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98165 Messina, Italy.'}, {'lastname': 'Siracusa', 'firstname': 'Rosalba', 'initials': 'R', 'affiliation': 'Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98165 Messina, Italy.'}, {'lastname': 'Paterniti', 'firstname': 'Irene', 'initials': 'I', 'affiliation': 'Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98165 Messina, Italy.'}, {'lastname': 'Ardizzone', 'firstname': 'Alessio', 'initials': 'A', 'affiliation': 'Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98165 Messina, Italy.'}, {'lastname': 'Scuderi', 'firstname': 'Sarah Adriana', 'initials': 'SA', 'affiliation': 'Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98165 Messina, Italy.'}, {'lastname': 'Cuzzocrea', 'firstname': 'Salvatore', 'initials': 'S', 'affiliation': 'Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98165 Messina, Italy.\nDepartment of Pharmacological and Physiological Science, Saint Louis University, Saint Louis, MO 63103, USA.'}, {'lastname': 'Esposito', 'firstname': 'Emanuela', 'initials': 'E', 'affiliation': 'Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98165 Messina, Italy.'}]",,,,,"10.3390/ijms21207486
10.1016/j.phrs.2014.04.011
10.1021/acschembio.5b00114
10.3389/fphar.2017.00308
10.1007/s12035-015-9253-8
10.1186/s12974-014-0136-0
10.3389/fphar.2018.00249
10.1097/j.pain.0000000000000623
10.1111/j.1526-4637.2012.01432.x
10.1016/j.phrs.2016.04.007
10.3389/fncel.2018.00072
10.1111/nyas.12855
10.3390/antiox9030216
10.3389/fphar.2019.00821
10.1016/j.plipres.2010.02.003
10.1074/jbc.M413473200
10.1016/j.drudis.2018.03.007
10.1016/j.bbalip.2010.08.010
10.1007/s13311-016-0420-z
10.1139/Y05-143
10.1016/j.drudis.2014.06.007
10.1111/bph.13580
10.1038/s41398-017-0076-4
10.1155/2018/4720532
10.1002/cbdv.200790159
10.1038/384083a0
10.1111/febs.12152
10.1038/srep13565
10.1016/j.molmed.2017.04.005
10.1186/s12974-019-1490-8
10.1038/s41598-019-42286-8
10.2174/1570159X14666151204122017
10.4097/kjae.2017.70.5.561
10.1021/jm300349j
10.1371/journal.pone.0059131
10.1124/pr.56.3.3
10.3389/fncel.2019.00263
10.2174/1871527313666140806124322
10.1101/cshperspect.a020537
10.1007/s12035-018-1347-7",<Element 'PubmedArticle' at 0x7f05de530a40>
200,"33030232
31038797
28259749
21654733
26320029
19560279
18349090
16804076
23110767
16428252
20853021
22474371
31167373
29206196
25081071
21995951
24336719
28256506
25522420
2118608
18702710
21531172
19822172
23201972
31404254
26256574
30227888
31302265
27915167
24419043
24613341
29081809
24318124
31423743
25178904
15677391
31129488
31016348
19906237
31316402
30809131
11350175
31399550
26116544
16919525
26657948
29332092
12782134
31495587
23339081
31423567
30487639
1356586
21907973
29246185
1680166
24959896
15591061
27648526
21865530",FKBP5 polymorphisms induce differential glucocorticoid responsiveness in primary CNS cells - First insights from novel humanized mice.,"The brain is a central hub for integration of internal and external conditions and, thus, a regulator of the stress response. Glucocorticoids are the essential communicators of this response. Aberrations in glucocorticoid signaling are a common symptom in patients with psychiatric disorders. The gene FKBP5 encodes a chaperone protein that functionally inhibits glucocorticoid signaling and, thus, contributes to the regulation of stress. In the context of childhood trauma, differential expression of FKBP5 has been found in psychiatric patients compared to controls. These variations in expression levels of FKBP5 were reported to be associated with differences in stress responsiveness in human carriers of the single nucleotide polymorphism (SNP) rs1360780. Understanding the mechanisms underlying FKBP5 polymorphism-associated glucocorticoid responsiveness in the CNS will lead to a better understanding of stress regulation or associated pathology. To study these mechanisms, two novel humanized mouse lines were generated. The lines carried either the risk (A/T) allele or the resilient (C/G) allele of rs1360780. Primary cells from CNS (astrocytes, microglia, and neurons) were analyzed for their basal expression levels of FKBP5 and their responsiveness to glucocorticoids. Differential expression of FKBP5 was found for these cell types and negatively correlated with the cellular glucocorticoid responsiveness. Astrocytes revealed the strongest transcriptional response, followed by microglia and neurons. Furthermore, the risk allele (A/T) was associated with greater induction of FKBP5 than the resilience allele. Novel FKBP5-humanized mice display differential glucocorticoid responsiveness due to a single intronic SNP. The vulnerability to stress signaling in the shape of glucocorticoids in the brain correlated with FKBP5 expression levels. The strong responsiveness of astrocytes to glucocorticoids implies astrocytes play a prominent role in the stress response, and in FKBP5-related differences in glucocorticoid signaling. The novel humanized mouse lines will allow for further study of the role that FKBP5 SNPs have in risk and resilience to stress pathology.","['\nFkbp5\n', 'CNS cell types', 'astrocyte', 'glucocorticoid responsiveness', 'psychiatric disorders']",The European journal of neuroscience,2020-10-09,"[{'lastname': 'Nold', 'firstname': 'Verena', 'initials': 'V', 'affiliation': 'Boehringer Ingelheim Pharma GmbH & Co KG, CNSDR, Ingelheim, Germany.\nInstitute of Psychology & Education, Clinical & Biological Psychology, Ulm University, Ulm, Germany.'}, {'lastname': 'Richter', 'firstname': 'Nadine', 'initials': 'N', 'affiliation': 'Boehringer Ingelheim Pharma GmbH & Co KG, CNSDR, Ingelheim, Germany.'}, {'lastname': 'Hengerer', 'firstname': 'Bastian', 'initials': 'B', 'affiliation': 'Boehringer Ingelheim Pharma GmbH & Co KG, CNSDR, Ingelheim, Germany.'}, {'lastname': 'Kolassa', 'firstname': 'Iris-Tatjana', 'initials': 'IT', 'affiliation': 'Institute of Psychology & Education, Clinical & Biological Psychology, Ulm University, Ulm, Germany.'}, {'lastname': 'Allers', 'firstname': 'Kelly Ann', 'initials': 'KA', 'affiliation': 'Boehringer Ingelheim Pharma GmbH & Co KG, CNSDR, Ingelheim, Germany.'}]",,,,© 2020 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.,"10.1111/ejn.14999
10.1002/glia.23625
10.1016/j.biocel.2017.02.011
10.1038/npp.2011.81
10.1016/j.pnpbp.2015.08.005
10.1016/j.psyneuen.2009.05.021
10.2337/db05-1038
10.1152/physiolgenomics.00097.2012
10.1136/bmj.38693.435301.80
10.1073/pnas.1118355109
10.3390/ijms20112738
10.1016/j.dcn.2014.07.001
10.1186/1752-0509-5-162
10.1523/JNEUROSCI.1337-13.2013
10.1038/srep42991
10.1093/ijnp/pyu087
10.1159/000125539
10.1111/j.1460-9568.2008.06332.x
10.1016/j.neubiorev.2009.10.002
10.1038/nn.3275
10.3389/fnbeh.2019.00143
10.1016/j.bbi.2015.08.007
10.1186/s13195-018-0422-7
10.1016/j.neuroscience.2019.07.012
10.1016/j.psychres.2016.11.027
10.1038/mp.2013.182
10.1155/2017/1719050
10.1111/cns.13212
10.1515/revneuro-2014-0035
10.1196/annals.1314.001
10.1016/j.psyneuen.2019.04.006
10.1007/s00018-019-03111-7
10.1111/j.1749-6632.2009.04978.x
10.3389/fpsyt.2019.00423
10.3389/fncel.2019.00044
10.1016/j.psyneuen.2019.07.212
10.1016/j.biopsych.2006.06.004
10.1159/000485383
10.1016/j.cub.2019.07.078
10.1002/glia.22460
10.1038/s41398-018-0300-x
10.1016/0006-8993(92)91356-J
10.1016/j.biopsych.2011.07.023
10.1186/s40246-017-0129-z
10.1111/j.1471-4159.1991.tb08309.x
10.1038/tp.2014.49",<Element 'PubmedArticle' at 0x7f05dec97360>
201,"33003412
21371747
28872215
26921134
32284590
31257151
28802038
27179961
22683129
21263438
24843720
15911795
25938784
25730668
27133169
21974744
22476197
29163128
26887612
31877702
25405316
30949921
19671905
28697184
27412896
31291963
17021169
31611548
21349862
20534432
22161565
17947321
32358220
27311886
18945929
28045396
28683286
32612262
24201279
30527741
28990588
22201683
20484628
18088381
26100639
20957377
24686304
31311133
20176121
18651634
26336035
24269929
30474797
31569518
30646475
23023125
29051531
28176819
25173628
32045578",Metabolic Defects Caused by High-Fat Diet Modify Disease Risk through Inflammatory and Amyloidogenic Pathways in a Mouse Model of Alzheimer's Disease.,"High-fat diet (HFD) has been shown to accelerate Alzheimer's disease (AD) pathology, but the exact molecular and cellular mechanisms remain incompletely understood. Moreover, it is unknown whether AD mice are more susceptible to HFD-induced metabolic dysfunctions. To address these questions, we used 5xFAD mice as an Alzheimer's disease model to study the physiological and molecular underpinning between HFD-induced metabolic defects and AD pathology. We systematically profiled the metabolic parameters, the gut microbiome composition, and hippocampal gene expression in 5xFAD and wild type (WT) mice fed normal chow diet and HFD. HFD feeding impaired energy metabolism in male 5xFAD mice, leading to increased locomotor activity, energy expenditure, and food intake. 5xFAD mice on HFD had elevated circulating lipids and worsened glucose intolerance. HFD caused profound changes in gut microbiome compositions, though no difference between genotype was detected. We measured hippocampal mRNAs related to AD neuropathology and neuroinflammation and showed that HFD elevated the expression of apoptotic, microglial, and amyloidogenic genes in 5xFAD mice. Pathway analysis revealed that differentially regulated genes were involved in insulin signaling, cytokine signaling, cellular stress, and neurotransmission. Collectively, our results showed that 5xFAD mice were more susceptible to HFD-induced metabolic dysregulation and suggest that targeting metabolic dysfunctions can ameliorate AD symptoms via effects on insulin signaling and neuroinflammation in the hippocampus.","['Alzheimer’s disease', 'diet', 'glucose', 'insulin', 'lipid', 'metabolism', 'neuroinflammation', 'nutrient']",Nutrients,2020-10-03,"[{'lastname': 'Reilly', 'firstname': 'Austin M', 'initials': 'AM', 'affiliation': 'Stark Neurosciences Research Institute, Medical Neuroscience Graduate Program, Indiana University School of Medicine, Indianapolis, IN 46202, USA.'}, {'lastname': 'Tsai', 'firstname': 'Andy P', 'initials': 'AP', 'affiliation': 'Stark Neurosciences Research Institute, Medical Neuroscience Graduate Program, Indiana University School of Medicine, Indianapolis, IN 46202, USA.'}, {'lastname': 'Lin', 'firstname': 'Peter B', 'initials': 'PB', 'affiliation': 'Stark Neurosciences Research Institute, Medical Neuroscience Graduate Program, Indiana University School of Medicine, Indianapolis, IN 46202, USA.'}, {'lastname': 'Ericsson', 'firstname': 'Aaron C', 'initials': 'AC', 'affiliation': 'Metagenomics Center, University of Missouri, Columbia, MO 65201, USA.'}, {'lastname': 'Oblak', 'firstname': 'Adrian L', 'initials': 'AL', 'affiliation': 'Stark Neurosciences Research Institute, Medical Neuroscience Graduate Program, Indiana University School of Medicine, Indianapolis, IN 46202, USA.'}, {'lastname': 'Ren', 'firstname': 'Hongxia', 'initials': 'H', 'affiliation': 'Stark Neurosciences Research Institute, Medical Neuroscience Graduate Program, Indiana University School of Medicine, Indianapolis, IN 46202, USA.\nHerman B. Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.\nCenter for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN 46202, USA.\nDepartment of Biochemistry & Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.\nDepartment of Pharmacology & Toxicology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.\nDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.'}]",,,,,"10.3390/nu12102977
10.1016/S0140-6736(10)61349-9
10.1111/ene.13439
10.1016/S0140-6736(15)01124-1
10.1038/s41591-020-0815-6
10.1016/j.cmet.2019.06.005
10.1016/j.cell.2017.07.023
10.1016/j.jalz.2016.02.010
10.1016/S0140-6736(12)60360-2
10.1038/nrendo.2010.228
10.1111/jdi.12087
10.1212/01.WNL.0000161871.83614.BB
10.1172/JCI79742
10.1038/nn.3966
10.1016/j.cell.2016.03.033
10.1111/j.1464-5491.2011.03464.x
10.1172/JCI59903
10.3389/fnagi.2017.00345
10.3109/00207454.2016.1155572
10.3390/nu12010035
10.1097/MCO.0000000000000131
10.1007/s13668-019-0271-4
10.1001/jama.2009.1146
10.1038/nm.4350
10.1161/JAHA.115.003154
10.1186/s12974-019-1515-3
10.1523/JNEUROSCI.1202-06.2006
10.1038/s41387-019-0096-7
10.1093/bioinformatics/btr087
10.1073/pnas.1000080107
10.14806/ej.17.1.200
10.1002/0471250953.bi1007s36
10.1093/nar/gkm864
10.1016/j.jagp.2016.03.001
10.2337/dc08-0272
10.1172/JCI88878
10.1016/j.cmet.2017.05.015
10.1038/s41573-020-0065-9
10.1038/nature12709
10.1016/j.cmet.2018.11.001
10.1038/ijo.2017.231
10.1172/JCI59660
10.1523/JNEUROSCI.1051-10.2010
10.1111/j.1471-4159.2007.05194.x
10.1074/jbc.M115.636852
10.1007/s00401-010-0759-x
10.1016/j.nbd.2014.03.011
10.3390/nu11071603
10.1016/j.nlm.2010.02.002
10.1002/hipo.20470
10.1016/j.bbi.2015.08.023
10.1093/gerona/glt177
10.1007/s12035-018-1435-8
10.3390/nu11102310
10.5056/jnm18087
10.1038/nature11450
10.1038/s41598-017-13601-y
10.1038/srep41802
10.1016/j.biopsych.2014.07.012
10.1016/j.trsl.2020.01.002",<Element 'PubmedArticle' at 0x7f05da5754a0>
202,"32999409
24613859
10893326
26858972
20384410
21167850
23671260
22902836
17697422
19103681
16614055
21862611
20107150
11906202
27877121
21527731
30465871
22530983
27013681
29274121
24462092
26192704
23881189
20679202
23047490
11596126
15285801
19666520
11133151
12210108
2808761
16815795
15459241
15308487
23660363
30456866
22751689
23871838
23310925
9486972
19144754
16054086
16965320
20394764
18706724
19516909
27007072
12386325
19615761
22128866
19433253
19761650",Early life overnutrition impairs plasticity of non-neuronal brainstem cells and drives obesity in offspring across development in rats.,"The prevalence of adolescent obesity has increased dramatically, becoming a serious public health concern. While previous evidence suggests that in utero- and early postnatal overnutrition increases adult-onset obesity risk, the neurobiological mechanisms underlying this outcome are not well understood. Non-neuronal cells play an underestimated role in the physiological responses to metabolic/nutrient signals. Hypothalamic glial-mediated inflammation is now considered a contributing factor in the development and perpetuation of obesity; however, attention on the role of gliosis and microglia activation in other nuclei is still needed.
Here, we demonstrate that early life consumption of high-fat/sucrose diet (HFSD) is sufficient to increase offspring body weight, hyperleptinemia and potentially maladaptive cytoarchitectural changes in the brainstem dorsal-vagal-complex (DVC), an essential energy balance processing hub, across postnatal development. Our data demonstrate that pre- and postnatal consumption of HFSD result in increased body weight, hyperleptinemia and dramatically affects the non-neuronal landscape, and therefore the plasticity of the DVC in the developing offspring.
Current findings are very provocative, considering the importance of the DVC in appetite regulation, suggesting that HFSD-consumption during early life may contribute to subsequent obesity risk via DVC cytoarchitectural changes.",[],International journal of obesity (2005),2020-10-02,"[{'lastname': 'Liberini', 'firstname': 'Claudia G', 'initials': 'CG', 'affiliation': 'Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. claudia.liberini@mssm.edu.'}, {'lastname': 'Ghidewon', 'firstname': 'Misgana', 'initials': 'M', 'affiliation': 'Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.'}, {'lastname': 'Ling', 'firstname': 'Tyler', 'initials': 'T', 'affiliation': 'Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.'}, {'lastname': 'Lhamo', 'firstname': 'Rinzin', 'initials': 'R', 'affiliation': 'Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.'}, {'lastname': 'Juntereal', 'firstname': 'Nina', 'initials': 'N', 'affiliation': 'Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.'}, {'lastname': 'Stein', 'firstname': 'Lauren M', 'initials': 'LM', 'affiliation': 'Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.'}, {'lastname': 'Hayes', 'firstname': 'Matthew R', 'initials': 'MR', 'affiliation': 'Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. hayesmr@pennmedicine.upenn.edu.'}]",,,,,10.1038/s41366-020-00658-5,<Element 'PubmedArticle' at 0x7f05df540310>
203,32956830,Modelling frontotemporal dementia using patient-derived induced pluripotent stem cells.,"Frontotemporal dementia (FTD) describes a group of clinically heterogeneous conditions that frequently affect people under the age of 65 (Le Ber et al., 2013). There are multiple genetic causes of FTD, including coding or splice-site mutations in MAPT, GRN mutations that lead to haploinsufficiency of progranulin protein, and a hexanucleotide GGGGCC repeat expansion in C9ORF72. Pathologically, FTD is characterised by abnormal protein accumulations in neurons and glia. These aggregates can be composed of the microtubule-associated protein tau (observed in FTD with MAPT mutations), the DNA/RNA-binding protein TDP-43 (seen in FTD with mutations in GRN or C9ORF72 repeat expansions) or dipeptide proteins generated by repeat associated non-ATG translation of the C9ORF72 repeat expansion. There are currently no disease-modifying therapies for FTD and the availability of in vitro models that recapitulate pathologies in a disease-relevant cell type would accelerate the development of novel therapeutics. It is now possible to generate patient-specific stem cells through the reprogramming of somatic cells from a patient with a genotype/phenotype of interest into induced pluripotent stem cells (iPSCs). iPSCs can subsequently be differentiated into a plethora of cell types including neurons, astrocytes and microglia. Using this approach has allowed researchers to generate in vitro models of genetic FTD in human cell types that are largely inaccessible during life. In this review we explore the recent progress in the use of iPSCs to model FTD, and consider the merits, limitations and future prospects of this approach.","['C9ORF72', 'FTD', 'Progranulin', 'TDP-43', 'Tau', 'iPSC']",Molecular and cellular neurosciences,2020-09-22,"[{'lastname': 'Lines', 'firstname': 'Georgie', 'initials': 'G', 'affiliation': 'Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, 1 Wakefield Street, London WC1N 1PJ, UK.'}, {'lastname': 'Casey', 'firstname': 'Jackie M', 'initials': 'JM', 'affiliation': 'Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, 1 Wakefield Street, London WC1N 1PJ, UK.'}, {'lastname': 'Preza', 'firstname': 'Elisavet', 'initials': 'E', 'affiliation': 'Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, 1 Wakefield Street, London WC1N 1PJ, UK.'}, {'lastname': 'Wray', 'firstname': 'Selina', 'initials': 'S', 'affiliation': 'Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, 1 Wakefield Street, London WC1N 1PJ, UK. Electronic address: selina.wray@ucl.ac.uk.'}]",,,,Crown Copyright © 2020. Published by Elsevier Inc. All rights reserved.,10.1016/j.mcn.2020.103553,<Element 'PubmedArticle' at 0x7f05df56ee50>
204,"32887883
26661176
27837191
20944625
20944627
16371949
30250261
27227366
24670647
28319610
21068832
29874566
19840553
29443965
30096314
30096299
30283141
30642436
28957666
26871627
23842566
25611508
30643288
29061693
31270459
31086348
31915375
19570816
29892066
21525299
23973293
19164583
27252647
28781108
31422062
28608285
20068138
31759969
25735732
31747801
26500843
29095968
31501550
32234477
31551601
28416077
9126055
27601468
18950871
17828272
22653056
30355080
26358779
31768052
19661627
29120328
25613900
31435019
8179300
9390772
30662816
27727239
29022597
29617641
26106189
12605958
15831717
31862977
26755608
29151590
31256193
28602351
30276955
29751771
31611708
30031157
29298427
29437957
29416036
25730668
24828044
24828040
24793238
22443187
12629557
26705676
31564456
9409336
30279211
31042697
32669714
29608179
25186741
25700174
26983021
29107053
24371313
29463736
27702788
30377364
22743772",Pharmacologically reversible zonation-dependent endothelial cell transcriptomic changes with neurodegenerative disease associations in the aged brain.,"The molecular signatures of cells in the brain have been revealed in unprecedented detail, yet the ageing-associated genome-wide expression changes that may contribute to neurovascular dysfunction in neurodegenerative diseases remain elusive. Here, we report zonation-dependent transcriptomic changes in aged mouse brain endothelial cells (ECs), which prominently implicate altered immune/cytokine signaling in ECs of all vascular segments, and functional changes impacting the blood-brain barrier (BBB) and glucose/energy metabolism especially in capillary ECs (capECs). An overrepresentation of Alzheimer disease (AD) GWAS genes is evident among the human orthologs of the differentially expressed genes of aged capECs, while comparative analysis revealed a subset of concordantly downregulated, functionally important genes in human AD brains. Treatment with exenatide, a glucagon-like peptide-1 receptor agonist, strongly reverses aged mouse brain EC transcriptomic changes and BBB leakage, with associated attenuation of microglial priming. We thus revealed transcriptomic alterations underlying brain EC ageing that are complex yet pharmacologically reversible.",[],Nature communications,2020-09-06,"[{'lastname': 'Zhao', 'firstname': 'Lei', 'initials': 'L', 'affiliation': 'Division of Neurology, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.\nLi Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.'}, {'lastname': 'Li', 'firstname': 'Zhongqi', 'initials': 'Z', 'affiliation': 'Division of Neurology, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.\nLi Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.'}, {'lastname': 'Vong', 'firstname': 'Joaquim S L', 'initials': 'JSL', 'affiliation': 'Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.\nDepartment of Chemical Pathology, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.'}, {'lastname': 'Chen', 'firstname': 'Xinyi', 'initials': 'X', 'affiliation': 'Division of Neurology, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.\nLi Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.'}, {'lastname': 'Lai', 'firstname': 'Hei-Ming', 'initials': 'HM', 'affiliation': 'Division of Neurology, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.\nLi Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.\nDepartment of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.\nGerald Choa Neuroscience Centre, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.\nMargaret K. L. Cheung Research Centre for Management of Parkinsonism, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.'}, {'lastname': 'Yan', 'firstname': 'Leo Y C', 'initials': 'LYC', 'affiliation': 'Division of Neurology, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.\nLi Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.'}, {'lastname': 'Huang', 'firstname': 'Junzhe', 'initials': 'J', 'affiliation': 'Division of Neurology, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.\nLi Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.'}, {'lastname': 'Sy', 'firstname': 'Samuel K H', 'initials': 'SKH', 'affiliation': 'Division of Neurology, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.\nLi Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.\nDepartment of Biomedical Engineering, Faculty of Engineering, The Chinese University of Hong Kong, Shatin, Hong Kong.'}, {'lastname': 'Tian', 'firstname': 'Xiaoyu', 'initials': 'X', 'affiliation': 'School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.'}, {'lastname': 'Huang', 'firstname': 'Yu', 'initials': 'Y', 'affiliation': 'School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.'}, {'lastname': 'Chan', 'firstname': 'Ho Yin Edwin', 'initials': 'HYE', 'affiliation': 'Gerald Choa Neuroscience Centre, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.\nSchool of Life Sciences, Faculty of Science, The Chinese University of Hong Kong, Shatin, Hong Kong.'}, {'lastname': 'So', 'firstname': 'Hon-Cheong', 'initials': 'HC', 'affiliation': 'Margaret K. L. Cheung Research Centre for Management of Parkinsonism, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.\nSchool of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.'}, {'lastname': 'Ng', 'firstname': 'Wai-Lung', 'initials': 'WL', 'affiliation': 'School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.'}, {'lastname': 'Tang', 'firstname': 'Yamei', 'initials': 'Y', 'affiliation': 'Department of Neurology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.'}, {'lastname': 'Lin', 'firstname': 'Wei-Jye', 'initials': 'WJ', 'affiliation': 'Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.\nGuangdong Provincial Key Laboratory of Brain Function and Disease, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.'}, {'lastname': 'Mok', 'firstname': 'Vincent C T', 'initials': 'VCT', 'affiliation': 'Division of Neurology, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong. vctmok@cuhk.edu.hk.\nGerald Choa Neuroscience Centre, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong. vctmok@cuhk.edu.hk.\nMargaret K. L. Cheung Research Centre for Management of Parkinsonism, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong. vctmok@cuhk.edu.hk.\nChow Yuk Ho Technology Center for Innovative Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong. vctmok@cuhk.edu.hk.\nTherese Pei Fong Chow Research Centre for Prevention of Dementia, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong. vctmok@cuhk.edu.hk.'}, {'lastname': 'Ko', 'firstname': 'Ho', 'initials': 'H', 'affiliation': 'Division of Neurology, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong. ho.ko@cuhk.edu.hk.\nLi Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong. ho.ko@cuhk.edu.hk.\nDepartment of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong. ho.ko@cuhk.edu.hk.\nGerald Choa Neuroscience Centre, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong. ho.ko@cuhk.edu.hk.\nMargaret K. L. Cheung Research Centre for Management of Parkinsonism, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong. ho.ko@cuhk.edu.hk.\nSchool of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong. ho.ko@cuhk.edu.hk.\nChow Yuk Ho Technology Center for Innovative Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong. ho.ko@cuhk.edu.hk.\nPeter Hung Pain Research Institute, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong. ho.ko@cuhk.edu.hk.'}]",,,,,10.1038/s41467-020-18249-3,<Element 'PubmedArticle' at 0x7f05df538360>
205,"32887744
27814616
25612542
15850653
20662807
23550806
24316227
30737481
16326933
29740045
15595733
31035566
18940959
7929402
9531316
24650793
29321741
21209361
23584393
26300484
19752239
28264694
19076375
26861302
11951050
26874206
28066412
28991260
2433349
18341643
28292310
31708347
32139808
10526319
10386832
29411031
29184623
8749817
29617675
25143819
17284346
1904901
23129776
16081791
23625857
16234578
17347308
18562281
31329297
25837312
21856753
18171695
28407740
27008854
29885791
20147536
18600420
31009095
22661954
16877764
22532571
31160204
26332016",Alcohol Increases Exosome Release from Microglia to Promote Complement C1q-Induced Cellular Death of Proopiomelanocortin Neurons in the Hypothalamus in a Rat Model of Fetal Alcohol Spectrum Disorders.,"Microglia, a type of CNS immune cell, have been shown to contribute to ethanol-activated neuronal death of the stress regulatory proopiomelanocortin (POMC) neuron-producing β-endorphin peptides in the hypothalamus in a postnatal rat model of fetal alcohol spectrum disorders. We determined whether the microglial extracellular vesicle exosome is involved in the ethanol-induced neuronal death of the β-endorphin neuron. Extracellular vesicles were prepared from hypothalamic tissues collected from postnatal rats (both males and females) fed daily with 2.5 mg/kg ethanol or control milk formula for 5 d or from hypothalamic microglia cells obtained from postnatal rats, grown in cultures for several days, and then challenged with ethanol or vehicle for 24 h. Nanoparticle tracking analysis and transmission electron microscopy indicated that these vesicles had the size range and shape of exosomes. Ethanol treatments increased the number and the β-endorphin neuronal killing activity of microglial exosomes both ","['apoptosis', 'complements', 'exosomes', 'fetal alcohol syndrome', 'microglia', 'proopiomelanocortin']",The Journal of neuroscience : the official journal of the Society for Neuroscience,2020-09-06,"[{'lastname': 'Mukherjee', 'firstname': 'Sayani', 'initials': 'S', 'affiliation': 'The Endocrine Program, Department of Animal Sciences, Rutgers, State University of New Jersey, New Brunswick, New Jersey 08901-1573.'}, {'lastname': 'Cabrera', 'firstname': 'Miguel A', 'initials': 'MA', 'affiliation': 'The Endocrine Program, Department of Animal Sciences, Rutgers, State University of New Jersey, New Brunswick, New Jersey 08901-1573.\nEndocrinology and Animal Biosciences Graduate Program, Rutgers, State University of New Jersey, New Brunswick, New Jersey 08901-1573.'}, {'lastname': 'Boyadjieva', 'firstname': 'Nadka I', 'initials': 'NI', 'affiliation': 'The Endocrine Program, Department of Animal Sciences, Rutgers, State University of New Jersey, New Brunswick, New Jersey 08901-1573.'}, {'lastname': 'Berger', 'firstname': 'Gregory', 'initials': 'G', 'affiliation': 'The Endocrine Program, Department of Animal Sciences, Rutgers, State University of New Jersey, New Brunswick, New Jersey 08901-1573.\nEndocrinology and Animal Biosciences Graduate Program, Rutgers, State University of New Jersey, New Brunswick, New Jersey 08901-1573.'}, {'lastname': 'Rousseau', 'firstname': 'Bénédicte', 'initials': 'B', 'affiliation': 'The Endocrine Program, Department of Animal Sciences, Rutgers, State University of New Jersey, New Brunswick, New Jersey 08901-1573.'}, {'lastname': 'Sarkar', 'firstname': 'Dipak K', 'initials': 'DK', 'affiliation': 'The Endocrine Program, Department of Animal Sciences, Rutgers, State University of New Jersey, New Brunswick, New Jersey 08901-1573 Dipak.sarkar@rutgers.edu.'}]",,,,Copyright © 2020 the authors.,"10.1523/JNEUROSCI.0284-20.2020
10.2741/4486
10.1038/srep07989
10.1016/j.brainresrev.2004.12.004
10.1111/j.1530-0277.2010.01271.x
10.1111/acer.12104
10.1016/j.febslet.2013.11.032
10.1038/s41386-019-0326-7
10.1124/mol.105.017004
10.1038/s41598-018-25515-4
10.1021/pr049882h
10.3390/biology8020025
10.1016/j.neurobiolaging.2014.02.012
10.3389/fphar.2017.00910
10.1152/ajpcell.00462.2010
10.1038/nrd3978
10.1016/j.bbadis.2015.08.010
10.4049/jimmunol.0803590
10.1186/s12974-017-0814-9
10.1196/annals.1418.016
10.3390/ijms17020171
10.1023/a:1015013609424
10.1016/j.bbamem.2016.02.011
10.1038/oncsis.2017.82
10.1111/j.1530-0277.2008.00627.x
10.1186/s12974-017-0819-4
10.1016/j.smim.2019.101340
10.1038/s41380-020-0698-4
10.1038/s41380-020-0698-4.
10.1002/(SICI)1097-4695(19991115)41:3<414::AID-NEU9>3.0.CO;2-F
10.1016/S0892-0362(98)00056-7
10.1001/jama.2017.21896
10.1080/20013078.2017.1378056
10.1111/j.1530-0277.1995.tb01014.x
10.1016/j.celrep.2018.03.037
10.1016/j.neulet.2006.10.062
10.1074/jbc.M112.404467
10.4049/jimmunol.175.4.2237
10.1002/glia.22497
10.1385/IR:33:2:103
10.1210/en.2006-1606
10.1073/pnas.0800289105
10.1111/acer.14148
10.1016/j.ymeth.2015.03.018
10.1096/fj.07-9357com
10.1186/s12974-017-0844-3
10.1016/j.jchemneu.2018.06.001
10.1523/JNEUROSCI.5249-09.2010
10.1007/s12149-008-0136-1
10.1111/acer.14066
10.3389/fphys.2012.00149
10.1093/jb/mvj128
10.1074/jbc.M112.340513
10.1016/S1474-4422(19)30150-4
10.1039/c5an00688k",<Element 'PubmedArticle' at 0x7f05dd603f90>
206,32860862,The role of non-neuronal cells in hypogonadotropic hypogonadism.,"The hypothalamic-pituitary-gonadal axis is controlled by gonadotropin-releasing hormone (GnRH) released by the hypothalamus. Disruption of this system leads to impaired reproductive maturation and function, a condition known as hypogonadotropic hypogonadism (HH). Most studies to date have focused on genetic causes of HH that impact neuronal development and function. However, variants may also impact the functioning of non-neuronal cells known as glia. Glial cells make up 50% of brain cells of humans, primates, and rodents. They include radial glial cells, microglia, astrocytes, tanycytes, oligodendrocytes, and oligodendrocyte precursor cells. Many of these cells influence the hypothalamic neuroendocrine system controlling fertility. Indeed, glia regulate GnRH neuronal activity and secretion, acting both at their cell bodies and their nerve endings. Recent work has also made clear that these interactions are an essential aspect of how the HPG axis integrates endocrine, metabolic, and environmental signals to control fertility. Recognition of the clinical importance of interactions between glia and the GnRH network may pave the way for the development of new treatment strategies for dysfunctions of puberty and adult fertility.","['Astrocytes', 'Development', 'Fertility', 'Glia', 'Glial cells', 'GnRH', 'Hypogonadotropic hypogonadism', 'Insulin', 'Kallmann syndrome', 'Leptin', 'Metabolic signals', 'Microglia', 'Neuroendocrine', 'OPCs', 'Oligodendrocytes', 'Puberty', 'Radial glia', 'Reproduction', 'Sirt1', 'Tanycytes']",Molecular and cellular endocrinology,2020-08-30,"[{'lastname': 'Smedlund', 'firstname': 'Kathryn B', 'initials': 'KB', 'affiliation': 'Department of Physiology and Pharmacology, College of Medicine and Life Sciences, The University of Toledo, Toledo, OH, 43614, USA; Center for Diabetes and Endocrine Research, College of Medicine and Life Sciences, The University of Toledo, Toledo, OH, 43614, USA.'}, {'lastname': 'Hill', 'firstname': 'Jennifer W', 'initials': 'JW', 'affiliation': 'Department of Physiology and Pharmacology, College of Medicine and Life Sciences, The University of Toledo, Toledo, OH, 43614, USA; Center for Diabetes and Endocrine Research, College of Medicine and Life Sciences, The University of Toledo, Toledo, OH, 43614, USA. Electronic address: JenniferW.Hill@utoledo.edu.'}]",,,,Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.,10.1016/j.mce.2020.110996,<Element 'PubmedArticle' at 0x7f05de948130>
207,"32846891
22466660
25216636
22725961
29769726
29606295
30578090
24601941
27158906
28099414
31292459
32415059
26965148
18429637
18096503
19307565
11470906
19029917
26311517
15941768
25130621
30075103
12684434
18334483
17401376
11391780
16822488
18657182
19695579
18535023
17626034
16387640
11156943
20468046
26585799
28373281
28317180
25658639
7917301
21388556
22743772
23108545
31932428
29279367
22553043
27246324
25533482
25385337
27459405
25270668
29973381
23452918
28420963
23850290
17329437
17360910
20657592
30114402
28584105
25452006
21538668
18406468
27182552
26212325
27775008
20729846
31813625
29437957
29892066
32532298
22848713
26687838
17353050
27458351
28625718",Gene Expression Analysis of Astrocyte and Microglia Endocannabinoid Signaling during Autoimmune Demyelination.,"The endocannabinoid system is associated with protective effects in multiple sclerosis (MS) that involve attenuated innate immune cell responses. Astrocytes and microglia are modulated by endocannabinoids and participate in the biosynthesis and metabolism of these compounds. However, the role of neuroglial cells as targets and mediators of endocannabinoid signaling in MS is poorly understood. Here we used a microfluidic RT-qPCR screen to assess changes in the expression of the main endocannabinoid signaling genes in astrocytes and microglia purified from female mice during the time-course of experimental autoimmune encephalomyelitis (EAE). We show that astrocytes and microglia upregulate the expression of genes encoding neurotoxic A1 and pro-inflammatory molecules at the acute disease with many of these transcripts remaining elevated during the recovery phase. Both cell populations exhibited an early onset decrease in the gene expression levels of 2-arachidonoylglycerol (2-AG) hydrolytic enzymes that persisted during EAE progression as well as cell-type-specific changes in the transcript levels for genes encoding cannabinoid receptors and molecules involved in anandamide (AEA) signaling. Our results demonstrate that astrocytes and microglia responses to autoimmune demyelination involve alterations in the expression of multiple endocannabinoid signaling-associated genes and suggest that this system may regulate the induction of neurotoxic and pro-inflammatory transcriptional programs in both cell types during MS.","['EAE', 'astrocytes', 'endocannabinoids', 'microglia', 'multiple sclerosis']",Biomolecules,2020-08-28,"[{'lastname': 'Moreno-García', 'firstname': 'Álvaro', 'initials': 'Á', 'affiliation': 'Department of Neurosciences, University of the Basque Country UPV/EHU, E-48940 Leioa, Spain.\nAchucarro Basque Center for Neuroscience, E-48940 Leioa, Spain.\nCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), E-28031 Madrid, Spain.'}, {'lastname': 'Bernal-Chico', 'firstname': 'Ana', 'initials': 'A', 'affiliation': 'Department of Neurosciences, University of the Basque Country UPV/EHU, E-48940 Leioa, Spain.\nAchucarro Basque Center for Neuroscience, E-48940 Leioa, Spain.\nCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), E-28031 Madrid, Spain.'}, {'lastname': 'Colomer', 'firstname': 'Teresa', 'initials': 'T', 'affiliation': 'Achucarro Basque Center for Neuroscience, E-48940 Leioa, Spain.'}, {'lastname': 'Rodríguez-Antigüedad', 'firstname': 'Alfredo', 'initials': 'A', 'affiliation': 'Department of Neurosciences, University of the Basque Country UPV/EHU, E-48940 Leioa, Spain.\nCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), E-28031 Madrid, Spain.\nBiocruces, Bizkaia, E-48903 Barakaldo, Spain.'}, {'lastname': 'Matute', 'firstname': 'Carlos', 'initials': 'C', 'affiliation': 'Department of Neurosciences, University of the Basque Country UPV/EHU, E-48940 Leioa, Spain.\nAchucarro Basque Center for Neuroscience, E-48940 Leioa, Spain.\nCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), E-28031 Madrid, Spain.'}, {'lastname': 'Mato', 'firstname': 'Susana', 'initials': 'S', 'affiliation': 'Department of Neurosciences, University of the Basque Country UPV/EHU, E-48940 Leioa, Spain.\nAchucarro Basque Center for Neuroscience, E-48940 Leioa, Spain.\nCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), E-28031 Madrid, Spain.\nBiocruces, Bizkaia, E-48903 Barakaldo, Spain.'}]",,,,,"10.3390/biom10091228
10.1172/JCI58649
10.1038/nm.3681
10.1111/j.1600-065X.2012.01135.x
10.1038/s41586-018-0119-x
10.1016/j.jneuroim.2018.02.015
10.1016/j.molmed.2018.11.005
10.1111/jnc.12705
10.1038/nm.4106
10.1038/nature21029
10.1038/s41598-019-46232-6
10.1038/s41419-020-2565-2
10.1016/j.plipres.2016.02.002
10.1021/cr0782067
10.1016/j.chembiol.2007.11.006
10.1073/pnas.0901515106
10.1073/pnas.161191698
10.1038/nchembio.129
10.1186/s12990-015-0056-8
10.1096/fj.04-2464fje
10.1002/glia.22742
10.1016/j.bcp.2018.07.042
10.1074/jbc.M707960200
10.1038/nm1561
10.1002/syn.1075
10.1016/j.brainres.2006.06.001
10.1111/j.1460-9568.2008.06377.x
10.1016/j.jns.2009.07.021
10.1136/jnnp.2007.139071
10.1093/brain/awm160
10.1016/j.neuron.2005.11.027
10.1096/fj.00-0399fje
10.1002/glia.20983
10.1038/nrn4036
10.1074/jbc.M116.765313
10.1002/glia.23140
10.1371/journal.pone.0116644
10.1016/0896-6273(94)90038-8
10.1186/1471-2164-12-144
10.1038/nmeth.2019
10.1098/rstb.2011.0387
10.1073/pnas.1901294117
10.1073/pnas.1716032115
10.1523/JNEUROSCI.6221-11.2012
10.1093/brain/aww113
10.1016/j.neuron.2014.11.018
10.1038/nrneurol.2014.207
10.1038/nn.4338
10.1016/j.jneuroim.2014.09.014
10.15252/emmm.201708743
10.1186/1742-2094-10-35
10.3389/fnmol.2017.00090
10.1016/j.celrep.2013.06.018
10.1523/JNEUROSCI.4814-06.2007
10.1523/JNEUROSCI.4830-06.2007
10.1038/nn.2601
10.1016/j.neuropharm.2018.08.013
10.1073/pnas.1704065114
10.1002/glia.22773
10.1002/hipo.20946
10.1016/j.jneumeth.2008.02.014
10.1523/ENEURO.0048-16.2016
10.1016/j.celrep.2015.06.075
10.1038/srep35829
10.1038/nn.2616
10.1016/j.cell.2019.11.016
10.1073/pnas.1800165115
10.1038/s41591-018-0051-5
10.1186/s12974-020-01861-x
10.1371/journal.pone.0042088
10.1016/j.neuron.2015.11.013
10.1016/j.molimm.2007.02.002
10.3389/fnint.2016.00024
10.1016/j.neuropharm.2017.06.017",<Element 'PubmedArticle' at 0x7f05de93db30>
208,"32802257
22359369
19755973
27411754
28984158
15898458
16162953
17716101
18512245
24588323
8858749
29366841
22234979
27444264
22778720
21172210
24848256
26989247
22286521
19085953
17952090
26867181
16299351
31672964
26740296
24819989
24905236
29382834
31772709
24388969
24996495
31050371
28875556
30929267
30230594
31541591
10622237
28199741
31107248
26824477
15325787
22884333
28890155
20383131
16741115
25352835
21903629
20709691
16820507
9254694
16332807
17220268
17892477
21690186
26157614
20003481
19360128
21702898
21574172
14632445
14597658
23975157
27917879
29471030
28002394
30040410
28242013
27090302
30833676
27259147
28814485
28423196
28247434
28099758
20478436
27500468
25180262
28092661
28360349
27670109
31122802
31487612
31327964
23637756
19701495
9662199
11600184
11380078
27095067
26314910
27832756
28592627
16585652
26030851
25411471
16165282
16086717
26868600
29562936
29227477
26860405
30582764
29910467",Melatonin Alleviates Neuroinflammation and Metabolic Disorder in DSS-Induced Depression Rats.,"There is a bidirectional relationship between inflammatory bowel disease (IBD) and depression/anxiety. Emerging evidences indicate that the liver may be involved in microbiota-gut-brain axis. This experiment focused on the role of melatonin in regulating the gut microbiota and explores its mechanism on dextran sulphate sodium- (DSS-) induced neuroinflammation and liver injury. Long-term DSS-treatment increased lipopolysaccharide (LPS), proinflammation cytokines IL-1",[],Oxidative medicine and cellular longevity,2020-08-18,"[{'lastname': 'Lv', 'firstname': 'Wei-Jie', 'initials': 'WJ', 'affiliation': 'Guangdong Laboratory for Lingnan Modern Agriculture/College of Veterinary Medicine, South China Agricultural University/Guangdong Technology Research for Traditional Chinese Veterinary Medicine and Natural Medicine, Guangzhou 510642, China.'}, {'lastname': 'Liu', 'firstname': 'Cui', 'initials': 'C', 'affiliation': 'Guangdong Laboratory for Lingnan Modern Agriculture/College of Veterinary Medicine, South China Agricultural University/Guangdong Technology Research for Traditional Chinese Veterinary Medicine and Natural Medicine, Guangzhou 510642, China.'}, {'lastname': 'Yu', 'firstname': 'Lin-Zeng', 'initials': 'LZ', 'affiliation': 'Institute of Animal Health, Guangdong Academy of Agricultural Sciences, Guangzhou 510640, China.'}, {'lastname': 'Zhou', 'firstname': 'Jia-Hao', 'initials': 'JH', 'affiliation': 'Guangdong Laboratory for Lingnan Modern Agriculture/College of Veterinary Medicine, South China Agricultural University/Guangdong Technology Research for Traditional Chinese Veterinary Medicine and Natural Medicine, Guangzhou 510642, China.'}, {'lastname': 'Li', 'firstname': 'Yue', 'initials': 'Y', 'affiliation': 'Guangdong Laboratory for Lingnan Modern Agriculture/College of Veterinary Medicine, South China Agricultural University/Guangdong Technology Research for Traditional Chinese Veterinary Medicine and Natural Medicine, Guangzhou 510642, China.'}, {'lastname': 'Xiong', 'firstname': 'Ying', 'initials': 'Y', 'affiliation': 'Guangdong Laboratory for Lingnan Modern Agriculture/College of Veterinary Medicine, South China Agricultural University/Guangdong Technology Research for Traditional Chinese Veterinary Medicine and Natural Medicine, Guangzhou 510642, China.'}, {'lastname': 'Guo', 'firstname': 'Ao', 'initials': 'A', 'affiliation': 'Guangdong Laboratory for Lingnan Modern Agriculture/College of Veterinary Medicine, South China Agricultural University/Guangdong Technology Research for Traditional Chinese Veterinary Medicine and Natural Medicine, Guangzhou 510642, China.'}, {'lastname': 'Chao', 'firstname': 'Li-Min', 'initials': 'LM', 'affiliation': 'Guangdong Laboratory for Lingnan Modern Agriculture/College of Veterinary Medicine, South China Agricultural University/Guangdong Technology Research for Traditional Chinese Veterinary Medicine and Natural Medicine, Guangzhou 510642, China.'}, {'lastname': 'Qu', 'firstname': 'Qian', 'initials': 'Q', 'affiliation': 'Guangdong Laboratory for Lingnan Modern Agriculture/College of Veterinary Medicine, South China Agricultural University/Guangdong Technology Research for Traditional Chinese Veterinary Medicine and Natural Medicine, Guangzhou 510642, China.'}, {'lastname': 'Wei', 'firstname': 'Guang-Wei', 'initials': 'GW', 'affiliation': 'Institute of Animal Health, Guangdong Academy of Agricultural Sciences, Guangzhou 510640, China.'}, {'lastname': 'Tang', 'firstname': 'Xing-Gang', 'initials': 'XG', 'affiliation': 'Institute of Animal Health, Guangdong Academy of Agricultural Sciences, Guangzhou 510640, China.'}, {'lastname': 'Yin', 'firstname': 'Yu-Long', 'initials': 'YL', 'affiliation': 'College of Animal Medicine, South China Agricultural University, Guangzhou 510642, China.\nKey Laboratory of Agro-Ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Hunan Provincial Key Laboratory of Animal Nutritional Physiology and Metabolic Process, Changsha, China.'}, {'lastname': 'Guo', 'firstname': 'Shi-Ning', 'initials': 'SN', 'affiliation': 'Guangdong Laboratory for Lingnan Modern Agriculture/College of Veterinary Medicine, South China Agricultural University/Guangdong Technology Research for Traditional Chinese Veterinary Medicine and Natural Medicine, Guangzhou 510642, China.'}]",,,,Copyright © 2020 Wei-jie Lv et al.,"10.1155/2020/1241894
10.1002/ibd.22916
10.1038/ajg.2009.529
10.1016/j.jpsychores.2016.06.001
10.1080/13548506.2017.1384554
10.1177/070674370505000402
10.1136/gut.2005.064261
10.1146/annurev.clinpsy.1.102803.144141
10.1002/ibd.20511
10.1111/apt.12669
10.3109/00365529609010354
10.1053/j.gastro.2018.01.027
10.1136/gutjnl-2011-300474
10.1111/apt.13738
10.1155/2012/106502
10.1016/j.crohns.2008.01.002
10.1126/scitranslmed.3008618
10.1126/science.aad2571
10.1159/000335606
10.1002/hep.22697
10.1038/nm1663
10.1016/j.chom.2016.01.003
10.1194/jlr.R500013-JLR200
10.1038/s41467-019-12896-x
10.1136/gutjnl-2015-310283
10.1016/j.steroids.2014.04.016
10.1111/liv.12612
10.1038/s41398-017-0078-2
10.1155/2019/7902874
10.1016/j.smrv.2013.12.001
10.1016/j.fertnstert.2014.06.014
10.1111/jpi.12584
10.1111/jpi.12448
10.1111/jpi.12574
10.1111/jpi.12524
10.1111/jpi.12611
10.1016/S0024-3205(99)00519-6
10.1111/jpi.12399
10.1172/jci123263
10.1371/journal.pone.0148115
10.1016/j.bbr.2004.04.008
10.1016/j.neuron.2012.05.027
10.1016/j.bbi.2017.09.001
10.1038/nmeth.f.303
10.1126/science.1124234
10.3389/fmicb.2014.00508
10.1093/bioinformatics/btr507
10.1093/bioinformatics/btq461
10.1128/AEM.03006-05
10.1093/nar/25.17.3389
10.1128/AEM.71.12.8228-8235.2005
10.1128/AEM.01996-06
10.1111/j.1574-6941.2007.00375.x
10.1111/j.2041-210X.2011.00127.x
10.1101/gr.120618.111
10.7717/peerj.1029
10.1186/1471-2180-9-259
10.1371/journal.pcbi.1000352
10.1186/gb-2011-12-6-r60
10.1002/hep.24423
10.1007/0-387-21529-8_16
10.1021/ci034160g
10.1101/gr.1239303
10.1038/nbt.2676
10.1038/srep37224
10.1016/j.bbi.2018.02.005
10.1038/540s113a
10.1021/acs.jafc.8b02462
10.1016/j.biopsych.2016.12.031
10.1038/mp.2016.46
10.1038/s41380-019-0380-x
10.1016/j.cell.2016.05.041
10.1136/gutjnl-2017-314759
10.1111/jpi.12415
10.1111/jpi.12404
10.1111/jpi.12389
10.1016/S0079-6123(08)81008-4
10.1111/jpi.12360
10.1152/physiol.00011.2014
10.1038/nn.4476
10.1161/circresaha.117.309715
10.1038/nmicrobiol.2016.113
10.1016/S2468-1253(19)30089-5
10.1016/j.jneuroim.2019.577029
10.3389/fimmu.2019.01511
10.1371/journal.pone.0060655
10.1593/tlo.09115
10.1097/00002030-199809000-00010
10.1016/S0165-1781(01)00298-0
10.1007/s001250051666
10.1186/s12866-016-0686-7
10.1016/j.ijbiomac.2015.08.044
10.1186/s12866-016-0862-9
10.1128/cvi.00037-17
10.1016/S0016-5085(17)32639-2
10.1099/jmm.0.46134-0
10.1038/nn.4030
10.1126/scitranslmed.3009759
10.1016/j.neuroscience.2005.06.090
10.1111/j.1572-0241.2005.50071.x
10.1016/j.neulet.2016.02.009
10.1186/s40168-018-0439-y
10.1038/nm.4453
10.1016/j.jhep.2016.02.002
10.1002/hep.30485
10.1038/s41380-018-0086-5",<Element 'PubmedArticle' at 0x7f05dbf0cb30>
209,"32792571
16862116
20737593
16862115
11823324
28404863
15147719
21645364
25435337
26021560
28438992
27100611
28862638
30735499
27114033
28602351
22470064
22396588
30872602
28890134
28379303
29378861
30559071
21454553
27143419
27341800
12359772
24162652
23971698
7378057
21695208
29036611
20026663
30180904
29700495
29020624
9224524
21232819
12928786
3027336
2832604
18184783
15312181
17601558
25581305
25591478
11008001
166606
4356788
15036626
19093132
28409123
24315093
30690031
28073925
23041626
25150836
25516281
12808457
16199517
25352553
14597658
26771021
10802651
30395331
31719114",Discovery of small molecules that normalize the transcriptome and enhance cysteine cathepsin activity in progranulin-deficient microglia.,"Patients with frontotemporal dementia (FTD) resulting from granulin (GRN) haploinsufficiency have reduced levels of progranulin and exhibit dysregulation in inflammatory and lysosomal networks. Microglia produce high levels of progranulin, and reduction of progranulin in microglia alone is sufficient to recapitulate inflammation, lysosomal dysfunction, and hyperproliferation in a cell-autonomous manner. Therefore, targeting microglial dysfunction caused by progranulin insufficiency represents a potential therapeutic strategy to manage neurodegeneration in FTD. Limitations of current progranulin-enhancing strategies necessitate the discovery of new targets. To identify compounds that can reverse microglial defects in Grn-deficient mouse microglia, we performed a compound screen coupled with high throughput sequencing to assess key transcriptional changes in inflammatory and lysosomal pathways. Positive hits from this initial screen were then further narrowed down based on their ability to rescue cathepsin activity, a critical biochemical readout of lysosomal capacity. The screen identified nor-binaltorphimine dihydrochloride (nor-BNI) and dibutyryl-cAMP, sodium salt (DB-cAMP) as two phenotypic modulators of progranulin deficiency. In addition, nor-BNI and DB-cAMP also rescued cell cycle abnormalities in progranulin-deficient cells. These data highlight the potential of a transcription-based platform for drug screening, and advance two novel lead compounds for FTD.",[],Scientific reports,2020-08-15,"[{'lastname': 'Telpoukhovskaia', 'firstname': 'Maria A', 'initials': 'MA', 'affiliation': 'Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA.\nDepartment of Neurology, University of California, San Francisco, CA, 94158, USA.'}, {'lastname': 'Liu', 'firstname': 'Kai', 'initials': 'K', 'affiliation': 'Gladstone Institute of Cardiovascular Disease, San Francisco, CA, 94158, USA.'}, {'lastname': 'Sayed', 'firstname': 'Faten A', 'initials': 'FA', 'affiliation': 'Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA.\nDepartment of Neurology, University of California, San Francisco, CA, 94158, USA.\nNeuroscience Graduate Program, University of California, San Francisco, CA, 94158, USA.'}, {'lastname': 'Etchegaray', 'firstname': 'Jon Iker', 'initials': 'JI', 'affiliation': 'Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA.'}, {'lastname': 'Xie', 'firstname': 'Min', 'initials': 'M', 'affiliation': 'Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA.\nGladstone Institute of Cardiovascular Disease, San Francisco, CA, 94158, USA.'}, {'lastname': 'Zhan', 'firstname': 'Lihong', 'initials': 'L', 'affiliation': 'Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA.\nDepartment of Neurology, University of California, San Francisco, CA, 94158, USA.'}, {'lastname': 'Li', 'firstname': 'Yaqiao', 'initials': 'Y', 'affiliation': 'Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA.'}, {'lastname': 'Zhou', 'firstname': 'Yungui', 'initials': 'Y', 'affiliation': 'Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA.'}, {'lastname': 'Le', 'firstname': 'David', 'initials': 'D', 'affiliation': 'Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA.'}, {'lastname': 'Bahr', 'firstname': 'Ben A', 'initials': 'BA', 'affiliation': 'Biotechnology Research and Training Center, University of North Carolina At Pembroke, Pembroke, NC, 28372, USA.'}, {'lastname': 'Bogyo', 'firstname': 'Matthew', 'initials': 'M', 'affiliation': 'Department of Pathology, Stanford University, Stanford, CA, 94305, USA.'}, {'lastname': 'Ding', 'firstname': 'Sheng', 'initials': 'S', 'affiliation': 'Gladstone Institute of Cardiovascular Disease, San Francisco, CA, 94158, USA.'}, {'lastname': 'Gan', 'firstname': 'Li', 'initials': 'L', 'affiliation': ""Gladstone Institute of Neurological Disease, San Francisco, CA, 94158, USA. lig2033@med.cornell.edu.\nDepartment of Neurology, University of California, San Francisco, CA, 94158, USA. lig2033@med.cornell.edu.\nHelen and Robert Appel Alzheimer's Disease Research Institute, Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, 10021, USA. lig2033@med.cornell.edu.""}]",,,,,"10.1038/s41598-020-70534-9
10.1038/nature05016
10.1002/cne.22430
10.1038/nature05017
10.1192/bjp.180.2.140
10.1126/scitranslmed.aah5642
10.1016/j.biocel.2003.08.009
10.1186/1742-2094-8-65
10.1016/j.neurobiolaging.2014.10.023
10.1016/j.bbi.2015.05.006
10.1073/pnas.1700477114
10.1002/glia.22988
10.1172/JCI90606
10.1371/journal.pbio.3000134
10.1016/j.cell.2016.04.001
10.1016/j.cell.2017.05.018
10.1002/0471142727.mb0413s98
10.1073/pnas.1200305109
10.1038/s41598-019-39016-5
10.1016/j.molmed.2017.08.004
10.1093/brain/awx060
10.1523/JNEUROSCI.3081-17.2018
10.1016/j.ymthe.2018.11.013
10.1074/jbc.M110.193433
10.1016/j.neurobiolaging.2016.03.001
10.1186/s13024-016-0114-3
10.1038/nn.3554
10.1021/ja4056068
10.1042/bj1860385
10.1371/journal.pone.0020501
10.1093/hmg/ddx364
10.1084/jem.20091568
10.1186/s13024-018-0281-5
10.1038/nrd.2018.65
10.1016/j.celrep.2017.09.039
10.1007/s004010050665
10.1016/j.neurobiolaging.2010.11.020
10.1007/s00109-003-0474-3
10.1021/jm00385a002
10.1021/jm00399a026
10.1523/JNEUROSCI.4458-07.2008
10.1111/j.1471-4159.2004.02589.x
10.1016/j.ejphar.2007.05.045
10.1111/adb.12206
10.1016/j.bbr.2015.01.008
10.1016/s0163-7258(00)00051-6
10.1146/annurev.bi.44.070175.002423
10.1016/0014-5793(73)80367-9
10.1016/j.neulet.2003.11.056
10.1007/s00436-008-1300-1
10.3389/fonc.2017.00051
10.1016/j.cell.2013.11.019
10.1016/j.jmb.2019.01.027
10.1093/hmg/ddx011
10.1172/JCI63113
10.1038/nbt.2931
10.1186/s13059-014-0550-8
10.1038/ng1180
10.1073/pnas.0506580102
10.1093/nar/gku1003
10.1101/gr.1239303
10.1016/j.cels.2015.12.004
10.1038/75556
10.1093/nar/gky1055
10.1083/jcb.201901097",<Element 'PubmedArticle' at 0x7f05da99e810>
210,"32759370
15705924
22654508
28229114
23983575
7346592
7346593
15256495
22488525
29858858
26607253
21362438
30711897
3523537
30550932
28216088
10686270
23671261
26441134
29194444
12450640
12372984
15064134
12140350
12127097
26037911
19349312
31109802
11585680
23337256
19408214
27106168
23686747
3497595
9920223
21084245
31974313
16098655
26291403
17311968
22634107
31597283
27592314
28241050
30707932
29544773
27981185
30416436
29524458
12297606
25595985
29104062
22041296
27981190
31615595
15471616
8378804
30515710
28892126
24944032
12872204
17965659
9505045
21796103
17481608
4005105
25331895
26674863
28939116
28888327
14573393
31917340
28963000
19352056
9435150
28527954
8300981
28323284
8255414
21377524
18178625
10964861
12577943
12823087
17956738
18923511
29759000
23089630
10700656
19251249
30082889
24710472
31181346
22497984
20800684
1511516
9367546
19085093
27018449
21062254
15982748
31563463
29615190
14523355
28128336
29184215
15973668
108702
19150053
26711676
22494534
12480034
25598426
10453051
15784782
23842577
11274622
11481159
18464318
28341582
20616673
1775506
19906234
16946190
24887568
16989107
19070658
9811905
29526689
23349294
29955150
15697325
22945416
25701613
28408299
27232630
19601883
21799550
3307672
25459283
29971587
11719636
12573295
19264351
22182318
11402106
20569521
11914591
25629589
14569273
30986204
9388012
31995664
24417575
31359117
18592034
26773400
17475444
17640948
30571600
15708765
29574669
29042248
17117478
31325456
16399150
22967776
12485415
29343269
29021005
8300980
1599592
22386198
28697890
9520494
20160137
25676490
30684650
23453939
11566046",Sex Differences in the Inflammatory Consequences of Stress: Implications for Pharmacotherapy.,"Women are at significantly greater risk of developing stress-related disorders such as depression. The increased risk begins during puberty and continues throughout life until menopause, suggesting a role for ovarian hormones in this increased susceptibility. Importantly, inflammation has been gaining momentum in its role in the pathogenesis of depression. Herein, clinical and preclinical studies have been reviewed to better understand how sex differences within the immune system may contribute to exaggerated risk of depression in females. First, studies that investigate the ability of psychologic stress episodes to engage the inflammatory systems both in the brain and periphery are reviewed with a special focus on sex-specific effects. Moreover, studies are discussed that identify whether imbalanced inflammatory milieu contributes to the development of depression in males versus females and whether these effects are regulated by estradiol. Importantly, we propose a locus coeruleus-norepinephrine-cytokine circuit as a conduit through which stress could increase stress susceptibly in females. Finally, the anti-inflammatory capacity of traditional and nontraditional antidepressants is investigated, with the goal of providing a better understanding of pharmacotherapeutics to enhance strategies to personalize antidepressant treatments between the sexes. The studies reviewed herein strongly support the need for further studies to elucidate whether females are especially sensitive to anti-inflammatory compounds as adjuvants to traditional therapies. SIGNIFICANCE STATEMENT: Women have hve an increased risk of developing stress-related disorders such as depression. In this review, literature from clinical and preclinical studies are integrated to define sex differences in stress-induced inflammatory responses as a potential source for the etiology of sex differences in depressive disorders. Moreover, the anti-inflammatory capacity of traditional and nontraditional antidepressants is reviewed to inform on potential pharmacotherapeutic strategies to personalize antidepressant therapy in a sex-dependent manner.",[],The Journal of pharmacology and experimental therapeutics,2020-08-08,"[{'lastname': 'Martinez-Muniz', 'firstname': 'Gustavo A', 'initials': 'GA', 'affiliation': 'Department of Pharmacology, Physiology, and Neuroscience, University of South Carolina School of Medicine, Columbia, South Carolina and Dorn Veterans Administration Medical Center, Columbia, South Carolina.'}, {'lastname': 'Wood', 'firstname': 'Susan K', 'initials': 'SK', 'affiliation': 'Department of Pharmacology, Physiology, and Neuroscience, University of South Carolina School of Medicine, Columbia, South Carolina and Dorn Veterans Administration Medical Center, Columbia, South Carolina Susan.Wood@uscmed.sc.edu.'}]",,,,Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics.,"10.1124/jpet.120.266205
10.106/S0306-4522(02)00156-2",<Element 'PubmedArticle' at 0x7f05dc6fc950>
211,32727775,A Novel Anti-inflammatory Phenotype Transformed by Repetitive Low-dose Lipopolysaccharide in Primary Peritoneal Tissue-resident Macrophages.,"Our previous studies suggested that oral administration of lipopolysaccharide (LPS) regulates the progression of various diseases via transformation of tissue-resident macrophages (MΦ). Recently, we characterized microglia transformed by repetitive low-dose LPS treatment (REPELL-microglia) in vitro, and this response was similar to that observed in response to oral administration of LPS in vivo. Here, we examined the characteristics of peritoneal tissue-resident MΦ (pMΦ) transformed by repetitive low-dose LPS treatment (REPELL-pMΦ).
Primary pMΦ were treated with low-dose LPS (1 ng/ml) three times; subsequently, phagocytic activity and gene expression were evaluated.
REPELL-pMΦ exhibited high phagocytic activity and elevated expression of Arg1, Gipr, Gdnf, and Fpr2. The gene expression profiles observed in REPELL-pMΦ were distinct from those of REPELL-microglia.
REPELL-pMΦ have the potential to promote clearance of xenobiotics and to suppress inflammation. The present study also demonstrates the diversity of tissue-resident MΦ transformation that reflect their tissue origin.","['Repetitive low-dose lipopolysaccharide', 'anti-inflammation', 'phagocytosis', 'tissue-resident macrophages']",Anticancer research,2020-07-31,"[{'lastname': 'Mizobuchi', 'firstname': 'Haruka', 'initials': 'H', 'affiliation': 'Control of Innate Immunity, Technology Research Association, Kagawa, Japan.'}, {'lastname': 'Yamamoto', 'firstname': 'Kazushi', 'initials': 'K', 'affiliation': 'Control of Innate Immunity, Technology Research Association, Kagawa, Japan.'}, {'lastname': 'Yamashita', 'firstname': 'Masafumi', 'initials': 'M', 'affiliation': 'Control of Innate Immunity, Technology Research Association, Kagawa, Japan.'}, {'lastname': 'Inagawa', 'firstname': 'Hiroyuki', 'initials': 'H', 'affiliation': 'Control of Innate Immunity, Technology Research Association, Kagawa, Japan.\nMacrophi Inc., Kagawa, Japan.\nResearch Institute for Healthy Living, Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan.'}, {'lastname': 'Kohchi', 'firstname': 'Chie', 'initials': 'C', 'affiliation': 'Macrophi Inc., Kagawa, Japan.'}, {'lastname': 'Soma', 'firstname': 'Gen-Ichiro', 'initials': 'GI', 'affiliation': 'Control of Innate Immunity, Technology Research Association, Kagawa, Japan mizobuchi@shizenmeneki.org.\nMacrophi Inc., Kagawa, Japan.\nResearch Institute for Healthy Living, Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan.'}]",,REPELL-pMΦ have the potential to promote clearance of xenobiotics and to suppress inflammation. The present study also demonstrates the diversity of tissue-resident MΦ transformation that reflect their tissue origin.,"REPELL-pMΦ exhibited high phagocytic activity and elevated expression of Arg1, Gipr, Gdnf, and Fpr2. The gene expression profiles observed in REPELL-pMΦ were distinct from those of REPELL-microglia.","Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.",10.21873/anticanres.14450,<Element 'PubmedArticle' at 0x7f05df236b30>
212,32705666,Melatonin Attenuates White Matter Injury via Reducing Oligodendrocyte Apoptosis After Subarachnoid Hemorrhage in Mice.,"To determine whether melatonin (MLT) mitigates white matter (WM) injury by attenuating NOD-like receptor family pyrin domain-containing 3 (NLRP3)-associated oligodendrocyte apoptosis after subarachnoid hemorrhage (SAH).
SAH model C57BL/6J mice were created using an endovascular perforation technique. The mice were injected intraperitoneally with MLT at doses of 50 mg/kg, 150 mg/kg and 300 mg/kg. The animals were evaluated for neurological outcomes according to neurological score, brain water content, myelin degradation, amyloid precursor protein (APP) accumulation, apoptosis, and levels of NLRP3, caspase-1, interleukin-1?, Bcl-2, and Bcl-2-interacting mediator of cell death (Bim) expression after SAH.
MLT at a dose of 50 mg/kg improved neurological score, alleviated brain edema, and reduced WM injury. In addition, loss of myelin basic protein (MBP) and accumulation of APP, and expression in the ipsilateral/left hemisphere were found after SAH, and were reversed by MLT treatment. NLRP3 signal activation was found in microglia and apoptosis in oligodendrocytes were observed after SAH. MLT reduced oligodendrocyte apoptosis by regulating Bim and Bcl-2.
Results of this study indicated that MLT exerts a WM-protective effect in SAH pathophysiology, possibly by attenuating apoptosis in oligodendrocytes.",[],Turkish neurosurgery,2020-07-25,"[{'lastname': 'Liu', 'firstname': 'Dongdong', 'initials': 'D', 'affiliation': 'General Hospital of Northern Theater Command (General Hospital of Shenyang Military Command), Department of Neurosurgery, Shenyang, China.'}, {'lastname': 'Dong', 'firstname': 'Yushu', 'initials': 'Y', 'affiliation': None}, {'lastname': 'Li', 'firstname': 'Gen', 'initials': 'G', 'affiliation': None}, {'lastname': 'Zou', 'firstname': 'Zheng', 'initials': 'Z', 'affiliation': None}, {'lastname': 'Hao', 'firstname': 'Guangzhi', 'initials': 'G', 'affiliation': None}, {'lastname': 'Feng', 'firstname': 'Hua', 'initials': 'H', 'affiliation': None}, {'lastname': 'Pan', 'firstname': 'Pengyu', 'initials': 'P', 'affiliation': None}, {'lastname': 'Liang', 'firstname': 'Guobiao', 'initials': 'G', 'affiliation': None}]",,"Results of this study indicated that MLT exerts a WM-protective effect in SAH pathophysiology, possibly by attenuating apoptosis in oligodendrocytes.","MLT at a dose of 50 mg/kg improved neurological score, alleviated brain edema, and reduced WM injury. In addition, loss of myelin basic protein (MBP) and accumulation of APP, and expression in the ipsilateral/left hemisphere were found after SAH, and were reversed by MLT treatment. NLRP3 signal activation was found in microglia and apoptosis in oligodendrocytes were observed after SAH. MLT reduced oligodendrocyte apoptosis by regulating Bim and Bcl-2.",,10.5137/1019-5149.JTN.27986-19.3,<Element 'PubmedArticle' at 0x7f05df248680>
213,"32661792
3286045
19342823
28488048
21755262
21393361
12003809
28219987
24560525
26537847
27267713
23224511
25655919
25885968
21394088
18086951
9344632
1763058
25427952
31853042
26056339
20547972
21624097
30612527
30358805
31427987
25963715
31150271
28912720
24343120
26637556
24752645
31792796
24508821
11835903
24944035
8913540
10977869
7724593
1568765
18637711
11967798
9218180
32389341
7477267
10930194
9389747
9407460
9858867
11751702
15197103
25301825
27323774
7689411
9729407
2890407
2443549
12195099
31284013
2301648
8214157
28701322
22323719
22922351
10831249
16980346
23871345
23887975
24048944
20360752
7889197
11641522
1858948
1885777
23754618
27698069
12388241
18768398
24958505
27469059
25776070
28710070
23691105
29143938
27443914
14576355
19423710
15059935
28986948
15882256
16242797
12052849
23877628
23486953
27468749
20462420
18650791
23045460
25052203
30076526
18818668
10098850
17569888
30539780
23426971
25712370
19471094
12467247",Brain Angiotensin Type-1 and Type-2 Receptors in Physiological and Hypertensive Conditions: Focus on Neuroinflammation.,"To review recent data that suggest opposing effects of brain angiotensin type-1 (AT
The renin-angiotensin system (RAS) plays an important role in regulating cardiovascular physiology. This includes brain AT","['AT1R', 'AT2R', 'Brain angiotensin receptors', 'Hypertension', 'Microglia', 'Neuroinflammation']",Current hypertension reports,2020-07-15,"[{'lastname': 'Elsaafien', 'firstname': 'Khalid', 'initials': 'K', 'affiliation': 'Department of Pharmacodynamics, University of Florida College of Pharmacy, Gainesville, FL, USA.'}, {'lastname': 'de Kloet', 'firstname': 'Annette D', 'initials': 'AD', 'affiliation': 'Department of Physiology and Functional Genomics, College of Medicine, University of Florida, Gainesville, FL, USA.\nCenter for Integrative Cardiovascular and Metabolic Diseases, University of Florida, Gainesville, FL, USA.\nEvelyn F. and William L. McKnight Brain Institute, University of Florida, Gainesville, FL, USA.'}, {'lastname': 'Krause', 'firstname': 'Eric G', 'initials': 'EG', 'affiliation': 'Department of Pharmacodynamics, University of Florida College of Pharmacy, Gainesville, FL, USA.\nCenter for Integrative Cardiovascular and Metabolic Diseases, University of Florida, Gainesville, FL, USA.\nEvelyn F. and William L. McKnight Brain Institute, University of Florida, Gainesville, FL, USA.'}, {'lastname': 'Sumners', 'firstname': 'Colin', 'initials': 'C', 'affiliation': 'Department of Physiology and Functional Genomics, College of Medicine, University of Florida, Gainesville, FL, USA. csumners@ufl.edu.\nCenter for Integrative Cardiovascular and Metabolic Diseases, University of Florida, Gainesville, FL, USA. csumners@ufl.edu.\nEvelyn F. and William L. McKnight Brain Institute, University of Florida, Gainesville, FL, USA. csumners@ufl.edu.'}]",,,,,"10.1007/s11906-020-01062-0
10.1159/000211202
10.1007/s11906-017-0746-x
10.1590/s0100-879×2011007500088
10.1177/1470320310394891
10.1152/ajpheart.00854.2001
10.1523/JNEUROSCI.3674-16.2017
10.1016/j.autneu.2014.02.001
10.1113/EP085390
10.1210/en.2016-1131
10.1007/s11906-012-0321-4
10.1042/CS20140776
10.1186/s12974-015-0261-4
10.1038/ajh.2011.33
10.1161/HYPERTENSIONAHA.107.101717
10.1006/frne.1997.0155
10.1073/pnas.88.24.11440
10.1007/s00429-014-0943-1
10.1038/s41440-019-0374-8
10.1161/HYPERTENSIONAHA.115.05333
10.1161/HYPERTENSIONAHA.110.150409
10.1111/j.1748-1716.2011.02313.x
10.1161/CIRCRESAHA.118.313882
10.1093/cvr/cvy268
10.3389/fphys.2019.00984
10.1161/CIRCRESAHA.117.305853
10.1152/ajpheart.00510.2018
10.3389/fphys.2017.00592
10.1161/HYPERTENSIONAHA.113.01743
10.1152/ajpheart.00247.2015
10.1371/journal.pone.0095762
10.1007/s12975-019-00752-5
10.1016/j.physbeh.2014.01.016
10.1111/j.1748-1716.1898.tb00272.x
10.1016/s0002-9149(01)02321-9
10.1002/cphy.c130040
10.1073/pnas.92.8.3521
10.1161/01.hyp.19.5.464
10.3317/jraas.2000.009
10.1097/00004872-199715060-00007
10.1016/j.cjca.2020.02.095
10.1038/377748a0
10.1097/00004872-200018070-00018
10.1172/JCI119829
10.1159/000025613
10.1161/hy1201.096576
10.1038/sj.bjp.0705838
10.1161/CIRCRESAHA.114.304975
10.1161/CIRCRESAHA.116.308384
10.1016/0006-8993(93)90216-a
10.1016/s0006-8993(98)00587-3
10.1016/0006-8993(87)90604-4
10.1016/0165-1838(87)90083-x
10.1097/00004872-200209000-00002
10.1016/j.bbr.2019.112075
10.1152/ajpregu.1990.258.1.R70
10.1152/ajpregu.1993.265.3.R625
10.1152/ajpregu.00168.2017
10.1523/JNEUROSCI.5360-11.2012
10.1016/j.neuroscience.2012.08.039
10.1046/j.1440-1681.2000.03261.x
10.1152/ajpheart.00998.2005
10.1016/j.ijcard.2013.06.051
10.1093/cvr/cvt183
10.1093/cvr/cvt217
10.1038/ajh.2010.64
10.3346/jkms.2001.16.5.553
10.1152/ajpregu.1991.261.1.R209
10.1172/JCI115395
10.1007/s11010-013-1717-4
10.1161/HYPERTENSIONAHA.116.07747
10.1152/ajpheart.00515.2002
10.1161/HYPERTENSIONAHA.108.116228
10.1161/HYPERTENSIONAHA.114.03188
10.1016/j.npep.2016.06.006
10.1161/HYPERTENSIONAHA.114.05112
10.1152/ajpheart.00280.2017
10.1371/journal.pone.0063847
10.1007/s00424-017-2081-0
10.1016/j.it.2016.06.006
10.1242/jcs.00755
10.1074/jbc.M109.000521
10.1161/01.RES.0000126924.23467.A3
10.1113/EP086434
10.1111/j.1523-1755.2005.00318.x
10.1016/j.ijcard.2005.07.046
10.1161/01.hyp.0000018590.26853.c7
10.1007/s12012-013-9219-x
10.1523/JNEUROSCI.3806-12.2013
10.1152/physiolgenomics.00029.2016
10.1186/1476-9255-7-21
10.1038/ki.2008.380
10.1161/HYPERTENSIONAHA.112.199547
10.1042/CS20130601
10.1007/s12035-018-1272-9
10.1038/gt.2008.151
10.1046/j.1471-4159.1999.721466.x
10.1161/CIRCRESAHA.107.148940
10.1016/j.cyto.2018.07.003
10.1152/ajpcell.00398.2012
10.1111/bph.13117
10.1159/000218173",<Element 'PubmedArticle' at 0x7f05df23f400>
214,32651843,Phoenixin-20 Ameliorates Lipopolysaccharide-Induced Activation of Microglial NLRP3 Inflammasome.,"Injury associated with neuroinflammation has been linked with several kinds of neurodegenerative diseases. The activation of the NLRP3 inflammasome plays an important role in microglia-mediated inflammation. Phoenixin (PNX)-20 is a newly discovered neuropeptide with pleiotropic effects involved in the regulation of reproductive and cognitive function, depression, and food uptake. This study investigated whether PNX-20 possesses a protective effect against lipopolysaccharide (LPS)-induced activation of the NLRP3 inflammasome in microglia. Firstly, our results show that the PNX-20 treatment significantly prevented LPS-induced expression of NADPH oxidase 4 (NOX-4) and the generation of reactive oxygen species (ROS). Secondly, PNX-20 mitigated LPS-induced upregulation of TxNIP, an upstream regulator of NLRP3 inflammasome activation. Thirdly, further evaluation of the major components of the NLRP3 inflammasome revealed that PNX-20 inhibited LPS-mediated upregulation of NLRP3, ASC, and cleaved caspase-1 (P10). Notably, based on our results, the inhibitory effect of PNX-20 on the NLRP3 inflammasome results in the inhibition of IL-1β and IL-18 secretions. Finally, we found that PNX-20 ameliorated the reduction in SIRT1 expression induced by LPS. When microglial SIRT1 was inhibited by nicotine, PNX-20 lost its suppressive effect on the expression of NLRP3, ASC, and caspase-1, as well as the secretion of IL-1β and IL-18. As a result of these findings, we draw the conclusion that the neuroprotective effect of PNX-20 is dependent on SIRT1. Collectively, the study shows that PNX-20 has a regulatory effect via modulation of neuroinflammation.","['Microglia', 'NLRP3 inflammasome', 'Neuroinflammation', 'Phoenixin 20', 'SIRT1']",Neurotoxicity research,2020-07-12,"[{'lastname': 'Zeng', 'firstname': 'Xiangliang', 'initials': 'X', 'affiliation': 'Department of Neurology, First Affiliated Hospital, Hunan University of Medicine, Huaihua, No.225, Yushi Road, Hecheng District, Huaihua City, 418000, Hunan Province, China.'}, {'lastname': 'Li', 'firstname': 'Yanchun', 'initials': 'Y', 'affiliation': 'Department of Neurology, First Affiliated Hospital, Hunan University of Medicine, Huaihua, No.225, Yushi Road, Hecheng District, Huaihua City, 418000, Hunan Province, China. liyanchun026@163.com.'}, {'lastname': 'Ma', 'firstname': 'Sicong', 'initials': 'S', 'affiliation': 'Department of Neurology, First Affiliated Hospital, Hunan University of Medicine, Huaihua, No.225, Yushi Road, Hecheng District, Huaihua City, 418000, Hunan Province, China.'}, {'lastname': 'Tang', 'firstname': 'Yidan', 'initials': 'Y', 'affiliation': 'Department of Neurology, First Affiliated Hospital, Hunan University of Medicine, Huaihua, No.225, Yushi Road, Hecheng District, Huaihua City, 418000, Hunan Province, China.'}, {'lastname': 'Li', 'firstname': 'Hanwen', 'initials': 'H', 'affiliation': 'Department of Neurology, First Affiliated Hospital, Hunan University of Medicine, Huaihua, No.225, Yushi Road, Hecheng District, Huaihua City, 418000, Hunan Province, China.'}]",,,,,10.1007/s12640-020-00225-w,<Element 'PubmedArticle' at 0x7f05dc4c3f40>
215,"32645874
26152294
19446389
24103368
24399084
24424382
24805069
24008734
26337121
25775556
31914678
24685982
23792783
24163150
29772377
32466385
29849895
30373775
30864712
28648389
21277368
27884727
22326729
30601069
30940045
29654318
31009361
32239449
32201254
32239625
31794744
30195027
31218587
28404595
15869954
19333725
25136295
25627810
24054992
28778433
30539825
25682174
32007102
30797557
21206507
7709410
15896872
25468770
22708584
20607446",Gonadal Hormones E2 and P Mitigate Cerebral Ischemia-Induced Upregulation of the AIM2 and NLRC4 Inflammasomes in Rats.,"Acute ischemic stroke (AIS) is a devastating neurological condition with a lack of neuroprotective therapeutic options, despite the reperfusion modalities thrombolysis and thrombectomy. Post-ischemic brain damage is aggravated by an excessive inflammatory cascade involving the activation and regulation of the pro-inflammatory cytokines IL-1β and IL-18 by inflammasomes. However, the role of AIM2 and NLRC4 inflammasomes and the influence of the neuroprotective steroids 17β-estradiol (E2) and progesterone (P) on their regulation after ischemic stroke have not yet been conclusively elucidated. To address the latter, we subjected a total of 65 rats to 1 h of transient Middle Cerebral Artery occlusion (tMCAO) followed by a reperfusion period of 72 h. Moreover, we evaluated the expression and regulation of AIM2 and NLRC4 in glial single-cell cultures (astroglia and microglia) after oxygen-glucose deprivation (OGD). The administration of E2 and P decreased both infarct sizes and neurological impairments after cerebral ischemia in rats. We detected a time-dependent elevation of gene and protein levels (Western Blot/immunohistochemistry) of the AIM2 and NLRC4 inflammasomes in the post-ischemic brains. E2 or P selectively mitigated the stroke-induced increase of AIM2 and NLRC4. While both inflammasomes seemed to be exclusively abundant in neurons under physiological and ischemic conditions in vivo, single-cell cultures of cortical astrocytes and microglia equally expressed both inflammasomes. In line with the in vivo data, E and P selectively reduced AIM2 and NLRC4 in primary cortical astrocytes and microglial cells after OGD. In conclusion, the post-ischemic elevation of AIM2 and NLRC4 and their down-regulation by E2 and P may shed more light on the anti-inflammatory effects of both gonadal hormones after stroke.","['AIM', 'Astrocytes', 'Estrogen', 'Inflammasomes', 'Microglia', 'NLRC4', 'Neuroprotection', 'OGD', 'Progesterone', 'Stroke']",International journal of molecular sciences,2020-07-11,"[{'lastname': 'Habib', 'firstname': 'Pardes', 'initials': 'P', 'affiliation': 'Department of Neurology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.\nInstitute of Biochemistry and Molecular Immunology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.'}, {'lastname': 'Harms', 'firstname': 'Julie', 'initials': 'J', 'affiliation': 'Institute of Neuroanatomy, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.'}, {'lastname': 'Zendedel', 'firstname': 'Adib', 'initials': 'A', 'affiliation': 'Institute of Neuroanatomy, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.'}, {'lastname': 'Beyer', 'firstname': 'Cordian', 'initials': 'C', 'affiliation': 'Institute of Neuroanatomy, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.\nJARA Brain, RWTH Aachen University, 52074 Aachen, Germany.'}, {'lastname': 'Slowik', 'firstname': 'Alexander', 'initials': 'A', 'affiliation': 'Institute of Neuroanatomy, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.'}]",,,,,"10.3390/ijms21134795
10.1161/STROKEAHA.114.007564
10.1016/j.clineuro.2009.04.001
10.1016/j.arr.2013.09.004
10.1038/nrn3638
10.1038/jcbfm.2013.242
10.1016/j.expneurol.2014.04.017
10.1038/cddis.2013.326
10.1159/000439435
10.1073/pnas.1419090112
10.1096/fj.201900394RRR
10.1159/000362279
10.1016/j.jsbmb.2013.06.003
10.1007/s12031-013-0137-y
10.1016/j.jsbmb.2018.05.003
10.3390/ijms21113740
10.1155/2018/4248526
10.1042/BSR20181117
10.1016/j.bbi.2017.06.012
10.1016/j.bbi.2011.01.013
10.1016/j.jsbmb.2016.11.018
10.1016/j.jsbmb.2012.01.007
10.1080/1061186X.2018.1564925
10.1177/1747493019841242
10.1038/s41598-018-24350-x
10.1161/STROKEAHA.118.023620
10.1007/s12035-020-01909-2
10.1016/j.bbi.2020.03.011
10.15252/emmm.201911002
10.1016/j.expneurol.2019.113139
10.1016/j.bbi.2018.09.001
10.1007/s12017-019-08544-8
10.1084/jem.20150237
10.1016/j.expneurol.2005.01.009
10.1007/s00011-009-0032-8
10.3389/fncel.2014.00216
10.1002/glia.22786
10.1016/j.neurobiolaging.2013.08.016
10.1016/j.jneuroim.2017.07.004
10.1016/j.cellimm.2015.01.018
10.1186/s12974-020-1715-x
10.1016/j.bbrc.2019.02.085
10.1038/jcbfm.2010.220
10.1161/01.STR.26.4.627
10.1016/j.molbrainres.2004.10.043
10.1016/j.jneuroim.2014.11.007
10.1186/1471-2105-13-134
10.1007/s12031-010-9419-9",<Element 'PubmedArticle' at 0x7f05dc4b2b80>
216,"32635261
28571979
28045402
29736898
20961460
10644531
18539769
18317734
29274064
16712853
26876434
28721154
20585248
23769708
25628573
27783852
30090086
8865078
29593557
26593437
25322465
27770485
24672641
26925824
26478012
22537491
29118400
24265422
24031088
30104964
14697306
17522123
28477448
31305518
22213199
19680817
22217997
18279024
20625286
25526549
26902932
20565988
22701308
26912499
26485433
18305141
28327129
26419876
30177968
21318295
28330953
21926273
22107956
25658324
23308110
22948212
22743758
22968153
15807655
169242
26903510",Immunohistochemical Analysis of Intestinal and Central Nervous System Morphology in an Obese Animal Model (,"The 3,5-diiodo-L-thyronine (3,5-T2) is an endogenous metabolite of thyroid hormones, whose administration to rodents fed high-fat diet (HFD) prevents body weight increase and reverts the expression pattern of pro-inflammatory factors associated to HFD. The diet-induced obese (D.I.O.) zebrafish (Danio rerio) has been recently used as an experimental model to investigate fundamental processes underlying central and peripheral obesity-driven inflammation. Herein, we aim to understand the role of 3,5-T2 in regulating central and peripheral inflammation in D.I.O. model of zebrafish. 3,5-T2 (10 nM and 100 nM) was administered with the obesity-inducing diet (D.I.O. with 3,5-T2) or after 4 weeks of obesity-inducing diet (D.I.O. flw 3,5-T2). 3,5-T2 significantly increased the body weight and serum triglyceride levels in D.I.O. zebrafish in both conditions. Moreover, 3,5-T2 sustained or increased inflammation in the anterior (AI) and mid (MI) intestine when administered with the obesity-inducing diet, as indicated by the immunoexpression of the inflammatory markers tumor-necrosis factor-α (TNFα), cyclooxygenase 2 (COX2), calnexin, caspase 3, and proliferating cell nuclear antigen (PCNA). On the contrary, when 3,5-T2 was administered after the obesity-inducing diet, partly reverted the intestinal alteration induced by D.I.O. In addition, brain inflammation, as indicated by the increase in the activation of microglia, was detected in D.I.O. zebrafish and D.I.O. treated with 3,5-T2. These findings reveal that the effects of 3,5-T2 on fish intestine and brain can deviate from those shown in obese mammals, opening new avenues to the investigation of the potential impact of this thyroid metabolite in different diseases including obesity.","['3,5-diiodo-L-thyronine', 'brain inflammation', 'diet-induced obesity', 'intestinal inflammation', 'zebrafish']",Animals : an open access journal from MDPI,2020-07-09,"[{'lastname': 'Imperatore', 'firstname': 'Roberta', 'initials': 'R', 'affiliation': 'Department of Science and Technology (DST), University of Sannio, 82100 Benevento, Italy.\nEndocannabinoid Research Group, Institute of Biomolecular Chemistry-National Research Council (ICB-CNR), 80078 Pozzuoli, Italy.'}, {'lastname': 'Tunisi', 'firstname': 'Lea', 'initials': 'L', 'affiliation': 'Endocannabinoid Research Group, Institute of Biomolecular Chemistry-National Research Council (ICB-CNR), 80078 Pozzuoli, Italy.\nDepartment of Veterinary Medicine and Animal Productions, University of Naples Federico II, 80137 Naples, Italy.'}, {'lastname': 'Mavaro', 'firstname': 'Isabella', 'initials': 'I', 'affiliation': 'Department of Veterinary Medicine and Animal Productions, University of Naples Federico II, 80137 Naples, Italy.\nCenter for Advanced Biomaterials for Healthcare, Istituto Italiano di Tecnologia, 80125 Naples, Italy.'}, {'lastname': ""D'Angelo"", 'firstname': 'Livia', 'initials': 'L', 'affiliation': 'Department of Veterinary Medicine and Animal Productions, University of Naples Federico II, 80137 Naples, Italy.'}, {'lastname': 'Attanasio', 'firstname': 'Chiara', 'initials': 'C', 'affiliation': 'Department of Veterinary Medicine and Animal Productions, University of Naples Federico II, 80137 Naples, Italy.\nCenter for Advanced Biomaterials for Healthcare, Istituto Italiano di Tecnologia, 80125 Naples, Italy.'}, {'lastname': 'Safari', 'firstname': 'Omid', 'initials': 'O', 'affiliation': 'Department of Fisheries, Faculty of Natural Resources and Environment, Ferdowsi University of Mashhad, Mashhad 9177948974, Iran.'}, {'lastname': 'Motlagh', 'firstname': 'Hamidreza Ahmadniaye', 'initials': 'HA', 'affiliation': 'Department of Fisheries, Faculty of Natural Resources and Environment, Ferdowsi University of Mashhad, Mashhad 9177948974, Iran.'}, {'lastname': 'De Girolamo', 'firstname': 'Paolo', 'initials': 'P', 'affiliation': 'Department of Veterinary Medicine and Animal Productions, University of Naples Federico II, 80137 Naples, Italy.'}, {'lastname': 'Cristino', 'firstname': 'Luigia', 'initials': 'L', 'affiliation': 'Endocannabinoid Research Group, Institute of Biomolecular Chemistry-National Research Council (ICB-CNR), 80078 Pozzuoli, Italy.'}, {'lastname': 'Varricchio', 'firstname': 'Ettore', 'initials': 'E', 'affiliation': 'Department of Science and Technology (DST), University of Sannio, 82100 Benevento, Italy.'}, {'lastname': 'Paolucci', 'firstname': 'Marina', 'initials': 'M', 'affiliation': 'Department of Science and Technology (DST), University of Sannio, 82100 Benevento, Italy.\nInstitute of Food Science, National Research Council (ISA-CNR), 83100 Avellino, Italy.'}]",,,,,"10.3390/ani10071131
10.1016/j.biochi.2017.05.019
10.1172/JCI92035
10.1007/s00248-018-1198-9
10.1186/1472-6793-10-21
10.1152/ajpendo.2000.278.1.E1
10.1210/jc.2008-0520
10.1007/s00213-008-1102-2
10.1007/s12020-017-1494-z
10.1016/j.atherosclerosis.2006.04.012
10.1038/ijo.2016.26
10.5114/aoms.2016.58928
10.1097/MED.0b013e32833c3026
10.1016/j.mce.2013.06.006
10.3389/fphys.2014.00528
10.1002/cphy.c150019
10.3389/fendo.2018.00427
10.1113/jphysiol.1996.sp021536
10.3389/fphys.2018.00194
10.2174/1567201813666151123124340
10.1210/en.2014-1604
10.1111/apha.12821
10.4254/wjh.v6.i3.114
10.1016/j.aanat.2016.02.001
10.1016/j.mod.2015.10.002
10.1016/j.ydbio.2012.04.013
10.1038/s41598-017-14913-9
10.1242/jeb.096602
10.1530/JME-13-0145
10.3389/fnana.2018.00062
10.1016/j.ygcen.2003.09.010
10.1152/ajpregu.00101.2007
10.1016/j.aanat.2017.03.005
10.3791/59308
10.1002/jemt.21124
10.1007/s11481-009-9163-5
10.1089/thy.2007.0248
10.1097/MED.0b013e32833cf354
10.1210/en.2014-1933
10.1016/j.dci.2016.02.020
10.1186/1471-2164-11-392
10.1155/2012/817341
10.1136/postgradmedj-2015-133285
10.1371/journal.pone.0140837
10.2337/db07-1403
10.1186/s12899-017-0031-x
10.1128/mBio.00687-15
10.3389/fcell.2018.00091
10.1007/s00395-011-0156-1
10.14814/phy2.13207
10.2337/db11-0207
10.1530/JOE-11-0288
10.1371/journal.pone.0116498
10.1371/journal.pone.0052328
10.1210/en.2012-1572
10.4161/gmic.21287
10.1038/nrn3346
10.1007/s10541-005-0097-0
10.1530/JME-15-0159",<Element 'PubmedArticle' at 0x7f05df8ee770>
217,32595037,The GLP-1 receptor herbal agonist morroniside attenuates neuropathic pain via spinal microglial expression of IL-10 and β-endorphin.,"To assess the protective effect of the glucagon-like peptide-1 receptor (GLP-1R) agonist morroniside against neuropathic pain and its downstream mechanisms of activating microglial GLP-1R/interleukin-10 (IL-10)/β-endorphin antinociceptive pathway.
Spinal nerve ligation-induced neuropathic pain rats were intrathecally injected with morroniside, with mechanical paw withdrawal threshold being assessed. The expression of spinal and cultured microglia IL-10 and β-endorphin were detected with qRT-PCR.
Morroniside alleviated mechanical allodynia in neuropathic rats, which was blocked by inhibiting or depleting microglia. In addition, neutralizing spinal IL-10 or β-endorphin with specialized antibodies or blocking the μ-opioid receptor was able to fully reverse the morroniside-induced mechanical antiallodynia. Morroniside treatment stimulated the gene expression of IL-10 and β-endorphin in the spinal lumbar enlargements of neuropathic rats as well as in primary cultured microglia. Furthermore, pretreatment with the IL-10 antibody blocked morroniside-stimulated β-endorphin expression in the spinal cords of neuropathic rats and cultured primary microglia, whereas the β-endorphin antibody failed to affect morroniside-stimulated gene expression of IL-10.
These results reveal that morroniside produces therapeutic effects in neuropathy through spinal microglial expression of IL-10 and subsequent β-endorphin after activation of GLP-1R.","['GLP-1 receptor (GLP-1R)', 'IL-10', 'Microglia', 'Morroniside', 'β-endorphin']",Biochemical and biophysical research communications,2020-07-01,"[{'lastname': 'Tang', 'firstname': 'Xueqi', 'initials': 'X', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, Shanghai, 200240, China.""}, {'lastname': 'Wu', 'firstname': 'Haiyun', 'initials': 'H', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, Shanghai, 200240, China.""}, {'lastname': 'Mao', 'firstname': 'Xiaofang', 'initials': 'X', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, Shanghai, 200240, China.""}, {'lastname': 'Li', 'firstname': 'Xinyan', 'initials': 'X', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, Shanghai, 200240, China.""}, {'lastname': 'Wang', 'firstname': 'Yongxiang', 'initials': 'Y', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, Shanghai, 200240, China. Electronic address: yxwang@sjtu.edu.cn.""}]",,,,Copyright © 2020 Elsevier Inc. All rights reserved.,10.1016/j.bbrc.2020.05.080,<Element 'PubmedArticle' at 0x7f05df8dcf90>
218,"32576879
19716187
29056410
27323709
24952943
28137791
25635985
20628090
29966381
23104765
24149114
28253935
29321684
15591151
28592656
22201683
25358444
29635361
31776456
30733616
17053832
17426960
22522614
30906281
27293318
24362405
19808018
18854155
24812431
28917655
30414927
22389645
22654837
19343034
23085193
22404339
12051555
11159046
18349428
14692621
31299618
17325984
29410383
17478729
28161889
25098336
23070544
26037109
19737522
21386060
15271881
26484582
29883952
26942683
22408695
22408694
18596224
27733761
26228462
22822160
24971882
16845389
29460051",Short-term exposure to air pollution (PM,"A previous study demonstrated that a high-fat diet (HFD), administered for one-three-days, induces hypothalamic inflammation before obesity's established, and the long term affects leptin signaling/action due to inflammation. We investigate whether exposure to particulate matter of a diameter of ≤2.5 μm (PM",[],Scientific reports,2020-06-25,"[{'lastname': 'Campolim', 'firstname': 'Clara Machado', 'initials': 'CM', 'affiliation': 'School of Applied Sciences, State University of Campinas (UNICAMP), Limeira, SP, Brazil.'}, {'lastname': 'Weissmann', 'firstname': 'Lais', 'initials': 'L', 'affiliation': 'Department of Internal Medicine, School of Medical Science, State University of Campinas (UNICAMP), Campinas, SP, Brazil.'}, {'lastname': 'Ferreira', 'firstname': 'Clílton Kraüss de Oliveira', 'initials': 'CKO', 'affiliation': 'School of Applied Sciences, State University of Campinas (UNICAMP), Limeira, SP, Brazil.'}, {'lastname': 'Zordão', 'firstname': 'Olivia Pizetta', 'initials': 'OP', 'affiliation': 'Department of Internal Medicine, School of Medical Science, State University of Campinas (UNICAMP), Campinas, SP, Brazil.'}, {'lastname': 'Dornellas', 'firstname': 'Ana Paula Segantine', 'initials': 'APS', 'affiliation': 'School of Applied Sciences, State University of Campinas (UNICAMP), Limeira, SP, Brazil.'}, {'lastname': 'de Castro', 'firstname': 'Gisele', 'initials': 'G', 'affiliation': 'Department of Internal Medicine, School of Medical Science, State University of Campinas (UNICAMP), Campinas, SP, Brazil.'}, {'lastname': 'Zanotto', 'firstname': 'Tamires Marques', 'initials': 'TM', 'affiliation': 'Department of Internal Medicine, School of Medical Science, State University of Campinas (UNICAMP), Campinas, SP, Brazil.'}, {'lastname': 'Boico', 'firstname': 'Vitor Ferreira', 'initials': 'VF', 'affiliation': 'School of Applied Sciences, State University of Campinas (UNICAMP), Limeira, SP, Brazil.'}, {'lastname': 'Quaresma', 'firstname': 'Paula Gabriele Fernandes', 'initials': 'PGF', 'affiliation': 'Department of Internal Medicine, School of Medical Science, State University of Campinas (UNICAMP), Campinas, SP, Brazil.'}, {'lastname': 'Lima', 'firstname': 'Raquel Patrícia Ataíde', 'initials': 'RPA', 'affiliation': 'School of Applied Sciences, State University of Campinas (UNICAMP), Limeira, SP, Brazil.'}, {'lastname': 'Donato', 'firstname': 'Jose', 'initials': 'J', 'affiliation': 'Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, SP, Brazil.'}, {'lastname': 'Veras', 'firstname': 'Mariana Matera', 'initials': 'MM', 'affiliation': 'Laboratório de Poluição Atmosférica Experimental LIM05, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo (USP), São Paulo, SP, Brazil.'}, {'lastname': 'Saldiva', 'firstname': 'Paulo Hilário Nascimento', 'initials': 'PHN', 'affiliation': 'Laboratório de Poluição Atmosférica Experimental LIM05, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo (USP), São Paulo, SP, Brazil.'}, {'lastname': 'Kim', 'firstname': 'Young-Bum', 'initials': 'YB', 'affiliation': 'Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.'}, {'lastname': 'Prada', 'firstname': 'Patricia Oliveira', 'initials': 'PO', 'affiliation': 'School of Applied Sciences, State University of Campinas (UNICAMP), Limeira, SP, Brazil. pprada@unicamp.br.\nDepartment of Internal Medicine, School of Medical Science, State University of Campinas (UNICAMP), Campinas, SP, Brazil. pprada@unicamp.br.'}]",,,,,10.1038/s41598-020-67040-3,<Element 'PubmedArticle' at 0x7f05dc129220>
219,"32554430
15156148
14988386
15546500
14993058
22824429
19738918
22982535
16135757
17997277
23998680
21490197
20685874
19299459
12000023
23054057
15465115
24744702
23998678
23717262
28158270
27459063
25460037
21376052
19500221
15509387
19372198
19131570
23407936
20144714
10453051
3166062
21722643
22857738
26464992
21508345
8967396
22632727
22182318
18286612
12017550
18083105
21072242
11245665
9459198",Estradiol Increases Microglial Response to Lipopolysaccharide in the Ventromedial Hypothalamus during the Peripubertal Sensitive Period in Female Mice.,"Sensitive periods are times of development during which the effects of experience are unusually strong and long lasting. The peripubertal period has emerged as one such sensitive period, and a single administration of lipopolysaccharide (LPS) during this time reduces hormone-induced sexual behavior in adult female mice. During periods of high synaptic turnover, maturation, and elimination, as occurs during this sensitive period, microglia are particularly active. Estradiol also regulates microglial numbers, morphology, and activation. In addition, a good deal of evidence suggests that estradiol may confer this vulnerability to the effects of a stressor during the peripubertal period. Therefore, we investigated the effects of estradiol on microglial morphology, cytokine levels, and the sickness response to LPS. Estradiol levels were manipulated by implanting an estradiol-filled SILASTIC capsule (or oil-filled control) in ovariectomized mice or by administering the aromatase inhibitor, formestane (or oil control), to ovary-intact mice. We found that (1) estradiol elevates basal microglial Iba1 immunoreactivity in the ventromedial nucleus of the hypothalamus (VMH), (2) LPS induces higher levels of proinflammatory cytokines in the presence of estradiol, and (3) LPS causes hypothermia in the presence of estradiol. Taken together, these data suggest that estradiol enhances the effect of LPS during the pubertal sensitive period.","['Iba1', 'estradiol', 'mice', 'microglia', 'peripubertal development']",eNeuro,2020-06-20,"[{'lastname': 'Velez-Perez', 'firstname': 'Amarylis', 'initials': 'A', 'affiliation': 'Neuroscience and Behavior Program, University of Massachusetts, Amherst, MA 01003.\nCenter for Neuroendocrine Studies, University of Massachusetts, Amherst, MA 01003.'}, {'lastname': 'Holder', 'firstname': 'Mary K', 'initials': 'MK', 'affiliation': 'Department of Psychological and Brain Sciences, University of Massachusetts, Amherst, MA 01003 mary.holder@psych.gatech.edu.\nNeuroscience and Behavior Program, University of Massachusetts, Amherst, MA 01003.\nCenter for Neuroendocrine Studies, University of Massachusetts, Amherst, MA 01003.'}, {'lastname': 'Fountain', 'firstname': 'Sam', 'initials': 'S', 'affiliation': 'Department of Psychological and Brain Sciences, University of Massachusetts, Amherst, MA 01003.'}, {'lastname': 'Blaustein', 'firstname': 'Jeffrey D', 'initials': 'JD', 'affiliation': 'Department of Psychological and Brain Sciences, University of Massachusetts, Amherst, MA 01003.\nNeuroscience and Behavior Program, University of Massachusetts, Amherst, MA 01003.\nCenter for Neuroendocrine Studies, University of Massachusetts, Amherst, MA 01003.'}]",,,,Copyright © 2020 Velez-Perez et al.,"10.1523/ENEURO.0505-19.2020
10.1038/nn1254
10.1210/en.2003-1363
10.1017/S1461145704004808
10.1196/annals.1286.024
10.1016/j.neuroscience.2012.07.029
10.1016/j.yfrne.2012.08.006
10.1523/JNEUROSCI.1748-05.2005
10.1016/j.bbi.2007.10.003
10.1016/j.yhbeh.2013.01.015
10.1523/JNEUROSCI.0209-11.2011
10.1210/en.2010-0371
10.1210/en.2008-1733
10.1111/j.1749-6632.2001.tb05827.x
10.1210/en.2012-1350
10.1016/j.steroids.2004.07.002
10.3389/fncel.2014.00101
10.1016/j.yhbeh.2012.09.012
10.3389/fncel.2013.00065
10.1371/journal.pone.0171381
10.1016/j.devcel.2016.07.006
10.1016/j.nlm.2014.11.009
10.1016/j.yhbeh.2011.02.010
10.1111/j.1365-2826.2009.01885.x
10.1162/0898929042304796
10.1210/en.2009-0099
10.1210/en.2008-1595
10.1523/JNEUROSCI.1268-12.2013
10.1111/j.1468-2958.2002.tb00828.x
10.1016/j.jsbmb.2010.02.001
10.1002/(SICI)1097-4695(19990915)40:4<484::AID-NEU6>3.0.CO;2-C
10.1113/jphysiol.1988.sp016999
10.1016/j.yhbeh.2011.06.005
10.1017/S1740925X12000105
10.1523/ENEURO.0036-15.2015
10.1161/ATVBAHA.110.207449
10.1152/ajpregu.1996.270.4.R693
10.1016/j.neuron.2012.03.026
10.1111/j.1471-4159.2011.07630.x
10.1002/glia.20644
10.1210/rp.57.1.317
10.1016/j.cell.2007.10.036
10.1371/journal.pbio.1000527
10.1523/JNEUROSCI.21-06-01809.2001
10.1016/S0960-0760(97)00072-1",<Element 'PubmedArticle' at 0x7f05dc15d590>
220,"32549763
6267699
27586075
23320836
22734681
27428651
22640813
26648475
25471398
26094765
22024597
28431620
26662865
19184072
28550160
20847117
6471907
26027838
30267577
23320836
11786305
9189917
9718281
10366634
16169595
16647243
23251825
7888181
10899439
17664130",Long-term UVA exposure to the eye compromises memory and learning ability in mice via corticotropin-releasing hormone type 2 receptor.,"Long-term eye exposure to ultraviolet (UV)A can effect memory and learning ability. However, the underlying mechanism behind these effects remain unknown. In this study, we used HR-1 mice to study effects of long-term UVA eye irradiation. The eyes or dorsal skin of the mice were exposed to UVA at the dose of 110kj/m","['Corticotropin-releasing hormone', 'Memory and learning ability', 'Microglia', 'Reactive oxygen species', 'Ultraviolet A', 'Urocortin 2']",International journal of biological sciences,2020-06-19,"[{'lastname': 'Hiramoto', 'firstname': 'Keiichi', 'initials': 'K', 'affiliation': 'Department of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Mie, Japan.'}, {'lastname': 'Yamate', 'firstname': 'Yurika', 'initials': 'Y', 'affiliation': 'Department of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Mie, Japan.'}]",,,,© The author(s).,10.7150/ijbs.45967,<Element 'PubmedArticle' at 0x7f05ddab44f0>
221,32513838,Shaping Microglial Phenotypes Through Estrogen Receptors: Relevance to Sex-Specific Neuroinflammatory Responses to Brain Injury and Disease.,"In mammals, 17",[],The Journal of pharmacology and experimental therapeutics,2020-06-10,"[{'lastname': 'Acosta-Martínez', 'firstname': 'Maricedes', 'initials': 'M', 'affiliation': 'Department of Physiology and Biophysics, Stony Brook Medicine, Stony Brook, New York Maricedes.acosta@stonybrook.edu.'}]",,,,Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics.,10.1124/jpet.119.264598,<Element 'PubmedArticle' at 0x7f05ddada400>
222,32464121,Ginsenoside 20(S)-protopanaxadiol attenuates depressive-like behaviour and neuroinflammation in chronic unpredictable mild stress-induced depressive rats.,"20 (S)-protopanaxadiol (PPD) possesses a variety of biological activities, including antioxidant, antifatigue and anti-inflammatory properties. This study was aimed to investigate the antidepressant-like effects of PPD and potential mechanisms in rats exposed to chronic unpredictable mild stress (CUMS) model. Results showed that chronic treatment with PPD for 14 days ameliorated depressive-like behaviour, as indicated by the increase in sucrose preference in the sucrose preference test and decrease in immobility in the forced swim test and tail suspension test. In addition, PPD decreased the elevated levels of CORT and proinflammatory cytokines (IL-6, IL-1β and TNF-α) in the serum and neurotransmitters (5-HT and NE) in the hippocampus and PFC induced by CUMS. PPD suppressed the microglial activation in the DG induced by CUMS. Furthermore, our results suggested that rats treated with PPD displayed decreased iNOS, COX2, cleaved-caspase3, cleaved-caspase9, Bax, Bcl-2, and ac-p65 levels and increased Sirt1 levels in the hippocampus. In conclusion, this study indicated that PPD exerts promising antidepressant-like effects in CUMS rats that are mediated in part through alterations in the dysfunction of the HPA axis, the normalization of the levels of neurotransmitters, and the suppression of neuronal apoptosis and neuroinflammation, possibly through the regulation of the SIRT1/NF-kB signalling pathway.","['20 (S)-protopanaxadiol', 'Chronic unpredictable mild stress', 'Depression', 'NF-κB', 'Neuroinflammation', 'SIRT1']",Behavioural brain research,2020-05-29,"[{'lastname': 'Jiang', 'firstname': 'Ning', 'initials': 'N', 'affiliation': 'Research Center for Pharmacology and Toxicology, Institute of Medicinal Plant Development (IMPLAD), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.'}, {'lastname': 'Jingwei', 'firstname': 'Lv', 'initials': 'L', 'affiliation': 'Research Center for Pharmacology and Toxicology, Institute of Medicinal Plant Development (IMPLAD), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.'}, {'lastname': 'Wang', 'firstname': 'Haixia', 'initials': 'H', 'affiliation': 'Research Center for Pharmacology and Toxicology, Institute of Medicinal Plant Development (IMPLAD), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.'}, {'lastname': 'Huang', 'firstname': 'Hong', 'initials': 'H', 'affiliation': 'Research Center for Pharmacology and Toxicology, Institute of Medicinal Plant Development (IMPLAD), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.'}, {'lastname': 'Wang', 'firstname': 'Qiong', 'initials': 'Q', 'affiliation': 'TCM Hospital/School of Pharmacy/Sino-Portugal TCM International Cooperation Center, Southwest Medical University, Luzhou 646000, China.'}, {'lastname': 'Zeng', 'firstname': 'Guirong', 'initials': 'G', 'affiliation': 'Research Center for Pharmacology and Toxicology, Institute of Medicinal Plant Development (IMPLAD), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.'}, {'lastname': 'Li', 'firstname': 'Shanshan', 'initials': 'S', 'affiliation': 'TCM Hospital/School of Pharmacy/Sino-Portugal TCM International Cooperation Center, Southwest Medical University, Luzhou 646000, China.'}, {'lastname': 'Liu', 'firstname': 'Xinmin', 'initials': 'X', 'affiliation': 'Research Center for Pharmacology and Toxicology, Institute of Medicinal Plant Development (IMPLAD), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address: liuxinmin@hotmail.com.'}]",,,,Copyright © 2020. Published by Elsevier B.V.,10.1016/j.bbr.2020.112710,<Element 'PubmedArticle' at 0x7f05ddac8860>
223,32450430,TLR-2 neutralization potentiates microglial M1 to M2 switching by the combinatorial treatment of ciprofloxacin and dexamethasone during S. aureus infection.,Microglial inflammation plays a pivotal role in the pathogenesis of S. aureus induced brain abscesses. The objective of this study was to regulate microglial activation by the combinatorial treatment of ciprofloxacin either with dexamethasone or celecoxib via targeting M1 and M2 polarization. The antibiotic-immunomodulator combinations were applied either by opening both TLR-2 and GR or neutralizing each of them. Our results confirmed that dexamethasone along with ciprofloxacin attenuated bacterial burden along with ROS production more efficiently than celecoxib combination during TLR-2 neutralization. FACS data indicated microglial M1 to M2 switching that was responsible for the better resolution of microglial inflammation.,"['Celecoxib', 'Ciprofloxacin', 'Dexamethasone', 'Microglial inflammation', 'Polarization switching', 'S. aureus']",Journal of neuroimmunology,2020-05-26,"[{'lastname': 'Dey', 'firstname': 'Rajen', 'initials': 'R', 'affiliation': 'Department of Physiology, Immunology Laboratory, University of Calcutta, University Colleges of Science and Technology, Calcutta, West Bengal, India.'}, {'lastname': 'Bishayi', 'firstname': 'Biswadev', 'initials': 'B', 'affiliation': 'Department of Physiology, Immunology Laboratory, University of Calcutta, University Colleges of Science and Technology, Calcutta, West Bengal, India. Electronic address: biswa_dev2@yahoo.com.'}]",,,,Copyright © 2020 Elsevier B.V. All rights reserved.,10.1016/j.jneuroim.2020.577262,<Element 'PubmedArticle' at 0x7f05debcb5e0>
224,32450066,Phoenixin 14 inhibits ischemia/reperfusion-induced cytotoxicity in microglia.,"The process of ischemia/reperfusion (IR) in ischemic stroke often leads to significant cell death and permanent neuronal damage. Safe and effective treatments are urgently needed to mitigate the damage caused by IR injury. The naturally occurring pleiotropic peptide phoenixin 14 (PNX-14) has recently come to light as a potential treatment for IR injury. In the present study, we examined the effects of PNX-14 on several key processes involved in ischemic injury, such as pro-inflammatory cytokine expression, oxidative stress, and the related cascade mediated through the toll-like receptor 4 (TLR4) pathway, using BV2 microglia exposed to oxygen-glucose deprivation and reoxygenation (OGD/R). Our results demonstrate an acute ability of PNX-14 to regulate the expression levels of proinflammatory cytokines including tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6). PNX-14 also prevented oxidative stress by reducing the generation of reactive oxygen species (ROS) and increasing the level of the antioxidant glutathione (GSH). Importantly, PNX-14 inhibited high-mobility group box 1 (HMGB1)/TLR4/myeloid differentiation primary response 88 (MyD88)/nuclear factor-κB (NF-κB) signaling pathway, by inhibiting the activation of TLR4 and preventing the nuclear translocation of p65 protein. We further confirmed the cerebroprotective effects of PNX-14 in an MCAO rat model, which resulted in reduced infarct volume and decreased microglia activation. Together, the results of this study implicate a possible protective role of PNX-14 against various aspects of IR injury in vitro.","['Ischemia/reperfusion', 'Microglia', 'NF-κB', 'Oxidative stress', 'Phoenixin 14', 'Stroke', 'TLR4']",Archives of biochemistry and biophysics,2020-05-26,"[{'lastname': 'Ma', 'firstname': 'Hongling', 'initials': 'H', 'affiliation': ""Department of Neurology, Liaocheng People's Hospital of Shandong First Medical University, Liaocheng City, Shandong Province, 252000, China.""}, {'lastname': 'Su', 'firstname': 'Daoqing', 'initials': 'D', 'affiliation': ""Department of Neurosurgery, Liaocheng People's Hospital of Shandong First Medical University, Liaocheng City, Shandong Province, 252000, China.""}, {'lastname': 'Wang', 'firstname': 'Qingdong', 'initials': 'Q', 'affiliation': ""Department of Neurology, Liaocheng People's Hospital of Shandong First Medical University, Liaocheng City, Shandong Province, 252000, China.""}, {'lastname': 'Chong', 'firstname': 'Zonglei', 'initials': 'Z', 'affiliation': ""Department of Neurosurgery, Liaocheng People's Hospital of Shandong First Medical University, Liaocheng City, Shandong Province, 252000, China.""}, {'lastname': 'Zhu', 'firstname': 'Qiushi', 'initials': 'Q', 'affiliation': ""Department of Neurosurgery, Liaocheng People's Hospital of Shandong First Medical University, Liaocheng City, Shandong Province, 252000, China.""}, {'lastname': 'He', 'firstname': 'Weibin', 'initials': 'W', 'affiliation': 'Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan City, Hubei Province, 430060, China.'}, {'lastname': 'Wang', 'firstname': 'Wei', 'initials': 'W', 'affiliation': ""Department of Neurology, Liaocheng People's Hospital of Shandong First Medical University, Liaocheng City, Shandong Province, 252000, China. Electronic address: weiw2256@163.com.""}]",,,,Copyright © 2020 Elsevier Inc. All rights reserved.,10.1016/j.abb.2020.108411,<Element 'PubmedArticle' at 0x7f05debe7e50>
225,"32424053
1584421
8586967
8808786
26299391
25477883
7280692
21767382
22408626
14581618
28209639
15784530
20647006
15817702
30089221
9622633
22933588
11602590
19185320
8058721
21595047
23470532
22985767
26747000
23138980
29760681
25253853
30291632
15702482
22497984
3541481
25076873
17440735
19013173
28575175
28860515
26464992
24713688
15116397
22561337
17348018
16122904
24501362
20887954
9087894
9894607
27706925
18614682
17875989
25074747
9634141
10632615
11784794
21999375
11245665
27196727
28171746
9681466
23619691
30962497",Inflammation Induced by Natural Neuronal Death and LPS Regulates Neural Progenitor Cell Proliferation in the Healthy Adult Brain.,"Inflammation is typically considered a negative response to injury or insult; however, recent advances demonstrate that inflammatory cells regulate development, plasticity, and homeostasis through anticytotoxic, progenerative responses. Here, we extend analyses of neuroinflammation to natural neurodegenerative and homeostatic states by exploiting seasonal plasticity in cytoarchitecture of the avian telencephalic song control nucleus, high vocal center [HVC (proper name)], in the songbird Gambel's white-crowned sparrow (","['apoptosis', 'neural plasticity', 'neural progenitor cell', 'neuroinflammation', 'sex steroids', 'songbird']",eNeuro,2020-05-20,"[{'lastname': 'Larson', 'firstname': 'Tracy A', 'initials': 'TA', 'affiliation': 'Department of Biology, University of Virginia, Charlottesville, Virginia 22904 larson.tracy@virginia.edu.\nDepartment of Biology, University of Washington, Seattle, Washington 98195-1800.'}, {'lastname': 'Tokareva', 'firstname': 'Yekaterina', 'initials': 'Y', 'affiliation': 'Department of Biology, University of Washington, Seattle, Washington 98195-1800.'}, {'lastname': 'Cole', 'firstname': 'Marianne Meritt', 'initials': 'MM', 'affiliation': 'Department of Psychology, University of Washington, Seattle, Washington 98195-1525.'}, {'lastname': 'Brenowitz', 'firstname': 'Eliot A', 'initials': 'EA', 'affiliation': 'Department of Biology, University of Washington, Seattle, Washington 98195-1800.\nDepartment of Psychology, University of Washington, Seattle, Washington 98195-1525.'}]",,,,Copyright © 2020 Larson et al.,"10.1523/ENEURO.0023-20.2020
10.1016/0306-4522(92)90347-5
10.1002/neu.480280108
10.1016/0197-0186(95)00141-7
10.1016/j.nbd.2015.08.013
10.3389/fimmu.2014.00594
10.1126/science.7280692
10.1186/1742-2094-8-81
10.3389/fphar.2012.00041
10.1073/pnas.2234031100
10.1126/science.aal2745
10.1128/IAI.73.4.1907-1916.2005
10.1016/j.brainres.2010.07.032
10.1189/jlb.0804477
10.1146/annurev-cellbio-100616-060509
10.1016/s0006-8993(98)00227-3
10.1161/STROKEAHA.112.659656
10.1074/jbc.M106639200
10.1016/j.jns.2008.12.025
10.1073/pnas.91.17.7844
10.1002/dneu.20918
10.1038/cddis.2013.54
10.1016/j.bbi.2012.09.003
10.1126/science.1228773
10.3389/fendo.2018.00205
10.1523/JNEUROSCI.3316-13.2014
10.1002/cne.24552
10.1002/glia.20164
10.1016/j.psyneuen.2012.02.018
10.1007/BF00688060
10.3389/fncel.2014.00180
10.1007/s00359-007-0222-1
10.1016/j.yhbeh.2008.10.006
10.1210/en.2017-00346
10.1038/s41598-017-10573-x
10.1523/ENEURO.0036-15.2015
10.1038/nrn3722
10.1002/cne.20118
10.1016/j.yhbeh.2012.04.007
10.1002/cne.21296
10.1016/j.jchemneu.2005.07.003
10.1523/JNEUROSCI.1619-13.2014
10.1016/j.stem.2010.08.014
10.1002/(SICI)1097-4695(199704)32:4<426::AID-NEU6>3.0.CO;2-8
10.1038/sj.cdd.4400449
10.1002/dneu.22457
10.1523/JNEUROSCI.0663-08.2008
10.1073/pnas.0707239104
10.1038/jcbfm.2014.130
10.1002/(SICI)1096-9861(19980629)396:2<186::AID-CNE4>3.0.CO;2-X
10.1523/JNEUROSCI.20-02-00854.2000
10.1186/1742-2094-8-140
10.1210/er.2016-1007
10.1016/j.devcel.2017.01.001
10.1046/j.1471-4159.1998.71020749.x
10.1038/nature12034
10.1038/s41598-019-42286-8",<Element 'PubmedArticle' at 0x7f05debd50e0>
226,32422516,PPARγ-mediated microglial activation phenotype is involved in depressive-like behaviors and neuroinflammation in stressed C57BL/6J and ob/ob mice.,"There is an increased risk for obese patients with chronic low-grade inflammation to develop depression. Stress induces microglial activation and neuroinflammation that play crucial roles in the pathogenesis of depression. Peroxisome proliferator-activated receptor gamma (PPARγ), a nuclear transcription factor, regulates microglial polarization and neuroinflammation. Our study aimed to investigate the role of PPARγ in the development of depressive symptoms and neuroinflammation induced by chronic unpredictable mild stress (CUMS) in wild-type/C57BL/6J (wt) and leptin-deficient (ob/ob) mice.
CUMS was used to build a depression model with wt and ob/ob mice. Depressive-like behaviors were evaluated by sucrose preference test, open field test, tail suspension test, and Morris water maze test. Cytokines, the activated microglial state, and nuclear factor-κB (NF-κB) and PPARγ expression in the prefrontal cortex (PFC) and hippocampus (HIP) were examined by enzyme-linked immunosorbent assay (ELISA), immunofluorescence, and western blotting. Additionally, pioglitazone, an agonist of PPARγ, was used as a treatment intervention.
After CUMS, ob/ob mice exhibited severe behavioral disorders and spatial memory impairment, and higher levels of pro-inflammatory cytokines, M1/M2 ratios, and NF-κB activation, as well as lower levels of anti-inflammatory cytokines and PPARγ expression in the PFC and HIP compared to wt mice. Administration of pioglitazone relieved these alterations in wt and ob/ob mice.
CUMS was able to induce severe depressive-like behaviors, neuroinflammation, and reduced expression of PPARγ in ob/ob mice as compared to wt mice. This suggests that PPARγ mediates the microglial activation phenotype, which might be related to the susceptibility of stressed ob/ob mice to develop depressive disorder.","['Cytokine', 'Depression', 'Microglia', 'Neuroinflammation', 'Obesity', 'PPARγ']",Psychoneuroendocrinology,2020-05-19,"[{'lastname': 'Qin', 'firstname': 'Xiaqing', 'initials': 'X', 'affiliation': 'Department of Medical Psychology and Ethics, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.'}, {'lastname': 'Wang', 'firstname': 'Wei', 'initials': 'W', 'affiliation': 'Department of Medical Psychology and Ethics, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.'}, {'lastname': 'Wu', 'firstname': 'Huiran', 'initials': 'H', 'affiliation': 'Department of Medical Psychology and Ethics, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.'}, {'lastname': 'Liu', 'firstname': 'Dexiang', 'initials': 'D', 'affiliation': 'Department of Medical Psychology and Ethics, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.'}, {'lastname': 'Wang', 'firstname': 'Rui', 'initials': 'R', 'affiliation': 'Department of Medical Psychology and Ethics, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.'}, {'lastname': 'Xu', 'firstname': 'Jingjing', 'initials': 'J', 'affiliation': 'Department of Medical Psychology and Ethics, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.'}, {'lastname': 'Jiang', 'firstname': 'Hong', 'initials': 'H', 'affiliation': 'Department of Medical Psychology and Ethics, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.'}, {'lastname': 'Pan', 'firstname': 'Fang', 'initials': 'F', 'affiliation': 'Department of Medical Psychology and Ethics, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China. Electronic address: panfang@sdu.edu.cn.'}]",,,"After CUMS, ob/ob mice exhibited severe behavioral disorders and spatial memory impairment, and higher levels of pro-inflammatory cytokines, M1/M2 ratios, and NF-κB activation, as well as lower levels of anti-inflammatory cytokines and PPARγ expression in the PFC and HIP compared to wt mice. Administration of pioglitazone relieved these alterations in wt and ob/ob mice.",Copyright © 2020 Elsevier Ltd. All rights reserved.,10.1016/j.psyneuen.2020.104674,<Element 'PubmedArticle' at 0x7f05df06ff40>
227,32420752,Acupuncture for Pain Management: Molecular Mechanisms of Action.,"Acupuncture reduces pain by activating specific areas called acupoints on the patient's body. When these acupoints are fully activated, sensations of soreness, numbness, fullness, or heaviness called De qi or Te qi are felt by clinicians and patients. There are two kinds of acupuncture, manual acupuncture and electroacupuncture (EA). Compared with non-acupoints, acupoints are easily activated on the basis of their special composition of blood vessels, mast cells, and nerve fibers that mediate the acupuncture signals. In the spinal cord, EA can inhibit glial cell activation by down-regulating the chemokine CX3CL1 and increasing the anti-inflammatory cytokine interleukin-10. This inhibits P38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways, which are associated with microglial activation of the C-Jun N-terminal kinase signaling pathway and subsequent astrocyte activation. The inactivation of spinal microglia and astrocytes mediates the immediate and long-term analgesic effects of EA, respectively. A variety of pain-related substances released by glial cells such as the proinflammatory cytokines tumor necrosis factor [Formula: see text], interleukin-1[Formula: see text], interleukin-6, and prostaglandins such as prostaglandins E2 can also be reduced. The descending pain modulation system in the brain, including the anterior cingulated cortex, the periaqueductal gray, and the rostral ventromedial medulla, plays an important role in EA analgesia. Multiple transmitters and modulators, including endogenous opioids, cholecystokinin octapeptide, 5-hydroxytryptamine, glutamate, noradrenalin, dopamine, [Formula: see text]-aminobutyric acid, acetylcholine, and orexin A, are involved in acupuncture analgesia. Finally, the ""Acupuncture [Formula: see text]"" strategy is introduced to help clinicians achieve better analgesic effects, and a newly reported acupuncture method called acupoint catgut embedding, which injects sutures made of absorbable materials at acupoints to achieve long-term effects, is discussed.","['Electroacupuncture', 'Glial Cells', 'Manual Acupuncture', 'Pain Modulation', 'Review']",The American journal of Chinese medicine,2020-05-19,"[{'lastname': 'Chen', 'firstname': 'Teng', 'initials': 'T', 'affiliation': 'Department of Integrative Medicine and Neurobiology, Institutes of Integrative Medicine School of Basic Medical Sciences, Institutes of Brain Science, Brain Science Collaborative Innovation Center, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Fudan University Shanghai, P. R. China.'}, {'lastname': 'Zhang', 'firstname': 'Wen Wen', 'initials': 'WW', 'affiliation': 'Department of Integrative Medicine and Neurobiology, Institutes of Integrative Medicine School of Basic Medical Sciences, Institutes of Brain Science, Brain Science Collaborative Innovation Center, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Fudan University Shanghai, P. R. China.'}, {'lastname': 'Chu', 'firstname': 'Yu-Xia', 'initials': 'YX', 'affiliation': 'Department of Integrative Medicine and Neurobiology, Institutes of Integrative Medicine School of Basic Medical Sciences, Institutes of Brain Science, Brain Science Collaborative Innovation Center, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Fudan University Shanghai, P. R. China.'}, {'lastname': 'Wang', 'firstname': 'Yan-Qing', 'initials': 'YQ', 'affiliation': 'Department of Integrative Medicine and Neurobiology, Institutes of Integrative Medicine School of Basic Medical Sciences, Institutes of Brain Science, Brain Science Collaborative Innovation Center, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Fudan University Shanghai, P. R. China.'}]",,,,,10.1142/S0192415X20500408,<Element 'PubmedArticle' at 0x7f05df058310>
228,32417342,"Melatonin Reverses the Depression-associated Behaviour and Regulates Microglia, Fractalkine Expression and Neurogenesis in Adult Mice Exposed to Chronic Mild Stress.","Depression may be precipitated by the negative impact of chronic stress, which is considered to play a key role in this neuropsychiatric disorder. Interestingly, depressed patients show decreased levels of melatonin. This hormone acts pro-neurogenic and exhibits anti-depressant effects in rodent models of predictive antidepressant-like effects. However, the benefits of melatonin in reversing the deleterious effects of chronic mild stress on the alterations in behaviour and in the neurogenic niche of the hippocampus in male BALB/c mice are unknown. In this study, we compared the effects of melatonin (2.5 mg/kg) and citalopram (5 mg/kg), an antidepressant drug belonging to the selective serotonin reuptake inhibitors, in male BALB/c mice exposed to chronic mild stress (CMS). We also investigated the potential effects of melatonin and citalopram on microglial cells, hippocampal neurogenesis and peripheral cytokine profiles. Melatonin and citalopram induced similar antidepressant-like activities that occurred with some of the the following findings: (1) reversal of the morphological alterations in microglia; (2) reversal of the decreased immunoreactivity to CX3CL1 and CX3CR1 in the dentate gyrus; (3) positive regulation of cell proliferation, survival and complexity of the dendritic trees of doublecortin-cells; and (4) modifications of peripheral CX3CL1 expression. This outcome is consistent with the hypothesis about the antidepressant-like effect of melatonin and supports its relevance as a modulator of the niche in the dentate gyrus.","['chronic mild stress', 'citalopram', 'doublecortin', 'hippocampal neurogenesis', 'melatonin', 'microglia']",Neuroscience,2020-05-18,"[{'lastname': 'Vega-Rivera', 'firstname': 'Nelly Maritza', 'initials': 'NM', 'affiliation': 'Laboratorio de Neuropsicofarmacología, Dirección de Neurociencias, Instituto Nacional de Psiquiatría ""Ramón de la Fuente Muñiz"", Calz. México-Xochimilco 101, 14370 Ciudad de México, Mexico.'}, {'lastname': 'Ortiz-López', 'firstname': 'Leonardo', 'initials': 'L', 'affiliation': 'Laboratorio de Neurogénesis, Subdirección de Investigaciones Clínicas, Instituto Nacional de Psiquiatría ""Ramón de la Fuente Muñiz"", Calzada México-Xochimilco 101, 14370 Ciudad de México, Mexico.'}, {'lastname': 'Granados-Juárez', 'firstname': 'Andrea', 'initials': 'A', 'affiliation': 'Laboratorio de Neurogénesis, Subdirección de Investigaciones Clínicas, Instituto Nacional de Psiquiatría ""Ramón de la Fuente Muñiz"", Calzada México-Xochimilco 101, 14370 Ciudad de México, Mexico.'}, {'lastname': 'Estrada-Camarena', 'firstname': 'Erika Monserrat', 'initials': 'EM', 'affiliation': 'Laboratorio de Neuropsicofarmacología, Dirección de Neurociencias, Instituto Nacional de Psiquiatría ""Ramón de la Fuente Muñiz"", Calz. México-Xochimilco 101, 14370 Ciudad de México, Mexico.'}, {'lastname': 'Ramírez-Rodríguez', 'firstname': 'Gerardo Bernabé', 'initials': 'GB', 'affiliation': 'Laboratorio de Neurogénesis, Subdirección de Investigaciones Clínicas, Instituto Nacional de Psiquiatría ""Ramón de la Fuente Muñiz"", Calzada México-Xochimilco 101, 14370 Ciudad de México, Mexico. Electronic address: gbernabe@imp.edu.mx.'}]",,,,Copyright © 2020 IBRO. Published by Elsevier Ltd. All rights reserved.,10.1016/j.neuroscience.2020.05.014,<Element 'PubmedArticle' at 0x7f05df041c20>
229,32375205,Melatonin prevents neuroinflammation and relieves depression by attenuating autophagy impairment through FOXO3a regulation.,"Major depressive disorder (MDD) is a life-threatening illness characterized by mood changes and high rates of suicide. Although the role of neuroinflammation in MMD has been studied, the mechanistic interplay between antidepressants, neuroinflammation, and autophagy is yet to be investigated. The present study investigated the effect of melatonin on LPS-induced neuroinflammation, depression, and autophagy impairment. Our results showed that in mice, lipopolysaccharide (LPS) treatment induced depressive-like behaviors and caused autophagy impairment by dysregulating ATG genes. Moreover, LPS treatment significantly increased the levels of cytokines (TNFα, IL-1β, IL-6), enhanced NF-ᴋB phosphorylation, caused glial (astrocytes and microglia) cell activation, dysregulated FOXO3a expression, increased the levels of redox signaling molecules such as ROS/TBARs, and altered expression of Nrf2, SOD2, and HO-1. Melatonin treatment significantly abolished the effects of LPS, as demonstrated by improved depressive-like behaviors, normalized autophagy-related gene expression, and reduced levels of cytokines. Further, we investigated the role of autophagy in LPS-induced depressive-like behavior and neuroinflammation using autophagy inhibitors 3-MA and Ly294002. Interestingly, inhibitor treatment significantly abolished and reversed the anti-depressive, pro-autophagy, and anti-inflammatory effects of melatonin. The present study concludes that the anti-depressive effects of melatonin in LPS-induced depression might be mediated via autophagy modulation through FOXO3a signaling.","['anti-depressive Agents', 'autophagy', 'depression', 'inflammation', 'lipopolysaccharides', 'melatonin']",Journal of pineal research,2020-05-07,"[{'lastname': 'Ali', 'firstname': 'Tahir', 'initials': 'T', 'affiliation': 'State Key Laboratory of Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China.'}, {'lastname': 'Rahman', 'firstname': 'Shafiq Ur', 'initials': 'SU', 'affiliation': 'State Key Laboratory of Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China.\nDepartment of Pharmacy, Shaheed Benazir Bhutto University, Sheringal Dir, Pakistan.'}, {'lastname': 'Hao', 'firstname': 'Qiang', 'initials': 'Q', 'affiliation': 'State Key Laboratory of Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China.'}, {'lastname': 'Li', 'firstname': 'Weifen', 'initials': 'W', 'affiliation': 'State Key Laboratory of Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China.'}, {'lastname': 'Liu', 'firstname': 'Zizhen', 'initials': 'Z', 'affiliation': 'State Key Laboratory of Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China.'}, {'lastname': 'Ali Shah', 'firstname': 'Fawad', 'initials': 'F', 'affiliation': 'State Key Laboratory of Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China.\nRiphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad., Islamabad, Pakistan.'}, {'lastname': 'Murtaza', 'firstname': 'Iram', 'initials': 'I', 'affiliation': 'Signal Transduction Lab, Department of Biochemistry, Faculty of Biological Sciences, Quaid-I-Azam University, Islamabad, Pakistan.'}, {'lastname': 'Zhang', 'firstname': 'Zaijun', 'initials': 'Z', 'affiliation': 'International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), Jinan University College of Pharmacy, Guangzhou, China.'}, {'lastname': 'Yang', 'firstname': 'Xifei', 'initials': 'X', 'affiliation': 'Key Laboratory of Modern Toxicology of Shenzhen, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.'}, {'lastname': 'Liu', 'firstname': 'Gongping', 'initials': 'G', 'affiliation': 'Department of Pathophysiology, School of Basic Medicine and the Collaborative Innovation Center for Brain Science, Key Laboratory of Ministry of Education of China and Hubei Province for Neurological Disorders, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.\nCo-innovation Center of Neuroregeneration, Nantong University, Nantong, China.'}, {'lastname': 'Li', 'firstname': 'Shupeng', 'initials': 'S', 'affiliation': 'State Key Laboratory of Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China.\nDepartment of Psychiatry, University of Toronto, Toronto, ON, Canada.'}]",,,,© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.,10.1111/jpi.12667,<Element 'PubmedArticle' at 0x7f05df06a680>
230,"32370224
11214935
15980141
17561271
20444991
12783912
17980667
8337941
16903141
16281905
7904883
8101989
12511861
24274755
20029438
30724769
27540165
7539162
22735515
23526370
27046083
28455699
24962261
8208340
8705276
8790403
9168844
11024157
14736847
23392676
27616557
16287689
22821398
24931403
25635871
26857744
29642165
30650564
26655603
28300322
31689427
26992135
17965659
18066056
27185853
29769333
18286612
21458888
28714865
89602
6686005
12621436
9920279
27052459
15313429
31771051
16943563
4209742
18198391
19589092
17555867
26298620
1301388
19139829
19840546
22265268
17657667
9626555
9528963
24184413
29891009
15452406
21072600
14568361
25724812
21245284
27880767
10858586
25125026
31520182
8760445
2125393
19187059
26108478
25220544
28502648
12045736
20967131
28752628
31915845
27445981
19302036
23252647
25257319
15954124
8745240
25136317
26470014
26990767
28690540
19765548
21633390
28636962
28099414
28476157
27654300
28838664
12270689
19679126
15465279
19066177
821790
6813384
18223273
14729865",Assessment of Glial Activation Response in the Progress of Natural Scrapie after Chronic Dexamethasone Treatment.,"Neuroinflammation has been correlated with the progress of neurodegeneration in many neuropathologies. Although glial cells have traditionally been considered to be protective, the concept of them as neurotoxic cells has recently emerged. Thus, a major unsolved question is the exact role of astroglia and microglia in neurodegenerative disorders. On the other hand, it is well known that glucocorticoids are the first choice to regulate inflammation and, consequently, neuroglial inflammatory activity. The objective of this study was to determine how chronic dexamethasone treatment influences the host immune response and to characterize the beneficial or detrimental role of glial cells. To date, this has not been examined using a natural neurodegenerative model of scrapie. With this aim, immunohistochemical expression of glial markers, prion protein accumulation, histopathological lesions and clinical evolution were compared with those in a control group. The results demonstrated how the complex interaction between glial populations failed to compensate for brain damage in natural conditions, emphasizing the need for using natural models. Additionally, the data showed that modulation of neuroinflammation by anti-inflammatory drugs might become a research focus as a potential therapeutic target for prion diseases, similar to that considered previously for other neurodegenerative disorders classified as prion-like diseases.","['astrocytes', 'dexamethasone', 'microglia', 'neuroinflammation', 'prion diseases', 'scrapie']",International journal of molecular sciences,2020-05-07,"[{'lastname': 'Guijarro', 'firstname': 'Isabel M', 'initials': 'IM', 'affiliation': 'Research Centre for Encephalopathies and Transmissible Emerging Diseases-Institute for Health Research Aragón (IIS), University of Zaragoza, C/Miguel Servet 155, 50013 Zaragoza, Spain.'}, {'lastname': 'Garcés', 'firstname': 'Moisés', 'initials': 'M', 'affiliation': 'Research Centre for Encephalopathies and Transmissible Emerging Diseases-Institute for Health Research Aragón (IIS), University of Zaragoza, C/Miguel Servet 155, 50013 Zaragoza, Spain.'}, {'lastname': 'Andrés-Benito', 'firstname': 'Pol', 'initials': 'P', 'affiliation': ""Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.""}, {'lastname': 'Marín', 'firstname': 'Belén', 'initials': 'B', 'affiliation': 'Research Centre for Encephalopathies and Transmissible Emerging Diseases-Institute for Health Research Aragón (IIS), University of Zaragoza, C/Miguel Servet 155, 50013 Zaragoza, Spain.'}, {'lastname': 'Otero', 'firstname': 'Alicia', 'initials': 'A', 'affiliation': 'Research Centre for Encephalopathies and Transmissible Emerging Diseases-Institute for Health Research Aragón (IIS), University of Zaragoza, C/Miguel Servet 155, 50013 Zaragoza, Spain.'}, {'lastname': 'Barrio', 'firstname': 'Tomás', 'initials': 'T', 'affiliation': 'Research Centre for Encephalopathies and Transmissible Emerging Diseases-Institute for Health Research Aragón (IIS), University of Zaragoza, C/Miguel Servet 155, 50013 Zaragoza, Spain.'}, {'lastname': 'Carmona', 'firstname': 'Margarita', 'initials': 'M', 'affiliation': ""Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.""}, {'lastname': 'Ferrer', 'firstname': 'Isidro', 'initials': 'I', 'affiliation': ""Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.""}, {'lastname': 'Badiola', 'firstname': 'Juan J', 'initials': 'JJ', 'affiliation': 'Research Centre for Encephalopathies and Transmissible Emerging Diseases-Institute for Health Research Aragón (IIS), University of Zaragoza, C/Miguel Servet 155, 50013 Zaragoza, Spain.'}, {'lastname': 'Monzón', 'firstname': 'Marta', 'initials': 'M', 'affiliation': 'Research Centre for Encephalopathies and Transmissible Emerging Diseases-Institute for Health Research Aragón (IIS), University of Zaragoza, C/Miguel Servet 155, 50013 Zaragoza, Spain.'}]",,,,,"10.3390/ijms21093231
10.1136/vr.156.26.846-b
10.1016/j.jneuroim.2007.05.006
10.1099/vir.0.021311-0
10.1001/jama.289.21.2819
10.1016/S1474-4422(07)70270-3
10.1007/BF00334672
10.1111/j.1365-2990.2005.00697.x
10.1097/00019052-199312000-00008
10.1073/pnas.90.14.6449
10.1038/nrn1007
10.1146/annurev-genet-110711-155524
10.1038/nrn2786
10.1097/WCO.0000000000000672
10.1126/science.aag2590
10.1620/tjem.174.295
10.1038/nn.3120
10.1007/s12031-013-0002-z
10.1371/journal.ppat.1005551
10.1007/s12035-017-0522-6
10.1038/nri3705
10.1111/j.1365-2990.1994.tb00956.x
10.1073/pnas.93.18.9754
10.1006/exnr.1997.6424
10.1128/JVI.74.21.10245-10248.2000
10.1523/JNEUROSCI.4303-03.2004
10.1523/JNEUROSCI.4440-12.2013
10.1016/j.it.2016.08.001
10.1080/13550280500187583
10.1007/s00441-012-1461-1
10.1007/s00441-014-1928-3
10.1371/journal.pone.0115351
10.1038/srep20762
10.1097/MD.0000000000010320
10.3390/v11010065
10.1016/j.bbadis.2015.11.014
10.1002/glia.23136
10.1016/j.mad.2019.111176
10.1002/glia.22963
10.1038/nn1997
10.1038/nn2028
10.1084/jem.20151000
10.1128/JVI.00549-18
10.1002/glia.20644
10.1016/j.neurobiolaging.2011.02.011
10.1172/JCI90605
10.1016/S0140-6736(79)91654-4
10.1007/BF01310854
10.1038/nature01457
10.1016/S0006-2952(98)00214-7
10.1007/s00204-016-1702-2
10.1016/j.intimp.2004.05.006
10.3233/JAD-190444
10.1523/JNEUROSCI.2797-06.2006
10.1038/249855a0
10.1099/vir.0.83281-0
10.1517/13543780903066780
10.1016/j.mce.2007.03.007
10.18632/aging.100797
10.1016/0303-7207(92)90091-J
10.1007/s10787-008-8046-3
10.1016/j.neuron.2009.09.032
10.1016/j.berh.2011.11.002
10.1080/03009740701340263
10.1210/er.19.3.269
10.1210/endo.139.4.5917
10.1016/j.physbeh.2013.10.035
10.1186/s40425-018-0371-5
10.1159/000080213
10.1007/s10787-010-0056-2
10.1016/S0301-0082(03)00114-X
10.1007/s00418-015-1314-6
10.1177/0300985810395784
10.1371/journal.pbio.1002579
10.1016/S0197-4580(00)00124-X
10.1177/1073858414547132
10.1007/s00424-019-02310-2
10.1099/0022-1317-77-8-1935
10.1007/BF01625735
10.1111/j.1365-2990.2008.00979.x
10.1186/s40478-015-0214-2
10.1002/glia.22751
10.1016/j.brainresbull.2017.05.003
10.1097/00019052-200206000-00020
10.1042/AN20100024
10.1111/cei.13018
10.1007/s00210-019-01775-3
10.3389/fendo.2016.00078
10.1146/annurev.immunol.021908.132528
10.1111/nan.12011
10.1186/s40478-014-0142-6
10.1002/jnr.20562
10.1111/j.1365-2990.1995.tb01097.x
10.3389/fnagi.2014.00198
10.1002/glia.22930
10.1111/jnc.13607
10.3389/fnagi.2017.00207
10.1016/j.bcp.2009.09.014
10.1038/cddis.2011.50
10.1016/j.immuni.2017.06.006
10.1038/nature21029
10.1186/s12974-017-0871-0
10.1128/JVI.01592-16
10.1006/nbdi.2002.0487
10.1016/j.expneurol.2009.07.032
10.1016/j.ijdevneu.2004.07.017
10.1136/ard.2008.100008
10.1093/infdis/146.5.657
10.1136/vr.162.4.130-c
10.1177/002215540405200201",<Element 'PubmedArticle' at 0x7f05dcc8a8b0>
231,"32370112
18865105
22896675
23635358
26431936
24861635
29916142
29896429
25752446
27230456
24144733
28179807
26343475
23406909
26839463
27870435
8122913
14432658
4399057
18195084
21068160
19028515
29307297
28642689
10880816
16255008
3975621
23407936
30827729
20966214
29881376
26441990
26134003
25193935
10567732
10433904
17043238
27196727
21778362
28931944
8193937
17965659
15831717
24860431
23100431
24871624
28618077
22182318
30184509
31743527
29139169
28341582
29924994
30481522
12426043
27102938
2089275
29239126
17357150
29275859
28620294
29096243
22497984
28219988
26246072
24434477
27197831
29426702
23994069
26037411
15111734
24623176
29801024
9343467
26441134
29194444
22837036
28270169
26120961
26472019
19056393
8552246
18853427
27145006
12480129
9952422
30962951
28888963
31992325
11872940
22450870
25373903
27717807
18258827
32058038
21745355
19682425
28848398
30108586
15042586
10221782
27634048
21527731
15895084
29439605
24761998
23999718
23711349
16049180
20681951
17299767
31831638
17351623
21209080
24047524
17410128
26099306
18951638
19443728
16732273
9724801
10805752
12125082
25426022
15993821
24175290
19302484
15728241
24990881
28442216
26941262
23238794
25663667
21435432
29526689
4945394
27092050
11283751
10322493
23307741
29712572
24270812
29316776
17960134
20584912
25680832
26403789
14993061
21208471
25380660
20012068
32044129
28099414
19782411
25668562
20946934
29717413
29728852
24462092
29269757
24733756
27983926
20427645
28607171
18614693
31105589
14999065
18567623
14559357
23348042
14634144
22435710
11040417
29755342
20392807
22396398
22981653
27530684
19505496
30386297
10077336
11136970
11295570
27789681
26303083
21907136
28980042
30635056
24730418
29259445
21680538
12209854
11850023
30570746
11245665
15896872
29158945
24447465
23804112
20404154
23429294
8084376
22645130
29114202
11014219
18286612
23401502
15798185
20351193
11149664
15256495
27127723
31435854
18522863
29311911
21564348
9890493
28974386
25423896
18829137
22581460
17462607
28041951
10973303
18460549
19533603
24999330
24722370
24637260
25305410
20169039
17186017
19447561
1893376
15528115
10564741
15337241
11384882
15337246
12207627
17113982
9106616
29582398
25086299
27250720
28948468",Microglial and Astrocytic Function in Physiological and Pathological Conditions: Estrogenic Modulation.,"There are sexual differences in the onset, prevalence, and outcome of numerous neurological diseases. Thus, in Alzheimer's disease, multiple sclerosis, and major depression disorder, the incidence in women is higher than in men. In contrast, men are more likely to present other pathologies, such as amyotrophic lateral sclerosis, Parkinson's disease, and autism spectrum. Although the neurological contribution to these diseases has classically always been studied, the truth is that neurons are not the only cells to be affected, and there are other cells, such as glial cells, that are also involved and could be key to understanding the development of these pathologies. Sexual differences exist not only in pathology but also in physiological processes, which shows how cells are differentially regulated in males and females. One of the reasons these sexual differences may occur could be due to the different action of sex hormones. Many studies have shown an increase in aromatase levels in the brain, which could indicate the main role of estrogens in modulating proinflammatory processes. This review will highlight data about sex differences in glial physiology and how estrogenic compounds, such as estradiol and tibolone, could be used as treatment in neurological diseases due to their anti-inflammatory effects and the ability to modulate glial cell functions.","['brain injury', 'estradiol', 'glial cells', 'neuroinflammation', 'phagocytosis', 'sex differences', 'tibolone']",International journal of molecular sciences,2020-05-07,"[{'lastname': 'Crespo-Castrillo', 'firstname': 'Andrea', 'initials': 'A', 'affiliation': 'Instituto Cajal, Consejo Superior de Investigaciones Científicas (CSIC), Avenida Doctor Arce, 37, 28002 Madrid, Spain.'}, {'lastname': 'Arevalo', 'firstname': 'Maria-Angeles', 'initials': 'MA', 'affiliation': 'Instituto Cajal, Consejo Superior de Investigaciones Científicas (CSIC), Avenida Doctor Arce, 37, 28002 Madrid, Spain.\nCentro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludables (CIBERFES), Instituto de Salud Carlos III, 28029 Madrid, Spain.'}]",,,,,"10.3390/ijms21093219
10.1126/scitranslmed.3003748
10.1186/1479-5876-11-107
10.1016/j.it.2015.08.006
10.1111/jnc.12755
10.1007/s12035-018-1183-9
10.14336/AD.2017.0926
10.1111/bph.13125
10.5213/inj.1632604.302
10.1016/j.neures.2013.10.004
10.1016/j.comppsych.2015.07.002
10.1097/WCO.0b013e32835ee548
10.1155/2015/676531
10.1002/jnr.23884
10.1146/annurev.ge.27.120193.000443
10.1210/endo-65-3-369
10.1098/rstb.1970.0052
10.1152/physrev.00010.2007
10.1210/en.2010-0607
10.1016/j.yfrne.2008.11.001
10.1177/1352458517737394
10.3389/fnsys.2017.00042
10.1016/S0149-7634(00)00018-X
10.1002/cne.20784
10.1126/science.3975621
10.1523/JNEUROSCI.1268-12.2013
10.1016/j.neuron.2019.02.006
10.1126/science.1194637
10.3389/fimmu.2018.01014
10.3389/fimmu.2015.00486
10.1101/cshperspect.a020537
10.4049/jimmunol.1400716
10.1016/S0165-3806(99)00113-3
10.1073/pnas.0607423103
10.1210/er.2016-1007
10.1126/science.1202529
10.1038/nrn.2017.110
10.1016/0361-9230(94)90189-9
10.1038/nn1997
10.1126/science.1110647
10.3389/fncel.2014.00129
10.1523/JNEUROSCI.1167-12.2012
10.1177/1073858414536468
10.1002/glia.23176
10.1111/j.1471-4159.2011.07630.x
10.1016/j.celrep.2018.08.001
10.1002/glia.23753
10.1002/glia.23263
10.1016/j.bbi.2017.03.010
10.1016/j.celrep.2018.05.048
10.20517/2347-8659.2019.31
10.1016/j.yfrne.2018.11.003
10.1016/S0006-8993(02)03475-3
10.1016/j.ygcen.2016.04.018
10.1016/0306-4522(90)90229-W
10.1002/dneu.22568
10.1002/glia.20500
10.1016/j.cell.2017.11.042
10.3389/fnsyn.2017.00010
10.1016/j.conb.2017.10.007
10.1016/j.psyneuen.2012.02.018
10.1523/JNEUROSCI.2906-16.2017
10.1007/s11011-015-9714-9
10.1016/j.expneurol.2014.01.003
10.1111/jnc.13590
10.1016/j.immuni.2018.01.011
10.1016/j.expneurol.2013.08.011
10.1002/glia.22867
10.1093/ilar.45.2.147
10.1002/ana.24135
10.1001/jamaneurol.2018.0821
10.1001/jama.1997.03550160069041
10.1016/j.bbi.2015.10.003
10.1371/journal.pone.0187631
10.1038/nn.3155
10.1186/s13041-017-0289-8
10.1038/nn.4053
10.1016/j.bbi.2015.10.006
10.1016/j.yhbeh.2008.10.016
10.1016/0306-4522(95)00250-M
10.1002/cne.21859
10.1210/en.2015-2012
10.1016/S0165-3806(02)00541-2
10.1523/JNEUROSCI.19-04-01464.1999
10.1038/s41420-019-0166-6
10.1016/j.neuint.2017.09.003
10.1186/s12974-020-1719-6
10.1159/000048726
10.1007/s10571-012-9829-z
10.1016/j.celrep.2014.09.025
10.1016/j.neuroscience.2016.09.047
10.1161/STROKEAHA.107.501460
10.1016/j.bbi.2020.02.001
10.1186/2042-6410-2-7
10.1016/j.yhbeh.2009.02.012
10.3389/fncel.2017.00235
10.3389/fimmu.2018.01753
10.1002/glia.10362
10.1016/S0301-0082(98)00069-0
10.1002/glia.23046
10.1152/physrev.00011.2010
10.1038/nn1472
10.1089/neu.2017.5530
10.1186/1742-2094-11-82
10.6091/ibj.1213.2013
10.1016/j.jneuroim.2013.04.008
10.1523/JNEUROSCI.5171-04.2005
10.1111/j.1471-4159.2010.06937.x
10.1002/glia.20489
10.1126/science.aax6752
10.1038/nm1555
10.1074/jbc.M110.169342
10.2174/18715273113126660173
10.1038/nature05704
10.1007/s12035-015-9282-3
10.1016/j.jneuroim.2008.09.010
10.1167/iovs.08-3357
10.1038/nn1715
10.1073/pnas.95.18.10896
10.1128/MCB.20.11.4106-4114.2000
10.1002/jnr.10304
10.3389/fncel.2014.00360
10.1016/j.jpain.2005.02.001
10.1155/2013/480702
10.1111/j.1471-4159.2009.06042.x
10.1084/jem.20041611
10.1126/scitranslmed.3009093
10.1016/j.molmed.2017.03.008
10.15252/emmm.201506123
10.1007/s11481-012-9427-3
10.1101/cshperspect.a020370
10.1016/j.ajpath.2010.12.051
10.1016/j.neuroscience.2018.02.048
10.1002/cne.901430405
10.3389/fnins.2016.00149
10.1038/35067582
10.1016/S0166-2236(98)01349-6
10.1126/science.1226740
10.1186/s13064-018-0104-y
10.1038/nature12776
10.4062/biomolther.2017.133
10.1038/nature06329
10.1083/jcb.201004096
10.1101/cshperspect.a020396
10.1007/s00018-015-2050-8
10.1196/annals.1286.027
10.1186/2042-6410-1-7
10.1101/cshperspect.a020420
10.1007/s00401-009-0619-8
10.1016/j.tins.2020.01.003
10.1038/nature21029
10.1016/j.tins.2009.08.002
10.1097/NEN.0000000000000165
10.1016/j.pneurobio.2010.09.005
10.1007/s13311-018-0631-6
10.1007/s13311-018-0630-7
10.1016/j.neuron.2013.12.034
10.1038/s41593-017-0033-9
10.1002/glia.22675
10.3727/096368916X693824
10.1523/JNEUROSCI.0137-10.2010
10.1523/JNEUROSCI.3351-16.2017
10.1523/JNEUROSCI.1709-08.2008
10.3389/fphys.2019.00486
10.1523/JNEUROSCI.3547-03.2004
10.1093/brain/awn109
10.1016/S0169-328X(03)00339-5
10.1016/j.molmed.2012.12.007
10.4049/jimmunol.171.11.6267
10.1089/neu.2011.2274
10.1016/S0301-0082(00)00025-3
10.3389/fnagi.2018.00124
10.1124/pr.109.002071
10.1523/JNEUROSCI.5372-11.2012
10.1016/j.yfrne.2012.08.004
10.5483/BMBRep.2016.49.9.141
10.1016/j.yfrne.2009.05.006
10.3389/fendo.2018.00610
10.1016/S0306-4522(98)00340-6
10.1016/S0092-8674(00)00188-4
10.1016/S1043-2760(01)00377-0
10.1124/jpet.116.237412
10.1016/j.beem.2015.04.008
10.1016/j.cmet.2011.08.005
10.1007/978-3-319-56895-9_6
10.1186/s13293-019-0219-9
10.1111/jne.12152
10.1002/rmb2.12006
10.1210/er.2010-0016
10.1002/cne.10325
10.1016/S0047-6374(01)00406-7
10.1111/jnc.14648
10.1523/JNEUROSCI.21-06-01809.2001
10.1016/j.molbrainres.2004.10.043
10.1038/sigtrans.2017.23
10.1016/j.mce.2014.01.010
10.1523/JNEUROSCI.0886-13.2013
10.1073/pnas.0910627107
10.1038/cddis.2013.30
10.1159/000126702
10.1074/jbc.M112.341867
10.3389/fnmol.2017.00330
10.1210/endo.141.10.7693
10.1002/glia.20644
10.1073/pnas.1300313110
10.1128/MCB.25.8.2957-2968.2005
10.4049/jimmunol.0903463
10.1097/00004647-200101000-00002
10.1210/en.2004-0619
10.1002/brb3.449
10.1007/s12311-019-01071-z
10.1016/j.yfrne.2008.04.001
10.3389/fnagi.2017.00430
10.1111/j.1365-2826.2011.02156.x
10.1097/00003072-199901000-00010
10.1016/j.yfrne.2017.09.002
10.1038/nrn3856
10.1016/j.neurobiolaging.2008.08.014
10.1210/en.2011-1859
10.1016/j.brainres.2007.03.082
10.1016/j.steroids.2016.12.011
10.1038/79637
10.1677/JOE-07-0294
10.1002/glia.20904
10.3389/fnagi.2014.00132
10.1371/journal.pone.0094320
10.1016/j.brainres.2014.03.002
10.1016/j.jsbmb.2014.10.002
10.2147/CIA.S6083
10.1038/nrc2048
10.1016/j.psyneuen.2009.04.012
10.1016/j.neuroimage.2004.07.036
10.1016/S0006-8993(99)02062-4
10.1016/j.maturitas.2004.02.013
10.1016/S0960-0760(01)00044-9
10.1016/j.maturitas.2004.02.012
10.1046/j.1365-2125.2002.01619.x
10.1016/j.jsbmb.2006.09.037
10.1124/mol.51.4.535
10.1007/s12035-018-1008-x
10.1016/j.jsbmb.2014.07.009
10.1016/j.mce.2016.05.024
10.1007/s12035-017-0777-y",<Element 'PubmedArticle' at 0x7f05dd5bb540>
232,32360190,Dexamethasone along with ciprofloxacin modulates S. aureus induced microglial inflammation via glucocorticoid (GC)-GC receptor-mediated pathway.,"Microglial inflammation is the hallmark of S. aureus induced brain abscesses. Conventional antibiotic therapy could not regulate inflammation and the use of steroids in CNS infection remained controversial. To address this issue the effect of dexamethasone along with ciprofloxacin on microglial inflammation has been attempted both in glucocorticoid receptor (GR) opened and blocked condition. We have investigated the effects of ciprofloxacin (0.24 μg/ml, pre-treatment) and dexamethasone (150 nM, pre-treatment) in combination with murine microglia infected with S. aureus for 30, 60 and 90 min by either keeping GR opened or blocked with GR antagonist RU486. Alterations in cellular motility, intracellular killing assay, free radical production, antioxidant enzyme activities, corticosterone, and cytokine levels were determined. The expressions of TLR-2, GR, and other inflammatory markers were determined in terms of this combinatorial treatment. Combination treatment significantly (p < 0.05) reduced the bacterial burden of microglia only when GR remained open and effectively suppressed S. aureus induced oxidative stress by augmenting SOD and catalase enzyme activity and suppressing other pro-inflammatory markers at 90 min. Arginase activity, a critical determinant of microglial polarization was found to be higher after treatment at 60 and 90 min. This situation was reversed when this combination treatment was applied by keeping GR blocked using GR antagonist RU486. Therefore, it can be concluded that combination treatment of ciprofloxacin and dexamethasone could regulate S. aureus induced microglial activation, in the presence of functional GR via utilizing glucocorticoid (GC)-GR pathway and ultimately confers protection to the host from brain inflammation.","['Ciprofloxacin', 'Dexamethasone', 'Glucocorticoid receptor (GR)', 'Microglial inflammation', 'S. aureus']",Microbial pathogenesis,2020-05-04,"[{'lastname': 'Dey', 'firstname': 'Rajen', 'initials': 'R', 'affiliation': 'Department of Physiology, Immunology Laboratory, University of Calcutta, University Colleges of Science and Technology, Calcutta, West Bengal, India.'}, {'lastname': 'Bishayi', 'firstname': 'Biswadev', 'initials': 'B', 'affiliation': 'Department of Physiology, Immunology Laboratory, University of Calcutta, University Colleges of Science and Technology, Calcutta, West Bengal, India. Electronic address: biswa_dev2@yahoo.com.'}]",,,,Copyright © 2020 Elsevier Ltd. All rights reserved.,10.1016/j.micpath.2020.104227,<Element 'PubmedArticle' at 0x7f05df678040>
233,"32340112
23993280
28418490
30496104
19351294
28848491
25060574
30692128
30496105
30954305
31333085
29065932
30254236
18296325
24757497
22492529
31212755
30275700
22293292
22133808
29218451
26140821
29671359
30843443
27431367
19238764
17066209
26005400
26086182
25681666
22349682
22012276
29738500
30326796
24440038
28532353
31013492
27304506
29936138
20723551
31539673
29299044
23168220
26758201
20186711
30568608
31671606
30359863
30206280
28852308
31315227
30561288
27793225
29902436
29754286
30747307
25415497
30292888
25078296
23222853
29134359
30023410
27148273
28343167
29797564
24065880
24690880
29483895
22794138
30468210
31694297
31914208
31241945
31861125
27417321
22401879
20408856
22674585
28691768
26786147
24655719
31379879
22814704
29438781
28523126
29950699
28419913
26228057
27421909
32053758",Diet and Mental Health: Review of the Recent Updates on Molecular Mechanisms.,"Over the last decades, there has been a substantial increase in the prevalence of mental health disorders, including an increased prevalence of depression, anxiety, cognitive, and sleep disorders. Diet and its bioactive components have been recognized among the modifiable risk factors, possibly influencing their pathogenesis. This review aimed to summarize molecular mechanisms underlying the putative beneficial effects toward brain health of different dietary factors, such as micro- and macronutrient intake and habits, such as feeding time and circadian rhythm. The role of hormonal homeostasis in the context of glucose metabolism and adiponectin regulation and its impact on systemic and neuro-inflammation has also been considered and deepened. In addition, the effect of individual bioactive molecules exerting antioxidant activities and acting as anti-inflammatory agents, such as omega-3 fatty acids and polyphenols, considered beneficial for the central nervous system via modulation of adult neurogenesis, synaptic and neuronal plasticity, and microglia activation has been summarized. An overview of the regulation of the gut-brain axis and its effect on the modulation of systemic inflammation and oxidative stress has been provided. Finally, the impact of bioactive molecules on inflammation and oxidative stress and its association with brain health has been summarized.","['brain', 'depression', 'diet', 'inflammation', 'mental health', 'neuronal plasticity', 'neurons', 'oxidative stress', 'polyphenols', 'sleep']","Antioxidants (Basel, Switzerland)",2020-04-29,"[{'lastname': 'Godos', 'firstname': 'Justyna', 'initials': 'J', 'affiliation': 'Oasi Research Institute-IRCCS, 94018 Troina, Italy.'}, {'lastname': 'Currenti', 'firstname': 'Walter', 'initials': 'W', 'affiliation': 'Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.'}, {'lastname': 'Angelino', 'firstname': 'Donato', 'initials': 'D', 'affiliation': 'Faculty of Bioscience and Technology for Food, Agriculture and Environment, University of Teramo, 64100 Teramo, Italy.'}, {'lastname': 'Mena', 'firstname': 'Pedro', 'initials': 'P', 'affiliation': 'Human Nutrition Unit, Department of Food and Drugs, University of Parma, 43125 Parma, Italy.'}, {'lastname': 'Castellano', 'firstname': 'Sabrina', 'initials': 'S', 'affiliation': 'Department of Educational Sciences, University of Catania, 95124 Catania, Italy.'}, {'lastname': 'Caraci', 'firstname': 'Filippo', 'initials': 'F', 'affiliation': 'Oasi Research Institute-IRCCS, 94018 Troina, Italy.\nDepartment of Drug Sciences, University of Catania, 95125 Catania, Italy.'}, {'lastname': 'Galvano', 'firstname': 'Fabio', 'initials': 'F', 'affiliation': 'Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.'}, {'lastname': 'Del Rio', 'firstname': 'Daniele', 'initials': 'D', 'affiliation': 'School of Advanced Studies on Food and Nutrition, University of Parma, 43125 Parma, Italy.\nDepartment of Veterinary Medicine, University of Parma, 43125 Parma, Italy.'}, {'lastname': 'Ferri', 'firstname': 'Raffaele', 'initials': 'R', 'affiliation': 'Oasi Research Institute-IRCCS, 94018 Troina, Italy.'}, {'lastname': 'Grosso', 'firstname': 'Giuseppe', 'initials': 'G', 'affiliation': 'Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.'}]",,,,,"10.3390/antiox9040346
10.1016/S0140-6736(13)61611-6
10.1001/jama.2017.3826
10.1016/S0140-6736(18)32279-7
10.5694/j.1326-5377.2009.tb02471.x
10.3389/fneur.2017.00393
10.1186/1880-6805-33-22
10.1136/bmj.l296
10.1016/S0140-6736(18)32225-6
10.1016/S0140-6736(19)30041-8
10.2174/1381612825666190722110458
10.1017/S0029665117003974
10.1038/s41380-018-0237-8
10.1155/2014/313570
10.2337/db11-1521
10.3390/nu11061315
10.1177/1178646918802282
10.1254/jphs.11R04FM
10.1016/j.neulet.2011.11.024
10.1007/s13679-017-0291-6
10.1016/j.biopsych.2015.05.014
10.1080/09637486.2018.1462309
10.1080/09637486.2019.1580682
10.1146/annurev-nutr-071715-050947
10.2174/1574362410666150205165504
10.1016/j.jalz.2015.04.011
10.1016/j.jalz.2014.11.009
10.3233/JAD-2012-111799
10.1007/s12263-011-0255-5
10.3390/nu10050580
10.1080/1028415X.2018.1533199
10.1016/j.cmet.2013.12.008
10.1146/annurev-vision-111815-114558
10.1159/000500071
10.1016/j.cmet.2016.06.001
10.1016/j.ebiom.2018.06.013
10.1016/j.physbeh.2010.08.006
10.1016/j.jad.2019.09.050
10.2174/1745017901713010213
10.1016/j.cmet.2012.08.012
10.3109/07853890.2015.1131327
10.1002/dneu.20758
10.3389/fpsyt.2018.00669
10.3390/nu11112602
10.1016/j.jnutbio.2018.09.013
10.1038/s41598-018-31855-y
10.3748/wjg.v23.i30.5486
10.3390/nu11071613
10.1017/S0029665118002719
10.1016/bs.irn.2016.08.009
10.1016/j.chom.2018.05.012
10.1007/s00125-018-4632-0
10.1007/s11883-019-0772-z
10.1097/YCO.0000000000000117
10.1016/j.cgh.2018.10.002
10.1016/j.bbr.2014.07.027
10.1097/MED.0b013e32835bc703
10.1007/s13311-017-0585-0
10.1016/j.jcmgh.2018.04.003
10.3389/fimmu.2016.00154
10.1515/revneuro-2016-0088
10.1111/acer.13781
10.3389/fnins.2013.00169
10.4161/gmic.28683
10.3389/fendo.2018.00021
10.1089/ars.2012.4581
10.1039/C8NP00062J
10.3390/nu11112678
10.1002/mnfr.201900890
10.1021/acs.jafc.9b02155
10.3390/antiox8120650
10.1007/s40263-016-0370-3
10.1016/j.metabol.2012.01.017
10.1111/j.1365-2249.2010.04150.x
10.1002/glia.22350
10.1002/ajmg.b.32567
10.2174/1570159X14666160119094646
10.1186/1742-2094-11-51
10.3389/fimmu.2019.01696
10.1016/B978-0-12-398314-5.00001-5
10.1016/j.phrs.2018.02.007
10.1038/cti.2017.9
10.1038/s41598-018-28048-y
10.1016/j.psyneuen.2017.02.035
10.1017/S0007114515002093
10.1016/j.mam.2016.07.002
10.1080/09637486.2020.1725961",<Element 'PubmedArticle' at 0x7f05df674f90>
234,32323368,Melatonin attenuates choroidal neovascularization by regulating macrophage/microglia polarization via inhibition of RhoA/ROCK signaling pathway.,"Choroidal neovascularization (CNV) is an important characteristic of advanced wet age-related macular degeneration (AMD) and leads to severe visual impairment among elderly patients. Previous studies have demonstrated that melatonin induces several biological effects related to antioxidation, anti-inflammation, and anti-angiogenesis. However, the role of melatonin in CNV, and its underlying mechanisms, has not been investigated thus far. In this study, we found that melatonin administration significantly reduced the scale and volume of CNV lesions, suppressed vascular leakage, and inhibited the capacity of vascular proliferation in the laser-induced mouse CNV model. Additionally, the results also show that the melatonin-treated retinal microglia in the laser-induced mice exhibited enhanced expression of M1-type markers, such as iNOS, CCL-3, CCL-5, and TNF-α, as well as decreased production of M2-type markers, such as Arg-1, Fizz-1, IL-10, YM-1, and CD206, indicating that melatonin switched the macrophage/microglia polarization from pro-angiogenic M2 phenotype to anti-angiogenic M1 phenotype. Furthermore, the RhoA/ROCK signaling pathway was activated during CNV formation, yet was suppressed after an intraperitoneal injection of melatonin. In conclusion, melatonin attenuated CNV, reduced vascular leakage, and inhibited vascular proliferation by switching the macrophage/microglia polarization from M2 phenotype to M1 phenotype via inhibition of RhoA/ROCK signaling pathway in CNV. This suggests that melatonin could be a novel agent for the treatment of AMD.","['RhoA/ROCK signaling pathway', 'age-related macular degeneration', 'choroidal neovascularization', 'macrophage', 'melatonin', 'microglia', 'polarization']",Journal of pineal research,2020-04-24,"[{'lastname': 'Xu', 'firstname': 'Yue', 'initials': 'Y', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong Province, China.'}, {'lastname': 'Cui', 'firstname': 'Kaixuan', 'initials': 'K', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong Province, China.'}, {'lastname': 'Li', 'firstname': 'Jia', 'initials': 'J', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong Province, China.'}, {'lastname': 'Tang', 'firstname': 'Xiaoyu', 'initials': 'X', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong Province, China.'}, {'lastname': 'Lin', 'firstname': 'Jianqiang', 'initials': 'J', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong Province, China.'}, {'lastname': 'Lu', 'firstname': 'Xi', 'initials': 'X', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong Province, China.'}, {'lastname': 'Huang', 'firstname': 'Rong', 'initials': 'R', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong Province, China.'}, {'lastname': 'Yang', 'firstname': 'Boyu', 'initials': 'B', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong Province, China.'}, {'lastname': 'Shi', 'firstname': 'Yuxun', 'initials': 'Y', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong Province, China.'}, {'lastname': 'Ye', 'firstname': 'Dan', 'initials': 'D', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong Province, China.'}, {'lastname': 'Huang', 'firstname': 'Jingjing', 'initials': 'J', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong Province, China.'}, {'lastname': 'Yu', 'firstname': 'Shanshan', 'initials': 'S', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong Province, China.'}, {'lastname': 'Liang', 'firstname': 'Xiaoling', 'initials': 'X', 'affiliation': 'State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong Province, China.'}]",,,,© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.,10.1111/jpi.12660,<Element 'PubmedArticle' at 0x7f05dc0a0ae0>
235,32315731,Revisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules.,"Barriers are the hallmark of a healthy physiology, blood-brain barrier (BBB) being a tough nut to crack for most of the antigens and chemical substances. The presence of tight junctions plays a remarkable role in defending the brain from antigenic and pathogenic attacks. BBB constitutes a diverse assemblage of multiple physical and chemical barriers that judiciously restrict the flux of blood solutes into and out of the brain. Restrictions through the paracellular pathway and the tight junctions between intercellular clefts, together create well regulated metabolic and transport barricades, critical to brain pathophysiology. The brain being impermeable to many essential metabolites and nutrients regulates transportation via specialized transport systems across the endothelial abluminal and luminal membranes. The epithelial cells enveloping capillaries of the choroid plexus regulates the transport of complement, growth factors, hormones, microelements, peptides and trace elements into ventricles. Nerve terminals, microglia, and pericytes associated with the endothelium support barrier induction and function, ensuring an optimally stable ionic microenvironment that facilitates neurotransmission, orchestrated by multiple ion channels (Na","['Active efflux', 'BBB dysfunction', 'Blood-brain barrier', 'Transport']",Brain research bulletin,2020-04-22,"[{'lastname': 'Harilal', 'firstname': 'Seetha', 'initials': 'S', 'affiliation': 'Department of Pharmacy, Kerala University of Health Sciences, Thrissur, Kerala, India.'}, {'lastname': 'Jose', 'firstname': 'Jobin', 'initials': 'J', 'affiliation': 'Department of Pharmaceutics, NGSM Institute of Pharmaceutical Science, NITTE Deemed to be University, Manglore, 575018, India.'}, {'lastname': 'Parambi', 'firstname': 'Della Grace Thomas', 'initials': 'DGT', 'affiliation': 'College of Pharmacy, Department of Pharmaceutical Chemistry, Jouf University, Sakaka, Al Jouf, 2014, Saudi Arabia.'}, {'lastname': 'Kumar', 'firstname': 'Rajesh', 'initials': 'R', 'affiliation': 'Department of Pharmacy, Kerala University of Health Sciences, Thrissur, Kerala, India.'}, {'lastname': 'Unnikrishnan', 'firstname': 'Mazhuvancherry Kesavan', 'initials': 'MK', 'affiliation': 'Department of Pharmaceutical Chemistry, National College of Pharmacy, Calicut, India.'}, {'lastname': 'Uddin', 'firstname': 'Md Sahab', 'initials': 'MS', 'affiliation': 'Department of Pharmacy, Southeast University, Dhaka, Bangladesh; Pharmakon Neuroscience Research Network, Dhaka, Bangladesh.'}, {'lastname': 'Mathew', 'firstname': 'Githa Elizabeth', 'initials': 'GE', 'affiliation': 'Department of Pharmacology, Grace College of Pharmacy, Palakkad, Kerala, India.'}, {'lastname': 'Pratap', 'firstname': 'Rahul', 'initials': 'R', 'affiliation': 'Department of Pharmacogonosy, DM WIMS College of Pharmacy, Wayanad, Kerala, India.'}, {'lastname': 'Marathakam', 'firstname': 'Akash', 'initials': 'A', 'affiliation': 'Department of Pharmaceutical Chemistry, National College of Pharmacy, Calicut, India.'}, {'lastname': 'Mathew', 'firstname': 'Bijo', 'initials': 'B', 'affiliation': 'Division of Drug Design and Medicinal Chemistry Research Lab, Department of Pharmaceutical Chemistry, Ahalia School of Pharmacy, Palakkad, 678557, Kerala, India. Electronic address: bijo.mathew@ahalia.ac.in.'}]",,,,Copyright © 2020 Elsevier Inc. All rights reserved.,10.1016/j.brainresbull.2020.03.018,<Element 'PubmedArticle' at 0x7f05dbfe34a0>
236,32251025,Persistent inflammatory states and their implications in brain disease.,"Apart from mental, motor and sensory functions, the human central nervous system (CNS) regulates a plethora of homeostatic (autonomic and hormonal) bodily functions. These functions are dependent on specialized neuronal networks. To ensure connectivity of these networks, they are continuously refined and supported by glial cells that outnumber neurons by, according to some accounts, an order of magnitude. Among glial cells, microglia - the brain resident macrophages - plays a crucial role in maintaining neuronal networks. However, in their concomitant role as brain immune cells microglia also engage in inflammatory signaling that may disrupt neuronal networks. Here, we review novel insights for molecular pathways involved in the protective functions of microglia and other immune cells in response to systemic signals and stimuli.
Recent evidence suggests that aging and systemic disease push individual microglia toward proinflammatory phenotypes compromising the connectivity of neuronal networks, resulting in neuropsychiatric disease. Furthermore, cells (self as well as the microbiome) outside the CNS have been shown to affect neuronal function.
These recent findings have critical implications for mental health, particularly of an aging population, in particular for the development of novel immunomodulatory therapies for brain disease.",[],Current opinion in neurology,2020-04-07,"[{'lastname': 'Valdés-Ferrer', 'firstname': 'Sergio I', 'initials': 'SI', 'affiliation': 'Departments of Neurology.\nInfectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, Mexico.\nCenter for Biomedical Sciences, The Feinstein Institute for Medical Research, Manhasset, New York, USA.'}, {'lastname': 'Benkendorff', 'firstname': 'Alexander', 'initials': 'A', 'affiliation': 'Institute of Neuropathology.'}, {'lastname': 'Sankowski', 'firstname': 'Roman', 'initials': 'R', 'affiliation': 'Institute of Neuropathology.\nBerta-Ottenstein-Programme for Clinician Scientists, Faculty of Medicine, University of Freiburg, Freiburg, Germany.'}]",,,,,"10.1097/WCO.0000000000000809
10.1002/mrm.28060
10.3389/fnagi.2018.00236
10.1038/s41380-019-0408-2
10.1038/s41380-018-0096-3
10.1038/s41398-018-0241-4
10.1038/s41380-019-0604-0
10.1038/s41380-019-0539-5
10.1038/s41467-019-14279-8
10.3389/fimmu.2017.01301.",<Element 'PubmedArticle' at 0x7f05dbfee0e0>
237,"32210273
17257453
16331772
24494689
25987988
1481730
10934282
24633536
18565509
9632219
15336606
24710472
2770410
28299231
16004669
16078334
19823760
27137783
16142502
16896507
20482322
22159672
25773046
22048967
24948120
22740331
17574758
26141479
20580684
24818655
29416128
19857544
10499494
12123694
6330007
9056725
12075354
29797679
26303600
20303952
23549442
20959778
15486424
24719311
12721371
7477966
22789984
20398327
19961904
22609935
21441897
26161124
15496676
9767454
9889327
23397032
23959680
17167420
27941788
26531254
12499858
28983699
26642091
26104116
3340425
7990513","Teriparatide relieves ovariectomy-induced hyperalgesia in rats, suggesting the involvement of functional regulation in primary sensory neurons by PTH-mediated signaling.","Clinical studies have reported that teriparatide (TPTD), a human parathyroid hormone analog, reduces back pain in osteoporotic patients. However, the mechanistic insights of this pharmacological action remain elusive. This study investigated the antinociceptive effect of TPTD mainly on primary sensory neurons in ovariectomized (OVX) rats. The plantar test showed thermal hyperalgesia in the OVX rats, which was significantly, but not fully, recovered immediately after the initial TPTD administration. The von Frey test also demonstrated reduced withdrawal threshold in the OVX rats. This was partially recovered by TPTD. Consistently, the number and size of spinal microglial cells were significantly increased in the OVX rats, while TPTD treatment significantly reduced the number but not size of these cells. RNA sequencing-based bioinformatics of the dorsal root ganglia (DRG) demonstrated that changes in neuro-protective and inflammatory genes were involved in the pharmacological effect of TPTD. Most neurons in the DRG expressed substantial levels of parathyroid hormone 1 receptor. TPTD treatment of the cultured DRG-derived neuronal cells reduced the cAMP level and augmented the intracellular calcium level as the concentration increased. These findings suggest that TPTD targets neuronal cells as well as bone cells to exert its pharmacological action.",[],Scientific reports,2020-03-27,"[{'lastname': 'Tanaka', 'firstname': 'Tomoya', 'initials': 'T', 'affiliation': 'Pharmaceuticals Research Center, Asahi Kasei Pharma Corporation, 632-1 Mifuku, Izunokuni city, Shizuoka, 410-2321, Japan.\nDepartment of Pharmacology, Graduate School of Dental Medicine, Hokkaido University, N13 W7, Sapporo, 060-8586, Japan.'}, {'lastname': 'Takao-Kawabata', 'firstname': 'Ryoko', 'initials': 'R', 'affiliation': 'Pharmaceuticals Research Center, Asahi Kasei Pharma Corporation, 632-1 Mifuku, Izunokuni city, Shizuoka, 410-2321, Japan. takao.rb@om.asahi-kasei.co.jp.'}, {'lastname': 'Takakura', 'firstname': 'Aya', 'initials': 'A', 'affiliation': 'Pharmaceuticals Research Center, Asahi Kasei Pharma Corporation, 632-1 Mifuku, Izunokuni city, Shizuoka, 410-2321, Japan.\nDepartment of Pharmacology, Graduate School of Dental Medicine, Hokkaido University, N13 W7, Sapporo, 060-8586, Japan.'}, {'lastname': 'Shimazu', 'firstname': 'Yukari', 'initials': 'Y', 'affiliation': 'Pharmaceuticals Research Center, Asahi Kasei Pharma Corporation, 632-1 Mifuku, Izunokuni city, Shizuoka, 410-2321, Japan.'}, {'lastname': 'Nakatsugawa', 'firstname': 'Momoko', 'initials': 'M', 'affiliation': 'Pharmaceuticals Research Center, Asahi Kasei Pharma Corporation, 632-1 Mifuku, Izunokuni city, Shizuoka, 410-2321, Japan.'}, {'lastname': 'Ito', 'firstname': 'Akitoshi', 'initials': 'A', 'affiliation': 'Pharmaceuticals Research Center, Asahi Kasei Pharma Corporation, 632-1 Mifuku, Izunokuni city, Shizuoka, 410-2321, Japan.'}, {'lastname': 'Lee', 'firstname': 'Ji-Won', 'initials': 'JW', 'affiliation': 'Department of Pharmacology, Graduate School of Dental Medicine, Hokkaido University, N13 W7, Sapporo, 060-8586, Japan.\nDivision of Bio-Imaging, Proteo-Science Center (PROS), Ehime University, Shitsukawa, Toon city, Ehime, 791-0295, Japan.'}, {'lastname': 'Kawasaki', 'firstname': 'Koh', 'initials': 'K', 'affiliation': 'Pharmaceuticals Research Center, Asahi Kasei Pharma Corporation, 632-1 Mifuku, Izunokuni city, Shizuoka, 410-2321, Japan.'}, {'lastname': 'Iimura', 'firstname': 'Tadahiro', 'initials': 'T', 'affiliation': 'Department of Pharmacology, Graduate School of Dental Medicine, Hokkaido University, N13 W7, Sapporo, 060-8586, Japan. iimura@den.hokudai.ac.jp.\nDivision of Bio-Imaging, Proteo-Science Center (PROS), Ehime University, Shitsukawa, Toon city, Ehime, 791-0295, Japan. iimura@den.hokudai.ac.jp.'}]",,,,,"10.1038/s41598-020-62045-4
10.1185/030079906X154097
10.1111/ejn.12462
10.1038/bonekey.2015.58
10.1002/jbmr.5650071213
10.1523/JNEUROSCI.20-16-06302.2000
10.1007/s00774-014-0574-x
10.1016/j.ejphar.2008.05.011
10.1016/S0091-3057(98)00015-X
10.1016/j.bone.2004.04.012
10.1371/journal.pone.0094312
10.1016/0024-3205(89)90631-0
10.1155/2017/7582716
10.1185/030079905X49671
10.1007/s00223-009-9299-6
10.1007/s00223-016-0143-5
10.1007/s00198-005-2013-2
10.1007/s00198-006-0177-z
10.1185/03007995.2010.488516
10.1007/s00198-011-1856-y
10.1007/s00774-014-0646-y
10.1530/EJE-11-0740
10.1038/nrd4334
10.1002/glia.22379
10.1016/j.pain.2007.04.041
10.1007/s00223-015-0026-1
10.1016/j.bone.2010.05.015
10.1038/ncomms4771
10.1038/nrn.2018.2
10.1016/j.pneurobio.2009.10.017
10.1210/endo.140.10.7040
10.1016/S0306-4522(02)00165-3
10.1146/annurev.neuro.20.1.567
10.1038/nature00816
10.1002/ejp.1251
10.1038/nrendo.2015.139
10.1016/j.expneurol.2010.03.006
10.1097/GME.0b013e31828837a6
10.1097/BRS.0b013e3181d5959e
10.1152/jn.00339.2004
10.1002/art.38656
10.1073/pnas.0937087100
10.1016/0306-4522(95)94333-T
10.1097/BRS.0b013e3182685ba1
10.1186/1744-8069-6-21
10.1016/j.neuroscience.2009.11.064
10.1016/j.neuroscience.2012.05.014
10.1038/emboj.2011.89
10.1155/2015/642081
10.1523/JNEUROSCI.0899-04.2004
10.1046/j.1365-2567.1998.00568.x
10.1016/S0169-328X(98)00329-5
10.1210/en.2013-1915
10.1113/jphysiol.2013.261180
10.1038/nature05394
10.1038/nn.4454
10.1007/s11302-015-9481-4
10.1097/01.wnr.0000048541.12213.bb
10.1038/nn.4189
10.1007/s00774-015-0670-6
10.1016/0304-3959(88)90026-7
10.1016/0165-0270(94)90144-9",<Element 'PubmedArticle' at 0x7f05dc0054a0>
238,"32178454
27157931
24137015
11504770
11550301
25082799
15758009
28434963
22536362
19931353
29163818
25960691
15372072
15574589
28473628
28809941
18692607
29263891
23054677
29115595
29234674
18765229
28440461
29985475
29076001
29451858
21383194
21609964
22944280
19011622
26993504
22153157
23420871
22903157
17486113
30106109
29901177
28978155
29641478
17470375
15033581
15033578
31012516
29239327
27661112
15567553
11180508
11484816
19604543
27306693
12671651
24631534
24929208
26536111
26165844
25978028
28410224
28855213
26433199
31269723
31533034
23596394
28173797
30240060
25926558
21882259
14705732
28445150
28153089
24581498
26871466
25818666
26479035
19775293
30073755
23981039
28040794
29559295
30968276
25635044
20223198
27379236
23690991
21242314
25565956
26274999
29458374
29187887
28287613
22431192
23076445
28824376
22260888
28338200
30290761
27282910
19446450
18977327
28698530
22159356
26155940
29457830
27481513
29531296
28596159
25129238
26799295
23201752
20956944
21859829
27345398
22442669
23391506
23034333
22848219
22415301
32102350
22740198
31952362
20382199
16453000
21827414
27989769
31160393
27287018
25864039
22558405
29434344
26713745
31629410
26973881
19029990
26769084
27220367
27459405
28674485
18077690
20195827
24582000
29861845
31462285
30518750
27253431
31133802
31638099
25477239
28459461
31218569
27376091
29540832
31427735
25960419
31485019
21196373
25342742
22895567
23534743
30248992
29016925
20380575
23568705
23155233
24084846
26717894
24270883
19826040
22570426
20633539
22753745
25625875
20113523
22075712
24675463
31013819
30917935
26887050
28901390
28419303
26208431
25595896
30683859
27047250
26978735
30530966
21561454
23174013
22674182
24435880
25756397
25636684
26230475
27476114
28211798
29076027
31614872
31933806
31727077
30820533
29444091",The Roles of miRNA in Glioblastoma Tumor Cell Communication: Diplomatic and Aggressive Negotiations.,"Glioblastoma (GBM) consists of a heterogeneous collection of competing cellular clones which communicate with each other and with the tumor microenvironment (TME). MicroRNAs (miRNAs) present various exchange mechanisms: free miRNA, extracellular vesicles (EVs), or gap junctions (GJs). GBM cells transfer miR-4519 and miR-5096 to astrocytes through GJs. Oligodendrocytes located in the invasion front present high levels of miR-219-5p, miR-219-2-3p, and miR-338-3p, all related to their differentiation. There is a reciprocal exchange between GBM cells and endothelial cells (ECs) as miR-5096 promotes angiogenesis after being transferred into ECs, whereas miR-145-5p acts as a tumor suppressor. In glioma stem cells (GSCs), miR-1587 and miR-3620-5p increase the proliferation and miR-1587 inhibits the hormone receptor co-repressor-1 (","['glioblastoma', 'intercellular communication', 'miRNA', 'tumor microenvironment']",International journal of molecular sciences,2020-03-18,"[{'lastname': 'Buruiană', 'firstname': 'Andrei', 'initials': 'A', 'affiliation': 'Department of Medical Genetics, Iuliu Hațieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania.'}, {'lastname': 'Florian', 'firstname': 'Ștefan Ioan', 'initials': 'ȘI', 'affiliation': 'Department of Neurosurgery, Iuliu Hațieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania.\nDepartment of Neurosurgery, Emergency County Hospital, 3-5 Clinicilor Street, 400006 Cluj-Napoca, Romania.'}, {'lastname': 'Florian', 'firstname': 'Alexandru Ioan', 'initials': 'AI', 'affiliation': 'Department of Neurosurgery, Iuliu Hațieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania.\nDepartment of Neurosurgery, Emergency County Hospital, 3-5 Clinicilor Street, 400006 Cluj-Napoca, Romania.'}, {'lastname': 'Timiș', 'firstname': 'Teodora-Larisa', 'initials': 'TL', 'affiliation': 'Department of Physiology, Iuliu Hațieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania.'}, {'lastname': 'Mihu', 'firstname': 'Carmen Mihaela', 'initials': 'CM', 'affiliation': 'Department of Morphological Sciences-Histology, Iuliu Hațieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania.'}, {'lastname': 'Miclăuș', 'firstname': 'Maria', 'initials': 'M', 'affiliation': 'Department of Medical Genetics, Emergency Hospital for Children, 68 Moților Street, 400370 Cluj-Napoca, Romania.'}, {'lastname': 'Oșan', 'firstname': 'Sergiu', 'initials': 'S', 'affiliation': 'Department of Medical Genetics, Iuliu Hațieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania.'}, {'lastname': 'Hrapșa', 'firstname': 'Iona', 'initials': 'I', 'affiliation': 'Department of Medical Genetics, Iuliu Hațieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania.'}, {'lastname': 'Cataniciu', 'firstname': 'Radu Constantin', 'initials': 'RC', 'affiliation': 'Department of Medical Genetics, Iuliu Hațieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania.'}, {'lastname': 'Farcaș', 'firstname': 'Marius', 'initials': 'M', 'affiliation': 'Department of Medical Genetics, Iuliu Hațieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania.\nDepartment of Genetics, IMOGEN Research Center, Louis Pasteur Street, 400349 Cluj-Napoca, Romania.'}, {'lastname': 'Șușman', 'firstname': 'Sergiu', 'initials': 'S', 'affiliation': 'Department of Morphological Sciences-Histology, Iuliu Hațieganu University of Medicine and Pharmacy, 8 Victor Babes Street, 400012 Cluj-Napoca, Romania.\nDepartment of Pathology, IMOGEN Research Center, Louis Pasteur Street, 400349 Cluj-Napoca, Romania.'}]",,,,,"10.3390/ijms21061950
10.1007/s00401-016-1545-1
10.1093/neuonc/not151
10.1093/jnci/93.16.1246
10.1093/neuonc/1.1.44
10.1093/neuonc/nou147
10.1056/NEJMoa043330
10.1016/j.wneu.2017.04.053
10.1371/journal.pone.0035262
10.1016/j.bbcan.2009.11.002
10.1186/s12935-015-0185-1
10.1038/sj.emboj.7600385
10.1101/gad.1262504
10.1042/BCJ20160759
10.1371/journal.pone.0183269
10.1016/j.bbagrm.2008.07.005
10.1038/sigtrans.2015.4
10.1007/s12035-012-8349-7
10.3892/mmr.2017.7895
10.1155/2017/7639084
10.1016/j.bbrc.2008.08.107
10.3892/ijo.2017.3973
10.1038/s41582-018-0025-8
10.1007/s11060-017-2639-x
10.1515/cclm-2017-0958
10.1016/j.als.2016.11.007
10.1073/pnas.1019055108
10.1093/nar/gkr254
10.1016/j.tibs.2012.08.003
10.1038/ncb1800
10.1007/s10571-015-0296-1
10.1016/j.cub.2011.10.011
10.1083/jcb.201211138
10.1016/j.pharmthera.2012.08.003
10.1038/ncb1596
10.3892/mmr.2018.9386
10.3892/mmr.2018.9106
10.18632/oncotarget.18332
10.3390/ijms19041159
10.1016/j.pbiomolbio.2007.03.011
10.1016/j.bbamem.2003.11.022
10.1016/j.bbamem.2004.01.008
10.1111/cas.14029
10.18632/oncotarget.12136
10.1016/j.clineuro.2004.03.006
10.1002/1098-1136(200102)33:2<107::AID-GLIA1010>3.0.CO;2-4
10.1007/s004010000305
10.1016/j.acthis.2009.05.008
10.1002/cam4.730
10.1038/nrm1072
10.1016/j.trsl.2014.05.011
10.1038/nature16071
10.1038/onc.2015.210
10.18632/oncotarget.3904
10.18632/oncotarget.16661
10.1158/0008-5472.CAN-16-2524
10.1093/neuonc/nov244
10.3390/jcm8070959
10.1016/j.celrep.2019.08.036
10.1186/s12885-017-3109-8
10.1002/glia.23520
10.18632/oncotarget.3407
10.1002/mc.20853
10.3171/jns.2003.99.6.1039
10.18632/oncotarget.16949
10.1016/j.ymthe.2016.11.004
10.1016/j.cell.2014.01.040
10.18632/oncotarget.7273
10.1111/cpr.12181
10.1038/nature15376
10.1111/j.1750-3639.2009.00328.x
10.1111/jcmm.13788
10.1111/imm.12163
10.1093/jnen/nlw098
10.1016/j.ebiom.2018.02.024
10.1007/s10014-019-00341-2
10.1101/cshperspect.a020610
10.1016/j.neuron.2010.02.018
10.3389/fcell.2016.00059
10.1371/journal.pone.0063164
10.1242/jcs.074088
10.3389/fncel.2014.00418
10.3171/2014.12.JNS1426
10.1186/s12943-018-0812-2
10.7150/jca.21024
10.1038/oncsis.2017.7
10.1002/glia.22325
10.3892/or.2012.2084
10.3389/fnmol.2017.00246
10.1016/j.tcb.2011.12.001
10.1186/s12987-018-0114-5
10.1002/cam4.775
10.1016/j.gde.2009.04.002
10.1016/j.ccr.2008.10.005
10.3390/cancers9070085
10.3892/or.2011.1588
10.18632/oncotarget.4384
10.1002/ijc.31329
10.1007/s13277-016-5138-3
10.1038/s41419-018-0343-1
10.2967/jnumed.116.188557
10.1186/1471-2164-15-686
10.3171/2015.8.JNS15437
10.1093/hmg/dds496
10.1038/onc.2010.465
10.1158/0008-5472.CAN-11-0991
10.1038/onc.2016.212
10.1371/journal.pone.0032709
10.18632/oncotarget.810
10.1038/cddis.2012.134
10.1155/2012/732874
10.1096/fj.11-202820
10.3390/cancers12020520
10.3390/cells9010220
10.1016/j.exphem.2010.03.021
10.1038/sj.leu.2404132
10.2174/138161211797249260
10.1016/j.stem.2016.11.003
10.1101/gad.324301.119
10.1186/s13059-016-0990-4
10.1016/j.molonc.2015.03.007
10.1371/journal.pone.0036248
10.1038/s41598-018-20929-6
10.1038/nn.4185
10.1186/s12929-019-0568-z
10.1172/jci.insight.85841
10.1038/nri2448
10.1186/s13046-015-0281-z
10.1186/s12974-016-0581-z
10.1038/nn.4338
10.3389/fnmol.2017.00191
10.1523/JNEUROSCI.2042-07.2007
10.1007/s12272-010-0211-8
10.1016/j.jneuroim.2014.02.005
10.18632/oncotarget.25116
10.1186/s13046-019-1371-0
10.1038/s41419-018-1149-x
10.12659/MSM.895439
10.3389/fnmol.2019.00125
10.1002/ijc.29379
10.1038/onc.2017.129
10.1007/s11010-019-03571-2
10.1155/2016/6031486
10.1038/s41388-018-0178-3
10.1038/s41388-019-0952-x
10.1016/j.matbio.2015.05.005
10.1038/s41388-019-0996-y
10.1074/jbc.M114.614503
10.3892/or.2012.1970
10.7314/APJCP.2013.14.1.309
10.3390/ijms19102879
10.1093/neuonc/nox142
10.1089/dna.2009.0978
10.1007/s13277-013-0772-5
10.1038/mtna.2013.60
10.3892/or.2015.4432
10.3892/mmr.2013.1814
10.1158/0008-5472.CAN-09-1996
10.1093/neuonc/nos089
10.1016/j.brainres.2010.07.009
10.3892/ijo.2015.2841
10.1186/1471-2407-10-27
10.1038/cddis.2014.111
10.3390/cells8040350
10.1016/j.ebiom.2019.03.016
10.18632/oncotarget.7346
10.3892/ijmm.2017.3124
10.1093/neuonc/nox070
10.1016/j.canlet.2015.07.013
10.18632/oncotarget.2778
10.1038/s41467-019-08390-z
10.2174/1389202916666150707155610
10.12659/MSM.897164
10.3233/CBM-181416
10.1111/j.1471-4159.2011.07307.x
10.1186/1756-9966-31-97
10.1002/ijc.27657
10.1093/neuonc/not218
10.1038/bjc.2015.91
10.1007/s12035-014-9079-9
10.3171/2015.1.JNS141577
10.1186/s13046-016-0393-0
10.3233/CBM-160146
10.1007/s13402-017-0355-3
10.3390/cancers11101546
10.1186/s12974-019-1590-5
10.1093/nar/gkz097
10.1371/journal.pone.0189452",<Element 'PubmedArticle' at 0x7f05dc60c2c0>
239,"32152264
18995817
12162730
16322792
8785064
26793048
10322493
21562080
16322792
24301293
27000556
21536893
21343257
24880214
18292187
8757296
24914942
22201683
26192704
20846876
22844271
20679202
24166765
24382295
17021370
17021366
18420740
11751615
23123165
9396073
17317774
12239088
24002186
22249232
19094094
6264602
11812690
25589770
27013681
19625519
22496569
21957265
29590557
23313342
10677609
7361889
7895052
25100584
9298853
19116341
1784332
4723224
3559554
7952264
26884166
29221640
28484229
19747514
28683286
22893404
6344096
23064363
23329815
20148679
16943543
12228064
17924866
29623545
20012068
27076082
22693203
11239989
12379901
28379213
27393312",Dorsal vagal complex and hypothalamic glia differentially respond to leptin and energy balance dysregulation.,"Previous studies identify a role for hypothalamic glia in energy balance regulation; however, a narrow hypothalamic focus provides an incomplete understanding of how glia throughout the brain respond to and regulate energy homeostasis. We examined the responses of glia in the dorsal vagal complex (DVC) to the adipokine leptin and high fat diet-induced obesity. DVC astrocytes functionally express the leptin receptor; in vivo pharmacological studies suggest that DVC astrocytes partly mediate the anorectic effects of leptin in lean but not diet-induced obese rats. Ex vivo calcium imaging indicated that these changes were related to a lower proportion of leptin-responsive cells in the DVC of obese versus lean animals. Finally, we investigated DVC microglia and astroglia responses to leptin and energy balance dysregulation in vivo: obesity decreased DVC astrogliosis, whereas the absence of leptin signaling in Zucker rats was associated with extensive astrogliosis in the DVC and decreased hypothalamic micro- and astrogliosis. These data uncover a novel functional heterogeneity of astrocytes in different brain nuclei of relevance to leptin signaling and energy balance regulation.",[],Translational psychiatry,2020-03-11,"[{'lastname': 'Stein', 'firstname': 'Lauren M', 'initials': 'LM', 'affiliation': 'Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.'}, {'lastname': 'Lhamo', 'firstname': 'Rinzin', 'initials': 'R', 'affiliation': 'Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.'}, {'lastname': 'Cao', 'firstname': 'Anh', 'initials': 'A', 'affiliation': 'Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.'}, {'lastname': 'Workinger', 'firstname': 'Jayme', 'initials': 'J', 'affiliation': 'Department of Chemistry, Syracuse University, Syracuse, NY, USA.'}, {'lastname': 'Tinsley', 'firstname': 'Ian', 'initials': 'I', 'affiliation': 'Department of Chemistry, Syracuse University, Syracuse, NY, USA.'}, {'lastname': 'Doyle', 'firstname': 'Robert P', 'initials': 'RP', 'affiliation': 'Department of Chemistry, Syracuse University, Syracuse, NY, USA.'}, {'lastname': 'Grill', 'firstname': 'Harvey J', 'initials': 'HJ', 'affiliation': 'Institute of Diabetes, Obesity and Metabolism and Department of Psychology, University of Pennsylvania, Philadelphia, PA, USA.'}, {'lastname': 'Hermann', 'firstname': 'Gerlinda E', 'initials': 'GE', 'affiliation': 'Department of Autonomic Neuroscience, Pennington Biomedical Research Center, Baton Rouge, LA, USA.'}, {'lastname': 'Rogers', 'firstname': 'Richard C', 'initials': 'RC', 'affiliation': 'Department of Autonomic Neuroscience, Pennington Biomedical Research Center, Baton Rouge, LA, USA.'}, {'lastname': 'Hayes', 'firstname': 'Matthew R', 'initials': 'MR', 'affiliation': 'Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. hayesmr@pennmedicine.upenn.edu.'}]",,,,,10.1038/s41398-020-0767-0,<Element 'PubmedArticle' at 0x7f05daa27770>
240,"32120833
16219483
30060265
16817850
30962427
22348528
30915118
29018332
29981776
27829983
28417262
31379746
31029764
26514204
16217123
30937953
21269327
28796402
21994366
25159133
30862067
28708259
21930182
30526767
25393080
30734962
27830959
25642419
23750306
22697290
19544386
21935701
31572196
29740062
30101571
28789477
11268363
30742657
22569153
25735211
27578426
11068944
24350834
24753900
27673420
30637551
30153673
23183236
26063194
27812200
28864909
27500468
14675124
8321083
31330909
30976981
30597622
12606543
30484873
19262508
30671433
31040648
29724989
25790768
18287515
26746864
29478025
19786048
28089775
28542400
29340071
25025067
23180823
28551846
29132743
20941378
17516504
24980917
25401748
26733801
20620956
23029496
23770291
9972818
9705133
11641446
28859332
18371179
19428957
23388509
31300734",SIRT1 Mediates Melatonin's Effects on Microglial Activation in Hypoxia: In Vitro and In Vivo Evidence.,"Melatonin exerts direct neuroprotection against cerebral hypoxic damage, but the mechanisms of its action on microglia have been less characterized. Using both in vitro and in vivo models of hypoxia, we here focused on the role played by silent mating type information regulation 2 homolog 1 (SIRT1) in melatonin's effects on microglia. Viability of rat primary microglia or microglial BV2 cells and SH-SY5Y neurons was significantly reduced after chemical hypoxia with CoCl","['5-methoxy-N-acetyltryptamine', 'amoeboid microglia', 'cobalt chloride', 'melatonin receptors', 'nuclear factor-kappa B (NF-kB)', 'rat common carotid artery occlusion (CCAO)', 'silent mating type information regulation 2 homolog 1 (SIRT1)']",Biomolecules,2020-03-04,"[{'lastname': 'Merlo', 'firstname': 'Sara', 'initials': 'S', 'affiliation': 'Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, 95123 Catania, Italy.'}, {'lastname': 'Luaces', 'firstname': 'Juan Pablo', 'initials': 'JP', 'affiliation': 'Laboratorio de Citoarquitectura y Plasticidad, Instituto de Investigaciones Cardiológicas, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires C1122, Argentina.'}, {'lastname': 'Spampinato', 'firstname': 'Simona Federica', 'initials': 'SF', 'affiliation': 'Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, 95123 Catania, Italy.'}, {'lastname': 'Toro-Urrego', 'firstname': 'Nicolas', 'initials': 'N', 'affiliation': 'Laboratorio de Citoarquitectura y Plasticidad, Instituto de Investigaciones Cardiológicas, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires C1122, Argentina.'}, {'lastname': 'Caruso', 'firstname': 'Grazia Ilaria', 'initials': 'GI', 'affiliation': 'Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, 95123 Catania, Italy.'}, {'lastname': ""D'Amico"", 'firstname': 'Fabio', 'initials': 'F', 'affiliation': 'Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.'}, {'lastname': 'Capani', 'firstname': 'Francisco', 'initials': 'F', 'affiliation': 'Laboratorio de Citoarquitectura y Plasticidad, Instituto de Investigaciones Cardiológicas, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires C1122, Argentina.'}, {'lastname': 'Sortino', 'firstname': 'Maria Angela', 'initials': 'MA', 'affiliation': 'Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, 95123 Catania, Italy.'}]",,,,,"10.3390/biom10030364
10.1016/j.biocel.2005.08.020
10.1055/a-0656-6643
10.1111/j.1742-4658.2006.05322.x
10.1038/s41419-019-1556-7
10.3109/14767058.2012.663232
10.1155/2019/9626715
10.3389/fncel.2017.00296
10.1016/j.phrs.2018.06.011
10.1155/2016/3472032
10.1007/s11064-017-2251-7
10.3389/fendo.2019.00480
10.1016/j.phrs.2019.04.015
10.1146/annurev-pharmtox-010814-124742
10.1385/ENDO:27:2:101
10.1111/jpi.12575
10.1111/j.1600-079X.2010.00837.x
10.1111/jpi.12443
10.1523/JNEUROSCI.3059-11.2011
10.1093/toxsci/kfu164
10.3390/ijms20051223
10.1111/jpi.12434
10.1016/j.pneurobio.2011.09.001
10.5483/BMBRep.2019.52.1.290
10.1038/jp.2014.186
10.1111/jpi.12565
10.1080/14737175.2017.1259567
10.3389/fped.2014.00144
10.1186/1471-2202-13-64
10.1002/glia.20896
10.1007/s00247-011-2238-5
10.3389/fphar.2019.01024
10.1038/s41598-018-25453-1
10.1111/cns.13050
10.1093/jnen/nlx046
10.1111/j.1749-6632.2000.tb05402.x
10.1371/journal.pone.0212138
10.1016/j.neuroscience.2012.04.070
10.1016/j.bbagen.2015.02.015
10.1016/j.expneurol.2016.08.017
10.1034/j.1600-0633.2002.290404.x
10.1111/jpi.12113
10.1038/pr.2016.198
10.1007/s11910-019-0916-0
10.1159/000491859
10.1093/brain/aws285
10.1136/archdischild-2014-306284
10.1371/journal.pone.0166010
10.2174/1570159053586681
10.1007/s00018-017-2609-7
10.1111/jpi.12360
10.1046/j.1600-079X.2003.00092.x
10.1016/0024-3205(93)90670-X
10.3390/cells8070760
10.1007/s12192-019-00994-0
10.1111/jpi.12550
10.13128/IJAE-16915
10.1074/jbc.M300463200
10.1002/jat.3749
10.1038/nature07813
10.3389/fcell.2018.00175
10.2147/DDDT.S194182
10.12659/MSM.905140
10.1038/ncomms7340
10.1523/JNEUROSCI.5323-07.2008
10.1177/0271678X15624933
10.1161/JAHA.117.007589
10.1016/j.brainresrev.2009.09.006
10.1016/j.exer.2017.01.003
10.1371/journal.pone.0178098
10.18632/oncotarget.22851
10.1155/2014/692061
10.4049/jimmunol.1202390
10.1007/s11010-017-3064-3
10.1016/j.cytogfr.2017.11.001
10.7150/ijbs.6.599
10.1002/jcp.21091
10.1111/jpi.12156
10.1111/jpi.12193
10.3389/fnmol.2015.00077
10.1016/j.molcel.2010.05.023
10.1371/journal.pone.0046364
10.1016/j.cellsig.2013.06.007
10.1002/(SICI)1097-4547(19990115)55:2<158::AID-JNR3>3.0.CO;2-1
10.1007/s004010050878
10.1203/00006450-200111000-00003
10.1093/jnen/nlx056
10.1111/j.1750-3639.2008.00138.x
10.1016/j.pneurobio.2009.01.003
10.1186/1742-2094-10-23
10.1038/s41423-019-0257-6",<Element 'PubmedArticle' at 0x7f05daa53d60>
241,"32111883
11193794
22284730
18650430
10806097
27425887
11120756
12603271
22229116
15509549
12515826
16823808
15886206
15030566
7489364
11816789
15923191
15052275
25512792
21742788
9209829
3317417
22424229
23794448
20962049
18486611
22500019
9830016
25700985
28059785
27911303
28363773
24614496
27687691
23964237
25523424
16399206
23951225
9663454
26071095
28528968
24239383
23966942
15201330
27163815
29067318
23197731
14985348
24685176
17321494
15851687
19647738
19501206
21682276
21318142
16149055
27565578
15456862
17515902
8245987
25120481
27833158
26344778
26747763
16200419",Amylin and pramlintide modulate γ-secretase level and APP processing in lipid rafts.,"A major characteristic of Alzheimer's disease (AD) is the accumulation of misfolded amyloid-β (Aβ) peptide. Several studies linked AD with type 2 diabetes due to similarities between Aβ and human amylin. This study investigates the effect of amylin and pramlintide on Aβ pathogenesis and the predisposing molecular mechanism(s) behind the observed effects in TgSwDI mouse, a cerebral amyloid angiopathy (CAA) and AD model. Our findings showed that thirty days of intraperitoneal injection with amylin or pramlintide increased Aβ burden in mice brains. Mechanistic studies revealed both peptides altered the amyloidogenic pathway and increased Aβ production by modulating amyloid precursor protein (APP) and γ-secretase levels in lipid rafts. In addition, both peptides increased levels of B4GALNT1 enzyme and GM1 ganglioside, and only pramlintide increased the level of GM2 ganglioside. Increased levels of GM1 and GM2 gangliosides play an important role in regulating amyloidogenic pathway proteins in lipid rafts. Increased brain Aβ burden by amylin and pramlintide was associated with synaptic loss, apoptosis, and microglia activation. In conclusion, our findings showed amylin or pramlintide increase Aβ levels and related pathology in TgSwDI mice brains, and suggest that increased amylin levels or the therapeutic use of pramlintide could increase the risk of AD.",[],Scientific reports,2020-03-01,"[{'lastname': 'Mousa', 'firstname': 'Youssef M', 'initials': 'YM', 'affiliation': 'Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, USA.'}, {'lastname': 'Abdallah', 'firstname': 'Ihab M', 'initials': 'IM', 'affiliation': 'Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, USA.'}, {'lastname': 'Hwang', 'firstname': 'Misako', 'initials': 'M', 'affiliation': 'Scott-Ritchey Research Center, Auburn University, Auburn, USA.'}, {'lastname': 'Martin', 'firstname': 'Douglas R', 'initials': 'DR', 'affiliation': 'Scott-Ritchey Research Center, Auburn University, Auburn, USA.\nDepartment of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, USA.\nCenter for Neuroscience Initiative, Auburn University, Auburn, AL, USA.'}, {'lastname': 'Kaddoumi', 'firstname': 'Amal', 'initials': 'A', 'affiliation': 'Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, USA. kaddoumi@auburn.edu.\nCenter for Neuroscience Initiative, Auburn University, Auburn, AL, USA. kaddoumi@auburn.edu.'}]",,,,,"10.1038/s41598-020-60664-5
10.1016/j.nic.2011.11.003
10.1074/jbc.R800019200
10.1016/j.nbd.2016.07.007
10.1172/JCI10498
10.1046/j.1460-9568.2003.02506.x
10.1101/cshperspect.a006189
10.1016/S0002-9440(10)63436-0
10.1083/jcb.200207113
10.1002/jnr.20981
10.1074/jbc.M503570200
10.1111/j.1600-0854.2004.0181.x
10.1038/nm1095-1062
10.1385/JMN:17:2:157
10.1074/jbc.M414525200
10.1038/sj.mp.4001509
10.4239/wjd.v5.i6.889
10.1152/physrev.00042.2009
10.1615/CritRevNeurobiol.v11.i2-3.40
10.1073/pnas.84.23.8628
10.1016/j.cell.2012.02.022
10.1002/ana.23956
10.1210/en.2010-0590
10.1016/j.febslet.2008.05.006
10.1074/jbc.M111.331181
10.1074/jbc.273.49.32730
10.1016/j.ajpath.2014.11.016
10.3233/JAD-160800
10.3233/JAD-160677
10.1016/j.neuropharm.2017.03.030
10.1038/mp.2014.17
10.1038/srep34505
10.3389/fnagi.2013.00038
10.2174/1567205012666141218140953
10.1016/j.neurobiolaging.2005.01.004
10.1371/journal.pone.0071702
10.1016/S0196-9781(98)00018-7
10.1124/pr.115.010629
10.1016/j.neuroscience.2017.05.024
10.1016/j.neurobiolaging.2013.10.076
10.3389/fnagi.2013.00042
10.1523/JNEUROSCI.1051-04.2004
10.3233/JAD-160047
10.1016/j.trci.2016.11.005
10.1523/JNEUROSCI.3028-12.2012
10.1016/j.neuron.2014.02.027
10.1016/j.bbamem.2007.01.018
10.1073/pnas.0407035102
10.1016/j.febslet.2009.07.044
10.1016/j.chemphyslip.2009.03.008
10.1021/bi200771m
10.1002/jcb.20596
10.1016/j.mcn.2016.08.006
10.1128/MCB.24.20.8872-8883.2004
10.1038/nn1903
10.1111/j.1471-4159.1993.tb07480.x
10.3389/fnagi.2014.00186
10.1038/srep37063
10.1016/j.jnutbio.2015.07.022
10.1007/s00401-005-1040-6",<Element 'PubmedArticle' at 0x7f05df272d60>
242,32087283,Neuroprotection by dihydrotestosterone in LPS-induced neuroinflammation.,"Microglia-induced neuroinflammation plays a vital role in the etiology and progression of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and multiple sclerosis. The neuroprotective role of androgens, including testosterone and its metabolite dihydrotestosterone (DHT), has been increasingly demonstrated in these diseases, but few studies investigated the effects of androgen on neuroinflammation. This study investigated the role of DHT in lipopolysaccharide (LPS)-induced neuroinflammation, neuronal damage and behavioral dysfunction, as well as underlying mechanisms. We showed that DHT inhibited LPS-induced release of proinflammatory factors, including TNF-α, IL-1β, IL-6; iNOS, COX-2, NO, and PGE2 in BV2 cells and primary microglia by suppressing the TLR4-mediated NF-κB and MAPK p38 signaling pathways, thus protecting SH-SY5Y neurons from inflammatory damage induced by activated microglia. In an LPS-induced neuroinflammation mouse model, endogenous DHT depletion by castration exacerbated inflammatory responses by upregulating the levels of TNF-α, IL-1β, IL-6, iNOS, and COX-2 in the serum and brain by increasing the LR4-mediated NF-κB and MAPK pathway activation, but these effects were restored by exogenous DHT supplementation. Moreover, DHT also regulated the mRNA levels of the anti-inflammatory cytokines IL-10 and IL-13 in the brain. In addition, DHT modulated the expression of Aβ, the apoptotic proteins caspase-3, Bcl-2, and Bax, and synaptophysin, as well as neuronal damage in LPS-treated mouse brains. Further behavioral tests revealed that DHT ameliorated LPS-induced spatial and learning impairment and motor incoordination, and partly improved the locomotor activity in LPS-injected mice. Therefore, this study suggests that DHT exerts anti-neuroinflammatory and neuroprotective effects; thus, androgen replacement therapy is a potential therapeutic strategy for improving cognitive and behavioral function in neuroinflammation-related diseases.","['Cognitive impairment', 'Dihydrotestosterone', 'Lipopolysaccharide', 'Neuroinflammation', 'Sickness behavior']",Neurobiology of disease,2020-02-23,"[{'lastname': 'Yang', 'firstname': 'Lei', 'initials': 'L', 'affiliation': ""Department of Urology, Jing'an District Central Hospital, Fudan University, Shanghai 200040, China.""}, {'lastname': 'Zhou', 'firstname': 'Renyuan', 'initials': 'R', 'affiliation': ""Department of Urology, Tianjin Medical University General Hospital, Tianjin Medical University 300070 Tianjin, China; Department of Urology, Jing'an District Central Hospital, Fudan University, Shanghai 200040, China.""}, {'lastname': 'Tong', 'firstname': 'Yu', 'initials': 'Y', 'affiliation': ""Department of Urology, Jing'an District Central Hospital, Fudan University, Shanghai 200040, China.""}, {'lastname': 'Chen', 'firstname': 'Pengfei', 'initials': 'P', 'affiliation': ""Department of Urology, Jing'an District Central Hospital, Fudan University, Shanghai 200040, China.""}, {'lastname': 'Shen', 'firstname': 'Yu', 'initials': 'Y', 'affiliation': ""Department of Urology, Jing'an District Central Hospital, Fudan University, Shanghai 200040, China.""}, {'lastname': 'Miao', 'firstname': 'Shuai', 'initials': 'S', 'affiliation': ""Department of Urology, Jing'an District Central Hospital, Fudan University, Shanghai 200040, China. Electronic address: msdiyi@163.com.""}, {'lastname': 'Liu', 'firstname': 'Xiaoqiang', 'initials': 'X', 'affiliation': 'Department of Urology, Tianjin Medical University General Hospital, Tianjin Medical University 300070 Tianjin, China. Electronic address: 15233367861@163.com.'}]",,,,Copyright © 2020. Published by Elsevier Inc.,10.1016/j.nbd.2020.104814,<Element 'PubmedArticle' at 0x7f05de8a0720>
243,"32082315
22674585
17180163
28375739
17339843
19296921
19913097
22951445
26464797
11128604
24210793
26157004
26838361
26511587
28097204
27989508
22071848
21778362
28466394
28539244
29057315
22315722
15791003
19399218
17600340
27151770
17537546
23108585
31036561
28447995
18604209
30622196
29775624
30862700
10075647
10092675
23161999
28651603
31301160
27703142
19906719
30277602
29859868
25059623
30618606
17571925
25644178
27348712
22166424
25969543
26523646
25421810
30385548
29249285
26121197
26119245
21839623
28892059
23383169
21747756
26124111
27147665
27280685
16959795
23973294
24489101
25451151
27114033
21224065
31122931",Molecular Signatures of Neuroinflammation Induced by αSynuclein Aggregates in Microglial Cells.,Alpha-synuclein (αSyn,"[""Parkinson's disease"", 'microglia', 'neuroinflammation', 'proteomics', 'synuclein']",Frontiers in immunology,2020-02-23,"[{'lastname': 'Sarkar', 'firstname': 'Souvarish', 'initials': 'S', 'affiliation': ""Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.\nDepartment of Biomedical Sciences, Iowa State University, Ames, IA, United States.""}, {'lastname': 'Dammer', 'firstname': 'Eric B', 'initials': 'EB', 'affiliation': 'Department of Biochemistry, Emory University, Atlanta, GA, United States.'}, {'lastname': 'Malovic', 'firstname': 'Emir', 'initials': 'E', 'affiliation': 'Department of Biomedical Sciences, Iowa State University, Ames, IA, United States.'}, {'lastname': 'Olsen', 'firstname': 'Abby L', 'initials': 'AL', 'affiliation': ""Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.""}, {'lastname': 'Raza', 'firstname': 'Syed Ali', 'initials': 'SA', 'affiliation': 'Department of Neurology, Emory University, Atlanta, GA, United States.'}, {'lastname': 'Gao', 'firstname': 'Tianwen', 'initials': 'T', 'affiliation': 'Department of Neurology, Emory University, Atlanta, GA, United States.'}, {'lastname': 'Xiao', 'firstname': 'Hailian', 'initials': 'H', 'affiliation': 'Department of Neurology, Emory University, Atlanta, GA, United States.'}, {'lastname': 'Oliver', 'firstname': 'Danielle L', 'initials': 'DL', 'affiliation': 'Department of Neuroscience, University of Florida College of Medicine, Gainesville, FL, United States.'}, {'lastname': 'Duong', 'firstname': 'Duc', 'initials': 'D', 'affiliation': 'Department of Biochemistry, Emory University, Atlanta, GA, United States.'}, {'lastname': 'Joers', 'firstname': 'Valerie', 'initials': 'V', 'affiliation': 'Department of Neuroscience, University of Florida College of Medicine, Gainesville, FL, United States.'}, {'lastname': 'Seyfried', 'firstname': 'Nicholas', 'initials': 'N', 'affiliation': 'Department of Biochemistry, Emory University, Atlanta, GA, United States.\nDepartment of Neurology, Emory University, Atlanta, GA, United States.'}, {'lastname': 'Huang', 'firstname': 'Meixiang', 'initials': 'M', 'affiliation': 'Department of Pharmacology and Chemical Biology, Emory University, Atlanta, GA, United States.'}, {'lastname': 'Kukar', 'firstname': 'Thomas', 'initials': 'T', 'affiliation': 'Department of Neurology, Emory University, Atlanta, GA, United States.\nDepartment of Pharmacology and Chemical Biology, Emory University, Atlanta, GA, United States.'}, {'lastname': 'Tansey', 'firstname': 'Malú G', 'initials': 'MG', 'affiliation': 'Department of Neuroscience, University of Florida College of Medicine, Gainesville, FL, United States.'}, {'lastname': 'Kanthasamy', 'firstname': 'Anumantha G', 'initials': 'AG', 'affiliation': 'Department of Biomedical Sciences, Iowa State University, Ames, IA, United States.'}, {'lastname': 'Rangaraju', 'firstname': 'Srikant', 'initials': 'S', 'affiliation': 'Department of Neurology, Emory University, Atlanta, GA, United States.'}]",,,,"Copyright © 2020 Sarkar, Dammer, Malovic, Olsen, Raza, Gao, Xiao, Oliver, Duong, Joers, Seyfried, Huang, Kukar, Tansey, Kanthasamy and Rangaraju.","10.3389/fimmu.2020.00033
10.1002/glia.22350
10.1038/nrn2038
10.1089/ars.2016.6905
10.1038/sj.bjp.0707167
10.1016/S1474-4422(09)70062-6
10.1016/j.nbd.2009.11.004
10.1101/cshperspect.a009373
10.1186/s40035-015-0042-0
10.1007/978-3-7091-6284-2_12
10.1016/j.jneuroim.2013.10.009
10.1523/JNEUROSCI.0302-15.2015
10.1007/s11481-016-9650-4
10.1002/glia.22935
10.1002/acn3.369
10.1016/j.cels.2016.11.006
10.1002/14651858.CD008454.pub2
10.1126/science.1202529
10.1007/s11481-017-9746-5
10.1016/j.neuro.2017.05.009
10.1038/s41531-017-0032-2
10.1101/cshperspect.a009381
10.1096/fj.04-2751com
10.3390/ijms10030724
10.1002/glia.20532
10.1016/j.nbd.2016.04.008
10.1016/j.neurobiolaging.2007.04.006
10.1002/glia.22437
10.1084/jem.20182191
10.3791/55364
10.1038/ni.1636
10.1126/scisignal.aat9900
10.1016/j.neuro.2018.05.002
10.1126/scisignal.aau4543
10.1074/jbc.274.12.7619
10.1074/jbc.274.14.9843
10.1126/science.1227157
10.1186/s12974-017-0906-6
10.1002/glia.23678
10.1038/ncomms12932
10.1093/nar/gkp1005
10.1002/glia.23467
10.1016/j.nbd.2018.05.019
10.1007/978-1-4939-1142-4_24
10.3389/fnmol.2018.00454
10.1371/journal.pgen.0030098
10.1002/pmic.201400449
10.1038/nmeth.3901
10.1016/S1353-8020(11)70008-6
10.1126/scisignal.2005965
10.1038/nn.4160
10.3390/toxins6113187
10.1126/science.aat8407
10.1016/j.neuron.2017.11.036
10.1038/nm.3893
10.1111/jnc.13217
10.1016/j.coi.2011.07.005
10.1038/ng.3955
10.1371/journal.pone.0055375
10.3389/fnins.2011.00080
10.1073/pnas.1510329112
10.1523/JNEUROSCI.4658-15.2016
10.1126/scitranslmed.aaf3634
10.1093/hmg/ddl243
10.1016/j.neuropharm.2013.07.035
10.4049/jimmunol.1302549
10.1016/j.ajpath.2014.08.025
10.1016/j.cell.2016.04.001
10.1016/j.ajpath.2010.11.002
10.15252/emmm.201809711",<Element 'PubmedArticle' at 0x7f05dc5c34a0>
244,32078472,Transforming Growth Factor Beta-Activated Kinase 1-Dependent Microglial and Macrophage Responses Aggravate Long-Term Outcomes After Ischemic Stroke.,"Background and Purpose- Microglia/macrophages (Mi/MΦ) can profoundly influence stroke outcomes by acquiring functionally dominant phenotypes (proinflammatory or anti-inflammatory; deleterious or salutary). Identification of the molecular mechanisms that dictate the functional status of Mi/MΦ after brain ischemia/reperfusion may reveal novel therapeutic targets for stroke. We hypothesized that activation of TAK1 (transforming growth factor beta-activated kinase 1), a key MAP3K upstream of multiple inflammation-regulating pathways, drives Mi/MΦ toward a proinflammatory phenotype and potentiates ischemia/reperfusion brain injury. Methods- Young adult mice were subjected to 1 hour of middle cerebral artery occlusion (MCAO) followed by reperfusion. TAK1 was targeted by tamoxifen-induced Mi/MΦ-specific knockout or administration of a selective inhibitor 5Z-7-Oxozeaenol after MCAO. Neurobehavioral deficits and long-term gray matter and white matter injury were assessed up to 35 days after MCAO. Mi/MΦ functional status and brain inflammatory profiles were assessed 3 days after MCAO by RNA-seq, flow cytometry, and immunohistochemistry. Results- TAK1 Mi/MΦ-specific knockout markedly ameliorated neurological deficits in the rotarod and cylinder tests for at least 35 days after MCAO. Mechanistically, RNA-seq of purified brain Mi/MΦ demonstrated that proinflammatory genes and their predicted biological functions were downregulated or inhibited in microglia and macrophages from TAK1 Mi/MΦ-specific knockout mice versus WT mice 3 days after MCAO. Consistent with the anti-inflammatory phenotype of Mi/MΦ-specific knockout, oxozeaenol treatment mitigated neuroinflammation 3 days after MCAO, manifested by less Iba1","['inflammation', 'macrophages', 'microglia', 'reperfusion', 'stroke', 'tamoxifen']",Stroke,2020-02-23,"[{'lastname': 'Wang', 'firstname': 'Rongrong', 'initials': 'R', 'affiliation': 'From the Department of Neurology, Pittsburgh Institute of Brain Disorders and Recovery, University of Pittsburgh, PA (R.W., H.P., Q.Y., M.J., Jie Chen, J.Z., S.L., Y.L., X.H., Jun Chen, Y.S.).'}, {'lastname': 'Pu', 'firstname': 'Hongjian', 'initials': 'H', 'affiliation': 'From the Department of Neurology, Pittsburgh Institute of Brain Disorders and Recovery, University of Pittsburgh, PA (R.W., H.P., Q.Y., M.J., Jie Chen, J.Z., S.L., Y.L., X.H., Jun Chen, Y.S.).'}, {'lastname': 'Ye', 'firstname': 'Qing', 'initials': 'Q', 'affiliation': 'From the Department of Neurology, Pittsburgh Institute of Brain Disorders and Recovery, University of Pittsburgh, PA (R.W., H.P., Q.Y., M.J., Jie Chen, J.Z., S.L., Y.L., X.H., Jun Chen, Y.S.).\nGeriatric Research, Educational and Clinical Center, Veterans Affairs Pittsburgh Health Care System, PA (Q.Y., X.H., Jun Chen, Y.S.).'}, {'lastname': 'Jiang', 'firstname': 'Ming', 'initials': 'M', 'affiliation': 'From the Department of Neurology, Pittsburgh Institute of Brain Disorders and Recovery, University of Pittsburgh, PA (R.W., H.P., Q.Y., M.J., Jie Chen, J.Z., S.L., Y.L., X.H., Jun Chen, Y.S.).'}, {'lastname': 'Chen', 'firstname': 'Jie', 'initials': 'J', 'affiliation': 'From the Department of Neurology, Pittsburgh Institute of Brain Disorders and Recovery, University of Pittsburgh, PA (R.W., H.P., Q.Y., M.J., Jie Chen, J.Z., S.L., Y.L., X.H., Jun Chen, Y.S.).'}, {'lastname': 'Zhao', 'firstname': 'Jingyan', 'initials': 'J', 'affiliation': 'From the Department of Neurology, Pittsburgh Institute of Brain Disorders and Recovery, University of Pittsburgh, PA (R.W., H.P., Q.Y., M.J., Jie Chen, J.Z., S.L., Y.L., X.H., Jun Chen, Y.S.).'}, {'lastname': 'Li', 'firstname': 'Sicheng', 'initials': 'S', 'affiliation': 'From the Department of Neurology, Pittsburgh Institute of Brain Disorders and Recovery, University of Pittsburgh, PA (R.W., H.P., Q.Y., M.J., Jie Chen, J.Z., S.L., Y.L., X.H., Jun Chen, Y.S.).'}, {'lastname': 'Liu', 'firstname': 'Yaan', 'initials': 'Y', 'affiliation': 'From the Department of Neurology, Pittsburgh Institute of Brain Disorders and Recovery, University of Pittsburgh, PA (R.W., H.P., Q.Y., M.J., Jie Chen, J.Z., S.L., Y.L., X.H., Jun Chen, Y.S.).'}, {'lastname': 'Hu', 'firstname': 'Xiaoming', 'initials': 'X', 'affiliation': 'From the Department of Neurology, Pittsburgh Institute of Brain Disorders and Recovery, University of Pittsburgh, PA (R.W., H.P., Q.Y., M.J., Jie Chen, J.Z., S.L., Y.L., X.H., Jun Chen, Y.S.).\nGeriatric Research, Educational and Clinical Center, Veterans Affairs Pittsburgh Health Care System, PA (Q.Y., X.H., Jun Chen, Y.S.).'}, {'lastname': 'Rocha', 'firstname': 'Marcelo', 'initials': 'M', 'affiliation': 'Department of Neurology, UPMC Stroke Institute, University of Pittsburgh, PA (M.R., A.P.J.).'}, {'lastname': 'Jadhav', 'firstname': 'Ashutosh P', 'initials': 'AP', 'affiliation': 'Department of Neurology, UPMC Stroke Institute, University of Pittsburgh, PA (M.R., A.P.J.).'}, {'lastname': 'Chen', 'firstname': 'Jun', 'initials': 'J', 'affiliation': 'From the Department of Neurology, Pittsburgh Institute of Brain Disorders and Recovery, University of Pittsburgh, PA (R.W., H.P., Q.Y., M.J., Jie Chen, J.Z., S.L., Y.L., X.H., Jun Chen, Y.S.).\nGeriatric Research, Educational and Clinical Center, Veterans Affairs Pittsburgh Health Care System, PA (Q.Y., X.H., Jun Chen, Y.S.).'}, {'lastname': 'Shi', 'firstname': 'Yejie', 'initials': 'Y', 'affiliation': 'From the Department of Neurology, Pittsburgh Institute of Brain Disorders and Recovery, University of Pittsburgh, PA (R.W., H.P., Q.Y., M.J., Jie Chen, J.Z., S.L., Y.L., X.H., Jun Chen, Y.S.).\nGeriatric Research, Educational and Clinical Center, Veterans Affairs Pittsburgh Health Care System, PA (Q.Y., X.H., Jun Chen, Y.S.).'}]",,,,,10.1161/STROKEAHA.119.028398,<Element 'PubmedArticle' at 0x7f05dc5aa680>
245,"32072640
19037247
28801921
30394609
19052228
21239618
25420069
31407664
11756501
31138656
25241747
30773341
24559678
28226226
15494728
31063129
10380923
10500226
23770587
29096072
14973393
11059815
18752469
27270589
29021743
11328825
19299558
23616747
31587281
15632172
25182530
30998185
22927325
10809664
26085943
17567808
12410313
10652499
26055705
8713135
9630473
624958
11030619
11865025
17928865
31502243
28348241
28771710
31428774
30220511
25871402
10944117
24074869
22078880
23770565
15342788
30638745
31524598
22266197
26087164
23630073
30989755
24471431
31529356
19066220
29621490
15452344
11190569
31398341
16127449
20084085
9777629
27571192
27756201
16751179
26187728
21179166
30846309
26101081
22684107
20012068
20374706
20371609
11001057
12121626
26727548
30382198
27865453
11493571
25892301
10907076
31152445
16212947
29134703
30827729
30902874
22078881
28475868
15111318
12628926
25700174
28775344
11931768
31511520
30664766",A cell type-specific expression map of NCoR1 and SMRT transcriptional co-repressors in the mouse brain.,"The ability to rapidly change gene expression patterns is essential for differentiation, development, and functioning of the brain. Throughout development, or in response to environmental stimuli, gene expression patterns are tightly regulated by the dynamic interplay between transcription activators and repressors. Nuclear receptor corepressor 1 (NCoR1) and silencing mediator for retinoid or thyroid-hormone receptors (SMRT) are the best characterized transcriptional co-repressors from a molecular point of view. They mediate epigenetic silencing of gene expression in a wide range of developmental and homeostatic processes in many tissues, including the brain. For instance, NCoR1 and SMRT regulate neuronal stem cell proliferation and differentiation during brain development and they have been implicated in learning and memory. However, we still have a limited understanding of their regional and cell type-specific expression in the brain. In this study, we used fluorescent immunohistochemistry to map their expression patterns throughout the adult mouse brain. Our findings reveal that NCoR1 and SMRT share an overall neuroanatomical distribution, and are detected in both excitatory and inhibitory neurons. However, we observed striking differences in their cell type-specific expression in glial cells. Specifically, all oligodendrocytes express NCoR1, but only a subset express SMRT. In addition, NCoR1, but not SMRT, was detected in a subset of astrocytes and in the microglia. These novel observations are corroborated by single cell transcriptomics and emphasize how NCoR1 and SMRT may contribute to distinct biological functions, suggesting an exclusive role of NCoR1 in innate immune responses in the brain.","['NCoR1', 'SMRT', 'gene expression', 'immunohistochemistry', 'transcriptional co-repressor']",The Journal of comparative neurology,2020-02-20,"[{'lastname': 'Iemolo', 'firstname': 'Attilio', 'initials': 'A', 'affiliation': 'Department of Medicine, University of California San Diego, La Jolla, California.'}, {'lastname': 'Montilla-Perez', 'firstname': 'Patricia', 'initials': 'P', 'affiliation': 'Department of Medicine, University of California San Diego, La Jolla, California.'}, {'lastname': 'Lai', 'firstname': 'I-Chi', 'initials': 'IC', 'affiliation': 'Department of Psychiatry, University of California San Diego, La Jolla, California.'}, {'lastname': 'Meng', 'firstname': 'Yinuo', 'initials': 'Y', 'affiliation': 'Department of Medicine, University of California San Diego, La Jolla, California.'}, {'lastname': 'Nolan', 'firstname': 'Syreeta', 'initials': 'S', 'affiliation': 'Department of Medicine, University of California San Diego, La Jolla, California.'}, {'lastname': 'Wen', 'firstname': 'Junneng', 'initials': 'J', 'affiliation': 'Department of Medicine, University of California San Diego, La Jolla, California.'}, {'lastname': 'Rusu', 'firstname': 'Iulia', 'initials': 'I', 'affiliation': 'Department of Medicine, University of California San Diego, La Jolla, California.'}, {'lastname': 'Dulcis', 'firstname': 'Davide', 'initials': 'D', 'affiliation': 'Department of Psychiatry, University of California San Diego, La Jolla, California.'}, {'lastname': 'Telese', 'firstname': 'Francesca', 'initials': 'F', 'affiliation': 'Department of Medicine, University of California San Diego, La Jolla, California.'}]",,,,"© 2020 Wiley Periodicals, Inc.","10.1002/cne.24886
10.1038/nature07541
10.1002/jnr.24130
10.1002/hipo.23049
10.1073/pnas.0804604105
10.1210/me.2010-0462
10.1038/nn.3887
10.7554/eLife.40855
10.1523/Jneurosci.22-01-00183.2002
10.1523/Jneurosci.0227-18.2019
10.1016/j.stemcr.2014.07.008
10.1016/j.ccell.2019.01.008
10.1016/j.neuron.2013.12.027
10.1146/annurev-immunol-051116-052358
10.1038/nn1340
10.7554/eLife.44702
10.1016/S0092-8674(00)80783-7
10.1073/pnas.96.20.11619
10.1038/nature12348
10.1016/j.neuron.2017.10.007
10.1042/BSR20080093
10.1038/nm.4114
10.3389/fncel.2017.00300
10.1101/gad.1773109
10.3389/fncel.2013.00045
10.1111/jnc.14885
10.1074/jbc.M411514200
10.1128/MCB.00554-14
10.7554/eLife.43770
10.1002/glia.22408
10.1523/Jneurosci.1419-07.2007
10.1038/nature01156
10.1074/jbc.M115.661058
10.1006/bbrc.1996.1112
10.1016/S0169-328x(98)00040-0
10.1038/nature06270
10.1002/cne.24771
10.1073/pnas.1700731114
10.1111/jnc.14135
10.1093/nar/gkz685
10.1016/j.neuron.2018.08.031
10.18632/oncotarget.3599
10.1093/emboj/19.16.4342
10.1016/j.cell.2013.08.054
10.1016/j.cell.2011.09.050
10.1038/nn.3434
10.1093/nar/gkh786
10.1016/j.neuron.2018.12.010
10.7554/eLife.46773
10.1016/j.mce.2012.01.006
10.1016/j.neuron.2015.05.018
10.1101/gad.214023.113
10.1002/glia.23626
10.1146/annurev-immunol-032713-120240
10.1007/s11011-019-00488-z
10.1073/pnas.0811012105
10.1016/j.neuron.2018.03.003
10.1073/pnas.0405786101
10.1016/j.cell.2019.07.024
10.1038/nature03988
10.1038/nrg2736
10.1038/nn.4366
10.1186/s12862-016-0781-2
10.1101/gad.1424806
10.1101/cshperspect.a020545
10.1038/nature09584
10.1016/j.neuron.2019.02.007
10.1101/cshperspect.a020479
10.1172/JCI60580
10.1007/s00401-009-0619-8
10.1016/S1877-1173(09)87007-5
10.1074/jbc.M110.107680
10.1038/35025070
10.1016/S0960-9822(02)00926-0
10.1038/nn.4216
10.1038/s41586-018-0654-5
10.1016/j.biopsych.2016.09.017
10.1016/j.neuron.2015.03.033
10.2144/00291bm09
10.1002/cne.24720
10.1016/j.brainres.2005.08.011
10.1002/glia.23256
10.1016/j.neuron.2019.02.006
10.1523/JNEUROSCI.3069-18.2019
10.1016/j.cell.2011.10.017
10.1016/j.molcel.2017.03.019
10.1016/S0002-9440(10)63730-3
10.1093/emboj/cdg120
10.1126/science.aaa1934
10.1038/nrn.2017.85
10.1016/S1097-2765(02)00468-9
10.1038/s41467-019-12049-0
10.1038/s41593-018-0311-1",<Element 'PubmedArticle' at 0x7f05dc7d6450>
246,32028545,New Nrf2-Inducer Compound ITH12674 Slows the Progression of Retinitis Pigmentosa in the Mouse Model rd10.,"It is well established that oxidative stress and inflammation are common pathogenic features of retinal degenerative diseases. ITH12674 is a novel compound that induces the transcription factor Nrf2; in so doing, the molecule exhibits anti-inflammatory, and antioxidant properties, and affords neuroprotection in rat cortical neurons subjected to oxidative stress. We here tested the hypothesis that ITH12674 could slow the retinal degeneration that causes blindness in rd10 mice, a model of retinitis pigmentosa.
Animals were intraperitoneally treated with 1 or 10 mg/Kg ITH12674 or placebo from P16 to P30. At P30, retinal functionality and visual acuity were analyzed by electroretinography and optomotor test. By immunohistochemistry we quantified the photoreceptor rows and analyzed their morphology and connectivity. Oxidative stress and inflammatory state was studied by Western blot, and microglia reactivity was monitored by flow cytometry. The blood-brain barrier permeation of ITH12674 was evaluated using a PAMPA-BBB assay.
In rd10 mice treated with 10 mg/Kg of the compound, the following changes were observed (with respect to placebo): (i) a decrease of vision loss with higher scotopic a- and b-waves; (ii) increased visual acuity; (iii) preservation of cone photoreceptors morphology, as well as their synaptic connectivity; (iv) reduced expression of TNF-α and NF-κB; (v) increased expression of p38 MAPK and Atg12-Atg5 complex; and (vi) decreased CD11c, MHC class II and CD169 positive cell populations.
These data support the view that a Nrf2 inducer compound may arise as a new therapeutic strategy to combat retinal neurodegeneration. At present, we are chemically optimising compound ITH12674 with the focus on improving its neuroprotective potential in retinal neurodegenerative diseases.",['Neuroprotection; Neurodegeneration; Retina; Retinitis pigmentosa; Compound ITH12674'],"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology",2020-02-07,"[{'lastname': 'Campello', 'firstname': 'Laura', 'initials': 'L', 'affiliation': 'Departamento de Fisiología, Genética y Microbiología, Universidad de Alicante, Alicante, Spain.\nNeurobiology-Neurodegeneration and Repair Laboratory, National Eye Institute, National Institutes of Health, Bethesda, MD, USA.'}, {'lastname': 'Kutsyr', 'firstname': 'Oksana', 'initials': 'O', 'affiliation': 'Departamento de Fisiología, Genética y Microbiología, Universidad de Alicante, Alicante, Spain.'}, {'lastname': 'Noailles', 'firstname': 'Agustina', 'initials': 'A', 'affiliation': 'Departamento de Fisiología, Genética y Microbiología, Universidad de Alicante, Alicante, Spain.'}, {'lastname': 'Michalska', 'firstname': 'Patrycja', 'initials': 'P', 'affiliation': 'Instituto Teófilo Hernando, Universidad Autónoma de Madrid, Madrid, Spain.\nDepartamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain.\nInstituto de Investigación Sanitaria, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain.'}, {'lastname': 'Fernández-Sánchez', 'firstname': 'Laura', 'initials': 'L', 'affiliation': 'Departamento de Óptica, Farmacología y Anatomía, Universidad de Alicante, Alicante, Spain.'}, {'lastname': 'Martínez-Gil', 'firstname': 'Natalia', 'initials': 'N', 'affiliation': 'Departamento de Fisiología, Genética y Microbiología, Universidad de Alicante, Alicante, Spain.'}, {'lastname': 'Ortuño-Lizarán', 'firstname': 'Isabel', 'initials': 'I', 'affiliation': 'Departamento de Fisiología, Genética y Microbiología, Universidad de Alicante, Alicante, Spain.'}, {'lastname': 'Sánchez-Sáez', 'firstname': 'Xavier', 'initials': 'X', 'affiliation': 'Departamento de Fisiología, Genética y Microbiología, Universidad de Alicante, Alicante, Spain.'}, {'lastname': 'de Juan', 'firstname': 'Emilio', 'initials': 'E', 'affiliation': 'Departamento de Fisiología, Genética y Microbiología, Universidad de Alicante, Alicante, Spain.'}, {'lastname': 'Lax', 'firstname': 'Pedro', 'initials': 'P', 'affiliation': 'Departamento de Fisiología, Genética y Microbiología, Universidad de Alicante, Alicante, Spain.'}, {'lastname': 'León', 'firstname': 'Rafael', 'initials': 'R', 'affiliation': 'Instituto Teófilo Hernando, Universidad Autónoma de Madrid, Madrid, Spain.\nDepartamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain.\nInstituto de Investigación Sanitaria, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain.'}, {'lastname': 'García', 'firstname': 'Antonio G', 'initials': 'AG', 'affiliation': 'Instituto Teófilo Hernando, Universidad Autónoma de Madrid, Madrid, Spain.\nDepartamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain.\nInstituto de Investigación Sanitaria, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain.'}, {'lastname': 'Cuenca', 'firstname': 'Nicolás', 'initials': 'N', 'affiliation': 'Departamento de Fisiología, Genética y Microbiología, Universidad de Alicante, Alicante, Spain.'}, {'lastname': 'Maneu', 'firstname': 'Victoria', 'initials': 'V', 'affiliation': 'Departamento de Óptica, Farmacología y Anatomía, Universidad de Alicante, Alicante, Spain, vmaneu@ua.es.'}]",,"These data support the view that a Nrf2 inducer compound may arise as a new therapeutic strategy to combat retinal neurodegeneration. At present, we are chemically optimising compound ITH12674 with the focus on improving its neuroprotective potential in retinal neurodegenerative diseases.","In rd10 mice treated with 10 mg/Kg of the compound, the following changes were observed (with respect to placebo): (i) a decrease of vision loss with higher scotopic a- and b-waves; (ii) increased visual acuity; (iii) preservation of cone photoreceptors morphology, as well as their synaptic connectivity; (iv) reduced expression of TNF-α and NF-κB; (v) increased expression of p38 MAPK and Atg12-Atg5 complex; and (vi) decreased CD11c, MHC class II and CD169 positive cell populations.",© Copyright by the Author(s). Published by Cell Physiol Biochem Press.,10.33594/000000210,<Element 'PubmedArticle' at 0x7f05df3b3720>
247,32018209,Rhodiola rosea L. modulates inflammatory processes in a CRH-activated BV2 cell model.,"Rhodiola rosea L. (Crassulaceae) has been used for years in the traditional medicine of several countries as an adaptogen drug, able to preserve homeostasis in response to stress stimuli. Currently R. rosea roots and rhizome are classified as a traditional herbal medicinal product for temporary relief of symptoms of stress, such as fatigue and sensation of weakness by the European Medicines Agency.
Increasing evidences suggest the involvement of neuroinflammation in response to stress. However, whether the modulation of neuroinflammatory parameters could be involved in the anti-stress effect of R. rosea has been barely studied. Thus, the aim of this work is to investigate the possible modulation of molecular inflammatory processes elicited by a R. rosea roots and rhizome ethanolic extract in an in vitro model of corticotropin releasing hormone (CRH)-stimulated BV2 microglial cells.
BV2 cells were stimulated with CRH 100 nM and changes in cell viability, cytokines production and heat shock protein 70 (HSP70) levels were evaluated. Intracellular pathways related to inflammation, such as nuclear factor kappa-light-chain enhancer of activated B cells (NF-κB) nuclear translocation and mitogen-activated protein kinases (MAPK) activation were also analyzed.
We found that R. rosea extract (2.7% m/m rosavin and 1% m/m salidroside) 20 µg/ml was able to counteract the neuroinflammatory effect of CRH by inhibiting NF-κB nuclear translocation with a mechanism of action involving the modulation of mitogen-activated protein kinase-activated protein kinase 2 (MKK2), extracellular signal-regulated kinase 1/2 (ERK 1/2) and c-Jun n-terminal kinase (JNK), resulting in a reduction of HSP70 expression.
This work expands the knowledge of the intracellular mechanisms involved in R. rosea anti-stress activity and may be useful for the study of other adaptogen drugs.","['CRH', 'HSP70', 'MAPK', 'NF-κB', 'Rhodiola rosea L.', 'microglia']",Phytomedicine : international journal of phytotherapy and phytopharmacology,2020-02-06,"[{'lastname': 'Borgonetti', 'firstname': 'Vittoria', 'initials': 'V', 'affiliation': 'Department of Neuroscience, Psychology, Pharmacology and Child Health (NEUROFARBA), University of Florence, Florence, Italy.'}, {'lastname': 'Governa', 'firstname': 'Paolo', 'initials': 'P', 'affiliation': 'Department of Biotechnology, Chemistry and Pharmacy - Department of Excellence 2018-2022, University of Siena, Siena, Italy.'}, {'lastname': 'Biagi', 'firstname': 'Marco', 'initials': 'M', 'affiliation': 'Department of Physical Sciences, Earth and Environment, University of Siena, Strada Laterina, 8 Siena 53100, Italy. Electronic address: biagi4@unisi.it.'}, {'lastname': 'Dalia', 'firstname': 'Pasquale', 'initials': 'P', 'affiliation': 'Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.'}, {'lastname': 'Corsi', 'firstname': 'Lorenzo', 'initials': 'L', 'affiliation': 'Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.'}]",,This work expands the knowledge of the intracellular mechanisms involved in R. rosea anti-stress activity and may be useful for the study of other adaptogen drugs.,"We found that R. rosea extract (2.7% m/m rosavin and 1% m/m salidroside) 20 µg/ml was able to counteract the neuroinflammatory effect of CRH by inhibiting NF-κB nuclear translocation with a mechanism of action involving the modulation of mitogen-activated protein kinase-activated protein kinase 2 (MKK2), extracellular signal-regulated kinase 1/2 (ERK 1/2) and c-Jun n-terminal kinase (JNK), resulting in a reduction of HSP70 expression.",Copyright © 2019 Elsevier GmbH. All rights reserved.,10.1016/j.phymed.2019.153143,<Element 'PubmedArticle' at 0x7f05df3eb950>
248,"31992325
11788614
28191467
11063905
11799344
19412477
18001721
22067260
24704246
25052429
24819940
28948468
25086299
28667487
30822454
27250720
29582398
15337246
17113982
18001325
21555578
30391959
3192762
29316776
24270812
27559087
21199938
28539349
28007993
28642575
28099414
26477569
31297095
10987824
21745355
27717807
26037411
27283249
25843666
30227622
28888963
23584859
11384882
10433246
29162485
16736049
16787981
29178139
11222926
23238794
26818951
29139169
28341582
27546235
1562533
12239082
26153859
7144917
11108858
21125645
28552663
19777158
17707846
20495459
21118039
21208397
26343475
24444786
21767382
23819447
23795693",The synthetic steroid tibolone exerts sex-specific regulation of astrocyte phagocytosis under basal conditions and after an inflammatory challenge.,"Tibolone is a synthetic steroid used in clinical practice for the treatment of climacteric symptoms and osteoporosis. Active metabolites of tibolone, generated in target tissues, have an affinity for estrogen and androgen receptors. Astrocytes are direct targets for estrogenic compounds and previous studies have shown that tibolone protects brain cortical neurons in association with a reduction in reactive astrogliosis in a mouse model of traumatic brain injury. Since phagocytosis is a crucial component of the neuroprotective function exerted by astrocytes, in the present study, we have assessed whether tibolone regulates phagocytosis in primary astrocytes incubated with brain-derived cellular debris.
Male and female astrocyte cell cultures were obtained from newborn (P0-P2) female and male Wistar rats. Astrocytic phagocytosis was first characterized using carboxylate beads, Escherichia coli particles, or brain-derived cellular debris. Then, the effect of tibolone on the phagocytosis of Cy3-conjugated cellular debris was quantified by measuring the intensity of Cy3 dye-emitted fluorescence in a given GFAP immunoreactive area. Before the phagocytosis assays, astrocytes were incubated with tibolone in the presence or absence of estrogen or androgen receptor antagonists or an inhibitor of the enzyme that synthesizes estradiol. The effect of tibolone on phagocytosis was analyzed under basal conditions and after inflammatory stimulation with lipopolysaccharide.
Tibolone stimulated phagocytosis of brain-derived cellular debris by male and female astrocytes, with the effect being more pronounced in females. The effect of tibolone in female astrocytes was blocked by a selective estrogen receptor β antagonist and by an androgen receptor antagonist. None of these antagonists affected tibolone-induced phagocytosis in male astrocytes. In addition, the inhibition of estradiol synthesis in the cultures enhanced the stimulatory effect of tibolone on phagocytosis in male astrocytes but blocked the effect of the steroid in female cells under basal conditions. However, after inflammatory stimulation, the inhibition of estradiol synthesis highly potentiated the stimulation of phagocytosis by tibolone, particularly in female astrocytes.
Tibolone exerts sex-specific regulation of phagocytosis in astrocytes of both sexes, both under basal conditions and after inflammatory stimulation.","['Androgen receptor', 'Astrocytes', 'Cellular debris', 'Estrogen receptor', 'LPS', 'Phagocytosis', 'Sex differences', 'Tibolone']",Journal of neuroinflammation,2020-01-30,"[{'lastname': 'Crespo-Castrillo', 'firstname': 'Andrea', 'initials': 'A', 'affiliation': 'Instituto Cajal, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.'}, {'lastname': 'Garcia-Segura', 'firstname': 'Luis-Miguel', 'initials': 'LM', 'affiliation': 'Instituto Cajal, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.\nCentro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludables (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain.'}, {'lastname': 'Arevalo', 'firstname': 'Maria-Angeles', 'initials': 'MA', 'affiliation': 'Instituto Cajal, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain. arevalo@cajal.csic.es.\nCentro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludables (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain. arevalo@cajal.csic.es.'}]",,,"Tibolone stimulated phagocytosis of brain-derived cellular debris by male and female astrocytes, with the effect being more pronounced in females. The effect of tibolone in female astrocytes was blocked by a selective estrogen receptor β antagonist and by an androgen receptor antagonist. None of these antagonists affected tibolone-induced phagocytosis in male astrocytes. In addition, the inhibition of estradiol synthesis in the cultures enhanced the stimulatory effect of tibolone on phagocytosis in male astrocytes but blocked the effect of the steroid in female cells under basal conditions. However, after inflammatory stimulation, the inhibition of estradiol synthesis highly potentiated the stimulation of phagocytosis by tibolone, particularly in female astrocytes.",,"10.1186/s12974-020-1719-6
10.1210/jcem.87.1.8141
10.1155/2017/8630764
10.1016/S0378-5122(00)00147-X
10.1097/00004714-200202000-00010
10.2147/nedt.2006.2.3.299
10.1016/j.fertnstert.2007.05.061
10.1016/j.yhbeh.2011.10.005
10.1016/j.nrl.2014.03.002
10.1007/s11064-014-1385-0
10.1007/s12035-017-0777-y
10.1016/j.jsbmb.2014.07.009
10.1016/j.mce.2019.02.017
10.1016/j.mce.2016.05.024
10.1007/s12035-018-1008-x
10.1016/j.maturitas.2004.02.012
10.1016/j.jsbmb.2006.09.037
10.1111/j.1365-2826.2007.01611.x
10.1073/pnas.1103833108
10.1159/000495078
10.1002/cne.902760109
10.4062/biomolther.2017.133
10.1038/nature12776
10.1073/pnas.1609896113
10.1073/pnas.1013965108
10.1523/JNEUROSCI.3981-16.2017
10.1093/brain/aww298
10.1038/s41467-017-00037-1
10.1038/nature21029
10.1038/srep15224
10.3389/fendo.2019.00420
10.1046/j.1471-4159.2000.0751447.x
10.1186/2042-6410-2-7
10.1016/j.neuroscience.2016.09.047
10.1002/glia.22867
10.1016/j.pneurobio.2016.06.002
10.1016/j.nbd.2015.03.028
10.3390/ijms19092793
10.1016/j.neuint.2017.09.003
10.1210/en.2012-2137
10.1016/S0960-0760(01)00044-9
10.1210/endo.140.8.6907
10.1016/j.neuint.2017.11.007
10.1038/sj.jcbfm.9600331
10.1210/jc.2006-0462
10.1002/glia.23270
10.1016/S0197-0186(00)00090-5
10.1007/s11481-012-9427-3
10.1186/s12974-016-0477-y
10.1002/glia.23263
10.1016/j.bbi.2017.03.010
10.1038/nri.2016.90
10.1016/0960-0760(92)90394-X
10.1210/en.2002-211438
10.1038/nature14583
10.1038/300648a0
10.1016/S0039-128X(00)00112-4
10.1002/glia.21094
10.1016/j.yfrne.2017.05.003
10.1007/s00011-009-0026-6
10.1016/S1550-8579(07)80026-X
10.1097/YCO.0b013e3283399b86
10.2217/WHE.10.69
10.1186/2042-6410-2-1
10.1016/j.comppsych.2015.07.002
10.1016/j.mce.2014.01.009
10.1186/1742-2094-8-81
10.1089/neu.2013.2951
10.1111/jne.12067",<Element 'PubmedArticle' at 0x7f05df3b54f0>
249,31987854,Downregulation of spinal angiotensin converting enzyme 2 is involved in neuropathic pain associated with type 2 diabetes mellitus in mice.,"We have previously reported that the spinal angiotensin (Ang) system is involved in the modulation of streptozotocin (STZ)-induced diabetic neuropathic pain in mice. An important drawback of this model however is the fact that the neuropathic pain is independent of hyperglycemia and produced by the direct stimulation of peripheral nerves. Here, using the leptin deficient ob/ob mouse as a type 2 diabetic model, we examined whether the spinal Ang system was involved in naturally occuring diabetic neuropathic pain. Blood glucose levels were increased in ob/ob mice at 5-15 weeks of age. Following the hyperglycemia, persistent tactile and thermal hyperalgesia were observed at 11-14 and 9-15 weeks of age, respectively, which was ameliorated by insulin treatment. At 12 weeks of age, the expression of Ang-converting enzyme (ACE) 2 in the spinal plasma membrane fraction was decreased in ob/ob mice. Spinal ACE2 was expressed in neurons and microglia but the number of NeuN-positive neurons was decreased in ob/ob mice. In addition, the intrathecal administration of Ang (1-7) and SB203580, a p38 MAPK inhibitor, attenuated hyperalgesia in ob/ob mice. The phosphorylation of spinal p38 MAPK was also attenuated by Ang (1-7) in ob/ob mice. These inhibitory effects of Ang (1-7) were prevented by A779, a Mas receptor antagonist. In conclusion, we revealed that the Ang (1-7)-generating system is downregulated in ob/ob mice and is accompanied by a loss of ACE2-positive neurons. Furthermore, Ang (1-7) decreased the diabetic neuropathic pain through inhibition of p38 MAPK phosphorylation via spinal Mas receptors.","['Angiotensin (1-7)', 'Angiotensin-converting enzyme 2', 'Neuropathic pain', 'Spinal cord', 'Type 2 diabetes']",Biochemical pharmacology,2020-01-29,"[{'lastname': 'Yamagata', 'firstname': 'Ryota', 'initials': 'R', 'affiliation': 'Department of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai 981-8558, Japan.'}, {'lastname': 'Nemoto', 'firstname': 'Wataru', 'initials': 'W', 'affiliation': 'Department of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai 981-8558, Japan. Electronic address: nemoto@tohoku-mpu.ac.jp.'}, {'lastname': 'Nakagawasai', 'firstname': 'Osamu', 'initials': 'O', 'affiliation': 'Department of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai 981-8558, Japan.'}, {'lastname': 'Takahashi', 'firstname': 'Kohei', 'initials': 'K', 'affiliation': 'Department of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai 981-8558, Japan.'}, {'lastname': 'Tan-No', 'firstname': 'Koichi', 'initials': 'K', 'affiliation': 'Department of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai 981-8558, Japan.'}]",,,,Copyright © 2020 Elsevier Inc. All rights reserved.,10.1016/j.bcp.2020.113825,<Element 'PubmedArticle' at 0x7f05df108400>
250,31980280,Cerebrospinal fluid progranulin is associated with increased cortical thickness in early stages of Alzheimer's disease.,"Progranulin plays an important role in neuroinflammation in Alzheimer's disease (AD) pathophysiology, being upregulated by activated microglia. This study assessed whether cerebrospinal fluid levels of progranulin correlated with structural neuroimaging measures and cognition in 122 cognitively normal individuals, 81 mild cognitive impairment, and 70 AD patients from the Alzheimer's Disease Neuroimaging Initiative. Cognitively normal subjects were classified into 3 groups using the AT(N) system, whereas all mild cognitive impairment and AD patients were A+/TN+. Correlations between progranulin with neuroanatomical measures and cognitive decline were performed within each group. Progranulin was associated with cortical thickening in parietal, occipital, and frontal regions in cognitively normal individuals with amyloid pathology. These subjects also showed cortical thickening compared with A-/TN- subjects, an effect that was partially mediated by progranulin. In addition, higher progranulin correlated with longitudinal cognitive decline. The association between progranulin and cortical thickening, together with regional ""brain swelling"" in A+/TN- subjects, suggests progranulin contributes to the neuroinflammatory structural changes in preclinical AD.","[""Alzheimer's disease"", 'Cerebrospinal fluid', 'Cortical thickness', 'Magnetic resonance imaging', 'Neuroinflammation', 'Progranulin']",Neurobiology of aging,2020-01-26,"[{'lastname': 'Batzu', 'firstname': 'Lucia', 'initials': 'L', 'affiliation': 'Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Huddinge, Sweden. Electronic address: luciabatzu@gmail.com.'}, {'lastname': 'Westman', 'firstname': 'Eric', 'initials': 'E', 'affiliation': 'Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Huddinge, Sweden.'}, {'lastname': 'Pereira', 'firstname': 'Joana B', 'initials': 'JB', 'affiliation': 'Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Huddinge, Sweden.'}, {'lastname': None, 'firstname': None, 'initials': None, 'affiliation': 'Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Huddinge, Sweden.'}]",,,,Copyright © 2019 Elsevier Inc. All rights reserved.,10.1016/j.neurobiolaging.2019.12.012,<Element 'PubmedArticle' at 0x7f05dba44220>
251,31954812,Facilitation of microglial motility by thyroid hormones requires the presence of neurons in cell culture: A distinctive feature of the brainstem versus the cortex.,"Microglia are critical for the refinement of neural networks that takes place during the perinatal period. Their phenotype and actions are guided by the signals produced by neighbouring cells and hormones present in their surrounding milieu. Cell populations and the signals they produce differ between regions. The fact that thyroid hormones (THs) promote the growth and morphological differentiation of microglia within the cortex contributes to the TH's powerful actions on the developing brain. The brainstem is especially active during early life owing to its role in generation of the rhythmic respiratory motor command. Despite evidences indicating that THs are necessary to proper development of the neural networks regulating this vital homeostatic function, their actions on microglia originating from the brainstem remain unknown. Using primary cultured microglia from newborn mice (C57BL/6J), we first report that regulation of microglial motility by THs is different between cortex and brainstem. Microglial motility (μm traveled over 3 h) was monitored with or without triiodothyronine (T3, 1μM). Exposure to T3 did not stimulate microglial motility from brainstem, but significantly stimulated (316 %) when they were co-cultured with neurons. Motility of cortex microglia was stimulated to the similar extent either with or without neurons. These data suggest that the microglial function in different regions of the brain is determined by the surrounding environment.","['Brainstem', 'Cell culture', 'Microglia', 'Migration', 'Thyroid hormones']",Brain research bulletin,2020-01-20,"[{'lastname': 'Rousseau', 'firstname': 'Jean-Philippe', 'initials': 'JP', 'affiliation': ""Department of Pediatrics, Centre de recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, G1V 4G5, Canada. Electronic address: Jean-philippe.rousseau@unityhealth.to.""}, {'lastname': 'Noda', 'firstname': 'Mami', 'initials': 'M', 'affiliation': 'Laboratory of Pathophysiology, Graduate School of Pharmaceutical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan.'}, {'lastname': 'Kinkead', 'firstname': 'Richard', 'initials': 'R', 'affiliation': ""Department of Pediatrics, Centre de recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, G1V 4G5, Canada.""}]",,,,Copyright © 2020 Elsevier Inc. All rights reserved.,10.1016/j.brainresbull.2020.01.010,<Element 'PubmedArticle' at 0x7f05df8d8090>
252,"31947687
27199290
30298825
30306845
20501670
30010844
10964719
31312100
29608929
18566114
22286004
27983867
19609045
27115820
29109970
22895714
27404794
28092660
11126391
8624731
18415116
31026414
28341037
16005735
29973684
19032979
21791557
19779720
28737511
26041910
25891508
31165009
27677607
25805644
26995317
29411111
29931997
29618972
30967783
25704502
27381166
30933927
30547889
20840250
29363567
20652472
23956762
29125559
30297514
12186688
20427135
9075691
31533319
9588697
12963097
10601814
24719525
30026944
27305321
31491842
30717384
30406179
2115435
12960020
21595758
10792581
23557940
28894751
8307966
9013781
12508571
30982981
30449598
29745937
24760020
29712570
21192080
11014231
20883673
16721036
28373090
8363725
17051272
25269386
20163400
23090753
21896757
23735672
19845835
19352414
23636330
24952104
30922440
18787387
27736314
28630099
29915601
10342831
22015330
14571320
18669662
10839541
15852394
10670522
29729230
23792036
24158306
20816944
17625423
24003334
22753534
28855891
23990408
31309172
24064031
30254630
14670988
27340554
25539190
28377875
28683286
25979502
27773938
28785099
22766885
22248073
29681442
22074955
16721030
12951633
20628204
26074346
28057770
19908934
19179437
26859602
19211814
25589226
26857932
15380807
22448029
26136779
11000114
25780937
25946091
16503925
21093546
23392256
21325051
15932928
18845637
30243474
21285322
31333520
30013511
14763914
26425884",Effect of Inflammation on Female Gonadotropin-Releasing Hormone (GnRH) Neurons: Mechanisms and Consequences.,,"['GnRH neuron', 'cytokines', 'estradiol', 'inflammation', 'obesity']",International journal of molecular sciences,2020-01-18,"[{'lastname': 'Barabás', 'firstname': 'Klaudia', 'initials': 'K', 'affiliation': 'Molecular Neuroendocrinology Research Group, Institute of Physiology, Medical School, Centre for Neuroscience, Szentágothai Research Institute, University of Pécs, H-7624 Pécs, Hungary.'}, {'lastname': 'Szabó-Meleg', 'firstname': 'Edina', 'initials': 'E', 'affiliation': 'Departement of Biophysics, Medical School, University of Pécs; H-7624 Pécs, Hungary.'}, {'lastname': 'Ábrahám', 'firstname': 'István M', 'initials': 'IM', 'affiliation': 'Molecular Neuroendocrinology Research Group, Institute of Physiology, Medical School, Centre for Neuroscience, Szentágothai Research Institute, University of Pécs, H-7624 Pécs, Hungary.'}]",,,,,"10.3390/ijms21020529
10.1038/nrendo.2016.70
10.1262/jrd.2018-110
10.1530/JOE-18-0269
10.1210/en.2010-0022
10.1210/en.2018-00389
10.1006/bbrc.2000.3350
10.1002/rmb2.12272
10.1016/j.yfrne.2018.03.005
10.1210/en.2008-0316
10.1159/000332822
10.1210/en.2016-1689
10.1507/endocrj.K09E-185
10.1523/ENEURO.0259-17.2017
10.1523/JNEUROSCI.1333-12.2012
10.1016/j.dci.2016.07.004
10.1038/nn.4475
10.1038/sj.mp.4000813
10.1016/0006-8993(95)00913-B
10.1007/s00418-008-0424-9
10.1146/annurev-immunol-042718-041417
10.1016/j.jaut.2016.10.006
10.1016/j.jneuroim.2005.04.018
10.1038/s41598-018-28518-3
10.1016/j.neuroscience.2008.10.047
10.1210/en.2011-1228
10.1007/s00281-009-0177-0
10.1172/JCI95769
10.1523/JNEUROSCI.2745-14.2015
10.1038/nrn3898
10.14336/AD.2018.0720
10.1007/s13311-016-0477-8
10.1093/brain/awv077
10.1016/j.bbi.2016.03.010
10.1007/s00401-018-1815-1
10.1177/1073858418783959
10.3389/fncel.2018.00072
10.3389/fphar.2019.00286
10.1016/j.imlet.2015.02.004
10.1111/aji.12537
10.1530/REP-18-0618
10.1684/ecn.2018.0412
10.1111/j.1749-6632.2010.05663.x
10.1530/REP-17-0406
10.1007/s13105-010-0030-x
10.1155/2013/926937
10.3390/molecules22111933
10.1242/jeb.185504
10.1080/10253890290027868
10.1016/j.anireprosci.2010.03.011
10.1210/endo.138.4.5044
10.3390/ijms20184598
10.1159/000054323
10.1016/S0739-7240(03)00043-2
10.1159/000026415
10.1155/2014/867170
10.1186/s40104-018-0267-8
10.1089/sur.2016.021
10.3390/ijms20184341
10.3390/toxins11020091
10.1523/ENEURO.0211-18.2018
10.1210/endo-127-2-849
10.1210/en.2003-0644
10.1111/j.1439-0531.2011.01800.x
10.1046/j.1365-2826.2000.00466.x
10.1016/j.anireprosci.2013.03.005
10.1155/2017/6823209
10.1016/S0169-328X(96)00129-5
10.1002/jcp.28647
10.1016/j.bbrc.2018.11.021
10.1088/1478-3975/aac3ba
10.1371/journal.pone.0095995
10.1186/s12974-018-1158-9
10.1002/cne.22529
10.1210/endo.141.10.7695
10.1016/j.brainres.2010.09.083
10.1159/000093155
10.1016/j.neulet.2017.03.051
10.1016/0167-5699(93)90235-D
10.1038/sj.gene.6364347
10.1111/aji.12329
10.1111/j.1600-0897.2010.00810.x
10.1507/endocrj.EJ12-0280
10.1073/pnas.1107533108
10.1159/000351867
10.1111/j.1365-2826.2009.01928.x
10.1016/S1642-431X(12)60091-6
10.1038/nature12143
10.1016/j.yhbeh.2014.06.007
10.1071/RD18277
10.1007/BF03345620
10.1210/jc.2016-2115
10.1530/REP-17-0191
10.3389/fimmu.2018.01269
10.1210/endo.140.6.6739
10.1016/j.physbeh.2011.09.025
10.1007/BF03402177
10.1073/pnas.0803237105
10.1038/35013070
10.1002/ana.20454
10.1016/j.mad.2018.04.008
10.1016/j.jamda.2013.05.009
10.1007/s11154-013-9279-z
10.1016/j.brainres.2010.08.088
10.1097/GCO.0b013e32825e1d70
10.1016/j.ddmec.2013.03.006
10.1161/CIRCULATIONAHA.111.087213
10.3389/fendo.2017.00197
10.1007/s11154-013-9261-9
10.15698/cst2019.07.191
10.1016/j.mce.2013.09.017
10.3389/fimmu.2018.01992
10.1210/en.2003-1406
10.1186/s12610-016-0034-7
10.3109/09513590.2014.994602
10.1016/j.molmet.2017.01.010
10.1016/j.cmet.2017.05.015
10.3945/an.114.006940
10.1038/ijo.2016.183
10.1038/s41598-017-07858-6
10.1194/jlr.D029546
10.1111/j.1471-4159.2012.07660.x
10.1016/j.cmet.2018.03.014
10.1016/j.peptides.2011.10.020
10.1159/000092753
10.1055/s-2003-41285
10.1172/JCI41069
10.1016/j.peptides.2015.05.016
10.1530/JME-16-0212
10.1210/en.2008-1693
10.14310/horm.2002.1649
10.3945/ajcn.2008.26788C
10.1111/obr.12243
10.4103/1596-3519.158524
10.1016/j.tem.2004.07.009
10.1530/JME-12-0025
10.1155/2015/508409
10.1126/science.289.5487.2122
10.1371/journal.pone.0119995
10.1371/journal.pone.0121974
10.1111/j.1365-2826.2006.01417.x
10.1016/j.neuroscience.2010.11.022
10.1210/en.2012-2056
10.1210/en.2010-1100
10.1210/en.2005-0337
10.1210/en.2008-0849
10.1016/j.ando.2018.07.012
10.1210/en.2010-1285
10.3389/fpsyt.2019.00479
10.3389/fendo.2018.00315
10.1530/eje.0.1500161
10.1210/jc.2015-1946",<Element 'PubmedArticle' at 0x7f05da1e5950>
253,31945450,Progranulin suppresses the age-dependent enhancement of neuronal activity in the hypothalamus.,"Our previous investigations revealed that progranulin (PGRN) is a lysosomal protein involved in hippocampal neurogenesis and neuroinflammation. However, the possible involvement of PGRN in regulating inflammatory response and mediating neuronal activity is still not well-defined. Here, we demonstrate that PGRN deficiency enhances the age-dependent increase of neuronal activity in the paraventricular nucleus (PVN) of the hypothalamus. Aging increased neuronal activity in the PVN of the hypothalamus, and PGRN deficiency enhanced the effects of age on hypothalamic neuronal activity. Aging increased the lysosomal biogenesis and inflammatory response in microglia, which was also aggravated in PGRN-knockout mice. Moreover, PGRN deficiency enhanced interleukin-1 beta and lysosomal genes levels. These results suggest that PGRN deficiency may enhance the age-dependent increase of neuronal activity possibly because PGRN facilitates immunological responses through regulating lysosomal function.","['Aging', 'Lysosome', 'Microglia', 'Neuronal activity', 'Progranulin']",Neuroscience letters,2020-01-17,"[{'lastname': 'Bai', 'firstname': 'Dongying', 'initials': 'D', 'affiliation': 'Department of Animal Physiology, College of Animal Science and Technology, Henan University of Science and Technology, Luoyang 471003, PR China.'}, {'lastname': 'Ma', 'firstname': 'Yihong', 'initials': 'Y', 'affiliation': 'Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-0811, Japan.'}, {'lastname': 'Lv', 'firstname': 'Leyuan', 'initials': 'L', 'affiliation': 'Department of Animal Physiology, College of Animal Science and Technology, Henan University of Science and Technology, Luoyang 471003, PR China.'}, {'lastname': 'Wang', 'firstname': 'Yun', 'initials': 'Y', 'affiliation': 'Key Laboratory of Aquatic Product Processing, Ministry of Agriculture, South China Pearl River Fisheries Research Institute, Chinese Academy of Fishery Sciences, Guangzhou 510300, PR China.'}, {'lastname': 'Yang', 'firstname': 'Wanqing', 'initials': 'W', 'affiliation': 'Department of Veterinary Physiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo 113-8657, Japan.'}, {'lastname': 'Ma', 'firstname': 'Yanbo', 'initials': 'Y', 'affiliation': 'Department of Animal Physiology, College of Animal Science and Technology, Henan University of Science and Technology, Luoyang 471003, PR China. Electronic address: mayanbo@haust.edu.cn.'}]",,,,Copyright © 2020 Elsevier B.V. All rights reserved.,10.1016/j.neulet.2020.134755,<Element 'PubmedArticle' at 0x7f05df8a7c20>
254,31915845,Dexamethasone sodium phosphate attenuates lipopolysaccharide-induced neuroinflammation in microglia BV2 cells.,"Abnormal neuroinflammation ignited by overproduction of chemokines and cytokines via microglial cells can induce the occurrence and development of neurodegenerative disorders. The aim of this study is to investigate the effects of dexamethasone sodium phosphate (Dex-SP) on chemokine and cytokine secretion in lipopolysaccharide (LPS)-activated microglial cells. LPS markedly enhanced the secretion of pro-inflammatory factors such as regulated on activation, normal T cell expressed and secreted (RANTES), transforming growth factor beta-β1 (TGF-β1) and nitric oxide (NO), but decreased the production of macrophage inflammatory protein-1α (MIP-1α) and interleukin 10 (IL-10) in BV-2 microglial cells. Furthermore, LPS increased BV-2 microglial cell migration. However, Dex-SP treatment had the opposite effect, dampening the secretion of RANTES, TGF-β1, and NO, while increasing the production of MIP-1α and IL-10 and blocking migration of LPS-stimulated BV-2 microglial cells. Furthermore, Dex-SP markedly suppressed the LPS-induced degradation of IRAK-1 and IRAK-4, and blocked the activation in TRAF6, p-TAK1, and p-JNK in BV-2 microglial cells. These results showed that Dex-SP inhibited the neuroinflammatory response and migration in LPS-activated BV-2 microglia by inhibiting the secretion of RANTES, TGF-β1, and NO and increasing the production of MIP-1α and IL-10. The molecular mechanism of Dex-SP may be associated with inhibition of TRAF6/TAK-1/JNK signaling pathways mediated by IRAK-1 and IRAK-4.","['Chemokine', 'Cytokine', 'Dexamethasone sodium phosphate', 'LPS', 'Microglia']",Naunyn-Schmiedeberg's archives of pharmacology,2020-01-10,"[{'lastname': 'Hui', 'firstname': 'Bin', 'initials': 'B', 'affiliation': 'College of Pharmacy, Shanghai University of Medical & Health Sciences, Shanghai, China.\nHealth School attached to Shanghai University of Medical & Health Sciences, Shanghai, China.'}, {'lastname': 'Yao', 'firstname': 'Xin', 'initials': 'X', 'affiliation': ""Jiyuan Shi People's Hospital, Jiyuan, Henan, China.""}, {'lastname': 'Zhang', 'firstname': 'Liping', 'initials': 'L', 'affiliation': ""Department of Emergency Medicine, Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, China. gszlp29@sina.com.""}, {'lastname': 'Zhou', 'firstname': 'Qinhua', 'initials': 'Q', 'affiliation': 'College of Medicine, Jiaxing University, Jiaxing, China. zhouqh2016@aliyun.com.'}]",,,,,10.1007/s00210-019-01775-3,<Element 'PubmedArticle' at 0x7f05df890b30>
255,31902595,Melatonin exerts neuroprotective effects by attenuating astro- and microgliosis and suppressing inflammatory response following spinal cord injury.,"Reactive gliosis and inflammatory reaction are common pathological change to spinal cord injury (SCI). Whereas, the effects of melatonin (MT) on the astro- and microgliosis and their related inflammatory response in the injured spinal cord are not fully understood. In this study, MT's effects on the accumulation and proliferation of microglia and astrocytes and their related inflammatory response were investigated in an acute SCI model. The effects of MT on oxidative stress, neuronal survival and behavioral performance were also tested. It was found that MT treatment significantly suppressed the accumulation and the proliferation of microglia and astrocytes. Quantitative PCR data showed that MT significantly down-regulated the pro-inflammatory markers iNOS, IL-1β and TNF-α expressions. The data showed that MT led to the rise in SOD, CAT and GSH-Px contents and the decrease in MDA content. Western blotting analysis verified that MT significantly down-regulated caspase-3, Bax and GFAP expressions, up-regulated Bcl-2 expression. Compared with the SCI vehicle-treated group, the SCI MT-treated group exhibited a greater Basso Mouse Scale (BMS) locomotor rating score. On the whole, these findings implied that MT exerts its neuroprotective effects by suppressing the accumulation and the proliferation of microglia and astrocytes and reducing the release of pro-inflammatory cytokines, which might be one of the underlying mechanisms of the MT's neuroprotective effect after SCI. Accordingly, MT may be a promising therapeutic candidate for acute SCI.","['Astrogliosis', 'Inflammatory response', 'Melatonin', 'Microgliosis', 'Neuroprotection', 'Spinal cord injury']",Neuropeptides,2020-01-07,"[{'lastname': 'Yang', 'firstname': 'Zhijie', 'initials': 'Z', 'affiliation': 'School of Life Science and Technology, Gansu Agricultural University, Lanzhou 730070, China. Electronic address: yl798512@163.com.'}, {'lastname': 'Bao', 'firstname': 'Yingying', 'initials': 'Y', 'affiliation': 'School of Life Science and Technology, Gansu Agricultural University, Lanzhou 730070, China.'}, {'lastname': 'Chen', 'firstname': 'Weigang', 'initials': 'W', 'affiliation': 'School of Life Science and Technology, Gansu Agricultural University, Lanzhou 730070, China.'}, {'lastname': 'He', 'firstname': 'Yuqin', 'initials': 'Y', 'affiliation': 'School of Life Science and Technology, Gansu Agricultural University, Lanzhou 730070, China. Electronic address: heyq@gsau.edu.cn.'}]",,,,Copyright © 2020 Elsevier Ltd. All rights reserved.,10.1016/j.npep.2019.102002,<Element 'PubmedArticle' at 0x7f05df8b15e0>
256,31884019,Angiotensin II and aldosterone activate retinal microglia.,"Microglial cells are important contributors to the neuroinflammation and blood vessel damage that occurs in ischemic retinopathies. We hypothesized that key effectors of the renin-angiotensin aldosterone system, angiotensin II (Ang II) and aldosterone, increase the density of microglia in the retina and stimulate their production of reactive oxygen species (ROS) as well as pro-angiogenic and pro-inflammatory factors. Two animal models were studied that featured up-regulation of Ang II or aldosterone and included transgenic Ren-2 rats which overexpress renin and Ang II in tissues including the retina, and Sprague Dawley rats with ischemic retinopathy and infused with aldosterone. Complementary studies were performed in primary cultures of retinal microglia from neonatal Sprague Dawley rats exposed to hypoxia (0.5% O","['Aldosterone', 'Angiotensin II', 'Chemokines', 'Microglia', 'NADPH oxidase', 'Reactive oxygen species']",Experimental eye research,2019-12-31,"[{'lastname': 'Rana', 'firstname': 'Indrajeetsinh', 'initials': 'I', 'affiliation': 'Department of Immunology and Pathology, The Central Clinical School, Monash University, Melbourne, Victoria, Australia; Victoria University, Ballarat Road, Footscray, Victoria, Australia.'}, {'lastname': 'Suphapimol', 'firstname': 'Varaporn', 'initials': 'V', 'affiliation': 'Department of Diabetes, The Central Clinical School, Monash University, Melbourne, Victoria, Australia; Department of Anatomy and Neuroscience, The University of Melbourne, Parkville, Victoria, Australia.'}, {'lastname': 'Jerome', 'firstname': 'Jack R', 'initials': 'JR', 'affiliation': 'Department of Diabetes, The Central Clinical School, Monash University, Melbourne, Victoria, Australia; Department of Anatomy and Neuroscience, The University of Melbourne, Parkville, Victoria, Australia.'}, {'lastname': 'Talia', 'firstname': 'Dean M', 'initials': 'DM', 'affiliation': 'Department of Immunology and Pathology, The Central Clinical School, Monash University, Melbourne, Victoria, Australia.'}, {'lastname': 'Deliyanti', 'firstname': 'Devy', 'initials': 'D', 'affiliation': 'Department of Diabetes, The Central Clinical School, Monash University, Melbourne, Victoria, Australia; Department of Anatomy and Neuroscience, The University of Melbourne, Parkville, Victoria, Australia.'}, {'lastname': 'Wilkinson-Berka', 'firstname': 'Jennifer L', 'initials': 'JL', 'affiliation': 'Department of Diabetes, The Central Clinical School, Monash University, Melbourne, Victoria, Australia; Department of Anatomy and Neuroscience, The University of Melbourne, Parkville, Victoria, Australia. Electronic address: jennifer.wilkinsonberka@unimelb.edu.au.'}]",,,,Copyright © 2019 Elsevier Ltd. All rights reserved.,10.1016/j.exer.2019.107902,<Element 'PubmedArticle' at 0x7f05dab15ae0>
257,31881271,Glucagon-like peptide-1 suppresses neuroinflammation and improves neural structure.,"Glucagon-like peptide-1 (GLP-1) is a hormone mainly secreted from enteroendocrine L cells. GLP-1 and its receptor are also expressed in the brain. GLP-1 signaling has pivotal roles in regulating neuroinflammation and memory function, but it is unclear how GLP-1 improves memory function by regulating neuroinflammation. Here, we demonstrated that GLP-1 enhances neural structure by inhibiting lipopolysaccharide (LPS)-induced inflammation in microglia with the effects of GLP-1 itself on neurons. Inflammatory secretions of BV-2 microglia by LPS aggravated mitochondrial function and cell survival, as well as neural structure in Neuro-2a neurons. In inflammatory condition, GLP-1 suppressed the secretion of tumor necrosis factor-alpha (TNF-α)-associated cytokines and chemokines in BV-2 microglia and ultimately enhanced neurite complexity (neurite length, number of neurites from soma, and secondary branches) in Neuro-2a neurons. We confirmed that GLP-1 improves neurite complexity, dendritic spine morphogenesis, and spine development in TNF-α-treated primary cortical neurons based on altered expression levels of the factors related to neurite growth and spine morphology. Given that our data that GLP-1 itself enhances neurite complexity and spine morphology in neurons, we suggest that GLP-1 has a therapeutic potential in central nervous system diseases.","['Dendritic spine morphology', 'Glucagon-like peptide 1 (GLP-1)', 'Lipopolysaccharides (LPS)', 'Neurite complexity', 'Neuroinflammation']",Pharmacological research,2019-12-28,"[{'lastname': 'Yoon', 'firstname': 'Gwangho', 'initials': 'G', 'affiliation': 'Department of Anatomy, Chonnam National University Medical School, Hwasun, 58128, Jeollanam-do, Republic of Korea; Department of Biochemistry, Chonnam National University Medical School, Hwasun, 58128, Jeollanam-do, Republic of Korea.'}, {'lastname': 'Kim', 'firstname': 'Young-Kook', 'initials': 'YK', 'affiliation': 'Department of Biochemistry, Chonnam National University Medical School, Hwasun, 58128, Jeollanam-do, Republic of Korea.'}, {'lastname': 'Song', 'firstname': 'Juhyun', 'initials': 'J', 'affiliation': 'Department of Anatomy, Chonnam National University Medical School, Hwasun, 58128, Jeollanam-do, Republic of Korea. Electronic address: juhyunsong@chonnam.ac.kr.'}]",,,,Copyright © 2019 Elsevier Ltd. All rights reserved.,10.1016/j.phrs.2019.104615,<Element 'PubmedArticle' at 0x7f05daae49a0>
258,"31873127
14744442
10766253
16002529
19144836
18854155
26208455
22201683
20585248
25200564
24074868
15486293
21673102
29127221
7285635
29663589
28178565
18852044
24505481
25685285
21683670
15077108
27166282
29351662
26578855
28542876
19116375
25497089
24210646
21467629
21219177
23825387
11412335
23091640
21911747
26970578
24166765
22457705
4337382
23077591
12184808
11846609
28575497
19131956
23520145",Reduced central and peripheral inflammatory responses and increased mitochondrial activity contribute to diet-induced obesity resistance in WSB/EiJ mice.,"Energy imbalance due to excess of calories is considered to be a major player in the current worldwide obesity pandemic and could be accompanied by systemic and central inflammation and mitochondrial dysfunctions. This hypothesis was tested by comparing the wild-derived diet-induced obesity- (DIO-) resistant mouse strain WSB/EiJ to the obesity-prone C57BL/6J strain. We analysed circulating and hypothalamic markers of inflammatory status and hypothalamic mitochondrial activity in both strains exposed to high-fat diet (HFD). We further analysed the regulations of hypothalamic genes involved in inflammation and mitochondrial pathways by high throughput microfluidic qPCR on RNA extracted from laser micro-dissected arcuate (ARC) and paraventricular (PVN) hypothalamic nuclei. HFD induced increased body weight gain, circulating levels of leptin, cholesterol, HDL and LDL in C57BL/6J whereas WSB/EiJ mice displayed a lower inflammatory status, both peripherally (lower levels of circulating cytokines) and centrally (less activated microglia in the hypothalamus) as well as more reactive mitochondria in the hypothalamus. The gene expression data analysis allowed identifying strain-specific hypothalamic metabolic pathways involved in the respective responses to HFD. Our results point to the involvement of hypothalamic inflammatory and mitochondrial pathways as key factors in the control of energy homeostasis and the resistance to DIO.",[],Scientific reports,2019-12-25,"[{'lastname': 'Terrien', 'firstname': 'Jérémy', 'initials': 'J', 'affiliation': 'CNRS/MNHN UMR 7221 ""Evolution des regulations endocriniennes"" Department of ""Life Adaptations"" Muséum National d\'Histoire Naturelle 57, rue Cuvier CP 32, 75231, Paris, CEDEX 05, France.\nCNRS/MNHN UMR 7179, ""Mécanismes Adaptatifs et Evolution"", 1 Avenue du Petit Château, 91800, Brunoy, France.'}, {'lastname': 'Seugnet', 'firstname': 'Isabelle', 'initials': 'I', 'affiliation': 'CNRS/MNHN UMR 7221 ""Evolution des regulations endocriniennes"" Department of ""Life Adaptations"" Muséum National d\'Histoire Naturelle 57, rue Cuvier CP 32, 75231, Paris, CEDEX 05, France.'}, {'lastname': 'Seffou', 'firstname': 'Bolaji', 'initials': 'B', 'affiliation': 'CNRS/MNHN UMR 7221 ""Evolution des regulations endocriniennes"" Department of ""Life Adaptations"" Muséum National d\'Histoire Naturelle 57, rue Cuvier CP 32, 75231, Paris, CEDEX 05, France.'}, {'lastname': 'Herrero', 'firstname': 'Maria J', 'initials': 'MJ', 'affiliation': 'CNRS/MNHN UMR 7221 ""Evolution des regulations endocriniennes"" Department of ""Life Adaptations"" Muséum National d\'Histoire Naturelle 57, rue Cuvier CP 32, 75231, Paris, CEDEX 05, France.\nCenter for Neuroscience Research Children\'s National Medical Center, 111 Michigan Ave NW, Washington DC, 20010, USA.'}, {'lastname': 'Bowers', 'firstname': 'James', 'initials': 'J', 'affiliation': 'CNRS/MNHN UMR 7221 ""Evolution des regulations endocriniennes"" Department of ""Life Adaptations"" Muséum National d\'Histoire Naturelle 57, rue Cuvier CP 32, 75231, Paris, CEDEX 05, France.'}, {'lastname': 'Chamas', 'firstname': 'Lamis', 'initials': 'L', 'affiliation': 'CNRS/MNHN UMR 7221 ""Evolution des regulations endocriniennes"" Department of ""Life Adaptations"" Muséum National d\'Histoire Naturelle 57, rue Cuvier CP 32, 75231, Paris, CEDEX 05, France.'}, {'lastname': 'Decherf', 'firstname': 'Stéphanie', 'initials': 'S', 'affiliation': 'CNRS/MNHN UMR 7221 ""Evolution des regulations endocriniennes"" Department of ""Life Adaptations"" Muséum National d\'Histoire Naturelle 57, rue Cuvier CP 32, 75231, Paris, CEDEX 05, France.'}, {'lastname': 'Duvernois-Berthet', 'firstname': 'Evelyne', 'initials': 'E', 'affiliation': 'CNRS/MNHN UMR 7221 ""Evolution des regulations endocriniennes"" Department of ""Life Adaptations"" Muséum National d\'Histoire Naturelle 57, rue Cuvier CP 32, 75231, Paris, CEDEX 05, France.'}, {'lastname': 'Djediat', 'firstname': 'Chakib', 'initials': 'C', 'affiliation': 'CNRS/MNHN UMR 7245 « Molécules de Communication et Adaptation des Microorganismes », 12 rue Buffon, 75005, Paris, France.'}, {'lastname': 'Ducos', 'firstname': 'Bertrand', 'initials': 'B', 'affiliation': 'Biology Platform of Physics Dpt High Throughput qPCR Facility of ENS LPS-ENS, 24 rue Lhomond, 75005, Paris, France.'}, {'lastname': 'Demeneix', 'firstname': 'Barbara A', 'initials': 'BA', 'affiliation': 'CNRS/MNHN UMR 7221 ""Evolution des regulations endocriniennes"" Department of ""Life Adaptations"" Muséum National d\'Histoire Naturelle 57, rue Cuvier CP 32, 75231, Paris, CEDEX 05, France.'}, {'lastname': 'Clerget-Froidevaux', 'firstname': 'Marie-Stéphanie', 'initials': 'MS', 'affiliation': 'CNRS/MNHN UMR 7221 ""Evolution des regulations endocriniennes"" Department of ""Life Adaptations"" Muséum National d\'Histoire Naturelle 57, rue Cuvier CP 32, 75231, Paris, CEDEX 05, France. marie-stephanie.froidevaux@mnhn.fr.'}]",,,,,"10.1038/s41598-019-56051-4
10.1016/S0092-8674(03)01081-X
10.1038/35007534
10.1210/en.2004-1520
10.1523/JNEUROSCI.2760-08.2009
10.1016/j.cell.2008.07.043
10.1016/j.bbrc.2015.07.097
10.1172/JCI59660
10.1097/MED.0b013e32833c3026
10.1038/nrendo.2014.160
10.1016/j.cell.2013.09.004
10.1126/science.1103160
10.1210/en.2011-0060
10.1152/physiolgenomics.00059.2017
10.1159/000238042
10.1111/tra.12573
10.1016/j.cmet.2016.12.022
10.1016/j.bbadis.2008.09.005
10.1371/journal.pone.0088352
10.4239/wjd.v6.i1.145
10.1016/j.stem.2011.05.017
10.1038/nm1029
10.1152/ajpendo.00121.2016
10.3389/fnins.2015.00387
10.1002/1873-3468.12691
10.1152/ajpendo.90377.2008
10.1016/j.celrep.2014.11.018
10.1016/j.diabet.2013.10.001
10.1248/bpb.34.453
10.1146/annurev-immunol-031210-101322
10.4049/jimmunol.1301035
10.1046/j.1365-2826.2001.00660.x
10.1371/journal.pone.0047713
10.2337/db11-0194
10.1016/j.bbr.2016.03.018
10.1002/glia.22580
10.1371/journal.pone.0031814
10.1006/meth.2001.1262
10.1093/hmg/ddx202
10.1038/nprot.2008.211
10.1242/dmm.009860",<Element 'PubmedArticle' at 0x7f05daaf3540>
259,"31864418
31375134
29296624
30040716
27582220
29744576
10858277
2268320
21645364
23041626
18378771
22781549
23830905
28073925
16862116
17458552
28479389
30448285
25261995
23516300
28070672
20667979
28379303
29378861
24804730
28837568
22890097
26682689
30482868
19776335
26124111
19557827
24684749
29044416
30260505
25130661
30135939
27356620
28640985
26370502
28541286
25461957
30858094
25619230
16237129
10560657
22112552
19399512
2341813
30076830
25448602
28638323
31340569
22930834
30361629
21886844
26599299
26381815
3977910
28828399
17071926
27114033
30180904
17291356
25575133
21092856
21698296
29690919
21178100
28453791
27903606
25478031
21497117",Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer's disease and aged brains: increased levels correlate with neuropathology.,"Progranulin (PGRN) is a protein encoded by the GRN gene with multiple identified functions including as a neurotrophic factor, tumorigenic growth factor, anti-inflammatory cytokine and regulator of lysosomal function. A single mutation in the human GRN gene resulting in reduced PGRN expression causes types of frontotemporal lobar degeneration resulting in frontotemporal dementia. Prosaposin (PSAP) is also a multifunctional neuroprotective secreted protein and regulator of lysosomal function. Interactions of PGRN and PSAP affect their functional properties. Their roles in Alzheimer's disease (AD), the leading cause of dementia, have not been defined. In this report, we examined in detail the cellular expression of PGRN in middle temporal gyrus samples of a series of human brain cases (n = 45) staged for increasing plaque pathology. Immunohistochemistry showed PGRN expression in cortical neurons, microglia, cerebral vessels and amyloid beta (Aβ) plaques, while PSAP expression was mainly detected in neurons and Aβ plaques, and to a limited extent in astrocytes. We showed that there were increased levels of PGRN protein in AD cases and corresponding increased levels of PSAP. Levels of PGRN and PSAP protein positively correlated with amyloid beta (Aβ), with PGRN levels correlating with phosphorylated tau (serine 205) levels in these samples. Although PGRN colocalized with lysosomal-associated membrane protein-1 in neurons, most PGRN associated with Aβ plaques did not. Aβ plaques with PGRN and PSAP deposits were identified in the low plaque non-demented cases suggesting this was an early event in plaque formation. We did not observe PGRN-positive neurofibrillary tangles. Co-immunoprecipitation studies of PGRN from brain samples identified only PSAP associated with PGRN, not sortilin or other known PGRN-binding proteins, under conditions used. Most PGRN associated with Aβ plaques were immunoreactive for PSAP showing a high degree of colocalization of these proteins that did not change between disease groups. As PGRN supplementation has been considered as a therapeutic approach for AD, the possible involvement of PGRN and PSAP interactions in AD pathology needs to be further considered.","['Aggregation', 'Alzheimer’s disease', 'Amyloid', 'Growth factors', 'Interactions', 'Neuropathology', 'Progranulin', 'Prosaposin', 'Tangles']",Acta neuropathologica communications,2019-12-23,"[{'lastname': 'Mendsaikhan', 'firstname': 'Anarmaa', 'initials': 'A', 'affiliation': 'Molecular Neuroscience Research Center, Shiga University of Medical Science, Seta, Otsu, Otsu, 520-2192, Japan.'}, {'lastname': 'Tooyama', 'firstname': 'Ikuo', 'initials': 'I', 'affiliation': 'Molecular Neuroscience Research Center, Shiga University of Medical Science, Seta, Otsu, Otsu, 520-2192, Japan.'}, {'lastname': 'Bellier', 'firstname': 'Jean-Pierre', 'initials': 'JP', 'affiliation': 'Molecular Neuroscience Research Center, Shiga University of Medical Science, Seta, Otsu, Otsu, 520-2192, Japan.'}, {'lastname': 'Serrano', 'firstname': 'Geidy E', 'initials': 'GE', 'affiliation': 'Civin Neuropathology Laboratory, Banner Sun Health Research Institute, Sun City, AZ, USA.'}, {'lastname': 'Sue', 'firstname': 'Lucia I', 'initials': 'LI', 'affiliation': 'Civin Neuropathology Laboratory, Banner Sun Health Research Institute, Sun City, AZ, USA.'}, {'lastname': 'Lue', 'firstname': 'Lih-Fen', 'initials': 'LF', 'affiliation': 'Civin Neuropathology Laboratory, Banner Sun Health Research Institute, Sun City, AZ, USA.\nSchool of Life Sciences and Neurodegenerative Disease Research Center, Biodesign Institute, Arizona State University, Tempe, AZ, USA.'}, {'lastname': 'Beach', 'firstname': 'Thomas G', 'initials': 'TG', 'affiliation': 'Civin Neuropathology Laboratory, Banner Sun Health Research Institute, Sun City, AZ, USA.'}, {'lastname': 'Walker', 'firstname': 'Douglas G', 'initials': 'DG', 'affiliation': 'Molecular Neuroscience Research Center, Shiga University of Medical Science, Seta, Otsu, Otsu, 520-2192, Japan. walker@belle.shiga-med.ac.jp.\nSchool of Life Sciences and Neurodegenerative Disease Research Center, Biodesign Institute, Arizona State University, Tempe, AZ, USA. walker@belle.shiga-med.ac.jp.'}]",,,,,"10.1186/s40478-019-0862-8
10.1186/s13024-019-0333-5
10.1002/acn3.469
10.3233/JAD-180145
10.1038/nature19323
10.1007/s00401-018-1861-8
10.1177/002215540004800713
10.1016/S0006-291X(05)80908-8
10.1186/1742-2094-8-65
10.1172/JCI63113
10.1083/jcb.200712039
10.1186/1750-1326-7-33
10.1016/j.neuroscience.2013.06.049
10.1093/hmg/ddx011
10.1038/nature05016
10.1007/s00401-007-0223-8
10.1016/j.exger.2017.05.003
10.1016/j.nbd.2018.11.011
10.1038/nm.3672
10.1523/JNEUROSCI.6103-11.2013
10.1007/s00401-017-1668-z
10.1096/fj.10-161471
10.1093/brain/awx060
10.1126/scitranslmed.aah5642
10.1523/JNEUROSCI.3081-17.2018
10.1371/journal.pone.0097032
10.1371/journal.pone.0182896
10.3233/JAD-2012-120946
10.3233/JAD-150746
10.15252/emmm.201809712
10.1177/1533317509346209
10.1073/pnas.1510329112
10.1002/path.2580
10.1186/alzrt247
10.1093/jnen/nlx085
10.1002/glia.23480
10.1016/j.brainres.2014.08.022
10.1016/j.ibror.2017.07.001
10.1038/ncomms11992
10.1111/jnc.14110
10.1083/jcb.201502029
10.1038/ncomms15277
10.1371/journal.pone.0110534
10.1016/j.cca.2019.03.243
10.1111/neup.12189
10.1212/01.wnl.0000187889.17253.b1
10.1097/00005072-199911000-00004
10.3233/JAD-2011-111340
10.1007/s00401-009-0538-8
10.1016/j.expneurol.2018.07.016
10.1016/j.neurobiolaging.2014.09.023
10.3390/cells8070766
10.1038/nmeth.2089
10.1038/s41598-018-33592-8
10.1371/journal.pone.0023939
10.3233/JPD-150670
10.1038/srep14211
10.1016/0006-291x(85)90311-0
10.1523/ENEURO.0100-17.2017
10.1093/brain/awl271
10.1016/j.cell.2016.04.001
10.1186/s13024-018-0281-5
10.1186/1742-2094-4-7
10.1097/NEN.0000000000000158
10.1016/j.neuron.2010.09.034
10.1371/journal.pone.0021023
10.1186/s13195-018-0370-2
10.1212/WNL.0b013e31820a0e3b
10.1093/hmg/ddx162
10.1083/jcb.201603079
10.1186/s13195-014-0070-5
10.1016/j.immuni.2011.01.018",<Element 'PubmedArticle' at 0x7f05dc974f90>
260,"31779639
27637674
29554978
25385337
25956409
26011640
19063914
24704258
18329265
20153425
26600009
28894299
12422368
14973190
17264205
21541365
24300521
25264773
27459405
28747667
29775591
20729857
24212761
28260801
1603325
16436770
16482081
22414893
26851161
28524175
25022952
30983988
11070493
25993987
17923864
29227285
24291544",DHEA Attenuates Microglial Activation via Induction of JMJD3 in Experimental Subarachnoid Haemorrhage.,"Microglia are resident immune cells in the central nervous system and central to the innate immune system. Excessive activation of microglia after subarachnoid haemorrhage (SAH) contributes greatly to early brain injury, which is responsible for poor outcomes. Dehydroepiandrosterone (DHEA), a steroid hormone enriched in the brain, has recently been found to regulate microglial activation. The purpose of this study was to address the role of DHEA in SAH.
We used in vivo models of endovascular perforation and in vitro models of haemoglobin exposure to illustrate the effects of DHEA on microglia in SAH.
In experimental SAH mice, exogenous DHEA administration increased DHEA levels in the brain and modulated microglial activation. Ameliorated neuronal damage and improved neurological outcomes were also observed in the SAH mice pretreated with DHEA, suggesting neuronal protective effects of DHEA. In cultured microglia, DHEA elevated the mRNA and protein levels of Jumonji d3 (JMJD3, histone 3 demethylase) after haemoglobin exposure, downregulated the H3K27me3 level, and inhibited the transcription of proinflammatory genes. The devastating proinflammatory microglia-mediated effects on primary neurons were also attenuated by DHEA; however, specific inhibition of JMJD3 abolished the protective effects of DHEA. We next verified that DHEA-induced JMJD3 expression, at least in part, through the tropomyosin-related kinase A (TrkA)/Akt signalling pathway.
DHEA has a neuroprotective effect after SAH. Moreover, DHEA increases microglial JMJD3 expression to regulate proinflammatory/anti-inflammatory microglial activation after haemoglobin exposure, thereby suppressing inflammation.","['Dehydroepiandrosterone', 'Inflammation', 'JMJD3', 'Microglia', 'Subarachnoid haemorrhage']",Journal of neuroinflammation,2019-11-30,"[{'lastname': 'Tao', 'firstname': 'Tao', 'initials': 'T', 'affiliation': 'Department of Neurosurgery, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, 210008, Jiangsu, China.'}, {'lastname': 'Liu', 'firstname': 'Guang-Jie', 'initials': 'GJ', 'affiliation': 'Department of Neurosurgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, Jiangsu, China.'}, {'lastname': 'Shi', 'firstname': 'Xuan', 'initials': 'X', 'affiliation': 'Department of Neurology, Jinling Hospital, Nanjing Medical University, Nanjing, China.'}, {'lastname': 'Zhou', 'firstname': 'Yan', 'initials': 'Y', 'affiliation': 'Department of Neurosurgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, Jiangsu, China.'}, {'lastname': 'Lu', 'firstname': 'Yue', 'initials': 'Y', 'affiliation': 'Department of Neurosurgery, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, 210008, Jiangsu, China.\nDepartment of Neurosurgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, Jiangsu, China.'}, {'lastname': 'Gao', 'firstname': 'Yong-Yue', 'initials': 'YY', 'affiliation': 'Department of Neurosurgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, Jiangsu, China.'}, {'lastname': 'Zhang', 'firstname': 'Xiang-Sheng', 'initials': 'XS', 'affiliation': 'Department of Neurosurgery, Beijing Friendship Hospital, Capital Medical University, Beijing, 100032, China.'}, {'lastname': 'Wang', 'firstname': 'Han', 'initials': 'H', 'affiliation': 'Department of Neurosurgery, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, 210008, Jiangsu, China.'}, {'lastname': 'Wu', 'firstname': 'Ling-Yun', 'initials': 'LY', 'affiliation': 'Department of Neurosurgery, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, 210008, Jiangsu, China.\nDepartment of Neurosurgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, Jiangsu, China.'}, {'lastname': 'Chen', 'firstname': 'Chun-Lei', 'initials': 'CL', 'affiliation': 'Department of Neurosurgery, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, 210008, Jiangsu, China.\nDepartment of Neurosurgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, Jiangsu, China.'}, {'lastname': 'Zhuang', 'firstname': 'Zong', 'initials': 'Z', 'affiliation': 'Department of Neurosurgery, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, 210008, Jiangsu, China.\nDepartment of Neurosurgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, Jiangsu, China.'}, {'lastname': 'Li', 'firstname': 'Wei', 'initials': 'W', 'affiliation': 'Department of Neurosurgery, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, 210008, Jiangsu, China. lwxzlw@126.com.\nDepartment of Neurosurgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, Jiangsu, China. lwxzlw@126.com.'}, {'lastname': 'Hang', 'firstname': 'Chun-Hua', 'initials': 'CH', 'affiliation': 'Department of Neurosurgery, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, 210008, Jiangsu, China. hang_neurosurgery@163.com.\nDepartment of Neurosurgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, Jiangsu, China. hang_neurosurgery@163.com.'}]",,,"In experimental SAH mice, exogenous DHEA administration increased DHEA levels in the brain and modulated microglial activation. Ameliorated neuronal damage and improved neurological outcomes were also observed in the SAH mice pretreated with DHEA, suggesting neuronal protective effects of DHEA. In cultured microglia, DHEA elevated the mRNA and protein levels of Jumonji d3 (JMJD3, histone 3 demethylase) after haemoglobin exposure, downregulated the H3K27me3 level, and inhibited the transcription of proinflammatory genes. The devastating proinflammatory microglia-mediated effects on primary neurons were also attenuated by DHEA; however, specific inhibition of JMJD3 abolished the protective effects of DHEA. We next verified that DHEA-induced JMJD3 expression, at least in part, through the tropomyosin-related kinase A (TrkA)/Akt signalling pathway.",,"10.1186/s12974-019-1641-y
10.1016/S0140-6736(16)30668-7
10.1186/s12974-018-1118-4
10.1038/nrneurol.2014.207
10.1007/s00401-015-1440-1
10.1172/JCI78443
10.1016/j.yfrne.2008.11.002
10.1016/j.jsbmb.2014.03.008
10.1016/j.jsbmb.2007.12.013
10.1016/j.jsbmb.2010.02.007
10.1016/j.psyneuen.2015.11.005
10.1038/mp.2017.167
10.1002/syn.10145
10.1073/pnas.0307325101
10.1073/pnas.0610898104
10.1371/journal.pbio.1001051
10.1038/nmeth.3125
10.1038/nn.4338
10.1038/s41598-017-06914-5
10.1016/j.cell.2018.05.003
10.1038/ni.1920
10.1038/cdd.2013.159
10.1038/aps.2016.162
10.1016/0306-4522(92)90500-2
10.1056/NEJMra052732
10.1038/sj.jcbfm.9600283
10.1016/j.pneurobio.2012.02.003
10.1016/j.pneurobio.2016.01.005
10.1038/nrneurol.2017.69
10.1007/s40265-014-0259-8
10.3389/fnagi.2019.00061
10.1002/1097-4547(20001115)62:4<503::AID-JNR4>3.0.CO;2-A
10.1186/s13054-015-0954-1
10.1038/cr.2007.83
10.1172/JCI95946
10.1016/j.pneurobio.2013.11.003",<Element 'PubmedArticle' at 0x7f05dc98ec70>
261,"31775776
31065801
27471859
29712534
28350947
27482201
30733059
12524533
20026663
29116422
22008260
23149338
28651064
21550343
29258611
25387791
22969170
26757107
25838514
21393509
27778404
19946692
29170141
29875635
16689667
18234196
20851742
21356829
29744576
30326935
29036611
26820675
30862089
26215834
26527034
26728399
21975064
30967837
30479916
30654804
30337851
30785088
23201826
27830532
19864556
24703938
25808205
22895182
30180904
28778989",Progranulin deficiency exacerbates spinal cord injury by promoting neuroinflammation and cell apoptosis in mice.,"Spinal cord injury (SCI) often results in significant and catastrophic dysfunction and disability and imposes a huge economic burden on society. This study aimed to determine whether progranulin (PGRN) plays a role in the progressive damage following SCI and evaluate the potential for development of a PGRN derivative as a new therapeutic target in SCI.
PGRN-deficient (Gr
After SCI, PGRN was highly expressed in activated macrophage/microglia and peaked at day 7 post-injury. Grn
PGRN deficiency exacerbates SCI by promoting neuroinflammation and cellular apoptosis, which can be alleviated by Atsttrin. Collectively, our data provide novel evidence of using PGRN derivatives as a promising therapeutic approach to improve the functional recovery for patients with spinal cord injury.","['Apoptosis', 'Inflammation', 'Progranulin', 'Spinal cord injury']",Journal of neuroinflammation,2019-11-30,"[{'lastname': 'Wang', 'firstname': 'Chao', 'initials': 'C', 'affiliation': 'Department of Orthopaedic Surgery, New York University School of Medicine, New York, NY, 10003, USA.\nDepartment of Spine Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.'}, {'lastname': 'Zhang', 'firstname': 'Lu', 'initials': 'L', 'affiliation': 'Department of Spine Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China.'}, {'lastname': 'Ndong', 'firstname': 'Jean De La Croix', 'initials': 'JC', 'affiliation': 'Department of Orthopaedic Surgery, New York University School of Medicine, New York, NY, 10003, USA.'}, {'lastname': 'Hettinghouse', 'firstname': 'Aubryanna', 'initials': 'A', 'affiliation': 'Department of Orthopaedic Surgery, New York University School of Medicine, New York, NY, 10003, USA.'}, {'lastname': 'Sun', 'firstname': 'Guodong', 'initials': 'G', 'affiliation': 'Department of Orthopaedic Surgery, New York University School of Medicine, New York, NY, 10003, USA.'}, {'lastname': 'Chen', 'firstname': 'Changhong', 'initials': 'C', 'affiliation': 'Department of Orthopaedic Surgery, New York University School of Medicine, New York, NY, 10003, USA.'}, {'lastname': 'Zhang', 'firstname': 'Chen', 'initials': 'C', 'affiliation': 'Department of Orthopaedic Surgery, New York University School of Medicine, New York, NY, 10003, USA.'}, {'lastname': 'Liu', 'firstname': 'Ronghan', 'initials': 'R', 'affiliation': 'Department of Orthopaedic Surgery, New York University School of Medicine, New York, NY, 10003, USA.'}, {'lastname': 'Liu', 'firstname': 'Chuan-Ju', 'initials': 'CJ', 'affiliation': 'Department of Orthopaedic Surgery, New York University School of Medicine, New York, NY, 10003, USA. Chuanju.Liu@nyulangone.org.\nDepartment of Cell Biology, New York University School of Medicine, New York, NY, 10016, USA. Chuanju.Liu@nyulangone.org.'}]",,"PGRN deficiency exacerbates SCI by promoting neuroinflammation and cellular apoptosis, which can be alleviated by Atsttrin. Collectively, our data provide novel evidence of using PGRN derivatives as a promising therapeutic approach to improve the functional recovery for patients with spinal cord injury.","After SCI, PGRN was highly expressed in activated macrophage/microglia and peaked at day 7 post-injury. Grn",,"10.1186/s12974-019-1630-1
10.3171/2018.2.FOCUS17778
10.1093/neuros/nyw080
10.1016/j.cytogfr.2019.01.002
10.1038/nm816
10.1084/jem.20091568
10.1007/s12032-017-1054-7
10.1016/j.pharmthera.2011.10.003
10.1016/j.jaut.2012.10.003
10.1016/j.drudis.2017.06.006
10.1016/j.febslet.2011.04.065
10.1186/s13075-017-1485-8
10.1038/srep07023
10.1155/2012/540794
10.1111/jcmm.12756
10.1093/brain/awv079
10.1126/science.1199214
10.1002/glia.23091
10.1007/s00401-009-0616-y
10.1016/j.jconrel.2017.11.028
10.3389/fncel.2018.00142
10.1089/neu.2006.23.635
10.1016/j.expneurol.2007.12.010
10.1016/j.neulet.2010.09.007
10.1007/s00401-018-1861-8
10.1186/s13024-018-0288-y
10.1093/hmg/ddx364
10.1007/s12035-016-9698-4
10.3390/cells8030230
10.1007/s12035-015-9358-0
10.1186/s12974-015-0415-4
10.1111/ene.12920
10.1186/1742-2094-8-130
10.3389/fneur.2019.00282
10.1002/advs.201800529
10.1186/s12974-019-1394-7
10.3389/fnins.2018.00690
10.1016/j.intimp.2019.02.006
10.1016/j.neuroscience.2012.11.032
10.1007/s12035-016-0245-0
10.1523/JNEUROSCI.3257-09.2009
10.1016/j.cellsig.2014.03.026
10.1089/ars.2015.6306
10.4161/cc.21262
10.1186/s13024-018-0281-5
10.1084/jem.20160999",<Element 'PubmedArticle' at 0x7f05db9fe450>
262,"31772707
28332488
27401947
29459845
26124091
19345186
31165004
26678495
26497037
18684475
27012974
20016108
11238740
16243425
27280045
14992536
12682352
16919462
1753798
28465707
20123040
23369986
24389454
27771535
23811724
26784178
11238711
21172413
23748408
17401348
30297827
28500766
19951692
9608532
17180160
9092472
20585380
14728584
24872833
12576209
16270931
27287315
10498956
17681692
15106839
22024154
23683503
30663689
27026638
26555190
18536709
23220632
26490873
29433359
28755482
19671681
17038671
30372493
15936344
27184815","Cicadidae Periostracum, the Cast-Off Skin of Cicada, Protects Dopaminergic Neurons in a Model of Parkinson's Disease.","Parkinson's disease (PD) is characterized by dopaminergic neuronal loss in the substantia nigra pars compacta (SNPC) and the striatum. Nuclear receptor-related 1 protein (Nurr1) is a nuclear hormone receptor implicated in limiting mitochondrial dysfunction, apoptosis, and inflammation in the central nervous system and protecting dopaminergic neurons and a promising therapeutic target for PD. Cicadidae Periostracum (CP), the cast-off skin of ",[],Oxidative medicine and cellular longevity,2019-11-28,"[{'lastname': 'Lim', 'firstname': 'Hye-Sun', 'initials': 'HS', 'affiliation': 'Herbal Medicine Resources Research Center, Korea Institute of Oriental Medicine, 111 Geonjae-ro, Naju-si, Jeollanam-do 58245, Republic of Korea.'}, {'lastname': 'Kim', 'firstname': 'Joong-Sun', 'initials': 'JS', 'affiliation': 'Herbal Medicine Resources Research Center, Korea Institute of Oriental Medicine, 111 Geonjae-ro, Naju-si, Jeollanam-do 58245, Republic of Korea.'}, {'lastname': 'Moon', 'firstname': 'Byeong Cheol', 'initials': 'BC', 'affiliation': 'Herbal Medicine Resources Research Center, Korea Institute of Oriental Medicine, 111 Geonjae-ro, Naju-si, Jeollanam-do 58245, Republic of Korea.'}, {'lastname': 'Choi', 'firstname': 'Goya', 'initials': 'G', 'affiliation': 'Herbal Medicine Resources Research Center, Korea Institute of Oriental Medicine, 111 Geonjae-ro, Naju-si, Jeollanam-do 58245, Republic of Korea.'}, {'lastname': 'Ryu', 'firstname': 'Seung Mok', 'initials': 'SM', 'affiliation': 'Herbal Medicine Resources Research Center, Korea Institute of Oriental Medicine, 111 Geonjae-ro, Naju-si, Jeollanam-do 58245, Republic of Korea.'}, {'lastname': 'Lee', 'firstname': 'Jun', 'initials': 'J', 'affiliation': 'Herbal Medicine Resources Research Center, Korea Institute of Oriental Medicine, 111 Geonjae-ro, Naju-si, Jeollanam-do 58245, Republic of Korea.'}, {'lastname': 'Ang', 'firstname': 'Mary Jasmin', 'initials': 'MJ', 'affiliation': 'College of Veterinary Medicine and BK21 Plus Project Team, Chonnam National University, Gwangju 61186, Republic of Korea.'}, {'lastname': 'Jeon', 'firstname': 'Mijin', 'initials': 'M', 'affiliation': 'College of Veterinary Medicine and BK21 Plus Project Team, Chonnam National University, Gwangju 61186, Republic of Korea.'}, {'lastname': 'Moon', 'firstname': 'Changjong', 'initials': 'C', 'affiliation': 'College of Veterinary Medicine and BK21 Plus Project Team, Chonnam National University, Gwangju 61186, Republic of Korea.'}, {'lastname': 'Park', 'firstname': 'Gunhyuk', 'initials': 'G', 'affiliation': 'Herbal Medicine Resources Research Center, Korea Institute of Oriental Medicine, 111 Geonjae-ro, Naju-si, Jeollanam-do 58245, Republic of Korea.'}]",,,,Copyright © 2019 Hye-Sun Lim et al.,"10.1155/2019/5797512
10.1038/nrdp.2017.13
10.1111/jnc.13691
10.3389/fneur.2018.00035
10.1073/pnas.1509742112
10.1016/j.parkreldis.2017.11.226
10.1016/j.cell.2009.01.038
10.14336/ad.2018.0615
10.1007/s12640-015-9586-0
10.1007/s12035-015-9477-7
10.1016/j.jns.2008.06.007
10.1111/cns.12536
10.1523/jneurosci.3910-09.2009
10.1046/j.1471-4159.2001.00181.x
10.1016/j.pneurobio.2005.09.001
10.3831/kpi.2016.19.002
10.1142/s0192415x03001521
10.1056/NEJMoa030685
10.1016/j.bmc.2006.07.063
10.1016/0378-8741(91)90136-2
10.1155/2017/8325049
10.1016/j.intimp.2010.01.011
10.1016/j.pbb.2013.01.017
10.1016/j.fct.2013.12.037
10.1016/j.neuroscience.2016.10.029
10.1038/aps.2013.57
10.3390/ijms17010108
10.1046/j.1471-4159.2001.00183.x
10.1016/j.jep.2010.12.016
10.3791/2609
10.1038/nprot.2006.342
10.1038/s41598-018-33317-x
10.1111/jpi.12420
10.1016/j.stem.2009.09.015
10.1006/mcne.1998.0673
10.1038/nrn2039
10.1126/science.276.5310.248
10.1007/978-3-319-10377-8_13
10.1007/s11192-009-0146-3
10.1155/2014/525340
10.1016/s0378-8741(02)00377-x
10.1017/s0376892900030605
10.1186/1746-4269-1-5
10.1093/toxsci/kfw106
10.1016/s0165-6147(99)01379-6
10.1016/j.neulet.2007.06.041
10.1097/00001756-200401190-00020
10.1016/j.biocel.2011.09.007
10.1186/1478-811x-11-34
10.3791/58653
10.1016/j.neubiorev.2016.03.016
10.1016/j.febslet.2015.11.006
10.1038/nn.2136
10.1126/scitranslmed.3004676
10.1523/jneurosci.1155-15.2015
10.1080/15548627.2017.1390636
10.1111/febs.14186
10.1158/1541-7786.mcr-08-0533
10.1634/stemcells.2006-0238
10.1371/journal.pone.0206624
10.1016/j.ydbio.2005.03.012
10.1186/s12861-016-0115-z",<Element 'PubmedArticle' at 0x7f05df7e9cc0>
263,"31771614
22328912
24588027
27096319
17486106
25900439
20399848
20562259
21446050
22649252
27404846
27400725
25627810
23980205
21349431
18424188
9794439
10448195
25147279
7479980
26451483
24262201
26092102
28618410
23548179
27821552
27813875
29740948
22890216
27616557
30546389
25339862
26119245
12191486
29990470
18604209
20107219
29895691
30140051
29106805
25619654
25654250
28540600
24398937
24484406
25775556
27561456
29886252
30539825
21943709
21057088
28062222
30904426
23045604
22245264
25199457
30104205
23850291
24531343
31511929
22871040
26448778
21471287
26944367
30642436
25161312
19890043
16494870
26154489
20457908
23870141
30846571
29247998
26927800
11567633
28679751
20890285
22046441
31301379
30680794
30127720
8886993
15289825
9356511
17021169
31189575
10207623
26107252
8564949
28362262
28243117",Type I interferon (IFN)-inducible Absent in Melanoma 2 proteins in neuroinflammation: implications for Alzheimer's disease.,"Cumulative evidence indicates that activation of innate immune responses in the central nervous system (CNS) induces the expression of type 1 interferons (T1 IFNs), a family of cytokines. The T1 IFNs (IFN-α/β), through activation of the JAK/STAT-signaling in microglia, astrocytes, and neurons, induce the expression of IFN-inducible proteins, which mediate the pro- and anti-inflammatory functions of IFNs. Accordingly, T1 IFN-inducible Absent in Melanoma 2 proteins (murine Aim2 and human AIM2) negatively regulate the expression of TI IFNs and, upon sensing higher levels of cytosolic DNA, assemble the Aim2/AIM2 inflammasome, resulting in activation of caspase-1, pyroptosis, and the secretion of pro-inflammatory cytokines (e.g., IL-1β and IL-18). Of interest, studies have indicated a role for the Aim2/AIM2 proteins in neuroinflammation and neurodegenerative diseases, including Alzheimer's disease (AD). The ability of Aim2/AIM2 proteins to exert pro- and anti-inflammatory effects in CNS may depend upon age, sex hormones, cell-types, and the expression of species-specific negative regulators of the Aim2/AIM2 inflammasome. Therefore, we discuss the role of Aim2/AIM2 proteins in the development of AD. An improved understanding of the role of Absent in Melanoma 2 proteins in AD could identify new approaches to treat patients.","['AIM2 proteins', 'Alzheimer’s disease', 'Neuroinflammation', 'Type I IFNs']",Journal of neuroinflammation,2019-11-28,"[{'lastname': 'Choubey', 'firstname': 'Divaker', 'initials': 'D', 'affiliation': 'Department of Environmental Health, University of Cincinnati, 160 Panzeca Way, P. O. Box 670056, Cincinnati, OH, 45267, USA. Divaker.choubey@uc.edu.'}]",,,,,"10.1186/s12974-019-1639-5
10.1016/j.coviro.2011.10.008
10.1002/glia.22608
10.1016/j.immuni.2016.04.005
10.1038/sj.mp.4002013
10.1016/j.bbi.2015.04.009
10.1016/j.bbi.2010.04.004
10.4049/jimmunol.0901753
10.1002/glia.21167
10.1523/JNEUROSCI.0203-12.2012
10.1002/glia.23028
10.1186/s40478-016-0341-4
10.1002/glia.22786
10.4049/jimmunol.1203450
10.1016/j.immuni.2011.02.006
10.1016/j.immuni.2008.03.011
10.1016/S0006-8993(99)01328-1
10.1126/science.1252945
10.1073/pnas.92.24.11284
10.1016/j.cell.2015.08.069
10.1016/j.neurobiolaging.2013.10.089
10.1016/j.bbi.2015.06.008
10.1159/000477092
10.1016/j.cytogfr.2013.03.006
10.1084/jem.20161596
10.1146/annurev-med-050715-104506
10.1111/bpa.12600
10.1038/nrneurol.2012.156
10.1016/j.it.2016.08.001
10.1111/cen3.12475
10.3389/fnins.2014.00315
10.1111/jnc.13217
10.1016/S1097-2765(02)00599-3
10.1016/j.jmb.2018.07.002
10.1038/ni.1636
10.1056/NEJMra0909142
10.1073/pnas.1722041115
10.1038/s41577-018-0051-1
10.1146/annurev-med-050715-104343
10.1016/j.neuron.2014.12.068
10.1016/j.neuron.2015.01.021
10.1007/s11064-017-2307-8
10.1038/jcbfm.2013.236
10.1111/jnc.12669
10.1073/pnas.1419090112
10.1038/srep32405
10.4103/1673-5374.245471
10.1016/j.molimm.2011.08.022
10.4049/jimmunol.1002468
10.1016/j.clim.2016.12.011
10.1084/jem.20121960
10.1016/j.clim.2011.12.007
10.1016/j.bcp.2014.08.031
10.1016/j.celrep.2013.06.024
10.1038/ni.2829
10.1007/s00125-019-04983-x
10.1186/1471-2148-12-140
10.1186/s12979-015-0043-y
10.1158/1541-7786.MCR-10-0565
10.1016/j.exger.2016.02.016
10.1016/j.jalz.2018.07.222
10.1093/rheumatology/keu318
10.4049/jimmunol.0802665
10.1016/j.febslet.2006.02.015
10.1007/s12035-015-9315-y
10.1073/pnas.1003738107
10.1016/j.molcel.2013.07.004
10.1126/science.aat8657
10.1111/imr.12618
10.4049/jimmunol.1502538
10.1016/S1074-7613(01)00196-0
10.1038/ni.1932
10.1371/journal.pone.0027040
10.1016/j.brainresbull.2019.07.011
10.1002/glia.23592
10.3389/fncel.2018.00206
10.1007/BF01541389
10.1038/sj.embor.7400210
10.1073/pnas.94.23.12688
10.1523/JNEUROSCI.1202-06.2006
10.1523/JNEUROSCI.0774-19.2019
10.1038/nm.3908
10.2147/OTT.S125039",<Element 'PubmedArticle' at 0x7f05df7e01d0>
264,"31741237
28521700
28341445
22224769
12379912
27653222
26518624
28860481
31016034
19390836
29309569
26125449
28258691
25582402
26685886
25598354
20219118
19387537
27020328
19455585
26253167
30988027
23519826
27595232
8870831
25225409
29202771
28292436
26646929
30443853
11513147
20203208
26520780
25748318
22535835
18606570
23145206
30833750
24651229
21501633
25252903
31142630
28759044
23806637
30953118
18617599
30581432
8884374",The sialoglycan-Siglec-E checkpoint axis in dexamethasone-induced immune subversion in glioma-microglia transwell co-culture system.,"Dexamethasone (Dex) is considered as the main steroid routinely used in the standard therapy of brain tumor-induced edema. Strong immunosuppressive effects of Dex on effector systems of the immune system affect the patients' antitumor immunity and may thereby worsen the prognosis. Siglecs and their interacting sialoglycans have been described as a novel glyco-immune checkpoint axis that promotes cancer immune evasion. Despite the aberrant glycosylation in cancer is described, mechanisms involved in regulation of immune checkpoints in gliomas are not fully understood. The aim of this study was to investigate the effect of Dex on the Siglec-sialic acid interplay and determine its significance in immune inversion in monocultured and co-cultured microglia and glioma cells. Both monocultured and co-cultured in transwell system embryonic stem cell-derived microglia (ESdM) and glioma GL261 cells were exposed to Dex. Cell viability, immune inversion markers, and interaction between sialic acid and Siglec-E were detected by flow cytometry. Cell invasion was analyzed by scratch-wound migration assay using inverted phase-contrast microscopy. Exposure to Dex led to significant changes in IL-1β, IL-10, Iba-1, and Siglec-E in co-cultured microglia compared to naïve or monocultured cells. These alterations were accompanied by increased α2.8-sialylation and Siglec-E fusion protein binding to co-cultured glioma cell membranes. This study suggests that the interplay between sialic acids and Siglecs is a sensitive immune checkpoint axis and may be crucial for Dex-induced dampening of antitumor immunity. The targeting of sialic acid-Siglec glyco-immune checkpoint can be a novel therapeutic method in glioma therapy.","['Glioma', 'Immunosurveillance', 'Microglia', 'Sialic acid', 'Siglec']",Immunologic research,2019-11-20,"[{'lastname': 'Wielgat', 'firstname': 'Przemyslaw', 'initials': 'P', 'affiliation': 'Department of Clinical Pharmacology, Medical University of Bialystok, Waszyngtona 15A, 15-274, Bialystok, Poland. przemyslaw.wielgat@umb.edu.pl.'}, {'lastname': 'Czarnomysy', 'firstname': 'Robert', 'initials': 'R', 'affiliation': 'Department of Synthesis and Technology of Drugs, Medical University of Bialystok, Kilińskiego 1, 15-089, Bialystok, Poland.'}, {'lastname': 'Trofimiuk', 'firstname': 'Emil', 'initials': 'E', 'affiliation': 'Department of Clinical Pharmacology, Medical University of Bialystok, Waszyngtona 15A, 15-274, Bialystok, Poland.'}, {'lastname': 'Car', 'firstname': 'Halina', 'initials': 'H', 'affiliation': 'Department of Clinical Pharmacology, Medical University of Bialystok, Waszyngtona 15A, 15-274, Bialystok, Poland.\nDepartment of Experimental Pharmacology, Medical University of Bialystok, Szpitalna 37, 15-295, Bialystok, Poland.'}]",,,,,10.1007/s12026-019-09106-7,<Element 'PubmedArticle' at 0x7f05dbf8cb80>
265,31715222,"Microglia, neurodegeneration and loss of neuroendocrine control.","Microglia, the primary regulators of inflammatory responses in the brain, suffer deterioration during aging culminating in their inability to generate adequate adaptive responses to maintain physiological homeostasis in brain tissue. Microglia affect the function of other glial cells and neurons, including those involved in the hypothalamic control of body homeostasis. Microglial dysfunction with aging in cognitive areas such as the hippocampus is known to associate with cognitive decline; more recently, microglial alterations in the hypothalamus during midlife was suggested to participate in changes in the endocrine and metabolic control exerted by this brain region. Consequently, the feed-back loops between endocrine glands and the hypothalamus are altered. This generates a vicious circle in which the plasma levels of key neuroprotective hormones, such as gonadal hormones, insulin-like growth factor-1, growth hormone and leptin and their hypothalamic signaling are decreased, which further enhances microglial alterations and deterioration of hypothalamic function. Hypothalamic dysfunction is a risk factor for neurodegenerative diseases and these diseases in turn promote additional alterations in hypothalamic microglial cells, which are unable to cope with the neurodegenerative process, resulting in permanent damage of the neuronal-glial circuits controlling endocrine homeostasis, food intake and body metabolism. Thus, a ""vicious cycle"" may such be initiated.","['Glia', 'Hypothalamus', 'Microglia', 'Neurodegeneration', 'Obesity']",Progress in neurobiology,2019-11-13,"[{'lastname': 'Chowen', 'firstname': 'Julie A', 'initials': 'JA', 'affiliation': 'Department of Pediatrics & Pediatric Endocrinology, Hospital Infantil Universitario Niño Jesús, Instituto de Investigación la Princisa. Madrid, Spain; Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, IMDEA Food Institute, CEI UAM + CSIC, Madrid, Spain. Electronic address: julieann.chowen@salud.madrid.org.'}, {'lastname': 'Garcia-Segura', 'firstname': 'Luis M', 'initials': 'LM', 'affiliation': 'Instituto Cajal, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain; CIBER de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain.'}]",,,,Copyright © 2019 Elsevier Ltd. All rights reserved.,10.1016/j.pneurobio.2019.101720,<Element 'PubmedArticle' at 0x7f05ddeb1ea0>
266,31689488,Mechanisms Mediating the Actions of Fatty Acids in the Hypothalamus.,"Selected neurons of the hypothalamus are equipped with molecules specialized in sensing the energy status of the organism. Upon activation or inhibition by central and systemic factors, such as neurotransmitters, hormones, cytokines, and nutrients, these molecules play important roles in the regulation of neuronal responses that control whole-body energy homeostasis. Dietary fats can control hypothalamic function by acting upon distinct energy sensing systems. They can be metabolized inside neurons, producing signals that control the expression of neurotransmitters involved in energy homeostasis; moreover, excessive amounts of certain fatty acids can activate inflammatory signaling in microglia, astrocytes, and neurons, leading to functional abnormalities and, eventually, neuronal apoptosis. In addition, recent studies have identified lipid-sensing G-protein-coupled receptors in the hypothalamus, revealing their involvement in the regulation of caloric intake and energy expenditure, as well as in the hypothalamic inflammatory response that occurs in obesity. Because of advances in the generation of synthetic ligands for this class of receptors, it is expected that pharmacological modulation of selected lipid-sensing G-protein-coupled receptors in the central nervous system could provide therapeutic advances in obesity and other metabolic diseases. Here we review seminal work in this field.","['G-protein-coupled receptors', 'hypothalamus', 'lipid', 'neuron', 'nutrient', 'obesity']",Neuroscience,2019-11-07,"[{'lastname': 'Dragano', 'firstname': 'Nathalia R', 'initials': 'NR', 'affiliation': 'Laboratory of Cell Signaling - Obesity and Comorbidities Research Center, University of Campinas, 13083-8864 Campinas, SP, Brazil.'}, {'lastname': 'Monfort-Pires', 'firstname': 'Milena', 'initials': 'M', 'affiliation': 'Laboratory of Cell Signaling - Obesity and Comorbidities Research Center, University of Campinas, 13083-8864 Campinas, SP, Brazil.'}, {'lastname': 'Velloso', 'firstname': 'Licio A', 'initials': 'LA', 'affiliation': 'Laboratory of Cell Signaling - Obesity and Comorbidities Research Center, University of Campinas, 13083-8864 Campinas, SP, Brazil. Electronic address: lavellos@unicamp.br.'}]",,,,Copyright © 2019 IBRO. Published by Elsevier Ltd. All rights reserved.,10.1016/j.neuroscience.2019.10.012,<Element 'PubmedArticle' at 0x7f05dded8d10>
267,31678553,HMGB1/TLR4 promotes apoptosis and reduces autophagy of hippocampal neurons in diabetes combined with OSA.,"Obstructive sleep apnea (OSA) combined with type 2 diabetes (T2DM) may lead to cognitive dysfunction. We previously reported that cognitive impairment is exacerbated in KKAy mice exposed to intermittent hypoxia (IH), during which the DNA binding protein HMGB1 mediates hippocampal neuronal apoptosis by maintaining microglia-associated neuroinflammation, but the underlying mechanism remains largely unknown.
We performed immunofluorescence, Western blotting, and immunohistochemistry experiments in mouse hippocampal tissues and HT22 cells. KKAy type 2 diabetes model mice and normal C57BL/6J mice were exposed to IH or intermittent normoxia. HT22 cells were cultured in high glucose medium and exposed to IH or intermittent normoxia. We transfected HMGB1 siRNA into HT22 cells and then treated them with high glucose combined with intermittent hypoxia.
In conclusion, IH aggravated apoptosis and autophagy defects in T2DM mice, and increased the protein expression of HMGB1 and TLR4. This was also confirmed in HG + IH-treated hippocampal HT22 cells. HMGB1 siRNA can significantly reduce the protein expression of HMGB1 and TLR4, reverse neuronal apoptosis and enhance autophagy.
We believe that HMGB1 is a key factor in the regulation of hippocampal neuronal apoptosis and autophagy defects in T2DM combined with OSA. Targeting HMGB1/TLR4 signaling as a novel approach may delay or prevent the increased apoptosis and decreased autophagy induced by T2DM combined with OSA, and may ultimately improve cognitive dysfunction.","['Autophagy', 'HMGB1/TLR4 signaling', 'Hippocampal neuronal apoptosis', 'Intermittent hypoxia', 'Type 2 diabetes mellitus']",Life sciences,2019-11-05,"[{'lastname': 'Guo', 'firstname': 'Xiangyu', 'initials': 'X', 'affiliation': 'Respiratory Department, Tianjin Medical University General Hospital, Tianjin Medical University, 300052, Tianjin, China.'}, {'lastname': 'Shi', 'firstname': 'Yu', 'initials': 'Y', 'affiliation': 'Respiratory Department, Tianjin Medical University General Hospital, Tianjin Medical University, 300052, Tianjin, China.'}, {'lastname': 'Du', 'firstname': 'Ping', 'initials': 'P', 'affiliation': 'Respiratory Department, Tianjin Medical University General Hospital, Tianjin Medical University, 300052, Tianjin, China.'}, {'lastname': 'Wang', 'firstname': 'Jiahui', 'initials': 'J', 'affiliation': 'Respiratory Department, Tianjin Medical University General Hospital, Tianjin Medical University, 300052, Tianjin, China.'}, {'lastname': 'Han', 'firstname': 'Yelei', 'initials': 'Y', 'affiliation': 'Respiratory Department, Tianjin Medical University General Hospital, Tianjin Medical University, 300052, Tianjin, China.'}, {'lastname': 'Sun', 'firstname': 'Bei', 'initials': 'B', 'affiliation': 'NHC Key Laboratory of Hormones and Development (Tianjin Medical University), Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin, 300134, China. Electronic address: sun_peipei220@hotmail.com.'}, {'lastname': 'Feng', 'firstname': 'Jing', 'initials': 'J', 'affiliation': 'Respiratory Department, Tianjin Medical University General Hospital, Tianjin Medical University, 300052, Tianjin, China. Electronic address: zyyhxkfj@126.com.'}]",,,,Copyright © 2019 Elsevier Inc. All rights reserved.,10.1016/j.lfs.2019.117020,<Element 'PubmedArticle' at 0x7f05ddedb6d0>
268,"31678139
12161747
9294397
17311007
17108182
12218412
21266900
7694279
27174996
21710624
22354151
17261708
14581618
14552871
27196935
23136554
10446041
15924343
15751027
15634701
27725773
21419118
16988024
18493257
30299260
25482245
30500112
30408465
22960105
22764235
25819103
29222114
19909815
19025772
22739623
15959458
30431198
25484283
29605425
26455456
19723026
26327363
17548654
30625322
14615545
17241745
18024854
17167090
12379867
12447935
15519241
16267827
11567054
22815838
29628394
22031820
17183542
19018268
23027402
24223607
19053043
12812760
16436614
27104929
11784794
10695723
29351512
19536070
17531349
15382256
16882007
18305256
27742890
24323721",Vitronectin mitigates stroke-increased neurogenesis only in female mice and through FAK-regulated IL-6.,"Vitronectin (VTN) is a blood protein produced mainly by the liver. We show that VTN leaks from the bloodstream into the injury site and neighboring subventricular zone (SVZ) following ischemic stroke (middle cerebral artery occlusion, MCAO) in adult mice. MCAO is known to increase neurogenesis after stroke. VTN inhibits this response in females, but not in males, as shown by ~70% more stroke-induced SVZ neurogenesis in female VTN-/- mice at 14 d. In female VTN-/- mice, stroke-induced expression of interleukin-6 (IL-6) at 24 h was reduced in the SVZ. The closely related leukemia inhibitory factor (LIF) or pro-neurogenic ciliary neurotrophic factor (CNTF) were not affected. The female-specific effect of VTN on IL-6 expression was not due to sex hormones, as shown by ovariectomy and castration. IL-6 injection next to the SVZ reversed the MCAO-induced increase in neurogenesis seen in VTN-/- mice. Our in vitro and vivo data suggest that plasma VTN activates focal adhesion kinase (FAK) in the SVZ following MCAO, which reduces IL-6 expression in astrocytes but increases it in other cells such as microglia/macrophages. Inducible conditional astrocytic FAK deletion increased MCAO-induced IL-6 expression in females at 24 h and blocked MCAO-induced neurogenesis at 14 d, confirming a key detrimental role of IL-6. Collectively, these data suggest that leakage of VTN into the SVZ reduces the neurogenic response to stroke in female mice by promoting IL-6 expression. Reducing VTN or VTN signaling may be an approach to promote neurogenesis for neuroprotection and cell replacement after stroke in females.","['Astrocyte', 'Cytokines', 'Focal adhesion kinase', 'Ischemic stroke', 'Neurogenesis', 'Vitronectin']",Experimental neurology,2019-11-05,"[{'lastname': 'Jia', 'firstname': 'Cuihong', 'initials': 'C', 'affiliation': 'Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA.'}, {'lastname': 'Keasey', 'firstname': 'Matthew P', 'initials': 'MP', 'affiliation': 'Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA.'}, {'lastname': 'Malone', 'firstname': 'Hannah M', 'initials': 'HM', 'affiliation': 'Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA.'}, {'lastname': 'Lovins', 'firstname': 'Chiharu', 'initials': 'C', 'affiliation': 'Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA.'}, {'lastname': 'Hagg', 'firstname': 'Theo', 'initials': 'T', 'affiliation': 'Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA. Electronic address: haggt1@etsu.edu.'}]",,,,Copyright © 2019 Elsevier Inc. All rights reserved.,10.1016/j.expneurol.2019.113088,<Element 'PubmedArticle' at 0x7f05ddeb8c70>
269,"31649619
23899598
12000545
29632177
22071480
25281562
27065163
10696570
15541569
22298650
25929826
10716540
26806035
9844854
15033418
25529630
24264576
20802226
25260700
19505943
22743226
26842848
25516281
14597658
26779321
15728214
25932362
12893096
25221612
6843904
9415946
15885495
25102410
23039899
28321184
25236887
24187535
26891860
28540928
21679928
11102586
16210372
22483308
16920372
16251949
22248723
17409265
27510422
18222099
27014180
30235220
30515150
18302763
1659887
22003328
25888514
19110131",Sleep Deprivation Alters the Pituitary Stress Transcriptome in Male and Female Mice.,"Poor sleep hygiene is a growing problem, with detrimental effects on many biological systems. The pituitary gland plays a crucial role in the regulation of sleep and the stress response, and its dysfunction leads to sleep-related disorders. However, the interaction between these critical functions remains unclear. Thus, we performed a comparative, whole-transcriptome, analysis to identify stress-induced genes and relevant pathways that may be affected by sleep deprivation. One day following 12 h of Paradoxical Sleep Deprivation (PSD), mice were restrained for 20 min. Gene expression changes in the pituitary were assessed via RNA-Seq and Gene Ontology in PSD and/or restrained groups compared to controls. We show that restraint triggers transcriptional responses involved in hormone secretion, the glucocorticoid response, and apoptosis in both sexes, with 285 differentially expressed genes in females and 93 in males. When PSD preceded restraint stress, the numbers of differentially expressed genes increased to 613 in females and 580 in males. The pituitary transcriptome of restraint+PSD animals was enriched for microglia and macrophage proliferation, cellular response to corticosteroids, and apoptosis, among others. Finally, we identify sex-specific differences in restraint-induced genes following PSD. These findings provide genetic targets to consider when studying sleep and the response to stress.","['RNA-seq', 'acute stress', 'hypothalamic-pituitary-adrenal axis', 'pituitary gland', 'sex differences', 'sleep deprivation', 'stress response', 'transcriptome']",Frontiers in endocrinology,2019-10-28,"[{'lastname': 'Oyola', 'firstname': 'Mario G', 'initials': 'MG', 'affiliation': 'Department of Obstetrics and Gynecology, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.\nCenter for Neuroscience and Regenerative Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.\nHenry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States.'}, {'lastname': 'Shupe', 'firstname': 'Elizabeth A', 'initials': 'EA', 'affiliation': 'Department of Obstetrics and Gynecology, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.'}, {'lastname': 'Soltis', 'firstname': 'Anthony R', 'initials': 'AR', 'affiliation': 'Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States.\nCollaborative Health Initiative Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.'}, {'lastname': 'Sukumar', 'firstname': 'Gauthaman', 'initials': 'G', 'affiliation': 'Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States.\nCollaborative Health Initiative Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.'}, {'lastname': 'Paez-Pereda', 'firstname': 'Marcelo', 'initials': 'M', 'affiliation': 'Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.'}, {'lastname': 'Larco', 'firstname': 'Darwin O', 'initials': 'DO', 'affiliation': 'Department of Obstetrics and Gynecology, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.'}, {'lastname': 'Wilkerson', 'firstname': 'Matthew D', 'initials': 'MD', 'affiliation': 'Collaborative Health Initiative Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.\nDepartment of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.'}, {'lastname': 'Rothwell', 'firstname': 'Stephen', 'initials': 'S', 'affiliation': 'Department of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.'}, {'lastname': 'Dalgard', 'firstname': 'Clifton L', 'initials': 'CL', 'affiliation': 'Collaborative Health Initiative Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.\nDepartment of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.'}, {'lastname': 'Wu', 'firstname': 'T John', 'initials': 'TJ', 'affiliation': 'Department of Obstetrics and Gynecology, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.\nCenter for Neuroscience and Regenerative Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.'}]",,,,"Copyright © 2019 Oyola, Shupe, Soltis, Sukumar, Paez-Pereda, Larco, Wilkerson, Rothwell, Dalgard and Wu.","10.3389/fendo.2019.00676
10.1016/B978-0-12-396971-2.00007-5
10.1046/j.0007-1331.2002.00790.x
10.1073/pnas.1721694115
10.1007/s00424-011-1044-0
10.1177/1479972314552806
10.1002/cphy.c150015
10.1210/er.21.1.55
10.1016/j.mce.2004.07.018
10.1152/physrev.00003.2011
10.1016/j.psyneuen.2015.04.006
10.1016/S0031-9384(99)00181-X
10.1016/j.neulet.2016.01.013
10.1046/j.1365-2869.1998.00122.x
10.1016/j.brainres.2004.01.019
10.1016/j.brainres.2014.12.031
10.1210/me.2013-1203
10.1093/nar/gkq622
10.1093/bioinformatics/btu638
10.1093/bioinformatics/btp352
10.1093/bioinformatics/bts356
10.1186/s12859-016-0922-z
10.1186/s13059-014-0550-8
10.1109/MCSE.2007.55
10.1101/gr.1239303
10.1016/j.slsci.2015.09.002
10.1210/jc.2004-1056
10.1186/2193-1801-3-728
10.1016/S0006-3223(03)00177-X
10.1177/1745691613506907
10.1016/0304-3940(83)90333-6
10.1016/j.ygeno.2005.02.013
10.1016/j.ijdevneu.2014.07.006
10.1111/ejn.12010
10.3389/fnbeh.2017.00035
10.1016/j.yhbeh.2014.09.001
10.3389/fnbeh.2013.00152
10.1016/j.bbi.2016.02.012
10.1038/npp.2017.102
10.1016/j.biopsych.2011.04.021
10.1016/S0006-8993(00)03008-0
10.1210/en.2005-0695
10.2174/187152712800792839
10.1016/j.smrv.2006.04.001
10.1038/nature04283
10.1159/000329484
10.1152/ajpregu.00105.2007
10.1038/npp.2016.148
10.1016/j.smrv.2007.07.007
10.3389/fneur.2016.00025
10.1371/journal.pone.0199237
10.3389/fimmu.2018.02596
10.1186/1742-2094-5-7
10.1016/0960-0760(91)90284-C
10.5664/jcsm.1356
10.1152/ajpheart.00859.2014
10.1016/j.pcad.2008.10.003",<Element 'PubmedArticle' at 0x7f05de8b8db0>
270,"31640144
17439356
24281743
20130219
27166859
10858277
24652679
12928786
23847387
12526812
2268320
21393509
18378771
8446979
11478925
1577120
2059402
8233123
15831717
20401171
29427321
22225875
29866203
24326388
11549552
17442825
23972823
22221732
2049103
22441751
23404144
24075485
25705423
7671322
20160675
27866373
944386
871258
23583594
20485441
11553680
3018187
14603460",Involvement of Progranulin and Granulin Expression in Inflammatory Responses after Cerebral Ischemia.,"Progranulin (PGRN) plays a crucial role in diverse biological processes, including cell proliferation and embryonic development. PGRN can be cleaved by neutrophil elastase to release granulin (GRN). PGRN has been found to inhibit inflammation. Whereas, GRN plays a role as a pro-inflammatory factor. However, the pathophysiological roles of PGRN and GRN, at early stages after cerebral ischemia, have not yet been fully understood. The aim of this study was to obtain further insight into the pathologic roles of PGRN and GRN. We demonstrated that the amount of PGRN was significantly increased in microglial cells after cerebral ischemia in rats and that neutrophil elastase activity was also increased at an early stage after cerebral ischemia, resulting in the production of GRN. The inhibition of neutrophil elastase activity suppressed PGRN cleavage and GRN production, as well as the increase in pro-inflammatory cytokines, after cerebral ischemia. The administration of an elastase inhibitor decreased the number of injured cells and improved the neurological deficits test scores. Our findings suggest that an increase in the activity of elastase to cleave PGRN, and to produce GRN, was involved in an inflammatory response at the early stages after cerebral ischemia, and that inhibition of elastase activity could suppress the progression of cerebral ischemic injury.","['cerebral ischemia', 'elastase', 'granulin', 'inflammatory cytokine', 'microglia', 'progranulin']",International journal of molecular sciences,2019-10-24,"[{'lastname': 'Horinokita', 'firstname': 'Ichiro', 'initials': 'I', 'affiliation': 'Department of Applied Biochemistry, Tokyo University of Pharmacy and Life Sciences; Hachioji 192-0392, Japan. y101156@toyaku.ac.jp.'}, {'lastname': 'Hayashi', 'firstname': 'Hideki', 'initials': 'H', 'affiliation': 'Department of Applied Biochemistry, Tokyo University of Pharmacy and Life Sciences; Hachioji 192-0392, Japan. hhayashi@toyaku.ac.jp.'}, {'lastname': 'Oteki', 'firstname': 'Rika', 'initials': 'R', 'affiliation': 'Department of Applied Biochemistry, Tokyo University of Pharmacy and Life Sciences; Hachioji 192-0392, Japan. y144039@toyaku.ac.jp.'}, {'lastname': 'Mizumura', 'firstname': 'Risa', 'initials': 'R', 'affiliation': 'Department of Applied Biochemistry, Tokyo University of Pharmacy and Life Sciences; Hachioji 192-0392, Japan. risa.piku.0811@gmail.com.'}, {'lastname': 'Yamaguchi', 'firstname': 'Tatsuaki', 'initials': 'T', 'affiliation': 'Department of Applied Biochemistry, Tokyo University of Pharmacy and Life Sciences; Hachioji 192-0392, Japan. coupy.is.all.lead@gmail.com.'}, {'lastname': 'Usui', 'firstname': 'Akane', 'initials': 'A', 'affiliation': 'Department of Applied Biochemistry, Tokyo University of Pharmacy and Life Sciences; Hachioji 192-0392, Japan. akane_1819@yahoo.co.jp.'}, {'lastname': 'Yuan', 'firstname': 'Bo', 'initials': 'B', 'affiliation': 'Laboratory of Pharmacology, School of Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, Sakado 350-0295, Japan. yuanbo@josai.ac.jp.'}, {'lastname': 'Takagi', 'firstname': 'Norio', 'initials': 'N', 'affiliation': 'Department of Applied Biochemistry, Tokyo University of Pharmacy and Life Sciences; Hachioji 192-0392, Japan. takagino@toyaku.ac.jp.'}]",,,,,"10.3390/ijms20205210
10.1089/neu.2006.0183
10.1038/jcbfm.2013.203
10.1189/jlb.1109766
10.1016/j.pneurobio.2016.05.001
10.1177/002215540004800713
10.1002/glia.22663
10.1007/s00109-003-0474-3
10.1093/cvr/cvt178
10.1016/S0092-8674(02)01141-8
10.1016/S0006-291X(05)80908-8
10.1126/science.1199214
10.1083/jcb.200712039
10.1161/01.STR.24.3.415
10.1016/S0006-8993(01)02640-3
10.1016/0014-4886(92)90160-R
10.1097/00002093-199100520-00007
10.1016/0168-0102(93)90047-T
10.1126/science.1110647
10.2217/fnl.10.1
10.1111/cns.12823
10.1016/j.cmet.2011.12.002
10.1186/s12974-018-1212-7
10.1038/jcbfm.2013.217
10.1164/ajrccm.164.5.2103040
10.1523/JNEUROSCI.5376-06.2007
10.1186/1742-2094-10-105
10.1016/j.brainres.2011.11.063
10.1016/0006-291X(91)91862-7
10.1183/09031936.00127011
10.3892/mmr.2013.1318
10.1016/j.athoracsur.2013.07.017
10.1186/s40560-014-0067-y
10.1006/cimm.1995.1183
10.1097/TP.0b013e3181d45a98
10.1007/s12035-016-0290-8
10.1212/WNL.26.4.297
10.1001/archneur.1977.00500180028006
10.1016/j.neulet.2013.03.053
10.1038/hr.2010.58
10.1046/j.1471-4159.2001.00488.x
10.1523/JNEUROSCI.06-08-02163.1986
10.1002/glia.10274",<Element 'PubmedArticle' at 0x7f05de8efea0>
271,31629950,CTRP3 acts as a novel regulator in depressive-like behavior associated inflammation and apoptosis by meditating p38 and JNK MAPK signaling.,"Depression is a complicated etiological pattern, and its pathology and effective treatments are highly limited.C1q-tumor necrosis factor-related protein-3 (CTRP3) is an adipokine, playing crucial roles in metabolic regulatory properties. However, the effects of CTRP3 on depression are largely unknown. In the present study, we found that CTRP3 expression levels were markedly reduced in hippocampus of mice with depression induced by chronic unpredictable mild stress (CUMS). In mouse model with depression, CTRP3-deficient mice aggravated depression-associated behaviors, as evidenced by the reduced locomotor activity and sucrose consumption, while the elevated immobility time in the tail suspension test (TST) and forced swimming test (FST). Moreover, CUMS-induced neuron death and increased expression of cleaved Caspase-3 were significantly accelerated by CTRP3 knockout. Furthermore, CTRP3 deletion intensified pro-inflammatory response in CUMS-exposed mice, which was associated with the activation of nuclear factor-κB(NF-κB) signaling. The activity of mitogen-activated protein kinases (MAPKs), including p38 and JNK, was further promoted in hippocampus of CTRP3-knockout mice with CUMS exposure. In contrast,CTRP3 over-expression showed anti-apoptotic and anti-inflammatory effects in lipopolysaccharide (LPS)-treated microglial cells. Importantly, the in vitro experiments demonstrated that CTRP3 knockdown-exacerbated apoptosis and inflammatory responsewere remarkably abrogated by the blockage of p38 and JNK signaling pathways in microglia stimulated by LPS. Next, in CUMS-exposed mice with CTRP3 deficiency, suppressing p38 and JNK markedly alleviated depressive-like behavior,hippocampal neuron death, apoptosis and inflammation. Therefore, CTRP3 may be an innovative therapeutic target for treating patients with depression through regulating p38 and JNK signaling.","['Apoptosis', 'CTRP3', 'Depression', 'Inflammation', 'p38 and JNK']",Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,2019-10-21,"[{'lastname': 'Meng', 'firstname': 'Jing', 'initials': 'J', 'affiliation': 'Department of Geriatrics, Wuhan Mental Health Center, Wuhan, 430022, China.'}, {'lastname': 'Wang', 'firstname': 'Dong-Ming', 'initials': 'DM', 'affiliation': 'Department of Geriatric Psychiatry, Qingdao Mental Heath Center, Qingdao, 266034, China.'}, {'lastname': 'Luo', 'firstname': 'Li-Ling', 'initials': 'LL', 'affiliation': ""Department of Psychosomatic, The Fourth People's Hospital of Shaanxi, Xi'an, 710043, China. Electronic address: da.waini619@qq.com.""}]",,,,Copyright © 2019. Published by Elsevier Masson SAS.,10.1016/j.biopha.2019.109489,<Element 'PubmedArticle' at 0x7f05dbdea860>
272,"31551509
9626554
24694306
28634745
15450164
10647003
16187836
15992800
22973440
12511652
17869008
20453850
16005000
16216005
21820505
23969780
24758841
17963758
20570717
23356710
26874070
28475602
18951951
28955800
15196698
8327594
16267236
18601698
23994182
24022869
23830906
18083105
22632727
22715882
25159150
25991443
27230456
27459063
28670274
29271125
19539698
17317019
29753862
9064606
27805868
29950682
28941407
30500398
24742619
26104289
26165640
25405940
23141067
21835341
23168450
16300887
7750466
7984495
26927534
30068291
28755878
12734009
1967618
19131956",Transcriptomic analysis reveals new hippocampal gene networks induced by prolactin.,"Prolactin (Prl) is a pleiotropic hormone with multiple functions in several tissues and organs, including the brain. In the hippocampus, Prl has been implicated in several functions, including neuroprotection against excitotoxicity in lactating rats and in Prl-treated ovariectomized animals. However, the molecular mechanisms involved in Prl actions in the hippocampus have not been completely elucidated. The aim of this study was to analyse the hippocampal transcriptome of female Prl-treated ovariectomized rats. Transcriptomic analysis by RNASeq revealed 162 differentially expressed genes throughout 24 h of Prl treatment. Gene Ontology analysis of those genes showed that 37.65% were involved in brain processes that are regulated by the hippocampus, such as learning, memory and behaviour, as well as new processes that we did not foresee, such as glial differentiation, axogenesis, synaptic transmission, postsynaptic potential, and neuronal and glial migration. Immunodetection analysis demonstrated that Prl significantly modified microglial morphology, reduced the expression of Cd11b/c protein, and altered the content and location of the neuronal proteins Tau, Map2 and Syp, which are involved in axogenic and synaptic functions. This novel delineation of Prl activity in the hippocampus highlights its importance as a neuroactive hormone, opens a new avenue for understanding its actions and supports its participation in neuronal plasticity of this brain area.",[],Scientific reports,2019-09-26,"[{'lastname': 'Cabrera-Reyes', 'firstname': 'Erika Alejandra', 'initials': 'EA', 'affiliation': 'Unidad de Investigación en Reproducción Humana, Instituto Nacional de Perinatología-Facultad de Química, Universidad Nacional Autónoma de México. CDMX, México, 04510, Mexico.'}, {'lastname': 'Vanoye-Carlo', 'firstname': 'América', 'initials': 'A', 'affiliation': 'Laboratorio de Neurociencias, Instituto Nacional de Pediatría, SS. CDMX, México, 04530, Mexico.'}, {'lastname': 'Rodríguez-Dorantes', 'firstname': 'Mauricio', 'initials': 'M', 'affiliation': 'Instituto Nacional de Medicina Genómica, CDMX, México, 14610, Mexico.'}, {'lastname': 'Vázquez-Martínez', 'firstname': 'Edgar Ricardo', 'initials': 'ER', 'affiliation': 'Unidad de Investigación en Reproducción Humana, Instituto Nacional de Perinatología-Facultad de Química, Universidad Nacional Autónoma de México. CDMX, México, 04510, Mexico.'}, {'lastname': 'Rivero-Segura', 'firstname': 'Nadia Alejandra', 'initials': 'NA', 'affiliation': 'División de Ciencias Básicas, Instituto Nacional de Geriatría, CDMX, México, 10200, Mexico.'}, {'lastname': 'Collazo-Navarrete', 'firstname': 'Omar', 'initials': 'O', 'affiliation': 'Laboratorio Nacional de Recursos Genómicos, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, CDMX, México, 04510, Mexico.'}, {'lastname': 'Cerbón', 'firstname': 'Marco', 'initials': 'M', 'affiliation': 'Unidad de Investigación en Reproducción Humana, Instituto Nacional de Perinatología-Facultad de Química, Universidad Nacional Autónoma de México. CDMX, México, 04510, Mexico. mcerbon85@yahoo.com.'}]",,,,,"10.1038/s41598-019-50228-7
10.1210/edrv.19.3.0334
10.1210/me.2013-1349
10.1007/s12020-017-1346-x
10.1016/j.neuron.2004.08.028
10.1038/45957
10.1037/0735-7044.119.4.1084
10.1016/j.yhbeh.2005.05.016
10.1371/journal.pone.0044371
10.1126/science.1076647
10.1016/j.neuroscience.2007.07.031
10.1038/nn.2550
10.1016/j.yhbeh.2005.05.017
10.1002/neu.20194
10.1016/j.bbi.2011.07.233
10.1159/000354701
10.4161/chan.28946
10.1016/j.yhbeh.2007.09.004
10.1016/j.neuroscience.2010.05.074
10.1111/jne.12028
10.1016/j.brainres.2016.02.011
10.1371/journal.pone.0176910
10.1016/j.mce.2008.09.025
10.1016/j.bbrep.2017.08.013
10.1016/j.mce.2004.04.001
10.1016/0031-9384(93)90057-M
10.1523/JNEUROSCI.2572-05.2005
10.1111/j.1365-2826.2008.01736.x
10.1016/j.neuroscience.2013.08.035
10.1152/ajpendo.00187.2013
10.1016/j.neuroscience.2013.06.052
10.1016/j.cell.2007.10.036
10.1016/j.neuron.2012.03.026
10.1146/annurev-neuro-061010-113810
10.1016/j.celrep.2014.07.042
10.1038/nrn3880
10.5213/inj.1632604.302
10.1016/j.devcel.2016.07.006
10.3389/fnagi.2017.00191
10.1002/dneu.22571
10.1016/j.neulet.2009.06.017
10.1016/j.neuroscience.2006.12.053
10.1016/j.neuroscience.2018.04.046
10.1016/0304-3940(95)12106-E
10.1210/en.2016-1516
10.1016/j.neurobiolaging.2017.08.010
10.1016/j.neulet.2018.11.052
10.1016/j.biopsych.2014.03.013
10.1038/jcbfm.2015.128
10.2131/jts.40.437
10.1093/cercor/bhu267
10.1016/j.neuron.2012.07.027
10.1016/j.neuron.2011.06.041
10.3233/JAD-121264
10.1016/j.neulet.2005.10.073
10.1210/endo.136.6.7750466
10.1016/0196-9781(94)90030-2
10.1016/j.rpsm.2015.11.003
10.1186/s12888-018-1827-3
10.1016/j.schres.2017.07.037
10.1186/gb-2003-4-5-p3
10.1002/cne.902910209
10.1038/nprot.2008.211",<Element 'PubmedArticle' at 0x7f05dbdfa5e0>
273,"31534953
8787671
9537324
10766253
21386802
23275931
20035790
24075719
26603190
26814590
28499988
15856065
16002529
18854155
20472136
28855891
19144836
24892821
28760600
27016501
2788034
2261637
25898198
9716487
30865890
20966214
22025055
30524228
32694719
25497089
28377875
25409701
29980196
24975592
17905568
21314736
29528526
26870797
26431692
10378877
17433555
26453898
26342944
26254332
29789127
11579142
20483490
17617622
20808781
28845299
26327363
29628394
24501362
12857678
30595477
30453385
17344397
11786910
21435392
12533608
26431939",Interleukin-6 Expression by Hypothalamic Microglia in Multiple Inflammatory Contexts: A Systematic Review.,"Interleukin-6 (IL-6) is a unique cytokine that can play both pro- and anti-inflammatory roles depending on the anatomical site and conditions under which it has been induced. Specific neurons of the hypothalamus provide important signals to control food intake and energy expenditure. In individuals with obesity, a microglia-dependent inflammatory response damages the neural circuits responsible for maintaining whole-body energy homeostasis, resulting in a positive energy balance. However, little is known about the role of IL-6 in the regulation of hypothalamic microglia. In this systematic review, we asked what types of conditions and stimuli could modulate microglial IL-6 expression in murine model. We searched the PubMed and Web of Science databases and analyzed 13 articles that evaluated diverse contexts and study models focused on IL-6 expression and microglia activation, including the effects of stress, hypoxia, infection, neonatal overfeeding and nicotine exposure, lipopolysaccharide stimulus, hormones, exercise protocols, and aging. The results presented in this review emphasized the role of ""injury-like"" stimuli, under which IL-6 acts as a proinflammatory cytokine, concomitant with marked microglial activation, which drive hypothalamic neuroinflammation. Emerging evidence indicates an important correlation of basal IL-6 levels and microglial function with the maintenance of hypothalamic homeostasis. Advances in our understanding of these different contexts will lead to the development of more specific pharmacological approaches for the management of acute and chronic conditions, like obesity and metabolic diseases, without disturbing the homeostatic functions of IL-6 and microglia in the hypothalamus.",[],BioMed research international,2019-09-20,"[{'lastname': 'Bobbo', 'firstname': 'Vanessa C D', 'initials': 'VCD', 'affiliation': 'Faculty of Nursing, University of Campinas, SP 13083-887, Brazil.\nLaboratory of Cell Signaling, Obesity and Comorbidities Research Center, University of Campinas, SP 13083-864, Brazil.'}, {'lastname': 'Jara', 'firstname': 'Carlos P', 'initials': 'CP', 'affiliation': 'Faculty of Nursing, University of Campinas, SP 13083-887, Brazil.\nLaboratory of Cell Signaling, Obesity and Comorbidities Research Center, University of Campinas, SP 13083-864, Brazil.'}, {'lastname': 'Mendes', 'firstname': 'Natália F', 'initials': 'NF', 'affiliation': 'Faculty of Nursing, University of Campinas, SP 13083-887, Brazil.\nLaboratory of Cell Signaling, Obesity and Comorbidities Research Center, University of Campinas, SP 13083-864, Brazil.'}, {'lastname': 'Morari', 'firstname': 'Joseane', 'initials': 'J', 'affiliation': 'Laboratory of Cell Signaling, Obesity and Comorbidities Research Center, University of Campinas, SP 13083-864, Brazil.'}, {'lastname': 'Velloso', 'firstname': 'Lício A', 'initials': 'LA', 'affiliation': 'Laboratory of Cell Signaling, Obesity and Comorbidities Research Center, University of Campinas, SP 13083-864, Brazil.'}, {'lastname': 'Araújo', 'firstname': 'Eliana P', 'initials': 'EP', 'affiliation': 'Faculty of Nursing, University of Campinas, SP 13083-887, Brazil.\nLaboratory of Cell Signaling, Obesity and Comorbidities Research Center, University of Campinas, SP 13083-864, Brazil.'}]",,,,,"10.1155/2019/1365210
10.1172/JCI118891
10.1038/32911
10.1038/35007534
10.1038/ijo.2011.56
10.1016/j.bbr.2009.12.024
10.1016/j.coph.2013.09.010
10.1016/j.cmet.2015.09.026
10.1038/nn.4202
10.1016/j.bbadis.2017.05.007
10.1038/nn1455
10.1210/en.2004-1520
10.1016/j.cell.2008.07.043
10.1523/JNEUROSCI.2760-08.2009
10.1210/en.2014-1090
10.1016/j.mce.2017.07.029
10.1016/j.bbamcr.2016.03.018
10.1016/0092-8674(89)90438-8
10.1016/0092-8674(90)90411-7
10.1038/ni.3153
10.1042/bj3340297
10.1016/j.celrep.2019.02.044
10.1126/science.1194637
10.1038/nri3086
10.1038/s42255-019-0040-0
10.1016/j.celrep.2014.11.018
10.2337/db14-0645
10.1186/s12974-018-1234-1
10.1016/j.bbi.2014.06.014
10.1016/j.bbi.2007.08.007
10.1111/j.1365-2826.2011.02113.x
10.1113/EP086780
10.1016/j.ebiom.2015.09.044
10.1016/j.bbi.2015.09.017
10.1016/S0165-5728(98)00217-3
10.1016/j.neuroscience.2007.02.043
10.1111/jne.12328
10.1016/j.bbi.2015.08.011
10.1152/ajpheart.00349.2015
10.1016/j.plefa.2018.04.003
10.1046/j.1471-4159.2001.00514.x
10.1016/j.tips.2010.04.001
10.4049/jimmunol.179.2.1292
10.1371/journal.pbio.1000465
10.1038/cddiscovery.2017.54
10.1016/j.neuroscience.2015.08.055
10.1016/j.stemcr.2018.03.008
10.1523/JNEUROSCI.1619-13.2014
10.1152/ajpendo.00074.2003
10.2139/ssrn.3254906
10.1002/glia.23505
10.1523/JNEUROSCI.5360-06.2007
10.1038/nm0102-75
10.1016/j.bbi.2011.03.012
10.1523/JNEUROSCI.23-02-00481.2003
10.1016/j.it.2015.08.003",<Element 'PubmedArticle' at 0x7f05dc2ac770>
274,"31447640
12370461
10845097
27903745
24704273
9723619
24578293
20817512
9405487
20399755
25576055
12699353
15721991
8616721
9537324
16355225
24780498
17374385
13886198
21099209
7987393
9619505
11746624
26017929
25748420
22536415
12573518
9463481
30692905
9796811
23064363
24166765
29174000
30531847
21343257
18367451
9011568
7624777
23196413
20679202
19293246
19747514
14824537
29416128
29867731
24880214
16216938
17410128
19922787
21550356
30319532
26885866
19139561
21304902
31191220
19620723
12439643
28091609
30386207
8674530
9202122
10579368
20702796
16289843
29287786
20838925
20703826
20167268
18292187
21086065
17224930
21070531
7624776
17419800
15064421
15476444
10632102
22040697
27506744
23085324
7669033
15710796
8787671
1982347
21331644
12482897
2549315
18466320
9589698
9500540
18222172
17617622
8548812
23332215
17620316
16670672
29351512
21745644
23688009
21622208
7560100
15863436
10767944
14242032
3734404
15982784
24199156
24852223
24199151
12171479
7984236",The Effects of Leptin on Glial Cells in Neurological Diseases.,"It is known that various endocrine modulators, including leptin and ghrelin, have neuroprotective roles in neurological diseases. Leptin is a hormone produced by adipocytes and was originally identified as a gene related to obesity in mice. The leptin receptors in the hypothalamus are the main target for the homeostatic regulation of body weight. Recent studies have demonstrated that leptin receptors are also expressed in other regions of the central nervous system (CNS), such as the hippocampus, cerebral cortex, and spinal cord. Accordingly, these studies identified the involvement of leptin in the regulation of neuronal survival and neural development. Furthermore, leptin has been shown to have neuroprotective functions in animal models of neurological diseases and demyelination. These observations also suggest that dysregulation of leptin signaling may be involved in the association between neurodegeneration and obesity. In this review, we summarize novel functions of leptin in animal models of neurodegenerative diseases. Specifically, we focus on the emerging evidence for the role of leptin in non-neuronal cells in the CNS, including astrocytes, microglia, and oligodendrocytes. Understanding leptin-mediated neuroprotective signals and molecular mechanisms underlying remyelination will be helpful to establish therapeutic strategies against neurological diseases.","['astrocyte', 'leptin', 'microglia', 'neuron', 'oligodendrocyte']",Frontiers in neuroscience,2019-08-27,"[{'lastname': 'Fujita', 'firstname': 'Yuki', 'initials': 'Y', 'affiliation': 'Department of Molecular Neuroscience, Graduate School of Medicine, Osaka University, Osaka, Japan.\nWPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.'}, {'lastname': 'Yamashita', 'firstname': 'Toshihide', 'initials': 'T', 'affiliation': 'Department of Molecular Neuroscience, Graduate School of Medicine, Osaka University, Osaka, Japan.\nWPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.\nGraduate School of Frontier Biosciences, Osaka University, Osaka, Japan.\nDepartment of Neuro-Medical Science, Graduate School of Medicine, Osaka University, Osaka, Japan.'}]",,,,,"10.3389/fnins.2019.00828
10.1212/wnl.59.7.1051
10.1146/annurev.physiol.62.1.413
10.2337/db16-0586
10.1016/j.euroneuro.2014.03.002
10.1038/29547
10.1530/JOE-13-0249
10.1016/j.conb.2010.08.005
10.1074/jbc.272.51.32686
10.1016/j.brainres.2010.04.011
10.2337/db14-1206
10.2174/1389450033491082
10.1016/j.freeradbiomed.2004.12.008
10.1038/nm0596-585
10.1038/32911
10.1038/nature04223
10.1016/j.nbd.2014.04.012
10.1016/j.mrfmmm.2007.01.013
10.1093/oxfordjournals.jhered.a107129
10.1159/000322472
10.1038/ng0994-59
10.1002/(sici)1096-9861(19980615)395:4<535::aid-cne9>3.3.co;2-7
10.1002/mds.1165
10.1080/15384101.2015.1041684
10.1016/j.lfs.2015.02.016
10.1371/journal.pone.0035594
10.1016/s0006-8993(02)04087-8
10.1124/mol.53.2.234
10.3389/fnins.2018.01027
10.1038/27376
10.1172/JCI64102
10.1002/glia.22580
10.1016/j.molmet.2017.11.003
10.1038/s41593-018-0286-y
10.1210/en.2010-1252
10.1074/jbc.M800053200
10.1172/JCI119125
10.1126/science.7624777
10.1097/WNR.0b013e32835ba875
10.1073/pnas.1004282107
10.1093/brain/awp029
10.1016/j.peptides.2009.08.023
10.1093/oxfordjournals.jhered.a106073
10.1038/nrn.2018.2
10.3389/fneur.2018.00322
10.1038/nn.3725
10.1001/archneur.62.10.1556
10.1038/nature05704
10.1016/j.bbi.2009.11.003
10.1016/j.physbeh.2011.04.060
10.3389/fneur.2018.00802
10.1097/WNR.0000000000000546
10.1172/JCI36785
10.1371/journal.pone.0016654
10.3389/fnins.2019.00508
10.1073/pnas.0903524106
10.1038/sj.ijo.0802142
10.1038/srep40397
10.3389/fncel.2018.00340
10.1016/0014-5793(96)00473-5
10.1038/43185
10.1210/endo.140.12.7288
10.1152/ajpregu.00449.2010
10.1016/j.neulet.2005.10.031
10.1016/j.eplepsyres.2017.12.009
10.1007/s12011-010-8836-5
10.1007/s12011-010-8793-z
10.1016/j.toxlet.2010.02.008
10.1210/en.2007-1673
10.1007/s12031-010-9470-6
10.1038/sj.ijo.0803536
10.1111/j.1742-1241.2010.02536.x
10.1126/science.7624776
10.1111/j.1471-4159.2007.04559.x
10.1126/science.1089459
10.1530/eje.0.1510451
10.1002/1531-8249(200001)47:1<64::aid-ana11>3.3.co;2-j
10.1016/j.mam.2011.10.012
10.1016/j.metabol.2016.05.018
10.1016/j.peptides.2012.10.002
10.1006/bbrc.1995.2266
10.1001/archinte.165.3.321
10.1172/JCI118891
10.1016/0304-3959(90)91074-s
10.1007/s11154-011-9171-7
10.1113/jphysiol.2002.029488
10.1016/0024-3205(89)90105-7
10.1111/j.1471-4159.2008.05457.x
10.1210/jcem.83.5.4952
10.1038/ng0398-213
10.1016/j.bbrc.2008.01.063
10.4049/jimmunol.179.2.1292
10.1016/j.placenta.2012.11.035
10.1002/jcp.21195
10.1152/physrev.00042.2016
10.1016/j.neuron.2011.05.028
10.2174/13816128113199990015
10.1172/JCI118254
10.1136/bmj.38446.466238.E0
10.1126/science.147.3662.1145
10.1093/oxfordjournals.jhered.a110206
10.1016/j.peptides.2004.12.033
10.1016/j.molmet.2013.01.004
10.1002/glia.22687
10.1016/j.molmet.2013.03.002
10.1046/j.1469-7580.2002.00068.x
10.1038/372425a0",<Element 'PubmedArticle' at 0x7f05dc2d1d10>
275,31445031,Melatonin regulates neuroinflammation ischemic stroke damage through interactions with microglia in reperfusion phase.,"Even today, ischemic stroke is a major cause of death and disabilities because of its high incidence, limited treatments and poor understanding of the pathophysiology of ischemia/reperfusion, neuroinflammation and secondary injuries following ischemic stroke. The function of microglia as a part of the immune system of the brain following ischemic stroke can be destructive or protective. Recent surveys indicate that melatonin, a strong antioxidant agent, has receptors on microglial cells and can regulate them to protective form; yet, more findings are required for better understanding of this mechanism, particularly in the reperfusion phase. In this study, we initially aimed to evaluate the therapeutic efficacy of melatonin intra-arterially and to clarify the underlying mechanisms. After that by using an in vitro approach, we evaluated the protective effects of melatonin on microglial cells following the hypoxia condition. Our results proved that a single dose of melatonin at the beginning of reperfusion phase improved structural and behavioral outcomes. Melatonin increased NeuN and decreased GFAP, Iba1 and active caspase-3 at protein level. Furthermore, melatonin elevated BDNF, MAP2, HSPA1A and reduced VEGF at mRNA level. We also showed that melatonin receptor 1B highly expressed in microglial cells after 3 h hypoxia. Besides, melatonin increased the ratio of TREM2/iNOS as a marker of the most protective form of microglia (M2). In summary, our data suggest that melatonin has the possibility to serve as targeting microglial action for preventing secondary injury of reperfusion phase after ischemic stroke.","['Ischemic stroke', 'Melatonin', 'Microglia', 'Neuroinflammation', 'Reperfusion phase']",Brain research,2019-08-25,"[{'lastname': 'Azedi', 'firstname': 'Fereshteh', 'initials': 'F', 'affiliation': 'Department of Neuroscience, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.'}, {'lastname': 'Mehrpour', 'firstname': 'Masoud', 'initials': 'M', 'affiliation': 'Department of Neurology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.'}, {'lastname': 'Talebi', 'firstname': 'Saeed', 'initials': 'S', 'affiliation': 'Department of Medical Genetics, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.'}, {'lastname': 'Zendedel', 'firstname': 'Adib', 'initials': 'A', 'affiliation': 'Institute of Neuroanatomy, RWTH Aachen University, 52074 Aachen, Germany.'}, {'lastname': 'Kazemnejad', 'firstname': 'Somaieh', 'initials': 'S', 'affiliation': 'Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.'}, {'lastname': 'Mousavizadeh', 'firstname': 'Kazem', 'initials': 'K', 'affiliation': 'Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.'}, {'lastname': 'Beyer', 'firstname': 'Cordian', 'initials': 'C', 'affiliation': 'Institute of Neuroanatomy, RWTH Aachen University, 52074 Aachen, Germany.'}, {'lastname': 'Zarnani', 'firstname': 'Amir-Hassan', 'initials': 'AH', 'affiliation': 'Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; Reproductive Immunology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran. Electronic address: zarnania@tums.ac.ir.'}, {'lastname': 'Joghataei', 'firstname': 'Mohammad Taghi', 'initials': 'MT', 'affiliation': 'Department of Neuroscience, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran; Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran. Electronic address: joghataei@iums.ac.ir.'}]",,,,Copyright © 2019 Elsevier B.V. All rights reserved.,10.1016/j.brainres.2019.146401,<Element 'PubmedArticle' at 0x7f05df6b4040>
276,"31435854
27459063
22632727
14980203
21778362
26464992
23262920
23407936
29581545
18612320
22182318
1304580
19756668
20887954
24582572
27228556
28341582
26745839
21072242
26780511
23054057
16126205
12351732
18195084
12960093
17626201
21208470
17408863
27683901
22512254
15156148
27196727
20478432
26979823
24551115
24607811
25276492
25447322
28620274
9182946
9460796
16337092
22975197
19195074
9630600
9373877
29311938
16280600
25336734
9735945
25247470
14504962
11226755
920968
2253324
27871289
23570274
15546155
16401547
22874006
26116891
25998072
16329132
18286612
11014219
10987824
11787778
10876074
9800279
11169476
25917865
19629762
28416446
24395130",Regulatory Control of Microglial Phagocytosis by Estradiol and Prostaglandin E2 in the Developing Rat Cerebellum.,"Microglia are essential to sculpting the developing brain, and they achieve this in part through the process of phagocytosis which is regulated by microenvironmental signals associated with cell death and synaptic connectivity. In the rat cerebellum, microglial phagocytosis reaches its highest activity during the third postnatal week of development but the factors regulating this activity are unknown. A signaling pathway, involving prostaglandin E","['Cerebellar cortex', 'Estrogen', 'Phagocytic cups', 'Phagocytic markers', 'Prostaglandins']","Cerebellum (London, England)",2019-08-23,"[{'lastname': 'Perez-Pouchoulen', 'firstname': 'Miguel', 'initials': 'M', 'affiliation': 'Department of Pharmacology, University of Maryland School of Medicine, 670 W. Baltimore Street, HSFIII 9-130, Baltimore, MD, 21201, USA. mpouchoulen@som.umaryland.edu.'}, {'lastname': 'Yu', 'firstname': 'Stacey J', 'initials': 'SJ', 'affiliation': 'Department of Pharmacology, University of Maryland School of Medicine, 670 W. Baltimore Street, HSFIII 9-130, Baltimore, MD, 21201, USA.'}, {'lastname': 'Roby', 'firstname': 'Clinton R', 'initials': 'CR', 'affiliation': 'Department of Pharmacology, University of Maryland School of Medicine, 670 W. Baltimore Street, HSFIII 9-130, Baltimore, MD, 21201, USA.'}, {'lastname': 'Bonsavage', 'firstname': 'Nicole', 'initials': 'N', 'affiliation': 'Department of Pharmacology, University of Maryland School of Medicine, 670 W. Baltimore Street, HSFIII 9-130, Baltimore, MD, 21201, USA.'}, {'lastname': 'McCarthy', 'firstname': 'Margaret M', 'initials': 'MM', 'affiliation': 'Department of Pharmacology, University of Maryland School of Medicine, 670 W. Baltimore Street, HSFIII 9-130, Baltimore, MD, 21201, USA.'}]",,,,,10.1007/s12311-019-01071-z,<Element 'PubmedArticle' at 0x7f05deeac090>
277,"31421410
23076408
28515690
24827941
28523794
27517478
28664398
27960152
28772270
23608137
25033060
25319470
29410737
27150190
28607392
15225806
25533012
27401255
30076526
26448556
29138801
28119569
25157786
27085714
26767952
22726353
24685992
24448902
29993274
28579120
28043680
24222043
22267242
24072555
29748075
20693391
20616348
29351514
29802210
21542804
23757400
30826386",Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: Role of renin-angiotensin system.,"Hypertension is one of the major predisposing factors for neurodegenerative disease characterized with activated renin-angiotensin system (RAS) in both periphery and brain. Vitamin D (VitD) is recently recognized as a pleiotropic hormone with strong neuroprotective properties. While multiple lines of evidence suggest that VitD can act on RAS, the evidence concerning the crosstalk between VitD and RAS in the brain is limited. Therefore, this study aims to evaluate whether VitD can modulate brain RAS to trigger neuroprotective actions in the brain of spontaneously hypertensive rats (SHR). Our data showed that calcitriol treatment induced VDR expression and inhibited neural death in the prefrontal cortex of SHR. Sustained calcitriol administration also inhibited microglia M1 polarization, but enhanced M2 polarization, accompanied with decreased expression of proinflammatory cytokines. We then further explored the potential mechanisms and showed that SHR exhibited overactivated classical RAS with increased expression of angiotensin II (Ang II) receptor type 1 (AT1), angiotensin converting enzyme (ACE) and Ang II production, whereas the counteracting arm of traditional RAS, ACE2/Ang(1-7)/MasR, was impaired in the SHR brain. Calcitriol nonsignificantly suppressed AT1 and ACE but markedly reduced Ang II formation. Intriguingly, calcitriol exerted pronouncedly impact on ACE2/Ang(1-7)/MasR axis with enhanced expression of ACE2, MasR and Ang(1-7) generation. Meanwhile, calcitriol ameliorated the overactivation of NADPH-oxidase (Nox), the downstream of RAS, in SHR, and also mitigated oxidative stress. In microglial (BV2) cells, we further found that calcitriol induced ACE2 and MasR with no significant impact on ACE and AT1. In accordance, calcitriol also attenuated Ang II-induced Nox activation and ROS production, and shifted the microglia polarization from M1 to M2 phenotype. However, co-treatment with A779, a specific MasR antagonist, abrogated the antioxidant and neuroimmune modulating actions of VitD. These findings strongly indicate the involvement of ACE2/Ang(1-7)/MasR pathway in the neuroprotective mechanisms of VitD in the hypertensive brain.","['ACE2/Ang(1–7)/MasR axis', 'Neuroinflammation', 'Oxidative stress', 'Renin-angiotensin system', 'Vitamin D']",Redox biology,2019-08-20,"[{'lastname': 'Cui', 'firstname': 'Changmeng', 'initials': 'C', 'affiliation': 'Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, China.'}, {'lastname': 'Xu', 'firstname': 'Pengfei', 'initials': 'P', 'affiliation': ""Jining First People's Hospital, Jining Medical University, Jining, China.""}, {'lastname': 'Li', 'firstname': 'Gongying', 'initials': 'G', 'affiliation': 'Department of Mental Health, Jining Medical University, Jining, China.'}, {'lastname': 'Qiao', 'firstname': 'Yi', 'initials': 'Y', 'affiliation': 'Department of Public Health, Jining Medical University, Jining, China.'}, {'lastname': 'Han', 'firstname': 'Wenxiu', 'initials': 'W', 'affiliation': ""Jining First People's Hospital, Jining Medical University, Jining, China.""}, {'lastname': 'Geng', 'firstname': 'Chunmei', 'initials': 'C', 'affiliation': ""Jining First People's Hospital, Jining Medical University, Jining, China.""}, {'lastname': 'Liao', 'firstname': 'Dehua', 'initials': 'D', 'affiliation': 'Hunan Cancer Hospital, Central South University, Changsha, China.'}, {'lastname': 'Yang', 'firstname': 'Mengqi', 'initials': 'M', 'affiliation': ""Jining First People's Hospital, Jining Medical University, Jining, China.""}, {'lastname': 'Chen', 'firstname': 'Dan', 'initials': 'D', 'affiliation': ""Jining First People's Hospital, Jining Medical University, Jining, China.""}, {'lastname': 'Jiang', 'firstname': 'Pei', 'initials': 'P', 'affiliation': ""Jining First People's Hospital, Jining Medical University, Jining, China; Department of Precision Medicine, Tengzhou Central People's Hospital, Tengzhou, China. Electronic address: jiangpeicsu@sina.com.""}]",,,,Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.,10.1016/j.redox.2019.101295,<Element 'PubmedArticle' at 0x7f05dee82860>
278,31408629,The renin-angiotensin system and the retinal neurovascular unit: A role in vascular regulation and disease.,"The retina is known to have a local renin-angiotensin system (RAS) and dysfunction in the RAS is often associated with diseases of the retinal vasculature that cause irreversible vision loss. Regulation of the retinal vasculature to meet the metabolic needs of the tissues occurs through a mechanism called neurovascular coupling, which is critical for maintaining homeostatic function and support for neurons. Neurovascular coupling is the process by which support cells, including glia, regulate blood vessel calibre and blood flow in response to neural activity. In retinal vascular diseases, this coupling mechanism is often disrupted. However, the role that angiotensin II (Ang II), the main effector peptide of the RAS, has in regulating both the retinal vasculature and neurovascular coupling is not fully understood. As components of the RAS are located on the principal neurons, glia and blood vessels of the retina, it is possible that Ang II has a role in regulating communication and function between these three cell types, and therefore the capacity to regulate neurovascular coupling. This review focuses on components of the RAS located on the retinal neurovascular unit, and the potential of this system to contribute to blood flow modulation in the healthy and compromised retina.","['Angiotensin', 'Diabetic retinopathy', 'Glia', 'Microglia', 'Pericyte', 'Retina']",Experimental eye research,2019-08-14,"[{'lastname': 'Phipps', 'firstname': 'Joanna A', 'initials': 'JA', 'affiliation': 'Department of Anatomy and Neuroscience, The University of Melbourne, Parkville, 3010, Victoria, Australia.'}, {'lastname': 'Dixon', 'firstname': 'Michael A', 'initials': 'MA', 'affiliation': 'Department of Anatomy and Neuroscience, The University of Melbourne, Parkville, 3010, Victoria, Australia.'}, {'lastname': 'Jobling', 'firstname': 'Andrew I', 'initials': 'AI', 'affiliation': 'Department of Anatomy and Neuroscience, The University of Melbourne, Parkville, 3010, Victoria, Australia.'}, {'lastname': 'Wang', 'firstname': 'Anna Y', 'initials': 'AY', 'affiliation': 'Department of Anatomy and Neuroscience, The University of Melbourne, Parkville, 3010, Victoria, Australia.'}, {'lastname': 'Greferath', 'firstname': 'Ursula', 'initials': 'U', 'affiliation': 'Department of Anatomy and Neuroscience, The University of Melbourne, Parkville, 3010, Victoria, Australia.'}, {'lastname': 'Vessey', 'firstname': 'Kirstan A', 'initials': 'KA', 'affiliation': 'Department of Anatomy and Neuroscience, The University of Melbourne, Parkville, 3010, Victoria, Australia.'}, {'lastname': 'Fletcher', 'firstname': 'Erica L', 'initials': 'EL', 'affiliation': 'Department of Anatomy and Neuroscience, The University of Melbourne, Parkville, 3010, Victoria, Australia. Electronic address: elf@unimelb.edu.au.'}]",,,,Copyright © 2019. Published by Elsevier Ltd.,10.1016/j.exer.2019.107753,<Element 'PubmedArticle' at 0x7f05ddca3590>
279,31401378,Dexamethasone exhibits its anti-inflammatory effects in S. aureus induced microglial inflammation via modulating TLR-2 and glucocorticoid receptor expression.,"Microglial inflammation plays crucial role in the pathogenesis of CNS infections including brain abscesses. Staphylococcus aureus (S. aureus) is considered as one of the major causative agents of brain abscesses. Due to the emergence of multidrug resistant bacteria the available treatment options including conventional antibiotics and steroid therapy become ineffective in terms of inflammation regulation which warrants further investigation to resolve this health issue. Microglial TLR-2 plays important roles in the bacterial recognition as well as induction of inflammation whereas glucocorticoid receptor (GR) triggers anti-inflammatory pathways in presence of glucocorticoids (GCs). The main objective of this study was to figure out the interdependency between TLR-2 and GR in presence of exogenous dexamethasone during microglial inflammation as an alternative therapeutic approach. Experiments were done either in TLR-2 neutralized condition or GR blocked condition in presence of dexamethasone. Free radicals production, arginase, superoxide dismutase (SOD), catalase enzyme activities and corticosterone concentration were measured along with Western blot analysis of TLR-2, GR and other inflammatory molecules. The results suggested that dexamethasone pre-treatment in TLR-2 neutralized condition efficiently reduces the inflammatory consequences of S. aureus induced microglial inflammation through up regulating GR expression. During TLR-2 blocking dexamethasone exerted its potent anti-inflammatory activities via suppressing reactive oxygen species (ROS), NO production and up regulating arginase, SOD and catalase activities at the time point of 90 min. Further in-vivo experiments are needed to conclude that dexamethasone could resolve brain inflammation possibly through microglial phenotypic switching from pro-inflammatory M1 to anti-inflammatory M2.","['Dexamethasone', 'Glucocorticoid receptor (GR)', 'Microglial inflammation', 'S. aureus', 'TLR-2']",International immunopharmacology,2019-08-12,"[{'lastname': 'Dey', 'firstname': 'Rajen', 'initials': 'R', 'affiliation': 'Department of Physiology, Immunology Laboratory, University of Calcutta, University College of Science and Technology, Calcutta, West Bengal, India.'}, {'lastname': 'Bishayi', 'firstname': 'Biswadev', 'initials': 'B', 'affiliation': 'Department of Physiology, Immunology Laboratory, University of Calcutta, University College of Science and Technology, Calcutta, West Bengal, India. Electronic address: biswa_dev2@yahoo.com.'}]",,,,Copyright © 2019 Elsevier B.V. All rights reserved.,10.1016/j.intimp.2019.105806,<Element 'PubmedArticle' at 0x7f05ddcb4040>
280,31394203,Glucocorticoid receptors modulate dendritic spine plasticity and microglia activity in an animal model of Alzheimer's disease.,"Chronic exposure to high circulating levels of glucocorticoids (GCs) may be a key risk factor for Alzheimer's Disease (AD) development and progression. In addition, hyper-activation of glucocorticoid receptors (GRs) induces brain alterations comparable to those produced by AD. In transgenic mouse models of AD, GCs increase the production of the most important and typical hallmarks of this dementia such as: Aβ40, Aβ42 and tau protein (both the total tau and its hyperphosphorylated isoforms). Moreover, GCs in brain are pivotal regulators of dendritic spine turnover and microglia activity, two phenomena strongly altered in AD. Although it is well-established that GCs primes the neuroinflammatory response in the brain to some stimuli, it is unknown whether or how GRs modulates dendritic spine plasticity and microglia activity in AD. In this study, we evaluated, using combined Golgi Cox and immunofluorescence techniques, the role of GR agonists and antagonists on dendritic spine plasticity and microglia activation in hippocampus of 3xTg-AD mice. We found that dexamethasone, an agonist of GRs, was able to significantly reduce dendritic spine density and induced proliferation and activation of microglia in CA1 region of hippocampus of 3xTg-AD mice at 6 and 10 months of age. On the contrary, the treatment with mifepristone, an antagonist of GRs, strongly enhanced dendritic spine density, decreased microglia density and improved the behavioural performance of 3xTg-AD mice. Additionally, primary microglial cells in vitro were directly activated by dexamethasone. Together, these data demonstrate that stress exacerbates AD and promotes a rapid progression of the pathology acting on both neurons and glial cells, supporting an important pro-inflammatory role of GC within CNS in AD. Consequently, these results further strengthen the need to test clinical interventions that correct GCs dysregulation as promising therapeutic strategy to delay the onset and slow down the progression of AD.","[""Alzheimer's disease"", 'Dendritic spines', 'Glucocorticoid receptor', 'Glucocorticoids', 'Hippocampus', 'Microglia']",Neurobiology of disease,2019-08-09,"[{'lastname': 'Pedrazzoli', 'firstname': 'Matteo', 'initials': 'M', 'affiliation': 'University of Verona, Department of Neurosciences, Biomedicine and Movement Sciences, Verona, Italy.'}, {'lastname': 'Losurdo', 'firstname': 'Morris', 'initials': 'M', 'affiliation': 'University of Milano-Bicocca, School of Medicine and Surgery, Milan, Italy.'}, {'lastname': 'Paolone', 'firstname': 'Giovanna', 'initials': 'G', 'affiliation': 'University of Verona, Department of Diagnostics and Public Health, Verona, Italy.'}, {'lastname': 'Medelin', 'firstname': 'Manuela', 'initials': 'M', 'affiliation': 'University of Verona, Department of Neurosciences, Biomedicine and Movement Sciences, Verona, Italy.'}, {'lastname': 'Jaupaj', 'firstname': 'Lejdi', 'initials': 'L', 'affiliation': 'University of Verona, Department of Neurosciences, Biomedicine and Movement Sciences, Verona, Italy.'}, {'lastname': 'Cisterna', 'firstname': 'Barbara', 'initials': 'B', 'affiliation': 'University of Verona, Department of Neurosciences, Biomedicine and Movement Sciences, Verona, Italy.'}, {'lastname': 'Slanzi', 'firstname': 'Anna', 'initials': 'A', 'affiliation': 'University of Verona, Department of Medicine, Verona, Italy.'}, {'lastname': 'Malatesta', 'firstname': 'Manuela', 'initials': 'M', 'affiliation': 'University of Verona, Department of Neurosciences, Biomedicine and Movement Sciences, Verona, Italy.'}, {'lastname': 'Coco', 'firstname': 'Silvia', 'initials': 'S', 'affiliation': 'University of Milano-Bicocca, School of Medicine and Surgery, Milan, Italy.'}, {'lastname': 'Buffelli', 'firstname': 'Mario', 'initials': 'M', 'affiliation': 'University of Verona, Department of Neurosciences, Biomedicine and Movement Sciences, Verona, Italy. Electronic address: mario.buffelli@univr.it.'}]",,,,Copyright © 2019 Elsevier Inc. All rights reserved.,10.1016/j.nbd.2019.104568,<Element 'PubmedArticle' at 0x7f05ddcc9b80>
281,"31364823
24028961
27397854
27885006
28239743
24136970
30679382
27931262
28576566
29195051
22896675
30561329
29479071
28826498
25204284
27234656
25589747
25471560
26526066
16237719
24512957
24470695
29773907
30535688
28412142
24263092
30192999
19246392
29880854
28123668
29632177
28679595
22120156
21148344
25947369
28043900
28539349
28109896
24367384
29549603
19855404
28722711
27549340
30876981
26255702
19779148
21281561
30347264
18495879
17121991
21329555
19660138
22365952
17074507
21257712
8987746
18951529
28551776
19393298
29405337
28755467",Aquaporin 4 deletion exacerbates brain impairments in a mouse model of chronic sleep disruption.,"As a normal physiological process, sleep has recently been shown to facilitate clearance of macromolecular metabolic wastes from the brain via the glymphatic system. The aim of the present study was to investigate pathophysiological roles of astroglial aquaporin 4 (AQP4), a functional regulator of glymphatic clearance, in a mouse model of chronic sleep disruption (SD).
Adult AQP4 null mice and wild-type (WT) mice were given 7 days of SD using the improved rotating rod method, and then received behavioral, neuropathological, and neurochemical analyses.
Aquaporin 4 deletion resulted in an impairment of glymphatic transport and accumulation of β-amyloid and Tau proteins in the brain following SD. AQP4 null SD mice exhibited severe activation of microglia, neuroinflammation, and synaptic protein loss in the hippocampus, as well as decreased working memory, compared with WT-SD mice.
These results demonstrate that AQP4-mediated glymphatic clearance ameliorates brain impairments caused by abnormal accumulation of metabolic wastes following chronic SD, thus serving as a potential target for sleep-related disorders.","['aquaporin-4', 'behavioral test', 'glymphatic system', 'hippocampus', 'sleep disruption']",CNS neuroscience & therapeutics,2019-08-01,"[{'lastname': 'Zhang', 'firstname': 'Rui', 'initials': 'R', 'affiliation': 'Department of Neurology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.\nJiangsu Province, Key Laboratory of Neurodegeneration, Nanjing Medical University, Nanjing, China.'}, {'lastname': 'Liu', 'firstname': 'Yun', 'initials': 'Y', 'affiliation': 'Department of Neurology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.\nJiangsu Province, Key Laboratory of Neurodegeneration, Nanjing Medical University, Nanjing, China.'}, {'lastname': 'Chen', 'firstname': 'Yan', 'initials': 'Y', 'affiliation': 'Jiangsu Province, Key Laboratory of Neurodegeneration, Nanjing Medical University, Nanjing, China.\nBrain Institute, the Affiliated Nanjing Brain Hospital of Nanjing Medical University, Nanjing, China.'}, {'lastname': 'Li', 'firstname': 'Qian', 'initials': 'Q', 'affiliation': 'Jiangsu Province, Key Laboratory of Neurodegeneration, Nanjing Medical University, Nanjing, China.\nBrain Institute, the Affiliated Nanjing Brain Hospital of Nanjing Medical University, Nanjing, China.'}, {'lastname': 'Marshall', 'firstname': 'Charles', 'initials': 'C', 'affiliation': 'Department of Rehabilitation Sciences, University of Kentucky Center of Excellence in Rural Health, Hazard, KY, USA.'}, {'lastname': 'Wu', 'firstname': 'Ting', 'initials': 'T', 'affiliation': 'Department of Neurology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.\nJiangsu Province, Key Laboratory of Neurodegeneration, Nanjing Medical University, Nanjing, China.'}, {'lastname': 'Hu', 'firstname': 'Gang', 'initials': 'G', 'affiliation': 'Jiangsu Province, Key Laboratory of Neurodegeneration, Nanjing Medical University, Nanjing, China.'}, {'lastname': 'Xiao', 'firstname': 'Ming', 'initials': 'M', 'affiliation': 'Jiangsu Province, Key Laboratory of Neurodegeneration, Nanjing Medical University, Nanjing, China.\nBrain Institute, the Affiliated Nanjing Brain Hospital of Nanjing Medical University, Nanjing, China.'}]",,"These results demonstrate that AQP4-mediated glymphatic clearance ameliorates brain impairments caused by abnormal accumulation of metabolic wastes following chronic SD, thus serving as a potential target for sleep-related disorders.","Aquaporin 4 deletion resulted in an impairment of glymphatic transport and accumulation of β-amyloid and Tau proteins in the brain following SD. AQP4 null SD mice exhibited severe activation of microglia, neuroinflammation, and synaptic protein loss in the hippocampus, as well as decreased working memory, compared with WT-SD mice.",© 2019 The Authors. CNS Neuroscience & Therapeutics Published by John Wiley & Sons Ltd.,10.1111/cns.13194,<Element 'PubmedArticle' at 0x7f05ddcd77c0>
282,31344367,Inhibition of PDE5 attenuates streptozotocin-induced neuroinflammation and tau hyperphosphorylation in a streptozotocin-treated rat model.,"Intracerebroventricular (icv) streptozotocin (STZ) injection decreases cerebral insulin signal pathway function and produces multiple effects that resemble the molecular, pathological, and behavioural features of Sporadic Alzheimer's disease (SAD). We previously reported that yonkenafil (yonk), the analogue of sildenafil and a novel PDE5 inhibitor exerts an anti-amyloidogenesis effect by regulating the Aβ level and inhibiting the expression of β-amyloid precursor protein in the APP/PS1 transgenic mice model. In this study, the effects of yonk on cognitive behaviors as well as the pathological features in streptozotocin-induced SAD rat model were investigated. The results demonstrated that administration of yonk at doses of 3 and 10 mg/kg for three weeks significantly improved cognitive deficits, attenuated STZ-induced neuronal death, inhibited the over-activation of microglia and astrocytes and the levels of pro-inflammatory markers, as well as decreased PDE5 protein expression in the hippocampus. Furthermore, yonk (3 mg/kg) notably prevented changes in tau hyperphosphorylation, decreased IRS-1and JNK phosphorylation and increased the GSK3β (ser9) phosphorylation induced by STZ. In summary, these data suggested that yonk significantly reversed STZ-induced memory deficits by inhibiting the over-activation of microglia and astrocytes, as well as ameliorated the levels of pro-inflammatory makers and tau hyperphosphorylation through regulating GSK3β signalling pathway.","['Neuroinflammation', 'PDE5 inhibitor', 'Streptozotocin', 'Tau hyperphosphorylation']",Brain research,2019-07-26,"[{'lastname': 'Zhu', 'firstname': 'Lei', 'initials': 'L', 'affiliation': 'Department of Pharmacology, Shenyang Pharmaceutical University, Box 31, 103 Wenhua Road, 110016 Shenyang, PR China.'}, {'lastname': 'Zhang', 'firstname': 'Zhen', 'initials': 'Z', 'affiliation': 'Department of Pharmacology, Shenyang Pharmaceutical University, Box 31, 103 Wenhua Road, 110016 Shenyang, PR China.'}, {'lastname': 'Hou', 'firstname': 'Xiao-Jie', 'initials': 'XJ', 'affiliation': 'Department of Pharmacology, Shenyang Pharmaceutical University, Box 31, 103 Wenhua Road, 110016 Shenyang, PR China.'}, {'lastname': 'Wang', 'firstname': 'Yong-Feng', 'initials': 'YF', 'affiliation': 'Zhuhai Oxforston PharmTech Co. Ltd., Tangjiawan, 519085 Zhuhai, PR China.'}, {'lastname': 'Yang', 'firstname': 'Jing-Yu', 'initials': 'JY', 'affiliation': 'Department of Pharmacology, Shenyang Pharmaceutical University, Box 31, 103 Wenhua Road, 110016 Shenyang, PR China. Electronic address: yangjingyu2006@gmail.com.'}, {'lastname': 'Wu', 'firstname': 'Chun-Fu', 'initials': 'CF', 'affiliation': 'Department of Pharmacology, Shenyang Pharmaceutical University, Box 31, 103 Wenhua Road, 110016 Shenyang, PR China. Electronic address: wucf@syphu.edu.cn.'}]",,,,Copyright © 2019. Published by Elsevier B.V.,10.1016/j.brainres.2019.146344,<Element 'PubmedArticle' at 0x7f05de40cea0>
283,"31327964
30396512
29434331
30195173
28669580
26829434
29104591
29630951
29848280
30242884
26639408
28546552
30174579
30618635
28226226
30206330
29902514
28196749
28263786
29016824
29212498
27923741
24859041
24513871
26750863
30146307
26540403
25324778
28441057
29717933
27825853
25528518
28247911
30180869
29119264
27470577
27646262
28109165
28891317
29802856
29643977
26176920
27690561
27016384
26048446
26485503
22930834
17210054
2789141
22747645
29458118
29203171
28398673
29862377
30248487
28864909
27959620
28403163
29423011
30862067
26551702
30576920
30585210
27812200
26924896
27421686
30386243
28986066
29326403
26866273
26566260
29427626
29681406
26048578
28058465
24388427",Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway.,"Inflammation is a crucial component of various stress-induced responses that contributes to the pathogenesis of major depressive disorder (MDD). Depressive-like behavior (DLB) is characterized by decreased mobility and depressive behavior that occurs in systemic infection induced by Lipopolysaccharide (LPS) in experimental animals and is considered as a model of exacerbation of MDD. We assessed the effects of melatonin on behavioral changes and inflammatory cytokine expression in hippocampus of mice in LPS-induced DLB, as well as its effects on NLR Family Pyrin Domain Containing 3 (NLRP3) inflammasome activation, oxidative stress and pyroptotic cell death in murine microglia ","['NLRP3 inflammasome', 'Nrf2', 'SIRT1', 'depressive-like behaviors', 'lipopolysaccharide', 'melatonin', 'microglia']",Frontiers in immunology,2019-07-23,"[{'lastname': 'Arioz', 'firstname': 'Burak I', 'initials': 'BI', 'affiliation': 'Izmir Biomedicine Genome Center, Izmir, Turkey.'}, {'lastname': 'Tastan', 'firstname': 'Bora', 'initials': 'B', 'affiliation': 'Izmir Biomedicine Genome Center, Izmir, Turkey.'}, {'lastname': 'Tarakcioglu', 'firstname': 'Emre', 'initials': 'E', 'affiliation': 'Izmir Biomedicine Genome Center, Izmir, Turkey.'}, {'lastname': 'Tufekci', 'firstname': 'Kemal Ugur', 'initials': 'KU', 'affiliation': 'Izmir Biomedicine Genome Center, Izmir, Turkey.'}, {'lastname': 'Olcum', 'firstname': 'Melis', 'initials': 'M', 'affiliation': 'Izmir Biomedicine Genome Center, Izmir, Turkey.'}, {'lastname': 'Ersoy', 'firstname': 'Nevin', 'initials': 'N', 'affiliation': 'Department of Histology and Embryology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.'}, {'lastname': 'Bagriyanik', 'firstname': 'Alper', 'initials': 'A', 'affiliation': 'Izmir Biomedicine Genome Center, Izmir, Turkey.\nDepartment of Histology and Embryology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.'}, {'lastname': 'Genc', 'firstname': 'Kursad', 'initials': 'K', 'affiliation': 'Department of Neuroscience, Health Sciences Institute, Dokuz Eylul University, Izmir, Turkey.'}, {'lastname': 'Genc', 'firstname': 'Sermin', 'initials': 'S', 'affiliation': 'Izmir Biomedicine Genome Center, Izmir, Turkey.\nDepartment of Neuroscience, Health Sciences Institute, Dokuz Eylul University, Izmir, Turkey.'}]",,,,,"10.3389/fimmu.2019.01511
10.1016/S0140-6736(18)31948-2
10.1038/s41598-018-21243-x
10.1016/j.jad.2018.06.045
10.1016/j.pnpbp.2017.06.036
10.4088/JCP.14077su1c.04
10.1155/2017/1835195
10.1016/j.arr.2018.04.003
10.2174/1871524918666180531083944
10.1111/jpi.12525
10.1111/jpi.12300
10.1038/s41598-017-02679-z
10.3389/fnins.2018.00547
10.3389/fncel.2018.00488
10.1146/annurev-immunol-051116-052358
10.1038/s41583-018-0055-7
10.1016/j.bbi.2018.06.010
10.1016/j.it.2017.01.003
10.1016/j.bbi.2017.03.002
10.1093/ijnp/pyx065
10.1186/s12974-017-1013-4
10.1016/j.neuroscience.2016.11.037
10.1016/j.bbi.2014.04.007
10.1016/j.bbi.2013.10.017
10.3109/08039488.2015.1100328
10.1016/j.neuron.2018.08.001
10.1016/j.jpsychires.2015.10.015
10.3389/fphys.2014.00352
10.1146/annurev-biochem-061516-045037
10.1152/physrev.00023.2017
10.1016/j.bbadis.2016.11.005
10.1016/j.mce.2014.12.013
10.1002/eji.201646665
10.1186/s12974-018-1294-2
10.1007/s00406-017-0848-0
10.1038/srep30659
10.1038/mp.2016.144
10.1111/jpi.12391
10.1089/ars.2017.7290
10.1016/j.pnpbp.2018.05.017
10.1155/2018/8596903
10.1038/nature14659
10.1176/appi.ajp.2016.16040394
10.1016/j.biopsych.2016.01.009
10.1016/j.steroids.2015.05.010
10.1016/j.ejphar.2015.10.026
10.1038/nmeth.2089
10.1111/j.1365-2818.2006.01706.x
10.1002/eji.1830190815
10.1186/1741-7015-10-66
10.1016/j.physbeh.2018.02.034
10.1016/j.jmb.2017.11.013
10.1111/jpi.12414
10.1016/j.cotox.2017.11.002
10.1016/j.molimm.2018.09.010
10.1007/s00018-017-2609-7
10.1146/annurev-physiol-022516-034406
10.1371/journal.pone.0175336
10.3390/ijms20051223
10.1042/BST20150014
10.1016/j.redox.2018.11.017
10.3390/ijms20010078
10.1371/journal.pone.0166010
10.1155/2016/1045657
10.1111/cns.12588
10.3389/fphar.2018.01182
10.1016/j.yexcr.2017.09.042
10.18632/aging.101361
10.1038/cddis.2016.3
10.1111/bph.13386
10.1016/j.bcp.2018.02.001
10.1016/j.jneuroim.2018.04.009
10.1186/s12974-015-0332-6
10.1007/s00394-016-1373-z
10.1016/j.tins.2013.12.001",<Element 'PubmedArticle' at 0x7f05de42bf40>
284,"31324781
2408759
20051473
23099477
11756160
30249809
20682855
24742461
22197934
28760770
12393599
29440354
22442384
29215000
23383005
25063453
15146183
27814941
7242681
22046273
23314290
29593242
1834496
9328346
23273845
27521519
23812096
24962162
8314887
8018921
26952982
11675359
25151491
29038658
29789388
30173915
27292029
21762674
27477514
25349429
28394333
30538339
22729249
29511065
20966214
26780511
25497733
27135602
31061494
30872492
28671693
28546318
25849463
30306644
28628214
24360280
28323268
25825708
22542597
30982608
26687838
18171944
29475558
25902481
25137049
28751473
25480296
27492475
28145440
20123678
28076784
26687625
20206554
27776109
27412700
28915372
16007221
28236968
29861285
20519640
28430923",Deletion of a Csf1r enhancer selectively impacts CSF1R expression and development of tissue macrophage populations.,"The proliferation, differentiation and survival of mononuclear phagocytes depend on signals from the receptor for macrophage colony-stimulating factor, CSF1R. The mammalian Csf1r locus contains a highly conserved super-enhancer, the fms-intronic regulatory element (FIRE). Here we show that genomic deletion of FIRE in mice selectively impacts CSF1R expression and tissue macrophage development in specific tissues. Deletion of FIRE ablates macrophage development from murine embryonic stem cells. Csf1r",[],Nature communications,2019-07-22,"[{'lastname': 'Rojo', 'firstname': 'Rocío', 'initials': 'R', 'affiliation': 'The Roslin Institute & Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, UK.\nTecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Av. Ignacio Morones Prieto 3000 Pte, Col. Los Doctores, C.P. 64710, Monterrey, N.L., Mexico.'}, {'lastname': 'Raper', 'firstname': 'Anna', 'initials': 'A', 'affiliation': 'The Roslin Institute & Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, UK.'}, {'lastname': 'Ozdemir', 'firstname': 'Derya D', 'initials': 'DD', 'affiliation': 'The Roslin Institute & Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, UK.'}, {'lastname': 'Lefevre', 'firstname': 'Lucas', 'initials': 'L', 'affiliation': 'The Roslin Institute & Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, UK.'}, {'lastname': 'Grabert', 'firstname': 'Kathleen', 'initials': 'K', 'affiliation': 'The Roslin Institute & Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, UK.\nDepartment of Environmental Medicine, Toxicology Unit, Karolinska Institutet, Box 210, SE-171 77, Stockholm, Sweden.'}, {'lastname': 'Wollscheid-Lengeling', 'firstname': 'Evi', 'initials': 'E', 'affiliation': 'The Roslin Institute & Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, UK.'}, {'lastname': 'Bradford', 'firstname': 'Barry', 'initials': 'B', 'affiliation': 'The Roslin Institute & Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, UK.'}, {'lastname': 'Caruso', 'firstname': 'Melanie', 'initials': 'M', 'affiliation': 'The Roslin Institute & Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, UK.'}, {'lastname': 'Gazova', 'firstname': 'Iveta', 'initials': 'I', 'affiliation': 'The Roslin Institute & Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, UK.'}, {'lastname': 'Sánchez', 'firstname': 'Alejandra', 'initials': 'A', 'affiliation': 'The Roslin Institute & Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, UK.'}, {'lastname': 'Lisowski', 'firstname': 'Zofia M', 'initials': 'ZM', 'affiliation': 'The Roslin Institute & Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, UK.'}, {'lastname': 'Alves', 'firstname': 'Joana', 'initials': 'J', 'affiliation': 'The Roslin Institute & Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, UK.'}, {'lastname': 'Molina-Gonzalez', 'firstname': 'Irene', 'initials': 'I', 'affiliation': ""The MRC University of Edinburgh Centre for Reproductive Health, The Queen's Medical Research Institute, Edinburgh BioQuarter, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK.""}, {'lastname': 'Davtyan', 'firstname': 'Hayk', 'initials': 'H', 'affiliation': 'Department of Neurobiology and Behavior, University of California Irvine, 3014 Gross Hall 845 Health Sciences Rd, Irvine, CA, 92697-1705, USA.'}, {'lastname': 'Lodge', 'firstname': 'Rebecca J', 'initials': 'RJ', 'affiliation': ""University of Edinburgh Centre for Inflammation Research, The Queen's Medical Research Institute, Edinburgh BioQuarter, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK.""}, {'lastname': 'Glover', 'firstname': 'James D', 'initials': 'JD', 'affiliation': 'The Roslin Institute & Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, UK.'}, {'lastname': 'Wallace', 'firstname': 'Robert', 'initials': 'R', 'affiliation': ""The Department of Orthopedic Surgery, University of Edinburgh, Chancellor's Building, Edinburgh BioQuarter, 49 Little France Crescent, Edinburgh, EH16 4SB, UK.""}, {'lastname': 'Munro', 'firstname': 'David A D', 'initials': 'DAD', 'affiliation': ""UK Dementia Research Institute, The University of Edinburgh, Chancellor's Building, Edinburgh BioQuarter, 49 Little France Crescent, Edinburgh, EH16 4SB, UK.""}, {'lastname': 'David', 'firstname': 'Eyal', 'initials': 'E', 'affiliation': 'Department of Immunology, Weizmann Institute of Science, 234 Herzl St., Rehovot, 7610001, Israel.'}, {'lastname': 'Amit', 'firstname': 'Ido', 'initials': 'I', 'affiliation': 'Department of Immunology, Weizmann Institute of Science, 234 Herzl St., Rehovot, 7610001, Israel.'}, {'lastname': 'Miron', 'firstname': 'Véronique E', 'initials': 'VE', 'affiliation': ""The MRC University of Edinburgh Centre for Reproductive Health, The Queen's Medical Research Institute, Edinburgh BioQuarter, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK.""}, {'lastname': 'Priller', 'firstname': 'Josef', 'initials': 'J', 'affiliation': ""UK Dementia Research Institute, The University of Edinburgh, Chancellor's Building, Edinburgh BioQuarter, 49 Little France Crescent, Edinburgh, EH16 4SB, UK.""}, {'lastname': 'Jenkins', 'firstname': 'Stephen J', 'initials': 'SJ', 'affiliation': ""University of Edinburgh Centre for Inflammation Research, The Queen's Medical Research Institute, Edinburgh BioQuarter, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK.""}, {'lastname': 'Hardingham', 'firstname': 'Giles E', 'initials': 'GE', 'affiliation': ""UK Dementia Research Institute, The University of Edinburgh, Chancellor's Building, Edinburgh BioQuarter, 49 Little France Crescent, Edinburgh, EH16 4SB, UK.\nCentre for Discovery Brain Sciences, University of Edinburgh, Hugh Robson Building, 15 George Square, Edinburgh, EH8 9XD, UK.""}, {'lastname': 'Blurton-Jones', 'firstname': 'Mathew', 'initials': 'M', 'affiliation': 'Department of Neurobiology and Behavior, University of California Irvine, 3014 Gross Hall 845 Health Sciences Rd, Irvine, CA, 92697-1705, USA.'}, {'lastname': 'Mabbott', 'firstname': 'Neil A', 'initials': 'NA', 'affiliation': 'The Roslin Institute & Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, UK.'}, {'lastname': 'Summers', 'firstname': 'Kim M', 'initials': 'KM', 'affiliation': 'Mater Research Institute-University of Queensland, Translational Research Institute, Woolloongabba, QLD, 4102, Australia.'}, {'lastname': 'Hohenstein', 'firstname': 'Peter', 'initials': 'P', 'affiliation': 'The Roslin Institute & Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, UK.\nLeiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands.'}, {'lastname': 'Hume', 'firstname': 'David A', 'initials': 'DA', 'affiliation': 'Mater Research Institute-University of Queensland, Translational Research Institute, Woolloongabba, QLD, 4102, Australia. David.Hume@uq.edu.au.'}, {'lastname': 'Pridans', 'firstname': 'Clare', 'initials': 'C', 'affiliation': ""University of Edinburgh Centre for Inflammation Research, The Queen's Medical Research Institute, Edinburgh BioQuarter, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK. clare.pridans@ed.ac.uk.\nSimons Initiative for the Developing Brain, Centre for Discovery Brain Sciences, University of Edinburgh, Hugh Robson Building, George Square, Edinburgh, EH8 9XD, UK. clare.pridans@ed.ac.uk.""}]",,,,,"10.1038/s41467-019-11053-8
10.1016/S0092-8674(85)80047-7
10.1189/jlb.0909624
10.1016/j.molimm.2012.09.008
10.1182/blood.V99.1.111
10.4049/jimmunol.1701783
10.1182/blood-2010-02-266296
10.1016/j.neuron.2014.02.040
10.1038/ng.1027
10.1042/CS20170238
10.1182/blood-2002-02-0569
10.4049/jimmunol.1701488
10.1126/science.1219179
10.1038/s41598-017-15999-x
10.1371/journal.pone.0054935
10.1242/dev.105593
10.1038/ng1361
10.1016/j.immuni.2016.10.011
10.1038/292154a0
10.1371/journal.pone.0026317
10.1016/j.scr.2012.12.001
10.1038/s41467-018-03638-6
10.1016/0012-1606(91)90336-2
10.1210/mend.11.11.0009
10.1016/j.immuni.2012.12.001
10.1016/j.semcdb.2016.08.009
10.1038/ni.2638
10.1038/mt.2014.112
10.1242/dev.129122
10.1182/blood.V98.9.2845
10.1038/ni.2967
10.3389/fimmu.2017.01254
10.1084/jem.20180019
10.1016/j.cell.2018.07.048
10.1038/ncomms11852
10.1016/j.ajpath.2011.05.037
10.1016/j.cell.2016.06.058
10.1073/pnas.1406508111
10.1038/nm.4326
10.1038/s41590-018-0272-2
10.1038/ni.2360
10.1084/jem.20171608
10.1126/science.1194637
10.1038/nn.4222
10.1038/ni.3423
10.1038/s41593-019-0393-4
10.1126/science.aau0964
10.1038/nn.4597
10.1126/science.aal3222
10.1371/journal.pone.0122912
10.1002/glia.23517
10.1111/jnc.14106
10.1016/j.cell.2013.11.030
10.1038/ni.3703
10.1073/pnas.1421480112
10.1016/j.ydbio.2012.03.026
10.1016/j.ajhg.2019.03.010
10.1016/j.neuron.2015.11.013
10.1523/JNEUROSCI.4178-07.2008
10.1016/j.cellimm.2018.01.001
10.1016/j.immuni.2015.03.011
10.1371/journal.pone.0105429
10.1189/jlb.1A0417-150RR
10.1016/j.cell.2014.11.018
10.1126/science.aaf4238
10.1038/mi.2016.142
10.1189/jlb.0809557
10.1016/j.celrep.2016.12.041
10.1016/j.cub.2015.11.034
10.1016/j.immuni.2010.02.008
10.1038/ni.3585
10.15252/embj.201693801
10.1016/j.cell.2015.12.046
10.1038/sj.onc.1208657
10.1016/bs.ctdb.2016.10.004
10.1016/j.neuron.2018.05.014
10.1189/jlb.0310158
10.1210/en.2016-1884",<Element 'PubmedArticle' at 0x7f05dc83bdb0>
285,"31323920
16822554
19077109
21119734
29495320
25406832
24174323
24936060
28667781
30954920
25654303
29074640
28103132
26741196
25470454
28640253
19409385
27873219
16906540
2791979
18329265
29511094
21924324
19298790
19366607
27524977
18374421
30189290
28530125
6641946
24692541
26627829
17059356
13925019
29300865
17973904
20107899
19463096
7537039
1373486
12560333
9144197",CRISPR-Cas9 Mediated TSPO Gene Knockout alters Respiration and Cellular Metabolism in Human Primary Microglia Cells.,"The 18 kDa translocator protein (TSPO) is an evolutionary conserved cholesterol binding protein localized in the outer mitochondrial membrane. It has been implicated in the regulation of various cellular processes including oxidative stress, proliferation, apoptosis, and steroid hormone biosynthesis. Since the expression of TSPO in activated microglia is upregulated in various neuroinflammatory and neurodegenerative disorders, we set out to examine the role of TSPO in an immortalized human microglia C20 cell line. To this end, we performed a dual approach and used (i) lentiviral shRNA silencing to reduce TSPO expression, and (ii) the CRISPR/Cas9 technology to generate complete TSPO knockout microglia cell lines. Functional characterization of control and TSPO knockdown as well as knockout cells, revealed only low de novo steroidogenesis in C20 cells, which was not dependent on the level of TSPO expression or influenced by the treatment with TSPO-specific ligands. In contrast to TSPO knockdown C20 cells, which did not show altered mitochondrial function, the TSPO deficient knockout cells displayed a significantly decreased mitochondrial membrane potential and cytosolic Ca","['Ca2+ homeostasis', 'TSPO', 'knockdown', 'knockout', 'mitochondria', 'mitochondrial membrane potential', 'oxidative phosphorylation', 'steroid synthesis']",International journal of molecular sciences,2019-07-22,"[{'lastname': 'Milenkovic', 'firstname': 'Vladimir M', 'initials': 'VM', 'affiliation': 'Molecular Neurosciences, Department of Psychiatry and Psychotherapy, University of Regensburg, 93053 Regensburg, Germany.'}, {'lastname': 'Slim', 'firstname': 'Dounia', 'initials': 'D', 'affiliation': 'Molecular Neurosciences, Department of Psychiatry and Psychotherapy, University of Regensburg, 93053 Regensburg, Germany.'}, {'lastname': 'Bader', 'firstname': 'Stefanie', 'initials': 'S', 'affiliation': 'Molecular Neurosciences, Department of Psychiatry and Psychotherapy, University of Regensburg, 93053 Regensburg, Germany.'}, {'lastname': 'Koch', 'firstname': 'Victoria', 'initials': 'V', 'affiliation': 'Molecular Neurosciences, Department of Psychiatry and Psychotherapy, University of Regensburg, 93053 Regensburg, Germany.'}, {'lastname': 'Heinl', 'firstname': 'Elena-Sofia', 'initials': 'ES', 'affiliation': 'Molecular Neurosciences, Department of Psychiatry and Psychotherapy, University of Regensburg, 93053 Regensburg, Germany.'}, {'lastname': 'Alvarez-Carbonell', 'firstname': 'David', 'initials': 'D', 'affiliation': 'Department of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, OH 44106, USA.'}, {'lastname': 'Nothdurfter', 'firstname': 'Caroline', 'initials': 'C', 'affiliation': 'Department of Psychiatry and Psychotherapy, University of Regensburg, 93053 Regensburg, Germany.'}, {'lastname': 'Rupprecht', 'firstname': 'Rainer', 'initials': 'R', 'affiliation': 'Department of Psychiatry and Psychotherapy, University of Regensburg, 93053 Regensburg, Germany.'}, {'lastname': 'Wetzel', 'firstname': 'Christian H', 'initials': 'CH', 'affiliation': 'Molecular Neurosciences, Department of Psychiatry and Psychotherapy, University of Regensburg, 93053 Regensburg, Germany. christian.wetzel@ukr.de.'}]",,,,,"10.3390/ijms20133359
10.1016/j.tips.2006.06.005
10.1111/j.1365-2990.2008.01006.x
10.1038/nrd3295
10.3390/medicines5010022
10.1038/ncomms6452
10.1210/en.2013-1556
10.1074/jbc.M114.578286
10.1111/jne.12500
10.1016/j.psyneuen.2019.03.029
10.1055/s-0035-1558003
10.1042/BCJ20170648
10.1080/15384101.2017.1281477
10.1210/en.2015-1795
10.4161/15548627.2014.991665
10.1038/cddis.2017.186
10.1016/j.expneurol.2009.04.016
10.1007/s13365-016-0499-3
10.1002/glia.20404
10.1210/endo-125-4-2083
10.1016/j.jsbmb.2007.12.013
10.1042/BCJ20170766
10.1016/j.mce.2011.08.041
10.1016/j.bbabio.2009.03.010
10.1016/j.bbabio.2009.01.019
10.3389/fendo.2016.00106
10.1016/j.pharmthera.2007.12.004
10.1016/j.pharmthera.2018.09.003
10.1177/0271678X17710182
10.1016/0014-5793(83)80842-4
10.1074/jbc.M114.549634
10.1074/jbc.M115.686360
10.1146/annurev.physiol.69.031905.163804
10.1210/en.2017-03065
10.1111/j.1365-2990.2007.00906.x
10.1134/S0006297909040105
10.1006/bbrc.1995.1491
10.1073/pnas.89.8.3170
10.1074/jbc.C200703200
10.1073/pnas.94.10.5101",<Element 'PubmedArticle' at 0x7f05df33c400>
286,"31297095
19538962
23731522
23196064
21767382
11351342
10200510
11113609
11014219
11245665
15748951
16369558
21900578
19595678
27020098
9826735
22493082
26101324
25512512
17372018
23277546
20962261
21836070
17283243
22897118
2110186
12475898
18338796
7181105
26321046
21348832
22403545
19104500
30381249
28974386
29985474
24607811
20392807
26891883
28862638
25002752
27196727
28861714
29125686
24762434
21900603
28810246
30017543
30001721
27127723
18262660
28964927
25105782
23881706
26659872
29654072
19536048
21774811
21127968
28620274
21277368
24163150
29202771",Estrogen Promotes Pro-resolving Microglial Behavior and Phagocytic Cell Clearance Through the Actions of Annexin A1.,"Local production of estrogen rapidly follows brain tissue injury, but the role this hormone plays in regulating the response to neural damage or in the modulation of mediators regulating inflammation is in many ways unclear. Using the murine BV2 microglia model as well as primary microglia from wild-type and annexin A1 (AnxA1) null mice, we have identified two related mechanisms whereby estradiol can modulate microglial behavior in a receptor specific fashion. Firstly, estradiol, via estrogen receptor β (ERβ), enhanced the phagocytic clearance of apoptotic cells, acting through increased production and release of the protein AnxA1. Secondly, stimulation of either ERβ or the G protein coupled estrogen receptor GPER promoted the adoption of an anti-inflammatory/pro-resolving phenotype, an action similarly mediated through AnxA1. Together, these data suggest the hypothesis that locally produced estrogen acts through AnxA1 to exert powerful pro-resolving actions, controlling and limiting brain inflammation and ultimately protecting this highly vulnerable organ. Given the high degree of receptor selectivity in evoking these responses, we suggest that the use of selective estrogen receptor ligands may hold therapeutic promise in the treatment of neuroinflammation, avoiding unwanted generalized effects.","['annexin A1', 'estrogen', 'microglia', 'phagocytosis', 'resolution']",Frontiers in endocrinology,2019-07-13,"[{'lastname': 'Loiola', 'firstname': 'Rodrigo Azevedo', 'initials': 'RA', 'affiliation': ""John Vane Science Centre, Barts and The London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.\nLaboratoire de la Barrière Hémato-Encéphalique, Faculty Jean Perrin, EA 2465, Université d'Artois, Arras, France.""}, {'lastname': 'Wickstead', 'firstname': 'Edward S', 'initials': 'ES', 'affiliation': 'School of Life Sciences, College of Liberal Arts & Sciences, University of Westminster, London, United Kingdom.\nBarts and The London School of Medicine and Dentistry, Institute of Dentistry, Blizard Institute, Queen Mary University of London, London, United Kingdom.'}, {'lastname': 'Solito', 'firstname': 'Egle', 'initials': 'E', 'affiliation': 'John Vane Science Centre, Barts and The London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.\nDipartimento di Medicina Molecolare e Biotecnologie Mediche, Universitá degli Studi di Napoli Federico II, Naples, Italy.'}, {'lastname': 'McArthur', 'firstname': 'Simon', 'initials': 'S', 'affiliation': 'Barts and The London School of Medicine and Dentistry, Institute of Dentistry, Blizard Institute, Queen Mary University of London, London, United Kingdom.'}]",,,,,"10.3389/fendo.2019.00420
10.1016/j.yhbeh.2009.06.002
10.1016/j.coph.2013.05.007
10.1016/j.jsbmb.2012.11.006
10.1186/1742-2094-8-81
10.1002/neu.1038
10.1038/sj.cdd.4400407
10.1016/S0531-5565(00)00161-3
10.1210/endo.141.10.7693
10.1523/JNEUROSCI.21-06-01809.2001
10.1016/j.jneuroim.2004.12.016
10.1038/ni1276
10.1523/JNEUROSCI.2102-11.2011
10.1016/j.brainres.2009.06.097
10.1038/nrd.2016.39
10.1073/pnas.95.24.14535
10.1189/jlb.0112008
10.4049/jimmunol.1500733
10.1073/pnas.1410938111
10.4049/jimmunol.178.7.4595
10.1073/pnas.1209362110
10.4049/jimmunol.1001095
10.1161/ATVBAHA.111.235176
10.1677/JOE-06-0132
10.1111/j.1476-5381.2012.02146.x
10.1016/0165-5728(90)90073-V
10.1096/fj.02-0239fje
10.1002/glia.20663
10.1016/0003-2697(82)90118-X
10.1016/j.bbi.2015.08.020
10.2174/138161211795049732
10.3389/fphar.2012.00027
10.1038/nri2470
10.1016/j.jsbmb.2018.10.015
10.1016/j.yfrne.2017.09.002
10.1038/s41582-018-0032-9
10.1016/j.jsbmb.2014.02.018
10.1124/pr.109.002071
10.1016/j.pneurobio.2015.12.008
10.1172/JCI90606
10.1084/jem.20132477
10.1210/er.2016-1007
10.1007/s10495-017-1413-z
10.1111/febs.14323
10.1172/JCI59901
10.1073/pnas.1104533108
10.1159/000478908
10.1016/j.cjtee.2018.04.003
10.1186/s12974-018-1246-x
10.1002/brb3.449
10.1016/j.tips.2007.12.003
10.1016/j.jsbmb.2017.09.019
10.1210/en.2014-1158
10.1007/s11481-013-9490-4
10.1007/s12035-015-9593-4
10.1530/JOE-18-0129
10.1097/SHK.0b013e3181b0ebcb
10.1186/1742-2094-8-82
10.1007/s11064-010-0336-7
10.3389/fnins.2017.00306
10.1016/j.bbi.2011.01.013
10.1007/s12031-013-0137-y
10.1186/s12974-017-1011-6",<Element 'PubmedArticle' at 0x7f05dbc009f0>
287,"31258534
26022637
25104492
19233729
22698888
30355103
29488822
24476434
24991764
17141506
29076500
29746630
26842216
30185777
27696525
14415935
1649044
8988899
8483103
25197811
27706852
27264986
20536686
18571301
26201382
15617535
28065781
28132129
30365930
29770487
25936762
28252651
19524513
19498109
19524512
22265413
24452471
25459880
24821786
24019532
15334086
26124703
24246475
23059429
27986908
29789522
25939025
18193028
20350200
28766251
26746866
19798088
22367398
26732561
27006454
25890011
26462739
30060752
28602351
28790012
29970985
29089374
23846218
23386613
28885615
16408008
28226226
26851161
9759494
15258597
15251990
30209212
21052097
25491480
30091210
27500468
27555371",Melatonin Suppresses Microglial Necroptosis by Regulating Deubiquitinating Enzyme A20 After Intracerebral Hemorrhage.,"Cell death is deeply involved in pathophysiology of brain injury after intracerebral hemorrhage (ICH). Necroptosis, one of the recently discovered forms of cell death, plays an important role in various diseases, including ICH. Previous studies have suggested that a considerable number of neurons undergoes necroptosis after ICH. However, necroptosis of microglia after ICH has not been reported to date. The present study demonstrated for the first time that necroptosis occurred in the microglia surrounding the hematoma after ICH in C57 mice, and melatonin, a hormone that is predominantly synthesized in and secreted from the pineal gland, exerted a neuroprotective effect by suppressing this process. When we further explored the potential underlying mechanism, we found that melatonin inhibits RIP3-mediated necroptosis by regulating the deubiquitinating enzyme A20 (also known as TNFAIP3) expression after ICH. In summary, we have demonstrated the role of microglial necroptosis in the pathogenesis of ICH. More importantly, A20 was identified as a novel target of melatonin, which opens perspectives for future research.","['A20', 'intracerebral hemorrhage (ICH)', 'melatonin', 'microglia', 'necroptosis']",Frontiers in immunology,2019-07-02,"[{'lastname': 'Lu', 'firstname': 'Jianan', 'initials': 'J', 'affiliation': 'Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.'}, {'lastname': 'Sun', 'firstname': 'Zeyu', 'initials': 'Z', 'affiliation': 'Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.'}, {'lastname': 'Fang', 'firstname': 'Yuanjian', 'initials': 'Y', 'affiliation': 'Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.'}, {'lastname': 'Zheng', 'firstname': 'Jingwei', 'initials': 'J', 'affiliation': 'Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.'}, {'lastname': 'Xu', 'firstname': 'Shenbin', 'initials': 'S', 'affiliation': 'Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.'}, {'lastname': 'Xu', 'firstname': 'Weilin', 'initials': 'W', 'affiliation': 'Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.'}, {'lastname': 'Shi', 'firstname': 'Ligen', 'initials': 'L', 'affiliation': 'Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.'}, {'lastname': 'Mei', 'firstname': 'Shuhao', 'initials': 'S', 'affiliation': 'Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.'}, {'lastname': 'Wu', 'firstname': 'Haijian', 'initials': 'H', 'affiliation': 'Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.'}, {'lastname': 'Liang', 'firstname': 'Feng', 'initials': 'F', 'affiliation': 'Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.'}, {'lastname': 'Zhang', 'firstname': 'Jianmin', 'initials': 'J', 'affiliation': 'Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.\nBrain Research Institute, Zhejiang University, Hangzhou, China.\nCollaborative Innovation Center for Brain Science, Zhejiang University, Hangzhou, China.'}]",,,,,"10.3389/fimmu.2019.01360
10.1161/STR.0000000000000069
10.1016/S2214-109X(13)70089-5
10.1016/S1474-4422(09)70025-0
10.1016/S1474-4422(12)70104-7
10.1161/STROKEAHA.117.019253
10.1152/physrev.00011.2017
10.1056/NEJMra1310050
10.1038/cddis.2014.277
10.1016/j.tibs.2006.11.001
10.1038/cr.2017.133
10.1093/cercor/bhy089
10.1186/s13024-016-0081-8
10.1038/s41419-018-0872-7
10.1111/jpi.12368
10.1210/edrv-12-2-151
10.1056/NEJM199701163360306
10.1111/j.1600-079X.1993.tb00478.x
10.5665/sleep.4088
10.1111/jpi.12370
10.1111/jpi.12348
10.1111/j.1600-079X.2010.00773.x
10.1016/j.pneurobio.2008.04.001
10.1111/jpi.12264
10.1111/j.1600-079X.2004.00172.x
10.1016/j.freeradbiomed.2017.01.005
10.1007/s10571-017-0461-9
10.1016/j.yjmcc.2018.10.018
10.1111/jpi.12503
10.1016/j.trsl.2015.04.002
10.1038/cddis.2017.58
10.1016/j.cell.2009.05.037
10.1126/science.1172308
10.1016/j.cell.2009.05.021
10.1016/j.cell.2011.11.031
10.1038/nrm3737
10.1016/j.molcel.2014.10.021
10.1073/pnas.1401857111
10.1074/jbc.M113.462341
10.1038/ni1110
10.3389/fnmol.2015.00021
10.1016/j.it.2013.10.005
10.1038/nri3313
10.4049/jimmunol.1600334
10.1038/s41467-018-04376-5
10.1038/ni.3172
10.1038/nprot.2007.513
10.1089/neu.2009.1163
10.1007/s12975-017-0559-x
10.1177/0271678X15625351
10.1038/nprot.2009.125
10.1007/s00221-012-3034-7
10.1161/STROKEAHA.115.012079
10.1161/STROKEAHA.115.011552
10.1186/s12974-015-0284-x
10.1111/jpi.12288
10.1186/s12974-018-1256-8
10.1016/j.cell.2017.05.018
10.1016/j.freeradbiomed.2017.08.003
10.3389/fnins.2018.00414
10.1084/jem.20170558
10.1038/cddis.2013.238
10.1074/jbc.M112.427880
10.1038/cdd.2017.141
10.1038/nchembio711
10.1146/annurev-immunol-051116-052358
10.1016/j.pneurobio.2016.01.005
10.1146/annurev.biochem.67.1.425
10.1038/nature02794
10.1182/blood-2003-02-0635
10.1073/pnas.1810584115
10.1038/cdd.2010.138
10.1111/jpi.12199
10.1111/jpi.12520
10.1111/jpi.12360
10.1111/jpi.12362",<Element 'PubmedArticle' at 0x7f05dbc18180>
288,"31228875
11352362
15939837
15982748
28556831
16908107
11543741
28596115
19401219
20139149
26441134
28697890
24995975
28886007
23407936
25305410
30193820
29924994
28689984
20153418
21878486
18286612
12209854
26320029
29096081
25663667
22747919
23512378
22189291
18825147
18639237
26780286
3061565
10340766
22581688
23943137
21745355
21283568
23835908
15564575
104044
23512738
15266654
27422366
29307257
29194444
22182318
15456824
21219963
12009507
16943543
17561817
24999330
14724248
12629162
26883475
17215394
21072242
27581371
15901656
7197991
19056393
22789020
20513656
29118417
28462931
30194779
23211561
24246855
29548746
19723561",Gonadal hormones differentially regulate sex-specific stress effects on glia in the medial prefrontal cortex.,"Women are more susceptible to various stress-linked psychopathologies, including depression. Dysfunction of the medial prefrontal cortex (mPFC) has been implicated in depression, and studies indicate sex differences in stress effects on mPFC structure and function. For example, chronic stress induces dendritic atrophy in the mPFC in male rats, yet dendritic growth in females. Recent findings suggest glial pathways toward depression. Glia are highly responsive to neuronal activity and function as critical regulators of synaptic plasticity. Preclinical models demonstrate stress-induced microglial activation in mPFC in males, yet deactivation in females. By contrast, stress reduces astrocyte complexity in mPFC in male rats, whereas the effects in females are unknown. Glia possess receptors for most gonadal hormones and gonadal hormones are known to modulate neuronal activity. Thus, gonadal hormones represent a potential mechanism underlying sex differences in glia, as well as divergent stress effects. Therefore, we examined the role of gonadal hormones in sex-specific stress effects on neuronal activity (ie FosB/ ΔFosB induction) and glia in the mPFC. The findings obtained indicate greater microglial activation in mPFC in females and a greater astrocyte area in males. Basal astrocyte morphology is modulated by androgens, whereas androgens or oestrogens dampen the microglial state in males. Astrocyte morphology is associated with neuronal activity in both sexes, regardless of hormonal condition. Chronic stress induced astrocytic atrophy in males, yet hypertrophy in females, with gonadal hormones partly regulating this difference. Stress effects on microglia are oestradiol-dependent in females. Taken together, these data suggest sex-specific, gonadal hormone-dependent stress effects on astrocytes and microglia in the mPFC.","['astroglia', 'depression', 'microglia', 'oestradiol', 'testosterone']",Journal of neuroendocrinology,2019-06-23,"[{'lastname': 'Bollinger', 'firstname': 'Justin L', 'initials': 'JL', 'affiliation': 'Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, USA.\nProgram in Neuroscience, Indiana University, Bloomington, IN, USA.\nCenter for the Integrative Study of Animal Behavior, Indiana University, Bloomington, IN, USA.'}, {'lastname': 'Salinas', 'firstname': 'Isabella', 'initials': 'I', 'affiliation': 'Center for the Integrative Study of Animal Behavior, Indiana University, Bloomington, IN, USA.'}, {'lastname': 'Fender', 'firstname': 'Emily', 'initials': 'E', 'affiliation': 'Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, USA.'}, {'lastname': 'Sengelaub', 'firstname': 'Dale R', 'initials': 'DR', 'affiliation': 'Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, USA.\nProgram in Neuroscience, Indiana University, Bloomington, IN, USA.\nCenter for the Integrative Study of Animal Behavior, Indiana University, Bloomington, IN, USA.'}, {'lastname': 'Wellman', 'firstname': 'Cara L', 'initials': 'CL', 'affiliation': 'Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, USA.\nProgram in Neuroscience, Indiana University, Bloomington, IN, USA.\nCenter for the Integrative Study of Animal Behavior, Indiana University, Bloomington, IN, USA.'}]",,,,© 2019 British Society for Neuroendocrinology.,10.1111/jne.12762,<Element 'PubmedArticle' at 0x7f05daac94a0>
289,"31220952
29880330
27351598
25722050
26846570
24997632
26254000
22747567
28337952
26985042
7715646
26535528
28094875
15944267
10592282
14698841
9421440
12660427
14602784
12438528
26004870
22527704
21735077
18029412
20102666
16134032
21833278
19218885
22608634
24074734
26183723
14521190
7290340
11127797
28929566
29559529
20525501
28017854
24740655
23447593
21115817
14606694
14736857
21988521
21215794
22794533
30884251
26190965
30574737",Effect of stress on learning and motivation-relevance to autism spectrum disorder.,"Learning and motivation are critical in the development of children, and to their acquisition of knowledge and skills. A case in point is autism spectrum disorder (ASD), a neurodevelopmental condition characterized by impaired social interactions and communication, as well as by stereotypic movements. Maternal stress has been strongly associated with increased risk of developing ASD. Children experience multiple stressors such as separation anxiety, fear of the unknown, physical and/or emotional trauma, bullying, as well as environmental exposures. Stress is well known to affect learning and motivation. However, patients with ASD have aggrevated tresponses to stress, especially fear response. There is extensive literature connecting the amygdala to social behavior and to pathophysiologic responses to stress. The amygdala regulate the responses to stress, and anatomical changes in amygdala have been reported in ASD. In particular, corticotropin-releasing hormone (CRH), which is secreted under stress, is high in children with ASD and stimulates both mast cells and microglia, thus providing possible targets for therapy. Factors and/or circumstances that could interfere with the neurodevelopmental pathways involved in learning and motivation are clearly important and should be recognized early.","['amygdala', 'corticotropin-releasing hormone', 'learning', 'mast cells', 'stress']",International journal of immunopathology and pharmacology,2019-06-22,"[{'lastname': 'Theoharides', 'firstname': 'Theoharis C', 'initials': 'TC', 'affiliation': '1 Laboratory of Molecular Immunopharmacology and Drug Discovery, Department of Immunology, Tufts University School of Medicine, Boston, MA, USA.\n2 Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, MA, USA.\n3 Department of Internal Medicine, Tufts University School of Medicine and Tufts Medical Center, Boston, MA, USA.'}, {'lastname': 'Kavalioti', 'firstname': 'Maria', 'initials': 'M', 'affiliation': '4 Biomedical Science Program, University of Greenwich, London, UK.\n5 BrainGate, Thessaloniki, Greece.'}]",,,,,10.1177/2058738419856760,<Element 'PubmedArticle' at 0x7f05df71a3b0>
290,"31199887
17296890
20212494
22581051
28962928
25489227
23209820
26310173
24523530
24382886
19131956
23020941
24984273
16129911
25392995
17111372
19087876
23553672
17403137
22581206
24506098
19441883
25130440
14691156
20937879
25489233
24042032
30093491
25981967
24907061
20580421
30303083
3880639
4052361
3377040
12634111
22986109
17284607
29551596
27653207
8981696
24762326
25725353
27314452
24929065
26139610
19443728
22986110
21763674
24920619
8394174
12223081
30565508
25392482
25957687
27803663
19134003
27438413
11381074
17908593
27889587",Rescuing cones and daylight vision in retinitis pigmentosa mice.,"Hallmark of retinitis pigmentosa (RP) is the primary, genetic degeneration of rods followed by secondary loss of cones, caused by still elusive biologic mechanisms. We previously shown that exposure of rd10 mutant mice, modeling autosomal recessive RP, to environmental enrichment (EE), with enhanced motor, sensorial and social stimuli, results into a sensible delay of retinal degeneration and vision loss. Searching for effectors of EE-mediated retinal protection, we performed transcriptome analysis of the retina of rd10 enriched and control mice and found that gene expression at the peaks of rod and cone degeneration is characterized by a strong inflammatory/immune response, which is however measurably lower in enrichment conditions. Treating rd10 mice with dexamethasone during the period of maximum photoreceptors death lowered retinal inflammation and caused a preservation of cones and cone-mediated vision. Our findings indicate a link between retinal inflammation and bystander cone degeneration, reinforcing the notion that cone vision in RP can be preserved using anti-inflammatory approaches.-Guadagni, V., Biagioni, M., Novelli, E., Aretini, P., Mazzanti, C. M., Strettoi, E. Rescuing cones and daylight vision in retinitis pigmentosa mice.","['bystander effect', 'cytokines', 'environmental enrichment', 'microglia', 'rod']",FASEB journal : official publication of the Federation of American Societies for Experimental Biology,2019-06-15,"[{'lastname': 'Guadagni', 'firstname': 'Viviana', 'initials': 'V', 'affiliation': 'Consiglio Nazionale delle Ricerche (CNR) Institute of Neuroscience, Pisa, Italy.'}, {'lastname': 'Biagioni', 'firstname': 'Martina', 'initials': 'M', 'affiliation': 'Consiglio Nazionale delle Ricerche (CNR) Institute of Neuroscience, Pisa, Italy.'}, {'lastname': 'Novelli', 'firstname': 'Elena', 'initials': 'E', 'affiliation': 'Consiglio Nazionale delle Ricerche (CNR) Institute of Neuroscience, Pisa, Italy.'}, {'lastname': 'Aretini', 'firstname': 'Paolo', 'initials': 'P', 'affiliation': 'Laboratory of Genomics and Transcriptomics, Fondazione Pisana per la Scienza, Pisa, Italy.'}, {'lastname': 'Mazzanti', 'firstname': 'Chiara Maria', 'initials': 'CM', 'affiliation': 'Laboratory of Genomics and Transcriptomics, Fondazione Pisana per la Scienza, Pisa, Italy.'}, {'lastname': 'Strettoi', 'firstname': 'Enrica', 'initials': 'E', 'affiliation': 'Consiglio Nazionale delle Ricerche (CNR) Institute of Neuroscience, Pisa, Italy.'}]",,,,,10.1096/fj.201900414R,<Element 'PubmedArticle' at 0x7f05df7233b0>
291,"31172340
15667655
30097509
16604073
20431983
17929310
16545974
20124406
12476352
17607352
10851062
25115800
20200349
12663437
29981834
24164678
26106458
9724801
23100431
19204324
12714508
24880340
12849213
8995420
26084002
25209291
15710462
26794939
21159979
25351366
19627440
24376517
16324111
12850572
23077045
18590684
25104923
15514116
15522954
22318507
16308487
25681617
24510275
28993153
19292870
30577543
21778362
24860431
11113131
23584152
24252754
19377077
7493948
16801915
15265744
26182354
17339397
28096133
21712541
26055723
19368990
14673173
24352739
24598129
30319362
12059974
23525041
23506423
24653700
28266714
17905609
30374287
29415739
19898775
23376588
25231526
9153303
23507975
16835372
20570721
16933319
25661672",Fractalkine Induces Hepcidin Expression of BV-2 Microglia and Causes Iron Accumulation in SH-SY5Y Cells.,"Fractalkine (CX3CL1) is a potent inflammatory mediator of the central nervous system, which is expressed by neurons and regulates microglial functions by binding to fractalkine receptor (CX3CR1). It has been demonstrated that neuroinflammation plays an important role in iron accumulation of the brain leading to neuronal cell death. The major regulator of iron homeostasis is the peptide hormone hepcidin. Hepcidin expression is triggered by inflammatory conditions, which may contribute to the neuronal iron accumulation. In the present study, we established a bilaminar co-culture system of differentiated SH-SY5Y cells and BV-2 microglia as a neuronal model to examine the effect of soluble fractalkine on iron homeostasis of microglia and SH-SY5Y cells. We determined the hepcidin expression of fractalkine-treated microglia which showed significant elevation. We examined the relation between increased hepcidin secretion, the known hepcidin regulators and the signalling pathways controlled by fractalkine receptor. Our data revealed that TMPRSS6 and alpha 1-antitrypsin levels decreased due to fractalkine treatment, as well as the activity of NFκB pathway and the tyrosine phosphorylation of STAT5 factor. Moreover, fractalkine-induced hepcidin production of microglia initiated ferroportin internalisation of SH-SY5Y cells, which contributed to iron accumulation of neurons. Our results demonstrate that soluble form of fractalkine regulates hepcidin expression of BV-2 cells through fractalkine-mediated CX3CR1 internalisation. Moreover, fractalkine indirectly contributes to the iron accumulation of SH-SY5Y cells by activating ferroportin internalisation and by triggering the expressions of divalent metal transporter-1, ferritin heavy chain and mitochondrial ferritin.","['Fractalkine', 'Hepcidin', 'Microglia', 'NFκB', 'TMPRSS6']",Cellular and molecular neurobiology,2019-06-07,"[{'lastname': 'Pandur', 'firstname': 'Edina', 'initials': 'E', 'affiliation': 'Department of Pharmaceutical Biology, Faculty of Pharmacy, University of Pécs, Rókus Str. 2, 7624, Pécs, Hungary. edina.pandur@aok.pte.hu.'}, {'lastname': 'Tamási', 'firstname': 'Kitti', 'initials': 'K', 'affiliation': 'Department of Pharmaceutical Biology, Faculty of Pharmacy, University of Pécs, Rókus Str. 2, 7624, Pécs, Hungary.'}, {'lastname': 'Pap', 'firstname': 'Ramóna', 'initials': 'R', 'affiliation': 'Department of Pharmaceutical Biology, Faculty of Pharmacy, University of Pécs, Rókus Str. 2, 7624, Pécs, Hungary.'}, {'lastname': 'Varga', 'firstname': 'Edit', 'initials': 'E', 'affiliation': 'Department of Pharmaceutical Biology, Faculty of Pharmacy, University of Pécs, Rókus Str. 2, 7624, Pécs, Hungary.'}, {'lastname': 'Miseta', 'firstname': 'Attila', 'initials': 'A', 'affiliation': 'Department of Laboratory Medicine, Medical School, University of Pécs, Ifjúság Str. 13, 7624, Pécs, Hungary.'}, {'lastname': 'Sipos', 'firstname': 'Katalin', 'initials': 'K', 'affiliation': 'Department of Pharmaceutical Biology, Faculty of Pharmacy, University of Pécs, Rókus Str. 2, 7624, Pécs, Hungary.'}]",,,,,10.1007/s10571-019-00694-4,<Element 'PubmedArticle' at 0x7f05dd56db30>
292,"31159306
30498474
28731040
26355342
29921793
24630989
30288079
28197094
27095436
27939990
30524237
25619431
30301953
30259418
25451977
28119132
27075756
26520666
28254441
16122875
16978784
29454840
21810933
31036637
26603489
28904023
12759443
24771982
15826936
23354059
23850759
28696286
29854017
30517945
25956016
31052203",Oxytocin Suppresses Inflammatory Responses Induced by Lipopolysaccharide through Inhibition of the eIF-2-ATF4 Pathway in Mouse Microglia.,"Microglia maintain brain homeostasis and modulate neuroinflammation and are implicated in the pathogenesis of various neurological diseases such as Alzheimer's disease. In this study, we found that in lipopolysaccharide (LPS)-stimulated microglia, the endoplasmic reticulum (ER) stress-related eIF-2-ATF4 pathway plays significant roles in TNF- and IL-6 production, as well as in the inflammasome-mediated production of IL-1. Furthermore, our analysis revealed that oxytocin (OT), a nonapeptide synthesized in the hypothalamus, suppressed the production of these proinflammatory cytokines by inhibiting activation of the eIF-2-ATF4 pathway. Our findings therefore suggest a novel anti-inflammatory axis of OT in activated microglia, which would be helpful for developing the novel effective strategies for regulating microglia-associated neuroinflammation.","['endoplasmic reticulum stress', 'inflammasome', 'inflammation', 'microglia', 'oxytocin']",Cells,2019-06-05,"[{'lastname': 'Inoue', 'firstname': 'Takayuki', 'initials': 'T', 'affiliation': 'Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan. taka2015.www@gmail.com.'}, {'lastname': 'Yamakage', 'firstname': 'Hajime', 'initials': 'H', 'affiliation': 'Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan. yamakage@satista.jp.'}, {'lastname': 'Tanaka', 'firstname': 'Masashi', 'initials': 'M', 'affiliation': 'Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan. masashi.7.tanaka@gmail.com.\nDepartment of Physical Therapy, Health Science University, Yamanashi 401-0380, Japan. masashi.7.tanaka@gmail.com.'}, {'lastname': 'Kusakabe', 'firstname': 'Toru', 'initials': 'T', 'affiliation': 'Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan. kusakabe@kuhp.kyoto-u.ac.jp.'}, {'lastname': 'Shimatsu', 'firstname': 'Akira', 'initials': 'A', 'affiliation': 'Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan. ashimats@kyotolan.hosp.go.jp.'}, {'lastname': 'Satoh-Asahara', 'firstname': 'Noriko', 'initials': 'N', 'affiliation': 'Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan. nsatoh@kuhp.kyoto-u.ac.jp.'}]",,,,,"10.3390/cells8060527
10.4172/2161-0460.1000380
10.3389/fneur.2018.00978
10.1038/nrneurol.2017.99
10.1038/cddis.2015.248
10.3390/cells7060063
10.1016/j.celrep.2014.02.015
10.2147/JIR.S141220
10.3389/fnagi.2017.00007
10.1186/s12974-016-0545-3
10.1016/j.ejphar.2016.12.014
10.3389/fncel.2018.00404
10.1016/j.psychres.2014.11.048
10.1038/s41583-018-0072-6
10.1007/s12640-018-9962-7
10.1016/j.mce.2014.11.008
10.1016/j.mce.2017.01.034
10.1186/s12974-016-0541-7
10.1016/j.bbagen.2015.10.025
10.1016/j.bbalip.2017.02.010
10.1016/j.bbagen.2005.08.001
10.1016/j.neulet.2006.08.044
10.1016/j.neuropharm.2018.02.007
10.1152/ajpendo.00029.2011
10.1073/pnas.1901659116
10.1038/srep17192
10.1096/fj.201700273R
10.4049/jimmunol.170.11.5630
10.1155/2014/352371
10.1074/jbc.M501759200
10.1007/s00018-012-1252-6
10.1016/j.bbamcr.2013.06.028
10.1073/pnas.1705521114
10.1155/2018/1849794
10.1159/000494761
10.1016/j.arr.2015.04.006
10.3390/ijms20092139",<Element 'PubmedArticle' at 0x7f05df954c70>
293,"31128596
26921134
20107219
1566067
25045405
28872215
16914853
21543591
18568035
27030592
25879763
27540165
23150934
25792098
18701698
17965659
24360280
11513911
28602351
17255335
15347683
23178247
21718299
16023994
18222103
15729572
17532004
15752770
17499232
12196466
19367731
15149866
22099423
14624132
15033490
18157956
26993045
15077108
25331877
26209808
27137743
29988086
27514756
23640763
28844957
24164711
29184485
23300647
27884163
17021169
17258715
29988553
15381143
26119401
20536390
21431325
26257642
12399581
28326017
29515462
29978896
22419736
29480476
27001618
19050283
19302050
19997086
26999213
23770291
24864265
20211864
22798688
12802337
17327425
30060752
21123619
18640841
20332107
23255609
16324117
24141019
24315369
17724122
16926764
26004156
12629164
29367720
28434692
28599834
3487617
27697064
11922661
28293644
28092660
16380487
29022894
28197095
26984188
30140051
25630253
25257319
24224195
22778410
18717813
28546318",Adiponectin suppresses amyloid-β oligomer (AβO)-induced inflammatory response of microglia via AdipoR1-AMPK-NF-κB signaling pathway.,"Microglia-mediated neuroinflammation is important in Alzheimer's disease (AD) pathogenesis. Extracellular deposition of β-amyloid (Aβ), a major pathological hallmark of AD, can induce microglia activation. Adiponectin (APN), an adipocyte-derived adipokine, exerts anti-inflammatory effects in the periphery and brain. Chronic APN deficiency leads to cognitive impairment and AD-like pathologies in aged mice. Here, we aim to study the role of APN in regulating microglia-mediated neuroinflammation in AD.
Inflammatory response of cultured microglia (BV2 cells) to AβO and effects of APN were studied by measuring levels of proinflammatory cytokines (tumor necrosis factor α [TNFα] and interleukin-1β [IL-1β]) in cultured medium before and after exposure to AβO, with and without APN pretreatment. Adiponectin receptor 1 (AdipoR1) and receptor 2 (AdipoR2) were targeted by small interference RNA. To study the neuroprotective effect of APN, cultured HT-22 hippocampal cells were treated with conditioned medium of AβO-exposed BV2 cells or were co-cultured with BV2 cells in transwells. The cytotoxicity of HT-22 hippocampal cells was assessed by MTT reduction. We generated APN-deficient AD mice (APN
AdipoR1 and AdipoR2 were expressed in BV2 cells and microglia of mice. Pretreatment with APN for 2 h suppressed TNFα and IL-1β release induced by AβO in BV2 cells. Additionally, APN rescued the decrease of AMPK phosphorylation and suppressed nuclear translocation of nuclear factor kappa B (NF-κB) induced by AβO. Compound C, an inhibitor of AMPK, abolished these effects of APN. Knockdown of AdipoR1, but not AdipoR2 in BV2 cells, inhibited the ability of APN to suppress proinflammatory cytokine release induced by AβO. Moreover, pretreatment with APN inhibited the cytotoxicity of HT-22 cells co-cultured with AβO-exposed BV2 cells. Lastly, APN deficiency exacerbated microglia activation in 9-month-old APN
Our findings demonstrate that APN inhibits inflammatory response of microglia to AβO via AdipoR1-AMPK-NF-κB signaling, and APN deficiency aggravates microglia activation and neuroinflammation in AD mice. APN may be a novel therapeutic agent for inhibiting neuroinflammation in AD.","['Adiponectin', 'Alzheimer’s disease', 'Microglia', 'Neuroinflammation']",Journal of neuroinflammation,2019-05-28,"[{'lastname': 'Jian', 'firstname': 'Min', 'initials': 'M', 'affiliation': 'Department of Medicine, LKS Faculty of Medicine, The University of Hong Kong, 8/F, 21 Sassoon Road, Pokfulam, Hong Kong, Special Administrative Region of China.'}, {'lastname': 'Kwan', 'firstname': 'Jason Shing-Cheong', 'initials': 'JS', 'affiliation': 'Department of Medicine, LKS Faculty of Medicine, The University of Hong Kong, 8/F, 21 Sassoon Road, Pokfulam, Hong Kong, Special Administrative Region of China.\nNeuroimmunology and Neuroinflammation Research Laboratory, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, Special Administrative Region of China.'}, {'lastname': 'Bunting', 'firstname': 'Myriam', 'initials': 'M', 'affiliation': 'Department of Medicine, LKS Faculty of Medicine, The University of Hong Kong, 8/F, 21 Sassoon Road, Pokfulam, Hong Kong, Special Administrative Region of China.'}, {'lastname': 'Ng', 'firstname': 'Roy Chun-Laam', 'initials': 'RC', 'affiliation': 'Department of Medicine, LKS Faculty of Medicine, The University of Hong Kong, 8/F, 21 Sassoon Road, Pokfulam, Hong Kong, Special Administrative Region of China. royclng@hku.hk.\nNeuroimmunology and Neuroinflammation Research Laboratory, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, Special Administrative Region of China. royclng@hku.hk.'}, {'lastname': 'Chan', 'firstname': 'Koon Ho', 'initials': 'KH', 'affiliation': ""Department of Medicine, LKS Faculty of Medicine, The University of Hong Kong, 8/F, 21 Sassoon Road, Pokfulam, Hong Kong, Special Administrative Region of China. koonho@hku.hk.\nNeuroimmunology and Neuroinflammation Research Laboratory, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, Special Administrative Region of China. koonho@hku.hk.\nResearch Center of Heart, Brain, Hormone and Healthy Aging, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, Special Administrative Region of China. koonho@hku.hk.\nHong Kong University Alzheimer's Disease Research Network, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, Special Administrative Region of China. koonho@hku.hk.\nDepartment of Medicine, The University of Hong Kong, 4/F, Professorial Block, Queen Mary Hospital, 102 Pokfulam Road, Pokfulam, Hong Kong, Special Administrative Region of China. koonho@hku.hk.""}]",,,"AdipoR1 and AdipoR2 were expressed in BV2 cells and microglia of mice. Pretreatment with APN for 2 h suppressed TNFα and IL-1β release induced by AβO in BV2 cells. Additionally, APN rescued the decrease of AMPK phosphorylation and suppressed nuclear translocation of nuclear factor kappa B (NF-κB) induced by AβO. Compound C, an inhibitor of AMPK, abolished these effects of APN. Knockdown of AdipoR1, but not AdipoR2 in BV2 cells, inhibited the ability of APN to suppress proinflammatory cytokine release induced by AβO. Moreover, pretreatment with APN inhibited the cytotoxicity of HT-22 cells co-cultured with AβO-exposed BV2 cells. Lastly, APN deficiency exacerbated microglia activation in 9-month-old APN",,"10.1186/s12974-019-1492-6
10.1016/S0140-6736(15)01124-1
10.1056/NEJMra0909142
10.1126/science.1566067
10.1186/alzrt272
10.1111/ene.13439
10.3233/JAD-2006-9S317
10.1523/JNEUROSCI.0203-11.2011
10.1038/nm1782
10.1002/mds.26624
10.1186/s12974-015-0263-2
10.1126/science.aag2590
10.1056/NEJMoa1211851
10.1016/S1474-4422(15)70016-5
10.1523/JNEUROSCI.0616-08.2008
10.1038/nn1997
10.1016/j.cell.2013.11.030
10.1016/S0140-6736(01)05625-2
10.1016/j.cell.2017.05.018
10.2353/ajpath.2007.060378
10.1074/jbc.M402034200
10.1038/nm.2965
10.1111/j.1476-5381.2011.01560.x
10.1016/j.bbrc.2005.06.187
10.1016/j.diabet.2007.09.006
10.1007/s00125-005-1675-9
10.1016/j.yjmcc.2007.04.014
10.1016/j.bbrc.2005.02.081
10.1016/j.cardiores.2007.04.011
10.2337/diabetes.51.9.2734
10.1111/j.1600-0684.2008.00298.x
10.1016/j.cccn.2004.02.020
10.1097/00041433-200312000-00003
10.1016/j.bbrc.2004.02.130
10.1016/j.amjcard.2007.07.041
10.1093/jmcb/mjw012
10.1038/nm1029
10.1073/pnas.1415219111
10.1016/j.bbi.2015.07.018
10.1038/mp.2016.58
10.1007/s12035-016-0036-7
10.1002/eji.201242836
10.1016/j.bbadis.2017.08.010
10.1111/cns.12198
10.3389/fncel.2017.00352
10.1371/journal.pone.0052354
10.1186/s13024-016-0136-x
10.1523/JNEUROSCI.1202-06.2006
10.1053/j.gastro.2006.11.026
10.3389/fimmu.2018.01438
10.1016/j.biocel.2004.06.010
10.3109/01677063.2015.1067203
10.1515/bc.2010.104
10.1007/s00109-011-0748-0
10.1126/science.1074069
10.3389/fphys.2018.00122
10.1002/cphy.c170046
10.1093/hmg/dds100
10.1007/978-1-4939-7598-3_12
10.1038/mp.2016.23
10.4049/jimmunol.181.12.8633
10.1146/annurev.immunol.021908.132641
10.1038/cr.2009.137
10.1016/j.cellsig.2013.06.007
10.1093/cvr/cvq080
10.1194/jlr.R025882
10.1038/nature01705
10.2337/db06-1432
10.1186/s12974-018-1256-8
10.1242/jcs.063354
10.1016/j.tibs.2008.06.003
10.1242/jcs.057919
10.1074/jbc.M112.404624
10.1111/j.1460-9568.2005.04457.x
10.1016/j.nbd.2013.10.007
10.1016/j.cmet.2013.11.002
10.1083/jcb.200705042
10.1016/j.jneuroim.2015.04.014
10.1523/JNEUROSCI.23-05-01605.2003
10.1038/s41598-018-19699-y
10.1016/j.neurobiolaging.2017.03.021
10.1016/j.cytogfr.2017.06.001
10.1084/jem.164.2.594
10.2174/1567205014666170117141330
10.1006/exnr.2002.7871
10.1155/2017/4626540
10.1038/nn.4475
10.2337/diabetes.55.01.06.db05-1077
10.1038/cddis.2017.491
10.3389/fnagi.2017.00008
10.1093/brain/aww017
10.1038/s41577-018-0051-1
10.1038/ncomms7176
10.1186/s40478-014-0142-6
10.1007/s00401-013-1182-x
10.1073/pnas.1202835109
10.1111/j.1471-4159.2008.05633.x
10.1126/science.aal3222",<Element 'PubmedArticle' at 0x7f05df978d10>
294,31059719,Emerging roles for hypothalamic microglia as regulators of physiological homeostasis.,"The hypothalamus is a crucial brain region that responds to external stressors and functions to maintain physiological homeostatic processes, such as core body temperature and energy balance. The hypothalamus regulates homeostasis by producing hormones that thereby influence the production of other hormones that then control the internal milieu of the body. Microglia are resident macrophages and phagocytic immune cells of the central nervous system (CNS), classically known for surveying the brain's environment, responding to neural insults, and disposing of cellular debris. Recent evidence has shown that microglia are also responsive to external stressors and can influence both the development and function of the hypothalamus in a sex-dependent manner. This emerging microglia-hypothalamic interaction raises the intriguing notion that microglia might play an unappreciated role in hypothalamic control of physiological homeostasis. In this review, we briefly outline how the hypothalamus regulates physiological homeostasis and then describe how this literature overlaps with our understanding of microglia's role in the CNS. We also outline the current literature demonstrating how microglia loss or activation affects the hypothalamus, and ultimately homeostasis. We conclude by proposing how microglia could be key regulators of homeostatic processes by sensing cues external to the CNS and transmitting them through the hypothalamus.","['Anorexia', 'Homeostasis', 'Hypothalamus', 'Inflammation', 'Microglia', 'Neuroendocrine', 'Obesity', 'Sexual dimorphism', 'Stress']",Frontiers in neuroendocrinology,2019-05-07,"[{'lastname': 'Rosin', 'firstname': 'Jessica M', 'initials': 'JM', 'affiliation': ""Department of Medical Genetics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada; Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.""}, {'lastname': 'Kurrasch', 'firstname': 'Deborah M', 'initials': 'DM', 'affiliation': ""Department of Medical Genetics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada; Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada. Electronic address: kurrasch@ucalgary.ca.""}]",,,,Copyright © 2019 Elsevier Inc. All rights reserved.,10.1016/j.yfrne.2019.100748,<Element 'PubmedArticle' at 0x7f05df944310>
295,31006904,Melatonin improves functional recovery in female rats after acute spinal cord injury by modulating polarization of spinal microglial/macrophages.,"Spinal cord injury (SCI) is a devastating neurological disorder, but few drugs have proven to be effective for its treatment. Neuroinflammation exaggerates the secondary injury subsequent to trauma. Emerging evidence suggests that melatonin may help protect neural tissue against secondary injury after SCI, but the underlying mechanisms remain elusive. Microglial/macrophages polarization plays an important role in regulating immune responses. To examine whether melatonin exerts neuroprotective effects after acute SCI by regulating microglial/macrophages polarization in the spinal cord, we administered intraperitoneal injections of melatonin (50 mg/kg) in female rats immediately after SCI and then daily for seven consecutive days (n = 6). Compared with the vehicle-treated group (n = 6), the melatonin-treated group exhibited a greater Basso, Beattie, and Bresnahan locomotor rating score, smaller spinal cavity, and less cleaved caspase 3 immunofluorescence staining in the injured spinal segments. Real-time PCR data revealed decreases in the expression levels of M1 microglia phenotypic markers and increases in M2 markers in the spinal cord of melatonin-treated SCI rats, as compared to levels in the vehicle-treated group. Melatonin increased the number of CD206","['macrophage', 'melatonin', 'microglia', 'neuroinflammation', 'spinal cord injury']",Journal of neuroscience research,2019-04-23,"[{'lastname': 'Zhang', 'firstname': 'Yan', 'initials': 'Y', 'affiliation': 'Central Laboratory, Beijing Luhe Hospital, Capital Medical University, Beijing, China.'}, {'lastname': 'Liu', 'firstname': 'Zongjian', 'initials': 'Z', 'affiliation': 'Central Laboratory, Beijing Luhe Hospital, Capital Medical University, Beijing, China.\nResearch Department, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China.'}, {'lastname': 'Zhang', 'firstname': 'Wenxiu', 'initials': 'W', 'affiliation': 'Central Laboratory, Beijing Luhe Hospital, Capital Medical University, Beijing, China.'}, {'lastname': 'Wu', 'firstname': 'Qichao', 'initials': 'Q', 'affiliation': 'Department of Orthopedics, Beijing Luhe Hospital, Capital Medical University, Beijing, China.'}, {'lastname': 'Zhang', 'firstname': 'Yanjun', 'initials': 'Y', 'affiliation': 'Department of Orthopedics, Beijing Luhe Hospital, Capital Medical University, Beijing, China.'}, {'lastname': 'Liu', 'firstname': 'Yadong', 'initials': 'Y', 'affiliation': 'Department of Orthopedics, Beijing Luhe Hospital, Capital Medical University, Beijing, China.'}, {'lastname': 'Guan', 'firstname': 'Yun', 'initials': 'Y', 'affiliation': 'Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland.\nDepartment of Neurological Surgery, Johns Hopkins University, Baltimore, Maryland.'}, {'lastname': 'Chen', 'firstname': 'Xueming', 'initials': 'X', 'affiliation': 'Central Laboratory, Beijing Luhe Hospital, Capital Medical University, Beijing, China.\nDepartment of Orthopedics, Beijing Luhe Hospital, Capital Medical University, Beijing, China.'}]",,,,"© 2019 Wiley Periodicals, Inc.",10.1002/jnr.24409,<Element 'PubmedArticle' at 0x7f05df80f450>
296,"30996341
19836412
16306382
28603139
17699877
11493581
27959620
30531847
22964544
15895084
10805752
10320027
17261674
20211688
20060897
10882782
27092009
28484229
26441134
21878486
27581371
27422366
22453629
22998689
25377529
25096025
12907851
25816800
29195782
28838855
19111355
19464360
29104062
24727435
11078453
24100548
3318508
12414765
17035503
26643538
28115398
29504946
23519030
28736330
8254363",Hypoglycemia-activated Hypothalamic Microglia Impairs Glucose Counterregulatory Responses.,"Glucose is a major fuel for the central nervous system and hypoglycemia is a significant homeostatic stressor, which elicits counterregulatory reactions. Hypothalamic metabolic- and stress-related neurons initiate these actions, however recruitment of glia in control such adaptive circuit remain unknown. Groups of fed- and fasted-, vehicle-injected, and fasted + insulin-injected male mice were compared in this study. Bolus insulin administration to fasted mice resulted in hypoglycemia, which increased hypothalamo-pituitary-adrenal (HPA) axis- and sympathetic activity, increased transcription of neuropeptide Y (Npy) and agouti-related peptide (Agrp) in the hypothalamic arcuate nucleus and activated IBA1+ microglia in the hypothalamus. Activated microglia were found in close apposition to hypoglycemia-responsive NPY neurons. Inhibition of microglia by minocycline increased counterregulatory sympathetic response to hypoglycemia. Fractalkine-CX3CR1 signaling plays a role in control of microglia during hypoglycemia, because density and solidity of IBA1-ir profiles was attenuated in fasted, insulin-treated, CX3CR1 KO mice, which was parallel with exaggerated neuropeptide responses and higher blood glucose levels following insulin administration. Hypoglycemia increased Il-1b expression in the arcuate nucleus, while IL-1a/b knockout mice display improved glycemic control to insulin administration. In conclusion, activated microglia in the arcuate nucleus interferes with central counterregulatory responses to hypoglycemia. These results underscore involvement of microglia in hypothalamic regulation of glucose homeostasis.",[],Scientific reports,2019-04-19,"[{'lastname': 'Winkler', 'firstname': 'Zsuzsanna', 'initials': 'Z', 'affiliation': 'Laboratory of Molecular Neuroendocrinology, Institute of Experimental Medicine, Budapest, Hungary.\nJános Szentágothai Doctoral School of Neurosciences, Semmelweis University, Budapest, Hungary.'}, {'lastname': 'Kuti', 'firstname': 'Dániel', 'initials': 'D', 'affiliation': 'Laboratory of Molecular Neuroendocrinology, Institute of Experimental Medicine, Budapest, Hungary.\nJános Szentágothai Doctoral School of Neurosciences, Semmelweis University, Budapest, Hungary.'}, {'lastname': 'Polyák', 'firstname': 'Ágnes', 'initials': 'Á', 'affiliation': 'Laboratory of Molecular Neuroendocrinology, Institute of Experimental Medicine, Budapest, Hungary.'}, {'lastname': 'Juhász', 'firstname': 'Balázs', 'initials': 'B', 'affiliation': 'Laboratory of Molecular Neuroendocrinology, Institute of Experimental Medicine, Budapest, Hungary.\nJános Szentágothai Doctoral School of Neurosciences, Semmelweis University, Budapest, Hungary.'}, {'lastname': 'Gulyás', 'firstname': 'Krisztina', 'initials': 'K', 'affiliation': 'Laboratory of Molecular Neuroendocrinology, Institute of Experimental Medicine, Budapest, Hungary.'}, {'lastname': 'Lénárt', 'firstname': 'Nikolett', 'initials': 'N', 'affiliation': 'Laboratory of Molecular Neuroendocrinology, Institute of Experimental Medicine, Budapest, Hungary.\nLaboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.'}, {'lastname': 'Dénes', 'firstname': 'Ádám', 'initials': 'Á', 'affiliation': 'Laboratory of Molecular Neuroendocrinology, Institute of Experimental Medicine, Budapest, Hungary.\nLaboratory of Neuroimmunology, Institute of Experimental Medicine, Budapest, Hungary.'}, {'lastname': 'Ferenczi', 'firstname': 'Szilamér', 'initials': 'S', 'affiliation': 'Laboratory of Molecular Neuroendocrinology, Institute of Experimental Medicine, Budapest, Hungary.'}, {'lastname': 'Kovács', 'firstname': 'Krisztina J', 'initials': 'KJ', 'affiliation': 'Laboratory of Molecular Neuroendocrinology, Institute of Experimental Medicine, Budapest, Hungary. kovacs@koki.hu.'}]",,,,,"10.1038/s41598-019-42728-3
10.1016/j.yfrne.2009.10.006
10.2337/diabetes.54.12.3592
10.2337/dbi16-0067
10.1210/edrv.22.4.0436
10.1146/annurev-physiol-022516-034406
10.1038/s41593-018-0286-y
10.1016/j.bbi.2012.08.012
10.1038/nn1472
10.1128/MCB.20.11.4106-4114.2000
10.1016/S0304-3940(99)00185-8
10.2337/db06-0567
10.1016/j.mce.2010.02.036
10.1016/j.bbadis.2010.01.006
10.1016/S0006-8993(00)02423-9
10.1073/pnas.1517275113
10.1038/s41598-017-01747-8
10.1016/j.bbi.2015.10.003
10.1093/cercor/bhr229
10.1186/s12974-016-0672-x
10.1016/j.biopsych.2016.04.022
10.1038/jcbfm.2012.30
10.1186/1742-2094-9-225
10.1002/glia.22766
10.1007/s11010-014-2176-2
10.1159/000071951
10.1016/j.bbi.2015.03.010
10.1016/j.bbi.2017.11.017
10.1016/j.it.2017.08.002
10.1016/j.jneuroim.2008.11.007
10.1016/j.bbi.2009.04.013
10.1016/j.bbi.2017.11.001
10.2337/db13-1600
10.2337/diabetes.49.11.1865
10.1007/s00429-013-0642-3
10.1073/pnas.0607076103
10.1038/mp.2015.174
10.2337/db16-1091
10.1172/JCI94330
10.1242/dmm.011601
10.1016/j.bbr.2017.07.023
10.1179/014788889794651870
10.1523/JNEUROSCI.13-12-05126.1993",<Element 'PubmedArticle' at 0x7f05df81c130>
297,"30981281
9344866
12496284
12629551
17583366
18064707
18519800
21565851
24881568
27749056
27171154
29704509
21593768
20211608
24349089
24550142
28189739
26976092
22137657
26482705
20522981
21658380
24612981
25281202
25889021
25362997
23500096
23060810
26071852
24719110
25176008
26363192
27577933
26762790
28189715
29926144
11921201
12405978
26067058
28202578
16949747
17965656
11170729
11358451
17174526
22584848
29928964
1333581
28327597
29084866
7682612
16702987
24373235
22742905
11880505
23470532
19301981
26645224
24247278
12184814
17974036
19428782
23869901
9233547
9061096
17467916
8101583
7910403
23290538
8112823
24974801
28446241",Activation of GPR40 produces mechanical antiallodynia via the spinal glial interleukin-10/β-endorphin pathway.,"The G protein-coupled receptor 40 (GPR40), broadly expressed in various tissues such as the spinal cord, exerts multiple physiological functions including pain regulation. This study aimed to elucidate the mechanisms underlying GPR40 activation-induced antinociception in neuropathic pain, particularly related to the spinal glial expression of IL-10 and subsequent β-endorphin.
Spinal nerve ligation-induced neuropathic pain model was used in this study. β-Endorphin and IL-10 levels were measured in the spinal cord and cultured primary microglia, astrocytes, and neurons. Double immunofluorescence staining of β-endorphin with glial and neuronal cellular biomarkers was also detected in the spinal cord and cultured primary microglia, astrocytes, and neurons.
GPR40 was expressed on microglia, astrocytes, and neurons in the spinal cords and upregulated by spinal nerve ligation. Intrathecal injection of the GPR40 agonist GW9508 dose-dependently attenuated mechanical allodynia and thermal hyperalgesia in neuropathic rats, with E
Our results illustrate that GPR40 activation produces antinociception via the spinal glial IL-10/β-endorphin antinociceptive pathway.","['Astrocytes', 'GPR40', 'IL-10', 'Microglia', 'Spinal cord', 'β-Endorphin']",Journal of neuroinflammation,2019-04-15,"[{'lastname': 'Mao', 'firstname': 'Xiao-Fang', 'initials': 'XF', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, 800 Dongchuan Road, Shanghai, 200240, China.""}, {'lastname': 'Wu', 'firstname': 'Hai-Yun', 'initials': 'HY', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, 800 Dongchuan Road, Shanghai, 200240, China.""}, {'lastname': 'Tang', 'firstname': 'Xue-Qi', 'initials': 'XQ', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, 800 Dongchuan Road, Shanghai, 200240, China.""}, {'lastname': 'Ali', 'firstname': 'Usman', 'initials': 'U', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, 800 Dongchuan Road, Shanghai, 200240, China.""}, {'lastname': 'Liu', 'firstname': 'Hao', 'initials': 'H', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, 800 Dongchuan Road, Shanghai, 200240, China.""}, {'lastname': 'Wang', 'firstname': 'Yong-Xiang', 'initials': 'YX', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, 800 Dongchuan Road, Shanghai, 200240, China. yxwang@sjtu.edu.cn.""}]",,,"GPR40 was expressed on microglia, astrocytes, and neurons in the spinal cords and upregulated by spinal nerve ligation. Intrathecal injection of the GPR40 agonist GW9508 dose-dependently attenuated mechanical allodynia and thermal hyperalgesia in neuropathic rats, with E",,"10.1186/s12974-019-1457-9
10.1006/bbrc.1997.7513
10.1074/jbc.M211495200
10.1038/nature01478
10.1016/j.neures.2007.05.001
10.1002/hipo.20393
10.2337/db08-0307
10.1530/JOE-11-0132
10.1016/j.bmcl.2014.05.019
10.1021/acs.jmedchem.6b00892
10.1080/13543784.2016.1189530
10.1016/j.cbi.2018.04.026
10.1038/jid.2011.123
10.1016/j.brainres.2010.03.002
10.1371/journal.pone.0081563
10.1002/hipo.22263
10.1016/j.pneurobio.2017.01.004
10.1016/j.nlm.2016.03.006
10.1016/j.brainres.2011.11.012
10.1016/j.jnutbio.2015.09.007
10.1248/bpb.33.1070
10.1016/j.ejphar.2011.05.047
10.1186/ar4502
10.1016/j.ejphar.2014.09.036
10.1186/s12990-015-0003-8
10.1111/bph.13003
10.1016/j.neuroscience.2013.03.003
10.3389/fphys.2012.00385
10.1016/j.ejphar.2015.06.013
10.1523/JNEUROSCI.4703-13.2014
10.1111/bph.12895
10.1016/j.neuropharm.2015.09.010
10.1186/s12974-016-0696-2
10.1016/j.jpain.2015.12.015
10.1016/j.bbi.2017.02.005
10.1007/s00213-018-4948-y
10.1002/glia.10050
10.1046/j.1460-9568.2002.02200.x
10.1016/j.pneurobio.2015.05.003
10.1124/mol.116.107102
10.1016/j.pain.2006.07.009
10.1038/nn1992
10.1006/exnr.2000.7604
10.1006/exnr.2001.7677
10.1016/j.bbi.2006.10.012
10.1007/s11064-012-0795-0
10.1016/j.bbi.2018.06.015
10.1016/0304-3959(92)90041-9
10.1038/srep45056
10.1523/JNEUROSCI.1799-17.2017
10.1038/sj.bjp.0706770
10.1016/B978-0-12-800101-1.00003-X
10.1016/j.neuroscience.2012.06.024
10.1523/JNEUROSCI.22-05-01763.2002
10.1038/cddis.2013.54
10.1086/597807
10.1007/s00213-015-4169-6
10.1186/gb-2002-3-7-reviews3009
10.1016/j.neuint.2009.01.011
10.1089/jir.2012.0146
10.1111/j.1399-6576.1997.tb04627.x
10.1016/j.neuroscience.2007.03.029
10.1016/0140-6736(93)91471-W
10.1073/pnas.91.10.4219
10.1016/j.npep.2012.10.006
10.1002/glia.440090408
10.1186/1471-2121-15-24
10.1186/s12974-017-0869-7",<Element 'PubmedArticle' at 0x7f05df842cc0>
298,"30961625
22245257
29166447
22265888
26166157
28850490
28453948
26821680
29287378
28689509
177835
18757188
18693301
15763368
23362211
25592533
28786979
26586374
30166546
23669322
21852795
27510423
29173175
25556835
29242136
24935250
25142459
22492045
19444816
25991441
25810524
28389335
25855176
26585043
26821292
26952745
25617481
27528056
27271499
29369791
30472482
25148733
27262345
11212592
24643418
23783199
23766733
27075542
25732149
25150775
27956638
29197563
28619359
26670081
27478142
30641141
29097017
29434376
23095663
25149438
27022872
25172711
22742452
27547674
30199144
25100600
25889665
17974009
26260133",Anxiolytic effects of Formononetin in an inflammatory pain mouse model.,"Chronic pain is commonly accompanied with anxiety disorder, which complicates treatment. In this study, we investigated the analgesic and anxiolytic effects of Formononetin (FMNT), an active component of traditional Chinese medicine red clover (Trifolium pratense L.) that is capable of protecting neurons from N-methyl-D-aspartate (NMDA)-evoked excitotoxic injury, on mice suffering from complete Freund's adjuvant (CFA)-induced chronic inflammatory pain. The results show that FMNT administration significantly reduces anxiety-like behavior but does not affect the nociceptive threshold in CFA-injected mice. The treatment reverses the upregulation of NMDA, GluA1, and GABA","['Amygdala', 'Anxiety', 'Chronic pain', 'Formononetin', 'Inflammation', 'NMDA']",Molecular brain,2019-04-10,"[{'lastname': 'Wang', 'firstname': 'Xin-Shang', 'initials': 'XS', 'affiliation': ""Department of Pharmacology, School of Pharmacy, and Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710032, China.""}, {'lastname': 'Guan', 'firstname': 'Shao-Yu', 'initials': 'SY', 'affiliation': ""Department of Pharmacology, School of Pharmacy, and Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710032, China.""}, {'lastname': 'Liu', 'firstname': 'An', 'initials': 'A', 'affiliation': ""Department of Pharmacology, School of Pharmacy, and Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710032, China.""}, {'lastname': 'Yue', 'firstname': 'Jiao', 'initials': 'J', 'affiliation': ""Department of Pharmacology, School of Pharmacy, and Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710032, China.""}, {'lastname': 'Hu', 'firstname': 'Li-Ning', 'initials': 'LN', 'affiliation': ""Department of Pharmacology, School of Pharmacy, and Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710032, China.""}, {'lastname': 'Zhang', 'firstname': 'Kun', 'initials': 'K', 'affiliation': ""Department of Pharmacology, School of Pharmacy, and Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710032, China.""}, {'lastname': 'Yang', 'firstname': 'Liu-Kun', 'initials': 'LK', 'affiliation': ""Department of Pharmacology, School of Pharmacy, and Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710032, China.""}, {'lastname': 'Lu', 'firstname': 'Liang', 'initials': 'L', 'affiliation': ""Department of Pharmacology, School of Pharmacy, and Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710032, China.""}, {'lastname': 'Tian', 'firstname': 'Zhen', 'initials': 'Z', 'affiliation': ""Department of Pharmacology, School of Pharmacy, and Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710032, China.\nThe 154th Central Hospital of PLA, Xinyang, 464000, China.""}, {'lastname': 'Zhao', 'firstname': 'Ming-Gao', 'initials': 'MG', 'affiliation': ""Department of Pharmacology, School of Pharmacy, and Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710032, China.""}, {'lastname': 'Liu', 'firstname': 'Shui-Bing', 'initials': 'SB', 'affiliation': ""Department of Pharmacology, School of Pharmacy, and Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710032, China. liushb1974@aliyun.com.""}]",,,,,"10.1186/s13041-019-0453-4
10.1016/j.bbr.2012.01.001
10.11606/S1518-8787.2017051007025
10.1016/j.jpsychires.2012.01.001
10.1016/j.physbeh.2015.07.004
10.1016/j.sjpain.2016.03.006
10.1016/j.jad.2017.04.026
10.1080/00325481.2016.1147925
10.1016/j.foodchem.2017.10.100
10.1017/S0007114517001556
10.1007/BF02532865
10.1016/j.phymed.2008.07.005
10.1002/ptr.2584
10.1016/j.jep.2004.12.027
10.1002/ptr.4928
10.1038/nature14188
10.1038/tp.2017.161
10.1002/jnr.23690
10.1038/s41467-018-05894-y
10.1016/j.psyneuen.2013.04.011
10.1038/nrn3098
10.1038/npp.2016.146
10.2174/1570159X15666171123201142
10.1016/j.neuron.2014.12.021
10.1016/j.brainresbull.2017.12.002
10.1186/1756-6606-7-47
10.1016/S1474-4422(14)70102-4
10.1523/JNEUROSCI.5828-11.2012
10.1002/jcc.21287
10.1002/jcc.540130714
10.1038/nrn3945
10.1523/JNEUROSCI.4485-14.2015
10.1016/j.bbr.2017.04.009
10.1523/JNEUROSCI.3650-14.2015
10.1186/s13041-015-0169-z
10.1016/j.bbr.2016.01.053
10.1016/j.bbi.2016.03.001
10.1016/j.cbi.2015.01.011
10.2174/0929867323666160814001040
10.1038/mp.2016.90
10.1016/j.mcn.2018.01.005
10.1016/j.bbi.2018.11.020
10.1016/j.neubiorev.2014.08.002
10.1016/j.psyneuen.2016.05.017
10.1007/s11427-014-4638-x
10.1038/nrn3524
10.1152/jn.01128.2015
10.2174/1566524015666150303003028
10.1016/j.neuro.2014.08.007
10.1073/pnas.1612963113
10.1016/j.brainresbull.2017.11.016
10.1016/j.euroneuro.2017.05.010
10.1016/j.chembiol.2015.10.013
10.1016/j.bbr.2016.07.042
10.1016/j.tins.2017.10.002
10.1038/s41593-018-0076-6
10.1186/1471-2105-13-S14-S13
10.1177/1094342017697471
10.1007/s00894-014-2401-7
10.1016/j.colsurfb.2016.03.056
10.1016/j.foodchem.2014.07.056
10.1021/jm300621j
10.1186/s40064-016-2914-x
10.1002/da.22790
10.1523/JNEUROSCI.5166-13.2014
10.1186/1744-8069-3-32
10.1186/s13041-015-0140-z",<Element 'PubmedArticle' at 0x7f05df77b1d0>
299,30943041,Endogenous amylin contributes to birth of microglial cells in arcuate nucleus of hypothalamus and area postrema during fetal development.,"Amylin acts in the area postrema (AP) and arcuate nucleus (ARC) to control food intake. Amylin also increases axonal fiber outgrowth from the AP→nucleus tractus solitarius and from ARC→hypothalamic paraventricular nucleus. More recently, exogenous amylin infusion for 4 wk was shown to increase neurogenesis in adult rats in the AP. Furthermore, amylin has been shown to enhance leptin signaling in the ARC and ventromedial nucleus of the hypothalamus (VMN). Thus, we hypothesized that endogenous amylin could be a critical factor in regulating cell birth in the ARC and AP and that amylin could also be involved in the birth of leptin-sensitive neurons. Amylin","['amylin', 'fetal development', 'hindbrain', 'hypothalamus', 'microglia']","American journal of physiology. Regulatory, integrative and comparative physiology",2019-04-04,"[{'lastname': 'Lutz', 'firstname': 'Thomas A', 'initials': 'TA', 'affiliation': 'Institute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich , Zurich , Switzerland.'}, {'lastname': 'Le Foll', 'firstname': 'Christelle', 'initials': 'C', 'affiliation': 'Institute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich , Zurich , Switzerland.'}]",,,,,10.1152/ajpregu.00004.2019,<Element 'PubmedArticle' at 0x7f05df656770>
300,30883417,"Neuroinflammation in the Developing Brain: Risk Factors, Involvement of Microglial Cells, and Implication for Early Anesthesia.","Microglia cells, the resident macrophages of the central nervous system, are key actors for specific brain functions that are critical for development and health. Microglial reactivity and functions, even when immature, play a major role if the developing brain is subjected to abnormal perinatal events. Brain exposure to general anesthesia, surgery, or analgesic drugs during early infancy may adversely affect its maturation and plasticity after injury. A better understanding of the regulation of microglial activation in the developing brain and interactions with specific anesthetic drugs is expected to give novel insights into the mechanisms underlying their potential adverse effects. This review recapitulates the most frequent perinatal circumstances associated with exacerbated systemic inflammation and neuroinflammation together with the double-edged role of microglia associated with subsequent brain damage. A role for microglial reactivity in both potential anesthetic toxicity and neuroprotection is emerging. However, further preclinical experiments are needed to better understand regulatory mechanisms of the developing microglia, and interaction between anesthesia and neuroinflammation in the developing brain.",[],Anesthesia and analgesia,2019-03-19,"[{'lastname': 'Baud', 'firstname': 'Olivier', 'initials': 'O', 'affiliation': 'From the Division of Neonatology and Pediatric Intensive Care, University Hospitals Geneva, Geneva, Switzerland.\nInserm U1141, Sorbonne, Paris Diderot University, Paris, France.'}, {'lastname': 'Saint-Faust', 'firstname': 'Marie', 'initials': 'M', 'affiliation': 'From the Division of Neonatology and Pediatric Intensive Care, University Hospitals Geneva, Geneva, Switzerland.'}]",,,,,10.1213/ANE.0000000000004032,<Element 'PubmedArticle' at 0x7f05df65ff90>
301,"30865890
24681814
25298514
29024103
10999830
19490366
8782523
3793928
3780570
27988368
21148479
14715917
21335378
16567518
14988240
24915455
27980421
27754934
26676252
19010617
9619505
23136554
26143620
20305672
25383904
24487027
11753584
11856971
26491097
18401558
11751615
24703692
19748567
27981186
12213309
24981837
12838424
19955772
27534878
25409701
29650350
10849588
24960169
11846609
20802499
23707189
28894301
27733389
26224855
28683288
29021624
20697689
29184215
28377046
17615358
29861386
25566082
23085146
25116706
22883707
11225716
7407557
25888401
22295972
26771110
26485294
25157144
24048027
19056818
12970313
25587342
28402851
21059919
21168428
26303312
22294347
12054638
11786910
19563755
28694517",Parabrachial Interleukin-6 Reduces Body Weight and Food Intake and Increases Thermogenesis to Regulate Energy Metabolism.,"Chronic low-grade inflammation and increased serum levels of the cytokine IL-6 accompany obesity. For brain-produced IL-6, the mechanisms by which it controls energy balance and its role in obesity remain unclear. Here, we show that brain-produced IL-6 is decreased in obese mice and rats in a neuroanatomically and sex-specific manner. Reduced IL-6 mRNA localized to lateral parabrachial nucleus (lPBN) astrocytes, microglia, and neurons, including paraventricular hypothalamus-innervating lPBN neurons. IL-6 microinjection into lPBN reduced food intake and increased brown adipose tissue (BAT) thermogenesis in male lean and obese rats by increasing thyroid and sympathetic outflow to BAT. Parabrachial IL-6 interacted with leptin to reduce feeding. siRNA-mediated reduction of lPBN IL-6 leads to increased weight gain and adiposity, reduced BAT thermogenesis, and increased food intake. Ambient cold exposure partly normalizes the obesity-induced suppression of lPBN IL-6. These results indicate that lPBN-produced IL-6 regulates feeding and metabolism and pinpoints (patho)physiological contexts interacting with lPBN IL-6.","['PVN', 'brown adipose tissue', 'cold exposure', 'diet-induced obesity', 'energy balance', 'hindbrain', 'lateral PBN', 'obesity', 'sex differences', 'thyroid']",Cell reports,2019-03-14,"[{'lastname': 'Mishra', 'firstname': 'Devesh', 'initials': 'D', 'affiliation': 'Department of Physiology and Metabolic Physiology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.'}, {'lastname': 'Richard', 'firstname': 'Jennifer E', 'initials': 'JE', 'affiliation': 'Department of Physiology and Metabolic Physiology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.'}, {'lastname': 'Maric', 'firstname': 'Ivana', 'initials': 'I', 'affiliation': 'Department of Physiology and Metabolic Physiology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.'}, {'lastname': 'Porteiro', 'firstname': 'Begona', 'initials': 'B', 'affiliation': 'Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, 15782, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), 15706, Spain.'}, {'lastname': 'Häring', 'firstname': 'Martin', 'initials': 'M', 'affiliation': 'Division of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.'}, {'lastname': 'Kooijman', 'firstname': 'Sander', 'initials': 'S', 'affiliation': 'Department of Medicine, Division of Endocrinology, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands.'}, {'lastname': 'Musovic', 'firstname': 'Saliha', 'initials': 'S', 'affiliation': 'Department of Physiology and Metabolic Physiology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.'}, {'lastname': 'Eerola', 'firstname': 'Kim', 'initials': 'K', 'affiliation': 'Department of Physiology and Metabolic Physiology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.'}, {'lastname': 'López-Ferreras', 'firstname': 'Lorena', 'initials': 'L', 'affiliation': 'Department of Physiology and Metabolic Physiology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.'}, {'lastname': 'Peris', 'firstname': 'Eduard', 'initials': 'E', 'affiliation': 'Department of Physiology and Metabolic Physiology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.'}, {'lastname': 'Grycel', 'firstname': 'Katarzyna', 'initials': 'K', 'affiliation': 'Department of Physiology and Metabolic Physiology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.'}, {'lastname': 'Shevchouk', 'firstname': 'Olesya T', 'initials': 'OT', 'affiliation': 'Department of Physiology and Metabolic Physiology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.'}, {'lastname': 'Micallef', 'firstname': 'Peter', 'initials': 'P', 'affiliation': 'Department of Physiology and Metabolic Physiology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.'}, {'lastname': 'Olofsson', 'firstname': 'Charlotta S', 'initials': 'CS', 'affiliation': 'Department of Physiology and Metabolic Physiology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.'}, {'lastname': 'Wernstedt Asterholm', 'firstname': 'Ingrid', 'initials': 'I', 'affiliation': 'Department of Physiology and Metabolic Physiology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.'}, {'lastname': 'Grill', 'firstname': 'Harvey J', 'initials': 'HJ', 'affiliation': 'Lynch Laboratory, Department of Psychology, University of Pennsylvania, Philadelphia, PA 19104, USA.'}, {'lastname': 'Nogueiras', 'firstname': 'Ruben', 'initials': 'R', 'affiliation': 'Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, 15782, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), 15706, Spain.'}, {'lastname': 'Skibicka', 'firstname': 'Karolina P', 'initials': 'KP', 'affiliation': 'Department of Physiology and Metabolic Physiology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden. Electronic address: karolina.skibicka@neuro.gu.se.'}]",,,,Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.,10.1016/j.celrep.2019.02.044,<Element 'PubmedArticle' at 0x7f05df669bd0>
302,"30862067
21451205
22724080
12149444
27763686
10631876
16957868
22964331
19047804
24112071
21193011
15338234
16876585
25341518
23609496
30242884
19286518
22179986
23604474
26335311
25323003
18005249
30374331
18705649
19650880
22085194
25159133
25052362
26327197
26094939
25975679
25401748
26918354
27599451
27421686
28803211
29990691
22034907
23791176
11899099
16217132
16729718
16623752
16817850
14715696
15562014
15589043
16014678
18294335
27696474
12594180
8077674
27021094
9531313
9765276
11692108
11544464
18219763
19144317
25840437
25254011
30342469
11475007
8483103
8981257
9629267
25697044
17606347
20549353
20812785
20032877
28785805
28864909
28785806
28803347
28819865
28785808
28791420
22652882
24822221
24717093
24831823
22896675
24199995
29195051
29279202
28523718
29637859
30368508
10847561
16674804
22107053
23857055
9407389
26123100
25491598
27068758
28294066
12753069
19538338
15777772
23939185
23407992
30542257
19029988
28179656
30046148
27165273
19053174
19218920
19648977
20078217
27235855
21649759
30097900
26336034
28247536
29895782
30362962
28993289
22569208
27789101
24358859
22342844
26498951
30296662
29054471
21735170
28370493
28759028
30368497
28398673
16609073
21062351
21709008
22348531
29352484
22537289
25655081
21355876
18312297
24995391
25998888
29755640
30015062
30553970
23766857
26303641
28546854
28380414
29132743
29621765
29658582
29782856
29845299
29424794
27614220
27908642
28888980
29257276
27916733
29701897
30026098
24940804
26522327
24751831
25004063
25275593
28122311
28738820
29312829
26899795
27070323
27683415
29414662
29448108
29207653
29149494
26607805
27317762
29457836
21499261
29867921
28025657
26308963
27630117
27753144
29277325
30597604
21954831
23796350
28505494
14690596
21084693
29482156
26045547
30485323
24668754
27739090
28781601
27742835
30545127
30563726
30476449
25310649
29021573
30344669
30406463
30519780
30622533
21615491
30107294
26453926
25232110
26261179
27203220
20634564
21288303
21720722
27756894
27914878
28272704
28699360
28810544
29774136
22206046
24373626
26248136
26354749
27603333
28373667
25019481
30637864
27357419
29115456
28214900
25660457
26594146
28929578
30453069
26870816
30391932
26687158
26967561
28929922
30622671
26182366
21350856
26246194
26552447
29623838
30446908
29435152
26376209
23960241
25217442
24352679
26164206
27441728
19167416
22364258
24048733
25132913
29091865
26180376
29137246
28709644
27646435
22550173
24901050
26794445
28569771
30078007
23409058
24576954
27683819
28478034
29550827
25368096
20083669
23285182
25974152
23492773
30257253
30394333
29853534
30328325
30439361
25089700
26549877
27546538
28288804
30224945
30260972
26549736
29205062
29689269
29741292
28724215
29848325
30482883
26844784
28939896
25024332
23153509
23006324
23006329
24021963
30542706
30031269
30240970
21596753
25966629
28732575
28717923
29936262
21926171
23943804
24161443
26289744
26341629
27573160
27115417
29285219
30014902
26718506
29358553
30137188
22575656
26244598
26439987
29174964
29207181
23797704
21113131
22373864
23808420
27462406
30316680
29727715
25556489
30030687
24416161
27062045
26110642
29367587
28195197
25683052
29254143
24862934
30522456
30655868
30617160
21062352
29024030
30291450
29137263
30201872
29631868
28335007
29670042
30386939
25113636
26820238
26965636
28502821
28716885
29599646
30523244
23446348
23446346
27982727
28296235
29532994
30207835
28798046
22010042
19145986
16362083
25248806
22109832
27884595
30092361
25135305
29575122
29855513","Aging, Melatonin, and the Pro- and Anti-Inflammatory Networks.","Aging and various age-related diseases are associated with reductions in melatonin secretion, proinflammatory changes in the immune system, a deteriorating circadian system, and reductions in sirtuin-1 (SIRT1) activity. In non-tumor cells, several effects of melatonin are abolished by inhibiting SIRT1, indicating mediation by SIRT1. Melatonin is, in addition to its circadian and antioxidant roles, an immune stimulatory agent. However, it can act as either a pro- or anti-inflammatory regulator in a context-dependent way. Melatonin can stimulate the release of proinflammatory cytokines and other mediators, but also, under different conditions, it can suppress inflammation-promoting processes such as NO release, activation of cyclooxygenase-2, inflammasome NLRP3, gasdermin D, toll-like receptor-4 and mTOR signaling, and cytokine release by SASP (senescence-associated secretory phenotype), and amyloid-β toxicity. It also activates processes in an anti-inflammatory network, in which SIRT1 activation, upregulation of Nrf2 and downregulation of NF-κB, and release of the anti-inflammatory cytokines IL-4 and IL-10 are involved. A perhaps crucial action may be the promotion of macrophage or microglia polarization in favor of the anti-inflammatory phenotype M2. In addition, many factors of the pro- and anti-inflammatory networks are subject to regulation by microRNAs that either target mRNAs of the respective factors or upregulate them by targeting mRNAs of their inhibitor proteins.","['circadian', 'immunosenescence', 'inflammaging', 'melatonin', 'microRNAs', 'sirtuin-1']",International journal of molecular sciences,2019-03-14,"[{'lastname': 'Hardeland', 'firstname': 'Rüdiger', 'initials': 'R', 'affiliation': 'Johann Friedrich Blumenbach Institute of Zoology and Anthropology, University of Göttingen, 37073 Göttingen, Germany. rhardel@gwdg.de.'}]",,,,,"10.3390/ijms20051223
10.4172/2155-9899.1000543
10.1073/pnas.152318499
10.1111/jpi.12377
10.1007/BF03339801
10.1007/s10522-006-9062-6
10.1159/000156470
10.1111/jpi.12090
10.1016/j.pneurobio.2010.12.004
10.1007/s00412-004-0296-2
10.3390/ijms14048638
10.1111/jpi.12525
10.32794/mr11250005
10.1126/science.1170803
10.1101/sqb.2011.76.010520
10.1097/MCO.0000000000000219
10.1038/srep06666
10.1111/j.1474-9726.2007.00355.x
10.3389/fendo.2018.00614
10.1111/j.1600-079X.2008.00626.x
10.1111/j.1600-079X.2009.00706.x
10.1111/j.1600-079X.2011.00939.x
10.1093/toxsci/kfu164
10.1111/jpi.12161
10.1111/jpi.12269
10.1111/jpi.12254
10.1111/jpi.12250
10.1111/jpi.12193
10.18632/oncotarget.7679
10.1038/srep32199
10.1111/cns.12588
10.1016/j.steroids.2017.08.005
10.1016/j.intimp.2018.06.033
10.1111/j.1600-079X.2011.00934.x
10.1016/j.cell.2013.05.027
10.2174/1568026023394335
10.1385/ENDO:27:2:189
10.1111/j.0959-9673.2006.00474.x
10.1111/j.1742-4658.2006.05322.x
10.1096/fj.03-0694fje
10.1210/jc.2004-1429
10.1016/j.jneuroim.2004.08.015
10.1136/ard.2005.038588
10.1111/j.1365-2125.2007.03088.x
10.1111/1440-1681.12678
10.1096/fj.02-0501fje
10.1007/s10517-016-3242-4
10.1074/jbc.273.42.27467
10.1067/mai.2001.119027
10.1067/mai.2001.117929
10.1007/s00005-007-0032-8
10.1016/j.immuni.2008.11.009
10.1093/intimm/dxv017
10.5114/pdia.2014.40954
10.1186/s12871-018-0607-4
10.1007/s007020170061
10.1111/j.1600-079X.1993.tb00478.x
10.1111/j.1600-079X.1996.tb00280.x
10.1111/j.1749-6632.1998.tb09579.x
10.1016/j.pneurobio.2015.02.001
10.1016/j.exger.2007.05.001
10.1007/s10522-010-9286-3
10.1089/ars.2010.3228
10.2174/1874196701003010039
10.5455/jeim.111210.ir.003
10.3390/molecules14125054
10.1007/s00018-017-2615-9
10.1007/s00018-017-2609-7
10.1007/s00018-017-2619-5
10.1007/s00018-017-2617-7
10.1007/s00018-017-2611-0
10.1007/s00018-017-2610-1
10.1007/s00018-017-2614-x
10.1155/2014/923670
10.1021/bi401606f
10.1016/j.neurobiolaging.2014.03.026
10.1126/scitranslmed.3003748
10.1089/rej.2013.1530
10.1146/annurev-pathol-051217-111018
10.1016/j.biopsych.2017.11.031
10.1111/pcn.12539
10.2174/1567205015666180411092551
10.1159/000494889
10.1007/s007020050018
10.1186/1744-9081-2-15
10.1111/j.1600-079X.2011.00937.x
10.3390/ijms140714575
10.1007/BF02736852
10.1111/jpi.12260
10.1111/jpi.12200
10.1016/j.neulet.2016.04.013
10.2174/1570159X15666170313123454
10.1046/j.1471-4159.2003.01654.x
10.1111/j.1600-079X.2009.00692.x
10.1016/j.brainres.2005.01.023
10.1016/j.bcp.2013.07.030
10.1007/s12035-013-8424-8
10.3389/fnins.2018.00830
10.1038/nri2449
10.1038/nature21363
10.1038/s41574-018-0059-4
10.1159/000446543
10.1371/journal.pbio.0060301
10.1038/embor.2009.22
10.1038/ncb0809-921
10.1146/annurev-pathol-121808-102144
10.1016/j.arr.2016.05.011
10.1111/j.1460-9568.2011.07738.x
10.1007/s10522-018-9767-3
10.1016/j.bbi.2015.08.024
10.1111/jpi.12405
10.3390/ijms19061742
10.18632/aging.101602
10.1016/j.arr.2017.10.001
10.1016/j.gene.2012.04.040
10.1016/j.tem.2016.09.005
10.12688/f1000research.2-148.v1
10.1016/j.immuni.2012.01.009
10.1007/s13238-015-0222-9
10.1016/j.coi.2018.09.013
10.1016/j.mito.2017.10.007
10.1007/s00439-011-1057-y
10.1111/jpi.12410
10.1038/ncb3586
10.1159/000492972
10.1111/jpi.12414
10.1182/blood-2005-09-3691
10.1111/j.1600-079X.2010.00821.x
10.1111/j.1600-079X.2012.00982.x
10.1111/jpi.12470
10.1111/j.1600-079X.2012.01002.x
10.1186/s12885-015-1032-4
10.1111/j.1600-079X.2011.00858.x
10.1111/j.1600-079X.2008.00560.x
10.1016/j.neuint.2014.06.015
10.1007/s11064-015-1613-2
10.1016/j.jphotobiol.2018.07.003
10.1016/j.freeradbiomed.2018.12.014
10.1155/2013/683920
10.1016/j.bbadis.2015.08.017
10.1155/2017/7543973
10.1016/j.biopha.2017.03.056
10.1016/j.cytogfr.2017.11.001
10.1159/000488736
10.3892/mmr.2018.8876
10.1016/j.ejphar.2018.05.017
10.3892/mmr.2018.9024
10.1097/SHK.0000000000001116
10.1016/j.intimp.2016.09.003
10.1016/j.imbio.2016.11.002
10.1016/j.bbrc.2017.08.062
10.3892/mmr.2017.8241
10.1016/j.lfs.2016.11.026
10.1111/sji.12667
10.1016/j.ijbiomac.2018.07.099
10.1038/ki.2014.217
10.1038/srep15971
10.1016/j.jhep.2014.04.010
10.1097/SHK.0000000000000225
10.1038/cddis.2014.406
10.1016/j.biopha.2017.01.087
10.1186/s12974-017-0917-3
10.7717/peerj.4208
10.1038/srep21884
10.1371/journal.pone.0152922
10.1182/blood-2016-05-719757
10.1016/j.intimp.2018.01.013
10.1016/j.bbrc.2018.02.102
10.18632/oncotarget.20592
10.1111/jpi.12457
10.1016/j.mce.2015.11.016
10.1194/jlr.M063537
10.1002/hep.29849
10.1038/nature09917
10.3389/fimmu.2018.00762
10.1007/s00011-016-1020-4
10.1111/jpi.12272
10.1186/s13195-016-0206-x
10.1111/jpi.12375
10.1016/j.bbadis.2017.12.029
10.1111/jpi.12547
10.1111/j.1600-079X.2011.00965.x
10.1111/jpi.12070
10.1016/j.intimp.2017.05.006
10.1016/S1097-2765(03)00490-8
10.1096/fj.10-170597
10.1016/j.intimp.2018.01.049
10.1096/fj.15-273656
10.1371/journal.pone.0207374
10.1096/fj.13-242040
10.1002/bies.201600204
10.1155/2017/8791832
10.1074/jbc.M116.756791
10.3390/ncrna4040040
10.1016/j.tig.2018.11.005
10.3390/epigenomes2020009
10.1146/annurev-genet-120417-031441
10.3390/ijms151018221
10.21767/2471-8084.100056
10.32794/mr11250012
10.1038/s41467-017-00972-z
10.3892/etm.2018.6692
10.1007/s10753-018-0922-4
10.1007/s00392-018-1398-9
10.3389/fimmu.2018.03012
10.1111/j.1600-079X.2011.00896.x
10.1016/j.redox.2018.07.022
10.1016/j.freeradbiomed.2015.09.010
10.1523/JNEUROSCI.0985-14.2014
10.1083/jcb.201501073
10.18632/oncotarget.9421
10.18632/aging.100176
10.1111/j.1742-4658.2011.08042.x
10.1007/s12031-011-9587-2
10.12659/MSM.897207
10.1016/j.joca.2016.11.014
10.1177/1535370217720884
10.3892/etm.2017.4595
10.4081/oncol.2018.348
10.1186/1476-4598-12-173
10.1016/j.bbrc.2015.07.158
10.1152/ajpcell.00122.2015
10.1097/MD.0000000000004315
10.1038/s41598-017-00629-3
10.1038/ncomms5386
10.1002/cbin.11104
10.3892/mmr.2016.5413
10.3892/mmr.2017.7899
10.1159/000455981
10.1016/j.bbrc.2015.01.117
10.3389/fnins.2015.00430
10.1002/jcp.26202
10.1016/j.gene.2018.11.025
10.1016/j.ebiom.2015.11.045
10.1515/hsz-2018-0343
10.1007/s00125-015-3832-0
10.18632/oncotarget.7978
10.1080/09674845.2017.1340225
10.1155/2018/7042105
10.1042/BSR20150071
10.1007/s11010-011-0752-2
10.1038/srep12911
10.1186/s12967-015-0710-y
10.2174/1567202615666180403170902
10.1007/s11010-018-3463-0
10.18632/oncotarget.23529
10.1089/jir.2014.0146
10.1161/CIRCRESAHA.113.301702
10.1093/eurheartj/ehu344
10.1098/rsif.2013.1057
10.18632/oncotarget.4596
10.1111/jpi.12354
10.1016/j.taap.2008.12.021
10.1042/CS20110563
10.1152/ajpcell.00203.2013
10.1016/j.biopha.2017.10.075
10.1155/2015/126408
10.18632/oncotarget.18294
10.1016/j.cellsig.2017.07.005
10.1186/s12974-016-0712-6
10.1073/pnas.1200081109
10.1038/cddis.2014.245
10.1038/cdd.2015.153
10.1038/cddis.2017.211
10.1159/000492350
10.1371/journal.pone.0055838
10.1093/cvr/cvu044
10.1093/infdis/jiw449
10.1016/j.bbrc.2017.05.007
10.1159/000488178
10.2337/db14-0991
10.4049/jimmunol.0902669
10.1371/journal.pone.0052782
10.1089/dna.2014.2760
10.1038/cddis.2013.46
10.1159/000493818
10.1016/j.jsbmb.2018.10.013
10.1042/BSR20180540
10.3349/ymj.2018.59.9.1096
10.1016/j.abb.2018.11.007
10.1371/journal.pone.0103948
10.1016/j.freeradbiomed.2015.11.003
10.4149/BLL_2016_074
10.1016/j.imlet.2017.02.015
10.1155/2018/7163057
10.1371/journal.pone.0203713
10.1016/j.imlet.2015.11.001
10.1177/0960327117741749
10.1016/j.bbrc.2018.04.168
10.1002/cbin.10985
10.1016/j.biopha.2017.07.010
10.1186/s12967-018-1486-7
10.1042/BSR20181139
10.1016/j.taap.2016.01.023
10.1038/s41598-017-06061-x
10.3233/JAD-140204
10.1016/j.biocel.2012.11.002
10.1172/JCI66058
10.1172/JCI62339
10.1159/000354462
10.3892/or.2018.6765
10.1016/j.redox.2018.07.007
10.1016/j.omtn.2018.08.015
10.1074/jbc.M111.229401
10.1016/j.metabol.2017.05.003
10.1007/s11010-017-3102-1
10.1016/j.gene.2018.06.061
10.1074/jbc.M111.275495
10.1158/1535-7163.MCT-13-0418
10.1016/j.freeradbiomed.2013.10.811
10.1111/cpr.12206
10.1042/BSR20150092
10.3892/ijmm.2016.2719
10.1007/s00125-016-3958-8
10.18632/oncotarget.20452
10.1016/j.redox.2018.07.002
10.3892/mmr.2015.4738
10.1007/s12038-017-9698-1
10.1093/abbs/gmy093
10.1016/j.febslet.2012.03.011
10.1038/srep12775
10.18632/oncotarget.5920
10.1016/j.gene.2017.11.058
10.1007/s12094-017-1772-5
10.1007/s00592-013-0492-8
10.1038/emboj.2010.296
10.1007/s10620-012-2099-2
10.1038/celldisc.2015.5
10.1016/j.jneuroim.2018.10.002
10.1016/j.biocel.2018.04.019
10.7314/APJCP.2014.15.23.10439
10.1007/s12079-018-0479-x
10.1371/journal.pone.0083166
10.1111/jpi.12331
10.1371/journal.pone.0121256
10.1038/s41419-017-0155-8
10.1038/srep42498
10.1016/j.chom.2015.01.007
10.1016/j.humimm.2014.05.007
10.1186/s12885-018-5085-z
10.3892/ol.2018.9692
10.1128/MCB.00410-18
10.1111/jpi.12449
10.1007/s00114-018-1585-6
10.3390/cancers10090320
10.1016/j.tem.2018.03.008
10.1093/nar/gkx156
10.3390/ncrna4020012
10.1007/s00439-018-1955-3
10.1016/j.it.2014.07.005
10.1002/eji.201444558
10.1189/jlb.2RU1215-575R
10.1016/j.mad.2017.05.004
10.1101/cshperspect.a028589
10.1155/2018/8050956
10.1038/s12276-018-0188-9
10.1038/nature11928
10.1038/nature11993
10.1080/15476286.2016.1271524
10.1111/febs.14045
10.1111/jcmm.13587
10.1080/15384047.2018.1507254
10.1126/science.aam8526
10.1177/1756285611406166
10.1515/REVNEURO.2008.19.4-5.245
10.1358/dnp.2005.18.7.939349
10.2174/1381612822666151214125543
10.1007/s11357-011-9336-z
10.1016/j.arr.2016.11.007
10.1016/j.arr.2018.07.010
10.1007/s11357-014-9707-3
10.1111/jpi.12491
10.1038/s41598-018-26547-6",<Element 'PubmedArticle' at 0x7f05df5dcb30>
303,30851189,"Neuroprotective effects of an engineered commensal bacterium in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine Parkinson disease mouse model via producing glucagon-like peptide-1.","While glucagon-like peptide-1 (GLP-1) was reported to have a positive impact on Parkinson disease, it is extremely short half-life greatly hindered its clinical use. In this study, the mouse strain MG1363-pMG36e-GLP-1 was engineered to continuously express GLP-1 to treat Parkinson disease in a 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-treated Parkinson disease model. In our study, oral supplementation with MG1363-pMG36e-GLP-1 significantly (p < 0.05) reduced MPTP-induced locomotor impairments, increased tyrosine hydroxylase-positive neurons, suppressed microglia and astrocyte activation, and down-regulated expression of several inflammation-related molecules. In addition, MG1363-pMG36e-GLP-1 significantly (p < 0.01) reduced intestinal pathogen Enterobacteriaceae and markedly enhanced the number of probiotic Lactobacillus and Akkermansia. These data suggest that MG1363-pMG36e-GLP-1 could be a novel therapeutic means for Parkinson disease.","['GLP-1', 'MG1363-pMG36e-GLP-1', 'Parkinson disease', 'TLR-4', 'high-throughput sequencing']",Journal of neurochemistry,2019-03-10,"[{'lastname': 'Fang', 'firstname': 'Xin', 'initials': 'X', 'affiliation': 'Department of Neurology, The First Affiliated Hospital of Nanchang University, Nanchang, China.'}, {'lastname': 'Tian', 'firstname': 'Puyuan', 'initials': 'P', 'affiliation': 'Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi, PR China.'}, {'lastname': 'Zhao', 'firstname': 'Xiaoxiao', 'initials': 'X', 'affiliation': 'Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi, PR China.'}, {'lastname': 'Jiang', 'firstname': 'Chunling', 'initials': 'C', 'affiliation': 'Department of Radiation Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi, PR China.'}, {'lastname': 'Chen', 'firstname': 'Tingtao', 'initials': 'T', 'affiliation': 'Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi, PR China.'}]",,,,© 2019 International Society for Neurochemistry.,10.1111/jnc.14694,<Element 'PubmedArticle' at 0x7f05df439590>
304,"30827729
16037095
16452678
12351732
26361539
28144625
24894465
16357196
22682109
24646669
15044630
15944132
23467340
28689984
25568329
28847562
28618077
11449279
25215491
23393609
21059913
30308165
23407936
29107332
25409697
14980203
28945222
21613996
3801906
7195594
6888663
27558646
9952422
26468197
18562289
17455241
21778362
1449641
8994213
26411510
11449278
22632727
22182318
24501362
20887954
25159150
18722389
18083105
24469251
23525041
27587003
21546088
26212325
26779719
18973587
18685038
12598628
14976257
21050275
18374335",Microglial Phagocytosis of Newborn Cells Is Induced by Endocannabinoids and Sculpts Sex Differences in Juvenile Rat Social Play.,"Brain sex differences are established developmentally and generate enduring changes in circuitry and behavior. Steroid-mediated masculinization of the rat amygdala during perinatal development produces higher levels of juvenile rough-and-tumble play by males. This sex difference in social play is highly conserved across mammals, yet the mechanisms by which it is established are unknown. Here, we report that androgen-induced increases in endocannabinoid tone promote microglia phagocytosis during a critical period of amygdala development. Phagocytic microglia engulf more viable newborn cells in males; in females, less phagocytosis allows more astrocytes to survive to the juvenile age. Blocking complement-dependent phagocytosis in males increases astrocyte survival and prevents masculinization of play. Moreover, increased astrocyte density in the juvenile amygdala reduces neuronal excitation during play. These findings highlight novel mechanisms of brain development whereby endocannabinoids induce microglia phagocytosis to regulate newborn astrocyte number and shape the sexual differentiation of social circuitry and behavior. VIDEO ABSTRACT.","['amygdala', 'astrocytes', 'brain development', 'endocannabinoids', 'glia', 'juvenile play', 'microglia', 'sex differences', 'sexual differentiation', 'social behavior']",Neuron,2019-03-05,"[{'lastname': 'VanRyzin', 'firstname': 'Jonathan W', 'initials': 'JW', 'affiliation': 'Program in Neuroscience, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.'}, {'lastname': 'Marquardt', 'firstname': 'Ashley E', 'initials': 'AE', 'affiliation': 'Program in Neuroscience, University of Maryland School of Medicine, Baltimore, MD 21201, USA.'}, {'lastname': 'Argue', 'firstname': 'Kathryn J', 'initials': 'KJ', 'affiliation': 'Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.'}, {'lastname': 'Vecchiarelli', 'firstname': 'Haley A', 'initials': 'HA', 'affiliation': 'Hotchkiss Brain Institute and Mathison Center for Mental Health Research and Education, Cumming School of Medicine, University of Calgary, Calgary, AB T2N4N1, Canada.'}, {'lastname': 'Ashton', 'firstname': 'Sydney E', 'initials': 'SE', 'affiliation': 'Program in Neuroscience, University of Maryland School of Medicine, Baltimore, MD 21201, USA.'}, {'lastname': 'Arambula', 'firstname': 'Sheryl E', 'initials': 'SE', 'affiliation': 'Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.'}, {'lastname': 'Hill', 'firstname': 'Matthew N', 'initials': 'MN', 'affiliation': 'Hotchkiss Brain Institute and Mathison Center for Mental Health Research and Education, Cumming School of Medicine, University of Calgary, Calgary, AB T2N4N1, Canada; Department of Cell Biology and Anatomy & Psychiatry, University of Calgary, Calgary, AB T2N4N1, Canada.'}, {'lastname': 'McCarthy', 'firstname': 'Margaret M', 'initials': 'MM', 'affiliation': 'Program in Neuroscience, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD 21201, USA. Electronic address: mmccarthy@som.umaryland.edu.'}]",,,,Copyright © 2019 Elsevier Inc. All rights reserved.,10.1016/j.neuron.2019.02.006,<Element 'PubmedArticle' at 0x7f05df442bd0>
305,"30816157
28365630
25671798
29364767
29129157
11818364
19429641
15129186
18436887
18551021
15963646
28364024
20200044
24090950
23583926
2777795
21685445
26448556
22817481
24824997
24814023
24440367
25523481
24142453
18538311
18990443
26661175
26933488
26451016
24508710
24471927
25326022
18367342
18031717
18478021
8784138
19654585
16020761
25617620
17496218
9051759
20656887
28758595
18538311
22109805
16150612
17916768
28701298
18417117
17614938
1071653
28744580
29663576
2643202
24138577
14663344",Assessing the effects of Ang-(1-7) therapy following transient middle cerebral artery occlusion.,"The counter-regulatory axis, Angiotensin Converting Enzyme 2, Angiotensin-(1-7), Mas receptor (ACE2/Ang-1-7/MasR), of the renin angiotensin system (RAS) is a potential therapeutic target in stroke, with Ang-(1-7) reported to have neuroprotective effects in pre-clinical stroke models. Here, an extensive investigation of the functional and mechanistic effects of Ang-(1-7) was performed in a rodent model of stroke. Using longitudinal magnetic resonance imaging (MRI) it was observed that central administration of Ang-(1-7) following transient middle cerebral artery occlusion (MCAO) increased the amount of tissue salvage compared to reperfusion alone. This protective effect was not due to early changes in blood brain barrier (BBB) permeability, microglia activation or inflammatory gene expression. However, increases in NADPH oxidase 1 (Nox1) mRNA expression were observed in the treatment group compared to control. In order to determine whether Ang-(1-7) has direct cerebrovascular effects, laser speckle contrast imaging (LSCI) was performed to measure dynamic changes in cortical perfusion following reperfusion. Delivery of Ang-(1-7) did not have any effect on cortical perfusion following reperfusion however; it showed an indication to prevent the 'steal phenomenon' within the contralateral hemisphere. The comprehensive series of studies have demonstrated a moderate protective effect of Ang-(1-7) when given alongside reperfusion to increase tissue salvage.",[],Scientific reports,2019-03-01,"[{'lastname': 'Arroja', 'firstname': 'M M C', 'initials': 'MMC', 'affiliation': 'Glasgow Experimental MRI Centre (GEMRIC), Institute of Neuroscience & Psychology, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.'}, {'lastname': 'Reid', 'firstname': 'E', 'initials': 'E', 'affiliation': 'Glasgow Experimental MRI Centre (GEMRIC), Institute of Neuroscience & Psychology, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.'}, {'lastname': 'Roy', 'firstname': 'L A', 'initials': 'LA', 'affiliation': 'Glasgow Experimental MRI Centre (GEMRIC), Institute of Neuroscience & Psychology, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.'}, {'lastname': 'Vallatos', 'firstname': 'A V', 'initials': 'AV', 'affiliation': 'Glasgow Experimental MRI Centre (GEMRIC), Institute of Neuroscience & Psychology, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.'}, {'lastname': 'Holmes', 'firstname': 'W M', 'initials': 'WM', 'affiliation': 'Glasgow Experimental MRI Centre (GEMRIC), Institute of Neuroscience & Psychology, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.'}, {'lastname': 'Nicklin', 'firstname': 'S A', 'initials': 'SA', 'affiliation': 'BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular & Medical Sciences, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.'}, {'lastname': 'Work', 'firstname': 'L M', 'initials': 'LM', 'affiliation': 'BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular & Medical Sciences, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK. Lorraine.Work@glasgow.ac.uk.'}, {'lastname': 'McCabe', 'firstname': 'C', 'initials': 'C', 'affiliation': 'Glasgow Experimental MRI Centre (GEMRIC), Institute of Neuroscience & Psychology, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.'}]",,,,,"10.1038/s41598-019-39102-8
10.7861/clinmedicine.17-2-161
10.1056/NEJMoa1414905
10.1056/NEJMoa1713973
10.1056/NEJMoa1706442
10.1096/fj.01-0601com
10.1113/expphysiol.2009.047936
10.1097/00004647-200405000-00008
10.1161/STROKEAHA.107.503458
10.1097/HJH.0b013e3283013b6e
10.1016/j.neuroscience.2005.03.054
10.1161/STROKEAHA.116.016269
10.1093/cvr/cvq059
10.1016/j.npep.2013.09.002
10.1016/j.neuropharm.2013.03.025
10.1113/expphysiol.2011.058578
10.1111/jnc.13386
10.1111/j.1476-5381.2012.02105.x
10.1111/bph.12770
10.1016/j.neuroscience.2014.04.060
10.1016/j.neuropharm.2014.01.004
10.1016/j.ejphar.2014.12.007
10.1113/expphysiol.2013.075242
10.1016/j.brainres.2008.04.057
10.1016/j.npep.2008.09.005
10.1177/0271678X15606722
10.1186/s13231-016-0015-0
10.1016/j.neuropharm.2014.01.044
10.1111/1440-1681.12210
10.1016/j.neuroscience.2008.02.012
10.1016/j.brainres.2007.10.052
10.1038/jcbfm.2008.42
10.1161/01.STR.27.9.1616
10.1038/jcbfm.2009.106
10.1161/01.STR.0000173408.94728.79
10.1371/journal.pone.0116814
10.1152/ajpheart.00141.2007
10.1097/00001756-199612200-00019
10.1152/ajpheart.00328.2010
10.1016/j.brainres.2008.04.057
10.1007/s10439-011-0469-0
10.1161/STROKEAHA.107.482810
10.1016/j.ejphar.2008.02.090
10.1111/j.1527-3466.2007.00012.x
10.1042/cs051399s
10.1007/s00726-017-2471-9
10.3995/jstroke.8.1
10.1161/01.STR.20.1.84
10.1111/ijs.12147
10.1097/01.WCB.0000100064.36077.03",<Element 'PubmedArticle' at 0x7f05df46fd10>
306,30814294,Early-life adversity programs long-term cytokine and microglia expression within the HPA axis in female Japanese quail.,"Stress exposure during prenatal and postnatal development can have persistent and often dysfunctional effects on several physiological systems, including immune function, affecting the ability to combat infection. The neuroimmune response is inextricably linked to the action of the hypothalamic-pituitary-adrenal (HPA) axis. Cytokines released from neuroimmune cells, including microglia, activate the HPA axis, while glucocorticoids in turn regulate cytokine release from microglia. Because of the close links between these two physiological systems, coupled with potential for persistent changes to HPA axis activity following developmental stress, components of the neuroimmune system could be targets for developmental programming. However, little is known of any programming effects of developmental stress on neuroimmune function. We investigated whether developmental stress exposure via elevated prenatal corticosterone (CORT) or postnatal unpredictable food availability had long-term effects on pro- (","['Anti-inflammatory', 'Cytokines', 'Developmental programming', 'Glucocorticoids', 'Neuroimmune', 'Neuroinflammation']",The Journal of experimental biology,2019-03-01,"[{'lastname': 'Walker', 'firstname': 'David J', 'initials': 'DJ', 'affiliation': 'School of Psychology and Neuroscience, University of St Andrews, St Andrews KY16 9JP, UK david.walker.3@glasgow.ac.uk.'}, {'lastname': 'Zimmer', 'firstname': 'Cédric', 'initials': 'C', 'affiliation': 'School of Psychology and Neuroscience, University of St Andrews, St Andrews KY16 9JP, UK.\nDepartment of Ecology and Evolutionary Biology, Cornell University, Ithaca, NY 14850, USA.'}, {'lastname': 'Larriva', 'firstname': 'Maria', 'initials': 'M', 'affiliation': 'School of Psychology and Neuroscience, University of St Andrews, St Andrews KY16 9JP, UK.'}, {'lastname': 'Healy', 'firstname': 'Susan D', 'initials': 'SD', 'affiliation': 'School of Biology, Harold Mitchell Building, University of St Andrews, St Andrews KY16 9TH, UK.'}, {'lastname': 'Spencer', 'firstname': 'Karen A', 'initials': 'KA', 'affiliation': 'School of Psychology and Neuroscience, University of St Andrews, St Andrews KY16 9JP, UK.'}]",,,,© 2019. Published by The Company of Biologists Ltd.,10.1242/jeb.187039,<Element 'PubmedArticle' at 0x7f05df420bd0>
307,"30790216
21978149
26598697
11460811
24277113
16730375
15665080
15135924
20383154
14987447
17965656
20948535
23573123
19392576
16741252
10524714
12972158
28780644
8843599
16734769
22674585
23956761
24100629
12734393
12927638
23500198
14654796
10350552
18480275
21159431
17537972
19303429
12490580
15102489
17577523
14681932
27296116
12151551
14622922
15131310
14624855
10846153
28394330
21345196
23199705
22072513
25467445
28782714
27657453
25010483
15233755
27657453
1890551
11291979
11381492
19655114
12752784
12374772
3137474
9179382
12871832
18923025
28389872
11470965
20117131
22226600
15836971
11596126
28211895
10985868
15223378
25305342
28484964
15968463
16467532
23727452
26300222",Thymosin Alpha-1 Inhibits Complete Freund's Adjuvant-Induced Pain and Production of Microglia-Mediated Pro-inflammatory Cytokines in Spinal Cord.,"Activation of inflammatory responses regulates the transmission of pain pathways through an integrated network in the peripheral and central nervous systems. The immunopotentiator thymosin alpha-1 (Tα1) has recently been reported to have anti-inflammatory and neuroprotective functions in rodents. However, how Tα1 affects inflammatory pain remains unclear. In the present study, intraperitoneal injection of Tα1 attenuated complete Freund's adjuvant (CFA)-induced pain hypersensitivity, and decreased the up-regulation of pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6) in inflamed skin and the spinal cord. We found that CFA-induced peripheral inflammation evoked strong microglial activation, but the effect was reversed by Tα1. Notably, Tα1 reversed the CFA-induced up-regulation of vesicular glutamate transporter (VGLUT) and down-regulated the vesicular γ-aminobutyric acid transporter (VGAT) in the spinal cord. Taken together, these results suggest that Tα1 plays a therapeutic role in inflammatory pain and in the modulation of microglia-induced pro-inflammatory cytokine production in addition to mediation of VGLUT and VGAT expression in the spinal cord.","['Cytokine', 'Microglia', 'Thymosin alpha-1', 'Vesicular glutamate transporter type 2', 'Vesicular γ-aminobutyric acid transporter']",Neuroscience bulletin,2019-02-23,"[{'lastname': 'Xu', 'firstname': 'Yunlong', 'initials': 'Y', 'affiliation': 'South China Research Center for Acupuncture and Moxibustion, Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China. yunlongxu69@outlook.com.'}, {'lastname': 'Jiang', 'firstname': 'Yanjun', 'initials': 'Y', 'affiliation': 'College of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.'}, {'lastname': 'Wang', 'firstname': 'Lin', 'initials': 'L', 'affiliation': 'South China Research Center for Acupuncture and Moxibustion, Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.'}, {'lastname': 'Huang', 'firstname': 'Jiahua', 'initials': 'J', 'affiliation': 'The First Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.'}, {'lastname': 'Wen', 'firstname': 'Junmao', 'initials': 'J', 'affiliation': 'Graduate College, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.'}, {'lastname': 'Lv', 'firstname': 'Hang', 'initials': 'H', 'affiliation': 'South China Research Center for Acupuncture and Moxibustion, Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.'}, {'lastname': 'Wu', 'firstname': 'Xiaoli', 'initials': 'X', 'affiliation': 'South China Research Center for Acupuncture and Moxibustion, Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.'}, {'lastname': 'Wan', 'firstname': 'Chaofan', 'initials': 'C', 'affiliation': 'South China Research Center for Acupuncture and Moxibustion, Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.'}, {'lastname': 'Yu', 'firstname': 'Chuanxin', 'initials': 'C', 'affiliation': 'South China Research Center for Acupuncture and Moxibustion, Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.'}, {'lastname': 'Zhang', 'firstname': 'Wenjie', 'initials': 'W', 'affiliation': 'South China Research Center for Acupuncture and Moxibustion, Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.'}, {'lastname': 'Zhao', 'firstname': 'Jiaying', 'initials': 'J', 'affiliation': 'South China Research Center for Acupuncture and Moxibustion, Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.'}, {'lastname': 'Zhou', 'firstname': 'Yinqi', 'initials': 'Y', 'affiliation': 'South China Research Center for Acupuncture and Moxibustion, Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.'}, {'lastname': 'Chen', 'firstname': 'Yongjun', 'initials': 'Y', 'affiliation': 'South China Research Center for Acupuncture and Moxibustion, Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China. ychen@gzucm.edu.cn.'}]",,,,,"10.1007/s12264-019-00346-z
10.1186/1471-2458-11-770
10.1073/pnas.1501372112
10.1093/bja/87.1.3
10.1007/s12630-013-0087-4
10.1073/pnas.0409225102
10.1016/j.neulet.2003.12.007
10.1038/nm.2123
10.1038/nn1992
10.1038/nm.2234
10.1517/14712590902911412
10.1182/blood-2006-02-004762
10.1016/S0197-0186(99)00084-4
10.1016/S0304-3940(03)00862-0
10.1007/s12264-017-0162-x
10.1016/0166-2236(96)10049-7
10.1111/j.1748-1716.2006.01568.x
10.1002/glia.22350
10.1155/2013/541259
10.1007/s00018-013-1480-4
10.1124/jpet.103.052407
10.1016/S0304-3959(03)00138-6
10.1016/j.ejphar.2013.01.072
10.1038/nrd1251
10.1016/S0006-8993(99)01326-8
10.1523/JNEUROSCI.3338-07.2008
10.1016/j.pain.2010.11.014
10.1523/JNEUROSCI.0176-07.2007
10.1124/jpet.102.038703
10.1016/j.tins.2003.11.005
10.1016/j.neuroscience.2007.02.068
10.1002/cne.10988
10.1016/j.neuint.2016.06.002
10.1523/JNEUROSCI.22-15-06724.2002
10.1016/j.neuroscience.2003.07.009
10.1126/science.1094925
10.1016/j.tins.2003.09.017
10.1126/science.288.5472.1765
10.1038/nm.4305
10.1016/j.pain.2012.10.009
10.1152/jn.00658.2011
10.1016/j.cell.2014.11.003
10.1016/j.bbi.2017.08.004
10.1016/j.neuron.2016.09.010
10.1016/j.brainresbull.2014.06.004
10.1111/j.1460-9568.2004.03514.x
10.1016/j.neuron.2016.09.010
10.1093/ajhp/58.10.879
10.1007/978-3-540-79090-7_12
10.1046/j.1460-9568.2003.02626.x
10.1096/fj.02-0101com
10.1038/334698a0
10.1038/sj.bjp.0701148
10.1038/sj.bjp.0705346
10.1523/JNEUROSCI.3593-08.2008
10.1007/s12264-017-0129-y
10.1097/00019052-200108000-00009
10.1016/j.pharmthera.2010.01.002
10.1016/j.expneurol.2011.12.021
10.1016/j.pain.2005.02.009
10.1002/glia.1107
10.1016/j.brainres.2004.04.068
10.1016/j.brainresbull.2014.10.002
10.1007/s12264-017-0136-z
10.1007/s00018-005-5107-2
10.1523/JNEUROSCI.4584-05.2006
10.1016/j.neuroscience.2013.05.044
10.1016/j.brainres.2015.08.010",<Element 'PubmedArticle' at 0x7f05df42eae0>
308,"30742662
14744438
19167326
19255566
21331081
24850099
16754881
20146715
23588363
26851161
21652514
22661952
17457343
22549785
24244499
22653784
24326348
24713688
20651288
25800044
18286801
21924288
25315390
24281104
19457575
21420365
18040791
20191092
19910459
21449980
23892791
21542829
22178458
23637839
25601726
17245363
25037227
26218440
21238581
27256343
28788104
22506672
25703248
26264914
28232276
19847654
24309936
25257544
27790143
24202177
25425209
27038180
27268054
25378491
26607731
20439781
19910308
18158296
24600468
18422969
19285060
21857159
22570483
17656095
18504431
16885212
26410391
27447824
29176977
22043967
17047224
21982894
23880293
19461653
22162084
26936847
18449946
20648656
22205705
26003520
11823794
22263797
24450631
23907446",miRNA expression profiles and molecular networks in resting and LPS-activated BV-2 microglia-Effect of cannabinoids.,"Mammalian microRNAs (miRNAs) play a critical role in modulating the response of immune cells to stimuli. Cannabinoids are known to exert beneficial actions such as neuroprotection and immunosuppressive activities. However, the underlying mechanisms which contribute to these effects are not fully understood. We previously reported that the psychoactive cannabinoid Δ9-tetrahydrocannabinol (THC) and the non-psychoactive cannabidiol (CBD) differ in their anti-inflammatory signaling pathways. Using lipopolysaccharide (LPS) to stimulate BV-2 microglial cells, we examined the role of cannabinoids on the expression of miRNAs. Expression was analyzed by performing deep sequencing, followed by Ingenuity Pathway Analysis to describe networks and intracellular pathways. miRNA sequencing analysis revealed that 31 miRNAs were differentially modulated by LPS and by cannabinoids treatments. In addition, we found that at the concentration tested, CBD has a greater effect than THC on the expression of most of the studied miRNAs. The results clearly link the effects of both LPS and cannabinoids to inflammatory signaling pathways. LPS upregulated the expression of pro-inflammatory miRNAs associated to Toll-like receptor (TLR) and NF-κB signaling, including miR-21, miR-146a and miR-155, whereas CBD inhibited LPS-stimulated expression of miR-146a and miR-155. In addition, CBD upregulated miR-34a, known to be involved in several pathways including Rb/E2f cell cycle and Notch-Dll1 signaling. Our results show that both CBD and THC reduced the LPS-upregulated Notch ligand Dll1 expression. MiR-155 and miR-34a are considered to be redox sensitive miRNAs, which regulate Nrf2-driven gene expression. Accordingly, we found that Nrf2-mediated expression of redox-dependent genes defines a Mox-like phenotype in CBD treated BV-2 cells. In summary, we have identified a specific repertoire of miRNAs that are regulated by cannabinoids, in resting (surveillant) and in LPS-activated microglia. The modulated miRNAs and their target genes are controlled by TLR, Nrf2 and Notch cross-talk signaling and are involved in immune response, cell cycle regulation as well as cellular stress and redox homeostasis.",[],PloS one,2019-02-12,"[{'lastname': 'Juknat', 'firstname': 'Ana', 'initials': 'A', 'affiliation': 'The Dr Miriam and Sheldon G. Adelson Center for the Biology of Addictive Diseases, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.\nDepartment of Neurobiology, Weizmann Institute of Science, Rehovot, Israel.'}, {'lastname': 'Gao', 'firstname': 'Fuying', 'initials': 'F', 'affiliation': 'Departments of Psychiatry and Neurology, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, CA, United States of America.'}, {'lastname': 'Coppola', 'firstname': 'Giovanni', 'initials': 'G', 'affiliation': 'Departments of Psychiatry and Neurology, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, CA, United States of America.'}, {'lastname': 'Vogel', 'firstname': 'Zvi', 'initials': 'Z', 'affiliation': 'The Dr Miriam and Sheldon G. Adelson Center for the Biology of Addictive Diseases, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.\nDepartment of Neurobiology, Weizmann Institute of Science, Rehovot, Israel.'}, {'lastname': 'Kozela', 'firstname': 'Ewa', 'initials': 'E', 'affiliation': 'The Dr Miriam and Sheldon G. Adelson Center for the Biology of Addictive Diseases, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.\nDepartment of Neurobiology, Weizmann Institute of Science, Rehovot, Israel.'}]",,,,,"10.1371/journal.pone.0212039
10.1016/j.cell.2009.01.002
10.1038/ncb0309-228
10.1038/nri2957
10.1007/s10495-014-0999-7
10.1073/pnas.0508889103
10.1111/j.1749-6632.2009.05121.x
10.1038/nrneurol.2013.67
10.1016/j.pneurobio.2016.01.005
10.1093/intimm/dxr034
10.3389/fphys.2012.00138
10.1038/nri2079
10.1074/jbc.M111.327031
10.1371/journal.pone.0079416
10.1002/glia.22363
10.1152/physiolgenomics.00140.2013
10.1038/nrn3722
10.1161/CIRCRESAHA.109.215715
10.1111/bph.13139
10.1016/j.pharmthera.2011.09.002
10.1038/nrn3811
10.3390/cancers2021013
10.1016/j.imbio.2009.04.001
10.1016/j.clim.2011.02.010
10.1007/s11481-005-9007-x
10.4155/fmc.09.93
10.1074/jbc.M109.069294
10.1111/j.1476-5381.2011.01379.x
10.1007/s11481-013-9493-1
10.1111/j.1476-5381.2011.01461.x
10.1016/j.neuint.2011.12.002
10.1371/journal.pone.0061462
10.1007/s11481-015-9584-2
10.1038/sj.bjp.0707133
10.1074/jbc.M114.557025
10.1111/bph.13250
10.1016/j.freeradbiomed.2011.01.007
10.1186/s12974-016-0603-x
10.3390/ijms18081669
10.1111/j.1365-2125.2012.04298.x
10.1016/j.bmc.2015.01.059
10.1007/s13311-015-0377-3
10.1016/j.pharmthera.2017.02.041
10.1007/s11481-009-9177-z
10.1038/cddis.2013.471
10.1111/bph.12944
10.1074/jbc.M113.503037
10.1111/bph.13026
10.1007/s00109-016-1404-5
10.1074/jbc.M116.719179
10.1128/JVI.01754-14
10.1007/s11481-015-9645-6
10.1534/genetics.110.114983
10.1093/bioinformatics/btp616
10.1093/nar/gkm995
10.3389/fgene.2014.00023
10.1111/j.1365-2567.2008.02849.x
10.1016/j.ejphar.2009.03.010
10.1074/jbc.M111.328054
10.1016/j.cub.2007.06.068
10.1038/onc.2008.171
10.1073/pnas.0605298103
10.1016/j.coph.2015.09.001
10.1371/journal.pone.0159724
10.3389/fimmu.2017.01520
10.1111/j.1365-2567.2011.03514.x
10.1016/j.freeradbiomed.2011.09.014
10.1016/j.freeradbiomed.2013.07.025
10.1038/cdd.2009.56
10.1002/jbt.20412
10.1007/s13238-016-0250-0
10.1002/glia.20692
10.1002/jnr.22429
10.1074/jbc.M111.310375
10.1016/j.freeradbiomed.2015.05.017
10.1038/nrm714
10.1042/BST20130156
10.1038/nri3494",<Element 'PubmedArticle' at 0x7f05df321400>
309,"30742657
21196131
19566837
29361405
29098089
28835252
26644079
30005742
30100517
15738989
10913045
27651753
27706848
22473697
22751353
20136703
28785808
24650045
24007241
22050439
25598354
25302502
29976873
6110810
30172748
25495651
28120943
30048986
29494287
17198536
14740000
29603319
25768341
25299692
18637016
27651753
26846222
11098051
25574840
12855674
20010438
26173855
29271525
28923365
27293185
11514614
27155536
27387769
30597604
18430751
30172371
26393435
26797282",Melatonin decreases M1 polarization via attenuating mitochondrial oxidative damage depending on UCP2 pathway in prorenin-treated microglia.,"Accumulating evidence suggests that neuroinflammation and oxidative stress in cardiovascular center contribute to the pathological processes underlying hypertension. Microglia activation triggers the inflammation and oxidative stress. Melatonin is a documented potent anti-inflammatory regent and antioxidant, the underlying roles of melatonin in regulating microglia activation via mitochondria remain unclear. In present study, we investigated the protective role of melatonin in decreasing M1 phenotype switching via attenuating mitochondrial oxidative damage in dependence on uncoupling protein 2 (UCP2) pathway in microglia. Prorenin (20 nmol/L; 24 hr) was used to induce inflammation in cultured microglia. Mitochondrial morphology was detected by transmission electron microscope. The reactive oxygen species (ROS) production by using DCFH-DA fluorescence imaging and mitochondrial membrane potential (MMP, ΔΨm) was evaluated by JC-1 staining. The indicator of the redox status as the ratio of the amount of total NADP+ to total NADPH, and the expression of 6 subunits of NADPH oxidase is measured. The pro-inflammatory cytokines releasing was measured by qPCR. UCP2 and activated AMPKα (p-AMPKα) expression were examined by immunoblot. Melatonin (100 μM) markedly alleviated the M1 microglia phenotype shifting and abnormal mitochondria morphology. Melatonin attenuated prorenin-induced ΔΨm increasing and ROS overproduction. Melatonin decreased the redox ratio (NADP+/NADPH) and the p47phox and gp91phox subunits of NADPH oxidase expression in prorenin-treated microglia. These effects were reversed in the presence of UCP2 siRNA. Our results suggested that the protective effect of melatonin against prorenin-induced M1 phenotype switching via attenuating mitochondrial oxidative damage depending on UCP2 upregulation in prorenin-treated microglia.",[],PloS one,2019-02-12,"[{'lastname': 'Hu', 'firstname': 'Li', 'initials': 'L', 'affiliation': 'Laboratory of Neuropharmacology and Neurotoxicology, Shanghai Key Laboratory of Bio-Energy Crops, College of Life Science, Shanghai University, Shanghai, P.R. China.'}, {'lastname': 'Zhang', 'firstname': 'Shutian', 'initials': 'S', 'affiliation': 'Department of Physiology and Pathophysiology, Basic Medicine College, Fudan University, Shanghai, P.R. China.'}, {'lastname': 'Wen', 'firstname': 'Haoyu', 'initials': 'H', 'affiliation': 'Department of Physiology and Pathophysiology, Basic Medicine College, Fudan University, Shanghai, P.R. China.'}, {'lastname': 'Liu', 'firstname': 'Tianfeng', 'initials': 'T', 'affiliation': 'Laboratory of Neuropharmacology and Neurotoxicology, Shanghai Key Laboratory of Bio-Energy Crops, College of Life Science, Shanghai University, Shanghai, P.R. China.'}, {'lastname': 'Cai', 'firstname': 'Jian', 'initials': 'J', 'affiliation': 'Department of neurology, Renji Hospital, Shanghai Jiaotong University, Shanghai, P.R. China.'}, {'lastname': 'Du', 'firstname': 'Dongshu', 'initials': 'D', 'affiliation': 'Laboratory of Neuropharmacology and Neurotoxicology, Shanghai Key Laboratory of Bio-Energy Crops, College of Life Science, Shanghai University, Shanghai, P.R. China.'}, {'lastname': 'Zhu', 'firstname': 'Danian', 'initials': 'D', 'affiliation': 'Department of Physiology and Pathophysiology, Basic Medicine College, Fudan University, Shanghai, P.R. China.'}, {'lastname': 'Chen', 'firstname': 'Fuxue', 'initials': 'F', 'affiliation': 'Laboratory of Neuropharmacology and Neurotoxicology, Shanghai Key Laboratory of Bio-Energy Crops, College of Life Science, Shanghai University, Shanghai, P.R. China.'}, {'lastname': 'Xia', 'firstname': 'Chunmei', 'initials': 'C', 'affiliation': 'Department of Physiology and Pathophysiology, Basic Medicine College, Fudan University, Shanghai, P.R. China.'}]",,,,,"10.1371/journal.pone.0212138
10.1016/j.coph.2010.12.001
10.1155/2017/3256325
10.1186/s12974-017-0942-2
10.1016/j.autneu.2018.06.003
10.1016/j.molmed.2018.07.007
10.1038/nrm1572
10.1152/ajpendo.2000.279.2.E433
10.4103/1673-5374.189159
10.1111/j.1600-079X.2009.00740.x
10.1111/jpi.12134
10.1111/jpi.12089
10.1007/s12035-014-9070-5
10.1371/journal.pone.0092937
10.1016/j.freeradbiomed.2018.08.032
10.1111/febs.13175
10.1038/srep41337
10.1159/000492095
10.3390/ijms16035572
10.3390/ijms151017920
10.4103/1673-5374.189159
10.1007/s12031-015-0694-3
10.1074/jbc.M006938200
10.1172/JCI78253
10.1161/01.RES.0000085581.60197.4D
10.1097/01.fjc.0000365898.92719.f0
10.1111/jnc.13244
10.1002/cbin.10921
10.1016/j.it.2017.08.006
10.1016/j.cell.2016.05.035
10.1091/mbc.12.8.2245
10.1016/j.neuint.2016.05.003
10.1016/j.freeradbiomed.2016.06.015
10.1111/jpi.12547
10.1093/cvr/cvn098
10.1016/j.bbrc.2018.08.027
10.1016/j.cbpb.2015.09.005
10.1016/j.bbrc.2016.01.089",<Element 'PubmedArticle' at 0x7f05df218b30>
310,"30737481
29411031
28828483
21499711
27297122
26543794
15956767
24917878
7195540
21143141
25175862
26695754
18190912
23500890
28674490
20662807
28407740
27263429
26337952
23422878
21262339
29643762
22031897
24289885
27604565
24638131
26524636
28431792
28187949
19545588
18266938
23474365
24961305
21376806
25856413
26996510
27240410
18348728
28941277
27246804
23470532
22709825
21397005
1877725
23544149
23283698
25409090
23485013
24528596
26421061
17478518
23683942
16868257
15888697
19308066",Early life alcohol exposure primes hypothalamic microglia to later-life hypersensitivity to immune stress: possible epigenetic mechanism.,"Growing evidence has shown that developmental alcohol exposure induces central nervous system inflammation and microglia activation, which may contribute to long-term health conditions, such as fetal alcohol spectrum disorders. These studies sought to investigate whether neonatal alcohol exposure during postnatal days (PND) 2-6 in rats (third trimester human equivalent) leads to long-term disruption of the neuroimmune response by microglia. Exposure to neonatal alcohol resulted in acute increases in activation and inflammatory gene expression in hypothalamic microglia including tumor necrosis factor alpha (TNF-α) and interleukin 6 (IL-6). Adults with neonatal alcohol pre-exposure (alcohol fed; AF) animals showed an exaggerated peripheral stress hormonal response to an immune challenge (lipopolysaccharides; LPS). In addition, there were significantly more microglia present in the hypothalamus of adult AF animals, and their hypothalamic microglia showed more cluster of differentiation molecule 11b (Cd11b) activation, TNF-α expression, and IL-6 expression in response to LPS. Interestingly, blocking microglia activation with minocycline treatment during PND 2-6 alcohol exposure ameliorated the hormonal and microglial hypersensitivity to LPS in AF adult animals. Investigation of possible epigenetic programming mechanisms by alcohol revealed neonatal alcohol decreased several repressive regulators of transcription in hypothalamic microglia, while concomitantly increasing histone H3 acetyl lysine 9 (H3K9ac) enrichment at TNF-α and IL-6 promoter regions. Importantly, adult hypothalamic microglia from AF animals showed enduring increases in H3K9ac enrichment of TNF-α and IL-6 promoters both at baseline and after LPS exposure, suggesting a possible epigenetic mechanism for the long-term immune disruption due to hypothalamic microglial priming.",[],Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,2019-02-10,"[{'lastname': 'Chastain', 'firstname': 'Lucy G', 'initials': 'LG', 'affiliation': 'The Endocrine Program, Department of Animal Sciences, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.'}, {'lastname': 'Franklin', 'firstname': 'Tina', 'initials': 'T', 'affiliation': 'The Endocrine Program, Department of Animal Sciences, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.'}, {'lastname': 'Gangisetty', 'firstname': 'Omkaram', 'initials': 'O', 'affiliation': 'The Endocrine Program, Department of Animal Sciences, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.'}, {'lastname': 'Cabrera', 'firstname': 'Miguel A', 'initials': 'MA', 'affiliation': 'The Endocrine Program, Department of Animal Sciences, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.\nEndocrinology and Animal Biosciences Graduate Program, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.'}, {'lastname': 'Mukherjee', 'firstname': 'Sayani', 'initials': 'S', 'affiliation': 'The Endocrine Program, Department of Animal Sciences, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.'}, {'lastname': 'Shrivastava', 'firstname': 'Pallavi', 'initials': 'P', 'affiliation': 'The Endocrine Program, Department of Animal Sciences, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.'}, {'lastname': 'Jabbar', 'firstname': 'Shaima', 'initials': 'S', 'affiliation': 'The Endocrine Program, Department of Animal Sciences, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.\nEndocrinology and Animal Biosciences Graduate Program, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.'}, {'lastname': 'Sarkar', 'firstname': 'Dipak K', 'initials': 'DK', 'affiliation': 'The Endocrine Program, Department of Animal Sciences, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA. sarkar@aesop.rutgers.edu.'}]",,,,,"10.1038/s41386-019-0326-7
10.1001/jama.2017.21896
10.1001/jamapediatrics.2017.1919
10.1007/s11065-011-9166-x
10.1002/bdrc.21129
10.1007/s40474-015-0053-7
10.1177/15353702-0323006-05
10.3389/fgene.2014.00154
10.1203/00006450-198106000-00005
10.2174/187152711794488575
10.1016/B978-0-12-801284-0.00004-X
10.1016/j.expneurol.2007.11.017
10.1016/j.tox.2013.03.001
10.3389/fnsyn.2017.00011
10.1111/j.1530-0277.2010.01271.x
10.1186/s12974-017-0844-3
10.1016/j.bbi.2016.05.022
10.1186/s12974-015-0382-9
10.1016/j.neuint.2013.02.012
10.1016/j.bbi.2011.01.006
10.3389/fnins.2018.00200
10.1523/JNEUROSCI.3688-11.2011
10.1016/j.biopsych.2013.10.014
10.1038/npp.2016.185
10.1038/nrneurol.2014.38
10.1016/j.bbadis.2015.10.026
10.1016/j.alcohol.2017.01.005
10.1016/j.alcohol.2016.11.009
10.1016/j.neubiorev.2009.06.004
10.1111/j.1365-2826.2008.01669.x
10.1016/j.yhbeh.2013.02.017
10.3390/brainsci3010001
10.1016/j.bbi.2011.02.016
10.1002/glia.22835
10.1016/j.neuroscience.2016.03.033
10.3390/brainsci6020016
10.1186/1742-2094-5-10
10.1111/acer.13511
10.1002/glia.23007
10.1038/cddis.2013.54
10.1016/j.bbi.2011.03.002
10.1111/j.1530-0277.1991.tb00536.x
10.1371/journal.pone.0060503
10.1007/s11064-012-0960-5
10.1371/journal.pone.0113228
10.1016/j.biopsych.2013.01.012
10.1017/S1461145714000054
10.1186/s13072-015-0031-7
10.1093/nar/gkm214
10.1016/B978-0-12-407708-9.00002-9
10.1182/blood-2006-02-005520
10.1056/NEJMoa041892
10.1038/nrg2540",<Element 'PubmedArticle' at 0x7f05df1c1180>
311,"30711897
21435391
11847483
30022063
29858858
12614646
16386803
25747320
22664265
15050647
16730336
16123744
3327424
3037584
12711078
15639551
12121498
16647243
18079203
17700577
21406198
24184413
16165282
18468841
22944319
10360120
12946659
22743370
29867615
26974501
25687843
8556346
26711676
16226365
12907843
9482808
10719064
14575884
8396018
12691837
10709966
22902349
21605631
26928198
15541765
22386198
21525267
24523548
25676490
15385601
28577990",Sex differences in the regulation of brain IL-1β in response to chronic stress.,"Elevations in brain interleukin-1 beta (IL-1β) during chronic stress exposure have been implicated in behavioral and cognitive impairments associated with depression and anxiety. Two critical regulators of brain IL-1β production during times of stress are glucocorticoids and catecholamines. These hormones work in opposition to one another to inhibit (via glucocorticoid receptors) or stimulate (via beta-adrenergic receptors: β-AR) IL-1β production. While chronic stress often heightens both corticosterone and catecholamine levels, it remains unknown as to how chronic stress may affect the ""yin-yang"" balance between adrenergic stimulation and glucocorticoid suppression of brain IL-1β. To investigate this further, male and female rats underwent 4 days of stress exposure or served as non-stressed controls. On day 5, animals were administered propranolol (β-AR antagonist), metyrapone (a glucocorticoid synthesis inhibitor), vehicle, or both drugs and brain IL-1β mRNA was measured by rtPCR in limbic brain areas. In males, administration of propranolol had no effect on IL-1β expression in non-stressed controls but significantly reduced IL-1β in the hippocampus and amygdala of chronically stressed animals. In females, propranolol significantly reduced IL-1β in the amygdala and hypothalamus of both control and stressed rats. In male rats, metyrapone treatment significantly increased IL-1β mRNA regardless of stress treatment in all brain areas, while in female rats metyrapone only increased IL-1β in the hypothalamus. Interestingly, propranolol treatment blocked the metyrapone-induced increase in brain IL-1β indicating the increase in brain IL-1β following metyrapone treatment was due to increase β-AR activation. Additional studies revealed that metyrapone significantly increases norepinephrine turnover in the hypothalamus and medial prefrontal cortex in male rats and that microglia appear to be the cell type contributing to the production of IL-1β. Overall, data reveal that stress exposure in male rats affects the regulation of brain IL-1β by the norepinephrine-β-AR pathway, while stress had no effect in the regulation of brain IL-1β in female rats.","['Beta-adrenergic receptor', 'Catecholamines', 'Corticosterone', 'Cytokines', 'Glucocorticoids', 'Norepinephrine']",Psychoneuroendocrinology,2019-02-04,"[{'lastname': 'Barnard', 'firstname': 'David F', 'initials': 'DF', 'affiliation': 'Kent State University, Biological Sciences Department, Kent, Ohio 44240, United States.'}, {'lastname': 'Gabella', 'firstname': 'Kristin M', 'initials': 'KM', 'affiliation': 'Kent State University, Biological Sciences Department, Kent, Ohio 44240, United States.'}, {'lastname': 'Kulp', 'firstname': 'Adam C', 'initials': 'AC', 'affiliation': 'Kent State University, School of Biomedical Sciences, Kent, Ohio 44240, United States.'}, {'lastname': 'Parker', 'firstname': 'Austin D', 'initials': 'AD', 'affiliation': 'Kent State University, Biological Sciences Department, Kent, Ohio 44240, United States.'}, {'lastname': 'Dugan', 'firstname': 'Patrick B', 'initials': 'PB', 'affiliation': 'Kent State University, Biological Sciences Department, Kent, Ohio 44240, United States.'}, {'lastname': 'Johnson', 'firstname': 'John D', 'initials': 'JD', 'affiliation': 'Kent State University, Biological Sciences Department, Kent, Ohio 44240, United States; Kent State University, School of Biomedical Sciences, Kent, Ohio 44240, United States. Electronic address: jjohns72@kent.edu.'}]",,,,Copyright © 2019 Elsevier Ltd. All rights reserved.,10.1016/j.psyneuen.2019.01.026,<Element 'PubmedArticle' at 0x7f05df1e8cc0>
312,30636594,Advantages of Vasoactive Intestinal Peptide for the Future Treatment of Parkinson's Disease.,"Parkinson's disease is the second most common neurodegenerative disorder in adults over the age of 65. The characteristic symptoms of Parkinson's disease, such as resting tremor, muscular rigidity, bradykinesia, postural instability and gait imbalance, are thought to be a result of the progressive degeneration of the dopaminergic neurons of the substantia nigra compacta, resulting in insufficient dopamine integrated signalling on GABAergic medium spiny neurons in the striatum. Despite tremendous research, the molecular mechanisms underlying the pathogenesis of neurodegeneration in Parkinson's disease have remained largely unknown. Although a variety of possible pathogenic mechanisms have been proposed over the years, including excessive release of oxygen free radicals, impairment of mitochondrial function, loss of trophic support, abnormal kinase activity, disruption of calcium homeostasis, dysfunction of protein degradation and neuroinflammation, the pathogenesis is still largely uncertain, and there is currently no effective cure for Parkinson's disease. To develop potential therapies for Parkinson's disease, inflammatory processes, mitochondrial dynamics, oxidative stress, production of reactive aldehydes, excitotoxicity and synucleinopathies are to be targeted. In this respect, vasoactive intestinal peptide has beneficial effects that provide an advantage for the treatment of Parkinson's disease. Vasoactive intestinal peptide is a major neuropeptide-neurotransmitter having antioxidant, anti-inflammatory, neurotropic, neuromodulator, and anti-apoptotic properties. In addition to its direct neuroprotective actions regulating the activity of astrocytes, microglia and brain mast cells, it also plays important roles for neuronal adaptation, maintenance and survival.","['6-hydroxydopamine', 'Alpha-synuclein', ""Parkinson's disease"", 'inflammation', 'oxidative stress', 'vasoactive intestinal peptide (VIP).']",Current pharmaceutical design,2019-01-15,"[{'lastname': 'Korkmaz', 'firstname': 'Orhan Tansel', 'initials': 'OT', 'affiliation': 'Eskisehir Osmangazi University, Medical Faculty, Department of Physiology and Neurophysiology Eskisehir 26480, Turkey.'}, {'lastname': 'Tunçel', 'firstname': 'Neşe', 'initials': 'N', 'affiliation': 'Eskisehir Osmangazi University, Medical Faculty, Department of Physiology and Neurophysiology Eskisehir 26480, Turkey.'}]",,,,"Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.",10.2174/1381612825666190111150953,<Element 'PubmedArticle' at 0x7f05df14ecc0>
313,30578932,Conditional microglial depletion in rats leads to reversible anorexia and weight loss by disrupting gustatory circuitry.,"Microglia are highly sensitive to dietary influence, becoming activated acutely and long-term by high fat diet. However, their role in regulating satiety and feeding in healthy individuals remains unclear. Here we show that microglia are essential for the normal regulation of satiety and metabolism in rats. Short-term microglial depletion in a Cx3cr1-Dtr rat led to a dramatic weight loss that was largely accounted for by an acute reduction in food intake. This weight loss and anorexia were not likely due to a sickness response since the rats did not display peripheral or central inflammation, withdrawal, anxiety-like behavior, or nausea-associated pica. Hormonal and hypothalamic anatomical changes were largely compensatory to the suppressed food intake, which occurred in association with disruption of the gustatory circuitry at the paraventricular nucleus of the thalamus. Thus, microglia are important in supporting normal feeding behaviors and weight, and regulating preference for palatable food. Inhibiting this circuitry is able to over-ride strong compensatory drives to eat, providing a potential target for satiety control.","['Arcuate nucleus', 'Cx3cr1-Dtr rat', 'Energy expenditure', 'Ghrelin', 'Hypothalamus', 'Inflammation', 'Leptin', 'Microglia', 'Neuropeptide Y', 'Paraventricular thalamic nucleus', 'Satiety']","Brain, behavior, and immunity",2018-12-24,"[{'lastname': 'De Luca', 'firstname': 'Simone N', 'initials': 'SN', 'affiliation': 'School of Health and Biomedical Sciences, RMIT University, Melbourne, Vic. 3138, Australia.'}, {'lastname': 'Sominsky', 'firstname': 'Luba', 'initials': 'L', 'affiliation': 'School of Health and Biomedical Sciences, RMIT University, Melbourne, Vic. 3138, Australia.'}, {'lastname': 'Soch', 'firstname': 'Alita', 'initials': 'A', 'affiliation': 'School of Health and Biomedical Sciences, RMIT University, Melbourne, Vic. 3138, Australia.'}, {'lastname': 'Wang', 'firstname': 'Hao', 'initials': 'H', 'affiliation': 'School of Health and Biomedical Sciences, RMIT University, Melbourne, Vic. 3138, Australia.'}, {'lastname': 'Ziko', 'firstname': 'Ilvana', 'initials': 'I', 'affiliation': 'School of Health and Biomedical Sciences, RMIT University, Melbourne, Vic. 3138, Australia.'}, {'lastname': 'Rank', 'firstname': 'Michelle M', 'initials': 'MM', 'affiliation': 'School of Health and Biomedical Sciences, RMIT University, Melbourne, Vic. 3138, Australia.'}, {'lastname': 'Spencer', 'firstname': 'Sarah J', 'initials': 'SJ', 'affiliation': 'School of Health and Biomedical Sciences, RMIT University, Melbourne, Vic. 3138, Australia. Electronic address: Sarah.Spencer@rmit.edu.au.'}]",,,,Copyright © 2018 Elsevier Inc. All rights reserved.,10.1016/j.bbi.2018.12.008,<Element 'PubmedArticle' at 0x7f05df158680>
314,30553970,Melatonin receptor activation provides cerebral protection after traumatic brain injury by mitigating oxidative stress and inflammation via the Nrf2 signaling pathway.,"Traumatic brain injury (TBI) is a principal cause of death and disability worldwide. Melatonin, a hormone made by the pineal gland, is known to have anti-inflammatory and antioxidant properties. In this study, using a weight-drop model of TBI, we investigated the protective effects of ramelteon, a melatonin MT1/MT2 receptor agonist, and its underlying mechanisms of action. Administration of ramelteon (10 mg/kg) daily at 10:00 a.m. alleviated TBI-induced early brain damage on day 3 and long-term neurobehavioral deficits on day 28 in C57BL/6 mice. Ramelteon also increased the protein levels of interleukin (IL)-10, IL-4, superoxide dismutase (SOD), glutathione, and glutathione peroxidase and reduced the protein levels of IL-1β, tumor necrosis factor, and malondialdehyde in brain tissue and serum on days 1, 3, and 7 post-TBI. Similarly, ramelteon attenuated microglial and astrocyte activation in the perilesional cortex on day 3. Furthermore, ramelteon decreased Keap 1 expression, promoted nuclear factor erythroid 2-related factor 2 (Nrf2) nuclear accumulation, and increased levels of downstream proteins, including SOD-1, heme oxygenase-1, and NQO1 on day 3 post-TBI. However, in Nrf2 knockout mice with TBI, ramelteon did not decrease the lesion volume, neuronal degeneration, or myelin loss on day 3; nor did it mitigate depression-like behavior or most motor behavior deficits on day 28. Thus, timed ramelteon treatment appears to prevent inflammation and oxidative stress via the Nrf2-antioxidant response element pathway and might represent a potential chronotherapeutic strategy for treating TBI.","['Chronotherapy', 'Inflammation', 'NF-E2-related factor', 'Oxidative stress', 'Ramelteon', 'Traumatic brain injury']",Free radical biology & medicine,2018-12-17,"[{'lastname': 'Wang', 'firstname': 'Junmin', 'initials': 'J', 'affiliation': 'Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, China; Department of Anatomy, College of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan 450000, China; The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China; Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. Electronic address: wangjunmin@zzu.edu.cn.'}, {'lastname': 'Jiang', 'firstname': 'Chao', 'initials': 'C', 'affiliation': 'Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.'}, {'lastname': 'Zhang', 'firstname': 'Kun', 'initials': 'K', 'affiliation': 'School of Life Science, Zhengzhou University, Zhengzhou, Henan 450000, China.'}, {'lastname': 'Lan', 'firstname': 'Xi', 'initials': 'X', 'affiliation': 'Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.'}, {'lastname': 'Chen', 'firstname': 'Xuemei', 'initials': 'X', 'affiliation': 'Department of Anatomy, College of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan 450000, China.'}, {'lastname': 'Zang', 'firstname': 'Weidong', 'initials': 'W', 'affiliation': 'Department of Anatomy, College of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan 450000, China.'}, {'lastname': 'Wang', 'firstname': 'Zhongyu', 'initials': 'Z', 'affiliation': 'Department of Anesthesiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, China.'}, {'lastname': 'Guan', 'firstname': 'Fangxia', 'initials': 'F', 'affiliation': 'Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, China; The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China; School of Life Science, Zhengzhou University, Zhengzhou, Henan 450000, China.'}, {'lastname': 'Zhu', 'firstname': 'Changlian', 'initials': 'C', 'affiliation': 'The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China; Henan Key Laboratory of Child Brain Injury, Institute of Neuroscience, Zhengzhou University, Zhengzhou, Henan 450052, China; Center for Brain Repair and Rehabilitation, Institute of Neuroscience and Physiology, University of Gothenburg, Göteborg 40530, Sweden.'}, {'lastname': 'Yang', 'firstname': 'Xiuli', 'initials': 'X', 'affiliation': 'Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA.'}, {'lastname': 'Lu', 'firstname': 'Hong', 'initials': 'H', 'affiliation': 'Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, China. Electronic address: zzu_luhong@163.com.'}, {'lastname': 'Wang', 'firstname': 'Jian', 'initials': 'J', 'affiliation': 'Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. Electronic address: jwang79@jhmi.edu.'}]",,,,Copyright © 2018 Elsevier Inc. All rights reserved.,10.1016/j.freeradbiomed.2018.12.014,<Element 'PubmedArticle' at 0x7f05df164a40>
315,30527678,Progesterone effects on oligodendrocyte differentiation in injured spinal cord.,"Spinal cord lesions result in chronic demyelination as a consequence of secondary injury. Although oligodendrocyte precursor cells proliferate the differentiation program fails. Successful differentiation implies progressive decrease of transcriptional inhibitors followed by upregulation of activators. Progesterone emerges as an anti-inflammatory and pro-myelinating agent which improves locomotor outcome after spinal cord injury. In this study, we have demonstrated that spinal cord injury enhanced oligodendrocyte precursor cell number and decreased mRNA expression of transcriptional inhibitors (Id2, Id4, hes5). However, mRNA expression of transcriptional activators (Olig2, Nkx2.2, Sox10 and Mash1) was down-regulated 3 days post injury. Interestingly, a differentiation factor such as progesterone increased transcriptional activator mRNA levels and the density of Olig2- expressing oligodendrocyte precursor cells. The differentiation program is regulated by extracellular signals which modify transcriptional factors and epigenetic players. As TGFβ1 is a known oligodendrocyte differentiation factor which is regulated by progesterone in reproductive tissues, we assessed whether TGFβ1 could mediate progesterone remyelinating actions after the lesion. Notwithstanding that astrocyte, oligodendrocyte precursor and microglial cell density increased after spinal cord injury, the number of these cells which expressed TGFβ1 remained unchanged regarding sham operated rats. However, progesterone treatment increased TGFβ1 mRNA expression and the number of astrocytes and microglial TGFβ1 expressing cells which would indirectly enhance oligodendrocyte differentiation. Therefore, TGFβ1 arises as a potential mediator of progesterone differentiating effects on oligodendrocyte linage.","['Microglial cells', 'Oligodendrocytes precursor cells', 'Progesterone', 'Remyelination', 'Spinal cord injury', 'TGFβ1']",Brain research,2018-12-12,"[{'lastname': 'Jure', 'firstname': 'Ignacio', 'initials': 'I', 'affiliation': 'Laboratory of Neuroendocrine Biochemistry, Instituto de Biologia y Medicina Experimental, Vuelta de Obligado 2490, 1428 Buenos Aires, Argentina.'}, {'lastname': 'De Nicola', 'firstname': 'Alejandro F', 'initials': 'AF', 'affiliation': 'Laboratory of Neuroendocrine Biochemistry, Instituto de Biologia y Medicina Experimental, Vuelta de Obligado 2490, 1428 Buenos Aires, Argentina; Dept. of Human Biochemistry, Faculty of Medicine, University of Buenos Aires, Paraguay 2155 C1121, Buenos Aires, Argentina.'}, {'lastname': 'Labombarda', 'firstname': 'Florencia', 'initials': 'F', 'affiliation': 'Laboratory of Neuroendocrine Biochemistry, Instituto de Biologia y Medicina Experimental, Vuelta de Obligado 2490, 1428 Buenos Aires, Argentina; Dept. of Human Biochemistry, Faculty of Medicine, University of Buenos Aires, Paraguay 2155 C1121, Buenos Aires, Argentina. Electronic address: florlabombarda@gmail.com.'}]",,,,Copyright © 2018 Elsevier B.V. All rights reserved.,10.1016/j.brainres.2018.12.005,<Element 'PubmedArticle' at 0x7f05df0bcc20>
316,30468814,Cuprizone-induced demyelination in the mouse hippocampus is alleviated by phytoestrogen genistein.,"One of the major female sex hormones, estrogen, can influence a variety of mental states. Individuals with multiple sclerosis (MS) often suffer from mental health issues, which are correlated with the pathology of gray matter. In this study, we aimed to elucidate the validity of phytoestrogen genistein (GEN) for treating the gray matter lesions in MS using the mouse model of cuprizone (CPZ)-induced demyelination. First, we confirmed that 5-week 0.2% CPZ intoxication induced demyelination in the hippocampus, and that myelination was successfully recovered by GEN. Loss of mature oligodendrocytes following CPZ intoxication was counteracted by GEN. Neither CPZ nor GEN affected the densities of oligodendrocyte precursor cells and astrocytes. CPZ-induced activation and proliferation of microglia were not inhibited by GEN. Upregulation of gene expression of the pro-inflammatory cytokine, interleukin-1β, in sorted microglia by CPZ was not inhibited by GEN either. However, the expression levels of genes related to phagocytosis, such as cluster of differentiation 68 and lysosomal-associated membrane protein 1, in sorted microglia were elevated by CPZ but lowered by GEN. Notably, physical contact of microglia with myelin was increased by CPZ but decreased by GEN. The expression levels of myelin-related genes, such as myelin basic protein and myelin oligodendrocyte glycoprotein, in the whole hippocampal tissue were decreased by CPZ but recovered by GEN. These results show that GEN may act on mature oligodendrocytes in the hippocampus by promoting their survival and myelin formation, and suggest the therapeutic potential of phytoestrogens for treating MS patients suffering from mental health issues.","['Cuprizone', 'Demyelination', 'Genistein', 'Hippocampus', 'Oligodendrocyte']",Toxicology and applied pharmacology,2018-11-24,"[{'lastname': 'Ohgomori', 'firstname': 'Tomohiro', 'initials': 'T', 'affiliation': 'Department of Anatomy and Neuroscience, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.'}, {'lastname': 'Jinno', 'firstname': 'Shozo', 'initials': 'S', 'affiliation': 'Department of Anatomy and Neuroscience, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan. Electronic address: sjnno@med.kyushu-u.ac.jp.'}]",,,,Copyright © 2018 Elsevier Inc. All rights reserved.,10.1016/j.taap.2018.11.009,<Element 'PubmedArticle' at 0x7f05df0ca680>
317,30461068,Region-specific control of microglia by adenosine A,"Epidemiologic studies have provided compelling evidence that prenatal stress, through excessive maternal glucocorticoids exposure, is associated with psychiatric disorders later in life. We have recently reported that anxiety associated with prenatal exposure to dexamethasone (DEX, a synthetic glucocorticoid) correlates with a gender-specific remodeling of microglia in the medial prefrontal cortex (mPFC), a core brain region in anxiety-related disorders. Gender differences in microglia morphology, the higher prevalence of anxiety in women and the negative impact of anxiety in cognition, led us to specifically evaluate cognitive behavior and associated circuits (namely mPFC-dorsal hippocampus, dHIP), as well as microglia morphology in female rats prenatally exposed to dexamethasone (in utero DEX, iuDEX). We report that iuDEX impaired recognition memory and deteriorated neuronal synchronization between mPFC and dHIP. These functional deficits are paralleled by microglia hyper-ramification in the dHIP and decreased ramification in the mPFC, showing a heterogeneous remodeling of microglia morphology, both postnatally and at adulthood in different brain regions, that differently affect mood and cognition. The chronic blockade of adenosine A","['A2A receptors', 'anxiety', 'cognition', 'gender dimorphism', 'microglia morphology']",Glia,2018-11-22,"[{'lastname': 'Duarte', 'firstname': 'Joana Mendes', 'initials': 'JM', 'affiliation': 'Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Portugal.\nCenter for Innovation in Biomedicine and Biotechnology (CIBB), University of Coimbra, Portugal.'}, {'lastname': 'Gaspar', 'firstname': 'Rita', 'initials': 'R', 'affiliation': 'Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Portugal.\nCenter for Innovation in Biomedicine and Biotechnology (CIBB), University of Coimbra, Portugal.'}, {'lastname': 'Caetano', 'firstname': 'Liliana', 'initials': 'L', 'affiliation': 'Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Portugal.\nCenter for Innovation in Biomedicine and Biotechnology (CIBB), University of Coimbra, Portugal.\nCNC - Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.'}, {'lastname': 'Patrício', 'firstname': 'Patrícia', 'initials': 'P', 'affiliation': ""Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.\nICVS/3B's -PT Government Associate Laboratory, Braga/Guimarães, Portugal.""}, {'lastname': 'Soares-Cunha', 'firstname': 'Carina', 'initials': 'C', 'affiliation': ""Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.\nICVS/3B's -PT Government Associate Laboratory, Braga/Guimarães, Portugal.""}, {'lastname': 'Mateus-Pinheiro', 'firstname': 'António', 'initials': 'A', 'affiliation': ""Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.\nICVS/3B's -PT Government Associate Laboratory, Braga/Guimarães, Portugal.""}, {'lastname': 'Alves', 'firstname': 'Nuno Dinis', 'initials': 'ND', 'affiliation': ""Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.\nICVS/3B's -PT Government Associate Laboratory, Braga/Guimarães, Portugal.""}, {'lastname': 'Santos', 'firstname': 'Ana Rita', 'initials': 'AR', 'affiliation': ""Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.\nICVS/3B's -PT Government Associate Laboratory, Braga/Guimarães, Portugal.""}, {'lastname': 'Ferreira', 'firstname': 'Samira G', 'initials': 'SG', 'affiliation': 'CNC - Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.'}, {'lastname': 'Sardinha', 'firstname': 'Vanessa', 'initials': 'V', 'affiliation': ""Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.\nICVS/3B's -PT Government Associate Laboratory, Braga/Guimarães, Portugal.""}, {'lastname': 'Oliveira', 'firstname': 'João Filipe', 'initials': 'JF', 'affiliation': ""Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.\nICVS/3B's -PT Government Associate Laboratory, Braga/Guimarães, Portugal.""}, {'lastname': 'Fontes-Ribeiro', 'firstname': 'Carlos', 'initials': 'C', 'affiliation': 'Institute of Pharmacology and Experimental Therapeutics, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.'}, {'lastname': 'Sousa', 'firstname': 'Nuno', 'initials': 'N', 'affiliation': ""Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.\nICVS/3B's -PT Government Associate Laboratory, Braga/Guimarães, Portugal.""}, {'lastname': 'Cunha', 'firstname': 'Rodrigo A', 'initials': 'RA', 'affiliation': 'Center for Innovation in Biomedicine and Biotechnology (CIBB), University of Coimbra, Portugal.\nCNC - Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.'}, {'lastname': 'Ambrósio', 'firstname': 'António F', 'initials': 'AF', 'affiliation': 'Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Portugal.\nCenter for Innovation in Biomedicine and Biotechnology (CIBB), University of Coimbra, Portugal.'}, {'lastname': 'Pinto', 'firstname': 'Luísa', 'initials': 'L', 'affiliation': ""Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.\nICVS/3B's -PT Government Associate Laboratory, Braga/Guimarães, Portugal.""}, {'lastname': 'Rodrigues', 'firstname': 'Ana João', 'initials': 'AJ', 'affiliation': ""Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.\nICVS/3B's -PT Government Associate Laboratory, Braga/Guimarães, Portugal.""}, {'lastname': 'Gomes', 'firstname': 'Catarina A', 'initials': 'CA', 'affiliation': 'Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Portugal.\nCenter for Innovation in Biomedicine and Biotechnology (CIBB), University of Coimbra, Portugal.\nInstitute of Pharmacology and Experimental Therapeutics, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.'}]",,,,"© 2018 Wiley Periodicals, Inc.",10.1002/glia.23476,<Element 'PubmedArticle' at 0x7f05df0d81d0>
318,"30422705
8978681
19752219
942051
8377226
7929392
11441186
29180222
25568892
25617315
28881033
20074531
29674342
26394692
11145990
9793760
12634421
27999108
15758166
26538149
26774027
10207053
27518562
6375662
29847142
27531392
24849570
26865611
16103124
12475085
11050115
20197648
1776759
12714508
19333550
17241124
28325794
27807285
11544248
24931034
20176720
28710249
28429777
29132916
29254096
20451588
19672057
18483477
7542371
15777180
25938784
28025127
24847884
27511018
29354221
18633112
17079810
8001115
22355794
24975292
26743972
22122230
18393365
7844473
27190008
30149448
22664838
29097597
11916953
10338291
28262782
22276186
26973101
18945929
27739227
24652830
27025652
3140239
17051221
15750215
22476197
23627794
23236292
22884903
1946448
29169962
27276998
18813847
18160654
18573216
25186741
7758106",Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues.,"The amyloid precursor protein (APP) is a type I transmembrane glycoprotein widely studied for its role as the source of β-amyloid peptide, accumulation of which is causal in at least some cases of Alzheimer's disease (AD). APP is expressed ubiquitously and is involved in diverse biological processes. Growing bodies of evidence indicate connections between AD and somatic metabolic disorders related to type 2 diabetes, and App","['Alzheimer’s disease', 'amyloid precursor protein', 'insulin', 'insulin-degrading enzyme', 'microglia']",American journal of physiology. Endocrinology and metabolism,2018-11-14,"[{'lastname': 'Kulas', 'firstname': 'Joshua A', 'initials': 'JA', 'affiliation': 'Department of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences , Grand Forks, North Dakota.'}, {'lastname': 'Franklin', 'firstname': 'Whitney F', 'initials': 'WF', 'affiliation': 'Department of Neuroscience and Cell Biology, University of Texas Medical Branch , Galveston, Texas.'}, {'lastname': 'Smith', 'firstname': 'Nicholas A', 'initials': 'NA', 'affiliation': 'Department of Pathology, University of North Dakota School of Medicine and Health Sciences , Grand Forks, North Dakota.'}, {'lastname': 'Manocha', 'firstname': 'Gunjan D', 'initials': 'GD', 'affiliation': 'Department of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences , Grand Forks, North Dakota.'}, {'lastname': 'Puig', 'firstname': 'Kendra L', 'initials': 'KL', 'affiliation': 'Department of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences , Grand Forks, North Dakota.'}, {'lastname': 'Nagamoto-Combs', 'firstname': 'Kumi', 'initials': 'K', 'affiliation': 'Department of Pathology, University of North Dakota School of Medicine and Health Sciences , Grand Forks, North Dakota.'}, {'lastname': 'Hendrix', 'firstname': 'Rachel D', 'initials': 'RD', 'affiliation': 'Department of Neurobiology and Developmental Sciences, University of Arkansas for Medical Sciences , Little Rock Arkansas.'}, {'lastname': 'Taglialatela', 'firstname': 'Giulio', 'initials': 'G', 'affiliation': 'Department of Neurology, University of Texas Medical Branch , Galveston, Texas.'}, {'lastname': 'Barger', 'firstname': 'Steven W', 'initials': 'SW', 'affiliation': 'Department of Geriatrics, University of Arkansas for Medical Sciences , Little Rock Arkansas.\nGeriatric Research, Education and Clinical Center, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas.'}, {'lastname': 'Combs', 'firstname': 'Colin K', 'initials': 'CK', 'affiliation': 'Department of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences , Grand Forks, North Dakota.'}]",,,,,"10.1152/ajpendo.00279.2018
10.1002/j.1460-2075.1996.tb01045.x
10.1210/er.2008-0047
10.1016/0003-2697(76)90527-3
10.1002/jnr.490350513
10.1126/science.1058783
10.1016/j.neuropharm.2017.11.037
10.15252/emmm.201404183
10.1111/jnc.14211
10.1016/j.cmet.2009.11.003
10.1530/JOE-18-0051
10.1038/ncomms9250
10.1046/j.1471-4159.2001.00012.x
10.1210/edrv.19.5.0349
10.1073/pnas.0230450100
10.2337/db16-0861
10.1523/JNEUROSCI.4998-04.2005
10.1007/s00401-015-1498-9
10.1016/j.jneumeth.2016.01.006
10.1128/MCB.19.5.3278
10.1016/j.cell.2016.07.028
10.1016/S0006-291X(84)80190-4
10.1152/ajpcell.00240.2017
10.1002/jnr.23823
10.1007/s00125-014-3269-x
10.1523/JNEUROSCI.3131-15.2016
10.1074/jbc.M502861200
10.1017/S104161020200844X
10.1523/JNEUROSCI.20-21-07951.2000
10.1159/000267865
10.1111/j.1749-6632.1991.tb00190.x
10.1182/blood-2002-12-3775
10.1007/s00018-009-0020-8
10.1111/j.1471-4159.2006.04330.x
10.2337/dci17-0005
10.1126/scitranslmed.aad9704
10.1074/jbc.C100447200
10.2337/db14-0568
10.1210/en.2009-1196
10.1530/JOE-17-0122
10.1038/srep46750
10.1016/j.tips.2017.10.008
10.3233/JAD-170720
10.1016/j.neuroscience.2010.04.078
10.1159/000235555
10.1038/oby.2008.267
10.1016/0306-4522(94)00555-J
10.2174/1386207053258488
10.1172/JCI79742
10.1016/j.exger.2016.12.019
10.1038/nature13297
10.1523/JNEUROSCI.4654-15.2016
10.1590/1980-57642016dn11-040010
10.2337/db06-0454
10.1016/0092-8674(94)90066-3
10.1101/cshperspect.a006288
10.1016/j.jneumeth.2014.05.021
10.1016/j.jneumeth.2015.12.008
10.1111/j.1471-4159.2011.07510.x
10.1002/path.2343
10.1093/brain/aww108
10.3233/JAD-180303
10.3791/3965
10.1523/JNEUROSCI.1346-17.2017
10.2337/diabetes.51.4.1256
10.1016/S0306-4522(98)00645-9
10.1038/srep43725
10.1371/journal.pone.0030378
10.1016/j.neurobiolaging.2015.12.021
10.2337/dc08-0272
10.1111/joim.12534
10.2967/jnumed.113.132647
10.15252/emmm.201606210
10.1073/pnas.85.19.7341
10.1038/nature05143
10.3233/JAD-2005-7107
10.1172/JCI59903
10.1186/1471-2164-14-290
10.1371/journal.pgen.1003107
10.1016/j.mcn.2012.07.009
10.1073/pnas.88.22.10302
10.1016/j.neuropharm.2017.11.027
10.1038/srep27524
10.3892/ijmm_00000038
10.1523/JNEUROSCI.4701-07.2007
10.1186/1749-8104-3-15
10.1523/JNEUROSCI.1860-14.2014
10.1016/0092-8674(95)90073-X",<Element 'PubmedArticle' at 0x7f05df0ea180>
319,"30381434
15950011
10340766
18639237
27870416
20548297
22508464
28974457
21335052
29106989
27048157
10818167
28159647
26441134
29194444
12614634
9137116
19406860
26830960
13808144
16299106
24403138
26306826
10571474
12482677
15251266
25459519
16123744
11925301
23624153
28697889
29524458
16647243
12948660
26056286
19401219
28690203
8941956
11208914
23899426
21679261
9784981
21878486
22710611
19162030
26674863
19111570
28939116
20357756
27272767
18001698
25592533
15509759
22581688
22865617
28656627
25583178
24105875
24342992
28825715
16887188
9165494
22741603
24549104
27899281
10609966
24936173
26105142
27241140
19653136
26743859
11063981
25529195
28596115
26904302
8149733
24485483
24134918
26876136
29428548
16396985
20102318
21778362
16095592
20410711
19302036
15456824
12566570
15537886
14973247
25930681
24995975
11336780
14618550
22182318
29548746
25629589
20139149
28421533
27365172
28190426
18286612
22048462
23764204
24958230
25746514
10799757
24858659
23512378
28013234
22649234
26121746
24623766
18922773
23835908
29581545
26331879
28606631
28697890
23452664",Sex Differences in Risk and Resilience: Stress Effects on the Neural Substrates of Emotion and Motivation.,"Risk for stress-sensitive psychopathologies differs in men and women, yet little is known about sex-dependent effects of stress on cellular structure and function in corticolimbic regions implicated in these disorders. Determining how stress influences these regions in males and females will deepen our understanding of the mechanisms underlying sex-biased psychopathology. Here, we discuss sex differences in CRF regulation of arousal and cognition, glucocorticoid modulation of amygdalar physiology and alcohol consumption, the age-dependent impact of social stress on prefrontal pyramidal cell excitability, stress effects on the prefrontal parvalbumin system in relation to emotional behaviors, contributions of stress and gonadal hormones to stress effects on prefrontal glia, and alterations in corticolimbic structure and function after cessation of chronic stress. These studies demonstrate that, while sex differences in stress effects may be nuanced, nonuniform, and nonlinear, investigations of these differences are nonetheless critical for developing effective, sex-specific treatments for psychological disorders.","['corticolimbic regions', 'corticosterone', 'corticotropin releasing factor', 'microglia', 'parvalbumin']",The Journal of neuroscience : the official journal of the Society for Neuroscience,2018-11-02,"[{'lastname': 'Wellman', 'firstname': 'Cara L', 'initials': 'CL', 'affiliation': 'Department of Psychological and Brain Sciences, Program in Neuroscience, and Center for the Integrative Study of Animal Behavior, Indiana University, Bloomington, Indiana 47405, wellmanc@indiana.edu.'}, {'lastname': 'Bangasser', 'firstname': 'Debra A', 'initials': 'DA', 'affiliation': 'Psychology Department and Neuroscience Program, Temple University, Philadelphia, Pennsylvania 19122.'}, {'lastname': 'Bollinger', 'firstname': 'Justin L', 'initials': 'JL', 'affiliation': 'Department of Pharmacology and Systems Physiology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45237.'}, {'lastname': 'Coutellier', 'firstname': 'Laurence', 'initials': 'L', 'affiliation': 'Departments of Psychology and Neuroscience, Ohio State University, Columbus, Ohio 43210.'}, {'lastname': 'Logrip', 'firstname': 'Marian L', 'initials': 'ML', 'affiliation': 'Department of Psychology, Indiana University-Purdue University Indianapolis, Indianapolis, Indiana 46202, and.'}, {'lastname': 'Moench', 'firstname': 'Kelly M', 'initials': 'KM', 'affiliation': 'Department of Psychological and Brain Sciences, Program in Neuroscience, and Center for the Integrative Study of Animal Behavior, Indiana University, Bloomington, Indiana 47405.'}, {'lastname': 'Urban', 'firstname': 'Kimberly R', 'initials': 'KR', 'affiliation': ""Children's Hospital of Philadelphia, Abramson Research Center, Philadelphia, Pennsylvania 19104.""}]",,,,Copyright © 2018 the authors 0270-6474/18/389423-10$15.00/0.,"10.1523/JNEUROSCI.1673-18.2018
10.1016/j.biopsych.2004.08.019
10.1002/(SICI)1098-1136(199905)26:3<260::AID-GLIA7>3.0.CO;2-R
10.1016/j.biopsych.2008.06.008
10.1016/j.biopsych.2017.02.167
10.1002/jnr.23812
10.1038/mp.2010.66
10.1038/mp.2012.24
10.1038/npp.2016.241
10.1016/j.physbeh.2017.09.025
10.1016/j.pneurobio.2011.01.001
10.1016/j.physbeh.2017.10.025
10.1016/j.physbeh.2017.10.025
10.1007/s00213-016-4278-x
10.1523/JNEUROSCI.20-11-04320.2000
10.1016/j.neuropharm.2017.01.037
10.1016/j.bbi.2015.10.003
10.1371/journal.pone.0187631
10.1016/S0018-506X(02)00022-3
10.1176/ajp.154.5.624
10.1177/1524838009334448
10.1038/npp.2016.15
10.1093/alcalc/agh242
10.1523/JNEUROSCI.2400-13.2014
10.1016/j.bbr.2015.08.023
10.1037/0735-7044.113.5.902
10.1016/S1074-7427(02)00018-7
10.1016/j.pbb.2004.04.025
10.1016/j.alcohol.2014.07.015
10.1038/sj.npp.1300875
10.1176/appi.ajp.159.4.620
10.1016/j.physbeh.2013.04.002
10.1016/j.biopsych.2017.05.024
10.1016/j.bbi.2018.03.005
10.1016/j.bbi.2006.03.005
10.1016/S0166-2236(03)00227-3
10.1073/pnas.1414728112
10.1016/j.neuroscience.2009.04.057
10.1016/j.pnpbp.2017.07.004
10.1098/rstb.1996.0129
10.1046/j.1471-4159.2001.00067.x
10.1016/j.addbeh.2013.06.016
10.1111/j.1521-0391.2011.00141.x
10.1002/(SICI)1520-6394(1998)8:2<71::AID-DA5>3.0.CO;2-N
10.1093/cercor/bhr229
10.1093/cercor/bhs151
10.1016/j.yhbeh.2008.12.004
10.1523/jneurosci.1392-15.2015
10.1016/j.neubiorev.2008.11.005
10.1016/j.biopsych.2017.08.005
10.1038/npp.2010.31
10.1038/npp.2016.85
10.1016/j.brainres.2007.07.100
10.1038/nature14188
10.1523/JNEUROSCI.2830-04.2004
10.1002/cne.23061
10.1002/mpr.1359
10.1111/adb.12525
10.1016/j.ejphar.2014.11.044
10.1002/syn.21716
10.1038/mp.2013.155
10.1038/nm.4386
10.1016/j.neubiorev.2006.06.001
10.1016/S0893-133X(96)00277-1
10.1111/j.1369-1600.2012.00460.x
10.1038/npp.2014.20
10.1016/j.neuropharm.2016.11.021
10.1037/1064-1297.7.4.318
10.3389/fncel.2014.00157
10.1038/npp.2015.180
10.1016/j.biopsych.2016.03.2101
10.1007/s12035-009-8079-7
10.1016/j.neubiorev.2015.10.013
10.1016/S0006-3223(00)00999-9
10.1016/j.neulet.2014.12.035
10.1016/j.neuroscience.2017.05.049
10.1155/2016/7539065
10.1016/0010-440X(94)90173-2
10.1016/j.psyneuen.2013.11.009
10.1186/1744-9081-9-39
10.1016/j.bbr.2016.02.013
10.1016/j.yfrne.2018.02.005
10.1210/en.2005-1041
10.3109/10253890802641966
10.1126/science.1202529
10.1016/j.expneurol.2005.07.008
10.1523/JNEUROSCI.2451-04.2004
10.1073/pnas.0437926100
10.1523/JNEUROSCI.3004-04.2004
10.1523/JNEUROSCI.5077-03.2004
10.1016/j.pneurobio.2015.04.003
10.1016/j.cell.2014.06.008
10.1016/S0165-0173(01)00044-3
10.1002/gps.1001
10.1111/j.1471-4159.2011.07630.x
10.1016/j.biopsych.2018.01.017
10.1001/jamapsychiatry.2014.2427
10.1093/cercor/bhq003
10.1007/s12035-017-0528-0
10.1016/j.neuroscience.2016.06.038
10.1016/j.biopsych.2016.12.002
10.1002/glia.20644
10.1038/npp.2011.268
10.1016/j.conb.2013.05.001
10.1007/s00213-014-3654-7
10.1016/j.bbr.2015.02.047
10.1016/S0306-4522(00)00050-6
10.1016/j.bbi.2014.05.007
10.1007/s00401-013-1102-0
10.1093/cercor/bhw388
10.1523/JNEUROSCI.0069-12.2012
10.1172/JCI79828
10.1016/S0920-9964(14)70098-2
10.1523/JNEUROSCI.1787-13.2014
10.1073/pnas.0804318105
10.1038/mp.2013.83
10.1038/s41467-018-03566-5
10.1111/acer.12815
10.1016/j.bbr.2017.06.004
10.1016/j.biopsych.2017.05.026
10.1016/j.biopsych.2013.01.026",<Element 'PubmedArticle' at 0x7f05df0ad950>
320,"30347410
26367423
19103603
9509985
3015512
328826
12111544
26950199
6735903
9196290
1723788
7929046
6438698
25700174
29539641
29545511
27284195
28166221
3967288
3165685
15245646
23076630
21797868
11432976
6308680
17164235
19482058
24553185
15247319
1403607
7785412
3897467
29608178
23984387
27861587
22768337
22654792
1667618
7732831
8267626
8263512
25240838
26666460
26216303
20801095
8513480
18291592
14725626
2171722
27019076
16168566
25057127
16687312
18083091
22715882
22072657
8394187
25867923
28902842
24056876
12112377",Single-cell RNA sequencing of the mammalian pineal gland identifies two pinealocyte subtypes and cell type-specific daily patterns of gene expression.,"The vertebrate pineal gland is dedicated to the production of the hormone melatonin, which increases at night to influence circadian and seasonal rhythms. This increase is associated with dramatic changes in the pineal transcriptome. Here, single-cell analysis of the rat pineal transcriptome was approached by sequencing mRNA from ~17,000 individual pineal cells, with the goals of profiling the cells that comprise the pineal gland and examining the proposal that there are two distinct populations of pinealocytes differentiated by the expression of Asmt, which encodes the enzyme that converts N-acetylserotonin to melatonin. In addition, this analysis provides evidence of cell-specific time-of-day dependent changes in gene expression. Nine transcriptomically distinct cell types were identified: ~90% were classified as melatonin-producing α- and β-pinealocytes (1:19 ratio). Non-pinealocytes included three astrocyte subtypes, two microglia subtypes, vascular and leptomeningeal cells, and endothelial cells. α-Pinealocytes were distinguished from β-pinealocytes by ~3-fold higher levels of Asmt transcripts. In addition, α-pinealocytes have transcriptomic differences that likely enhance melatonin formation by increasing the availability of the Asmt cofactor S-adenosylmethionine, resulting from increased production of a precursor of S-adenosylmethionine, ATP. These transcriptomic differences include ~2-fold higher levels of the ATP-generating oxidative phosphorylation transcriptome and ~8-fold lower levels of the ribosome transcriptome, which is expected to reduce the consumption of ATP by protein synthesis. These findings suggest that α-pinealocytes have a specialized role in the pineal gland: efficiently O-methylating the N-acetylserotonin produced and released by β-pinealocytes, thereby improving the overall efficiency of melatonin synthesis. We have also identified transcriptomic changes that occur between night and day in seven cell types, the majority of which occur in β-pinealocytes and to a lesser degree in α-pinealocytes; many of these changes were mimicked by adrenergic stimulation with isoproterenol. The cellular heterogeneity of the pineal gland as revealed by this study provides a new framework for understanding pineal cell biology at single-cell resolution.",[],PloS one,2018-10-23,"[{'lastname': 'Mays', 'firstname': 'Joseph C', 'initials': 'JC', 'affiliation': 'Section on Developmental Neuroscience, Laboratory of Cochlear Development, Division of Intramural Research, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland, United States of America.'}, {'lastname': 'Kelly', 'firstname': 'Michael C', 'initials': 'MC', 'affiliation': 'Section on Developmental Neuroscience, Laboratory of Cochlear Development, Division of Intramural Research, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland, United States of America.'}, {'lastname': 'Coon', 'firstname': 'Steven L', 'initials': 'SL', 'affiliation': 'Molecular Genomics Core Facility, Office of the Scientific Director, Intramural Research Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States of America.'}, {'lastname': 'Holtzclaw', 'firstname': 'Lynne', 'initials': 'L', 'affiliation': 'Microscopy and Imaging Core, Office of the Scientific Director, Intramural Research Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States of America.'}, {'lastname': 'Rath', 'firstname': 'Martin F', 'initials': 'MF', 'affiliation': 'Department of Neuroscience, Panum Institute, University of Copenhagen, Copenhagen, Denmark.'}, {'lastname': 'Kelley', 'firstname': 'Matthew W', 'initials': 'MW', 'affiliation': 'Section on Developmental Neuroscience, Laboratory of Cochlear Development, Division of Intramural Research, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland, United States of America.'}, {'lastname': 'Klein', 'firstname': 'David C', 'initials': 'DC', 'affiliation': 'Office of the Scientific Director, Intramural Research Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States of America.'}]",,,,,"10.1371/journal.pone.0205883
10.1371/journal.pone.0137548
10.1074/jbc.M808394200
10.1530/ror.0.0030013
10.1007/s00441-002-0580-5
10.1210/en.2015-1888
10.1159/000125965
10.1126/science.aaa1934
10.1038/nature25980
10.1126/science.aam8999
10.1126/science.aaf6463
10.1038/nn.4495
10.1177/0748730404267340
10.1007/s11064-012-0906-y
10.1111/j.1471-4159.2011.07405.x
10.1074/jbc.R600036200
10.1016/j.mce.2009.05.013
10.1152/ajpcell.00354.2013
10.1124/mol.104.002345
10.1038/nbt.4103
10.1155/2013/618432
10.1371/journal.pone.0167063
10.1371/journal.pone.0040142
10.3389/fendo.2011.00010
10.1016/j.bbalip.2014.09.007
10.1111/apha.12642
10.1016/j.gene.2015.07.073
10.1016/j.abb.2010.08.016
10.1016/j.neuroscience.2007.12.029
10.1111/jpi.12328
10.1016/j.bbcan.2005.08.004
10.1161/CIRCRESAHA.115.304718
10.1080/07420520500521855
10.1016/j.cell.2007.11.031
10.1146/annurev-neuro-061010-113810
10.1523/JNEUROSCI.4158-11.2011
10.1038/nbt.3192
10.1038/nature24029
10.1038/nmeth.2645
10.1002/glia.10085",<Element 'PubmedArticle' at 0x7f05defbfa40>
321,30307084,Cannabidiol affects circadian clock core complex and its regulation in microglia cells.,"Cannabis is often used by consumers for sleep disorders. Studies show that circadian rhythm could be affected by a misuse of cannabis. Recent research has connected the role of microglial cells with psychiatric disorders such as substance abuse. The aim was to show the effect of two major components of cannabis on circadian genes regulation in microglial cells. In BV-2 microglial cells, cannabidiol (CBD) induces a deregulation of circadian genes with (P-value = 0.039) or without (P-value = 0.0015) lipopolisaccharides stimulation. CBD up regulated Arntl (P = 9.72E-5) and down regulated Clock (P = 0.0034) in BV-2 cells. Temporal expression of Arntl (light and dark P = 0.0054) and Clock (light and dark P = 0.047) was confirmed to have 24 hours light and dark rhythmic regulation in dissected suprachiasmatic nucleus as well as of Cb1 cannabinoid receptor (light and dark P = 0.019). In BV-2 microglia cells, CBD also up regulated CRY2 (P = 0.0473) and PER1 (P = 0.0131). Other nuclear molecules show a deregulation of circadian rhythm in microglial cells by CBD, such as RORA, RevErbα, RORB, CREBBP, AFT4, AFT5 and NFIL3. Our study suggests that circadian rhythm in microglial cells is deregulated by CBD but not by THC. It is consistent with clinical observations of the use of therapeutic cannabis to treat insomnia.","['THC', 'cannabidiol', 'circadian genes', 'microglial cells']",Addiction biology,2018-10-12,"[{'lastname': 'Lafaye', 'firstname': 'Geneviève', 'initials': 'G', 'affiliation': 'Dpt Addictologie, AP-HP, GH Paris-Sud, Hôpital Paul Brousse, Villejuif, France.\nINSERM U1178, Villejuif, France.'}, {'lastname': 'Desterke', 'firstname': 'Christophe', 'initials': 'C', 'affiliation': 'UFR Medecine, INSERM UMS 33, University Paris Saclay, Villejuif, France.'}, {'lastname': 'Marulaz', 'firstname': 'Laurent', 'initials': 'L', 'affiliation': 'Dpt Addictologie, AP-HP, GH Paris-Sud, Hôpital Paul Brousse, Villejuif, France.\nINSERM U1178, Villejuif, France.'}, {'lastname': 'Benyamina', 'firstname': 'Amine', 'initials': 'A', 'affiliation': 'Dpt Addictologie, AP-HP, GH Paris-Sud, Hôpital Paul Brousse, Villejuif, France.\nINSERM U1178, Villejuif, France.'}]",,,,© 2018 Society for the Study of Addiction.,10.1111/adb.12660,<Element 'PubmedArticle' at 0x7f05defeb310>
322,30267656,Photo-regulation of rod precursor cell proliferation.,"Teleosts are unique in their ability to undergo persistent neurogenesis and to regenerate damaged and lost retinal neurons in adults. This contrasts with the human retina, which is incapable of replacing lost retinal neurons causing vision loss/blindness in the affected individuals. Two cell populations within the adult teleost retina generate new retinal neurons throughout life. Stem cells within the ciliary marginal zone give rise to all retinal cell types except for rod photoreceptors, which are produced by the resident Müller glia that are located within the inner nuclear layer of the entire retina. Understanding the mechanisms that regulate the generation of photoreceptors in the adult teleost retina may ultimately aid developing strategies to overcome vision loss in diseases such as retinitis pigmentosa. Here, we investigated whether photic deprivation alters the proliferative capacity of rod precursor cells, which are generated from Müller glia. In dark-adapted retinas, rod precursor cell proliferation increased, while the number of proliferating Müller glia and their derived olig2:EGFP-positive neuronal progenitor cells was not significantly changed. Cell death of rod photoreceptors was excluded as the inducer of rod precursor cell proliferation, as the number of TUNEL-positive cells and l-plastin-positive microglia in both the outer (ONL) and inner nuclear layer (INL) remained at a similar level throughout the dark-adaptation timecourse. Rod precursor cell proliferation in response to dark-adaptation was characterized by an increased number of EdU-positive cells, i.e. cells that were undergoing DNA replication. These proliferating rod precursor cells in dark-adapted zebrafish differentiated into rod photoreceptors at a comparable percentage and in a similar time frame as those maintained under standard light conditions suggesting that the cell cycle did not stall in dark-adapted retinas. Inhibition of IGF1-receptor signaling reduced the dark-adaptation-mediated proliferation response; however, caloric restriction which has been suggested to be integrated by the IGF1/growth hormone signaling axis did not influence rod precursor cell proliferation in dark-adapted retinas, as similar numbers were observed in starved and normal fed zebrafish. In summary, photic deprivation induces cell cycle entry of rod precursor cells via IGF1-receptor signaling independent of Müller glia proliferation.","['Adult neurogenesis', 'Dark-adaptation', 'IGF-Receptor', 'Light-damage', 'Retina', 'Rod photoreceptor', 'Rod precursor cell', 'Zebrafish']",Experimental eye research,2018-09-30,"[{'lastname': 'Lahne', 'firstname': 'Manuela', 'initials': 'M', 'affiliation': 'Department of Biological Sciences, The Center for Stem Cells and Regenerative Medicine and The Center for Zebrafish Research, Galvin Life Sciences Building, University of Notre Dame, Notre Dame, IN, 46556, USA.'}, {'lastname': 'Piekos', 'firstname': 'Samantha M', 'initials': 'SM', 'affiliation': 'Department of Biological Sciences, The Center for Stem Cells and Regenerative Medicine and The Center for Zebrafish Research, Galvin Life Sciences Building, University of Notre Dame, Notre Dame, IN, 46556, USA.'}, {'lastname': ""O'Neill"", 'firstname': 'John', 'initials': 'J', 'affiliation': 'Department of Biological Sciences, The Center for Stem Cells and Regenerative Medicine and The Center for Zebrafish Research, Galvin Life Sciences Building, University of Notre Dame, Notre Dame, IN, 46556, USA.'}, {'lastname': 'Ackerman', 'firstname': 'Kristin M', 'initials': 'KM', 'affiliation': 'Department of Biological Sciences, The Center for Stem Cells and Regenerative Medicine and The Center for Zebrafish Research, Galvin Life Sciences Building, University of Notre Dame, Notre Dame, IN, 46556, USA.'}, {'lastname': 'Hyde', 'firstname': 'David R', 'initials': 'DR', 'affiliation': 'Department of Biological Sciences, The Center for Stem Cells and Regenerative Medicine and The Center for Zebrafish Research, Galvin Life Sciences Building, University of Notre Dame, Notre Dame, IN, 46556, USA. Electronic address: dhyde@nd.edu.'}]",,,,Copyright © 2018 Elsevier Ltd. All rights reserved.,10.1016/j.exer.2018.09.015,<Element 'PubmedArticle' at 0x7f05def79db0>
323,"30259418
8714026
25688351
9517466
17466566
28259722
21454302
25203138
22719267
11223663
6542868
22388959
16707192
16081203
17180163
18431594
25091898
18509340
6153132
10922459
26779183
20399835
25534809
19931575
16607396
23628372
14736707
12796723
14982943
25413317
22525371
24453463
11089557
25378700
25524407
25951955
17936181
6642186
27426517
24501331
5527837
16931790
19767732
6287293
23172145
26335886
18655867
21666036
24623760
25915053
25632023
11815388
22230548
24675466
26727629
11106749
28076767
22682222
28805558
20188671
10564271
27828947
22251901
22013210
10350641
10575039
15652655
23954133
19918053
28888963
20012748
28283579
25786174
27767042
17129784
21960564
18984149
24813923
23410756
24198165
26520666
29795335
21193739
21438114
25723161
19258667
20965422
21334975
27374498
15589267
14559994
18041090
11850408
14463785
26778478
28119696
24695221
16429122
12115731
20351694
8797841
24934179
8011301
12901335
18650913
28669986
29424373
25643991
23610393
12040534
27667687
26926566
25889215
19767743
21151103
25773600
22700657
27904144
14479157
19556253
22057000
29949403
23183119
25800044
16923392
9354079
25565206
29226911
25274306
10074801
7056222
14578353
28566324
28687630
17913878
17565364
29054471
27512604
23516373
20513765
11541392
19960051
20303873
15603751
15952902
27767096
22342844
5394424
29065123
21866331
26415118
29054552
3973621
27795298
24681257
22202167
23040812
16987022
18940936
28049625
20504162
20959854
27333444
23535595
23761072
28668382
16814729
28608978
22116877
23533374
29180055
26245374
7608204
25582199
17371619
17765680
15280428
11779464
14583651
27075756
22698579
20203610
22450316
18195013
21124315
17015805
23205122","Mitochondria, Oxytocin, and Vasopressin: Unfolding the Inflammatory Protein Response.","Neuroendocrine and immune signaling pathways are activated following insults such as stress, injury, and infection, in a systemic response aimed at restoring homeostasis. Mitochondrial metabolism and function have been implicated in the control of immune responses. Commonly studied along with mitochondrial function, reactive oxygen species (ROS) are closely linked to cellular inflammatory responses. It is also accepted that cells experiencing mitochondrial or endoplasmic reticulum (ER) stress induce response pathways in order to cope with protein-folding dysregulation, in homeostatic responses referred to as the unfolded protein responses (UPRs). Recent reports indicate that the UPRs may play an important role in immune responses. Notably, the homeostasis-regulating hormones oxytocin (OXT) and vasopressin (AVP) are also associated with the regulation of inflammatory responses and immune function. Intriguingly, OXT and AVP have been linked with ER unfolded protein responses (UPR","['Glutathione', 'Microglia', 'NADPH oxidase', 'NF-κB', 'Unfolded protein response']",Neurotoxicity research,2018-09-28,"[{'lastname': 'Bordt', 'firstname': 'Evan A', 'initials': 'EA', 'affiliation': 'Department of Pediatrics, Lurie Center for Autism, Massachusetts General Hospital for Children, Harvard Medical School, Boston, MA, 02129, USA. ebordt@mgh.harvard.edu.'}, {'lastname': 'Smith', 'firstname': 'Caroline J', 'initials': 'CJ', 'affiliation': 'Department of Pediatrics, Lurie Center for Autism, Massachusetts General Hospital for Children, Harvard Medical School, Boston, MA, 02129, USA.'}, {'lastname': 'Demarest', 'firstname': 'Tyler G', 'initials': 'TG', 'affiliation': 'Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health, Baltimore, MD, 21224, USA.\nLaboratory of Neurosciences, National Institute on Aging, National Institutes of Health, Baltimore, MD, 21224, USA.'}, {'lastname': 'Bilbo', 'firstname': 'Staci D', 'initials': 'SD', 'affiliation': 'Department of Pediatrics, Lurie Center for Autism, Massachusetts General Hospital for Children, Harvard Medical School, Boston, MA, 02129, USA.'}, {'lastname': 'Kingsbury', 'firstname': 'Marcy A', 'initials': 'MA', 'affiliation': 'Department of Pediatrics, Lurie Center for Autism, Massachusetts General Hospital for Children, Harvard Medical School, Boston, MA, 02129, USA.'}]",,,,,"10.1007/s12640-018-9962-7
10.14814/phy2.12169
10.4172/2167-0501.1000211
10.1016/j.neuint.2017.09.003
10.1038/s41418-018-0133-4
10.1038/nri.2017.66
10.1152/ajpcell.00275.2017
10.1038/nri.2017.139
10.1016/j.mito.2017.10.007
10.1016/j.yfrne.2017.10.004
10.1128/MCB.00282-16
10.1016/j.neulet.2017.06.050
10.1016/j.mito.2017.11.004",<Element 'PubmedArticle' at 0x7f05def874f0>
324,"30248302
9385085
28532466
20152845
9854452
24744759
6245013
18602555
20407007
12086747
12000023
15464048
15616790
18662748
23460298
26188276
28318543
7708827
15316239
3050629
26048578
23623982
22687335
21960564
25982133
25164474
2611413
10896869
20644737
26224094
11416162
26937001
8761159
11073457
19115394
2670006
26834383
11960635
24566385
9466417
26070900
2115435
9636227
18273712
25527485
25278832
24368305
26808316
10536211
10378877
8590819
20970492
27075756
16415867",Sexual activity modulates neuroinflammatory responses in male rats.,"Immune activity influences reproduction, however, the extent to which mating experience may inversely alter immune pathways is poorly understood. A few studies in humans suggest that mating triggers a circulating immune and hypothalamic-pituitary-adrenal axis response. In male rats, mating experience enhances neuroplasticity and improves cognitive function and affective-like behavior, independent of the physical activity component. Yet, the extent to which mating experience may influence immune responses in the brain remain unexplored. Here, we hypothesized that recent mating experience in male rats increases neuroinflammatory signaling (via lipopolysaccharide [LPS] stimulation, i.p.) and associated sickness behaviors (i.e., food intake, weight loss) relative to sexually-naïve controls. Virgin male rats were exposed to a sexually non-receptive (control) or sexually-receptive female for 30 min for six consecutive days. Immediately following the last mating experience, rats were administered a saline or LPS injection and euthanized four hours later. Mating increased Tnfα responses to LPS in the brain, which positively correlated with LPS-induced weight loss. Mating also increased peripheral corticosterone among saline-treated rats, but this corticosterone response was attenuated in the most proficient copulators (e.g., shortest latencies). Thus, recent mating experience may be a unique modulator of select stimulated inflammatory signals that are relevant to adaptive neuroimmune responses and behavior.","['Corticosterone', 'Cytokines', 'Lipopolysaccharide', 'Mating', 'Microglia', 'Tnf-alpha']",Physiology & behavior,2018-09-25,"[{'lastname': 'Pyter', 'firstname': 'Leah M', 'initials': 'LM', 'affiliation': 'Institute for Behavioral Medicine Research, Ohio State University Wexner Medical Center, Columbus, OH, USA; Departments of Psychiatry and Behavioral Health, Ohio State University Wexner Medical Center, Columbus, OH, USA; Department of Neuroscience, Ohio State University Wexner Medical Center, Columbus, OH, USA; Behavioral Neuroendocrinology Group, Ohio State University Wexner Medical Center, Columbus, OH, USA; Arthur G. James Comprehensive Cancer Center, Solove Research Institute, Ohio State University Wexner Medical Center, Columbus, OH, USA. Electronic address: leah.pyter@osumc.edu.'}, {'lastname': 'Bever', 'firstname': 'Savannah R', 'initials': 'SR', 'affiliation': 'Institute for Behavioral Medicine Research, Ohio State University Wexner Medical Center, Columbus, OH, USA; Departments of Psychiatry and Behavioral Health, Ohio State University Wexner Medical Center, Columbus, OH, USA.'}, {'lastname': 'Khantsis', 'firstname': 'Sabina', 'initials': 'S', 'affiliation': 'Department of Psychology, University of Maryland, College Park, MD, USA.'}, {'lastname': 'Glasper', 'firstname': 'Erica R', 'initials': 'ER', 'affiliation': 'Department of Psychology, University of Maryland, College Park, MD, USA; Program in Neuroscience and Cognitive Science, University of Maryland, College Park, MD, USA.'}]",,,,Copyright © 2018 Elsevier Inc. All rights reserved.,10.1016/j.physbeh.2018.09.009,<Element 'PubmedArticle' at 0x7f05def60bd0>
325,30240345,Adverse early life environment induces anxiety-like behavior and increases expression of FKBP5 mRNA splice variants in mouse brain.,"Adverse early life environment (AELE) predisposes adult offspring toward anxiety disorders. Anxiety disorders are associated with prenatal injuries in key regions of the brain including prefrontal cortex (PFC), hippocampus (HP), and hypothalamus (HT). Injuries in these brain regions result in an impaired hypothalamus-pituitary-adrenal axis (HPA axis) and stress response. An important regulator of the stress response is FK506-binding protein 5 (FKBP5). FKBP5 is a cochaperone of the glucocorticoid receptor (GR) and inhibits GR-mediated regulatory feed-back on the HPA axis in response to stress. Human studies have shown that polymorphisms of FKBP5 are associated with higher FKBP5 levels. Increased FKBP5 leads to GR resistance and impaired negative feedback, which is associated with anxiety disorders. FKBP5 and its mRNA splice variants in the aforementioned brain regions have not been reported. We hypothesized that AELE will increase expression of FKBP5 and its mRNA splice variants in PFC, HP, and HT as well as increase anxiety in adult mice. AELE increased expression of FKBP5 and its mRNA variants in PFC, HP and HT at postnatal day 21. Additionally, AELE caused anxiety and increased GR abundance in association with these changes in FKBP5 expression. We speculate that these changes in FKBP5 mRNA variants affect HPA axis function and contributes to subsequent anxiety-like behavior later in life in AELE mice.","['FKBP5 mRNA variants', 'adverse early life environment', 'hippocampus', 'hypothalamus', 'prefrontal cortex']",Physiological genomics,2018-09-22,"[{'lastname': 'Ke', 'firstname': 'Xingrao', 'initials': 'X', 'affiliation': 'Division of Neonatology, Department of Pediatrics, Medical College of Wisconsin , Milwaukee, Wisconsin.'}, {'lastname': 'Fu', 'firstname': 'Qi', 'initials': 'Q', 'affiliation': 'Division of Neonatology, Department of Pediatrics, Medical College of Wisconsin , Milwaukee, Wisconsin.'}, {'lastname': 'Majnik', 'firstname': 'Amber', 'initials': 'A', 'affiliation': 'Division of Neonatology, Department of Pediatrics, Medical College of Wisconsin , Milwaukee, Wisconsin.'}, {'lastname': 'Cohen', 'firstname': 'Susan', 'initials': 'S', 'affiliation': 'Division of Neonatology, Department of Pediatrics, Medical College of Wisconsin , Milwaukee, Wisconsin.'}, {'lastname': 'Liu', 'firstname': 'Qiuli', 'initials': 'Q', 'affiliation': 'Division of Neonatology, Department of Pediatrics, Medical College of Wisconsin , Milwaukee, Wisconsin.'}, {'lastname': 'Lane', 'firstname': 'Robert', 'initials': 'R', 'affiliation': 'Division of Neonatology, Department of Pediatrics, Medical College of Wisconsin , Milwaukee, Wisconsin.'}]",,,,,10.1152/physiolgenomics.00054.2018,<Element 'PubmedArticle' at 0x7f05def04040>
326,"30208760
23007702
22260389
23840238
25008549
23354834
20411441
26254059
25773147
28086065
29025968
28921554
21723251
18006683
15077152
20959619
17362839
21979913
20811354
21884931
28334843
23191986
25888640
25899084
20548331
21801009
15798367
11038174
11060023
15355958
16286508
26799652
22342941
22441107
28928406
23516279
29246612
27704281
21460614
24009854
27281615
23372817
24036151
24401604
26165754
25485521
27803889
22078875
22449030
20104028
22248718
24084739
26505221
25417929
26120731
27624289
17487163",Mir223 restrains autophagy and promotes CNS inflammation by targeting ATG16L1.,"Microglia are innate immune cells in the central nervous system (CNS), that supplies neurons with key factors for executing autophagosomal/lysosomal functions. Macroautophagy/autophagy is a cellular catabolic process that maintains cell balance in response to stress-related stimulation. Abnormal autophagy occurs with many pathologies, such as cancer, and autoimmune and neurodegenerative diseases. Hence, clarification of the mechanisms of autophagy regulation is of utmost importance. Recently, researchers presented microRNAs (miRNAs) as novel and potent modulators of autophagic activity. Here, we found that Mir223 deficiency significantly ameliorated CNS inflammation, demyelination and the clinical symptoms of experimental autoimmune encephalomyelitis (EAE) and increased resting microglia and autophagy in brain microglial cells. In contrast, the autophagy inhibitor 3-methylademine (3-MA) aggravated the clinical symptoms of EAE in wild-type (WT) and Mir223-deficienct mice. Furthermore, it was confirmed that Mir223 deficiency in mice increased the protein expression of ATG16L1 (autophagy related 16-like 1 [S. cerevisiae]) and LC3-II in bone marrow-derived macrophage cells compared with cells from WT mice. Indeed, the cellular level of Atg16l1 was decreased in BV2 cells upon Mir223 overexpression and increased following the introduction of antagomirs. We also showed that the 3' UTR of Atg16l1 contained functional Mir223-responsive sequences and that overexpression of ATG16L1 returned autophagy to normal levels even in the presence of Mir223 mimics. Collectively, these data indicate that Mir223 is a novel and important regulator of autophagy and that Atg16l1 is a Mir223 target in this process, which may have implications for improving our understanding of the neuroinflammatory process of EAE. Abbreviations: 3-MA: 3-methylademine; ACTB/β-actin: actin, beta; ATG: autophagy related; ATG16L1: autophagy related 16-like 1 (S. cerevisiae); BECN1: beclin 1, autophagy related; CNR2: cannabinoid receptor 2 (macrophage); CNS: central nervous system; CQ: chloroquine; EAE: experimental autoimmune encephalomyelitis; FOXO3: forkhead box O3; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; H&E: hematoxylin and eosin; ITGAM: integrin alpha M; LPS: lipoplysaccharide; MAP1LC3/LC3: microtubule-associated protein 1 light chain 3; miRNAs: microRNAs; MS: multiple sclerosis; PPARG: peroxisome proliferator activated receptor gamma; PTPRC: protein tyrosine phosphatase, receptor type, C; RA: rheumatoid arthritis; SQSTM1: sequestosome 1; TB: tuberculosis; TIMM23: translocase of inner mitochondrial membrane 23; TLR: toll-like receptor.","['ATG16L1', 'CNS inflammation', 'autophagy', 'experimental autoimmune encephalomyelitis', 'microglia']",Autophagy,2018-09-14,"[{'lastname': 'Li', 'firstname': 'Yan', 'initials': 'Y', 'affiliation': 'a Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Hormones and Development (Ministry of Health) , Tianjin Medical University , Tianjin , China.'}, {'lastname': 'Zhou', 'firstname': 'Dongmei', 'initials': 'D', 'affiliation': 'a Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Hormones and Development (Ministry of Health) , Tianjin Medical University , Tianjin , China.'}, {'lastname': 'Ren', 'firstname': 'Yinghui', 'initials': 'Y', 'affiliation': 'b Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute , Tianjin Medical University General Hospital , Tianjin , China.'}, {'lastname': 'Zhang', 'firstname': 'Zimu', 'initials': 'Z', 'affiliation': 'a Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Hormones and Development (Ministry of Health) , Tianjin Medical University , Tianjin , China.'}, {'lastname': 'Guo', 'firstname': 'Xiangdong', 'initials': 'X', 'affiliation': 'a Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Hormones and Development (Ministry of Health) , Tianjin Medical University , Tianjin , China.'}, {'lastname': 'Ma', 'firstname': 'MingKun', 'initials': 'M', 'affiliation': 'a Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Hormones and Development (Ministry of Health) , Tianjin Medical University , Tianjin , China.\nc Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine , Tianjin , China.'}, {'lastname': 'Xue', 'firstname': 'Zhenyi', 'initials': 'Z', 'affiliation': 'a Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Hormones and Development (Ministry of Health) , Tianjin Medical University , Tianjin , China.'}, {'lastname': 'Lv', 'firstname': 'Jienv', 'initials': 'J', 'affiliation': 'a Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Hormones and Development (Ministry of Health) , Tianjin Medical University , Tianjin , China.\nd Hexi Women & Children Healthcare and Family Planning Service Center , Tianjin , China.'}, {'lastname': 'Liu', 'firstname': 'Hongkun', 'initials': 'H', 'affiliation': 'a Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Hormones and Development (Ministry of Health) , Tianjin Medical University , Tianjin , China.'}, {'lastname': 'Xi', 'firstname': 'Qing', 'initials': 'Q', 'affiliation': 'a Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Hormones and Development (Ministry of Health) , Tianjin Medical University , Tianjin , China.'}, {'lastname': 'Jia', 'firstname': 'Long', 'initials': 'L', 'affiliation': 'a Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Hormones and Development (Ministry of Health) , Tianjin Medical University , Tianjin , China.'}, {'lastname': 'Zhang', 'firstname': 'Lijuan', 'initials': 'L', 'affiliation': 'a Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Hormones and Development (Ministry of Health) , Tianjin Medical University , Tianjin , China.'}, {'lastname': 'Liu', 'firstname': 'Ying', 'initials': 'Y', 'affiliation': 'a Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Hormones and Development (Ministry of Health) , Tianjin Medical University , Tianjin , China.'}, {'lastname': 'Zhang', 'firstname': 'Qi', 'initials': 'Q', 'affiliation': 'e Institute of Integrative Medicines for Acute Abdominal Diseases , Nankai Hospital , Tianjin , China.'}, {'lastname': 'Yan', 'firstname': 'Jun', 'initials': 'J', 'affiliation': 'f Tianjin Institute of Animal husbandry and veterinary , Tianjin , China.'}, {'lastname': 'Da', 'firstname': 'Yurong', 'initials': 'Y', 'affiliation': 'a Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Hormones and Development (Ministry of Health) , Tianjin Medical University , Tianjin , China.'}, {'lastname': 'Gao', 'firstname': 'Fei', 'initials': 'F', 'affiliation': 'g State Key Laboratory of Reproductive Biology, Institute of Zoology , Chinese Academy of Sciences , Beijing , China.'}, {'lastname': 'Yue', 'firstname': 'Jianbo', 'initials': 'J', 'affiliation': 'h Department of Biomedical Sciences , City University of Hong Kong , Hong Kong , China.'}, {'lastname': 'Yao', 'firstname': 'Zhi', 'initials': 'Z', 'affiliation': 'a Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Hormones and Development (Ministry of Health) , Tianjin Medical University , Tianjin , China.'}, {'lastname': 'Zhang', 'firstname': 'Rongxin', 'initials': 'R', 'affiliation': 'a Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Hormones and Development (Ministry of Health) , Tianjin Medical University , Tianjin , China.\ni Guangdong Province Key Laboratory for Biotechnology Drug Candidates, School of Life Sciences and Biopharmaceutics , Guangdong Pharmaceutical University , Guangzhou , China.'}]",,,,,"10.1080/15548627.2018.1522467
10.1002/eji.201646375",<Element 'PubmedArticle' at 0x7f05def11130>
327,"30152284
23390181
20107219
16551656
18218341
18620039
19833208
21718217
23494748
25083916
16923397
19199928
12112074
22382683
9568715
20932114
11431595
24838579
21146687
21115000
23207766
23060470
19635982
16305809
9561840
18650918
16696956
24291733
25134730
26713087
10934192
16127449
9422509
10996210
11424194
18537664
22836247
26163517
23197723
20336061
21617889
24933538
12191966
12584205
10781090
10908610
12930788
15817521
23524568
16407166
19621015
12897211
26416887
15668425
26399707
26673814
26021802
19648749
21068429
22442467
24694076
18549781
20188211
26890773
19201410
21718217
21034223
22476197
25512792
16876572
19695307
22473784
25504005
19923038
23175826
24623782
22495349
17360474
18492729
26149638
24277156
22420664
18285614
20129921
25523934
26566726
24887686
17965419
17250680
18560439
19135426
19141539
22661092
25083916
25490415
24409422
26210873
16770341
24374061
23153990
24370585
15051507
25875370
24431460
26967226
21044348
20849944
20176121
16286438
16446752
10461029
12112074
25697476
25113171
22503969
25974006
23874687
25575659
27802237
27525190
21963672
20837824
20733306
21592048
25852732
22620268
26001206
18784309
18652670",Current Progress on Peroxisome Proliferator-activated Receptor Gamma Agonist as an Emerging Therapeutic Approach for the Treatment of Alzheimer's Disease: An Update.,"Alzheimer's disease (AD) is an age-related progressive neurodegenerative disorder, characterized by the deposition of amyloid-β within the brain parenchyma resulting in a significant decline in cognitive functions. The pathophysiological conditions of the disease are recognized by the perturbation of synaptic function, energy and lipid metabolism. In Addition deposition of amyloid plaques also triggers inflammation upon the induction of microglia. Peroxisome proliferatoractivated receptors (PPARs) are ligand-activated transcription factors known to play important role in the regulation of glucose absorption, homeostasis of lipid metabolism and are further known to involved in repressing the expression of genes related to inflammation. Therefore, agonists of this receptor represent an attractive therapeutic target for AD. Recently, both clinical and preclinical studies showed that use of Peroxisome proliferator-activated receptor gamma (PPARγ) agonist improves both learning and memory along with other AD related pathology. Thus, PPARγ signifies a significant new therapeutic target in treating AD. In this review, we have shed some light on the recent progress of how, PPARγ agonist selectively modulated different cellular targets in AD and its amazing potential in the treatment of AD.","[""Alzheimer's disease"", 'Blood-brain-barrier', 'Insulin sensitivity', 'Peroxisome proliferator-activated receptors', 'Rosiglitazone', 'Thiazolidinedione', 'Transactivation', 'β-amyloid.']",Current neuropharmacology,2018-08-29,"[{'lastname': 'Khan', 'firstname': 'Mahmood Ahmad', 'initials': 'MA', 'affiliation': 'Department of Biochemistry, University College of Medical Sciences and GTB Hospital, University of Delhi, Dilshad Garden, Delhi 110095, India.'}, {'lastname': 'Alam', 'firstname': 'Qamre', 'initials': 'Q', 'affiliation': 'King Fahd Medical Research Center, King Abdulaziz University, P.O. Box 80216, Jeddah 21589, Saudi Arabia.'}, {'lastname': 'Haque', 'firstname': 'Absarul', 'initials': 'A', 'affiliation': 'King Fahd Medical Research Center, King Abdulaziz University, P.O. Box 80216, Jeddah 21589, Saudi Arabia.'}, {'lastname': 'Ashafaq', 'firstname': 'Mohammad', 'initials': 'M', 'affiliation': 'Department of Pharmacology and Toxicology, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.'}, {'lastname': 'Khan', 'firstname': 'Mohd Jahir', 'initials': 'MJ', 'affiliation': 'School of Biotechnology, Jawaharlal Nehru University, New Delhi 110067, India.'}, {'lastname': 'Ashraf', 'firstname': 'Ghulam Md', 'initials': 'GM', 'affiliation': 'King Fahd Medical Research Center, King Abdulaziz University, P.O. Box 80216, Jeddah 21589, Saudi Arabia.'}, {'lastname': 'Ahmad', 'firstname': 'Mahboob', 'initials': 'M', 'affiliation': 'Department of Biochemistry, Hind Institute of Medical Sciences, Sitapur-2613013, India.'}]",,,,"Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.",10.2174/1570159X16666180828100002,<Element 'PubmedArticle' at 0x7f05deeb5a90>
328,30126591,"Polycaprolactone/polysialic acid hybrid, multifunctional nanofiber scaffolds for treatment of spinal cord injury.","Scaffold-based tissue engineering is widely used for spinal cord injury (SCI) treatment by creating supporting and guiding neuronal tissue regeneration. However, how to enhance the axonal regeneration capacity following SCI still remains a challenge. Polysialic acid (PSA), a natural, biodegradable polysaccharide, has been increasingly explored for controlling central nervous system (CNS) development by regulating cell adhesive properties and promoting axonal growth. Here, a polycaprolactone (PCL)/PSA hybrid nanofiber scaffold encapsulating glucocorticoid methylprednisolone (MP) is developed for SCI treatment. Rat models with spinal cord transection is established and the PCL/PSA/MP scaffold is transplanted into lesion area. PCL/PSA/MP scaffold decreases tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) release by inhibiting ionized calcium-binding adapter molecule 1 (Iba1) positive microglia/macrophage activation and reduces apoptosis-associated Caspase-3 protein expression. In addition, the PCL/PSA/MP scaffold inhibits axonal demyelination and glial fibrillary acidic protein (GFAP) expression, increases neurofilament 200 (NF-200) expression and improves functional outcome by Basso, Beattie and Bresnahan (BBB) test. These results demonstrate the therapeutic potential of PSA hybrid nanofiber scaffold in promoting axonal growth and enhancing the functional recovery following SCI.
Scaffold-based tissue engineering is widely used for spinal cord injury (SCI) treatment by creating supporting and guiding neuronal tissue regeneration. And how to enhance the axonal regeneration capacity following SCI still remains a challenge. Polysialic acid (PSA), a natural, biodegradable polysaccharide, has been increasingly explored for controlling central nervous system (CNS) development by regulating cell adhesive properties and promoting axonal growth. However, in vivo therapeutic effect of PSA scaffolds towards SCI is still lack of evidence and needs to be further explored. In this study, a novel electrospun polycaprolactone/PSA scaffold loaded with methylprednisolone (MP) was developed to achieve efficient therapeutic effects towards SCI. And we believe that it broadens the application of PSA for SCI treatment.","['Electrospinning', 'Methylprednisolone', 'Polysialic acid', 'Spinal cord injury']",Acta biomaterialia,2018-08-22,"[{'lastname': 'Zhang', 'firstname': 'Shuo', 'initials': 'S', 'affiliation': 'Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.'}, {'lastname': 'Wang', 'firstname': 'Xiao-Juan', 'initials': 'XJ', 'affiliation': 'Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.'}, {'lastname': 'Li', 'firstname': 'Wei-Shuo', 'initials': 'WS', 'affiliation': 'Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.'}, {'lastname': 'Xu', 'firstname': 'Xiao-Ling', 'initials': 'XL', 'affiliation': 'Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.'}, {'lastname': 'Hu', 'firstname': 'Jing-Bo', 'initials': 'JB', 'affiliation': 'Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.'}, {'lastname': 'Kang', 'firstname': 'Xu-Qi', 'initials': 'XQ', 'affiliation': 'Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.'}, {'lastname': 'Qi', 'firstname': 'Jing', 'initials': 'J', 'affiliation': 'Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.'}, {'lastname': 'Ying', 'firstname': 'Xiao-Ying', 'initials': 'XY', 'affiliation': 'Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.'}, {'lastname': 'You', 'firstname': 'Jian', 'initials': 'J', 'affiliation': 'Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.'}, {'lastname': 'Du', 'firstname': 'Yong-Zhong', 'initials': 'YZ', 'affiliation': 'Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. Electronic address: duyongzhong@zju.edu.cn.'}]",,,,Copyright © 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.,10.1016/j.actbio.2018.06.038,<Element 'PubmedArticle' at 0x7f05dee399f0>
329,"30121200
20590558
22197668
27069692
23630038
19647113
17965741
9466436
16204639
24185999
24255040
11470906
29133122
19126760
22420504
26956082
21727141
29793509
20803619
10750830
27861558
25502644
27373505
22921769
22021672
9685662
10762343
24060343
20468046
10588745
12740409
10476817
7575630
23074242
27695415
24308861
26410875
27402121
26245868
25374096
26833913",Revisiting cannabinoid receptor 2 expression and function in murine retina.,"The cannabinoid receptor CB2 plays a significant role in the regulation of immune function whereas neuronal expression remains a subject of contention. Multiple studies have described CB2 in retina and a recent study showed that CB2 deletion altered retinal visual processing. We revisited CB2 expression using immunohistochemistry and a recently developed CB2-eGFP reporter mouse. We examined the consequence of acute vs. prolonged CB2 deactivation on the electroretinogram (ERG) responses. We also examined lipidomics in CB2 knockout mice and potential changes in microglia using Scholl analysis. Consistent with a published report, in CB2 receptor knockout mice see an increased ERG scotopic a-wave, as well as stronger responses in dark adapted cone-driven ON bipolar cells and, to a lesser extent cone-driven ON bipolar cells early in light adaptation. Significantly, however, acute block with CB2 antagonist, AM630, did not mimic the results observed in the CB2 knockout mice whereas chronic (7 days) block did. Immunohistochemical studies show no CB2 in retina under non-pathological conditions, even with published antibodies. Retinal CB2-eGFP reporter signal is minimal under baseline conditions but upregulated by intraocular injection of either LPS or carrageenan. CB2 knockout mice see modest declines in a broad spectrum of cannabinoid-related lipids. The numbers and morphology of microglia were unaltered. In summary minimal CB2 expression is seen in healthy retina. CB2 appears to be upregulated under pathological conditions. Previously reported functional consequences of CB2 deletion are an adaptive response to prolonged blockade of these receptors. CB2 therefore impacts retinal signaling but perhaps in an indirect, potentially extra-ocular fashion.","['CB2', 'Cannabinoid', 'ERG', 'Electroretinogram', 'Retina']",Neuropharmacology,2018-08-20,"[{'lastname': 'Borowska-Fielding', 'firstname': 'Joanna', 'initials': 'J', 'affiliation': 'Department of Pharmacology, Dalhousie University, Halifax, NS, Canada.'}, {'lastname': 'Murataeva', 'firstname': 'Natalia', 'initials': 'N', 'affiliation': 'Department of Psychological and Brain Sciences, Gill Center for Biomolecular Science, Indiana University, Bloomington, IN, USA.'}, {'lastname': 'Smith', 'firstname': 'Ben', 'initials': 'B', 'affiliation': 'Physiology and Biophysics, Dalhousie University, Halifax, NS, Canada.'}, {'lastname': 'Szczesniak', 'firstname': 'Anna-Maria', 'initials': 'AM', 'affiliation': 'Department of Pharmacology, Dalhousie University, Halifax, NS, Canada.'}, {'lastname': 'Leishman', 'firstname': 'Emma', 'initials': 'E', 'affiliation': 'Department of Psychological and Brain Sciences, Gill Center for Biomolecular Science, Indiana University, Bloomington, IN, USA.'}, {'lastname': 'Daily', 'firstname': 'Laura', 'initials': 'L', 'affiliation': 'Department of Psychological and Brain Sciences, Gill Center for Biomolecular Science, Indiana University, Bloomington, IN, USA.'}, {'lastname': 'Toguri', 'firstname': 'J Thomas', 'initials': 'JT', 'affiliation': 'Department of Pharmacology, Dalhousie University, Halifax, NS, Canada.'}, {'lastname': 'Hillard', 'firstname': 'Cecelia J', 'initials': 'CJ', 'affiliation': 'Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA.'}, {'lastname': 'Romero', 'firstname': 'Julian', 'initials': 'J', 'affiliation': 'Faculty of Experimental Sciences, Universidad Francisco de Vitoria, Pozuelo de Alarcón, 28223, Madrid, Spain.'}, {'lastname': 'Bradshaw', 'firstname': 'Heather', 'initials': 'H', 'affiliation': 'Department of Psychological and Brain Sciences, Gill Center for Biomolecular Science, Indiana University, Bloomington, IN, USA.'}, {'lastname': 'Kelly', 'firstname': 'Melanie E M', 'initials': 'MEM', 'affiliation': 'Department of Pharmacology, Dalhousie University, Halifax, NS, Canada; Physiology and Biophysics, Dalhousie University, Halifax, NS, Canada; Anesthesia, Dalhousie University, Halifax, NS, Canada.'}, {'lastname': 'Straiker', 'firstname': 'Alex', 'initials': 'A', 'affiliation': 'Department of Psychological and Brain Sciences, Gill Center for Biomolecular Science, Indiana University, Bloomington, IN, USA. Electronic address: straiker@indiana.edu.'}]",,,,Copyright © 2018 Elsevier Ltd. All rights reserved.,10.1016/j.neuropharm.2018.08.007,<Element 'PubmedArticle' at 0x7f05dee4bf40>
330,"30118343
16357085
22160349
24236177
221551
28101102
24991871
19246694
23954431
23316164
29531174
17406392
11607037
28974571
26923165
24379184
25834234
16269659
10698067
29335605
27841763
6253831
25173821
25757753
20130219
23266544
28698768
28842441
26968546
27874975
18347231
23995626
23585139
25910805
26453324
14517164
24566081
21350432
22930834
20152116
23242312
22556255
25005230
22395208
24276217
9774106
25416190
8038870
23889563
29109190
22684104
27185599",Mineralocorticoid receptor antagonism improves parenchymal arteriole dilation via a TRPV4-dependent mechanism and prevents cognitive dysfunction in hypertension.,"Hypertension and mineralocorticoid receptor activation cause cerebral parenchymal arteriole remodeling; this can limit cerebral perfusion and contribute to cognitive dysfunction. We used a mouse model of angiotensin II-induced hypertension to test the hypothesis that mineralocorticoid receptor activation impairs both transient receptor potential vanilloid (TRPV)4-mediated dilation of cerebral parenchymal arterioles and cognitive function. Mice (16-18 wk old, male, C57Bl/6) were treated with angiotensin II (800 ng·kg","['aldosterone', 'endothelium', 'hypertension', 'microcirculation', 'transient receptor potential vanilloid 4 channels', 'vasculature']",American journal of physiology. Heart and circulatory physiology,2018-08-18,"[{'lastname': 'Diaz-Otero', 'firstname': 'Janice M', 'initials': 'JM', 'affiliation': 'Department of Pharmacology and Toxicology, Michigan State University , East Lansing, Michigan.'}, {'lastname': 'Yen', 'firstname': 'Ting-Chieh', 'initials': 'TC', 'affiliation': 'Department of Pharmacology and Toxicology, Michigan State University , East Lansing, Michigan.'}, {'lastname': 'Fisher', 'firstname': 'Courtney', 'initials': 'C', 'affiliation': 'Department of Pharmacology and Toxicology, Michigan State University , East Lansing, Michigan.'}, {'lastname': 'Bota', 'firstname': 'Daniel', 'initials': 'D', 'affiliation': 'Department of Pharmacology and Toxicology, Michigan State University , East Lansing, Michigan.'}, {'lastname': 'Jackson', 'firstname': 'William F', 'initials': 'WF', 'affiliation': 'Department of Pharmacology and Toxicology, Michigan State University , East Lansing, Michigan.'}, {'lastname': 'Dorrance', 'firstname': 'Anne M', 'initials': 'AM', 'affiliation': 'Department of Pharmacology and Toxicology, Michigan State University , East Lansing, Michigan.'}]",,,,,"10.1152/ajpheart.00207.2018
10.1152/japplphysiol.00937.2005
10.1007/s10339-011-0430-z
10.1371/journal.pone.0080355
10.1037/h0077579
10.1159/000450601
10.1097/HJH.0000000000000259
10.1161/STROKEAHA.108.535435
10.1016/j.cub.2013.07.002
10.3389/fphys.2012.00484
10.1161/HYPERTENSIONAHA.118.10865
10.1038/nprot.2006.170
10.1111/j.1527-3466.2001.tb00064.x
10.1161/HYPERTENSIONAHA.117.09598
10.1016/j.brainres.2016.02.034
10.1161/HYPERTENSIONAHA.113.01273
10.1152/physrev.00026.2014
10.1161/01.RES.0000194321.60300.d6
10.1097/00004647-200002000-00011
10.1038/s41593-017-0059-z
10.1172/JCI86950
10.1038/288373a0
10.1016/j.steroids.2014.08.014
10.1038/jcbfm.2015.31
10.1189/jlb.1109766
10.1161/HYPERTENSIONAHA.111.00299
10.1155/2017/6501046
10.1152/ajpheart.00638.2016
10.1152/ajpheart.00890.2015
10.1111/jnc.13905
10.1161/HYPERTENSIONAHA.107.105718
10.1038/nri3520
10.1152/ajpheart.00490.2012
10.1152/ajpheart.00168.2015
10.1152/ajpheart.00140.2015
10.1161/01.CIR.0000091405.00772.6E
10.1161/HYPERTENSIONAHA.113.01803
10.1038/ajh.2011.20
10.1038/nmeth.2089
10.1016/j.neuron.2009.11.032
10.1038/nn.3278
10.1126/science.1216283
10.1126/scisignal.2005052
10.1038/jcbfm.2012.25
10.1001/jamaneurol.2013.4781
10.1038/26758
10.1152/ajpheart.00457.2014
10.1111/bph.12315
10.1161/HYPERTENSIONAHA.117.09767
10.1172/JCI61427
10.1016/j.kjms.2016.03.004",<Element 'PubmedArticle' at 0x7f05dee6b770>
331,"30090016
23128416
7951315
11301001
15944186
22704732
16877434
22705597
10463344
18022954
26010551
22915113
27723799
24501362
22497888
28490764
21224065
25261995
27114033
17764761
27030285
17428999
25385337
21205789
28099414
24742461
16547132
21419501
18981228
25598354
25035950
27459405
21778362
25159150
28931408
11709709
18951638
27242437
19557831",Microglia increases the proliferation of retinal precursor cells during postnatal development.,"In mice, retinal development continues throughout the postnatal stage accompanied by the proliferation of retinal precursor cells. Previous reports showed that during the postnatal stage microglia increase from postnatal day 0 (P0) to P7. However, how microglia are associated with retinal development remains unknown.
The involvement of microglia in retinal development was investigated by two approaches, microglial activation and loss, using lipopolysaccharide (LPS) and PLX3397 (pexidartinib), respectively.
LPS injection at 1 mg/kg, intraperitoneally (i.p.) in the neonatal mice increased the number of retinal microglia at P7. 5-Bromo-2´-deoxyuridine (BrdU)-positive proliferative cells were increased by LPS treatment compared to the control group. The proliferative cells were mainly colocalized with paired box 6 (Pax6), a marker of retinal precursor cells. However, the depletion of microglia by treatment with PLX3397 decreased the BrdU-positive proliferative cells. Moreover, progranulin deficiency decreased the number of microglia and retinal precursor cells.
These findings indicated that microglia regulate the proliferation of immature retinal cells.",[],Molecular vision,2018-08-10,"[{'lastname': 'Kuse', 'firstname': 'Yoshiki', 'initials': 'Y', 'affiliation': 'Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.'}, {'lastname': 'Ohuchi', 'firstname': 'Kazuki', 'initials': 'K', 'affiliation': 'Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.'}, {'lastname': 'Nakamura', 'firstname': 'Shinsuke', 'initials': 'S', 'affiliation': 'Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.'}, {'lastname': 'Hara', 'firstname': 'Hideaki', 'initials': 'H', 'affiliation': 'Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.'}, {'lastname': 'Shimazawa', 'firstname': 'Masamitsu', 'initials': 'M', 'affiliation': 'Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.'}]",,,"LPS injection at 1 mg/kg, intraperitoneally (i.p.) in the neonatal mice increased the number of retinal microglia at P7. 5-Bromo-2´-deoxyuridine (BrdU)-positive proliferative cells were increased by LPS treatment compared to the control group. The proliferative cells were mainly colocalized with paired box 6 (Pax6), a marker of retinal precursor cells. However, the depletion of microglia by treatment with PLX3397 decreased the BrdU-positive proliferative cells. Moreover, progranulin deficiency decreased the number of microglia and retinal precursor cells.",,,<Element 'PubmedArticle' at 0x7f05dee19400>
332,"30060752
22698888
28947377
12451000
16634986
19367731
29184485
27795806
24030394
19617399
28747068
16636195
20421294
27840174
22190365
26251254
29030969
23613493
20350200
22013966
25550365
12151381
18787108
21836066
25701788
25870106
29178914
24680995
26831741
17884449
20963555
29359786
15319349
22357512
17647137
18971219
12802337
24915968
18158361
17033693
24746980
26118345
19466213
18854421
29286084
22514273
18451326
15745931
16280284
17998473
17549259
24172895
16121980
17053178",Recombinant CTRP9 administration attenuates neuroinflammation via activating adiponectin receptor 1 after intracerebral hemorrhage in mice.,"Neuroinflammation is a crucial factor contributing to neurological injuries after intracerebral hemorrhage (ICH). C1q/TNF-related protein 9 (CTRP9), an agonist of adiponectin receptor 1 (AdipoR1), has recently been shown to reduce inflammatory responses in systemic diseases. The objective of this study was to investigate the protective role of CTRP9 against neuroinflammation after ICH in a mouse model and to explore the contribution of adenosine monophosphate-activated protein kinase (AMPK)/nuclear factor kappa B (NFκB) pathway in AdipoR1-mediated protection.
Adult male CD1 mice (n = 218) were randomly assigned to different groups for the study. ICH was induced via intrastriatal injection of bacterial collagenase. Recombinant CTRP9 (rCTRP9) was administered intranasally at 1 h after ICH. To elucidate the underlying mechanism, AdipoR1 small interfering ribonucleic acid (siRNA) and selective phosphorylated AMPK inhibitor Dorsomorphin were administered prior to rCTRP9 treatment. Brain edema, short- and long-term neurobehavior evaluation, blood glucose level, western blot, and immunofluorescence staining were performed.
Endogenous CTRP9 and AdipoR1 expression was increased and peaked at 24 h after ICH. AdipoR1 was expressed by microglia, neurons, and astrocytes. Administration of rCTRP9 reduced brain edema, improved short- and long-term neurological function, enhanced the expression of AdipoR1 and p-AMPK, and decreased the expression of phosphorylated NFκB and inflammatory cytokines after ICH. The protective effects of rCTRP9 were abolished by administration of AdipoR1 siRNA and Dorsomorphin.
Our findings demonstrated that administration of rCTRP9 attenuated neuroinflammation through AdipoR1/AMPK/NFκB signaling pathway after ICH in mice, thereby reducing brain edema and improving neurological function after experimental ICH in mice. Therefore, CTRP9 may provide a potential therapeutic strategy to alleviate neuroinflammation in ICH patients.","['Adenosine monophosphate-activated protein kinase', 'Adiponectin receptor 1', 'C1q/TNF-related protein 9', 'Intracerebral hemorrhage', 'Neuroinflammation']",Journal of neuroinflammation,2018-08-01,"[{'lastname': 'Zhao', 'firstname': 'Lianhua', 'initials': 'L', 'affiliation': 'Department of Neurology, Tianjin TEDA Hospital, Tianjin, China.\nDepartment of Physiology and Pharmacology, Loma Linda University, 11041 Campus St, Loma Linda, CA, 92354, USA.'}, {'lastname': 'Chen', 'firstname': 'Shengpan', 'initials': 'S', 'affiliation': 'Department of Physiology and Pharmacology, Loma Linda University, 11041 Campus St, Loma Linda, CA, 92354, USA.\nDepartment of Neurosurgery, Affiliated Haikou Hospital, Xiangya School of Medicine, Central South University, Haikou, China.'}, {'lastname': 'Sherchan', 'firstname': 'Prativa', 'initials': 'P', 'affiliation': 'Department of Physiology and Pharmacology, Loma Linda University, 11041 Campus St, Loma Linda, CA, 92354, USA.'}, {'lastname': 'Ding', 'firstname': 'Yan', 'initials': 'Y', 'affiliation': 'Department of Physiology and Pharmacology, Loma Linda University, 11041 Campus St, Loma Linda, CA, 92354, USA.'}, {'lastname': 'Zhao', 'firstname': 'Wei', 'initials': 'W', 'affiliation': 'Department of Neurology, Tianjin TEDA Hospital, Tianjin, China.'}, {'lastname': 'Guo', 'firstname': 'Zaiyu', 'initials': 'Z', 'affiliation': 'Department of Neurology, Tianjin TEDA Hospital, Tianjin, China.'}, {'lastname': 'Yu', 'firstname': 'Jing', 'initials': 'J', 'affiliation': 'Department of Physiology and Pharmacology, Loma Linda University, 11041 Campus St, Loma Linda, CA, 92354, USA.'}, {'lastname': 'Tang', 'firstname': 'Jiping', 'initials': 'J', 'affiliation': 'Department of Physiology and Pharmacology, Loma Linda University, 11041 Campus St, Loma Linda, CA, 92354, USA. jtang@llu.edu.'}, {'lastname': 'Zhang', 'firstname': 'John H', 'initials': 'JH', 'affiliation': 'Department of Physiology and Pharmacology, Loma Linda University, 11041 Campus St, Loma Linda, CA, 92354, USA. johnzhang3910@yahoo.com.'}]",,,"Endogenous CTRP9 and AdipoR1 expression was increased and peaked at 24 h after ICH. AdipoR1 was expressed by microglia, neurons, and astrocytes. Administration of rCTRP9 reduced brain edema, improved short- and long-term neurological function, enhanced the expression of AdipoR1 and p-AMPK, and decreased the expression of phosphorylated NFκB and inflammatory cytokines after ICH. The protective effects of rCTRP9 were abolished by administration of AdipoR1 siRNA and Dorsomorphin.",,"10.1186/s12974-018-1256-8
10.1016/S1474-4422(12)70104-7
10.1016/j.neuropharm.2017.09.033
10.1161/01.CIR.0000042707.50032.19
10.1111/j.1463-1326.2005.00510.x
10.1111/j.1600-0684.2008.00298.x
10.3389/fncel.2017.00352
10.1161/CIRCULATIONAHA.112.000010
10.1165/2009-0147OC
10.1089/ars.2017.7003
10.1161/01.HYP.0000221429.94591.72
10.1074/jbc.M110.123620
10.1016/j.mce.2016.11.010
10.1002/ana.22549
10.1161/STROKEAHA.115.009792
10.1111/jnc.14238
10.1161/STROKEAHA.111.000427
10.1089/neu.2009.1163
10.1089/neu.2011.1864
10.1161/STROKEAHA.114.007265
10.1074/jbc.C200362200
10.1096/fj.08-114991
10.1161/ATVBAHA.111.231050
10.1016/j.bbrc.2015.02.054
10.1128/MCB.01518-14
10.1186/s12974-017-1005-4
10.1016/j.imlet.2014.03.005
10.1186/s12974-016-0490-1
10.1016/j.metabol.2007.05.009
10.1007/s12020-009-9278-8
10.1210/en.2004-0503
10.1038/gt.2012.7
10.1055/s-2007-981660
10.1677/JOE-08-0348
10.1038/nature01705
10.1007/s12035-014-8765-y
10.1161/CIRCULATIONAHA.107.725044
10.1038/sj.jcbfm.9600403
10.1016/j.tem.2014.03.009
10.1016/j.bbadis.2015.06.019
10.1590/S0004-27302009000200012
10.1152/ajpendo.90731.2008
10.1074/jbc.M112.357939
10.1161/ATVBAHA.108.163303
10.1530/eje.1.01851
10.1016/j.amjhyper.2005.05.026
10.1161/HYPERTENSIONAHA.107.099424
10.1172/JCI29623
10.1038/nature12656
10.3171/jns.2005.103.1.0097
10.1161/01.STR.0000249008.18669.5a",<Element 'PubmedArticle' at 0x7f05dedb8cc0>
333,30032988,"Depletion of regulator-of-G-protein signaling-10 in mice exaggerates high-fat diet-induced insulin resistance and inflammation, and this effect is mitigated by dietary green tea extract.","The interaction between insulin resistance and inflammation plays a central role in the development of chronic diseases, although the mechanism is not fully understood. We previously demonstrated that regulator of G-protein signaling-10 (RGS10) protein is a negative modulator of the inflammatory response in macrophages and microglia. Because inflammation is a critical component in the development of high fat diet-induced insulin resistance, in this study we investigated whether RGS10 is involved in the diet-dependent regulation of glucose tolerance and insulin sensitivity. We hypothesized that the absence of RGS10 would exaggerate high-fat diet (HFD)-induced insulin resistance and inflammation response. Our results showed that RGS10 knockout (KO) mice fed a HFD gained significantly more weight and developed severe insulin resistance compared to wild-type (WT) mice fed HFD. Furthermore, compared to WT HFD-fed mice, KO mice fed the HFD displayed inflammatory phenotypes such as decreased adipose tissue expression of the anti-inflammatory M2 markers YM1 and Fizz1 and increased expression of the proinflammatory M1 cytokine interleukin 6 in adipose and CD11b, CD68 and interleukin 1β in liver tissues. The impact of RGS10 deficiency on the exaggeration of HFD-induced insulin resistance and inflammation was ameliorated by oral consumption of green tea extract. Our results demonstrate that RGS10 is an important part of a protective mechanism involved in in regulating metabolic homeostasis by reducing inflammatory responses, which could potentially lead to an innovative new approach targeting inflammation and insulin resistance.","['Antioxidants', 'Glucose tolerance', 'Obesity', 'Phytochemicals', 'RGS']","Nutrition research (New York, N.Y.)",2018-07-24,"[{'lastname': 'Fang', 'firstname': 'Xi', 'initials': 'X', 'affiliation': 'Department of Foods and Nutrition, College of Family and Consumer Sciences, University of Georgia, Athens, GA 30602. Electronic address: xi.fang25@uga.edu.'}, {'lastname': 'Chung', 'firstname': 'Jaegwon', 'initials': 'J', 'affiliation': 'Department of Physiology and Pharmacology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602. Electronic address: jaechung@uga.edu.'}, {'lastname': 'Olsen', 'firstname': 'Erik', 'initials': 'E', 'affiliation': 'Department of Physiology and Pharmacology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602. Electronic address: erik.olsen25@uga.edu.'}, {'lastname': 'Snider', 'firstname': 'Isabelle', 'initials': 'I', 'affiliation': 'Department of Physiology and Pharmacology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602. Electronic address: ivs36369@uga.edu.'}, {'lastname': 'Earls', 'firstname': 'Rachael H', 'initials': 'RH', 'affiliation': 'Department of Physiology and Pharmacology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602. Electronic address: rachaelhart1226@gmail.com.'}, {'lastname': 'Jeon', 'firstname': 'Julie', 'initials': 'J', 'affiliation': 'Department of Foods and Nutrition, College of Family and Consumer Sciences, University of Georgia, Athens, GA 30602. Electronic address: Julie.Jeon@uga.edu.'}, {'lastname': 'Park', 'firstname': 'Hea Jin', 'initials': 'HJ', 'affiliation': 'Department of Foods and Nutrition, College of Family and Consumer Sciences, University of Georgia, Athens, GA 30602. Electronic address: hjpark@uga.edu.'}, {'lastname': 'Lee', 'firstname': 'Jae-Kyung', 'initials': 'JK', 'affiliation': 'Department of Physiology and Pharmacology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602. Electronic address: jamlee@uga.edu.'}]",,,,Copyright © 2018 Elsevier Inc. All rights reserved.,10.1016/j.nutres.2018.06.004,<Element 'PubmedArticle' at 0x7f05dedeca40>
334,30016726,Sleep and brain infections.,"Sleep is frequently altered in systemic infections as a component of sickness behavior in response to inflammation. Sleepiness in sickness behavior has been extensively investigated. Much less attention has instead been devoted to sleep and wake alterations in brain infections. Most of these, as other neuroinfections, are prevalent in sub-Saharan Africa. The present overview highlights the importance of this topic from both the clinical and pathogenetic points of view. Vigilance states and their regulation are first summarized, emphasizing that key nodes in this distributed brain system can be targeted by neuroinflammatory signaling. Sleep-wake changes in the parasitic disease human African trypanosomiasis (HAT) and its animal models are then reviewed and discussed. Experimental data have revealed that the suprachiasmatic nucleus, the master circadian pacemaker, and peptidergic cell populations of the lateral hypothalamus (the wake-promoting orexin neurons and the sleep-promoting melanin-concentrating hormone neurons) are targeted by African trypanosome infection. It is then discussed how prominent and disturbing are sleep changes in HIV/AIDS, also when the infection is cured with antiretroviral therapy. This recalls attention on the bidirectional interactions between sleep and immune system, including the specialized brain immune response of which microglial cells are protagonists. Sleep changes in an ancient viral disease, rabies, and in the emerging infection due to Zika virus which causes a congenital syndrome, are also dealt with. Altogether the findings indicate that sleep-wake regulation is targeted by brain infections caused by different pathogens and, although the relevant pathogenetic mechanisms largely remain to be clarified, these alterations differ from hypersomnia occurring in sickness behavior. Thus, brain infections point to the vulnerability of the neural network of sleep-wake regulation as a highly relevant clinical and basic science challenge.","['African trypanosomiasis', 'HIV/AIDS', 'NeuroAIDS', 'Neuroinflammation', 'Rabies', 'Sickness behavior', 'Zika virus']",Brain research bulletin,2018-07-18,"[{'lastname': 'Tesoriero', 'firstname': 'Chiara', 'initials': 'C', 'affiliation': 'Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Italy.'}, {'lastname': 'Del Gallo', 'firstname': 'Federico', 'initials': 'F', 'affiliation': 'Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Italy.'}, {'lastname': 'Bentivoglio', 'firstname': 'Marina', 'initials': 'M', 'affiliation': 'Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Italy. Electronic address: marina.bentivoglio@univr.it.'}]",,,,Copyright © 2018 Elsevier Inc. All rights reserved.,10.1016/j.brainresbull.2018.07.002,<Element 'PubmedArticle' at 0x7f05ded7b450>
335,29939407,Evidence of altered depression and dementia-related proteins in the brains of young rats after ovariectomy.,"Menopause, a risk factor for brain dysfunction in women, is characterized by neuropsychological symptoms including depression and dementia, which are closely related to alterations in different brain regions after menopause. However, little is known about the variability in pathophysiologic changes associated with menopause in the brain. Here, we observed that menopause in rats induced by bilateral ovariectomy (OVX) showed depressive and dementia-related behaviors along with neuronal loss in the prefrontal cortex (PFC), hippocampus (HIP), hypothalamus (HYP), and amygdala (AMY) by Nissl staining. Meanwhile, by immunohistochemical staining, increased microglia in the HIP and AMY and increased astrocytes in the PFC, HYP, and AMY were shown. Using quantitative proteomics, we identified 146 differentially expressed proteins in the brains of OVX rats, for example, 20 in the PFC, 41 in the HIP, 17 in the HYP, and 79 in the AMY, and performed further detection by western blotting. A link between neuronal loss and apoptosis was suggested, as evidenced by increases in adenylate kinase 2 (AK2), B-cell lymphoma 2 associated X (Bax), cleaved caspase 3, and phosphorylated p53 and decreases in Huntingtin-interacting protein K, hexokinase, and phosphorylated B-cell lymphoma 2 (Bcl-2), and apoptosis might be triggered by endoplasmic reticulum stress (probed by increased glucose-regulated protein 78 (GRP78), cleaved caspase 12, phosphorylated protein kinase R (PKR)-like endoplasmic reticulum kinase, inositol-requiring enzyme-1 and activating transcription factor 6), and mitochondrial dysfunction (probed by increased cytochrome c and cleaved caspase 3 and decreased sideroflexin-1 (SFXN1) and NADH dehydrogenase (ubiquinone) 1 α subcomplex 11 (NDUFA11)). Activation of autophagy was also indicated by increased autophagy-related 7, γ-aminobutyric acid (GABA) receptor-associated protein-like 2, and oxysterol-binding protein-related protein 1 and confirmed by increased microtubule-associated protein light chain 3 (LC3II/I), autophagy-related 5, and Beclin1 in the HIP and AMY. In the AMY, which is important in emotion, higher GABA transporter 3 and lower vesicular glutamate transporter 1 levels indicated an imbalance between excitatory and inhibitory neurotransmission, and the increased calretinin and decreased calbindin levels suggested an adjustment of GABAergic transmission after OVX. In addition, cytoskeletal abnormalities including tau hyperphosphorylation, dysregulated Ca²","['amygdala', 'apoptosis', 'autophagy', 'endoplasmic reticulum stress', 'ovariectomy']",Journal of neurochemistry,2018-06-26,"[{'lastname': 'Fang', 'firstname': 'Ying-Yan', 'initials': 'YY', 'affiliation': 'Department of Pathology and Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.\nInstitute for Brain Research, Huazhong University of Science and Technology, Wuhan, China.'}, {'lastname': 'Zeng', 'firstname': 'Peng', 'initials': 'P', 'affiliation': 'Department of Pathology and Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.\nInstitute for Brain Research, Huazhong University of Science and Technology, Wuhan, China.'}, {'lastname': 'Qu', 'firstname': 'Na', 'initials': 'N', 'affiliation': 'Institute for Brain Research, Huazhong University of Science and Technology, Wuhan, China.\nAffiliated Mental Health Center, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.'}, {'lastname': 'Ning', 'firstname': 'Lin-Na', 'initials': 'LN', 'affiliation': 'Department of Pathology and Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.\nInstitute for Brain Research, Huazhong University of Science and Technology, Wuhan, China.'}, {'lastname': 'Chu', 'firstname': 'Jiang', 'initials': 'J', 'affiliation': 'Department of Pathology and Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.\nInstitute for Brain Research, Huazhong University of Science and Technology, Wuhan, China.'}, {'lastname': 'Zhang', 'firstname': 'Teng', 'initials': 'T', 'affiliation': 'Department of Pathology and Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.\nInstitute for Brain Research, Huazhong University of Science and Technology, Wuhan, China.'}, {'lastname': 'Zhou', 'firstname': 'Xin-Wen', 'initials': 'XW', 'affiliation': 'Department of Pathology and Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.\nInstitute for Brain Research, Huazhong University of Science and Technology, Wuhan, China.'}, {'lastname': 'Tian', 'firstname': 'Qing', 'initials': 'Q', 'affiliation': 'Department of Pathology and Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.\nInstitute for Brain Research, Huazhong University of Science and Technology, Wuhan, China.'}]",,,,© 2018 International Society for Neurochemistry.,10.1111/jnc.14537,<Element 'PubmedArticle' at 0x7f05ded85720>
336,"29924994
6370082
22139074
28446774
26884166
12483206
23686747
23924954
16672344
24742461
28264694
12372013
19265055
24643079
18787197
28618077
22674334
25385337
23312512
23630462
28714861
27141961
17344397
23407936
6163211
27338705
18195084
26347630
14507969
24909826
15111734
18567623
27580035
25551794
24713688
27899606
9705133
28886007
22829357
18286612
27870410
19123998
22383036
22072657
8133751
11245665
11920150
26477569
27196727
19804754
26431938",Sex-Specific Features of Microglia from Adult Mice.,"Sex has a role in the incidence and outcome of neurological illnesses, also influencing the response to treatments. Neuroinflammation is involved in the onset and progression of several neurological diseases, and the fact that estrogens have anti-inflammatory activity suggests that these hormones may be a determinant in the sex-dependent manifestation of brain pathologies. We describe significant differences in the transcriptome of adult male and female microglia, possibly originating from perinatal exposure to sex steroids. Microglia isolated from adult brains maintain the sex-specific features when put in culture or transplanted in the brain of the opposite sex. Female microglia are neuroprotective because they restrict the damage caused by acute focal cerebral ischemia. This study therefore provides insight into a distinct perspective on the mechanisms underscoring a sexual bias in the susceptibility to brain diseases.","['cell transfer', 'estrogens', 'ischemic stroke', 'microglia', 'neuroinflammation', 'sexual differentiation']",Cell reports,2018-06-21,"[{'lastname': 'Villa', 'firstname': 'Alessandro', 'initials': 'A', 'affiliation': 'Center of Excellence on Neurodegenerative Diseases of the University of Milan, Milan 20133, Italy; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy.'}, {'lastname': 'Gelosa', 'firstname': 'Paolo', 'initials': 'P', 'affiliation': 'Centro Cardiologico Monzino IRCCS, Milan 20138, Italy.'}, {'lastname': 'Castiglioni', 'firstname': 'Laura', 'initials': 'L', 'affiliation': 'Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy.'}, {'lastname': 'Cimino', 'firstname': 'Mauro', 'initials': 'M', 'affiliation': 'Department of Biomolecular Sciences, University of Urbino, Urbino 61029, Italy.'}, {'lastname': 'Rizzi', 'firstname': 'Nicoletta', 'initials': 'N', 'affiliation': 'Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy.'}, {'lastname': 'Pepe', 'firstname': 'Giovanna', 'initials': 'G', 'affiliation': 'Center of Excellence on Neurodegenerative Diseases of the University of Milan, Milan 20133, Italy; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy.'}, {'lastname': 'Lolli', 'firstname': 'Federica', 'initials': 'F', 'affiliation': 'Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy.'}, {'lastname': 'Marcello', 'firstname': 'Elena', 'initials': 'E', 'affiliation': 'Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy.'}, {'lastname': 'Sironi', 'firstname': 'Luigi', 'initials': 'L', 'affiliation': 'Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy; Centro Cardiologico Monzino IRCCS, Milan 20138, Italy.'}, {'lastname': 'Vegeto', 'firstname': 'Elisabetta', 'initials': 'E', 'affiliation': 'Center of Excellence on Neurodegenerative Diseases of the University of Milan, Milan 20133, Italy; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy.'}, {'lastname': 'Maggi', 'firstname': 'Adriana', 'initials': 'A', 'affiliation': 'Center of Excellence on Neurodegenerative Diseases of the University of Milan, Milan 20133, Italy; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy. Electronic address: adriana.maggi@unimi.it.'}]",,,,Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.,10.1016/j.celrep.2018.05.048,<Element 'PubmedArticle' at 0x7f05ded94db0>
337,29920821,The influence of sex and neonatal stress on medullary microglia in rat pups.,"What is the central question of the study? Does neonatal stress, in the form of neonatal maternal separation, influence the maturation of microglial density, morphology and neuronal signalling in medullary regions regulating cardiorespiratory function in rat pups? What is the main finding and its importance? Using Iba-1 immunohistochemistry, we show that neonatal maternal separation augments microglial density and the proportion of cells with an amoeboid morphology in the medulla. Although the current understanding of the effect of early life stress on medullary development is relatively limited, these data show that within this area, microglia are affected by neonatal stress. Microglia could therefore be important effectors in cardiorespiratory disorders resulting from maternal separation.
Neonatal stress has wide-ranging consequences for the developing brain, including the medullary cardiorespiratory network. In rat pups, the reflexive cardiorespiratory inhibition triggered by the presence of liquids near the larynx is augmented by neonatal maternal separation (NMS), especially in males. Sex-specific enhancement of synaptic connectivity by NMS might explain this cardiorespiratory dysfunction. Microglia influence the formation, maturation, activity and elimination of developing synapses, but their role in the wiring of medullary networks is unknown. Owing to their sensitivity to sex hormones and stress hormones, microglial dysfunction could contribute to the abnormal cardiorespiratory phenotype observed in NMS pups. Here, we first used ionized calcium-binding adapter molecule-1 (Iba-1) immunolabelling to compare the density and morphology of microglia in the medulla of male versus female rat pups (14-15 days old) that were either undisturbed or subjected to NMS (3 h day","['CX3CL1', 'CX3CR1', 'dorsal motor nucleus of the vagus', 'fractalkine', 'nucleus of the solitary tract']",Experimental physiology,2018-06-20,"[{'lastname': 'Baldy', 'firstname': 'Cécile', 'initials': 'C', 'affiliation': ""Département de Pédiatrie, Centre de Recherche de l'Institut Universitaire de Cardiologie et Pneumologie de Québec, Université Laval, Québec, QC, Canada.""}, {'lastname': 'Fournier', 'firstname': 'Stéphanie', 'initials': 'S', 'affiliation': ""Département de Pédiatrie, Centre de Recherche de l'Institut Universitaire de Cardiologie et Pneumologie de Québec, Université Laval, Québec, QC, Canada.""}, {'lastname': 'Boisjoly-Villeneuve', 'firstname': 'Samuel', 'initials': 'S', 'affiliation': ""Département de Pédiatrie, Centre de Recherche de l'Institut Universitaire de Cardiologie et Pneumologie de Québec, Université Laval, Québec, QC, Canada.\nDépartement de Médecine Moléculaire, Centre de Recherche du CHU de Québec, Université Laval, Québec, QC, Canada.""}, {'lastname': 'Tremblay', 'firstname': 'Marie-Ève', 'initials': 'MÈ', 'affiliation': 'Département de Médecine Moléculaire, Centre de Recherche du CHU de Québec, Université Laval, Québec, QC, Canada.'}, {'lastname': 'Kinkead', 'firstname': 'Richard', 'initials': 'R', 'affiliation': ""Département de Pédiatrie, Centre de Recherche de l'Institut Universitaire de Cardiologie et Pneumologie de Québec, Université Laval, Québec, QC, Canada.""}]",,,,© 2018 The Authors. Experimental Physiology © 2018 The Physiological Society.,10.1113/EP087088,<Element 'PubmedArticle' at 0x7f05decf81d0>
338,"29907890
19734226
22328144
28461492
28685525
27046448
17127318
20874703
20160089
17702952
24565356
6120194
27358339
23385670
26342944
26038194
10027877
10707895
29504360
29504369
25366915
23370232
8940412
27327647
18606459
28691472
23891892
26856948
23449592
25065370
29504371
23637859
27278642
26265356
22561833
27358151
21185371
29552870
19393021
29254299
19782662
24811097
11544459
2107255
16436037
27095287
27358146
8834089
29254286
26889214
27049090
24275599
26813861
16688636
21704703
23933981
23895397
27334012
16052036
24210352
2825938
8382735
9886758
29552875
20206673
16162953
26442697
9292513
23570274
15771585
10517906
24275600
26781461
24441519
26648785
15860230
25695654
18977036
9184654
24784142
20211628
10201880
16289311
12769601
22898207
14568962
29685016
24180395
26966318
18172175
8587796
15491778
8386517
28952282
12644313
29504362",Impact of mast cells in depression disorder: inhibitory effect of IL-37 (new frontiers).,"The purpose of this article is to study the involvement of inflammatory mast cells (MCs) in depression which may be inhibited by IL-37. We evaluate mast cells in depression on the basis of our previous experimental data, and using the most relevant studies reported in the literature. Dysfunction of mood, feelings, and thoughts is a major risk factor for several metabolic diseases and may influence the physiology of the body leading to depression. Depression, present in mastocytosis, is an important endogenous process that promotes the activation of meningeal cell receptors through a low-grade neurogenic chronic inflammation, and MCs. Mast cells are localized along meningeal blood vessels and connective tissues, as well as between the ganglion cells and nerve fibers. They are present in the hypothalamus of mammalian brains capable of communication with nerves. MCs are classically activated by binding to IgE cross-link FcεRI high-affinity receptor leading to release a plethora of mediators responsible for the generation of inflammatory cytokines. Corticotropin-releasing hormone (CRH), produced by MCs, has been found in microglial cells where it regulates immune cells and contributes to the pathogenesis of neurodegenerative diseases including depression. Inflammatory cytokines released by MCs aggravate depression and could be partially inhibited by IL-37. A detailed understanding of the interaction between the immune system, including MCs and depression, is necessary in order to address an effective therapy which could include IL-37. As a consequence, the concepts reviewed here have treatment implications.","['Cytokines', 'Depression', 'IL-37', 'Inflammation', 'Mast cells']",Immunologic research,2018-06-17,"[{'lastname': 'Conti', 'firstname': 'Pio', 'initials': 'P', 'affiliation': ""Postgraduate Medical School, University of Chieti-Pescara, Viale Unità d'Italia 73, Chieti, 66013, Italy. pconti@unich.it.""}, {'lastname': 'Caraffa', 'firstname': 'Alessandro', 'initials': 'A', 'affiliation': 'University of Perugia, Perugia, Italy.'}, {'lastname': 'Ronconi', 'firstname': 'Gianpaolo', 'initials': 'G', 'affiliation': 'Clinica dei Pazienti del Territorio, Policlinico Gemelli, Rome, Italy.'}, {'lastname': 'Conti', 'firstname': 'Chiara M', 'initials': 'CM', 'affiliation': 'Department of Clinical Psychology, University of Chieti, Chieti, Italy.'}, {'lastname': 'Kritas', 'firstname': 'Spiros K', 'initials': 'SK', 'affiliation': 'Department of Microbiology and Infectious Diseases, Aristotle University of Thessaloniki, Thessaloniki, Macedonia, Greece.'}, {'lastname': 'Mastrangelo', 'firstname': 'Filiberto', 'initials': 'F', 'affiliation': 'Department of Medical Science and Biotechnology, University of Foggia, Foggia, Italy.'}, {'lastname': 'Tettamanti', 'firstname': 'Lucia', 'initials': 'L', 'affiliation': 'Department of Medical and Morphological Science, University of Insubria, Varese, Italy.'}, {'lastname': 'Theoharides', 'firstname': 'Theoharis C', 'initials': 'TC', 'affiliation': 'Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, Boston, MA, USA.'}]",,,,,10.1007/s12026-018-9004-9,<Element 'PubmedArticle' at 0x7f05ded070e0>
339,29890414,A synthetic diosgenin primary amine derivative attenuates LPS-stimulated inflammation via inhibition of NF-κB and JNK MAPK signaling in microglial BV2 cells.,"Diosgenin, a precursor of steroid hormones in plants, is known to exhibit diverse pharmacological activities including anti-inflammatory properties. In this study, (3β, 25R)‑spirost‑5‑en‑3‑oxyl (2‑((2((2‑aminoethyl)amino)ethyl)amino)ethyl) carbamate (DGP), a new synthetic diosgenin derivative incorporating primary amine was used to investigate its anti-inflammatory effects and underlying mechanisms of action in lipopolysaccharide (LPS)-stimulated microglial BV2 cells. Pretreatment with DGP resulted in significant inhibition of nitric oxide (NO) synthesis, and down-regulation of nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in LPS-stimulated microglial BV2 cells. In addition, DGP decreased the production of reactive oxygen species (ROS) and pro-inflammatory cytokines such as interleukin (IL)-6, IL-1β, and tumor necrosis factor alpha (TNF-α). The inhibitory effects of DGP on these inflammatory mediators in LPS-stimulated microglial BV2 cells were regulated by NF-κB signaling through blocking p65 nuclear translocation and NF-κB p65/DNA binding activity. DGP also blocked the phosphorylation of c-Jun amino-terminal kinase (JNK), but not p38 kinase or extracellular signal-regulated kinases (ERK). The NF-κB inhibitor JSH-23 and JNK-specific inhibitor SP600125 significantly decreased NO production and IL-6 release in LPS-stimulated BV2 cells, respectively. The overall results demonstrate that DGP has anti-inflammatory effects on LPS-stimulated BV2 cells via inhibition of NF-κB and JNK activation, suggesting that DGP is a potential prophylactic agent in various neurodegenerative disorders.","['Diosgenin derivative', 'MAPK', 'Microglia', 'NF-κB', 'Neuroinflammation']",International immunopharmacology,2018-06-12,"[{'lastname': 'Cai', 'firstname': 'Bangrong', 'initials': 'B', 'affiliation': 'Dental Science Research Institute, Department of Oral Physiology, School of Dentistry, Chonnam National University, Gwangju, Republic of Korea.'}, {'lastname': 'Seong', 'firstname': 'Kyung-Joo', 'initials': 'KJ', 'affiliation': 'Dental Science Research Institute, Department of Oral Physiology, School of Dentistry, Chonnam National University, Gwangju, Republic of Korea.'}, {'lastname': 'Bae', 'firstname': 'Sun-Woong', 'initials': 'SW', 'affiliation': 'Dental Science Research Institute, Department of Oral Physiology, School of Dentistry, Chonnam National University, Gwangju, Republic of Korea.'}, {'lastname': 'Chun', 'firstname': 'Changju', 'initials': 'C', 'affiliation': 'Research Institute of Drug Development, College of Pharmacy, Chonnam National University, Gwangju, Republic of Korea.'}, {'lastname': 'Kim', 'firstname': 'Won-Jae', 'initials': 'WJ', 'affiliation': 'Dental Science Research Institute, Department of Oral Physiology, School of Dentistry, Chonnam National University, Gwangju, Republic of Korea. Electronic address: wjkim@jnu.ac.kr.'}, {'lastname': 'Jung', 'firstname': 'Ji-Yeon', 'initials': 'JY', 'affiliation': 'Dental Science Research Institute, Department of Oral Physiology, School of Dentistry, Chonnam National University, Gwangju, Republic of Korea. Electronic address: jjy@jnu.ac.kr.'}]",,,,Copyright © 2018. Published by Elsevier B.V.,10.1016/j.intimp.2018.05.021,<Element 'PubmedArticle' at 0x7f05ded287c0>
340,"29849895
1997500
9445346
16049426
11186229
9347981
17379265
9809515
11896151
24462786
9344403
19890493
18716201
24064221
22172623
8885820
10893061
26286657
22079780
23994581
27317847
25423896
27843532
28477436
24594140
19889994
26891883
25892506
26189910
18297067
20479872
21808025
16527848
12777704
15488487
23261660
24882635
19103177
27916979
24399084
8843599
23686747
19565166
28210215
25800044
22933588
22710659
28555105
22669167
26490364
28127698
27957680
27036651
26337121
10453051
24508637
18522863
27196727
23994069
27127723
23792783
24163150
2110186
37614
23737832
25387796
7953717
18505597
28848398
27364756
29119451
26627258
16125703
22538356
17239878
25578260
28260801
24889886
26538310
28823928
26269636
27013935
23404620
25774010
28365213
28642697
27830532
10987824
26246072
26732561
26802724
16872778
12209854
21774811
24551115
26973103
12878732
23385013
25305410
22046440
28284347
11014219
11245665",17,17,[],Oxidative medicine and cellular longevity,2018-06-01,"[{'lastname': 'Thakkar', 'firstname': 'Roshni', 'initials': 'R', 'affiliation': 'Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA.'}, {'lastname': 'Wang', 'firstname': 'Ruimin', 'initials': 'R', 'affiliation': 'Department of Neurobiology, North China University of Science and Technology, Tangshan, Hebei, China.'}, {'lastname': 'Wang', 'firstname': 'Jing', 'initials': 'J', 'affiliation': 'Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA.'}, {'lastname': 'Vadlamudi', 'firstname': 'Ratna K', 'initials': 'RK', 'affiliation': 'Department of Obstetrics and Gynecology, University of Texas Health, San Antonio, TX, USA.'}, {'lastname': 'Brann', 'firstname': 'Darrell W', 'initials': 'DW', 'affiliation': 'Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA.'}]",,,,,"10.1155/2018/4248526
10.1038/jcbfm.1991.61
10.1161/01.STR.29.1.159
10.1038/sj.jcbfm.9600194
10.1089/neu.2000.17.1155
10.3171/jns.1997.87.5.0724
10.1016/j.steroids.2007.02.003
10.1097/00004647-199811000-00012
10.1016/j.mce.2014.01.013
10.1016/S0002-9343(97)00260-X
10.1177/1756285608100427
10.1523/JNEUROSCI.2752-08.2008
10.1016/j.psyneuen.2013.08.005
10.1016/S1474-4422(11)70269-1
10.1001/archinte.1996.00440180075009
10.1016/j.jshs.2014.04.003
10.1034/j.1600-0404.2000.102001037.x
10.1101/lm.037267.114
10.1016/j.yfrne.2011.10.001
10.1016/j.yfrne.2013.08.001
10.1016/j.brainres.2016.06.016
10.1038/nrn3856
10.1155/2016/8309031
10.1111/jne.12482
10.1016/j.mce.2014.01.024
10.1523/JNEUROSCI.3574-09.2009
10.1016/j.pneurobio.2015.12.008
10.1016/j.neuropharm.2015.04.006
10.1016/j.jsbmb.2015.06.014
10.1038/nn2057
10.1371/journal.pone.0009851
10.1073/pnas.1104391108
10.1210/en.2005-1177
10.1385/ENDO:21:1:59
10.1016/j.brainres.2004.08.038
10.1016/j.brainres.2012.12.015
10.1016/j.yfrne.2014.05.003
10.1016/j.brainres.2008.12.011
10.1038/nri.2016.123
10.1038/nrn3638
10.1016/0166-2236(96)10049-7
10.1002/jnr.23242
10.3389/fncel.2017.00018
10.1111/bph.13139
10.1161/STROKEAHA.112.659656
10.1007/s00005-012-0181-2
10.3389/fnagi.2017.00139
10.1038/npp.2012.82
10.1111/jnc.13404
10.1007/s12035-017-0400-2
10.1007/s12035-016-0322-4
10.1016/j.bbr.2016.03.044
10.1159/000439435
10.1002/(SICI)1097-4695(19990915)40:4<484::AID-NEU6>3.0.CO;2-C
10.1016/j.mce.2013.12.019
10.1016/j.yfrne.2008.04.001
10.1210/er.2016-1007
10.1016/j.expneurol.2013.08.011
10.1002/brb3.449
10.1016/j.jsbmb.2013.06.003
10.1007/s12031-013-0137-y
10.1016/0165-5728(90)90073-V
10.1161/01.STR.10.3.267
10.1155/2013/459723
10.1007/s12192-014-0552-1
10.1016/0006-8993(94)90334-4
10.1186/1471-2199-9-53
10.3389/fncel.2017.00235
10.1186/s12974-016-0621-8
10.1007/s12640-017-9837-3
10.1073/pnas.1516729112
10.1016/j.yhbeh.2005.07.010
10.1159/000338409
10.1016/j.yhbeh.2006.12.002
10.1016/j.brainres.2014.12.045
10.1038/aps.2016.162
10.1186/1742-2094-11-98
10.1186/s12974-015-0411-8
10.1016/j.nbd.2017.08.009
10.1523/JNEUROSCI.1685-15.2015
10.3389/fnins.2016.00061
10.1002/glia.22478
10.1016/j.bbi.2015.03.005
10.1016/j.nbd.2017.03.016
10.3389/fnagi.2017.00176
10.1007/s12035-016-0245-0
10.1007/s11011-015-9714-9
10.1161/STROKEAHA.115.012079
10.1016/j.bbr.2016.01.028
10.1016/j.exger.2006.06.032
10.1002/cne.10325
10.1186/1742-2094-8-82
10.1371/journal.pone.0088540
10.1016/j.neurobiolaging.2016.01.002
10.1073/pnas.1531957100
10.1016/j.steroids.2012.12.015
10.1016/j.jsbmb.2014.10.002
10.1371/journal.pone.0027039
10.1016/j.jneuroim.2016.12.018
10.1210/endo.141.10.7693",<Element 'PubmedArticle' at 0x7f05decb9a90>
341,29793601,Adiponectin regulates thermal nociception in a mouse model of neuropathic pain.,"Adiponectin, a cytokine secreted by adipocytes, plays an important role in regulating glucose and lipid metabolism. However, the role of adiponectin in pain conditions is largely unknown. This study aimed to identify the role and mechanism of adiponectin in nociceptive sensitivity under physiological and pathological states utilising adiponectin knockout (KO) mice.
Wild type (WT) and adiponectin KO mice were subjected to partial sciatic nerve ligation (pSNL) or sham operation. Pain-like behavioural tests, including thermal allodynia, hyperalgesia, and mechanical allodynia, were performed before and after pSNL from Day 3-21. Dorsal root ganglions (DRGs), lumbar spinal segments at L3-5, and somatosensory cortex were collected for protein measurement via western blotting and immunofluorescence staining.
Compared with WT mice, KO mice had significantly lower (40-50%) paw withdrawal latency to innocuous and noxious stimuli before and after pSNL. In DRG neurones from KO mice, where adiponectin receptor (AdipoR) 2 is located, phosphorylated p38 mitogen-activated protein kinase (p-p38 MAPK) and heat-sensitive transient receptor potential cation channel subfamily V member 1 (TRPV1) were significantly higher (by two- to three-fold) than from WT mice. In spinal microglia and somatosensory cortical neurones, where AdipoR1 is mainly located, p-p38 MAPK and TRPV1 were also higher (by two- to three-fold) in KO compared with WT mice, and altered signalling of these molecules was exacerbated (1.2- to 1.3-fold) by pSNL.
Our results show that adiponectin regulates thermal nociceptive sensitivity by inhibiting activation of DRG neurones, spinal microglia, and somatosensory cortical neurones in physiological and neuropathic pain states. This study has relevance for patients with adiponectin disorders, such as obesity and diabetes.","['adiponectin', 'hyperalgesia', 'neuralgia', 'neuroinflammation', 'p38 mitogen-activated protein kinase']",British journal of anaesthesia,2018-05-26,"[{'lastname': 'Sun', 'firstname': 'L', 'initials': 'L', 'affiliation': 'Laboratory and Clinical Research Institute for Pain, The University of Hong Kong, China; Department of Anaesthesiology, The University of Hong Kong, China.'}, {'lastname': 'Li', 'firstname': 'H', 'initials': 'H', 'affiliation': 'Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Harvard University, Boston, MA, USA.'}, {'lastname': 'Tai', 'firstname': 'L W', 'initials': 'LW', 'affiliation': 'Laboratory and Clinical Research Institute for Pain, The University of Hong Kong, China; Department of Anaesthesiology, The University of Hong Kong, China.'}, {'lastname': 'Gu', 'firstname': 'P', 'initials': 'P', 'affiliation': 'Laboratory and Clinical Research Institute for Pain, The University of Hong Kong, China; Department of Anaesthesiology, The University of Hong Kong, China.'}, {'lastname': 'Cheung', 'firstname': 'C W', 'initials': 'CW', 'affiliation': 'Laboratory and Clinical Research Institute for Pain, The University of Hong Kong, China; Department of Anaesthesiology, The University of Hong Kong, China. Electronic address: cheucw@hku.hk.'}]",,,"Compared with WT mice, KO mice had significantly lower (40-50%) paw withdrawal latency to innocuous and noxious stimuli before and after pSNL. In DRG neurones from KO mice, where adiponectin receptor (AdipoR) 2 is located, phosphorylated p38 mitogen-activated protein kinase (p-p38 MAPK) and heat-sensitive transient receptor potential cation channel subfamily V member 1 (TRPV1) were significantly higher (by two- to three-fold) than from WT mice. In spinal microglia and somatosensory cortical neurones, where AdipoR1 is mainly located, p-p38 MAPK and TRPV1 were also higher (by two- to three-fold) in KO compared with WT mice, and altered signalling of these molecules was exacerbated (1.2- to 1.3-fold) by pSNL.",Copyright © 2018 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.,10.1016/j.bja.2018.01.016,<Element 'PubmedArticle' at 0x7f05dec37e50>
342,29782911,"Estrogen deficiency exacerbates Aβ-induced memory impairment through enhancement of neuroinflammation, amyloidogenesis and NF-ĸB activation in ovariectomized mice.","Estrogen is well known to have a preventative effect in Alzheimer's disease (AD) pathology. Several studies have demonstrated that nuclear factor kappa-B (NF-ĸB) can contribute to the effects of estrogen on the development of AD. We investigated whether NF-ĸB affects amyloid-beta (Aβ)-induced memory impairment in an estrogen-lacking condition. In the present study, nine-week-old Institute cancer research (ICR) mice were ovariectomized to block estrogen stimulation. Ten weeks after the ovariectomization, mice were administered with Aβ (300 pmol) via intracerebroventricular (ICV) infusion for 2 weeks. Memory impairment, neuroinflammatory protein expression, and amyloidogenic pathways were then measured. Ovariectomized mice demonstrated severe memory impairment, Aβ accumulation, neprilysin downregulation, and activation of NF-ĸB signaling compared to sham-control mice. In vitro experiments demonstrated that β-estradiol (10 μM) inhibited Aβ (1 μM)-induced neuroinflammation in microglial BV-2 cells and prevented Aβ-induced cell death in primary cultured neuronal cells. As in in vivo experiments, NF-ĸB activation was significantly upregulated in in vitro experiments. Furthermore β-estradiol treatment inhibited NF-ĸB activation in both of microglial BV-2 cells and cultured neuronal cells. These findings suggest that estrogen may protect against memory impairment through the regulation of Aβ accumulation and neurogenic inflammation by inhibiting NF-κB activity.","['Alzheimer disease (AD)', 'Amyloid-beta (Aβ)', 'Estrogens', 'NF-κB', 'Neuroinflammation']","Brain, behavior, and immunity",2018-05-22,"[{'lastname': 'Yun', 'firstname': 'Jaesuk', 'initials': 'J', 'affiliation': 'College of Pharmacy and Medical Research Center, Chungbuk National University, Osongsaengmyeong 1-ro 194-31, Osong-eup, Heungduk-gu, Cheongju, Chungbuk 28160, Republic of Korea; College of Pharmacy, Wonkwang University, Iksandaero 460, Iksan, Jeonbuk 54538, Republic of Korea.'}, {'lastname': 'Yeo', 'firstname': 'In Jun', 'initials': 'IJ', 'affiliation': 'College of Pharmacy and Medical Research Center, Chungbuk National University, Osongsaengmyeong 1-ro 194-31, Osong-eup, Heungduk-gu, Cheongju, Chungbuk 28160, Republic of Korea.'}, {'lastname': 'Hwang', 'firstname': 'Chul Ju', 'initials': 'CJ', 'affiliation': 'College of Pharmacy and Medical Research Center, Chungbuk National University, Osongsaengmyeong 1-ro 194-31, Osong-eup, Heungduk-gu, Cheongju, Chungbuk 28160, Republic of Korea.'}, {'lastname': 'Choi', 'firstname': 'Dong-Young', 'initials': 'DY', 'affiliation': 'College of Pharmacy, Yeungnam University, 280, Daehak-Ro, Gyeongsan, Gyeongbuk 712-749, Republic of Korea.'}, {'lastname': 'Im', 'firstname': 'Hyung-Sik', 'initials': 'HS', 'affiliation': 'College of Pharmacy and Medical Research Center, Chungbuk National University, Osongsaengmyeong 1-ro 194-31, Osong-eup, Heungduk-gu, Cheongju, Chungbuk 28160, Republic of Korea.'}, {'lastname': 'Kim', 'firstname': 'Ji Youg', 'initials': 'JY', 'affiliation': 'College of Pharmacy and Medical Research Center, Chungbuk National University, Osongsaengmyeong 1-ro 194-31, Osong-eup, Heungduk-gu, Cheongju, Chungbuk 28160, Republic of Korea.'}, {'lastname': 'Choi', 'firstname': 'Won Rak', 'initials': 'WR', 'affiliation': 'College of Pharmacy and Medical Research Center, Chungbuk National University, Osongsaengmyeong 1-ro 194-31, Osong-eup, Heungduk-gu, Cheongju, Chungbuk 28160, Republic of Korea.'}, {'lastname': 'Jung', 'firstname': 'Myung Hee', 'initials': 'MH', 'affiliation': 'College of Pharmacy and Medical Research Center, Chungbuk National University, Osongsaengmyeong 1-ro 194-31, Osong-eup, Heungduk-gu, Cheongju, Chungbuk 28160, Republic of Korea.'}, {'lastname': 'Han', 'firstname': 'Sang-Bae', 'initials': 'SB', 'affiliation': 'College of Pharmacy and Medical Research Center, Chungbuk National University, Osongsaengmyeong 1-ro 194-31, Osong-eup, Heungduk-gu, Cheongju, Chungbuk 28160, Republic of Korea.'}, {'lastname': 'Hong', 'firstname': 'Jin Tae', 'initials': 'JT', 'affiliation': 'College of Pharmacy and Medical Research Center, Chungbuk National University, Osongsaengmyeong 1-ro 194-31, Osong-eup, Heungduk-gu, Cheongju, Chungbuk 28160, Republic of Korea. Electronic address: jinthong@chungbuk.ac.kr.'}]",,,,Copyright © 2018 Elsevier Inc. All rights reserved.,10.1016/j.bbi.2018.05.013,<Element 'PubmedArticle' at 0x7f05dec45d60>
343,29772377,Impact of steroid hormones E2 and P on the NLRP3/ASC/Casp1 axis in primary mouse astroglia and BV-2 cells after in vitro hypoxia.,"Clinical and animal model studies have demonstrated the neuroprotective and anti-inflammatory effects of 17beta-estradiol (E2) and progesterone (P) in different disease models of the central nervous system (CNS) including ischemic stroke. Inflammasomes are involved in the interleukin-1 beta (IL1beta) maturation, in particular, NLRP3, the adaptor protein apoptosis-associated speck-like protein containing a CARD (ASC) and the active caspase-1 (Casp1) form. Recently, we showed that administration of E2 or P selectively regulated these components after experimental ischemic stroke in rats. Therefore, we investigated the impact of E2 and P on the NLRP3/ASC/Casp1 axis in the murine microglia-like cell line BV-2 cells and primary astrocytes after short-term in vitro hypoxia. The inflammatory cytokine IL1beta but not IL18 was increased after short-term hypoxia in astroglia and BV-2 cells. The same applied to NLPR3 and ASC. Casp1 activity was also elevated in astroglia and BV-2 cells after hypoxia. The administration of E2 or P selectively dampened IL1beta, ASC and NLRP3 expression mainly in BV-2 cells. Both steroid hormones failed to reduce Casp1 activity after hypoxia. We conclude that E2- and P-mediated anti-inflammatory mechanisms occur upstream of Casp1 through the regulation of NLRP3 and its adaptor ASC.","['Astrocytes', 'BV-2', 'Estrogen', 'NLRP3', 'Neuroinflammation', 'Neuroprotection', 'Progesterone']",The Journal of steroid biochemistry and molecular biology,2018-05-18,"[{'lastname': 'Slowik', 'firstname': 'Alexander', 'initials': 'A', 'affiliation': 'Institute of Neuroanatomy, RWTH Aachen University, Aachen, Germany. Electronic address: aslowik@ukaachen.de.'}, {'lastname': 'Lammerding', 'firstname': 'Leoni', 'initials': 'L', 'affiliation': 'Department of Neurology, University Hospital of Münster, Münster, Germany.'}, {'lastname': 'Zendedel', 'firstname': 'Adib', 'initials': 'A', 'affiliation': 'Institute of Neuroanatomy, RWTH Aachen University, Aachen, Germany; Giulan Neuroscience Research Center, Department of Anatomical Sciences, Faculty of Medicine, Guilan University of Medical Sciences, Rasht, Iran.'}, {'lastname': 'Habib', 'firstname': 'Pardes', 'initials': 'P', 'affiliation': 'Department of Neurology, RWTH Aachen University, Aachen, Germany.'}, {'lastname': 'Beyer', 'firstname': 'Cordian', 'initials': 'C', 'affiliation': 'Institute of Neuroanatomy, RWTH Aachen University, Aachen, Germany; JARA-Brain, RWTH Aachen University, Aachen, Germany.'}]",,,,Copyright © 2018 Elsevier Ltd. All rights reserved.,10.1016/j.jsbmb.2018.05.003,<Element 'PubmedArticle' at 0x7f05dec58950>
344,"29765306
26697495
23959119
6278093
28469598
19735725
1664329
26666666
8544901
1430157
20402965
21835190
20964644
9672144
24577465
19877171
26990767
24625061
21593435
16912050
25920959
29255847
20303880
25869103
16470015
16154999
17321748
24962261
19080340
25731011
16698015
11169611
25680080
23312512
21903077
22580532
16889769
14973251
26861289
20205644
27716676
8757015
12676175
16177542
16678218
22122230
17021169
26662122
28449585
22827472
26993513
11445253
17324119
23207766
19595728
22651808
10471976
26567746
28385651
27562846
19635982
24316465
22776970
27490783
18160199
28597200
16754269
20870012
20063035
21297982
23562443
17687040",Microglial Activation Is Modulated by Captopril: ,"The renin-angiotensin system (RAS) is an important peripheral system involved in homeostasis modulation, with angiotensin II (Ang II) serving as the main effector hormone. The main enzyme involved in Ang II formation is angiotensin-converting enzyme (ACE). ACE inhibitors (ACEIs) such as captopril (Cap) are predominantly used for the management of hypertension. All of the components of the RAS have also been identified in brain. Centrally located hormones such as Ang II can induce glial inflammation. Moreover, in Alzheimer's disease (AD) models, where glial inflammation occurs and is thought to contribute to the propagation of the disease, increased levels of Ang II and ACE have been detected. Interestingly, ACE overexpression in monocytes, migrating to the brain was shown to prevent AD cognitive decline. However, the specific effects of captopril on glial inflammation and AD remain obscure. In the present study, we investigated the effect of captopril, given at a wide concentration range, on inflammatory mediators released by lipopolysaccharide (LPS)-treated glia. In the current study, both primary glial cells and the BV2 microglial cell line were used. Captopril decreased LPS-induced nitric oxide (NO) release from primary mixed glial cells as well as regulating inducible NO synthase (iNOS) expression, NO, tumor necrosis factor-α (TNF-α) and induced interleukin-10 (IL-10) production by BV2 microglia. We further obtained data regarding intranasal effects of captopril on cortical amyloid β (Aβ) and CD11b expression in 5XFAD cortex over three different time periods. Interestingly, we noted decreases in Aβ burden in captopril-treated mice over time which was paralleled by increased microglial activation. These results thus shed light on the neuroprotective role of captopril in AD which might be related to modulation of microglial activation.","['Alzheimer’s disease', 'angiotensin II', 'angiotensin-converting enzyme', 'captopril', 'glial inflammation']",Frontiers in cellular neuroscience,2018-05-17,"[{'lastname': 'Asraf', 'firstname': 'Keren', 'initials': 'K', 'affiliation': 'Department of Clinical Biochemistry and Pharmacology, Ben-Gurion University of the Negev, Beersheba, Israel.'}, {'lastname': 'Torika', 'firstname': 'Nofar', 'initials': 'N', 'affiliation': 'Department of Clinical Biochemistry and Pharmacology, Ben-Gurion University of the Negev, Beersheba, Israel.'}, {'lastname': 'Apte', 'firstname': 'Ron N', 'initials': 'RN', 'affiliation': 'The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben Gurion University of the Negev, Beersheba, Israel.'}, {'lastname': 'Fleisher-Berkovich', 'firstname': 'Sigal', 'initials': 'S', 'affiliation': 'Department of Clinical Biochemistry and Pharmacology, Ben-Gurion University of the Negev, Beersheba, Israel.'}]",,,,,"10.3389/fncel.2018.00116
10.1155/2015/917156
10.3390/ijms140816917
10.1111/j.1471-4159.1982.tb07930.x
10.3389/fendo.2017.00082
10.1016/j.bbi.2009.09.001
10.1016/0014-2999(91)90584-d
10.1007/s12035-015-9584-5
10.1016/0197-4580(95)00049-k
10.1016/0165-5728(92)90143-9
10.1111/j.1471-4159.2010.06736.x
10.1016/j.toxicon.2011.07.013
10.1111/j.1365-2249.2010.04270.x
10.1016/s0165-2478(98)00025-x
10.3233/JAD-132189
10.1002/jps.21924
10.1111/jnc.13607
10.1186/1742-2094-11-48
10.1096/fj.11-182873
10.1074/jbc.M605827200
10.1038/jcbfm.2015.79
10.7326/M17-1529
10.1016/j.cell.2010.02.016
10.1016/j.pbb.2015.04.002
10.1093/ajcn/83.2.470S
10.1074/jbc.M508460200
10.1016/j.nbd.2007.01.004
10.1038/nri3705
10.2298/SARH1412756I
10.1016/j.exer.2006.03.005
10.1002/1097-4547(20010101)63:1<27::aid-jnr4>3.3.co;2-r
10.1021/cn500363g
10.1016/j.neuron.2012.12.023
10.1016/j.neuron.2011.07.001
10.1016/s1734-1140(12)70742-9
10.1016/j.ejphar.2006.06.074
10.1523/JNEUROSCI.4580-03.2004
10.3390/ijms17020206
10.2174/187152710791012071
10.3233/jad-160488
10.1212/wnl.47.2.425
10.1016/S1357-2725(02)00306-0
10.1254/jphs.srj05001x
10.1016/j.neuropharm.2006.03.004
10.1111/j.1471-4159.2011.07510.x
10.1523/JNEUROSCI.1202-06.2006
10.1177/1533317517707288
10.1042/CS20120078
10.1007/s10571-015-0327-y
10.1016/s0197-4580(00)00259-1
10.1042/cs20060247
10.1248/bpb.b12-00387
10.1016/j.peptides.2009.07.003
10.1186/1742-2094-9-115
10.1023/A:1020568013953
10.2174/1567205013666151116125012
10.1016/j.bbi.2017.04.001
10.1007/s11481-016-9703-8
10.1161/HYPERTENSIONAHA.109.136879
10.1016/j.neuropharm.2013.11.022
10.3233/JAD-2012-120763
10.1097/MNH.0000000000000250
10.1016/j.pneurobio.2007.10.009
10.1007/s12035-017-0621-4
10.1080/08037050600771583
10.1016/j.neuroscience.2010.09.029
10.1007/s00018-009-0250-9
10.1371/journal.pone.0016037
10.1016/j.ajpath.2013.01.053
10.1523/JNEUROSCI.1549-07.2007",<Element 'PubmedArticle' at 0x7f05dec65e00>
345,"29760681
11459116
21673906
26988999
4815174
14432658
18195084
15583024
27530684
16684650
558037
10746941
17013392
17222505
11444439
18374402
28144231
23357432
19401209
10328986
17596438
9030643
11113338
9925890
11751611
25511993
11978836
17266735
639042
24882635
8341652
23322319
8603038
15313771
10882835
19458217
12808104
16971528
19828812
22072656
12960034
18323418
12086642
10027289
23123886
17600562
25307223
15073041
8298194
20224563
9890981
9688926
10924060
10512927
11641386
11029403
15496504
2277354
19664713
9227446
20460386
22391220
17065532
12167775
16371946
19847447
26698019
15711064
15001666
1562533
26538779
19393685
25092805
5861717
6474166
2643827
11826092
20354534
21929623
15313799
26032719
17282988
11283751
21609825
25074747
9437023
23433260
25253853
28625813
9809557
23746839
29625071
29513649
26170290
8962152
7560271
9182802
12122071
9658334
3419503
3411349
20187140
26330519
10413781
20156817
17348018
2045885
7972037
22262875
15593136
15888646
8058723
12218180
14694190
973554
17196590
27364569
17261778
20966214
15831717
20887954
11099416
24772353
24713688
22933588
23872599
23942366
24607811
21277368
8808786
10359581
9517572
26745968
12390516
15798185
11245665
22497984
29243403
17356684
20012068
24231735
1279865
10732996
11340204
21292979
16388306
22152301
15254070
11158678
24270812
11701765
16310865
10941153
15731004
19759299
21143654
12106687
15389604
19797123
8313156
18328572
19031445
10501189
17850464
19533603
7996194
10077336
15818556
11264718
21767382
17823932
22561337
22825593
8841321
21911834
1148661
15188374
20351193
15353495
12852833
16797503
18322171
15294932
21304144
14581618
14615545
21787860
17823975
18172772
16977605
16420418
16297637
19714501
11784794
21983279
19557094
18635871
14664813
15211466
17565708
22983209
26606999
19539954
19853640
15845917
16793889
21555578
23401502
22985767
23690824
27871670
18522863
22189676
16337092
28757878
21564348
27115998
21198642
26862926
27074377
26952870
28826723
27524440
28362944
10838594
15749165
9087894
10632615
11500839
19458226
19013173
8058721
17875989
18614682
15967447
19357283
26747664
21595047
13756296
9710521
10630192
22007133
23138980
22824261","Sex Steroids, Adult Neurogenesis, and Inflammation in CNS Homeostasis, Degeneration, and Repair.","Sex steroidal hormones coordinate the development and maintenance of tissue architecture in many organs, including the central nervous systems (CNS). Within the CNS, sex steroids regulate the morphology, physiology, and behavior of a wide variety of neural cells including, but not limited to, neurons, glia, endothelial cells, and immune cells. Sex steroids spatially and temporally control distinct molecular networks, that, in turn modulate neural activity, synaptic plasticity, growth factor expression and function, nutrient exchange, cellular proliferation, and apoptosis. Over the last several decades, it has become increasingly evident that sex steroids, often in conjunction with neuroinflammation, have profound impact on the occurrence and severity of neuropsychiatric and neurodegenerative disorders. Here, I review the foundational discoveries that established the regulatory role of sex steroids in the CNS and highlight recent advances toward elucidating the complex interaction between sex steroids, neuroinflammation, and CNS regeneration through adult neurogenesis. The majority of recent work has focused on neuroinflammatory responses following acute physical damage, chronic degeneration, or pharmacological insult. Few studies directly assess the role of immune cells in regulating adult neurogenesis under healthy, homeostatic conditions. As such, I also introduce tractable, non-traditional models for examining the role of neuroimmune cells in natural neuronal turnover, seasonal plasticity of neural circuits, and extreme CNS regeneration.","['apoptosis', 'astrocyte', 'microglia', 'neural homeostasis', 'neural plasticity', 'neurodegenerative', 'neurogenesis', 'steroidal hormone']",Frontiers in endocrinology,2018-05-16,"[{'lastname': 'Larson', 'firstname': 'Tracy A', 'initials': 'TA', 'affiliation': 'Department of Biology, University of Virginia, Charlottesville, VA, United States.'}]",,,,,"10.3389/fendo.2018.00205
10.1254/jjp.86.137
10.3390/ijms12031533
10.1016/j.yfrne.2016.03.002
10.1210/jcem-38-3-476
10.1210/endo-65-3-369
10.1152/physrev.00010.2007
10.1210/er.2003-0030
10.5483/BMBRep.2016.49.9.141
10.1080/03602530600569877
10.1016/0006-8993(77)90624-2
10.1093/toxsci/54.1.138
10.1038/ng1901
10.1016/j.mce.2006.12.010
10.1385/ENDO:14:3:407
10.1016/j.yfrne.2008.02.001
10.3389/fendo.2017.00002
10.1016/j.steroids.2013.01.003
10.1016/j.yfrne.2009.04.007
10.1006/frne.1999.0177
10.1523/JNEUROSCI.0909-07.2007
10.1523/JNEUROSCI.17-05-01848.1997
10.1016/S0306-4522(00)00439-5
10.1111/j.1469-7793.1999.209ad.x
10.1210/endo.143.1.8582
10.1016/j.brainres.2014.12.011
10.1111/j.1471-4159.2006.04264.x
10.1016/j.yfrne.2014.05.003
10.1073/pnas.90.14.6439
10.1007/s10571-012-9903-6
10.1016/0960-0760(95)00234-0
10.1196/annals.1298.013
10.1016/S0891-0618(00)00051-X
10.1523/JNEUROSCI.0638-09.2009
10.1128/MCB.23.13.4649-4662.2003
10.1523/JNEUROSCI.1443-06.2006
10.1523/JNEUROSCI.3059-09.2009
10.1523/JNEUROSCI.4097-11.2011
10.1210/en.2003-0724
10.1126/science.1152677
10.1016/S0896-6273(02)00722-5
10.1016/S0896-6273(00)80678-9
10.1016/j.neuroscience.2012.09.023
10.1111/j.1440-1681.2007.04683.x
10.1016/bs.apha.2014.06.018
10.1161/01.RES.0000127719.13255.81
10.1091/mbc.4.10.973
10.1038/nprot.2010.6
10.1074/jbc.274.4.2185
10.1152/ajpheart.2000.279.2.H610
10.1161/01.STR.30.10.2186
10.1152/jappl.2001.91.5.2391
10.1161/01.RES.87.8.677
10.1124/mol.104.004465
10.1113/jphysiol.1990.sp018243
10.1016/j.nbd.2009.07.030
10.1124/jpet.110.168930
10.3233/JAD-2012-112189
10.1167/iovs.06-0322
10.1097/00001756-200208070-00024
10.1038/nrn1826
10.1007/s00401-009-0601-5
10.1016/j.neubiorev.2015.11.016
10.1159/000082141
10.1210/me.2003-0441
10.1016/0960-0760(92)90394-X
10.1016/j.yfrne.2009.04.004
10.1002/glia.22736
10.1002/cne.901240303
10.1126/science.6474166
10.1038/scientificamerican0289-74
10.1038/nrn2822
10.1111/j.1460-9568.2011.07851.x
10.1196/annals.1298.024
10.1101/cshperspect.a019000
10.1098/rstb.2006.2015
10.1038/35067582
10.1016/j.neuron.2011.05.001
10.1038/jcbfm.2014.130
10.1523/JNEUROSCI.18-03-01020.1998
10.1186/1749-8104-8-3
10.1523/JNEUROSCI.3316-13.2014
10.1016/j.bcp.2017.06.116
10.1038/3305
10.1016/j.cell.2013.05.002
10.1016/j.stem.2018.03.015
10.1038/nature25975
10.1073/pnas.1508545112
10.1073/pnas.93.25.14895
10.1002/cne.903560411
10.1016/S0896-6273(00)80317-7
10.1523/JNEUROSCI.22-14-06106.2002
10.1002/(SICI)1097-4695(199807)36:1<1::AID-NEU1>3.0.CO;2-6
10.1038/335353a0
10.1523/JNEUROSCI.08-08-02707.1988
10.1002/cne.22281
10.1101/cshperspect.a018812
10.1002/(SICI)1096-9861(19990830)411:3<487::AID-CNE10>3.0.CO;2-M
10.1098/rstb.2009.0220
10.1002/cne.21296
10.1523/JNEUROSCI.11-06-01756.1991
10.1073/pnas.91.23.11217
10.1523/JNEUROSCI.3434-11.2012
10.1002/cne.20385
10.1523/JNEUROSCI.4520-04.2005
10.1073/pnas.91.17.7854
10.1073/pnas.192308799
10.1073/pnas.2630225100
10.1111/j.1600-0404.1976.tb04363.x
10.1016/j.exer.2006.11.008
10.7554/eLife.19109
10.1196/annals.1386.035
10.1126/science.1194637
10.1126/science.1110647
10.1016/j.stem.2010.08.014
10.1126/science.290.5497.1768
10.1155/2014/610343
10.1038/nrn3722
10.1161/STROKEAHA.112.659656
10.1038/nn.3469
10.1038/jcbfm.2013.146
10.1016/j.jsbmb.2014.02.018
10.1016/j.bbi.2011.01.013
10.1016/0197-0186(95)00141-7
10.1084/jem.189.11.1777
10.1002/(SICI)1098-1136(199804)22:4<401::AID-GLIA9>3.0.CO;2-5
10.1007/s12640-015-9592-2
10.1046/j.1471-4159.2002.01122.x
10.1128/MCB.25.8.2957-2968.2005
10.1523/JNEUROSCI.21-06-01809.2001
10.1016/j.psyneuen.2012.02.018
10.1002/dneu.22569
10.1017/S1740925X06000202
10.1007/s00401-009-0619-8
10.1016/j.neuroscience.2013.10.050
10.1016/0166-2236(92)90191-A
10.1016/S0197-0186(99)00137-0
10.1126/science.1059162
10.1126/science.1197598
10.1038/nn1623
10.1016/j.cmet.2011.08.016
10.1194/jlr.R400004-JLR200
10.1126/science.291.5504.657
10.1038/nature12776
10.1046/j.1471-4159.2001.00595.x
10.1016/j.tips.2005.11.002
10.1002/1098-1136(200009)31:3<267::AID-GLIA80>3.0.CO;2-N
10.1242/jcs.01658
10.1523/JNEUROSCI.1514-09.2009
10.1111/j.1460-9568.2010.07516.x
10.1016/S0169-328X(02)00379-0
10.1002/neu.20043
10.1210/en.2009-0352
10.1016/0006-8993(93)90964-O
10.1016/j.jneuroim.2008.01.006
10.1002/glia.20806
10.1046/j.1471-4159.1999.0731453.x
10.1111/j.1365-2826.2007.01588.x
10.1002/glia.20904
10.1523/JNEUROSCI.14-12-07541.1994
10.1016/S0306-4522(98)00340-6
10.1002/neu.20147
10.1046/j.1365-2826.2001.00647.x
10.1186/1742-2094-8-81
10.1002/dneu.20548
10.1016/j.yhbeh.2012.04.007
10.1007/s00401-012-1018-0
10.1161/01.STR.27.10.1739
10.1182/blood-2011-03-340281
10.1136/bmj.2.5969.473
10.1002/art.20309
10.4049/jimmunol.0903463
10.1161/01.CIR.0000142050.19488.C7
10.1016/j.cardiores.2006.05.015
10.4049/jimmunol.180.6.3661
10.4049/jimmunol.173.4.2227
10.1176/appi.neuropsych.23.1.90
10.1073/pnas.2234031100
10.1126/science.1088417
10.1016/j.bbi.2011.07.225
10.1002/glia.20571
10.1007/s12031-007-9028-4
10.1002/glia.20419
10.1111/j.1460-9568.2005.04539.x
10.1016/j.mcn.2005.10.006
10.1007/s12035-009-8081-0
10.1523/JNEUROSCI.22-02-00486.2002
10.1016/j.bbi.2011.09.012
10.1634/stemcells.2008-0116
10.1016/S1044-7431(03)00218-5
10.1002/cne.20157
10.1002/dneu.20564
10.1038/nn.3212
10.1016/j.neuron.2015.10.037
10.1016/j.jns.2009.05.028
10.1016/j.neulet.2009.10.051
10.1677/joe.1.06063
10.1523/JNEUROSCI.0453-06.2006
10.1073/pnas.1103833108
10.1073/pnas.1300313110
10.1016/j.bbi.2012.09.003
10.1155/2013/608654
10.1016/j.biopsych.2016.10.004
10.1016/j.yfrne.2008.04.001
10.1007/s10571-011-9783-1
10.1016/j.neuroscience.2005.07.060
10.1155/2017/4653936
10.1111/j.1365-2826.2011.02156.x
10.1371/journal.pone.0154022
10.1111/j.1471-4159.2010.07168.x
10.1056/NEJMoa1600651
10.1056/NEJMsr1604338
10.1016/j.stem.2016.02.016
10.1016/j.stem.2017.07.014
10.1016/j.stem.2016.07.019
10.1093/cid/ciw878
10.1016/S0166-2236(00)01558-7
10.1016/j.tins.2005.01.004
10.1002/(SICI)1097-4695(199704)32:4<426::AID-NEU6>3.0.CO;2-8
10.1523/JNEUROSCI.20-02-00854.2000
10.1002/neu.1055
10.1523/JNEUROSCI.5571-08.2009
10.1016/j.yhbeh.2008.10.006
10.1073/pnas.91.17.7844
10.1073/pnas.0707239104
10.1523/JNEUROSCI.0663-08.2008
10.1016/j.yhbeh.2005.04.009
10.1523/JNEUROSCI.5423-08.2009
10.1101/cshperspect.a019018
10.1002/dneu.20918
10.1006/exnr.1998.6853
10.1006/exnr.1999.7182
10.1242/dev.072587
10.1126/science.1228773
10.1186/1749-8104-7-27",<Element 'PubmedArticle' at 0x7f05deb96040>
346,29747742,G protein-coupled estrogen receptor is involved in the anti-inflammatory effects of genistein in microglia.,"Genistein (GEN), a phytoestrogen that is extracted from leguminous plants, can bind to estrogen receptor and exert biological effects. G protein-coupled estrogen receptor (GPER), a novel membrane estrogen receptor, has been reported to be involved in the anti-inflammatory process. In the present study, using BV2 microglial cell line and primary microglial culture, we evaluated the involvement of GPER in the anti-inflammatory effects of genistein against lipopolysaccharide (LPS)-induced microglia activation.
The anti-inflammatory effects of genistein were investigated in LPS-induced microglial activation in murine BV2 microglial cell line and primary microglial culture. Anti-inflammatory properties of genistein were determined by MTT, real time PCR, ELISA and western blot analysis. The pharmacological blockade and lentivirus-mediated siRNA knockdown of GPER were used to study the underlying mechanism.
The results showed that genistein exerted inhibitory effects on LPS-induced expressions of cyclooxygenase-2 (COX-2), inducible nitric oxide (iNOS), tumor necrosis factor-α (TNF-α), interleukin-1 β (IL-1β) and interleukin-6 (IL-6). Pre-treatment with GPER antagonist G15 could significantly block the anti-inflammatory effects of genistein. Moreover, the inhibitory effects of genistein on LPS-induced activation of MAPKs and NF-κB signaling pathways could also be blocked by G15. Lentivirus-mediated siRNA knockdown of GPER significantly inhibited the anti-inflammatory effects of genistein in BV2 cells. Further study revealed that genistein treatment could increase the gene and protein expressions of GPER in BV2 cells.
Taken together, these data provide the first evidence that genistein exerts anti-inflammatory effects in microglial cells via GPER activation. These beneficial effects of genistein may represent a new strategy for the treatment of neuroinflammatory diseases.","['G protein-coupled estrogen receptor', 'Genistein', 'Lipopolysaccharide', 'Microglia', 'Neuroinflammation']",Phytomedicine : international journal of phytotherapy and phytopharmacology,2018-05-12,"[{'lastname': 'Du', 'firstname': 'Zhong-Rui', 'initials': 'ZR', 'affiliation': 'Department of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders, State Key Disciplines: Physiology, Medical College of Qingdao University, Qingdao 266071, China.'}, {'lastname': 'Feng', 'firstname': 'Xiao-Qing', 'initials': 'XQ', 'affiliation': 'Department of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders, State Key Disciplines: Physiology, Medical College of Qingdao University, Qingdao 266071, China.'}, {'lastname': 'Li', 'firstname': 'Na', 'initials': 'N', 'affiliation': 'Department of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders, State Key Disciplines: Physiology, Medical College of Qingdao University, Qingdao 266071, China.'}, {'lastname': 'Qu', 'firstname': 'Jiang-Xue', 'initials': 'JX', 'affiliation': 'Department of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders, State Key Disciplines: Physiology, Medical College of Qingdao University, Qingdao 266071, China.'}, {'lastname': 'Feng', 'firstname': 'Lu', 'initials': 'L', 'affiliation': 'Department of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders, State Key Disciplines: Physiology, Medical College of Qingdao University, Qingdao 266071, China.'}, {'lastname': 'Chen', 'firstname': 'Lei', 'initials': 'L', 'affiliation': 'Department of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders, State Key Disciplines: Physiology, Medical College of Qingdao University, Qingdao 266071, China.'}, {'lastname': 'Chen', 'firstname': 'Wen-Fang', 'initials': 'WF', 'affiliation': 'Department of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders, State Key Disciplines: Physiology, Medical College of Qingdao University, Qingdao 266071, China. Electronic address: chenwenfangqd@163.com.'}]",,"Taken together, these data provide the first evidence that genistein exerts anti-inflammatory effects in microglial cells via GPER activation. These beneficial effects of genistein may represent a new strategy for the treatment of neuroinflammatory diseases.","The results showed that genistein exerted inhibitory effects on LPS-induced expressions of cyclooxygenase-2 (COX-2), inducible nitric oxide (iNOS), tumor necrosis factor-α (TNF-α), interleukin-1 β (IL-1β) and interleukin-6 (IL-6). Pre-treatment with GPER antagonist G15 could significantly block the anti-inflammatory effects of genistein. Moreover, the inhibitory effects of genistein on LPS-induced activation of MAPKs and NF-κB signaling pathways could also be blocked by G15. Lentivirus-mediated siRNA knockdown of GPER significantly inhibited the anti-inflammatory effects of genistein in BV2 cells. Further study revealed that genistein treatment could increase the gene and protein expressions of GPER in BV2 cells.",Copyright © 2018 Elsevier GmbH. All rights reserved.,10.1016/j.phymed.2018.03.039,<Element 'PubmedArticle' at 0x7f05de69c090>
347,"29744576
21658239
20522652
27021778
22028881
27770818
29116422
19487464
16862116
11846389
2268320
28453791
21785136
8790604
1542665
23136129
27126638
18505826
18505826
21087763
22859297
28778989
22895706
19128208
23699531
20946666
23775425
16862115
10858277
23706646
15372498
25033727
28903038
21178100
21204008
16950801
22781549
18543312
12900424
15255780
24619111
26124111
22396764
12928786
12359772
12524533
9143348
28828399
28845019
8784346
21047645
21092856
23089745
27789271
27515686
26651479
22890097
21368173
28435163
18568075
28728022
19195801
19321167
20967127
22511793
12083803
28743268
21212639
12370467
11134521
27114033
17071926
27306735
23041626
9756851
25261995
19046946
26026925
2298731
2717620
16983685
28656016
19946692
9855500
27903606
27356620
23742080
27629553
14985763
2001789
20215705
26248158
21497117
19557827
22062772
21107132
21224065
1618805
27009575
27009575
18723524
12058088
28330615
23280835
21943601
19860916
26109656
19556463
25802027
24357581
17371905
22316048
17495518
24680777
2236009
29186371
22608501
17003069
20188224
25066864
22509390
28070672
25022663
23201826
21393509
14996734
15117809
23741441
21691802
18359860
10715107
11298924
29398357
29036611
18378771
20154673
28837568
21104415
27114232
10424355
20028451
28404863
22733568
18596065
18596065
26820675
17307734
11743107
11479377
9517007
28823651
29444210
20026663
20667979
10537317
25186741
21698296
28493053
28835281
28640985
26370502
28541286
28126008
12526812","The lysosomal function of progranulin, a guardian against neurodegeneration.","Progranulin (PGRN), encoded by the GRN gene in humans, is a secreted growth factor implicated in a multitude of processes ranging from regulation of inflammation to wound healing and tumorigenesis. The clinical importance of PGRN became especially evident in 2006, when heterozygous mutations in the GRN gene, resulting in haploinsufficiency, were found to be one of the main causes of frontotemporal lobar degeneration (FTLD). FTLD is a clinically heterogenous disease that results in the progressive atrophy of the frontal and temporal lobes of the brain. Despite significant research, the exact function of PGRN and its mechanistic relationship to FTLD remain unclear. However, growing evidence suggests a role for PGRN in the lysosome-most striking being that homozygous GRN mutation leads to neuronal ceroid lipofuscinosis, a lysosomal storage disease. Since this discovery, several links between PGRN and the lysosome have been established, including the existence of two independent lysosomal trafficking pathways, intralysosomal processing of PGRN into discrete functional peptides, and direct and indirect regulation of lysosomal hydrolases. Here, we summarize the cellular functions of PGRN, its roles in the nervous system, and its link to multiple neurodegenerative diseases, with a particular focus dedicated to recent lysosome-related mechanistic developments.","['Alzheimer’s disease (AD)', 'Cathepsin', 'Frontotemporal lobar degeneration (FTLD)', 'GBA', 'Inflammation', 'Lysosomal storage disease (LSD)', 'Lysosome', 'Microglia', 'Neuronal ceroid lipofuscinosis (NCL)', 'Progranulin', 'Prosaposin', 'Sortilin', 'TMEM106B']",Acta neuropathologica,2018-05-11,"[{'lastname': 'Paushter', 'firstname': 'Daniel H', 'initials': 'DH', 'affiliation': 'Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, USA.'}, {'lastname': 'Du', 'firstname': 'Huan', 'initials': 'H', 'affiliation': 'Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, USA.'}, {'lastname': 'Feng', 'firstname': 'Tuancheng', 'initials': 'T', 'affiliation': 'Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, USA.'}, {'lastname': 'Hu', 'firstname': 'Fenghua', 'initials': 'F', 'affiliation': 'Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, USA. fh87@cornell.edu.'}]",,,,,"10.1007/s00401-018-1861-8
10.1186/1471-2407-11-231
10.2353/ajpath.2010.090915
10.1016/j.neurobiolaging.2016.02.019
10.1371/journal.pone.0026454
10.1186/s13024-016-0132-1
10.1007/s12032-017-1054-7
10.1128/MCB.00056-09
10.1006/bbrc.2002.6431
10.1093/hmg/ddx162
10.1093/nar/gkr593
10.1093/hmg/dds475
10.1093/hmg/ddw127
10.1128/MCB.01775-07
10.1016/j.ajhg.2010.11.002
10.1074/jbc.R112.399170
10.1084/jem.20160999
10.1523/JNEUROSCI.0521-12.2012
10.1523/JNEUROSCI.5336-12.2013
10.1186/1750-1326-5-41
10.1007/s11910-013-0366-z
10.1016/j.neurobiolaging.2013.04.022
10.1016/j.humpath.2014.05.011
10.1016/j.celrep.2017.08.056
10.1212/WNL.0b013e31820a0e3b
10.1007/s13238-010-0067-1
10.1186/1750-1326-7-33
10.1042/BJ20040175
10.1007/s00401-014-1262-6
10.1073/pnas.1510329112
10.1371/journal.pone.0032422
10.1006/abbi.1997.9958
10.1523/ENEURO.0100-17.2017
10.1538/expanim.17-0060
10.1016/j.jns.2010.10.009
10.1016/j.neuron.2010.09.034
10.1189/jlb.0812429
10.1016/j.ebiom.2016.10.010
10.1016/j.ebiom.2016.08.004
10.1186/s13041-015-0177-z
10.3233/JAD-2012-120946
10.1073/pnas.1100650108
10.1038/nrn.2017.36
10.1016/j.neuron.2017.06.026
10.1016/j.braindev.2008.12.008
10.1016/j.atherosclerosis.2009.02.017
10.1371/journal.pone.0013368
10.1074/jbc.M112.365098
10.1186/s13024-017-0196-6
10.1159/000322538
10.1016/j.cell.2016.04.001
10.1111/jnc.13588
10.1172/JCI63113
10.1038/nm.3672
10.1016/j.brainres.2008.10.021
10.1016/j.bbadis.2015.05.011
10.1007/s00401-009-0616-y
10.1083/jcb.201603079
10.1038/ncomms11992
10.1111/jnc.12329
10.1684/epd.2016.0844
10.1371/journal.pone.0133749
10.1016/j.immuni.2011.01.018
10.1016/j.nbd.2011.10.016
10.1097/NEN.0b013e3181fc9aea
10.1016/j.ajpath.2010.11.002
10.1111/jnc.13622
10.1111/jnc.13622
10.1093/hmg/ddn257
10.1016/j.cels.2017.02.009
10.1002/ana.23722
10.1016/j.neuron.2011.07.021
10.1186/1471-2202-10-130
10.1523/JNEUROSCI.4808-14.2015
10.1126/science.1174447
10.1016/j.mcn.2015.03.013
10.1002/embj.201385857
10.1186/bcr3111
10.1016/j.gene.2014.03.041
10.1093/brain/awx314
10.1016/j.ajhg.2012.04.021
10.1016/j.jprot.2010.02.013
10.1016/j.mcn.2014.07.006
10.1371/journal.pone.0035115
10.1007/s00401-017-1668-z
10.1186/s40478-014-0078-x
10.1016/j.neuroscience.2012.11.032
10.1126/science.1199214
10.1371/journal.pone.0064989
10.1007/s12031-011-9569-4
10.1016/j.neuron.2018.01.018
10.1093/hmg/ddx364
10.1083/jcb.200712039
10.1038/ng.536
10.1371/journal.pone.0182896
10.1007/s00401-010-0782-y
10.1002/med.21394
10.1111/j.1471-4159.2009.06546.x
10.1126/scitranslmed.aah5642
10.1002/path.4043
10.1074/mcp.M800095-MCP200
10.1007/s12035-016-9698-4
10.1016/j.cca.2017.07.024
10.1093/brain/awy029
10.1084/jem.20091568
10.1096/fj.10-161471
10.1523/JNEUROSCI.1860-14.2014
10.1371/journal.pone.0021023
10.1007/s00401-017-1719-5
10.1186/s13024-017-0205-9
10.1111/jnc.14110
10.1083/jcb.201502029
10.1038/ncomms15277
10.1186/s40478-017-0412-1",<Element 'PubmedArticle' at 0x7f05de6ae540>
348,"29706926
14550698
12970630
28285426
23746775
16962082
29030525
18587151
24616027
18356754
24361462
15128927
22281673
24794920
18715410
2301497
15183137
26003063
24084547
27916232
16250014
12416551
25580736
17317196
16254494
22337231
28099414
17965659
23467340
25159150
24593277
27400854
18951639
29134703
21802506
29223280
21536123
12096891
19885996
20135342
17240075
16289758
19756668
26431692
25814933
22520439
22450375
17194565
22968814
22295073
18536531
28086911
24877622
26972154
2367615
15044536
9202224
26338335
10718919
19027101
28703909
21960564
28259722
27075756
18800053
28812263
28959464
27052180
24403144
24503856
17170309
23467988
18787232
11274341
8930795
7071605
6489942
20228171
11606726
11106970
20153585
17958710
20441692
21288253
23045678
10903573
9560276
15501588
9287218",Modulating the Oxytocin System During the Perinatal Period: A New Strategy for Neuroprotection of the Immature Brain?,"Oxytocin is a neurohypophysal hormone known for its activity during labor and its role in lactation. However, the function of oxytocin (OTX) goes far beyond the peripheral regulation of reproduction, and the central effects of OTX have been extensively investigated, since it has been recognized to influence the learning and memory processes. OTX has also prominent effects on social behavior, anxiety, and autism. Interaction between glucocorticoids, OTX, and maternal behavior may have long-term effects on the developmental program of the developing brain subjected to adverse events during pre and perinatal periods. OTX treatment in humans improves many aspects of social cognition and behavior. Its effects on the hypothalamic-pituitary-adrenal axis and inflammation appear to be of interest in neonates because these properties may confer benefits when the perinatal brain has been subjected to injury. Indeed, early life inflammation and abnormal adrenal response to stress have been associated with an abnormal white matter development. Recent investigations demonstrated that OTX is involved in the modulation of microglial reactivity in the developing brain. This review recapitulates state-of-the art data supporting the hypothesis that the OTX system could be considered as an innovative candidate for neuroprotection, especially in the immature brain.","['GABA', 'glucocorticosteroid', 'intra-uterine growth restriction', 'maternal behavior', 'microglia', 'neuro-inflammation', 'oxytocin', 'white matter brain injury']",Frontiers in neurology,2018-05-01,"[{'lastname': 'Zinni', 'firstname': 'Manuela', 'initials': 'M', 'affiliation': 'INSERM U1141 Protect, Paris-Diderot University, Paris, France.'}, {'lastname': 'Colella', 'firstname': 'Marina', 'initials': 'M', 'affiliation': 'INSERM U1141 Protect, Paris-Diderot University, Paris, France.'}, {'lastname': 'Batista Novais', 'firstname': 'Aline Rideau', 'initials': 'AR', 'affiliation': ""INSERM U1141 Protect, Paris-Diderot University, Paris, France.\nNeonatal Intensive Care Unit, Robert Debré Children's Hospital, Paris, France.""}, {'lastname': 'Baud', 'firstname': 'Olivier', 'initials': 'O', 'affiliation': ""INSERM U1141 Protect, Paris-Diderot University, Paris, France.\nUniversity of Geneva, Geneva, Switzerland.\nDivision of Neonatology, Geneva Children's Hospital, Geneva, Switzerland.""}, {'lastname': 'Mairesse', 'firstname': 'Jérôme', 'initials': 'J', 'affiliation': 'INSERM U1141 Protect, Paris-Diderot University, Paris, France.\nUniversity of Geneva, Geneva, Switzerland.'}]",,,,,"10.3389/fneur.2018.00229
10.1067/S0022-3476(03)00181-1
10.1007/s00404-017-4341-9
10.1016/S0140-6736(13)60993-9
10.1016/j.brainres.2006.08.004
10.1542/peds.2017-0697
10.1093/brain/awn137
10.1002/uog.13360
10.1203/PDR.0b013e318165c005
10.1016/j.brainres.2013.12.007
10.1203/01.PDR.0000128983.54614.7E
10.1016/j.neuroimage.2012.01.059
10.1093/cercor/bhu073
10.1111/j.1471-0528.2008.01827.x
10.1016/0002-9378(90)90856-3
10.1016/j.bpobgyn.2004.02.011
10.1016/j.ajog.2015.05.034
10.1097/AOG.0b013e3182a265ab
10.1016/j.placenta.2016.11.012
10.1002/ana.20662
10.1046/j.1440-1789.2002.00438.x
10.1038/pr.2015.4
10.1016/j.nbd.2007.01.001
10.1097/01.jnen.0000187052.81889.57
10.1038/pr.2012.26
10.1038/nature21029
10.1038/nn1997
10.1523/JNEUROSCI.3441-12.2013
10.1016/j.celrep.2014.07.042
10.1111/ejn.12508
10.1038/mp.2016.103
10.1016/j.tins.2008.09.002
10.1002/glia.23256
10.1016/j.ijdevneu.2011.07.008
10.1016/j.beem.2017.09.001
10.1016/j.bbi.2011.04.013
10.1006/brbi.2001.0638
10.1097/CCM.0b013e3181a592b3
10.1007/s10519-010-9333-5
10.1016/j.psyneuen.2006.11.005
10.1016/j.bbi.2005.09.006
10.1007/s00401-009-0590-4
10.1016/j.bbi.2015.09.017
10.3389/fncel.2015.00082
10.1186/1742-2094-9-71
10.1016/j.bbi.2006.11.006
10.1038/npp.2012.149
10.1371/journal.pone.0030148
10.4161/epi.3.2.6034
10.1186/s12974-016-0782-5
10.1210/en.2013-1411
10.1016/j.ygcen.2016.03.014
10.1016/0306-4530(90)90046-C
10.1523/JNEUROSCI.3432-03.2004
10.1210/endo.138.7.5255
10.1523/JNEUROSCI.1345-14.2015
10.1046/j.1365-2826.2000.00442.x
10.1016/j.biopsych.2008.10.011
10.1111/jmwh.12610
10.1161/STROKEAHA.111.628008
10.1016/j.pnpbp.2017.02.022
10.1186/s12974-016-0541-7
10.1038/mp.2008.70
10.1007/7854_2017_6
10.1136/svn-2016-000012
10.1016/j.celrep.2016.03.013
10.1523/JNEUROSCI.4447-13.2014
10.1126/science.1247190
10.1126/science.1133212
10.3389/fncel.2013.00020
10.1093/cercor/bhn159
10.1152/physrev.2001.81.2.629
10.1002/(SICI)1520-6661(199609/10)5:5<245::AID-MFM3>3.0.CO;2-H
10.1126/science.7071605
10.1016/0018-506X(84)90016-3
10.1210/en.2009-1271
10.1073/pnas.221224598
10.1046/j.1365-2826.2000.00599.x
10.1016/j.psyneuen.2010.01.013
10.1111/j.1467-9280.2007.02010.x
10.1017/S0033291709991279
10.1348/026151010X533229
10.1073/pnas.1204599109
10.1038/77702
10.1073/pnas.95.9.5335
10.1016/j.neuroscience.2004.08.009
10.1126/science.277.5332.1659",<Element 'PubmedArticle' at 0x7f05de60e6d0>
349,"29582398
8313156
3251580
15337241
22183707
25080336
10453048
24761998
28681915
18173309
16469811
25380660
25823474
22387107
19818384
10854701
22832283
26037411
17636227
25276492
29439605
9106616
25052429
26683475
16310968
15337246
15665606
25828533
28041951
23547621
20881113
22520439
25423896
11384882
19464167
24638131
17186017
12209854
21093516
3986520
17113982
19849845
24999330
21258044
17169418
19094079
22362507
27283249
26082062
27250720
24704246
16785595
23190172
24722370
16607099
23659385
28485080
2073590
17420283
12182896
27696022
26257642
24882635
19797123
25086299
18292191
26671410
22401743
15356068
10996139
19533603
28667487
18001325
10379913
22747981
24926283
11283953
18460549
21564348
24637260
15312894
21803156
27959620
24607811
17561817
11241743
23407936
14769827
11170719
24666402
25377795
25305410
27127723
18286612
28191467
28948468
8406684",The Synthetic Steroid Tibolone Decreases Reactive Gliosis and Neuronal Death in the Cerebral Cortex of Female Mice After a Stab Wound Injury.,"Previous studies have shown that estradiol reduces reactive gliosis after a stab wound injury in the cerebral cortex. Since the therapeutic use of estradiol is limited by its peripheral hormonal effects, it is of interest to determine whether synthetic estrogenic compounds with tissue-specific actions regulate reactive gliosis. Tibolone is a synthetic steroid that is widely used for the treatment of climacteric symptoms and/or the prevention of osteoporosis. In this study, we have assessed the effect of tibolone on reactive gliosis in the cerebral cortex after a stab wound brain injury in ovariectomized adult female mice. By 7 days after brain injury, tibolone reduced the number of glial fibrillary acidic protein (GFAP) immunoreactive astrocytes, the number of ionized calcium binding adaptor molecule 1 (Iba1) immunoreactive microglia, and the number of microglial cells with a reactive phenotype in comparison to vehicle-injected animals. These effects on gliosis were associated with a reduction in neuronal loss in the proximity to the wound, suggesting that tibolone exerts beneficial homeostatic actions in the cerebral cortex after an acute brain injury.","['Astrocytes', 'Brain trauma', 'Microglia', 'Neuroinflammation', 'Neuroprotection', 'Steroid receptors']",Molecular neurobiology,2018-03-28,"[{'lastname': 'Crespo-Castrillo', 'firstname': 'Andrea', 'initials': 'A', 'affiliation': 'Consejo Superior de Investigaciones Científicas (CSIC), Instituto Cajal, Madrid, Spain.'}, {'lastname': 'Yanguas-Casás', 'firstname': 'Natalia', 'initials': 'N', 'affiliation': 'Consejo Superior de Investigaciones Científicas (CSIC), Instituto Cajal, Madrid, Spain.\nCentro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain.'}, {'lastname': 'Arevalo', 'firstname': 'Maria Angeles', 'initials': 'MA', 'affiliation': 'Consejo Superior de Investigaciones Científicas (CSIC), Instituto Cajal, Madrid, Spain.\nCentro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain.'}, {'lastname': 'Azcoitia', 'firstname': 'Iñigo', 'initials': 'I', 'affiliation': 'Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain.\nDepartment of Cell Biology, Faculty of Biology, Universidad Complutense, 28040, Madrid, Spain.'}, {'lastname': 'Barreto', 'firstname': 'George E', 'initials': 'GE', 'affiliation': 'Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá D.C., Colombia. gsampaio@javeriana.edu.co.'}, {'lastname': 'Garcia-Segura', 'firstname': 'Luis M', 'initials': 'LM', 'affiliation': 'Consejo Superior de Investigaciones Científicas (CSIC), Instituto Cajal, Madrid, Spain. lmgs@cajal.csic.es.\nCentro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain. lmgs@cajal.csic.es.'}]",,,,,10.1007/s12035-018-1008-x,<Element 'PubmedArticle' at 0x7f05de5c1d10>
350,29580890,Mifepristone attenuates depression-like changes induced by chronic central administration of interleukin-1β in rats.,"Increased proinflammatory cytokines, such as interleukin (IL)-1β, may play an important role in the etiology of depression because they cause the hypothalamic-pituitary-adrenal axis to release glucocorticoids (GC) and induce dysfunction of serotonin and norepinephrine neurotransmission. Sustained increase in GC may activate microglia to induce neuroinflammation, and suppress astrocytes to produce neurotrophins, which lead to neuronal apoptosis. Here, we tested the hypothesis that glucocorticoid receptor (GR) antagonist mifepristone (RU486) may attenuate IL-1β-induced depression-like behavior by regulating the neuroinflammation and neurotrophin functions of microglia and astrocytes. Rats received intracerebroventricular injections of IL-1β (10 ng) and/or subcutaneous injections of RU486 for 14 days. Then animal depression-like behaviors, serum corticosterone concentration, the levels of pro-inflammatory cytokines (TNF-α, IL-6), mRNA and protein expressions of CD11b, GFAP and neurotrophins (pro-BDNF, BDNF, GDNF and their receptors TrkB, p75, GFRα-1 and GFRα-2) in the amygdala were studied. Compared to controls, significantly decreased rearing score and increased defecation in the open field test, decreases in ratio of open/closed time in the elevated plus maze and in sucrose preference, while increased level of corticosterone in the serum were found in the rats administrated with IL-1β. IL-1β administration also reduced the expressions of GFAP, BDNF, GDNF and its receptor GFR-α1, but increased the expressions of CD11b, pro-BDNF, p75 and pro-inflammatory cytokines (TNF-α, IL-6) concentrations. RU486 treatment markedly attenuated these changes induced by IL-1β, except for the expressions of GFR-α1. In conclusion, RU486 may improve depression-like changes by suppressing microglia and inflammation and promoting astrocytes to restore neurotrophin function.","['Depression', 'Glucocorticoids (GC)', 'Interleukin (IL)-1β', 'Mifepristone (RU486)']",Behavioural brain research,2018-03-28,"[{'lastname': 'Zhang', 'firstname': 'Yong-Ping', 'initials': 'YP', 'affiliation': 'Research Institute for Marine Drugs and Nutrition, College of Food Science and Technology, Guangdong Ocean University, Zhanjiang, 524088, China; Shenzhen Institute of Guangdong Ocean University, Shenzhen, 518120, China.'}, {'lastname': 'Wang', 'firstname': 'Hao-Yin', 'initials': 'HY', 'affiliation': 'Research Institute for Marine Drugs and Nutrition, College of Food Science and Technology, Guangdong Ocean University, Zhanjiang, 524088, China; Shenzhen Institute of Guangdong Ocean University, Shenzhen, 518120, China.'}, {'lastname': 'Zhang', 'firstname': 'Cai', 'initials': 'C', 'affiliation': 'Research Institute for Marine Drugs and Nutrition, College of Food Science and Technology, Guangdong Ocean University, Zhanjiang, 524088, China; Shenzhen Institute of Guangdong Ocean University, Shenzhen, 518120, China.'}, {'lastname': 'Liu', 'firstname': 'Bai-Ping', 'initials': 'BP', 'affiliation': 'Research Institute for Marine Drugs and Nutrition, College of Food Science and Technology, Guangdong Ocean University, Zhanjiang, 524088, China; Shenzhen Institute of Guangdong Ocean University, Shenzhen, 518120, China.'}, {'lastname': 'Peng', 'firstname': 'Zhi-Lan', 'initials': 'ZL', 'affiliation': 'Research Institute for Marine Drugs and Nutrition, College of Food Science and Technology, Guangdong Ocean University, Zhanjiang, 524088, China.'}, {'lastname': 'Li', 'firstname': 'Yu-Yu', 'initials': 'YY', 'affiliation': 'Research Institute for Marine Drugs and Nutrition, College of Food Science and Technology, Guangdong Ocean University, Zhanjiang, 524088, China.'}, {'lastname': 'Liu', 'firstname': 'Feng-Ming', 'initials': 'FM', 'affiliation': 'Coreway Metablic Care Center, CA 91765, USA.'}, {'lastname': 'Song', 'firstname': 'Cai', 'initials': 'C', 'affiliation': 'Research Institute for Marine Drugs and Nutrition, College of Food Science and Technology, Guangdong Ocean University, Zhanjiang, 524088, China; Shenzhen Institute of Guangdong Ocean University, Shenzhen, 518120, China. Electronic address: cai.song@dal.ca.'}]",,,,Copyright © 2018 Elsevier B.V. All rights reserved.,10.1016/j.bbr.2018.03.033,<Element 'PubmedArticle' at 0x7f05de5ed090>
351,"29574689
24126629
29055040
29055032
29055034
29055035
18679164
16571781
20639693
28012949
23746459
26114403
22342378
27616310
23317354
25819934
17141334
26260390
28069688
22051914
19413484
25434589
22578468
21806316
21832997
21989247
29149325
19951898
23900071
20649561
16781706
20400460
27790057
25964986
24703394
15204022
24369373
7846037
29100067
8446170
8899654
17241118
22608070
28468939
19833869
16183560
15189359
18246065
16512913",Targeting glial cannabinoid CB,"Cannabinoid CB
We treated TDP-43 (A315T) transgenic mice with the non-selective agonist WIN55,212-2, alone or combined with selective CB
WIN55,212-2 had modest beneficial effects in the rotarod test, Nissl staining of motor neurons, and GFAP and Iba-1 immunostainings in the spinal cord, which were mediated in part by CB
Our study shows an important role for glial CB
This article is part of a themed section on 8",[],British journal of pharmacology,2018-03-27,"[{'lastname': 'Espejo-Porras', 'firstname': 'Francisco', 'initials': 'F', 'affiliation': 'Instituto Universitario de Investigación en Neuroquímica, Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Universidad Complutense, Madrid, Spain.\nCentro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.\nInstituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.'}, {'lastname': 'García-Toscano', 'firstname': 'Laura', 'initials': 'L', 'affiliation': 'Instituto Universitario de Investigación en Neuroquímica, Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Universidad Complutense, Madrid, Spain.\nCentro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.\nInstituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.'}, {'lastname': 'Rodríguez-Cueto', 'firstname': 'Carmen', 'initials': 'C', 'affiliation': 'Instituto Universitario de Investigación en Neuroquímica, Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Universidad Complutense, Madrid, Spain.\nCentro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.\nInstituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.'}, {'lastname': 'Santos-García', 'firstname': 'Irene', 'initials': 'I', 'affiliation': 'Instituto Universitario de Investigación en Neuroquímica, Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Universidad Complutense, Madrid, Spain.\nCentro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.\nInstituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.'}, {'lastname': 'de Lago', 'firstname': 'Eva', 'initials': 'E', 'affiliation': 'Instituto Universitario de Investigación en Neuroquímica, Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Universidad Complutense, Madrid, Spain.\nCentro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.\nInstituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.'}, {'lastname': 'Fernandez-Ruiz', 'firstname': 'Javier', 'initials': 'J', 'affiliation': 'Instituto Universitario de Investigación en Neuroquímica, Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Universidad Complutense, Madrid, Spain.\nCentro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.\nInstituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.'}]",,,,© 2018 The British Pharmacological Society.,10.1111/bph.14216,<Element 'PubmedArticle' at 0x7f05de1af310>
352,29549796,Post-treatment with the GLP-1 analogue liraglutide alleviate chronic inflammation and mitochondrial stress induced by Status epilepticus.,"Glucagon-like peptide-1(GLP-1) is a growth factor that has neuroprotective and anti-inflammatory properties. The protease resistant GLP-1 analogue liraglutide has been shown to be neuroprotective in previous studies in animal models of Alzheimer's disease or Parkinson's disease. Status epilepticus (SE) is a complex disorder, involving many underlying pathological processes, including excitotoxic and chronic inflammatory events. The present pilot study aims to investigate whether liraglutide alleviates the chronic inflammation response and mitochondrial stress induced by SE in the lithium-pilocarpine animal model. We found that treatment with 25nmol/kg. i.p. once-daily after the induction of SE for 7 days reduced chronic inflammation as shown by reduced numbers of activated microglia and astrocytes, and reduced levels of TNF-α and IL-1ß in the hippocampus. The mitochondrial stress marker BAX was reduced and the survival factor Bcl-2 was enhanced by liraglutide. Blood glucose levels were not affected by liraglutide. We show for the first time that liraglutide can reduce the chronic inflammation and mitochondrial stress induced by SE, and the results suggest that GLP-1 receptor agonists such as liraglutide have restorative and protective effects in the brain after SE and could serve as a potential treatment.","['Apoptosis', 'GLP-1', 'Inflammation', 'Insulin', 'Liraglutide', 'Neuroprotection']",Epilepsy research,2018-03-20,"[{'lastname': 'Wang', 'firstname': 'Rui-Fang', 'initials': 'RF', 'affiliation': 'Department of Neurology, The Second Affiliated Hospital of Shanxi Medical University, No. 382 Wuyi Road, Taiyuan 030001, Shanxi Province, China.'}, {'lastname': 'Xue', 'firstname': 'Guo-Fang', 'initials': 'GF', 'affiliation': 'Department of Neurology, The Second Affiliated Hospital of Shanxi Medical University, No. 382 Wuyi Road, Taiyuan 030001, Shanxi Province, China. Electronic address: xueguofangty@163.com.'}, {'lastname': 'Hölscher', 'firstname': 'Christian', 'initials': 'C', 'affiliation': 'Department of Neurology, The Second Affiliated Hospital of Shanxi Medical University, No. 382 Wuyi Road, Taiyuan 030001, Shanxi Province, China; Division of Biomedical and Life Science, Faculty of Health and Medicine, Lancaster University, Lancaster LA14YQ, UK.'}, {'lastname': 'Tian', 'firstname': 'Miao-Jing', 'initials': 'MJ', 'affiliation': 'Department of Neurology, The Second Affiliated Hospital of Shanxi Medical University, No. 382 Wuyi Road, Taiyuan 030001, Shanxi Province, China.'}, {'lastname': 'Feng', 'firstname': 'Peng', 'initials': 'P', 'affiliation': 'Department of Neurology, The Second Affiliated Hospital of Shanxi Medical University, No. 382 Wuyi Road, Taiyuan 030001, Shanxi Province, China.'}, {'lastname': 'Zheng', 'firstname': 'Ji-Ying', 'initials': 'JY', 'affiliation': 'Department of Neurology, The Second Affiliated Hospital of Shanxi Medical University, No. 382 Wuyi Road, Taiyuan 030001, Shanxi Province, China.'}, {'lastname': 'Li', 'firstname': 'Dong-Fang', 'initials': 'DF', 'affiliation': 'Department of Neurology, The Second Affiliated Hospital of Shanxi Medical University, No. 382 Wuyi Road, Taiyuan 030001, Shanxi Province, China. Electronic address: lidongfang898@163.com.'}]",,,,Copyright © 2018 Elsevier B.V. All rights reserved.,10.1016/j.eplepsyres.2018.03.009,<Element 'PubmedArticle' at 0x7f05de1d5540>
353,29548998,mTORC1 pathway disruption abrogates the effects of the ciliary neurotrophic factor on energy balance and hypothalamic neuroinflammation.,"Ciliary neurotrophic factor (CNTF) potently decreases food intake and body weight in diet-induced obese mice by acting through neuronal circuits and pathways located in the arcuate nucleus (ARC) of the hypothalamus. CNTF also exerts pro-inflammatory actions within the brain. Here we tested whether CNTF modifies energy balance by inducing inflammatory responses in the ARC and whether these effects depend upon the mechanistic target of rapamycin complex 1 (mTORC1) pathway, which regulates both energy metabolism and inflammation. To this purpose, chow- and high fat diet (HFD)- fed mice lacking the S6 kinase 1 (S6K1","['CNTF', 'Glia cells', 'Hypothalamus', 'Inflammation', 'Microglia', 'Obesity', 'S6K1', 'mTOR']","Brain, behavior, and immunity",2018-03-20,"[{'lastname': 'André', 'firstname': 'Caroline', 'initials': 'C', 'affiliation': 'INSERM, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U1215, F-33000 Bordeaux, France; University of Bordeaux, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U1215, F-33000 Bordeaux, France.'}, {'lastname': 'Catania', 'firstname': 'Caterina', 'initials': 'C', 'affiliation': 'INSERM, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U1215, F-33000 Bordeaux, France; University of Bordeaux, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U1215, F-33000 Bordeaux, France.'}, {'lastname': 'Remus-Borel', 'firstname': 'Julie', 'initials': 'J', 'affiliation': 'INRA, Nutrition et Neurobiologie Intégrée, UMR 1286, F-33076 Bordeaux, France; University of Bordeaux, Nutrition et Neurobiologie Intégrée, UMR 1286, F-33076 Bordeaux, France.'}, {'lastname': 'Ladeveze', 'firstname': 'Elodie', 'initials': 'E', 'affiliation': 'INSERM, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U1215, F-33000 Bordeaux, France; University of Bordeaux, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U1215, F-33000 Bordeaux, France.'}, {'lastname': 'Leste-Lasserre', 'firstname': 'Thierry', 'initials': 'T', 'affiliation': 'INSERM, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U1215, F-33000 Bordeaux, France; University of Bordeaux, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U1215, F-33000 Bordeaux, France.'}, {'lastname': 'Mazier', 'firstname': 'Wilfrid', 'initials': 'W', 'affiliation': 'INSERM, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U1215, F-33000 Bordeaux, France; University of Bordeaux, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U1215, F-33000 Bordeaux, France.'}, {'lastname': 'Binder', 'firstname': 'Elke', 'initials': 'E', 'affiliation': 'INSERM, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U1215, F-33000 Bordeaux, France; University of Bordeaux, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U1215, F-33000 Bordeaux, France.'}, {'lastname': 'Gonzales', 'firstname': 'Delphine', 'initials': 'D', 'affiliation': 'INSERM, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U1215, F-33000 Bordeaux, France; University of Bordeaux, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U1215, F-33000 Bordeaux, France.'}, {'lastname': 'Clark', 'firstname': 'Samantha', 'initials': 'S', 'affiliation': 'INSERM, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U1215, F-33000 Bordeaux, France; University of Bordeaux, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U1215, F-33000 Bordeaux, France.'}, {'lastname': 'Guzman-Quevedo', 'firstname': 'Omar', 'initials': 'O', 'affiliation': 'INSERM, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U1215, F-33000 Bordeaux, France; University of Bordeaux, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U1215, F-33000 Bordeaux, France.'}, {'lastname': 'Abrous', 'firstname': 'Djoher Nora', 'initials': 'DN', 'affiliation': 'INSERM, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U1215, F-33000 Bordeaux, France; University of Bordeaux, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U1215, F-33000 Bordeaux, France.'}, {'lastname': 'Layé', 'firstname': 'Sophie', 'initials': 'S', 'affiliation': 'INRA, Nutrition et Neurobiologie Intégrée, UMR 1286, F-33076 Bordeaux, France; University of Bordeaux, Nutrition et Neurobiologie Intégrée, UMR 1286, F-33076 Bordeaux, France.'}, {'lastname': 'Cota', 'firstname': 'Daniela', 'initials': 'D', 'affiliation': 'INSERM, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U1215, F-33000 Bordeaux, France; University of Bordeaux, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, U1215, F-33000 Bordeaux, France. Electronic address: daniela.cota@inserm.fr.'}]",,,,Copyright © 2018 Elsevier Inc. All rights reserved.,10.1016/j.bbi.2018.03.014,<Element 'PubmedArticle' at 0x7f05dd7244a0>
354,29526689,Brain Response to Injuries: When Microglia Go Sexist.,"Microglia are the principle immune cells of the brain. Once activated, microglial cells may exhibit a wide repertoire of the context-dependent profiles ranging from highly neurotoxic to more protective and pro-regenerative cellular phenotypes. While to date the mechanisms involved in the molecular regulation of the microglia polarization phenotypes remain elusive, growing evidence suggests that gender may markedly affect the inflammatory and/or glial responses following brain injuries. In the recent years, special attention has been given to the role of microglia in sexual dimorphism, both in healthy brain and diseased brain. Here, we review recent advances revealing microglia as an important determinant of gender differences under physiological conditions and in injured brain. We also discuss how microglia-driven innate immunity and signaling pathways might be involved in the sex-dependent responses following brain ischemic injury. Finally we describe how advanced methods such as live imaging techniques may help elucidate the role of microglia in the modulation of immune responses and gender difference after stroke.","['bioluminescence imaging', 'brain ischemia', 'inflammation', 'innate immune response', 'microglia activation', 'sex difference']",Neuroscience,2018-03-13,"[{'lastname': 'Rahimian', 'firstname': 'Reza', 'initials': 'R', 'affiliation': 'Department of Psychiatry and Neuroscience, Faculty of Medicine, CERVO Brain Research Centre, Laval University, Quebec, Quebec G1J 2G3, Canada.'}, {'lastname': 'Cordeau', 'firstname': 'Pierre', 'initials': 'P', 'affiliation': 'Department of Psychiatry and Neuroscience, Faculty of Medicine, CERVO Brain Research Centre, Laval University, Quebec, Quebec G1J 2G3, Canada.'}, {'lastname': 'Kriz', 'firstname': 'Jasna', 'initials': 'J', 'affiliation': 'Department of Psychiatry and Neuroscience, Faculty of Medicine, CERVO Brain Research Centre, Laval University, Quebec, Quebec G1J 2G3, Canada. Electronic address: jasna.kriz@fmed.ulaval.ca.'}]",,,,Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.,10.1016/j.neuroscience.2018.02.048,<Element 'PubmedArticle' at 0x7f05dd735860>
355,"29524458
25300872
25559333
28216088
17950926
22426413
16732273
24565378
23916893
28219988
19286276
7588279
25433170
26799851
16647243
24485491
19647070
22041296
23459026
27981190
16125247
24944032
28618077
12096891
12399247
25304538
27546235
25902532
16148231
19151626
27581371
28373688
24470773
16597735
28341582
24860431
16316783
20610348
22387107
22182318
25520774
16397184
18941241
26120961
26315370
25568124
3124165
22386198
21525267
20570721",Neuroinflammatory priming to stress is differentially regulated in male and female rats.,"Exposure to stressors can enhance neuroinflammatory responses, and both stress and neuroinflammation are predisposing factors in the development of psychiatric disorders. Females suffer disproportionately more from several psychiatric disorders, yet stress-induced changes in neuroinflammation have primarily been studied in males. Here we tested whether exposure to inescapable tail shock sensitizes or 'primes' neuroinflammatory responses in male and female rats. At 24 h post-stress, male and female rats exposed to a peripheral immune challenge enhanced neuroinflammatory responses and exacerbated anxiety- and depressive-like behaviors. These changes are likely glucocorticoid dependent, as administering exogenous CORT, caused a similar primed inflammatory response in the hippocampus of male and female rats. Further, stress disinhibited anti-inflammatory signaling mechanisms (such as CD200R) in the hippocampus of male and female rats. In males, microglia are considered the likely cellular source mediating neuroinflammatory priming; stress increased cytokine expression in ex vivo male microglia. Conversely, microglia isolated from stressed or CORT treated females did not exhibit elevated cytokine responses. Microglia isolated from both stressed male and female rats reduced phagocytic activity; however, suggesting that microglia from both sexes experience stress-induced functional impairments. Finally, an immune challenge following either stress or CORT in females, but not males, increased peripheral inflammation (serum IL-1β). These novel data suggest that although males and females both enhance stress-induced neuroinflammatory and behavioral responses to an immune challenge, this priming may occur through distinct, sex-specific mechanisms.","['Glucocorticoids', 'Microglia', 'Neuroimmune', 'Sex differences', 'Sickness behavior', 'Stressors']","Brain, behavior, and immunity",2018-03-11,"[{'lastname': 'Fonken', 'firstname': 'Laura K', 'initials': 'LK', 'affiliation': 'Department of Psychology and Neuroscience, University of Colorado, Boulder, CO 80309, USA. Electronic address: laura.fonken@austin.utexas.edu.'}, {'lastname': 'Frank', 'firstname': 'Matthew G', 'initials': 'MG', 'affiliation': 'Department of Psychology and Neuroscience, University of Colorado, Boulder, CO 80309, USA.'}, {'lastname': 'Gaudet', 'firstname': 'Andrew D', 'initials': 'AD', 'affiliation': 'Department of Psychology and Neuroscience, University of Colorado, Boulder, CO 80309, USA.'}, {'lastname': ""D'Angelo"", 'firstname': 'Heather M', 'initials': 'HM', 'affiliation': 'Department of Psychology and Neuroscience, University of Colorado, Boulder, CO 80309, USA.'}, {'lastname': 'Daut', 'firstname': 'Rachel A', 'initials': 'RA', 'affiliation': 'Department of Psychology and Neuroscience, University of Colorado, Boulder, CO 80309, USA.'}, {'lastname': 'Hampson', 'firstname': 'Emma C', 'initials': 'EC', 'affiliation': 'Department of Psychology and Neuroscience, University of Colorado, Boulder, CO 80309, USA.'}, {'lastname': 'Ayala', 'firstname': 'Monica T', 'initials': 'MT', 'affiliation': 'Department of Psychology and Neuroscience, University of Colorado, Boulder, CO 80309, USA.'}, {'lastname': 'Watkins', 'firstname': 'Linda R', 'initials': 'LR', 'affiliation': 'Department of Psychology and Neuroscience, University of Colorado, Boulder, CO 80309, USA.'}, {'lastname': 'Maier', 'firstname': 'Steven F', 'initials': 'SF', 'affiliation': 'Department of Psychology and Neuroscience, University of Colorado, Boulder, CO 80309, USA.'}]",,,,Copyright © 2018 Elsevier Inc. All rights reserved.,10.1016/j.bbi.2018.03.005,<Element 'PubmedArticle' at 0x7f05dd73e950>
356,29501766,"β-Amyrin, the cannabinoid receptors agonist, abrogates mice brain microglial cells inflammation induced by lipopolysaccharide/interferon-γ and regulates Mφ","Inflammation is a primary response to infection that can pathologically lead to various diseases including neurodegenerative diseases. The purpose of this study was to evaluate the effect of β-Amyrin, a naturally occurring pentacyclic triterpenoid compound, on inflammation induced by lipopolysaccharide (LPS) and interferone-γ (IFN-γ) in rat microglial cells.
Cytotoxicity of β-Amyrin (3-100) μM on microglial cells was evaluated using the MTT assay. Also, the protective effect of various β-Amyrin (2-16 μM) concentrations with LPS/IFN-γ-induced mice microglial cells was studied. The concentrations of TNF-α (Tumor Necrosis Factor-α), IL-1β (Interleukin-1β), IL-6 (Interleukin-6) and PGE-2 (Prostaglandin E2) were evaluated using ELISA. Gene expressions of TNF-α, IL-1β, IL-6, COX-2 (Cyclooxygenase-2), iNOS and arginase-1 were also evaluated using the Real-Time PCR method. Nitrite oxide and urea were measured using biochemical methods.
The studied concentrations ​​of β-Amyrin had no significant effects on the viability of microglial cells. Interestingly, β-Amyrin concentration dependently and significantly increased the reduced cell proliferation concerning to LPS/IFN-γ exposure (p < 0.001). The concentrations and expression levels of pro-inflammatory factors including TNF-α, IL-1β, IL-6, PGE-2, COX-2 were significantly reduced after β-Amyrin treatment in LPS/IFN-γ-induced microglial cells (p < 0.05-0.001). β-Amyrin also decreased the levels of nitric oxide, increased urea and down regulated the expression of nitric oxide synthesis while arginase-1 expression was enhanced (p < 0.001). The ratio of NO/urea and iNOS/Arg1 were also markedly increased in comparison to the LPS/IFN-g group (p < 0.001).
β-Amyrin reduces inflammation in microglial cells and can be used as a potential anti-inflammatory agent in central nervous system neurodegenerative diseases such as Alzheimer and multiple sclerosis, by affecting the inflammatory cytokine and differentiation of microglia as resident CNS macrophages.","['Inflammation', 'LPS/IFN-γ-induced cell', 'MTT', 'Microglia', 'β-Amyrin']",Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,2018-03-05,"[{'lastname': 'Askari', 'firstname': 'Vahid Reza', 'initials': 'VR', 'affiliation': 'Student Research Committee, Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: vahidrezaaskary@yahoo.com.'}, {'lastname': 'Fereydouni', 'firstname': 'Narges', 'initials': 'N', 'affiliation': 'Student Research Committee, Department of Modern Sciences and Technologies, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.'}, {'lastname': 'Baradaran Rahimi', 'firstname': 'Vafa', 'initials': 'V', 'affiliation': 'Student Research Committee, Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.'}, {'lastname': 'Askari', 'firstname': 'Nafiseh', 'initials': 'N', 'affiliation': 'Student Research Committee, Sabzevar University of Medical Sciences, Sabzevar, Iran.'}, {'lastname': 'Sahebkar', 'firstname': 'Amir Hossein', 'initials': 'AH', 'affiliation': 'Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.'}, {'lastname': 'Rahmanian-Devin', 'firstname': 'Pouria', 'initials': 'P', 'affiliation': 'Student Research Committee, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.'}, {'lastname': 'Samzadeh-Kermani', 'firstname': 'Alireza', 'initials': 'A', 'affiliation': 'Department of Chemistry, Faculty of Science, University of Zabol, Zabol, Iran. Electronic address: arsamzadeh@yahoo.com.'}]",,"β-Amyrin reduces inflammation in microglial cells and can be used as a potential anti-inflammatory agent in central nervous system neurodegenerative diseases such as Alzheimer and multiple sclerosis, by affecting the inflammatory cytokine and differentiation of microglia as resident CNS macrophages.","The studied concentrations ​​of β-Amyrin had no significant effects on the viability of microglial cells. Interestingly, β-Amyrin concentration dependently and significantly increased the reduced cell proliferation concerning to LPS/IFN-γ exposure (p < 0.001). The concentrations and expression levels of pro-inflammatory factors including TNF-α, IL-1β, IL-6, PGE-2, COX-2 were significantly reduced after β-Amyrin treatment in LPS/IFN-γ-induced microglial cells (p < 0.05-0.001). β-Amyrin also decreased the levels of nitric oxide, increased urea and down regulated the expression of nitric oxide synthesis while arginase-1 expression was enhanced (p < 0.001). The ratio of NO/urea and iNOS/Arg1 were also markedly increased in comparison to the LPS/IFN-g group (p < 0.001).",Copyright © 2018 Elsevier Masson SAS. All rights reserved.,10.1016/j.biopha.2018.02.098,<Element 'PubmedArticle' at 0x7f05dd6e1e50>
357,29501084,The inhibition of CB,Cannabinoid 1 receptor (CB,"['Cannabinoid 1 receptor (CB(1)R)', 'Experimental autoimmune encephalomyelitis (EAE)', 'Microglia/macrophages polarization', 'Selective CB(1)R antagonist (SR141716A)', 'Signal pathway']",Journal of neuroimmunology,2018-03-05,"[{'lastname': 'Lou', 'firstname': 'Zhi-Yin', 'initials': 'ZY', 'affiliation': 'Department of Neurology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.'}, {'lastname': 'Cheng', 'firstname': 'Jie', 'initials': 'J', 'affiliation': 'Department of Neurology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.'}, {'lastname': 'Wang', 'firstname': 'Xiao-Rong', 'initials': 'XR', 'affiliation': 'Department of Neurology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.'}, {'lastname': 'Zhao', 'firstname': 'Yong-Fei', 'initials': 'YF', 'affiliation': 'Department of Neurology, JinShan Hospital, Fudan Univeristy, Shanghai, China.'}, {'lastname': 'Gan', 'firstname': 'Jing', 'initials': 'J', 'affiliation': 'Department of Neurology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.'}, {'lastname': 'Zhou', 'firstname': 'Guo-Yu', 'initials': 'GY', 'affiliation': 'Department of Geriatric, Qilu Hospital, Shandong University, Jinan, China.'}, {'lastname': 'Liu', 'firstname': 'Zhen-Guo', 'initials': 'ZG', 'affiliation': 'Department of Neurology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. Electronic address: liuzhenguo@xinhuamed.com.cn.'}, {'lastname': 'Xiao', 'firstname': 'Bao-Guo', 'initials': 'BG', 'affiliation': 'Institute of Neurology, Huashan Hospital, Institutes of Brain Science, State Key Laboratory of Medical Neurobiology, Fudan University, Shanghai, China. Electronic address: bgxiao@shmu.edu.cn.'}]",,,,Copyright © 2018 Elsevier B.V. All rights reserved.,10.1016/j.jneuroim.2018.02.001,<Element 'PubmedArticle' at 0x7f05dd6f6220>
358,"29500668
26342194
24343120
12535154
8110434
9170008
25619659
20547972
17136771
26056339
1481946
19127280
16760914
23979225
6095085
15001194
8485449
9263210
1279679
22915113
19655400
29222949
24691121
9043814
27783857
26673558
11274064
15854152
16755308
11448960
23791197
18655885",Assessing the role of hypothalamic microglia and blood vessel disruption in the development of angiotensin II-dependent hypertension in Cyp1a1-Ren2 rats.,"Elevated plasma levels of the hormone vasopressin have been implicated in the pathogenesis of some forms of hypertension. Hypothalamic paraventricular and supraoptic nuclei neurons regulate vasopressin secretion into the circulation. Vasopressin neuron activity is elevated by day 7 in the development of angiotensin II-dependent hypertension in Cyp1a1-Ren2 rats. While microglial activation and blood-brain barrier (BBB) breakdown contribute to the maintenance of well-established hypertension, it is not known whether these mechanisms contribute to the early onset of hypertension. Hence, we aimed to determine whether microglia are activated and/or the BBB is compromised during the onset of hypertension. Here, we used the Cyp1a1-Ren2 rat model of hypertension and showed that ionised calcium-binding adapter molecule 1 staining of microglia does not change in the paraventricular and supraoptic nuclei on day 7 (early onset) and day 28 (well established) of hypertension, compared to the normotensive control. Endothelial transferrin receptor staining, which stains endothelia and reflects blood vessel density, was also unchanged at day 7, but was reduced at day 28, suggesting that breakdown of the BBB begins between day 7 and day 28 in the development of hypertension. Hence, this study does not support the idea that microglial activation or BBB disruption contribute to the onset of angiotensin II-dependent hypertension in Cyp1a1-Ren2 rats, although BBB disruption might contribute to the progression from the early onset to well-established hypertension.","['Angiotensin II', 'Blood-brain barrier', 'Hypertension', 'Microglia', 'Oxytocin', 'Vasopressin']",Pflugers Archiv : European journal of physiology,2018-03-04,"[{'lastname': 'Korpal', 'firstname': 'Aaron K', 'initials': 'AK', 'affiliation': 'Brain Health Research Centre, University of Otago, Dunedin, New Zealand.\nCentre for Neuroendocrinology, University of Otago, Dunedin, New Zealand.\nDepartment of Physiology, University of Otago, Dunedin, New Zealand.'}, {'lastname': 'Brown', 'firstname': 'Colin H', 'initials': 'CH', 'affiliation': 'Brain Health Research Centre, University of Otago, Dunedin, New Zealand.\nCentre for Neuroendocrinology, University of Otago, Dunedin, New Zealand.\nDepartment of Physiology, University of Otago, Dunedin, New Zealand.'}, {'lastname': 'Schwenke', 'firstname': 'Daryl O', 'initials': 'DO', 'affiliation': 'HeartOtago, University of Otago, Dunedin, New Zealand. daryl.schwenke@otago.ac.nz.\nDepartment of Physiology, University of Otago, Dunedin, New Zealand. daryl.schwenke@otago.ac.nz.'}]",,,,,10.1007/s00424-018-2128-x,<Element 'PubmedArticle' at 0x7f05dd702630>
359,"29490521
22266116
22110065
19056300
19474209
22615780
25359392
23874797
25610879
28681194
23207548
29287085
15134438
18728222
22328823
26888251
18480052",Toll-like receptor 4 regulates insulin signal transduction in retinal Müller cells.,"Dysfunctional insulin signalling is a causative factor in type-2 diabetes. While insulin signal transduction has been well investigated in many tissues, less is known in retinal tissues. We have previously reported that toll-like receptor 4 (TLR4) is involved in retinal damage in diabetes. We used TLR4 retinal Müller cell-specific knockout mice and Müller cells in culture to investigate the effects of loss of TLR4 on Müller cell insulin signal transduction. Loss of TLR4 in the mouse retinal Müller cells led to increased insulin receptor and Akt phosphorylation, with reduced insulin receptor substrate 1 (IRS-1) phosphorylation on serine 307, which was associated with reduced cleavage of caspase 3. In retinal Müller cells grown in high glucose, insulin signal transduction was impaired, but these responses were reduced with cells were transfected with TLR4 siRNA. Taken together, the data suggest that TLR4 regulates insulin signal transduction in retinal Müller cells.","['Insulin signaling', 'Müller cells', 'knockout mice', 'retina']","Growth factors (Chur, Switzerland)",2018-03-02,"[{'lastname': 'Liu', 'firstname': 'Li', 'initials': 'L', 'affiliation': 'a Department of Anatomy and Cell Biology , Wayne State University School of Medicine , Detroit , MI , USA.'}, {'lastname': 'Steinle', 'firstname': 'Jena J', 'initials': 'JJ', 'affiliation': 'a Department of Anatomy and Cell Biology , Wayne State University School of Medicine , Detroit , MI , USA.\nb Department of Ophthalmology , Wayne State University School of Medicine , Detroit , MI , USA.'}]",,,,,10.1080/08977194.2018.1442833,<Element 'PubmedArticle' at 0x7f05dd716ea0>
360,29484707,2-AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs.,"The innate immune response is mediated by primary immune modulators such as cytokines and chemokines that together with immune cells and resident glia orchestrate CNS immunity and inflammation. Growing evidence supports that the endocannabinoid 2-arachidonoylglycerol (2-AG) exerts protective actions in CNS injury models. Here, we used the acute phase of Theiler's virus induced demyelination disease (TMEV-IDD) as a model of acute neuroinflammation to investigate whether 2-AG modifies the brain innate immune responses to TMEV and CNS leukocyte trafficking. 2-AG or the inhibition of its hydrolysis diminished the reactivity and number of microglia at the TMEV injection site reducing their morphological complexity and modulating them towards an anti-inflammatory state via CB2 receptors. Indeed, 2-AG dampened the infiltration of immune cells into the CNS and inhibited their egress from the spleen, resulting in long-term beneficial effects at the chronic phase of the disease. Intriguingly, it is not a generalized action over leukocytes since 2-AG increased the presence and suppressive potency of myeloid derived suppressor cells (MDSCs) in the brain resulting in higher apoptotic CD4","['2-AG', 'CB receptors', 'MAGL', 'MDSCs', 'TMEV', 'inflammation', 'microglia']",Glia,2018-02-28,"[{'lastname': 'Mecha', 'firstname': 'Miriam', 'initials': 'M', 'affiliation': 'Departamento de Neurobiología Funcional y de Sistemas, Grupo de Neuroinmunología, Instituto Cajal, CSIC, Madrid, Spain.'}, {'lastname': 'Feliú', 'firstname': 'Ana', 'initials': 'A', 'affiliation': 'Departamento de Neurobiología Funcional y de Sistemas, Grupo de Neuroinmunología, Instituto Cajal, CSIC, Madrid, Spain.'}, {'lastname': 'Machín', 'firstname': 'Isabel', 'initials': 'I', 'affiliation': 'Laboratorio de Neuroinmuno-Reparación, Hospital Nacional de Parapléjicos-SESCAM Finca ""La Peraleda"" s/n, Toledo, Spain.'}, {'lastname': 'Cordero', 'firstname': 'Cesar', 'initials': 'C', 'affiliation': 'Departamento de Neurobiología Funcional y de Sistemas, Grupo de Neuroinmunología, Instituto Cajal, CSIC, Madrid, Spain.'}, {'lastname': 'Carrillo-Salinas', 'firstname': 'Francisco', 'initials': 'F', 'affiliation': 'Departamento de Neurobiología Funcional y de Sistemas, Grupo de Neuroinmunología, Instituto Cajal, CSIC, Madrid, Spain.'}, {'lastname': 'Mestre', 'firstname': 'Leyre', 'initials': 'L', 'affiliation': 'Departamento de Neurobiología Funcional y de Sistemas, Grupo de Neuroinmunología, Instituto Cajal, CSIC, Madrid, Spain.'}, {'lastname': 'Hernández-Torres', 'firstname': 'Gloria', 'initials': 'G', 'affiliation': 'Departamento de Química Orgánica, Facultad de Químicas, Universidad Complutense de Madrid, Madrid, Spain.'}, {'lastname': 'Ortega-Gutiérrez', 'firstname': 'Silvia', 'initials': 'S', 'affiliation': 'Departamento de Química Orgánica, Facultad de Químicas, Universidad Complutense de Madrid, Madrid, Spain.'}, {'lastname': 'López-Rodríguez', 'firstname': 'María L', 'initials': 'ML', 'affiliation': 'Departamento de Química Orgánica, Facultad de Químicas, Universidad Complutense de Madrid, Madrid, Spain.'}, {'lastname': 'de Castro', 'firstname': 'Fernando', 'initials': 'F', 'affiliation': 'Departamento de Neurobiología Funcional y de Sistemas, Grupo de Neurobiología del Desarrollo. Instituto Cajal, CSIC, Madrid, Spain.'}, {'lastname': 'Clemente', 'firstname': 'Diego', 'initials': 'D', 'affiliation': 'Laboratorio de Neuroinmuno-Reparación, Hospital Nacional de Parapléjicos-SESCAM Finca ""La Peraleda"" s/n, Toledo, Spain.'}, {'lastname': 'Guaza', 'firstname': 'Carmen', 'initials': 'C', 'affiliation': 'Departamento de Neurobiología Funcional y de Sistemas, Grupo de Neuroinmunología, Instituto Cajal, CSIC, Madrid, Spain.'}]",,,,"© 2018 Wiley Periodicals, Inc.",10.1002/glia.23317,<Element 'PubmedArticle' at 0x7f05db3e95e0>
361,"29463646
18985363
20127344
18772396
19228619
22343889
28465358
27116977
28319047
20478531
19576519
26860959
22306293
21620138
22056988
23451252
22901803
19305417
23644491
23690610
22451913
26322579
23671189
19935646
23633299
15959903
9482734
11834740
15473860
12699626
27149849
11532957
23355908
18301784
22588877
23550210
8232556
28298418
28575679
23178880
24366912
21289278
8047169
20975057
26311851
27029062
20161613
20399149
21887505
27148686
8262564
26061751
24336570
24120142
28472509
26824661",Mutant Isocitrate Dehydrogenase 1 Disrupts PKM2-β-Catenin-BRG1 Transcriptional Network-Driven CD47 Expression.,"A gain-of-function mutation in isocitrate dehydrogenase 1 (IDH1) affects immune surveillance in gliomas. As elevated CD47 levels are associated with immune evasion in cancers, its status in gliomas harboring mutant IDH1 (IDH1-MT cells) was investigated. Decreased CD47 expression in IDH1-R132H-overexpressing cells was accompanied by diminished nuclear β-catenin, pyruvate kinase isoform M2 (PKM2), and TCF4 levels compared to those in cells harboring wild-type IDH1 (IDH1-WT cells). The inhibition of β-catenin in IDH1-WT cells abrogated CD47 expression, β-catenin-TCF4 interaction, and the transactivational activity of β-catenin/TCF4. The reverse effect was observed in IDH1-MT cells upon the pharmacological elevation of nuclear β-catenin levels. Genetic and pharmacological manipulation of nuclear PKM2 levels in IDH1-WT and IDH1-MT cells suggested that PKM2 is a positive regulator of the β-catenin-TCF4 interaction. The Cancer Genome Atlas (TCGA) data sets indicated diminished CD47, PKM2, and β-catenin levels in IDH1-MT gliomas compared to IDH1-WT gliomas. Also, elevated BRG1 levels with mutations in the ATP-dependent chromatin-remodeling site were observed in IDH1-MT glioma. The ectopic expression of ATPase-deficient BRG1 diminished CD47 expression as well as TCF4 occupancy on its promoter. Sequential chromatin immunoprecipitation (ChIP-re-ChIP) revealed the recruitment of the PKM2-β-catenin-BRG1-TCF4 complex to the TCF4 site on the CD47 promoter. This occupancy translated into CD47 transcription, as a diminished recruitment of this complex was observed in glioma cells bearing IDH1-R132H. In addition to its involvement in CD47 transcriptional regulation, PKM2-β-catenin-BRG1 cross talk affected the phagocytosis of IDH1-MT cells by microglia.","['BRG1', 'CD47', 'IDH1', 'PKM2', 'β-catenin']",Molecular and cellular biology,2018-02-22,"[{'lastname': 'Gowda', 'firstname': 'Pruthvi', 'initials': 'P', 'affiliation': 'National Brain Research Centre, Manesar, Haryana, India.'}, {'lastname': 'Patrick', 'firstname': 'Shruti', 'initials': 'S', 'affiliation': 'National Brain Research Centre, Manesar, Haryana, India.'}, {'lastname': 'Singh', 'firstname': 'Ankita', 'initials': 'A', 'affiliation': 'National Brain Research Centre, Manesar, Haryana, India.'}, {'lastname': 'Sheikh', 'firstname': 'Touseef', 'initials': 'T', 'affiliation': 'National Brain Research Centre, Manesar, Haryana, India.'}, {'lastname': 'Sen', 'firstname': 'Ellora', 'initials': 'E', 'affiliation': 'National Brain Research Centre, Manesar, Haryana, India ellora@nbrc.ac.in.'}]",,,,Copyright © 2018 American Society for Microbiology.,"10.1128/MCB.00001-18
10.1007/s00401-008-0455-2
10.1007/s00401-010-0645-6
10.1126/science.1164382
10.1056/NEJMoa0808710
10.1038/nature10866
10.1101/gad.294991.116
10.1093/neuonc/now061
10.1172/JCI90644
10.1016/j.ccr.2010.03.020
10.1016/j.neuint.2009.03.016
10.1016/j.biocel.2016.02.007
10.1016/j.molcel.2012.01.001
10.1016/j.cell.2011.03.054
10.1038/nature10598
10.1371/journal.pone.0057610
10.1016/j.cell.2012.07.018
10.1038/nrm2654
10.1038/ng.2628
10.1073/pnas.1305569110
10.1073/pnas.1121623109
10.1038/nm.3931
10.1128/MCB.01254-12
10.1038/nature08617
10.1002/glia.22501
10.1002/jnr.20485
10.1093/emboj/17.5.1371
10.1074/jbc.M111635200
10.1146/annurev.cellbio.20.010403.113126
10.1016/S0960-9822(03)00240-9
10.1016/j.celrep.2016.03.070
10.1093/emboj/20.17.4935
10.1371/journal.pone.0055119
10.1621/nrs.06004
10.1158/2159-8290.CD-12-0095
10.1126/scisignal.2004088
10.1038/366170a0
10.1126/scitranslmed.aaf2968
10.1016/j.cell.2017.05.016
10.1038/ncb2629
10.1093/neuonc/not243
10.1073/pnas.1019393108
10.1038/370477a0
10.1212/WNL.0b013e3181f96282
10.1074/jbc.M115.665752
10.18632/oncotarget.8384
10.1126/scitranslmed.3000139
10.1016/j.ccr.2010.03.017
10.1007/s00109-011-0807-6
10.1038/cddis.2016.117
10.3109/08820139309063419
10.1056/NEJMoa1402121
10.1126/science.1239947
10.1016/j.cell.2013.09.034
10.1093/neuonc/nox086
10.1016/j.cell.2015.12.028",<Element 'PubmedArticle' at 0x7f05db3f8e50>
362,29407440,Thyroid Hormone in the CNS: Contribution of Neuron-Glia Interaction.,"The endocrine system and the central nervous system (CNS) are intimately linked. Among hormones closely related to the nervous system, thyroid hormones (THs) are critical for the regulation of development and differentiation of neurons and neuroglia and hence for development and function of the CNS. T3 (3,3',5-triiodothyronine), an active form of TH, is important not only for neuronal development but also for differentiation of astrocytes and oligodendrocytes, and for microglial development. In adult brain, T3 affects glial morphology with sex- and age-dependent manner and therefore may affect their function, leading to influence on neuron-glia interaction. T3 is an important signaling factor that affects microglial functions such as migration and phagocytosis via complex mechanisms. Therefore, dysfunction of THs may impair glial function as well as neuronal function and thus disturb the brain, which may cause mental disorders. Investigations on molecular and cellular basis of hyperthyroidism and hypothyroidism will help us to understand changes in neuron-glia interaction and therefore consequent psychiatric symptoms.","['Hyperthyroidism', 'Hypothyroidism', 'Microglia', 'Migration', 'Neuroglia', 'Phagocytosis', 'Psychiatric symptoms']",Vitamins and hormones,2018-02-07,"[{'lastname': 'Noda', 'firstname': 'Mami', 'initials': 'M', 'affiliation': 'Laboratory of Pathophysiology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan. Electronic address: noda@phar.kyushu-u.ac.jp.'}]",,,,© 2018 Elsevier Inc. All rights reserved.,10.1016/bs.vh.2017.05.005,<Element 'PubmedArticle' at 0x7f05db3a86d0>
363,29368003,The Role of Angiotensin II/AT1 Receptor Signaling in Regulating Retinal Microglial Activation.,"This study explored whether the proangiogenic factor Angiotensin II (AngII) had a direct effect on the activation state of microglia via the Angiotensin type 1 receptor (AT1-R).
Microglial dynamic activity was investigated in live retinal flatmounts from adult Cx3Cr1+/GFP mice under control, AngII (5 μM) or AngII (5 μM) + candesartan (0.227 μM) conditions. The effects of intravitreal administration of AngII (10 mM) were also investigated at 24 hours, with retinae processed for immunocytochemistry, flow cytometry, or inflammatory quantitative PCR arrays.
We found FACS isolated retinal microglia expressed AT1-R. In retinal flatmounts, microglia showed characteristic movement of processes under control conditions. Perfusion of AngII induced an immediate change in process length (-42%, P < 0.05) and activation state of microglia that was ameliorated by AT1-R blockade, suggesting a direct effect of AngII on microglia via the AT1-R. Intravitreal injection of AngII induced microglial activation after 24 hours, which was characterized by increased soma size (23%, P < 0.001) and decreased process length (20%, P < 0.05). Further analysis indicated a significant decrease in the number of microglial contacts with retinal neurons (saline 15.6 ± 2.31 versus AngII 7.8 ± 1.06, P < 0.05). Retinal cytokine and chemokine expression was modulated, indicative of an inflammatory retinal phenotype.
We show that retinal microglia express AT1-R and their activation state is significantly altered by the angiogenic factor, AngII. Specifically, AngII may directly activate AT1-Rs on microglia and contribute to retinal inflammation. This may have implications for diseases like diabetic retinopathy where increases in AngII and inflammation have been shown to play an important role.",[],Investigative ophthalmology & visual science,2018-01-26,"[{'lastname': 'Phipps', 'firstname': 'Joanna A', 'initials': 'JA', 'affiliation': 'Department of Anatomy and Neuroscience, The University of Melbourne, Parkville, Australia.'}, {'lastname': 'Vessey', 'firstname': 'Kirstan A', 'initials': 'KA', 'affiliation': 'Department of Anatomy and Neuroscience, The University of Melbourne, Parkville, Australia.'}, {'lastname': 'Brandli', 'firstname': 'Alice', 'initials': 'A', 'affiliation': 'Department of Anatomy and Neuroscience, The University of Melbourne, Parkville, Australia.'}, {'lastname': 'Nag', 'firstname': 'Nupur', 'initials': 'N', 'affiliation': 'Department of Anatomy and Neuroscience, The University of Melbourne, Parkville, Australia.'}, {'lastname': 'Tran', 'firstname': 'Mai X', 'initials': 'MX', 'affiliation': 'Department of Anatomy and Neuroscience, The University of Melbourne, Parkville, Australia.'}, {'lastname': 'Jobling', 'firstname': 'Andrew I', 'initials': 'AI', 'affiliation': 'Department of Anatomy and Neuroscience, The University of Melbourne, Parkville, Australia.'}, {'lastname': 'Fletcher', 'firstname': 'Erica L', 'initials': 'EL', 'affiliation': 'Department of Anatomy and Neuroscience, The University of Melbourne, Parkville, Australia.'}]",,,"We found FACS isolated retinal microglia expressed AT1-R. In retinal flatmounts, microglia showed characteristic movement of processes under control conditions. Perfusion of AngII induced an immediate change in process length (-42%, P < 0.05) and activation state of microglia that was ameliorated by AT1-R blockade, suggesting a direct effect of AngII on microglia via the AT1-R. Intravitreal injection of AngII induced microglial activation after 24 hours, which was characterized by increased soma size (23%, P < 0.001) and decreased process length (20%, P < 0.05). Further analysis indicated a significant decrease in the number of microglial contacts with retinal neurons (saline 15.6 ± 2.31 versus AngII 7.8 ± 1.06, P < 0.05). Retinal cytokine and chemokine expression was modulated, indicative of an inflammatory retinal phenotype.",,10.1167/iovs.17-22416,<Element 'PubmedArticle' at 0x7f05db3aed10>
364,"29278365
22249600
15525724
19683971
22254140
27027601
22123886
21074140
19647504
15526952
22474588
2011592
24871624
17426354
23583307
26272384
7235629
16336947
22143064
23651512
9813271
9660403
8594055
26599266
9950062
21420433
27126393
19672074
15312162
24434477
25620049
23395861
26289716
15592434
19542909
25889641
10994850
12172379
17971506
17166174
9230442
19551849
18567941
24184979
27555552
16443153
28134843
22056248
27197831
27683241
2342827
28931035
18437097
26851769
23495069
22531298
16736041
22949477
24323275
14615545
16988041
21900578
22182318
19706184
23686747
22497984
17203473
26037411
22562356
18810232
24323337
11895221
1379488
8072645
23750306
18460549
11014219
23731522
27222132
24163150
21796662
29070584
28924010
27777645
29111308",Sexually Dimorphic Outcomes after Neonatal Stroke and Hypoxia-Ischemia.,"Cohort studies have demonstrated a higher vulnerability in males towards ischemic and/or hypoxic-ischemic injury in infants born near- or full-term. Male sex was also associated with limited brain repair following neonatal stroke and hypoxia-ischemia, leading to increased incidence of long-term cognitive deficits compared to females with similar brain injury. As a result, the design of pre-clinical experiments considering sex as an important variable was supported and investigated because neuroprotective strategies to reduce brain injury demonstrated sexual dimorphism. While the mechanisms underlining these differences between boys and girls remain unclear, several biological processes are recognized to play a key role in long-term neurodevelopmental outcomes: gonadal hormones across developmental stages, vulnerability to oxidative stress, modulation of cell death, and regulation of microglial activation. This review summarizes the current evidence for sex differences in neonatal hypoxic-ischemic and/or ischemic brain injury, considering the major pathways known to be involved in cognitive and behavioral deficits associated with damages of the developing brain.","['cell death', 'developing brain', 'gender', 'hypoxic-ischemic encephalopathy', 'microglia', 'oxidative stress', 'stroke']",International journal of molecular sciences,2017-12-27,"[{'lastname': 'Charriaut-Marlangue', 'firstname': 'Christiane', 'initials': 'C', 'affiliation': 'U1141 PROTECT, Inserm, Université Paris Diderot, Sorbonne Paris Cité, Hôpital Robert Debré, 48 boulevard Sérurier, 75019 Paris, France. christiane.marlangue@gmail.com.'}, {'lastname': 'Besson', 'firstname': 'Valérie C', 'initials': 'VC', 'affiliation': ""U1141 PROTECT, Inserm, Université Paris Diderot, Sorbonne Paris Cité, Hôpital Robert Debré, 48 boulevard Sérurier, 75019 Paris, France. valerie.besson@parisdescartes.fr.\nEA4475-Pharmacologie de la Circulation Cérébrale, Faculté de Pharmacie de Paris, Université Paris Descartes, Sorbonne Paris Cité, 4 Avenue de l'Observatoire, 75006 Paris, France. valerie.besson@parisdescartes.fr.""}, {'lastname': 'Baud', 'firstname': 'Olivier', 'initials': 'O', 'affiliation': ""U1141 PROTECT, Inserm, Université Paris Diderot, Sorbonne Paris Cité, Hôpital Robert Debré, 48 boulevard Sérurier, 75019 Paris, France. olivierfrancois.baud@hcuge.ch.\nDivision of Neonatology and Pediatric Intensive Care, Children's University Hospital of Geneva and University of Geneva, 1205 Geneva, Switzerland. olivierfrancois.baud@hcuge.ch.""}]",,,,,"10.3390/ijms19010061
10.1007/s00247-011-2332-8
10.1056/NEJMra041996
10.1016/j.siny.2009.07.009
10.1155/2011/734506
10.1111/dmcn.13040
10.1542/peds.2011-1148
10.1016/j.ajog.2010.09.022
10.1016/j.siny.2009.07.003
10.1177/08830738040190070301
10.1155/2012/867531
10.1073/pnas.88.7.2845
10.1177/1073858414536468
10.1385/NI:5:1:79
10.1016/j.pneurobio.2013.04.001
10.1161/STROKEAHA.115.007776
10.1002/ana.410090206
10.1016/j.brainres.2005.10.043
10.1016/j.expneurol.2011.11.025
10.1016/j.expneurol.2013.04.015
10.1016/S0006-8993(98)00892-0
10.1161/01.STR.29.7.1454
10.1097/00004647-199603000-00008
10.1159/000441663
10.1016/S0168-0102(98)00096-0
10.1016/j.jneumeth.2011.02.030
10.1186/s12974-016-0560-4
10.1159/000232564
10.1111/j.1471-4159.2004.02547.x
10.1016/j.expneurol.2014.01.003
10.1016/j.neuroscience.2014.12.074
10.1016/j.neuroscience.2013.01.066
10.3109/00207454.2015.1047016
10.1038/sj.cdd.4401545
10.1203/PDR.0b013e3181b1bc34
10.1186/s12974-015-0251-6
10.1097/00004647-200009000-00003
10.1097/00004647-200208000-00005
10.1177/1073858407308889
10.1111/j.1471-4159.2006.04269.x
10.1038/40901
10.1002/ana.21714
10.4161/auto.6398
10.1016/j.neuroscience.2013.10.046
10.1016/j.neuroscience.2016.08.026
10.1016/j.freeradbiomed.2005.08.040
10.3390/ijms18020265
10.1016/j.mito.2011.10.002
10.1111/jnc.13590
10.1007/s10863-016-9678-4
10.1203/00006450-199004000-00003
10.1371/journal.pone.0184643
10.1203/PDR.0b013e31817cfcc0
10.1016/j.neures.2016.01.008
10.1002/ana.23842
10.1016/j.expneurol.2012.04.001
10.1038/sj.jcbfm.9600342
10.1161/STROKEAHA.112.664243
10.1007/s12975-012-0217-2
10.1126/science.1088417
10.1523/JNEUROSCI.2723-06.2006
10.1523/JNEUROSCI.2102-11.2011
10.1111/j.1471-4159.2011.07630.x
10.1186/1742-2094-6-24
10.1002/jnr.23242
10.1016/j.psyneuen.2012.02.018
10.1002/glia.20468
10.1002/glia.22867
10.1007/s00401-012-0990-8
10.1159/000155983
10.1007/s12975-012-0230-5
10.1046/j.1365-2265.2001.01416.x
10.3109/13813459209035274
10.1111/j.1365-2990.1994.tb01173.x
10.1677/JOE-07-0294
10.1210/endo.141.10.7693
10.1016/j.coph.2013.05.007
10.1016/j.expneurol.2016.05.024
10.1007/s12031-013-0137-y
10.1002/ana.22489
10.1096/fj.201700139RRR
10.1523/JNEUROSCI.1139-17.2017
10.1155/2016/6032306",<Element 'PubmedArticle' at 0x7f05db3bae00>
365,"29249750
17485518
9771457
19795409
1542665
13807523
4350147
19347309
22933625
12115952
22967900
17764761
23509419
28273689
24703938
21798099
9207234
8655404
12973694
1618805
22833472
23201826
18593877
22179841
20026663
8496151
12526812","Progranulin deficiency leads to prolonged persistence of macrophages, accompanied with myofiber hypertrophy in regenerating muscle.","Skeletal muscle has an ability to regenerate in response to injury due to the presence of satellite cells. Injury in skeletal muscle causes infiltration of pro-inflammatory macrophages (M1 macrophages) to remove necrotic myofibers, followed by their differentiation into anti-inflammatory macrophages (M2 macrophages) to terminate the inflammation. Since both M1 and M2 macrophages play important roles, coordinated regulation of their kinetics is important to complete muscle regeneration successfully. Progranulin (PGRN) is a pluripotent growth factor, having a protective role against the inflamed tissue. In the central nervous system, PGRN regulates inflammation by inhibiting the activation of microglia. Here we used muscle injury model of PGRN-knockout (PGRN-KO) mice to elucidate whether it has a role in the kinetics of macrophages during muscle regeneration. We found the prolonged persistence of macrophages at the late phase of regeneration in PGRN-KO mice, and these macrophages were suggested to be M2 macrophages since this was accompanied with an increased CD206 expression. We also observed muscle hypertrophy in PGRN-KO mice at the late stage of muscle regeneration. Since M2 macrophages are known to have a role in maturation of myofibers, this muscle hypertrophy may be due to the presence of increased number of M2 macrophages. Our results suggest that PGRN plays a role in the regulation of kinetics of macrophages for the systemic progress of muscle regeneration.","['inflammation', 'macrophage', 'progranulin', 'regeneration', 'skeletal muscle']",The Journal of veterinary medical science,2017-12-19,"[{'lastname': 'Sugihara', 'firstname': 'Hidetoshi', 'initials': 'H', 'affiliation': 'Department of Veterinary Physiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.'}, {'lastname': 'Miyaji', 'firstname': 'Kei', 'initials': 'K', 'affiliation': 'Department of Veterinary Physiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.'}, {'lastname': 'Yamanouchi', 'firstname': 'Keitaro', 'initials': 'K', 'affiliation': 'Department of Veterinary Physiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.'}, {'lastname': 'Matsuwaki', 'firstname': 'Takashi', 'initials': 'T', 'affiliation': 'Department of Veterinary Physiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.'}, {'lastname': 'Nishihara', 'firstname': 'Masugi', 'initials': 'M', 'affiliation': 'Department of Veterinary Physiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.'}]",,,,,"10.1292/jvms.17-0638
10.1084/jem.20070075
10.1677/joe.0.1580145
10.1002/bies.200900086
10.1073/pnas.89.5.1715
10.1083/jcb.7.3.559
10.1002/aja.1001370202
10.1007/978-1-59745-396-7_3
10.4049/jimmunol.1103180
10.1002/mus.10162
10.1016/j.febslet.2012.07.077
10.1016/j.bbr.2007.07.020
10.1155/2013/491497
10.1111/resp.13023
10.1016/j.cellsig.2014.03.026
10.1186/2044-5040-1-21
10.1006/bbrc.1997.6823
10.1242/dev.069088
10.1016/j.neuroscience.2012.11.032
10.1101/gad.465908
10.1007/s00018-011-0901-5
10.1084/jem.20091568
10.1016/S0092-8674(02)01141-8",<Element 'PubmedArticle' at 0x7f05db372810>
366,"29241670
25259918
18653240
26617070
17499941
18282734
14067907
25865484
22084601
28212884
27799931
27142940
22917616
27184538
21359206
27225497
18073775
29520368
26232788
20678226
26724575
11477543
9784247
22895526
24472498
18075491
27235347
26130057
18814846
22683764
22374709
19323847
19428689
6164003
12813115
22751107
27392942
23866724
12401474
26083579
11846609
24281669
27500965
26404710
28223071
24489090
17671174
24402311
18465467
17430106
22404766
22139324
6361014
22742584
28214871
19339614
19234218
18195714
26690895
20815922
17070667
19906237
16785275
22189158
27233247
27754481
10822161
7824198
1465184
22504306
27221627
25686798
7560060
27288072
26925576
23558111
26965653
24380658
26714730
24391212
26819772
9878816
20451602
19577630
24984273
23630570
7296169
18026683
26279502
28179106
11566046",Glia- and tissue-specific changes in the Kynurenine Pathway after treatment of mice with lipopolysaccharide and dexamethasone.,"Behavioral symptoms associated with mood disorders have been intimately linked with immunological and psychological stress. Induction of immune and stress pathways is accompanied by increased tryptophan entry into the Kynurenine (Kyn) Pathway as governed by the rate-limiting enzymes indoleamine/tryptophan 2,3-dioxygenases (DO's: Ido1, Ido2, Tdo2). Indeed, elevated DO expression is associated with inflammation- and stress-related depression symptoms. Here we examined central (brain, astrocyte and microglia) and peripheral (lung, liver and spleen) DO expression in mice treated intraperitoneally with lipopolysaccharide (LPS) and dexamethasone (DEX) to model the response of the Kyn Pathway to inflammation and glucocorticoids. LPS-induced expression of cytokines in peripheral tissues was attenuated by DEX, confirming inflammatory and anti-inflammatory responses, respectively. Increased Kyn levels following LPS and DEX administration verified Kyn Pathway activation. Expression of multiple mRNA isoforms for each DO, which we have shown to be differentially utilized and regulated, were quantified including reference/full-length (FL) and variant (v) transcripts. LPS increased Ido1-FL in brain (∼1000-fold), a response paralleled by increased expression in both astrocytes and microglia. Central Ido1-FL was not changed by DEX; however, LPS-induced Ido1-FL was decreased by DEX in peripheral tissues. In contrast, DEX increased Ido1-v1 expression by astrocytes and microglia, but not peripheral tissues. In comparison, brain Ido2 was minimally induced by LPS or DEX. Uniquely, Ido2-v6 was LPS- and DEX-inducible in astrocytes, suggesting a unique role for astrocytes in response to inflammation and glucocorticoids. Only DEX increased central Tdo2 expression; however, peripheral Tdo2 was upregulated by either LPS or DEX. In summary, specific DO isoforms are increased by LPS and DEX, but LPS-dependent Ido1 and Ido2 induction are attenuated by DEX only in the periphery indicating that elevated DO expression and Kyn production within the brain can occur independent of the periphery. These findings demonstrate a plausible interaction between immune activation and glucocorticoids associated with depression.","['Astrocyte', 'Inflammation', 'Kynurenine', 'Microglia', 'Stress']","Brain, behavior, and immunity",2017-12-16,"[{'lastname': 'Dostal', 'firstname': 'Carlos R', 'initials': 'CR', 'affiliation': 'Neuroscience Program, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States; Medical Scholars Program, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States; Integrative Immunology and Behavior Program, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States. Electronic address: cdostal2@illinois.edu.'}, {'lastname': 'Gamsby', 'firstname': 'Nicolaus S', 'initials': 'NS', 'affiliation': 'School of Earth, Society and Environment, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States. Electronic address: ngamsby2@illinois.edu.'}, {'lastname': 'Lawson', 'firstname': 'Marcus A', 'initials': 'MA', 'affiliation': 'Neuroscience Program, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States; Integrative Immunology and Behavior Program, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States; Department of Animal Sciences, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States. Electronic address: mlawson@illinois.edu.'}, {'lastname': 'McCusker', 'firstname': 'Robert H', 'initials': 'RH', 'affiliation': 'Neuroscience Program, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States; Integrative Immunology and Behavior Program, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States; Department of Animal Sciences, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States; Department of Pathology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States. Electronic address: rmccuske@illinois.edu.'}]",,,,Copyright © 2017 Elsevier Inc. All rights reserved.,"10.1016/j.bbi.2017.12.006
10.1016/j.cell.2014.07.051
10.1016/j.jneuroim.2008.06.011
10.1016/j.neuropharm.2015.11.015
10.1016/j.gene.2007.04.010
10.1016/j.biocel.2008.01.005
10.1084/jem.118.4.587
10.1016/j.psychres.2015.03.031
10.4137/IJTR.S7052
10.1016/j.bbi.2017.02.010
10.3389/fimmu.2016.00422
10.1186/s12974-016-0563-1
10.1016/j.neuroscience.2012.08.031
10.1016/B978-012088576-3/50030-7
10.1186/s12974-016-0572-0
10.1371/journal.pone.0014698
10.1007/7854_2016_6
10.1038/nrn2297
10.1093/ijnp/pyv089
10.1186/1742-2094-7-43
10.1016/j.bbi.2015.12.020
10.1002/1521-4141(200108)31:8<2313::AID-IMMU2313>3.0.CO;2-S
10.1006/abbi.1998.0861
10.1369/0022155412458926
10.1017/S1461145713001673
10.1038/sj.npp.1301649
10.1016/j.jneuroim.2016.04.006
10.1016/j.bbi.2015.06.022
10.1016/j.bbi.2008.09.002
10.1016/j.bbi.2012.05.010
10.1002/glia.22322
10.1186/1756-6606-2-8
10.1016/j.neures.2009.02.004
10.1001/jama.289.23.3095
10.1172/JCI61884
10.1016/j.bbagen.2016.07.002
10.1186/1742-2094-10-87
10.1016/S0889-1591(02)00014-4
10.1016/j.rasd.2014.08.015.Social
10.1006/meth.2001.1262
10.1159/000356144
10.1016/j.neurobiolaging.2016.07.006
10.1038/nn.4086
10.1016/j.clim.2017.01.016
10.4049/jimmunol.1303012
10.1158/0008-5472.CAN-07-1872
10.1093/intimm/dxt073
10.1080/10253890701754068
10.2174/138920007780362509
10.1111/j.1742-4658.2012.08551.x
10.1007/s00702-011-0741-3
10.1186/1742-2094-9-147
10.1159/000455228
10.1523/JNEUROSCI.5032-08.2009
10.4049/jimmunol.0802722
10.1038/sj.mp.4002148
10.1016/j.neuropharm.2015.12.004
10.1186/1756-6606-3-26
10.1016/j.bbi.2006.08.009
10.1111/j.1749-6632.2009.04978.x
10.1177/1359786806066063
10.1186/1742-2094-8-179
10.1186/s12974-016-0590-y
10.1038/tp.2016.200
10.1016/S0361-9230(00)00252-5
10.1016/j.yhbeh.2012.03.010
10.1007/7854_2016_12
10.1016/j.bbi.2015.02.007
10.1172/JCI118214
10.1016/bs.apha.2016.01.005
10.1186/s12974-016-0517-7
10.1093/alcalc/agt028
10.1016/j.bbi.2016.03.002
10.1089/cell.2013.0057
10.4049/jimmunol.1300720
10.1155/2016/7215684
10.1016/S0006-8993(98)01091-9
10.1016/j.bbi.2010.04.015
10.1016/j.bbi.2009.06.152
10.1016/j.pnpbp.2014.06.008
10.1371/journal.pone.0059749
10.1111/j.1476-5381.1981.tb10480.x
10.1007/s00239-007-9049-1
10.1016/j.bbi.2017.01.022
10.1006/brbi.2000.0597",<Element 'PubmedArticle' at 0x7f05db389a40>
367,"29233861
23877425
24914942
20826561
24742194
23307790
16423919
17200702
12360474
17011505
16002529
9149095
20178795
26174421
20441777
15509864
28368434
25379403
28179656
9630473
12663466
26910628
16988703
26042199
11196643
26016745
16473887
15111983
17493645
23297228
18769626
22201683
11057670
26208455
24651458
6168883",Restoration of metabolic inflammation-related ghrelin resistance by weight loss.,"High-fat diet (HFD)-induced metabolic inflammation in the central and peripheral organs contributes to the pathogenesis of obesity. Long-term HFD blunts signaling by ghrelin, a gastric-derived orexigenic peptide, in the vagal afferent nerve via a mechanism involving ","['ghrelin', 'high-fat diet', 'hypothalamus', 'inflammation', 'vagal nerve']",Journal of molecular endocrinology,2017-12-14,"[{'lastname': 'Naznin', 'firstname': 'Farhana', 'initials': 'F', 'affiliation': 'Division of NeurologyRespirology, Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.'}, {'lastname': 'Toshinai', 'firstname': 'Koji', 'initials': 'K', 'affiliation': 'Division of NeurologyRespirology, Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.\nDepartment of Sports and FitnessFaculty of Wellness, Shigakkan University, Obu, Japan.'}, {'lastname': 'Waise', 'firstname': 'T M Zaved', 'initials': 'TMZ', 'affiliation': 'Division of NeurologyRespirology, Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.'}, {'lastname': 'Okada', 'firstname': 'Tadashi', 'initials': 'T', 'affiliation': 'Division of NeurologyRespirology, Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.'}, {'lastname': 'Sakoda', 'firstname': 'Hideyuki', 'initials': 'H', 'affiliation': 'Division of NeurologyRespirology, Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.'}, {'lastname': 'Nakazato', 'firstname': 'Masamitsu', 'initials': 'M', 'affiliation': 'Division of NeurologyRespirology, Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan nakazato@med.miyazaki-u.ac.jp.\nAgency for Medical Research and Development-Core Research for Evolutional Medical Science and Technology (AMED-CREST)Japan Agency for Medical Research and Development, Tokyo, Japan.'}]",,,,© 2018 The authors.,"10.1530/JME-17-0192
10.1038/nrendo.2013.136
10.1210/en.2014-1121
10.1210/en.2010-0556
10.1210/en.2013-1861
10.1210/en.2012-1421
10.1152/ajpgi.00543.2005
10.1172/JCI30227
10.1053/gast.2002.35954
10.1016/j.cmet.2006.09.004
10.1210/en.2004-1520
10.1016/S0169-328X(96)00138-6
10.1053/j.gastro.2010.02.012
10.1113/JP270788
10.1016/j.brainresrev.2010.04.009
10.1242/jcs.01540
10.1210/en.2016-1832
10.1016/j.molmet.2014.08.003
10.1038/nature21363
10.1016/S0169-328X(98)00040-0
10.2337/diabetes.52.4.948
10.1590/2359-3997000000129
10.1038/nature05026
10.1016/j.molmet.2015.03.005
10.1038/35051587
10.1530/JOE-15-0139
10.1096/fj.05-4882fje
10.1038/sj.ijo.0802640
10.1016/j.physbeh.2007.03.026
10.1073/pnas.1212137110
10.1172/JCI34260
10.1172/JCI59660
10.1038/35038090
10.1016/j.bbrc.2015.07.097
10.3390/ijms15034837
10.1016/0024-3205(81)90022-9",<Element 'PubmedArticle' at 0x7f05db34bae0>
368,"29202771
2089275
20966214
1603325
21125659
28076784
25035950
23392676
25215243
18417708
19733170
21847523
21482444
17188663
24490760
26198916
26163371
24101381
26269636
23087426
24966389
27470986
28317921
16469811
25551794
11245665
24769859
26477569
27966637
27685637
20371618
9590229
27196727
15798185
23023392
22855601
23177320
22542597
22729249
22186992
27174644
26747862
28495878",Selective proliferative response of microglia to alternative polarization signals.,"Microglia are resident myeloid cells of the central nervous system (CNS) that are maintained by self-renewal and actively participate in tissue homeostasis and immune defense. Under the influence of endogenous or pathological signals, microglia undertake biochemical transformations that are schematically classified as the pro-inflammatory M1 phenotype and the alternatively activated M2 state. Dysregulated proliferation of M1-activated microglia has detrimental effects, while an increased number of microglia with the alternative, pro-resolving phenotype might be beneficial in brain pathologies; however, the proliferative response of microglia to M2 signals is not yet known. We thus evaluated the ability of interleukin-4 (IL-4), a typical M2 and proliferative signal for peripheral macrophages, to induce microglia proliferation and compared it with other proliferative and M2 polarizing stimuli for macrophages, namely colony-stimulating factor-1 (CSF-1) and the estrogen hormone, 17β-estradiol (E
Recombinant IL-4 was delivered to the brain of adult mice by intracerebroventricular (i.c.v.) injection; whole brain areas or ex vivo-sorted microglia were analyzed by real-time PCR for assessing the mRNA levels of genes related with cell proliferation (Ki67, CDK-1, and CcnB2) and M2 polarization (Arg1, Fizz1, Ym-1) or by FACS analyses of in vivo BrdU incorporation in microglia. Primary cultures of microglia and astrocytes were also tested for proliferative effects.
Our results show that IL-4 only slightly modified the expression of cell cycle-related genes in some brain areas but not in microglia, where it strongly enhanced M2 gene expression; on the contrary, brain delivery of CSF-1 triggered proliferation as well as M2 polarization of microglia both in vivo and in vitro. Similar to IL-4, the systemic E
Our data show that, in contrast to the wider responsiveness of peripheral macrophages, microglia proliferation is stimulated by selected M2 polarizing stimuli suggesting a role for the local microenvironment and developmental origin of tissue macrophages in regulating self-renewal following alternative activating stimuli.","['Estrogen', 'Interleukin-4', 'Microglia', 'Proliferation']",Journal of neuroinflammation,2017-12-06,"[{'lastname': 'Pepe', 'firstname': 'Giovanna', 'initials': 'G', 'affiliation': 'Center of Excellence on Neurodegenerative Diseases and Department Pharmacological and Biomolecular Sciences, University of Milan, Via Balzaretti, 9, 20133, Milan, Italy.'}, {'lastname': 'De Maglie', 'firstname': 'Marcella', 'initials': 'M', 'affiliation': 'Mouse and Animal Pathology Laboratory (MAPLab), Fondazione Filarete, Viale Ortles, 22/4, 20139, Milan, Italy.\nDepartment of Veterinary Medicine, University of Milan, Via Celoria, 10, 20133, Milan, Italy.'}, {'lastname': 'Minoli', 'firstname': 'Lucia', 'initials': 'L', 'affiliation': 'Mouse and Animal Pathology Laboratory (MAPLab), Fondazione Filarete, Viale Ortles, 22/4, 20139, Milan, Italy.\nDepartment of Veterinary Medicine, University of Milan, Via Celoria, 10, 20133, Milan, Italy.'}, {'lastname': 'Villa', 'firstname': 'Alessandro', 'initials': 'A', 'affiliation': 'Center of Excellence on Neurodegenerative Diseases and Department Pharmacological and Biomolecular Sciences, University of Milan, Via Balzaretti, 9, 20133, Milan, Italy.'}, {'lastname': 'Maggi', 'firstname': 'Adriana', 'initials': 'A', 'affiliation': 'Center of Excellence on Neurodegenerative Diseases and Department Pharmacological and Biomolecular Sciences, University of Milan, Via Balzaretti, 9, 20133, Milan, Italy.'}, {'lastname': 'Vegeto', 'firstname': 'Elisabetta', 'initials': 'E', 'affiliation': 'Center of Excellence on Neurodegenerative Diseases and Department Pharmacological and Biomolecular Sciences, University of Milan, Via Balzaretti, 9, 20133, Milan, Italy. elisabetta.vegeto@unimi.it.'}]",,,"Our results show that IL-4 only slightly modified the expression of cell cycle-related genes in some brain areas but not in microglia, where it strongly enhanced M2 gene expression; on the contrary, brain delivery of CSF-1 triggered proliferation as well as M2 polarization of microglia both in vivo and in vitro. Similar to IL-4, the systemic E",,"10.1186/s12974-017-1011-6
10.1016/0306-4522(90)90229-W
10.1126/science.1194637
10.1016/0306-4522(92)90500-2
10.1002/glia.21104
10.1016/j.celrep.2016.12.041
10.1016/j.immuni.2014.06.008
10.1523/JNEUROSCI.4440-12.2013
10.1155/2014/693851
10.1523/JNEUROSCI.4814-07.2008
10.1016/j.expneurol.2009.08.021
10.1007/s10875-011-9579-6
10.1016/j.neurobiolaging.2011.02.015
10.1016/j.brainres.2006.11.085
10.1186/1742-2094-11-26
10.1016/j.jneuroim.2015.05.014
10.1016/j.immuni.2015.06.012
10.1084/jem.20121999
10.1523/JNEUROSCI.1685-15.2015
10.4049/jimmunol.1202246
10.1523/JNEUROSCI.1146-14.2014
10.1002/glia.23041
10.1038/srep44270
10.1210/en.2005-1330
10.1186/s12974-014-0211-6
10.1038/jid.2014.175
10.1038/srep15224
10.1038/srep39204
10.1002/glia.23053
10.1096/fj.10-155317
10.1210/er.2016-1007
10.1128/MCB.25.8.2957-2968.2005
10.1038/ni.2419
10.1182/blood-2012-02-408252
10.1016/j.immuni.2012.11.001
10.1016/j.ydbio.2012.03.026
10.1038/ni.2360
10.1182/blood-2011-09-379214
10.1038/srep25663
10.1093/brain/awv379
10.1126/science.aaj2067",<Element 'PubmedArticle' at 0x7f05db2ed3b0>
369,"29105727
29055037
29055040
29055032
29055036
29055034
24669209
15239122
22347798
12771987
18645592
5344859
9392442
16313492
8574683
19095474
10493527
12846415
16322268
3315253
28555330
15562014
22654792
20205557
25757565
23733368
17179764
10831154
12490959
19236342
22753734
18845357
11604479
15852007
17659349
27919824
26954684
17014691
19076264
15725340
3148005
20418777
11846459
17728245
28493341
9619447
20303878
1578339
21778461
10403512
28728370
10878815
19878981
15617533
17349021
27314810
20066113
16497591
23844130
9152044
26510398
22280241
16829554
26383232
20026420
22856590
24460899
26659895
24975205
23497121
11235023
11711054
16612844
27829983
12869499
16082917
22812624
26728119
18073503
23708099
23523917
1155357
15917719
21062257
27146515
15150588
12111544
10915838
19029990
9230218
23284853
26887983
25218873
20066092
2162676
26266918
19013253
22935823
24363121
23745599
16879319
17910605
12396291
28420185
10801305
16030307
19124483
11604480
12783938
1826599
24928439
28294066
20586888
22768337
28522814
12773631
12543278
10499491
12769226
12039872
21482951
26464438
16885212
6796259
7079745
21103056
16260852
23689687
24129182
3401709
11320658
11642733
17975006
23054680
22271210
18836471
28505494
2717784
28086098
27989773
8351960
28011485
12887656",Immune-pineal axis - acute inflammatory responses coordinate melatonin synthesis by pinealocytes and phagocytes.,"Melatonin is well known for its circadian production by the pineal gland, and there is a growing body of data showing that it is also produced by many other cells and organs, including immune cells. The chronobiotic role of pineal melatonin, as well as its protective effects in vitro and in vivo, have been extensively explored. However, the interaction between the chronobiotic and defence functions of endogenous melatonin has been little investigated. This review details the current knowledge regarding the coordinated shift in melatonin synthesis from the pineal gland (circadian and monitoring roles) to the regulation of acute immune responses via immune cell production and autocrine effects, producing systemic interactions termed the immune-pineal axis. An acute inflammatory response drives the transcription factor, NFκB, to switch melatonin synthesis from pinealocytes to macrophages/microglia and, upon acute inflammatory resolution, back to pinealocytes. The potential pathophysiological relevance of immune-pineal axis dysregulation is highlighted, with both research and clinical implications, across several medical conditions, including host/parasite interaction, neurodegenerative diseases and cancer. LINKED ARTICLES: This article is part of a themed section on Recent Developments in Research of Melatonin and its Potential Therapeutic Applications. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.16/issuetoc.",[],British journal of pharmacology,2017-11-07,"[{'lastname': 'Markus', 'firstname': 'Regina P', 'initials': 'RP', 'affiliation': 'Laboratory of Chronopharmacology and Laboratory of Neuroimmunomodulation - Department of Physiology, Institute of Bioscience, University of São Paulo, São Paulo, Brazil.'}, {'lastname': 'Fernandes', 'firstname': 'Pedro A', 'initials': 'PA', 'affiliation': 'Laboratory of Chronopharmacology and Laboratory of Neuroimmunomodulation - Department of Physiology, Institute of Bioscience, University of São Paulo, São Paulo, Brazil.'}, {'lastname': 'Kinker', 'firstname': 'Gabriela S', 'initials': 'GS', 'affiliation': 'Laboratory of Chronopharmacology and Laboratory of Neuroimmunomodulation - Department of Physiology, Institute of Bioscience, University of São Paulo, São Paulo, Brazil.'}, {'lastname': 'da Silveira Cruz-Machado', 'firstname': 'Sanseray', 'initials': 'S', 'affiliation': 'Laboratory of Chronopharmacology and Laboratory of Neuroimmunomodulation - Department of Physiology, Institute of Bioscience, University of São Paulo, São Paulo, Brazil.'}, {'lastname': 'Marçola', 'firstname': 'Marina', 'initials': 'M', 'affiliation': 'Laboratory of Chronopharmacology and Laboratory of Neuroimmunomodulation - Department of Physiology, Institute of Bioscience, University of São Paulo, São Paulo, Brazil.'}]",,,,© 2017 The British Pharmacological Society.,10.1111/bph.14083,<Element 'PubmedArticle' at 0x7f05db30fae0>
370,"29086247
22407459
28161727
18499466
9120691
17125841
18239157
23925977
25071471
17224059
21975039
24184050
12609817
24664288
23212695
28515690
20940627
27763643
28880266
20580712
21846363
22189567
22407749
11581665
25285746
22362508
28560490
22035192
10720409
16766636
18600228
19706525
12842860
21713375
12829792
12468106
17499413
27693730
19245663
12709402
15599669
18986737
20888078
24529758
28461604
25328009
20964730
19384591
21872656
23446738
21542804
27217404
27896943
26101159","Paracrine and Intracrine Angiotensin 1-7/Mas Receptor Axis in the Substantia Nigra of Rodents, Monkeys, and Humans.","In addition to the classical hormonal (tissue-to-tissue) renin-angiotensin system (RAS), there are a paracrine (cell-to-cell) and an intracrine (intracellular/nuclear) RAS. A local paracrine brain RAS has been associated with several brain disorders, including Parkinson's disease (PD). Classically, angiotensin II (Ang II) is the main RAS effector peptide and acts through two major receptors: Ang II type 1 and 2 (AT1 and AT2) receptors. It has been shown that enhanced activation of the Ang II/AT1 axis exacerbates dopaminergic cell death. Several new components of the RAS have more recently been discovered. However, the role of new Ang 1-7/Mas receptor RAS component was not investigated in the brain and particularly in the dopaminergic system. In the present study, we observed Mas receptor labeling in dopaminergic neurons and glial cells in rat mesencephalic primary cultures; substantia nigra of rats, monkeys, and humans; and human induced pluripotent stem (iPS) cells derived from healthy controls and sporadic PD patients. The present data support a neuroprotective role of the Ang 1-7/Mas receptor axis in the dopaminergic system. We observed that this axis is downregulated with aging, which may contribute to the aging-related vulnerability to neurodegeneration. We have also identified an intracellular Ang 1-7/Mas axis that modulates mitochondrial and nuclear levels of superoxide. The present data suggest that nuclear RAS receptors regulate the adequate balance between the detrimental and the protective arms of the cell RAS. The results further support that the brain RAS should be taken into account for the design of new therapeutic strategies for PD.","['Aging', 'Dopaminergic', 'Neuroprotection', 'Nuclear receptors', 'Parkinson’s disease', 'Renin-angiotensin system']",Molecular neurobiology,2017-11-01,"[{'lastname': 'Costa-Besada', 'firstname': 'Maria A', 'initials': 'MA', 'affiliation': 'Laboratory of Neuroanatomy and Experimental Neurology, Dept. of Morphological Sciences, CIMUS, Faculty of Medicine, University of Santiago de Compostela, 15782, Santiago de Compostela, Spain.\nNetworking Research Center on Neurodegenerative Diseases (CIBERNED), Madrid, Spain.'}, {'lastname': 'Valenzuela', 'firstname': 'Rita', 'initials': 'R', 'affiliation': 'Laboratory of Neuroanatomy and Experimental Neurology, Dept. of Morphological Sciences, CIMUS, Faculty of Medicine, University of Santiago de Compostela, 15782, Santiago de Compostela, Spain.\nNetworking Research Center on Neurodegenerative Diseases (CIBERNED), Madrid, Spain.'}, {'lastname': 'Garrido-Gil', 'firstname': 'Pablo', 'initials': 'P', 'affiliation': 'Laboratory of Neuroanatomy and Experimental Neurology, Dept. of Morphological Sciences, CIMUS, Faculty of Medicine, University of Santiago de Compostela, 15782, Santiago de Compostela, Spain.\nNetworking Research Center on Neurodegenerative Diseases (CIBERNED), Madrid, Spain.'}, {'lastname': 'Villar-Cheda', 'firstname': 'Begoña', 'initials': 'B', 'affiliation': 'Laboratory of Neuroanatomy and Experimental Neurology, Dept. of Morphological Sciences, CIMUS, Faculty of Medicine, University of Santiago de Compostela, 15782, Santiago de Compostela, Spain.\nNetworking Research Center on Neurodegenerative Diseases (CIBERNED), Madrid, Spain.'}, {'lastname': 'Parga', 'firstname': 'Juan A', 'initials': 'JA', 'affiliation': 'Laboratory of Neuroanatomy and Experimental Neurology, Dept. of Morphological Sciences, CIMUS, Faculty of Medicine, University of Santiago de Compostela, 15782, Santiago de Compostela, Spain.\nNetworking Research Center on Neurodegenerative Diseases (CIBERNED), Madrid, Spain.'}, {'lastname': 'Lanciego', 'firstname': 'Jose L', 'initials': 'JL', 'affiliation': 'Networking Research Center on Neurodegenerative Diseases (CIBERNED), Madrid, Spain.\nNeurosciences Division, CIMA, University of Navarra, Pamplona, Spain.'}, {'lastname': 'Labandeira-Garcia', 'firstname': 'Jose L', 'initials': 'JL', 'affiliation': 'Laboratory of Neuroanatomy and Experimental Neurology, Dept. of Morphological Sciences, CIMUS, Faculty of Medicine, University of Santiago de Compostela, 15782, Santiago de Compostela, Spain. joseluis.labandeira@usc.es.\nNetworking Research Center on Neurodegenerative Diseases (CIBERNED), Madrid, Spain. joseluis.labandeira@usc.es.'}]",,,,,"10.1007/s12035-017-0805-y
10.1007/s00429-012-0402-9
10.1007/s00429-016-1357-z
10.1016/j.nbd.2008.03.003
10.1097/00004872-199609002-00018
10.1016/j.pharmthera.2006.10.001
10.1161/ATVBAHA.107.155564
10.1002/mds.25614
10.3389/fnana.2014.00067
10.1186/1750-1326-2-1
10.1186/1742-2094-8-129
10.1016/j.expneurol.2013.10.014
10.1152/ajpregu.00476.2002
10.1161/HYPERTENSIONAHA.113.01274
10.1007/s11906-012-0324-1
10.3389/fnagi.2017.00129
10.1097/NEN.0b013e3181fa0308
10.1038/cddis.2016.327
10.1038/cddis.2017.439
10.1016/j.expneurol.2010.05.015
10.1186/1750-1326-6-58
10.1093/brain/awr320
10.1002/emmm.201200215
10.1038/nbt1001-971
10.1007/s00441-012-1354-3
10.1021/ac202028g
10.1161/01.RES.86.5.494
10.1152/ajpheart.01270.2005
10.1038/nprot.2008.105
10.1073/pnas.0906805106
10.1152/ajprenal.00414.2002
10.1007/s11357-011-9284-7
10.1073/pnas.1432869100
10.1016/S0167-0115(02)00156-8
10.1016/j.pnpbp.2007.04.002
10.1016/j.yfrne.2016.09.003
10.1111/j.1471-4159.2009.05999.x
10.1096/fj.02-1049fje
10.1007/s00059-004-2625-x
10.1016/j.neurobiolaging.2008.09.010
10.1016/j.neurobiolaging.2010.08.006
10.1016/j.neurobiolaging.2014.01.017
10.1161/HYPERTENSIONAHA.116.08814
10.1042/CS20130515
10.1111/j.1460-9568.2010.07448.x
10.1007/s12640-009-9010-8
10.1016/j.freeradbiomed.2011.08.005
10.1161/CIRCRESAHA.113.301077
10.1042/CS20110036
10.1161/HYPERTENSIONAHA.116.07572
10.1111/jdi.12603
10.1016/j.yexcr.2015.06.010",<Element 'PubmedArticle' at 0x7f05db2d5860>
371,29054751,NG2/CSPG4 and progranulin in the posttraumatic glial scar.,"Traumatic injury of the central nervous system is one of the leading causes of death and disability in young adults. Failure of regeneration is caused by autonomous neuronal obstacles and by formation of the glial scar, which is essential to seal the injury but also constitutes a barrier for regrowing axons. The scar center is highly inflammatory and populated by NG2+ glia, whereas astrocytes form the sealing border and trap regrowing axons, suggesting that the non-permissive environment of activated astrocytes and extracellular matrix components is one of the reasons for the regenerative failure. Particularly, secreted chondroitin-sulfate proteoglycans, CSPGs, of the lectican family hinder axonal regrowth. In contrast, the transmembrane CSPG, NG2/CSPG4, appears to be functionally closer related to axon growth permissive heparan sulfate proteoglycans, HSPGs, and synaptic adhesion molecules, which all regulate synaptic signaling and plasticity upon alpha-secretase mediated shedding. Consequently, knockout of NG2/CSPG4 aggravates tissue loss, inflammation and neurologic deficits after brain injury, a phenotype partly mimicked by deletion of HSPG-binding proteins such as the HSPG2/perlecan-interacting protein, progranulin that is also a functional ligand of Notch and Eph2a. Indeed, structural features or progranulin's targets and NG2 may point to direct reciprocal regulations that may act in concert to overcome injury-evoked inflammation and neuronal dystrophy. This review provides an overview of the pathophysiology of the glial scar after brain injury, with a specific focus on NG2/CSPG4, its functions before and after shedding and putative reciprocal influences with the glycoprotein progranulin.","['ADAM10', 'Astrocytes', 'Chondroitin sulfate proteoglycan', 'Glial scar', 'Growth factor', 'Microglia', 'Perlecan', 'Progranulin', 'Receptor protein phosphatase', 'Traumatic brain injury']",Matrix biology : journal of the International Society for Matrix Biology,2017-10-22,"[{'lastname': 'Schäfer', 'firstname': 'Michael K E', 'initials': 'MKE', 'affiliation': 'Department of Anesthesiology, University Medical Center, Johannes Gutenberg-University Mainz, Germany.'}, {'lastname': 'Tegeder', 'firstname': 'Irmgard', 'initials': 'I', 'affiliation': 'Institute of Clinical Pharmacology, Goethe-University Hospital, Frankfurt, Germany. Electronic address: tegeder@em.uni-frankfurt.de.'}]",,,,Copyright © 2017 Elsevier B.V. All rights reserved.,10.1016/j.matbio.2017.10.002,<Element 'PubmedArticle' at 0x7f05db284720>
372,29054452,Mechanism of aquaporin 4 (AQP 4) up-regulation in rat cerebral edema under hypobaric hypoxia and the preventative effect of puerarin.,"We aim to investigate the mechanism of aquaporin 4 (AQP 4) up-regulation during high-altitude cerebral edema (HACE) in rats under hypobaric hypoxia and preventative effect of puerarin.
Rats were exposed to a hypobaric chamber with or without the preventative treatment of puerarin or dexamethasone. Morriz water maze was used to evaluate the spatial memory injury. HE staining and W/D ratio were used to evaluate edema injury. Rat astrocytes and microglia were co-cultured under the condition of hypoxia with the administration of p38 inhibitor, NF-κB inhibitor or puerarin. Interleukin 6 (IL-6) and tumor necrosis factor α (TNF α) of cortex and culture supernatant were measured with ELISA. AQP4, phosphorylation of MAPKs, NF-κB pathway of cortex and astrocytes were measured by Western blot.
Weakened spatial memory and cerebral edema were observed after hypobaric hypoxia exposure. AQP4, phosphorylation of NF-κB and MAPK signal pathway of cortex increased after hypoxia exposure and decreased with preventative treatment of puerarin. Hypoxia increased TNF-α and IL-6 levels in cortex and microglia and puerarin could prevent the increase of them. AQP4 of astrocytes increased after co-cultured with microglia when both were exposed to hypoxia. AQP4 showed a decrease after administered with p38 inhibitor, NF-κB inhibitor or puerarin.
Hypoxia triggers inflammatory response, during which AQP4 of astrocytes can be up regulated through the release of TNF-α and IL-6 from microglia. Puerarin can exert a preventative effect on the increase of AQP4 through inhibiting the release of TNF-α and phosphorylation of NF-κB, MAPK pathway.","['Aquaporin', 'Astrocyte', 'High-altitude cerebral edema', 'Inflammation', 'Microglia']",Life sciences,2017-10-22,"[{'lastname': 'Wang', 'firstname': 'Chi', 'initials': 'C', 'affiliation': 'Department of Clinical Laboratory, PLA General Hospital, 100853 Beijing, China.'}, {'lastname': 'Yan', 'firstname': 'Muyang', 'initials': 'M', 'affiliation': 'Department of Hyperbaric Chamber, PLA General Hospital, 100853 Beijing, China.'}, {'lastname': 'Jiang', 'firstname': 'Hui', 'initials': 'H', 'affiliation': 'Department of Hyperbaric Chamber, PLA General Hospital, 100853 Beijing, China.'}, {'lastname': 'Wang', 'firstname': 'Qi', 'initials': 'Q', 'affiliation': ""Outpatient Department of Chinese People's Liberation Army Aviation School, 101023 Beijing, China.""}, {'lastname': 'He', 'firstname': 'Shang', 'initials': 'S', 'affiliation': 'Department of Clinical Laboratory, PLA General Hospital, 100853 Beijing, China.'}, {'lastname': 'Chen', 'firstname': 'Jingwen', 'initials': 'J', 'affiliation': 'Department of Hyperbaric Chamber, PLA General Hospital, 100853 Beijing, China.'}, {'lastname': 'Wang', 'firstname': 'Chengbin', 'initials': 'C', 'affiliation': 'Department of Clinical Laboratory, PLA General Hospital, 100853 Beijing, China. Electronic address: wangcb301301@163.com.'}]",,,,Copyright © 2017 Elsevier Inc. All rights reserved.,10.1016/j.lfs.2017.10.021,<Element 'PubmedArticle' at 0x7f05db2910e0>
373,29038005,Prednisone alleviates demyelination through regulation of the NLRP3 inflammasome in a C57BL/6 mouse model of cuprizone-induced demyelination.,"Myelin abnormalities, oligodendrocyte damage, and concomitant glia activation are common in demyelinating diseases of the central nervous system (CNS). Increasing evidence has demonstrated that the inflammatory response triggers demyelination and gliosis in demyelinating disorders. Numerous clinical interventions, including those used to treat multiple sclerosis (MS), have confirmed prednisone (PDN) as a powerful anti-inflammatory drug that reduces the inflammatory response and promotes tissue repair in multiple inflammation sites. However, the underlying mechanism of PDN in ameliorating myelin damage is not well understood. In our study, a cuprizone (CPZ)-induced demyelinated mouse model was used to explore the mechanism of the protection provided by PDN. Open-field tests showed that CPZ-treated mice exhibited significantly increased anxiety and decreased exploration. However, PDN improved emotional behavior, as evidenced by an increase in the total distance traveled, and central distance traveled as well as the mean amount of time spent in the central area. CPZ-induced demyelination was observed to be alleviated in PDN-treated mice based on luxol fast blue (LFB) staining and myelin basic protein (MBP) expression analyses. In addition, PDN reduced astrocyte and microglia activation in the corpus callosum. Furthermore, we demonstrated that PDN inhibited the Nod-like receptor pyrin domain containing 3 (NLRP3) inflammasome signaling pathway and related inflammatory cytokines and chemokines, including TNF-α, CCL8, CXCL10 and CXCL16. PDN also reduced the serum corticosterone levels in the CPZ-treated mice. Taken together, these results suggest that inhibition of the NLRP3 signaling pathway may be a novel mechanism by which PDN exerts its protective actions in demyelinating diseases.","['Chemokine', 'Demyelination', 'Inflammation', 'NLRP3', 'Prednisone']",Brain research,2017-10-19,"[{'lastname': 'Yu', 'firstname': 'Hao', 'initials': 'H', 'affiliation': 'Neurobiological Research Center, Xuzhou Medical University, 209(#) Tongshan Road, Yunlong District, Xuzhou 221000, China.'}, {'lastname': 'Wu', 'firstname': 'Mingfeng', 'initials': 'M', 'affiliation': 'Neurobiological Research Center, Xuzhou Medical University, 209(#) Tongshan Road, Yunlong District, Xuzhou 221000, China.'}, {'lastname': 'Lu', 'firstname': 'Geng', 'initials': 'G', 'affiliation': 'Department of Clinical Medicine, Xuzhou Medical University, 209(#) Tongshan Road, Yunlong District, Xuzhou 221000, China.'}, {'lastname': 'Cao', 'firstname': 'Tingting', 'initials': 'T', 'affiliation': 'Department of Clinical Medicine, Xuzhou Medical University, 209(#) Tongshan Road, Yunlong District, Xuzhou 221000, China.'}, {'lastname': 'Chen', 'firstname': 'Nan', 'initials': 'N', 'affiliation': 'Department of Clinical Medicine, Xuzhou Medical University, 209(#) Tongshan Road, Yunlong District, Xuzhou 221000, China.'}, {'lastname': 'Zhang', 'firstname': 'Yijia', 'initials': 'Y', 'affiliation': 'Department of Clinical Medicine, Xuzhou Medical University, 209(#) Tongshan Road, Yunlong District, Xuzhou 221000, China.'}, {'lastname': 'Jiang', 'firstname': 'Zhiguo', 'initials': 'Z', 'affiliation': 'Department of Clinical Medicine, Xuzhou Medical University, 209(#) Tongshan Road, Yunlong District, Xuzhou 221000, China.'}, {'lastname': 'Fan', 'firstname': 'Hongbin', 'initials': 'H', 'affiliation': 'Department of Neurology, Affiliated Hospital of Xuzhou Medical University, 99(#) Huaihai Road, Quanshan District, Xuzhou 221009, China.'}, {'lastname': 'Yao', 'firstname': 'Ruiqin', 'initials': 'R', 'affiliation': 'Neurobiological Research Center, Xuzhou Medical University, 209(#) Tongshan Road, Yunlong District, Xuzhou 221000, China. Electronic address: wenxi_yao@163.com.'}]",,,,Copyright © 2017 Elsevier B.V. All rights reserved.,10.1016/j.brainres.2017.09.034,<Element 'PubmedArticle' at 0x7f05db2a0d10>
374,28900061,[Microglia in Brain Development].,"Microglia, traditionally known as resident immune cells in the brain, have been recently identified as one of the important cell types engaging in the formation and maintenance of neural circuitry, especially during the development. In this review, I describe the diversity of microglial functions revealed in different phases of development, ranging from neurogenesis to circuit formation. In particular, microglia possess dual functions in supporting the survival of neuronal structures or neural cells themselves, and removing excess neural components. Understanding these processes and underlying molecular mechanisms will provide important insights into the regulation of neural circuitry development. It further implicates the involvement of microglial dysfunction in neurodevelopmental disorders.",[],Brain and nerve = Shinkei kenkyu no shinpo,2017-09-14,"[{'lastname': 'Ueno', 'firstname': 'Masaki', 'initials': 'M', 'affiliation': 'Brain Research Institute, Niigata University.'}]",,,,,10.11477/mf.1416200858,<Element 'PubmedArticle' at 0x7f05db22f7c0>
375,"28894299
11281367
15390121
22842901
11739531
15374110
25929188
6458035
20303880
18329265
11934890
15148390
24713688
19779457
15013000
22632897
19567879
21565615
24277697
16253392
12777709
11563938
19665809
25392271
12422368
19063914
15289442
25855789
16845207
17192562
24212761
11743142
11150483
17868907
9829964
16684650
24703936
22025055
16474209
28414311
10662535
19699171
10433246
20060904
24585880
10914496
22647600
18771935
23074265
16407456
24794824
10593612
1312193
18955974
21084670
10600750
20729857
11070493
21541365
25330101
26600009
26205628
17825402
26982357
26708712
4262849
12671646
15994348
9262478
11331412
22410777
25619719
27003214
25710533
9626133
24704258
10068196
9600709
20153425
26908835",DHEA inhibits acute microglia-mediated inflammation through activation of the TrkA-Akt1/2-CREB-Jmjd3 pathway.,"Dehydroepiandrosterone (DHEA) is the most abundant circulating steroid hormone in humans, produced by the adrenals, the gonads and the brain. DHEA was previously shown to bind to the nerve growth factor receptor, tropomyosin-related kinase A (TrkA), and to thereby exert neuroprotective effects. Here we show that DHEA reduces microglia-mediated inflammation in an acute lipopolysaccharide-induced neuro-inflammation model in mice and in cultured microglia in vitro. DHEA regulates microglial inflammatory responses through phosphorylation of TrkA and subsequent activation of a pathway involving Akt1/Akt2 and cAMP response element-binding protein. The latter induces the expression of the histone 3 lysine 27 (H3K27) demethylase Jumonji d3 (Jmjd3), which thereby controls the expression of inflammation-related genes and microglial polarization. Together, our data indicate that DHEA-activated TrkA signaling is a potent regulator of microglia-mediated inflammation in a Jmjd3-dependent manner, thereby providing the platform for potential future therapeutic interventions in neuro-inflammatory pathologies.",[],Molecular psychiatry,2017-09-13,"[{'lastname': 'Alexaki', 'firstname': 'V I', 'initials': 'VI', 'affiliation': 'Institute for Clinical Chemistry and Laboratory Medicine, University Clinic Carl Gustav Carus, TU Dresden, Dresden, Germany.'}, {'lastname': 'Fodelianaki', 'firstname': 'G', 'initials': 'G', 'affiliation': 'Institute for Clinical Chemistry and Laboratory Medicine, University Clinic Carl Gustav Carus, TU Dresden, Dresden, Germany.'}, {'lastname': 'Neuwirth', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Institute for Clinical Chemistry and Laboratory Medicine, University Clinic Carl Gustav Carus, TU Dresden, Dresden, Germany.'}, {'lastname': 'Mund', 'firstname': 'C', 'initials': 'C', 'affiliation': 'Institute for Clinical Chemistry and Laboratory Medicine, University Clinic Carl Gustav Carus, TU Dresden, Dresden, Germany.'}, {'lastname': 'Kourgiantaki', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Department of Pharmacology, Medical School, University of Crete, Heraklion, Greece.\nInstitute of Molecular Biology and Biotechnology, Foundation of Research and Technology-Hellas, Heraklion, Greece.'}, {'lastname': 'Ieronimaki', 'firstname': 'E', 'initials': 'E', 'affiliation': 'Department of Clinical Chemistry, Medical School, University of Crete, Heraklion, Greece.'}, {'lastname': 'Lyroni', 'firstname': 'K', 'initials': 'K', 'affiliation': 'Department of Clinical Chemistry, Medical School, University of Crete, Heraklion, Greece.'}, {'lastname': 'Troullinaki', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Institute for Clinical Chemistry and Laboratory Medicine, University Clinic Carl Gustav Carus, TU Dresden, Dresden, Germany.'}, {'lastname': 'Fujii', 'firstname': 'C', 'initials': 'C', 'affiliation': 'Institute for Clinical Chemistry and Laboratory Medicine, University Clinic Carl Gustav Carus, TU Dresden, Dresden, Germany.'}, {'lastname': 'Kanczkowski', 'firstname': 'W', 'initials': 'W', 'affiliation': 'Institute for Clinical Chemistry and Laboratory Medicine, University Clinic Carl Gustav Carus, TU Dresden, Dresden, Germany.\nDepartment of Internal Medicine III, University Clinic Carl Gustav Carus, TU Dresden, Dresden, Germany.'}, {'lastname': 'Ziogas', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Institute for Clinical Chemistry and Laboratory Medicine, University Clinic Carl Gustav Carus, TU Dresden, Dresden, Germany.'}, {'lastname': 'Peitzsch', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Institute for Clinical Chemistry and Laboratory Medicine, University Clinic Carl Gustav Carus, TU Dresden, Dresden, Germany.'}, {'lastname': 'Grossklaus', 'firstname': 'S', 'initials': 'S', 'affiliation': 'Institute for Clinical Chemistry and Laboratory Medicine, University Clinic Carl Gustav Carus, TU Dresden, Dresden, Germany.'}, {'lastname': 'Sönnichsen', 'firstname': 'B', 'initials': 'B', 'affiliation': 'Life Science Inkubator Sachsen GmbH & Co. KG, Dresden, Germany.'}, {'lastname': 'Gravanis', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Department of Pharmacology, Medical School, University of Crete, Heraklion, Greece.\nInstitute of Molecular Biology and Biotechnology, Foundation of Research and Technology-Hellas, Heraklion, Greece.'}, {'lastname': 'Bornstein', 'firstname': 'S R', 'initials': 'SR', 'affiliation': ""Department of Internal Medicine III, University Clinic Carl Gustav Carus, TU Dresden, Dresden, Germany.\nSection of Diabetes and Nutritional Sciences, Rayne Institute, Denmark Hill Campus, King's College London, London, UK.""}, {'lastname': 'Charalampopoulos', 'firstname': 'I', 'initials': 'I', 'affiliation': 'Department of Pharmacology, Medical School, University of Crete, Heraklion, Greece.'}, {'lastname': 'Tsatsanis', 'firstname': 'C', 'initials': 'C', 'affiliation': 'Department of Clinical Chemistry, Medical School, University of Crete, Heraklion, Greece.'}, {'lastname': 'Chavakis', 'firstname': 'T', 'initials': 'T', 'affiliation': 'Institute for Clinical Chemistry and Laboratory Medicine, University Clinic Carl Gustav Carus, TU Dresden, Dresden, Germany.'}]",,,,,10.1038/mp.2017.167,<Element 'PubmedArticle' at 0x7f05db236900>
376,"28806788
20691747
27376853
24517920
25955232
27487302
26799851
16597735
20943909
24485491
27061744
1854034
12421590
12399247
21907418
27504457
15734255
9878301
14616316
24857381
18602982
24886300
9482808
14575884
19286276
21525267
17194565
23077050
15919760
16316783
21143141
26315370
23493481
27339881
23459026
8198631
10624540
16146456
8239251
22248083
19840546
21411668
20970492
10415381
15382250
23747574
27098858
26231972
24342992
22537595",Chronic unpredictable stress exacerbates surgery-induced sickness behavior and neuroinflammatory responses via glucocorticoids secretion in adult rats.,"Sprague-Dawley adult male rats (12-14 weeks old) were exposed to 14-day CUS and then subjected to partial hepatectomy 24 h after the last stress session. The rats were pretreated with an antagonist of the glucocorticoids (GCs) receptor RU486 (30 mg/kg, i.p.) 1 h prior to stress exposure. The behavioral changes were evaluated with open field test and elevated plus-maze test. The hippocampal cytokines interleukin (IL)-1β and IL-6 were measured on postoperative days 1, 3 and 7. Ionized calcium binding adaptor protein (Iba)-1, microglial M2 phenotype marker Arg1, brain derived neurotrophic factor (BDNF) and CD200 were also examined at each time point.
CUS exacerbated surgery-induced sickness behavior. Exposure to CUS alone failed to alter the levels of pro-inflammatory cytokines in the brain. However, CUS exaggerated surgery-induced pro-inflammatory cytokines expression (e.g. IL-1β and IL-6) and upregulated the levels of Iba-1 on postoperative days 1 and 3. An additional significant decreased BDNF, CD200 and a lower level of Arg1 were also observed in the stressed rats following surgical procedure. Pretreatment with RU486 blunted the potentiating effects of CUS on surgery-induced sickness behavior and neuroinflammatory responses.
Chronic unpredictable stress enhanced surgery-induced sickness behavior and neuroinflammatory responses. Stress-induced GCs played a pivotal role in enhancing surgery-induced neuroinflammatory processes by modulation of microglia functions.",[],PloS one,2017-08-15,"[{'lastname': 'Wang', 'firstname': 'Na', 'initials': 'N', 'affiliation': 'Department of Anesthesiology, The First Hospital of China Medical University, Shenyang, Liaoning, China.'}, {'lastname': 'Ma', 'firstname': 'Hong', 'initials': 'H', 'affiliation': 'Department of Anesthesiology, The First Hospital of China Medical University, Shenyang, Liaoning, China.'}, {'lastname': 'Li', 'firstname': 'Zhe', 'initials': 'Z', 'affiliation': 'Department of Anesthesiology, The First Hospital of China Medical University, Shenyang, Liaoning, China.'}, {'lastname': 'Gao', 'firstname': 'Yalei', 'initials': 'Y', 'affiliation': 'Department of Anesthesiology, The First Hospital of China Medical University, Shenyang, Liaoning, China.'}, {'lastname': 'Cao', 'firstname': 'Xuezhao', 'initials': 'X', 'affiliation': 'Department of Anesthesiology, The First Hospital of China Medical University, Shenyang, Liaoning, China.'}, {'lastname': 'Jiang', 'firstname': 'Yanhua', 'initials': 'Y', 'affiliation': 'Department of Anesthesiology, The First Hospital of China Medical University, Shenyang, Liaoning, China.'}, {'lastname': 'Zhou', 'firstname': 'Yongjian', 'initials': 'Y', 'affiliation': 'Department of Anesthesiology, The First Hospital of China Medical University, Shenyang, Liaoning, China.'}, {'lastname': 'Liu', 'firstname': 'Sidan', 'initials': 'S', 'affiliation': 'Department of Anesthesiology, The First Hospital of China Medical University, Shenyang, Liaoning, China.'}]",,Chronic unpredictable stress enhanced surgery-induced sickness behavior and neuroinflammatory responses. Stress-induced GCs played a pivotal role in enhancing surgery-induced neuroinflammatory processes by modulation of microglia functions.,"CUS exacerbated surgery-induced sickness behavior. Exposure to CUS alone failed to alter the levels of pro-inflammatory cytokines in the brain. However, CUS exaggerated surgery-induced pro-inflammatory cytokines expression (e.g. IL-1β and IL-6) and upregulated the levels of Iba-1 on postoperative days 1 and 3. An additional significant decreased BDNF, CD200 and a lower level of Arg1 were also observed in the stressed rats following surgical procedure. Pretreatment with RU486 blunted the potentiating effects of CUS on surgery-induced sickness behavior and neuroinflammatory responses.",,"10.1371/journal.pone.0183077
10.1016/j.pnpbp.2010.07.027
10.1016/j.intimp.2016.06.031
10.1016/j.bbi.2014.02.002
10.3892/mmr.2015.3744
10.1016/j.brainres.2016.07.045
10.1016/j.psyneuen.2016.01.006
10.1523/JNEUROSCI.4398-05.2006
10.1523/JNEUROSCI.0303-09.2010
10.1016/j.psyneuen.2013.11.006
10.1111/jcmm.12854
10.1152/ajpregu.00230.2002
10.1016/j.jneuroim.2011.08.011
10.1155/2016/9085273
10.1016/j.orthres.2004.08.010
10.1006/jsre.1998.5429
10.1016/j.ejso.2014.04.006
10.1016/j.exger.2008.06.004
10.1186/1742-2094-11-85
10.1016/j.neurobiolaging.2009.01.012
10.1523/JNEUROSCI.0450-11.2011
10.1016/j.bbi.2006.11.00
10.1523/JNEUROSCI.2173-12.2012
10.1096/fj.05-3776fje
10.1016/j.it.2005.11.006
10.1016/j.neurobiolaging.2015.07.027
10.3389/fncel.2013.00022
10.1016/j.bbi.2013.02.004
10.1111/j.1399-6576.2005.00791.x
10.1186/1742-2094-9-9
10.1016/j.neuron.2009.09.032
10.1523/JNEUROSCI.5818-10.2011
10.1016/j.bbi.2010.10.015
10.1002/hipo.10220
10.1016/j.neuropharm.2013.04.011
10.1016/j.bbi.2015.07.024
10.1038/mp.2013.155
10.1016/j.brainresbull.2012.04.008",<Element 'PubmedArticle' at 0x7f05db25a4a0>
377,28805558,Oxytocin Modulates Expression of Neuron and Glial Markers in the Rat Hippocampus.,"Neuropeptides including oxytocin belong to the group of factors that may play a role in the control of neuronal cell survival, proliferation and differentiation. The aim of the present study was to investigate potential contribution of oxytocin to neuronal differentiation by measuring gene and protein expression of specific neuron and glial markers in the brain. Neonatal and adult oxytocin administration was used to reveal developmental and/or acute effects of oxytocin in Wistar rats. Gene and protein expression of neuron-specific enolase (NSE) in the hippocampus was increased in 21-day and 2-month old rats in response to neonatal oxytocin administration. Neonatal oxytocin treatment induced a significant increase of gene and protein expression of the marker of astrocytes - glial fibrillary acid protein (GFAP). Oxytocin treatment resulted in a decrease of oligodendrocyte marker mRNA - 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) - in 21-day and 2-month old rats, while no change of CD68 mRNA, marker of microglia, was observed. Central oxytocin administration in adult rats induced a significant increase of gene expression of NSE and CNPase. The present study provides the first data revealing the effect of oxytocin on the expression of neuron and glial markers in the brain. It may be suggested that the oxytocin system is involved in the regulation of development of neuronal precursor cells in the brain.",[],Folia biologica,2017-08-15,"[{'lastname': 'Havránek', 'firstname': 'T', 'initials': 'T', 'affiliation': 'Biomedical Research Center, Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovakia.'}, {'lastname': 'Lešťanová', 'firstname': 'Z', 'initials': 'Z', 'affiliation': 'Biomedical Research Center, Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovakia.'}, {'lastname': 'Mravec', 'firstname': 'B', 'initials': 'B', 'affiliation': 'Biomedical Research Center, Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovakia.\nInstitute of Physiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.'}, {'lastname': 'Štrbák', 'firstname': 'V', 'initials': 'V', 'affiliation': 'Biomedical Research Center, Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovakia.\nDepartment of Normal and Pathological Physiology, Faculty of Medicine, Slovak Medical University, Bratislava, Slovakia.'}, {'lastname': 'Bakoš', 'firstname': 'J', 'initials': 'J', 'affiliation': 'Biomedical Research Center, Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovakia.\nInstitute of Physiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.'}, {'lastname': 'Bačová', 'firstname': 'Z', 'initials': 'Z', 'affiliation': 'Biomedical Research Center, Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovakia.\nDepartment of Normal and Pathological Physiology, Faculty of Medicine, Slovak Medical University, Bratislava, Slovakia.'}]",,,,,,<Element 'PubmedArticle' at 0x7f05db2042c0>
378,"28778445
15256495
11160259
27049561
28284347
22031325
23133617
24009988
22247749
23039230
21413005
11823674
20383131
22402401
27553057
28288099
9682040
25057045
14993065
20709691
26030851
26521018
25956531
26488817
27771018
18854238
22863002
20126401
20660719
25516281
25888258
19620304
27333153
23630581
25843302
28286112
11520464
24060131
25286403
21326918
18606647
17261780
17052660
26141651
25326801
27103314
15771584
28018327
11526378
21091909
27911839
17586664
25006655
25043484
11526384
23973225
26198929
25776868",Estrogen protection against EAE modulates the microbiota and mucosal-associated regulatory cells.,"Sex hormones promote immunoregulatory effects on multiple sclerosis. In the current study we evaluated the composition of the gut microbiota and the mucosal-associated regulatory cells in estrogen or sham treated female mice before and after autoimmune encephalomyelitis (EAE) induction. Treatment with pregnancy levels of estrogen induces changes in the composition and diversity of gut microbiota. Additionally, estrogen prevents EAE-associated changes in the gut microbiota and might promote the enrichment of bacteria that are associated with immune regulation. Our results point to a possible cross-talk between the sex hormones and the gut microbiota, which could promote neuroprotection.","['EAE', 'Estrogen', 'M2-like macrophage/microglia', 'Microbiota', 'Regulatory B cell']",Journal of neuroimmunology,2017-08-06,"[{'lastname': 'Benedek', 'firstname': 'Gil', 'initials': 'G', 'affiliation': 'Neuroimmunology Research, VA Portland Health Care System, 3710 SW U.S. Veterans Hospital Rd, Portland, OR 97239, USA; Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, USA.'}, {'lastname': 'Zhang', 'firstname': 'Jun', 'initials': 'J', 'affiliation': 'Neuroimmunology Research, VA Portland Health Care System, 3710 SW U.S. Veterans Hospital Rd, Portland, OR 97239, USA; Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, USA.'}, {'lastname': 'Nguyen', 'firstname': 'Ha', 'initials': 'H', 'affiliation': 'Neuroimmunology Research, VA Portland Health Care System, 3710 SW U.S. Veterans Hospital Rd, Portland, OR 97239, USA; Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, USA.'}, {'lastname': 'Kent', 'firstname': 'Gail', 'initials': 'G', 'affiliation': 'Neuroimmunology Research, VA Portland Health Care System, 3710 SW U.S. Veterans Hospital Rd, Portland, OR 97239, USA; Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, USA.'}, {'lastname': 'Seifert', 'firstname': 'Hilary A', 'initials': 'HA', 'affiliation': 'Neuroimmunology Research, VA Portland Health Care System, 3710 SW U.S. Veterans Hospital Rd, Portland, OR 97239, USA; Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, USA.'}, {'lastname': 'Davin', 'firstname': 'Sean', 'initials': 'S', 'affiliation': 'Division of Arthritis and Rheumatic Diseases, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, USA.'}, {'lastname': 'Stauffer', 'firstname': 'Patrick', 'initials': 'P', 'affiliation': 'Division of Arthritis and Rheumatic Diseases, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, USA.'}, {'lastname': 'Vandenbark', 'firstname': 'Arthur A', 'initials': 'AA', 'affiliation': 'Neuroimmunology Research, VA Portland Health Care System, 3710 SW U.S. Veterans Hospital Rd, Portland, OR 97239, USA; Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, USA; Department of Molecular Microbiology & Immunology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, USA.'}, {'lastname': 'Karstens', 'firstname': 'Lisa', 'initials': 'L', 'affiliation': 'Division of Bioinformatics and Computational Biology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, USA; Division of Urogynecology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, USA.'}, {'lastname': 'Asquith', 'firstname': 'Mark', 'initials': 'M', 'affiliation': 'Division of Arthritis and Rheumatic Diseases, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, USA.'}, {'lastname': 'Offner', 'firstname': 'Halina', 'initials': 'H', 'affiliation': 'Neuroimmunology Research, VA Portland Health Care System, 3710 SW U.S. Veterans Hospital Rd, Portland, OR 97239, USA; Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, USA; Department of Anesthesiology and Perioperative Medicine, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, USA. Electronic address: offnerva@ohsu.edu.'}]",,,,Copyright © 2017 Elsevier B.V. All rights reserved.,10.1016/j.jneuroim.2017.06.007,<Element 'PubmedArticle' at 0x7f05db20e810>
379,28769008,Ketamine Alleviates Depressive-Like Behaviors via Down-Regulating Inflammatory Cytokines Induced by Chronic Restraint Stress in Mice.,"The purpose of the present study was to investigate whether ketamine's rapid antidepressant effects were associated with its anti-inflammatory actions and to explore the underlying molecular mechanism. Depressive-like behaviors was induced in mice using chronic restraint stress (CRS) method. Anti-depressive effects of ketamine were evaluated by forced swimming tests (FST) and sucrose preference test (SPT). Subsequently, brain tissue was harvested to investigate inflammatory response in the hippocampus via investigating reactive microglia numbers, serum cytokines levels and the toll-like receptor type 4 (TLR4)/p38 mitogen-activated protein kinase (MAPK) pathway. CRS exposure caused depressive-like behaviors in mice, which was associated with increased pre-inflammatory cytokines (interleukin (IL)-1β, tumor necrosis factor (TNF)-α and IL-6) levels, reactive microglia numbers and up-regulated regulatory molecules such as TLR4/p38 and P2X7 receptor in hippocampus. Such neurobehavioral and biochemical abnormalities were normalized by ketamine treatment. CRS-induced depression-like behaviours are associated with activation of hippocampal inflammatory response, whereas down-regulation of pro-inflammatory cytokines may contribute to ketamine's antidepressant effects in mice.","['P2X7', 'depression', 'inflammation', 'ketamine', 'toll-like receptor type 4 (TLR4)']",Biological & pharmaceutical bulletin,2017-08-05,"[{'lastname': 'Tan', 'firstname': 'Sijie', 'initials': 'S', 'affiliation': 'Department of Histology and Embryology, School of Medicine, University of South China.'}, {'lastname': 'Wang', 'firstname': 'Yan', 'initials': 'Y', 'affiliation': 'Department of Histology and Embryology, School of Medicine, University of South China.'}, {'lastname': 'Chen', 'firstname': 'Ke', 'initials': 'K', 'affiliation': 'Department of Ultrasound Diagnosis, Affiliated Nanhua Hospital, University of South China.'}, {'lastname': 'Long', 'firstname': 'Zhifeng', 'initials': 'Z', 'affiliation': 'Department of Histology and Embryology, School of Medicine, University of South China.'}, {'lastname': 'Zou', 'firstname': 'Ju', 'initials': 'J', 'affiliation': 'Department of Parasitology, School of Medicine, University of South China.'}]",,,,,10.1248/bpb.b17-00131,<Element 'PubmedArticle' at 0x7f05db1b7360>
380,28736330,Impaired microglia fractalkine signaling affects stress reaction and coping style in mice.,"Microglia, resident immune cells of the CNS are sensitive to various perturbations of the environment, such as stress exposure, and may be involved in translating these changes to behavior. Among the pathways mediating stress-related neuronal cues to microglia, the fractalkine-fractalkine receptor (CX","['CX(3)CR1', 'Chronic stress', 'Depression', 'Energy expenditure', 'Microglia', 'c-Fos']",Behavioural brain research,2017-07-25,"[{'lastname': 'Winkler', 'firstname': 'Zsuzsanna', 'initials': 'Z', 'affiliation': 'Laboratory of Molecular Neuroendocrinology, Institute of Experimental Medicine, Budapest, Hungary; János Szentágothai Doctoral School of Neurosciences, Semmelweis University, Budapest, Hungary.'}, {'lastname': 'Kuti', 'firstname': 'Dániel', 'initials': 'D', 'affiliation': 'Laboratory of Molecular Neuroendocrinology, Institute of Experimental Medicine, Budapest, Hungary; János Szentágothai Doctoral School of Neurosciences, Semmelweis University, Budapest, Hungary.'}, {'lastname': 'Ferenczi', 'firstname': 'Szilamér', 'initials': 'S', 'affiliation': 'Laboratory of Molecular Neuroendocrinology, Institute of Experimental Medicine, Budapest, Hungary.'}, {'lastname': 'Gulyás', 'firstname': 'Krisztina', 'initials': 'K', 'affiliation': 'Laboratory of Molecular Neuroendocrinology, Institute of Experimental Medicine, Budapest, Hungary; Faculty of Information Technology and Bionics, Pázmány Péter Catholic University, Budapest, Hungary.'}, {'lastname': 'Polyák', 'firstname': 'Ágnes', 'initials': 'Á', 'affiliation': 'Laboratory of Molecular Neuroendocrinology, Institute of Experimental Medicine, Budapest, Hungary.'}, {'lastname': 'Kovács', 'firstname': 'Krisztina J', 'initials': 'KJ', 'affiliation': 'Laboratory of Molecular Neuroendocrinology, Institute of Experimental Medicine, Budapest, Hungary. Electronic address: kovacs@koki.hu.'}]",,,,Copyright © 2017 Elsevier B.V. All rights reserved.,10.1016/j.bbr.2017.07.023,<Element 'PubmedArticle' at 0x7f05db1c3310>
381,28734673,Somatostatin protects human retinal pericytes from inflammation mediated by microglia.,"Diabetic retinopathy (DR) is usually considered a microvascular disease. However, involvement of the neuroretina in the early stages of DR has recently gained major credit. Inflammatory processes, leading to glial activation and neuronal apoptosis, develop early in the retina of diabetic subjects. Pericytes constitute a link between the vascular and the neural retina, play a central role in blood-retinal barrier maintenance, and may influence neuroinflammation. Somatostatin (SST) is a potent neuroprotective factor, which is down-regulated during early DR. In this paper, we have investigated the effects of the inflammatory signals triggered by the activation of microglia on inflammation and apoptosis/survival pathways in pericytes. Microglia cells (Bv-2) were stimulated with lipopolysaccharide (LPS) and/or SST. Human retinal pericytes (HRP) were exposed to conditioned media (CM) collected from Bv-2 cells in physiological conditions and in the settings described above. A panel of inflammation, apoptosis and survival mediators was analyzed. HRP treated with LPS-CM showed a significant increase of pro-inflammatory (iNos and TNFα) and pro-apoptotic mediators (FasL, active caspase-8, tBid and Bax), and a concomitant decrease in pro-survival factors (BclxL and pAkt). SST added to LPS was able to counteract these effects in all conditions. In conclusion, SST is able to modulate apoptosis/survival pathways in HRP during microglia-mediated inflammation. These results demonstrate a crosstalk between microglia and retinal pericytes, evidencing a possible defensive role of microglia in the early phases of DR.","['Apoptosis', 'Diabetic retinopathy', 'Inflammation', 'Microglia', 'Pericyte', 'Somatostatin']",Experimental eye research,2017-07-25,"[{'lastname': 'Mazzeo', 'firstname': 'Aurora', 'initials': 'A', 'affiliation': 'Dept of Medical Sciences, University of Turin, Corso AM Dogliotti 14, 10126 Torino, Italy. Electronic address: aurora.mazzeo@unito.it.'}, {'lastname': 'Arroba', 'firstname': 'Ana I', 'initials': 'AI', 'affiliation': 'Alberto Sols Biomedical Research Institute (IIBm) (CSIC/UAM), C/Arturo Duperier 4, 28029 Madrid, Spain; Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERdem), ISCIII, Instituto de Salud Carlos III, C/ Monforte de Lemos 3-5, 28029 Madrid, Spain. Electronic address: aarroba@iib.uam.es.'}, {'lastname': 'Beltramo', 'firstname': 'Elena', 'initials': 'E', 'affiliation': 'Dept of Medical Sciences, University of Turin, Corso AM Dogliotti 14, 10126 Torino, Italy. Electronic address: elena.beltramo@unito.it.'}, {'lastname': 'Valverde', 'firstname': 'Angela M', 'initials': 'AM', 'affiliation': 'Alberto Sols Biomedical Research Institute (IIBm) (CSIC/UAM), C/Arturo Duperier 4, 28029 Madrid, Spain; Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERdem), ISCIII, Instituto de Salud Carlos III, C/ Monforte de Lemos 3-5, 28029 Madrid, Spain. Electronic address: avalverde@iib.uam.es.'}, {'lastname': 'Porta', 'firstname': 'Massimo', 'initials': 'M', 'affiliation': 'Dept of Medical Sciences, University of Turin, Corso AM Dogliotti 14, 10126 Torino, Italy. Electronic address: massimo.porta@unito.it.'}]",,,,Copyright © 2017 Elsevier Ltd. All rights reserved.,10.1016/j.exer.2017.07.011,<Element 'PubmedArticle' at 0x7f05db1d2310>
382,"28698257
19566837
21196131
9016301
17875676
11380825
21403086
26254332
20547972
20142564
25302502
26056339
25470051
27776109
23334579
24360280
22632727
26040959
24316888
27294511
24313777
24859199
14687548
27893460
20407134
9231833
18390891
23968981
26134639
17490814
2828236
14534577
16702209
23906810
24712567
22391036
11840268
24270184
26485285
20937129",Brain Transforming Growth Factor-β Resists Hypertension Via Regulating Microglial Activation.,"Hypertension is the major risk factor for stroke. Recent work unveiled that hypertension is associated with chronic neuroinflammation; microglia are the major players in neuroinflammation, and the activated microglia elevate sympathetic nerve activity and blood pressure. This study is to understand how brain homeostasis is kept from hypertensive disturbance and microglial activation at the onset of hypertension.
Hypertension was induced by subcutaneous delivery of angiotensin II, and blood pressure was monitored in conscious animals. Microglial activity was analyzed by flow cytometry and immunohistochemistry. Antibody, pharmacological chemical, and recombinant cytokine were administered to the brain through intracerebroventricular infusion. Microglial depletion was performed by intracerebroventricular delivering diphtheria toxin to CD11b-diphtheria toxin receptor mice. Gene expression profile in sympathetic controlling nucleus was analyzed by customized qRT-PCR array.
Transforming growth factor-β (TGF-β) is constitutively expressed in the brains of normotensive mice. Removal of TGF-β or blocking its signaling before hypertension induction accelerated hypertension progression, whereas supplementation of TGF-β1 substantially suppressed neuroinflammation, kidney norepinephrine level, and blood pressure. By means of microglial depletion and adoptive transfer, we showed that the effects of TGF-β on hypertension are mediated through microglia. In contrast to the activated microglia in established hypertension, the resting microglia are immunosuppressive and important in maintaining neural homeostasis at the onset of hypertension. Further, we profiled the signature molecules of neuroinflammation and neuroplasticity associated with hypertension and TGF-β by qRT-PCR array.
Our results identify that TGF-β-modulated microglia are critical to keeping brain homeostasis responding to hypertensive disturbance.","['blood pressure', 'diphtheria toxin', 'hypertension', 'microglia', 'stroke']",Stroke,2017-07-13,"[{'lastname': 'Li', 'firstname': 'You', 'initials': 'Y', 'affiliation': 'From the School of Life Science and Technology, Tongji University, Shanghai, China (Y.L., T.V.Z., J.F.); The Second Affiliated Hospital of Zhejiang University (P.S.), Institute of Translational Medicine (P.S.), and Department of Physiology (X.Z.S.), Zhejiang University School of Medicine, Hangzhou, China; Department of Neurology (Y.L., L.L., P.L., P.S.) and Department of Biomedical Science (T.V.Z., K.E.B.), Cedars-Sinai Medical Center, Los Angeles, CA; and Pharmacological and Brain Sciences, University of Iowa (A.K.J.).'}, {'lastname': 'Shen', 'firstname': 'Xiao Z', 'initials': 'XZ', 'affiliation': 'From the School of Life Science and Technology, Tongji University, Shanghai, China (Y.L., T.V.Z., J.F.); The Second Affiliated Hospital of Zhejiang University (P.S.), Institute of Translational Medicine (P.S.), and Department of Physiology (X.Z.S.), Zhejiang University School of Medicine, Hangzhou, China; Department of Neurology (Y.L., L.L., P.L., P.S.) and Department of Biomedical Science (T.V.Z., K.E.B.), Cedars-Sinai Medical Center, Los Angeles, CA; and Pharmacological and Brain Sciences, University of Iowa (A.K.J.).'}, {'lastname': 'Li', 'firstname': 'Liang', 'initials': 'L', 'affiliation': 'From the School of Life Science and Technology, Tongji University, Shanghai, China (Y.L., T.V.Z., J.F.); The Second Affiliated Hospital of Zhejiang University (P.S.), Institute of Translational Medicine (P.S.), and Department of Physiology (X.Z.S.), Zhejiang University School of Medicine, Hangzhou, China; Department of Neurology (Y.L., L.L., P.L., P.S.) and Department of Biomedical Science (T.V.Z., K.E.B.), Cedars-Sinai Medical Center, Los Angeles, CA; and Pharmacological and Brain Sciences, University of Iowa (A.K.J.).'}, {'lastname': 'Zhao', 'firstname': 'Tuantuan V', 'initials': 'TV', 'affiliation': 'From the School of Life Science and Technology, Tongji University, Shanghai, China (Y.L., T.V.Z., J.F.); The Second Affiliated Hospital of Zhejiang University (P.S.), Institute of Translational Medicine (P.S.), and Department of Physiology (X.Z.S.), Zhejiang University School of Medicine, Hangzhou, China; Department of Neurology (Y.L., L.L., P.L., P.S.) and Department of Biomedical Science (T.V.Z., K.E.B.), Cedars-Sinai Medical Center, Los Angeles, CA; and Pharmacological and Brain Sciences, University of Iowa (A.K.J.).'}, {'lastname': 'Bernstein', 'firstname': 'Kenneth E', 'initials': 'KE', 'affiliation': 'From the School of Life Science and Technology, Tongji University, Shanghai, China (Y.L., T.V.Z., J.F.); The Second Affiliated Hospital of Zhejiang University (P.S.), Institute of Translational Medicine (P.S.), and Department of Physiology (X.Z.S.), Zhejiang University School of Medicine, Hangzhou, China; Department of Neurology (Y.L., L.L., P.L., P.S.) and Department of Biomedical Science (T.V.Z., K.E.B.), Cedars-Sinai Medical Center, Los Angeles, CA; and Pharmacological and Brain Sciences, University of Iowa (A.K.J.).'}, {'lastname': 'Johnson', 'firstname': 'Alan K', 'initials': 'AK', 'affiliation': 'From the School of Life Science and Technology, Tongji University, Shanghai, China (Y.L., T.V.Z., J.F.); The Second Affiliated Hospital of Zhejiang University (P.S.), Institute of Translational Medicine (P.S.), and Department of Physiology (X.Z.S.), Zhejiang University School of Medicine, Hangzhou, China; Department of Neurology (Y.L., L.L., P.L., P.S.) and Department of Biomedical Science (T.V.Z., K.E.B.), Cedars-Sinai Medical Center, Los Angeles, CA; and Pharmacological and Brain Sciences, University of Iowa (A.K.J.).'}, {'lastname': 'Lyden', 'firstname': 'Patrick', 'initials': 'P', 'affiliation': 'From the School of Life Science and Technology, Tongji University, Shanghai, China (Y.L., T.V.Z., J.F.); The Second Affiliated Hospital of Zhejiang University (P.S.), Institute of Translational Medicine (P.S.), and Department of Physiology (X.Z.S.), Zhejiang University School of Medicine, Hangzhou, China; Department of Neurology (Y.L., L.L., P.L., P.S.) and Department of Biomedical Science (T.V.Z., K.E.B.), Cedars-Sinai Medical Center, Los Angeles, CA; and Pharmacological and Brain Sciences, University of Iowa (A.K.J.).'}, {'lastname': 'Fang', 'firstname': 'Jianmin', 'initials': 'J', 'affiliation': 'From the School of Life Science and Technology, Tongji University, Shanghai, China (Y.L., T.V.Z., J.F.); The Second Affiliated Hospital of Zhejiang University (P.S.), Institute of Translational Medicine (P.S.), and Department of Physiology (X.Z.S.), Zhejiang University School of Medicine, Hangzhou, China; Department of Neurology (Y.L., L.L., P.L., P.S.) and Department of Biomedical Science (T.V.Z., K.E.B.), Cedars-Sinai Medical Center, Los Angeles, CA; and Pharmacological and Brain Sciences, University of Iowa (A.K.J.).'}, {'lastname': 'Shi', 'firstname': 'Peng', 'initials': 'P', 'affiliation': 'From the School of Life Science and Technology, Tongji University, Shanghai, China (Y.L., T.V.Z., J.F.); The Second Affiliated Hospital of Zhejiang University (P.S.), Institute of Translational Medicine (P.S.), and Department of Physiology (X.Z.S.), Zhejiang University School of Medicine, Hangzhou, China; Department of Neurology (Y.L., L.L., P.L., P.S.) and Department of Biomedical Science (T.V.Z., K.E.B.), Cedars-Sinai Medical Center, Los Angeles, CA; and Pharmacological and Brain Sciences, University of Iowa (A.K.J.). ship@zju.edu.cn jfang@tongji.edu.cn.'}]",,,"Transforming growth factor-β (TGF-β) is constitutively expressed in the brains of normotensive mice. Removal of TGF-β or blocking its signaling before hypertension induction accelerated hypertension progression, whereas supplementation of TGF-β1 substantially suppressed neuroinflammation, kidney norepinephrine level, and blood pressure. By means of microglial depletion and adoptive transfer, we showed that the effects of TGF-β on hypertension are mediated through microglia. In contrast to the activated microglia in established hypertension, the resting microglia are immunosuppressive and important in maintaining neural homeostasis at the onset of hypertension. Further, we profiled the signature molecules of neuroinflammation and neuroplasticity associated with hypertension and TGF-β by qRT-PCR array.","© 2017 American Heart Association, Inc.",10.1161/STROKEAHA.117.017370,<Element 'PubmedArticle' at 0x7f05db1df590>
383,28688912,Inhibition of the kynurenine pathway protects against reactive microglial-associated reductions in the complexity of primary cortical neurons.,"Brain glia possess the rate limiting enzyme indoleamine 2, 3-dioxygenase (IDO) which catalyses the conversion of tryptophan to kynurenine. Microglia also express kynurenine monooxygenase (KMO) and kynureninase (KYNU) which lead to the production of the free radical producing metabolites, 3-hydroxykynurenine and 3-hydroxyanthranillic acid respectively and subsequently production of the NMDA receptor agonist quinolinic acid. The aim of this study was to examine the effect of IFNγ-stimulated kynurenine pathway (KP) induction in microglia on neurite outgrowth and complexity, and to determine whether alterations could be abrogated using pharmacological inhibitors of the KP. BV-2 microglia were treated with IFNγ (5ng/ml) for 24h and conditioned media (CM) was placed on primary cortical neurons 3 days in vitro (DIV) for 48h. Neurons were fixed and neurite outgrowth and complexity was assessed using fluorescent immunocytochemistry followed by Sholl analysis. Results show increased mRNA expression of IDO, KMO and KYNU, and increased concentrations of tryptophan, kynurenine, and 3-hydroxykynurenine in the CM of IFNγ-stimulated BV-2 microglia. The IFNγ-stimulated BV-2 microglial CM reduced neurite outgrowth and complexity with reductions in various parameters of neurite outgrowth prevented when BV-2 microglia were pre-treated with either the IDO inhibitor, 1-methyltryptophan (1-MT) (L) (0.5mM; 30min), the KMO inhibitor, Ro 61-8048 (1μM; 30min), the synthetic glucocorticoid, dexamethasone (1μM; 2h) -which suppresses IFNγ-induced IDO - and the N-methyl-D-aspartate (NMDA) receptor antagonist, MK801 (0.1μM; 30min). Overall this study indicates that inhibition of the KP in microglia may be targeted to protect against reactive microglial-associated neuronal atrophy.","['Inflammation', 'Kynurenine pathway', 'Microglia', 'Neurite complexity', 'Neurodegeneration']",European journal of pharmacology,2017-07-10,"[{'lastname': ""O'Farrell"", 'firstname': 'Katherine', 'initials': 'K', 'affiliation': 'Neuropsychopharmacology Research Group, School of Pharmacy and Pharmaceutical Sciences & Trinity College Institute of Neuroscience, Trinity College, Dublin 2, Ireland.'}, {'lastname': 'Fagan', 'firstname': 'Eimear', 'initials': 'E', 'affiliation': 'Neuroimmunology Research Group, Department of Physiology, School of Medicine & Trinity College Institute of Neuroscience, Trinity College, Dublin 2, Ireland.'}, {'lastname': 'Connor', 'firstname': 'Thomas J', 'initials': 'TJ', 'affiliation': 'Neuroimmunology Research Group, Department of Physiology, School of Medicine & Trinity College Institute of Neuroscience, Trinity College, Dublin 2, Ireland.'}, {'lastname': 'Harkin', 'firstname': 'Andrew', 'initials': 'A', 'affiliation': 'Neuropsychopharmacology Research Group, School of Pharmacy and Pharmaceutical Sciences & Trinity College Institute of Neuroscience, Trinity College, Dublin 2, Ireland; Neuroimmunology Research Group, Department of Physiology, School of Medicine & Trinity College Institute of Neuroscience, Trinity College, Dublin 2, Ireland. Electronic address: aharkin@tcd.ie.'}]",,,,Copyright © 2017 Elsevier B.V. All rights reserved.,10.1016/j.ejphar.2017.07.008,<Element 'PubmedArticle' at 0x7f05db1415e0>
384,28621412,The not-so-long history of zebrafish research in Israel.,"The zebrafish has become a model of choice in fundamental and applied life sciences and is widely used in various fields of biomedical research as a human disease model for cancer, metabolic and neurodegenerative diseases, and regenerative medicine. The transparency of the zebrafish embryo allows real-time visualization of the development and morphogenesis of practically all of its tissues and organs. Zebrafish are amenable to genetic manipulation, for which innovative genetic and molecular techniques are constantly being introduced. These include the study of gene function and regulation using gene knockdown, knockout and knock-in, as well as transgenesis and tissue-specific genetic perturbations. Complementing this genetic toolbox, the zebrafish exhibits measurable behavioral and hormonal responses already at the larval stages, providing a viable vertebrate animal model for high-throughput drug screening and chemical genetics. With the available tools of the genomic era and the abundance of disease-associated human genes yet to be explored, the zebrafish model is becoming the preferred choice in many studies. Its advantages and potential are being increasingly recognized within the Israeli scientific community, and its use as a model system for basic and applied science has expanded in Israel in recent years. Since the first zebrafish-focused laboratory was introduced at Tel Aviv University 16 years ago, seven more zebrafish-centric research groups have been established, along with more than two dozen academic research groups and three bio-medical companies that are now utilizing this model.",[],The International journal of developmental biology,2017-06-18,"[{'lastname': 'Blechman', 'firstname': 'Janna', 'initials': 'J', 'affiliation': 'Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot, Israel.'}, {'lastname': 'Levkowitz', 'firstname': 'Gil', 'initials': 'G', 'affiliation': None}, {'lastname': 'Gothilf', 'firstname': 'Yoav', 'initials': 'Y', 'affiliation': None}]",,,,,10.1387/ijdb.160346gl,<Element 'PubmedArticle' at 0x7f05db14fae0>
385,28608355,[Neuronal glycolipids regulate glial cell division negatively during development and following a lesion].,"Glial cells in the central nervous system of adult mammals outnumber neurons 10-fold. Their number remains stationary throughout adulthood, controlled by the concomitant presence of mitogens and mitogen inhibitors. The most abundant inhibitor, neurostatin, is ganglioside GD1b O-acetylated on hydroxyl 9 of its outermost sialic acid. Neurostatin inhibited the proliferation of primary microglia and astroblasts in culture (cytostatic) as well as both rodent and human glioma cells (cytotoxic) at nanomolar concentrations. At those concentrations neurostatin had no effect on non-glial lineage cells or differentiated glia. Neurostatin shows direct antimitotic activity on tumoral cells, interfering with multiple signals regulating cell cycle progression. But it also promotes indirectly total destruction of experimental rat brain glioma, presumably by making it visible to the host immune system and activating CD4+ and CD8+ lymphocytes. Neurostatin could be a new anti-inflammatory agent, with multiple convergent direct and indirect actions on glioma growth, a pathology without satisfactory clinical treatment. Neurostatin is produced by neurons but its expression is up-regulated by neuron-astrocyte contact. The action of neurostatin could be mediated by a number of receptor proteins, including integrins, Toll-like receptors and siglecs.
Glicolipidos neuronales regulan negativamente la division glial durante el desarrollo y tras una lesion.
En el sistema nervioso central de los mamiferos, las celulas gliales superan diez veces en numero a las neuronas. Su numero permanente estacionario durante la edad adulta, controlado por la presencia simultanea de mitogenos gliales e inhibidores de esos mitogenos. El inhibidor mas abundante, la neurostatina, es el gangliosido GD1b O-acetilado en el grupo 9 del acido sialico mas externo. La neurostatina y los oligosacaridos sinteticos inhiben la proliferacion de astroblastos en cultivo primario (citostaticos) y de celulas de gliomas (citotoxicos), tanto de roedores como de humanos, en concentracion nanomolar. A esas concentraciones, la neurostatina no tuvo efecto sobre celulas de linaje no glial ni sobre glia madura. La neurostatina y sus analogos mostraron actividad antimitotica directa sobre las celulas tumorales, interfiriendo con la progresion del ciclo celular en multiples sitios, pero tambien actuaron indirectamente, haciendo visibles las celulas tumorales al sistema inmune del huesped y activando linfocitos CD4+ y CD8+. Analogos de neurostatina podrian generar nuevos farmacos antiinflamatorios, con multiples acciones directas e indirectas contra el crecimiento de gliomas, una patologia todavia sin tratamiento clinico satisfactorio. La neurostatina es producida por las neuronas, pero el contacto de estas con astrocitos estimula notablemente su expresion. La accion de la neurostatina puede estar mediada por numerosas proteinas receptoras, incluyendo integrinas, siglecs y receptores Toll-like.",[],Revista de neurologia,2017-06-14,"[{'lastname': 'Nieto-Sampedro', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Hospital Nacional de Paraplejicos, 45071 Toledo, Espana.'}, {'lastname': 'Muneton-Gomez', 'firstname': 'V C', 'initials': 'VC', 'affiliation': 'CSIC. Instituto de Neurobiologia Ramon y Cajal, 28002 Madrid, Espana.'}]",,,,,,<Element 'PubmedArticle' at 0x7f05db15b040>
386,"28573424
26818421
25169849
9826442
26338824
25959126
25446356
26438529
10816471
22529524
23401126
24831467
25092518
24779968
26404359
26369600
22537547
21889955
18364436
19705460
23911725
22837040
26481434
21995874
26467407
23377209
18651709
23169921
25009084
21664425
26047814
22079836
22941409
17367745",Vitamin D inhibits the Staphylococcal enterotoxin B-induced expression of tumor necrosis factor in microglial cells.,"Microglial cells play a crucial role in inflammatory responses in neural tissue. Vitamin D (VitD3) deficiency is associated with the pathogenesis of inflammation. Staphylococcal enterotoxin B (SEB) is a superantigen and can initiate inflammation. This study tests a hypothesis that VitD3 deficiency upregulates the expression of tumor necrosis factor (TNF) in microglial cells. Microglial cells were isolated from the mouse brain. The microglial cells were cultured in the presence or absence of VitD3 or/and SEB. The expression of TNF in the microglial cells was assessed by RT-qPCR and Western blotting. We observed that SEB increased the expression of TNF in microglial cells. The presence of calcitriol (an active form of VitD3) inhibited the SEB-induced TNF production by microglial cells in a dose-dependent manner. Exposure to SEB increased the binding of vitamin D receptor (VDR) to the TNF promoter, which was inhibited by the presence of calcitriol with the mechanism being the formation of a complex of VDR and LITAF (a transcription factor of TNF) in microglial cells; the complex prevented the binding of LITAF to the promoter of the TNF gene. Exposure to calcitriol also increased the expression of IL-10 in microglial cells; the inhibition of SEB-induced TNF expression was partially due to the IL-10 induced by calcitriol (Heine G, Niesner U, Chang HD, teinmeyer A, Zügel U, Zuberbier T, et al. 1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur J Immunol. 2008;38(8):2210-8). Hormonal vitamin D [calcitriol] can inhibit the SEB-induced TNF expression in microglial cells.","['Microglial cell', 'SEB', 'TNF', 'Vitamin D', 'Vitamin D receptor']",Immunologic research,2017-06-03,"[{'lastname': 'He', 'firstname': 'Jinggui', 'initials': 'J', 'affiliation': 'Department of Cadre Clinic, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China. jingguirhe@outlook.com.'}, {'lastname': 'Guo', 'firstname': 'Xiyun', 'initials': 'X', 'affiliation': 'Department of Cadre Clinic, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China.'}, {'lastname': 'Liu', 'firstname': 'Zhi-Qiang', 'initials': 'ZQ', 'affiliation': 'The Research Center of Allergy & Immunology, Shenzhen University School of Medicine, Shenzhen, 518060, China.'}, {'lastname': 'Yang', 'firstname': 'Ping-Chang', 'initials': 'PC', 'affiliation': 'The Research Center of Allergy & Immunology, Shenzhen University School of Medicine, Shenzhen, 518060, China.'}, {'lastname': 'Yang', 'firstname': 'Shaobo', 'initials': 'S', 'affiliation': 'Department of Cadre Clinic, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853, China. ysb924@sohu.com.'}]",,,,,10.1007/s12026-017-8930-2,<Element 'PubmedArticle' at 0x7f05db0e7c70>
387,28567989,"The novel synthetic microneurotrophin BNN27 protects mature oligodendrocytes against cuprizone-induced death, through the NGF receptor TrkA.","BNN27, a member of a chemical library of C17-spiroepoxy derivatives of the neurosteroid DHEA, has been shown to regulate neuronal survival through its selective interaction with NGF receptors (TrkA and p75","['OLs', 'microglia', 'multiple sclerosis', 'neuroprotection', 'neurosteroid']",Glia,2017-06-02,"[{'lastname': 'Bonetto', 'firstname': 'Giulia', 'initials': 'G', 'affiliation': 'Department of Basic Science, Faculty of Medicine, University of Crete, Crete, Greece.\nInstitute of Molecular Biology & Biotechnology - FoRTH, Heraklion, Crete, Greece.'}, {'lastname': 'Charalampopoulos', 'firstname': 'Ioannis', 'initials': 'I', 'affiliation': 'Department of Pharmacology, Faculty of Medicine, University of Crete, Crete, Greece.'}, {'lastname': 'Gravanis', 'firstname': 'Achille', 'initials': 'A', 'affiliation': 'Institute of Molecular Biology & Biotechnology - FoRTH, Heraklion, Crete, Greece.\nDepartment of Pharmacology, Faculty of Medicine, University of Crete, Crete, Greece.'}, {'lastname': 'Karagogeos', 'firstname': 'Domna', 'initials': 'D', 'affiliation': 'Department of Basic Science, Faculty of Medicine, University of Crete, Crete, Greece.\nInstitute of Molecular Biology & Biotechnology - FoRTH, Heraklion, Crete, Greece.'}]",,,,"© 2017 Wiley Periodicals, Inc.",10.1002/glia.23170,<Element 'PubmedArticle' at 0x7f05db0fca40>
388,"28544365
8880734
24078816
24439723
7510610
8707928
18832152
21822589
26512331
16024755
1650522
17666053
24245565
25711529
24517230
16212944
20424564
22396865
26244935
16552414
21613996
15964248
10537031
17578509
20974732
24341993
25373903
16988703
16580998
7723929
23039106
15757637
26780286
10089130
21935936
15486815
22560222
25907790
26268661
22182318
18631321
27312235
16445986
20573720
22201683
24590317
10378877
27314003
23636330
26394137
19894723",Anti-aging drugs reduce hypothalamic inflammation in a sex-specific manner.,"Aging leads to hypothalamic inflammation, but does so more slowly in mice whose lifespan has been extended by mutations that affect GH/IGF-1 signals. Early-life exposure to GH by injection, or to nutrient restriction in the first 3 weeks of life, also modulate both lifespan and the pace of hypothalamic inflammation. Three drugs extend lifespan of UM-HET3 mice in a sex-specific way: acarbose (ACA), 17-α-estradiol (17αE2), and nordihydroguaiaretic acid (NDGA), with more dramatic longevity increases in males in each case. In this study, we examined the effect of these anti-aging drugs on neuro-inflammation in hypothalamus and hippocampus. We found that age-associated hypothalamic inflammation is reduced in males but not in females at 12 months of age by ACA and 17αE2 and at 22 months of age in NDGA-treated mice. The three drugs blocked indices of hypothalamic reactive gliosis associated with aging, such as Iba-1-positive microglia and GFAP-positive astrocytes, as well as age-associated overproduction of TNF-α. This effect was not observed in drug-treated female mice or in the hippocampus of the drug-treated animals. On the other hand, caloric restriction (CR; an intervention that extends the lifespan in both sexes) significantly reduced hypothalamic microglia and TNF-α in both sexes at 12 months of age. Together, these results suggest that the extent of drug-induced changes in hypothalamic inflammatory processes is sexually dimorphic in a pattern that parallels the effects of these agents on mouse longevity and that mimics the changes seen, in both sexes, of long-lived nutrient restricted or mutant mice.","['\nNDGA\n', '17-α Estradiol', 'Acarbose', 'aging', 'hypothalamus', 'inflammation', 'longevity', 'sexual dimorphism']",Aging cell,2017-05-26,"[{'lastname': 'Sadagurski', 'firstname': 'Marianna', 'initials': 'M', 'affiliation': 'Division of Geriatric and Palliative Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.'}, {'lastname': 'Cady', 'firstname': 'Gillian', 'initials': 'G', 'affiliation': 'Department of Pathology and Geriatrics Center, University of Michigan, Ann Arbor, MI, USA.'}, {'lastname': 'Miller', 'firstname': 'Richard A', 'initials': 'RA', 'affiliation': 'Department of Pathology and Geriatrics Center, University of Michigan, Ann Arbor, MI, USA.'}]",,,,© 2017 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.,10.1111/acel.12590,<Element 'PubmedArticle' at 0x7f05db10c8b0>
389,"28529912
17826211
11036909
21352227
17426553
10485681
18234750
16639155
21955684
17659431
11063824
15748951
15932748
17011666
19575469
15698624
16051891
8283269
2734318
22233347
23962089
7932797
6471907
19306376
10856063
15083873
8283270
11410269
17826842
15380490
15582278
25313690
23659385
27604709
24448183
9445346
18276910
18755197
17196460
14676142
25950715
19803787
17610350
19109539
17521631
16960300",Female gonadal hormone effects on microglial activation and functional outcomes in a mouse model of moderate traumatic brain injury.,"To address the hypothesis that young, gonad-intact female mice have improved long-term recovery associated with decreased neuroinflammation compared to male mice.
Eight to ten week-old male, female, and ovariectomized (OVX) mice underwent closed cranial impact. Gonad-intact female mice were injured only in estrus state. After injury, between group differences were assessed using complementary immunohistochemical staining for microglial cells at 1 h, mRNA polymerase chain reaction for inflammatory markers at 1 h after injury, Rotarod over days 1-7, and water maze on days 28-31 after injury.
Male mice had a greater area of injury (
Differences in mortality, long-term neurological recovery, and markers of neuroinflammation exist between female and male mice after moderate traumatic brain injury (MTBI). Unexpectedly, OVX mice have decreased long term neurological function after MTBI when compared to gonad intact male and female mice. As such, it can be concluded that the presence of female gonadal hormones may influence behavioural outcomes after MTBI, though mechanisms involved are unclear.","['Functional recovery', 'Inflammation', 'Microglia', 'Sex', 'Traumatic brain injury']",World journal of critical care medicine,2017-05-23,"[{'lastname': 'Umeano', 'firstname': 'Odera', 'initials': 'O', 'affiliation': 'Odera Umeano, School of Medicine, Duke University, Durham, NC 27710, United States.'}, {'lastname': 'Wang', 'firstname': 'Haichen', 'initials': 'H', 'affiliation': 'Odera Umeano, School of Medicine, Duke University, Durham, NC 27710, United States.'}, {'lastname': 'Dawson', 'firstname': 'Hana', 'initials': 'H', 'affiliation': 'Odera Umeano, School of Medicine, Duke University, Durham, NC 27710, United States.'}, {'lastname': 'Lei', 'firstname': 'Beilei', 'initials': 'B', 'affiliation': 'Odera Umeano, School of Medicine, Duke University, Durham, NC 27710, United States.'}, {'lastname': 'Umeano', 'firstname': 'Afoma', 'initials': 'A', 'affiliation': 'Odera Umeano, School of Medicine, Duke University, Durham, NC 27710, United States.'}, {'lastname': 'Kernagis', 'firstname': 'Dawn', 'initials': 'D', 'affiliation': 'Odera Umeano, School of Medicine, Duke University, Durham, NC 27710, United States.'}, {'lastname': 'James', 'firstname': 'Michael L', 'initials': 'ML', 'affiliation': 'Odera Umeano, School of Medicine, Duke University, Durham, NC 27710, United States.'}]",,"Differences in mortality, long-term neurological recovery, and markers of neuroinflammation exist between female and male mice after moderate traumatic brain injury (MTBI). Unexpectedly, OVX mice have decreased long term neurological function after MTBI when compared to gonad intact male and female mice. As such, it can be concluded that the presence of female gonadal hormones may influence behavioural outcomes after MTBI, though mechanisms involved are unclear.",Male mice had a greater area of injury (,,10.5492/wjccm.v6.i2.107,<Element 'PubmedArticle' at 0x7f05db0b3d10>
390,28526435,"The bidirectional gut-brain-microbiota axis as a potential nexus between traumatic brain injury, inflammation, and disease.","As head injuries and their sequelae have become an increasingly salient matter of public health, experts in the field have made great progress elucidating the biological processes occurring within the brain at the moment of injury and throughout the recovery thereafter. Given the extraordinary rate at which our collective knowledge of neurotrauma has grown, new insights may be revealed by examining the existing literature across disciplines with a new perspective. This article will aim to expand the scope of this rapidly evolving field of research beyond the confines of the central nervous system (CNS). Specifically, we will examine the extent to which the bidirectional influence of the gut-brain axis modulates the complex biological processes occurring at the time of traumatic brain injury (TBI) and over the days, months, and years that follow. In addition to local enteric signals originating in the gut, it is well accepted that gastrointestinal (GI) physiology is highly regulated by innervation from the CNS. Conversely, emerging data suggests that the function and health of the CNS is modulated by the interaction between 1) neurotransmitters, immune signaling, hormones, and neuropeptides produced in the gut, 2) the composition of the gut microbiota, and 3) integrity of the intestinal wall serving as a barrier to the external environment. Specific to TBI, existing pre-clinical data indicates that head injuries can cause structural and functional damage to the GI tract, but research directly investigating the neuronal consequences of this intestinal damage is lacking. Despite this void, the proposed mechanisms emanating from a damaged gut are closely implicated in the inflammatory processes known to promote neuropathology in the brain following TBI, which suggests the gut-brain axis may be a therapeutic target to reduce the risk of Chronic Traumatic Encephalopathy and other neurodegenerative diseases following TBI. To better appreciate how various peripheral influences are implicated in the health of the CNS following TBI, this paper will also review the secondary biological injury mechanisms and the dynamic pathophysiological response to neurotrauma. Together, this review article will attempt to connect the dots to reveal novel insights into the bidirectional influence of the gut-brain axis and propose a conceptual model relevant to the recovery from TBI and subsequent risk for future neurological conditions.","['Chronic Traumatic Encephalopathy', 'Concussion', 'Gut', 'Gut-brain axis', 'Intestinal dysfunction', 'Microbiota', 'Microglia', 'Neurodegenerative disease', 'Neuroinflammation', 'Traumatic Brain Injury']","Brain, behavior, and immunity",2017-05-21,"[{'lastname': 'Sundman', 'firstname': 'Mark H', 'initials': 'MH', 'affiliation': 'Department of Psychology, University of Arizona, Tucson, AZ, USA. Electronic address: marksundman@email.arizona.edu.'}, {'lastname': 'Chen', 'firstname': 'Nan-Kuei', 'initials': 'NK', 'affiliation': 'Department of Biomedical Engineering, University of Arizona, Tucson, AZ, USA.'}, {'lastname': 'Subbian', 'firstname': 'Vignesh', 'initials': 'V', 'affiliation': 'Department of Biomedical Engineering, University of Arizona, Tucson, AZ, USA; Department of Systems and Industrial Engineering, University of Arizona, Tucson, AZ, USA.'}, {'lastname': 'Chou', 'firstname': 'Ying-Hui', 'initials': 'YH', 'affiliation': 'Department of Psychology, University of Arizona, Tucson, AZ, USA; Cognitive Science Program, University of Arizona, Tucson, AZ, USA; Arizona Center on Aging, University of Arizona, Tucson, AZ, USA.'}]",,,,Copyright © 2017 Elsevier Inc. All rights reserved.,10.1016/j.bbi.2017.05.009,<Element 'PubmedArticle' at 0x7f05db0ca8b0>
391,28502879,"Genetic deletion of P-glycoprotein alters stress responsivity and increases depression-like behavior, social withdrawal and microglial activation in the hippocampus of female mice.","P-glycoprotein (P-gp) is an ABC transporter expressed at the blood brain barrier and regulates the brain uptake of various xenobiotics and endogenous mediators including glucocorticoid hormones which are critically important to the stress response. Moreover, P-gp is expressed on microglia, the brain's immune cells, which are activated by stressors and have an emerging role in psychiatric disorders. We therefore hypothesised that germline P-gp deletion in mice might alter the behavioral and microglial response to stressors. Female P-gp knockout mice displayed an unusual, frantic anxiety response to intraperitoneal injection stress in the light-dark test. They also tended to display reduced conditioned fear responses compared to wild-type (WT) mice in a paradigm where a single electric foot-shock stressor was paired to a context. Foot-shock stress reduced social interaction and decreased microglia cell density in the amygdala which was not varied by P-gp genotype. Independently of stressor exposure, female P-gp deficient mice displayed increased depression-like behavior, idiosyncratic darting behavior, age-related social withdrawal and hyperactivity, facilitated sensorimotor gating and altered startle reactivity. In addition, P-gp deletion increased microglia cell density in the CA3 region of the hippocampus, and the microglial cells exhibited a reactive, hypo-ramified morphology. Further, female P-gp KO mice displayed increased glucocorticoid receptor (GR) expression in the hippocampus. In conclusion, this research shows that germline P-gp deletion affected various behaviors of relevance to psychiatric conditions, and that altered microglial cell activity and enhanced GR expression in the hippocampus may play a role in mediating these behaviors.","['ABC transporter', 'Depression', 'Microglia', 'P-glycoprotein', 'Post-traumatic stress disorder', 'Stress']","Brain, behavior, and immunity",2017-05-16,"[{'lastname': 'Brzozowska', 'firstname': 'Natalia I', 'initials': 'NI', 'affiliation': 'Discipline of Pharmacology, School of Medical Science, University of Sydney, Camperdown, NSW, Australia; The Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia.'}, {'lastname': 'Smith', 'firstname': 'Kristie L', 'initials': 'KL', 'affiliation': 'Discipline of Pharmacology, School of Medical Science, University of Sydney, Camperdown, NSW, Australia; The Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia.'}, {'lastname': 'Zhou', 'firstname': 'Cilla', 'initials': 'C', 'affiliation': 'Discipline of Pharmacology, School of Medical Science, University of Sydney, Camperdown, NSW, Australia; The Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia.'}, {'lastname': 'Waters', 'firstname': 'Peter M', 'initials': 'PM', 'affiliation': 'Discipline of Pharmacology, School of Medical Science, University of Sydney, Camperdown, NSW, Australia.'}, {'lastname': 'Cavalcante', 'firstname': 'Ligia Menezes', 'initials': 'LM', 'affiliation': 'Discipline of Pharmacology, School of Medical Science, University of Sydney, Camperdown, NSW, Australia; The Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia.'}, {'lastname': 'Abelev', 'firstname': 'Sarah V', 'initials': 'SV', 'affiliation': 'Discipline of Pharmacology, School of Medical Science, University of Sydney, Camperdown, NSW, Australia; The Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia.'}, {'lastname': 'Kuligowski', 'firstname': 'Michael', 'initials': 'M', 'affiliation': 'The Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia; Australian Microscopy & Microanalysis Research Facility, University of Sydney, Camperdown, NSW, Australia.'}, {'lastname': 'Clarke', 'firstname': 'David J', 'initials': 'DJ', 'affiliation': 'Discipline of Pharmacology, School of Medical Science, University of Sydney, Camperdown, NSW, Australia; The Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia.'}, {'lastname': 'Todd', 'firstname': 'Stephanie M', 'initials': 'SM', 'affiliation': 'Discipline of Pharmacology, School of Medical Science, University of Sydney, Camperdown, NSW, Australia; The Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia.'}, {'lastname': 'Arnold', 'firstname': 'Jonathon C', 'initials': 'JC', 'affiliation': 'Discipline of Pharmacology, School of Medical Science, University of Sydney, Camperdown, NSW, Australia; The Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia. Electronic address: jonathon.arnold@sydney.edu.au.'}]",,,,Copyright © 2017 Elsevier Inc. All rights reserved.,10.1016/j.bbi.2017.05.008,<Element 'PubmedArticle' at 0x7f05db0d4b30>
392,28492437,Continuous Intrathecal Infusion of Cannabinoid Receptor Agonists Attenuates Nerve Ligation-Induced Pain in Rats.,"Cannabinoid receptors (CB1R/CB2R) are known to play important roles in pain transmission. In this study, we investigated the effects of continuous intrathecal infusion of CB1/2R agonists in the L5/6 spinal nerve ligation pain model.
Under isoflurane anesthesia, rats received nerve ligation and intrathecal catheter connected to an infusion pump. After surgery, saline (1 μL/h), CB1/2R agonist WIN55,212-2, CB1R agonist ACEA, or CB2R agonist AM1241 (1 μmol/h) was given intrathecally for 7 days. The mechanical and thermal sensitivities of rat hindpaw were determined by von Frey hair and radiant heat tests. The expression of CB1/2R and protein levels of CB1/2R, Iba1, glial fibrillary acidic protein, and tumor necrosis factor α were examined by immunofluorescence study and Western blotting.
On postligation day 7, rats that received WIN55,212-2, ACEA or AM1241 had significantly higher mean withdrawal thresholds (6.8, 8.4, and 10.2 g) and latencies (6.3, 7.3, and 9.1 seconds) than did saline-treated rats (1.7 g, 2.2 seconds). Cannabinoid receptors were expressed not only in IB4 (isolectin B4) and CGRP (calcitonin gene-related peptide) dorsal root ganglion neurons, their central terminals, and peripheral axons, but also in neurons, microglia, and astrocytes in spinal cord. Cannabinoid receptor agonists enhanced nerve ligation-induced up-regulation of cannabinoid receptor in spinal cord and dorsal root ganglion. Treatment with WIN55,212-2 or AM1241, but not ACEA, markedly reduced nerve ligation-induced up-regulation of Iba1, glial fibrillary acidic protein, and tumor necrosis factor α in spinal cord.
Continuous intrathecal infusion of CB1/2R agonists elicits antinociception in the pain model. The mechanisms might involve their actions on neurons and glial cells. CB2R, but not CB1R, seems to play an important role in the regulation of nerve injury-induced neuroinflammation.",[],Regional anesthesia and pain medicine,2017-05-12,"[{'lastname': 'Shiue', 'firstname': 'Sheng-Jie', 'initials': 'SJ', 'affiliation': 'From the *Department of Anesthesiology, MacKay Memorial Hospital, Taipei; †Department of Medicine, MacKay Medical College, New Taipei City; and ‡Department of Anesthesiology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.'}, {'lastname': 'Peng', 'firstname': 'Hsien-Yu', 'initials': 'HY', 'affiliation': None}, {'lastname': 'Lin', 'firstname': 'Chung-Ren', 'initials': 'CR', 'affiliation': None}, {'lastname': 'Wang', 'firstname': 'Shih-Wei', 'initials': 'SW', 'affiliation': None}, {'lastname': 'Rau', 'firstname': 'Ruey-Horng', 'initials': 'RH', 'affiliation': None}, {'lastname': 'Cheng', 'firstname': 'Jen-Kun', 'initials': 'JK', 'affiliation': None}]",,,"On postligation day 7, rats that received WIN55,212-2, ACEA or AM1241 had significantly higher mean withdrawal thresholds (6.8, 8.4, and 10.2 g) and latencies (6.3, 7.3, and 9.1 seconds) than did saline-treated rats (1.7 g, 2.2 seconds). Cannabinoid receptors were expressed not only in IB4 (isolectin B4) and CGRP (calcitonin gene-related peptide) dorsal root ganglion neurons, their central terminals, and peripheral axons, but also in neurons, microglia, and astrocytes in spinal cord. Cannabinoid receptor agonists enhanced nerve ligation-induced up-regulation of cannabinoid receptor in spinal cord and dorsal root ganglion. Treatment with WIN55,212-2 or AM1241, but not ACEA, markedly reduced nerve ligation-induced up-regulation of Iba1, glial fibrillary acidic protein, and tumor necrosis factor α in spinal cord.",,10.1097/AAP.0000000000000601,<Element 'PubmedArticle' at 0x7f05db064540>
393,"28489068
22660301
18955701
11181838
13679428
18073775
22940906
22201683
24166765
27405276
17051205
26858267
19808793
22958818
23564345
14561818
21873987
25240284
23791197
17179932
26138975
15057970
15810980",TNFα drives mitochondrial stress in POMC neurons in obesity.,"Consuming a calorically dense diet stimulates microglial reactivity in the mediobasal hypothalamus (MBH) in association with decreased number of appetite-curbing pro-opiomelanocortin (POMC) neurons; whether the reduction in POMC neuronal function is secondary to the microglial activation is unclear. Here we show that in hypercaloric diet-induced obese mice, persistently activated microglia in the MBH hypersecrete TNFα that in turn stimulate mitochondrial ATP production in POMC neurons, promoting mitochondrial fusion in their neurites, and increasing POMC neuronal firing rates and excitability. Specific disruption of the gene expressions of TNFα downstream signals TNFSF11A or NDUFAB1 in the MBH of diet-induced obese mice reverses mitochondrial elongation and reduces obesity. These data imply that in a hypercaloric environment, persistent elevation of microglial reactivity and consequent TNFα secretion induces mitochondrial stress in POMC neurons that contributes to the development of obesity.",[],Nature communications,2017-05-11,"[{'lastname': 'Yi', 'firstname': 'Chun-Xia', 'initials': 'CX', 'affiliation': 'Institute for Diabetes and Obesity, Helmholtz Diabetes Center at Helmholtz Zentrum München, Division of Metabolic Diseases, Department of Medicine, Technische Universität München, German Center for Diabetes Research (DZD), 85764 München-Neuherberg, Germany.\nDepartment of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, 1105AZ Amsterdam, The Netherlands.'}, {'lastname': 'Walter', 'firstname': 'Marc', 'initials': 'M', 'affiliation': 'Institute for Diabetes and Obesity, Helmholtz Diabetes Center at Helmholtz Zentrum München, Division of Metabolic Diseases, Department of Medicine, Technische Universität München, German Center for Diabetes Research (DZD), 85764 München-Neuherberg, Germany.'}, {'lastname': 'Gao', 'firstname': 'Yuanqing', 'initials': 'Y', 'affiliation': 'Institute for Diabetes and Obesity, Helmholtz Diabetes Center at Helmholtz Zentrum München, Division of Metabolic Diseases, Department of Medicine, Technische Universität München, German Center for Diabetes Research (DZD), 85764 München-Neuherberg, Germany.'}, {'lastname': 'Pitra', 'firstname': 'Soledad', 'initials': 'S', 'affiliation': 'Department of Physiology, Augusta University, Augusta, Georgia 30912, USA.'}, {'lastname': 'Legutko', 'firstname': 'Beata', 'initials': 'B', 'affiliation': 'Institute for Diabetes and Obesity, Helmholtz Diabetes Center at Helmholtz Zentrum München, Division of Metabolic Diseases, Department of Medicine, Technische Universität München, German Center for Diabetes Research (DZD), 85764 München-Neuherberg, Germany.'}, {'lastname': 'Kälin', 'firstname': 'Stefanie', 'initials': 'S', 'affiliation': 'Institute for Diabetes and Obesity, Helmholtz Diabetes Center at Helmholtz Zentrum München, Division of Metabolic Diseases, Department of Medicine, Technische Universität München, German Center for Diabetes Research (DZD), 85764 München-Neuherberg, Germany.'}, {'lastname': 'Layritz', 'firstname': 'Clarita', 'initials': 'C', 'affiliation': 'Institute for Diabetes and Obesity, Helmholtz Diabetes Center at Helmholtz Zentrum München, Division of Metabolic Diseases, Department of Medicine, Technische Universität München, German Center for Diabetes Research (DZD), 85764 München-Neuherberg, Germany.'}, {'lastname': 'García-Cáceres', 'firstname': 'Cristina', 'initials': 'C', 'affiliation': 'Institute for Diabetes and Obesity, Helmholtz Diabetes Center at Helmholtz Zentrum München, Division of Metabolic Diseases, Department of Medicine, Technische Universität München, German Center for Diabetes Research (DZD), 85764 München-Neuherberg, Germany.'}, {'lastname': 'Bielohuby', 'firstname': 'Maximilian', 'initials': 'M', 'affiliation': 'Endocrine Research Unit, Klinikum der Ludwig-Maximilians-Universität, 81377 Munich, Germany.'}, {'lastname': 'Bidlingmaier', 'firstname': 'Martin', 'initials': 'M', 'affiliation': 'Endocrine Research Unit, Klinikum der Ludwig-Maximilians-Universität, 81377 Munich, Germany.'}, {'lastname': 'Woods', 'firstname': 'Stephen C', 'initials': 'SC', 'affiliation': 'Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, Cincinnati, Ohio 45220, USA.'}, {'lastname': 'Ghanem', 'firstname': 'Alexander', 'initials': 'A', 'affiliation': 'Max von Pettenkofer Institute and Gene Center, Ludwig-Maximilians-Universität, 80539 Munich, Germany.'}, {'lastname': 'Conzelmann', 'firstname': 'Karl-Klaus', 'initials': 'KK', 'affiliation': 'Max von Pettenkofer Institute and Gene Center, Ludwig-Maximilians-Universität, 80539 Munich, Germany.'}, {'lastname': 'Stern', 'firstname': 'Javier E', 'initials': 'JE', 'affiliation': 'Department of Physiology, Augusta University, Augusta, Georgia 30912, USA.'}, {'lastname': 'Jastroch', 'firstname': 'Martin', 'initials': 'M', 'affiliation': 'Institute for Diabetes and Obesity, Helmholtz Diabetes Center at Helmholtz Zentrum München, Division of Metabolic Diseases, Department of Medicine, Technische Universität München, German Center for Diabetes Research (DZD), 85764 München-Neuherberg, Germany.'}, {'lastname': 'Tschöp', 'firstname': 'Matthias H', 'initials': 'MH', 'affiliation': 'Institute for Diabetes and Obesity, Helmholtz Diabetes Center at Helmholtz Zentrum München, Division of Metabolic Diseases, Department of Medicine, Technische Universität München, German Center for Diabetes Research (DZD), 85764 München-Neuherberg, Germany.'}]",,,,,10.1038/ncomms15143,<Element 'PubmedArticle' at 0x7f05db071180>
394,"28466267
9597135
23212448
10430862
17540012
16873059
24587895
6701097
26111663
10669420
21651395
27421686
23493093
24481440
10235310
21851833
11981132
24783201
15605983
17067360
3155867
20078221
4127281
15681027
26315713
17431646
23645118
25701025
19641587
8833885
20580929
11882342
16282329
15134560
12829422
12055609
2172709
16156783
18174526
12435477
24997566
22240163
21194380
20007851
27128904
22613133
21776259
27001618
20657404
23888142
15205477
23417962",17β-Estradiol via SIRT1/Acetyl-p53/NF-kB Signaling Pathway Rescued Postnatal Rat Brain Against Acute Ethanol Intoxication.,"Growing evidences reveal that 17β-estradiol has a wide variety of neuroprotective potential. Recently, it has been shown that 17β-estradiol can limit ethanol-induced neurotoxicity in neonatal rats. Whether it can stimulate SIRT1 signaling against ethanol intoxicity in developing brain remain elusive. Here, we report for the first time that 17β-estradiol activated SIRT1 to deacetylate p53 proteins against acute ethanol-induced oxidative stress, neuroinflammation, and neurodegeneration. A single subcutaneous injection of ethanol-induced oxidative stress triggered phospho c-jun N terminal kinase (p-JNK) and phospho mammalian target of rapamycin (p-mTOR) accompanied by neuroinflammation and widespread neurodegeneration. In contrast, 17β-estradiol cotreatment positively regulated SIRT1, inhibited p53 acetylation, reactive oxygen species (ROS) production, p-JNK, and p-mTOR activation and reduced neuroinflammation and neuronal cell death in the postnatal rat brain. Interestingly, SIRT1 inhibition with its inhibitor, i.e., EX527 further enhanced ethanol intoxication and also abolished the beneficial effects of 17β-estradiol against ethanol in the young rat's brain. Indeed, 17β-estradiol treatment increased the cell viability (HT22 cells), inhibited ROS production via the SIRT1/Acetyl-p53 pathway, and reduced the nuclear translocation of phospho-nuclear factor kappa B (p-NF-kB) in the BV2 microglia cells. Taken together, these results show that 17β-estradiol can be used as a potential neuroprotective agent against acute ethanol intoxication.","['Brain', 'Estradiol', 'Ethanol', 'Neuroinflammation', 'ROS', 'SIRT1']",Molecular neurobiology,2017-05-04,"[{'lastname': 'Khan', 'firstname': 'Mehtab', 'initials': 'M', 'affiliation': 'Department of Biology and Applied Life Science (BK 21plus), College of Natural Sciences, Gyeongsang National University, Jinju, 660-701, Republic of Korea.'}, {'lastname': 'Shah', 'firstname': 'Shahid Ali', 'initials': 'SA', 'affiliation': 'Department of Biology and Applied Life Science (BK 21plus), College of Natural Sciences, Gyeongsang National University, Jinju, 660-701, Republic of Korea.'}, {'lastname': 'Kim', 'firstname': 'Myeong Ok', 'initials': 'MO', 'affiliation': 'Department of Biology and Applied Life Science (BK 21plus), College of Natural Sciences, Gyeongsang National University, Jinju, 660-701, Republic of Korea. mokim@gsnu.ac.kr.'}]",,,,,10.1007/s12035-017-0520-8,<Element 'PubmedArticle' at 0x7f05db08a5e0>
395,"28456941
11493160
23259618
15959904
23964105
22150224
24719110
24582776
24019748
24007818
19164583
16609877
23999914
18540945
9044391
22066025
18278032
7814894
22774922
23431360
21487412
21901364
26979865
3385016
25101679
12925848
24464856
19570816
25789481
17125767
22384126
19617854
21472764
22363635
23209191
25704852
21810596
12220687
21177428
22203900
18760331
11835378
21525299
23915189
21391234
20374430
8156917
10657494
11984595
23686747
25452009
23276669
23035582
16720054
15655721
26500843
27878229
17252050
24312624
27110066
21729281",Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.,"The signaling axis of glucagon-like peptide-1 (GLP-1)/GLP-1 receptor (GLP-1R) has been an important component in overcoming diabetes, and recent reports have uncovered novel beneficial roles of this signaling axis in central nervous system (CNS) disorders, such as Alzheimer's disease, Parkinson's disease, and cerebral ischemia, accelerating processes for exendin-4 repositioning. Here, we studied whether multiple sclerosis (MS) could be a complement to the CNS disorders that are associated with the GLP-1/GLP-1R signaling axis. Both components of the signaling axis, GLP-1 and GLP-1R proteins, are expressed in neurons, astrocytes, and microglia in the spinal cord of normal mice. In particular, they are abundant in Iba1-positive microglia. Upon challenge by experimental autoimmune encephalomyelitis (EAE), an animal model of MS, the mRNA expression of both GLP-1 and GLP-1R was markedly downregulated in EAE-symptomatic spinal cords, indicating attenuated activity of GLP-1/GLP-1R signaling in EAE. Such a downregulation obviously occurred in LPS-stimulated rat primary microglia, a main cell type to express both GLP-1 and GLP-1R, further indicating attenuated activity of GLP-1/GLP-1R signaling in activated microglia. To investigate whether increased activity of GLP-1R has a therapeutic benefit, exendin-4 (5 μg/kg, i.p.), a GLP-1R agonist, was administered daily to EAE-symptomatic mice. Exendin-4 administration to symptomatic EAE mice significantly improved the clinical signs of the disease, along with the reversal of histopathological sequelae such as cell accumulation, demyelination, astrogliosis, microglial activation, and morphological transformation of activated microglia in the injured spinal cord. Such an improvement by exendin-4 was comparable to that by FTY720 (3 mg/kg, i.p.), a drug for MS. The neuroprotective effects of exendin-4 against EAE were also associated with decreased mRNA expression of proinflammatory cytokines, such as interleukin (IL)-17, IL-1β, IL-6, and tumor necrosis factor (TNF)-α, all of which are usually upregulated in injured sites of the EAE spinal cord. Interestingly, exendin-4 exposure similarly reduced mRNA levels of IL-1β and TNF-α in LPS-stimulated microglia. Furthermore, exendin-4 administration significantly attenuated activation of NF-κB signaling in EAE spinal cord and LPS-stimulated microglia. Collectively, the current study demonstrates the therapeutic potential of exendin-4 for MS by reducing immune responses in the CNS, highlighting the importance of the GLP-1/GLP-1R signaling axis in the development of a novel therapeutic strategy for MS.","['Exendin-4', 'Experimental autoimmune encephalomyelitis', 'Glucagon-like peptide 1', 'Glucagon-like peptide 1 receptor', 'Microglia']",Molecular neurobiology,2017-05-01,"[{'lastname': 'Lee', 'firstname': 'Chi-Ho', 'initials': 'CH', 'affiliation': 'Laboratory of Neuropharmacology, College of Pharmacy and Gachon Institute of Pharmaceutical Sciences, Gachon University, Incheon, 406-799, South Korea.\nLaboratory of Immunology, College of Pharmacy and Gachon Institute of Pharmaceutical Sciences, Gachon University, Incheon, 406-799, South Korea.'}, {'lastname': 'Jeon', 'firstname': 'Se Jin', 'initials': 'SJ', 'affiliation': 'Departments of Life and Nanopharmaceutical Science and Oriental Pharmaceutical Science, College of Pharmacy, Kyung Hee University, Seoul, 130-701, South Korea.'}, {'lastname': 'Cho', 'firstname': 'Kyu Suk', 'initials': 'KS', 'affiliation': 'Departments of Life and Nanopharmaceutical Science and Oriental Pharmaceutical Science, College of Pharmacy, Kyung Hee University, Seoul, 130-701, South Korea.'}, {'lastname': 'Moon', 'firstname': 'Eunjung', 'initials': 'E', 'affiliation': 'Laboratory of Neuropharmacology, College of Pharmacy and Gachon Institute of Pharmaceutical Sciences, Gachon University, Incheon, 406-799, South Korea.'}, {'lastname': 'Sapkota', 'firstname': 'Arjun', 'initials': 'A', 'affiliation': 'Laboratory of Neuropharmacology, College of Pharmacy and Gachon Institute of Pharmaceutical Sciences, Gachon University, Incheon, 406-799, South Korea.'}, {'lastname': 'Jun', 'firstname': 'Hee Sook', 'initials': 'HS', 'affiliation': 'Laboratory of Immunology, College of Pharmacy and Gachon Institute of Pharmaceutical Sciences, Gachon University, Incheon, 406-799, South Korea.'}, {'lastname': 'Ryu', 'firstname': 'Jong Hoon', 'initials': 'JH', 'affiliation': 'Departments of Life and Nanopharmaceutical Science and Oriental Pharmaceutical Science, College of Pharmacy, Kyung Hee University, Seoul, 130-701, South Korea.'}, {'lastname': 'Choi', 'firstname': 'Ji Woong', 'initials': 'JW', 'affiliation': 'Laboratory of Neuropharmacology, College of Pharmacy and Gachon Institute of Pharmaceutical Sciences, Gachon University, Incheon, 406-799, South Korea. pharmchoi@gachon.ac.kr.'}]",,,,,10.1007/s12035-017-0550-2,<Element 'PubmedArticle' at 0x7f05db022a90>
396,"28445478
18468545
26811276
18815396
25649802
26581023
26119323
16453316
10441299
6272455
8173671
8955928
19654585
18645567
19064779
17457674
17420989
16565723
18292653
16790993
27180033
26962212
20670828
18463660
19664070
19375666
22643075
9131253
11387502
20236058
9335258
10398599
16901919
9538899
23299242
2643202
22994217
22595494
18289024
24309662
15570890
12711075
21421915
24123158
23596393
18831008
20588315
26671410
26655603
27027288
11063991
22653056
21521168
24590682
25257319
16406093
24946078
25657720
25982835
24578611
12627328
16368716
17188266
11018070
8478396",Delayed histochemical alterations within the neurovascular unit due to transient focal cerebral ischemia and experimental treatment with neurotrophic factors.,"Current stroke therapy is focused on recanalizing strategies, but neuroprotective co-treatments are still lacking. Modern concepts of the ischemia-affected neurovascular unit (NVU) and surrounding penumbra emphasize the complexity during the transition from initial damaging to regenerative processes. While early treatment with neurotrophic factors was shown to result in lesion size reduction and blood-brain barrier (BBB) stabilization, cellular consequences from these treatments are poorly understood. This study explored delayed cellular responses not only to ischemic stroke, but also to an early treatment with neurotrophic factors. Rats underwent 60 minutes of focal cerebral ischemia. Fluorescence labeling was applied to sections from brains perfused 7 days after ischemia. Analyses focused on NVU constituents including the vasculature, astrocytes and microglia in the ischemic striatum, the border zone and the contralateral hemisphere. In addition to histochemical signs of BBB breakdown, a strong up-regulation of collagen IV and microglia activation occurred within the ischemic core with simultaneous degradation of astrocytes and their endfeet. Activated astroglia were mainly depicted at the border zone in terms of a glial scar formation. Early treatment with pigment epithelium-derived factor (PEDF) resulted in an attenuation of the usually up-regulated collagen IV-immunoreactivity. However, glial activation was not influenced by treatment with PEDF or the epidermal growth factor (EGF). In conclusion, these data on ischemia-induced cellular reactions within the NVU might help to develop treatments addressing the transition from injury towards regeneration. Thereby, the integrity of the vasculature in close relation to neighboring structures like astrocytes appears as a promising target.",[],PloS one,2017-04-27,"[{'lastname': 'Michalski', 'firstname': 'Dominik', 'initials': 'D', 'affiliation': 'Department of Neurology, University of Leipzig, Liebigstr. 20, Leipzig, Germany.'}, {'lastname': 'Pitsch', 'firstname': 'Roman', 'initials': 'R', 'affiliation': 'Paul Flechsig Institute for Brain Research, University of Leipzig, Liebigstr. 19, Leipzig, Germany.'}, {'lastname': 'Pillai', 'firstname': 'Deepu R', 'initials': 'DR', 'affiliation': 'Department of Neurology, University of Regensburg and Clinic for Neurological Rehabilitation II, Universitätsstr. 84, Regensburg, Germany.\nInstitute of Neuroscience and Medicine (INM) 4, Forschungszentrum Jülich GmbH, Jülich, Germany.'}, {'lastname': 'Mages', 'firstname': 'Bianca', 'initials': 'B', 'affiliation': 'Department of Neurology, University of Leipzig, Liebigstr. 20, Leipzig, Germany.\nPaul Flechsig Institute for Brain Research, University of Leipzig, Liebigstr. 19, Leipzig, Germany.'}, {'lastname': 'Aleithe', 'firstname': 'Susanne', 'initials': 'S', 'affiliation': 'Department of Neurology, University of Leipzig, Liebigstr. 20, Leipzig, Germany.\nPaul Flechsig Institute for Brain Research, University of Leipzig, Liebigstr. 19, Leipzig, Germany.'}, {'lastname': 'Grosche', 'firstname': 'Jens', 'initials': 'J', 'affiliation': 'Effigos GmbH, Am Deutschen Platz 4, Leipzig, Germany.'}, {'lastname': 'Martens', 'firstname': 'Henrik', 'initials': 'H', 'affiliation': 'Synaptic Systems, Göttingen, Germany.'}, {'lastname': 'Schlachetzki', 'firstname': 'Felix', 'initials': 'F', 'affiliation': 'Department of Neurology, University of Regensburg and Clinic for Neurological Rehabilitation II, Universitätsstr. 84, Regensburg, Germany.'}, {'lastname': 'Härtig', 'firstname': 'Wolfgang', 'initials': 'W', 'affiliation': 'Paul Flechsig Institute for Brain Research, University of Leipzig, Liebigstr. 19, Leipzig, Germany.'}]",,,,,"10.1371/journal.pone.0174996
10.1016/S0140-6736(08)60694-7
10.1161/CIR.0000000000000366
10.1056/NEJMoa0804656
10.1161/STROKEAHA.114.008454
10.1016/S1474-4422(15)00140-4
10.1038/jcbfm.2009.106
10.1007/s11064-007-9342-9
10.1002/ana.21127
10.1038/nm1387
10.1159/000118039
10.1159/000093098
10.1016/S1474-4422(16)00114-9
10.1136/jim-2016-000104
10.1016/j.neuron.2010.07.002
10.1038/nm1735
10.1111/j.1742-4658.2009.07176.x
10.1016/S1474-4422(09)70061-4
10.1179/1743132812Y.0000000019
10.1146/annurev.pharmtox.37.1.239
10.1002/(SICI)1097-4547(19970915)49:6<710::AID-JNR5>3.0.CO;2-A
10.1677/jme.1.02008
10.1097/00004647-199804000-00002
10.1038/jcbfm.2012.201
10.1111/j.1749-6632.2012.06691.x
10.1016/j.tips.2012.04.006
10.1038/nm.3407
10.1002/glia.22575
10.3389/fncel.2013.00038
10.1002/jnr.21877
10.1038/jcbfm.2010.97
10.1007/s00401-015-1513-1
10.1016/j.bbadis.2015.11.014
10.1038/nature17623
10.1172/JCI60842
10.1002/glia.22654
10.1186/s40478-014-0142-6
10.1016/j.tins.2005.12.005
10.1111/bpa.12162
10.4103/1673-5374.147929
10.1016/j.nbd.2015.05.003
10.7150/ijms.8140
10.1007/s00125-002-1013-4
10.1096/fj.05-4313fje
10.1016/j.expneurol.2006.11.001
10.1172/JCI9369
10.1038/jcbfm.1993.51",<Element 'PubmedArticle' at 0x7f05db042b80>
397,28429852,Anti-inflammatory and retinal protective effects of capsaicin on ischaemia-induced injuries through the release of endogenous somatostatin.,"The mechanisms regarding the retinal protective and anti-inflammatory effects of capsaicin (CAP) remain unclear. Somatostatin is contained in CAP-sensitive sensory neurons, including nerve terminals, from which it can be released by capsaicin. The present study provides a novel neurohumoral regulatory mechanism for CAP-induced-endogenous somatostatin in a retinal ischaemia-reperfusion (I/R) mouse model. CAP (0.5 mg/kg) was injected subcutaneously 5 minutes after I/R. A selective somatostatin-depleting agent, cysteamine, was applied subcutaneously 4 hours before the experiment to examine the effects of endogenous somatostatin. Ischaemia and oxidative stress-induced inflammatory factors (CXCL10, CXCR3 and NF-κB p65) were also examined in the present study. The morphometric evaluation showed that the retinal thickness was increased 24 hours after I/R injury and attenuated 7 days after I/R injury. The number of ganglion cells was reduced 7 days after I/R injury. The application of CAP significantly prevented retinal I/R damage. Cysteamine pretreatment reversed the effects of CAP. Inhibition of CXCL10/CXCR3 and NF-κB (especially in astrocytes and microglia/macrophage) was involved in capsaicin-induced retinal protection through endogenous somatostatin. CAP has anti-inflammatory and neuroprotective effects in ischaemia-induced retinal injuries through endogenous somatostatin. Novel therapeutic remedies for inflammation or neuronal injuries were developed based on the systemic humoral effects related to CAP.","['capsaicin', 'ischaemia-reperfusion', 'retina', 'somatostatin']",Clinical and experimental pharmacology & physiology,2017-04-22,"[{'lastname': 'Wang', 'firstname': 'Jun', 'initials': 'J', 'affiliation': 'Henan University School of Medicine, Kaifeng, China.'}, {'lastname': 'Tian', 'firstname': 'Wenke', 'initials': 'W', 'affiliation': 'Henan University School of Medicine, Kaifeng, China.'}, {'lastname': 'Wang', 'firstname': 'Shuaiwei', 'initials': 'S', 'affiliation': 'Henan University School of Medicine, Kaifeng, China.'}, {'lastname': 'Wei', 'firstname': 'Wenqiang', 'initials': 'W', 'affiliation': 'Henan University School of Medicine, Kaifeng, China.'}, {'lastname': 'Wu', 'firstname': 'Dongdong', 'initials': 'D', 'affiliation': 'Henan University School of Medicine, Kaifeng, China.'}, {'lastname': 'Wang', 'firstname': 'Honggang', 'initials': 'H', 'affiliation': 'Henan University School of Medicine, Kaifeng, China.'}, {'lastname': 'Wang', 'firstname': 'Li', 'initials': 'L', 'affiliation': 'The First Affiliated Hospital of Henan University, Kaifeng, China.'}, {'lastname': 'Yang', 'firstname': 'Ruisheng', 'initials': 'R', 'affiliation': 'The First Affiliated Hospital of Henan University, Kaifeng, China.'}, {'lastname': 'Ji', 'firstname': 'Ailing', 'initials': 'A', 'affiliation': 'Henan University School of Medicine, Kaifeng, China.'}, {'lastname': 'Li', 'firstname': 'Yanzhang', 'initials': 'Y', 'affiliation': 'Henan University School of Medicine, Kaifeng, China.'}]",,,,"© 2017 John Wiley & Sons Australia, Ltd.",10.1111/1440-1681.12769,<Element 'PubmedArticle' at 0x7f05daff6130>
398,"28407740
23454862
23495833
22982535
18940959
25175868
26793073
20662807
22823548
23550806
17347308
21376806
25175862
19912768
11085885
15956767
24078884
18220778
24352739
27277867
28959464
18562281
23813365
15567326
9630473
27478307
25623413
19320628
27246804
23470532
10816638
18338799
25105291
24200890
10844131
23050949
24618600
6271786
23252647
22710659
15530839
25954735
22428664
23461397
23912236
21864608
22886465
19036960",Mu-opioid receptor and delta-opioid receptor differentially regulate microglial inflammatory response to control proopiomelanocortin neuronal apoptosis in the hypothalamus: effects of neonatal alcohol.,"Opioid receptors are known to control neurotransmission of various peptidergic neurons, but their potential role in regulation of microglia and neuronal cell communications is unknown. We investigated the role of mu-opioid receptors (MOR) and delta-opioid receptors (DOR) on microglia in the regulation of apoptosis in proopiomelanocortin (POMC) neurons induced by neonatal ethanol in the hypothalamus.
Neonatal rat pups were fed a milk formula containing ethanol or control diets between postnatal days 2-6. Some of the alcohol-fed rats additionally received pretreatment of a microglia activation blocker minocycline. Two hours after the last feeding, some of the pups were sacrificed and processed for histochemical detection of microglial cell functions or confocal microscopy for detection of cellular physical interaction or used for gene and protein expression analysis. The rest of the pups were dissected for microglia separation by differential gradient centrifugation and characterization by measuring production of various activation markers and cytokines. In addition, primary cultures of microglial cells were prepared using hypothalamic tissues of neonatal rats and used for determination of cytokine production/secretion and apoptotic activity of neurons.
In the hypothalamus, neonatal alcohol feeding elevated cytokine receptor levels, increased the number of microglial cells with amoeboid-type circularity, enhanced POMC and microglial cell physical interaction, and decreased POMC cell numbers. Minocycline reversed these cellular effects of alcohol. Alcohol feeding also increased levels of microglia MOR protein and pro-inflammatory signaling molecules in the hypothalamus, and MOR receptor antagonist naltrexone prevented these effects of alcohol. In primary cultures of hypothalamic microglia, both MOR agonist [D-Ala 2, N-MePhe 4, Gly-ol]-enkephalin (DAMGO) and ethanol increased microglial cellular levels and secretion of pro-inflammatory cell signaling proteins. However, a DOR agonist [D-Pen2,5]enkephalin (DPDPE) increased microglial secretion of anti-inflammatory cytokines and suppressed ethanol's ability to increase microglial production of inflammatory signaling proteins and secretion of pro-inflammatory cytokines. In addition, MOR-activated inflammation promoted while DOR-suppressed inflammation inhibited the apoptotic effect of ethanol on POMC neurons.
These results suggest that ethanol's neurotoxic action on POMC neurons results from MOR-activated neuroinflammatory signaling. Additionally, these results identify a protective effect of a DOR agonist against the pro-inflammatory and neurotoxic action of ethanol.","['DOR', 'Fetal alcohol', 'Inflammatory and anti-inflammatory cytokines', 'MOR', 'Microglia', 'POMC']",Journal of neuroinflammation,2017-04-15,"[{'lastname': 'Shrivastava', 'firstname': 'Pallavi', 'initials': 'P', 'affiliation': 'The Endocrine Program, Department of Animal Sciences, Rutgers, The State University of New Jersey, 67 Poultry Lane, New Brunswick, NJ, 08901, USA.'}, {'lastname': 'Cabrera', 'firstname': 'Miguel A', 'initials': 'MA', 'affiliation': 'The Endocrine Program, Department of Animal Sciences, Rutgers, The State University of New Jersey, 67 Poultry Lane, New Brunswick, NJ, 08901, USA.'}, {'lastname': 'Chastain', 'firstname': 'Lucy G', 'initials': 'LG', 'affiliation': 'The Endocrine Program, Department of Animal Sciences, Rutgers, The State University of New Jersey, 67 Poultry Lane, New Brunswick, NJ, 08901, USA.'}, {'lastname': 'Boyadjieva', 'firstname': 'Nadka I', 'initials': 'NI', 'affiliation': 'The Endocrine Program, Department of Animal Sciences, Rutgers, The State University of New Jersey, 67 Poultry Lane, New Brunswick, NJ, 08901, USA.'}, {'lastname': 'Jabbar', 'firstname': 'Shaima', 'initials': 'S', 'affiliation': 'The Endocrine Program, Department of Animal Sciences, Rutgers, The State University of New Jersey, 67 Poultry Lane, New Brunswick, NJ, 08901, USA.'}, {'lastname': 'Franklin', 'firstname': 'Tina', 'initials': 'T', 'affiliation': 'The Endocrine Program, Department of Animal Sciences, Rutgers, The State University of New Jersey, 67 Poultry Lane, New Brunswick, NJ, 08901, USA.'}, {'lastname': 'Sarkar', 'firstname': 'Dipak K', 'initials': 'DK', 'affiliation': 'The Endocrine Program, Department of Animal Sciences, Rutgers, The State University of New Jersey, 67 Poultry Lane, New Brunswick, NJ, 08901, USA. sarkar@aesop.rutgers.edu.'}]",,,"In the hypothalamus, neonatal alcohol feeding elevated cytokine receptor levels, increased the number of microglial cells with amoeboid-type circularity, enhanced POMC and microglial cell physical interaction, and decreased POMC cell numbers. Minocycline reversed these cellular effects of alcohol. Alcohol feeding also increased levels of microglia MOR protein and pro-inflammatory signaling molecules in the hypothalamus, and MOR receptor antagonist naltrexone prevented these effects of alcohol. In primary cultures of hypothalamic microglia, both MOR agonist [D-Ala 2, N-MePhe 4, Gly-ol]-enkephalin (DAMGO) and ethanol increased microglial cellular levels and secretion of pro-inflammatory cell signaling proteins. However, a DOR agonist [D-Pen2,5]enkephalin (DPDPE) increased microglial secretion of anti-inflammatory cytokines and suppressed ethanol's ability to increase microglial production of inflammatory signaling proteins and secretion of pro-inflammatory cytokines. In addition, MOR-activated inflammation promoted while DOR-suppressed inflammation inhibited the apoptotic effect of ethanol on POMC neurons.",,"10.1186/s12974-017-0844-3
10.1016/j.bbi.2013.02.005
10.1021/pr301038f
10.1016/j.yfrne.2012.08.006
10.1093/alcalc/agn079
10.1016/B978-0-12-801284-0.00010-5
10.3389/fnint.2015.00065
10.1111/j.1530-0277.2010.01271.x
10.1210/en.2006-1606
10.1016/j.bbi.2011.02.016
10.1016/B978-0-12-801284-0.00004-X
10.1016/1044-7431(90)90022-V
10.1006/mcne.2000.0890
10.1177/15353702-0323006-05
10.1155/2013/456857
10.2174/187152707783399193
10.1098/rsob.130181
10.1038/nrn.2016.69
10.1136/svn-2016-000012
10.1073/pnas.0800289105
10.1007/978-1-62703-520-0_3
10.1016/j.molmed.2004.10.006
10.1016/S0169-328X(98)00040-0
10.1111/acer.12611
10.1111/j.1530-0277.2009.00911.x
10.1002/glia.23007
10.1038/cddis.2013.54
10.1111/j.1749-6632.1999.tb08662.x
10.1002/jnr.21653
10.1371/journal.pone.0104420
10.1016/j.resuscitation.2013.10.022
10.1016/S0014-2999(00)00222-3
10.1111/j.1530-0277.2012.01951.x
10.1371/journal.pone.0090380
10.1111/nan.12011
10.1007/s00005-012-0181-2
10.1016/j.it.2004.09.015
10.3389/fped.2015.00027
10.1111/j.1476-5381.2012.01948.x
10.1111/adb.12040
10.3390/ijms140815959
10.1016/j.neuint.2011.08.005
10.1007/s00429-012-0446-x
10.1523/JNEUROSCI.4569-08.2008",<Element 'PubmedArticle' at 0x7f05db002d10>
399,28385651,Intranasal telmisartan ameliorates brain pathology in five familial Alzheimer's disease mice.,"The renin-angiotensin system (RAS) is a major circulative system engaged in homeostasis modulation. Angiotensin II (Ang II) serves as its main effector hormone upon binding to its primary receptor, Ang II receptor type 1 (AT","['Alzheimer’s disease', 'Angiotensin II', 'Glial inflammation', 'Microglia', 'Telmisartan']","Brain, behavior, and immunity",2017-04-08,"[{'lastname': 'Torika', 'firstname': 'Nofar', 'initials': 'N', 'affiliation': 'Department of Clinical Biochemistry and Pharmacology, Ben-Gurion University of the Negev, Beer-Sheva P.O.B 653, Israel.'}, {'lastname': 'Asraf', 'firstname': 'Keren', 'initials': 'K', 'affiliation': 'Department of Clinical Biochemistry and Pharmacology, Ben-Gurion University of the Negev, Beer-Sheva P.O.B 653, Israel.'}, {'lastname': 'Cohen', 'firstname': 'Hagit', 'initials': 'H', 'affiliation': 'Anxiety and Stress Research Unit, Beer-Sheva Mental Health Center, Ministry of Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel; Department of Psychology, Ben-Gurion University of the Negev, Beer-Sheva, Israel.'}, {'lastname': 'Fleisher-Berkovich', 'firstname': 'Sigal', 'initials': 'S', 'affiliation': 'Department of Clinical Biochemistry and Pharmacology, Ben-Gurion University of the Negev, Beer-Sheva P.O.B 653, Israel. Electronic address: fleisher@bgu.ac.il.'}]",,,,Copyright © 2017 Elsevier Inc. All rights reserved.,10.1016/j.bbi.2017.04.001,<Element 'PubmedArticle' at 0x7f05dafa9a40>
400,"28382978
15148141
21913970
24931033
24443714
22820012
24881967
15750215
15288712
16936707
15964100
21911655
26298663
25744568
24918340
24910612
19458242
23150171
23996345
17448147
24142524
26635213
18448228
16262633
10191253
1325671
11754997
17262990
10403017
12399581
26268336
22476197
22205300
26401706
26879001
21533606
16412093
18077675
17241267
27076423
25792098
20552234
12612547
22315714
25663025
20107219
17123555
16627931
23554921
24069173
27457264
19930651
10588583
10588584
19777393
25088942
19815707
22337827
15262337","Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer's rat model.","Recent evidence reveals that aberrant brain insulin signaling plays an important role in the pathology of Alzheimer's disease (AD). Intranasal insulin administration has been reported to improve memory and attention in healthy participants and in AD patients. However, the underlying molecular mechanisms are poorly understood. Here, we treated intracerebroventricular streptozotocin-injected (ICV-STZ) rats, a commonly used animal model of sporadic AD, with daily intranasal delivery of insulin (2 U/day) for 6 consecutive weeks and then studied their cognitive function with the Morris water maze test and biochemical changes via Western blotting. We observed cognitive deficits, tau hyperphosphorylation, and neuroinflammation in the brains of ICV-STZ rats. Intranasal insulin treatment for 6 weeks significantly improved cognitive function, attenuated the level of tau hyperphosphorylation, ameliorated microglial activation, and enhanced neurogenesis in ICV-STZ rats. Additionally, our results indicate that intranasal delivery of insulin probably attenuates tau hyperphosphorylation through the down-regulation of ERK1/2 and CaMKII in the brains of ICV-STZ rats. Our findings demonstrate a beneficial effect of intranasal insulin and provide the mechanistic basis for treating AD patients with intranasal insulin.",[],Scientific reports,2017-04-07,"[{'lastname': 'Guo', 'firstname': 'Zhangyu', 'initials': 'Z', 'affiliation': 'Department of Neurology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China.'}, {'lastname': 'Chen', 'firstname': 'Yanxing', 'initials': 'Y', 'affiliation': 'Department of Neurology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China.'}, {'lastname': 'Mao', 'firstname': 'Yan-Fang', 'initials': 'YF', 'affiliation': 'Department of Neurology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China.'}, {'lastname': 'Zheng', 'firstname': 'Tingting', 'initials': 'T', 'affiliation': 'Department of Neurology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China.'}, {'lastname': 'Jiang', 'firstname': 'Yasi', 'initials': 'Y', 'affiliation': 'Department of Neurology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China.'}, {'lastname': 'Yan', 'firstname': 'Yaping', 'initials': 'Y', 'affiliation': 'Department of Neurology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China.'}, {'lastname': 'Yin', 'firstname': 'Xinzhen', 'initials': 'X', 'affiliation': 'Department of Neurology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China.'}, {'lastname': 'Zhang', 'firstname': 'Baorong', 'initials': 'B', 'affiliation': 'Department of Neurology, the Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China.'}]",,,,,10.1038/srep45971,<Element 'PubmedArticle' at 0x7f05dafb5c70>
401,28359740,Bilateral tactile hypersensitivity and neuroimmune responses after spared nerve injury in mice lacking vasoactive intestinal peptide.,"Vasoactive intestinal peptide (VIP) is one of the neuropeptides showing the strongest up-regulation in the nociceptive pathway after peripheral nerve injury and has been proposed to support neuropathic pain. Nevertheless, the story may be more complicated considering the known suppressive effects of the peptide on the immune reactivity of microglial cells, which have been heavily implicated in the onset and maintenance of pain after nerve injury. We here used mice deficient in VIP and the model of spared nerve injury, characterized by persistent tactile hypersensitivity. While tactile hypersensitivity developed similarly to wild type mice for the ipsilateral hindpaw, only transgenic mice showed a mirror-image tactile hypersensitivity in the contralateral hindpaw. This exacerbated neuropathic pain phenotype appeared to be mediated through a local mechanism acting at the level of the lumbar spinal cord as a distant nerve lesion in the front limb did not lead to hindpaw hypersensitivity in VIP-deficient mice. Innocuous tactile hindpaw stimulation was found to increase a neuronal activation marker in the bilateral superficial laminae of the lumbar dorsal horn of VIP-deficient, but not wild type mice, after SNI. A deeper study into the immune responsiveness to the nerve lesion also proved that VIP-deficient mice had a stronger early pro-inflammatory cytokine response and a more pronounced microglial reactivity compared to wild type controls. The latter was also observed at four weeks after spared nerve injury, a time at which bilateral tactile hypersensitivity persisted in VIP-deficient mice. These data suggest an action of VIP in neuropathic states that is more complicated than previously assumed. Future research is now needed for a deeper understanding of the relative contribution of receptors and fiber populations involved in the VIP-neuropathic pain link.","['Astrocytes', 'Central sensitization', 'Chronic pain', 'Cytokines', 'Microglia', 'Mirror-image pain', 'Neuropathic pain']",Experimental neurology,2017-04-01,"[{'lastname': 'Gallo', 'firstname': 'Alessandro', 'initials': 'A', 'affiliation': 'Institute of Neuroscience, Université catholique de Louvain, Av. Hippocrate 54, Brussels, Belgium.'}, {'lastname': 'Leerink', 'firstname': 'Marjolein', 'initials': 'M', 'affiliation': 'Institute of Neuroscience, Université catholique de Louvain, Av. Hippocrate 54, Brussels, Belgium.'}, {'lastname': 'Michot', 'firstname': 'Benoît', 'initials': 'B', 'affiliation': 'Institute of Neuroscience, Université catholique de Louvain, Av. Hippocrate 54, Brussels, Belgium.'}, {'lastname': 'Ahmed', 'firstname': 'Eman', 'initials': 'E', 'affiliation': 'Institute of Neuroscience, Université catholique de Louvain, Av. Hippocrate 54, Brussels, Belgium.'}, {'lastname': 'Forget', 'firstname': 'Patrice', 'initials': 'P', 'affiliation': 'Institute of Neuroscience, Université catholique de Louvain, Av. Hippocrate 54, Brussels, Belgium.'}, {'lastname': 'Mouraux', 'firstname': 'André', 'initials': 'A', 'affiliation': 'Institute of Neuroscience, Université catholique de Louvain, Av. Hippocrate 54, Brussels, Belgium.'}, {'lastname': 'Hermans', 'firstname': 'Emmanuel', 'initials': 'E', 'affiliation': 'Institute of Neuroscience, Université catholique de Louvain, Av. Hippocrate 54, Brussels, Belgium.'}, {'lastname': 'Deumens', 'firstname': 'Ronald', 'initials': 'R', 'affiliation': 'Institute of Neuroscience, Université catholique de Louvain, Av. Hippocrate 54, Brussels, Belgium. Electronic address: ronald.deumens@uclouvain.be.'}]",,,,Copyright © 2017. Published by Elsevier Inc.,10.1016/j.expneurol.2017.03.019,<Element 'PubmedArticle' at 0x7f05dafde310>
402,28342971,A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model.,"Alzheimer's disease (AD) is a progressive neurodegenerative disorder, accompanied by memory loss and cognitive impairments, and there is no effective treatment for it at present. Since type 2 diabetes (T2DM) has been identified as a risk factor for AD, the incretins glucagon-like peptide 1 (GLP-1) and glucose dependent insulinotropic polypeptide (GIP), promising antidiabetic agents for the treatment of type 2 diabetes, have been tested in models of neurodegenerative disease including AD and achieved good results. Here we show for the first time the potential neuroprotective effect of a novel dual GLP-1/GIP receptor agonist (DA-JC4) in the icv. streptozotocin (STZ)-induced AD rat model. Treatment with DA-JC4 (10nmol/kg ip.) once-daily for 14days after STZ intracerebroventricular (ICV) administration significantly prevented spatial learning deficits in a Y- maze test and Morris water maze tests, and decreased phosphorylated tau levels in the rat cerebral cortex and hippocampus. DA-JC4 also alleviated the chronic inflammation response in the brain (GFAP-positive astrocytes, IBA1-positive microglia). Apoptosis was reduced as shown in the reduced ratio of pro-apoptotic BAX to anti- apoptotic Bcl-2 levels. Importantly, insulin signaling was re-sensitized as evidenced by a reduction of phospho-IRS1","['Alzheimer’s disease', 'Apoptosis', 'Incretin', 'Inflammation', 'Insulin signaling', 'Tau phosphorylation', 'Type 2 diabetes mellitus']",Behavioural brain research,2017-03-28,"[{'lastname': 'Shi', 'firstname': 'Lijuan', 'initials': 'L', 'affiliation': 'Key Laboratory of Cellular Physiology, Shanxi Medical University, Taiyuan, Shanxi, PR China.'}, {'lastname': 'Zhang', 'firstname': 'Zhihua', 'initials': 'Z', 'affiliation': 'Key Laboratory of Cellular Physiology, Shanxi Medical University, Taiyuan, Shanxi, PR China.'}, {'lastname': 'Li', 'firstname': 'Lin', 'initials': 'L', 'affiliation': 'Key Laboratory of Cellular Physiology, Shanxi Medical University, Taiyuan, Shanxi, PR China. Electronic address: linlilin999@163.com.'}, {'lastname': 'Hölscher', 'firstname': 'Christian', 'initials': 'C', 'affiliation': 'Biomedical and Life Science, Faculty of Health and Medicine, Lancaster University, Lancaster LA1 4YQ, UK; Neurology Department, The Second Affiliated Hospital of Shanxi Medical University, Taiyuan, Shanxi, PR China.'}]",,,,Copyright © 2017 Elsevier B.V. All rights reserved.,10.1016/j.bbr.2017.03.032,<Element 'PubmedArticle' at 0x7f05daf302c0>
403,"28341582
23296992
10567732
2262596
14988386
15156148
25425146
21208470
24646669
21800138
23977213
23686747
23467340
8986873
9825958
26576723
26790970
20966214
26043079
23447624
19302484
10867819
23756184
21068160
21059913
23836548
23407936
20962261
18601700
23086334
27199256
24838858
26470014
25821913
26464992
25142016
6714163
19590530
22632727
22182318
21911834
24501362
11412902
25130376
22581365
23525041
23747829
18685038
25728668
7349961
18333959
25186741
23818057",Sex differences in microglial phagocytosis in the neonatal hippocampus.,"Microglia regulate brain development through many processes, such as promoting neurogenesis, supporting cell survival, and phagocytizing progenitor, newly-born, and dying cells. Many of these same developmental processes show robust sex differences, yet very few studies have assessed sex differences in microglia function during development. Hormonally-induced sexual differentiation of the brain occurs during the perinatal period, thus we examined sex differences in microglial morphology, phagocytosis, and proliferation in the hippocampus during the early postnatal period. We found that the neonatal female hippocampus had significantly more microglia with phagocytic cups than the male hippocampus. We subsequently found that female microglia phagocytized more neural progenitor cells and healthy cells compared to males, but there were no sex differences in the number of newly-born or dying cells targeted by microglial phagocytosis. We found that the number of phagocytic microglia in females was reduced to male-typical levels by treatment with estradiol, the hormone responsible for masculinizing the rodent brain. Females also had higher expression of several phagocytic pathway genes in the hippocampus compared to males. In contrast to robust sex differences in phagocytic microglia, we found no sex differences in the number of microglia with amoeboid, transitioning, or ramified morphologies or differences in three-dimensional reconstructions of microglial morphology. While we did not find a baseline sex difference in microglial proliferation during or following the prenatal gonadal hormone surge in males, we found that estradiol treatment increased microglia proliferation in females. Overall, these data show that there are important sex differences in microglia function in the hippocampus during the early neonatal period.","['Development', 'Microglia', 'Phagocytosis', 'Sex differences']","Brain, behavior, and immunity",2017-03-28,"[{'lastname': 'Nelson', 'firstname': 'Lars H', 'initials': 'LH', 'affiliation': 'Department of Neuroscience, The Ohio State University, 333 W. 10th Ave., Columbus, OH 43210, USA; Group in Behavioral Neuroendocrinology, The Ohio State University, Columbus OH, USA. Electronic address: nelson.1246@osu.edu.'}, {'lastname': 'Warden', 'firstname': 'Spencer', 'initials': 'S', 'affiliation': 'Department of Psychology, The Ohio State University, 1835 Neil Ave, Columbus, OH 43210, USA; Group in Behavioral Neuroendocrinology, The Ohio State University, Columbus OH, USA.'}, {'lastname': 'Lenz', 'firstname': 'Kathryn M', 'initials': 'KM', 'affiliation': 'Department of Neuroscience, The Ohio State University, 333 W. 10th Ave., Columbus, OH 43210, USA; Department of Psychology, The Ohio State University, 1835 Neil Ave, Columbus, OH 43210, USA; Group in Behavioral Neuroendocrinology, The Ohio State University, Columbus OH, USA. Electronic address: lenz.56@osu.edu.'}]",,,,Copyright © 2017 Elsevier Inc. All rights reserved.,"10.1016/j.bbi.2017.03.010
10.1002/cne.23298
10.1210/en.2003-1363
10.1038/ncomms6611
10.1007/s00251-011-0562-4
10.1371/journal.pone.0072083
10.1002/jnr.23242
10.1523/JNEUROSCI.3441-12.2013
10.1016/j.bbi.2015.11.009
10.1016/j.yfrne.2016.01.001
10.1126/science.1194637
10.1038/cddis.2015.151
10.1523/JNEUROSCI.4185-12.2013
10.1111/j.1471-4159.2009.06042.x
10.1007/s004410000199
10.1016/j.neuroscience.2013.05.061
10.1210/en.2010-0607
10.1073/pnas.1005003107
10.1002/glia.22540
10.1523/JNEUROSCI.1268-12.2013
10.4049/jimmunol.1001095
10.1111/j.1365-2826.2008.01723.x
10.1002/cne.24041
10.1002/glia.22693
10.1002/glia.22930
10.1038/nn.3988
10.1523/ENEURO.0036-15.2015
10.1002/glia.22744
10.1210/endo-114-5-1754
10.1016/j.neuron.2012.03.026
10.1111/j.1471-4159.2011.07630.x
10.1182/blood-2011-03-340281
10.1523/JNEUROSCI.1619-13.2014.
10.1002/glia.22740
10.1007/s00018-012-1015-4.
10.1038/nn.3358
10.1016/j.yhbeh.2013.05.009
10.1523/JNEUROSCI.1006-08.2008
10.1016/j.cell.2015.01.049
10.1210/endo-106-1-306
10.1111/j.1460-9568.2008.06073.x
10.1523/JNEUROSCI.1860-14.2014
10.1002/cne.23400",<Element 'PubmedArticle' at 0x7f05daf3eef0>
404,"28336953
21527731
19840548
26067058
25177273
26257642
20468046
19804829
19476641
16343349
7724569
11301536
23813098
24844438
20221904
18602217
23533304
23394524
16796380
9685157
11098711
15963531
26965148
16204639
16624951
19043829
19496827
14639155
8819477
16324856
19005077
22548457
22383251
23174891
22913292
26260027
26266053
25866824
18600578
19096368
25182477
18657182
19933834
24904283
24927796
4439865
22244572
26063967
27539936
392005
12379903
17982478
11175805
25914169
12944505
12598628
15652407
10779390
10617657
21350020
11485574
20629190
24272707
23242999
17704823
21749725",Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: involvement of the CB2 receptor.,"The endogenous fatty acid amide palmitoylethanolamide (PEA) has been shown to exert anti-inflammatory actions mainly through inhibition of the release of pro-inflammatory molecules from mast cells, monocytes and macrophages. Indirect activation of the endocannabinoid (eCB) system is among the several mechanisms of action that have been proposed to underlie the different effects of PEA in vivo. In this study, we used cultured rat microglia and human macrophages to evaluate whether PEA affects eCB signaling. PEA was found to increase CB2 mRNA and protein expression through peroxisome proliferator-activated receptor-α (PPAR-α) activation. This novel gene regulation mechanism was demonstrated through: (i) pharmacological PPAR-α manipulation, (ii) PPAR-α mRNA silencing, (iii) chromatin immunoprecipitation. Moreover, exposure to PEA induced morphological changes associated with a reactive microglial phenotype, including increased phagocytosis and migratory activity. Our findings suggest indirect regulation of microglial CB2R expression as a new possible mechanism underlying the effects of PEA. PEA can be explored as a useful tool for preventing/treating the symptoms associated with neuroinflammation in CNS disorders.",[],Scientific reports,2017-03-25,"[{'lastname': 'Guida', 'firstname': 'F', 'initials': 'F', 'affiliation': 'Department of Experimental Medicine, Section of Pharmacology L. Donatelli, Università degli Studi della Campania ""Luigi Vanvitelli"" (Ex SUN), 80138, Naples, Italy.\nEndocannabinoid Research Group, Institute of Biomolecular Chemistry, C.N.R., Pozzuoli, Italy.'}, {'lastname': 'Luongo', 'firstname': 'L', 'initials': 'L', 'affiliation': 'Department of Experimental Medicine, Section of Pharmacology L. Donatelli, Università degli Studi della Campania ""Luigi Vanvitelli"" (Ex SUN), 80138, Naples, Italy.\nEndocannabinoid Research Group, Institute of Biomolecular Chemistry, C.N.R., Pozzuoli, Italy.'}, {'lastname': 'Boccella', 'firstname': 'S', 'initials': 'S', 'affiliation': 'Department of Experimental Medicine, Section of Pharmacology L. Donatelli, Università degli Studi della Campania ""Luigi Vanvitelli"" (Ex SUN), 80138, Naples, Italy.'}, {'lastname': 'Giordano', 'firstname': 'M E', 'initials': 'ME', 'affiliation': 'Department of Experimental Medicine, Section of Pharmacology L. Donatelli, Università degli Studi della Campania ""Luigi Vanvitelli"" (Ex SUN), 80138, Naples, Italy.'}, {'lastname': 'Romano', 'firstname': 'R', 'initials': 'R', 'affiliation': 'Department of Experimental Medicine, Section of Pharmacology L. Donatelli, Università degli Studi della Campania ""Luigi Vanvitelli"" (Ex SUN), 80138, Naples, Italy.'}, {'lastname': 'Bellini', 'firstname': 'G', 'initials': 'G', 'affiliation': 'Department of Women, Child and General and Specialistic Surgery, Università degli Studi della Campania ""Luigi Vanvitelli"" (Ex SUN), 80138, Naples, Italy.'}, {'lastname': 'Manzo', 'firstname': 'I', 'initials': 'I', 'affiliation': 'Department of Women, Child and General and Specialistic Surgery, Università degli Studi della Campania ""Luigi Vanvitelli"" (Ex SUN), 80138, Naples, Italy.'}, {'lastname': 'Furiano', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Department of Experimental Medicine, Section of Pharmacology L. Donatelli, Università degli Studi della Campania ""Luigi Vanvitelli"" (Ex SUN), 80138, Naples, Italy.'}, {'lastname': 'Rizzo', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Department of Experimental Medicine, Section of Microbiology and Clinical Microbiology, Università degli Studi della Campania ""Luigi Vanvitelli"" (Ex SUN), 80138, Naples, Italy.'}, {'lastname': 'Imperatore', 'firstname': 'R', 'initials': 'R', 'affiliation': 'Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche, Pozzuoli, Italy.\nDepartment of Science and Technology, University of Sannio, Benevento, Italy.'}, {'lastname': 'Iannotti', 'firstname': 'F A', 'initials': 'FA', 'affiliation': 'Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche, Pozzuoli, Italy.\nEndocannabinoid Research Group, Institute of Biomolecular Chemistry, C.N.R., Pozzuoli, Italy.'}, {'lastname': ""D'Aniello"", 'firstname': 'E', 'initials': 'E', 'affiliation': 'Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche, Pozzuoli, Italy.\nEndocannabinoid Research Group, Institute of Biomolecular Chemistry, C.N.R., Pozzuoli, Italy.'}, {'lastname': 'Piscitelli', 'firstname': 'F', 'initials': 'F', 'affiliation': 'Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche, Pozzuoli, Italy.\nEndocannabinoid Research Group, Institute of Biomolecular Chemistry, C.N.R., Pozzuoli, Italy.'}, {'lastname': 'Sca Rossi', 'firstname': 'F', 'initials': 'F', 'affiliation': 'Department of Women, Child and General and Specialistic Surgery, Università degli Studi della Campania ""Luigi Vanvitelli"" (Ex SUN), 80138, Naples, Italy.'}, {'lastname': 'Cristino', 'firstname': 'L', 'initials': 'L', 'affiliation': 'Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche, Pozzuoli, Italy.\nEndocannabinoid Research Group, Institute of Biomolecular Chemistry, C.N.R., Pozzuoli, Italy.'}, {'lastname': 'Di Marzo', 'firstname': 'V', 'initials': 'V', 'affiliation': 'Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche, Pozzuoli, Italy.\nEndocannabinoid Research Group, Institute of Biomolecular Chemistry, C.N.R., Pozzuoli, Italy.'}, {'lastname': 'de Novellis', 'firstname': 'V', 'initials': 'V', 'affiliation': 'Department of Experimental Medicine, Section of Pharmacology L. Donatelli, Università degli Studi della Campania ""Luigi Vanvitelli"" (Ex SUN), 80138, Naples, Italy.\nEndocannabinoid Research Group, Institute of Biomolecular Chemistry, C.N.R., Pozzuoli, Italy.'}, {'lastname': 'Maione', 'firstname': 'S', 'initials': 'S', 'affiliation': 'Department of Experimental Medicine, Section of Pharmacology L. Donatelli, Università degli Studi della Campania ""Luigi Vanvitelli"" (Ex SUN), 80138, Naples, Italy. sabatino.maione@unina2.it.\nEndocannabinoid Research Group, Institute of Biomolecular Chemistry, C.N.R., Pozzuoli, Italy. sabatino.maione@unina2.it.'}]",,,,,"10.1038/s41598-017-00342-1
10.1152/physrev.00011.2010
10.1016/j.neuron.2009.09.033
10.1016/j.pneurobio.2015.05.003
10.3389/fncel.2014.00240
10.1002/glia.20983
10.1016/j.nbd.2009.09.021
10.1186/1742-2094-2-29
10.1073/pnas.92.8.3376
10.1046/j.1365-3164.2001.00214.x
10.1007/s12035-013-8487-6
10.1016/j.phrs.2014.05.006
10.1007/s12640-010-9166-2
10.1016/j.pain.2008.06.003
10.2174/1871527311312010009
10.1208/aapsj080234
10.1038/28393
10.1016/S0079-6123(00)29034-1
10.1016/j.lfs.2005.05.012
10.1016/j.plipres.2016.02.002
10.1189/jlb.0405216
10.1038/nature07413
10.1111/j.1601-183X.2009.00498.x
10.1097/00000542-200312000-00024
10.1016/j.tvjl.2005.10.003
10.1523/JNEUROSCI.3400-08.2008
10.1021/jm3003334
10.1002/cmdc.201100573
10.3390/molecules171213712
10.1186/1744-8069-8-60
10.1186/s13041-015-0139-5
10.1155/2015/265967
10.1038/nrn2533
10.1038/ncomms5767
10.1111/j.1460-9568.2008.06377.x
10.1128/IAI.01110-09
10.3389/fncel.2014.00138
10.1186/1742-2094-11-108
10.1007/BF00560353
10.1016/j.jneuroim.2011.12.013
10.1002/glia.10150
10.1038/sj.bjp.0707523
10.1038/84224
10.1002/glia.22845
10.1016/j.jneuroim.2004.10.003
10.1074/jbc.275.1.605
10.1124/mol.111.071290
10.1042/bj3580249
10.1002/glia.21042
10.1002/glia.22592
10.1091/mbc.E11-12-1044
10.1038/sj.bjp.0707424
10.1186/1743-7075-8-51",<Element 'PubmedArticle' at 0x7f05daee8040>
405,28336086,"Incretin hormones regulate microglia oxidative stress, survival and expression of trophic factors.","The incretin hormones glucagon-like peptide (GLP)-1 and glucose-dependent insulinotropic polypeptide (GIP) are primarily known for their metabolic function in the periphery. GLP-1 and GIP are secreted by intestinal endocrine cells in response to ingested nutrients. Both GLP-1 and GIP stimulate the production and release of insulin from pancreatic β cells as well as exhibit several growth-regulating effects on peripheral tissues. GLP-1 and GIP are also present in the brain, where they provide modulatory and anti-apoptotic signals to neurons. However, very limited information is available regarding the effects of these hormones on glia, the immune and supporting cells of the brain. Therefore, we set out to resolve whether primary human microglia and astrocytes, two subtypes of glial cells, express the GLP-1 receptor (GLP-1R) and GIP receptor (GIPR), which are necessary to detect and respond to GLP-1 and GIP, respectively. We further tested whether these hormones, similar to their effects on neuronal cells, have growth-regulating, antioxidant and anti-apoptotic effects on microglia. We show for the first time expression of the GLP-1R and the GIPR by primary human microglia and astrocytes. We demonstrate that GLP-1 and GIP reduce apoptotic death of murine BV-2 microglia through the binding and activation of the GLP-1R and GIPR, respectively, with subsequent activation of the protein kinase A (PKA) pathway. Moreover, we reveal that incretins upregulate BV-2 microglia expression of brain derived neurotrophic factor (BDNF), glial cell-line derived neurotrophic factor (GDNF) and nerve growth factor (NGF) in a phosphoinositide 3-kinase (PI3K)- and PKA-dependent manner. We also show that incretins reduce oxidative stress in BV-2 microglia by inhibiting the accumulation of intracellular reactive oxygen species (ROS) and release of nitric oxide (NO), as well as by increasing the expression of the antioxidant glutathione peroxidase 1 (GPx1) and superoxide dismutase 1 (SOD1). We confirm these results by demonstrating that GLP-1 and GIP also inhibit apoptosis of primary murine microglia, and upregulate expression of BDNF by primary murine microglia. These results indicate that GLP-1 and GIP affect several critical homeostatic functions of microglia, and could therefore be tested as a novel therapeutic treatment option for brain disorders that are characterized by increased oxidative stress and microglial degeneration.","['Alzheimer’s disease', 'Apoptosis', 'Cell death', 'Incretins', 'Microglia degeneration', 'Parkinson’s disease']",European journal of cell biology,2017-03-25,"[{'lastname': 'Spielman', 'firstname': 'Lindsay Joy', 'initials': 'LJ', 'affiliation': 'Department of Biology, University of British Columbia Okanagan Campus, 3187 University Way, Kelowna, BC V1V 1V7, Canada. Electronic address: lindsayspielman@live.ca.'}, {'lastname': 'Gibson', 'firstname': 'Deanna Lynn', 'initials': 'DL', 'affiliation': 'Department of Biology, University of British Columbia Okanagan Campus, 3187 University Way, Kelowna, BC V1V 1V7, Canada. Electronic address: deanna.gibson@ubc.ca.'}, {'lastname': 'Klegeris', 'firstname': 'Andis', 'initials': 'A', 'affiliation': 'Department of Biology, University of British Columbia Okanagan Campus, 3187 University Way, Kelowna, BC V1V 1V7, Canada. Electronic address: andis.klegeris@ubc.ca.'}]",,,,Copyright © 2017 Elsevier GmbH. All rights reserved.,10.1016/j.ejcb.2017.03.004,<Element 'PubmedArticle' at 0x7f05daf1a1d0>
406,28330615,Differential Aging Analysis in Human Cerebral Cortex Identifies Variants in TMEM106B and GRN that Regulate Aging Phenotypes.,"Human age-associated traits, such as cognitive decline, can be highly variable across the population, with some individuals exhibiting traits that are not expected at a given chronological age. Here we present differential aging (Δ-aging), an unbiased method that quantifies individual variability in age-associated phenotypes within a tissue of interest, and apply this approach to the analysis of existing transcriptome-wide cerebral cortex gene expression data from several cohorts totaling 1,904 autopsied human brain samples. We subsequently performed a genome-wide association study and identified the TMEM106B and GRN gene loci, previously associated with frontotemporal dementia, as determinants of Δ-aging in the cerebral cortex with genome-wide significance. TMEM106B risk variants are associated with inflammation, neuronal loss, and cognitive deficits, even in the absence of known brain disease, and their impact is highly selective for the frontal cerebral cortex of older individuals (>65 years). The methodological framework we describe can be broadly applied to the analysis of quantitative traits associated with aging or with other parameters.","['TMEM106B', 'aging', 'brain', 'genome-wide association study', 'genomics', 'inflammaging', 'inflammation', 'microglia', 'progranulin']",Cell systems,2017-03-24,"[{'lastname': 'Rhinn', 'firstname': 'Herve', 'initials': 'H', 'affiliation': ""Departments of Pathology, Cell Biology, and Neurology, Columbia University, New York, NY 10032, USA; Taub Institute for Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY 10032, USA. Electronic address: hr2239@columbia.edu.""}, {'lastname': 'Abeliovich', 'firstname': 'Asa', 'initials': 'A', 'affiliation': ""Departments of Pathology, Cell Biology, and Neurology, Columbia University, New York, NY 10032, USA; Taub Institute for Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY 10032, USA. Electronic address: aa900@columbia.edu.""}]",,,,Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.,10.1016/j.cels.2017.02.009,<Element 'PubmedArticle' at 0x7f05daea7bd0>
407,"28298457
9024144
12075056
11773609
23023511
15769967
22581922
24560815
26510437
12364355
16246966
16230485
19805637
23248154
22184329
17875676
21875910
11161575
10621974
24646994
18467643
21528437
22753191
26184620
19225050
24843165
21415386
10884368
23383302
11834706
25143378
20645309
11804982
11349005
17363703
14757432
18481258
11738065",Distinct Regulatory Effects of Myeloid Cell and Endothelial Cell NAPDH Oxidase 2 on Blood Pressure.,"Hypertension caused by increased renin-angiotensin system activation is associated with elevated reactive oxygen species production. Previous studies implicate NADPH oxidase (Nox) proteins as important reactive oxygen species sources during renin-angiotensin system activation, with different Nox isoforms being potentially involved. Among these, Nox2 is expressed in multiple cell types, including endothelial cells, fibroblasts, immune cells, and microglia. Blood pressure (BP) is regulated at the central nervous system, renal, and vascular levels, but the cell-specific role of Nox2 in BP regulation is unknown.
We generated a novel mouse model with a floxed Nox2 gene and used Tie2-Cre, LysM Cre, or Cdh5-CreERT2 driver lines to develop cell-specific models of Nox2 perturbation to investigate its role in BP regulation.
Unexpectedly, Nox2 deletion in myeloid but not endothelial cells resulted in a significant reduction in basal BP. Both Tie2-CreNox2 knockout (KO) mice (in which Nox2 was deficient in both endothelial cells and myeloid cells) and LysM CreNox2KO mice (in which Nox2 was deficient in myeloid cells) had significantly lower BP than littermate controls, whereas basal BP was unaltered in Cdh5-CreERT2 Nox2KO mice (in which Nox2 is deficient only in endothelial cells). The lower BP was attributable to an increased NO bioavailability that dynamically dilated resistance vessels in vivo under basal conditions without a change in renal function. Myeloid-specific Nox2 deletion had no effect on angiotensin II-induced hypertension, which, however, was blunted in Tie2-CreNox2KO mice, along with preservation of endothelium-dependent relaxation during angiotensin II stimulation.
We identify a hitherto unrecognized modulation of basal BP by myeloid cell Nox2, whereas endothelial cell Nox2 regulates angiotensin II-induced hypertension. These results identify distinct cell-specific roles for Nox2 in BP regulation.","['NADPH oxidase', 'angiotensin II', 'blood pressure', 'mice']",Circulation,2017-03-17,"[{'lastname': 'Sag', 'firstname': 'Can Martin', 'initials': 'CM', 'affiliation': ""From King's College London British Heart Foundation Centre of Excellence, Cardiovascular Division, United Kingdom (C.M.S., M.S., J.Z., C.E.M., A.P., C.X.C.S., G.S., X.Z., H.M.-D., D.A.R., A.C.B., A.P., P.J.E., A.M.S.); Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg, Regensburg, Germany (C.M.S., L.S.M.); Department of Cardiology and Pneumology, Medical Center Goettingen, Germany (M.S.); and Center for Cardiology and Center for Thrombosis and Hemostasis, University Medical Center Mainz, Germany (S.K., P.W.).""}, {'lastname': 'Schnelle', 'firstname': 'Moritz', 'initials': 'M', 'affiliation': ""From King's College London British Heart Foundation Centre of Excellence, Cardiovascular Division, United Kingdom (C.M.S., M.S., J.Z., C.E.M., A.P., C.X.C.S., G.S., X.Z., H.M.-D., D.A.R., A.C.B., A.P., P.J.E., A.M.S.); Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg, Regensburg, Germany (C.M.S., L.S.M.); Department of Cardiology and Pneumology, Medical Center Goettingen, Germany (M.S.); and Center for Cardiology and Center for Thrombosis and Hemostasis, University Medical Center Mainz, Germany (S.K., P.W.).""}, {'lastname': 'Zhang', 'firstname': 'Juqian', 'initials': 'J', 'affiliation': ""From King's College London British Heart Foundation Centre of Excellence, Cardiovascular Division, United Kingdom (C.M.S., M.S., J.Z., C.E.M., A.P., C.X.C.S., G.S., X.Z., H.M.-D., D.A.R., A.C.B., A.P., P.J.E., A.M.S.); Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg, Regensburg, Germany (C.M.S., L.S.M.); Department of Cardiology and Pneumology, Medical Center Goettingen, Germany (M.S.); and Center for Cardiology and Center for Thrombosis and Hemostasis, University Medical Center Mainz, Germany (S.K., P.W.).""}, {'lastname': 'Murdoch', 'firstname': 'Colin E', 'initials': 'CE', 'affiliation': ""From King's College London British Heart Foundation Centre of Excellence, Cardiovascular Division, United Kingdom (C.M.S., M.S., J.Z., C.E.M., A.P., C.X.C.S., G.S., X.Z., H.M.-D., D.A.R., A.C.B., A.P., P.J.E., A.M.S.); Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg, Regensburg, Germany (C.M.S., L.S.M.); Department of Cardiology and Pneumology, Medical Center Goettingen, Germany (M.S.); and Center for Cardiology and Center for Thrombosis and Hemostasis, University Medical Center Mainz, Germany (S.K., P.W.).""}, {'lastname': 'Kossmann', 'firstname': 'Sabine', 'initials': 'S', 'affiliation': ""From King's College London British Heart Foundation Centre of Excellence, Cardiovascular Division, United Kingdom (C.M.S., M.S., J.Z., C.E.M., A.P., C.X.C.S., G.S., X.Z., H.M.-D., D.A.R., A.C.B., A.P., P.J.E., A.M.S.); Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg, Regensburg, Germany (C.M.S., L.S.M.); Department of Cardiology and Pneumology, Medical Center Goettingen, Germany (M.S.); and Center for Cardiology and Center for Thrombosis and Hemostasis, University Medical Center Mainz, Germany (S.K., P.W.).""}, {'lastname': 'Protti', 'firstname': 'Andrea', 'initials': 'A', 'affiliation': ""From King's College London British Heart Foundation Centre of Excellence, Cardiovascular Division, United Kingdom (C.M.S., M.S., J.Z., C.E.M., A.P., C.X.C.S., G.S., X.Z., H.M.-D., D.A.R., A.C.B., A.P., P.J.E., A.M.S.); Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg, Regensburg, Germany (C.M.S., L.S.M.); Department of Cardiology and Pneumology, Medical Center Goettingen, Germany (M.S.); and Center for Cardiology and Center for Thrombosis and Hemostasis, University Medical Center Mainz, Germany (S.K., P.W.).""}, {'lastname': 'Santos', 'firstname': 'Celio X C', 'initials': 'CXC', 'affiliation': ""From King's College London British Heart Foundation Centre of Excellence, Cardiovascular Division, United Kingdom (C.M.S., M.S., J.Z., C.E.M., A.P., C.X.C.S., G.S., X.Z., H.M.-D., D.A.R., A.C.B., A.P., P.J.E., A.M.S.); Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg, Regensburg, Germany (C.M.S., L.S.M.); Department of Cardiology and Pneumology, Medical Center Goettingen, Germany (M.S.); and Center for Cardiology and Center for Thrombosis and Hemostasis, University Medical Center Mainz, Germany (S.K., P.W.).""}, {'lastname': 'Sawyer', 'firstname': 'Greta', 'initials': 'G', 'affiliation': ""From King's College London British Heart Foundation Centre of Excellence, Cardiovascular Division, United Kingdom (C.M.S., M.S., J.Z., C.E.M., A.P., C.X.C.S., G.S., X.Z., H.M.-D., D.A.R., A.C.B., A.P., P.J.E., A.M.S.); Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg, Regensburg, Germany (C.M.S., L.S.M.); Department of Cardiology and Pneumology, Medical Center Goettingen, Germany (M.S.); and Center for Cardiology and Center for Thrombosis and Hemostasis, University Medical Center Mainz, Germany (S.K., P.W.).""}, {'lastname': 'Zhang', 'firstname': 'Xiaohong', 'initials': 'X', 'affiliation': ""From King's College London British Heart Foundation Centre of Excellence, Cardiovascular Division, United Kingdom (C.M.S., M.S., J.Z., C.E.M., A.P., C.X.C.S., G.S., X.Z., H.M.-D., D.A.R., A.C.B., A.P., P.J.E., A.M.S.); Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg, Regensburg, Germany (C.M.S., L.S.M.); Department of Cardiology and Pneumology, Medical Center Goettingen, Germany (M.S.); and Center for Cardiology and Center for Thrombosis and Hemostasis, University Medical Center Mainz, Germany (S.K., P.W.).""}, {'lastname': 'Mongue-Din', 'firstname': 'Heloise', 'initials': 'H', 'affiliation': ""From King's College London British Heart Foundation Centre of Excellence, Cardiovascular Division, United Kingdom (C.M.S., M.S., J.Z., C.E.M., A.P., C.X.C.S., G.S., X.Z., H.M.-D., D.A.R., A.C.B., A.P., P.J.E., A.M.S.); Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg, Regensburg, Germany (C.M.S., L.S.M.); Department of Cardiology and Pneumology, Medical Center Goettingen, Germany (M.S.); and Center for Cardiology and Center for Thrombosis and Hemostasis, University Medical Center Mainz, Germany (S.K., P.W.).""}, {'lastname': 'Richards', 'firstname': 'Daniel A', 'initials': 'DA', 'affiliation': ""From King's College London British Heart Foundation Centre of Excellence, Cardiovascular Division, United Kingdom (C.M.S., M.S., J.Z., C.E.M., A.P., C.X.C.S., G.S., X.Z., H.M.-D., D.A.R., A.C.B., A.P., P.J.E., A.M.S.); Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg, Regensburg, Germany (C.M.S., L.S.M.); Department of Cardiology and Pneumology, Medical Center Goettingen, Germany (M.S.); and Center for Cardiology and Center for Thrombosis and Hemostasis, University Medical Center Mainz, Germany (S.K., P.W.).""}, {'lastname': 'Brewer', 'firstname': 'Alison C', 'initials': 'AC', 'affiliation': ""From King's College London British Heart Foundation Centre of Excellence, Cardiovascular Division, United Kingdom (C.M.S., M.S., J.Z., C.E.M., A.P., C.X.C.S., G.S., X.Z., H.M.-D., D.A.R., A.C.B., A.P., P.J.E., A.M.S.); Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg, Regensburg, Germany (C.M.S., L.S.M.); Department of Cardiology and Pneumology, Medical Center Goettingen, Germany (M.S.); and Center for Cardiology and Center for Thrombosis and Hemostasis, University Medical Center Mainz, Germany (S.K., P.W.).""}, {'lastname': 'Prysyazhna', 'firstname': 'Oleksandra', 'initials': 'O', 'affiliation': ""From King's College London British Heart Foundation Centre of Excellence, Cardiovascular Division, United Kingdom (C.M.S., M.S., J.Z., C.E.M., A.P., C.X.C.S., G.S., X.Z., H.M.-D., D.A.R., A.C.B., A.P., P.J.E., A.M.S.); Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg, Regensburg, Germany (C.M.S., L.S.M.); Department of Cardiology and Pneumology, Medical Center Goettingen, Germany (M.S.); and Center for Cardiology and Center for Thrombosis and Hemostasis, University Medical Center Mainz, Germany (S.K., P.W.).""}, {'lastname': 'Maier', 'firstname': 'Lars S', 'initials': 'LS', 'affiliation': ""From King's College London British Heart Foundation Centre of Excellence, Cardiovascular Division, United Kingdom (C.M.S., M.S., J.Z., C.E.M., A.P., C.X.C.S., G.S., X.Z., H.M.-D., D.A.R., A.C.B., A.P., P.J.E., A.M.S.); Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg, Regensburg, Germany (C.M.S., L.S.M.); Department of Cardiology and Pneumology, Medical Center Goettingen, Germany (M.S.); and Center for Cardiology and Center for Thrombosis and Hemostasis, University Medical Center Mainz, Germany (S.K., P.W.).""}, {'lastname': 'Wenzel', 'firstname': 'Philip', 'initials': 'P', 'affiliation': ""From King's College London British Heart Foundation Centre of Excellence, Cardiovascular Division, United Kingdom (C.M.S., M.S., J.Z., C.E.M., A.P., C.X.C.S., G.S., X.Z., H.M.-D., D.A.R., A.C.B., A.P., P.J.E., A.M.S.); Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg, Regensburg, Germany (C.M.S., L.S.M.); Department of Cardiology and Pneumology, Medical Center Goettingen, Germany (M.S.); and Center for Cardiology and Center for Thrombosis and Hemostasis, University Medical Center Mainz, Germany (S.K., P.W.).""}, {'lastname': 'Eaton', 'firstname': 'Philip J', 'initials': 'PJ', 'affiliation': ""From King's College London British Heart Foundation Centre of Excellence, Cardiovascular Division, United Kingdom (C.M.S., M.S., J.Z., C.E.M., A.P., C.X.C.S., G.S., X.Z., H.M.-D., D.A.R., A.C.B., A.P., P.J.E., A.M.S.); Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg, Regensburg, Germany (C.M.S., L.S.M.); Department of Cardiology and Pneumology, Medical Center Goettingen, Germany (M.S.); and Center for Cardiology and Center for Thrombosis and Hemostasis, University Medical Center Mainz, Germany (S.K., P.W.).""}, {'lastname': 'Shah', 'firstname': 'Ajay M', 'initials': 'AM', 'affiliation': ""From King's College London British Heart Foundation Centre of Excellence, Cardiovascular Division, United Kingdom (C.M.S., M.S., J.Z., C.E.M., A.P., C.X.C.S., G.S., X.Z., H.M.-D., D.A.R., A.C.B., A.P., P.J.E., A.M.S.); Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg, Regensburg, Germany (C.M.S., L.S.M.); Department of Cardiology and Pneumology, Medical Center Goettingen, Germany (M.S.); and Center for Cardiology and Center for Thrombosis and Hemostasis, University Medical Center Mainz, Germany (S.K., P.W.). ajay.shah@kcl.ac.uk.""}]",,,"Unexpectedly, Nox2 deletion in myeloid but not endothelial cells resulted in a significant reduction in basal BP. Both Tie2-CreNox2 knockout (KO) mice (in which Nox2 was deficient in both endothelial cells and myeloid cells) and LysM CreNox2KO mice (in which Nox2 was deficient in myeloid cells) had significantly lower BP than littermate controls, whereas basal BP was unaltered in Cdh5-CreERT2 Nox2KO mice (in which Nox2 is deficient only in endothelial cells). The lower BP was attributable to an increased NO bioavailability that dynamically dilated resistance vessels in vivo under basal conditions without a change in renal function. Myeloid-specific Nox2 deletion had no effect on angiotensin II-induced hypertension, which, however, was blunted in Tie2-CreNox2KO mice, along with preservation of endothelium-dependent relaxation during angiotensin II stimulation.",© 2017 The Authors.,10.1161/CIRCULATIONAHA.116.023877,<Element 'PubmedArticle' at 0x7f05daeb3860>
408,"28288671
21796662
23328927
23078831
26226245
26678483
18579741
18296574
18177464
18520330
22367679
21622239
19428957
15693397
12416551
11483018
18942743
22159112
16492984
18371179
23280059
23510988
23486975
12706413
12139924
12629164
22190366
23431360
24498101
11264425
9751173
2817336
20223197
24162655
25635910
25957409
23124969
8201029
23585478
20633607
9763431
9398473
14662745
25429144
24719088
24122820
19188338
16246116
11082065
8838578
4212377
8586560
21639720
22422202
20406232
16787408
21791245
15770175
17784957
22621398",Microglia-derived IL-1β contributes to axon development disorders and synaptic deficit through p38-MAPK signal pathway in septic neonatal rats.,"Axon development plays a pivotal role in the formation of synapse, nodes of Ranvier, and myelin sheath. Interleukin-1β (IL-1β) produced by microglia may cause myelination disturbances through suppression of oligodendrocyte progenitor cell maturation in the septic neonatal rats. Here, we explored if a microglia-derived IL-1β would disturb axon development in the corpus callosum (CC) following lipopolysaccharide (LPS) administration, and if so, whether it is associated with disorder of synapse formation in the cerebral cortex and node of Ranvier.
Sprague-Dawley rats (1-day old) in the septic model group were intraperitoneally administrated with lipopolysaccharide (1 mg/kg) and then sacrificed for detection of IL-1β, interleukin-1 receptor (IL-1R
In 1-day old septic rats, IL-1β expression was increased in microglia coupled with upregulated expression of IL-1R
The present results suggest that microglia-derived IL-1β might suppress axon development through activation of p38-MAPK signaling pathway that would contribute to formation disorder of cortical synapses and node of Ranvier following LPS exposure.","['Axon', 'IL-1β', 'LPS', 'Microglia', 'Neurofilament', 'PWMD', 'Synapse']",Journal of neuroinflammation,2017-03-16,"[{'lastname': 'Han', 'firstname': 'Qianpeng', 'initials': 'Q', 'affiliation': ""Southern Medical University, Guangzhou, 510515, People's Republic of China.\nDepartment of Critical Care and Emergency, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China.\nDepartment of Critical Care Medicine, Yueyang First People's Hospital, Yueyang, 414000, People's Republic of China.""}, {'lastname': 'Lin', 'firstname': 'Qiongyu', 'initials': 'Q', 'affiliation': ""Southern Medical University, Guangzhou, 510515, People's Republic of China.\nDepartment of Critical Care and Emergency, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China.""}, {'lastname': 'Huang', 'firstname': 'Peixian', 'initials': 'P', 'affiliation': ""Department of Critical Care and Emergency, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China.\nShantou University Medical College, Shantou, Guangdong, 515063, People's Republic of China.""}, {'lastname': 'Chen', 'firstname': 'Mengmeng', 'initials': 'M', 'affiliation': ""Department of Critical Care and Emergency, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China.\nShantou University Medical College, Shantou, Guangdong, 515063, People's Republic of China.""}, {'lastname': 'Hu', 'firstname': 'Xin', 'initials': 'X', 'affiliation': ""Department of Anatomy, Basic medical school of Wuhan University, Wuhan, Hubei, 430071, People's Republic of China.""}, {'lastname': 'Fu', 'firstname': 'Hui', 'initials': 'H', 'affiliation': ""Department of Anatomy, Basic medical school of Wuhan University, Wuhan, Hubei, 430071, People's Republic of China.""}, {'lastname': 'He', 'firstname': 'Shaoru', 'initials': 'S', 'affiliation': ""Department of Neonatology, Guangzhou General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China.""}, {'lastname': 'Shen', 'firstname': 'Fengcai', 'initials': 'F', 'affiliation': ""Department of Critical Care and Emergency, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China.\nShantou University Medical College, Shantou, Guangdong, 515063, People's Republic of China.""}, {'lastname': 'Zeng', 'firstname': 'Hongke', 'initials': 'H', 'affiliation': ""Southern Medical University, Guangzhou, 510515, People's Republic of China. zenghongke@vip.163.com.\nDepartment of Critical Care and Emergency, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China. zenghongke@vip.163.com.""}, {'lastname': 'Deng', 'firstname': 'Yiyu', 'initials': 'Y', 'affiliation': ""Southern Medical University, Guangzhou, 510515, People's Republic of China. yiyudeng666@163.com.\nDepartment of Critical Care and Emergency, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China. yiyudeng666@163.com.""}]",,,"In 1-day old septic rats, IL-1β expression was increased in microglia coupled with upregulated expression of IL-1R",,"10.1186/s12974-017-0805-x
10.1002/ana.22489
10.1038/jp.2012.167
10.1016/j.earlhumdev.2012.09.011
10.1038/jp.2015.86
10.1002/glia.22950
10.1523/JNEUROSCI.1702-08.2008
10.1136/adc.2006.108837
10.1111/j.1750-3639.2007.00107.x
10.1203/PDR.0b013e31816c825c
10.1007/s11481-012-9347-2
10.2741/194
10.1016/j.pneurobio.2009.01.003
10.1053/j.semperi.2004.10.010
10.1046/j.1440-1789.2002.00438.x
10.1053/siny.2001.0043
10.1002/glia.20790
10.1523/JNEUROSCI.2250-11.2011
10.1203/01.pdr.0000199905.08848.55
10.1111/j.1750-3639.2008.00138.x
10.1016/j.ijdevneu.2012.12.005
10.1016/j.bbi.2013.03.003
10.1523/JNEUROSCI.4361-12.2013
10.1016/S0889-1591(02)00098-3
10.1006/mcne.2002.1127
10.1002/ana.22550
10.1371/journal.pone.0054722
10.1371/journal.pone.0087420
10.1203/00006450-200104000-00003
10.1046/j.1471-4159.1998.71041421.x
10.1016/0003-2697(89)90101-2
10.1016/j.neuron.2010.01.027
10.1038/nn.3560
10.1016/j.ceb.2015.01.003
10.1074/jbc.R115.640359
10.1002/cm.21087
10.1002/cne.903420202
10.1172/JCI66387
10.1016/j.neuroscience.2010.07.014
10.1083/jcb.143.1.195
10.1006/exnr.1997.6654
10.1083/jcb.200308159
10.1523/JNEUROSCI.3360-14.2014
10.1523/JNEUROSCI.4752-13.2014
10.1177/1073858413504627
10.1124/mol.108.052357
10.1042/BST0331350
10.1002/jnr.490430111
10.1161/01.STR.5.4.470
10.1089/neu.2010.1591
10.1055/s-0032-1306381
10.1111/j.1471-4159.2006.03964.x
10.1016/j.mcn.2011.07.003
10.1097/01.brs.0000155410.48700.9e
10.1186/1742-2094-4-21
10.1186/1471-2202-13-50",<Element 'PubmedArticle' at 0x7f05daed5e00>
409,"28284347
21804537
15256495
8926037
11160259
27049561
24009988
26246072
21413005
6256443
25505471
11823674
9682040
17620361
14993065
25002862
12511873
16027236
24607811
2145387
27771018
23986569
21108469
19620304
25484301
18802481
20813772
24601941
23872599
11520464
20097228
20163399
16428820
17261780
12606489
16253347
16676326
15161628
14507666
27459405
21145597
21565615
15771584
22209870
21091909
26527007
27107946
25303489
27196727
21971527
15130950
19302141
24743305
20468007
26198929
25776868",Novel feedback loop between M2 macrophages/microglia and regulatory B cells in estrogen-protected EAE mice.,"Immunoregulatory sex hormones, including estrogen and estriol, may prevent relapses in multiple sclerosis during pregnancy. Our previous studies have demonstrated that regulatory B cells are crucial for estrogen-mediated protection against experimental autoimmune encephalomyelitis (EAE). Herein, we demonstrate an estrogen-dependent induction of alternatively activated (M2) macrophages/microglia that results in an increased frequency of regulatory B cells in the spinal cord of estrogen treated mice with EAE. We further demonstrate that cultured M2-polarized microglia promote the induction of regulatory B cells. Our study suggests that estrogen neuroprotection induces a regulatory feedback loop between M2 macrophages/microglia and regulatory B cells.","['EAE', 'Estrogen', 'IL-10', 'M1/2 microglia', 'Regulatory B cells']",Journal of neuroimmunology,2017-03-13,"[{'lastname': 'Benedek', 'firstname': 'Gil', 'initials': 'G', 'affiliation': 'Neuroimmunology Research, VA Portland Health Care System, 3710 SW U.S. Veterans Hospital Rd., Portland, OR 97239, USA; Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, OR 97239, USA.'}, {'lastname': 'Zhang', 'firstname': 'Jun', 'initials': 'J', 'affiliation': 'Neuroimmunology Research, VA Portland Health Care System, 3710 SW U.S. Veterans Hospital Rd., Portland, OR 97239, USA; Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, OR 97239, USA.'}, {'lastname': 'Nguyen', 'firstname': 'Ha', 'initials': 'H', 'affiliation': 'Neuroimmunology Research, VA Portland Health Care System, 3710 SW U.S. Veterans Hospital Rd., Portland, OR 97239, USA; Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, OR 97239, USA.'}, {'lastname': 'Kent', 'firstname': 'Gail', 'initials': 'G', 'affiliation': 'Neuroimmunology Research, VA Portland Health Care System, 3710 SW U.S. Veterans Hospital Rd., Portland, OR 97239, USA; Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, OR 97239, USA.'}, {'lastname': 'Seifert', 'firstname': 'Hilary', 'initials': 'H', 'affiliation': 'Neuroimmunology Research, VA Portland Health Care System, 3710 SW U.S. Veterans Hospital Rd., Portland, OR 97239, USA; Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, OR 97239, USA.'}, {'lastname': 'Vandenbark', 'firstname': 'Arthur A', 'initials': 'AA', 'affiliation': 'Neuroimmunology Research, VA Portland Health Care System, 3710 SW U.S. Veterans Hospital Rd., Portland, OR 97239, USA; Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, OR 97239, USA; Department of Molecular Microbiology & Immunology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, OR, 97239, USA.'}, {'lastname': 'Offner', 'firstname': 'Halina', 'initials': 'H', 'affiliation': 'Neuroimmunology Research, VA Portland Health Care System, 3710 SW U.S. Veterans Hospital Rd., Portland, OR 97239, USA; Department of Neurology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, OR 97239, USA; Department of Anesthesiology and Perioperative Medicine, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, OR 97239, USA. Electronic address: offnerva@ohsu.edu.'}]",,,,Copyright © 2017 Elsevier B.V. All rights reserved.,10.1016/j.jneuroim.2016.12.018,<Element 'PubmedArticle' at 0x7f05dae8b900>
410,"28264445
25365584
16533711
21639405
27206527
20347861
22096317
22461212
23161396
27080886
19288574
18976694
25384233
21955647
16998908
24046281
16857839
24034304
22113864
24569543
18973749
24164197
23304223
19710188
24373791
20631292
23704808
19076434
16337092
24792340
8194655
27775647
27294954
22254019
18375789
26639457
17203472
22465818
27288923
7540822
20716914
11083861
25198009
22794138
22442308
16081203
22207656
11083274
2951017
17504139
18569457
24349638
2396565
20457564
22915113
25206809
23492769
18097445
22698587
25224590
22664464
26420421","Equol, a Dietary Daidzein Gut Metabolite Attenuates Microglial Activation and Potentiates Neuroprotection In Vitro.","Estrogen deficiency has been well characterized in inflammatory disorders including neuroinflammation. Daidzein, a dietary alternative phytoestrogen found in soy (Glycine max) as primary isoflavones, possess anti-inflammatory activity, but the effect of its active metabolite Equol (7-hydroxy-3-(4'-hydroxyphenyl)-chroman) has not been well established. In this study, we investigated the anti-neuroinflammatory and neuroprotective effect of Equol in vitro. To evaluate the potential effects of Equol, three major types of central nervous system (CNS) cells, including microglia (BV-2), astrocytes (C6), and neurons (N2a), were used. Effects of Equol on the expression of inducible nitric oxide synthase (iNOS), cyclooxygenase (COX-2), Mitogen activated protein kinase (MAPK) signaling proteins, and apoptosis-related proteins were measured by western blot analysis. Equol inhibited the lipopolysaccharide (LPS)-induced TLR4 activation, MAPK activation, NF-kB-mediated transcription of inflammatory mediators, production of nitric oxide (NO), release of prostaglandin E2 (PGE-2), secretion of tumor necrosis factor-α (TNF-α) and interleukin 6 (IL-6), in Lipopolysaccharide (LPS)-activated murine microglia cells. Additionally, Equol protects neurons from neuroinflammatory injury mediated by LPS-activated microglia through downregulation of neuronal apoptosis, increased neurite outgrowth in N2a cell and neurotrophins like nerve growth factor (NGF) production through astrocytes further supporting its neuroprotective potential. These findings provide novel insight into the anti-neuroinflammatory effects of Equol on microglial cells, which may have clinical significance in cases of neurodegeneration.","['Equol', '\xa0apoptosis', '\xa0neuroinflammation', '\xa0neuroprotection', '\xa0phytoestrogen']",Nutrients,2017-03-08,"[{'lastname': 'Subedi', 'firstname': 'Lalita', 'initials': 'L', 'affiliation': 'College of Pharmacy, Gachon University, #191, Hambakmoero, Yeonsu-gu, Incheon 21936, Korea. subedilali@gmail.com.'}, {'lastname': 'Ji', 'firstname': 'Eunhee', 'initials': 'E', 'affiliation': 'College of Pharmacy, Gachon University, #191, Hambakmoero, Yeonsu-gu, Incheon 21936, Korea. ehji@gachon.ac.kr.'}, {'lastname': 'Shin', 'firstname': 'Dongyun', 'initials': 'D', 'affiliation': 'College of Pharmacy, Gachon University, #191, Hambakmoero, Yeonsu-gu, Incheon 21936, Korea. dyshin@gachon.ac.kr.'}, {'lastname': 'Jin', 'firstname': 'Jongsik', 'initials': 'J', 'affiliation': 'Department Oriental Medicine Resources, College of Environmental & Bioresources Sciences, Chonbuk National University, Jeonju City 54896, Korea. jongsik.jin@jbnu.ac.kr.'}, {'lastname': 'Yeo', 'firstname': 'Joo Hong', 'initials': 'JH', 'affiliation': 'National Institute of Biological Resources, Environmental Research Complex, 42 Hwangyeong-ro, Seo-gu, Incheon 22689, Korea. naasyeo@korea.kr.'}, {'lastname': 'Kim', 'firstname': 'Sun Yeou', 'initials': 'SY', 'affiliation': 'College of Pharmacy, Gachon University, #191, Hambakmoero, Yeonsu-gu, Incheon 21936, Korea. sunnykim@gachon.ac.kr.\nGachon Medical Research Institute, Gil Medical Center, Inchon 21565, Korea. sunnykim@gachon.ac.kr.\nGachon Institute of Pharmaceutical Science, Gachon University;\xa0#191\xa0Hambakmoe-ro,\xa0Yeonsu-gu,\xa0\xa0 Incheon\xa021565,\xa0Korea. sunnykim@gachon.ac.kr.'}]",,,,,"10.3390/nu9030207
10.1080/10408398.2013.772091
10.1016/S1359-6446(05)03681-0
10.2165/11591310-000000000-00000
10.1186/s12864-016-2705-3
10.1016/j.yfrne.2010.03.003
10.4103/0973-7847.79098
10.1007/s13318-012-0112-y
10.1016/j.foodchem.2016.03.059
10.1002/cncr.24250
10.1016/j.neuroscience.2008.10.003
10.1089/jmf.2014.3150
10.3945/ajcn.111.019638
10.1002/bdrb.20086
10.1152/physiolgenomics.00096.2013
10.1186/1475-2891-12-127
10.3945/jn.111.148247
10.1038/ejcn.2014.23
10.1016/j.cbi.2008.09.031
10.2174/09298673113206660297
10.1155/2012/921684
10.3945/ajcn.2009.27981
10.1016/j.jsbmb.2013.12.010
10.1152/ajpregu.00031.2010
10.3164/jcbn.13-2
10.1196/annals.1427.023
10.1016/j.neuroscience.2005.07.060
10.1097/WCO.0000000000000091
10.1016/0028-2243(94)90213-5
10.3390/nu8100659
10.3390/nu8060361
10.3390/nu2030241
10.1124/jpet.108.136275
10.2174/1570159X14666151204122017
10.1002/glia.20467
10.1016/j.neuropharm.2012.03.016
10.1016/j.phymed.2016.05.002
10.1006/abbi.1995.1356
10.4161/oxim.2.5.9498
10.1074/jbc.M006406200
10.2174/1567202611666140908094517
10.1089/ars.2012.4581
10.1158/1535-7163.MCT-11-0960
10.1016/j.pneurobio.2005.06.004
10.1124/jpet.111.189035
10.1002/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K
10.1248/cpb.34.4425
10.2174/092986707780597961
10.1080/13550280802093927
10.1177/1947601913485414
10.1101/cshperspect.a001651
10.1523/JNEUROSCI.0730-12.2012
10.1038/cddis.2013.59
10.1038/nrm2308
10.1016/j.neulet.2012.06.013
10.1186/s12974-014-0162-y
10.3390/molecules17066728
10.1007/s11481-015-9631-z",<Element 'PubmedArticle' at 0x7f05dae2fc20>
411,"28233273
27496374
17098089
23684623
26831302
25380238
22933116
14715917
26924394
25815991
19357406
9044391
8319572
23332584
20018525
12615957
26132939
19545590
20570597
23553357
10794683
20503261
25777969
25202976
26212334
24762441
25202980
26254578
25887869
24917578
26049402
22938097
28057699
11861804
18492290
22150224
21312223
22443187
21525299
23973293
26916241
24166765
9449682
22236411
26179187
25018121
24703047
15331566
24323912
22446097
15277417
22735035
23999198
17317222
22000927
25071023
26284720
26786780
25249651
26607841
27466218
27049466
27015674
24105478
27436514
27939242
16517403
27345422
23433305
21430088
27496641
15181098
25573030
27880981
27639082
20225396
23462665
26331843
26094857
26851597
26385462
26116695
27489336
23728174
27282865
26283736
24529526",Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain-Adipocyte Axis.,"The complexity of neural circuits that control food intake and energy balance in the hypothalamic nuclei explains some of the constraints involved in the prevention and treatment of obesity. Two major neuronal populations present in the arcuate nucleus control caloric intake and energy expenditure: one population co-expresses orexigenic agouti-related peptide (AgRP) and neuropeptide Y and the other expresses the anorexigenic anorectic neuropeptides proopiomelanocortin and cocaine- and amphetamine-regulated transcript (POMC/CART). In addition to integrating signals from neurotransmitters and hormones, the hypothalamic systems that regulate energy homeostasis are affected by nutrients. Fat-rich diets, for instance, elicit hypothalamic inflammation (reactive activation and proliferation of microglia, a condition named gliosis). This process generates resistance to the anorexigenic hormones leptin and insulin, contributing to the genesis of obesity. Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs) have increasingly been used to treat type 2 diabetes mellitus. One compound (liraglutide) was recently approved for the treatment of obesity. Although most studies suggest that GLP-1RAs promote weight loss mainly due to their inhibitory effect on food intake, other central effects that have been described for native GLP-1 and some GLP-1RAs in rodents and humans encourage future clinical trials to explore additional mechanisms that potentially underlie the beneficial effects observed with this drug class. In this article we review the most relevant data exploring the mechanisms involved in the effects of GLP-1RAs in the brain-adipocyte axis.",[],Drugs,2017-02-25,"[{'lastname': 'Geloneze', 'firstname': 'Bruno', 'initials': 'B', 'affiliation': 'Laboratory of Investigation in Metabolism and Diabetes-LIMED, University of Campinas, UNICAMP, Campinas, 13084-970, Brazil. bgeloneze@terra.com.br.'}, {'lastname': 'de Lima-Júnior', 'firstname': 'José Carlos', 'initials': 'JC', 'affiliation': 'Laboratory of Investigation in Metabolism and Diabetes-LIMED, University of Campinas, UNICAMP, Campinas, 13084-970, Brazil.\nLaboratory of Cell Signaling, Obesity and Comorbidities Research Center, University of Campinas-UNICAMP, Campinas, Brazil.'}, {'lastname': 'Velloso', 'firstname': 'Lício A', 'initials': 'LA', 'affiliation': 'Laboratory of Cell Signaling, Obesity and Comorbidities Research Center, University of Campinas-UNICAMP, Campinas, Brazil.'}]",,,,,"10.1007/s40265-017-0706-4
10.1530/JOE-16-0056
10.1016/S0140-6736(06)69705-5
10.1016/j.cmet.2013.04.008
10.1007/s00125-016-3874-y
10.1210/en.2014-1675
10.2337/db11-1556
10.1152/physrev.00015.2003
10.1007/s00125-016-3896-5
10.1016/j.cell.2015.02.023
10.1056/NEJMoa0810780
10.1016/S0306-4522(96)00434-4
10.1210/endo.133.1.8319572
10.1016/j.tem.2009.11.007
10.1124/pr.55.1.6
10.1056/NEJMoa1411892
10.1016/j.pharmthera.2009.06.002
10.1016/j.regpep.2010.05.008
10.1002/phar.1240
10.1021/jm9909645
10.1002/dmrr.1080
10.1007/s40265-015-0370-5
10.1172/JCI78371
10.1016/j.celrep.2015.06.062
10.1172/JCI72434
10.1172/JCI75276
10.1007/s00125-015-3727-0
10.2337/db14-0302
10.1007/s00125-015-3651-3
10.2165/11635890-000000000-00000
10.1124/jpet.300.3.958
10.1186/1742-2094-5-19
10.1042/CS20110374
10.1002/jnr.22565
10.1186/1471-2202-13-33
10.1523/JNEUROSCI.0529-11.2011
10.1002/oby.21387
10.1002/glia.22580
10.1172/JCI990
10.1136/bmj.d7771
10.1111/dom.12534
10.1016/S0140-6736(14)60976-4
10.1016/S2213-8587(13)70214-6
10.2337/diabetes.53.9.2492
10.1530/JOE-13-0414
10.1016/j.diabres.2012.02.016
10.2337/diacare.27.8.1915
10.1139/h2012-068
10.1038/ijo.2013.162
10.1016/j.neuroimage.2006.12.035
10.1016/j.cmet.2011.09.010
10.2337/db14-0849
10.1001/jama.2015.9676
10.1152/ajpendo.00471.2015
10.2337/dc14-0893
10.1038/srep16968
10.1530/EJE-16-0286
10.1210/me.2015-1164
10.1016/j.biochi.2016.03.007
10.1210/en.2013-1578
10.1038/srep29921
10.1016/j.cmet.2006.01.004
10.1016/j.cmet.2016.06.009
10.1111/dom.12085
10.2337/db10-0474
10.1016/j.mce.2016.07.032
10.1210/jc.2003-031403
10.1002/hep.28827
10.1007/s00125-009-1643-x
10.2337/dc12-1925
10.1002/oby.21200
10.1111/dom.12506
10.1016/j.drudis.2016.01.013
10.1007/s00125-015-3754-x
10.2337/db14-1718
10.2337/dc15-2706
10.1172/JCI68295
10.1016/j.metabol.2016.03.009
10.1016/j.jalz.2013.12.012",<Element 'PubmedArticle' at 0x7f05dade46d0>
412,28189715,Cynandione A attenuates neuropathic pain through p38β MAPK-mediated spinal microglial expression of β-endorphin.,"Cynanchi Wilfordii Radix (baishouwu), a medicinal herb, has been widely used in Asia to treat a variety of diseases or illnesses. Cynandione A isolated from C. Wilfordii is the principle acetophenone and exhibits neuroprotective and anti-inflammatory activities. This study aims to evaluate the antihypersensitivity activities of cynandione A in neuropathy and explored its mechanisms of action. Intrathecal injection of cynandione A dose-dependently attenuated spinal nerve ligation-induced mechanical allodynia and thermal hyperalgesia, with maximal possible effects of 57% and 59%, ED","['Cynandione A', 'Microglia', 'Neuropathic pain', 'p38β MAPK', 'β-Endorphin']","Brain, behavior, and immunity",2017-02-13,"[{'lastname': 'Huang', 'firstname': 'Qian', 'initials': 'Q', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, 800 Dongchuan Road, Shanghai 200240, China. Electronic address: windysalad@hotmail.com.""}, {'lastname': 'Mao', 'firstname': 'Xiao-Fang', 'initials': 'XF', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, 800 Dongchuan Road, Shanghai 200240, China. Electronic address: nancylittle@163.com.""}, {'lastname': 'Wu', 'firstname': 'Hai-Yun', 'initials': 'HY', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, 800 Dongchuan Road, Shanghai 200240, China. Electronic address: wuhaiyunsjtu@163.com.""}, {'lastname': 'Liu', 'firstname': 'Hao', 'initials': 'H', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, 800 Dongchuan Road, Shanghai 200240, China. Electronic address: lh.tiger.9@gmail.com.""}, {'lastname': 'Sun', 'firstname': 'Ming-Li', 'initials': 'ML', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, 800 Dongchuan Road, Shanghai 200240, China. Electronic address: sunny1991725@163.com.""}, {'lastname': 'Wang', 'firstname': 'Xiao', 'initials': 'X', 'affiliation': 'Shandong Analysis and Test Center, Shandong Academy of Sciences, 19 Keyuan Street, Jinan 250014, Shandong, China. Electronic address: wangx@sdas.org.'}, {'lastname': 'Wang', 'firstname': 'Yong-Xiang', 'initials': 'YX', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, 800 Dongchuan Road, Shanghai 200240, China. Electronic address: yxwang@sjtu.edu.cn.""}]",,,,Copyright © 2017 Elsevier Inc. All rights reserved.,10.1016/j.bbi.2017.02.005,<Element 'PubmedArticle' at 0x7f05dae1b720>
413,28183451,The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia.,"Irisin is a novel exercise-induced myokine involved in the regulation of adipose browning and thermogenesis. In this study, we investigated the potential role of irisin in cerebral ischemia and determined whether irisin is involved in the neuroprotective effect of physical exercise in mice.
The middle cerebral artery occlusion (MCAO) model was used to produce cerebral ischemia in mice. First, the plasma irisin levels and changes in expression of the irisin precursor protein FNDC5 in skeletal muscle were determined post ischemic stroke. Second, the association between plasma irisin levels and the neurological deficit score, brain infarct volume, or plasma concentrations of tumor necrosis factor-α (TNF-α), interleukin (IL)-6 and IL-1β in mice with MCAO were evaluated. Third, the therapeutic effect of irisin on ischemic brain injury was evaluated in vivo and in vitro. Recombinant irisin was injected directly into the tail vein 30min after the MCAO operation, and then the effects of irisin treatment on brain infarct volume, neurological deficit, neuroinflammation, microglia activation, monocyte infiltration, oxidative stress and intracellular signaling pathway activation (Akt and ERK1/2) were measured. Irisin was also administered in cultured PC12 neuronal cells with oxygen and glucose deprivation (OGD). Finally, to assess the potential involvement of irisin in the neuroprotection of physical exercise, mice were exercised for 2weeks and an irisin neutralizing antibody was injected into these mice to block irisin 1h before the MCAO operation.
The plasma irisin concentration and intramuscular FNDC5 protein expression decreased after ischemic stroke. Plasma irisin levels were negatively associated with brain infarct volume, the neurological deficit score, plasma TNF-α and plasma IL-6 concentrations. In OGD neuronal cells, irisin protected against cell injury. In mice with MCAO, irisin treatment reduced the brain infarct volume, neurological deficits, brain edema and the decline in body weight. Irisin treatment inhibited activation of Iba-1
Irisin reduces ischemia-induced neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotective effect of physical exercise against cerebral ischemia, suggesting that irisin may be a factor linking metabolism and cardio-cerebrovascular diseases.","['Cerebral ischemia', 'Irisin', 'Neuroinflammation', 'Neuroprotection', 'Physical exercise']",Metabolism: clinical and experimental,2017-02-12,"[{'lastname': 'Li', 'firstname': 'Dong-Jie', 'initials': 'DJ', 'affiliation': ""Department of Pharmacy, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China. Electronic address: djli@tongji.edu.cn.""}, {'lastname': 'Li', 'firstname': 'Yong-Hua', 'initials': 'YH', 'affiliation': 'Department of Anesthesiology, Changzheng Hospital, Second Military Medical University, Shanghai, China.'}, {'lastname': 'Yuan', 'firstname': 'Hong-Bin', 'initials': 'HB', 'affiliation': 'Department of Anesthesiology, Changzheng Hospital, Second Military Medical University, Shanghai, China.'}, {'lastname': 'Qu', 'firstname': 'Le-Feng', 'initials': 'LF', 'affiliation': 'Department of Vascular and Endovascular Surgery, Changzheng Hospital, Second Military Medical University, Shanghai, China.'}, {'lastname': 'Wang', 'firstname': 'Pei', 'initials': 'P', 'affiliation': 'Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai, China. Electronic address: pwang@smmu.edu.cn.'}]",,"Irisin reduces ischemia-induced neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotective effect of physical exercise against cerebral ischemia, suggesting that irisin may be a factor linking metabolism and cardio-cerebrovascular diseases.","The plasma irisin concentration and intramuscular FNDC5 protein expression decreased after ischemic stroke. Plasma irisin levels were negatively associated with brain infarct volume, the neurological deficit score, plasma TNF-α and plasma IL-6 concentrations. In OGD neuronal cells, irisin protected against cell injury. In mice with MCAO, irisin treatment reduced the brain infarct volume, neurological deficits, brain edema and the decline in body weight. Irisin treatment inhibited activation of Iba-1",Copyright © 2016 Elsevier Inc. All rights reserved.,10.1016/j.metabol.2016.12.003,<Element 'PubmedArticle' at 0x7f05dadab1d0>
414,"28176050
24623768
21527759
21763611
11535514
11914546
16361023
10549828
12364741
14747742
25035058
22257737
3216047
16636234
10433861
16610049
15865932
15961235
17562483
16425150
8961277
18992731
9916983
19847447",Upregulated Expression of SSTR3 is Involved in Neuronal Apoptosis After Intracerebral Hemorrhage in Adult Rats.,"Somatostatin which is a multifunctional growth hormone inhibitory neuropeptide shows diverse physiological effects, such as neurotransmission, cell growth, apoptosis, and endocrine signaling as well as exerts inhibitory effects on hormonal products and other secretory proteins. SSTR3 is a member of superfamily of somatostatin receptors (SSTR), which are G-protein-coupled plasma membrane receptors. Previous studies proved that SSTR3 regulates antiproliferative signaling and apoptosis in several cells. Here, we explored a potential role of SSTR3 in the regulation of neuronal apoptosis in the course of intracerebral hemorrhage (ICH). An ICH rat model was established and assessed by behavioral tests. We found SSTR3 was significantly upregulated surrounding the hematoma after ICH by Western blot and immunohistochemistry. Double immunofluorescence-manifested SSTR3 was strikingly increased in neurons, not astrocytes or microglia. Moreover, increasing SSTR3 level was found to be accompanied by the upregulation of p53, Bax, and active caspase-3 in vivo and in vitro studies. Furthermore, we detected that neuronal apoptosis marker active caspase-3 was co-localized with SSTR3 suggesting its potential role in neuronal apoptosis. In addition, in vitro study, revealed that SSTR3 knockdown specifically resulted in reducing neuronal apoptosis in PC12 cells, which further indicated that SSTR3 might exert its pro-apoptotic function on neuronal apoptosis. All our findings suggested that upregulated SSTR3 may be involved in neuronal apoptosis after ICH.","['Adult rats', 'Apoptosis', 'Intracerebral hemorrhage (ICH)', 'SSTR3']",Cellular and molecular neurobiology,2017-02-09,"[{'lastname': 'Yao', 'firstname': 'Qi', 'initials': 'Q', 'affiliation': 'Department of Neurosurgery, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, China.'}, {'lastname': 'Liu', 'firstname': 'Qianqian', 'initials': 'Q', 'affiliation': 'Department of Neurosurgery, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, China.'}, {'lastname': 'Xu', 'firstname': 'Hui', 'initials': 'H', 'affiliation': ""Department of Neurosurgery, The Sixth People's Hospital of Nantong, Nantong, 226001, Jiangsu, China.""}, {'lastname': 'Wu', 'firstname': 'Zhonghua', 'initials': 'Z', 'affiliation': ""Department of Neurosurgery, The Sixth People's Hospital of Nantong, Nantong, 226001, Jiangsu, China.""}, {'lastname': 'Zhou', 'firstname': 'Liang', 'initials': 'L', 'affiliation': 'Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, 215006, Jiangsu, China.'}, {'lastname': 'Gu', 'firstname': 'Zhikai', 'initials': 'Z', 'affiliation': 'Department of Neurosurgery, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, China.'}, {'lastname': 'Gong', 'firstname': 'Peipei', 'initials': 'P', 'affiliation': 'Department of Neurosurgery, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, China. ntnsgpp@163.com.'}, {'lastname': 'Shen', 'firstname': 'Jianhong', 'initials': 'J', 'affiliation': 'Department of Neurosurgery, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, China. ntdxfsyysjh@sina.com.'}]",,,,,10.1007/s10571-017-0471-7,<Element 'PubmedArticle' at 0x7f05dadb8590>
415,"28154473
26067058
12915048
8866675
12220687
23690824
23792284
17974036
23792284
16355225
15836971
16624951
20418178
23111678
16307586
17307159
26881105
17904651
24504982
11023702
24588018
15001661
22566831
9045742
9620667
7544012
8603997
10486285
16647700
17588564
16414116
23940690
18625277
8415620
7854347
9120297
12817018
10358199
12384937
16293345
10233018
15787746
15699165
16371321
10702221
23468969
15833358
27359332
14572638
9743348
11239505
1490338
20965575
9152411
25105291
8755601
20959451
23211819
10804204
12112366
9757047
20937084
11113362
11857684
25170632
8926038
8846399
21803157
17419800
17617622
12684452
11786404
12796468
23386811
11169794
22290798
21703408
24009773
23689030
12798410
3017502
15026153
9878783
14559360
15617771
11050135
20081244
17915196
19306358
8112823
24719110
26363192
25176008
7560019
24664661
12427855
16403466
17919885
12359508
15337367
24184719
22007767
22805317
18495419
25206918
17353067
17239992
22136135
17976913
17194506
5450698
25422088
2872248
6571696
2803320
19805477
22289055
19109992
23517078
15985713
12525573
12372411
17826030
12054537
15194876
15476707
12754213
12020953
9916753
9973433
25653374
12923064
25550371
22643083
23720065
18442091
22328918
16891616
12666096
12626429
15584490
10431211
16202621
10457173
10337915
11029467
9813054
10433861
18325491
19552966
22509294
25777539
23935251
16764934
8622767
18374474
11227737
12915402
15823563
20063038
21388399
12684217
12519865
16537513
16492802
17151007
21940421
23918980
24333694
23371349
20883741
24382888
11062498
12383518
11874202
8808790
9187934
7678597
11438168
15100316
18523290
26604896
974776
16449797
25209287
22724132
26386297
12950462
20398373
18790011
20609516
22825006
25871534
15342200
22384199
18660829
6283379
14615490
8387282
3535798
3317417
15269340
9620797
15576460
12749828
15047974
10980200
18498438
12145288
17981883
15070851
16025744
9328930
19568255
16039904
24321213
24746422
15486424
22145886
25707377
20804799
19299480
20691540
25305050
7489415
8616722
8801538
10579368
15634336
10867658
19350671
9392508
8603777
9927310
20399755
15122202
8996253
8621806
15388782
16842830
10873603
24166765
19922787
25142458
23895348
24780498
19139561
19620723
22536415
10604470
11243865
11272130
25107984
11162448
9379845
11196643
17634369
20444938
25309797
26079709
20351014
22416219
19384567
19620309
21983104
15176951
19382238
24513955","Neuropeptides and Microglial Activation in Inflammation, Pain, and Neurodegenerative Diseases.","Microglial cells are responsible for immune surveillance within the CNS. They respond to noxious stimuli by releasing inflammatory mediators and mounting an effective inflammatory response. This is followed by release of anti-inflammatory mediators and resolution of the inflammatory response. Alterations to this delicate process may lead to tissue damage, neuroinflammation, and neurodegeneration. Chronic pain, such as inflammatory or neuropathic pain, is accompanied by neuroimmune activation, and the role of glial cells in the initiation and maintenance of chronic pain has been the subject of increasing research over the last two decades. Neuropeptides are small amino acidic molecules with the ability to regulate neuronal activity and thereby affect various functions such as thermoregulation, reproductive behavior, food and water intake, and circadian rhythms. Neuropeptides can also affect inflammatory responses and pain sensitivity by modulating the activity of glial cells. The last decade has witnessed growing interest in the study of microglial activation and its modulation by neuropeptides in the hope of developing new therapeutics for treating neurodegenerative diseases and chronic pain. This review summarizes the current literature on the way in which several neuropeptides modulate microglial activity and response to tissue damage and how this modulation may affect pain sensitivity.",[],Mediators of inflammation,2017-02-06,"[{'lastname': 'Carniglia', 'firstname': 'Lila', 'initials': 'L', 'affiliation': 'INBIOMED (Instituto de Investigaciones Biomédicas), UBA-CONICET, Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, Ciudad Autónoma de Buenos Aires, Argentina.'}, {'lastname': 'Ramírez', 'firstname': 'Delia', 'initials': 'D', 'affiliation': 'INBIOMED (Instituto de Investigaciones Biomédicas), UBA-CONICET, Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, Ciudad Autónoma de Buenos Aires, Argentina.'}, {'lastname': 'Durand', 'firstname': 'Daniela', 'initials': 'D', 'affiliation': 'INBIOMED (Instituto de Investigaciones Biomédicas), UBA-CONICET, Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, Ciudad Autónoma de Buenos Aires, Argentina.'}, {'lastname': 'Saba', 'firstname': 'Julieta', 'initials': 'J', 'affiliation': 'INBIOMED (Instituto de Investigaciones Biomédicas), UBA-CONICET, Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, Ciudad Autónoma de Buenos Aires, Argentina.'}, {'lastname': 'Turati', 'firstname': 'Juan', 'initials': 'J', 'affiliation': 'INBIOMED (Instituto de Investigaciones Biomédicas), UBA-CONICET, Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, Ciudad Autónoma de Buenos Aires, Argentina.'}, {'lastname': 'Caruso', 'firstname': 'Carla', 'initials': 'C', 'affiliation': 'INBIOMED (Instituto de Investigaciones Biomédicas), UBA-CONICET, Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, Ciudad Autónoma de Buenos Aires, Argentina.'}, {'lastname': 'Scimonelli', 'firstname': 'Teresa N', 'initials': 'TN', 'affiliation': 'IFEC-CONICET, Depto. Farmacología, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.'}, {'lastname': 'Lasaga', 'firstname': 'Mercedes', 'initials': 'M', 'affiliation': 'INBIOMED (Instituto de Investigaciones Biomédicas), UBA-CONICET, Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, Ciudad Autónoma de Buenos Aires, Argentina.'}]",,,,,"10.1155/2017/5048616
10.1016/j.pneurobio.2015.05.003
10.1016/S0165-6147(03)00176-7
10.1016/0165-0173(95)00011-9
10.1016/s0022-510x(02)00207-1
10.1155/2013/608654
10.1016/j.pain.2013.06.022
10.1186/1744-8069-3-33
10.1016/j.pain.2013.06.022
10.1038/nature04223
10.1016/j.pain.2005.02.009
10.1523/jneurosci.0003-06.2006
10.1016/j.jpain.2010.02.010
10.1007/s13105-012-0217-4
10.1111/j.1460-9568.2005.04451.x
10.1016/j.ejphar.2007.01.013
10.1155/2016/3276383
10.1016/j.tins.2007.07.007
10.1002/glia.22633
10.1006/phrs.2000.0725
10.1038/nrn3657
10.1124/pr.56.1.1
10.3389/fimmu.2011.00041
10.1073/pnas.92.17.8016
10.1006/bbrc.1999.1276
10.1016/j.ejphar.2006.03.038
10.1016/j.ejphar.2007.05.025
10.1016/j.npep.2005.10.006
10.1371/journal.pone.0071056
10.1016/j.peptides.2008.06.009
10.5772/32672
10.1073/pnas.90.19.8856
10.1210/me.8.10.1298
10.4049/jimmunol.171.1.353
10.1002/art.10526
10.1016/j.peptides.2005.01.031
10.1111/j.1365-3083.2005.01565.x
10.4049/jimmunol.174.4.2297
10.1007/bf03033980
10.1074/jbc.275.10.6695
10.1371/journal.pone.0057313
10.1016/j.jneuroim.2005.01.008
10.1371/journal.pone.0158564
10.1016/S0014-5793(03)01029-9
10.1016/s0006-2952(00)00583-9
10.3109/02713689208999545
10.1016/j.jneuroim.2010.09.025
10.1371/journal.pone.0104420
10.1073/pnas.93.15.8051
10.1074/jbc.m110.164020
10.1167/iovs.12-10776
10.1002/glia.10098
10.1016/S0169-328X(98)00184-3
10.1186/1742-2094-7-61
10.1016/s0306-4522(00)00398-5
10.1002/glia.10034
10.1159/000363041
10.1002/glia.440150408
10.1139/y95-148
10.1016/j.mcn.2011.07.006
10.1111/j.1471-4159.2007.04559.x
10.4049/jimmunol.179.2.1292
10.1016/s0002-9440(10)64354-4
10.1084/jem.20021546
10.3389/fncel.2013.00006
10.1002/1098-1136(20010101)33:1<87::aid-glia1008>3.0.co;2-s
10.1002/glia.22298
10.1016/j.ajpath.2011.03.042
10.1371/journal.pone.0074488
10.1016/j.jneuroim.2013.04.019
10.1016/S0024-3205(03)00349-7
10.1016/0006-8993(86)90283-0
10.1016/j.neulet.2003.12.096
10.1016/s0169-328x(98)00291-5
10.1016/j.molbrainres.2003.08.001
10.1016/j.bbr.2004.06.008
10.1016/s1734-1140(09)70171-9
10.1016/j.brainres.2007.08.054
10.1002/glia.20871
10.1002/glia.440090408
10.1523/jneurosci.4703-13.2014
10.1016/j.neuropharm.2015.09.010
10.1111/bph.12895
10.1016/0165-5728(95)00089-K
10.1002/j.1532-2149.2014.493.x
10.1016/j.brainres.2005.11.066
10.1016/j.bbi.2007.07.014
10.1054/npep.2002.0897
10.1016/j.npep.2004.06.002
10.1016/j.pneurobio.2013.10.002
10.1111/j.1471-4159.2011.07541.x
10.1111/j.1460-9568.2012.08232.x
10.1016/j.bbi.2008.03.009
10.4103/1673-5374.133140
10.1016/j.neuint.2007.01.010
10.1016/j.peptides.2006.07.029
10.1186/1742-2094-8-169
10.1016/j.pain.2007.09.016
10.1016/j.peptides.2006.09.029
10.1126/science.169.3951.1217
10.1111/apha.12427
10.1007/BF03348097
10.1038/304547a0
10.1016/0006-291X(89)91757-9
10.1124/pr.109.001370
10.1111/j.1476-5381.2012.01871.x
10.1016/j.pharmthera.2008.11.006
10.1111/bph.12181
10.1189/jlb.0702372
10.1016/S0006-291X(02)02305-7
10.1016/S0006-291X(02)00283-8
10.1097/01.wnr.0000130541.29635.6f
10.1016/j.brainres.2004.08.017
10.1074/jbc.m303199200
10.1016/S0165-5728(02)00059-0
10.1523/JNEUROSCI.4058-14.2015
10.1096/fj.02-1029fje
10.1161/strokeaha.114.006864
10.1179/1743132812Y.0000000028
10.1007/s12031-013-0017-5
10.1002/glia.20681
10.1371/journal.pone.0029790
10.1124/jpet.106.102236
10.1002/ana.10483
10.1191/1352458504ms1096oa
10.1016/s0165-6147(99)01340-1
10.1016/j.mcn.2005.08.016
10.1046/j.1460-9568.1999.00693.x
10.1016/s0165-5728(99)00023-5
10.1074/jbc.m006923200
10.1074/jbc.273.47.31427
10.1006/frne.1999.0183
10.1016/j.ejphar.2008.02.025
10.1016/j.jneuroim.2009.05.016
10.1371/journal.pone.0034376
10.3892/mmr.2015.3494
10.1155/2013/952375
10.1016/j.pharmthera.2006.04.010
10.1038/381242a0
10.1016/j.mce.2007.12.014
10.1007/BF03343800
10.1074/jbc.m302456200
10.1016/j.bbrc.2005.03.088
10.1007/s00018-009-0240-y
10.1111/j.1749-6632.2011.05985.x
10.1152/ajpendo.00048.2003
10.1210/jc.2002-020950
10.1073/pnas.0508997103
10.1084/jem.20052017
10.1136/ard.2006.062703
10.1093/infdis/jir608
10.4049/jimmunol.1300384
10.1016/j.nbd.2013.11.022
10.1002/art.37877
10.1016/j.peptides.2010.09.018
10.1152/physrev.00031.2013
10.1038/80826
10.1016/S0378-1119(02)00861-2
10.1023/A:1013911205494
10.1016/0197-0186(95)00140-9
10.1016/0165-5728(93)90212-H
10.1016/S0165-5728(01)00295-8
10.4049/jimmunol.172.9.5707
10.4049/jimmunol.180.12.8241
10.4103/1673-5374.165505
10.1016/0006-8993(76)90907-0
10.1096/fj.05-4553com
10.1523/JNEUROSCI.2238-14.2014
10.1016/j.ejphar.2012.03.025
10.1016/j.neuroscience.2015.09.036
10.1046/j.1471-4159.2003.01969.x
10.1186/1742-2094-7-27
10.1016/j.neulet.2008.09.009
10.1016/j.pain.2010.06.017
10.1097/WNR.0b013e3283572206
10.1016/j.ajpath.2015.02.011
10.1016/j.jneuroim.2004.06.005
10.1371/journal.pone.0032268
10.1038/bjp.2008.301
10.1038/298240a0
10.1074/jbc.m305332200
10.1006/bbrc.1993.1451
10.1016/0006-291X(86)90708-4
10.1073/pnas.84.23.8628
10.1152/physrev.00037.2003
10.1038/30666
10.1210/en.2004-1080
10.1016/s1094-5539(03)00049-x
10.1074/jbc.M006512200
10.1111/j.1471-4159.2008.05494.x
10.1074/jbc.m204619200
10.1093/ndt/gfm600
10.1210/en.2003-1583
10.1291/hypres.28.165
10.1038/ki.1997.413
10.1038/jcbfm.2009.92
10.1016/j.it.2005.07.004
10.1016/j.bbi.2013.11.021
10.1016/j.jneuroim.2014.03.008
10.1152/jn.00339.2004
10.1186/1744-8069-7-94
10.1002/art.39082
10.1016/j.peptides.2010.08.020
10.1096/fj.08-128348
10.1016/j.pain.2010.07.006
10.1016/j.metabol.2014.09.010
10.1038/nm1295-1311
10.1038/nm0596-589
10.1016/0196-9781(96)00025-3
10.1210/endo.140.12.7288
10.1111/j.1432-1033.2004.04391.x
10.1002/1096-9861(20000724)423:2<261::aid-cne6>3.0.co;2-6
10.1002/cne.22025
10.2337/diab.46.12.2119
10.2337/diab.45.4.531
10.1210/en.140.2.814
10.1016/j.brainres.2010.04.011
10.1038/nri1350
10.1084/jem.185.1.171
10.1172/JCI118653
10.1113/jphysiol.2004.074351
10.1016/j.physbeh.2006.05.016
10.1006/bbrc.2000.2937
10.1002/glia.22580
10.1016/j.bbi.2009.11.003
10.1016/s1474-4422(14)70085-7
10.1111/jnc.12380
10.1016/j.nbd.2014.04.012
10.1172/JCI36785
10.1073/pnas.0903524106
10.1371/journal.pone.0035594
10.1038/45230
10.1006/bbrc.2001.4518
10.2337/diabetes.50.2.227
10.1124/pr.113.008433
10.1006/bbrc.2000.4039
10.1016/S0169-328X(97)00071-5
10.1038/35051587
10.1523/jneurosci.1661-07.2007
10.1210/en.2009-1416
10.3803/enm.2014.29.3.371
10.1016/j.nbd.2015.06.002
10.1677/JOE-10-0040
10.4196/kjpp.2012.16.1.43
10.1007/s12640-009-9037-x
10.4049/jimmunol.0803362
10.1016/j.peptides.2011.09.019
10.1042/bj20040036
10.1002/jnr.22088
10.1097/aap.0000000000000050",<Element 'PubmedArticle' at 0x7f05dadc8270>
416,"27986987
10766253
10766251
7984236
24462092
22201683
25497089
25668019
23881189
16988703
16002529
17167474
16823477
18769626
25303559
20176722
19116375
19144836
25373903
18854155
15271881
19808018
19220919
24166765
24848869
22844271
18995817
22162024
26432479
26578855
21692661
25002280
25921535
21068834
20966214
21804537
24162652
20303880
27393312
27166944
25646713
24352739
23507975
16732273
22252034
24456845
24947351
26393344
23582329
9390561
10805752
24316888
25186741
20012068
27518562
8785064
3018177
8199863
17251391
15578727
12679378
22180782
21376239
24379353
27122369
15968634
23064363
24880214
26629411
19293246
23329815
27026049
27013681
27751234
23548599
25685690
23047490
24914942
23548614
26530930
24024123
24903651
20679202
26081217
7615345
12859684
20531973
21297988
23562080
24506870
22446882
23804023
22284631
3305799
26010717
18837053
19486010
19096367
24205170
21494606
21183934
23512884
21894161
25027223
25423565
21146506
24388427
26687838
23472873",Glia: silent partners in energy homeostasis and obesity pathogenesis.,"Body weight stability requires homeostatic regulation to balance energy intake and energy expenditure. Research on this system and how it is affected by obesity has largely focused on the role of hypothalamic neurons as integrators of information about long-term fuel storage, short-term nutrient availability and metabolic demand. Recent studies have uncovered glial cells as additional contributors to energy balance regulation and obesity pathogenesis. Beginning with early work on leptin signalling in astrocytes, this area of research rapidly emerged after the discovery of hypothalamic inflammation and gliosis in obese rodents and humans. Current studies have revealed the involvement of a wide variety of glial cell types in the modulation of neuronal activity, regulation of hormone and nutrient availability, and participation in the physiological regulation of feeding behaviour. In addition, one glial type, microglia, has recently been implicated in susceptibility to diet-induced obesity. Together, these exciting new findings deepen our understanding of energy homeostasis regulation and raise the possibility of identifying novel mechanisms that contribute to the pathogenesis of obesity.","['Astrocytes', 'Brain', 'Central nervous system', 'Diabetes', 'Energy homeostasis', 'Glia', 'Hypothalamus', 'Inflammation', 'Microglia', 'Obesity', 'Review']",Diabetologia,2016-12-18,"[{'lastname': 'Douglass', 'firstname': 'John D', 'initials': 'JD', 'affiliation': 'UW Diabetes Institute and Department of Medicine, University of Washington, 850 Republican St, S248, Box 358055, Seattle, WA, 98109, USA.'}, {'lastname': 'Dorfman', 'firstname': 'Mauricio D', 'initials': 'MD', 'affiliation': 'UW Diabetes Institute and Department of Medicine, University of Washington, 850 Republican St, S248, Box 358055, Seattle, WA, 98109, USA.'}, {'lastname': 'Thaler', 'firstname': 'Joshua P', 'initials': 'JP', 'affiliation': 'UW Diabetes Institute and Department of Medicine, University of Washington, 850 Republican St, S248, Box 358055, Seattle, WA, 98109, USA. jpthaler@uw.edu.'}]",,,,,10.1007/s00125-016-4181-3,<Element 'PubmedArticle' at 0x7f05dace7860>
417,"27980422
22084578
27072742
12396664
15051507
15206722
1830237
26114426
11684348
111294
22404766
26497015
22814706
20658274
24454842
26251845
27342132
24793874
24722144
15804489
26321672
19595736
9409365
11798468
18032661
12003349
23409146
22314502
23017145
21744051
23580432
12508119
23284853
11567036
27114543
22248144
26194183
24886967
25288889",Progesterone Alters Kynurenine Pathway Activation in IFN-γ-Activated Macrophages - Relevance for Neuroinflammatory Diseases.,"We have previously demonstrated that the kynurenine pathway (KP), the major biochemical pathway for tryptophan metabolism, is dysregulated in many inflammatory disorders that are often associated with sexual dimorphisms. We aimed to identify a potential functional interaction between the KP and gonadal hormones. We have treated primary human macrophages with progesterone in the presence and absence of inflammatory cytokine interferon-gamma (interferon-γ) that is known to be a potent inducer of regulating the KP enzyme. We found that progesterone attenuates interferon-γ-induced KP activity, decreases the levels of the excitotoxin quinolinic acid, and increases the neuroprotective kynurenic acid levels. We also showed that progesterone was able to reduce the inflammatory marker neopterin. These results may shed light on the gender disparity in response to inflammation.","['inflammation', 'kynurenine pathway', 'macrophage', 'microglia', 'tryptophan']",International journal of tryptophan research : IJTR,2016-12-17,"[{'lastname': 'de Bie', 'firstname': 'J', 'initials': 'J', 'affiliation': 'Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.'}, {'lastname': 'Lim', 'firstname': 'C K', 'initials': 'CK', 'affiliation': 'Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.'}, {'lastname': 'Guillemin', 'firstname': 'G J', 'initials': 'GJ', 'affiliation': 'Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.'}]",,,,,"10.4137/IJTR.S40332
10.1016/j.pneurobio.2015.12.009
10.1038/nature01339
10.1038/mp.2015.90",<Element 'PubmedArticle' at 0x7f05dad1cdb0>
418,27965141,In vivo two-photon imaging reveals a role of progesterone in reducing axonal dieback after spinal cord injury in mice.,"Progesterone (PG) as a neuroprotective reagent has been used for the treatment of spinal cord injury (SCI) in experimental animal models. However, its effect and mechanism on axonal dieback at the early stage of SCI remain unclear. Here, we investigate the dynamics of injured axons and the effect of PG on the axonal dieback, glial response, and behavioral recovery in a mouse model of SCI. Two-photon intravital imaging combined with a simplified imaging window chamber were used to image axons in hemisected spinal cords over a period of 3 days. Repeated imaging showed that axonal dieback distance in mice treated with PG after SCI was significantly reduced than that in mice treated with vehicle after SCI (P < 0.05) at the time point of 24 h, 48 h, and 72 h after SCI. The densities of astrocytes and microglia in the SCI-vehicle treated group were significantly higher than those in mice treated with PG after SCI (P < 0.05). Real time polymerase chain reaction assay indicated that administration of PG after SCI down-regulated the expression of pro-inflammatory cytokines MCP-1, NOS2, and IL-1β (P < 0.05). PG treatment also improved the behavioral performance post injury. These findings suggested that PG exerted a neuroprotective effect by attenuating axonal dieback, reducing the accumulation of astrocytes and microglia and inhibiting the release of pro-inflammatory cytokines.","['Axonal dieback', 'Inflammation', 'Microglia', 'Progesterone', 'Spinal cord injury', 'Two-photon imaging']",Neuropharmacology,2016-12-15,"[{'lastname': 'Yang', 'firstname': 'Zhijie', 'initials': 'Z', 'affiliation': 'Gansu Key Laboratory of Biomonitoring and Bioremediation for Environmental Pollution, School of Life Sciences, Lanzhou University, Lanzhou 730000, China; School of Life Science and Technology, Gansu Agricultural University, Lanzhou, 730070, China.'}, {'lastname': 'Xie', 'firstname': 'Wenguang', 'initials': 'W', 'affiliation': 'Gansu Key Laboratory of Biomonitoring and Bioremediation for Environmental Pollution, School of Life Sciences, Lanzhou University, Lanzhou 730000, China.'}, {'lastname': 'Ju', 'firstname': 'Furong', 'initials': 'F', 'affiliation': 'Gansu Key Laboratory of Biomonitoring and Bioremediation for Environmental Pollution, School of Life Sciences, Lanzhou University, Lanzhou 730000, China.'}, {'lastname': 'Khan', 'firstname': 'Akbar', 'initials': 'A', 'affiliation': 'Gansu Key Laboratory of Biomonitoring and Bioremediation for Environmental Pollution, School of Life Sciences, Lanzhou University, Lanzhou 730000, China.'}, {'lastname': 'Zhang', 'firstname': 'Shengxiang', 'initials': 'S', 'affiliation': 'Gansu Key Laboratory of Biomonitoring and Bioremediation for Environmental Pollution, School of Life Sciences, Lanzhou University, Lanzhou 730000, China. Electronic address: sxzhang@lzu.edu.cn.'}]",,,,Copyright © 2016 Elsevier Ltd. All rights reserved.,10.1016/j.neuropharm.2016.12.007,<Element 'PubmedArticle' at 0x7f05dacb13b0>
419,27938937,Amylin and Leptin: Co-Regulators of Energy Homeostasis and Neuronal Development.,"While the regulation of energy homeostasis by amylin is already well-characterized, emerging data suggest that amylin is also crucial for the development of neural pathways in the hypothalamus and caudal hindbrain (area postrema, AP; nucleus tractus solitarius, NTS). Exciting new findings demonstrate crucial amylin-leptin interactions in altering the activity of specific hypothalamic and AP neurons, and a role for amylin as a novel class of 'leptin sensitizers' which enhance leptin signaling in both leptin-sensitive and -resistant individuals, in part by stimulating IL-6 production by hypothalamic microglia. This review summarizes these findings and provides a hypothetical framework for future studies to elucidate the mechanisms by which amylin and leptin act individually and as co-conspirators to alter energy homeostasis and neuronal development.","['NPY/AgRP', 'POMC', 'amylin', 'area postrema', 'hypothalamus', 'leptin', 'ventral tegmental area']",Trends in endocrinology and metabolism: TEM,2016-12-13,"[{'lastname': 'Levin', 'firstname': 'Barry E', 'initials': 'BE', 'affiliation': 'Department of Neurology, Rutgers, New Jersey Medical School, Newark, NJ 07103, USA. Electronic address: levin@njms.rutgers.edu.'}, {'lastname': 'Lutz', 'firstname': 'Thomas A', 'initials': 'TA', 'affiliation': 'Institute of Veterinary Physiology, University of Zurich, Zurich, Switzerland.'}]",,,,Copyright © 2016 Elsevier Ltd. All rights reserved.,10.1016/j.tem.2016.11.004,<Element 'PubmedArticle' at 0x7f05dacbf590>
420,27919822,Astrocyte contributes to pain development via MMP2-JNK1/2 signaling in a mouse model of complex regional pain syndrome.,"The activation of spinal glial cells (astrocyte and microglia) is reported in patient with complex regional pain syndrome (CRPS). However, the roles of spinal glial activities in the pathophysiology of CRPS are unclear. Here, we explored the roles of spinal astrocyte and microglia and the molecular mechanisms underlying CRPS using a mouse model of chronic post-ischemia pain (CPIP).
CPIP injury increased the level of glial fibrillary acidic protein (GFAP, reactive astrocyte biomarker), but had no significant impact on ionized calcium binding adaptor molecule 1 (IBA1, reactive microglia biomarker), in the ipsilateral dorsal horn on post-injury day (PID) 3 when the pain threshold started to reduce significantly. Astrocytic inhibition with fluorocitrate but not microglial inhibition with minocycline attenuated the development of allodynia in CPIP-injured mice, which was concomitant with increased spinal levels of phosphorylated c-jun N-terminal kinase 1/2 (pJNK1/2) on PID 3. Furthermore, the intrathecal administration of SP600125 (JNK inhibitor) prevented the development of allodynia in CPIP-injured mice. Double immunofluorescence staining showed that pJNK1/2 was mainly co-localized with GFAP. Subsequently, increased levels of pJNK1/2 were reversed by intrathecal fluorocitrate. Furthermore, the level of spinal matrix metalloproteinase-2 (MMP2) was increased and mainly expressed in NeuN (neuron biomarker) on PID 3 in the CPIP-injured mice, while intrathecal APR 100 (MMP2 inhibitor) delayed the development of allodynia and decreased spinal levels of GFAP and pJNK1/2 on PID 3.
This study shows that activation of astrocyte MMP2/JNK1/2 signaling pathway contributes to the pathogenesis of pain hypersensitivity in the CPIP model.","['Astrocyte', 'Chronic post-ischemia pain', 'Matrix metalloproteinase-2', 'Spinal cord', 'c-jun N-terminal kinase']",Life sciences,2016-12-07,"[{'lastname': 'Tian', 'firstname': 'Guogang', 'initials': 'G', 'affiliation': 'Department of Anesthesiology, Xiangya Hospital of Central South University, Changsha, China; Department of Anesthesiology and Pain Medicine, Affiliated Haikou Hospital of Xiangya Medical School, Central South University, Haikou, China.'}, {'lastname': 'Luo', 'firstname': 'Xin', 'initials': 'X', 'affiliation': 'Department of Anaesthesiology, The University of Hong Kong, HKSAR, China; Laboratory and Clinical Research Institute for Pain, The University of Hong Kong, HKSAR, China.'}, {'lastname': 'Tang', 'firstname': 'Chaoliang', 'initials': 'C', 'affiliation': 'Department of Anaesthesiology, The University of Hong Kong, HKSAR, China; Laboratory and Clinical Research Institute for Pain, The University of Hong Kong, HKSAR, China.'}, {'lastname': 'Cheng', 'firstname': 'Xiang', 'initials': 'X', 'affiliation': 'Department of Anesthesiology and Pain Medicine, Affiliated Haikou Hospital of Xiangya Medical School, Central South University, Haikou, China.'}, {'lastname': 'Chung', 'firstname': 'Sookja Kim', 'initials': 'SK', 'affiliation': 'Department of Anatomy, The University of Hong Kong, HKSAR, China; Research Center of Heart, Brain, Hormone and Healthy Aging, The University of Hong Kong, HKSAR, China; Laboratory and Clinical Research Institute for Pain, The University of Hong Kong, HKSAR, China.'}, {'lastname': 'Xia', 'firstname': 'Zhengyuan', 'initials': 'Z', 'affiliation': 'Department of Anaesthesiology, The University of Hong Kong, HKSAR, China.'}, {'lastname': 'Cheung', 'firstname': 'Chi Wai', 'initials': 'CW', 'affiliation': 'Department of Anaesthesiology, The University of Hong Kong, HKSAR, China; Research Center of Heart, Brain, Hormone and Healthy Aging, The University of Hong Kong, HKSAR, China; Laboratory and Clinical Research Institute for Pain, The University of Hong Kong, HKSAR, China. Electronic address: cheucw@hku.hk.'}, {'lastname': 'Guo', 'firstname': 'Qulian', 'initials': 'Q', 'affiliation': 'Department of Anesthesiology, Xiangya Hospital of Central South University, Changsha, China. Electronic address: qulianguo2011@163.com.'}]",,This study shows that activation of astrocyte MMP2/JNK1/2 signaling pathway contributes to the pathogenesis of pain hypersensitivity in the CPIP model.,"CPIP injury increased the level of glial fibrillary acidic protein (GFAP, reactive astrocyte biomarker), but had no significant impact on ionized calcium binding adaptor molecule 1 (IBA1, reactive microglia biomarker), in the ipsilateral dorsal horn on post-injury day (PID) 3 when the pain threshold started to reduce significantly. Astrocytic inhibition with fluorocitrate but not microglial inhibition with minocycline attenuated the development of allodynia in CPIP-injured mice, which was concomitant with increased spinal levels of phosphorylated c-jun N-terminal kinase 1/2 (pJNK1/2) on PID 3. Furthermore, the intrathecal administration of SP600125 (JNK inhibitor) prevented the development of allodynia in CPIP-injured mice. Double immunofluorescence staining showed that pJNK1/2 was mainly co-localized with GFAP. Subsequently, increased levels of pJNK1/2 were reversed by intrathecal fluorocitrate. Furthermore, the level of spinal matrix metalloproteinase-2 (MMP2) was increased and mainly expressed in NeuN (neuron biomarker) on PID 3 in the CPIP-injured mice, while intrathecal APR 100 (MMP2 inhibitor) delayed the development of allodynia and decreased spinal levels of GFAP and pJNK1/2 on PID 3.",Copyright © 2016 Elsevier Inc. All rights reserved.,10.1016/j.lfs.2016.11.030,<Element 'PubmedArticle' at 0x7f05dacc8680>
421,27913104,D-Ala2-GIP-glu-PAL is neuroprotective in a chronic Parkinson's disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation.,"Type 2 diabetes mellitus (T2DM) is a risk factor for Parkinson's disease (PD). Therefore, treatment to improve insulin resistance in T2DM may be useful for PD patients. Glucose dependent insulinotropic polypeptide (GIP) is a member of the incretin hormone family that can promote insulin release and improve insulin resistance. Several GIP analogues have been developed as potential treatments for T2DM. We had shown previously that D-Ala2-GIP-glu-PAL, a novel long-acting GIP analogue, can play a neuroprotective role in the PD mouse model induced by acute MPTP injection. The drug reduced damage to the dopaminergic neurons and increased CREB-mediated Bcl-2 expression to prevent apoptosis and reduced chronic inflammation in the brain. In the present study, we further tested the effects of chronic treatment by D-Ala2-GIP-glu-PAL in a chronic PD mouse model induced by MPTP (25mg/kg ip.) combination with probenecid (250mg/kg ip.) injection for 5 weeks. The results demonstrated that chronic treatment with D-Ala2-GIP-glu-PAL inhibits MPTP -induced Parkinsonism-like motor disorders in mice, and that the drug prevents dopaminergic neuronal loss in the substantia nigra pars compacta (SNpc). Moreover, D-Ala2-GIP-glu-PAL also inhibited the increased levels of expression of α-synuclein in the SNpc and striatum induced by MPTP. Furthermore, drug treatment reduced chronic neuroinflammation, oxidative stress and lipid peroxidation, and increased the expression of BDNF. These findings show that GIP signaling is neuroprotective and holds promise as a novel treatment of PD.","['Brain', 'Dopamine', 'Growth factor', 'Incretin', 'Insulin', 'Neurodegeneration']",European journal of pharmacology,2016-12-04,"[{'lastname': 'Li', 'firstname': 'Yanwei', 'initials': 'Y', 'affiliation': 'Key Laboratory of Cellular Physiology, Shanxi Medical University, Taiyuan, Shanxi, PR China; Department of human anatomy, Shaoyang Medical College, Shaoyang, Hunan, PR China.'}, {'lastname': 'Liu', 'firstname': 'WeiZhen', 'initials': 'W', 'affiliation': 'Key Laboratory of Cellular Physiology, Shanxi Medical University, Taiyuan, Shanxi, PR China.'}, {'lastname': 'Li', 'firstname': 'Lin', 'initials': 'L', 'affiliation': 'Key Laboratory of Cellular Physiology, Shanxi Medical University, Taiyuan, Shanxi, PR China. Electronic address: linlilin999@163.com.'}, {'lastname': 'Hölscher', 'firstname': 'Christian', 'initials': 'C', 'affiliation': 'Biomedical and Life Science, Faculty of Health and Medicine, Lancaster University, Lancaster LA1 4YQ, UK; Second hospital, Neurology department, Shanxi medical University, Taiyuan, Shanxi, PR China.'}]",,,,Copyright © 2017. Published by Elsevier B.V.,10.1016/j.ejphar.2016.11.050,<Element 'PubmedArticle' at 0x7f05dacd3e50>
422,"27911303
19457065
22424230
24239383
24614496
9663454
17614161
23183359
8606530
12805660
20962049
7564878
10907112
23595620
19361613
22897878
14769913
18048135
19114008
21943601
17567613
12925520
17576678
17784955
15028117
15980487
22500019
18786637
2606943
21166690
11124442
8713135
17341475
19513731
23943781
25430817
27033548
26436904
12111820
22210083
25620700
12900169
19494434
25964739
25120481
16840705
19853658
22466004
19638972
18332434
17151600
24653673
23551972
19866952
23794448
8245987
9623635
21671898
10026261
20518811
26136651
24896327",Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model.,"Our recent study has demonstrated that peripheral amylin treatment reduces the amyloid pathology in the brain of Alzheimer's disease (AD) mouse models, and improves their learning and memory. We hypothesized that the beneficial effects of amylin for AD was beyond reducing the amyloids in the brain, and have now directly tested the actions of amylin on other aspects of AD pathogenesis, especially neuroinflammation. A 10-week course of peripheral amylin treatment significantly reduced levels of cerebral inflammation markers, Cd68 and Iba1, in amyloid precursor protein (APP) transgenic mice. Mechanistic studies indicated the protective effect of amylin required interaction with its cognate receptor because silencing the amylin receptor expression blocked the amylin effect on Cd68 in microglia. Using weighted gene co-expression network analysis, we discovered that amylin treatment influenced two gene modules linked with amyloid pathology: 1) a module related to proinflammation and transport/vesicle process that included a hub gene of Cd68, and 2) a module related to mitochondria function that included a hub gene of Atp5b. Amylin treatment restored the expression of most genes in the APP cortex toward levels observed in the wild-type (WT) cortex in these two modules including Cd68 and Atp5b. Using a human dataset, we found that the expression levels of Cd68 and Atp5b were significantly correlated with the neurofibrillary tangle burden in the AD brain and with their cognition. These data suggest that amylin acts on the pathological cascade in animal models of AD, and further supports the therapeutic potential of amylin-type peptides for AD.","['Alzheimer’s disease', 'WGCNA', 'amylin', 'hub gene', 'transcriptome']",Journal of Alzheimer's disease : JAD,2016-12-03,"[{'lastname': 'Wang', 'firstname': 'Erming', 'initials': 'E', 'affiliation': 'Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.'}, {'lastname': 'Zhu', 'firstname': 'Haihao', 'initials': 'H', 'affiliation': 'Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.'}, {'lastname': 'Wang', 'firstname': 'Xiaofan', 'initials': 'X', 'affiliation': 'Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.'}, {'lastname': 'Gower', 'firstname': 'Adam C', 'initials': 'AC', 'affiliation': 'Clinical and Translational Science Institute, Boston University School of Medicine, Boston, MA, USA.'}, {'lastname': 'Wallack', 'firstname': 'Max', 'initials': 'M', 'affiliation': 'Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.'}, {'lastname': 'Blusztajn', 'firstname': 'Jan Krzysztof', 'initials': 'JK', 'affiliation': 'Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, USA.'}, {'lastname': 'Kowall', 'firstname': 'Neil', 'initials': 'N', 'affiliation': ""Department of Neurology, Boston University School of Medicine, Boston, MA, USA.\nAlzheimer's Disease Center, Boston University School of Medicine, Boston, MA, USA.""}, {'lastname': 'Qiu', 'firstname': 'Wei Qiao', 'initials': 'WQ', 'affiliation': ""Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.\nAlzheimer's Disease Center, Boston University School of Medicine, Boston, MA, USA.\nDepartment of Psychiatry, Boston University School of Medicine, Boston, MA, USA.""}]",,,,,10.3233/JAD-160677,<Element 'PubmedArticle' at 0x7f05dac63220>
423,"27891070
22658946
15777732
2737792
21789566
25590967
22960850
17223086
22982254
8096377
21681557
38325
10322493
20850389
8719028
17212700
21441606
18639237
2139189
26415919
18372288
6280074
26427608
20196795
26544593
24948484
22758607
22210279
20043029
23219031
25769377
21175212
26606998
15715998
17762320
23692496
11453105
23238976
3703913
9453469
11860278
16443286
24062645
11069974
9241279
3004318
26986179
23146067
19480470
8112229
18181565
13194705
11931695
12644274
18138512
18615128
25221471
15140183
20969569
27223666
14724239
19966779
25732035
23230232
24609207
15808341
25471567
2166921
25769369
1732702
8937441
2563686
9178847
25813654
9483565
27013075
15862514
12065073
15505174
11597777
11008171
23298414
26617215
10721879
18790822
23188702
25481722
8773250
19682955
16383150
24607445
18160701
12076101
11218071
20493725
15371287
25044816
22957244
15465138
19837769
6822959
1612101
8880732
12513948
15050708
8048747
16473127
25852551
25386820
12563283
23395350
21193011
12270969
17588547
10759301
20655708
8632190
9928241
22881836
2540882
25750618
23468209
9795156
17069795
27371672
18936753
26647175
10432472
18771755
26797191
23532506
14769389
9482787
16125861
16169281
11028680
20153428
16140503
17341653
9739010
11640977
9657646
23665640
19375285
7614912
20808325
18685554
338448
8522988
5300187
8216882
1321029
11421848
21777827
12811638
20384765
7865169
24690630
21951270
590223
21684291
15993434
8667204
9886681
10027835
18727636
3365458
22768266
11812526
26841829
21185346
21971003
17548158
22681516
7823126
2494052
18054462
19591935
3034636
15928827
27595591
12750432
1124270
21261789
15533323
11879979
17985260
24905529
3133314
26302787
8884171
18420859
18781914
26392380
25721336
27375423
10773209
6617734
1619966
24935789
23780309
18367215
16320306
25412650
26908034
25418676
22578701
11580772
16313900
16313900
17276417
23333373
24440891
1968684
23090943
21864289
13944086
3280560
1592842
24020973
21323924
23469922
23116392
2716948
21094615
20478436
7561864
21214537
14697902
24472685
21964255
15060530
10928964
11356863
24776492
844488
7712172
9517442
22957248
10206230
10733010
10924870
9024952
22191083
11121072
22829357
17618543
21498047
20619420
1846044
1393577
22453856
16958986
19138464
26822114
4080761
8787131
8603634
11888556
20435093
26924854
15183527
15894059
20304332
20074235
9180080
25922088
26321393
21277833
7700379
15346169
22782314
12444482
26191504
20625330
3022184
3037865
18076117
27252617
9831290
12608709
24009559
27085605
8843604
9562184
9221955
25034463
9696406
11504801
11567066
2159408
25243904
16765343
20485326
17485199
18566292
23562670
9507130
8504793
1374472
24093801
24429728
22543085
15548424
8101246
19810877
16552415
20827273
22505826",Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs.,"A large body of experimental and clinical evidence has strongly suggested that monoamines play an important role in regulating epileptogenesis, seizure susceptibility, convulsions, and comorbid psychiatric disorders commonly seen in people with epilepsy (PWE). However, neither the relative significance of individual monoamines nor their interaction has yet been fully clarified due to the complexity of these neurotransmitter systems. In addition, epilepsy is diverse, with many different seizure types and epilepsy syndromes, and the role played by monoamines may vary from one condition to another. In this review, we will focus on the role of serotonin, dopamine, noradrenaline, histamine, and melatonin in epilepsy. Recent experimental, clinical, and genetic evidence will be reviewed in consideration of the mutual relationship of monoamines with the other putative neurotransmitters. The complexity of epileptic pathogenesis may explain why the currently available drugs, developed according to the classic drug discovery paradigm of ""one-molecule-one-target,"" have turned out to be effective only in a percentage of PWE. Although, no antiepileptic drugs currently target specifically monoaminergic systems, multi-target directed ligands acting on different monoaminergic proteins, present on both neurons and glia cells, may represent a new approach in the management of seizures, and their generation as well as comorbid neuropsychiatric disorders.","['antiepileptic drugs', 'astrocytes', 'epilepsy', 'epileptogenesis', 'microglia', 'monoamine receptors', 'multi-target direct ligands', 'quad-partite synapse']",Frontiers in neuroscience,2016-11-29,"[{'lastname': 'Svob Strac', 'firstname': 'Dubravka', 'initials': 'D', 'affiliation': 'Division of Molecular Medicine, Rudjer Boskovic Institute Zagreb, Croatia.'}, {'lastname': 'Pivac', 'firstname': 'Nela', 'initials': 'N', 'affiliation': 'Division of Molecular Medicine, Rudjer Boskovic Institute Zagreb, Croatia.'}, {'lastname': 'Smolders', 'firstname': 'Ilse J', 'initials': 'IJ', 'affiliation': 'Department of Pharmaceutical Chemistry and Drug Analysis, Vrije Universiteit Brussel Brussels, Belgium.'}, {'lastname': 'Fogel', 'firstname': 'Wieslawa A', 'initials': 'WA', 'affiliation': 'Department of Hormone Biochemistry, Medical University of Lodz Lodz, Poland.'}, {'lastname': 'De Deurwaerdere', 'firstname': 'Philippe', 'initials': 'P', 'affiliation': 'Centre National de la Recherche Scientifique (Unité Mixte de Recherche 5293) Bordeaux, France.'}, {'lastname': 'Di Giovanni', 'firstname': 'Giuseppe', 'initials': 'G', 'affiliation': 'Laboratory of Neurophysiology, Department of Physiology and Biochemistry, University of Malta Msida, Malta.'}]",,,,,"10.3389/fnins.2016.00492
10.1016/j.yebeh.2012.04.134
10.1016/j.eplepsyres.2005.02.002
10.1007/s11011-011-9254-x
10.1097/FBP.0000000000000127
10.1097/MJT.0b013e31825b9eb5
10.1016/j.biopsych.2006.09.023
10.1016/j.neuropharm.2012.08.023
10.1146/annurev.ne.16.030193.000445
10.1007/s10571-011-9726-x
10.1111/j.2042-7158.1979.tb13563.x
10.1016/S0166-2236(98)01349-6
10.1016/j.yebeh.2010.07.030
10.1016/S0893-133X(96)80057-1
10.1111/j.1471-4159.2006.04277.x
10.1016/S1734-1140(11)70393-0
10.1016/j.biopsych.2008.06.008
10.1016/0306-4522(90)90314-T
10.1111/epi.13201
10.1093/cercor/bhn040
10.1038/297076a0
10.1002/cmdc.201500383
10.1111/j.1528-1167.2010.02522.x
10.1371/journal.pone.0141098
10.1016/j.schres.2014.03.035
10.1111/j.1476-5381.2012.02093.x
10.1016/j.addr.2011.11.006
10.1038/nrd2997
10.1016/j.eplepsyres.2012.10.001
10.1016/j.eplepsyres.2015.01.001
10.1021/jm101359c
10.1016/j.neuron.2015.10.046
10.1016/j.eplepsyres.2004.12.001
10.1097/wnf.0b013e3180413d7d
10.1111/epi.12220
10.1007/s00702-012-0948-y
10.1016/0091-3057(86)90591-5
10.1007/PL00005123
10.1006/mcne.2001.1064
10.1016/j.tins.2006.01.002
10.3389/fncel.2013.00157
10.1038/ng0897-387
10.1002/ana.410190106
10.1002/14651858.CD006967.pub3
10.1111/bph.12052
10.2165/00023210-200923060-00006
10.1111/j.1528-1157.1994.tb02905.x
10.1021/jm7009364
10.3181/00379727-86-21149
10.1016/S0006-8993(03)02229-7
10.1001/jama.1949.02910010020004
10.2174/157015906776359540
10.3389/fncel.2014.00250
10.1111/j.1471-4159.2004.02355.x
10.1111/j.1471-4159.2010.07065.x
10.1097/WNF.0000000000000159
10.1523/JNEUROSCI.2806-03.2004
10.1038/nm.2058
10.1101/cshperspect.a022434
10.1113/jphysiol.2012.243378
10.1177/1073858414523320
10.1016/j.tips.2005.02.007
10.1523/JNEUROSCI.1465-14.2014
10.1016/0028-3908(90)90062-V
10.1016/j.eplepsyres.2014.12.013
10.1016/0024-3205(92)90340-U
10.1016/S0006-2952(96)00509-6
10.1016/0920-1211(89)90063-6
10.1016/S0304-3940(97)00288-7
10.1016/j.bcp.2015.03.011
10.1016/S0306-4522(97)00414-4
10.1016/j.pneurobio.2016.03.004
10.1016/j.brainres.2005.02.027
10.1016/S0014-2999(02)01536-4
10.1212/01.WNL.0000142092.16719.AD
10.1016/S0169-328X(01)00240-6
10.1016/S0306-4522(00)00266-9
10.1016/j.tins.2012.11.008
10.1016/j.pharmthera.2015.11.009
10.1055/s-2000-8449
10.1093/brain/awn220
10.1007/s12031-012-9927-x
10.1007/s13760-014-0400-1
10.1007/BF00230052
10.1016/j.yebeh.2009.07.022
10.1016/j.pharmthera.2014.02.010
10.1124/pr.59.07103
10.1053/seiz.2001.0644
10.1007/s002100000341
10.1016/j.seizure.2010.04.011
10.1093/brain/awh267
10.1002/hipo.22327
10.1155/2012/809843
10.1016/j.neubiorev.2004.06.008
10.2967/jnumed.109.063743
10.1016/0014-2999(92)90412-W
10.1016/0149-7634(95)00052-6
10.1016/S0006-3223(02)01440-3
10.1016/j.neulet.2004.01.072
10.1111/j.1530-0277.1994.tb00034.x
10.1016/S0140-6736(06)68182-8
10.3389/fphar.2015.00046
10.2174/0929867321666141106122628
10.1038/nrn1034
10.1016/j.yebeh.2012.10.009
10.1016/j.pneurobio.2010.12.004
10.1212/wnl.59.6_suppl_4.s48
10.1016/j.biopsych.2007.02.015
10.3906/biy-1507-32
10.1016/S0920-1211(99)00116-3
10.1016/j.eplepsyres.2010.06.008
10.1046/j.1471-4159.1996.66062621.x
10.1111/j.1749-6632.1998.tb10175.x
10.1111/j.1528-1167.2012.03603.x
10.1016/0006-8993(89)90743-9
10.3389/fnbeh.2015.00308
10.1136/jmedgenet-2012-101448
10.1016/S0169-328X(98)00206-X
10.1016/j.ejphar.2006.09.049
10.1101/cshperspect.a028043
10.1038/nchembio.118
10.1016/j.ymgme.2015.11.008
10.1016/S0893-133X(99)00030-5
10.1016/j.intimp.2008.08.004
10.1016/j.pneurobio.2015.12.003
10.1007/s40264-013-0033-y
10.1016/S0014-4886(03)00352-2
10.1016/j.neuroscience.2005.06.066
10.1016/j.yebeh.2005.07.014
10.1016/j.nbd.2010.02.001
10.1016/j.eplepsyres.2005.07.007
10.1124/mol.106.031773
10.1016/S0361-9230(98)00048-3
10.1016/S0166-4328(01)00218-2
10.1016/S0920-1211(98)00005-9
10.1016/j.yebeh.2013.03.018
10.1016/j.eplepsyres.2009.03.010
10.1111/j.1528-1157.1995.tb00996.x
10.1038/ejhg.2010.149
10.1111/j.1440-1819.1977.tb02637.x
10.1046/j.1471-4159.1996.66010047.x
10.1254/jjp.17.409
10.1016/0741-8329(93)90022-G
10.1111/j.1528-1157.1992.tb02336.x
10.1034/j.1600-0404.2001.103006360.x
10.1016/S1474-4422(11)70141-7
10.1007/s00702-003-0825-9
10.1111/j.1528-1167.2010.02569.x
10.1007/BF01276434
10.1371/journal.pone.0093158
10.1111/j.1468-1331.2011.03521.x
10.1111/j.1528-1157.1977.tb04991.x
10.1016/j.lfs.2011.05.011
10.1016/j.neuropharm.2005.03.020
10.1016/S0028-3908(98)00130-0
10.1111/j.1468-2982.2008.01677.x
10.1016/0006-3223(88)90070-4
10.1371/journal.pone.0040262
10.1016/S0091-3057(01)00654-2
10.1038/jhg.2016.5
10.1016/j.pnpbp.2010.12.017
10.1016/B978-0-12-386467-3.00004-2
10.1016/j.neulet.2007.05.022
10.1111/j.1469-1809.2012.00713.x
10.1016/0014-4886(89)90002-2
10.1016/j.eplepsyres.2007.10.007
10.1016/j.nbd.2009.06.015
10.1016/0014-2999(87)90690-X
10.1007/s00011-004-0418-6
10.1016/j.eplepsyres.2016.08.029
10.1124/jpet.103.051797
10.1111/j.1442-200X.2011.03328.x
10.1016/j.brainres.2004.09.014
10.1016/S0378-4274(01)00475-1
10.1055/s-2007-985138
10.1016/j.pharep.2013.10.006
10.1186/s13073-015-0214-7
10.1016/0920-1211(96)00030-7
10.1213/ane.0b013e31816ba49d
10.2174/138920008785821738
10.1038/nrneurol.2015.172
10.1007/s40263-015-0236-0
10.3389/fnins.2016.00265
10.1016/S0006-8993(00)02141-7
10.1016/0014-2999(83)90369-2
10.1111/cns.12285
10.1007/s00221-013-3594-1
10.1016/j.neuropharm.2008.02.011
10.1002/syn.20225
10.2174/1381612821666141121114917
10.1007/s13760-016-0616-3
10.1021/cn5002182
10.1016/j.eplepsyres.2012.04.004
10.1046/j.1528-1157.2001.28100.x
10.1016/j.ejphar.2005.10.021
10.1016/j.ejphar.2005.10.021
10.1016/j.brainres.2007.01.019
10.1016/j.brainres.2012.12.045
10.1016/j.yebeh.2013.12.013
10.1002/syn.890050210
10.1113/jphysiol.2012.242016
10.2174/092986711797379302
10.1002/jps.2600520217
10.2174/13894501113149990209
10.1111/j.1471-4159.2011.07214.x
10.2174/13894501113149990156
10.2174/1381612811319140004
10.1159/000125088
10.1016/j.seizure.2010.10.029
10.1016/S0079-6123(08)81008-4
10.1046/j.1471-4159.1995.65041674.x
10.1111/j.1528-1167.2010.02908.x
10.1016/S0161-813X(03)00106-2
10.1016/j.yebeh.2014.01.001
10.1016/j.nbd.2011.09.006
10.1038/nrd1346
10.1038/sj.bjp.0703457
10.1097/FBP.0000000000000042
10.1016/0014-2999(77)90188-1
10.1016/0006-8993(94)01235-A
10.1016/S0028-3908(97)00134-2
10.1155/2012/863702
10.1002/(SICI)1096-8628(19990416)88:2<126::AID-AJMG6>3.0.CO;2-M
10.1016/S0197-0186(99)00134-5
10.1016/S0920-1211(00)00120-0
10.1016/S0006-3223(96)00044-3
10.1073/pnas.97.26.14731
10.1002/glia.22389
10.1007/s11910-007-0053-z
10.1016/j.eplepsyres.2011.03.013
10.1016/j.jpsychires.2010.06.005
10.1016/0006-8993(92)91580-8
10.1007/s10571-012-9828-0
10.1111/j.1527-3458.2006.00123.x
10.1179/174313209X385545
10.1021/acschemneuro.5b00342
10.1016/0091-3057(85)90067-X
10.1002/(SICI)1098-2396(199602)22:2<159::AID-SYN8>3.0.CO;2-C
10.1111/j.1528-1157.1996.tb00565.x
10.1016/S0091-3057(01)00742-0
10.1016/j.neulet.2010.04.060
10.4172/2167-6801.1000129
10.1016/j.neuroscience.2004.04.030
10.1016/j.pbb.2005.01.020
10.1016/j.pediatrneurol.2009.11.001
10.1111/j.1528-1167.2009.02423.x
10.1126/science.276.5319.1699
10.1016/j.yebeh.2015.03.021
10.1016/j.brainresbull.2015.08.006
10.1016/j.yebeh.2010.12.021
10.1038/374542a0
10.1046/j.1535-7597.2003.03508.x
10.2967/jnumed.112.103093
10.1007/s00221-002-1259-6
10.15171/bi.2015.07
10.1097/WNR.0b013e32833d5891
10.1016/0028-3908(86)90029-8
10.1007/BF02074683
10.1002/ajmg.a.32070
10.3389/fnins.2016.00205
10.1016/S0014-2999(98)00621-9
10.1023/A:1022433421761
10.3389/fncel.2013.00139
10.1016/j.neuropharm.2016.04.016
10.1016/0166-2236(96)10048-5
10.1002/(SICI)1098-1136(199805)23:1<45::AID-GLIA5>3.0.CO;2-3
10.1016/S0006-8993(97)00366-1
10.1007/s12035-014-8806-6
10.1016/S0014-2999(98)00255-6
10.1016/0014-4886(90)90020-S
10.1111/cbdd.12438
10.1016/j.ejphar.2006.04.049
10.1038/ejhg.2010.41
10.1016/j.eplepsyres.2007.03.017
10.1124/jpet.108.139212
10.1016/j.expneurol.2013.03.023
10.1016/S0006-8993(97)01139-6
10.1016/0920-1211(93)90047-B
10.1089/gtmb.2013.0341
10.1007/s12264-013-1396-x
10.1016/j.ejphar.2012.04.011
10.1016/j.molbrainres.2004.08.019
10.1586/14737175.3.6.737
10.1038/nrn1883
10.1038/npp.2010.116
10.2147/IJGM.S29320",<Element 'PubmedArticle' at 0x7f05dac8bc20>
424,"27870450
25863812
20498670
18026097
10567732
12351732
12421344
15156148
19446073
19028515
24398264
15256495
18406680
17561817
24888361
24759411
22178198
22982535
20124437
19782746
26472628
24184474
23823752
24797632
22488761
15289276
23337946
17395708
18249087
18386786
24969261
15708626
19250439
26822608
22175701
17029703
19706184
23686747
26949719
23467340
22568433
22825593
22040257
24191147
26733814
26279833
12388607
16488877
23207108
22520439
26797518
11596126
552788
24742461
19914372
25110235
22869038
4715291
17553574
22841693
12209854
3061565
16495461
7420225
20966214
26408796
25610363
24132902
19756668
18970899
17965659
11596120
1583531
26809250
21752601
21527731
17764664
12838577
25311587
22674620
24009762
26643539
8843599
19805359
25218900
25199956
24871624
23407936
22363256
11831551
22198119
16013043
19429388
18726913
22497984
26872595
20212133
11678351
24509090
10732804
18195084
21613996
16672647
16378711
19442688
18023140
21219963
24837101
24973728
9952422
12480129
21849535
22516109
20674603
15452574
18768700
22632453
19004805
25468773
15831717
25821913
26464992
14432658
21131957
17952068
23752249
24012647
24863806
19305396
4715296
25725160
18940377
21745355
24157239
22829357
22182318
19155488
25172349
18286612
23845731
25814933
17913903
24642725
26300736
20012068
21907243
16567644
8469435
23404112
26184457
15380298
22697211
23089258
24129217
15546155
18522863
11245665
20557401
26892004
22031897
26370672
19846715
20417572
16325480
25042426
8225253
9284073",The immune system as a novel regulator of sex differences in brain and behavioral development.,"Sexual differentiation of the brain occurs early in life as a result of sex-typical hormone action and sex chromosome effects. Immunocompetent cells are being recognized as underappreciated regulators of sex differences in brain and behavioral development, including microglia, astrocytes, and possibly other less well studied cell types, including T cells and mast cells. Immunocompetent cells in the brain are responsive to steroid hormones, but their role in sex-specific brain development is an emerging field of interest. This Review presents a summary of what is currently known about sex differences in the number, morphology, and signaling profile of immune cells in the developing brain and their role in the early-life programming of sex differences in brain and behavior. We review what is currently known about sex differences in the response to early-life perturbations, including stress, inflammation, diet, and environmental pollutants. We also discuss how and why understanding sex differences in the developing neuroimmune environment may provide insight into understanding the etiology of several neurodevelopmental disorders. This Review also highlights what remains to be discovered in this emerging field of developmental neuroimmunology and underscores the importance of filling in these knowledge gaps. © 2016 Wiley Periodicals, Inc.","['astrocytes', 'behavior', 'brain', 'development', 'hormone', 'immune response', 'inflammation', 'microglia', 'sex', 'sex differences']",Journal of neuroscience research,2016-11-22,"[{'lastname': 'Nelson', 'firstname': 'Lars H', 'initials': 'LH', 'affiliation': 'Program in Neuroscience, The Ohio State University, Columbus, Ohio.\nGroup in Behavioral Neuroendocrinology, The Ohio State University, Columbus, Ohio.'}, {'lastname': 'Lenz', 'firstname': 'Kathryn M', 'initials': 'KM', 'affiliation': 'Group in Behavioral Neuroendocrinology, The Ohio State University, Columbus, Ohio.\nDepartment of Psychology, The Ohio State University, Columbus, Ohio.\nDepartment of Neuroscience, The Ohio State University, Columbus, Ohio.'}]",,,,"© 2016 Wiley Periodicals, Inc.","10.1002/jnr.23821
10.1186/s13293-015-0032-z
10.1016/j.bbi.2015.09.015
10.3389/fnins.2014.00420
10.1016/j.biopsych.2015.11.024
10.1038/nrneurol.2014.187
10.1371/journal.pone.0073699
10.1038/mp.2015.183
10.1523/ENEURO.0036-15.2015
10.3389/fncel.2015.00082
10.3389/fncel.2015.00301",<Element 'PubmedArticle' at 0x7f05dabb1180>
425,27864692,Transglutaminase 2 is involved in amyloid-beta,"Deposition of amyloid-beta (Aβ) peptides has been shown to induce the release of inflammatory factors by activated microglia and brain infiltrating monocytes/macrophages. Interestingly, the enzyme transglutaminase 2 (TG2) has been shown to play a key role in neuroinflammation and regulation of transcription factors involved in immunomodulation. In this study, we aimed to better elucidate the mechanisms underlying TG2 involvement in the pro-inflammatory signaling pathway activated by fibrillar Aβ","['AP1', 'Amyloid-beta1–42', 'Cytokines', 'R283', 'THP-1 monocytes', 'Transglutaminase 2']",Amino acids,2016-11-20,"[{'lastname': 'Currò', 'firstname': 'Monica', 'initials': 'M', 'affiliation': 'Department of Biomedical Sciences, Dental Sciences and Morpho-functional Imaging, Polyclinic Hospital University, Via C. Valeria, 98125, Messina, Italy.'}, {'lastname': 'Gangemi', 'firstname': 'Chiara', 'initials': 'C', 'affiliation': 'Department of Biomedical Sciences, Dental Sciences and Morpho-functional Imaging, Polyclinic Hospital University, Via C. Valeria, 98125, Messina, Italy.'}, {'lastname': 'Giunta', 'firstname': 'Maria Laura', 'initials': 'ML', 'affiliation': 'Department of Biomedical Sciences, Dental Sciences and Morpho-functional Imaging, Polyclinic Hospital University, Via C. Valeria, 98125, Messina, Italy.'}, {'lastname': 'Ferlazzo', 'firstname': 'Nadia', 'initials': 'N', 'affiliation': 'Department of Biomedical Sciences, Dental Sciences and Morpho-functional Imaging, Polyclinic Hospital University, Via C. Valeria, 98125, Messina, Italy.\nDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Annunziata, 98168, Messina, Italy.'}, {'lastname': 'Navarra', 'firstname': 'Michele', 'initials': 'M', 'affiliation': 'Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Annunziata, 98168, Messina, Italy.'}, {'lastname': 'Ientile', 'firstname': 'Riccardo', 'initials': 'R', 'affiliation': 'Department of Biomedical Sciences, Dental Sciences and Morpho-functional Imaging, Polyclinic Hospital University, Via C. Valeria, 98125, Messina, Italy. ientile@unime.it.'}, {'lastname': 'Caccamo', 'firstname': 'Daniela', 'initials': 'D', 'affiliation': 'Department of Biomedical Sciences, Dental Sciences and Morpho-functional Imaging, Polyclinic Hospital University, Via C. Valeria, 98125, Messina, Italy.'}]",,,,,10.1007/s00726-016-2366-1,<Element 'PubmedArticle' at 0x7f05dab7fe50>
426,27864453,Glial cells and energy balance.,"The search for new strategies and drugs to abate the current obesity epidemic has led to the intensification of research aimed at understanding the neuroendocrine control of appetite and energy expenditure. This intensified investigation of metabolic control has also included the study of how glial cells participate in this process. Glia, the most abundant cell type in the central nervous system, perform a wide spectrum of functions and are vital for the correct functioning of neurons and neuronal circuits. Current evidence indicates that hypothalamic glia, in particular astrocytes, tanycytes and microglia, are involved in both physiological and pathophysiological mechanisms of appetite and metabolic control, at least in part by regulating the signals reaching metabolic neuronal circuits. Glia transport nutrients, hormones and neurotransmitters; they secrete growth factors, hormones, cytokines and gliotransmitters and are a source of neuroprogenitor cells. These functions are regulated, as glia also respond to numerous hormones and nutrients, with the lack of specific hormonal signaling in hypothalamic astrocytes disrupting metabolic homeostasis. Here, we review some of the more recent advances in the role of glial cells in metabolic control, with a special emphasis on the differences between glial cell responses in males and females.","['gliosis', 'high-fat diet', 'hypothalamic inflammation', 'sexual dimorphism']",Journal of molecular endocrinology,2016-11-20,"[{'lastname': 'Argente-Arizón', 'firstname': 'Pilar', 'initials': 'P', 'affiliation': 'Departments of Pediatrics & Pediatric EndocrinologyHospital Infantil Universitario Niño Jesús, Instituto de Investigación La Princesa, Department of Pediatrics, Universidad Autónoma de Madrid, CIBEROBN, Instituto de Salud Carlos III, Madrid, Spain.'}, {'lastname': 'Guerra-Cantera', 'firstname': 'Santiago', 'initials': 'S', 'affiliation': 'Departments of Pediatrics & Pediatric EndocrinologyHospital Infantil Universitario Niño Jesús, Instituto de Investigación La Princesa, Department of Pediatrics, Universidad Autónoma de Madrid, CIBEROBN, Instituto de Salud Carlos III, Madrid, Spain.'}, {'lastname': 'Garcia-Segura', 'firstname': 'Luis Miguel', 'initials': 'LM', 'affiliation': 'Instituto CajalConsejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.'}, {'lastname': 'Argente', 'firstname': 'Jesús', 'initials': 'J', 'affiliation': 'Departments of Pediatrics & Pediatric EndocrinologyHospital Infantil Universitario Niño Jesús, Instituto de Investigación La Princesa, Department of Pediatrics, Universidad Autónoma de Madrid, CIBEROBN, Instituto de Salud Carlos III, Madrid, Spain.'}, {'lastname': 'Chowen', 'firstname': 'Julie A', 'initials': 'JA', 'affiliation': 'Departments of Pediatrics & Pediatric EndocrinologyHospital Infantil Universitario Niño Jesús, Instituto de Investigación La Princesa, Department of Pediatrics, Universidad Autónoma de Madrid, CIBEROBN, Instituto de Salud Carlos III, Madrid, Spain julieann.chowen@salud.madrid.org.'}]",,,,© 2017 Society for Endocrinology.,10.1530/JME-16-0182,<Element 'PubmedArticle' at 0x7f05dab95c70>
427,"27848175
20056019
9842048
22078110
22126762
26799652
1126630
10775772
22258259
11756670
18464797
21697485
22889139
15705855
17187072
21980521
22801223
22170342
21151176
20303880
25140166
22762340
20421432
24428125
15765805
17581253
23293645
11886259
23339605
17389748
23157435
25139436
18265332
7923996
24485991
16497588
20078993
12007645
16239148
23175366
16794605
19475621
26694447
25444403
9854452
22439724
24367714",Glucocorticoids Prevent Enterovirus 71 Capsid Protein VP1 Induced Calreticulin Surface Exposure by Alleviating Neuronal ER Stress.,"Severe hand-foot-and-mouth disease (HFMD) caused by Enterovirus 71 (EV71) always accompanies with inflammation and neuronal damage in the central nervous system (CNS). During neuronal injuries, cell surface-exposed calreticulin (Ecto-CRT) is an important mediator for primary phagocytosis of viable neurons by microglia. Our data confirmed that brainstem neurons underwent neuronophagia by glia in EV71-induced death cases of HFMD. EV71 capsid proteins VP1, VP2, VP3, or VP4 did not induce apoptosis of brainstem neurons. Interestingly, we found VP1-activated endoplasmic reticulum (ER) stress and autophagy could promote Ecto-CRT upregulation, but ER stress or autophagy alone was not sufficient to induce CRT exposure. Furthermore, we demonstrated that VP1-induced autophagy activation was mediated by ER stress. Meaningfully, we found dexamethasone treatment could attenuate Ecto-CRT upregulation by alleviating VP1-induced ER stress. Altogether, these findings identify VP1-promoted Ecto-CRT upregulation as a novel mechanism of EV71-induced neuronal cell damage and highlight the potential of the use of glucocorticoids to treat severe HFMD patients with CNS complications.","['Calreticulin', 'Enterovirus 71', 'Glucocorticoids', 'Hand-foot-and-mouth disease']",Neurotoxicity research,2016-11-17,"[{'lastname': 'Hu', 'firstname': 'Dan-Dan', 'initials': 'DD', 'affiliation': ""Department of Anatomy Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China.\nGuangzhou Women and Children's Medical Center, Guangzhou, 510623, Guangdong, China.""}, {'lastname': 'Mai', 'firstname': 'Jian-Ning', 'initials': 'JN', 'affiliation': ""Guangzhou Women and Children's Medical Center, Guangzhou, 510623, Guangdong, China.""}, {'lastname': 'He', 'firstname': 'Li-Ya', 'initials': 'LY', 'affiliation': ""Guangzhou Women and Children's Medical Center, Guangzhou, 510623, Guangdong, China.""}, {'lastname': 'Li', 'firstname': 'Pei-Qing', 'initials': 'PQ', 'affiliation': ""Guangzhou Women and Children's Medical Center, Guangzhou, 510623, Guangdong, China.""}, {'lastname': 'Chen', 'firstname': 'Wen-Xiong', 'initials': 'WX', 'affiliation': ""Guangzhou Women and Children's Medical Center, Guangzhou, 510623, Guangdong, China.""}, {'lastname': 'Yan', 'firstname': 'Jian-Jiang', 'initials': 'JJ', 'affiliation': ""Guangzhou Women and Children's Medical Center, Guangzhou, 510623, Guangdong, China.""}, {'lastname': 'Zhu', 'firstname': 'Wei-Dong', 'initials': 'WD', 'affiliation': ""Guangzhou Women and Children's Medical Center, Guangzhou, 510623, Guangdong, China.""}, {'lastname': 'Deng', 'firstname': 'Li', 'initials': 'L', 'affiliation': ""Guangzhou Women and Children's Medical Center, Guangzhou, 510623, Guangdong, China.""}, {'lastname': 'Wei', 'firstname': 'Dan', 'initials': 'D', 'affiliation': 'First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.'}, {'lastname': 'Liu', 'firstname': 'Di-Hui', 'initials': 'DH', 'affiliation': 'United Family Healthcare Guangzhou Clinic, Guangzhou, 510600, China.'}, {'lastname': 'Yang', 'firstname': 'Si-Da', 'initials': 'SD', 'affiliation': ""Guangzhou Women and Children's Medical Center, Guangzhou, 510623, Guangdong, China. sidayang@gmail.com.""}, {'lastname': 'Yao', 'firstname': 'Zhi-Bin', 'initials': 'ZB', 'affiliation': 'Department of Anatomy Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China. yaozb_sysu@sina.com.'}]",,,,,10.1007/s12640-016-9670-0,<Element 'PubmedArticle' at 0x7f05dab21270>
428,"27814376
17113430
11853768
17267005
24367157
18639614
17111372
22562504
22546314
27160072
21689103
26447367
27081297
26750157
17965659
18644426
18567623
20561356
26139610
24920619
22986110
24929065
24599476
26527153
24397957
21565615
24023619
17827340
18546601
11846609
23470532
18079678
20573418
12110890
25505286
15955682
17572686
16951368
3876985
9890430
18554968
17653052
23022404
16270028
26576678
25595590
16043876
7550361
25873768
11495925
25191897
15774461
9024663
12714508
19723636
9390561
9724801
22536384
16732273
10652441
19627440
24989686
27314452
22039242
26170250
12663039
15904993
23499256
26038823
26329692
26514658
10899174",Progesterone Attenuates Microglial-Driven Retinal Degeneration and Stimulates Protective Fractalkine-CX3CR1 Signaling.,"Retinitis pigmentosa (RP) is a degenerative disease leading to photoreceptor cell loss. Mouse models of RP, such as the rd10 mouse (B6.CXBl-Pde6brd10/J), have enhanced our understanding of the disease, allowing for development of potential therapeutics. In 2011, our group first demonstrated that the synthetic progesterone analogue 'Norgestrel' is neuroprotective in two mouse models of retinal degeneration, including the rd10 mouse. We have since elucidated several mechanisms by which Norgestrel protects stressed photoreceptors, such as upregulating growth factors. This study consequently aimed to further characterize Norgestrel's neuroprotective effects. Specifically, we sought to investigate the role that microglia might play; for microglial-derived inflammation has been shown to potentiate neurodegeneration. Dams of post-natal day (P) 10 rd10 pups were given a Norgestrel-supplemented diet (80mg/kg). Upon weaning, pups remained on Norgestrel. Tissue was harvested from P15-P50 rd10 mice on control or Norgestrel-supplemented diet. Norgestrel-diet administration provided significant retinal protection out to P40 in rd10 mice. Alterations in microglial activity coincided with significant protection, implicating microglial changes in Norgestrel-induced neuroprotection. Utilizing primary cultures of retinal microglia and 661W photoreceptor-like cells, we show that rd10 microglia drive neuronal cell death. We reveal a novel role of Norgestrel, acting directly on microglia to reduce pro-inflammatory activation and prevent neuronal cell death. Norgestrel effectively suppresses cytokine, chemokine and danger-associated molecular pattern molecule (DAMP) expression in the rd10 retina. Remarkably, Norgestrel upregulates fractalkine-CX3CR1 signaling 1 000-fold at the RNA level, in the rd10 mouse. Fractalkine-CX3CR1 signaling has been shown to protect neurons by regulating retinal microglial activation and migration. Ultimately, these results present Norgestrel as a promising treatment for RP, with dual actions as a neuroprotective and anti-inflammatory agent in the retina.",[],PloS one,2016-11-05,"[{'lastname': 'Roche', 'firstname': 'Sarah L', 'initials': 'SL', 'affiliation': 'Cell Development and Disease Laboratory, Biochemistry Department, Biosciences Institute, University College Cork, Cork, Ireland.'}, {'lastname': 'Wyse-Jackson', 'firstname': 'Alice C', 'initials': 'AC', 'affiliation': 'Cell Development and Disease Laboratory, Biochemistry Department, Biosciences Institute, University College Cork, Cork, Ireland.'}, {'lastname': 'Gómez-Vicente', 'firstname': 'Violeta', 'initials': 'V', 'affiliation': 'Departamento de Óptica, Farmacología y Anatomía, Universidad de Alicante, Alicante, Spain.'}, {'lastname': 'Lax', 'firstname': 'Pedro', 'initials': 'P', 'affiliation': 'Departamento de Fisiología, Genética y Microbiología, Universidad de Alicante, Alicante, Spain.'}, {'lastname': 'Ruiz-Lopez', 'firstname': 'Ana M', 'initials': 'AM', 'affiliation': 'Cell Development and Disease Laboratory, Biochemistry Department, Biosciences Institute, University College Cork, Cork, Ireland.'}, {'lastname': 'Byrne', 'firstname': 'Ashleigh M', 'initials': 'AM', 'affiliation': 'Cell Development and Disease Laboratory, Biochemistry Department, Biosciences Institute, University College Cork, Cork, Ireland.'}, {'lastname': 'Cuenca', 'firstname': 'Nicolás', 'initials': 'N', 'affiliation': 'Departamento de Fisiología, Genética y Microbiología, Universidad de Alicante, Alicante, Spain.'}, {'lastname': 'Cotter', 'firstname': 'Thomas G', 'initials': 'TG', 'affiliation': 'Cell Development and Disease Laboratory, Biochemistry Department, Biosciences Institute, University College Cork, Cork, Ireland.'}]",,,,,"10.1371/journal.pone.0165197
10.1016/S0140-6736(06)69740-7
10.1016/j.visres.2006.11.020
10.1016/j.neuroscience.2008.06.042
10.1002/cne.21144
10.1016/j.exer.2012.04.004
10.1387/ijdb.150400tc
10.1111/j.1471-4159.2011.07354.x
10.1111/jnc.13388
10.1111/ejn.13166
10.1038/nn1997
10.1016/j.neuroscience.2008.06.046
10.1111/j.1365-2567.2009.03225.x
10.15252/emmm.201505298
10.1016/j.ophtha.2012.07.008
10.1016/j.neuroscience.2014.05.065
10.1186/1742-2094-11-3
10.1016/j.cell.2011.03.050
10.1371/journal.pone.0072457
10.1189/jlb.0707447
10.1016/j.imbio.2010.05.010
10.1038/nature00858
10.1016/j.coi.2005.06.002
10.1038/nm1603
10.1002/(SICI)1097-4547(19990101)55:1<17::AID-JNR3>3.0.CO;2-J
10.1016/j.exer.2012.08.013
10.1155/2015/673090
10.1074/jbc.M106434200
10.1371/journal.pone.0106562
10.1074/jbc.M413073200
10.1038/385640a0
10.1182/blood-2002-12-3775
10.1074/jbc.M109.045682
10.1371/journal.pone.0035446
10.1038/nn1715
10.1111/j.1471-4159.2009.06253.x
10.1002/glia.22715
10.1002/glia.23016
10.1038/srep11764
10.1016/j.neuint.2005.04.018
10.1016/j.jneuroim.2013.02.008
10.1371/journal.pone.0127730
10.1186/s12974-015-0386-5",<Element 'PubmedArticle' at 0x7f05dab38ea0>
429,"27812200
22367679
24513088
11940709
25634435
22159112
19428957
18371179
23388509
21389984
21836616
10203688
26215419
25545035
25126957
24826922
25187344
22473697
22751353
20136703
22288937
25672725
25017304
26004897
25558000
26547530
20002786
20449875",Melatonin Suppresses Toll Like Receptor 4-Dependent Caspase-3 Signaling Activation Coupled with Reduced Production of Proinflammatory Mediators in Hypoxic Microglia.,"Microglia activation and associated inflammatory response play pivotal roles in the pathogenesis of different neurodegenerative diseases including neonatal hypoxic brain injury. Here we show that caspase3 expression was upregulated in activated microglia after hypoxic exposure, and remarkably, the cell viability remained unaffected alluding to the possibility of a non-apoptotic role of caspase3 in activated microglia. Chemical inhibition of caspase3 suppressed microglia activation as evident by an obvious reduction in expression of proinflammatory mediators and NF-κB signaling activation. Hypoxia induced caspase3 activation was TLR4 dependent as supported by the fact that caspase3 activation was hindered in cells with TLR4 knockdown. Interestingly, melatonin treatment significantly suppressed caspase3 activation. More importantly, melatonin also inhibited the increase in TLR4 protein and mRNA expression in hypoxic microglia. Inhibition of TLR4 expression by melatonin was also found in microglia of postnatal rats subjected to hypoxic exposure. Taken together, it is concluded that melatonin could inhibit TLR4 expression in hypoxic microglia followed by suppression of caspase3 activation leading to decrease in production of proinflammatory mediators.",[],PloS one,2016-11-05,"[{'lastname': 'Yao', 'firstname': 'Linli', 'initials': 'L', 'affiliation': 'School of Life Science and Technology, ShanghaiTech University, Shanghai, China.\nShanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.'}, {'lastname': 'Lu', 'firstname': 'Pengfei', 'initials': 'P', 'affiliation': 'School of Life Science and Technology, ShanghaiTech University, Shanghai, China.'}, {'lastname': 'Ling', 'firstname': 'Eng-Ang', 'initials': 'EA', 'affiliation': 'Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.'}]",,,,,"10.1371/journal.pone.0166010
10.1007/s11481-012-9347-2
10.1016/j.nbd.2014.01.020
10.1159/000368770
10.1016/j.pneurobio.2009.01.003
10.1111/j.1750-3639.2008.00138.x
10.1186/1742-2094-10-23
10.1038/nature09788
10.1038/cdd.2011.107
10.1038/sj.cdd.4400420
10.18097/PBMC20156103394
10.1111/jpi.12204
10.1055/s-0034-1384587
10.1002/ddr.21177
10.1111/jpi.12173
10.3233/RNN-2012-120217
10.1111/j.1600-079X.2009.00740.x
10.1111/j.1600-079X.2012.00972.x
10.1016/j.pharmthera.2014.07.002
10.1016/j.jtemb.2015.03.005
10.1007/s10495-014-1076-y
10.1016/j.phymed.2015.08.009
10.1111/j.1365-2567.2009.03203.x",<Element 'PubmedArticle' at 0x7f05daa6b1d0>
430,27778404,Progranulin protects against exaggerated axonal injury and astrogliosis following traumatic brain injury.,"In response to traumatic brain injury (TBI) microglia/macrophages and astrocytes release inflammatory mediators with dual effects on secondary brain damage progression. The neurotrophic and anti-inflammatory glycoprotein progranulin (PGRN) attenuates neuronal damage and microglia/macrophage activation in brain injury but mechanisms are still elusive. Here, we studied histopathology, neurology and gene expression of inflammatory markers in PGRN-deficient mice (Grn","['TNFα', 'astrocytes', 'neuroinflammation', 'progranulin', 'traumatic brain injury']",Glia,2016-10-26,"[{'lastname': 'Menzel', 'firstname': 'Lutz', 'initials': 'L', 'affiliation': 'Department of Anesthesiology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.'}, {'lastname': 'Kleber', 'firstname': 'Lisa', 'initials': 'L', 'affiliation': 'Department of Anesthesiology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.'}, {'lastname': 'Friedrich', 'firstname': 'Carina', 'initials': 'C', 'affiliation': 'Department of Anesthesiology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.'}, {'lastname': 'Hummel', 'firstname': 'Regina', 'initials': 'R', 'affiliation': 'Department of Anesthesiology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.'}, {'lastname': 'Dangel', 'firstname': 'Larissa', 'initials': 'L', 'affiliation': 'Department of Anesthesiology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.'}, {'lastname': 'Winter', 'firstname': 'Jennifer', 'initials': 'J', 'affiliation': 'Institute of Human Genetics, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.\nFocus Program Translational Neurosciences (FTN) of the Johannes Gutenberg-University, Mainz, Germany.'}, {'lastname': 'Schmitz', 'firstname': 'Katja', 'initials': 'K', 'affiliation': 'Clinical Pharmacology, Goethe-University Hospital, Frankfurt, Germany.'}, {'lastname': 'Tegeder', 'firstname': 'Irmgard', 'initials': 'I', 'affiliation': 'Clinical Pharmacology, Goethe-University Hospital, Frankfurt, Germany.'}, {'lastname': 'Schäfer', 'firstname': 'Michael K E', 'initials': 'MK', 'affiliation': 'Department of Anesthesiology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.\nFocus Program Translational Neurosciences (FTN) of the Johannes Gutenberg-University, Mainz, Germany.'}]",,,,"© 2016 Wiley Periodicals, Inc.",10.1002/glia.23091,<Element 'PubmedArticle' at 0x7f05daa812c0>
431,"27770818
20826198
21120927
21205324
21965333
19400724
19096368
14624855
21645236
19860916
1542665
18359860
16983685
21092856
21393509
23699531
22781549
23706646
8784346
9771457
2236009
24797263
26186194
12588854
22378895
17705199
23741441
18454144
18333964
17057711
24336722
19946692
20215436
26522918
23171551
17210054
12417579
19805384
18378771
7697721
20418862
20486134
19567869
22162134
19447603
21698296
22942912
19729648
12620110
19525946
15084270
21215938
22818956
19503073
12900424
23319599
24805975
24070898
24385951
23575851
22564672
18838115
20142524
22732773
17898224
22511793
24619111
25022663
21490216
24790203
12555269
11590595
16042313
24038411
22707941
8398989
15048809
20026663
21331036
20836253
3923523
21209361
23176165
19099609
16287856
19010892
22615585
24771340",Progranulin promotes peripheral nerve regeneration and reinnervation: role of notch signaling.,"Peripheral nerve injury is a frequent cause of lasting motor deficits and chronic pain. Although peripheral nerves are capable of regrowth they often fail to re-innervate target tissues.
Using newly generated transgenic mice with inducible neuronal progranulin overexpression we show that progranulin accelerates axonal regrowth, restoration of neuromuscular synapses and recovery of sensory and motor functions after injury of the sciatic nerve. Oppositely, progranulin deficient mice have long-lasting deficits in motor function tests after nerve injury due to enhanced losses of motor neurons and stronger microglia activation in the ventral horn of the spinal cord. Deep proteome and gene ontology (GO) enrichment analysis revealed that the proteins upregulated in progranulin overexpressing mice were involved in 'regulation of transcription' and 'response to insulin' (GO terms). Transcription factor prediction pointed to activation of Notch signaling and indeed, co-immunoprecipitation studies revealed that progranulin bound to the extracellular domain of Notch receptors, and this was functionally associated with higher expression of Notch target genes in the dorsal root ganglia of transgenic mice with neuronal progranulin overexpression. Functionally, these transgenic mice recovered normal gait and running, which was not achieved by controls and was stronger impaired in progranulin deficient mice.
We infer that progranulin activates Notch signaling pathways, enhancing thereby the regenerative capacity of partially injured neurons, which leads to improved motor function recovery.","['Locomotion', 'Motor neuron', 'Nerve injury', 'Notch', 'Progranulin', 'Proteomics']",Molecular neurodegeneration,2016-10-25,"[{'lastname': 'Altmann', 'firstname': 'Christine', 'initials': 'C', 'affiliation': 'Institute of Clinical Pharmacology, Goethe-University Hospital, Frankfurt, Germany.'}, {'lastname': 'Vasic', 'firstname': 'Verica', 'initials': 'V', 'affiliation': 'Molecular Signal Transduction Laboratories, Institute for Microscopic Anatomy and Neurobiology, Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University, Mainz, Germany.'}, {'lastname': 'Hardt', 'firstname': 'Stefanie', 'initials': 'S', 'affiliation': 'Institute of Clinical Pharmacology, Goethe-University Hospital, Frankfurt, Germany.'}, {'lastname': 'Heidler', 'firstname': 'Juliana', 'initials': 'J', 'affiliation': 'Functional Proteomics, SFB815 Core Unit, Goethe-University, Frankfurt, Germany.'}, {'lastname': 'Häussler', 'firstname': 'Annett', 'initials': 'A', 'affiliation': 'Institute of Clinical Pharmacology, Goethe-University Hospital, Frankfurt, Germany.'}, {'lastname': 'Wittig', 'firstname': 'Ilka', 'initials': 'I', 'affiliation': 'Functional Proteomics, SFB815 Core Unit, Goethe-University, Frankfurt, Germany.'}, {'lastname': 'Schmidt', 'firstname': 'Mirko H H', 'initials': 'MHH', 'affiliation': 'Molecular Signal Transduction Laboratories, Institute for Microscopic Anatomy and Neurobiology, Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University, Mainz, Germany.'}, {'lastname': 'Tegeder', 'firstname': 'Irmgard', 'initials': 'I', 'affiliation': 'Institute of Clinical Pharmacology, Goethe-University Hospital, Frankfurt, Germany. tegeder@em.uni-frankfurt.de.'}]",,"We infer that progranulin activates Notch signaling pathways, enhancing thereby the regenerative capacity of partially injured neurons, which leads to improved motor function recovery.","Using newly generated transgenic mice with inducible neuronal progranulin overexpression we show that progranulin accelerates axonal regrowth, restoration of neuromuscular synapses and recovery of sensory and motor functions after injury of the sciatic nerve. Oppositely, progranulin deficient mice have long-lasting deficits in motor function tests after nerve injury due to enhanced losses of motor neurons and stronger microglia activation in the ventral horn of the spinal cord. Deep proteome and gene ontology (GO) enrichment analysis revealed that the proteins upregulated in progranulin overexpressing mice were involved in 'regulation of transcription' and 'response to insulin' (GO terms). Transcription factor prediction pointed to activation of Notch signaling and indeed, co-immunoprecipitation studies revealed that progranulin bound to the extracellular domain of Notch receptors, and this was functionally associated with higher expression of Notch target genes in the dorsal root ganglia of transgenic mice with neuronal progranulin overexpression. Functionally, these transgenic mice recovered normal gait and running, which was not achieved by controls and was stronger impaired in progranulin deficient mice.",,"10.1186/s13024-016-0132-1
10.1016/j.neuroscience.2010.08.067
10.1002/cne.22500
10.1186/1744-8069-7-1
10.1172/JCI58675
10.1146/annurev.neuro.051508.135531
10.1038/nrn2533
10.1016/j.tins.2003.09.017
10.1111/j.1582-4934.2011.01350.x
10.1186/1471-2202-10-130
10.1073/pnas.89.5.1715
10.1110/ps.073295308
10.1002/ana.20963
10.1016/j.neuron.2010.09.034
10.1126/science.1199214
10.1523/JNEUROSCI.5336-12.2013
10.1186/1750-1326-7-33
10.1016/j.neurobiolaging.2013.04.022
10.1038/nsb0996-747
10.1677/joe.0.1580145
10.1073/pnas.87.20.7912
10.1074/mcp.M114.038596
10.1016/j.cell.2015.06.043
10.1242/dev.00374
10.1523/JNEUROSCI.6398-11.2012
10.1002/glia.20553
10.1371/journal.pone.0064989
10.1038/nn.2118
10.1111/j.1460-9568.2008.06065.x
10.1038/nm1490
10.1523/JNEUROSCI.4318-13.2013
10.1093/nar/gkq149
10.1091/mbc.E12-02-0081
10.1111/j.1365-2818.2006.01706.x
10.1083/jcb.200207058
10.1073/pnas.0906571106
10.1083/jcb.200712039
10.1016/0092-8674(95)90294-5
10.1038/nature08959
10.1002/bies.200900140
10.1074/jbc.M109.014845
10.1083/jcb.201104146
10.1016/j.gde.2009.04.005
10.1371/journal.pone.0021023
10.1515/bmc-2011-0060
10.1126/science.1171004
10.1186/gb-2003-4-2-105
10.1038/nn.2323
10.1016/S1074-7613(04)00081-0
10.1016/j.cub.2010.10.034
10.1016/j.ceb.2012.06.006
10.1038/ncb1896
10.1074/jbc.C300310200
10.1083/jcb.201207036
10.1016/j.febslet.2013.09.024
10.3389/fncel.2013.00257
10.1523/JNEUROSCI.5087-12.2013
10.1016/j.jpain.2012.02.010
10.1016/j.neuroscience.2008.08.067
10.1523/JNEUROSCI.3421-07.2007
10.1074/jbc.M112.365098
10.1186/s40478-014-0078-x
10.1523/JNEUROSCI.6810-10.2011
10.1523/JNEUROSCI.4673-13.2014
10.1002/neu.10191
10.1002/ar.1159
10.1097/01.jnen.0000171650.94341.46
10.1002/glia.22558
10.3389/fphys.2012.00205
10.1093/intimm/5.8.957
10.1002/gene.20010
10.1084/jem.20091568
10.1038/nature09793
10.1038/nmeth.1484
10.1007/BF00428203
10.1152/ajpcell.00462.2010
10.1186/1471-2105-9-552
10.1128/MCB.25.23.10433-10441.2005
10.1158/0008-5472.CAN-07-6555
10.1371/journal.pgen.1002728
10.1093/nar/gku331",<Element 'PubmedArticle' at 0x7f05daa92cc0>
432,"27568094
16309885
11009419
21832188
18664380
15893410
25559333
19486645
20854134
12893774
22216357
24674978
24917789
20944004
24881883
24560196
17084685
17129640
20560709
19477935
24062487
1928438
22539850
25433170
24012645
24673196
26799851
15890435
20537730
16125247
15919760
26780511
21147170
25697044
17409491
15344914
19955445
16847346
10428031
23340916
20409612
19916840
22483041
24270424
26464996
21752996
23970558
23071720
25033025
18487414
23916625
26175004
15647483
25452149
16426706
19935677
24307731
23152603
22019350
15561803
22895791
17265475
22434077
9435649
17123666",Diminished circadian rhythms in hippocampal microglia may contribute to age-related neuroinflammatory sensitization.,"Aged animals exhibit diminished circadian rhythms, and both aging and circadian disruption sensitize neuroinflammatory responses. Microglia-the innate immune cell of the central nervous system-possess endogenous timekeeping mechanisms that regulate immune responses. Here, we explored whether aging is associated with disrupted diurnal rhythms in microglia and neuroinflammatory processes. First, hippocampal microglia isolated from young rats (4 months F344XBN) rhythmically expressed circadian clock genes, whereas microglia isolated from the hippocampus of aged rats (25 months) had aberrant Per1 and Per2 rhythms. Unstimulated microglia from young rats exhibited robust rhythms of TNFα and IL-1β mRNA expression, whereas those from aged rats had flattened and tonically elevated cytokine expression. Similarly, microglial activation markers were diurnally regulated in the hippocampus of young but not aged rats and diurnal differences in responsiveness to both ex vivo and in vivo inflammatory challenges were abolished in aged rats. Corticosterone is an entraining signal for extra-suprachiasmatic nucleus circadian rhythms. Here, corticosterone stimulation elicited similar Per1 induction in aged and young microglia. Overall, these results indicate that aging dysregulates circadian regulation of neuroinflammatory functions.","['Aging', 'Glia', 'IL-1β', 'Neuroinflammation', 'Priming']",Neurobiology of aging,2016-10-25,"[{'lastname': 'Fonken', 'firstname': 'Laura K', 'initials': 'LK', 'affiliation': 'Department of Psychology and Neuroscience, University of Colorado, Boulder, CO, USA. Electronic address: laura.fonken@colorado.edu.'}, {'lastname': 'Kitt', 'firstname': 'Meagan M', 'initials': 'MM', 'affiliation': 'Department of Psychology and Neuroscience, University of Colorado, Boulder, CO, USA.'}, {'lastname': 'Gaudet', 'firstname': 'Andrew D', 'initials': 'AD', 'affiliation': 'Department of Psychology and Neuroscience, University of Colorado, Boulder, CO, USA.'}, {'lastname': 'Barrientos', 'firstname': 'Ruth M', 'initials': 'RM', 'affiliation': 'Department of Psychology and Neuroscience, University of Colorado, Boulder, CO, USA.'}, {'lastname': 'Watkins', 'firstname': 'Linda R', 'initials': 'LR', 'affiliation': 'Department of Psychology and Neuroscience, University of Colorado, Boulder, CO, USA.'}, {'lastname': 'Maier', 'firstname': 'Steven F', 'initials': 'SF', 'affiliation': 'Department of Psychology and Neuroscience, University of Colorado, Boulder, CO, USA.'}]",,,,Copyright © 2016 Elsevier Inc. All rights reserved.,10.1016/j.neurobiolaging.2016.07.019,<Element 'PubmedArticle' at 0x7f05daa132c0>
433,"27739425
11576799
22715071
15338490
16359793
14760811
10871832
19840548
16932531
15667933
11517241
9204914
12917686
18463248
21371995
22365541
12198538
17094740
12894240
11937022
5047187
9886827
25500935
10531440
12435431
9145302
9063706
15852223
24886406
12650700
20068232
18404506
11696858
12395124
1281220
16452661
18414449
12736329
15715654
20884646
20022389
21385992
24307733
16715052
23339081
23516288
21108841
12374740
15456833
26120961
23391992
17014730
22863835
24781577
9927693
19571591
8883412
21472658
23055545
12727880
18375954",Glucocorticoid regulation of ATP release from spinal astrocytes underlies diurnal exacerbation of neuropathic mechanical allodynia.,"Diurnal variations in pain hypersensitivity are common in chronic pain disorders, but the underlying mechanisms are enigmatic. Here, we report that mechanical pain hypersensitivity in sciatic nerve-injured mice shows pronounced diurnal alterations, which critically depend on diurnal variations in glucocorticoids from the adrenal glands. Diurnal enhancement of pain hypersensitivity is mediated by glucocorticoid-induced enhancement of the extracellular release of ATP in the spinal cord, which stimulates purinergic receptors on microglia in the dorsal horn. We identify serum- and glucocorticoid-inducible kinase-1 (SGK-1) as the key molecule responsible for the glucocorticoid-enhanced release of ATP from astrocytes. SGK-1 protein levels in spinal astrocytes are increased in response to glucocorticoid stimuli and enhanced ATP release by opening the pannexin-1 hemichannels. Our findings reveal an unappreciated circadian machinery affecting pain hypersensitivity caused by peripheral nerve injury, thus opening up novel approaches to the management of chronic pain.",[],Nature communications,2016-10-16,"[{'lastname': 'Koyanagi', 'firstname': 'Satoru', 'initials': 'S', 'affiliation': 'Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.\nDepartment of Glocal Healthcare, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.'}, {'lastname': 'Kusunose', 'firstname': 'Naoki', 'initials': 'N', 'affiliation': 'Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.'}, {'lastname': 'Taniguchi', 'firstname': 'Marie', 'initials': 'M', 'affiliation': 'Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.'}, {'lastname': 'Akamine', 'firstname': 'Takahiro', 'initials': 'T', 'affiliation': 'Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.'}, {'lastname': 'Kanado', 'firstname': 'Yuki', 'initials': 'Y', 'affiliation': 'Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.'}, {'lastname': 'Ozono', 'firstname': 'Yui', 'initials': 'Y', 'affiliation': 'Department of Molecular and System Pharmacology, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.'}, {'lastname': 'Masuda', 'firstname': 'Takahiro', 'initials': 'T', 'affiliation': 'Department of Life Innovation, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.'}, {'lastname': 'Kohro', 'firstname': 'Yuta', 'initials': 'Y', 'affiliation': 'Department of Life Innovation, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.'}, {'lastname': 'Matsunaga', 'firstname': 'Naoya', 'initials': 'N', 'affiliation': 'Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.\nDepartment of Glocal Healthcare, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.'}, {'lastname': 'Tsuda', 'firstname': 'Makoto', 'initials': 'M', 'affiliation': 'Department of Life Innovation, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.'}, {'lastname': 'Salter', 'firstname': 'Michael W', 'initials': 'MW', 'affiliation': 'Program in Neuroscience and Mental Health, Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8.\nDepartment of Physiology, University of Toronto, Toronto, Ontario, Canada M5S 1A8.\nUniversity of Toronto Centre for the Study of Pain, Toronto, Ontario, Canada M5T 1P8.'}, {'lastname': 'Inoue', 'firstname': 'Kazuhide', 'initials': 'K', 'affiliation': 'Department of Molecular and System Pharmacology, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.'}, {'lastname': 'Ohdo', 'firstname': 'Shigehiro', 'initials': 'S', 'affiliation': 'Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.'}]",,,,,10.1038/ncomms13102,<Element 'PubmedArticle' at 0x7f05da93af40>
434,"27730514
23238038
25792098
17385716
21893081
23685326
15319270
12678878
15288712
21329555
21044348
22622544
11443198
22936005
12829233
24315369
25889938
24337945
18786637
21286247
23420079
20228227
2413968
10574963
18586353
19236346
15645264
25088942
25158313
21864581
18838174
24918340
9336395
15590928
19679110
9720972
11754994
19705549
23257117
16936707
22403710
15708439
17222916
16627931
25503661
8524413
11443130
10783157
26254549
23021418
22654105
15750214
26136647
11287063
22119812
18162053
14907713
15102433
21195590
5950056
25288670
19807652
11162920
18564425
24333387
18445780
22329651
22119441
11052931
21804018
10600748
17942819
16567017
21911655
15262337
19188609","Intranasal Insulin Administration Ameliorates Streptozotocin (ICV)-Induced Insulin Receptor Dysfunction, Neuroinflammation, Amyloidogenesis, and Memory Impairment in Rats.","Alzheimer's disease (AD) is associated with reduced insulin level and impairment of insulin receptor (IR) signaling in the brain, which correlates to amyloid pathology, neuroinflammation, and synaptic neurotoxicity. Clinical studies show that intranasal insulin improves memory in AD patients without peripheral hypoglycemia. However, neuroprotective molecular mechanism of the beneficial effect of intranasal insulin in AD pathology is unexplored. Therefore, we investigated the role of intranasal insulin on intracerebroventricular (ICV) streptozotocin (STZ)-induced memory impairment in rats as evaluated in the Morris water maze test. STZ (ICV) treated rats had shown memory impairment along with a significant decrease in IR signaling molecules (IR, pIRS-1, pAkt, and pGSK-3α/β expression) and IDE expression in both hippocampus and cerebral cortex. Intranasal insulin delivery prevented these changes. Moreover, intranasal insulin was found to inhibit significantly glial cell activation (GFAP and Iba-1 expression), neuroinflammation (COX-2 expression, NFκB translocation, TNF-α, and IL-10 level) and amyloidogenic protein expression (BACE-1 and Aβ","['Amyloidogenic protein expression', 'Glial activation', 'Insulin receptor dysfunction', 'Intranasal insulin', 'post synaptic neurotoxicity']",Molecular neurobiology,2016-10-13,"[{'lastname': 'Rajasekar', 'firstname': 'N', 'initials': 'N', 'affiliation': 'Divisions of Pharmacology and Toxicology, CSIR-Central Drug Research Institute, Lucknow, 226031, India.\nAcademy of Scientific and Innovative Research (AcSIR), Chennai, India.'}, {'lastname': 'Nath', 'firstname': 'Chandishwar', 'initials': 'C', 'affiliation': 'Divisions of Pharmacology and Toxicology, CSIR-Central Drug Research Institute, Lucknow, 226031, India.\nAcademy of Scientific and Innovative Research (AcSIR), Chennai, India.'}, {'lastname': 'Hanif', 'firstname': 'Kashif', 'initials': 'K', 'affiliation': 'Divisions of Pharmacology and Toxicology, CSIR-Central Drug Research Institute, Lucknow, 226031, India.\nAcademy of Scientific and Innovative Research (AcSIR), Chennai, India.'}, {'lastname': 'Shukla', 'firstname': 'Rakesh', 'initials': 'R', 'affiliation': 'Divisions of Pharmacology and Toxicology, CSIR-Central Drug Research Institute, Lucknow, 226031, India. rakeshshuklacdri@gmail.com.\nAcademy of Scientific and Innovative Research (AcSIR), Chennai, India. rakeshshuklacdri@gmail.com.'}]",,,,,10.1007/s12035-016-0169-8,<Element 'PubmedArticle' at 0x7f05da8e2ea0>
435,"27725661
15940303
26404710
24342992
20410132
22829357
24360280
21778362
23363775
9145302
21935638
22371048
15895084
26404713
24982640
26404714
23077044
25847308
24943696
17068773
24278397
23393609
21320597
27296672
21235574
15831717
26404711
24871624
19525944
18441260
21344016
22182318
26431938
26834566
26441134
24726984
24917790
9622630
24632419
19564873
24051277
16197924
22980050
16797134
26056314
23407936
23312512
12013026
24995975
23820821
21145878
18286612
23683655
22710611
11522598",Adenosine A,"Developmental risk factors, such as the exposure to stress or high levels of glucocorticoids (GCs), may contribute to the pathogenesis of anxiety disorders. The immunomodulatory role of GCs and the immunological fingerprint found in animals prenatally exposed to GCs point towards an interplay between the immune and the nervous systems in the etiology of these disorders. Microglia are immune cells of the brain, responsive to GCs and morphologically altered in stress-related disorders. These cells are regulated by adenosine A",[],Molecular psychiatry,2016-10-12,"[{'lastname': 'Caetano', 'firstname': 'L', 'initials': 'L', 'affiliation': 'CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.\nInstitute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.'}, {'lastname': 'Pinheiro', 'firstname': 'H', 'initials': 'H', 'affiliation': 'Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.\nCNC.IBILI Consortium, Coimbra, Portugal.'}, {'lastname': 'Patrício', 'firstname': 'P', 'initials': 'P', 'affiliation': ""Life and Health Sciences Research Institute (ICVS), University of Minho, Braga, Portugal.\nICVS/3B's-PT Government Associate Laboratory, Guimarães, Portugal.""}, {'lastname': 'Mateus-Pinheiro', 'firstname': 'A', 'initials': 'A', 'affiliation': ""Life and Health Sciences Research Institute (ICVS), University of Minho, Braga, Portugal.\nICVS/3B's-PT Government Associate Laboratory, Guimarães, Portugal.""}, {'lastname': 'Alves', 'firstname': 'N D', 'initials': 'ND', 'affiliation': ""Life and Health Sciences Research Institute (ICVS), University of Minho, Braga, Portugal.\nICVS/3B's-PT Government Associate Laboratory, Guimarães, Portugal.""}, {'lastname': 'Coimbra', 'firstname': 'B', 'initials': 'B', 'affiliation': ""Life and Health Sciences Research Institute (ICVS), University of Minho, Braga, Portugal.\nICVS/3B's-PT Government Associate Laboratory, Guimarães, Portugal.""}, {'lastname': 'Baptista', 'firstname': 'F I', 'initials': 'FI', 'affiliation': 'Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.\nCNC.IBILI Consortium, Coimbra, Portugal.'}, {'lastname': 'Henriques', 'firstname': 'S N', 'initials': 'SN', 'affiliation': 'Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.'}, {'lastname': 'Cunha', 'firstname': 'C', 'initials': 'C', 'affiliation': ""ICVS/3B's-PT Government Associate Laboratory, Guimarães, Portugal.""}, {'lastname': 'Santos', 'firstname': 'A R', 'initials': 'AR', 'affiliation': ""ICVS/3B's-PT Government Associate Laboratory, Guimarães, Portugal.""}, {'lastname': 'Ferreira', 'firstname': 'S G', 'initials': 'SG', 'affiliation': 'CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.\nCNC.IBILI Consortium, Coimbra, Portugal.'}, {'lastname': 'Sardinha', 'firstname': 'V M', 'initials': 'VM', 'affiliation': ""Life and Health Sciences Research Institute (ICVS), University of Minho, Braga, Portugal.\nICVS/3B's-PT Government Associate Laboratory, Guimarães, Portugal.""}, {'lastname': 'Oliveira', 'firstname': 'J F', 'initials': 'JF', 'affiliation': ""Life and Health Sciences Research Institute (ICVS), University of Minho, Braga, Portugal.\nICVS/3B's-PT Government Associate Laboratory, Guimarães, Portugal.""}, {'lastname': 'Ambrósio', 'firstname': 'A F', 'initials': 'AF', 'affiliation': 'Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.\nCNC.IBILI Consortium, Coimbra, Portugal.\nFaculty of Medicine, University of Coimbra, Coimbra, Portugal.'}, {'lastname': 'Sousa', 'firstname': 'N', 'initials': 'N', 'affiliation': ""Life and Health Sciences Research Institute (ICVS), University of Minho, Braga, Portugal.\nICVS/3B's-PT Government Associate Laboratory, Guimarães, Portugal.""}, {'lastname': 'Cunha', 'firstname': 'R A', 'initials': 'RA', 'affiliation': 'CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.\nCNC.IBILI Consortium, Coimbra, Portugal.\nFaculty of Medicine, University of Coimbra, Coimbra, Portugal.'}, {'lastname': 'Rodrigues', 'firstname': 'A J', 'initials': 'AJ', 'affiliation': ""Life and Health Sciences Research Institute (ICVS), University of Minho, Braga, Portugal.\nICVS/3B's-PT Government Associate Laboratory, Guimarães, Portugal.""}, {'lastname': 'Pinto', 'firstname': 'L', 'initials': 'L', 'affiliation': ""Life and Health Sciences Research Institute (ICVS), University of Minho, Braga, Portugal.\nICVS/3B's-PT Government Associate Laboratory, Guimarães, Portugal.""}, {'lastname': 'Gomes', 'firstname': 'C A', 'initials': 'CA', 'affiliation': 'CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.\nInstitute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.\nCNC.IBILI Consortium, Coimbra, Portugal.\nFaculty of Medicine, University of Coimbra, Coimbra, Portugal.'}]",,,,,10.1038/mp.2016.173,<Element 'PubmedArticle' at 0x7f05da90c090>
436,27693730,Menopause and Parkinson's disease. Interaction between estrogens and brain renin-angiotensin system in dopaminergic degeneration.,"The neuroprotective effects of menopausal hormonal therapy in Parkinson's disease (PD) have not yet been clarified, and it is controversial whether there is a critical period for neuroprotection. Studies in animal models and clinical and epidemiological studies indicate that estrogens induce dopaminergic neuroprotection. Recent studies suggest that inhibition of the brain renin-angiotensin system (RAS) mediates the effects of estrogens in PD models. In the substantia nigra, ovariectomy induces a decrease in levels of estrogen receptor-α (ER-α) and increases angiotensin activity, NADPH-oxidase activity and expression of neuroinflammatory markers, which are regulated by estrogen replacement therapy. There is a critical period for the neuroprotective effect of estrogen replacement therapy, and local ER-α and RAS play a major role. Astrocytes play a major role in ER-α-induced regulation of local RAS, but neurons and microglia are also involved. Interestingly, treatment with angiotensin receptor antagonists after the critical period induced neuroprotection.","['Angiotensin', 'Dopamine', 'Estrogens', 'Hormonal therapy', 'Hypoestrogenicity', 'Menopause', 'Neurodegeneration', 'Neuroinflammation', 'Neuroprotection', 'Parkinson']",Frontiers in neuroendocrinology,2016-10-04,"[{'lastname': 'Labandeira-Garcia', 'firstname': 'Jose L', 'initials': 'JL', 'affiliation': 'Laboratory of Neuroanatomy and Experimental Neurology, Dept. of Morphological Sciences, CIMUS, University of Santiago de Compostela, Santiago de Compostela, Spain; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Spain. Electronic address: joseluis.labandeira@usc.es.'}, {'lastname': 'Rodriguez-Perez', 'firstname': 'Ana I', 'initials': 'AI', 'affiliation': 'Laboratory of Neuroanatomy and Experimental Neurology, Dept. of Morphological Sciences, CIMUS, University of Santiago de Compostela, Santiago de Compostela, Spain; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Spain.'}, {'lastname': 'Valenzuela', 'firstname': 'Rita', 'initials': 'R', 'affiliation': 'Laboratory of Neuroanatomy and Experimental Neurology, Dept. of Morphological Sciences, CIMUS, University of Santiago de Compostela, Santiago de Compostela, Spain; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Spain.'}, {'lastname': 'Costa-Besada', 'firstname': 'Maria A', 'initials': 'MA', 'affiliation': 'Laboratory of Neuroanatomy and Experimental Neurology, Dept. of Morphological Sciences, CIMUS, University of Santiago de Compostela, Santiago de Compostela, Spain; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Spain.'}, {'lastname': 'Guerra', 'firstname': 'Maria J', 'initials': 'MJ', 'affiliation': 'Laboratory of Neuroanatomy and Experimental Neurology, Dept. of Morphological Sciences, CIMUS, University of Santiago de Compostela, Santiago de Compostela, Spain; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Spain.'}]",,,,Copyright Â© 2016 Elsevier Inc. All rights reserved.,10.1016/j.yfrne.2016.09.003,<Element 'PubmedArticle' at 0x7f05da8a9b80>
437,"27588681
24418360
25351351
23348042
15574366
12042878
23804112
17261778
20685874
16469811
21774811
12878732
14684367
15256495
11014219
20808546
16750270
8352945
8637870
11588192
22832605
11255454
21920712
2006000
22723832
17932106
16608856
25763113
23828038
9886832
17947358
11846609
18546601
12424112
15537344
22434086
11162939
10491605
9150134
19505602
9150133
11920150
17640948
16483936
16492687
14675539
10958685
18714023
21477662
11564889
15811852
11931769
12887889
14550281
11389100
22608095
11527420
25609169",Mechanisms by Which 17β-Estradiol (E2) Suppress Neuronal cox-2 Gene Expression.,"E2 attenuates inflammatory responses by suppressing expression of pro-inflammatory genes. Given that inflammation is increasingly being associated with neurodegenerative and psychiatric processes, we sought to elucidate mechanisms by which E2 down-regulates a component of an inflammatory response, cyclooxygenase- 2 (COX-2) expression. Although inflammatory processes in the brain are usually associated with microglia and astrocytes, we found that the COX-2 gene (cox-2) was expressed in a neuronal context, specifically in an amygdalar cell line (AR-5). Given that COX-2 has been reported to be in neurons in the brain, and that the amygdala is a site involved in neurodegenerative and neuropsychiatric processes, we investigated mechanisms by which E2 could down-regulate cox-2 expression in the AR-5 line. These cells express estrogen receptors alpha (ERα) and beta (ERβ), and as shown here cox-2. At the level of RNA, E2 and the ERβ selective ligand diarylpropionitrile (DPN) both attenuated gene expression, whereas the ERα selective ligand propyl pyrazole triol (PPT) had no effect. Neither ligand increased ERβ at the cox-2 promoter. Rather, DPN decreased promoter occupancy of NF-κB p65 and histone 4 (H4) acetylation. Treatment with the non-specific HDAC inhibitor Trichostatin A (TSA) counteracted DPN's repressive effects on cox-2 expression. In keeping with the TSA effect, E2 and DPN increased histone deacetylase one (HDAC1) and switch-independent 3A (Sin3A) promoter occupancy. Lastly, even though E2 increased CpG methylation, DPN did not. Taken together, the pharmacological data indicate that ERβ contributes to neuronal cox-2 expression, as measured by RNA levels. Furthermore, ER ligands lead to increased recruitment of HDAC1, Sin3A and a concomitant reduction of p65 occupancy and Ac-H4 levels. None of the events, however, are associated with a significant recruitment of ERβ at the promoter. Thus, ERβ directs recruitment to the cox-2 promoter, but does so in the absence of being recruited itself.",[],PloS one,2016-09-03,"[{'lastname': 'Stacey', 'firstname': 'Winfred', 'initials': 'W', 'affiliation': ""Graduate School of Biomedical Sciences, University of North Texas Health Science Center, Fort Worth, Texas, United States of America.\nInstitute for Healthy Aging, Center for Alzheimer's and Neurodegenerative Disease Research, University of North Texas Health Science Center, Fort Worth, Texas, United States of America.""}, {'lastname': 'Bhave', 'firstname': 'Shreyas', 'initials': 'S', 'affiliation': ""Graduate School of Biomedical Sciences, University of North Texas Health Science Center, Fort Worth, Texas, United States of America.\nInstitute for Healthy Aging, Center for Alzheimer's and Neurodegenerative Disease Research, University of North Texas Health Science Center, Fort Worth, Texas, United States of America.""}, {'lastname': 'Uht', 'firstname': 'Rosalie M', 'initials': 'RM', 'affiliation': ""Graduate School of Biomedical Sciences, University of North Texas Health Science Center, Fort Worth, Texas, United States of America.\nInstitute for Healthy Aging, Center for Alzheimer's and Neurodegenerative Disease Research, University of North Texas Health Science Center, Fort Worth, Texas, United States of America.""}]",,,,,"10.1371/journal.pone.0161430
10.11613/BM.2014.035
10.1016/j.molmed.2012.12.007
10.1038/nrn846
10.1523/JNEUROSCI.0886-13.2013
10.1210/en.2010-0371
10.1186/1742-2094-8-82
10.1073/pnas.1531957100
10.1152/ajpheart.00481.2003
10.1210/en.2004-0619
10.1210/endo.141.10.7693
10.2174/157015910790909485
10.1038/tp.2011.27
10.1016/j.pscychresns.2011.06.014
10.1371/journal.pone.0036890
10.1186/s13148-015-0045-9
10.1093/nar/gkt595
10.1210/endo.140.1.6406
10.1006/meth.2001.1262
10.1021/jm049631k
10.1210/en.2011-1002
10.1038/13165
10.1016/j.bbagrm.2009.05.007
10.1038/sj.mp.4001007
10.1016/j.drudis.2011.03.009
10.1128/MCB.21.20.7065-7077.2001
10.1186/2047-783X-17-12
10.1006/bbrc.2001.5519
10.1126/scitranslmed.3010626",<Element 'PubmedArticle' at 0x7f05da8b5590>
438,27567942,"Involvement of the dynorphin/KOR system on the nociceptive, emotional and cognitive manifestations of joint pain in mice.","Joint pain is a major clinical problem mainly associated to osteoarthritis, and characterized by articular cartilage degradation resulting in a complex chronic pain state that includes nociceptive, emotional and cognitive manifestations. Memory impairment, depressive- and anxiety-like symptoms have been reported to be associated with chronic pain, leading to a decrease of life quality. In this study, we evaluated the involvement of the endogenous dynorphin/kappa opioid receptor (KOR) system on the nociceptive, emotional, cognitive, neurochemical and epigenetic manifestations of joint pain. The murine model of monosodium iodoacetate (MIA) was used to induce joint pain in knockout mice for KOR (KOR-KO), prodynorphin (PDYN-KO) and their wild-type (WT) littermates. KOR-KO and PDYN-KO mice developed mechanical allodynia after intra-articular injection of MIA. This allodynia was significantly increased in both KOR-KO and PDYN-KO when compared to WT mice. Accordingly, both mutants showed increased microglial activation on the lumbar section of the spinal cord after MIA. The emotional responses were evaluated by measuring anxiety-like behaviour in the elevated plus maze and anhedonia as depressive-like behaviour, and cognitive alterations in the object recognition paradigm. Emotional and cognitive impairments after joint pain were differently modified in KOR-KO and PDYN-KO mice. Alterations of corticotropin-releasing factor (CRF) on the amygdala and hippocampus and down regulation of histone 3 acetylation on the amygdala suggest a possible mechanism to explain these emotional and cognitive manifestations. Our results reveal a specific involvement of the dynorphin/KOR system on joint pain manifestations that are usually associated to osteoarthritis.","['Anhedonia', 'Anxiety', 'Cognition', 'Dynorphin', 'KOR', 'Opioids', 'Osteoarthritis']",Neuropharmacology,2016-08-29,"[{'lastname': 'Negrete', 'firstname': 'Roger', 'initials': 'R', 'affiliation': 'Laboratory of Neuropharmacology, Department of Experimental and Health Science, Pompeu Fabra University (CEXS-UPF), Barcelona, Spain.'}, {'lastname': 'García Gutiérrez', 'firstname': 'María Salud', 'initials': 'MS', 'affiliation': 'Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, Alicante, Spain; Red Temática de Investigación Cooperativa en Salud (RETICS), Red de Trastornos Adictivos, Instituto de Salud Carlos III, MICINN and FEDER, Madrid, Spain.'}, {'lastname': 'Manzanares', 'firstname': 'Jorge', 'initials': 'J', 'affiliation': 'Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, Alicante, Spain; Red Temática de Investigación Cooperativa en Salud (RETICS), Red de Trastornos Adictivos, Instituto de Salud Carlos III, MICINN and FEDER, Madrid, Spain.'}, {'lastname': 'Maldonado', 'firstname': 'Rafael', 'initials': 'R', 'affiliation': 'Laboratory of Neuropharmacology, Department of Experimental and Health Science, Pompeu Fabra University (CEXS-UPF), Barcelona, Spain. Electronic address: rafael.maldonado@upf.edu.'}]",,,,Copyright © 2016 Elsevier Ltd. All rights reserved.,10.1016/j.neuropharm.2016.08.026,<Element 'PubmedArticle' at 0x7f05da8d94a0>
439,"27566245
16731270
11343485
15785146
15276120
16339459
17210891
9183351
21330626
24281743
9445344
24853726
23008413
17498508
25640912
21487412
22493441
21344483
18955553
22207510
15525785
21129477
25309941
23421686
12761548
18772448
23881959
8418534
15081592
25374509
25585014
12746231
16230839
16097392
11169618
27364756
24478310
21318404
18604199
12065646
12489109
23418486
23613493
20864106
19540498
14729859
1866765
17577005
6541300
12749025
12925848
8524413
11740206
18624906
21738161
17495630
12860525
19182083",The glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia.,"As the number of patients with cardioembolic ischemic stroke is predicted to be double by 2030, increased burden of warfarin-associated hemorrhagic transformation (HT) after cerebral ischemia is an expected consequence. However, thus far, no effective treatment strategy is available for HT prevention in routine clinical practice. While the glucagon-like peptide-1 receptor (GLP-1R) agonist exendin-4 (Ex-4) is known to protect against oxidative stress and neuronal cell death caused by ischemic brain damage, its effect on preventing warfarin-associated HT after cerebral ischemia is yet unknown. Therefore, we hypothesized that Ex-4 would stabilize the blood-brain barrier (BBB) and suppress neuroinflammation through PI3K-Akt-induced inhibition of glycogen synthase kinase-3β (GSK-3β) after warfarin-associated HT post-cerebral ischemia.
We used male C57BL/6 mice for all experiments. A 5-mg warfarin sodium tablet was dissolved in animals' drinking water (effective warfarin uptake 0.04 mg (2 mg/kg) per mouse). The mice were fed for 0, 6, 12, and 24 h with ad libitum access to the treated water. To study the effects of Ex-4, temporary middle cerebral artery occlusion (MCAO) was performed. Then, either Ex-4 (10 mg/kg) or saline was injected through the tail vein, and in the Ex-4 + wortmannin group, PI3K inhibitor wortmannin was intravenously injected, after reperfusion. The infarct volume, neurological deficits, and integrity of the BBB were assessed 72 h post MCAO. One- or two-way ANOVA was used to test the difference between means followed by Newman-Keuls post hoc testing for pair-wise comparison.
We observed that Ex-4 ameliorated warfarin-associated HT and preserved the integrity of the BBB after cerebral ischemia through the PI3K/Akt/GSK-3β pathway. Furthermore, Ex-4 suppressed oxidative DNA damage and lipid peroxidation, attenuated pro-inflammatory cytokine expression levels, and suppressed microglial activation and neutrophil infiltration in warfarin-associated HT post-cerebral ischemia. However, these effects were totally abolished in the mice treated with Ex-4 + the PI3K inhibitor-wortmannin. The PI3K/Akt-GSK-3β signaling pathway appeared to contribute to the protection afforded by Ex-4 in the warfarin-associated HT model.
GLP-1 administration could reduce warfarin-associated HT in mice. This beneficial effect of GLP-1 is associated with attenuating neuroinflammation and BBB disruption by inactivating GSK-3β through the PI3K/Akt pathway.","['Blood-brain barrier', 'Cerebral ischemia', 'Exendin-4', 'Hemorrhagic transformation', 'Neuroinflammation', 'PI3K/Akt-GSK-3β signaling pathway', 'Warfarin']",Journal of neuroinflammation,2016-08-28,"[{'lastname': 'Chen', 'firstname': 'Fangzhe', 'initials': 'F', 'affiliation': 'Department of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology, Fudan University, No. 12 Middle Wulumuqi Road, Shanghai, 200040, China.'}, {'lastname': 'Wang', 'firstname': 'Weifeng', 'initials': 'W', 'affiliation': ""The Department of Clinical Laboratory, Central Laboratory, Jing'an District Centre Hospital of Shanghai, Huashan Hospital Fudan University Jing'an Branch, No. 259 Xi Kang Road, Shanghai, 200040, China.""}, {'lastname': 'Ding', 'firstname': 'Hongyan', 'initials': 'H', 'affiliation': 'Department of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology, Fudan University, No. 12 Middle Wulumuqi Road, Shanghai, 200040, China.'}, {'lastname': 'Yang', 'firstname': 'Qi', 'initials': 'Q', 'affiliation': 'Department of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology, Fudan University, No. 12 Middle Wulumuqi Road, Shanghai, 200040, China.'}, {'lastname': 'Dong', 'firstname': 'Qiang', 'initials': 'Q', 'affiliation': 'Department of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology, Fudan University, No. 12 Middle Wulumuqi Road, Shanghai, 200040, China. dong_qiang@fudan.edu.cn.'}, {'lastname': 'Cui', 'firstname': 'Mei', 'initials': 'M', 'affiliation': 'Department of Neurology, Huashan Hospital, State Key Laboratory of Medical Neurobiology, Fudan University, No. 12 Middle Wulumuqi Road, Shanghai, 200040, China. cuimei@fudan.edu.cn.'}]",,,"We observed that Ex-4 ameliorated warfarin-associated HT and preserved the integrity of the BBB after cerebral ischemia through the PI3K/Akt/GSK-3β pathway. Furthermore, Ex-4 suppressed oxidative DNA damage and lipid peroxidation, attenuated pro-inflammatory cytokine expression levels, and suppressed microglial activation and neutrophil infiltration in warfarin-associated HT post-cerebral ischemia. However, these effects were totally abolished in the mice treated with Ex-4 + the PI3K inhibitor-wortmannin. The PI3K/Akt-GSK-3β signaling pathway appeared to contribute to the protection afforded by Ex-4 in the warfarin-associated HT model.",,"10.1186/s12974-016-0661-0
10.1016/S0140-6736(06)68770-9
10.1001/jama.285.18.2370
10.1111/j.1076-7460.2005.02278.x
10.1016/j.amjcard.2004.04.050
10.1161/01.STR.0000196989.09900.f8
10.1212/01.wnl.0000250340.05202.8b
10.1161/01.STR.28.6.1198
10.1161/STROKEAHA.110.604652
10.1038/jcbfm.2013.203
10.1161/01.STR.29.1.144
10.1159/000358297
10.1212/WNL.0b013e3182697e70
10.1053/j.gastro.2007.03.054
10.1016/j.ejps.2015.01.010
10.1038/jcbfm.2011.51
10.1074/jbc.M111.324798
10.1002/jcb.23067
10.1083/jcb.200806024
10.1161/STROKEAHA.111.639989
10.1523/JNEUROSCI.2057-04.2004
10.1016/j.jep.2010.11.054
10.1021/cn300182g
10.1038/nature01640
10.1161/STROKEAHA.108.517482
10.1161/STROKEAHA.113.001183
10.1161/01.STR.24.1.117
10.1016/j.expneurol.2004.01.004
10.1038/sj.bjp.0705200
10.1539/joh.47.445
10.1080/13547500500038783
10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9
10.1186/s12974-016-0621-8
10.4103/2347-8659.139719
10.1074/jbc.M113.531012
10.1007/s12031-011-9496-4
10.1038/ncb1752
10.1046/j.1471-4159.2002.00838.x
10.1002/mc.10087
10.1371/journal.pone.0055972
10.1161/STROKEAHA.111.000427
10.1016/j.atherosclerosis.2010.07.061
10.1016/j.atherosclerosis.2009.05.012
10.1194/jlr.M300376-JLR200
10.1161/01.STR.22.8.983
10.7326/0003-4819-146-12-200706190-00007
10.1212/WNL.34.10.1285
10.1002/jnr.10611
10.1038/nm919
10.1038/378785a0
10.1097/00004647-200112000-00009
10.1038/nm.2399
10.1097/WCO.0b013e32813ba151
10.1016/S1471-4906(03)00139-X
10.1161/STROKEAHA.108.531632",<Element 'PubmedArticle' at 0x7f05da867c70>
440,"27559172
25597706
22801496
21749490
26076353
7498461
12077178
23174033
12970084
15456834
8598206
4404211
21737531
8786426
16355225
11373681
15056721
23292683
21486800
9796811
25915476
25155958
25135400
19641589
9338789
26231831
23077035
22535247
24742463
26329458
23206935
10694247
25524119
19641588
11256077
9687579
16885977
23040806
10460235
11171941
12917379
7957605
25131689
9466408
17151600
15134869
21844344
24115920
14749439
18446618
12270951
9311920
21212160
17325196
17493799
18079156
27072848
25033184
12077332
17940064
17675190
12508281
12105201
15985462
24995975
24550775
8551329
16299475
8441014
15044552
16943557
23756153
8622997
26359991
25402352
19800813
19283779
10811723
22393055
20231374
12917686
18971468
20562826
23828736
8602843
25803606
23604007
24671605
24935743
15130891
25921535
24622244
18428622
9306400
22465817
24564661",P2X4 Receptor Reporter Mice: Sparse Brain Expression and Feeding-Related Presynaptic Facilitation in the Arcuate Nucleus.,"P2X4 receptors are ATP-gated cation channels that are widely expressed in the nervous system. To identify P2X4 receptor-expressing cells, we generated BAC transgenic mice expressing tdTomato under the control of the P2X4 receptor gene (P2rx4). We found sparse populations of tdTomato-positive neurons in most brain areas with patterns that matched P2X4 mRNA distribution. tdTomato expression within microglia was low but was increased by an experimental manipulation that triggered microglial activation. We found surprisingly high tdTomato expression in the hypothalamic arcuate nucleus (Arc) (i.e., within parts of the neural circuitry controlling feeding). Immunohistochemistry and genetic crosses of P2rx4 tdTomato mice with cell-specific GFP reporter lines showed that the tdTomato-expressing cells were mainly AgRP-NPY neurons and tanycytes. There was no electrophysiological evidence for functional expression of P2X4 receptors on AgRP-NPY neuron somata, but instead, we found clear evidence for functional presynaptic P2X4 receptor-mediated responses in terminals of AgRP-NPY neurons onto two of their postsynaptic targets (Arc POMC and paraventricular nucleus neurons), where ATP dramatically facilitated GABA release. The presynaptic responses onto POMC neurons, and the expression of tdTomato in AgRP-NPY neurons and tanycytes, were significantly decreased by food deprivation in male mice in a manner that was partially reversed by the satiety-related peptide leptin. Overall, we provide well-characterized tdTomato reporter mice to study P2X4-expressing cells in the brain, new insights on feeding-related regulation of presynaptic P2X4 receptor responses, and the rationale to explore extracellular ATP signaling in the control of feeding behaviors.
Cells expressing ATP-gated P2X4 receptors have proven problematic to identify and study in brain slice preparations because P2X4 expression is sparse. To address this limitation, we generated and characterized BAC transgenic P2rx4 tdTomato reporter mice. We report the distribution of tdTomato-expressing cells throughout the brain and particularly strong expression in the hypothalamic arcuate nucleus. Together, our studies provide a new, well-characterized tool with which to study P2X4 receptor-expressing cells. The electrophysiological studies enabled by this mouse suggest previously unanticipated roles for ATP and P2X4 receptors in the neural circuitry controlling feeding.","['ATP', 'P2X', 'arcuate', 'ion channel', 'mouse model', 'receptor']",The Journal of neuroscience : the official journal of the Society for Neuroscience,2016-08-26,"[{'lastname': 'Xu', 'firstname': 'Ji', 'initials': 'J', 'affiliation': 'Departments of Physiology and.'}, {'lastname': 'Bernstein', 'firstname': 'Alexander M', 'initials': 'AM', 'affiliation': 'Neurobiology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California 90095.'}, {'lastname': 'Wong', 'firstname': 'Angela', 'initials': 'A', 'affiliation': 'Neurobiology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California 90095.'}, {'lastname': 'Lu', 'firstname': 'Xiao-Hong', 'initials': 'XH', 'affiliation': 'Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California-Los Angeles, Los Angeles, California 90095.'}, {'lastname': 'Khoja', 'firstname': 'Sheraz', 'initials': 'S', 'affiliation': 'Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, California 90089.'}, {'lastname': 'Yang', 'firstname': 'X William', 'initials': 'XW', 'affiliation': 'Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California-Los Angeles, Los Angeles, California 90095, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California 90095, and.'}, {'lastname': 'Davies', 'firstname': 'Daryl L', 'initials': 'DL', 'affiliation': 'Titus Family Department of Clinical Pharmacy, School of Pharmacy, University of Southern California, Los Angeles, California 90089.'}, {'lastname': 'Micevych', 'firstname': 'Paul', 'initials': 'P', 'affiliation': 'Neurobiology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California 90095.'}, {'lastname': 'Sofroniew', 'firstname': 'Michael V', 'initials': 'MV', 'affiliation': 'Neurobiology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California 90095.'}, {'lastname': 'Khakh', 'firstname': 'Baljit S', 'initials': 'BS', 'affiliation': 'Departments of Physiology and Neurobiology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California 90095, bkhakh@mednet.ucla.edu.'}]",,,,Copyright © 2016 the authors 0270-6474/16/368903-19$15.00/0.,"10.1523/JNEUROSCI.1496-16.2016
10.1124/mol.114.096222
10.1038/nature11270
10.1111/j.1460-9568.2011.07763.x
10.1371/journal.pone.0129934
10.1016/0014-5793(95)01203-Q
10.1017/S1461145712000909
10.1038/sj.bjp.0705459
10.1523/JNEUROSCI.2660-04.2004
10.1124/pr.110.003129
10.1038/nature04223
10.1038/35078085
10.1523/JNEUROSCI.5429-03.2004
10.1038/nn.3295
10.1113/jphysiol.2010.202051
10.1038/27376
10.1038/nn.4011
10.1016/j.neuron.2014.07.024
10.1007/s11481-014-9559-8
10.1038/nature08218
10.1038/39639
10.1016/j.neuropharm.2015.07.032
10.1523/JNEUROSCI.1256-12.2012
10.1038/nature11010
10.1016/j.neuron.2014.02.041
10.7554/eLife.09800
10.7554/eLife.09800
10.1016/j.tibs.2012.10.006
10.1038/sj.bjp.0703059
10.1038/nrn3875
10.1038/nature08198
10.1038/35058521
10.1124/mol.54.2.372
10.1038/nature04886
10.1016/j.neuron.2012.09.024
10.1016/0014-2999(94)90500-2
10.1111/jne.12191
10.1016/S0306-4522(97)00365-5
10.1038/nature05453
10.1016/j.peptides.2004.01.005
10.1073/pnas.1101039108
10.3389/fncel.2013.00171
10.1523/JNEUROSCI.1366-03.2004
10.1080/09687680802050385
10.1152/physrev.00015.2002
10.1126/science.278.5335.135
10.1124/jpet.110.176990
10.1085/jgp.200609693
10.1016/j.conb.2007.04.008
10.1113/jphysiol.2007.148635
10.1016/j.neuroscience.2016.04.009
10.1016/j.neuron.2014.06.005
10.1128/MCB.22.14.5027-5035.2002
10.1242/jcs.010348
10.1016/j.neuropharm.2007.06.010
10.1002/bies.10200
10.1074/jbc.M204844200
10.1242/jcs.02451
10.1016/j.cell.2014.06.008
10.3389/fncel.2014.00006
10.1038/nmeth819
10.1523/JNEUROSCI.0090-04.2004
10.1523/JNEUROSCI.2370-06.2006
10.1016/j.yhbeh.2013.06.001
10.1073/pnas.93.8.3684
10.1016/j.cell.2015.08.032
10.1159/000369072
10.1016/j.tem.2009.05.005
10.1002/eji.200838818
10.1111/j.1469-7793.2000.00041.x
10.1074/jbc.M111.329334
10.1085/jgp.200910336
10.1038/nature01786
10.1523/JNEUROSCI.2308-08.2008
10.1038/emboj.2010.126
10.1002/glia.22516
10.1006/bbrc.1996.0380
10.1371/journal.pone.0120530
10.1038/npp.2013.98
10.1007/s11064-014-1271-9
10.1085/jgp.201411169
10.1152/ajpheart.00079.2004
10.1016/j.celrep.2015.04.002
10.1161/CIRCHEARTFAILURE.113.001023
10.1002/0471142301.ns0520s31
10.1038/nbt0997-859
10.1016/j.neuropharm.2012.03.014",<Element 'PubmedArticle' at 0x7f05da89b630>
441,"27534449
13532578
8534274
1596084
11261504
6605787
3260555
1914160
11701250
7846062
11786305
9372207
11558798
12093084
12431840
16533575
20608959
26835388
20331730
11701275
12694381
14559355
6212778
19407655
9522363
9829688
6603658
23312951
8895325
17379631
3614346
11276228
17167071
12611980
12533630
22698524
15163692
18308824
7511890
11107163
23591846
16893426
15860230
11902119
12485415
21135885",Upregulations of CRH and CRHR1 in the Epileptogenic Tissues of Patients with Intractable Infantile Spasms.,"Infantile spasms (IS) are an age-specific epileptic syndrome with specific clinical symptom and electroencephalogram (EEG) features, lacking treatment options, and a poor prognosis. Excessive endogenous corticotropin-releasing hormone (CRH) in infant brain might result in IS. However, the data from human IS are limited. In our study, we investigated the expressions of CRH and its receptor type 1 (CRHR1) in surgical tissues from patients with IS and autopsy controls.
Specimens surgically removed from 17 patients with IS, and six autopsy controls were included in the study. Real-time PCR, Western blotting, and immunostaining were used to detect the expressions of mRNA, protein expression, and distribution. The correlation between variates was analyzed by Spearman rank correlation.
The expressions of CRH and CRHR1 were significantly upregulated in the epileptogenic tissues of IS patients compared with the control group. CRH was distributed mainly in neurons, while CRHR1 was distributed in neurons, astrocytes, and microglia. The expression levels of CRH and CRHR1 were positively correlated with the frequency of epileptic spasms. Moreover, the expression of protein kinase C (PKC), which was an important downstream factor of CRHR1, was significantly upregulated in the epileptogenic tissues of patients with IS and was positively correlated with the CRHR1 expression levels and the frequency of epileptic spasms.
These results suggest that the CRH signal transduction pathway might participate in the epileptogenesis of IS, supporting the hypothesis that CRH is related to the pathogenesis of IS.","['Corticotrophin-releasing hormone receptor 1 (CRHR1)', 'Corticotropin-releasing hormone (CRH)', 'Infantile spasms (IS)', 'Protein Kinase C (PKC)']",CNS neuroscience & therapeutics,2016-08-19,"[{'lastname': 'Yang', 'firstname': 'Xiao-Lin', 'initials': 'XL', 'affiliation': 'Department of Neurosurgery, Second affiliated Hospital, Third Military Medical University, Chongqing, China.'}, {'lastname': 'Chen', 'firstname': 'Bing', 'initials': 'B', 'affiliation': 'Department of Neurosurgery, Second affiliated Hospital, Third Military Medical University, Chongqing, China.'}, {'lastname': 'Zhang', 'firstname': 'Xiao-Qing', 'initials': 'XQ', 'affiliation': 'Department of Neurosurgery, Second affiliated Hospital, Third Military Medical University, Chongqing, China.'}, {'lastname': 'Chen', 'firstname': 'Xin', 'initials': 'X', 'affiliation': 'Department of Neurosurgery, Second affiliated Hospital, Third Military Medical University, Chongqing, China.'}, {'lastname': 'Yang', 'firstname': 'Mei-Hua', 'initials': 'MH', 'affiliation': 'Department of Neurosurgery, Second affiliated Hospital, Third Military Medical University, Chongqing, China.'}, {'lastname': 'Zhang', 'firstname': 'Wei', 'initials': 'W', 'affiliation': 'Department of Neurosurgery, Second affiliated Hospital, Third Military Medical University, Chongqing, China.'}, {'lastname': 'Chen', 'firstname': 'Huan-Ran', 'initials': 'HR', 'affiliation': 'Department of Neurosurgery, Second affiliated Hospital, Third Military Medical University, Chongqing, China.'}, {'lastname': 'Zang', 'firstname': 'Zhen-Le', 'initials': 'ZL', 'affiliation': 'Department of Neurosurgery, Second affiliated Hospital, Third Military Medical University, Chongqing, China.'}, {'lastname': 'Li', 'firstname': 'Wei', 'initials': 'W', 'affiliation': 'Department of Neurosurgery, Second affiliated Hospital, Third Military Medical University, Chongqing, China.'}, {'lastname': 'Yang', 'firstname': 'Hui', 'initials': 'H', 'affiliation': 'Department of Neurosurgery, Second affiliated Hospital, Third Military Medical University, Chongqing, China.'}, {'lastname': 'Liu', 'firstname': 'Shi-Yong', 'initials': 'SY', 'affiliation': 'Department of Neurosurgery, Second affiliated Hospital, Third Military Medical University, Chongqing, China.'}]",,"These results suggest that the CRH signal transduction pathway might participate in the epileptogenesis of IS, supporting the hypothesis that CRH is related to the pathogenesis of IS.","The expressions of CRH and CRHR1 were significantly upregulated in the epileptogenic tissues of IS patients compared with the control group. CRH was distributed mainly in neurons, while CRHR1 was distributed in neurons, astrocytes, and microglia. The expression levels of CRH and CRHR1 were positively correlated with the frequency of epileptic spasms. Moreover, the expression of protein kinase C (PKC), which was an important downstream factor of CRHR1, was significantly upregulated in the epileptogenic tissues of patients with IS and was positively correlated with the CRHR1 expression levels and the frequency of epileptic spasms.",© 2016 John Wiley & Sons Ltd.,10.1111/cns.12598,<Element 'PubmedArticle' at 0x7f05da7e2ea0>
442,"27529240
8685080
17562927
12621309
15665420
16179555
21035878
16137790
18163175
18373731
19735445
25217340
12110327
2499400
10516262
16179412
2566131
5845854
9401939
1448489
8498494
7832464
9827668
0
1978921
8778149
12535572
26052893
12905028
14579113
12769665
12883891
16330770
24745985
17473959
17460754
23506881
26327616
2342989
15907950
19110196
17678968
15715660
19503084
16978905
23000246
12871090
15197240
21194351
24281078
25784296
10373503
11134171
14708018
26831258
23900742
22033929
19162179
26281945
9887101
12145307
12653965
12682069
16968214
20215646
18241676
16585964
24699213
19121370
22444871
24647116
25620241
26828721
15331427
18549826
16962933
17681938
11012661
16647047
16822172
24619348
24002662
24035917
26902584
26779612
26635528
26576229
26225772
26073124
23989796
14517290
22841895
19919955
16879082
25478815
26733784
24603212
26584004
24163350
18471431
20229265
22674585
20012068
24144733
26435451
26347610
26342753
26041981
22185821
16156895
8446170
14526083
16741123",The Role of Cyclo(His-Pro) in Neurodegeneration.,"Neurodegenerative diseases may have distinct genetic etiologies and pathological manifestations, yet share common cellular mechanisms underpinning neuronal damage and dysfunction. These cellular mechanisms include excitotoxicity, calcium dysregulation, oxidative damage, ER stress and neuroinflammation. Recent data have identified a dual role in these events for glial cells, such as microglia and astrocytes, which are able both to induce and to protect against damage induced by diverse stresses. Cyclo(His-Pro), a cyclic dipeptide derived from the hydrolytic removal of the amino-terminal pyroglutamic acid residue of the hypothalamic thyrotropin-releasing hormone, may be important in regulating the nature of the glial cell contribution. Cyclo(His-Pro) is ubiquitous in the central nervous system and is a key substrate of organic cation transporters, which are strongly linked to neuroprotection. The cyclic dipeptide can also cross the brain-blood-barrier and, once in the brain, can affect diverse inflammatory and stress responses by modifying the Nrf2-NF-κB signaling axis. For these reasons, cyclo(His-Pro) has striking potential for therapeutic application by both parenteral and oral administration routes and may represent an important new tool in counteracting neuroinflammation-based degenerative pathologies. In this review, we discuss the chemistry and biology of cyclo(His-Pro), how it may interact with the biological mechanisms driving neurodegenerative disease, such as amyotrophic lateral sclerosis, and thereby act to preserve or restore neuronal function.","['endoplasmic reticulum stress', 'neuroinflammation', 'oxidative stress']",International journal of molecular sciences,2016-08-17,"[{'lastname': 'Grottelli', 'firstname': 'Silvia', 'initials': 'S', 'affiliation': ""Dipartimento di Medicina Sperimentale, Università di Perugia, Polo Unico Sant'Andrea delle Fratte, Piazzale Gambuli, 06132 Perugia, Italy. silvia.grottelli@unipg.it.""}, {'lastname': 'Ferrari', 'firstname': 'Ilaria', 'initials': 'I', 'affiliation': 'Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano ed Istituto di Neuroscienze, Consiglio Nazionale delle Ricerche, Via Vanvitelli 32, 20129 Milano, Italy. Ilaria.ferrari87@hotmail.it.'}, {'lastname': 'Pietrini', 'firstname': 'Grazia', 'initials': 'G', 'affiliation': 'Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano ed Istituto di Neuroscienze, Consiglio Nazionale delle Ricerche, Via Vanvitelli 32, 20129 Milano, Italy. grazia.pietrini@unimi.it.'}, {'lastname': 'Peirce', 'firstname': 'Matthew J', 'initials': 'MJ', 'affiliation': ""Dipartimento di Medicina Sperimentale, Università di Perugia, Polo Unico Sant'Andrea delle Fratte, Piazzale Gambuli, 06132 Perugia, Italy. mattpeirce69@gmail.com.""}, {'lastname': 'Minelli', 'firstname': 'Alba', 'initials': 'A', 'affiliation': ""Dipartimento di Medicina Sperimentale, Università di Perugia, Polo Unico Sant'Andrea delle Fratte, Piazzale Gambuli, 06132 Perugia, Italy. alba.minelli@unipg.it.""}, {'lastname': 'Bellezza', 'firstname': 'Ilaria', 'initials': 'I', 'affiliation': ""Dipartimento di Medicina Sperimentale, Università di Perugia, Polo Unico Sant'Andrea delle Fratte, Piazzale Gambuli, 06132 Perugia, Italy. ilaria.bellezza@unipg.it.""}]",,,,,"10.3390/ijms17081332
10.1111/j.1600-0773.1996.tb00173.x
10.1001/archneur.64.6.794
10.1097/01.WCB.0000046143.31247.FD
10.1196/annals.1344.041
10.1016/j.tips.2010.09.005
10.1016/j.peptides.2005.07.010
10.1007/s00726-007-0629-6
10.1111/j.1582-4934.2008.00326.x
10.1111/j.1471-4159.2009.06376.x
10.1016/j.molmed.2014.08.003
10.1016/S0968-0896(02)00132-3
10.1016/0006-8993(89)90509-X
10.1210/en.2005-0553
10.1159/000125150
10.1111/j.2042-7158.1997.tb06043.x
10.1016/0091-3057(92)90428-I
10.1111/j.1749-6632.1994.tb19811.x
10.1089/thy.1998.8.969
10.1016/0196-9781(94)00017-Z
10.1016/0140-6736(90)93169-P
10.1080/07315724.1996.10718585
10.4172/2157-7609.1000105
10.1016/S0169-409X(02)00169-2
10.1038/nsmb.3040
10.1007/s00424-003-1168-y
10.2174/1389200033489460
10.1007/s00424-003-1089-9
10.1073/pnas.0506483102
10.1007/s11095-007-9254-z
10.1371/journal.pone.0000385
10.1016/j.mam.2012.10.010
10.1016/0196-9781(90)90123-M
10.1016/j.neuropharm.2005.04.001
10.1016/j.nurt.2008.10.029
10.1111/j.1471-4159.2004.02929.x
10.1038/nn.2334
10.1016/j.biocel.2006.07.001
10.1016/j.freeradbiomed.2012.09.016
10.2174/0929867033456792
10.1242/jcs.01166
10.1089/ars.2010.3534
10.3390/cancers2020483
10.1128/MCB.19.7.4547
10.1172/JCI11830
10.1038/nrd1279
10.2174/1871527315666160202125914
10.1007/s12035-013-8517-4
10.1074/jbc.M111.274407
10.1016/j.bbadis.2008.12.006
10.1016/j.freeradbiomed.2015.07.147
10.1074/jbc.M206530200
10.1046/j.1365-2443.2003.00640.x
10.1074/jbc.M300931200
10.1146/annurev.pharmtox.46.120604.141046
10.1126/scisignal.3112re3
10.1016/j.bbamcr.2008.01.002
10.1172/JCI25790
10.1016/j.biocel.2014.03.023
10.1016/j.bbcan.2008.11.001
10.1016/j.jnutbio.2011.10.012
10.1016/j.tibs.2014.02.002
10.2174/1568026615666150114160543
10.1111/jcmm.12748
10.1016/S0002-9440(10)63365-2
10.1016/j.freeradbiomed.2008.05.013
10.1016/j.freeradbiomed.2006.06.010
10.1074/jbc.M701916200
10.1046/j.1432-1327.2000.01701.x
10.1016/j.brainres.2006.03.063
10.1146/annurev.cellbio.21.122303.120200
10.1038/nrn3689
10.1515/hsz-2013-0174
10.1016/j.neuropharm.2013.08.034
10.1080/15548627.2015.1121360
10.1111/bpa.12355
10.3389/fncel.2015.00448
10.1155/2015/964518
10.1038/cddis.2015.183
10.1016/j.freeradbiomed.2015.05.038
10.1038/nrd3976
10.1128/MCB.23.20.7198-7209.2003
10.1016/j.cellsig.2012.07.018
10.1093/jb/mvp189
10.1146/annurev.pharmtox.47.120505.105311
10.1016/j.nbd.2014.11.015
10.3389/fnins.2015.00469
10.1016/j.drudis.2014.02.006
10.1016/j.expneurol.2015.09.019
10.1073/pnas.1313029110
10.1016/j.bbabio.2008.04.017
10.1007/s00424-010-0809-1
10.1002/glia.22350
10.1007/s00401-009-0619-8
10.1016/j.neures.2013.10.004
10.1016/j.jsbmb.2015.09.039
10.3389/fncel.2015.00322
10.1016/j.expneurol.2015.08.018
10.3389/fnins.2015.00173
10.1016/j.biocel.2011.12.006
10.1186/1742-2094-2-20
10.1038/362059a0
10.1126/science.1086071
10.1126/science.1123511",<Element 'PubmedArticle' at 0x7f05da807e00>
443,"27493972
20868274
25628605
26668118
23545000
7364927
3090812
26084002
21745103
17984113
19158403
18799597
19505305
20051527
18601701
24980696
25231442
26873887
22007951
23313345
25673072
18219570
18280526
19838061
15931389
23847541
10714678
19879961
24458693
22844479
24920943
19305396
22304915
25182982
20477948
9317159
19471279
24928987
24642726
11867072
11777551
12044976
20720435
11784351
26243185
24889886
23942366
25836044
22710659
24352739
10754331
26482372
25643925
26157361
26347402
25152714
24789099
21701972
23640055
24856117
20029421
25784853
26756636",Actions of Thyroid Hormone Analogues on Chemokines.,"The extracellular domain of plasma membrane integrin αvβ3 contains a receptor for thyroid hormone (L-thyroxine, T4; 3,5,3'-triiodo-L-thyronine, T3); this receptor also binds tetraiodothyroacetic acid (tetrac), a derivative of T4. Tetrac inhibits the binding of T4 and T3 to the integrin. Fractalkine (CX3CL1) is a chemokine relevant to inflammatory processes in the CNS that are microglia-dependent but also important to normal brain development. Expression of the CX3CL1 gene is downregulated by tetrac, suggesting that T4 and T3 may stimulate fractalkine expression. Independently of its specific receptor (CX3CR1), fractalkine binds to αvβ3 at a site proximal to the thyroid hormone-tetrac receptor and changes the physical state of the integrin. Tetrac also affects expression of the genes for other CNS-relevant chemokines, including CCL20, CCL26, CXCL2, CXCL3, and CXCL10. The chemokine products of these genes are important to vascularity of the brain, particularly of the choroid plexus, to inflammatory processes in the CNS and, in certain cases, to neuroprotection. Thyroid hormones are known to contribute to regulation of each of these CNS functions. We propose that actions of thyroid hormone and hormone analogues on chemokine gene expression contribute to regulation of inflammatory processes in brain and of brain blood vessel formation and maintenance.",[],Journal of immunology research,2016-08-06,"[{'lastname': 'Davis', 'firstname': 'Paul J', 'initials': 'PJ', 'affiliation': 'Department of Medicine, Albany Medical College, Albany, NY 12208, USA; Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Albany, NY 12144, USA.'}, {'lastname': 'Glinsky', 'firstname': 'Gennadi V', 'initials': 'GV', 'affiliation': 'Institute of Engineering in Medicine, University of California, San Diego, CA 92093, USA.'}, {'lastname': 'Lin', 'firstname': 'Hung-Yun', 'initials': 'HY', 'affiliation': 'PhD Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan; Taipei Cancer Center, Taipei Medical University, Taipei 11031, Taiwan.'}, {'lastname': 'Mousa', 'firstname': 'Shaker A', 'initials': 'SA', 'affiliation': 'Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Albany, NY 12144, USA.'}]",,,,,"10.1155/2016/3147671
10.1146/annurev-pharmtox-010510-100512
10.3389/fendo.2014.00240
10.1038/nrendo.2015.205
10.3109/07435800.2013.778865
10.1210/jcem-50-4-712
10.1111/nyas.12805
10.1089/thy.2010.0429
10.1093/carcin/bgm239
10.1152/ajpcell.00305.2008
10.1152/jn.90801.2008
10.1186/1749-8104-4-20
10.1210/er.2009-0007
10.1111/j.1365-2826.2008.01733.x
10.1016/j.bbagrm.2014.06.015
10.1159/000363153
10.1177/0271678x16629153
10.1111/j.1365-2990.2011.01228.x
10.1016/j.phrs.2012.12.009
10.1586/14737175.2015.1013465
10.1007/s10571-008-9260-7
10.1016/j.steroids.2007.12.016
10.4161/cc.8.21.9963
10.1172/jci23412
10.3389/fphys.2013.00159
10.1016/s1074-7613(00)80165-x
10.1016/j.vph.2009.10.007
10.1007/s10456-014-9418-5
10.1371/journal.pone.0041445
10.3389/fncel.2014.00154
10.1038/ni.1716
10.1016/j.cell.2012.01.022
10.1007/s00005-014-0313-y
10.1111/j.1471-4159.2010.06809.x
10.1038/jcbfm.2009.71
10.4049/jimmunol.1400825
10.1159/000357780
10.1016/S0022-510X(01)00680-3
10.1016/s0165-5728(01)00453-2
10.1016/s0165-5728(02)00097-8
10.1159/000317394
10.1046/j.1468-1331.2001.00327.x
10.1007/s12035-015-9375-z
10.1186/1742-2094-11-98
10.1038/jcbfm.2013.146
10.1016/j.expneurol.2015.03.021
10.1007/s00005-012-0181-2
10.1098/rsob.130181
10.4049/jimmunol.164.8.4313
10.1007/s12035-015-9480-z
10.1002/glia.22792
10.3389/fncel.2015.00236
10.1155/2015/689404
10.3389/fncel.2014.00229
10.1371/journal.pone.0096372
10.1007/978-1-61779-139-0_10
10.1096/fj.12-227132
10.1016/j.surg.2014.02.006
10.1038/nrc2748
10.3389/fnins.2015.00066
10.1002/cphy.c150011",<Element 'PubmedArticle' at 0x7f05da7c9770>
444,"27421686
15912963
20195798
22726116
17675325
11672522
15520384
18371449
15152190
17446436
18800364
21912480
21431325
23891678
21605162
24554058
21752095
20210856
7593265
21615492
20676767
19627457
7660855
9570533
21736617
24613717
25705693
16945173
16313497
22339795
23645118
25701025
24481440
27001618
25401971
24997566
18281254
16162852
16769026
9427616
20831192
19573038
18643875
8750343
14675124
16098085
11034116
18373555
19552758
24116971
12213568
20210857
19771167
10463945
21358973
22725668
23727938
11462772
9831328",Melatonin Stimulates the SIRT1/Nrf2 Signaling Pathway Counteracting Lipopolysaccharide (LPS)-Induced Oxidative Stress to Rescue Postnatal Rat Brain.,"Lipopolysaccharide (LPS) induces oxidative stress and neuroinflammation both in vivo and in vitro. Here, we provided the first detailed description of the mechanism of melatonin neuroprotection against LPS-induced oxidative stress, acute neuroinflammation, and neurodegeneration in the hippocampal dentate gyrus (DG) region of the postnatal day 7 (PND7) rat brain.
The neuroprotective effects of melatonin against LPS-induced neurotoxicity were analyzed using multiple research techniques, including Western blotting, immunofluorescence, and enzyme-linked immunosorbent assays (ELISAs) in PND7 rat brain homogenates and BV2 cell lysates in vitro. We also used EX527 to inhibit silent information regulator transcript-1 (SIRT1).
A single intraperitoneal (i.p) injection of LPS to PND7 rats significantly induced glial cell activation, acute neuroinflammation, reactive oxygen species (ROS) production and apoptotic neurodegeneration in hippocampal DG region after 4 h. However, the coadministration of melatonin significantly inhibited both LPS-induced acute neuroinflammation and apoptotic neurodegeneration and improved synaptic dysfunction in the hippocampal DG region of PND7 rats. Most importantly, melatonin stimulated the SIRT1/Nrf2 (nuclear factor-erythroid 2-related factor 2) signaling pathway to reduce LPS-induced ROS generation. The beneficial effects of melatonin were further confirmed in LPS-stimulated BV2 microglia cell lines in vitro using EX527 as an inhibitor of SIRT1. LPS-induced oxidative stress, Nrf2 inhibition, and neuroinflammation are SIRT1-dependent in BV2 microglia cell lines.
These results demonstrated that melatonin treatment rescued the hippocampal DG region of PND7 rat brains against LPS-induced oxidative stress damage, acute neuroinflammation, and apoptotic neurodegeneration via SIRT1/Nrf2 signaling pathway activation.","['Lipopolysaccharide', 'Melatonin', 'Neuroinflammation', 'Nuclear factor-erythroid 2-related factor 2', 'Reactive oxygen species', 'Silent information regulator transcript-1']",CNS neuroscience & therapeutics,2016-07-17,"[{'lastname': 'Shah', 'firstname': 'Shahid Ali', 'initials': 'SA', 'affiliation': 'Department of Biology and Applied Life Science, College of Natural Sciences, Gyeongsang National University, Jinju, Republic of Korea.'}, {'lastname': 'Khan', 'firstname': 'Mehtab', 'initials': 'M', 'affiliation': 'Department of Biology and Applied Life Science, College of Natural Sciences, Gyeongsang National University, Jinju, Republic of Korea.'}, {'lastname': 'Jo', 'firstname': 'Myeung-Hoon', 'initials': 'MH', 'affiliation': 'Department of Biology and Applied Life Science, College of Natural Sciences, Gyeongsang National University, Jinju, Republic of Korea.'}, {'lastname': 'Jo', 'firstname': 'Min Gi', 'initials': 'MG', 'affiliation': 'Department of Biology and Applied Life Science, College of Natural Sciences, Gyeongsang National University, Jinju, Republic of Korea.'}, {'lastname': 'Amin', 'firstname': 'Faiz Ul', 'initials': 'FU', 'affiliation': 'Department of Biology and Applied Life Science, College of Natural Sciences, Gyeongsang National University, Jinju, Republic of Korea.'}, {'lastname': 'Kim', 'firstname': 'Myeong Ok', 'initials': 'MO', 'affiliation': 'Department of Biology and Applied Life Science, College of Natural Sciences, Gyeongsang National University, Jinju, Republic of Korea.'}]",,"These results demonstrated that melatonin treatment rescued the hippocampal DG region of PND7 rat brains against LPS-induced oxidative stress damage, acute neuroinflammation, and apoptotic neurodegeneration via SIRT1/Nrf2 signaling pathway activation.","A single intraperitoneal (i.p) injection of LPS to PND7 rats significantly induced glial cell activation, acute neuroinflammation, reactive oxygen species (ROS) production and apoptotic neurodegeneration in hippocampal DG region after 4 h. However, the coadministration of melatonin significantly inhibited both LPS-induced acute neuroinflammation and apoptotic neurodegeneration and improved synaptic dysfunction in the hippocampal DG region of PND7 rats. Most importantly, melatonin stimulated the SIRT1/Nrf2 (nuclear factor-erythroid 2-related factor 2) signaling pathway to reduce LPS-induced ROS generation. The beneficial effects of melatonin were further confirmed in LPS-stimulated BV2 microglia cell lines in vitro using EX527 as an inhibitor of SIRT1. LPS-induced oxidative stress, Nrf2 inhibition, and neuroinflammation are SIRT1-dependent in BV2 microglia cell lines.",© 2016 John Wiley & Sons Ltd.,"10.1111/cns.12588
10.1155/2015/854359",<Element 'PubmedArticle' at 0x7f05da775360>
445,27389824,Pioglitazone and exenatide enhance cognition and downregulate hippocampal beta amyloid oligomer and microglia expression in insulin-resistant rats.,"Insulin resistance is known to be a risk factor for cognitive impairment, most likely linked to insulin signaling, microglia overactivation, and beta amyloid (Aβ) deposition in the brain. Exenatide, a long lasting glucagon-like peptide-1 (GLP-1) analogue, enhances insulin signaling and shows neuroprotective properties. Pioglitazone, a peroxisome proliferated-activated receptor-γ (PPAR-γ) agonist, was previously reported to enhance cognition through its effect on Aβ accumulation and clearance. In the present study, insulin resistance was induced in male rats by drinking fructose for 12 weeks. The effect of monotherapy with pioglitazone (10 mg·kg(-1)) and exenatide or their combination on memory dysfunction was determined and some of the probable underlying mechanisms were studied. The current results confirmed that (1) feeding male rats with fructose syrup for 12 weeks resulted in a decline of learning and memory registered in eight-arm radial maze test; (2) treatment with pioglitazone or exenatide enhanced cognition, reduced hippocampal neurodegeneration, and reduced hippocampal microglia expression and beta amyloid oligomer deposition in a manner that is equal to monotherapies. These results may give promise for the use of pioglitazone or exenatide for ameliorating the learning and memory deficits associated with insulin resistance in clinical setting.","['cognitive impairment', 'déficit cognitif', 'exenatide', 'insulin-resistant rats', 'microglia', 'microglie', 'pioglitazone', 'rats insulino-résistants']",Canadian journal of physiology and pharmacology,2016-07-09,"[{'lastname': 'Gad', 'firstname': 'Enas S', 'initials': 'ES', 'affiliation': 'a Medical Department at Faculty of Commerce, Suez Canal University, Ismailia, Egypt.'}, {'lastname': 'Zaitone', 'firstname': 'Sawsan A', 'initials': 'SA', 'affiliation': 'b Department of Pharmacology and Toxicology, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.'}, {'lastname': 'Moustafa', 'firstname': 'Yasser M', 'initials': 'YM', 'affiliation': 'b Department of Pharmacology and Toxicology, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.'}]",,,,,10.1139/cjpp-2015-0242,<Element 'PubmedArticle' at 0x7f05da79f090>
446,"27351598
24074734
24329180
19218885
25891009
25464374
26403076
26124551
23401516
25313509
24670961
22495912
24096533
18606459
20643385
25992747
26183723
22143005
22747567
20087183
26154789
25776987
18483499
21185371
24003389
23688533
23570274
26793298
26834565
24488158
26893400
21219177
21741097
19633655
19241089
26481668
21633179
17347881
22874006
17148014
19945651
21289534
18381541
17882539
16968363
12094096
21833278
25957197
23553149
25602249
21735077
22527704
16682628
8906462
24144485
12438528
15944267
17127408
26476479
22727152
23537508
25722050
26327239
24997632
20074449
21792637
23583982
22387972
16894082
19840888
18272414
20441426
21210299
23245818
25280829
25681541
24333575
22707950
19527167
17030235
20222982
19734227
22918031
24518398
21572830
26215319
26152436
21763705
19854819
12142947
23222182
22099159
19464335
22130689
21765404
20203610
20583030
20498670
22783258
23284625
22559745
23831684
20065039
21083929
21263444
18650915
22334391
23064447
15246020
25418720
21906670
26189694
24011823
23867105
22689191
17029701
21420487
26004870
23726766
16139734
19157572
26418275
20705131
26392128
24951035
21810230
17197430
25214635
26429861
22748016
26298322
26822608
22802640
17913903
12829195
14568962
12218373
15885646
26153655
21933705
22555146
16512356
15879091
16263412
11694332
21573053
21629840
21935439
23404369
26431939
21778362
22632727
15546155
20674603
25330013
25494366
25998072
26116891
11902119
12598608
22341525
26556286
20920308
26412966
24136242
26849906
18354181
24752587
22613992
25470401
26797518
24895332
24144704
24165274
25602248
25329798
22722515
23865950
20643382
26688372
18055656
20393790
26142065
9512308
8863094
10382136
26696596
22854260
24739187
25313065
24061784
22342106
23886027
25957927
25580916
23688534
22697063
26190965
11121513
20133810
23270976
22194327
25669997
10718847
15912140
25498791
20074346
18490655
18952146
19766327
17698276
24525647
22980637",Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders.,"Autism spectrum disorders (ASDs) affect as many as 1 in 45 children and are characterized by deficits in sociability and communication, as well as stereotypic movements. Many children also show severe anxiety. The lack of distinct pathogenesis and reliable biomarkers hampers the development of effective treatments. As a result, most children with ASD are prescribed psychopharmacologic agents that do not address the core symptoms of ASD. Autoantibodies against brain epitopes in mothers of children with ASD and many such children strongly correlate with allergic symptoms and indicate an aberrant immune response, as well as disruption of the blood-brain barrier (BBB). Recent epidemiological studies have shown a strong statistical correlation between risk for ASD and either maternal or infantile atopic diseases, such as asthma, eczema, food allergies and food intolerance, all of which involve activation of mast cells (MCs). These unique tissue immune cells are located perivascularly in all tissues, including the thalamus and hypothalamus, which regulate emotions. MC-derived inflammatory and vasoactive mediators increase BBB permeability. Expression of the inflammatory molecules interleukin (IL-1β), IL-6, 1 L-17 and tumor necrosis factor (TNF) is increased in the brain, cerebrospinal fluid and serum of some patients with ASD, while NF-kB is activated in brain samples and stimulated peripheral blood immune cells of other patients; however, these molecules are not specific. Instead the peptide neurotensin is uniquely elevated in the serum of children with ASD, as is corticotropin-releasing hormone, secreted from the hypothalamus under stress. Both peptides trigger MC to release IL-6 and TNF, which in turn, stimulate microglia proliferation and activation, leading to disruption of neuronal connectivity. MC-derived IL-6 and TGFβ induce maturation of Th17 cells and MCs also secrete IL-17, which is increased in ASD. Serum IL-6 and TNF may define an ASD subgroup that benefits most from treatment with the natural flavonoid luteolin. Atopic diseases may create a phenotype susceptible to ASD and formulations targeting focal inflammation of the brain could have great promise in the treatment of ASD.",[],Translational psychiatry,2016-06-29,"[{'lastname': 'Theoharides', 'firstname': 'T C', 'initials': 'TC', 'affiliation': 'Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, Boston, MA, USA.\nSackler School of Graduate Biomedical Sciences, Program in Cell, Molecular and Developmental Biology, Tufts University, Boston, MA, USA.\nDepartment of Internal Medicine, Tufts University School of Medicine and Tufts Medical Center, Boston, MA, USA.\nDepartment of Psychiatry, Tufts University School of Medicine and Tufts Medical Center, Boston, MA, USA.'}, {'lastname': 'Tsilioni', 'firstname': 'I', 'initials': 'I', 'affiliation': 'Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, Boston, MA, USA.'}, {'lastname': 'Patel', 'firstname': 'A B', 'initials': 'AB', 'affiliation': 'Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine, Boston, MA, USA.\nSackler School of Graduate Biomedical Sciences, Program in Cell, Molecular and Developmental Biology, Tufts University, Boston, MA, USA.'}, {'lastname': 'Doyle', 'firstname': 'R', 'initials': 'R', 'affiliation': 'Department of Child Psychiatry, Harvard Medical School, Massachusetts General Hospital and McLean Hospital, Boston, MA, USA.'}]",,,,,10.1038/tp.2016.77,<Element 'PubmedArticle' at 0x7f05da72f3b0>
447,27269711,Dairy fat blend improves brain DHA and neuroplasticity and regulates corticosterone in mice.,"Mimicking the breast milk lipid composition appears to be necessary for infant formula to cover the brain's needs in n-3 PUFA. In this study, we evaluated the impact of partial replacement of vegetable oil (VL) in infant formula by dairy fat (DL) on docosahexaenoic acid (DHA) brain level, neuroplasticity and corticosterone in mice. Mice were fed with balanced VL or balanced DL diets enriched or not in DHA and arachidonic acid (ARA) from the first day of gestation. Brain DHA level, microglia number, neurogenesis, corticosterone and glucocorticoid receptor expression were measured in the offsprings. DL diet increased DHA and neuroplasticity in the brain of mice at postnatal day (PND) 14 and at adulthood compared to VL. At PND14, ARA and DHA supplementation increased DHA in VL but not in DL mice brain. Importantly, DHA and ARA supplementation further improved neurogenesis and decreased corticosterone level in DL mice at adulthood. In conclusion, dairy lipids improve brain DHA level and neuroplasticity.","['DHA', 'Dairy lipid', 'HPA axis', 'Microglia', 'Neurogenesis', 'PUFA']","Prostaglandins, leukotrienes, and essential fatty acids",2016-06-09,"[{'lastname': 'Dinel', 'firstname': 'A L', 'initials': 'AL', 'affiliation': 'Nutrition et Neurobiologie Intégrée, INRA UMR 1286, 33076 Bordeaux, France; University of Bordeaux, Bordeaux, France.'}, {'lastname': 'Rey', 'firstname': 'C', 'initials': 'C', 'affiliation': 'Nutrition et Neurobiologie Intégrée, INRA UMR 1286, 33076 Bordeaux, France; University of Bordeaux, Bordeaux, France; ITERG, Institut des Corps Gras, 33600 Pessac, France.'}, {'lastname': 'Bonhomme', 'firstname': 'C', 'initials': 'C', 'affiliation': 'Lactalis Nutrition Europe, Torce F-35370, France.'}, {'lastname': 'Le Ruyet', 'firstname': 'P', 'initials': 'P', 'affiliation': 'Lactalis, R&D, Retiers F-35240, France.'}, {'lastname': 'Joffre', 'firstname': 'C', 'initials': 'C', 'affiliation': 'Nutrition et Neurobiologie Intégrée, INRA UMR 1286, 33076 Bordeaux, France; University of Bordeaux, Bordeaux, France.'}, {'lastname': 'Layé', 'firstname': 'S', 'initials': 'S', 'affiliation': 'Nutrition et Neurobiologie Intégrée, INRA UMR 1286, 33076 Bordeaux, France; University of Bordeaux, Bordeaux, France.'}]",,,,Copyright © 2016 Elsevier Ltd. All rights reserved.,10.1016/j.plefa.2016.03.013,<Element 'PubmedArticle' at 0x7f05da70b6d0>
448,"27223094
22347798
12960258
19494313
16158446
8349951
16644475
12401470
14975591
10215666
15885313
16125247
9332905
6327970
12639960
14254430
19017533
18929502
22841997
17481608
18477398
18814846
18639562
3567337
16402124
17510233
20427720
16165282
14706417
17178210
9334417
10996474
18855941
9367546
12404604
9253341
23468190
9671113
9759920
17349776
1582705
22790082
25701613
7488148
23942470
8891088
7668562
7855445
11958817
11353685
23434605
21525267
25653581
23966702
20570721
8880223
8680860
7890297
8243274
17690258",Antidepressant imipramine diminishes stress-induced inflammation in the periphery and central nervous system and related anxiety- and depressive- like behaviors.,"In order to relieve anxiety and depression accompanying stress, physicians resort to tricyclic antidepressants, such as imipramine. We had previously shown that imipramine reversed stress-induced social avoidance behavior, and down-regulated microglial activation 24days after stress cessation. To further characterize the effects of imipramine on stress induced neuroimmune dysregulation and associated changes in behavior, the aims of this study were to determine if imipramine 1) ameliorated stress-induced inflammation in the periphery and central nervous system, and 2) prevented stress related anxiety- and depressive-like behaviors. C57BL/6 mice were treated with imipramine (15mg/kg) in their drinking water, and exposed to repeated social defeat (RSD). Imipramine attenuated stress-induced corticosterone and IL-6 responses in plasma. Imipramine decreased the percentage of monocytes and granulocytes in the bone marrow and circulation. However, imipramine did not prevent splenomegaly, stress-related increased percentage of granulocytes in this organ, and the production of pro-inflammatory cytokines in the spleen, following RSD. Moreover, imipramine abrogated the accumulation of macrophages in the brain in mice exposed to RSD. Imipramine blocked neuroinflammatory signaling and prevented stress-related anxiety- and depressive-like behaviors. These data support the notion that pharmacomodulation of the monoaminergic system, besides exerting anxiolytic and antidepressant effects, may have therapeutic effects as a neuroimmunomodulator during stress.","['Anxiety-like behavior', 'Imipramine', 'Microglia', 'Psychosocial stress', 'Social avoidance', 'Social defeat']","Brain, behavior, and immunity",2016-05-26,"[{'lastname': 'Ramirez', 'firstname': 'Karol', 'initials': 'K', 'affiliation': 'Division of Biosciences, The Ohio State University College of Dentistry, Columbus, OH 43210, USA; Faculty of Dentistry, University of Costa Rica, San Pedro, San José 11501-2060, Costa Rica; Neuroscience Research Center, University of Costa Rica, San Pedro, San José 11501-2060, Costa Rica. Electronic address: karol.ramirez@ucr.ac.cr.'}, {'lastname': 'Sheridan', 'firstname': 'John F', 'initials': 'JF', 'affiliation': 'Division of Biosciences, The Ohio State University College of Dentistry, Columbus, OH 43210, USA; Institute for Behavioral Medicine Research, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA. Electronic address: sheridan.1@osu.edu.'}]",,,,Copyright © 2016 Elsevier Inc. All rights reserved.,10.1016/j.bbi.2016.05.008,<Element 'PubmedArticle' at 0x7f05da71a9a0>
449,27189760,Function of Thymosin Beta-4 in Ethanol-Induced Microglial Activation.,"Neuroinflammation mediated by activated microglia may play a pivotal role in a variety of central nervous system (CNS) pathologic conditions, including ethanol-induced neurotoxicity. The purpose of this study was to investigate the function of Tβ4 in ethanol-induced microglia activation.
Quantitative real-time PCR was conducted to assess the expression of Tβ4 and miR-339-5p. Western blot analysis was used to measure the expression of Tβ4, phosphorylated p38, ERK, JNK, Akt, and NF-x03BA;B p65. The concentration of TNF-α and IL-1β was determined using ELISA. NO concentration was measured using a nitric oxide colorimetric BioAssay Kit. Double immunofluorescence was performed to determine Tβ4 expression, in order to assess microglial activation in neonatal mouse FASD model.
Increased Tβ4 expression was observed in ethanol treated microglia. Knockdown of Tβ4 enhanced ethanol-induced inflammatory mediators tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) and nitric oxide (NO) in BV-2 cells was performed. Exogenous Tβ4 treatment significantly inhibited expression and secretion of these inflammatory mediators. Tβ4 treatment attenuated p38, ERK MAPKs, and nuclear factor-kappa B (NF-x03BA;B) pathway activation, and enhanced miR-339-5p expression induced by ethanol exposure in microglia. A neonatal mouse fetal alcohol spectrum disorders (FASD) model showed that Tβ4 expression in the microglia of the hippocampus was markedly enhanced, while Tβ4 treatment effectively blocked the ethanol-induced increase in inflammatory mediators, to the level expressed in vehicle-treated control animals.
This study is the first to demonstrate the function of Tβ4 in ethanol-induced microglia activation, thus contributing to a more robust understanding of the role of Tβ4 treatment in CNS disease.",[],"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology",2016-05-18,"[{'lastname': 'Zhang', 'firstname': 'Jianfeng', 'initials': 'J', 'affiliation': None}, {'lastname': 'Wu', 'firstname': 'Junfeng', 'initials': 'J', 'affiliation': None}, {'lastname': 'Zeng', 'firstname': 'Weichen', 'initials': 'W', 'affiliation': None}, {'lastname': 'Yao', 'firstname': 'Kai', 'initials': 'K', 'affiliation': None}, {'lastname': 'Zu', 'firstname': 'Hengbing', 'initials': 'H', 'affiliation': None}, {'lastname': 'Zhao', 'firstname': 'Yongfei', 'initials': 'Y', 'affiliation': None}]",,"This study is the first to demonstrate the function of Tβ4 in ethanol-induced microglia activation, thus contributing to a more robust understanding of the role of Tβ4 treatment in CNS disease.","Increased Tβ4 expression was observed in ethanol treated microglia. Knockdown of Tβ4 enhanced ethanol-induced inflammatory mediators tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) and nitric oxide (NO) in BV-2 cells was performed. Exogenous Tβ4 treatment significantly inhibited expression and secretion of these inflammatory mediators. Tβ4 treatment attenuated p38, ERK MAPKs, and nuclear factor-kappa B (NF-x03BA;B) pathway activation, and enhanced miR-339-5p expression induced by ethanol exposure in microglia. A neonatal mouse fetal alcohol spectrum disorders (FASD) model showed that Tβ4 expression in the microglia of the hippocampus was markedly enhanced, while Tβ4 treatment effectively blocked the ethanol-induced increase in inflammatory mediators, to the level expressed in vehicle-treated control animals.","© 2016 The Author(s) Published by S. Karger AG, Basel.",10.1159/000445578,<Element 'PubmedArticle' at 0x7f05da6ba040>
450,27166944,Adult NG2-Glia Are Required for Median Eminence-Mediated Leptin Sensing and Body Weight Control.,"While leptin is a well-known regulator of body fat mass, it remains unclear how circulating leptin is sensed centrally to maintain energy homeostasis. Here we show that genetic and pharmacological ablation of adult NG2-glia (also known as oligodendrocyte precursors), but not microglia, leads to primary leptin resistance and obesity in mice. We reveal that NG2-glia contact the dendritic processes of arcuate nucleus leptin receptor (LepR) neurons in the median eminence (ME) and that these processes degenerate upon NG2-glia elimination, which explains the consequential attenuation of these neurons' molecular and electrical responses to leptin. Our data therefore indicate that LepR dendrites in the ME represent the principal conduits of leptin's anorexigenic action and that NG2-glia are essential for their maintenance. Given that ME-directed X-irradiation confirmed the pharmacological and genetically mediated ablation effects on body weight, our findings provide a rationale for the known obesity risk associated with cranial radiation therapy.",[],Cell metabolism,2016-05-12,"[{'lastname': 'Djogo', 'firstname': 'Tina', 'initials': 'T', 'affiliation': 'Department of Medicine, McGill University Health Center Research Institute, McGill University, Montreal, QC H4A 3J1, Canada.'}, {'lastname': 'Robins', 'firstname': 'Sarah C', 'initials': 'SC', 'affiliation': 'Department of Medicine, McGill University Health Center Research Institute, McGill University, Montreal, QC H4A 3J1, Canada.'}, {'lastname': 'Schneider', 'firstname': 'Sarah', 'initials': 'S', 'affiliation': 'Physiological Genomics, Institute of Physiology, Ludwig Maximilians University Munich, 80336 Munich, Germany.'}, {'lastname': 'Kryzskaya', 'firstname': 'Darya', 'initials': 'D', 'affiliation': 'Department of Medicine, McGill University Health Center Research Institute, McGill University, Montreal, QC H4A 3J1, Canada.'}, {'lastname': 'Liu', 'firstname': 'Xiaohong', 'initials': 'X', 'affiliation': 'Department of Medicine, McGill University Health Center Research Institute, McGill University, Montreal, QC H4A 3J1, Canada.'}, {'lastname': 'Mingay', 'firstname': 'Andrew', 'initials': 'A', 'affiliation': 'Department of Medicine, McGill University Health Center Research Institute, McGill University, Montreal, QC H4A 3J1, Canada.'}, {'lastname': 'Gillon', 'firstname': 'Colleen J', 'initials': 'CJ', 'affiliation': 'Department of Medicine, McGill University Health Center Research Institute, McGill University, Montreal, QC H4A 3J1, Canada.'}, {'lastname': 'Kim', 'firstname': 'Joo Hyun', 'initials': 'JH', 'affiliation': 'Department of Medicine, McGill University Health Center Research Institute, McGill University, Montreal, QC H4A 3J1, Canada.'}, {'lastname': 'Storch', 'firstname': 'Kai-Florian', 'initials': 'KF', 'affiliation': 'Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, QC H4H 1R3, Canada.'}, {'lastname': 'Boehm', 'firstname': 'Ulrich', 'initials': 'U', 'affiliation': 'Department of Pharmacology and Toxicology, University of Saarland School of Medicine, 66421 Homburg, Germany.'}, {'lastname': 'Bourque', 'firstname': 'Charles W', 'initials': 'CW', 'affiliation': 'Centre for Research in Neuroscience, Montreal General Hospital, McGill University, Montreal, QC H3G 1A4, Canada.'}, {'lastname': 'Stroh', 'firstname': 'Thomas', 'initials': 'T', 'affiliation': 'Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC H3A 2B4, Canada.'}, {'lastname': 'Dimou', 'firstname': 'Leda', 'initials': 'L', 'affiliation': 'Physiological Genomics, Institute of Physiology, Ludwig Maximilians University Munich, 80336 Munich, Germany.'}, {'lastname': 'Kokoeva', 'firstname': 'Maia V', 'initials': 'MV', 'affiliation': 'Department of Medicine, McGill University Health Center Research Institute, McGill University, Montreal, QC H4A 3J1, Canada. Electronic address: maia.kokoeva@mcgill.ca.'}]",,,,Copyright © 2016 Elsevier Inc. All rights reserved.,10.1016/j.cmet.2016.04.013,<Element 'PubmedArticle' at 0x7f05da6cb2c0>
451,"27159982
23334790
21979916
17515897
15079038
23220632
17675560
21428963
11553630
25410408
24584059
12756136
20079437
26383113
12209851
24852325
23161447
16493583
20566846
25406165
7705655
18684475
7811288
21752397
23341612
21403007
22996661
22827504
9092472
1491694
22309633
21532567
25759364
20016108
21468021
22566377
10529899
20126412
12774125
12496759
11118147
3272167
25917081
19345186",Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients.,"Parkinson's disease (PD) is a neurodegenerative pathology characterized by the degeneration of midbrain dopamine neurons, whose development and maintenance in brain is related to the transcription factor NR4A2 (also called Nurr1). Notably, NR4A2 is a neuroprotective agent with anti-inflammatory role in microglia and astrocytes. Furthermore, mutations in NR4A2 gene are associated to the familial form of PD, and its gene expression level is down-regulated in blood obtained from PD patients. NR4A2 belongs to the NR4A subfamily consisting of three members: NR4A1, NR4A2, and NR4A3. The NR4A subfamily shares high degree of homology in their molecular structure and cooperates in a spectrum of functions ranging from central nervous system to immune control during physiological and pathological conditions. Considering the close functional link between the member of NR4A subfamily, we performed a gene expression analysis of NR4A1, NR4A2, and NR4A3 in peripheral blood obtained from PD patients and healthy controls (HC). Then, in order to evaluate possible involvement of the NR4A subfamily in other neurodegenerative processes, we carried out the same analysis on blood obtained from Alzheimer's disease (AD) patients. A correlation between clinical features and gene expression was also evaluated. We found a marked down-regulated gene expression of the NR4A subfamily obtained from PD patients, but only a NR4A1 decrease in AD patients compared to HC. This study reports that the entire NR4A subfamily and not only NR4A2 could be systemically involved in PD suggesting that the study of these factors could be a promising approach to develop PD therapy.","['Alzheimer’s disease', 'NR4A subfamily', 'Neurodegenerative diseases', 'Nurr1', 'Parkinson’s disease']",Neurotoxicity research,2016-05-11,"[{'lastname': 'Montarolo', 'firstname': 'Francesca', 'initials': 'F', 'affiliation': 'Neurobiology Unit, Neurologia 2 - CReSM (Regional Referring Center of Multiple Sclerosis), Neuroscience Institute Cavalieri Ottolenghi (NICO), University of Turin & AOU San Luigi Gonzaga, Regione Gonzole, 10, 10043, Orbassano, TO, Italy. francesca.montarolo@unito.it.'}, {'lastname': 'Perga', 'firstname': 'Simona', 'initials': 'S', 'affiliation': 'Neurobiology Unit, Neurologia 2 - CReSM (Regional Referring Center of Multiple Sclerosis), Neuroscience Institute Cavalieri Ottolenghi (NICO), University of Turin & AOU San Luigi Gonzaga, Regione Gonzole, 10, 10043, Orbassano, TO, Italy.'}, {'lastname': 'Martire', 'firstname': 'Serena', 'initials': 'S', 'affiliation': 'Neurobiology Unit, Neurologia 2 - CReSM (Regional Referring Center of Multiple Sclerosis), Neuroscience Institute Cavalieri Ottolenghi (NICO), University of Turin & AOU San Luigi Gonzaga, Regione Gonzole, 10, 10043, Orbassano, TO, Italy.'}, {'lastname': 'Navone', 'firstname': 'Désirée Nicole', 'initials': 'DN', 'affiliation': 'Neurobiology Unit, Neurologia 2 - CReSM (Regional Referring Center of Multiple Sclerosis), Neuroscience Institute Cavalieri Ottolenghi (NICO), University of Turin & AOU San Luigi Gonzaga, Regione Gonzole, 10, 10043, Orbassano, TO, Italy.'}, {'lastname': 'Marchet', 'firstname': 'Alberto', 'initials': 'A', 'affiliation': 'Division of Neurology, Martini Hospital, Via Tofane, 71, 10141, Turin, TO, Italy.'}, {'lastname': 'Leotta', 'firstname': 'Daniela', 'initials': 'D', 'affiliation': 'Division of Neurology, Martini Hospital, Via Tofane, 71, 10141, Turin, TO, Italy.'}, {'lastname': 'Bertolotto', 'firstname': 'Antonio', 'initials': 'A', 'affiliation': 'Neurobiology Unit, Neurologia 2 - CReSM (Regional Referring Center of Multiple Sclerosis), Neuroscience Institute Cavalieri Ottolenghi (NICO), University of Turin & AOU San Luigi Gonzaga, Regione Gonzole, 10, 10043, Orbassano, TO, Italy.'}]",,,,,10.1007/s12640-016-9626-4,<Element 'PubmedArticle' at 0x7f05da6db9a0>
452,"27093924
26139594
23234315
22219191
16989956
21419501
24410883
15059975
17203472
14586007
12921904
10858591
10858586
9458167
15059975
25360394
22959056
19931610
23674516
15664187
21311758
24675468
26118757
24310172
22078883
21125645
10195894
20457564
17180163
20195798
12824464
22351073
10845916
17382599
15868401
18040779
20404851
12806257
10196138
15229469
12007537
15897298
12039862
11994753
16984903
19776284
23300647
17391153
21081836
22028977
12023390
23474308
12818176
10797012",Osmotin attenuates LPS-induced neuroinflammation and memory impairments via the TLR4/NFκB signaling pathway.,"Toll-like receptor 4 (TLR4) signaling in the brain mediates autoimmune responses and induces neuroinflammation that results in neurodegenerative diseases, such as Alzheimer's disease (AD). The plant hormone osmotin inhibited lipopolysaccharide (LPS)-induced TLR4 downstream signaling, including activation of TLR4, CD14, IKKα/β, and NFκB, and the release of inflammatory mediators, such as COX-2, TNF-α, iNOS, and IL-1β. Immunoprecipitation demonstrated colocalization of TLR4 and AdipoR1 receptors in BV2 microglial cells, which suggests that osmotin binds to AdipoR1 and inhibits downstream TLR4 signaling. Furthermore, osmotin treatment reversed LPS-induced behavioral and memory disturbances and attenuated LPS-induced increases in the expression of AD markers, such as Aβ, APP, BACE-1, and p-Tau. Osmotin improved synaptic functionality via enhancing the activity of pre- and post-synaptic markers, like PSD-95, SNAP-25, and syntaxin-1. Osmotin also prevented LPS-induced apoptotic neurodegeneration via inhibition of PARP-1 and caspase-3. Overall, our studies demonstrated that osmotin prevented neuroinflammation-associated memory impairment and neurodegeneration and suggest AdipoR1 as a therapeutic target for the treatment of neuroinflammation and neurological disorders, such as AD.",[],Scientific reports,2016-04-21,"[{'lastname': 'Badshah', 'firstname': 'Haroon', 'initials': 'H', 'affiliation': 'Division of Applied Life Science (BK 21), College of Natural Sciences (RINS), Gyeongsang National University, Jinju, 660-701, Republic of Korea.'}, {'lastname': 'Ali', 'firstname': 'Tahir', 'initials': 'T', 'affiliation': 'Division of Applied Life Science (BK 21), College of Natural Sciences (RINS), Gyeongsang National University, Jinju, 660-701, Republic of Korea.'}, {'lastname': 'Kim', 'firstname': 'Myeong Ok', 'initials': 'MO', 'affiliation': 'Division of Applied Life Science (BK 21), College of Natural Sciences (RINS), Gyeongsang National University, Jinju, 660-701, Republic of Korea.'}]",,,,,10.1038/srep24493,<Element 'PubmedArticle' at 0x7f05da672cc0>
453,27063783,Alendronate Attenuates Spinal Microglial Activation and Neuropathic Pain.,"Many derivatives of bisphosphonates, which are inhibitors of bone resorption, have been developed as promising agents for painful pathologies in patients with bone resorption-related diseases. The mechanism for pain relief by bisphosphonates remains uncertain. Studies have reported that bisphosphonates could reduce central neurochemical changes involved in the generation and maintenance of bone cancer pain. In this study, we hypothesized that bisphosphonates would inhibit spinal microglial activation and prevent the development of hyperalgesia caused by peripheral tissue injury. We investigated the effects of alendronate (a nitrogen-containing bisphosphonate) on the development of neuropathic pain and its role in modulating microglial activation in vivo and in vitro. Intrathecal and intraperitoneal administration of alendronate relieved neuropathic pain behaviors induced by chronic constriction sciatic nerve injury. Alendronate also significantly attenuated spinal microglial activation and p38 mitogen-activated protein kinase (MAPK) phosphorylation without affecting astrocytes. In vitro, alendronate downregulated phosphorylated p38 and phosphorylated extracellular signal regulated kinase expression in lipopolysaccharide-stimulated primary microglia within 1 hour, and pretreatment with alendronate for 12 and 24 hours decreased the expression of inflammatory cytokines (tumor necrosis factor α, and interleukins 1β and 6). These findings indicate that alendronate could effectively relieve chronic constriction sciatic nerve injury-induced neuropathic pain by at least partially inhibiting the activation of spinal microglia and the p38 MAPK signaling pathway.
Alendronate could relieve neuropathic pain behaviors in animals by inhibiting the activation of spinal cord microglia and the p38 MAPK cell signaling pathway. Therapeutic applications of alendronate may be extended beyond bone metabolism-related disease.","['Alendronate', 'chronic constriction injury', 'inflammatory cytokines', 'microglial activation', 'p38 mitogen-activated protein kinase']",The journal of pain,2016-04-12,"[{'lastname': 'Yao', 'firstname': 'Yao', 'initials': 'Y', 'affiliation': 'Center for TMD and Orofacial Pain, Peking University School and Hospital of Stomatology, Beijing, China.'}, {'lastname': 'Tan', 'firstname': 'Yong-Hui', 'initials': 'YH', 'affiliation': 'Center for TMD and Orofacial Pain, Peking University School and Hospital of Stomatology, Beijing, China.'}, {'lastname': 'Light', 'firstname': 'Alan R', 'initials': 'AR', 'affiliation': 'Department of Anesthesiology and Neurobiology and Anatomy, University of Utah, Salt Lake City, Utah.'}, {'lastname': 'Mao', 'firstname': 'Jianren', 'initials': 'J', 'affiliation': 'Department of Anesthesia and Critical Care, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.'}, {'lastname': 'Yu', 'firstname': 'Albert Cheung Hoi', 'initials': 'AC', 'affiliation': 'Neuroscience Research Institute, Peking University and Department of Neurobiology, Peking University Health Science Center, Beijing, China.'}, {'lastname': 'Fu', 'firstname': 'Kai-Yuan', 'initials': 'KY', 'affiliation': 'Center for TMD and Orofacial Pain, Peking University School and Hospital of Stomatology, Beijing, China. Electronic address: kqkyfu@bjmu.edu.cn.'}]",,,,Copyright © 2016 American Pain Society. All rights reserved.,10.1016/j.jpain.2016.03.008,<Element 'PubmedArticle' at 0x7f05da68eae0>
454,27012766,Melatonin reverses morphine tolerance by inhibiting microglia activation and HSP27 expression.,"Melatonin has been reported to attenuate opioid tolerance. In this study, we explored the possible mechanism of melatonin in diminishing morphine tolerance.
Two intrathecal (i.t.) catheters were implanted in male Wistar rats for drug delivery. One was linked to a mini-osmotic pump for morphine or saline infusion. On the seventh day, 50μg of melatonin or vehicle was injected through the other catheter instantly after discontinuation of morphine or saline infusion; 3h later, 15μg of morphine or saline was injected. The antinociceptive response was then measured using the tail-flick test every 30min for 120min.
The results showed that chronic morphine infusion elicited antinociceptive tolerance and upregulated heat shock protein 27 (HSP27) expression in the dorsal horn of the rat spinal cord. Melatonin pretreatment partially restored morphine's antinociceptive effect in morphine-tolerant rats and reversed morphine-induced HSP27 upregulation. In addition, chronic morphine infusion induced microglial cell activation and was reversed by melatonin treatment.
The present study provides evidence that melatonin, acting via inhibiting morphine-induced neuroinflammation, can be useful as a therapeutic adjuvant for patients under long-term opioid treatment for pain relief.","['Antinociception', 'Heat shock protein 27', 'Intrathecal injection', 'Melatonin', 'Microglial activation', 'Morphine tolerance', 'Neuroinflammation', 'Tail-flick latency']",Life sciences,2016-03-26,"[{'lastname': 'Lin', 'firstname': 'Sheng-Hsiung', 'initials': 'SH', 'affiliation': 'Graduate Institute of Medical Science, National Defense Medical Center, Taipei City, Taiwan; Medical Service Office, Tri-Service General Hospital Songshang Branch, Taipei City, Taiwan.'}, {'lastname': 'Huang', 'firstname': 'Ya-Ni', 'initials': 'YN', 'affiliation': 'Department of Nursing, Hsin Sheng Junior College of Medical Care and Management, Taoyuan City, Taiwan.'}, {'lastname': 'Kao', 'firstname': 'Jen-Hsin', 'initials': 'JH', 'affiliation': 'Department of Anesthesiology, Cathay General Hospital, Taipei City, Taiwan; Cathay Medical Research Institute, Cathay General Hospital, Taipei City, Taiwan.'}, {'lastname': 'Tien', 'firstname': 'Lu-Tai', 'initials': 'LT', 'affiliation': 'School of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan.'}, {'lastname': 'Tsai', 'firstname': 'Ru-Yin', 'initials': 'RY', 'affiliation': 'Department of Nursing, Da-Yeh University, Changhua City, Taiwan.'}, {'lastname': 'Wong', 'firstname': 'Chih-Shung', 'initials': 'CS', 'affiliation': 'Graduate Institute of Medical Science, National Defense Medical Center, Taipei City, Taiwan; Department of Anesthesiology, Cathay General Hospital, Taipei City, Taiwan; School of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan. Electronic address: w82556@gmail.com.'}]",,,,Copyright © 2016 Elsevier Inc. All rights reserved.,10.1016/j.lfs.2016.03.032,<Element 'PubmedArticle' at 0x7f05da627f40>
455,"26960267
17418429
19913097
12442672
19821032
3399080
15668962
10964613
12068076
10720625
19450656
16240369
17433296
2330103
11087781
21327582
16084662
8461992
25926772
15831717
17965659
11241743
21527731
21295135
7517635
18286612
21565615
11245665
10934283
23817277
20086079
23536230
23953759
24315728
18650345
20851176
16130149
19539954
11418693
20351193
10886344
15003854
17437542
23348042
19224575
12496090
15798185
15261308
12878732
22886465
8840164
2313087
19889994
22840752
17287517
17584622
16087902
19553526
19376196",Estrogen ameliorates microglial activation by inhibiting the Kir2.1 inward-rectifier K(+) channel.,"Microglial activation is implicated in the pathogenesis of Parkinson's disease (PD). Although the etiology of PD remains unclear, age and male gender are known PD risk factors. By comparing microglia and dopaminergic (DA) neurons in the substantia nigra (SN) of male and female mice of different ages, we found that the degrees of microglial activation and DA neuron loss increased with age in both genders, but were more pronounced in males, as were peripheral lipopolysaccharide (LPS)-induced microglial activation and DA neuron loss. A bilateral ovariectomy (OVX) eliminated the female-associated protection against age- and LPS-induced microglial activation, which suggests that ovary hormones are involved in gender-specific responses. Treating female mice with 17β-estradiol supplements reduced the age-associated microglial activation in OVX mice. Moreover, pretreating mouse BV2 microglial cells with 17β-estradiol inhibited LPS-induced elevation of Toll-like receptor 4, phosphorylated p38, and TNF-α levels. We then examined the effect of 17β-estradiol on inward-rectifier K(+) channel Kir2.1, a known regulator of microglial activation. We found that 17β-estradiol inhibited the Kir2.1 activity of BV2 cells by reducing the probability that the channel would be open. We conclude that age- and inflammation-associated microglial activation is attenuated by ovarian estrogen, because it inhibits Kir2.1.",[],Scientific reports,2016-03-11,"[{'lastname': 'Wu', 'firstname': 'Shih-Ying', 'initials': 'SY', 'affiliation': 'Institute of Basic Medical Sciences, National Cheng Kung University, Tainan, Taiwan.'}, {'lastname': 'Chen', 'firstname': 'Yun-Wen', 'initials': 'YW', 'affiliation': 'Department of Cell Biology and Anatomy, National Cheng Kung University, Tainan, Taiwan.\nDepartment of Chinese Medicine for Post-Baccalaureate, I-Shou University, Kaohsiung, Taiwan.'}, {'lastname': 'Tsai', 'firstname': 'Sheng-Feng', 'initials': 'SF', 'affiliation': 'Institute of Basic Medical Sciences, National Cheng Kung University, Tainan, Taiwan.'}, {'lastname': 'Wu', 'firstname': 'Sheng-Nan', 'initials': 'SN', 'affiliation': 'Department of Physiology, National Cheng Kung University, Tainan, Taiwan.'}, {'lastname': 'Shih', 'firstname': 'Yao-Hsiang', 'initials': 'YH', 'affiliation': 'Institute of Basic Medical Sciences, National Cheng Kung University, Tainan, Taiwan.'}, {'lastname': 'Jiang-Shieh', 'firstname': 'Ya-Fen', 'initials': 'YF', 'affiliation': 'Department of Cell Biology and Anatomy, National Cheng Kung University, Tainan, Taiwan.'}, {'lastname': 'Yang', 'firstname': 'Ting-Ting', 'initials': 'TT', 'affiliation': 'Department of Chinese Medicine for Post-Baccalaureate, I-Shou University, Kaohsiung, Taiwan.'}, {'lastname': 'Kuo', 'firstname': 'Yu-Min', 'initials': 'YM', 'affiliation': 'Institute of Basic Medical Sciences, National Cheng Kung University, Tainan, Taiwan.\nDepartment of Cell Biology and Anatomy, National Cheng Kung University, Tainan, Taiwan.'}]",,,,,10.1038/srep22864,<Element 'PubmedArticle' at 0x7f05da6352c0>
456,"26954031
7272714
10767311
6663313
3041313
8596916
9989622
20156111
11113228
23859341
19679182
25104852
20383327
17098208
11113228
22706278
12832285
14570713
20090835
11113228
10607838
14637250
10589547
15857398
9224623
17581577
23143307
18188152
25161822
21356345
191856
3286045
22542954
20628203
11852098
15126346
8682794
24970148
17664623
17287287
15285801
17965659
17180163
20880502
25310643
11135624
11179503
15159442
23025350
21840268
18190523
20370487
17224059",Frataxin Deficiency Promotes Excess Microglial DNA Damage and Inflammation that Is Rescued by PJ34.,"An inherited deficiency in the frataxin protein causes neurodegeneration of the dorsal root ganglia and Friedreich's ataxia (FA). Frataxin deficiency leads to oxidative stress and inflammatory changes in cell and animal models; however, the cause of the inflammatory changes, and especially what causes brain microglial activation is unclear. Here we investigated: 1) the mechanism by which frataxin deficiency activates microglia, 2) whether a brain-localized inflammatory stimulus provokes a greater microglial response in FA animal models, and 3) whether an anti-inflammatory treatment improves their condition. Intracerebroventricular administration of LPS induced higher amounts of microglial activation in the FA mouse model vs controls. We also observed an increase in oxidative damage in the form of 8-oxoguanine (8-oxo-G) and the DNA repair proteins MUTYH and PARP-1 in cerebellar microglia of FA mutant mice. We hypothesized that frataxin deficiency increases DNA damage and DNA repair genes specifically in microglia, activating them. siRNA-mediated frataxin knockdown in microglial BV2 cells clearly elevated DNA damage and the expression of DNA repair genes MUTYH and PARP-1. Frataxin knockdown also induced a higher level of PARP-1 in MEF cells, and this was suppressed in MUTYH-/- knockout cells. Administration of the PARP-1 inhibitor PJ34 attenuated the microglial activation induced by intracerebroventricular injection of LPS. The combined administration of LPS and angiotensin II provoke an even stronger activation of microglia and neurobehavioral impairment. PJ34 treatment attenuated the neurobehavioral impairments in FA mice. These results suggest that the DNA repair proteins MUTYH and PARP-1 may form a pathway regulating microglial activation initiated by DNA damage, and inhibition of microglial PARP-1 induction could be an important therapeutic target in Friedreich's ataxia.",[],PloS one,2016-03-10,"[{'lastname': 'Shen', 'firstname': 'Yan', 'initials': 'Y', 'affiliation': 'Department of Molecular Biosciences, University of California Davis, Davis, California, 95616, United States of America.'}, {'lastname': 'McMackin', 'firstname': 'Marissa Z', 'initials': 'MZ', 'affiliation': 'Department of Molecular Biosciences, University of California Davis, Davis, California, 95616, United States of America.'}, {'lastname': 'Shan', 'firstname': 'Yuxi', 'initials': 'Y', 'affiliation': 'Department of Molecular Biosciences, University of California Davis, Davis, California, 95616, United States of America.'}, {'lastname': 'Raetz', 'firstname': 'Alan', 'initials': 'A', 'affiliation': 'Department of Chemistry, University of California Davis, Davis, California, 95616, United States of America.'}, {'lastname': 'David', 'firstname': 'Sheila', 'initials': 'S', 'affiliation': 'Department of Chemistry, University of California Davis, Davis, California, 95616, United States of America.'}, {'lastname': 'Cortopassi', 'firstname': 'Gino', 'initials': 'G', 'affiliation': 'Department of Molecular Biosciences, University of California Davis, Davis, California, 95616, United States of America.'}]",,,,,"10.1371/journal.pone.0151026
10.1089/ars.2009.3015
10.1111/jnc.12303
10.1016/j.bbadis.2009.07.011
10.1093/hmg/ddu407
10.1371/journal.pone.0010025
10.1093/hmg/dds230
10.1038/sj.emboj.7601975
10.1002/brb3.239
10.1016/j.ajpath.2010.12.004
10.1016/j.nbd.2012.04.010
10.3390/biom2040524
10.1016/j.nurt.2010.07.005
10.1038/oncsis.2014.35
10.1021/cb300317y
10.1016/j.dnarep.2011.07.006
10.1111/j.1460-9568.2007.06014.x
10.1089/rej.2009.0944",<Element 'PubmedArticle' at 0x7f05da658360>
457,26916241,Effects of liraglutide in hypothalamic arcuate nucleus of obese mice.,"The neuroprotective effects of liraglutide (200 μg/kg, twice daily, subcutaneous administration) in the hypothalamic arcuate nucleus (ARC) of diet-induced obese mice were investigated.
C57BL/6 mice were separated into groups: standard chow treated with vehicle or liraglutide and the respective liraglutide pair-fed group; high-fat diet treated with vehicle or liraglutide and the respective pair-fed group. Body mass (BM) evolution, carbohydrate metabolism, leptin resistance, proteins involved in energetic balance, apoptosis, and microglia in the ARC were studied.
Obese animals showed glucose intolerance, resistance to insulin and to anorexigenic effect of leptin, and microgliosis accompanied by elevated Bax/Bcl2 ratio in the ARC. Liraglutide improved the carbohydrate metabolism, BM loss, and the activation of pro-opiomelanocortin (POMC) and cocaine and amphetamine-regulated transcript (CART) in the ARC. The liraglutide enhanced leptin sensitivity and diminished the microgliosis with decrease in Bax/Bcl2 ratio.
Liraglutide activates central anorexigenic pathways, thereby diminishing the energy intake of obese mice and improving the metabolic parameters related to obesity. Liraglutide is a relevant neuroprotective agent, which can decrease the microgliosis and stimulate the anti-apoptotic pathway, a significant effect in the treatment of obesity and its comorbidities. Some benefits of liraglutide are independent of the BM loss, which usually accompanies the drug administration.",[],"Obesity (Silver Spring, Md.)",2016-02-27,"[{'lastname': 'Barreto-Vianna', 'firstname': 'Andre R C', 'initials': 'AR', 'affiliation': 'Laboratory of Morphometry, Metabolism, and Cardiovascular Disease, Biomedical Center, Institute of Biology, State University of Rio De Janeiro, Rio De Janeiro, Brazil.'}, {'lastname': 'Aguila', 'firstname': 'Marcia B', 'initials': 'MB', 'affiliation': 'Laboratory of Morphometry, Metabolism, and Cardiovascular Disease, Biomedical Center, Institute of Biology, State University of Rio De Janeiro, Rio De Janeiro, Brazil.'}, {'lastname': 'Mandarim-de-Lacerda', 'firstname': 'Carlos A', 'initials': 'CA', 'affiliation': 'Laboratory of Morphometry, Metabolism, and Cardiovascular Disease, Biomedical Center, Institute of Biology, State University of Rio De Janeiro, Rio De Janeiro, Brazil.'}]",,,"Obese animals showed glucose intolerance, resistance to insulin and to anorexigenic effect of leptin, and microgliosis accompanied by elevated Bax/Bcl2 ratio in the ARC. Liraglutide improved the carbohydrate metabolism, BM loss, and the activation of pro-opiomelanocortin (POMC) and cocaine and amphetamine-regulated transcript (CART) in the ARC. The liraglutide enhanced leptin sensitivity and diminished the microgliosis with decrease in Bax/Bcl2 ratio.",© 2016 The Obesity Society.,10.1002/oby.21387,<Element 'PubmedArticle' at 0x7f05da5f9860>
458,"26870797
2584240
7624778
8608603
19028534
8990120
9346963
16644674
9622598
21813697
7624777
10931946
16189248
1961764
18979232
10452611
25409701
10359836
21664248
20178827
2372374
15208705
17036007
7624776
18443592
17525125
22295972
7592907
7768358
24048027
8607798
11201732
17617622
11786910
17895523
7984236","Mimecan, a Hormone Abundantly Expressed in Adipose Tissue, Reduced Food Intake Independently of Leptin Signaling.","Adipokines such as leptin play important roles in the regulation of energy metabolism, particularly in the control of appetite. Here, we describe a hormone, mimecan, which is abundantly expressed in adipose tissue. Mimecan was observed to inhibit food intake and reduce body weight in mice. Intraperitoneal injection of a mimecan-maltose binding protein (-MBP) complex inhibited food intake in C57BL/6J mice, which was attenuated by pretreatment with polyclonal antibody against mimecan. Notably, mimecan-MBP also induced anorexia in A(y)/a and db/db mice. Furthermore, the expression of interleukin (IL)-1β and IL-6 was up-regulated in the hypothalamus by mimecan-MBP, as well as in N9 microglia cells by recombinant mouse mimecan. Taken together, the results suggest that mimecan is a satiety hormone in adipose tissue, and that mimecan inhibits food intake independently of leptin signaling by inducing IL-1β and IL-6 expression in the hypothalamus.","['Anorexia', 'IL-1β', 'IL-6', 'Leptin', 'Mimecan']",EBioMedicine,2016-02-13,"[{'lastname': 'Cao', 'firstname': 'Huang-Ming', 'initials': 'HM', 'affiliation': 'State Key Laboratory of Medical Genomics, Molecular Medicine Center, Shanghai Institute of Endocrinology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.'}, {'lastname': 'Ye', 'firstname': 'Xiao-Ping', 'initials': 'XP', 'affiliation': ""State Key Laboratory of Medical Genomics, Molecular Medicine Center, Shanghai Institute of Endocrinology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China; Medical Center of Clinical Research, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200011, China.""}, {'lastname': 'Ma', 'firstname': 'Jun-Hua', 'initials': 'JH', 'affiliation': 'State Key Laboratory of Medical Genomics, Molecular Medicine Center, Shanghai Institute of Endocrinology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.'}, {'lastname': 'Jiang', 'firstname': 'He', 'initials': 'H', 'affiliation': 'State Key Laboratory of Medical Genomics, Molecular Medicine Center, Shanghai Institute of Endocrinology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.'}, {'lastname': 'Li', 'firstname': 'Sheng-Xian', 'initials': 'SX', 'affiliation': 'State Key Laboratory of Medical Genomics, Molecular Medicine Center, Shanghai Institute of Endocrinology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.'}, {'lastname': 'Li', 'firstname': 'Rong-Ying', 'initials': 'RY', 'affiliation': 'State Key Laboratory of Medical Genomics, Molecular Medicine Center, Shanghai Institute of Endocrinology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.'}, {'lastname': 'Li', 'firstname': 'Xue-Song', 'initials': 'XS', 'affiliation': 'State Key Laboratory of Medical Genomics, Molecular Medicine Center, Shanghai Institute of Endocrinology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.'}, {'lastname': 'Guo', 'firstname': 'Cui-Cui', 'initials': 'CC', 'affiliation': 'State Key Laboratory of Medical Genomics, Molecular Medicine Center, Shanghai Institute of Endocrinology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.'}, {'lastname': 'Wang', 'firstname': 'Zhi-Quan', 'initials': 'ZQ', 'affiliation': 'State Key Laboratory of Medical Genomics, Molecular Medicine Center, Shanghai Institute of Endocrinology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.'}, {'lastname': 'Zhan', 'firstname': 'Ming', 'initials': 'M', 'affiliation': 'State Key Laboratory of Medical Genomics, Molecular Medicine Center, Shanghai Institute of Endocrinology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.'}, {'lastname': 'Zuo', 'firstname': 'Chun-Lin', 'initials': 'CL', 'affiliation': 'State Key Laboratory of Medical Genomics, Molecular Medicine Center, Shanghai Institute of Endocrinology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.'}, {'lastname': 'Pan', 'firstname': 'Chun-Ming', 'initials': 'CM', 'affiliation': 'State Key Laboratory of Medical Genomics, Molecular Medicine Center, Shanghai Institute of Endocrinology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.'}, {'lastname': 'Zhao', 'firstname': 'Shuang-Xia', 'initials': 'SX', 'affiliation': 'State Key Laboratory of Medical Genomics, Molecular Medicine Center, Shanghai Institute of Endocrinology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.'}, {'lastname': 'Zheng', 'firstname': 'Cui-Xia', 'initials': 'CX', 'affiliation': ""Medical Center of Clinical Research, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200011, China.""}, {'lastname': 'Song', 'firstname': 'Huai-Dong', 'initials': 'HD', 'affiliation': ""State Key Laboratory of Medical Genomics, Molecular Medicine Center, Shanghai Institute of Endocrinology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China; Medical Center of Clinical Research, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200011, China.""}]",,,,,10.1016/j.ebiom.2015.09.044,<Element 'PubmedArticle' at 0x7f05da60a130>
459,"26861286
25595674
26610255
15755670
1564476
6140548
9613715
9749577
9600990
8786384
22951445
21467220
24803746
15285801
17982277
11754997
19296921
17652153
10322410
20638440
25116357
18845573
17395898
24574581
22933144
15313368
9419378
7601337
19913097
17203472
23916477
12068076
11978789
23823479
15817468
10484065
24618100
12761501
12881424","GLP-2 Attenuates LPS-Induced Inflammation in BV-2 Cells by Inhibiting ERK1/2, JNK1/2 and NF-κB Signaling Pathways.","The pathogenesis of Parkinson's disease (PD) often involves the over-activation of microglia. Over-activated microglia could produce several inflammatory mediators, which trigger excessive inflammation and ultimately cause dopaminergic neuron damage. Anti-inflammatory effects of glucagon-like peptide-2 (GLP-2) in the periphery have been shown. Nonetheless, it has not been illustrated in the brain. Thus, in this study, we aimed to understand the role of GLP-2 in microglia activation and to elucidate the underlying mechanisms. BV-2 cells were pretreated with GLP-2 and then stimulated by lipopolysaccharide (LPS). Cells were assessed for the responses of pro-inflammatory enzymes (iNOS and COX-2) and pro-inflammatory cytokines (IL-1β, IL-6 and TNF-α); the related signaling pathways were evaluated by Western blotting. The rescue effect of GLP-2 on microglia-mediated neurotoxicity was also examined. The results showed that GLP-2 significantly reduced LPS-induced production of inducible nitric oxide synthase (iNOS), cyclooxygenase-s (COX-2), IL-1β, IL-6 and TNF-α. Blocking of Gαs by NF449 resulted in a loss of this anti-inflammatory effect in BV-2 cells. Analyses in signaling pathways demonstrated that GLP-2 reduced LPS-induced phosphorylation of ERK1/2, JNK1/2 and p65, while no effect was observed on p38 phosphorylation. In addition, GLP-2 could suppress microglia-mediated neurotoxicity. All results imply that GLP-2 inhibits LPS-induced microglia activation by collectively regulating ERK1/2, JNK1/2 and p65.","['MAPK', 'NF-κB', 'Parkinson’s disease', 'glucagon-like peptide-2', 'microglia']",International journal of molecular sciences,2016-02-11,"[{'lastname': 'Li', 'firstname': 'Nan', 'initials': 'N', 'affiliation': 'College of Animal Science and Veterinary Medicine, Jilin University, Changchun 130062, China. ln657748288@gmail.com.'}, {'lastname': 'Liu', 'firstname': 'Bo-Wen', 'initials': 'BW', 'affiliation': 'College of Animal Science and Veterinary Medicine, Jilin University, Changchun 130062, China. Bowenliucn@outlook.com.'}, {'lastname': 'Ren', 'firstname': 'Wen-Zhi', 'initials': 'WZ', 'affiliation': 'College of Animal Science and Veterinary Medicine, Jilin University, Changchun 130062, China. rwz1964@163.com.'}, {'lastname': 'Liu', 'firstname': 'Ju-Xiong', 'initials': 'JX', 'affiliation': 'College of Animal Science and Veterinary Medicine, Jilin University, Changchun 130062, China. juxiong@jlu.edu.cn.'}, {'lastname': 'Li', 'firstname': 'Su-Nan', 'initials': 'SN', 'affiliation': 'College of Animal Science and Veterinary Medicine, Jilin University, Changchun 130062, China. lsnlhh2006@163.com.'}, {'lastname': 'Fu', 'firstname': 'Shou-Peng', 'initials': 'SP', 'affiliation': 'College of Animal Science and Veterinary Medicine, Jilin University, Changchun 130062, China. shoupengfu@163.com.'}, {'lastname': 'Zeng', 'firstname': 'Ya-Long', 'initials': 'YL', 'affiliation': 'College of Animal Science and Veterinary Medicine, Jilin University, Changchun 130062, China. zengyalong@foxmail.com.'}, {'lastname': 'Xu', 'firstname': 'Shi-Yao', 'initials': 'SY', 'affiliation': 'College of Animal Science and Veterinary Medicine, Jilin University, Changchun 130062, China. xushiyao1989@163.com.'}, {'lastname': 'Yan', 'firstname': 'Xuan', 'initials': 'X', 'affiliation': 'College of Animal Science and Veterinary Medicine, Jilin University, Changchun 130062, China. yanxuan1992@outlook.com.'}, {'lastname': 'Gao', 'firstname': 'Ying-Jie', 'initials': 'YJ', 'affiliation': 'College of Animal Science and Veterinary Medicine, Jilin University, Changchun 130062, China. yjgao@jlu.edu.cn.'}, {'lastname': 'Liu', 'firstname': 'Dian-Feng', 'initials': 'DF', 'affiliation': 'College of Animal Science and Veterinary Medicine, Jilin University, Changchun 130062, China. ccdf@163.com.'}, {'lastname': 'Wang', 'firstname': 'Wei', 'initials': 'W', 'affiliation': 'College of Animal Science and Veterinary Medicine, Jilin University, Changchun 130062, China. wang_wei99@jluhp.edu.cn.'}]",,,,,"10.3390/ijms17020190
10.1186/s12974-014-0230-3
10.1517/14728222.2016.1086340
10.1016/j.nbd.2004.12.005
10.1136/jnnp.55.3.181
10.1016/S0140-6736(83)90802-4
10.1002/ana.410440712
10.1073/pnas.95.11.6469
10.1097/00005072-199603000-00001
10.1101/cshperspect.a009373
10.1073/pnas.1017820108
10.1155/2014/983401
10.1186/1742-2094-1-14
10.1159/000110455
10.1016/S0197-4580(01)00287-1
10.1016/S1474-4422(09)70062-6
10.1152/ajpendo.00149.2007
10.1016/S1043-2760(98)00136-2
10.1016/j.pneurobio.2010.07.003
10.1159/000363025
10.1152/ajpgi.90494.2008
10.1152/ajpgi.00530.2006
10.1155/2013/548073
10.1016/j.jss.2004.04.009
10.1073/pnas.95.1.346
10.1016/j.nbd.2009.11.004
10.1002/glia.20467
10.1016/j.neuropharm.2013.07.020
10.1046/j.1471-4159.2002.00928.x
10.1074/jbc.M201358200
10.1016/j.cmet.2013.06.014
10.1074/jbc.M500078200
10.1186/1742-2094-11-47
10.1038/sj.onc.1206406
10.1093/emboj/cdg379",<Element 'PubmedArticle' at 0x7f05da5a7e00>
460,26836768,Inhibition of p38 pathway-dependent MPTP-induced dopaminergic neurodegeneration in estrogen receptor alpha knockout mice.,"Approximately, 7-10 million people in the world suffer from Parkinson's disease (PD). Recently, increasing evidence has suggested the protective effect of estrogens against nigrostriatal dopaminergic damage in PD. In this study, we investigated whether estrogen affects 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced behavioral impairment in estrogen receptor alpha (ERα)-deficient mice. MPTP (15mg/kg, four times with 1.5-h interval)-induced dopaminergic neurodegeneration was evaluated in ERα wild-type (WT) and knockout (KO) mice. Larger dopamine depletion, behavioral impairments (Rotarod test, Pole test, and Gait test), activation of microglia and astrocytes, and neuroinflammation after MPTP injection were observed in ERα KO mice compared to those in WT mice. Immunostaining for tyrosine hydroxylase (TH) after MPTP injection showed fewer TH-positive neurons in ERα KO mice than WT mice. Levels of dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC, metabolite of dopamine) were also lowered in ERα KO mice after MPTP injection. Interestingly, a higher immunoreactivity for monoamine oxidase (MAO) B was found in the substantia nigra and striatum of ERα KO mice after MPTP injection. We also found an increased activation of p38 kinase (which positively regulates MAO B expression) in ERα KO mice. In vitro estrogen treatment inhibited neuroinflammation in 1-methyl-4-phenyl pyridium (MPP+)-treated cultured astrocyte cells; however, these inhibitory effects were removed by p38 inhibitor. These results indicate that ERα might be important for dopaminergic neuronal survival through inhibition of p38 pathway.","['Estrogen', 'Estrogen receptor alpha', 'MAO', 'P38', ""Parkinson's disease""]",Hormones and behavior,2016-02-03,"[{'lastname': 'Hwang', 'firstname': 'Chul Ju', 'initials': 'CJ', 'affiliation': 'College of Pharmacy and Medical Research Center, Chungbuk National University, Osongsaengmyeong 1-ro 194-31, Osong-eup, Heungdeok-gu, Cheongju, Chungbuk 361-951, South Korea.'}, {'lastname': 'Choi', 'firstname': 'Dong-Young', 'initials': 'DY', 'affiliation': 'College of Pharmacy, Yeungnam University, 280, Daehak-ro, Gyeongsan, Gyeongbuk 712-749, South Korea.'}, {'lastname': 'Jung', 'firstname': 'Yu Yeon', 'initials': 'YY', 'affiliation': 'College of Pharmacy and Medical Research Center, Chungbuk National University, Osongsaengmyeong 1-ro 194-31, Osong-eup, Heungdeok-gu, Cheongju, Chungbuk 361-951, South Korea.'}, {'lastname': 'Lee', 'firstname': 'Young-Jung', 'initials': 'YJ', 'affiliation': 'School of Equine Science, Cheju Halla University, 38 Halladaehak-ro, Jeju-si, Jeju Special Self-Governing Province 690-708, South Korea.'}, {'lastname': 'Yun', 'firstname': 'Jae Suk', 'initials': 'JS', 'affiliation': 'Osong Health Technology Administration Complex, 187 Osongsaengmyeong2(i)-ro, Osong-eup, Cheongju, Chungbuk 363-700, South Korea.'}, {'lastname': 'Oh', 'firstname': 'Ki-Wan', 'initials': 'KW', 'affiliation': 'College of Pharmacy and Medical Research Center, Chungbuk National University, Osongsaengmyeong 1-ro 194-31, Osong-eup, Heungdeok-gu, Cheongju, Chungbuk 361-951, South Korea.'}, {'lastname': 'Han', 'firstname': 'Sang-Bae', 'initials': 'SB', 'affiliation': 'College of Pharmacy and Medical Research Center, Chungbuk National University, Osongsaengmyeong 1-ro 194-31, Osong-eup, Heungdeok-gu, Cheongju, Chungbuk 361-951, South Korea.'}, {'lastname': 'Oh', 'firstname': 'Seikwan', 'initials': 'S', 'affiliation': 'Department of Neuroscience and Tissue Injury Defense Research Center, School of Medicine, Ewha Womans University, Seoul 158-710, South Korea.'}, {'lastname': 'Park', 'firstname': 'Mi Hee', 'initials': 'MH', 'affiliation': 'College of Pharmacy and Medical Research Center, Chungbuk National University, Osongsaengmyeong 1-ro 194-31, Osong-eup, Heungdeok-gu, Cheongju, Chungbuk 361-951, South Korea. Electronic address: pmh5205@hanmail.net.'}, {'lastname': 'Hong', 'firstname': 'Jin Tae', 'initials': 'JT', 'affiliation': 'College of Pharmacy and Medical Research Center, Chungbuk National University, Osongsaengmyeong 1-ro 194-31, Osong-eup, Heungdeok-gu, Cheongju, Chungbuk 361-951, South Korea. Electronic address: jinthong@chungbuk.ac.kr.'}]",,,,Copyright © 2016 Elsevier Inc. All rights reserved.,10.1016/j.yhbeh.2016.01.011,<Element 'PubmedArticle' at 0x7f05da5d0590>
461,26826331,Effect of axotomy and 17β-estradiol on P2X7 receptor expression pattern in the hypoglossal nucleus of ovariectomized mice.,"The objective of the study was to examine whether axotomy and 17β-estradiol affects P2X7 receptor expression and distribution in the hypoglossal nucleus. The left hypoglossal nerve of ovariectomized mice was cut and animals received a single injection of 17β-estradiol (25 μg/100g b.w. in 20% (2-hydroxypropyl)-β-cyclodextrin) or vehicle one hour after axotomy. Mice were sacrificed on day 4 following surgery. The area fraction of P2X7 receptor immunoreactive structures and of CD11b immunolabeled microglia, P2X7 protein concentration, and the immunoreactivity pattern of estrogen receptor (ER) alpha/beta were analyzed on both sides of the hypoglossal nucleus. Following axotomy the area fraction of P2X7 immunoreactive neurons showed a decreasing tendency, while the area fraction of P2X7 immunolabeled microglia increased significantly on the axotomized side compared with the control side in mice injected with vehicle. In animals treated with 17β-estradiol the decrease in area fraction of neural and the increase in area fraction of microglial P2X7 immunostaining on the axotomized side were significantly enhanced compared with animals injected with vehicle. The P2X7 immunoreactivity pattern on the control side of the nucleus remained unchanged after 17β-estradiol injection. Semi-quantitative Western blots revealed no significant difference in P2X7 protein concentration comparing the axotomized side with the control side in either experimental group. The CD11b immunoreactive microglia area fraction increased significantly following axotomy, but was not affected by 17β-estradiol. Neither ER alpha, nor beta colocalized with CD11b. Our results suggest that axotomy induces cell-type specific changes in P2X7 receptor expression, which may be directly regulated by 17β-estradiol through ER alpha or beta in neurons, but not in activated microglia.","['P2X7 receptor', 'axotomy', 'estrogen receptor', 'hypoglossal nucleus', 'microglia']",Neuroscience,2016-01-31,"[{'lastname': 'Barabási', 'firstname': 'B', 'initials': 'B', 'affiliation': 'Institute of Biophysics, Biological Research Centre of the Hungarian Academy of Sciences, 6726 Szeged, Temesvári krt. 62, Hungary.'}, {'lastname': 'Csondor', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Institute of Biophysics, Biological Research Centre of the Hungarian Academy of Sciences, 6726 Szeged, Temesvári krt. 62, Hungary.'}, {'lastname': 'Martín-Pozas', 'firstname': 'T', 'initials': 'T', 'affiliation': 'Institute of Biophysics, Biological Research Centre of the Hungarian Academy of Sciences, 6726 Szeged, Temesvári krt. 62, Hungary.'}, {'lastname': 'Pulupa Sánchez', 'firstname': 'A M', 'initials': 'AM', 'affiliation': 'Institute of Biophysics, Biological Research Centre of the Hungarian Academy of Sciences, 6726 Szeged, Temesvári krt. 62, Hungary.'}, {'lastname': 'Antalffy', 'firstname': 'G', 'initials': 'G', 'affiliation': '3DHISTECH Ltd. 1121 Budapest, Konkoly-Thege M. út 29-33, Hungary.'}, {'lastname': 'Siklós', 'firstname': 'L', 'initials': 'L', 'affiliation': 'Institute of Biophysics, Biological Research Centre of the Hungarian Academy of Sciences, 6726 Szeged, Temesvári krt. 62, Hungary.'}, {'lastname': 'Gómez-Pinedo', 'firstname': 'U', 'initials': 'U', 'affiliation': 'Instituto de Neurociencias, IdISSC, Hospital Clínico San Carlos, Universidad Complutense, c/ Prof Martín Lagos s/n, 28040 Madrid, Spain.'}, {'lastname': 'Párducz', 'firstname': 'Á', 'initials': 'Á', 'affiliation': 'Institute of Biophysics, Biological Research Centre of the Hungarian Academy of Sciences, 6726 Szeged, Temesvári krt. 62, Hungary.'}, {'lastname': 'Hoyk', 'firstname': 'Z', 'initials': 'Z', 'affiliation': 'Institute of Biophysics, Biological Research Centre of the Hungarian Academy of Sciences, 6726 Szeged, Temesvári krt. 62, Hungary. Electronic address: hoyk.zsofia@brc.mta.hu.'}]",,,,Copyright © 2016 IBRO. Published by Elsevier Ltd. All rights reserved.,10.1016/j.neuroscience.2016.01.049,<Element 'PubmedArticle' at 0x7f05da5dbf90>
462,"26824325
18521112
11440935
19236260
14987627
17484889
17087127
11575713
25160710
24836296
11323130
19789075
11854769
16873338
11758520
25197647
26152292
25732721
25088370
21181480
25212534
22585736
19811050
24828945
23242694
17264735
22359935
25715439
22354705
18183533
16237479
21426373
23992823
25888914
24693137
26242341
24076098
23864865
25685815
24312195
25653478
25796592
11817511
19609589
20363293
25799920
24216135
15607953
17484726
12834810
22321918",Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2.,"Chronic pain is commonly and closely correlated with inflammation. Both cannabinoid signaling and mesenchymal stem cells (MSCs) have been demonstrated to reduce inflammatory pain. Although cannabinoid signaling is essential for mesenchymal stem cell survival and differentiation, little is known about its role in modulatory effect of MSCs on inflammation and pain sensitivity. Here we showed that mouse bone-marrow derived MSCs (BM-MSCs) expressed both cannabinoid receptor type 1 and 2 (CB1 and CB2). CB2 expression level in BM-MSCs increased with their maturation. In addition, we found that tetrahydrocannabinol (THC) activated CB2 receptor and ERK signaling, consequently enhancing the modulation of MSCs on inflammation-associated cytokine release from lipopolysaccharides-stimulated microglia. Consistent with in vitro data, THC pretreatment enhanced the immunomodulatory effects of BM-MSC on thermal hyperalgesia and mechanical allodynia in chronic constriction injury model, by decreasing the release of pro-inflammation cytokines. Our study revealed the crucial role of THC in promoting the immunomodulatory effects of MSCs and proposed a new strategy to alleviate pain based on stem cells therapy.","['Immune response', 'Immunity', 'Immunology and Microbiology Section', 'cannabinoid receptor', 'inflammation', 'mesenchymal stem cells', 'pain', 'tetrahydrocannabinol']",Oncotarget,2016-01-30,"[{'lastname': 'Xie', 'firstname': 'Junran', 'initials': 'J', 'affiliation': ""Department of Anesthesiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China.""}, {'lastname': 'Xiao', 'firstname': 'Dongju', 'initials': 'D', 'affiliation': ""Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical College, Xuzhou, People's Republic of China.\nJiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, Xuzhou, People's Republic of China.""}, {'lastname': 'Xu', 'firstname': 'Yun', 'initials': 'Y', 'affiliation': ""Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical College, Xuzhou, People's Republic of China.\nJiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, Xuzhou, People's Republic of China.""}, {'lastname': 'Zhao', 'firstname': 'Jinning', 'initials': 'J', 'affiliation': ""Department of Anesthesiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China.""}, {'lastname': 'Jiang', 'firstname': 'Li', 'initials': 'L', 'affiliation': ""Department of Anesthesiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China.""}, {'lastname': 'Hu', 'firstname': 'Xuming', 'initials': 'X', 'affiliation': ""Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical College, Xuzhou, People's Republic of China.\nJiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, Xuzhou, People's Republic of China.""}, {'lastname': 'Zhang', 'firstname': 'Yaping', 'initials': 'Y', 'affiliation': ""Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical College, Xuzhou, People's Republic of China.\nJiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, Xuzhou, People's Republic of China.""}, {'lastname': 'Yu', 'firstname': 'Lina', 'initials': 'L', 'affiliation': ""Department of Anesthesiology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China.""}]",,,,,10.18632/oncotarget.7042,<Element 'PubmedArticle' at 0x7f05da52a6d0>
463,"26799851
23711982
17950926
21940629
16732273
20944004
24117520
25936823
24881883
25241802
18073775
17084685
23916893
5046756
25433170
24012645
16647243
24485491
19647070
22041296
26087336
16125247
14398944
16473474
12096891
12399247
3016585
25580235
19916840
25737228
19141540
24860431
25542734
18000511
12510013
22895791
9143239
25568124
22386198
25640603
20570721",Stress-induced neuroinflammatory priming is time of day dependent.,"Circadian rhythms are endogenous cycles of physiology and behavior that align with the daily rotation of the planet and resulting light-dark cycle. The circadian system ensures homeostatic balance and regulates many aspects of physiology, including the stress response and susceptibility to and/or severity of stress-related sequelae. Both acute and chronic stressors amplify neuroinflammatory responses to a subsequent immune challenge, however it is not known whether circadian timing of the stressor regulates the priming response. Here, we test whether stress-induced neuroinflammatory priming is regulated by the circadian system. As has been previously shown, exposure to 100 inescapable tails shocks (IS) increased hippocampal cytokines following a subsequent inflammatory challenge. However, this effect was limited to animals that experienced the stressor during the light phase. Rats exposed to stress during the dark phase did not alter inflammatory potential following lipopolysaccharide (LPS) challenge. To determine whether microglia might be involved in diurnal differences in neuroinflammatory priming, microglia were isolated 24h after stress that occurred either during the middle of the light or dark phase. Only microglia isolated from animals stressed during the light phase demonstrated an exaggerated inflammatory response when treated ex vivo with LPS. To determine possible circadian dependency of microglia responsiveness to glucocorticoids - the likely proximal mediator for stress associated neuroinflammatory priming - microglia were isolated during the middle of the light or dark phase and treated ex vivo with corticosterone. Glucocorticoids treatment downregulated CX3CR1 and CD200R, two genes involved in microglial inflammatory ""off"" signaling; however, there was no effect of time of day on expression of either gene. Importantly, while absolute concentrations of corticosterone were comparable following IS during the light and dark phase, the magnitude of change in corticosterone was greater during the light phase. This work highlights the importance of studying circadian rhythms to elucidate biological mechanisms of stress.","['Circadian', 'Microglia', 'Neuroinflammation', 'Stress']",Psychoneuroendocrinology,2016-01-23,"[{'lastname': 'Fonken', 'firstname': 'Laura K', 'initials': 'LK', 'affiliation': 'Department of Psychology and Neuroscience, University of Colorado, Boulder, CO 80309, USA. Electronic address: laura.fonken@colorado.edu.'}, {'lastname': 'Weber', 'firstname': 'Michael D', 'initials': 'MD', 'affiliation': 'Department of Psychology and Neuroscience, University of Colorado, Boulder, CO 80309, USA.'}, {'lastname': 'Daut', 'firstname': 'Rachel A', 'initials': 'RA', 'affiliation': 'Department of Psychology and Neuroscience, University of Colorado, Boulder, CO 80309, USA.'}, {'lastname': 'Kitt', 'firstname': 'Meagan M', 'initials': 'MM', 'affiliation': 'Department of Psychology and Neuroscience, University of Colorado, Boulder, CO 80309, USA.'}, {'lastname': 'Frank', 'firstname': 'Matthew G', 'initials': 'MG', 'affiliation': 'Department of Psychology and Neuroscience, University of Colorado, Boulder, CO 80309, USA.'}, {'lastname': 'Watkins', 'firstname': 'Linda R', 'initials': 'LR', 'affiliation': 'Department of Psychology and Neuroscience, University of Colorado, Boulder, CO 80309, USA.'}, {'lastname': 'Maier', 'firstname': 'Steven F', 'initials': 'SF', 'affiliation': 'Department of Psychology and Neuroscience, University of Colorado, Boulder, CO 80309, USA.'}]",,,,Copyright © 2016 Elsevier Ltd. All rights reserved.,10.1016/j.psyneuen.2016.01.006,<Element 'PubmedArticle' at 0x7f05da54ab30>
464,26724742,Treadmill exercise ameliorates ischemia-induced brain edema while suppressing Na⁺/H⁺ exchanger 1 expression.,"Exercise may be one of the most effective and sound therapies for stroke; however, the mechanisms underlying the curative effects remain unclear. In this study, the effects of forced treadmill exercise with electric shock on ischemic brain edema were investigated. Wistar rats were subjected to transient (90 min) middle cerebral artery occlusion (tMCAO). Eighty nine rats with substantially large ischemic lesions were evaluated using magnetic resonance imaging (MRI) and were randomly assigned to exercise and non-exercise groups. The rats were forced to run at 4-6m/s for 10 min/day on days 2, 3 and 4. Brain edema was measured on day 5 by MRI, histochemical staining of brain sections and tissue water content determination (n=7, each experiment). Motor function in some rats was examined on day 30 (n=6). Exercise reduced brain edema (P<0.05-0.001, varied by the methods) and ameliorated motor function (P<0.05). The anti-glucocorticoid mifepristone or the anti-mineralocorticoid spironolactone abolished these effects, but orally administered corticosterone mimicked the ameliorating effects of exercise. Exercise prevented the ischemia-induced expression of mRNA encoding aquaporin 4 (AQP4) and Na(+)/H(+) exchangers (NHEs) (n=5 or 7, P<0.01). Microglia and NG2 glia expressed NHE1 in the peri-ischemic region of rat brains and also in mixed glial cultures. Corticosterone at ~10nM reduced NHE1 and AQP4 expression in mixed glial and pure microglial cultures. Dexamethasone and aldosterone at 10nM did not significantly alter NHE1 and AQP4 expression. Exposure to a NHE inhibitor caused shrinkage of microglial cells. These results suggest that the stressful short-period and slow-paced treadmill exercise suppressed NHE1 and AQP4 expression resulting in the amelioration of brain edema at least partly via the moderate increase in plasma corticosterone levels.","['Aquaporin 4', 'Corticosterone', 'Edema', 'Glucocorticoid', 'Immunohistochemistry', 'Microglia', 'Mineralocorticoid', 'NHE', 'Stroke']",Experimental neurology,2016-01-03,"[{'lastname': 'Nishioka', 'firstname': 'Ryutaro', 'initials': 'R', 'affiliation': 'Department of Molecular and Cellular Physiology, Graduate School of Medicine, Ehime University, Japan.'}, {'lastname': 'Sugimoto', 'firstname': 'Kana', 'initials': 'K', 'affiliation': 'Department of Legal Medicine, Graduate School of Medicine/Faculty of Medicine, Osaka University, Japan.'}, {'lastname': 'Aono', 'firstname': 'Hitomi', 'initials': 'H', 'affiliation': 'Department of Molecular and Cellular Physiology, Graduate School of Medicine, Ehime University, Japan.'}, {'lastname': 'Mise', 'firstname': 'Ayano', 'initials': 'A', 'affiliation': 'Department of Molecular and Cellular Physiology, Graduate School of Medicine, Ehime University, Japan.'}, {'lastname': 'Choudhury', 'firstname': 'Mohammed E', 'initials': 'ME', 'affiliation': 'Department of Molecular and Cellular Physiology, Graduate School of Medicine, Ehime University, Japan.'}, {'lastname': 'Miyanishi', 'firstname': 'Kazuya', 'initials': 'K', 'affiliation': 'Department of Molecular and Cellular Physiology, Graduate School of Medicine, Ehime University, Japan.'}, {'lastname': 'Islam', 'firstname': 'Afsana', 'initials': 'A', 'affiliation': 'Department of Molecular and Cellular Physiology, Graduate School of Medicine, Ehime University, Japan.'}, {'lastname': 'Fujita', 'firstname': 'Takahiro', 'initials': 'T', 'affiliation': 'Department of Molecular and Cellular Physiology, Graduate School of Medicine, Ehime University, Japan.'}, {'lastname': 'Takeda', 'firstname': 'Haruna', 'initials': 'H', 'affiliation': 'Department of Molecular and Cellular Physiology, Graduate School of Medicine, Ehime University, Japan.'}, {'lastname': 'Takahashi', 'firstname': 'Hisaaki', 'initials': 'H', 'affiliation': 'Center for Advanced Research and Education, Asahikawa Medical University, Japan.'}, {'lastname': 'Yano', 'firstname': 'Hajime', 'initials': 'H', 'affiliation': 'Department of Molecular and Cellular Physiology, Graduate School of Medicine, Ehime University, Japan.'}, {'lastname': 'Tanaka', 'firstname': 'Junya', 'initials': 'J', 'affiliation': 'Department of Molecular and Cellular Physiology, Graduate School of Medicine, Ehime University, Japan. Electronic address: jtanaka@m.ehime-u.ac.jp.'}]",,,,Copyright © 2015 Elsevier Inc. All rights reserved.,10.1016/j.expneurol.2015.12.016,<Element 'PubmedArticle' at 0x7f05da4e8e00>
465,"28256950
15207256
8276885
19260033
16782234
26239227
17124188
24114452
19351733
19436313
21535417
11459116
19458604
20595940
22326729
19436313
22585832
9163280
21192956
24013726
21467220
11328886
17125750
19664713
17761522
19174516
18510863
9182670
26938869
21152390
26998684
15795901
17203475
25784952
19659460
23196064
18215617
22048062
16085017
23744073
17430246",Chronic depletion of gonadal testosterone leads to blood-brain barrier dysfunction and inflammation in male mice.,"A dysfunction in the blood-brain barrier (BBB) is associated with many neurological and metabolic disorders. Although sex steroid hormones have been shown to impact vascular tone, endothelial function, oxidative stress, and inflammatory responses, there are still no data on the role of testosterone in the regulation of BBB structure and function. In this context, we investigated the effects of gonadal testosterone depletion on the integrity of capillary BBB and the surrounding parenchyma in male mice. Our results show increased BBB permeability for different tracers and endogenous immunoglobulins in chronically testosterone-depleted male mice. These results were associated with disorganization of tight junction structures shown by electron tomography and a lower amount of tight junction proteins such as claudin-5 and ZO-1. BBB leakage was also accompanied by activation of astrocytes and microglia, and up-regulation of inflammatory molecules such as inducible nitric oxide synthase (iNOS), cyclooxygenase 2 (COX-2), interleukin 1 beta (IL-1β), and tumor necrosis factor (TNF). Supplementation of castrated male mice with testosterone restored BBB selective permeability, tight junction integrity, and almost completely abrogated the inflammatory features. The present demonstration that testosterone transiently impacts cerebrovascular physiology in adult male mice should help gain new insights into neurological and metabolic diseases linked to hypogonadism in men of all ages.","['Blood–brain barrier', 'inflammation', 'mouse', 'testosterone', 'tight junction']",Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,2016-01-01,"[{'lastname': 'Atallah', 'firstname': 'Afnan', 'initials': 'A', 'affiliation': 'Sorbonne Universités, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine (NPS-IBPS), Paris, France.'}, {'lastname': 'Mhaouty-Kodja', 'firstname': 'Sakina', 'initials': 'S', 'affiliation': 'Sorbonne Universités, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine (NPS-IBPS), Paris, France.'}, {'lastname': 'Grange-Messent', 'firstname': 'Valérie', 'initials': 'V', 'affiliation': 'Sorbonne Universités, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine (NPS-IBPS), Paris, France.'}]",,,,,10.1177/0271678X16683961,<Element 'PubmedArticle' at 0x7f05da4fb900>
466,26698019,Female sex steroids and glia cells: Impact on multiple sclerosis lesion formation and fine tuning of the local neurodegenerative cellular network.,"Multiple sclerosis (MS) is a chronic inflammatory and demyelinating disease that shows a female-to-male gender prevalence and alleviation of disease activity during late stage pregnancy. In MS-related animal models, sex steroids ameliorate symptoms and protect from demyelination and neuronal damage. Underlying mechanisms of these protective avenues are continuously discovered, in part by using novel transgenic animal models. In this review article, we highlight the regulation of glia cell function by female sex steroids. We specifically focus on the relevance of glia cells for immune cell recruitment into the central nervous system and show how estrogen and progesterone can modulate these cell-cell communication pathways. Since MS is considered to have a strong neurodegenerative component, principal neuroprotective mechanisms, exerted by sex-steroids will be discussed as well. Activation of steroid receptors might not just act as immunosuppressant but at the same time harmonize brain-intrinsic networks to dampen neurodegeneration and, thus, disease progression in MS.","['Astroglia', 'Estrogen', 'Immune cells', 'Inflammation', 'Invasion', 'Microglia', 'Multiple sclerosis', 'Neuroinflammation', 'Neuroprotection', 'Progesterone']",Neuroscience and biobehavioral reviews,2015-12-25,"[{'lastname': 'Kipp', 'firstname': 'Markus', 'initials': 'M', 'affiliation': 'Department of Neuroanatomy, Ludwig-Maximilians-University of Munich, Munich, Germany. Electronic address: markus.kipp@med.uni-muenchen.de.'}, {'lastname': 'Hochstrasser', 'firstname': 'Tanja', 'initials': 'T', 'affiliation': 'Department of Neuroanatomy, Ludwig-Maximilians-University of Munich, Munich, Germany.'}, {'lastname': 'Schmitz', 'firstname': 'Christoph', 'initials': 'C', 'affiliation': 'Department of Neuroanatomy, Ludwig-Maximilians-University of Munich, Munich, Germany.'}, {'lastname': 'Beyer', 'firstname': 'Cordian', 'initials': 'C', 'affiliation': 'Institute of Neuroanatomy, Faculty of Medicine, RWTH Aachen University, 52074 Aachen, Germany.'}]",,,,Copyright © 2015 Elsevier Ltd. All rights reserved.,10.1016/j.neubiorev.2015.11.016,<Element 'PubmedArticle' at 0x7f05da518ef0>
467,"26660113
10529897
12231228
15238991
22627078
11244481
7911130
11263692
9690668
20036713
8450947
23806776
17507914
10882750
23998452
24936772
19481109
24942467
25582288
21820505
23823694
16609825
18651664
20463226
23665938
22770862
17666589
16855095
12136055
9619192
11473107
12204193
10599796
24144492
15548416
18200448
12475729
18316065
21525267
16108456
19553468
20723245
24508286
23383124
22841957
11312305
20153418
11430844
23613074
23312512
23583307
16454531
19007798
17306230
6664494
15269271
25069260
15537713
24987341",Postnatal Stress Induced by Injection with Valproate Leads to Developing Emotional Disorders Along with Molecular and Cellular Changes in the Hippocampus and Amygdala.,"Stress derived from an adverse environment during brain development could contribute to psychiatric disorders. To study the influence of stress occurring at birth on behavior development in human, we performed an intraperitoneal injection (i.p.) of valproic acid (VPA; 200 mg/kg), a histone deacetylation inhibitor (HDACi), into male rat pups at the age of postnatal day 7 (P7) that is equivalent to an infant at 36-40 weeks gestation. Our results showed that neuronal differentiation genes, doublecortin (DCX) and NeuroD1, were downregulated in the hippocampus at 24 h post VPA injection. In addition, the cell proliferation was increased in the dentate gyrus and amygdala of rats receiving VPA injection. DCX","['Early life stress', 'Emotional disorders', 'Microglia', 'Valproic acid']",Molecular neurobiology,2015-12-15,"[{'lastname': 'Wang', 'firstname': 'Chih-Yen', 'initials': 'CY', 'affiliation': 'Institute of Life Sciences, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan, Taiwan.'}, {'lastname': 'Cheng', 'firstname': 'Chien-Wen', 'initials': 'CW', 'affiliation': 'Institute of Life Sciences, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan, Taiwan.'}, {'lastname': 'Wang', 'firstname': 'Wei-Hua', 'initials': 'WH', 'affiliation': 'Institute of Life Sciences, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan, Taiwan.'}, {'lastname': 'Chen', 'firstname': 'Po-See', 'initials': 'PS', 'affiliation': 'Department of Psychiatry, College of Medicine, National Cheng Kung University, Tainan, Taiwan.'}, {'lastname': 'Tzeng', 'firstname': 'Shun-Fen', 'initials': 'SF', 'affiliation': 'Institute of Life Sciences, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan, Taiwan. stzeng@mail.ncku.edu.tw.'}]",,,,,10.1007/s12035-015-9600-9,<Element 'PubmedArticle' at 0x7f05da4a52c0>
468,"26639668
15571983
19309040
16290019
21135885
9133393
17600108
22612815
21339903
20719879
20506409
11440347
15540387
19187293
15254550
17086191
21554899
22885100
19219549
10370869
9342721
10843709
15662844
12072154
12470882
21111721
20560755
12037381
11812529
23290932
16493685
17618126
18579133
18796338
24001081
21669285
19850449
24001067
16488380
10088996
15080894
21278730
25012374
23054073
22788578
23031823
17726376
24675465
23159308
16397579
22302935
24329535
21985866
24713688
25808087
10934264
15309170
11955713
14534276
17042797
24468242
17314278
25627672
14725617
15673445
17129216
16002067
21915341
23322452",Resveratrol Treatment after Status Epilepticus Restrains Neurodegeneration and Abnormal Neurogenesis with Suppression of Oxidative Stress and Inflammation.,"Antiepileptic drug therapy, though beneficial for restraining seizures, cannot thwart status epilepticus (SE) induced neurodegeneration or down-stream detrimental changes. We investigated the efficacy of resveratrol (RESV) for preventing SE-induced neurodegeneration, abnormal neurogenesis, oxidative stress and inflammation in the hippocampus. We induced SE in young rats and treated with either vehicle or RESV, commencing an hour after SE induction and continuing every hour for three-hours on SE day and twice daily thereafter for 3 days. Seizures were terminated in both groups two-hours after SE with a diazepam injection. In contrast to the vehicle-treated group, the hippocampus of animals receiving RESV during and after SE presented no loss of glutamatergic neurons in hippocampal cell layers, diminished loss of inhibitory interneurons expressing parvalbumin, somatostatin and neuropeptide Y in the dentate gyrus, reduced aberrant neurogenesis with preservation of reelin + interneurons, lowered concentration of oxidative stress byproduct malondialdehyde and pro-inflammatory cytokine tumor necrosis factor-alpha, normalized expression of oxidative stress responsive genes and diminished numbers of activated microglia. Thus, 4 days of RESV treatment after SE is efficacious for thwarting glutamatergic neuron degeneration, alleviating interneuron loss and abnormal neurogenesis, and suppressing oxidative stress and inflammation. These results have implications for restraining SE-induced chronic temporal lobe epilepsy.",[],Scientific reports,2015-12-08,"[{'lastname': 'Mishra', 'firstname': 'Vikas', 'initials': 'V', 'affiliation': ""Institute for Regenerative Medicine, Texas A &M Health Science Center College of Medicine at Scott &White, Temple, Texas, USA.\nResearch Service, Olin E. Teague Veterans' Affairs Medical Center, Central Texas Veterans Health Care System, Temple, Texas, USA.\nDepartment of Molecular and Cellular Medicine, Texas A&M Health Science Center College of Medicine, College Station, Texas, USA.""}, {'lastname': 'Shuai', 'firstname': 'Bing', 'initials': 'B', 'affiliation': ""Institute for Regenerative Medicine, Texas A &M Health Science Center College of Medicine at Scott &White, Temple, Texas, USA.\nResearch Service, Olin E. Teague Veterans' Affairs Medical Center, Central Texas Veterans Health Care System, Temple, Texas, USA.\nDepartment of Molecular and Cellular Medicine, Texas A&M Health Science Center College of Medicine, College Station, Texas, USA.""}, {'lastname': 'Kodali', 'firstname': 'Maheedhar', 'initials': 'M', 'affiliation': ""Institute for Regenerative Medicine, Texas A &M Health Science Center College of Medicine at Scott &White, Temple, Texas, USA.\nResearch Service, Olin E. Teague Veterans' Affairs Medical Center, Central Texas Veterans Health Care System, Temple, Texas, USA.\nDepartment of Molecular and Cellular Medicine, Texas A&M Health Science Center College of Medicine, College Station, Texas, USA.""}, {'lastname': 'Shetty', 'firstname': 'Geetha A', 'initials': 'GA', 'affiliation': ""Institute for Regenerative Medicine, Texas A &M Health Science Center College of Medicine at Scott &White, Temple, Texas, USA.\nResearch Service, Olin E. Teague Veterans' Affairs Medical Center, Central Texas Veterans Health Care System, Temple, Texas, USA.\nDepartment of Molecular and Cellular Medicine, Texas A&M Health Science Center College of Medicine, College Station, Texas, USA.""}, {'lastname': 'Hattiangady', 'firstname': 'Bharathi', 'initials': 'B', 'affiliation': ""Institute for Regenerative Medicine, Texas A &M Health Science Center College of Medicine at Scott &White, Temple, Texas, USA.\nResearch Service, Olin E. Teague Veterans' Affairs Medical Center, Central Texas Veterans Health Care System, Temple, Texas, USA.\nDepartment of Molecular and Cellular Medicine, Texas A&M Health Science Center College of Medicine, College Station, Texas, USA.""}, {'lastname': 'Rao', 'firstname': 'Xiaolan', 'initials': 'X', 'affiliation': ""Institute for Regenerative Medicine, Texas A &M Health Science Center College of Medicine at Scott &White, Temple, Texas, USA.\nResearch Service, Olin E. Teague Veterans' Affairs Medical Center, Central Texas Veterans Health Care System, Temple, Texas, USA.\nDepartment of Molecular and Cellular Medicine, Texas A&M Health Science Center College of Medicine, College Station, Texas, USA.""}, {'lastname': 'Shetty', 'firstname': 'Ashok K', 'initials': 'AK', 'affiliation': ""Institute for Regenerative Medicine, Texas A &M Health Science Center College of Medicine at Scott &White, Temple, Texas, USA.\nResearch Service, Olin E. Teague Veterans' Affairs Medical Center, Central Texas Veterans Health Care System, Temple, Texas, USA.\nDepartment of Molecular and Cellular Medicine, Texas A&M Health Science Center College of Medicine, College Station, Texas, USA.""}]",,,,,10.1038/srep17807,<Element 'PubmedArticle' at 0x7f05da4c1770>
469,"26637556
14764725
21150913
12467247
20034060
24343120
21825233
20402965
16116043
20678153
22492044
22106405
23624625
17372179
15246823
25619659
16219027
24667851
18495130
23486953
26195767
24534266
16331108
19342823
16125247
1893644
23150519
19486591
25757753
19471094
8741760
17627496
23045460
19246475
15817892
15117836
20628203
24742639
12824464
7609644
23034047
19118600
23954950
14684626
18304834
7453950
18579222
25811788
12676175
8993847
6324205
19144836
18190523
21822148
15356140
19805637
9851930
22696576
23573410
24317407
22971929
20156424
25494574
18499466
17704767
16481883
12410849
15039334
22025055
11133218
9606965
20547972
23791197
21637379
24576725
15746442
11554921
11306611
12770924
17982277
23225134
21273786
16675600
23754618
19271152
20089930
10557349
23877628
12063317
18162560
15729290
12456490
15192025",Cross talk between AT1 receptors and Toll-like receptor 4 in microglia contributes to angiotensin II-derived ROS production in the hypothalamic paraventricular nucleus.,"ANG II is thought to increase sympathetic outflow by increasing oxidative stress and promoting local inflammation in the paraventricular nucleus (PVN) of the hypothalamus. However, the relative contributions of inflammation and oxidative stress to sympathetic drive remain poorly understood, and the underlying cellular and molecular targets have yet to be examined. ANG II has been shown to enhance Toll-like receptor (TLR)4-mediated signaling on microglia. Thus, in the present study, we aimed to determine whether ANG II-mediated activation of microglial TLR4 signaling is a key molecular target initiating local oxidative stress in the PVN. We found TLR4 and ANG II type 1 (AT1) receptor mRNA expression in hypothalamic microglia, providing molecular evidence for the potential interaction between these two receptors. In hypothalamic slices, ANG II induced microglial activation within the PVN (∼65% increase, P < 0.001), an effect that was blunted in the absence of functional TLR4. ANG II increased ROS production, as indicated by dihydroethidium fluorescence, within the PVN of rats and mice (P < 0.0001 in both cases), effects that were also dependent on the presence of functional TLR4. The microglial inhibitor minocycline attenuated ANG II-mediated ROS production, yet ANG II effects persisted in PVN single-minded 1-AT1a knockout mice, supporting the contribution of a non-neuronal source (likely microglia) to ANG II-driven ROS production in the PVN. Taken together, these results support functional interactions between AT1 receptors and TLR4 in mediating ANG II-dependent microglial activation and oxidative stress within the PVN. More broadly, our results support a functional interaction between the central renin-angiotensin system and innate immunity in the regulation of neurohumoral outflows from the PVN.","['Toll-like receptor', 'angiotensin II', 'angiotensin II type 1 receptor', 'microglia', 'paraventricular nucleus']",American journal of physiology. Heart and circulatory physiology,2015-12-08,"[{'lastname': 'Biancardi', 'firstname': 'Vinicia Campana', 'initials': 'VC', 'affiliation': 'Department of Physiology, Medical College of Georgia, Georgia Regents University, Augusta, Georgia; vbiancardi@gru.edu.'}, {'lastname': 'Stranahan', 'firstname': 'Alexis M', 'initials': 'AM', 'affiliation': 'Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Georgia Regents University, Augusta, Georgia;'}, {'lastname': 'Krause', 'firstname': 'Eric G', 'initials': 'EG', 'affiliation': 'Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida.'}, {'lastname': 'de Kloet', 'firstname': 'Annette D', 'initials': 'AD', 'affiliation': 'Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida.'}, {'lastname': 'Stern', 'firstname': 'Javier E', 'initials': 'JE', 'affiliation': 'Department of Physiology, Medical College of Georgia, Georgia Regents University, Augusta, Georgia;'}]",,,,Copyright © 2016 the American Physiological Society.,10.1152/ajpheart.00247.2015,<Element 'PubmedArticle' at 0x7f05da475360>
470,"26580484
19664713
16371949
11720713
7900904
1363284
19259805
11821012
24343120
21755262
57126
22492044
22106405
6089597
21097645
25519738
2185149
17519129
23280789
20360752
19342823
9043813
6360884
9043812
19127280
11015592
17531276
22773773
2831773
365183
11812516
16760914
21536848
6509326
12623990
12364362
1621811
19246475
7300559
20651292
24742639
9344632
24937322
23316344
8103642
7796134
12676175
11492952
21143281
10523349
21196131
20558826
2467761
6324205
18190523
1674644
23485486
24309662
19229193
17519130
22507981
11230517
18585782
18443753
23971690
21164491
19491620
23585139
22971929
18499466
22025055
11959620
1623412
20547972
1577995
23691105
19506719
11758761
6132586
17855497
8336821
8453478
15258771
25362113
21044218
21601658
17420334
17124345
25935397
24009582
21940972
23608099
12456490
15192025",Compromised blood-brain barrier permeability: novel mechanism by which circulating angiotensin II signals to sympathoexcitatory centres during hypertension.,"Angiotensin II (AngII) is a pivotal peptide implicated in the regulation of blood pressure. In addition to its systemic vascular and renal effects, AngII acts centrally to modulate the activities of neuroendocrine and sympathetic neuronal networks, influencing in turn sympatho-humoral outflows to the circulation. Moreover, a large body of evidence supports AngII signalling dysregulation as a key mechanism contributing to exacerbated sympathoexcitation during hypertension. Due to its hydrophilic actions, circulating AngII does not cross the blood-brain barrier (BBB), signalling to the brain via the circumventricular organs which lack a tight BBB. In this review, we present and discuss recent studies from our laboratory showing that elevated circulating levels of AngII during hypertension result in disruption of the BBB integrity, allowing access of circulating AngII to critical sympathoexcitatory brain centres such as the paraventricular nucleus of the hypothalamus and the rostral ventrolateral medulla. We propose the novel hypothesis that AngII-driven BBB breakdown constitutes a complementary mechanism by which circulating AngII, working in tandem with the central renin-angiotensin system, further exacerbates sympatho-humoral activation during hypertension. These results are discussed within the context of a growing body of evidence in the literature supporting AngII as a pro-inflammatory signal, and brain microglia as key cell targets mediating central AngII actions during hypertension.",[],The Journal of physiology,2015-11-19,"[{'lastname': 'Biancardi', 'firstname': 'V C', 'initials': 'VC', 'affiliation': 'Department of Physiology, Georgia Regents University, Augusta, GA, USA.'}, {'lastname': 'Stern', 'firstname': 'J E', 'initials': 'JE', 'affiliation': 'Department of Physiology, Georgia Regents University, Augusta, GA, USA.'}]",,,,© 2015 The Authors. The Journal of Physiology © 2015 The Physiological Society.,10.1113/JP271584,<Element 'PubmedArticle' at 0x7f05da4297c0>
471,"26565024
12505697
15390110
18096503
2165569
20855465
20729846
21454566
14526074
11586361
12598628
19244215
22021672
15371507
24559669
11478374
24106265
21613483
23823475
11668683
12077339
25218901
22217458
15890404
15344923
24782539
9110424
18221379
24236177
24548922
22814969
22381575
26166819
18422832
20045008
26048578
8070571
23142242
22813736
26075589
19029917
21768162
21663537
22446881
22385967
1824862
15009672
18162486
20157512
20412387
25393148
21659471
16101543
26212325
21486787",Deletion of Monoglyceride Lipase in Astrocytes Attenuates Lipopolysaccharide-induced Neuroinflammation.,"Monoglyceride lipase (MGL) is required for efficient hydrolysis of the endocannabinoid 2-arachidonoylglyerol (2-AG) in the brain generating arachidonic acid (AA) and glycerol. This metabolic function makes MGL an interesting target for the treatment of neuroinflammation, since 2-AG exhibits anti-inflammatory properties and AA is a precursor for pro-inflammatory prostaglandins. Astrocytes are an important source of AA and 2-AG, and highly express MGL. In the present study, we dissected the distinct contribution of MGL in astrocytes on brain 2-AG and AA metabolism by generating a mouse model with genetic deletion of MGL specifically in astrocytes (MKO(GFAP)). MKO(GFAP) mice exhibit moderately increased 2-AG and reduced AA levels in brain. Minor accumulation of 2-AG in the brain of MKO(GFAP) mice does not cause cannabinoid receptor desensitization as previously observed in mice globally lacking MGL. Importantly, MKO(GFAP) mice exhibit reduced brain prostaglandin E2 and pro-inflammatory cytokine levels upon peripheral lipopolysaccharide (LPS) administration. These observations indicate that MGL-mediated degradation of 2-AG in astrocytes provides AA for prostaglandin synthesis promoting LPS-induced neuroinflammation. The beneficial effect of astrocyte-specific MGL-deficiency is not fully abrogated by the inverse cannabinoid receptor 1 agonist SR141716 (Rimonabant) suggesting that the anti-inflammatory effects are rather caused by reduced prostaglandin synthesis than by activation of cannabinoid receptors. In conclusion, our data demonstrate that MGL in astrocytes is an important regulator of 2-AG levels, AA availability, and neuroinflammation.","['arachidonic acid (AA) (ARA)', 'astrocyte', 'endocannabinoid', 'lipopolysaccharide (LPS)', 'neuroinflammation']",The Journal of biological chemistry,2015-11-14,"[{'lastname': 'Grabner', 'firstname': 'Gernot F', 'initials': 'GF', 'affiliation': 'From the Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.'}, {'lastname': 'Eichmann', 'firstname': 'Thomas O', 'initials': 'TO', 'affiliation': 'From the Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.'}, {'lastname': 'Wagner', 'firstname': 'Bernhard', 'initials': 'B', 'affiliation': 'the Institute of Biomedical Science, FH Joanneum University of Applied Sciences, 8020 Graz, Austria.'}, {'lastname': 'Gao', 'firstname': 'Yuanqing', 'initials': 'Y', 'affiliation': 'the Institute of Diabetes and Obesity, Helmholtz Center Munich, 85748 Garching, Germany.'}, {'lastname': 'Farzi', 'firstname': 'Aitak', 'initials': 'A', 'affiliation': 'the Institute of Experimental and Clinical Pharmacology, Medical University of Graz, 8010 Graz, Austria, and.'}, {'lastname': 'Taschler', 'firstname': 'Ulrike', 'initials': 'U', 'affiliation': 'From the Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.'}, {'lastname': 'Radner', 'firstname': 'Franz P W', 'initials': 'FP', 'affiliation': 'From the Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.'}, {'lastname': 'Schweiger', 'firstname': 'Martina', 'initials': 'M', 'affiliation': 'From the Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.'}, {'lastname': 'Lass', 'firstname': 'Achim', 'initials': 'A', 'affiliation': 'From the Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.'}, {'lastname': 'Holzer', 'firstname': 'Peter', 'initials': 'P', 'affiliation': 'the Institute of Experimental and Clinical Pharmacology, Medical University of Graz, 8010 Graz, Austria, and.'}, {'lastname': 'Zinser', 'firstname': 'Erwin', 'initials': 'E', 'affiliation': 'the Institute of Biomedical Science, FH Joanneum University of Applied Sciences, 8020 Graz, Austria.'}, {'lastname': 'Tschöp', 'firstname': 'Matthias H', 'initials': 'MH', 'affiliation': 'the Institute of Diabetes and Obesity, Helmholtz Center Munich, 85748 Garching, Germany.'}, {'lastname': 'Yi', 'firstname': 'Chun-Xia', 'initials': 'CX', 'affiliation': 'the Institute of Diabetes and Obesity, Helmholtz Center Munich, 85748 Garching, Germany, the Department of Endocrinology and Metabolism, Academic Medical Center Amsterdam, 1105 Amsterdam, The Netherlands.'}, {'lastname': 'Zimmermann', 'firstname': 'Robert', 'initials': 'R', 'affiliation': 'From the Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria, robert.zimmermann@uni-graz.at.'}]",,,,"© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.","10.1074/jbc.M115.683615
10.1016/j.bbrc.2015.07.019",<Element 'PubmedArticle' at 0x7f05da45a590>
472,26535964,Stress-induced anhedonia is associated with the activation of the inflammatory system in the rat brain: Restorative effect of pharmacological intervention.,"Major depression is a complex disease that originates from the interaction between a genetic background of susceptibility and environmental factors such as stress. At molecular level, it is characterized by dysfunctions of multiple systems including neurotransmitters, hormones, signalling pathways, neurotrophic and neuroplastic molecules and - more recently - inflammatory mediators. Accordingly, in the present study we used the chronic mild stress (CMS) paradigm in the rat to elucidate to what extent brain inflammation may contribute to the development and/or the maintenance of an anhedonic phenotype and how pharmacological intervention may interfere with such behavioral and molecular stress-induced alterations. To this aim, adult male rats were exposed to CMS for 2 weeks and the cerebral expression of several mediators of the inflammatory system was evaluated in the hippocampus and prefrontal cortex of both stressed and control animals in parallel with the sucrose intake. Next, the animals that showed a decreased sucrose consumption were exposed to five further weeks of CMS and treated with the antidepressants imipramine or agomelatine, or the antipsychotic lurasidone. Our results demonstrate that only the stressed animals that were characterized by a deficit in sucrose intake showed increased expression of the pro-inflammatory cytokines IL-1β, IL-6 and up-regulation of markers and mediators of microglia activation such as CD11b, CX3CL1 and its receptor CX3CR1 in comparison with stress-resilient animals. Some of these molecular alterations persisted also after longer stress exposure and were modulated, similarly to the behavioral effects of CMS, by chronic pharmacological treatment. These data suggest that neuroinflammation may have a key role in the pathological consequences of stress exposure, thus contributing to the subject's vulnerability for depression.","['Agomelatine: N-[2-(7-methoxynaphthalen-1-yl) ethyl]acetamide', 'Antidepressant', 'Chronic mild stress', 'Cytokines', 'Differential susceptibility', 'Imipramine: 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine', 'Lurasidone: (3aR,4S,7R,7aS)-2-{(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl) piperazin-1-ylmethyl] cyclohexylmethyl} hexahydro-4,7-methano-2H-isoindole-1,3-dione', 'Microglia activation', 'Sucrose intake']",Pharmacological research,2015-11-05,"[{'lastname': 'Rossetti', 'firstname': 'Andrea C', 'initials': 'AC', 'affiliation': 'Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy. Electronic address: andreacarlo.rossetti@unimi.it.'}, {'lastname': 'Papp', 'firstname': 'Mariusz', 'initials': 'M', 'affiliation': 'Institute of Pharmacology, Polish Academy of Sciences, Kracow, Poland. Electronic address: nfpapp@cyfronet.pl.'}, {'lastname': 'Gruca', 'firstname': 'Piotr', 'initials': 'P', 'affiliation': 'Institute of Pharmacology, Polish Academy of Sciences, Kracow, Poland. Electronic address: gruca@if-pan.krakow.pl.'}, {'lastname': 'Paladini', 'firstname': 'Maria Serena', 'initials': 'MS', 'affiliation': 'Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy. Electronic address: mariaserena.paladini@studenti.unimi.it.'}, {'lastname': 'Racagni', 'firstname': 'Giorgio', 'initials': 'G', 'affiliation': 'Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy. Electronic address: giorgio.racagni@unimi.it.'}, {'lastname': 'Riva', 'firstname': 'Marco A', 'initials': 'MA', 'affiliation': 'Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy. Electronic address: m.riva@unimi.it.'}, {'lastname': 'Molteni', 'firstname': 'Raffaella', 'initials': 'R', 'affiliation': 'Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy. Electronic address: raffaella.molteni@unimi.it.'}]",,,,Copyright © 2015 Elsevier Ltd. All rights reserved.,10.1016/j.phrs.2015.10.022,<Element 'PubmedArticle' at 0x7f05da400770>
473,"26517721
22577257
18026124
18781985
25585882
25601726
19884325
12598628
18467029
20631292
17321521
16651814
23287539
20590562
21970716
16309307
15901805
10422789
21854743
17275834
22576106
11586361
26244281
23414569
17145957
17245417
18722389
23069763
20739683
25195527
22388959","Non-Selective Cannabinoid Receptor Antagonists, Hinokiresinols Reduce Infiltration of Microglia/Macrophages into Ischemic Brain Lesions in Rat via Modulating 2-Arachidonolyglycerol-Induced Migration and Mitochondrial Activity.","Growing evidence suggests that therapeutic strategies to modulate the post-ischemic inflammatory responses are promising approaches to improve stroke outcome. Although the endocannabinoid system has been emerged as an endogenous therapeutic target to regulate inflammation after stroke insult, the downstream mechanisms and their potentials for therapeutic intervention remain controversial. Here we identified trans- and cis-hinokiresinols as novel non-selective antagonists for two G-protein-coupled cannabinoid receptors, cannabinoid receptor type 1 and type 2. The Electric Cell-substrate Impedance Sensing and Boyden chamber migration assays using primary microglial cultures revealed that both hinokiresinols significantly inhibited an endocannabinoid, 2-arachidonoylglycerol-induced migration. Hinokiresinols modulated 2-arachidonoylglycerol-induced mitochondrial bioenergetics in microglia as evidenced by inhibition of ATP turnover and reduction in respiratory capacity, thereby resulting in impaired migration activity. In rats subjected to transient middle cerebral artery occlusion (1.5-h) followed by 24-h reperfusion, post-ischemic treatment with hinokiresinols (2 and 7-h after the onset of ischemia, 10 mg/kg) significantly reduced cerebral infarct and infiltration of ED1-positive microglial/macrophage cells into cerebral ischemic lesions in vivo. Co-administration of exogenous 2-AG (1 mg/kg, i.v., single dose at 2 h after starting MCAO) abolished the protective effect of trans-hinokiresionol. These results suggest that hinokiresinols may serve as stroke treatment by targeting the endocannabinoid system. Alteration of mitochondrial bioenergetics and consequent inhibition of inflammatory cells migration may be a novel mechanism underlying anti-ischemic effects conferred by cannabinoid receptor antagonists.",[],PloS one,2015-10-31,"[{'lastname': 'Jalin', 'firstname': 'Angela M A Anthony', 'initials': 'AM', 'affiliation': 'Department of Neuroscience, College of Medicine, Korea University, Seoul, Republic of Korea.'}, {'lastname': 'Rajasekaran', 'firstname': 'Maheswari', 'initials': 'M', 'affiliation': 'Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America.'}, {'lastname': 'Prather', 'firstname': 'Paul L', 'initials': 'PL', 'affiliation': 'Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America.'}, {'lastname': 'Kwon', 'firstname': 'Jin Sun', 'initials': 'JS', 'affiliation': 'Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea.'}, {'lastname': 'Gajulapati', 'firstname': 'Veeraswamy', 'initials': 'V', 'affiliation': 'Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea.'}, {'lastname': 'Choi', 'firstname': 'Yongseok', 'initials': 'Y', 'affiliation': 'Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea.'}, {'lastname': 'Kim', 'firstname': 'Chunsook', 'initials': 'C', 'affiliation': 'Department of Nursing, Kyungdong University, Wonju, Kangwon-do, Republic of Korea.'}, {'lastname': 'Pahk', 'firstname': 'Kisoo', 'initials': 'K', 'affiliation': 'Department of Neuroscience, College of Medicine, Korea University, Seoul, Republic of Korea.'}, {'lastname': 'Ju', 'firstname': 'Chung', 'initials': 'C', 'affiliation': 'Department of Neuroscience, College of Medicine, Korea University, Seoul, Republic of Korea.'}, {'lastname': 'Kim', 'firstname': 'Won-Ki', 'initials': 'WK', 'affiliation': 'Department of Neuroscience, College of Medicine, Korea University, Seoul, Republic of Korea.'}]",,,,,"10.1371/journal.pone.0141600
10.1155/2012/824093
10.1038/sj.bjp.0707582
10.1111/imm.12441
10.1007/s11481-015-9584-2
10.1096/fj.09-141275
10.1016/j.neulet.2008.04.058
10.1152/ajpregu.00031.2010
10.1016/j.expneurol.2007.01.015
10.1159/000091703
10.1016/j.neuropharm.2012.12.006
10.1111/j.1476-5381.2010.00745.x
10.3109/00498254.2011.609570
10.1021/np0502995
10.1124/jpet.105.085282
10.1016/S0014-2999(99)00349-0
10.1016/j.ajpath.2011.07.006
10.1016/j.jim.2006.12.005
10.1038/nprot.2012.048
10.1038/35097089
10.1016/j.expneurol.2015.07.024
10.1016/j.expneurol.2015.07.024
10.1016/j.ajpath.2012.11.024
10.1084/jem.20061877
10.1038/sj.jcbfm.9600447
10.1016/j.neuropharm.2008.07.037
10.1016/j.neuroscience.2012.09.080
10.2337/db09-1881
10.1016/j.toxlet.2014.09.002
10.1038/nn.3053",<Element 'PubmedArticle' at 0x7f05da413310>
474,26499171,Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats.,"Over 180 million people consume cannabis globally. Cannabis use peaks during adolescence with a trend for continued consumption by adults. Notably, several studies have shown that long-term and heavy cannabis use during adolescence can impair brain maturation and predispose to neurodevelopmental disorders, although the neurobiological mechanisms underlying this association remain largely unknown. In this study, we evaluated whether, in female rats, chronic administration of increasing doses of the psychotropic plant-derived cannabis constituent, delta-9-tetrahydrocannabinol (THC), during adolescence (PND 35-45) could affect microglia function in the long-term. Furthermore, we explored a possible contribution of microglia to the development of THC-induced alterations in mood and cognition in adult female rats. Present data indicate that adolescent THC administration induces a persistent neuroinflammatory state specifically localized within the adult prefrontal cortex (PFC), characterized by increased expression of the pro-inflammatory markers, TNF-α, iNOS and COX-2, and reduction of the anti-inflammatory cytokine, IL-10. This neuroinflammatory phenotype is associated with down-regulation of CB1 receptor on neuronal cells and up-regulation of CB2 on microglia cells, conversely. Interestingly, blocking microglia activation with ibudilast during THC treatment significantly attenuates short-term memory impairments in adulthood, simultaneously preventing the increases in TNF-α, iNOS, COX-2 levels as well as the up-regulation of CB2 receptors on microglia cells. In contrast, THC-induced depressive-like behaviors were unaffected by ibudilast treatment. Our findings demonstrate that adolescent THC administration is associated with persistent neuroinflammation within the PFC and provide evidence for a causal association between microglial activation and the development long-term cognitive deficits induced by adolescent THC treatment.","['Adolescence', 'Cognition', 'Neuroinflammation', 'Prefrontal cortex', 'Rats', 'THC']",European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,2015-10-27,"[{'lastname': 'Zamberletti', 'firstname': 'Erica', 'initials': 'E', 'affiliation': 'Department of Theoretical and Applied Sciences, University of Insubria, Busto Arsizio (VA), Italy; Zardi Gori Foundation, Milan, Italy.'}, {'lastname': 'Gabaglio', 'firstname': 'Marina', 'initials': 'M', 'affiliation': 'Department of Theoretical and Applied Sciences, University of Insubria, Busto Arsizio (VA), Italy.'}, {'lastname': 'Prini', 'firstname': 'Pamela', 'initials': 'P', 'affiliation': 'Department of Theoretical and Applied Sciences, University of Insubria, Busto Arsizio (VA), Italy.'}, {'lastname': 'Rubino', 'firstname': 'Tiziana', 'initials': 'T', 'affiliation': 'Department of Theoretical and Applied Sciences, University of Insubria, Busto Arsizio (VA), Italy.'}, {'lastname': 'Parolaro', 'firstname': 'Daniela', 'initials': 'D', 'affiliation': 'Department of Theoretical and Applied Sciences, University of Insubria, Busto Arsizio (VA), Italy; Zardi Gori Foundation, Milan, Italy. Electronic address: daniela.parolaro@uninsubria.it.'}]",,,,Copyright © 2015 Elsevier B.V. and ECNP. All rights reserved.,10.1016/j.euroneuro.2015.09.021,<Element 'PubmedArticle' at 0x7f05da3b3860>
475,"26483037
17876303
23891880
16633105
24930711
25580634
20708099
22722514
15454346
24228900
20381618
14610053
17511970
19460156
24994592
25703248
21732409
20124950
15044630
23040807
22990943
20098669
18781987
11329626
24889886
22534181
23305936
8900284
12697742
22466657
18073775
1470919
20015486
16631126
12509806
17141334
24076098
20649579
16352709
21111017
23850810
10588688
18388242
21483776
18643796
22776763
22214537
18311684
12970089
24180398
21878486
21747398
25522414
19188531
10428044
23041513
14966476
17360153
24480318
16224541
17123480
9341166
12960289
25322082
24342992
2834017
21253405
7473135
19819298
10559698
6574523
12949078
14653768
19029917
25169051
26030524
25637536
16543970
11556820
24086771
7772617
7899532
10088138
24877594
2165569
23047058
23039393
24622769
7605349
16687994
19150053
25240202
9738948
7689702
25429645
22021672
25589364
12466348
3422573
14634025
18286196
22102284
19428268
11586361
18675469
15331569
25666933
19005078
18801471
16316783
18955701
23471521
21923193
12907793
21983278
8632988
22963995
9629951
15771584
17174336
20468046
18722389
15390110
15285801
25711936
20709233
16399150
21964469
22606285
17030030
19126434
20664582
16037678
22386198
25488672
24798725
11566046
20406665
22553073",Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?,"The endocannabinoid (eCB) system, an endogenous lipid signaling system, appears to be dysregulated in depression. The role of endocannabinoids (eCBs) as potent immunomodulators, together with the accumulating support for a chronic low-grade inflammatory profile in depression, suggests a compelling hypothesis for a fundamental impairment in their intercommunication, in depression.
We aim to review previous literature on individual associations between the immune and eCB systems and depression. It will focus on peripheral and central mechanisms of crosstalk between the eCB and immune systems. A potential dysregulation in this crosstalk will be discussed in the context of depression.
Investigations largely report a hypoactivity of the eCB system and increased inflammatory markers in individuals with depression. Findings depict a multifaceted communication whereby immunocompetent and eCB-related cells can both influence the suppression and enhancement of the other's activity in both the periphery and central nervous system. A dysregulation of the eCB system, as seen in depression, appears to be associated with central and peripheral concentrations of inflammatory agents implicated in the pathophysiology of this illness.
The eCB and immune systems have been individually associated with and implicated in pathogenic mechanisms of depression. Both systems tightly regulate the other's activity. As such, a dysregulation in this crosstalk has potential to influence the onset and maintenance of this neuropsychiatric illness. However, few studies have investigated both systems and depression conjointly. This review highlights the demand to consider joint eCB-immune interactions in the pathoetiology of depression.","['2-AG', 'Anandamide', 'CNS', 'Cytokine', 'Eicosanoids', 'Inflammation', 'Lymphocyte', 'Microglia', 'Microglial polarisation', 'Prostaglandin']",Psychopharmacology,2015-10-21,"[{'lastname': 'Boorman', 'firstname': 'Emily', 'initials': 'E', 'affiliation': ""Stress, Psychiatry and Immunology Laboratory, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.""}, {'lastname': 'Zajkowska', 'firstname': 'Zuzanna', 'initials': 'Z', 'affiliation': ""Stress, Psychiatry and Immunology Laboratory, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.""}, {'lastname': 'Ahmed', 'firstname': 'Rumsha', 'initials': 'R', 'affiliation': ""Stress, Psychiatry and Immunology Laboratory, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.""}, {'lastname': 'Pariante', 'firstname': 'Carmine M', 'initials': 'CM', 'affiliation': ""Stress, Psychiatry and Immunology Laboratory, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.""}, {'lastname': 'Zunszain', 'firstname': 'Patricia A', 'initials': 'PA', 'affiliation': ""Stress, Psychiatry and Immunology Laboratory, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK. patricia.zunszain@kcl.ac.uk.""}]",,"The eCB and immune systems have been individually associated with and implicated in pathogenic mechanisms of depression. Both systems tightly regulate the other's activity. As such, a dysregulation in this crosstalk has potential to influence the onset and maintenance of this neuropsychiatric illness. However, few studies have investigated both systems and depression conjointly. This review highlights the demand to consider joint eCB-immune interactions in the pathoetiology of depression.","Investigations largely report a hypoactivity of the eCB system and increased inflammatory markers in individuals with depression. Findings depict a multifaceted communication whereby immunocompetent and eCB-related cells can both influence the suppression and enhancement of the other's activity in both the periphery and central nervous system. A dysregulation of the eCB system, as seen in depression, appears to be associated with central and peripheral concentrations of inflammatory agents implicated in the pathophysiology of this illness.",,"10.1007/s00213-015-4105-9
10.1038/sj.bjp.0707456
10.1016/j.drudis.2013.07.009
10.1097/01.mcg.0000210099.36500.fe
10.1016/j.physbeh.2014.06.003
10.1016/j.bbalip.2010.08.002
10.1097/JCP.0b013e31825d9982
10.1016/j.lfs.2004.06.006
10.1186/1741-7015-11-1
10.1016/j.nbd.2010.03.020
10.1083/jcb.200305129
10.1016/j.biopsych.2006.12.001
10.1186/1471-2091-10-14
10.1016/j.bbi.2014.06.015
10.1002/jcb.23245
10.1097/FPC.0b013e3283367c6b
10.1124/mol.65.4.999
10.1016/j.neuron.2012.09.020
10.1038/npp.2012.191
10.1371/journal.pone.0008688
10.2174/138161208785740018
10.1002/jcb.1103
10.1186/1742-2094-11-98
10.1016/j.jpsychires.2012.03.021
10.1016/j.bbi.2012.12.017
10.1038/384083a0
10.1172/JCI58656
10.1038/nrn2297
10.1126/science.1470919
10.1016/j.biopsych.2009.09.033
10.1016/j.biopsych.2006.02.013
10.1002/glia.10177
10.1016/j.tips.2006.11.001
10.1016/j.plipres.2013.05.004
10.1021/ja01062a046
10.1111/j.1476-5381.2010.00819.x
10.1073/pnas.0509591102
10.1016/j.pnpbp.2010.11.021
10.1016/j.bbi.2013.06.010
10.1073/pnas.96.25.14228
10.1124/mol.108.047035
10.1111/j.1471-4159.2008.05567.x
10.1016/j.neubiorev.2012.07.001
10.1016/j.neuroscience.2011.12.030
10.1055/s-2007-993211
10.1038/sj.bjp.0705468
10.1093/cercor/bhr229
10.1038/mp.2011.82
10.1097/PSY.0b013e3181907c1b
10.1046/j.1471-4159.1999.0730493.x
10.1016/j.neuroscience.2012.09.067
10.1038/sj.mp.4001376
10.1016/j.bbi.2007.01.010
10.1016/j.neubiorev.2014.01.008
10.1172/JCI25509
10.1016/j.biopsych.2006.07.024
10.1074/jbc.272.43.27218
10.1189/jlb.0303101
10.1001/jamapsychiatry.2014.1611
10.1038/mp.2013.155
10.1016/0006-8993(88)91597-1
10.4306/pi.2010.7.4.231
10.1016/j.neulet.2009.10.017
10.1016/0262-1746(83)90048-3
10.1074/jbc.M306062200
10.1038/nchembio.129
10.1038/nature14432
10.1016/j.bbrc.2015.01.073
10.1006/abbi.2001.2500
10.1371/journal.pone.0077227
10.1007/BF02190412
10.1016/0306-4530(94)00066-J
10.1016/S0893-133X(98)00088-8
10.1038/346561a0
10.1016/j.bbr.2012.09.053
10.1586/ern.12.98
10.1371/journal.pone.0089566
10.1016/0006-2952(95)00109-D
10.1097/00004850-200607000-00005
10.1016/j.biopsych.2008.11.029
10.1016/j.conb.2014.08.012
10.1016/S0014-5793(98)00851-5
10.1038/365061a0
10.3390/ph7121028
10.1126/science.1209200
10.1210/jc.2002-020575
10.1016/0006-3223(88)90283-1
10.1074/jbc.M306642200
10.1371/journal.pone.0001640
10.1074/jbc.M111.291294
10.1016/j.phrs.2009.03.019
10.1038/35097089
10.1016/j.tins.2008.06.006
10.1210/en.2004-0638
10.1523/JNEUROSCI.3402-08.2008
10.1016/j.biopsych.2008.08.010
10.1016/j.it.2005.11.006
10.1073/pnas.0806682105
10.1007/s11481-013-9445-9
10.1021/cr2002799
10.1126/science.1083328
10.1016/j.bbi.2011.09.011
10.1073/pnas.93.9.3908
10.1016/j.bbr.2012.07.026
10.1016/S0165-0327(98)00025-1
10.1146/annurev.immunol.23.021704.115707
10.1016/j.jpsychires.2006.10.013
10.1002/glia.20983
10.1016/j.neuropharm.2008.07.037
10.1002/glia.20084
10.1186/1742-2094-1-14
10.1016/j.neuroscience.2015.02.028
10.1016/S0140-6736(10)60935-X
10.1016/S0140-6736(05)67763-X
10.1016/j.neuroscience.2011.09.031
10.1371/journal.pone.0036743
10.1016/j.ejphar.2006.08.083
10.1016/j.prostaglandins.2008.12.002
10.1038/npp.2010.99
10.1159/000087097
10.1016/j.psyneuen.2012.02.003
10.1517/17460441.2014.966680
10.2217/pgs.14.40
10.1006/brbi.2000.0597
10.1016/j.pnpbp.2010.04.011
10.1007/7854_2012_211",<Element 'PubmedArticle' at 0x7f05da3c3360>
476,26364961,Prothymosin-alpha preconditioning activates TLR4-TRIF signaling to induce protection of ischemic retina.,"Prothymosin-alpha protects the brain and retina from ischemic damage. Although prothymosin-alpha contributes to toll-like receptor (TLR4)-mediated immnunopotentiation against viral infection, the beneficial effects of prothymosin-alpha-TLR4 signaling in protecting against ischemia remain to be elucidated. In this study, intravitreal administration of prothymosin-alpha 48 h before induction of retinal ischemia prevented retinal cellular damage as evaluated by histology, and retinal functional deficits as evaluated by electroretinography. Prothymosin-alpha preconditioning completely prevented the ischemia-induced loss of ganglion cells with partial survival of bipolar and photoreceptor cells, but not amacrine cells, in immunohistochemistry experiments. Prothymosin-alpha treatment in the absence of ischemia caused mild activation, proliferation, and migration of retinal microglia, whereas the ischemia-induced microglial activation was inhibited by prothymosin-alpha preconditioning. All these preventive effects of prothymosin-alpha preconditioning were abolished in TLR4 knock-out mice and by pre-treatments with anti-TLR4 antibodies or minocycline, a microglial inhibitor. Prothymosin-alpha preconditioning inhibited the retinal ischemia-induced up-regulation of TLR4-related injury genes, and increased expression of TLR4-related protective genes. Furthermore, the prothymosin-alpha preconditioning-induced prevention of retinal ischemic damage was abolished in TIR-domain-containing adapter-inducing interferon-β knock-out mice, but not in myeloid differentiation primary response gene 88 knock-out mice. Taken together, the results of this study suggest that prothymosin-alpha preconditioning selectively drives TLR4-TIR-domain-containing adapter-inducing interferon-β signaling and microglia in the prevention of retinal ischemic damage. We propose the following mechanism for prothymosin-alpha (ProTα) preconditioning-induced retinal prevention against ischemia: ProTα preconditioning-induced prevention of retinal ischemic damage is mediated by selective activation of the TIR-domain-containing adapter-inducing interferon-β (TRIF)- interferon regulatory factor 3 (IRF3) pathway downstream of toll-like receptor 4 (TLR4) in microglia, resulting in up-regulation of TRIF-IRF3-dependent protective genes and down-regulation of myeloid differentiation primary response gene 88 (MyD88)-Nuclear factor (NF)κB-dependent injury genes. Detailed investigations would be helpful to test the efficacy of ProTα as a therapeutic agent for the prevention of ischemic disorders.","['TLR4', 'TRIF', 'ischemia', 'microglia', 'neuroprotection', 'prothymosin-alpha']",Journal of neurochemistry,2015-09-15,"[{'lastname': 'Halder', 'firstname': 'Sebok Kumar', 'initials': 'SK', 'affiliation': 'Department of Pharmacology and Therapeutic Innovation, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.'}, {'lastname': 'Matsunaga', 'firstname': 'Hayato', 'initials': 'H', 'affiliation': 'Department of Pharmacology and Therapeutic Innovation, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.'}, {'lastname': 'Ishii', 'firstname': 'Ken J', 'initials': 'KJ', 'affiliation': 'Laboratory of Vaccine Science, Immunology Frontier Research Center, Osaka University, Osaka, Japan.'}, {'lastname': 'Ueda', 'firstname': 'Hiroshi', 'initials': 'H', 'affiliation': 'Department of Pharmacology and Therapeutic Innovation, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.'}]",,,,© 2015 International Society for Neurochemistry.,10.1111/jnc.13356,<Element 'PubmedArticle' at 0x7f05da396ef0>
477,26363192,"Shanzhiside methylester, the principle effective iridoid glycoside from the analgesic herb Lamiophlomis rotata, reduces neuropathic pain by stimulating spinal microglial β-endorphin expression.","Lamiophlomis rotata (L. rotata, Duyiwei) is an orally available Tibetan analgesic herb widely prescribed in China. Shanzhiside methylester (SM) is a principle effective iridoid glycoside of L. rotata and serves as a small molecule glucagon-like peptide-1 (GLP-1) receptor agonist. This study aims to evaluate the signal mechanisms underlying SM anti-allodynia, determine the ability of SM to induce anti-allodynic tolerance, and illustrate the interactions between SM and morphine, or SM and β-endorphin, in anti-allodynia and anti-allodynic tolerance. Intrathecal SM exerted dose-dependent and long-lasting (>4 h) anti-allodynic effects in spinal nerve injury-induced neuropathic rats, with a maximal inhibition of 49% and a projected ED50 of 40.4 μg. SM and the peptidic GLP-1 receptor agonist exenatide treatments over 7 days did not induce self-tolerance to anti-allodynia or cross-tolerance to morphine or β-endorphin. In contrast, morphine and β-endorphin induced self-tolerance and cross-tolerance to SM and exenatide. In the spinal dorsal horn and primary microglia, SM significantly evoked β-endorphin expression, which was completely prevented by the microglial inhibitor minocycline and p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580. SM anti-allodynia was totally inhibited by the GLP-1 receptor antagonist exendin(9-39), minocycline, β-endorphin antiserum, μ-opioid receptor antagonist CTAP, and SB203580. SM and exenatide specifically activated spinal p38 MAPK phosphorylation. These results indicate that SM reduces neuropathic pain by activating spinal GLP-1 receptors and subsequently stimulating microglial β-endorphin expression via the p38 MAPK signaling. Stimulation of the endogenous β-endorphin expression may be a novel and effective strategy for the discovery and development of analgesics for the long-term treatment of chronic pain.","['Anti-allodynia', 'Glucagon-like peptide-1 (GLP-1) receptor', 'Microglia', 'Shanzhiside methylester (SM)', 'p38 mitogen-activated protein kinase (MAPK)', 'β-endorphin']",Neuropharmacology,2015-09-13,"[{'lastname': 'Fan', 'firstname': 'Hui', 'initials': 'H', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, 800 Dongchuan Road, Shanghai, 200240, China.""}, {'lastname': 'Li', 'firstname': 'Teng-Fei', 'initials': 'TF', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, 800 Dongchuan Road, Shanghai, 200240, China.""}, {'lastname': 'Gong', 'firstname': 'Nian', 'initials': 'N', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, 800 Dongchuan Road, Shanghai, 200240, China.""}, {'lastname': 'Wang', 'firstname': 'Yong-Xiang', 'initials': 'YX', 'affiliation': ""King's Lab, Shanghai Jiao Tong University School of Pharmacy, 800 Dongchuan Road, Shanghai, 200240, China. Electronic address: yxwang@sjtu.edu.cn.""}]",,,,Copyright © 2015 Elsevier Ltd. All rights reserved.,10.1016/j.neuropharm.2015.09.010,<Element 'PubmedArticle' at 0x7f05da323f90>
478,26337121,Poststroke Inflammasome Expression and Regulation in the Peri-Infarct Area by Gonadal Steroids after Transient Focal Ischemia in the Rat Brain.,"CNS ischemia results in locally confined and rapid tissue damage accompanied by a loss of neurons and their circuits. Early and time-delayed inflammatory responses are critical variables determining the extent of neural disintegration and regeneration. Inflammasomes are vital effectors in innate immunity. Their activation in brain-intrinsic immune cells contributes to ischemia-related brain damage. The steroids 17β-estradiol (E2) and progesterone (P) are neuroprotective and anti-inflammatory. Using a transient focal rat ischemic model, we evaluated the time response of different inflammasomes in the peri-infarct zone from the early to late phases after poststroke ischemia. We show that the different inflammasome complexes reveal a specific time-oriented sequential expression pattern with a maximum at approximately 24 h after the infarct. Within the limits of antibody availability, immunofluorescence labeling demonstrated that microglia and neurons are major sources of the locally activated inflammasomes NOD-like receptor protein-3 (NLRP3) and associated speck-like protein (ASC), respectively. E2 and P given for 24 h immediately after ischemia onset reduced hypoxia-induced mRNA expression of the inflammasomes NLRC4, AIM2 and ASC, and decreased the protein levels of ASC and NLRP3. In addition, mRNA protein levels of the cytokines interleukin-1β (IL1β), IL18 and TNFα were reduced by the steroids. The findings provide for the first time a detailed flow chart of hypoxia-driven inflammasome regulation in the peri-infarct cerebral cortex. Further, we demonstrate that E2 and P alleviate the expression of certain inflammasome components, sometimes in a hormone-specific way. Besides directly regulating other cellular neuroprotective pathways, the control of inflammasomes by these steroids might contribute to its neuroprotective potency.",[],Neuroendocrinology,2015-09-05,"[{'lastname': 'Lammerding', 'firstname': 'Leoni', 'initials': 'L', 'affiliation': None}, {'lastname': 'Slowik', 'firstname': 'Alexander', 'initials': 'A', 'affiliation': None}, {'lastname': 'Johann', 'firstname': 'Sonja', 'initials': 'S', 'affiliation': None}, {'lastname': 'Beyer', 'firstname': 'Cordian', 'initials': 'C', 'affiliation': None}, {'lastname': 'Zendedel', 'firstname': 'Adib', 'initials': 'A', 'affiliation': None}]",,,,"© 2015 S. Karger AG, Basel.",10.1159/000439435,<Element 'PubmedArticle' at 0x7f05da3339a0>
479,26305431,Voltage-dependent BK and Hv1 channels expressed in non-excitable tissues: New therapeutics opportunities as targets in human diseases.,"Voltage-gated ion channels are the molecular determinants of cellular excitability. This group of ion channels is one of the most important pharmacological targets in excitable tissues such as nervous system, cardiac and skeletal muscle. Moreover, voltage-gated ion channels are expressed in non-excitable cells, where they mediate key cellular functions through intracellular biochemical mechanisms rather than rapid electrical signaling. This review aims at illustrating the pharmacological impact of these ion channels, highlighting in particular the structural details and physiological functions of two of them - the high conductance voltage- and Ca(2+)-gated K(+) (BK) channels and voltage-gated proton (Hv1) channels- in non-excitable cells. BK channels have been implicated in a variety of physiological processes ranging from regulation of smooth muscle tone to modulation of hormone and neurotransmitter release. Interestingly, BK channels are also involved in modulating K(+) transport in the mammalian kidney and colon epithelium with a potential role in the hyperkalemic phenotype observed in patients with familial hyperkalemic hypertension type 2, and in the pathophysiology of hypertension. In addition, BK channels are responsible for resting and stimulated Ca(2+)-activated K(+) secretion in the distal colon. Hv1 channels have been detected in many cell types, including macrophages, blood cells, lung epithelia, skeletal muscle and microglia. These channels have a central role in the phagocytic system. In macrophages, Hv1 channels participate in the generation of reactive oxygen species in the respiratory burst during the process of phagocytosis.","['BK channel', 'H(v)1 channel', 'Phagocytosis', 'Potassium secretion', 'Voltage-dependent potassium channels', 'Voltage-dependent proton channel']",Pharmacological research,2015-08-26,"[{'lastname': 'Morera', 'firstname': 'Francisco J', 'initials': 'FJ', 'affiliation': 'Institute of Pharmacology and Morphophysiology, Faculty of Veterinary Sciences, Universidad Austral de Chile, Valdivia, Chile. Electronic address: fjmorera@uach.cl.'}, {'lastname': 'Saravia', 'firstname': 'Julia', 'initials': 'J', 'affiliation': 'Institute of Pharmacology and Morphophysiology, Faculty of Veterinary Sciences, Universidad Austral de Chile, Valdivia, Chile.'}, {'lastname': 'Pontigo', 'firstname': 'Juan Pablo', 'initials': 'JP', 'affiliation': 'Institute of Marine Sciences and Limnology, Faculty of Sciences, Universidad Austral de Chile, Valdivia, Chile.'}, {'lastname': 'Vargas-Chacoff', 'firstname': 'Luis', 'initials': 'L', 'affiliation': 'Institute of Marine Sciences and Limnology, Faculty of Sciences, Universidad Austral de Chile, Valdivia, Chile.'}, {'lastname': 'Contreras', 'firstname': 'Gustavo F', 'initials': 'GF', 'affiliation': 'Interdisciplinary Center for Neuroscience of Valparaiso, Faculty of Sciences, Universidad de Valparaiso, Valparaiso, Chile.'}, {'lastname': 'Pupo', 'firstname': 'Amaury', 'initials': 'A', 'affiliation': 'Interdisciplinary Center for Neuroscience of Valparaiso, Faculty of Sciences, Universidad de Valparaiso, Valparaiso, Chile.'}, {'lastname': 'Lorenzo', 'firstname': 'Yenisleidy', 'initials': 'Y', 'affiliation': 'Interdisciplinary Center for Neuroscience of Valparaiso, Faculty of Sciences, Universidad de Valparaiso, Valparaiso, Chile.'}, {'lastname': 'Castillo', 'firstname': 'Karen', 'initials': 'K', 'affiliation': 'Interdisciplinary Center for Neuroscience of Valparaiso, Faculty of Sciences, Universidad de Valparaiso, Valparaiso, Chile.'}, {'lastname': 'Tilegenova', 'firstname': 'Cholpon', 'initials': 'C', 'affiliation': 'Cell Physiology and Molecular Biophysics, Center for Membrane Protein Research, Texas Tech University Health Sciences Center, Lubcock, TX, USA.'}, {'lastname': 'Cuello', 'firstname': 'Luis G', 'initials': 'LG', 'affiliation': 'Cell Physiology and Molecular Biophysics, Center for Membrane Protein Research, Texas Tech University Health Sciences Center, Lubcock, TX, USA. Electronic address: luis.cuello@ttuhsc.edu.'}, {'lastname': 'Gonzalez', 'firstname': 'Carlos', 'initials': 'C', 'affiliation': 'Interdisciplinary Center for Neuroscience of Valparaiso, Faculty of Sciences, Universidad de Valparaiso, Valparaiso, Chile. Electronic address: carlos.gonzalezl@uv.cl.'}]",,,,Copyright © 2015 Elsevier Ltd. All rights reserved.,10.1016/j.phrs.2015.08.011,<Element 'PubmedArticle' at 0x7f05da342400>
480,26209808,Enriched environment decreases microglia and brain macrophages inflammatory phenotypes through adiponectin-dependent mechanisms: Relevance to depressive-like behavior.,"Regulation of neuroinflammation by glial cells plays a major role in the pathophysiology of major depression. While astrocyte involvement has been well described, the role of microglia is still elusive. Recently, we have shown that Adiponectin (ApN) plays a crucial role in the anxiolytic/antidepressant neurogenesis-independent effects of enriched environment (EE) in mice; however its mechanisms of action within the brain remain unknown. Here, we show that in a murine model of depression induced by chronic corticosterone administration, the hippocampus and the hypothalamus display increased levels of inflammatory cytokines mRNA, which is reversed by EE housing. By combining flow cytometry, cell sorting and q-PCR, we show that microglia from depressive-like mice adopt a pro-inflammatory phenotype characterized by higher expression levels of IL-1β, IL-6, TNF-α and IκB-α mRNAs. EE housing blocks pro-inflammatory cytokine gene induction and promotes arginase 1 mRNA expression in brain-sorted microglia, indicating that EE favors an anti-inflammatory activation state. We show that microglia and brain-macrophages from corticosterone-treated mice adopt differential expression profiles for CCR2, MHC class II and IL-4recα surface markers depending on whether the mice are kept in standard environment or EE. Interestingly, the effects of EE were abolished when cells are isolated from ApN knock-out mouse brains. When injected intra-cerebroventricularly, ApN, whose level is specifically increased in cerebrospinal fluid of depressive mice raised in EE, rescues microglia phenotype, reduces pro-inflammatory cytokine production by microglia and blocks depressive-like behavior in corticosterone-treated mice. Our data suggest that EE-induced ApN increase within the brain regulates microglia and brain macrophages phenotype and activation state, thus reducing neuroinflammation and depressive-like behaviors in mice.","['Adiponectin', 'Antidepressant', 'Brain macrophages', 'Cytokines', 'Depression', 'Enriched environment', 'Microglia', 'Neuroinflammation']","Brain, behavior, and immunity",2015-07-26,"[{'lastname': 'Chabry', 'firstname': 'Joëlle', 'initials': 'J', 'affiliation': 'Université de Nice Sophia Antipolis, 06103 Nice, France; Centre National de la Recherche Scientifique (CNRS), Institut de Pharmacologie Moléculaire et Cellulaire, UMR 7275, 06560 Valbonne, France.'}, {'lastname': 'Nicolas', 'firstname': 'Sarah', 'initials': 'S', 'affiliation': 'Université de Nice Sophia Antipolis, 06103 Nice, France; Centre National de la Recherche Scientifique (CNRS), Institut de Pharmacologie Moléculaire et Cellulaire, UMR 7275, 06560 Valbonne, France.'}, {'lastname': 'Cazareth', 'firstname': 'Julie', 'initials': 'J', 'affiliation': 'Université de Nice Sophia Antipolis, 06103 Nice, France; Centre National de la Recherche Scientifique (CNRS), Institut de Pharmacologie Moléculaire et Cellulaire, UMR 7275, 06560 Valbonne, France.'}, {'lastname': 'Murris', 'firstname': 'Emilie', 'initials': 'E', 'affiliation': 'Université de Nice Sophia Antipolis, 06103 Nice, France; Centre National de la Recherche Scientifique (CNRS), Institut de Pharmacologie Moléculaire et Cellulaire, UMR 7275, 06560 Valbonne, France.'}, {'lastname': 'Guyon', 'firstname': 'Alice', 'initials': 'A', 'affiliation': 'Université de Nice Sophia Antipolis, 06103 Nice, France; Centre National de la Recherche Scientifique (CNRS), Institut de Pharmacologie Moléculaire et Cellulaire, UMR 7275, 06560 Valbonne, France.'}, {'lastname': 'Glaichenhaus', 'firstname': 'Nicolas', 'initials': 'N', 'affiliation': 'Université de Nice Sophia Antipolis, 06103 Nice, France; Centre National de la Recherche Scientifique (CNRS), Institut de Pharmacologie Moléculaire et Cellulaire, UMR 7275, 06560 Valbonne, France.'}, {'lastname': 'Heurteaux', 'firstname': 'Catherine', 'initials': 'C', 'affiliation': 'Université de Nice Sophia Antipolis, 06103 Nice, France; Centre National de la Recherche Scientifique (CNRS), Institut de Pharmacologie Moléculaire et Cellulaire, UMR 7275, 06560 Valbonne, France.'}, {'lastname': 'Petit-Paitel', 'firstname': 'Agnès', 'initials': 'A', 'affiliation': 'Université de Nice Sophia Antipolis, 06103 Nice, France; Centre National de la Recherche Scientifique (CNRS), Institut de Pharmacologie Moléculaire et Cellulaire, UMR 7275, 06560 Valbonne, France. Electronic address: paitel@ipmc.cnrs.fr.'}]",,,,Copyright © 2015 Elsevier Inc. All rights reserved.,10.1016/j.bbi.2015.07.018,<Element 'PubmedArticle' at 0x7f05da34e3b0>
481,26209152,Rapidly activated epidermal growth factor receptor mediates lipopolysaccharide-triggered migration of microglia.,"Previous reports have suggested that epidermal growth factor receptor (EGFR) is involved in microglia activation characterized by cell morphology changes, cytokine production and cell migration; and the biochemical regulation of the microglia migration is a potential therapeutic target following CNS inflammatory damages. However, the role of EGFR in microglia motility after inflammatory stimulation remains unknown. In the present study, lipopolysaccharide (LPS) was found to trigger rapid EGFR phosphorylation within 10 min, which was sustained during long-term stimulation in both primary microglial cells and the cultured BV2 microglial cells, furthermore, blocking EGFR phosphorylation by AG1478 significantly attenuated the LPS-induced chemotactic and chemokinetic migration of microglia. In addition, LPS could initiate calcium oscillation in microglia during live-cell recording, however, an intracellular calcium chelator and a selective inhibitor of calcium/calmodulin-dependent protein kinase II, but not an extracellular calcium chelator, remarkably suppressed the LPS-induced EGFR phosphorylation in BV2 microglia cells. As EGFR is not a traditional receptor for LPS, these findings suggest that the rapid phosphorylation of EGFR is attributed to the LPS-triggered intracellular calcium mobilization. By examining the downstream signals of EGFR, we further proved that extracellular signal-regulated kinase (ERK) is essential for EGFR-mediated microglia migration, because ERK inhibition attenuated the chemotactic and chemokinetic migration of microglia that had been induced by either LPS or EGF. Collectively, these results suggest that LPS could trigger the rapid phosphorylation of EGFR and subsequent ERK activation through mobilizing calcium activity, which underlies the microglia migration in an inflammatory condition.","['Calcium oscillation', 'Epidermal growth factor receptor', 'Lipopolysaccharide', 'Microglia', 'Migration']",Neurochemistry international,2015-07-26,"[{'lastname': 'Qu', 'firstname': 'Wen-Sheng', 'initials': 'WS', 'affiliation': 'Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PR China.'}, {'lastname': 'Liu', 'firstname': 'Jun-Li', 'initials': 'JL', 'affiliation': 'Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430023, PR China.'}, {'lastname': 'Li', 'firstname': 'Chun-Yu', 'initials': 'CY', 'affiliation': 'Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PR China.'}, {'lastname': 'Li', 'firstname': 'Xiao', 'initials': 'X', 'affiliation': 'Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PR China.'}, {'lastname': 'Xie', 'firstname': 'Min-Jie', 'initials': 'MJ', 'affiliation': 'Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PR China.'}, {'lastname': 'Wang', 'firstname': 'Wei', 'initials': 'W', 'affiliation': 'Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PR China.'}, {'lastname': 'Tian', 'firstname': 'Dai-Shi', 'initials': 'DS', 'affiliation': 'Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PR China. Electronic address: tiands@tjh.tjmu.edu.cn.'}]",,,,Copyright © 2015 Elsevier Ltd. All rights reserved.,10.1016/j.neuint.2015.07.007,<Element 'PubmedArticle' at 0x7f05da35db30>
482,"26200703
17540609
21195345
11135624
18208449
7522345
8430212
12675907
23846492
24686186
12114611
18971490
12941577
12433052
19584310
10494847
17079549
22830525
12114629
22805998
8858209
24950664
11696579
15312162
10852851
15962096
16929344
20646308
15207836
15185221
19956568
18582442
8843599
11306611
15343385
15927546
8700830
15504977
9298801
20570286
19687776",Recurrent hypoinsulinemic hyperglycemia in neonatal rats increases PARP-1 and NF-κB expression and leads to microglial activation in the cerebral cortex.,"Hyperglycemia is a common metabolic problem in extremely low-birth-weight preterm infants. Neonatal hyperglycemia is associated with increased mortality and brain injury. Glucose-mediated oxidative injury may be responsible. Poly(ADP-ribose) polymerase-1 (PARP-1) is a nuclear enzyme involved in DNA repair and cell survival. However, PARP-1 overactivation leads to cell death. NF-κB is coactivated with PARP-1 and regulates microglial activation. The effects of recurrent hyperglycemia on PARP-1/NF-κB expression and microglial activation are not well understood.
Rat pups were subjected to recurrent hypoinsulinemic hyperglycemia of 2 h duration twice daily from postnatal (P) day 3-P12 and killed on P13. mRNA and protein expression of PARP-1/NF-κB and their downstream effectors were determined in the cerebral cortex. Microgliosis was determined using CD11 immunohistochemistry.
Recurrent hyperglycemia increased PARP-1 expression confined to the nucleus and without causing PARP-1 overactivation and cell death. NF-κB mRNA expression was increased, while IκB mRNA expression was decreased. inducible nitric oxide synthase (iNOS), endothelial nitric oxide synthase (eNOS), and neuronal nitric oxide synthase (nNOS) mRNA expressions were decreased. Hyperglycemia significantly increased the number of microglia.
Recurrent hyperglycemia in neonatal rats is associated with upregulation of PARP-1 and NF-κB expression and subsequent microgliosis but not neuronal cell death in the cerebral cortex.",[],Pediatric research,2015-07-23,"[{'lastname': 'Gisslen', 'firstname': 'Tate', 'initials': 'T', 'affiliation': 'Division of Neonatology, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.'}, {'lastname': 'Ennis', 'firstname': 'Kathleen', 'initials': 'K', 'affiliation': 'Division of Neonatology, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.'}, {'lastname': 'Bhandari', 'firstname': 'Vineet', 'initials': 'V', 'affiliation': ""Department of Pediatrics (Neonatology) and Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut.\nCurrent address: Department of Pediatrics, Division of Neonatology, St. Christopher's Hospital for Children, Drexel University, Philadelphia, Pennsylvania.""}, {'lastname': 'Rao', 'firstname': 'Raghavendra', 'initials': 'R', 'affiliation': 'Division of Neonatology, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.'}]",,Recurrent hyperglycemia in neonatal rats is associated with upregulation of PARP-1 and NF-κB expression and subsequent microgliosis but not neuronal cell death in the cerebral cortex.,"Recurrent hyperglycemia increased PARP-1 expression confined to the nucleus and without causing PARP-1 overactivation and cell death. NF-κB mRNA expression was increased, while IκB mRNA expression was decreased. inducible nitric oxide synthase (iNOS), endothelial nitric oxide synthase (eNOS), and neuronal nitric oxide synthase (nNOS) mRNA expressions were decreased. Hyperglycemia significantly increased the number of microglia.",,10.1038/pr.2015.136,<Element 'PubmedArticle' at 0x7f05da2ead60>
483,26159205,Insulin Modulates In Vitro Secretion of Cytokines and Cytotoxins by Human Glial Cells.,"Alzheimer's disease (AD) is the most common form of dementia worldwide. Type 2 diabetes (T2D) has been implicated as a risk factor for AD. Since T2D is a peripheral inflammatory condition, and AD brains exhibit exacerbated neuroinflammation, we hypothesized that inflammatory mechanisms could contribute to the observed link between T2D and AD. Abnormal peripheral and brain insulin concentrations have been reported in both T2D and AD. The neurotrophic role of insulin has been described; however, this hormone can also regulate inflammatory responses in the periphery. Therefore we used in vitro human cell culture systems to elucidate the possible effects of insulin on neuroinflammation. We show that human astrocytes and microglia express both isoforms of the insulin receptor as well as the insulin-like growth factor (IGF)-1 receptor. They also express insulin receptor substrate (IRS)-1 and IRS-2, which are required for propagation of insulin/IGF- 1 signaling. We show that at low nanomolar concentrations, insulin could be pro-inflammatory by upregulating secretion of interleukin (IL)-6 and IL-8 from stimulated human astrocytes and secretion of IL-8 from stimulated human microglia. This effect dissipates at higher insulin concentrations. In contrast, insulin at a broader concentration range (10 pM - 1 μM) reduces the toxicity of stimulated human microglia and THP-1 monocytic cells towards SH-SY5Y neuronal cells. These data show that insulin may regulate the inflammatory status of glial cells by modulating their select functions, which in turn can influence the survival of neurons contributing to the observed link between T2D and AD.",[],Current Alzheimer research,2015-07-15,"[{'lastname': 'Spielman', 'firstname': 'Lindsay J', 'initials': 'LJ', 'affiliation': None}, {'lastname': 'Bahniwal', 'firstname': 'Manpreet', 'initials': 'M', 'affiliation': None}, {'lastname': 'Little', 'firstname': 'Jonathan P', 'initials': 'JP', 'affiliation': None}, {'lastname': 'Walker', 'firstname': 'Douglas G', 'initials': 'DG', 'affiliation': None}, {'lastname': 'Klegeris', 'firstname': 'Andis', 'initials': 'A', 'affiliation': 'Department of Biology, University of British Columbia Okanagan Campus, 3187 University Way, Kelowna, BC, Canada, V1V 1V7. andis.klegeris@ubc.ca.'}]",,,,,10.2174/1567205012666150710104428,<Element 'PubmedArticle' at 0x7f05da306630>
484,26142757,"Effect of carnosine, methylprednisolone and their combined application on irisin levels in the plasma and brain of rats with acute spinal cord injury.","Spinal cord injury (SCI) might occur to anybody at any time and any age. In its treatment, methylprednisolone (MP) is a first choice worldwide, but there is still no significant breakthrough in truly beneficial treatment due to SCI's complex pathophysiology. We investigated the effect of carnosine, methylprednisolone (MP) and its combination on irisin levels in the plasma, brain and medulla spinalis tissues in SCI using a rat model. The rats were divided into 6 groups: I (Control, saline); II (sham animals with laminectomy without cross-clamping); III (SCI); IV (SCI treated with 150mg/kg carnosine); V (SCI treated with 30mg/kg methylprednisolone); and VI (SCI treated with a combination of carnosine and MP). The animals were given traumatic SCI after laminectomy, using 70-g closing force aneurysm clips (Yasargil FE 721). Irisin concentration was measured by ELISA. The distribution of irisin in brain and spinal cord tissues was examined by immunochemistry. Irisin was mainly expressed in the astrocytes and microglia of brain tissues, and multipolar neurones of the anterior horn of spinal cord tissue in rats of all groups, indicating that irisin is physiologically indispensable. MP and carnosine and the combination of the two, significantly increased irisin in plasma and were accompanied by a significant rise in irisin immunoreactivity of brain and spinal cord tissues of the injured rats compared with control and sham. This finding raises the possibility that methylprednisolone and carnosine regulate the brain and spinal cord tissues in SCI by inducing irisin expression, and may therefore offer a better neurological prognosis.","['Carnosine', 'Irisin', 'Methylprednisolone', 'Spinal cord injury']",Neuropeptides,2015-07-06,"[{'lastname': 'Albayrak', 'firstname': 'Serdal', 'initials': 'S', 'affiliation': 'Department of Neurosurgery, Elazig Education and Research Hospital, 23100, Elazig, Turkey.'}, {'lastname': 'Atci', 'firstname': 'İbrahim Burak', 'initials': 'İB', 'affiliation': 'Department of Neurosurgery, Elazig Education and Research Hospital, 23100, Elazig, Turkey.'}, {'lastname': 'Kalayci', 'firstname': 'Mehmet', 'initials': 'M', 'affiliation': 'Laboratory of Medical Biochemistry, Elazig Education and Research Hospital, Elazig 23100, Turkey.'}, {'lastname': 'Yilmaz', 'firstname': 'Musa', 'initials': 'M', 'affiliation': 'Firat University, School of Medicine, Department of Medical Biochemistry (Firat Hormones Research Group), 23119 Elazig, Turkey.'}, {'lastname': 'Kuloglu', 'firstname': 'Tuncay', 'initials': 'T', 'affiliation': 'Firat University, School of Medicine, Department of Histology&Embryology, 23119, Elazig, Turkey.'}, {'lastname': 'Aydin', 'firstname': 'Suna', 'initials': 'S', 'affiliation': 'Cardiovascular Surgery- Anatomy, Elazig Education and Research Hospital, 23100, Elazig, Turkey.'}, {'lastname': 'Kom', 'firstname': 'Mustafa', 'initials': 'M', 'affiliation': 'Firat University, Veterinary of Medicine, Department of Surgery, Elazig 23119, Turkey.'}, {'lastname': 'Ayden', 'firstname': 'Omer', 'initials': 'O', 'affiliation': 'Department of Neurosurgery, Elazig Education and Research Hospital, 23100, Elazig, Turkey.'}, {'lastname': 'Aydin', 'firstname': 'Suleyman', 'initials': 'S', 'affiliation': 'Firat University, School of Medicine, Department of Medical Biochemistry (Firat Hormones Research Group), 23119 Elazig, Turkey. Electronic address: saydin1@hotmail.com.'}]",,,,Copyright © 2015 Elsevier B.V. All rights reserved.,10.1016/j.npep.2015.06.004,<Element 'PubmedArticle' at 0x7f05da3136d0>
485,"26138585
21519550
22157874
8221104
21872218
19444917
24231246
23582155
25349575
6267699
20923560
1686211
22392969
18389420
24076008
25406759
17062708
24284839
23840363
15315264
24841552
15907645
3340425
17392412
25540945
6877845
10601667
24659554
25888454
17375137
16725112",Corticotropin-releasing factor mediates bone cancer induced pain through neuronal activation in rat spinal cord.,"Corticotropin-releasing factor (CRF) serves as a neuromodulator in the hypothalamic-pituitary-adrenal axis, playing an essential role in depression, anxiety, and pain regulation. However, its biological role in bone cancer induced pain has not been investigated. In the present study, we aimed to elucidate the expression and distribution of CRF in spinal cord using a rodent model of bone cancer pain. Our study showed that implantation of Walker 256 mammary gland carcinoma cells into the tibia of rats significantly increased CRF expression in the spinal cord in a time-dependent manner. The upregulated expression of CRF mainly expressed in the superficial dorsal horn of spinal cord. Moreover, immunofluorescence double staining showed that CRF was extensively colocalized with neurons, but hardly with astrocytes or microglia. In addition, intrathecal injection of CRF receptor antagonist (α-helical-CRF) significantly inhibited heat hyperalgesia, mechanical allodynia, and the expression of c-Fos in spinal dorsal horn of bone cancer pain rats. In summary, our study demonstrates that CRF plays an important role in the development and maintenance of bone cancer pain via activation of neurons.","['Bone cancer pain', 'CRF', 'Neuron', 'Spinal cord']",Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,2015-07-04,"[{'lastname': 'Fan', 'firstname': 'Hou-Bao', 'initials': 'HB', 'affiliation': 'Department of Pain Medicine, Xuzhou Renci Hospital & Jiangsu Province Key Laboratory of Anaesthesiology, Xuzhou Medical College, 99 Huaihai West Road, Xuzhou, 221002, China.'}, {'lastname': 'Zhang', 'firstname': 'Ting', 'initials': 'T', 'affiliation': 'Jiangsu Province Key Laboratory of Anaesthesiology, Xuzhou Medical College, Xuzhou, Jiangsu, 221004, China.'}, {'lastname': 'Sun', 'firstname': 'Kai', 'initials': 'K', 'affiliation': 'Department of Pain Medicine, The Affiliated Hospital of Xuzhou Medical College, 99 Huaihai West Road, Xuzhou, 221002, China.'}, {'lastname': 'Song', 'firstname': 'Su-Pei', 'initials': 'SP', 'affiliation': 'Jiangsu Province Key Laboratory of Anaesthesiology, Xuzhou Medical College, Xuzhou, Jiangsu, 221004, China.'}, {'lastname': 'Cao', 'firstname': 'Shou-Bin', 'initials': 'SB', 'affiliation': 'Jiangsu Province Key Laboratory of Anaesthesiology, Xuzhou Medical College, Xuzhou, Jiangsu, 221004, China.'}, {'lastname': 'Zhang', 'firstname': 'Hai-Long', 'initials': 'HL', 'affiliation': 'Jiangsu Province Key Laboratory of Anaesthesiology, Xuzhou Medical College, Xuzhou, Jiangsu, 221004, China.'}, {'lastname': 'Shen', 'firstname': 'Wen', 'initials': 'W', 'affiliation': 'Department of Pain Medicine, The Affiliated Hospital of Xuzhou Medical College, 99 Huaihai West Road, Xuzhou, 221002, China. wen_shen501@126.com.'}]",,,,,10.1007/s13277-015-3670-1,<Element 'PubmedArticle' at 0x7f05da2a19a0>
486,"26131323
5320560
14228531
16742013
16987706
3905480
4749457
5120249
21355967
21330636
8423228
15271645
8036284
11334402
11246881
18795210
12540611
11502801
20871975
19074620
12399437
11108273
8866556
22262078
21795304
20018525
17498508
24684709
7750665
23356279
17928588
10098504
16219666
0
16049395
8635662
15780429
9044391
3385016
21329743
17433266
23439117
11473030
12196469
12110536
17306374
12615957
22968320
15561912
21868452
12970080
7543091
8391428
18519802
11016446
12519856
7657039
18054732
21194356
10537167
20153005
20638440
25140306
25216328
12892317
16025254
8577927
8843738
19336511
17213311
16939389
16416146
18535325
24285927
22725703
22405266
21320267
20460445
20580422
19848045
15715491
8396143
17975905
10794683
22236356
21450987
20332351
19515413
23141817
19171732
20709939
23129399
25071725
24406898
24824430
21205109
25126392
22236411
19688338
23671882
24373150
24176437
19151200
22284365
22037645
25183970
23163663
21700561
22762797
22392833
24152968
22950055
24796231
24972503
24672252
25043423
27713278
24815575
24323912
23295502
20298455
18487451
8538742
18506089
21994361
21693680
18948395
15331566
22446097
20951098
24905058
23566334
23812094
22785236
21844879
20332357
18848880
24703603
22290178
24643136
24220636
25114929
25197672
23657152
25182811
24931033
25149184
25202927
25113171
24582776
12904469
19770104
17942819
9054233
21902669
24718034
24280021
23400497
18805403
8017169
21703262
19470380
18706004
14980532
20157308
19399381
18468545
24223607
22500228
21907815
19188609
21489811
15094073
24969117
22954151
24529522
22476196
23061885
22427376
17175109
15734146
24931034
24931035
15755688
18278798
21763311
24347322
24992836
22940631
24582101
18673148
21277873
25333029
21623793
20010958
24304575
24117480
22443187
23999914
23314196
21312223
24840661
20622169
21094907
12925848
23276669
20035739
22592020
23973293
23011726
21525299
23536825
23948890
17803225
18492290
19164583
23728174
24177570
23000625
21472764
24112036",Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutide.,"Long-acting glucagon-like peptide-1 (GLP-1) analogues marketed for type 2 diabetes (T2D) treatment have been showing positive and protective effects in several different tissues, including pancreas, heart or even brain. This gut secreted hormone plays a potent insulinotropic activity and an important role in maintaining glucose homeostasis. Furthermore, growing evidences suggest the occurrence of several commonalities between T2D and neurodegenerative diseases, insulin resistance being pointed as a main cause for cognitive decline and increased risk to develop dementia. In this regard, it has also been suggested that stimulation of brain insulin signaling may have a protective role against cognitive deficits. As GLP-1 receptors (GLP-1R) are expressed throughout the central nervous system and GLP-1 may cross the blood-brain-barrier, an emerging hypothesis suggests that they may be promising therapeutic targets against brain dysfunctional insulin signaling-related pathologies. Importantly, GLP-1 actions depend not only on the direct effect mediated by its receptor activation, but also on the gut-brain axis involving an exchange of signals between both tissues via the vagal nerve, thereby regulating numerous physiological functions (e.g., energy homeostasis, glucose-dependent insulin secretion, as well as appetite and weight control). Amongst the incretin/GLP-1 mimetics class of anti-T2D drugs with an increasingly described neuroprotective potential, the already marketed liraglutide emerged as a GLP-1R agonist highly resistant to dipeptidyl peptidase-4 degradation (thereby having an increased half-life) and whose systemic GLP-1R activity is comparable to that of native GLP-1. Importantly, several preclinical studies showed anti-apoptotic, anti-inflammatory, anti-oxidant and neuroprotective effects of liraglutide against T2D, stroke and Alzheimer disease (AD), whereas several clinical trials, demonstrated some surprising benefits of liraglutide on weight loss, microglia inhibition, behavior and cognition, and in AD biomarkers. Herein, we discuss the GLP-1 action through the gut-brain axis, the hormone's regulation of some autonomic functions and liraglutide's neuroprotective potential.","['Alzheimer disease', 'Brain', 'Glucagon-like peptide-1', 'Gut', 'Insulin', 'Liraglutide', 'Neuroprotection', 'Type 2 diabetes']",World journal of diabetes,2015-07-02,"[{'lastname': 'Candeias', 'firstname': 'Emanuel Monteiro', 'initials': 'EM', 'affiliation': 'Emanuel Monteiro Candeias, Inês Carolina Sebastião, Susana Maria Cardoso, Sónia Correia Correia, Cristina Isabel Carvalho, Ana Isabel Plácido, Maria Sancha Santos, Catarina Resende Oliveira, Paula Isabel Moreira, Ana Isabel Duarte, CNC - Center for Neuroscience and Cell Biology, Rua Larga, Faculty of Medicine (1 Floor), University of Coimbra, 3004-517 Coimbra, Portugal.'}, {'lastname': 'Sebastião', 'firstname': 'Inês Carolina', 'initials': 'IC', 'affiliation': 'Emanuel Monteiro Candeias, Inês Carolina Sebastião, Susana Maria Cardoso, Sónia Correia Correia, Cristina Isabel Carvalho, Ana Isabel Plácido, Maria Sancha Santos, Catarina Resende Oliveira, Paula Isabel Moreira, Ana Isabel Duarte, CNC - Center for Neuroscience and Cell Biology, Rua Larga, Faculty of Medicine (1 Floor), University of Coimbra, 3004-517 Coimbra, Portugal.'}, {'lastname': 'Cardoso', 'firstname': 'Susana Maria', 'initials': 'SM', 'affiliation': 'Emanuel Monteiro Candeias, Inês Carolina Sebastião, Susana Maria Cardoso, Sónia Correia Correia, Cristina Isabel Carvalho, Ana Isabel Plácido, Maria Sancha Santos, Catarina Resende Oliveira, Paula Isabel Moreira, Ana Isabel Duarte, CNC - Center for Neuroscience and Cell Biology, Rua Larga, Faculty of Medicine (1 Floor), University of Coimbra, 3004-517 Coimbra, Portugal.'}, {'lastname': 'Correia', 'firstname': 'Sónia Catarina', 'initials': 'SC', 'affiliation': 'Emanuel Monteiro Candeias, Inês Carolina Sebastião, Susana Maria Cardoso, Sónia Correia Correia, Cristina Isabel Carvalho, Ana Isabel Plácido, Maria Sancha Santos, Catarina Resende Oliveira, Paula Isabel Moreira, Ana Isabel Duarte, CNC - Center for Neuroscience and Cell Biology, Rua Larga, Faculty of Medicine (1 Floor), University of Coimbra, 3004-517 Coimbra, Portugal.'}, {'lastname': 'Carvalho', 'firstname': 'Cristina Isabel', 'initials': 'CI', 'affiliation': 'Emanuel Monteiro Candeias, Inês Carolina Sebastião, Susana Maria Cardoso, Sónia Correia Correia, Cristina Isabel Carvalho, Ana Isabel Plácido, Maria Sancha Santos, Catarina Resende Oliveira, Paula Isabel Moreira, Ana Isabel Duarte, CNC - Center for Neuroscience and Cell Biology, Rua Larga, Faculty of Medicine (1 Floor), University of Coimbra, 3004-517 Coimbra, Portugal.'}, {'lastname': 'Plácido', 'firstname': 'Ana Isabel', 'initials': 'AI', 'affiliation': 'Emanuel Monteiro Candeias, Inês Carolina Sebastião, Susana Maria Cardoso, Sónia Correia Correia, Cristina Isabel Carvalho, Ana Isabel Plácido, Maria Sancha Santos, Catarina Resende Oliveira, Paula Isabel Moreira, Ana Isabel Duarte, CNC - Center for Neuroscience and Cell Biology, Rua Larga, Faculty of Medicine (1 Floor), University of Coimbra, 3004-517 Coimbra, Portugal.'}, {'lastname': 'Santos', 'firstname': 'Maria Sancha', 'initials': 'MS', 'affiliation': 'Emanuel Monteiro Candeias, Inês Carolina Sebastião, Susana Maria Cardoso, Sónia Correia Correia, Cristina Isabel Carvalho, Ana Isabel Plácido, Maria Sancha Santos, Catarina Resende Oliveira, Paula Isabel Moreira, Ana Isabel Duarte, CNC - Center for Neuroscience and Cell Biology, Rua Larga, Faculty of Medicine (1 Floor), University of Coimbra, 3004-517 Coimbra, Portugal.'}, {'lastname': 'Oliveira', 'firstname': 'Catarina Resende', 'initials': 'CR', 'affiliation': 'Emanuel Monteiro Candeias, Inês Carolina Sebastião, Susana Maria Cardoso, Sónia Correia Correia, Cristina Isabel Carvalho, Ana Isabel Plácido, Maria Sancha Santos, Catarina Resende Oliveira, Paula Isabel Moreira, Ana Isabel Duarte, CNC - Center for Neuroscience and Cell Biology, Rua Larga, Faculty of Medicine (1 Floor), University of Coimbra, 3004-517 Coimbra, Portugal.'}, {'lastname': 'Moreira', 'firstname': 'Paula Isabel', 'initials': 'PI', 'affiliation': 'Emanuel Monteiro Candeias, Inês Carolina Sebastião, Susana Maria Cardoso, Sónia Correia Correia, Cristina Isabel Carvalho, Ana Isabel Plácido, Maria Sancha Santos, Catarina Resende Oliveira, Paula Isabel Moreira, Ana Isabel Duarte, CNC - Center for Neuroscience and Cell Biology, Rua Larga, Faculty of Medicine (1 Floor), University of Coimbra, 3004-517 Coimbra, Portugal.'}, {'lastname': 'Duarte', 'firstname': 'Ana Isabel', 'initials': 'AI', 'affiliation': 'Emanuel Monteiro Candeias, Inês Carolina Sebastião, Susana Maria Cardoso, Sónia Correia Correia, Cristina Isabel Carvalho, Ana Isabel Plácido, Maria Sancha Santos, Catarina Resende Oliveira, Paula Isabel Moreira, Ana Isabel Duarte, CNC - Center for Neuroscience and Cell Biology, Rua Larga, Faculty of Medicine (1 Floor), University of Coimbra, 3004-517 Coimbra, Portugal.'}]",,,,,10.4239/wjd.v6.i6.807,<Element 'PubmedArticle' at 0x7f05da2b2ea0>
487,26086345,Endocannabinoids drive the acquisition of an alternative phenotype in microglia.,"The ability of microglia to acquire diverse states of activation, or phenotypes, reflects different features that are determinant for their contribution to homeostasis in the adult CNS, and their activity in neuroinflammation, repair or immunomodulation. Despite the widely reported immunomodulatory effects of cannabinoids in both the peripheral immune system and the CNS, less is known about how the endocannabinoid signaling system (eCBSS) influence the microglial phenotype. The general aim of the present study was to investigate the role of endocannabinoids in microglia polarization by using microglia cell cultures. We show that alternative microglia (M2a) and acquired deactivated microglia (M2c) exhibit changes in the eCB machinery that favor the selective synthesis of 2-AG and AEA, respectively. Once released, these eCBs might be able to act through CB1 and/or CB2 receptors in order to influence the acquisition of an M2 phenotype. We present three lines of evidence that the eCBSS is critical for the acquisition of the M2 phenotype: (i) M2 polarization occurs on exposure to the two main endocannabinoids 2-AG and AEA in microglia cultures; (ii) cannabinoid receptor antagonists block M2 polarization; and (iii) M2 polarization is dampened in microglia from CB2 receptor knockout mice. Taken together, these results indicate the interest of eCBSS for the regulation of microglial activation in normal and pathological conditions.","['2-AG', 'AEA', 'CB2 receptors', 'M2 polarization', 'Microglia']","Brain, behavior, and immunity",2015-06-19,"[{'lastname': 'Mecha', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Department of Functional and Systems Neurobiology, Neuroimmunology Group, Instituto Cajal, CSIC, Madrid, Spain. Electronic address: miriammecha@cajal.csic.es.'}, {'lastname': 'Feliú', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Department of Functional and Systems Neurobiology, Neuroimmunology Group, Instituto Cajal, CSIC, Madrid, Spain.'}, {'lastname': 'Carrillo-Salinas', 'firstname': 'F J', 'initials': 'FJ', 'affiliation': 'Department of Functional and Systems Neurobiology, Neuroimmunology Group, Instituto Cajal, CSIC, Madrid, Spain.'}, {'lastname': 'Rueda-Zubiaurre', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Department of Organic Chemistry, Chemistry Faculty, University Complutense of Madrid, Spain.'}, {'lastname': 'Ortega-Gutiérrez', 'firstname': 'S', 'initials': 'S', 'affiliation': 'Department of Organic Chemistry, Chemistry Faculty, University Complutense of Madrid, Spain.'}, {'lastname': 'de Sola', 'firstname': 'R García', 'initials': 'RG', 'affiliation': 'Clinical Neurophysiology Service, Hospital Universitario la Princesa, Madrid, Spain.'}, {'lastname': 'Guaza', 'firstname': 'C', 'initials': 'C', 'affiliation': 'Department of Functional and Systems Neurobiology, Neuroimmunology Group, Instituto Cajal, CSIC, Madrid, Spain.'}]",,,,Copyright © 2015 Elsevier Inc. All rights reserved.,10.1016/j.bbi.2015.06.002,<Element 'PubmedArticle' at 0x7f05da2946d0>
488,"26084692
18779436
2903678
19215431
24559669
214310
20638485
1363284
22152301
22843099
21150913
19259805
25620630
17106878
11426226
11544994
24343120
24958505
21576930
16729874
20128808
18472227
25655919
6289182
23047490
2203997
24462092
8074205
11756501
22106405
16141072
15356186
2901438
22323719
9711980
9673825
3015330
19723538
11985533
23458610
23486953
24508821
25427952
1593089
16009403
9500964
24227742
16788004
7679686
16211561
10969042
25834057
11259646
17276138
19342823
3399033
9043813
3766770
9043812
21624366
22362508
20868737
4325865
21394088
24687998
18086951
22893724
22922351
18697992
22661512
20200044
17046695
16760914
23840911
17207662
15141377
23139827
9650837
17143608
23150519
7768295
12515751
8663175
7028209
7477267
3555708
7004736
6763166
2352643
25217656
16177072
3419518
8741760
8738151
8760087
1610361
9734405
19748527
15640278
21527731
9272647
22016534
8843599
20628203
20651292
9344632
12832527
15681656
19118600
23424239
22526255
24246383
8103642
12388241
11357940
23535460
21684291
16429122
19038235
9096120
12933337
24256254
25601869
12676175
6324205
8001672
22454480
18190523
25520374
17045572
11481032
18243793
12045255
11994753
21797869
17519130
21967900
25446442
19703969
19948188
10562346
18443753
6100613
25287860
14766975
17804587
22696576
23303942
11098118
22466658
23583926
3410745
25930681
8785064
22827472
6283434
6289966
18310257
23165303
1599461
25539713
7644700
9729407
20689062
23547238
16109805
20547972
25302502
19566837
16027241
23791197
3828827
23691105
21952934
22257799
25546497
23375650
3201232
3480523
3039401
7927641
1881896
7451682
6132586
6109264
20163518
8726692
11306195
22128866
22201683
3605376
23545209
1858948
4075168
880623
25052203
1469631
19339593
18703386
18722165
18948166
25260613
22493069
17715340
23754618
23812385
21719524
9790946
18424635
2455902
15854742
8876246
23319541
21536990",Role of neurons and glia in the CNS actions of the renin-angiotensin system in cardiovascular control.,"Despite tremendous research efforts, hypertension remains an epidemic health concern, leading often to the development of cardiovascular disease. It is well established that in many instances, the brain plays an important role in the onset and progression of hypertension via activation of the sympathetic nervous system. Further, the activity of the renin-angiotensin system (RAS) and of glial cell-mediated proinflammatory processes have independently been linked to this neural control and are, as a consequence, both attractive targets for the development of antihypertensive therapeutics. Although it is clear that the predominant effector peptide of the RAS, ANG II, activates its type-1 receptor on neurons to mediate some of its hypertensive actions, additional nuances of this brain RAS control of blood pressure are constantly being uncovered. One of these complexities is that the RAS is now thought to impact cardiovascular control, in part, via facilitating a glial cell-dependent proinflammatory milieu within cardiovascular control centers. Another complexity is that the newly characterized antihypertensive limbs of the RAS are now recognized to, in many cases, antagonize the prohypertensive ANG II type 1 receptor (AT1R)-mediated effects. That being said, the mechanism by which the RAS, glia, and neurons interact to regulate blood pressure is an active area of ongoing research. Here, we review the current understanding of these interactions and present a hypothetical model of how these exchanges may ultimately regulate cardiovascular function.","['angiotensin II', 'astrocyte', 'microglia', 'neurogenic hypertension', 'renin']","American journal of physiology. Regulatory, integrative and comparative physiology",2015-06-19,"[{'lastname': 'de Kloet', 'firstname': 'Annette D', 'initials': 'AD', 'affiliation': 'Department of Physiology and Functional Genomics, and McKnight Brain Institute, University of Florida College of Medicine, Gainesville, Florida; and.'}, {'lastname': 'Liu', 'firstname': 'Meng', 'initials': 'M', 'affiliation': 'Department of Physiology and Functional Genomics, and McKnight Brain Institute, University of Florida College of Medicine, Gainesville, Florida; and.'}, {'lastname': 'Rodríguez', 'firstname': 'Vermalí', 'initials': 'V', 'affiliation': 'Department of Physiology and Functional Genomics, and McKnight Brain Institute, University of Florida College of Medicine, Gainesville, Florida; and.'}, {'lastname': 'Krause', 'firstname': 'Eric G', 'initials': 'EG', 'affiliation': 'Department of Pharmacodynamics, University of Florida College of Pharmacy, Gainesville, Florida.'}, {'lastname': 'Sumners', 'firstname': 'Colin', 'initials': 'C', 'affiliation': 'Department of Physiology and Functional Genomics, and McKnight Brain Institute, University of Florida College of Medicine, Gainesville, Florida; and csumners@ufl.edu.'}]",,,,Copyright © 2015 the American Physiological Society.,10.1152/ajpregu.00078.2015,<Element 'PubmedArticle' at 0x7f05da221ef0>
489,"26056339
19710497
20101001
16760914
12492778
20547972
24366083
19246475
17140851
20966214
24742461
23023392
24162652
24962261
21527731
25047355
24360280
10221782
12427977
16322748
15630444
24647951
23525041
12535154
24966471
23575851
19476542
23686171",Microglia participate in neurogenic regulation of hypertension.,"Hypertension is associated with neuroinflammation and increased sympathetic tone. Interference with neuroinflammation by an anti-inflammatory reagent or overexpression of interleukin-10 in the brain was found to attenuate hypertension. However, the cellular mechanism of neuroinflammation, as well as its impact on neurogenic regulation of blood pressure, is unclear. Here, we found that hypertension, induced by either angiotensin II or l-N(G)-nitro-l-arginine methyl ester, is accompanied by microglial activation as manifested by microgliosis and proinflammatory cytokine upregulation. Targeted depletion of microglia significantly attenuated neuroinflammation, glutamate receptor expression in the paraventricular nucleus, plasma vasopressin level, kidney norepinephrine concentration, and blood pressure. Furthermore, when microglia were preactivated and transferred into the brains of normotensive mice, there was a significantly prolonged pressor response to intracerebroventricular injection of angiotensin II, and inactivation of microglia eliminated these effects. These data demonstrate that microglia, the resident immune cells in the brain, are the major cellular factors in mediating neuroinflammation and modulating neuronal excitation, which contributes to the elevated blood pressure.","['angiotensin', 'hypertension', 'microglia', 'neuroimmunomodulation']","Hypertension (Dallas, Tex. : 1979)",2015-06-10,"[{'lastname': 'Shen', 'firstname': 'Xiao Z', 'initials': 'XZ', 'affiliation': 'From the Departments of Biomedical Sciences (X.Z.S., K.H.S., K.E.B.), Neurology (Y.L., L.L., P.L., P.S.), and Pathology and Laboratory Medicine (X.Z.S., K.E.B.), Cedars-Sinai Medical Center, Los Angeles, CA.'}, {'lastname': 'Li', 'firstname': 'You', 'initials': 'Y', 'affiliation': 'From the Departments of Biomedical Sciences (X.Z.S., K.H.S., K.E.B.), Neurology (Y.L., L.L., P.L., P.S.), and Pathology and Laboratory Medicine (X.Z.S., K.E.B.), Cedars-Sinai Medical Center, Los Angeles, CA.'}, {'lastname': 'Li', 'firstname': 'Liang', 'initials': 'L', 'affiliation': 'From the Departments of Biomedical Sciences (X.Z.S., K.H.S., K.E.B.), Neurology (Y.L., L.L., P.L., P.S.), and Pathology and Laboratory Medicine (X.Z.S., K.E.B.), Cedars-Sinai Medical Center, Los Angeles, CA.'}, {'lastname': 'Shah', 'firstname': 'Kandarp H', 'initials': 'KH', 'affiliation': 'From the Departments of Biomedical Sciences (X.Z.S., K.H.S., K.E.B.), Neurology (Y.L., L.L., P.L., P.S.), and Pathology and Laboratory Medicine (X.Z.S., K.E.B.), Cedars-Sinai Medical Center, Los Angeles, CA.'}, {'lastname': 'Bernstein', 'firstname': 'Kenneth E', 'initials': 'KE', 'affiliation': 'From the Departments of Biomedical Sciences (X.Z.S., K.H.S., K.E.B.), Neurology (Y.L., L.L., P.L., P.S.), and Pathology and Laboratory Medicine (X.Z.S., K.E.B.), Cedars-Sinai Medical Center, Los Angeles, CA.'}, {'lastname': 'Lyden', 'firstname': 'Patrick', 'initials': 'P', 'affiliation': 'From the Departments of Biomedical Sciences (X.Z.S., K.H.S., K.E.B.), Neurology (Y.L., L.L., P.L., P.S.), and Pathology and Laboratory Medicine (X.Z.S., K.E.B.), Cedars-Sinai Medical Center, Los Angeles, CA.'}, {'lastname': 'Shi', 'firstname': 'Peng', 'initials': 'P', 'affiliation': 'From the Departments of Biomedical Sciences (X.Z.S., K.H.S., K.E.B.), Neurology (Y.L., L.L., P.L., P.S.), and Pathology and Laboratory Medicine (X.Z.S., K.E.B.), Cedars-Sinai Medical Center, Los Angeles, CA. Peng.Shi@cshs.org.'}]",,,,"© 2015 American Heart Association, Inc.",10.1161/HYPERTENSIONAHA.115.05333,<Element 'PubmedArticle' at 0x7f05da1c0770>
490,26031312,Allosteric modulation of sigma-1 receptors by SKF83959 inhibits microglia-mediated inflammation.,"Recent studies have shown that sigma-1 receptor orthodox agonists can inhibit neuroinflammation. SKF83959 (3-methyl-6-chloro-7,8-hydroxy-1-[3-methylphenyl]-2,3,4,5-tetrahydro-1H-3-benzazepine), an atypical dopamine receptor-1 agonist, has been recently identified as a potent allosteric modulator of sigma-1 receptor. Here, we investigated the anti-inflammatory effects of SKF83959 in lipopolysaccharide (LPS)-stimulated BV2 microglia. Our results indicated that SKF83959 significantly suppressed the expression/release of the pro-inflammatory mediators, such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), inducible nitric oxide synthase (iNOS), and inhibited the generation of reactive oxygen species. All of these responses were blocked by selective sigma-1 receptor antagonists (BD1047 or BD1063) and by ketoconazole (an inhibitor of enzyme cytochrome c17 to inhibit the synthesis of endogenous dehydroepiandrosterone, DHEA). Additionally, we found that SKF83959 promoted the binding activity of DHEA with sigma-1 receptors, and enhanced the inhibitory effects of DHEA on LPS-induced microglia activation in a synergic manner. Furthermore, in a microglia-conditioned media system, SKF83959 inhibited the cytotoxicity of conditioned medium generated by LPS-activated microglia toward HT-22 neuroblastoma cells. Taken together, our study provides the first evidence that allosteric modulation of sigma-1 receptors by SKF83959 inhibits microglia-mediated inflammation. SKF83959 is a potent allosteric modulator of sigma-1 receptor. Our results indicated that SKF83959 enhanced the activity of endogenous dehydroepiandrosterone (DHEA) in a synergic manner, and inhibited the activation of BV2 microglia and the expression/release of the pro-inflammatory mediators, such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), inducible nitric oxide synthase (iNOS).","['SKF83959', 'allosteric modulation', 'dehydroepiandrosterone', 'microglia', 'neuroinflammation', 'sigma-1 receptor']",Journal of neurochemistry,2015-06-03,"[{'lastname': 'Wu', 'firstname': 'Zhuang', 'initials': 'Z', 'affiliation': 'Jiangsu Key laboratory of Translational Research and Therapy for Neuropsychiatric-disorders & Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, China.'}, {'lastname': 'Li', 'firstname': 'Linlang', 'initials': 'L', 'affiliation': 'Jiangsu Key laboratory of Translational Research and Therapy for Neuropsychiatric-disorders & Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, China.'}, {'lastname': 'Zheng', 'firstname': 'Long-Tai', 'initials': 'LT', 'affiliation': 'Jiangsu Key laboratory of Translational Research and Therapy for Neuropsychiatric-disorders & Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, China.'}, {'lastname': 'Xu', 'firstname': 'Zhihong', 'initials': 'Z', 'affiliation': 'Jiangsu Huayi Technology Co, Changshu, Jiangsu, China.'}, {'lastname': 'Guo', 'firstname': 'Lin', 'initials': 'L', 'affiliation': 'Jiangsu Key laboratory of Translational Research and Therapy for Neuropsychiatric-disorders & Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, China.'}, {'lastname': 'Zhen', 'firstname': 'Xuechu', 'initials': 'X', 'affiliation': 'Jiangsu Key laboratory of Translational Research and Therapy for Neuropsychiatric-disorders & Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, China.'}]",,,,© 2015 International Society for Neurochemistry.,10.1111/jnc.13182,<Element 'PubmedArticle' at 0x7f05da1d9d60>
491,"26029700
11007544
11373843
22570805
23882187
23529044
14651788
1278093
1553754
16739120
1572297
6276132
9294221
11404222
2394838
21303950
17962037
9460170
12060829
16702774
22138353
7925183
9777756
11861977
18217984
15500540
23288053
10805704
136041
22191960
10198280
11986682
21383777
21765985
1141955
1797872
1401246
5056979
9664219
11245686
16406011
18567604
7532272
9023076
9537838
14659995
18484101
3430576
21093964
1793176
6737468
3761363
17332058
6927643
1949040
11854140
15555679
3936093
9952425
9733190
10453052
9002997
12581879
8026323
2411494
15256491
9106469
7680668
17317780
7599532
11059815
649786
14659995
23644076
23422217
24487234
22549954
23988237
12356760
17408906
9664219
16648287
20879691
11803437
17628004
20458138
503191
7898308
8207437
12730956
2156867
8950100
9086583
22892247
8277006
14519490
12933695
19997993
18456449
21655286
9570788","Developmental neurotoxicity of 3,3',4,4'-tetrachloroazobenzene with thyroxine deficit: Sensitivity of glia and dentate granule neurons in the absence of behavioral changes.","Thyroid hormones (TH) regulate biological processes implicated in neurodevelopmental disorders and can be altered with environmental exposures. Developmental exposure to the dioxin-like compound, 3,3',4,4'-tetrachloroazobenzene (TCAB), induced a dose response deficit in serum T4 levels with no change in 3,5,3'- triiodothyronine or thyroid stimulating hormone. Female Sprague-Dawley rats were orally gavaged (corn oil, 0.1, 1.0, or 10 mg TCAB/kg/day) two weeks prior to cohabitation until post-partum day 3 and male offspring from post-natal day (PND)4-21. At PND21, the high dose showed a deficit in body weight gain. Conventional neuropathology detected no neuronal death, myelin disruption, or gliosis. Astrocytes displayed thinner and less complex processes at 1.0 and 10 mg/kg/day. At 10 mg/kg/day, microglia showed less complex processes, unbiased stereology detected fewer hippocampal CA1 pyramidal neurons and dentate granule neurons (GC) and Golgi staining of the cerebellum showed diminished Purkinje cell dendritic arbor. At PND150, normal maturation of GC number and Purkinje cell branching area was not observed in the 1.0 mg/kg/day dose group with a diminished number and branching suggestive of effects initiated during developmental exposure. No effects were observed on post-weaning behavioral assessments in control, 0.1 and 1.0mg/kg/day dose groups. The demonstrated sensitivity of hippocampal neurons and glial cells to TCAB and T4 deficit raises support for considering additional anatomical features of brain development in future DNT evaluations.","['Golgi Purkinje cells', 'astrocytes', 'dentate granule cells', 'developmental neurotoxicology', 'dioxin', 'glial fibrillary acidic protein', 'hippocampus', 'microglia', 'thyroid hormone']",Toxics,2015-06-02,"[{'lastname': 'Harry', 'firstname': 'G Jean', 'initials': 'GJ', 'affiliation': 'Neurotoxicology Group, National Toxicology Program Laboratory, NIEHS, RTP, NC.'}, {'lastname': 'Hooth', 'firstname': 'Michelle J', 'initials': 'MJ', 'affiliation': 'Division of the National Toxicology Program, NIEHS, RTP, NC.'}, {'lastname': 'Vallant', 'firstname': 'Molly', 'initials': 'M', 'affiliation': 'Division of the National Toxicology Program, NIEHS, RTP, NC.'}, {'lastname': 'Behl', 'firstname': 'Mamta', 'initials': 'M', 'affiliation': 'Division of the National Toxicology Program, NIEHS, RTP, NC.'}, {'lastname': 'Travlos', 'firstname': 'Gregory S', 'initials': 'GS', 'affiliation': 'Division of the National Toxicology Program, NIEHS, RTP, NC.'}, {'lastname': 'Howard', 'firstname': 'James L', 'initials': 'JL', 'affiliation': 'Howard Associates, RTP, NC.'}, {'lastname': 'Price', 'firstname': 'Catherine J', 'initials': 'CJ', 'affiliation': 'RTI International, RTP, NC.'}, {'lastname': 'McBride', 'firstname': 'Sandra', 'initials': 'S', 'affiliation': 'Social and Scientific Systems, Inc., Durham, NC.'}, {'lastname': 'Mervis', 'firstname': 'Ron', 'initials': 'R', 'affiliation': 'NeuroStructural Research Labs, Inc, Tampa, FL.'}, {'lastname': 'Mouton', 'firstname': 'Peter R', 'initials': 'PR', 'affiliation': 'Department of Pathology & Cell Biology, University of South Florida School of Medicine, Tampa, FL ; Stereology Resource Center, Tampa, FL.'}]",,,,,10.3390/toxics2030496,<Element 'PubmedArticle' at 0x7f05da16f180>
492,26021560,Inflammatory molecules in Frontotemporal Dementia: cerebrospinal fluid signature of progranulin mutation carriers.,"Mutations in progranulin gene (GRN) are one of the major causes of autosomal dominant Frontotemporal Lobar Degeneration (FTLD). Progranulin displays anti-inflammatory properties and is likely a ligand of Tumor Necrosis Factor (TNF) receptor 2, expressed on microglia. A few cytokines and chemokines are altered in cerebrospinal fluid (CSF) from patients with sporadic FTLD, whereas no information is available in familial cases. We evaluated, through BioPlex, levels of 27 inflammatory molecules, including cytokines, chemokines, and related receptors, in CSF and matched serum, from FTLD patients carrying GRN mutations as compared with sporadic FTLD with no GRN mutations and controls. Mean±SD Monocyte Chemoattractant Protein-1 (MCP-1) levels were significantly increased in CSF from sporadic FTLD patients as compared with controls (334.27±151.5 versus 159.7±49pg/ml; P⩽0.05). In GRN mutation carriers versus controls, CSF levels of MCP-1 were unchanged, whereas Interferon-γ-inducible protein-10 (IP-10) levels were increased (809.17±240.0 versus 436.61±202.5pg/ml; P=0.012). In the same group, TNFα and Interleukin (IL)-15 levels were decreased (3.18±1.41 versus 35.68±30.5pg/ml; P=0.013 and 9.34±5.54 versus 19.15±10.03pg/ml; P=0.023, respectively). Conversely, Regulated upon Activation, Normal T-cell Expressed, and Secreted (RANTES) levels were decreased in patients, with or without mutations, as compared with controls (4.63±3.30 and 2.58±20 versus 87.57±70pg/ml, respectively; P<0.05). Moreover, IP-10, IL-15 and RANTES CSF levels were not influenced by age, whereas MCP-1 levels increased with age (ρ=0.48; P=0.007). In conclusion, inflammatory de-regulation was observed in both sporadic FTLD and GRN carriers compared to controls, with a specific inflammatory profile for the latter group.","['Cerebrospinal fluid', 'Chemokines', 'Cytokines', 'Frontotemporal Dementia (FTD)', 'Frontotemporal Lobar Degeneration (FTLD)', 'Inflammation', 'Pick dementia', 'Progranulin (GRN)']","Brain, behavior, and immunity",2015-05-30,"[{'lastname': 'Galimberti', 'firstname': 'D', 'initials': 'D', 'affiliation': 'Department of Pathophysiology and Transplantation, University of Milan, Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Via F. Sforza 35, 20122 Milan, Italy. Electronic address: daniela.galimberti@unimi.it.'}, {'lastname': 'Bonsi', 'firstname': 'R', 'initials': 'R', 'affiliation': 'Department of Pathophysiology and Transplantation, University of Milan, Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Via F. Sforza 35, 20122 Milan, Italy.'}, {'lastname': 'Fenoglio', 'firstname': 'C', 'initials': 'C', 'affiliation': 'Department of Pathophysiology and Transplantation, University of Milan, Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Via F. Sforza 35, 20122 Milan, Italy.'}, {'lastname': 'Serpente', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Department of Pathophysiology and Transplantation, University of Milan, Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Via F. Sforza 35, 20122 Milan, Italy.'}, {'lastname': 'Cioffi', 'firstname': 'S M G', 'initials': 'SM', 'affiliation': 'Department of Pathophysiology and Transplantation, University of Milan, Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Via F. Sforza 35, 20122 Milan, Italy.'}, {'lastname': 'Fumagalli', 'firstname': 'G', 'initials': 'G', 'affiliation': 'Department of Pathophysiology and Transplantation, University of Milan, Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Via F. Sforza 35, 20122 Milan, Italy.'}, {'lastname': 'Arighi', 'firstname': 'A', 'initials': 'A', 'affiliation': 'Department of Pathophysiology and Transplantation, University of Milan, Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Via F. Sforza 35, 20122 Milan, Italy.'}, {'lastname': 'Ghezzi', 'firstname': 'L', 'initials': 'L', 'affiliation': 'Department of Pathophysiology and Transplantation, University of Milan, Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Via F. Sforza 35, 20122 Milan, Italy.'}, {'lastname': 'Arcaro', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Department of Pathophysiology and Transplantation, University of Milan, Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Via F. Sforza 35, 20122 Milan, Italy.'}, {'lastname': 'Mercurio', 'firstname': 'M', 'initials': 'M', 'affiliation': 'Department of Pathophysiology and Transplantation, University of Milan, Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Via F. Sforza 35, 20122 Milan, Italy.'}, {'lastname': 'Rotondo', 'firstname': 'E', 'initials': 'E', 'affiliation': 'Department of Pathophysiology and Transplantation, University of Milan, Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Via F. Sforza 35, 20122 Milan, Italy.'}, {'lastname': 'Scarpini', 'firstname': 'E', 'initials': 'E', 'affiliation': 'Department of Pathophysiology and Transplantation, University of Milan, Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Via F. Sforza 35, 20122 Milan, Italy.'}]",,,,Copyright © 2015 Elsevier Inc. All rights reserved.,10.1016/j.bbi.2015.05.006,<Element 'PubmedArticle' at 0x7f05da199680>
493,"26009773
10322493
8812295
9287225
15009653
26009774
9034833
19020082
9246951
11595667
3047413
23278277
19460859
9107052
15062980
8320266
12106332
8860235
12676146
8843599
10616913
12379902
19339593
23312512
3116087
9843148
15446581
18808689
23717262
15305983
9179382
9582261
12752784
18783922
23298414
14523090
14744251
2765923
6248568
24421756
1431889
3759657
2393389
3339434
22539260
21518343
11389473
19171180
15934945
23300470
10839371
18438927
18410547
22214786
21345196
21145890
11553296
23791959
17315033
24919967
26009770
25051502
25135966
25135971
10651854
238229",Regulation of neuronal excitability by release of proteins from glial cells.,"Effects of glial cells on electrical isolation and shaping of synaptic transmission between neurons have been extensively studied. Here we present evidence that the release of proteins from astrocytes as well as microglia may regulate voltage-activated Na(+) currents in neurons, thereby increasing excitability and speed of transmission in neurons kept at distance from each other by specialized glial cells. As a first example, we show that basic fibroblast growth factor and neurotrophin-3, which are released from astrocytes by exposure to thyroid hormone, influence each other to enhance Na(+) current density in cultured hippocampal neurons. As a second example, we show that the presence of microglia in hippocampal cultures can upregulate Na(+) current density. The effect can be boosted by lipopolysaccharides, bacterial membrane-derived stimulators of microglial activation. Comparable effects are induced by the exposure of neuron-enriched hippocampal cultures to tumour necrosis factor-α, which is released from stimulated microglia. Taken together, our findings suggest that release of proteins from various types of glial cells can alter neuronal excitability over a time course of several days. This explains changes in neuronal excitability occurring in states of thyroid hormone imbalance and possibly also in seizures triggered by infectious diseases.","['fibroblast growth factor-2', 'microglia', 'neurotrophin-3', 'thyroid hormone', 'tumour necrosis factor-α', 'voltage-activated sodium currents']","Philosophical transactions of the Royal Society of London. Series B, Biological sciences",2015-05-27,"[{'lastname': 'Igelhorst', 'firstname': 'Birte A', 'initials': 'BA', 'affiliation': 'Department of Biochemistry II, Ruhr University Bochum, Universitätsstraße 150, Bochum 44780, Germany.'}, {'lastname': 'Niederkinkhaus', 'firstname': 'Vanessa', 'initials': 'V', 'affiliation': 'Department of Biochemistry II, Ruhr University Bochum, Universitätsstraße 150, Bochum 44780, Germany International Graduate School for Neuroscience, Ruhr University Bochum, Universitätsstraße 150, Bochum 44780, Germany.'}, {'lastname': 'Karus', 'firstname': 'Claudia', 'initials': 'C', 'affiliation': 'Department of Biochemistry II, Ruhr University Bochum, Universitätsstraße 150, Bochum 44780, Germany.'}, {'lastname': 'Lange', 'firstname': 'Maren D', 'initials': 'MD', 'affiliation': 'Department of Biochemistry II, Ruhr University Bochum, Universitätsstraße 150, Bochum 44780, Germany.'}, {'lastname': 'Dietzel', 'firstname': 'Irmgard D', 'initials': 'ID', 'affiliation': 'Department of Biochemistry II, Ruhr University Bochum, Universitätsstraße 150, Bochum 44780, Germany irmgard.d.dietzel-meyer@rub.de.'}]",,,,© 2015 The Author(s) Published by the Royal Society. All rights reserved.,"10.1098/rstb.2014.0194
10.1016/S0166-2236(98)01349-6
10.1006/frne.1996.0005
10.1126/science.277.5332.1684
10.1046/j.1471-4159.2003.02301.x
10.1098/rstb.2014.0195
10.1002/(SICI)1098-1136(199702)19:2<171::AID-GLIA8>3.0.CO;2-3
10.1073/pnas.0803464105
10.1677/joe.0.1540167
10.1002/jnr.490200102
10.1111/jnc.12087
10.1210/me.2009-0132
10.1098/rspb.1997.0053
10.1016/j.neuroscience.2004.01.047
10.1083/jcb.122.2.443
10.1111/j.1460-9568.1992.tb00896.x
10.1007/BF02736783
10.1016/S0306-4522(02)00814-X
10.1016/0166-2236(96)10049-7
10.1016/S0168-0102(99)00071-1
10.1002/glia.10161
10.1523/JNEUROSCI.4363-08.2009
10.1016/j.neuron.2012.12.023
10.1002/(SICI)1097-4547(19981201)54:5<574::AID-JNR2>3.0.CO;2-0
10.1111/j.1750-3639.2004.tb00063.x
10.1186/1742-2094-5-39
10.3389/fncel.2013.00065
10.1111/j.1365-2990.2003.00546.x
10.1038/sj.bjp.0701148
10.1006/exnr.1998.6797
10.1046/j.1460-9568.2003.02626.x
10.1016/j.eplepsyres.2008.07.018
10.1016/j.tins.2012.11.008
10.1146/annurev.pharmtox.44.101802.121627
10.1016/0006-8993(89)90144-3
10.1083/jcb.85.3.890
10.3389/fncel.2013.00277
10.1111/j.1471-4159.1992.tb10085.x
10.7164/antibiotics.39.1059
10.1016/0006-291X(90)91369-4
10.1093/brain/aws090
10.1111/j.1469-8749.2011.03928.x
10.1038/35077553
10.1016/j.neuroscience.2008.12.063
10.1111/j.1471-4159.2005.03118.x
10.1371/journal.pgen.1003172
10.1016/S0896-6273(00)81185-X
10.1002/jnr.21685
10.1111/j.1365-2265.2008.03267.x
10.1016/j.yfrne.2011.12.002
10.1186/1744-8069-7-16
10.1016/j.expneurol.2010.11.017
10.1046/j.0953-816x.2001.01661.x
10.1016/j.neuropharm.2013.05.043
10.1038/ncpendmet0424
10.1093/brain/awu140
10.1098/rstb.2014.0191
10.1016/j.jmb.2014.07.012
10.1098/rstb.2013.0505
10.1098/rstb.2013.0510
10.1046/j.1460-9568.2000.00871.x
10.1098/rstb.1975.0010
10.5772/48310",<Element 'PubmedArticle' at 0x7f05da12c090>
494,"25989524
22258943
11805601
23161735
15590148
23508337
23516432
23507938
17548571
24643079
24826969
23860568
7250287
2278545
22020592
19559699
11835756
23083733
22293983
22761686
15006675
15717009
21424941
17618980
23100450
12137616
10487132
10383635
20694004
23124261
21437247
22641787
15821747
20468054
22836145
19185913
16506468
18618653
12533578
7054403
21611834
3533279
7131067
9291100
17662717
24154617
24790202
18799667
24480947
22266542
11086982
22378886
12177207
21304420
14507967
8855329
22868200
18192022
19470644
17456007
19459038
18846097
20091771
16689667","In vivo two-photon imaging of axonal dieback, blood flow, and calcium influx with methylprednisolone therapy after spinal cord injury.","Severe spinal cord injury (SCI) can cause neurological dysfunction and paralysis. However, the early dynamic changes of neurons and their surrounding environment after SCI are poorly understood. Although methylprednisolone (MP) is currently the standard therapeutic agent for treating SCI, its efficacy remains controversial. The purpose of this project was to investigate the early dynamic changes and MP's efficacy on axonal damage, blood flow, and calcium influx into axons in a mouse SCI model. YFP H-line and Thy1-GCaMP transgenic mice were used in this study. Two-photon microscopy was used for imaging of axonal dieback, blood flow, and calcium influx post-injury. We found that MP treatment attenuated progressive damage of axons, increased blood flow, and reduced calcium influx post-injury. Furthermore, microglia/macrophages accumulated in the lesion site after SCI and expressed the proinflammatory mediators iNOS, MCP-1 and IL-1β. MP treatment markedly inhibited the accumulation of microglia/macrophages and reduced the expression of the proinflammatory mediators. MP treatment also improved the recovery of behavioral function post-injury. These findings suggest that MP exerts a neuroprotective effect on SCI treatment by attenuating progressive damage of axons, increasing blood flow, reducing calcium influx, and inhibiting the accumulation of microglia/macrophages after SCI.",[],Scientific reports,2015-05-20,"[{'lastname': 'Tang', 'firstname': 'Peifu', 'initials': 'P', 'affiliation': ""Department of Orthopedics, the General Hospital of Chinese People's Liberation Army, Beijing, China, 100853.""}, {'lastname': 'Zhang', 'firstname': 'Yiling', 'initials': 'Y', 'affiliation': ""1] Department of Orthopedics, the General Hospital of Chinese People's Liberation Army, Beijing, China, 100853 [2] Key Laboratory of Chemical Genomics, Shenzhen Graduate School, Peking University, Shenzhen, China, 518055.""}, {'lastname': 'Chen', 'firstname': 'Chao', 'initials': 'C', 'affiliation': ""1] Department of Orthopedics, the General Hospital of Chinese People's Liberation Army, Beijing, China, 100853 [2] Key Laboratory of Chemical Genomics, Shenzhen Graduate School, Peking University, Shenzhen, China, 518055.""}, {'lastname': 'Ji', 'firstname': 'Xinran', 'initials': 'X', 'affiliation': ""Department of Orthopedics, the General Hospital of Chinese People's Liberation Army, Beijing, China, 100853.""}, {'lastname': 'Ju', 'firstname': 'Furong', 'initials': 'F', 'affiliation': 'School of Life Sciences, Lanzhou University, Lanzhou, China, 73000.'}, {'lastname': 'Liu', 'firstname': 'Xingyu', 'initials': 'X', 'affiliation': 'Beijing YouAn Hospital, Capital Medical University, Beijing, China, 100069.'}, {'lastname': 'Gan', 'firstname': 'Wen-Biao', 'initials': 'WB', 'affiliation': '1] Key Laboratory of Chemical Genomics, Shenzhen Graduate School, Peking University, Shenzhen, China, 518055 [2] Skirball Institute, Department of Neuroscience and Physiology, New York University School of Medicine, New York, USA, 10016.'}, {'lastname': 'He', 'firstname': 'Zhigang', 'initials': 'Z', 'affiliation': ""F.M. Kirby Program in Neuroscience, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts, USA, 02115.""}, {'lastname': 'Zhang', 'firstname': 'Shengxiang', 'initials': 'S', 'affiliation': 'School of Life Sciences, Lanzhou University, Lanzhou, China, 73000.'}, {'lastname': 'Li', 'firstname': 'Wei', 'initials': 'W', 'affiliation': 'Key Laboratory of Chemical Genomics, Shenzhen Graduate School, Peking University, Shenzhen, China, 518055.'}, {'lastname': 'Zhang', 'firstname': 'Lihai', 'initials': 'L', 'affiliation': ""Department of Orthopedics, the General Hospital of Chinese People's Liberation Army, Beijing, China, 100853.""}]",,,,,10.1038/srep09691,<Element 'PubmedArticle' at 0x7f05da15c8b0>
495,25963415,Cannabinoid receptor 2 attenuates microglial accumulation and brain injury following germinal matrix hemorrhage via ERK dephosphorylation in vivo and in vitro.,"Microglia accumulation plays detrimental roles in the pathology of germinal matrix hemorrhage (GMH) in the immature preterm brain. However, the underlying mechanisms remain poorly defined. Here, we investigated the effects of a cannabinoid receptor 2 (CB2R) agonist on microglia proliferation and the possible involvement of the mitogen-activated protein kinase (MAPK) family pathway in a collagenase-induced GMH rat model and in thrombin-induced rat microglia cells. We demonstrated that activation of CB2R played a key role in attenuating brain edema, neuronal degeneration, microglial accumulation and the phosphorylated extracellular signal-regulated kinase (p-ERK) protein level 24 h following GMH. In vitro, Western blot analysis and immunostaining indicated that ERK and P38 phosphorylation levels in microglia stimulated by thrombin were decreased after JWH-133 (CB2R selective agonist) treatment in a concentration-dependent manner. Microglia proliferation (EDU + microglia) and inflammatory and oxidative stress responses were attenuated by UO126 (ERK pathway inhibitor) 24 h after thrombin stimulation, an activity that was prevented by AM630 (CB2R selective antagonist). Overall, these findings suggest that activation of the endocannabinoid system might attenuate inflammation-induced secondary brain injury after GMH in rats by reducing microglia accumulation through a mechanism involving ERK dephosphorylation. Enhancing CB2R activation is a potential treatment to slow down the course of GMH in preterm newborns.","['Cannabinoid receptor 2', 'MAPK pathway', 'Microglia', 'Neonatal stroke', 'Proliferation']",Neuropharmacology,2015-05-13,"[{'lastname': 'Tang', 'firstname': 'Jun', 'initials': 'J', 'affiliation': 'Department of Neurosurgery, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China.'}, {'lastname': 'Tao', 'firstname': 'Yihao', 'initials': 'Y', 'affiliation': 'Department of Neurosurgery, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China.'}, {'lastname': 'Tan', 'firstname': 'Liang', 'initials': 'L', 'affiliation': 'Department of Neurosurgery, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China.'}, {'lastname': 'Yang', 'firstname': 'Liming', 'initials': 'L', 'affiliation': 'Department of Neurosurgery, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China.'}, {'lastname': 'Niu', 'firstname': 'Yin', 'initials': 'Y', 'affiliation': 'Department of Neurosurgery, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China.'}, {'lastname': 'Chen', 'firstname': 'Qianwei', 'initials': 'Q', 'affiliation': 'Department of Neurosurgery, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China.'}, {'lastname': 'Yang', 'firstname': 'Yunfeng', 'initials': 'Y', 'affiliation': 'Department of Neurosurgery, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China.'}, {'lastname': 'Feng', 'firstname': 'Hua', 'initials': 'H', 'affiliation': 'Department of Neurosurgery, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China.'}, {'lastname': 'Chen', 'firstname': 'Zhi', 'initials': 'Z', 'affiliation': 'Department of Neurosurgery, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China. Electronic address: zhichen@tmmu.edu.cn.'}, {'lastname': 'Zhu', 'firstname': 'Gang', 'initials': 'G', 'affiliation': 'Department of Neurosurgery, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China. Electronic address: gangzhu6666@sina.com.'}]",,,,Copyright © 2015 Elsevier Ltd. All rights reserved.,10.1016/j.neuropharm.2015.04.028,<Element 'PubmedArticle' at 0x7f05da1032c0>
496,25951933,Apelin activates the expression of inflammatory cytokines in microglial BV2 cells via PI-3K/Akt and MEK/Erk pathways.,"This paper aims to observe the changes of the inflammatory cytokines in microglial BV2 cells stimulated by apelin, and investigate the mechanism of inflammatory cytokines secretion after apelin stimulation. Immunofluorescence and quantitative real-time PCR were performed to observe expression of TNF-α, IL-1β, IL-10, MIP-1α, and MCP-1 in BV2 cells. Western blot was used to investigate the expression of phosphorylation PI-3K/Akt and phosphorylation Erk signaling pathways in BV2 cells after stimulation by apelin. Furthermore, PI-3K/Akt inhibitor (LY294402) and Erk inhibitor (U0126) were used as antagonists to detect the secretion mechanisms of cytokines in BV2 cells stimulated by apelin. Exogenous recombinant apelin activated the expression of TNF-α, IL-1β, MCP-1 and MIP-1α in BV2 cells by the detection of fluorescence expression and mRNA. Apelin also unregulated the protein expression of p-PI-3K/Akt and p-Erk in BV2 cells induced by apelin. LY294002 and U0126 inhibited activation of p-PI-3K/Akt and p-Erk expression by Western blot and attenuated the expression of inflammation factors in BV2 cells by fluorescence staining. This study demonstrates that apelin is a potential activator of inflammation factors through the PI3K/Akt and Erk signaling pathway and is potential therapeutically relevant to inflammatory responses of microglia cells.",[],Science China. Life sciences,2015-05-09,"[{'lastname': 'Chen', 'firstname': 'Li', 'initials': 'L', 'affiliation': ""Department of Ophthalmology, People' Hospital, Peking University, Beijing, 100044, China.""}, {'lastname': 'Tao', 'firstname': 'Yong', 'initials': 'Y', 'affiliation': None}, {'lastname': 'Jiang', 'firstname': 'YanRong', 'initials': 'Y', 'affiliation': None}]",,,,,10.1007/s11427-015-4861-0,<Element 'PubmedArticle' at 0x7f05da113db0>
497,"25917865
14988386
12351732
12421344
15156148
22078126
23361913
16876166
8743964
4857634
20215437
21208470
10645971
22682109
24646669
19657334
8896803
19446075
23122051
25005482
1545126
1469384
9786979
9047268
22336348
23616747
656937
7440781
20980725
2606795
25385609
7217370
23244600
22521312
21068160
19805359
21143664
24871624
23407936
21490976
1887219
18195084
9047279
12480129
11903812
11241390
19497973
24471431
18567623
15831717
20538023
8807525
14432658
24752783
24791686
14607241
12097485
2394991
2331785
24337296
14525915
14986860
18498739
10792577
23386811
20887954
12052919
2859086
20471112
25770416
17412802
10668987
7571001
25262919
24223607
16126205
18164816
17013925
21687671
23747829
13666847
19657024
9831256
1613547
18726914
19846715
20813326
18374335
12657695",Surprising origins of sex differences in the brain.,"This article is part of a Special Issue ""SBN 2014"". Discerning the biologic origins of neuroanatomical sex differences has been of interest since they were first reported in the late 60's and early 70's. The centrality of gonadal hormone exposure during a developmental critical window cannot be denied but hormones are indirect agents of change, acting to induce gene transcription or modulate membrane bound signaling cascades. Sex differences in the brain include regional volume differences due to differential cell death, neuronal and glial genesis, dendritic branching and synaptic patterning. Early emphasis on mechanism therefore focused on neurotransmitters and neural growth factors, but by and large these endpoints failed to explain the origins of neural sex differences. More recently evidence has accumulated in favor of inflammatory mediators and immune cells as principle regulators of brain sexual differentiation and reveal that the establishment of dimorphic circuits is not cell autonomous but instead requires extensive cell-to-cell communication including cells of non-neuronal origin. Despite the multiplicity of cells involved the nature of the sex differences in the neuroanatomical endpoints suggests canalization, a process that explains the robustness of individuals in the face of intrinsic and extrinsic variability. We propose that some neuroanatomical endpoints are canalized to enhance sex differences in the brain by reducing variability within one sex while also preventing the sexes from diverging too greatly. We further propose mechanisms by which such canalization could occur and discuss what relevance this may have to sex differences in behavior.","['Estradiol', 'Microglia', 'Preoptic area', 'Prostaglandins', 'Sex differences']",Hormones and behavior,2015-04-29,"[{'lastname': 'McCarthy', 'firstname': 'Margaret M', 'initials': 'MM', 'affiliation': 'Department of Pharmacology, Program in Neuroscience and Program in Molecular Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA. Electronic address: mmccarth@umaryland.edu.'}, {'lastname': 'Pickett', 'firstname': 'Lindsay A', 'initials': 'LA', 'affiliation': 'Department of Pharmacology, Program in Neuroscience and Program in Molecular Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.'}, {'lastname': 'VanRyzin', 'firstname': 'Jonathan W', 'initials': 'JW', 'affiliation': 'Department of Pharmacology, Program in Neuroscience and Program in Molecular Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.'}, {'lastname': 'Kight', 'firstname': 'Katherine E', 'initials': 'KE', 'affiliation': 'Department of Pharmacology, Program in Neuroscience and Program in Molecular Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.'}]",,,,Copyright © 2015 Elsevier Inc. All rights reserved.,10.1016/j.yhbeh.2015.04.013,<Element 'PubmedArticle' at 0x7f05da0a6450>
498,25917763,Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies.,"Anandamide (AEA) is an endocannabinoid (EC) that modulates multiple functions in the CNS and that is released in areas of injury, exerting putative neuroprotective actions. In the present study, we have used intravital microscopy to analyze the role of the EC system in the glial response against an acute insult. Our data show that AEA modulates astroglial function in vivo by increasing connexin-43 hemichannel (HC) activity. Furthermore, the genetic inactivation of the AEA-degrading enzyme, fatty acid amide hydrolase (FAAH), also increased HC activity and enhanced the microglial response against an acute injury to the brain parenchyma, effects that were mediated by cannabinoid CB1 receptors. The contribution of ATP released through an astrocytic HC was critical for the microglial response, as this was prevented by the use of the HC blocker flufenamic acid and by apyrase. As could be expected, brain concentrations of AEA, palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) were elevated in FAAH-null mice, while 2-arachidonoylglycerol (2-AG) concentrations remained unaltered. In summary, these findings demonstrate that AEA modifies glial functions by promoting an enhanced pro-inflammatory glial response in the brain.","['Astrocytes', 'Endocannabinoids', 'Hemichannels', 'Microglia', 'Multiphoton microscopy', 'Neuroprotection']",Neurobiology of disease,2015-04-29,"[{'lastname': 'Vázquez', 'firstname': 'Carmen', 'initials': 'C', 'affiliation': 'Laboratorio de Apoyo a la Investigación, Hospital Universitario Fundación Alcorcón, 28922 Alcorcón, Madrid, Spain.'}, {'lastname': 'Tolón', 'firstname': 'Rosa María', 'initials': 'RM', 'affiliation': 'Laboratorio de Apoyo a la Investigación, Hospital Universitario Fundación Alcorcón, 28922 Alcorcón, Madrid, Spain.'}, {'lastname': 'Pazos', 'firstname': 'María Ruth', 'initials': 'MR', 'affiliation': 'Laboratorio de Apoyo a la Investigación, Hospital Universitario Fundación Alcorcón, 28922 Alcorcón, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), 28031 Madrid, Spain.'}, {'lastname': 'Moreno', 'firstname': 'Marta', 'initials': 'M', 'affiliation': 'Laboratorio de Apoyo a la Investigación, Hospital Universitario Fundación Alcorcón, 28922 Alcorcón, Madrid, Spain.'}, {'lastname': 'Koester', 'firstname': 'Erin C', 'initials': 'EC', 'affiliation': 'Neuroscience Research Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA.'}, {'lastname': 'Cravatt', 'firstname': 'Benjamin F', 'initials': 'BF', 'affiliation': 'The Skaggs Institute for Chemical Biology and Department of Chemical Physiology, The Scripps Research Institute, La Jolla, CA, 92037, USA.'}, {'lastname': 'Hillard', 'firstname': 'Cecilia J', 'initials': 'CJ', 'affiliation': 'Neuroscience Research Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA.'}, {'lastname': 'Romero', 'firstname': 'Julián', 'initials': 'J', 'affiliation': 'Laboratorio de Apoyo a la Investigación, Hospital Universitario Fundación Alcorcón, 28922 Alcorcón, Madrid, Spain; School of Biosciences, Universidad Francisco de Vitoria, Pozuelo de Alarcón, 28223 Madrid, Spain. Electronic address: jromerop@fhalcorcon.es.'}]",,,,Copyright © 2015 Elsevier Inc. All rights reserved.,10.1016/j.nbd.2015.04.005,<Element 'PubmedArticle' at 0x7f05da0d5720>
499,"25914169
16216776
8647116
11408610
11789671
16672367
15044630
9152411
19655259
18848818
7544292
9108078
16343349
12509806
23630338
22007767
21735070
12944505
17965659
17115040
10696146
15974991
12379904
12379903
24038453
21527731
16844083
23892791
19910459
18837048
20206681
19804829
20346144
17982478
19053059
11890697
19029990
17765871
22837040
21079038
10594923
12892049
19476641
17876302
20468046
11175805
8469420
23331000
8301141
10027878
12598628
9760220",Alkylindole-sensitive receptors modulate microglial cell migration and proliferation.,"Ligands targeting G protein-coupled receptors (GPCR) expressed by microglia have been shown to regulate distinct components of their activation process, including cell proliferation, migration and differentiation into M1 or M2 phenotypes. Cannabinoids, including the active component of the Cannabis plant, tetrahydrocannabinol (THC), and the synthetic alkylindole (AI) compound, WIN55212-2 (WIN-2), activate two molecularly identified GPCRs: CB1 and CB2 . Previous studies reported that WIN-2 activates an additional unknown GPCR that is not activated by plant-derived cannabinoids, and evidence indicates that microglia express these receptors. Detailed studies on the role of AI-sensitive receptors in microglial cell activation were difficult as no selective pharmacological tools were available. Here, three newly-developed AI analogues allowed us to determine if microglia express AI-sensitive receptors and if so, study how they regulate the microglial cell activation process. We found that mouse microglia in primary culture express functional AI-sensitive receptors as measured by radioligand binding and changes in intracellular cAMP levels, and that these receptors control both basal and ATP-stimulated migration. AI analogues inhibit cell proliferation stimulated by macrophage-colony stimulating factor (M-CSF) without affecting basal cell proliferation. Remarkably, AI analogues do not control the expression of effector proteins characteristic of M1 or M2 phenotypes; yet activating microglia with M1 and M2 cytokines reduces the microglial response to AI analogues. Our results suggest that microglia express functional AI-sensitive receptors that control select components of their activation process. Agonists of these novel targets might represent a novel class of therapeutics to influence the microglial cell activation process.","['GPCR', 'cannabinoid', 'cell migration and cell proliferation', 'microglia']",Glia,2015-04-29,"[{'lastname': 'Fung', 'firstname': 'Susan', 'initials': 'S', 'affiliation': 'Department of Pharmacology, University of Washington, 1959 NE Pacific Way, Seattle, Washington.\nGraduate Program in Neurobiology and Behavior, University of Washington, 1959 NE Pacific St., Seattle, Washington.'}, {'lastname': 'Cherry', 'firstname': 'Allison E', 'initials': 'AE', 'affiliation': 'Department of Pharmacology, University of Washington, 1959 NE Pacific Way, Seattle, Washington.'}, {'lastname': 'Xu', 'firstname': 'Cong', 'initials': 'C', 'affiliation': 'Department of Pharmacology, University of Washington, 1959 NE Pacific Way, Seattle, Washington.'}, {'lastname': 'Stella', 'firstname': 'Nephi', 'initials': 'N', 'affiliation': 'Department of Pharmacology, University of Washington, 1959 NE Pacific Way, Seattle, Washington.\nGraduate Program in Neurobiology and Behavior, University of Washington, 1959 NE Pacific St., Seattle, Washington.\nDepartment of Psychiatry and Behavioral Sciences, University of Washington, 1959 NE Pacific Way, Seattle, Washington.'}]",,,,"© 2015 Wiley Periodicals, Inc.","10.1002/glia.22845
10.1038/nn.3161",<Element 'PubmedArticle' at 0x7f05da0688b0>
